-DOCSTART - (8701013)

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
medical	ADJ	O	O
microbiology	NOUN	O	O

However,	ADV	O	O
there	PRON	O	O
are	VERB	O	O
few	ADJ	O	O
and	CCONJ	O	O
limited	VERB	O	O
clinical	ADJ	O	O
studies.	NOUN	O	O
(	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

No	DET	O	O
significant	ADJ	O	O
changes	NOUN	O	O
in	ADP	O	O
HIV	NOUN	O	B-outcome
viral	ADJ	O	I-outcome
load	NOUN	O	I-outcome
,	PUNCT	O	O
CD4(+)	NOUN	O	B-outcome
or	CCONJ	O	Seperator
CD8(+)	NOUN	O	B-outcome
T	NOUN	O	I-outcome
cell	NOUN	O	I-outcome
counts	NOUN	O	E3-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
(BMI)	PUNCT	O	I-outcome
or	CCONJ	O	O
middle-upper-arm	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
(MUAC)	NUM	O	I-outcome
could	VERB	O	O
be	VERB	O	O
detected.	NOUN	O	O

One	NUM	O	O
hundred	NUM	O	O
eighty-five	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
this	DET	O	O
single-center,	NOUN	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
open-label	NOUN	O	O
study.	NOUN	O	O

Future	NOUN	O	O
studies	NOUN	O	O
are	VERB	O	O
still	ADV	O	O
needed	VERB	O	O
to	PART	O	O
warrant	ADJ	O	O
these	DET	O	O
results.	NOUN	O	O

A	DET	O	O
number	NOUN	O	O
was	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
each	DET	O	O
eye	NOUN	O	O
drop,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
volunteer	NOUN	O	O
was	VERB	O	O
asked	VERB	O	O
to	PART	O	O
identify	NOUN	O	O
it	PRON	O	O
by	ADP	O	O
color.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/20	ADJ	O	O
00:00	NOUN	O	O
[revised]	PUNCT	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
320	NUM	O	O
treatment-naive	ADJ	O	O
HBeAg-positive	ADJ	O	O
CHB	NOUN	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
randomly	ADV	O	O
a	DET	O	O
single	ADJ	O	O
regimen	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
entecavir	NOUN	O	O
capsule	NOUN	O	O
(ETV)	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
160)	NOUN	O	O
or	CCONJ	O	O
tenofovir	NOUN	O	O
disoproxil	NOUN	O	O
fumarate	NOUN	O	O
capsule	NOUN	O	O
(TDF)	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
160)	NOUN	O	O
for	ADP	O	O
144	NUM	O	O
weeks	NOUN	O	O
were	VERB	O	O
consecutively	ADV	O	O
enrolled	VERB	O	O
from	ADP	O	O
14	NUM	O	O
tertiary	ADJ	O	O
hospitals	NOUN	O	O
or	CCONJ	O	O
university	NOUN	O	O
hospitals	NOUN	O	O
in	ADP	O	O
China	NOUN	O	O
between	ADP	O	O
January	NOUN	O	O
2012	NUM	O	O
and	CCONJ	O	O
December	NOUN	O	O
2014.	NUM	O	O

Overall,	NOUN	O	O
the	DET	O	O
103	NUM	O	O
enrolled	VERB	O	O
participants	NOUN	O	O
were	VERB	O	O
>/=85th	NOUN	O	O
percentile	ADJ	O	O
of	ADP	O	O
age	NOUN	O	O
and	CCONJ	O	O
sex-specific	ADJ	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
(BMI).	PUNCT	O	O

Findings	NOUN	O	O
reveal	VERB	O	O
that	ADP	O	O
respondents	NOUN	O	O
(N	PUNCT	O	O
=	SYM	O	O
205)	NOUN	O	O
are	VERB	O	O
not	ADV	O	O
averse	ADJ	O	B-outcome
to	PART	O	I-outcome
bitter	NOUN	O	I-outcome
taste	NOUN	O	I-outcome
;	PUNCT	O	O
while,	NOUN	O	O
socio-demographic	ADJ	O	O
traits	NOUN	O	O
influence	NOUN	O	O
bitter	NOUN	O	B-outcome
acceptance	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
higher	ADJ	O	O
education	NOUN	O	O
level	NOUN	O	O
and	CCONJ	O	O
gender	NOUN	O	O
(female)	NOUN	O	O
positively	ADV	O	O
affect	NOUN	O	O
preferences	NOUN	O	B-outcome
,	PUNCT	O	O
together	ADV	O	O
with	ADP	O	O
specific	ADJ	O	O
individual	ADJ	O	O
characteristics	NOUN	O	O
as	ADP	O	O
high	ADJ	O	O
compensatory	ADJ	O	O
health	NOUN	O	O
beliefs.	NOUN	O	O

Journal-Name:Pediatric	ADJ	O	O
physical	ADJ	O	O
therapy	NOUN	O	O
:	PUNCT	O	O
the	DET	O	O
official	ADJ	O	O
publication	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Section	NOUN	O	O
on	ADP	O	O
Pediatrics	NOUN	O	O
of	ADP	O	O
the	DET	O	O
American	ADJ	O	O
Physical	ADJ	O	O
Therapy	NOUN	O	O
Association	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/17	NOUN	O	O
06:00'	NUM	O	O

In	ADP	O	O
Study	NOUN	O	O
1,	NOUN	O	O
this	DET	O	O
effect	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
end-of-day	NOUN	O	B-outcome
positive	ADJ	O	I-outcome
affect	NOUN	O	I-outcome
.	PUNCT	O	O
In	ADP	O	O
Study	NOUN	O	O
2,	NOUN	O	O
this	DET	O	O
effect	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
end-of-day	NOUN	O	B-outcome
and	CCONJ	O	Seperator
momentary	ADJ	O	B-outcome
positive	ADJ	O	I-outcome
affect	NOUN	O	E2-outcome
outcomes.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/19	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Method:Ninety	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
and	CCONJ	O	O
severe	ADJ	O	O
OSA	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
negative	ADJ	O	O
emotions	NOUN	O	O
diagnosed	VERB	O	O
by	ADP	O	O
PSG,	NOUN	O	O
self-rating	VERB	O	O
depression	NOUN	O	O
scale	NOUN	O	O
(SDS)	PUNCT	O	O
and	CCONJ	O	O
self-rating	VERB	O	O
anxiety	NOUN	O	O
scale	NOUN	O	O
SAS	NUM	O	O
were	VERB	O	O
selected	VERB	O	O
from	ADP	O	O
the	DET	O	O
respiratory	ADJ	O	O
department	NOUN	O	O
of	ADP	O	O
our	ADJ	O	O
hospital	NOUN	O	O
from	ADP	O	O
February	ADJ	O	O
2015	NUM	O	O
to	PART	O	O
February	ADJ	O	O
2018.	NUM	O	O

Title:	NOUN	O	O
[Efficacy	NOUN	O	O
of	ADP	O	O
fluvoxamine	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
extended-release	NOUN	O	O
methylphenidate	NOUN	O	O
on	ADP	O	O
treatment-refractory	NOUN	O	O
obsessive-compulsive	ADJ	O	O
disorder].	NOUN	O	O

Findings	NOUN	O	O
remained	VERB	O	O
consistent	ADJ	O	O
after	ADP	O	O
adjustment	NOUN	O	O
for	ADP	O	O
confounders	NOUN	O	O
and/or	CCONJ	O	O
in	ADP	O	O
a	DET	O	O
sensitivity	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
radiologically	ADV	O	O
confirmed	VERB	O	O
CAP	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
1604,	NUM	O	O
76.1%).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Hemodynamic	ADJ	O	B-outcome
variables	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
and	CCONJ	O	O
blood	NOUN	O	O
samples	NOUN	O	O
were	VERB	O	O
drawn	VERB	O	O
before	ADP	O	O
induction	NOUN	O	O
and	CCONJ	O	O
for	ADP	O	O
15	NUM	O	O
minutes	NOUN	O	O
afterwards.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal-Name:The	ADJ	O	O
American	ADJ	O	O
surgeon	NOUN	O	O

Material	ADJ	O	O
and	CCONJ	O	O
methods:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
longitudinal	ADJ	O	O
and	CCONJ	O	O
prospective	ADJ	O	O
clinical	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
conducted.	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
experimental	ADJ	O	O
(n=25)	PUNCT	O	O
and	CCONJ	O	O
control	NOUN	O	O
(n=25)	PUNCT	O	O
groups.	NOUN	O	O

METHODS:	NOUN	O	O
Patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
referred	VERB	O	O
to	PART	O	O
Veterans	NOUN	O	O
Affairs	NOUN	O	O
(VA)	NOUN	O	O
gastroenterology	NOUN	O	O
clinics	NOUN	O	O
for	ADP	O	O
PPI-refractory	ADJ	O	O
heartburn	ADP	O	O
received	VERB	O	O
20	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
omeprazole	NOUN	O	O
twice	ADV	O	O
daily	ADJ	O	O
for	ADP	O	O
2	NUM	O	O
weeks,	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
with	ADP	O	O
persistent	ADJ	O	O
heartburn	ADP	O	O
underwent	VERB	O	O
endoscopy,	ADP	O	O
esophageal	ADJ	O	O
biopsy,	ADP	O	O
esophageal	ADJ	O	O
manometry,	NOUN	O	O
and	CCONJ	O	O
multichannel	NOUN	O	O
intraluminal	ADJ	O	O
impedance-pH	NOUN	O	O
monitoring.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

The	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
SPOC	NOUN	O	O
scores	NOUN	O	O
to	PART	O	O
an	DET	O	O
adjusted	VERB	O	O
regression	NOUN	O	O
model	NOUN	O	O
to	PART	O	O
predict	VERB	O	O
persistent	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
improved	VERB	O	O
the	DET	O	O
concordance	NOUN	O	O
statistic	ADJ	O	O
from	ADP	O	O
0.66	NUM	O	O
to	PART	O	O
0.74,	NOUN	O	O
and	CCONJ	O	O
found	VERB	O	O
the	DET	O	O
greatest	ADV	O	O
risk	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
high	ADJ	O	O
(>/=74)	PUNCT	O	O
SPOC	NOUN	O	O
scores	NOUN	O	O
[odds	NOUN	O	O
ratio:	NOUN	O	O
5.63;	NOUN	O	O
99%	ADV	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
(CI):	NOUN	O	O
3.59-8.84;	NOUN	O	O
absolute	ADJ	O	O
risk	NOUN	O	O
increase	NOUN	O	O
40.6%;	ADJ	O	O
99%	ADV	O	O
CI:	NOUN	O	O
30.8%,	NUM	O	O
48.6%].	NOUN	O	O
Thirty-eight	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
(484	PUNCT	O	O
of	ADP	O	O
1277)	ADP	O	O
reported	VERB	O	O
moderate	ADJ	O	O
to	PART	O	O
extreme	NOUN	O	O
pain	NOUN	O	B-outcome
interference	NOUN	O	I-outcome
at	ADP	O	O
1	NUM	O	O
yr.	PUNCT	O	O

Title:	NOUN	O	O
Mindfulness	ADV	O	O
mechanisms	NOUN	O	O
and	CCONJ	O	O
psychological	ADJ	O	B-outcome
effects	NOUN	O	O
for	ADP	O	O
aMCI	NOUN	O	O
patients:	NOUN	O	O
A	DET	O	O
comparison	NOUN	O	O
with	ADP	O	O
psychoeducation.	ADV	O	O

Randomisation	NOUN	O	O
was	VERB	O	O
stratified	VERB	O	O
according	ADJ	O	O
to	PART	O	O
centre	NOUN	O	O
and	CCONJ	O	O
disease	NOUN	O	O
risk.	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
MRSA	NOUN	O	B-outcome
infection	NOUN	O	I-outcome
determined	VERB	O	O
on	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
clinical	ADJ	O	O
judgment,	NOUN	O	O
infection	NOUN	O	O
from	ADP	O	O
any	DET	O	O
cause,	NOUN	O	O
and	CCONJ	O	O
infection-related	VERB	O	O
hospitalization.	NOUN	O	O

Patients	NOUN	O	O
received	VERB	O	O
concomitant	ADJ	O	O
palonosetron	NOUN	O	O
(0.75	NUM	O	O
mg	NOUN	O	O
intravenously	ADV	O	O
[i.v.]	PUNCT	O	O

Preoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
celecoxib	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
post	ADV	O	O
operation;	NOUN	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
celecoxib	NOUN	O	O
post	ADV	O	O
operation,	NOUN	O	O
all	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
TKA	NOUN	O	O
and	CCONJ	O	O
intravenous	ADJ	O	O
patient-controlled	VERB	O	O
analgesia	NOUN	O	O
(PCA)	PUNCT	O	O
post	ADV	O	O
operation.	ADV	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
full-term	NOUN	O	B-outcome
(>/=37	NOUN	O	X
weeks'	ADP	O	X
gestational	ADJ	O	X
age)	NOUN	O	X
livebirth	ADJ	O	I-outcome
,	PUNCT	O	O
which	ADP	O	O
was	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
all	DET	O	O
eligible	ADJ	O	O
couples	NOUN	O	O
who	ADP	O	O
completed	VERB	O	O
follow-up.	PUNCT	O	O

To	PART	O	O
objectify	NOUN	O	O
the	DET	O	O
treatment	NOUN	O	O
outcomes	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
treatment,	NOUN	O	O
we	PRON	O	O
measured	VERB	O	O
myostatin	NOUN	O	O
concentration	NOUN	O	O
and	CCONJ	O	O
performed	VERB	O	O
the	DET	O	O
urinary	ADJ	O	B-outcome
incontinence	NOUN	O	I-outcome
severity	NOUN	O	I-outcome
assessment	NOUN	O	O
(	NOUN	O	O
The	DET	O	O
Revised	VERB	O	O
Urinary	ADJ	O	B-outcome
Incontinence	NOUN	O	I-outcome
Scale]),	NOUN	O	O
perceived	VERB	O	O
self-efficacy	NOUN	O	B-outcome
assessment	NOUN	O	O
(General	ADJ	O	O
Self-Efficacy	NOUN	O	B-outcome
Scale),	NOUN	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
severity	NOUN	O	O
assessment	NOUN	O	O
(	NOUN	O	O
Beck	NOUN	O	O
Depression	NOUN	O	B-outcome
Inventory]).	ADJ	O	O

In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
we	PRON	O	O
compared	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
no	DET	O	O
NMBD	NOUN	O	O
and	CCONJ	O	O
continuous	ADJ	O	O
rocuronium	NOUN	O	O
infusion	NOUN	O	O
on	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
patient	NOUN	O	O
involuntary	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
and	CCONJ	O	O
motor	NOUN	O	B-outcome
evoked	VERB	O	I-outcome
potential	ADJ	O	I-outcome
(MEP)	PUNCT	O	I-outcome
monitoring.	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
radiation-induced	VERB	O	O
complications	NOUN	O	B-outcome
was	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
these	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
effects	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
anesthesia	NOUN	O	O
methods	NOUN	O	O
on	ADP	O	O
the	DET	O	O
first	ADV	O	O
night	NOUN	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
in	ADP	O	O
middle-aged	NOUN	O	O
and	CCONJ	O	O
elderly	NOUN	O	O
patients	NOUN	O	O
after	ADP	O	O
surgery.	VERB	O	O

CONCLUSION:	NOUN	O	O
Preoperative	ADJ	O	O
low-dose	NOUN	O	O
MDCT	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
used	VERB	O	O
for	ADP	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
uncontrolled	VERB	O	O
chronic	ADJ	O	O
rhinosinusitis	NOUN	O	O
for	ADP	O	O
decision	NOUN	O	O
making	VERB	O	O
of	ADP	O	O
sinus	NOUN	O	O
surgeries.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

As	ADP	O	O
well	ADV	O	O
as	ADP	O	O
having	VERB	O	O
important	ADJ	O	O
development	NOUN	O	O
benefits,	NOUN	O	O
interventions	NOUN	O	O
that	ADP	O	O
address	NOUN	O	O
the	DET	O	O
upstream	ADJ	O	O
structural	ADJ	O	O
and	CCONJ	O	O
gender-norms	NOUN	O	O
based	VERB	O	O
determinants	NOUN	O	O
of	ADP	O	O
poor	ADJ	O	O
mental	ADJ	O	O
health,	NOUN	O	O
and	CCONJ	O	O
provide	VERB	O	O
adolescent	NOUN	O	O
services	NOUN	O	O
for	ADP	O	O
girls	NOUN	O	O
who	ADP	O	O
require	VERB	O	O
treatment	NOUN	O	O
and	CCONJ	O	O
support,	NOUN	O	O
should	VERB	O	O
have	VERB	O	O
important	ADJ	O	O
benefits	NOUN	O	O
for	ADP	O	O
girls'	NOUN	O	O
psychological	ADJ	O	O
wellbeing.	NOUN	O	O

Overweight	NOUN	O	O
and	CCONJ	O	O
obesity	NOUN	O	O
are	VERB	O	O
a	DET	O	O
global	ADJ	O	O
concern.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
an	DET	O	O
early	ADJ	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
at	ADP	O	O
48	NUM	O	O
to	PART	O	O
72	NUM	O	O
hours,	NOUN	O	O
defined	VERB	O	O
as	ADP	O	O
survival	NOUN	O	B-outcome
with	ADP	O	O
a	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
lesion	NOUN	O	B-outcome
size	NOUN	O	I-outcome
of	ADP	O	O
at	ADP	O	O
least	ADV	O	O
20%	NUM	O	O
without	ADP	O	O
rescue	NOUN	O	B-outcome
antibacterial	ADJ	O	I-outcome
therapy	NOUN	O	I-outcome
.	PUNCT	O	O
A	DET	O	O
secondary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
an	DET	O	O
investigator-assessed	VERB	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
at	ADP	O	O
the	DET	O	O
post-treatment	NOUN	O	O
evaluation	NOUN	O	O
7	NUM	O	O
to	PART	O	O
14	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
the	DET	O	O
last	NOUN	O	O
dose,	NOUN	O	O
with	ADP	O	O
clinical	ADJ	O	O
response	NOUN	O	O
defined	VERB	O	O
as	ADP	O	O
survival	NOUN	O	B-outcome
with	ADP	O	O
resolution	NOUN	O	O
or	CCONJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
signs	NOUN	O	B-outcome
or	CCONJ	O	Seperator
symptoms	NOUN	O	I-outcome
of	ADP	O	I-outcome
infection	NOUN	O	I-outcome
to	PART	O	O
the	DET	O	O
extent	NOUN	O	O
that	ADP	O	O
further	ADV	O	O
antibacterial	ADJ	O	O
therapy	NOUN	O	O
was	VERB	O	O
unnecessary.	VERB	O	O

Participants	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
from	ADP	O	O
the	DET	O	O
Institute	NOUN	O	O
of	ADP	O	O
Dentistry,	PUNCT	O	O
Barts	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
London	PROPN	O	O
School	NOUN	O	O
of	ADP	O	O
Medicine	NOUN	O	O
and	CCONJ	O	O
Dentistry,	PUNCT	O	O
London,	NOUN	O	O
United	VERB	O	O
Kingdom,	NOUN	O	O
and	CCONJ	O	O
recalled	VERB	O	O
at	ADP	O	O
6-	NUM	O	O
to	PART	O	O
8-week	NOUN	O	O
intervals.	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
Corneal	ADJ	O	O
Epithelial	ADJ	O	O
Remodeling	VERB	O	O
Over	ADP	O	O
2	NUM	O	O
Years	NOUN	O	O
in	ADP	O	O
LASIK	NOUN	O	O
Versus	CCONJ	O	O
SMILE:	NOUN	O	O
A	DET	O	O
Contralateral	ADJ	O	O
Eye	NOUN	O	O
Study.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

The	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
inhaled	VERB	O	O
2%	NUM	O	O
lavender	NOUN	O	O
essential	ADJ	O	O
oil	NOUN	O	O
every	DET	O	O
night	NOUN	O	O
before	ADP	O	O
bedtime	NOUN	O	O
for	ADP	O	O
20	NUM	O	O
minutes	NOUN	O	O
during	ADP	O	O
one	NUM	O	O
month.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
assessed	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
equivalent	ADJ	O	O
weight	NOUN	O	O
loss	NOUN	O	O
with	ADP	O	O
or	CCONJ	O	O
without	ADP	O	O
exercise	NOUN	O	O
on	ADP	O	O
(intra-)	NOUN	O	O
abdominal	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
in	ADP	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
in	ADP	O	O
the	DET	O	O
SHAPE-2	NOUN	O	O
study.	NOUN	O	O

Conclusion:	NOUN	O	O
Children	NOUN	O	O
with	ADP	O	O
HIV	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
to	PART	O	O
have	VERB	O	O
the	DET	O	O
most	DET	O	O
difficulty	NOUN	O	O
on	ADP	O	O
Test	NOUN	O	O
of	ADP	O	O
Playfulness	ADV	O	B-outcome
(ToP)	ADV	O	O
items	NOUN	O	O
relating	VERB	O	O
to	PART	O	O
the	DET	O	O
play	VERB	O	B-outcome
elements	NOUN	O	O
of	ADP	O	O
internal	ADJ	O	B-outcome
control	NOUN	O	I-outcome
and	CCONJ	O	O
freedom	NOUN	O	B-outcome
from	ADP	O	I-outcome
constraints	NOUN	O	I-outcome
of	ADP	O	I-outcome
reality	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
PICIHBI	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
improve	VERB	O	O
children's	NOUN	O	O
play	VERB	O	B-outcome
and	CCONJ	O	O
was	VERB	O	O
not	ADV	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
the	DET	O	O
conventional	ADJ	O	O
intervention.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985213R	NOUN	O	O

Independent	ADJ	O	O
research	NOUN	O	O
on	ADP	O	O
the	DET	O	O
experiences	NOUN	O	O
and	CCONJ	O	O
behavioral	ADJ	O	O
aspects	NOUN	O	O
of	ADP	O	O
using	VERB	O	O
IQOS(TM),	NUM	O	O
and	CCONJ	O	O
how	ADP	O	O
it	PRON	O	O
compares	NOUN	O	O
to	PART	O	O
e-cigarettes,	NOUN	O	O
is	VERB	O	O
largely	ADV	O	O
lacking.	NOUN	O	O

No	DET	O	O
patients	NOUN	O	O
experienced	VERB	O	O
a	DET	O	O
deterioration	NOUN	O	O
in	ADP	O	O
disease	NOUN	O	B-outcome
activity	NOUN	O	I-outcome
scores	NOUN	O	O
during	ADP	O	O
the	DET	O	O
exercise	NOUN	O	O
intervention.	NOUN	O	O

Title:	NOUN	O	O
Does	VERB	O	O
nifedipine	NOUN	O	O
improve	VERB	O	O
outcomes	NOUN	O	O
of	ADP	O	O
embryo	NOUN	O	O
transfer?:	NOUN	O	O

CONCLUSION:	NOUN	O	O
We	PRON	O	O
conclude	NOUN	O	O
that	ADP	O	O
yoga	NOUN	O	O
has	VERB	O	O
strong	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
depression	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
and	CCONJ	O	O
blood	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
therefore	ADV	O	O
it	PRON	O	O
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
as	ADP	O	O
a	DET	O	O
complementary	ADJ	O	O
or	CCONJ	O	O
alternative	ADJ	O	O
remedy	NOUN	O	O
for	ADP	O	O
PMS	NOUN	O	O
patients.	NOUN	O	O

The	DET	O	O
children	NOUN	O	O
in	ADP	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
the	DET	O	O
traditional	ADJ	O	O
symptomatic	ADJ	O	O
supportive	ADJ	O	O
treatment,	NOUN	O	O
supplemented	VERB	O	O
by	ADP	O	O
drugs	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
nerve	NOUN	O	O
cell	NOUN	O	O
growth.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Acute	ADJ	O	O
consumption	NOUN	O	O
of	ADP	O	O
RS	NOUN	O	O
at	ADP	O	O
breakfast/lunch	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
the	DET	O	O
energy	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
at	ADP	O	O
the	DET	O	O
ad	NOUN	O	O
libitum	ADV	O	O
dinner	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.017).	NUM	O	O

Participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
four	NUM	O	O
infusions	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
zoledronate	ADJ	O	O
at	ADP	O	O
a	DET	O	O
dose	NOUN	O	O
of	ADP	O	O
5	NUM	O	O
mg	NOUN	O	O
(zoledronate	NUM	O	O
group)	ADJ	O	O
or	CCONJ	O	O
normal	ADJ	O	O
saline	NOUN	O	O
(placebo	PUNCT	O	O
group)	ADJ	O	O
at	ADP	O	O
18-month	NOUN	O	O
intervals.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/25	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Small	ADJ	O	O
bowel	NOUN	O	O
capsule	NOUN	O	O
endoscopy	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
2	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
low-dose	NOUN	O	O
aspirin	NOUN	O	O
administration.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/24	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
mean	NOUN	O	O
time	NOUN	O	B-outcome
required	VERB	O	I-outcome
to	PART	O	I-outcome
complete	ADJ	O	I-outcome
test-1	NOUN	O	I-outcome
was	VERB	O	O
84.6	NUM	O	O
+/-	SYM	O	O
26.6	NUM	O	O
seconds	NOUN	O	O
in	ADP	O	O
training	VERB	O	O
group	NOUN	O	O
and	CCONJ	O	O
90.7	NUM	O	O
+/-	SYM	O	O
43.9	NUM	O	O
seconds	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
-34.0	NUM	O	O
to	PART	O	O
21.7;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.653);	PUNCT	O	O
in	ADP	O	O
test-2,	NOUN	O	O
the	DET	O	O
time	NOUN	O	B-outcome
required	VERB	O	O
was	VERB	O	O
56.6	NUM	O	O
+/-	SYM	O	O
27.9	NUM	O	O
and	CCONJ	O	O
91.2	NUM	O	O
+/-	SYM	O	O
43.8	NUM	O	O
seconds	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
-63.0	NUM	O	O
to	PART	O	O
-6.2;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.019),	PUNCT	O	O
respectively.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
three	NUM	O	O
non-serious	ADJ	O	O
exercise-related	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
two	NUM	O	O
exercise	NOUN	O	O
participants	NOUN	O	O
experienced	VERB	O	O
disease	NOUN	O	B-outcome
relapse	NOUN	O	I-outcome
during	ADP	O	O
follow-up.	PUNCT	O	O

Secondary	ADJ	O	O
endpoints	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
estimating	VERB	O	O
serum	NOUN	O	O
aspartate	NOUN	O	B-outcome
aminotransferase	NOUN	O	I-outcome
(AST)	NOUN	O	I-outcome
,	PUNCT	O	O
alanine	NOUN	O	B-outcome
aminotransferase	NOUN	O	I-outcome
(ALT)	PUNCT	O	I-outcome
and	CCONJ	O	O
creatine	NOUN	O	B-outcome
kinase	NOUN	O	I-outcome
MM	NOUN	O	I-outcome
(CK-MM)	PUNCT	O	I-outcome
levels	NOUN	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
drug	NOUN	O	I-outcome
reactions	NOUN	O	I-outcome
(ADRs)	NUM	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
61	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
of	ADP	O	O
which	ADP	O	O
46	NUM	O	O
completed	VERB	O	O
the	DET	O	O
study	NOUN	O	O
(24	NOUN	O	O
in	ADP	O	O
DR	NOUN	O	O
vs	CCONJ	O	O
22	NUM	O	O
in	ADP	O	O
EODR	NOUN	O	O
group).	NOUN	O	O

CONCLUSION:	NOUN	O	O
Compared	VERB	O	O
with	ADP	O	O
AGS,	ADV	O	O
SHM	NOUN	O	O
could	VERB	O	O
decrease	NOUN	O	O
the	DET	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
during	ADP	O	O
hemostatic	ADJ	O	O
process	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
postoperative	ADJ	O	O
drainage	NOUN	O	B-outcome
volume	NOUN	O	I-outcome
in	ADP	O	O
posterior	ADJ	O	O
operation	NOUN	O	O
of	ADP	O	O
lumbar	ADJ	O	O
degenerative	ADJ	O	O
disease.	NOUN	O	O

PMID:	NOUN	O	O
31619437	NUM	O	O

By	ADP	O	O
day	NOUN	O	O
28,	NUM	O	O
74	NUM	O	O
patients	NOUN	O	O
(34.9%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
peripheral	ADJ	O	O
perfusion	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
92	NUM	O	O
patients	NOUN	O	O
(43.4%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
lactate	VERB	O	O
group	NOUN	O	O
had	VERB	O	O
died	VERB	O	B-outcome
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.75	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
0.55	NUM	O	O
to	PART	O	O
1.02];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.06;	NOUN	O	O
risk	NOUN	O	O
difference,	NOUN	O	O
-8.5%	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-18.2%	NUM	O	O
to	PART	O	O
1.2%]).	NOUN	O	O

Other	ADJ	O	O
parameters	NOUN	O	O
evaluated	VERB	O	O
were	VERB	O	O
apolipoprotein	NOUN	O	B-outcome
B	NOUN	O	I-outcome
(Apo	NUM	O	I-outcome
B)	NOUN	O	I-outcome
,	PUNCT	O	O
apolipoprotein	NOUN	O	B-outcome
A1	NOUN	O	I-outcome
(Apo	NUM	O	I-outcome
A1)	NOUN	O	I-outcome
,	PUNCT	O	O
Coenzyme	NOUN	O	B-outcome
Q10	NOUN	O	I-outcome
(CoQ10)	PUNCT	O	I-outcome
,	PUNCT	O	O
high-sensitive	ADJ	O	B-outcome
C-reactive	ADJ	O	I-outcome
protein	NOUN	O	I-outcome
(hsCRP)	NOUN	O	I-outcome
,	PUNCT	O	O
fasting	VERB	O	B-outcome
blood	NOUN	O	I-outcome
sugar	NOUN	O	I-outcome
(FBS)	PUNCT	O	I-outcome
,	PUNCT	O	O
homocysteine	NOUN	O	B-outcome
and	CCONJ	O	O
thyroid	NOUN	O	B-outcome
stimulating	VERB	O	I-outcome
hormone	NOUN	O	I-outcome
(TSH)	ADJ	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
In	ADP	O	O
12	NUM	O	O
weeks,	NOUN	O	O
the	DET	O	O
major	ADJ	O	O
lipids	NOUN	O	B-outcome
such	ADJ	O	O
as	ADP	O	O
total	ADJ	O	O
cholesterol	NOUN	O	B-outcome
(TC)	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.0003),	NUM	O	O
triglyceride	NOUN	O	B-outcome
(TG)	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.0003),	NUM	O	O
low	ADJ	O	B-outcome
density	NOUN	O	I-outcome
lipoprotein	NOUN	O	I-outcome
cholesterol	NOUN	O	I-outcome
(LDL-C)	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.0064)	NUM	O	O
and	CCONJ	O	O
very	ADV	O	B-outcome
low	ADJ	O	I-outcome
density	NOUN	O	I-outcome
lipoprotein	NOUN	O	I-outcome
cholesterol	NOUN	O	I-outcome
(VLDL-C)	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.0001)	NUM	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
amla	NOUN	O	O
group	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
placebo	NOUN	O	O
group.	VERB	O	O

No	DET	O	O
additional	ADJ	O	O
significant	ADJ	O	O
benefit	NUM	O	O
could	VERB	O	O
be	VERB	O	O
shown	VERB	O	O
from	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
standard	ADJ	O	O
management.	NOUN	O	O

The	DET	O	O
median	ADJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
69.2	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
no-lymphadenectomy	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
65.5	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
lymphadenectomy	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
for	ADP	O	O
death	NOUN	O	O
in	ADP	O	O
the	DET	O	O
lymphadenectomy	NOUN	O	O
group,	NOUN	O	O
1.06;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.83	NUM	O	O
to	PART	O	O
1.34;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.65),	NUM	O	O
and	CCONJ	O	O
median	ADJ	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
25.5	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
for	ADP	O	O
progression	NOUN	O	O
or	CCONJ	O	O
death	NOUN	O	O
in	ADP	O	O
the	DET	O	O
lymphadenectomy	NOUN	O	O
group,	NOUN	O	O
1.11;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.92	NUM	O	O
to	PART	O	O
1.34;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.29).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8900488	NUM	O	O

In	ADP	O	O
both	CCONJ	O	O
studies,	NOUN	O	O
end-of-day	NOUN	O	B-outcome
and	CCONJ	O	Seperator
momentary	ADJ	O	B-outcome
positive	ADJ	O	I-outcome
affect	NOUN	O	E2-outcome
and	CCONJ	O	O
negative	ADJ	O	B-outcome
affect	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
in	ADP	O	O
daily	ADJ	O	O
life	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
days	NOUN	O	O
pre-	ADJ	O	O
and	CCONJ	O	O
post-intervention	NOUN	O	O
using	VERB	O	O
ambulatory	ADJ	O	O
assessments.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/15	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

PARTICIPANTS:	NOUN	O	O
180	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain,	NOUN	O	O
previous	ADJ	O	O
disc	NOUN	O	O
herniation,	NOUN	O	O
and	CCONJ	O	O
type	NOUN	O	O
1	NUM	O	O
(n=118)	NOUN	O	O
or	CCONJ	O	O
type	NOUN	O	O
2	NUM	O	O
(n=62)	NOUN	O	O
Modic	NOUN	O	O
changes	NOUN	O	O
enrolled	VERB	O	O
from	ADP	O	O
June	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
September	NOUN	O	O
2017.	NUM	O	O

BACKGROUND:	NOUN	O	O
Oscillatory	ADJ	O	O
positive	ADJ	O	O
expiratory	ADJ	O	O
pressure	NOUN	O	O
(OPEP)	PUNCT	O	O
training	VERB	O	O
is	VERB	O	O
a	DET	O	O
kind	NOUN	O	O
of	ADP	O	O
breathing	VERB	O	O
exercise	NOUN	O	O
with	ADP	O	O
Acapella.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/15	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal-Name:The	ADJ	O	O
international	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
behavioral	ADJ	O	O
nutrition	NOUN	O	O
and	CCONJ	O	O
physical	ADJ	O	O
activity	NOUN	O	O

Journal-Name:Taiwanese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
obstetrics	NOUN	O	O
&	CCONJ	O	O
gynecology	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
showed	VERB	O	O
significantly	ADV	O	O
better	ADJ	O	O
treatment	NOUN	O	B-outcome
responses	NOUN	O	I-outcome
than	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.05	NUM	O	O
or	CCONJ	O	O
0.01).	NOUN	O	O

To	PART	O	O
date,	VERB	O	O
methohexital	ADJ	O	O
has	VERB	O	O
not	ADV	O	O
been	VERB	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
most	DET	O	O
commonly	ADV	O	O
used	VERB	O	O
induction	NOUN	O	O
agent,	NOUN	O	O
propofol.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
supraglottic	ADJ	O	O
tracheal	ADJ	O	O
tube	NOUN	O	O
ventilation	NOUN	O	O
by	ADP	O	O
comparing	VERB	O	O
with	ADP	O	O
modified	VERB	O	O
laryngeal	ADJ	O	O
mask	NOUN	O	O
airway	NOUN	O	O
ventilation	NOUN	O	O
during	ADP	O	O
painless	NOUN	O	O
fiberbronchoscopy.	NOUN	O	O

Enrollment	NOUN	O	O
was	VERB	O	O
September	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
April	NOUN	O	O
2018,	NUM	O	O
with	ADP	O	O
follow-up	NOUN	O	O
ending	VERB	O	O
in	ADP	O	O
April	NOUN	O	O
2019.	NUM	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
selective	ADJ	O	O
brain	NOUN	O	O
hypothermia	NOUN	O	O
(SBH)	NUM	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
neonates	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
or	CCONJ	O	O
severe	ADJ	O	O
neonatal	ADJ	O	O
hypoxic-ischemic	ADJ	O	O
encephalopathy	NOUN	O	O
(HIE),	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
on	ADP	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
neuron-specific	ADJ	O	B-outcome
enolase	NOUN	O	I-outcome
(NSE)	NOUN	O	I-outcome
and	CCONJ	O	O
central	ADJ	O	B-outcome
nervous	ADJ	O	I-outcome
specific	ADJ	O	I-outcome
protein	NOUN	O	I-outcome
S100	NOUN	O	I-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
A	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted.	NOUN	O	O

In	ADP	O	O
CLA	NOUN	O	O
group,	NOUN	O	O
93	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
the	DET	O	O
same	ADJ	O	O
regimen	NOUN	O	O
except	ADP	O	O
FZD	NOUN	O	O
was	VERB	O	O
replaced	VERB	O	O
by	ADP	O	O
CLA.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
parallel,	ADV	O	O
two-group,	NOUN	O	O
randomised	VERB	O	O
trial	NOUN	O	O
included	VERB	O	O
couples	NOUN	O	O
undergoing	VERB	O	O
an	DET	O	O
ICSI	NOUN	O	O
procedure	NOUN	O	O
with	ADP	O	O
fresh	ADJ	O	O
embryo	NOUN	O	O
transfer	NOUN	O	O
at	ADP	O	O
16	NUM	O	O
assisted	VERB	O	O
conception	NOUN	O	O
units	NOUN	O	O
in	ADP	O	O
the	DET	O	O
UK.	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
delirium	NOUN	O	B-outcome
duration	NOUN	O	I-outcome
,	PUNCT	O	O
cognitive	ADJ	O	B-outcome
decline	NOUN	O	I-outcome
,	PUNCT	O	O
breakthrough	NOUN	O	O
analgesia	NOUN	O	B-outcome
within	ADP	O	O
the	DET	O	O
first	ADV	O	O
48	NUM	O	O
hours,	NOUN	O	O
and	CCONJ	O	O
ICU	NOUN	O	B-outcome
and	CCONJ	O	Seperator
hospital	NOUN	O	I-outcome
length	NOUN	O	I-outcome
of	ADP	O	I-outcome
stay	NOUN	O	I-outcome
.	PUNCT	O	O
Results:	NOUN	O	O
Among	ADP	O	O
121	NUM	O	O
patients	NOUN	O	O
randomized	VERB	O	O
(median	PUNCT	O	O
age,	NOUN	O	O
69	NUM	O	O
years;	NOUN	O	O
19	NUM	O	O
women	NOUN	O	O
[15.8%]),	ADJ	O	O
120	NUM	O	O
completed	VERB	O	O
the	DET	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Common	ADJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
included	VERB	O	O
nasopharyngitis	NOUN	O	B-outcome
,	PUNCT	O	O
abdominal	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
diarrhea	NOUN	O	B-outcome
.	PUNCT	O	O
Serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
6	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
givosiran	NOUN	O	O
in	ADP	O	O
parts	NOUN	O	O
A	DET	O	O
through	ADP	O	O
C	NOUN	O	O
combined.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
demonstrated	VERB	O	O
that	ADP	O	O
8	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
PrimaVie(R)	NOUN	O	O
Shilajit	ADJ	O	O
supplementation	NOUN	O	O
at	ADP	O	O
500	NUM	O	O
mg.d(-	NOUN	O	O
1)	NUM	O	O
promoted	VERB	O	O
the	DET	O	O
retention	NOUN	O	O
of	ADP	O	O
maximal	ADJ	O	B-outcome
muscular	ADJ	O	I-outcome
strength	NOUN	O	I-outcome
following	VERB	O	O
the	DET	O	O
fatiguing	VERB	O	O
protocol	NOUN	O	O
and	CCONJ	O	O
decreased	VERB	O	O
baseline	NOUN	O	O
HYP.	NOUN	O	O

Two	NUM	O	O
blinded	VERB	O	O
and	CCONJ	O	O
standardized	VERB	O	O
evaluators	NOUN	O	O
assessed	VERB	O	O
the	DET	O	O
radiographic	ADJ	O	O
outcomes.	ADJ	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
recovery	NOUN	O	B-outcome
perceived	VERB	O	O
by	ADP	O	O
the	DET	O	O
patient.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Health	NOUN	O	O
education	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
considered	VERB	O	O
as	ADP	O	O
the	DET	O	O
effectiveness	NOUN	O	O
method	NOUN	O	O
to	PART	O	O
increase	NOUN	O	O
the	DET	O	O
self-care	NOUN	O	O
skills	NOUN	O	O
of	ADP	O	O
diabetes	NOUN	O	O
patients.	NOUN	O	O

Anti-HA	NOUN	O	B-outcome
virus	NOUN	O	I-outcome
(HAV)	PUNCT	O	I-outcome
immunoglobulin	NOUN	O	I-outcome
(Ig)	NUM	O	I-outcome
G	NOUN	O	I-outcome
was	VERB	O	O
measured	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
geometric	ADJ	O	O
mean	NOUN	O	O
concentrations	NOUN	O	O
(GMCs)	ADV	O	O
and	CCONJ	O	O
seropositvity	NOUN	O	O
rates	NOUN	O	O
(>/=20	PUNCT	O	O
mIU/mL	NOUN	O	O
anti-HAV	NOUN	O	O
IgG).	ADP	O	O

Of	ADP	O	O
the	DET	O	O
841	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
randomization,	NOUN	O	O
the	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
occurred	VERB	O	O
in	ADP	O	O
25	NUM	O	O
of	ADP	O	O
420	NUM	O	O
patients	NOUN	O	O
(6.0%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rivaroxaban	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
37	NUM	O	O
of	ADP	O	O
421	NUM	O	O
(8.8%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.66;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.40	NUM	O	O
to	PART	O	O
1.09;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.10)	NUM	O	O
in	ADP	O	O
the	DET	O	O
period	NOUN	O	O
up	ADP	O	O
to	PART	O	O
day	NOUN	O	O
180.	NOUN	O	O

BACKGROUOND:	NOUN	O	O
The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
resting	VERB	O	O
the	DET	O	O
metabolic	ADJ	O	O
response	NOUN	O	O
to	PART	O	O
the	DET	O	O
ingestion	NOUN	O	B-outcome
of	ADP	O	O
a	DET	O	O
complex	NOUN	O	O
containing	VERB	O	O
Citrus	NOUN	O	O
Aurantium	NOUN	O	O
+	SYM	O	O
Caffeine	NOUN	O	O
(CA	NOUN	O	O
+	SYM	O	O
C)	NOUN	O	O
and	CCONJ	O	O
if	ADP	O	O
its	ADJ	O	O
consumption	NOUN	O	O
influences	NOUN	O	O
metabolic	ADJ	O	B-outcome
recovery	NOUN	O	I-outcome
following	VERB	O	O
a	DET	O	O
high-intensity	NOUN	O	O
anaerobic	ADJ	O	O
exercise	NOUN	O	O
bout	NOUN	O	O
in	ADP	O	O
habitual	ADJ	O	O
caffeine	NOUN	O	O
users.	NOUN	O	O

Journal-Name:British	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
anaesthesia	NOUN	O	O

Achaogen,	VERB	O	O
South	NOUN	O	O
San	NOUN	O	O
Francisco,	ADV	O	O
CA.	NOUN	O	O

Journal-Name:Health	ADJ	O	O
and	CCONJ	O	O
quality	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
outcomes	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study	NOUN	O	O

Conclusion:	NOUN	O	O
The	DET	O	O
protocol	NOUN	O	O
for	ADP	O	O
changing	VERB	O	O
the	DET	O	O
attribution	NOUN	O	O
to	PART	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
and	CCONJ	O	O
negative	ADJ	O	O
information	NOUN	O	O
transmission	NOUN	O	O
for	ADP	O	O
risk	NOUN	O	O
behavior	NOUN	O	O
consequences	NOUN	O	O
was	VERB	O	O
proved	VERB	O	O
to	PART	O	O
effectively	ADV	O	O
reduce	VERB	O	O
children's	NOUN	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
risk	NOUN	O	B-outcome
behaviors	NOUN	O	I-outcome
and	CCONJ	O	O
relevant	ADJ	O	O
events.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Finally,	NOUN	O	O
18	NUM	O	O
children	NOUN	O	O
of	ADP	O	O
each	DET	O	O
group	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
analysis.	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
opacity	NOUN	O	B-outcome
on	ADP	O	O
chest	NOUN	O	O
radiography	NOUN	O	O
in	ADP	O	O
the	DET	O	O
48	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
tracheal	ADJ	O	O
intubation	NOUN	O	O
was	VERB	O	O
16.4%	NUM	O	O
and	CCONJ	O	O
14.8%,	NUM	O	O
respectively	ADV	O	O
(P	NUM	O	O
=	SYM	O	O
0.73).	NUM	O	O

Neuromuscular	ADJ	O	O
monitoring	VERB	O	O
is	VERB	O	O
usually	ADV	O	O
used	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
neuromuscular	ADJ	O	O
recovery	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Music	ADJ	O	O
therapy	NOUN	O	O
had	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
and	CCONJ	O	O
positive	ADJ	O	O
impact	NOUN	O	O
on	ADP	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
depression	NOUN	O	B-outcome
,	PUNCT	O	O
acting	VERB	O	O
on	ADP	O	O
prevention	NOUN	O	O
of	ADP	O	O
cardiovascular	ADJ	O	O
diseases,	NOUN	O	O
major	ADJ	O	O
threats	NOUN	O	O
to	PART	O	O
modern	NOUN	O	O
society.	NOUN	O	O

T	NOUN	O	O
Ober	NOUN	O	O
test],	NUM	O	O
the	DET	O	O
Thomas	NOUN	O	O
test],	NUM	O	O
and	CCONJ	O	O
transabdominal	ADJ	O	O
pelvic	ADJ	O	B-outcome
floor	NOUN	O	I-outcome
muscles	NOUN	O	I-outcome
(PFM)	PUNCT	O	I-outcome
ultrasound	NOUN	O	O
measurements	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

30582753_PD.tx	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/09	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
Sham	NOUN	O	O
group,	NOUN	O	O
OSTAP	NOUN	O	O
block	VERB	O	O
reduced	VERB	O	O
the	DET	O	O
VAS	NOUN	O	O
scores	NOUN	O	O
at	ADP	O	O
all	DET	O	O
time	NOUN	O	O
points	NOUN	O	O
during	ADP	O	O
movement.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
components	NOUN	O	O
of	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcome,	ADJ	O	O
confirmed	VERB	O	O
or	CCONJ	O	O
suspected	VERB	O	O
late-onset	NOUN	O	O
sepsis	NOUN	O	B-outcome
,	PUNCT	O	O
necrotizing	VERB	O	B-outcome
enterocolitis	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
cerebral	ADJ	O	B-outcome
palsy	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Among	ADP	O	O
2804	NUM	O	O
infants	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
randomization,	NOUN	O	O
the	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
1224	NUM	O	O
(87.4%)	NUM	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
faster	ADJ	O	O
increment	NOUN	O	O
and	CCONJ	O	O
1246	NUM	O	O
(88.7%)	NUM	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
slower	NOUN	O	O
increment.	NOUN	O	O

Advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
2	NUM	O	O
or	CCONJ	O	O
fewer	ADJ	O	O
metastatic	ADJ	O	O
sites	NOUN	O	O
experienced	VERB	O	O
longer	ADJ	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
than	ADP	O	O
those	DET	O	O
with	ADP	O	O
more	ADV	O	O
than	ADP	O	O
2	NUM	O	O
sites.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
APN	NOUN	O	O
and	CCONJ	O	O
AdipoR1	VERB	O	O
are	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
T2DM	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
T2DM	NOUN	O	O
+	SYM	O	O
MVC	NOUN	O	O
group,	NOUN	O	O
showing	VERB	O	O
lowest	ADV	O	O
value	NOUN	O	O
in	ADP	O	O
T2DM	NOUN	O	O
+	SYM	O	O
MVC	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Success	NOUN	O	O
rate	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	B-outcome
deformity	NOUN	O	I-outcome
correction	NOUN	O	I-outcome
following	VERB	O	O
surgical	ADJ	O	O
procedure	NOUN	O	O
regardless	ADV	O	O
of	ADP	O	O
type	NOUN	O	O
of	ADP	O	O
administered	VERB	O	O
rod	NOUN	O	O
was	VERB	O	O
86.76	NUM	O	O
+/-	SYM	O	O
11.30	NUM	O	O
percent	NOUN	O	O
(62.5-100%).	ADV	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
will	VERB	O	O
include	VERB	O	O
vaccine	NOUN	O	O
hesitation	NOUN	O	B-outcome
and	CCONJ	O	O
intention	NOUN	O	B-outcome
scores,	NOUN	O	O
mother's	NOUN	O	O
knowledge	NOUN	O	B-outcome
,	PUNCT	O	O
attitudes	NOUN	O	B-outcome
and	CCONJ	O	O
beliefs	NOUN	O	B-outcome
about	ADV	O	O
immunization,	NOUN	O	O
and	CCONJ	O	O
psychosocial	ADJ	O	B-outcome
determinants	NOUN	O	O
of	ADP	O	O
intention	NOUN	O	O
to	PART	O	O
vaccinate.	NOUN	O	O

Omadacycline,	NOUN	O	O
an	DET	O	O
aminomethylcycline	NOUN	O	O
antibiotic	ADJ	O	O
that	ADP	O	O
can	VERB	O	O
be	VERB	O	O
administered	VERB	O	O
once	ADP	O	O
daily	ADJ	O	O
either	CCONJ	O	O
orally	ADV	O	O
or	CCONJ	O	O
intravenously,	NOUN	O	O
is	VERB	O	O
active	ADJ	O	O
against	ADP	O	O
pathogens	NOUN	O	O
that	ADP	O	O
commonly	ADV	O	O
cause	ADP	O	O
such	ADJ	O	O
infections,	NOUN	O	O
including	VERB	O	O
antibiotic-resistant	ADJ	O	O
strains.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/08	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

A	DET	O	O
simple	NOUN	O	O
population	NOUN	O	O
pharmacokinetic	ADJ	O	O
model	NOUN	O	O
was	VERB	O	O
developed	VERB	O	O
to	PART	O	O
visualize	NOUN	O	O
measured	VERB	O	O
and	CCONJ	O	O
predicted	VERB	O	O
belatacept	ADV	O	O
serum	NOUN	O	O
concentrations.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
an	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(14	NOUN	O	O
individuals	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group)	ADJ	O	O
and	CCONJ	O	O
then	ADV	O	O
were	VERB	O	O
post-tested	VERB	O	O
after	ADP	O	O
two	NUM	O	O
months.	NOUN	O	O

The	DET	O	O
outcome	NOUN	O	O
parameters	NOUN	O	O
were	VERB	O	O
recession	NOUN	O	B-outcome
depth	NOUN	O	I-outcome
/	NOUN	O	X
width	NOUN	O	S1-outcome
,	PUNCT	O	O
root	NOUN	O	B-outcome
coverage	NOUN	O	I-outcome
percentage,	ADP	O	O
and	CCONJ	O	O
root	NOUN	O	B-outcome
coverage	NOUN	O	I-outcome
aesthetic	ADJ	O	I-outcome
score	NOUN	O	O
(RES).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
between	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
self-efficacy	NOUN	O	B-outcome
indices	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(p=0.001).	NOUN	O	O

Givosiran	NOUN	O	O
is	VERB	O	O
an	DET	O	O
investigational	ADJ	O	O
RNA	NOUN	O	O
interference	NOUN	O	O
therapeutic	ADJ	O	O
agent	NOUN	O	O
that	ADP	O	O
inhibits	NOUN	O	O
hepatic	ADJ	O	O
ALAS1	NOUN	O	O
synthesis.	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
in	ADP	O	O
the	DET	O	O
median	ADJ	O	O
number	NOUN	O	O
[range]	NOUN	O	O
of	ADP	O	O
small	ADJ	O	B-outcome
intestinal	ADJ	O	I-outcome
lesions	NOUN	O	I-outcome
between	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
two	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
low-dose	NOUN	O	O
aspirin	NOUN	O	O
administration	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
(baseline:	PUNCT	O	O
1	NUM	O	O
[0-5],	PUNCT	O	O
after:	NOUN	O	O
5	NUM	O	O
[1-11];	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.0059)	NUM	O	O
but	CCONJ	O	O
not	ADV	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
(baseline:	PUNCT	O	O
0.5	NUM	O	O
[0-9],	NUM	O	O
after:	NOUN	O	O
3	NUM	O	O
[0-23];	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.0586).	NUM	O	O

For	ADP	O	O
the	DET	O	O
majority,	NOUN	O	O
the	DET	O	O
provision	NOUN	O	O
of	ADP	O	O
education	NOUN	O	O
and	CCONJ	O	O
positive	ADJ	O	O
interventions	NOUN	O	O
aimed	VERB	O	O
at	ADP	O	O
promoting	VERB	O	O
healthy	ADJ	O	O
exercise	NOUN	O	O
and	CCONJ	O	O
self-management	ADJ	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
significant	ADJ	O	O
benefit	NUM	O	O
without	ADP	O	O
the	DET	O	O
need	NOUN	O	O
for	ADP	O	O
more	ADV	O	O
complex	NOUN	O	O
interventions.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
56	NUM	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
in	ADP	O	O
total,	ADJ	O	O
including	VERB	O	O
31	NUM	O	O
in	ADP	O	O
the	DET	O	O
PICSI	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
25	NUM	O	O
in	ADP	O	O
the	DET	O	O
ICSI	NOUN	O	O
group;	ADJ	O	O
most	DET	O	O
were	VERB	O	O
congenital	ADJ	O	B-outcome
abnormalities	NOUN	O	I-outcome
and	CCONJ	O	O
none	NUM	O	O
were	VERB	O	O
attributed	VERB	O	O
to	PART	O	O
treatment.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
The	DET	O	O
original	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
retrospectively	ADV	O	O
registered	VERB	O	O
under	ADP	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier	NOUN	O	O
NCT01660204	NOUN	O	O
on	ADP	O	O
August	NOUN	O	O
8th,	NOUN	O	O
2012.	NUM	O	O

BACKGROUND:	NOUN	O	O
Shoulder	ADV	O	O
pain	NOUN	O	O
syndrome	NOUN	O	O
(SPS)	PUNCT	O	O
is	VERB	O	O
frequent	ADJ	O	O
and	CCONJ	O	O
management	NOUN	O	O
in	ADP	O	O
primary	ADJ	O	O
care	NOUN	O	O
is	VERB	O	O
precarious,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
high	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
referral	ADJ	O	O
without	ADP	O	O
adequate	ADJ	O	O
treatment,	NOUN	O	O
overloading	VERB	O	O
rehabilitation	NOUN	O	O
and	CCONJ	O	O
orthopedic	ADJ	O	O
services.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101643584	NUM	O	O

It	PRON	O	O
scavenges	NOUN	O	O
free	ADJ	O	O
radicals	NOUN	O	O
and	CCONJ	O	O
reactive	ADJ	O	O
oxygen	NOUN	O	O
species	NOUN	O	O
(ROS),	NUM	O	O
which	ADP	O	O
are	VERB	O	O
produced	VERB	O	O
during	ADP	O	O
metabolic	ADJ	O	O
pathways.	NOUN	O	O

CONCLUSION:	NOUN	O	O
the	DET	O	O
early	ADJ	O	O
stimulation	NOUN	O	O
is	VERB	O	O
a	DET	O	O
therapy	NOUN	O	O
with	ADP	O	O
bidirectional	ADJ	O	O
effect,	NOUN	O	O
because	ADP	O	O
it	PRON	O	O
has	VERB	O	O
favorable	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
the	DET	O	O
person	NOUN	O	O
who	ADP	O	O
administers	NOUN	O	O
it;	NOUN	O	O
promotes	NOUN	O	O
health	NOUN	O	O
and	CCONJ	O	O
prevents	NOUN	O	O
illness	NOUN	O	O
in	ADP	O	O
the	DET	O	O
process	NOUN	O	O
of	ADP	O	O
adaptation	NOUN	O	O
to	PART	O	O
birth;	NOUN	O	O
especially	ADV	O	O
in	ADP	O	O
contexts	NOUN	O	O
of	ADP	O	O
vulnerability.	NOUN	O	O

Additional	ADJ	O	O
research,	NOUN	O	O
including	VERB	O	O
comparison	NOUN	O	O
of	ADP	O	O
IV	NUM	O	O
vs	CCONJ	O	O
oral	ADJ	O	O
acetaminophen	ADV	O	O
and	CCONJ	O	O
other	ADJ	O	O
potentially	ADV	O	O
opioid-sparing	VERB	O	O
analgesics,	ADJ	O	O
on	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
delirium	NOUN	O	O
is	VERB	O	O
warranted.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

Journal-Name:Medicine	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
on	ADP	O	O
240	NUM	O	O
patients	NOUN	O	O
of	ADP	O	O
dyslipidemia	NOUN	O	O
(as	PUNCT	O	O
per	ADP	O	O
ACC/AHA	NOUN	O	O
2013	NUM	O	O
lipid	NOUN	O	O
guidelines)	NOUN	O	O
attending	VERB	O	O
the	DET	O	O
OPD/wards/CCU	NOUN	O	O
of	ADP	O	O
department	NOUN	O	O
of	ADP	O	O
cardiology,	NOUN	O	O
Sir	NOUN	O	O
Ganga	NOUN	O	O
Ram	NOUN	O	O
Hospital.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Postdischarge	NOUN	O	O
MRSA	NOUN	O	O
decolonization	NOUN	O	O
with	ADP	O	O
chlorhexidine	NOUN	O	O
and	CCONJ	O	O
mupirocin	NOUN	O	O
led	VERB	O	O
to	PART	O	O
a	DET	O	O
30%	NOUN	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
MRSA	NOUN	O	B-outcome
infection	NOUN	O	I-outcome
than	ADP	O	O
education	NOUN	O	O
alone.	NOUN	O	O
(	PUNCT	O	O

Conclusions:	NOUN	O	O
Resin	NOUN	O	O
infiltration	NOUN	O	O
and	CCONJ	O	O
fluoride	NOUN	O	O
varnish	NOUN	O	O
are	VERB	O	O
clinically	ADV	O	O
feasible	ADJ	O	B-outcome
and	CCONJ	O	O
efficacious	ADJ	O	O
methods	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
anterior	ADJ	O	O
white	ADP	O	B-outcome
spot	NOUN	O	I-outcome
lesions	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
inhibition	NOUN	O	O
of	ADP	O	O
caries	NOUN	O	O
progression	NOUN	O	O
by	ADP	O	O
resin	NOUN	O	O
infiltration	NOUN	O	O
should	VERB	O	O
now	ADV	O	O
be	VERB	O	O
considered	VERB	O	O
an	DET	O	O
alternative	ADJ	O	O
to	PART	O	O
fluoride	NOUN	O	O
treatment.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
493	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
resected	VERB	O	O
pancreatic	ADJ	O	O
ductal	ADJ	O	O
adenocarcinoma	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
a	DET	O	O
modified	VERB	O	O
FOLFIRINOX	NOUN	O	O
regimen	NOUN	O	O
(oxaliplatin	NOUN	O	O
[85	NOUN	O	O
mg	NOUN	O	O
per	ADP	O	O
square	VERB	O	O
meter	NOUN	O	O
of	ADP	O	O
body-surface	NOUN	O	O
area],	NOUN	O	O
irinotecan	NOUN	O	O
[180	PUNCT	O	O
mg	NOUN	O	O
per	ADP	O	O
square	VERB	O	O
meter,	NOUN	O	O
reduced	VERB	O	O
to	PART	O	O
150	NUM	O	O
mg	NOUN	O	O
per	ADP	O	O
square	VERB	O	O
meter	NOUN	O	O
after	ADP	O	O
a	DET	O	O
protocol-specified	VERB	O	O
safety	NOUN	O	O
analysis],	NUM	O	O
leucovorin	NOUN	O	O
[400	ADV	O	O
mg	NOUN	O	O
per	ADP	O	O
square	VERB	O	O
meter],	NUM	O	O
and	CCONJ	O	O
fluorouracil	NOUN	O	O
[2400	ADP	O	O
mg	NOUN	O	O
per	ADP	O	O
square	VERB	O	O
meter	NOUN	O	O
every	DET	O	O
2	NUM	O	O
weeks)	NOUN	O	O
or	CCONJ	O	O
gemcitabine	NOUN	O	O
(1000	NUM	O	O
mg	NOUN	O	O
per	ADP	O	O
square	VERB	O	O
meter	NOUN	O	O
on	ADP	O	O
days	NOUN	O	O
1,	NOUN	O	O
8,	NOUN	O	O
and	CCONJ	O	O
15	NUM	O	O
every	DET	O	O
4	NUM	O	O
weeks)	NOUN	O	O
for	ADP	O	O
24	NUM	O	O
weeks.	NOUN	O	O

After	ADP	O	O
the	DET	O	O
exacerbation,	NOUN	O	O
mean	NOUN	O	O
FEV1	NOUN	O	B-outcome
improved	VERB	O	O
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
return	NOUN	O	O
to	PART	O	O
pre-exacerbation	NOUN	O	O
levels	NOUN	O	O
(mean	NUM	O	O
Days	NOUN	O	O
36-56	NUM	O	O
after	ADP	O	O
the	DET	O	O
exacerbation,	NOUN	O	O
0.875	NUM	O	O
L).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101471610	NUM	O	O

Title:	NOUN	O	O
Cost-effectiveness	NOUN	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
of	ADP	O	O
a	DET	O	O
diet	NOUN	O	O
intervention	NOUN	O	O
postpartum:	NOUN	O	O
2-year	NOUN	O	O
results	NOUN	O	O
from	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
regression-adjusted	VERB	O	O
effects	NOUN	O	O
on	ADP	O	O
other	ADJ	O	O
outcomes,	NOUN	O	O
although	ADP	O	O
the	DET	O	O
direction	NOUN	O	O
of	ADP	O	O
change	NOUN	O	O
was	VERB	O	O
consistent	ADJ	O	O
with	ADP	O	O
improvements.	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
isrctn.com	NOUN	O	O
Identifier:	NOUN	O	O
ISRCTN89898870.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
daily	ADJ	O	O
administration	NOUN	O	O
of	ADP	O	O
250	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
elemental	ADJ	O	O
Mg	NOUN	O	O
indicated	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
HbA1C	NOUN	O	B-outcome
(8.32	NOUN	O	O
to	PART	O	O
7.96%,	NUM	O	O
p	NOUN	O	O
<	SYM	O	O
0.001),	NUM	O	O
insulin	NOUN	O	B-outcome
levels	NOUN	O	O
(IL)	NOUN	O	O
(15.56	PUNCT	O	O
to	PART	O	O
12.18	NUM	O	O
muIU/mL,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.001),	NUM	O	O
C-peptide	ADJ	O	B-outcome
(2.28	PUNCT	O	O
to	PART	O	O
1.90	NUM	O	O
ng/mL,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.001),	NUM	O	O
HOMA.IR	NOUN	O	B-outcome
(6.16	NOUN	O	O
to	PART	O	O
4.44,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.001)	NUM	O	O
and	CCONJ	O	O
HOMA.beta	NOUN	O	B-outcome
%	SYM	O	O
(59.99	PUNCT	O	O
to	PART	O	O
52.37,	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.036)	NUM	O	O
of	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
after	ADP	O	O
three	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
intervention.	NOUN	O	O

To	PART	O	O
test	NOUN	O	O
this	DET	O	O
hypothesis,	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
double-blind	ADJ	O	O
placebo-controlled	VERB	O	O
study	NOUN	O	O
was	VERB	O	O
performed.	NOUN	O	O

These	DET	O	O
results	NOUN	O	O
indicate	VERB	O	O
that	ADP	O	O
EMDs	NOUN	O	O
contribute	NOUN	O	O
to	PART	O	O
the	DET	O	O
healing	VERB	O	B-outcome
of	ADP	O	O
soft	NOUN	O	O
tissue	NOUN	O	O
without	ADP	O	O
scarring.	ADV	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
infant	NOUN	O	O
stimulation	NOUN	O	O
on	ADP	O	O
the	DET	O	O
adaptation	NOUN	O	B-outcome
to	PART	O	I-outcome
birth	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
randomized	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/22	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

However,	ADV	O	O
the	DET	O	O
benefit	NUM	O	O
of	ADP	O	O
thromboprophylaxis	NOUN	O	O
in	ADP	O	O
these	DET	O	O
patients	NOUN	O	O
is	VERB	O	O
uncertain.	NOUN	O	O

Title:	NOUN	O	O
Analgesic	ADP	O	O
effect	NOUN	O	O
of	ADP	O	O
trigger	ADP	O	O
point	NOUN	O	O
injection	NOUN	O	O
and	CCONJ	O	O
EMLA	NOUN	O	O
for	ADP	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
total	ADJ	O	O
laparoscopic	ADJ	O	O
hysterectomy:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
study.	NOUN	O	O

The	DET	O	O
average	NOUN	O	O
age	NOUN	O	O
was	VERB	O	O
65.41	NUM	O	O
years	NOUN	O	O
(+/-SD	NOUN	O	O
4.08).	NOUN	O	O

RESULTS:	NOUN	O	O
Analysis	NOUN	O	O
identified	VERB	O	O
different	ADJ	O	O
views	NOUN	O	O
and	CCONJ	O	O
considerations	NOUN	O	O
for	ADP	O	O
engaging	VERB	O	O
in	ADP	O	O
a	DET	O	O
weight	NOUN	O	O
loss	NOUN	O	O
intervention	NOUN	O	O
at	ADP	O	O
the	DET	O	O
workplace.	ADV	O	O

The	DET	O	O
outcome	NOUN	O	O
was	VERB	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
within	ADP	O	O
one-year	NOUN	O	O
follow-up.	PUNCT	O	O

The	DET	O	O
human	NOUN	O	O
immunodeficiency	NOUN	O	O
virus	NOUN	O	O
(HIV)	PUNCT	O	O
and	CCONJ	O	O
resulting	VERB	O	O
progressive	ADJ	O	O
HIV	NOUN	O	O
encephalopathy	NOUN	O	O
(PHE)	PUNCT	O	O
is	VERB	O	O
a	DET	O	O
pandemic	NOUN	O	O
in	ADP	O	O
this	DET	O	O
area,	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
development	NOUN	O	O
delays	NOUN	O	O
that	ADP	O	O
are	VERB	O	O
not	ADV	O	O
addressed	VERB	O	O
by	ADP	O	O
highly	ADV	O	O
active	ADJ	O	O
antiretroviral	ADJ	O	O
treatment	NOUN	O	O
(HAART).	NUM	O	O

Journal-Name:Nutrients	NOUN	O	O

METHODS:	NOUN	O	O
Ninety-three	NUM	O	O
infertile	NOUN	O	O
women	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
into	ADP	O	O
1	NUM	O	O
of	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
placebo	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
47)	NOUN	O	O
or	CCONJ	O	O
nifedipine	NOUN	O	O
20	NUM	O	O
mg	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
46).	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
(+/-SD)	NOUN	O	O
Unified	VERB	O	O
Parkinson's	NOUN	O	B-outcome
Disease	NOUN	O	I-outcome
Rating	VERB	O	O
Scale	NOUN	O	O
(UPDRS)	NUM	O	O
score	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
was	VERB	O	O
28.1+/-11.4	NOUN	O	O
points	NOUN	O	O
in	ADP	O	O
the	DET	O	O
early-start	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
29.3+/-12.1	NOUN	O	O
points	NOUN	O	O
in	ADP	O	O
the	DET	O	O
delayed-start	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/06	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/16	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Approved	VERB	O	O
by	ADP	O	O
the	DET	O	O
Ethics	NOUN	O	O
Committee	NOUN	O	O
of	ADP	O	O
Lower	ADJ	O	O
Austria	NOUN	O	O
(GS4-EK-4/107-2010).	NOUN	O	O

Complete-case,	NOUN	O	O
per-protocol,	NOUN	O	O
and	CCONJ	O	O
sensitivity	NOUN	O	O
analyses	NOUN	O	O
supported	VERB	O	O
this	DET	O	O
result.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

However,	ADV	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
on	ADP	O	O
krill	NOUN	O	O
powder	NOUN	O	O
are	VERB	O	O
scarce	NOUN	O	O
and	CCONJ	O	O
systematic	ADJ	O	O
data	NOUN	O	O
of	ADP	O	O
krill	NOUN	O	O
meal	ADJ	O	O
on	ADP	O	O
human	NOUN	O	O
safety	NOUN	O	O
is	VERB	O	O
limited.	NOUN	O	O

For	ADP	O	O
creatine	NOUN	O	B-outcome
kinase	NOUN	O	I-outcome
,	PUNCT	O	O
SuperPATH	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
and	CCONJ	O	O
3	NUM	O	O
days	NOUN	O	O
were	VERB	O	O
lower	ADJ	O	O
than	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(	PUNCT	O	O
P<0.05),	NOUN	O	O
while	ADP	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
before	ADP	O	O
operation	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
14	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
(	PUNCT	O	O
P>0.05).	NOUN	O	O

Lancet	NOUN	O	O
2019;393:2213-21.This	NOUN	O	O
project	NOUN	O	O
was	VERB	O	O
funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
NIHR	NOUN	O	O
Health	NOUN	O	O
Services	NOUN	O	O
and	CCONJ	O	O
Delivery	NOUN	O	O
Research	NOUN	O	O
Programme	NOUN	O	O
(project	NOUN	O	O
number	NOUN	O	O
12/5005/10).To	NUM	O	O
read	VERB	O	O
the	DET	O	O
full	ADJ	O	O
NIHR	NOUN	O	O
Signal,	ADJ	O	O
go	VERB	O	O
to	PART	O	O
https://discover.dc.nihr.ac.uk/content/signal-000789/national-quality-improvement	NOUN	O	O
-programmes-need-time-and-resources-to-have-impact.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
training	VERB	O	O
with	ADP	O	O
N95	NOUN	O	O
or	CCONJ	O	O
higher	ADJ	O	O
filter	NOUN	O	O
respirators	NOUN	O	O
on	ADP	O	O
the	DET	O	O
protection	NOUN	O	B-outcome
performance	NOUN	O	O
of	ADP	O	O
respirators	NOUN	O	O
among	ADP	O	O
healthcare	NOUN	O	O
providers	NOUN	O	O
in	ADP	O	O
the	DET	O	O
emergency	NOUN	O	O
medical	ADJ	O	O
center	NOUN	O	O
(EMC).	NOUN	O	O

Additional	ADJ	O	O
arterial	ADJ	O	O
or	CCONJ	O	O
vein	NOUN	O	O
grafts	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
as	ADP	O	O
indicated.	NOUN	O	O

Title:	NOUN	O	O
Moderate-intensity	NOUN	O	O
aerobic	ADJ	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
exercise	NOUN	O	O
is	VERB	O	O
safe	ADJ	O	O
and	CCONJ	O	O
favorably	ADV	O	O
influences	NOUN	O	O
body	NOUN	O	B-outcome
composition	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
quiescent	ADJ	O	O
Inflammatory	ADJ	O	O
Bowel	NOUN	O	O
Disease:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
cross-over	NOUN	O	O
trial.	NOUN	O	O

However,	ADV	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
for	ADP	O	O
median	ADJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
(5.0	PUNCT	O	O
vs.	CCONJ	O	O
4.0	NUM	O	O
months;	NOUN	O	O
HR	NOUN	O	O
=	SYM	O	O
1.03;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.56-1.90;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.914).	PUNCT	O	O

Subjects	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
demographic	ADJ	O	O
and	CCONJ	O	O
Beck	NOUN	O	O
Depression	NOUN	O	O
Inventory-II	NOUN	O	O
(BDI-II)	NUM	O	O
questionnaires	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
intervention.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
an	DET	O	O
exercise	NOUN	O	O
program	NOUN	O	O
on	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
in	ADP	O	O
older	ADJ	O	O
breast	NOUN	O	O
cancer	NOUN	O	O
survivors	NOUN	O	O
undergoing	VERB	O	O
aromatase	NOUN	O	O
inhibitor	NOUN	O	O
therapy:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
A	DET	O	O
multicenter,	NOUN	O	O
parallel-group,	NOUN	O	O
cluster-randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
with	ADP	O	O
integrated	VERB	O	O
economic	ADJ	O	O
and	CCONJ	O	O
process	NOUN	O	O
evaluations	NOUN	O	O
conducted	VERB	O	O
in	ADP	O	O
24	NUM	O	O
ICUs	NOUN	O	O
in	ADP	O	O
the	DET	O	O
United	VERB	O	O
Kingdom.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
stratified	VERB	O	O
case	NOUN	O	O
study	NOUN	O	O
was	VERB	O	O
conducted.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
removing	VERB	O	O
co-payment	NOUN	O	O
barriers	NOUN	O	O
increases	NOUN	O	O
P2Y12	NOUN	O	B-outcome
inhibitor	NOUN	O	I-outcome
persistence	NOUN	O	I-outcome
and	CCONJ	O	O
lowers	NOUN	O	O
risk	NOUN	O	O
of	ADP	O	O
major	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
cardiovascular	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(MACE)	PUNCT	O	I-outcome
.	PUNCT	O	O
Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Cluster	NOUN	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
among	ADP	O	O
301	NUM	O	O
hospitals	NOUN	O	O
enrolling	VERB	O	O
adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
MI	NOUN	O	O
(June	PUNCT	O	O
5,	ADJ	O	O
2015,	NUM	O	O
through	ADP	O	O
September	NOUN	O	O
30,	NUM	O	O
2016);	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
after	ADP	O	O
discharge	NOUN	O	O
(final	NUM	O	O
date	NOUN	O	O
of	ADP	O	O
follow-up	NOUN	O	O
was	VERB	O	O
October	ADJ	O	O
23,	NUM	O	O
2017),	ADP	O	O
with	ADP	O	O
blinded	VERB	O	O
adjudication	NOUN	O	O
of	ADP	O	O
major	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
cardiovascular	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(MACE)	PUNCT	O	I-outcome
;	PUNCT	O	O
choice	NOUN	O	O
of	ADP	O	O
P2Y12	NOUN	O	O
inhibitor	NOUN	O	O
was	VERB	O	O
per	ADP	O	O
clinician	NOUN	O	O
discretion.	NOUN	O	O

Journal-Name:Pediatric	ADJ	O	O
rheumatology	NOUN	O	O
online	ADP	O	O
journal	ADJ	O	O

Introduction:	NOUN	O	O
Peri-	NOUN	O	O
and	CCONJ	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
frequently	ADV	O	O
suffer	NOUN	O	O
from	ADP	O	O
urinary	ADJ	O	O
incontinence	NOUN	O	O
(UI).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODOLOGY/PRINCIPAL	ADP	O	O
FINDINGS:	ADJ	O	O
An	DET	O	O
open-label,	ADV	O	O
non-comparative	ADJ	O	O
randomized	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
AmBisome	NOUN	O	O
(30	NOUN	O	O
mg/kg)	NOUN	O	O
with	ADP	O	O
miltefosine	NOUN	O	O
(100	NUM	O	O
mg/day	NOUN	O	O
for	ADP	O	O
28	NUM	O	O
days),	NOUN	O	O
and	CCONJ	O	O
AmBisome	NOUN	O	O
monotherapy	NOUN	O	O
(40	NOUN	O	O
mg/kg)	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
in	ADP	O	O
Ethiopian	NOUN	O	O
VL	NOUN	O	O
patients	NOUN	O	O
co-infected	VERB	O	O
with	ADP	O	O
HIV	NOUN	O	O
(NCT02011958).	NUM	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
a	DET	O	O
mixture	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
Lactobacillus	NOUN	O	O
strains	NOUN	O	O
in	ADP	O	O
decreasing	VERB	O	O
infant	NOUN	O	B-outcome
cry	NOUN	O	I-outcome
and	CCONJ	O	Seperator
fuss	NOUN	O	S1-outcome
in	ADP	O	O
this	DET	O	O
population.	ADV	O	O

Importance:	NOUN	O	O
Whether	ADP	O	O
using	VERB	O	O
magnetic	ADJ	O	O
resonance	NOUN	O	O
imaging	VERB	O	O
(MRI)	PUNCT	O	O
to	PART	O	O
guide	NOUN	O	O
treatment	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
rheumatoid	ADJ	O	O
arthritis	NOUN	O	O
(RA)	NOUN	O	O
improves	NOUN	O	O
disease	NOUN	O	O
activity	NOUN	O	O
and	CCONJ	O	O
slows	NOUN	O	O
joint	NOUN	O	O
damage	NOUN	O	O
progression	NOUN	O	O
is	VERB	O	O
unknown.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
cancer	NOUN	O	O
research	NOUN	O	O
and	CCONJ	O	O
therapeutics	NOUN	O	O

The	DET	O	O
investigated	VERB	O	O
program	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
improved	VERB	O	O
by	ADP	O	O
considering	VERB	O	O
the	DET	O	O
following	VERB	O	O
suggestions:	NOUN	O	O
The	DET	O	O
quality	NOUN	O	O
of	ADP	O	O
the	DET	O	O
implementation	NOUN	O	O
process	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
monitored	VERB	O	O
during	ADP	O	O
the	DET	O	O
implementation	NOUN	O	O
phase,	NOUN	O	O
and	CCONJ	O	O
regular	ADJ	O	O
feedback	NOUN	O	O
loops	NOUN	O	O
and	CCONJ	O	O
learning	VERB	O	O
opportunities	NOUN	O	O
for	ADP	O	O
teachers	NOUN	O	O
should	VERB	O	O
accompany	DET	O	O
a	DET	O	O
program.	NOUN	O	O

Mean	NOUN	O	O
+/-	SYM	O	O
SD	NOUN	O	O
central	ADJ	O	O
ECD	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
was	VERB	O	O
2453	NUM	O	O
+/-	SYM	O	O
359	NUM	O	O
cells/mm,	NOUN	O	O
decreasing	VERB	O	O
by	ADP	O	O
10%	ADP	O	O
+/-	SYM	O	O
14%	NOUN	O	O
to	PART	O	O
2195	NUM	O	O
+/-	SYM	O	O
517	NUM	O	O
cells/mm	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
0.001)	NUM	O	O
but	CCONJ	O	O
stabilizing	VERB	O	O
thereafter	ADV	O	O
with	ADP	O	O
mean	NOUN	O	O
endothelial	ADJ	O	B-outcome
cell	NOUN	O	I-outcome
loss	NOUN	O	O
(ECL)	ADV	O	O
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
24	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
9%	NOUN	O	O
+/-	SYM	O	O
13%	ADJ	O	O
(P	NUM	O	O
<	SYM	O	O
0.001).	NUM	O	O

201404134736	NUM	O	O
N6	NOUN	O	O
.	PUNCT	O	O

METHOD/DESIGN:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
a	DET	O	O
multicenter,	NOUN	O	O
open-label,	ADV	O	O
randomized,	NOUN	O	O
controlled,	NOUN	O	O
and	CCONJ	O	O
equivalence	NOUN	O	O
trial	NOUN	O	O
with	ADP	O	O
2	NUM	O	O
parallel	ADJ	O	O
arms.	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8216186	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Similarly,	NOUN	O	O
fewer	ADJ	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
breaks	NOUN	O	I-outcome
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
other	ADJ	O	O
conditions	NOUN	O	O
impeded	VERB	O	O
the	DET	O	O
program's	NOUN	O	O
success.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
Green	NOUN	O	O
tea	NOUN	O	O
was	VERB	O	O
an	DET	O	O
effective	ADJ	O	O
adjunct	ADP	O	O
to	PART	O	O
trimethoprim-sulfamethoxazole	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
acute	ADJ	O	O
uncomplicated	VERB	O	O
cystitis	NOUN	O	O
in	ADP	O	O
women.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
improvements	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

RESULTS:	NOUN	O	O
Both	CCONJ	O	O
groups	NOUN	O	O
heat	NOUN	O	B-outcome
acclimated	VERB	O	I-outcome
similarly	ADV	O	O
(p>0.05)	PUNCT	O	O
evidenced	VERB	O	O
by	ADP	O	O
lower	ADJ	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
thermoregulatory,	NOUN	O	B-outcome
physiological,	ADJ	O	B-outcome
and	CCONJ	O	Seperator
perceptual	ADJ	O	B-outcome
responses	NOUN	O	E1-outcome
(	PUNCT	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
,	PUNCT	O	O
fatigue	NOUN	O	B-outcome
,	PUNCT	O	O
thermal	ADJ	O	B-outcome
sensation	NOUN	O	I-outcome
)	PUNCT	O	O
Pre	NOUN	O	O
HA	NOUN	O	O
vs.	CCONJ	O	O
Post	ADV	O	O
HA	NOUN	O	O
(p</=0.05).	NOUN	O	O

Except	ADP	O	O
that	ADP	O	O
the	DET	O	O
Oswestry	NOUN	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(ODI)	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
of	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
last	NOUN	O	O
follow-up	NOUN	O	O
(	PUNCT	O	O
P<0.05),	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
VAS	NOUN	O	O
score	NOUN	O	O
and	CCONJ	O	O
Oswestry	NOUN	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(ODI)	NOUN	O	O
score	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
the	DET	O	O
other	ADJ	O	O
time	NOUN	O	O
points	NOUN	O	O
(	PUNCT	O	O
P>0.05).	NOUN	O	O

There	PRON	O	O
is	VERB	O	O
a	DET	O	O
paucity	NOUN	O	O
of	ADP	O	O
research	NOUN	O	O
on	ADP	O	O
the	DET	O	O
determinants	NOUN	O	O
of	ADP	O	O
psychological	ADJ	O	O
distress,	ADJ	O	O
particularly	ADV	O	O
among	ADP	O	O
the	DET	O	O
poorest	ADV	O	O
girls	NOUN	O	O
in	ADP	O	O
the	DET	O	O
poorest	ADV	O	O
communities.	NOUN	O	O

DESIGN:	NOUN	O	O
Randomized	VERB	O	O
control	NOUN	O	O
trial.	NOUN	O	O

These	DET	O	O
occurred	VERB	O	O
in	ADP	O	O
11	NUM	O	O
of	ADP	O	O
207	NUM	O	O
(5.3%),	NOUN	O	O
18	NUM	O	O
of	ADP	O	O
250	NUM	O	O
(7.2%),	NOUN	O	O
and	CCONJ	O	O
31	NUM	O	O
of	ADP	O	O
277	NUM	O	O
(11.2%)	NUM	O	O
patients	NOUN	O	O
exposed	VERB	O	O
to	PART	O	O
azithromycin,	ADV	O	O
clarithromycin,	NOUN	O	O
and	CCONJ	O	O
erythromycin	NOUN	O	O
for	ADP	O	O
at	ADP	O	O
least	ADV	O	O
one	NUM	O	O
day,	ADP	O	O
and	CCONJ	O	O
in	ADP	O	O
9	NUM	O	O
of	ADP	O	O
234	NUM	O	O
(3.8%),	NOUN	O	O
5	NUM	O	O
of	ADP	O	O
194	NUM	O	O
(2.6%),	PUNCT	O	O
and	CCONJ	O	O
23	NUM	O	O
of	ADP	O	O
566	NUM	O	O
(4.1%)	NOUN	O	O
exposed	VERB	O	O
to	PART	O	O
ciprofloxacin,	NOUN	O	O
levofloxacin,	ADV	O	O
and	CCONJ	O	O
moxifloxacin,	NOUN	O	O
respectively.	NOUN	O	O

Journal-Name:	NOUN	O	O
The	DET	O	O
International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
periodontics	NOUN	O	O
&	CCONJ	O	O
restorative	ADJ	O	O
dentistry	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
revealed	VERB	O	O
that	ADP	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
plaque	NOUN	O	B-outcome
index	NOUN	O	O
(PI)	NOUN	O	O
and	CCONJ	O	O
probing	VERB	O	B-outcome
depth	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
test	NOUN	O	O
group	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

BACKGROUND:	NOUN	O	O
To	PART	O	O
identify	NOUN	O	O
baseline	NOUN	O	O
patient	NOUN	O	O
characteristics	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
early	ADJ	O	O
clinically	ADV	O	O
significant	ADJ	O	O
visual	ADJ	O	B-outcome
acuity	NOUN	O	I-outcome
(VA)	NOUN	O	I-outcome
improvements	NOUN	O	O
within	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
initiation	NOUN	O	O
in	ADP	O	O
ranibizumab-treated	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
retinal	ADJ	O	O
vein	NOUN	O	O
occlusion	NOUN	O	O
(RVO)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
SHORE	DET	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

In	ADP	O	O
the	DET	O	O
group	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
diagnosed	VERB	O	O
with	ADP	O	O
asthma,	NOUN	O	O
percentage	NOUN	O	O
differences	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
with	ADP	O	O
good	ADJ	O	O
body	NOUN	O	O
posture	ADJ	O	O
(without	ADV	O	O
postural	ADJ	O	O
defects)	NOUN	O	O
were	VERB	O	O
statistically	ADV	O	O
significant.	NOUN	O	O

Compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
lesser	ADJ	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
[47(26,	VERB	O	O
120)	NOUN	O	O
mg/g	ADV	O	O
vs	CCONJ	O	O
68(28,	PUNCT	O	O
158)	NOUN	O	O
mg/g,	VERB	O	O
P=0.039],	NOUN	O	O
and	CCONJ	O	O
lower	ADJ	O	O
serum	NOUN	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
[(0.83+/-0.30)	NOUN	O	O
mg/L	NOUN	O	O
vs	CCONJ	O	O
(0.96+/-0.30)mg/L,	NOUN	O	O
P=0.041].	NOUN	O	O
Berberine	NOUN	O	O
had	VERB	O	O
no	DET	O	O
obvious	ADJ	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
.	PUNCT	O	O
Multiple	ADJ	O	O
linear	ADJ	O	O
regression	NOUN	O	O
analysis	NOUN	O	O
revealed	VERB	O	O
that	ADP	O	O
the	DET	O	O
berberine	NOUN	O	O
administration	NOUN	O	O
was	VERB	O	O
independently	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
the	DET	O	O
reduction	NOUN	O	O
of	ADP	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
(beta=-0.051,	PUNCT	O	O
P=0.041)	NOUN	O	O
and	CCONJ	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
(beta=-0.068,	NUM	O	O
P=0.033)	NOUN	O	O
in	ADP	O	O
T2DM	NOUN	O	O
patients.	NOUN	O	O

Title:	NOUN	O	O
Live	ADJ	O	O
Music	ADJ	O	O
Therapy	NOUN	O	O
During	ADP	O	O
Rehabilitation	NOUN	O	O
After	ADP	O	O
Total	ADJ	O	O
Knee	NOUN	O	O
Arthroplasty:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Participants	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
lost	VERB	O	O
to	PART	O	O
follow-up	NOUN	O	O
or	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
provide	VERB	O	O
biochemical	ADJ	O	O
validation	NOUN	O	O
were	VERB	O	O
considered	VERB	O	O
to	PART	O	O
not	ADV	O	O
be	VERB	O	O
abstinent.	NOUN	O	O

Infant	NOUN	O	O
colic	ADJ	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
condition	NOUN	O	O
of	ADP	O	O
unknown	VERB	O	O
pathogenesis	NOUN	O	O
that	ADP	O	O
brings	NOUN	O	O
frustration	NOUN	O	O
to	PART	O	O
families	NOUN	O	O
seeking	VERB	O	O
for	ADP	O	O
effective	ADJ	O	O
management.	NOUN	O	O

Primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
active	ADJ	O	O
bleeding	VERB	O	B-outcome
control	NOUN	O	I-outcome
and	CCONJ	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
six	NUM	O	O
weeks	NOUN	O	O
rebleeding	VERB	O	B-outcome
,	PUNCT	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
mortality	NOUN	O	B-outcome
among	ADP	O	O
the	DET	O	O
studied	VERB	O	O
patients.	NOUN	O	O

We	PRON	O	O
investigated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
intraduodenally	ADV	O	O
administered	VERB	O	O
L-valine	NOUN	O	O
on	ADP	O	O
antropyloroduodenal	ADJ	O	B-outcome
pressures	NOUN	O	I-outcome
,	PUNCT	O	O
plasma	NOUN	O	O
cholecystokinin	NOUN	O	B-outcome
,	PUNCT	O	O
blood	NOUN	O	B-outcome
glucose	NOUN	O	I-outcome
and	CCONJ	O	O
energy	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
.	PUNCT	O	O
Twelve	NUM	O	O
healthy	ADJ	O	O
lean	ADJ	O	O
men	NOUN	O	O
(age:	NOUN	O	O
29	NUM	O	O
+/-	SYM	O	O
2	NUM	O	O
years,	NOUN	O	O
BMI:	NOUN	O	O
22.5	NUM	O	O
+/-	SYM	O	O
0.7	NUM	O	O
kg/m(2))	NOUN	O	O
were	VERB	O	O
studied	VERB	O	O
on	ADP	O	O
3	NUM	O	O
separate	ADJ	O	O
occasions	NOUN	O	O
in	ADP	O	O
randomised,	NOUN	O	O
double-blind	ADJ	O	O
order.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
of	ADP	O	O
overall	ADJ	O	O
(0-120	NOUN	O	O
h	NOUN	O	O
after	ADP	O	O
chemotherapy	NOUN	O	O
administration)	NOUN	O	O
complete	ADJ	O	B-outcome
response	NOUN	O	I-outcome
(CR)	NOUN	O	I-outcome
rate	NOUN	O	O
(no	PUNCT	O	O
emesis,	NOUN	O	O
no	DET	O	O
rescue	NOUN	O	O
medication)	NOUN	O	O
was	VERB	O	O
64.2%,	NUM	O	O
60.0%	NUM	O	O
and	CCONJ	O	O
54.9%	NUM	O	O
in	ADP	O	O
the	DET	O	O
30-,	NOUN	O	O
100-	NUM	O	O
and	CCONJ	O	O
300-mg	NUM	O	O
arms,	NOUN	O	O
respectively,	NOUN	O	O
without	ADP	O	O
statistical	ADJ	O	O
significance	NOUN	O	O
for	ADP	O	O
dose-response.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

BACKGROUND:	NOUN	O	O
Heartburn	NOUN	O	O
that	ADP	O	O
persists	NOUN	O	O
despite	ADP	O	O
proton-pump	NOUN	O	O
inhibitor	NOUN	O	O
(PPI)	NOUN	O	O
treatment	NOUN	O	O
is	VERB	O	O
a	DET	O	O
frequent	ADJ	O	O
clinical	ADJ	O	O
problem	ADP	O	O
with	ADP	O	O
multiple	ADJ	O	O
potential	ADJ	O	O
causes.	NOUN	O	O

RESULTS:	NOUN	O	O
Patients'	NOUN	O	O
main	ADJ	O	B-outcome
curve	NOUN	O	I-outcome
correction	NOUN	O	I-outcome
after	ADP	O	O
surgical	ADJ	O	O
procedure	NOUN	O	O
regardless	ADV	O	O
type	NOUN	O	O
of	ADP	O	O
rod	NOUN	O	O
was	VERB	O	O
48.95+/-11.04	NUM	O	O
(13-75)	NOUN	O	O
degree.	NOUN	O	O

Journal-Name:The	ADJ	O	O
Lancet.	NOUN	O	O

The	DET	O	O
LBW	NOUN	O	O
patients	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
278)	NOUN	O	O
were	VERB	O	O
injected	VERB	O	O
with	ADP	O	O
679	NUM	O	O
mg	NOUN	O	O
iodine/kg	DET	O	O
(men)	ADV	O	O
or	CCONJ	O	O
762	NUM	O	O
mg	NOUN	O	O
iodine/kg	DET	O	O
(women).	NOUN	O	O

Parents	NOUN	O	O
and	CCONJ	O	O
caregivers	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
6	NUM	O	O
to	PART	O	O
40	NUM	O	O
months	NOUN	O	O
age	NOUN	O	O
group	NOUN	O	O
in	ADP	O	O
intervention	NOUN	O	O
villages	NOUN	O	O
received	VERB	O	O
intensive	ADJ	O	O
education	NOUN	O	O
on	ADP	O	O
hand	NOUN	O	O
hygiene.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

In	ADP	O	O
the	DET	O	O
SSD	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
37)	NOUN	O	O
and	CCONJ	O	O
NPWT	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
36)	NOUN	O	O
cohorts,	NOUN	O	O
the	DET	O	O
superficial	ADJ	O	O
surgical	ADJ	O	B-outcome
site	NOUN	O	I-outcome
infection	NOUN	O	I-outcome
(SSI)	NOUN	O	I-outcome
,	PUNCT	O	O
deep	ADJ	O	B-outcome
surgical	ADJ	O	I-outcome
site	NOUN	O	I-outcome
infection	NOUN	O	I-outcome
(SSI)	NOUN	O	I-outcome
,	PUNCT	O	O
seroma	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
dehiscence	NOUN	O	B-outcome
rates	NOUN	O	O
were	VERB	O	O
16	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
and	CCONJ	O	O
14	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
(P	NUM	O	O
>	SYM	O	O
0.99),	NUM	O	O
5	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
and	CCONJ	O	O
8	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
(P	NUM	O	O
=	SYM	O	O
0.67),	NUM	O	O
16	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
and	CCONJ	O	O
11	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
(P	NUM	O	O
=	SYM	O	O
0.74),	NUM	O	O
and	CCONJ	O	O
5	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
and	CCONJ	O	O
3	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
(P	NUM	O	O
>/=	NOUN	O	O
0.99),	NUM	O	O
respectively.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

T	NOUN	O	O
Lund-Mackay	NOUN	O	O
score],	NUM	O	O
modified	VERB	O	O
Lund-Mackay	NOUN	O	O
score],	NUM	O	O
estimated	VERB	O	B-outcome
radiation	NOUN	O	I-outcome
exposure	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
surgical	ADJ	O	B-outcome
complications	NOUN	O	I-outcome
were	VERB	O	O
evaluated	VERB	O	O
for	ADP	O	O
each	DET	O	O
patient.	NOUN	O	O

BACKGROUND:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
a	DET	O	O
bandage	NOUN	O	O
contact	NOUN	O	O
lens	NOUN	O	O
for	ADP	O	O
alleviating	VERB	O	O
dry	ADJ	O	B-outcome
eye	NOUN	O	I-outcome
discomfort	NOUN	O	I-outcome
after	ADP	O	O
phacoemulsification.	NOUN	O	O

Serum	NOUN	O	O
APN	NOUN	O	O
levels	NOUN	O	O
were	VERB	O	O
positively	ADV	O	O
correlated	VERB	O	O
with	ADP	O	O
FINS	NOUN	O	O
and	CCONJ	O	O
TG	NOUN	O	O
(r	NUM	O	O
=	SYM	O	O
0.412,	NOUN	O	O
0.316,	NUM	O	O
respectively;	NOUN	O	O
both	CCONJ	O	O
P<0.05),	NOUN	O	O
and	CCONJ	O	O
negatively	ADV	O	O
correlated	VERB	O	O
with	ADP	O	O
SBP,	NOUN	O	O
DBP	NOUN	O	O
and	CCONJ	O	O
LDL-C	NOUN	O	O
(r	NUM	O	O
=	SYM	O	O
-0.292,	NOUN	O	O
-0.383,	SYM	O	O
-0.334,	NOUN	O	O
respectively;	NOUN	O	O
all	DET	O	O
P<0.05).	NOUN	O	O

The	DET	O	O
median	ADJ	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
an	DET	O	Seperator
objective	ADP	O	I-outcome
response	NOUN	O	I-outcome
among	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
a	DET	O	O
response	NOUN	O	O
was	VERB	O	O
9.6	NUM	O	O
months	NOUN	O	O
(interquartile	NUM	O	O
range,	VERB	O	O
6.6	NUM	O	O
to	PART	O	O
16.7)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sorafenib	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
13.3	NUM	O	O
months	NOUN	O	O
(interquartile	NUM	O	O
range,	VERB	O	O
11.2	NUM	O	O
to	PART	O	O
31.1)	ADJ	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

Journal-Name:	NOUN	O	O
Journal	ADJ	O	O
of	ADP	O	O
computer	NOUN	O	O
assisted	VERB	O	O
tomography	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/14	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

BACKGROUND:	NOUN	O	O
Riociguat	ADP	O	O
is	VERB	O	O
a	DET	O	O
soluble	ADJ	O	O
guanylate	NOUN	O	O
cyclase	NOUN	O	O
stimulator	NOUN	O	O
approved	VERB	O	O
for	ADP	O	O
pulmonary	ADJ	O	O
arterial	ADJ	O	O
hypertension	NOUN	O	O
(PAH)	PUNCT	O	O
and	CCONJ	O	O
chronic	ADJ	O	O
thromboembolic	ADJ	O	O
pulmonary	ADJ	O	O
hypertension	NOUN	O	O
(CTPEH).	NOUN	O	O

The	DET	O	O
CMFCs	NOUN	O	O
were	VERB	O	O
defined	VERB	O	O
as	ADP	O	O
having	VERB	O	O
emergency	NOUN	O	B-outcome
C-section	NOUN	O	I-outcome
,	PUNCT	O	O
perineal	ADJ	O	B-outcome
trauma	NOUN	O	I-outcome
,	PUNCT	O	O
pregnancy-induced	VERB	O	B-outcome
hypertension	NOUN	O	I-outcome
and	CCONJ	O	Seperator
preeclampsia	NOUN	O	I-outcome
,	PUNCT	O	O
prematurity	NOUN	O	B-outcome
,	PUNCT	O	O
large-for-gestational-age	NOUN	O	B-outcome
,	PUNCT	O	O
and/or	CCONJ	O	O
small-for-gestational-age	NOUN	O	B-outcome
.	PUNCT	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
874	NUM	O	O
women	NOUN	O	O
were	VERB	O	O
stratified	VERB	O	O
into	ADP	O	O
three	NUM	O	O
groups	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
late	ADJ	O	O
first-trimester	NOUN	O	O
compliance	NOUN	O	O
with	ADP	O	O
six	NUM	O	O
food	NOUN	O	O
targets:	NOUN	O	O
>12	NOUN	O	O
servings/week	NOUN	O	O
of	ADP	O	O
vegetables,	NOUN	O	O
>12	NOUN	O	O
servings/week	NOUN	O	O
of	ADP	O	O
fruits,	NOUN	O	O
<2	NOUN	O	O
servings/week	NOUN	O	O
of	ADP	O	O
juice,	NOUN	O	O
>3	NOUN	O	O
servings/week	NOUN	O	O
of	ADP	O	O
nuts,	NOUN	O	O
>6	NOUN	O	O
days/week	NOUN	O	O
consumption	NOUN	O	O
of	ADP	O	O
extra	ADJ	O	O
virgin	PUNCT	O	O
olive	ADJ	O	O
oil	NOUN	O	O
(EVOO),	NOUN	O	O
and	CCONJ	O	O
>/=40	ADJ	O	O
mL/day	NOUN	O	O
of	ADP	O	O
EVOO.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

RESULTS:	NOUN	O	O
Fifty-two	NUM	O	O
residents	NOUN	O	O
participated	VERB	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
(Group	PUNCT	O	O
C:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
27,	NUM	O	O
Group	NOUN	O	O
3D:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
25).	NOUN	O	O

Participants	NOUN	O	O
viewed	VERB	O	O
promotional	ADJ	O	O
videos	NOUN	O	O
and	CCONJ	O	O
news	NOUN	O	O
stories	NOUN	O	O
about	ADV	O	O
an	DET	O	O
upcoming	VERB	O	O
international,	PUNCT	O	O
multi-sport	NOUN	O	O
event	NOUN	O	O
(with	PUNCT	O	O
sponsor	ADP	O	O
content	NOUN	O	O
edited	VERB	O	O
to	PART	O	O
reflect	NOUN	O	O
each	DET	O	O
condition),	NOUN	O	O
completed	VERB	O	O
a	DET	O	O
distractor	NOUN	O	O
task,	NOUN	O	O
and	CCONJ	O	O
then	ADV	O	O
answered	VERB	O	O
questions	NOUN	O	O
assessing	VERB	O	O
the	DET	O	O
response	NOUN	O	O
variables.	NUM	O	O

No	DET	O	O
major	ADJ	O	O
complications	NOUN	O	B-outcome
were	VERB	O	O
noted.	NOUN	O	O

Although	ADP	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
general	ADJ	O	O
trend	NOUN	O	O
of	ADP	O	O
fasting	VERB	O	B-outcome
blood	NOUN	O	I-outcome
sugar	NOUN	O	I-outcome
(FBS)	PUNCT	O	I-outcome
reduction,	NOUN	O	O
the	DET	O	O
numbers	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
who	ADP	O	O
may	VERB	O	O
be	VERB	O	O
classified	VERB	O	O
as	ADP	O	O
pre-diabetes	NOUN	O	O
and	CCONJ	O	O
diabetes	NOUN	O	O
groups	NOUN	O	O
(	PUNCT	O	O
fasting	VERB	O	B-outcome
blood	NOUN	O	I-outcome
sugar	NOUN	O	I-outcome
(FBS)	PUNCT	O	I-outcome
100	NUM	O	O
mg/dl)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
amla	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
only	ADV	O	O
8.	NUM	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
WHO	NOUN	O	O
ACE	NOUN	O	O
approach	NOUN	O	O
supported	VERB	O	O
development	NOUN	O	O
and	CCONJ	O	O
sustainment	ADP	O	O
of	ADP	O	O
a	DET	O	O
network	NOUN	O	O
of	ADP	O	O
organizations	NOUN	O	O
linking	VERB	O	O
health	NOUN	O	O
care	NOUN	O	O
and	CCONJ	O	O
social	ADJ	O	O
services	NOUN	O	O
across	ADP	O	O
East	ADV	O	O
Baltimore.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
and	CCONJ	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
six	NUM	O	O
months.	NOUN	O	O

Schools	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
free	ADJ	O	O
vision	NOUN	O	O
care	NOUN	O	O
and	CCONJ	O	O
eyeglasses,	NOUN	O	O
if	ADP	O	O
needed,	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group,	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
glasses	NOUN	O	O
only	ADV	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
benefits	NOUN	O	O
of	ADP	O	O
treating	VERB	O	O
the	DET	O	O
donor	NOUN	O	O
liver	NOUN	O	O
with	ADP	O	O
Simvastatin	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
standard	ADJ	O	O
transplant	NOUN	O	O
procedure.	NOUN	O	O

Plazomicin	NOUN	O	O
is	VERB	O	O
an	DET	O	O
aminoglycoside	NOUN	O	O
with	ADP	O	O
bactericidal	ADJ	O	O
activity	NOUN	O	O
against	ADP	O	O
multidrug-resistant	ADJ	O	O
(including	PUNCT	O	O
carbapenem-resistant)	NOUN	O	O
Enterobacteriaceae.	NOUN	O	O

These	DET	O	O
results	NOUN	O	O
confirm	NOUN	O	O
retrospective	ADJ	O	O
studies	NOUN	O	O
and	CCONJ	O	O
add	NOUN	O	O
that	ADP	O	O
histopathology	NOUN	O	O
subtype	NOUN	O	O
is	VERB	O	O
a	DET	O	O
strong	ADJ	O	O
determinant	NOUN	O	O
of	ADP	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(DFS)	NOUN	O	I-outcome
in	ADP	O	O
resected	VERB	O	O
MAGE-A3-positive	ADJ	O	O
NSCLC.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/16	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
Effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Multidisciplinary	ADJ	O	O
Lifestyle	NOUN	O	O
Intervention	NOUN	O	O
on	ADP	O	O
Obesity	NOUN	O	B-outcome
Status,	NOUN	O	O
Body	NOUN	O	B-outcome
Composition	NOUN	O	I-outcome
,	PUNCT	O	O
Physical	ADJ	O	B-outcome
Fitness	ADV	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
Cardiometabolic	ADJ	O	B-outcome
Risk	NOUN	O	O
Markers	NOUN	O	O
in	ADP	O	O
Children	NOUN	O	O
and	CCONJ	O	O
Adolescents	NOUN	O	O
with	ADP	O	O
Obesity.	ADP	O	O

No	DET	O	O
difference	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
event	NOUN	O	I-outcome
incidences	NOUN	O	O
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
was	VERB	O	O
observed.	NOUN	O	O

Conclusions:	NOUN	O	O
CBT-i	NOUN	O	O
for	ADP	O	O
chronic	ADJ	O	O
insomnia	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
both	CCONJ	O	O
CBT-i	NOUN	O	O
alone	ADJ	O	O
and	CCONJ	O	O
combination	NOUN	O	O
with	ADP	O	O
tapered	VERB	O	O
hypnotic	ADJ	O	O
agents.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Overall,	NOUN	O	B-outcome
abdominal,	ADJ	O	B-outcome
and	CCONJ	O	Seperator
shoulder	NOUN	O	B-outcome
pains	NOUN	O	E1-outcome
were	VERB	O	O
evaluated	VERB	O	O
at	ADP	O	O
rest	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
motion	NOUN	O	O
on	ADP	O	O
postoperative	ADJ	O	O
day	NOUN	O	O
3.	NUM	O	O

Title:	NOUN	O	O
Therapeutic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
dimethyldiguanide	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
polycystic	ADJ	O	O
ovary	NOUN	O	O
syndrome.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Once-daily	NOUN	O	O
plazomicin	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
meropenem	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
complicated	VERB	O	O
UTIs	NOUN	O	O
and	CCONJ	O	O
acute	ADJ	O	O
pyelonephritis	NOUN	O	O
caused	VERB	O	O
by	ADP	O	O
Enterobacteriaceae,	NOUN	O	O
including	VERB	O	O
multidrug-resistant	ADJ	O	O
strains.	NUM	O	O
(	PUNCT	O	O

Potential	NOUN	O	O
for	ADP	O	O
skin	NOUN	O	O
irritation	NOUN	O	O
and	CCONJ	O	O
dryness,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
pigmentary	NOUN	O	O
changes	NOUN	O	O
are	VERB	O	O
key	ADJ	O	O
concerns.	NOUN	O	O

The	DET	O	O
PICIHBI	NOUN	O	O
group	NOUN	O	O
demonstrated	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
one	NUM	O	O
Test	NOUN	O	O
of	ADP	O	O
Playfulness	ADV	O	B-outcome
(ToP)	ADV	O	O
item	NOUN	O	O
score	NOUN	O	O
at	ADP	O	O
midassessment.	NOUN	O	O

RESULTS:	NOUN	O	O
Total	ADJ	O	O
30-min	NOUN	O	O
time-trial	ADJ	O	B-outcome
distance	NOUN	O	I-outcome
significantly	ADV	O	O
increased	VERB	O	O
from	ADP	O	O
T1-T3	NOUN	O	O
within	ADP	O	O
betaA1	NOUN	O	O
only	ADV	O	O
(7397	NOUN	O	O
+/-	SYM	O	O
195	NUM	O	O
m	NOUN	O	O
to	PART	O	O
7580	NUM	O	O
+/-	SYM	O	O
171	NUM	O	O
m,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.002,	NUM	O	O
np(2)	ADJ	O	O
=	SYM	O	O
0.196),	NUM	O	O
including	VERB	O	O
absolute	ADJ	O	O
average	NOUN	O	O
power	NOUN	O	B-outcome
(194.8	ADP	O	O
+/-	SYM	O	O
18.3	NUM	O	O
W	NOUN	O	O
to	PART	O	O
204.2	NUM	O	O
+/-	SYM	O	O
15.5	NUM	O	O
W,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.04,	NUM	O	O
np(2)	ADJ	O	O
=	SYM	O	O
0.115)	NOUN	O	O
and	CCONJ	O	O
relative	ADJ	O	O
average	NOUN	O	O
power	NOUN	O	B-outcome
output	NOUN	O	I-outcome
(2.28	PUNCT	O	O
+/-	SYM	O	O
0.15	NUM	O	O
W.kg(-	NOUN	O	O
1)	NUM	O	O
to	PART	O	O
2.41	NUM	O	O
+/-	SYM	O	O
0.12	NUM	O	O
W.kg(-	NOUN	O	O
1),	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.031,	NUM	O	O
np(2)	ADJ	O	O
=	SYM	O	O
0.122).	NUM	O	O

METHODS:	NOUN	O	O
The	DET	O	O
phase	NOUN	O	O
3,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
TOURMALINE-MM3	PUNCT	O	O
study	NOUN	O	O
took	VERB	O	O
place	NOUN	O	O
in	ADP	O	O
167	NUM	O	O
clinical	ADJ	O	O
or	CCONJ	O	O
hospital	NOUN	O	O
sites	NOUN	O	O
in	ADP	O	O
30	NUM	O	O
countries	NOUN	O	O
in	ADP	O	O
Europe,	NOUN	O	O
the	DET	O	O
Middle	ADJ	O	O
East,	NOUN	O	O
Africa,	NOUN	O	O
Asia,	ADV	O	O
and	CCONJ	O	O
North	NOUN	O	O
and	CCONJ	O	O
South	NOUN	O	O
America.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Materials	NOUN	O	O
and	CCONJ	O	O
Methods:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
prospective	ADJ	O	O
study,	NOUN	O	O
80	NUM	O	O
patients	NOUN	O	O
that	ADP	O	O
underwent	VERB	O	O
radical	NOUN	O	O
resection	NOUN	O	O
for	ADP	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
four	NUM	O	O
groups:	NOUN	O	O
(1)	PUNCT	O	O
the	DET	O	O
parecoxib	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
preintravenous	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
parecoxib	NOUN	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
PCIA	NOUN	O	O
after	ADP	O	O
surgery;	NOUN	O	O
(2)	PUNCT	O	O
the	DET	O	O
TAP	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
TAP	NOUN	O	O
block	VERB	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
PCIA;	NOUN	O	O
(3)	PUNCT	O	O
the	DET	O	O
parecoxib	NOUN	O	O
+	SYM	O	O
TAP	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
parecoxib	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
TAP	NOUN	O	O
block	VERB	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
PCIA;	NOUN	O	O
and	CCONJ	O	O
(4)	PUNCT	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
only	ADV	O	O
postoperative	ADJ	O	O
PCIA	NOUN	O	O
and	CCONJ	O	O
preinjection	NOUN	O	O
of	ADP	O	O
normal	ADJ	O	O
saline.	NOUN	O	O

Twenty	NUM	O	O
minutes	NOUN	O	O
before	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
surgery,	NOUN	O	O
single	ADJ	O	O
bolus	NOUN	O	O
injection	NOUN	O	O
of	ADP	O	O
fentanyl,	NOUN	O	O
50	NUM	O	O
mug	NUM	O	O
(fentanyl	PUNCT	O	O
group	NOUN	O	O
[group	NOUN	O	O
F],	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
23)	NUM	O	O
or	CCONJ	O	O
oxycodone,	ADV	O	O
4	NUM	O	O
mg	NOUN	O	O
(oxycodone	NUM	O	O
group	NOUN	O	O
[group	NOUN	O	O
O],	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
23)	NUM	O	O
was	VERB	O	O
administered	VERB	O	O
intravenously.	NOUN	O	O
[	PUNCT	O	O

Title:	NOUN	O	O
When	ADP	O	O
color	NOUN	O	O
helps.	NOUN	O	O

RESULTS:	NOUN	O	O
Women	NOUN	O	O
in	ADP	O	O
the	DET	O	O
green	ADV	O	O
tea	NOUN	O	O
group	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
decrease	NOUN	O	O
in	ADP	O	O
the	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
cystitis	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
and	CCONJ	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
the	DET	O	O
urinalysis	ADV	O	B-outcome
results	NOUN	O	O
except	ADP	O	O
for	ADP	O	O
hematuria	NOUN	O	O
after	ADP	O	O
3	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

The	DET	O	O
inflammatory	ADJ	O	O
response	NOUN	O	O
indicators	NOUN	O	O
(	PUNCT	O	O
C-reactive	ADJ	O	B-outcome
protein	NOUN	O	I-outcome
,	PUNCT	O	O
erythrocyte	NOUN	O	B-outcome
sedimentation	NOUN	O	I-outcome
rate	NOUN	O	I-outcome
)	PUNCT	O	O
and	CCONJ	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
index	NOUN	O	O
(	PUNCT	O	O
creatine	NOUN	O	B-outcome
kinase	NOUN	O	I-outcome
)	PUNCT	O	O
were	VERB	O	O
recorded	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

INTERVENTION(S):	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
participants	NOUN	O	O
to	PART	O	O
1	NUM	O	O
of	ADP	O	O
4	NUM	O	O
groups:	NOUN	O	O
rigid	NOUN	O	O
taping,	NOUN	O	O
Kinesio	NOUN	O	O
taping,	NOUN	O	O
placebo,	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
(no	PUNCT	O	O
taping).	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
ethnopharmacology	NOUN	O	O

Conclusion:	NOUN	O	O
Foot	NOUN	O	O
and	CCONJ	O	O
ankle	NOUN	O	O
characteristics	NOUN	O	O
were	VERB	O	O
different	ADJ	O	O
in	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
PFOA	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
control	NOUN	O	O
participants,	NOUN	O	O
however	ADV	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
dynamic	ADJ	O	O
knee	NOUN	O	O
valgus	NOUN	O	O
during	ADP	O	O
single	ADJ	O	O
leg	NOUN	O	O
squat.	NOUN	O	O

Journal-Name:	NOUN	O	O
Lin	NOUN	O	O
chuang	NOUN	O	O
er	NOUN	O	O
bi	ADP	O	O
yan	NOUN	O	O
hou	VERB	O	O
tou	NOUN	O	O
jing	VERB	O	O
wai	CCONJ	O	O
ke	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
otorhinolaryngology,	NOUN	O	O
head,	ADJ	O	O
and	CCONJ	O	O
neck	NOUN	O	O
surgery	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Title:	NOUN	O	O
Why	NOUN	O	O
people	NOUN	O	O
engage	NOUN	O	O
in	ADP	O	O
a	DET	O	O
weight	NOUN	O	O
loss	NOUN	O	O
intervention	NOUN	O	O
at	ADP	O	O
their	ADJ	O	O
workplace	ADJ	O	O
-	PUNCT	O	O
a	DET	O	O
stratified	VERB	O	O
case	NOUN	O	O
study.	NOUN	O	O

RESULTS:	NOUN	O	O
TXA	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
perioperative	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.001);	NUM	O	O
the	DET	O	O
mean	NOUN	O	O
differences	NOUN	O	O
were	VERB	O	O
525.3	NUM	O	O
ml	NOUN	O	O
(short-TXA	PUNCT	O	O
vs	CCONJ	O	O
placebo)	NOUN	O	O
and	CCONJ	O	O
550.1	NUM	O	O
ml	NOUN	O	O
(long-TXA	PUNCT	O	O
vs	CCONJ	O	O
placebo).	NOUN	O	O

Efficacy	NOUN	O	O
assessments	NOUN	O	O
included	VERB	O	O
changes	NOUN	O	O
in	ADP	O	O
baseline	NOUN	O	O
inflammatory	ADJ	O	O
and	CCONJ	O	O
noninflammatory	ADJ	O	O
lesions	NOUN	O	B-outcome
and	CCONJ	O	O
treatment	NOUN	O	B-outcome
success	NOUN	O	I-outcome
(at	NUM	O	O
least	ADV	O	O
2-grade	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
Evaluator's	NOUN	O	O
Global	NOUN	O	O
Severity	NOUN	O	O
Score	NOUN	O	O
(EGSS)	PUNCT	O	O
and	CCONJ	O	O
clear/almost	NOUN	O	O
clear).	NOUN	O	O

The	DET	O	O
proportion	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
SAEs	NOUN	O	B-outcome
in	ADP	O	O
groups	NOUN	O	O
receiving	VERB	O	O
IBU	NOUN	O	O
was	VERB	O	O
15%,	NUM	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
PCM-alone	NOUN	O	O
group,	NOUN	O	O
was	VERB	O	O
11%.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
include	VERB	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
cure	NOUN	O	B-outcome
rate	NOUN	O	O
and	CCONJ	O	O
intensity	NOUN	O	B-outcome
reduction	NOUN	O	O
rate	NOUN	O	O
between	ADP	O	O
the	DET	O	O
intense	ADJ	O	O
and	CCONJ	O	O
standard	ADJ	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
other	ADJ	O	O
diagnostic	ADJ	O	O
tests,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
the	DET	O	O
accuracy	NOUN	O	O
of	ADP	O	O
the	DET	O	O
different	ADJ	O	O
diagnostic	ADJ	O	O
tests,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
PZQ.	NOUN	O	O

The	DET	O	O
visual	ADJ	O	O
analog	NOUN	O	O
score	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
measure	NOUN	O	O
the	DET	O	O
pain	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
mean	NOUN	O	O
operative	ADJ	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
patient-controlled	VERB	O	O
intravenous	ADJ	O	O
analgesia	NOUN	O	B-outcome
pressing	VERB	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
time	NOUN	O	B-outcome
for	ADP	O	Seperator
first	ADV	O	I-outcome
out-of-bed	VERB	O	I-outcome
activity	NOUN	O	I-outcome
,	PUNCT	O	O
first	ADV	O	B-outcome
anus	NOUN	O	I-outcome
exhaust	ADV	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
hospital	NOUN	O	B-outcome
stay	NOUN	O	I-outcome
duration	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
complications	NOUN	O	B-outcome
were	VERB	O	O
recorded.	NOUN	O	O

METHODS:	NOUN	O	O
65	NUM	O	O
randomly	ADV	O	O
selected	VERB	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
elective	ADJ	O	O
complex	NOUN	O	O
percutaneous	ADJ	O	O
coronary	ADJ	O	O
intervention	NOUN	O	O
(PCI)	PUNCT	O	O
procedures	NOUN	O	O
from	ADP	O	O
January	NOUN	O	O
2017	NUM	O	O
to	PART	O	O
2017	NUM	O	O
were	VERB	O	O
randomized	VERB	O	O
in	ADP	O	O
a	DET	O	O
1:1	ADJ	O	O
pattern	NOUN	O	O
with	ADP	O	O
or	CCONJ	O	O
without	ADP	O	O
the	DET	O	O
RADPAD.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
28-day	NOUN	O	O
neonatal	ADJ	O	B-outcome
behavioral	ADJ	O	I-outcome
neurological	ADJ	O	I-outcome
assessment	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
the	DET	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
by	ADP	O	O
2.9	NUM	O	O
[95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
(95%CI)	NOUN	O	O
=	SYM	O	O
1.0-4.8],	NOUN	O	O
Bayley	PROPN	O	O
scales	NOUN	O	O
of	ADP	O	O
infant	NOUN	O	B-outcome
development	NOUN	O	I-outcome
(BSID)	NUM	O	O
score	NOUN	O	O
at	ADP	O	O
15	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
age	NOUN	O	O
was	VERB	O	O
improved	VERB	O	O
significantly,	NOUN	O	O
mental	ADJ	O	B-outcome
development	NOUN	O	I-outcome
index	NOUN	O	O
(MDI)	NOUN	O	O
score	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
by	ADP	O	O
11.8	NUM	O	O
(95%CI	PUNCT	O	O
=	SYM	O	O
4.3-19.3),	NOUN	O	O
and	CCONJ	O	O
psychomotor	NOUN	O	B-outcome
development	NOUN	O	I-outcome
index	NOUN	O	O
(PDI)	NOUN	O	O
score	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
by	ADP	O	O
12.4	NUM	O	O
(95%CI	PUNCT	O	O
=	SYM	O	O
2.5-22.3),	NOUN	O	O
with	ADP	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(all	PUNCT	O	O
P	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Fifty	NUM	O	O
participants	NOUN	O	O
(male	PUNCT	O	O
and	CCONJ	O	O
female	NOUN	O	O
aged	VERB	O	O
20	NUM	O	O
to	PART	O	O
50	NUM	O	O
years)	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
two	NUM	O	O
groups.	NOUN	O	O

Hyaluronan-selected	VERB	O	O
sperm	NOUN	O	O
have	VERB	O	O
reduced	VERB	O	O
levels	NOUN	O	O
of	ADP	O	O
DNA	NOUN	O	O
damage	NOUN	O	O
and	CCONJ	O	O
aneuploidy.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Small	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
effects	NOUN	O	O
seen	VERB	O	O
between	ADP	O	O
genders	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
attributed	VERB	O	O
to	PART	O	O
the	DET	O	O
different	ADJ	O	O
sizes	NOUN	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
and	CCONJ	O	O
need	NOUN	O	O
to	PART	O	O
be	VERB	O	O
further	ADV	O	O
evaluated	VERB	O	O
in	ADP	O	O
randomized	VERB	O	O
trials	NOUN	O	O
that	ADP	O	O
are	VERB	O	O
appropriately	ADV	O	O
powered	VERB	O	O
for	ADP	O	O
gender	NOUN	O	O
analysis.	NOUN	O	O

Adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
that	ADP	O	O
emerged	VERB	O	O
after	ADP	O	O
treatment	NOUN	O	O
initiation	NOUN	O	O
were	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
41.1%	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
omadacycline	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
48.5%	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
moxifloxacin	NOUN	O	O
group;	ADJ	O	O
the	DET	O	O
most	DET	O	O
frequent	ADJ	O	O
events	NOUN	O	O
were	VERB	O	O
gastrointestinal	ADJ	O	B-outcome
(10.2%	VERB	O	O
and	CCONJ	O	O
18.0%,	NUM	O	O
respectively),	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
largest	ADV	O	O
difference	NOUN	O	O
was	VERB	O	O
for	ADP	O	O
diarrhea	NOUN	O	B-outcome
(1.0%	NOUN	O	O
and	CCONJ	O	O
8.0%).	NOUN	O	O

Recruitment	NOUN	O	O
was	VERB	O	O
from	ADP	O	O
January	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
May	NOUN	O	O
2018,	NUM	O	O
with	ADP	O	O
follow-up	NOUN	O	O
until	ADP	O	O
July	NOUN	O	O
2018.	NUM	O	O

Among	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
sorafenib,	NOUN	O	O
the	DET	O	O
most	DET	O	O
frequently	ADV	O	O
reported	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
grade	NOUN	O	O
1	NUM	O	O
or	CCONJ	O	O
2	NUM	O	O
events	NOUN	O	O
of	ADP	O	O
rash	NOUN	O	B-outcome
(73%),	NOUN	O	O
fatigue	NOUN	O	B-outcome
(67%),	NOUN	O	O
hypertension	NOUN	O	B-outcome
(55%),	NOUN	O	O
and	CCONJ	O	O
diarrhea	NOUN	O	B-outcome
(51%).	PUNCT	O	O

Small	ADJ	O	B-outcome
for	ADP	O	Seperator
gestational	ADJ	O	I-outcome
age	NOUN	O	I-outcome
at	ADP	O	Seperator
birth	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
more	ADV	O	O
often	ADV	O	O
detected	VERB	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group	NOUN	O	O
(179	PUNCT	O	O
of	ADP	O	O
556	NUM	O	O
(32%)	NUM	O	O
v	NUM	O	O
78	NUM	O	O
of	ADP	O	O
407	NUM	O	O
(19%),	NOUN	O	O
P<0.001).	NUM	O	O

Results	NOUN	O	O
demonstrated	VERB	O	O
both	CCONJ	O	O
subjective	ADJ	O	O
and	CCONJ	O	O
objective	ADP	O	O
functional	ADJ	O	B-outcome
mobility	NOUN	O	I-outcome
improvements	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
participants	NOUN	O	O
receiving	VERB	O	O
hippotherapy	NOUN	O	O
and	CCONJ	O	O
standard	ADJ	O	O
outpatient	ADJ	O	O
PT,	NOUN	O	O
as	ADP	O	O
determined	VERB	O	O
by	ADP	O	O
the	DET	O	O
Peabody	NOUN	O	O
Developmental	ADJ	O	B-outcome
Motor	NOUN	O	I-outcome
Scales-2],	NOUN	O	O
the	DET	O	O
Pediatric	ADJ	O	O
Evaluation	NOUN	O	O
of	ADP	O	O
Disability	NOUN	O	B-outcome
Inventory],	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
Goal	NOUN	O	B-outcome
Attainment	NOUN	O	I-outcome
Scaling].	NOUN	O	O
STATEMENT	NOUN	O	O
OF	ADP	O	O
CONCLUSION	NOUN	O	O
AND	CCONJ	O	O
RECOMMENDATIONS	NOUN	O	O
FOR	ADP	O	O
CLINICAL	ADJ	O	O
PRACTICE::	NOUN	O	O
When	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
standard	ADJ	O	O
outpatient	ADJ	O	O
PT,	NOUN	O	O
hippotherapy	NOUN	O	O
appears	NOUN	O	O
to	PART	O	O
be	VERB	O	O
a	DET	O	O
viable	ADJ	O	O
treatment	NOUN	O	O
strategy	NOUN	O	O
for	ADP	O	O
children	NOUN	O	O
aged	VERB	O	O
2	NUM	O	O
to	PART	O	O
5	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
neurological	ADJ	O	O
impairments	NOUN	O	O
and	CCONJ	O	O
gross	ADJ	O	O
motor	NOUN	O	O
delays,	NOUN	O	O
but	CCONJ	O	O
additional	ADJ	O	O
research	NOUN	O	O
in	ADP	O	O
this	DET	O	O
area	NOUN	O	O
is	VERB	O	O
needed	VERB	O	O
to	PART	O	O
validate	NOUN	O	O
findings.	NOUN	O	O

FUNDING:	NOUN	O	O
Neovii	NOUN	O	O
Biotech.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Inhalation	NOUN	O	O
aromatherapy	NOUN	O	O
using	VERB	O	O
lavender	NOUN	O	O
essential	ADJ	O	O
oil	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
of	ADP	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
with	ADP	O	O
a	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
severity	NOUN	O	O
of	ADP	O	O
complications	NOUN	O	B-outcome
and	CCONJ	O	O
physical-psychological	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
.	PUNCT	O	O

Patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
received	VERB	O	O
Garlicin	NOUN	O	O
Capsules	NOUN	O	O
1/time,	NOUN	O	O
3	NUM	O	O
times/d,	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
Kangfuxin	NOUN	O	O
liquid	ADV	O	O
10	NUM	O	O
mL	NOUN	O	O
to	PART	O	O
gargle	NOUN	O	O
3	NUM	O	O
times/d;	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
only	ADV	O	O
received	VERB	O	O
Kangfuxin	NOUN	O	O
liquid	ADV	O	O
10	NUM	O	O
mL	NOUN	O	O
gargle	NOUN	O	O
5	NUM	O	O
min,	NOUN	O	O
3/d.	NUM	O	O

24	NUM	O	O
+/-	SYM	O	O
4	NUM	O	O
kg/m(2))	NOUN	O	O
males	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
13)	DET	O	O
and	CCONJ	O	O
females	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
13)	DET	O	O
after	ADP	O	O
exercise-induced	VERB	O	O
dehydration	NOUN	O	O
(~	PUNCT	O	O
2.0%DeltaBody	NUM	O	O
Weight	NOUN	O	O
[BW])	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
heat	NOUN	O	O
(30	NOUN	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
50%	NUM	O	O
relative	ADJ	O	O
humidity	NOUN	O	O
[RH]).	NUM	O	O

Funded	VERB	O	O
by	ADP	O	O
Alnylam	NOUN	O	O
Pharmaceuticals;	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02452372	NOUN	O	O
.).	NOUN	O	O

Saliva	ADJ	O	O
cortisol	NOUN	O	B-outcome
,	PUNCT	O	O
a	DET	O	O
marker	NOUN	O	O
of	ADP	O	O
the	DET	O	O
endocrine	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
response	NOUN	O	I-outcome
system,	ADV	O	O
was	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Spearman	NOUN	O	O
rank	NOUN	O	O
correlation	NOUN	O	O
analysis	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
correlations	NOUN	O	O
between	ADP	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
and	CCONJ	O	O
TOFr.	NOUN	O	O

The	DET	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
sensory	ADJ	O	I-outcome
block	VERB	O	I-outcome
was	VERB	O	O
120.5	NUM	O	O
+/-	SYM	O	O
37.0	NUM	O	O
minutes	NOUN	O	O
in	ADP	O	O
Dex	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
70.5	NUM	O	O
+/-	SYM	O	O
34.5	NUM	O	O
minutes	NOUN	O	O
in	ADP	O	O
Control	NOUN	O	O
group,	NOUN	O	O
respectively	ADV	O	O
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

All	DET	O	O
participants	NOUN	O	O
received	VERB	O	O
allotments	NOUN	O	O
of	ADP	O	O
extra-virgin	NOUN	O	O
olive	ADJ	O	O
oil	NOUN	O	O
(1	NOUN	O	O
L/mo)	NOUN	O	O
and	CCONJ	O	O
nuts	NOUN	O	O
(125	NUM	O	O
g/mo)	ADP	O	O
for	ADP	O	O
free.	NOUN	O	O

Title:	NOUN	O	O
Vitamin	NOUN	O	O
D	NOUN	O	O
Daily	ADJ	O	O
versus	CCONJ	O	O
Monthly	ADV	O	O
Administration:	NOUN	O	O
Bone	NOUN	O	B-outcome
Turnover	ADV	O	I-outcome
and	CCONJ	O	O
Adipose	ADJ	O	B-outcome
Tissue	NOUN	O	I-outcome
Influences.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Results:	NOUN	O	O
Among	ADP	O	O
6874	NUM	O	O
randomized	VERB	O	O
participants	NOUN	O	O
(mean	NUM	O	O
[SD]	PUNCT	O	O
age,	NOUN	O	O
65.0	NUM	O	O
[4.9]	ADV	O	O
years;	NOUN	O	O
3406	NUM	O	O
[52%]	NUM	O	O
men),	NOUN	O	O
6583	NUM	O	O
(96%)	ADV	O	O
completed	VERB	O	O
the	DET	O	O
12-month	NOUN	O	O
follow-up	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
main	ADJ	O	O
analysis.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Observational	ADJ	O	O
Study	NOUN	O	O

Whether	ADP	O	O
hybrid	NOUN	O	O
minimally	ADV	O	O
invasive	ADJ	O	O
esophagectomy	NOUN	O	O
results	NOUN	O	O
in	ADP	O	O
lower	ADJ	O	O
morbidity	NOUN	O	O
than	ADP	O	O
open	ADJ	O	O
esophagectomy	NOUN	O	O
is	VERB	O	O
unclear.	NOUN	O	O

The	DET	O	O
toxicity	NOUN	O	B-outcome
were	VERB	O	O
evaluated	VERB	O	O
in	ADP	O	O
all	DET	O	O
patients	NOUN	O	O
this	DET	O	O
study	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
National	ADJ	O	O
Cancer	NOUN	O	O
Institute	NOUN	O	O
Common	ADJ	O	O
Toxicity	NOUN	O	O
Criteria	NOUN	O	O
4	NUM	O	O
(NCI	NOUN	O	O
CTC	NOUN	O	O
version	NOUN	O	O
4.0).A	PUNCT	O	O
total	ADJ	O	O
of	ADP	O	O
53	NUM	O	O
well-matched	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
were	VERB	O	O
retrospectively	ADV	O	O
analyzed.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/05/26	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Facilitators:	NOUN	O	O
peer	NOUN	O	O
influence,	NOUN	O	O
teacher	NOUN	O	O
influence,	NOUN	O	O
staggered	VERB	O	O
implementation,	ADP	O	O
incentives,	ADP	O	O
rewards,	NOUN	O	O
challenges	NOUN	O	O
and	CCONJ	O	O
competition,	NOUN	O	O
flexibility	NOUN	O	O
and	CCONJ	O	O
adaptability,	ADJ	O	O
child	NOUN	O	O
ownership,	NOUN	O	O
routine.	SYM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/15	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Barriers:	NOUN	O	O
time	NOUN	O	O
within	ADP	O	O
an	DET	O	O
intense	ADJ	O	O
curriculum,	NOUN	O	O
space,	NOUN	O	O
sustaining	VERB	O	O
child	NOUN	O	O
interest,	NOUN	O	O
parental	ADJ	O	O
support,	NOUN	O	O
school	NOUN	O	O
policies.	NOUN	O	O

The	DET	O	O
current	ADJ	O	O
study	NOUN	O	O
protocol	NOUN	O	O
aims	NOUN	O	O
at	ADP	O	O
scaling	VERB	O	O
up	ADP	O	O
these	DET	O	O
results	NOUN	O	O
at	ADP	O	O
a	DET	O	O
provincial	ADJ	O	O
level	NOUN	O	O
using	VERB	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
design.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
probabilities	NOUN	O	O
of	ADP	O	O
decompression	NOUN	O	O
being	VERB	O	O
cost-effective	ADJ	O	O
compared	VERB	O	O
with	ADP	O	O
no	DET	O	O
treatment	NOUN	O	O
at	ADP	O	O
a	DET	O	O
willingness-to-pay	NOUN	O	O
threshold	NOUN	O	O
of	ADP	O	O
pound20	NOUN	O	O
000	NUM	O	O
per	ADP	O	O
QALY	NOUN	O	O
were	VERB	O	O
close	ADJ	O	O
to	PART	O	O
0%	NOUN	O	O
at	ADP	O	O
six	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
approximately	ADV	O	O
50%	NUM	O	O
at	ADP	O	O
one	NUM	O	O
year,	ADV	O	O
with	ADP	O	O
this	DET	O	O
probability	NOUN	O	O
potentially	ADV	O	O
increasing	VERB	O	O
for	ADP	O	O
the	DET	O	O
extrapolation	NOUN	O	O
to	PART	O	O
two	NUM	O	O
years.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Genotypes	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
plasma	NOUN	O	O
arachidonic	ADJ	O	B-outcome
acid	NOUN	O	I-outcome
levels	NOUN	O	O
and,	NOUN	O	O
if	ADP	O	O
considered	VERB	O	O
together	ADV	O	O
with	ADP	O	O
the	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
the	DET	O	O
precursor	NOUN	O	O
alpha-linolenic	ADJ	O	O
acid,	NOUN	O	O
also	ADV	O	O
with	ADP	O	O
DHA	NOUN	O	B-outcome
.	PUNCT	O	O
Functional	ADJ	O	B-outcome
outcomes	NOUN	O	O
and	CCONJ	O	O
supplementation	NOUN	O	O
effects	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
genotype.	NOUN	O	O

The	DET	O	O
Schirmer	NOUN	O	O
test	NOUN	O	O
results	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
change	NOUN	O	O
postoperatively.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
incidences	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
agitation	NOUN	O	B-outcome
and	CCONJ	O	O
oxygen	NOUN	O	B-outcome
saturation	NOUN	O	I-outcome
(SpO2)	ADV	O	I-outcome
.	PUNCT	O	O
Compared	VERB	O	O
with	ADP	O	O
control	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
of	ADP	O	O
DEX	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
decreased	VERB	O	O
after	ADP	O	O
20	NUM	O	O
minutes	NOUN	O	O
of	ADP	O	O
drug	NOUN	O	O
administration	NOUN	O	O
[(97.13+/-12.93)	NOUN	O	O
beats/min	NOUN	O	O
vs.(104.53+/-11.97)	NOUN	O	O
beats/min,	NOUN	O	O
P<0.05].	NOUN	O	O
The	DET	O	O
changes	NOUN	O	O
of	ADP	O	O
the	DET	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
and	CCONJ	O	O
oxygen	NOUN	O	B-outcome
saturation	NOUN	O	I-outcome
(SpO2)	ADV	O	I-outcome
in	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
within	ADP	O	O
the	DET	O	O
normal	ADJ	O	O
range.	ADJ	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
local	ADJ	O	O
application	NOUN	O	O
of	ADP	O	O
curcumin	NOUN	O	O
gel	NOUN	O	O
when	ADP	O	O
used	VERB	O	O
in	ADP	O	O
conjunction	NOUN	O	O
with	ADP	O	O
SRP	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
periodontal	ADJ	O	O
parameters	NOUN	O	O
and	CCONJ	O	O
has	VERB	O	O
a	DET	O	O
beneficial	ADJ	O	O
effect	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
periodontitis.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101213819	NUM	O	O

All	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
sufentanil	NOUN	O	O
(0.3	NOUN	O	O
mug/kg)	NOUN	O	O
30	NUM	O	O
min	NOUN	O	O
before	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
operation	NOUN	O	O
and	CCONJ	O	O
then	ADV	O	O
received	VERB	O	O
intravenous	ADJ	O	O
analgesia	NOUN	O	O
pump	NOUN	O	O
for	ADP	O	O
postoperative	ADJ	O	O
patient	NOUN	O	O
controlled	VERB	O	O
analgesia(PCA).	NOUN	O	O

L-valine	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
affect	NOUN	O	O
antral,	ADJ	O	B-outcome
pyloric	ADJ	O	B-outcome
(mean	NOUN	O	X
number;	NOUN	O	X
control:	NOUN	O	X
14	NUM	O	X
+/-	SYM	O	X
5;	NOUN	O	X
L-Val-0.15:	NOUN	O	X
21	NUM	O	X
+/-	SYM	O	X
9;	NOUN	O	X
L-Val-0.45:	NOUN	O	X
11	NUM	O	X
+/-	SYM	O	X
4)	NUM	O	X
or	CCONJ	O	Seperator
duodenal	ADJ	O	B-outcome
pressures	NOUN	O	E1-outcome
,	PUNCT	O	O
plasma	NOUN	O	O
cholecystokinin	NOUN	O	B-outcome
(mean	NUM	O	O
concentration,	NOUN	O	O
pmol/L;	NOUN	O	O
control:	NOUN	O	O
3.1	NUM	O	O
+/-	SYM	O	O
0.3;	NUM	O	O
L-Val-0.15:	NOUN	O	O
3.2	NUM	O	O
+/-	SYM	O	O
0.3;	NUM	O	O
L-Val-0.45:	NOUN	O	O
3.0	NUM	O	O
+/-	SYM	O	O
0.3),	NUM	O	O
blood	NOUN	O	B-outcome
glucose	NOUN	O	I-outcome
,	PUNCT	O	O
appetite	NOUN	O	B-outcome
perceptions	NOUN	O	I-outcome
,	PUNCT	O	O
symptoms	NOUN	O	B-outcome
or	CCONJ	O	O
energy	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
(kcal;	NOUN	O	O
control:	NOUN	O	O
1040	NUM	O	O
+/-	SYM	O	O
73;	NUM	O	O
L-Val-0.15:	NOUN	O	O
1040	NUM	O	O
+/-	SYM	O	O
81;	NUM	O	O
L-Val-0.45:	NOUN	O	O
1056	NUM	O	O
+/-	SYM	O	O
100),	NOUN	O	O
at	ADP	O	O
either	CCONJ	O	O
load	NOUN	O	O
(p	PUNCT	O	O
>	SYM	O	O
0.05	NUM	O	O
for	ADP	O	O
all).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
TPI	NOUN	O	O
and	CCONJ	O	O
EMLA	NOUN	O	O
with	ADP	O	O
occlusive	ADJ	O	O
dressing	VERB	O	O
effectively	ADV	O	O
reduced	VERB	O	O
the	DET	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
after	ADP	O	O
total	ADJ	O	O
laparoscopic	ADJ	O	O
hysterectomy.	NOUN	O	O

The	DET	O	O
experimental	ADJ	O	O
sets	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
to	PART	O	O
momentary	ADJ	O	O
muscular	ADJ	O	O
failure.	NOUN	O	O

The	DET	O	O
data	NOUN	O	O
of	ADP	O	O
age,	NOUN	O	O
sex,	NOUN	O	O
and	CCONJ	O	O
laterality	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
through	ADP	O	O
pairwise	NOUN	O	O
comparison.	NOUN	O	O

Furthermore,	NOUN	O	O
we	PRON	O	O
observed	VERB	O	O
a	DET	O	O
strong	ADJ	O	O
correlation	NOUN	O	O
between	ADP	O	O
noggin	NOUN	O	B-outcome
and	CCONJ	O	O
wrist	NOUN	O	B-outcome
bone	NOUN	O	I-outcome
mineral	NOUN	O	I-outcome
density	NOUN	O	I-outcome
(r	NUM	O	O
=	SYM	O	O
-0.641,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.002)	NUM	O	O
only	ADV	O	O
in	ADP	O	O
the	DET	O	O
denosumab	NOUN	O	O
group.	VERB	O	O

There	PRON	O	O
were	VERB	O	O
98	NUM	O	O
male	NOUN	O	O
and	CCONJ	O	O
131	NUM	O	O
female	NOUN	O	O
patients,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
65.5	NUM	O	O
years	NOUN	O	O
(32	PUNCT	O	O
to	PART	O	O
91).	NOUN	O	O

1.6%	ADP	O	O
reported	VERB	O	O
sexual	ADJ	O	O
abuse,	NOUN	O	O
8.0%	NOUN	O	O
recent	ADJ	O	O
eve	VERB	O	O
teasing	VERB	O	O
and	CCONJ	O	O
6.3%	ADJ	O	O
having	VERB	O	O
no	DET	O	O
parental	ADJ	O	O
emotional	ADJ	O	O
support.	NOUN	O	O

All	DET	O	O
local	ADJ	O	B-outcome
solicited	VERB	O	I-outcome
and	CCONJ	O	Seperator
unsolicited	VERB	O	I-outcome
AEs	NOUN	O	I-outcome
were	VERB	O	O
grade	NOUN	O	O
1	NUM	O	O
or	CCONJ	O	O
2.	NUM	O	O

Limitations:	NOUN	O	O
This	DET	O	O
post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
was	VERB	O	O
limited	VERB	O	O
to	PART	O	O
patients	NOUN	O	O
with	ADP	O	O
moderate-to-severe	ADV	O	O
plaque	NOUN	O	O
psoriasis	NOUN	O	O
with	ADP	O	O
IGA	NOUN	O	O
>/=3	NOUN	O	O
and	CCONJ	O	O
BSA	NOUN	O	O
involvement	NOUN	O	O
(3%-12%).	PUNCT	O	O

Journal-Name:	NOUN	O	O
BMJ	NOUN	O	O
(Clinical	ADJ	O	O
research	NOUN	O	O
ed.)	NOUN	O	O

RESULTS:	NOUN	O	O
Initial	ADJ	O	O
bleeding	VERB	O	B-outcome
control	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
cyanoacrylate	VERB	O	O
versus	CCONJ	O	O
sclerotherapy	NOUN	O	O
groups	NOUN	O	O
(98.25,	PUNCT	O	O
83.93%	PUNCT	O	O
respectively,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.007).	NUM	O	O

Objective:	NOUN	O	O
The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
preintravenous	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
parecoxib,	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
transversus	NOUN	O	O
abdominis	NOUN	O	O
plane	ADJ	O	O
(TAP)	PUNCT	O	O
block	VERB	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
patient-controlled	VERB	O	O
intravenous	ADJ	O	O
analgesia	NOUN	O	O
(PCIA)	PUNCT	O	O
pump,	NOUN	O	O
in	ADP	O	O
strategy	NOUN	O	O
of	ADP	O	O
enhanced	VERB	O	O
recovery	NOUN	O	B-outcome
after	ADP	O	O
surgery	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
radical	NOUN	O	O
resection	NOUN	O	O
of	ADP	O	O
colorectal	ADJ	O	O
cancer.	NOUN	O	O

Participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
tested	VERB	O	O
again	ADV	O	O
after	ADP	O	O
1	NUM	O	O
week	NOUN	O	O
(test-2).	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Hypoxemia	NOUN	O	O
is	VERB	O	O
the	DET	O	O
most	DET	O	O
common	ADJ	O	O
complication	NOUN	O	O
during	ADP	O	O
tracheal	ADJ	O	O
intubation	NOUN	O	O
of	ADP	O	O
critically	ADV	O	O
ill	ADJ	O	O
adults	NOUN	O	O
and	CCONJ	O	O
may	VERB	O	O
increase	NOUN	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
cardiac	ADJ	O	O
arrest	NOUN	O	O
and	CCONJ	O	O
death.	ADP	O	O

The	DET	O	O
significance	NOUN	O	O
level	NOUN	O	O
adopted	VERB	O	O
was	VERB	O	O
of	ADP	O	O
0.05.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
We	PRON	O	O
examined	VERB	O	O
baseline	NOUN	O	O
characteristics	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(DFS)	NOUN	O	I-outcome
and	CCONJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
among	ADP	O	O
757	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
resected,	NOUN	O	O
histologically	ADV	O	O
proven,	NOUN	O	O
MAGE-A3-positive	ADJ	O	O
Stage	NOUN	O	O
IB-IIIA	NOUN	O	O
NSCLC	NOUN	O	O
assigned	VERB	O	O
to	PART	O	O
placebo	NOUN	O	O
in	ADP	O	O
the	DET	O	O
MAGRIT	NOUN	O	O
study	NOUN	O	O
(NCT00480025).	NUM	O	O

Plasma	NOUN	O	O
fentanyl	NOUN	O	O
levels	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
admission,	NOUN	O	O
1,	NOUN	O	O
6,	NOUN	O	O
12,	NUM	O	O
24,	NUM	O	O
and	CCONJ	O	O
48	NUM	O	O
h	NOUN	O	O
postoperatively.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
SPT	NOUN	O	O
intervention	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
functional	ADJ	O	O
outcomes	NOUN	O	O
of	ADP	O	O
upper	ADJ	O	O
extremity	NOUN	O	O
in	ADP	O	O
people	NOUN	O	O
after	ADP	O	O
stroke.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
infectious	ADJ	O	O
diseases	NOUN	O	O

CONCLUSION:	NOUN	O	O
Pharmacotherapeutic	ADJ	O	O
education	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
T2DM	NOUN	O	O
can	VERB	O	O
significantly	ADV	O	O
improve	VERB	O	O
30-day	NOUN	O	O
post-discharge	NOUN	O	O
medication	NOUN	O	O
adherence	NOUN	O	B-outcome
,	PUNCT	O	O
without	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
adverse	ADJ	O	B-outcome
clinical	ADJ	O	I-outcome
outcomes	NOUN	O	I-outcome
.	PUNCT	O	O
ClinicalTrial.gov	NOUN	O	O
identification	NOUN	O	O
number:	NOUN	O	O
NCT03438162.	NOUN	O	O

The	DET	O	O
Monitoring	VERB	O	O
+	SYM	O	O
Acceptance	ADV	O	O
Theory	ADJ	O	O
(MAT)	NOUN	O	O
postulates	NOUN	O	O
that	ADP	O	O
MBI	NOUN	O	O
improves	NOUN	O	O
cognition	NOUN	O	O
through	ADP	O	O
monitoring,	NOUN	O	O
and	CCONJ	O	O
psychological	ADJ	O	O
well-being,	NOUN	O	O
through	ADP	O	O
acceptance.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
prospective,	NOUN	O	O
interventional,	ADJ	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
done	NOUN	O	O
at	ADP	O	O
Alpha	NOUN	O	O
Vision	NOUN	O	O
Center,	NOUN	O	O
Zagazig,	ADJ	O	O
Egypt.	NOUN	O	O

The	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
success	NOUN	O	O
between	ADP	O	O
the	DET	O	O
active	ADJ	O	O
medical	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
control	NOUN	O	O
medical	ADJ	O	O
group	NOUN	O	O
was	VERB	O	O
16	NUM	O	O
percentage	NOUN	O	O
points	NOUN	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
interval,	ADP	O	O
-5	NUM	O	O
to	PART	O	O
38;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.17).	NUM	O	O

Several	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
linked	VERB	O	O
increased	VERB	O	O
intake	NOUN	O	O
of	ADP	O	O
dietary	ADJ	O	O
fibre	NOUN	O	O
to	PART	O	O
improvement	NOUN	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
body	NOUN	O	O
weight.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/20	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
total	ADJ	O	O
induction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
order	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
administration.	ADV	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
large	ADJ	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
to	PART	O	O
collect	NOUN	O	O
data	NOUN	O	O
to	PART	O	O
enhance	NOUN	O	O
the	DET	O	O
validity	NOUN	O	O
and	CCONJ	O	O
applicability	NOUN	O	O
of	ADP	O	O
the	DET	O	O
evidence	NOUN	O	O
from	ADP	O	O
previous	ADJ	O	O
trials	NOUN	O	O
to	PART	O	O
inform	NOUN	O	O
practice.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
explored	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
WPI	NOUN	O	O
for	ADP	O	O
improving	VERB	O	O
cognitive	ADJ	O	B-outcome
function	NOUN	O	I-outcome
via	ADP	O	O
delivery	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
B12.	NOUN	O	O

Further	ADV	O	O
studies	NOUN	O	O
are	VERB	O	O
required	VERB	O	O
to	PART	O	O
demonstrate	VERB	O	O
the	DET	O	O
clinical	ADJ	O	O
benefits	NOUN	O	O
and	CCONJ	O	O
risks	NOUN	O	O
of	ADP	O	O
nifedipine	NOUN	O	O
usage	NOUN	O	O
in	ADP	O	O
embryo	NOUN	O	O
transfer.	NOUN	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
received	VERB	O	O
brief	ADJ	O	O
advice	NOUN	O	O
about	ADV	O	O
healthy	ADJ	O	O
eating	VERB	O	O
and	CCONJ	O	O
physical	ADJ	O	O
activity.	NOUN	O	O

November	NOUN	O	O
27,	NUM	O	O
2013.	NUM	O	O

Changes	NOUN	O	O
in	ADP	O	O
QOL	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
using	VERB	O	O
the	DET	O	O
36-item	NOUN	O	O
Short	NOUN	O	O
Form	NOUN	O	O
Health	NOUN	O	B-outcome
Survey	NOUN	O	O
and	CCONJ	O	O
EQ-5D].	VERB	O	O
The	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
cost-effectiveness	NOUN	O	O
was	VERB	O	O
a	DET	O	O
cost-utility	NOUN	O	O
analysis	NOUN	O	O
with	ADP	O	O
a	DET	O	O
health	NOUN	O	O
care	NOUN	O	O
perspective	ADJ	O	O
and	CCONJ	O	O
included	VERB	O	O
costs	NOUN	O	B-outcome
of	ADP	O	I-outcome
intervention	NOUN	O	I-outcome
for	ADP	O	O
stakeholder,	NOUN	O	O
quality-adjusted	VERB	O	O
life-years	NOUN	O	O
(QALYs)	NOUN	O	O
gained	VERB	O	O
and	CCONJ	O	O
savings	NOUN	O	B-outcome
in	ADP	O	Seperator
health	NOUN	O	I-outcome
care	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
likelihood	NOUN	O	O
of	ADP	O	O
cost-effectiveness	NOUN	O	O
was	VERB	O	O
examined	VERB	O	O
using	VERB	O	O
the	DET	O	O
net	ADJ	O	O
monetary	ADJ	O	O
benefit	NUM	O	O
method.	NOUN	O	O

Title:	NOUN	O	O
Intrathecal	ADJ	O	O
dexmedetomidine	NOUN	O	O
can	VERB	O	O
decrease	NOUN	O	O
the	DET	O	O
95%	NOUN	O	O
effective	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
bupivacaine	NOUN	O	O
in	ADP	O	O
spinal	ADJ	O	O
anesthesia	NOUN	O	O
for	ADP	O	O
cesarean	NOUN	O	O
section:	NOUN	O	O
A	DET	O	O
prospective,	NOUN	O	O
double-blinded,	NOUN	O	O
randomized	VERB	O	O
study.	NOUN	O	O

Yi	NOUN	O	O
xue	NOUN	O	O
ban	NOUN	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
Central	ADJ	O	O
South	NOUN	O	O
University.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
reduced	VERB	O	O
in	ADP	O	O
EMLA	NOUN	O	O
group	NOUN	O	O
(56%)	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
control	NOUN	O	O
(88%)	NOUN	O	O
or	CCONJ	O	O
TPI	NOUN	O	O
(88%)	NOUN	O	O
groups	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.025	NUM	O	O
in	ADP	O	O
both);	NOUN	O	O
the	DET	O	O
severity	NOUN	O	O
of	ADP	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
was	VERB	O	O
mitigated	VERB	O	O
in	ADP	O	O
EMLA	NOUN	O	O
and	CCONJ	O	O
TPI	NOUN	O	O
groups	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.001,	PUNCT	O	O
each).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

BACKGROUND:	NOUN	O	O
Myelomeningocele	NOUN	O	O
is	VERB	O	O
a	DET	O	O
congenital	ADJ	O	O
anomaly	NOUN	O	O
of	ADP	O	O
Central	ADJ	O	O
Nervous	ADJ	O	O
System	NOUN	O	O
(CNS)	NOUN	O	O
leading	VERB	O	O
to	PART	O	O
serious	ADJ	O	O
sequels	NOUN	O	O
related	VERB	O	O
to	PART	O	O
various	ADJ	O	O
systems	NOUN	O	O
and	CCONJ	O	O
organs	NOUN	O	O
of	ADP	O	O
the	DET	O	O
affected	VERB	O	O
patient.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Fracture	NOUN	O	O
Prevention	NOUN	O	O
with	ADP	O	O
Zoledronate	NOUN	O	O
in	ADP	O	O
Older	ADJ	O	O
Women	NOUN	O	O
with	ADP	O	O
Osteopenia.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
critically	ADV	O	O
ill	ADJ	O	O
adults	NOUN	O	O
undergoing	VERB	O	O
tracheal	ADJ	O	O
intubation,	NOUN	O	O
patients	NOUN	O	O
receiving	VERB	O	O
bag-mask	ADJ	O	O
ventilation	NOUN	O	O
had	VERB	O	O
higher	ADJ	O	O
oxygen	NOUN	O	B-outcome
saturations	NOUN	O	I-outcome
and	CCONJ	O	O
a	DET	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
hypoxemia	NOUN	O	I-outcome
than	ADP	O	O
those	DET	O	O
receiving	VERB	O	O
no	DET	O	O
ventilation.	ADV	O	O
(	PUNCT	O	O

The	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
tafenoquine	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
shown	VERB	O	O
to	PART	O	O
be	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
that	ADP	O	O
of	ADP	O	O
primaquine	NOUN	O	O
(odds	NOUN	O	O
ratio	NOUN	O	O
for	ADP	O	O
recurrence,	NOUN	O	O
1.81;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.82	NUM	O	O
to	PART	O	O
3.96).	NOUN	O	O

Nd:YAG	NOUN	O	O
laser	NOUN	O	O
goniopuncture	NOUN	O	O
was	VERB	O	O
done	NOUN	O	O
in	ADP	O	O
cases	NOUN	O	O
where	ADP	O	O
the	DET	O	O
intraocular	ADJ	O	O
pressure	NOUN	O	O
(IOP)	ADV	O	O
was	VERB	O	O
elevated	VERB	O	O
above	ADP	O	O
21	NUM	O	O
mmHg	NOUN	O	O
after	ADP	O	O
discontinuation	NOUN	O	O
of	ADP	O	O
corticosteroid	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
at	ADP	O	O
any	DET	O	O
follow-up	NOUN	O	O
visit.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
repeated	VERB	O	O
measures	NOUN	O	O
ANOVA	NOUN	O	O
between	ADP	O	O
the	DET	O	O
GCAF	NOUN	O	O
and	CCONJ	O	O
GCON	NOUN	O	O
groups	NOUN	O	O
revealed	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
2	NUM	O	O
variables.	NUM	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
observe	NOUN	O	O
the	DET	O	O
clinical	ADJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
dopamine	NOUN	O	O
modulator	NOUN	O	O
methylphenidate	NOUN	O	O
(MPH)	PUNCT	O	O
of	ADP	O	O
extended-release	NOUN	O	O
formulations	NOUN	O	O
(MPH-ER)	PUNCT	O	O
augmentation	NOUN	O	O
of	ADP	O	O
ongoing	VERB	O	O
fluvoxamine	NOUN	O	O
treatment	NOUN	O	O
in	ADP	O	O
refractory	ADJ	O	O
obsessive-compulsive	ADJ	O	O
disorder	ADP	O	O
(OCD)	NOUN	O	O
and	CCONJ	O	O
its	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
patient's	NOUN	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
.	PUNCT	O	O
Methods:	NOUN	O	O
A	DET	O	O
pilot	NOUN	O	O
randomized,	NOUN	O	O
placebo-controlled,	NOUN	O	O
and	CCONJ	O	O
double-blind	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
at	ADP	O	O
an	DET	O	O
outpatient,	ADP	O	O
single-center	NOUN	O	O
academic	ADJ	O	O
setting.	NOUN	O	O

Post-hoc	NOUN	O	O
tests	NOUN	O	O
demonstrated	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
time	NOUN	O	B-outcome
under	ADP	O	Seperator
tension	NOUN	O	I-outcome
(TUT)	PUNCT	O	I-outcome
when	ADP	O	O
comparing	VERB	O	O
the	DET	O	O
group	NOUN	O	O
supplemented	VERB	O	O
with	ADP	O	O
caffeine	NOUN	O	O
(13.689	NOUN	O	O
s	NOUN	O	O
GCAF)	NOUN	O	O
to	PART	O	O
the	DET	O	O
one	NUM	O	O
ingesting	VERB	O	O
a	DET	O	O
placebo	NOUN	O	O
(15.332	PUNCT	O	O
s	NOUN	O	O
GCON)	NOUN	O	O
at	ADP	O	O
p	NOUN	O	O
=	SYM	O	O
0.002.	NUM	O	O

RESULTS:	NOUN	O	O
An	DET	O	O
overall	ADJ	O	O
treatment	NOUN	O	O
effect	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.019)	NUM	O	O
was	VERB	O	O
evident	ADJ	O	O
for	ADP	O	O
increased	VERB	O	O
hits	NOUN	O	B-outcome
with	ADP	O	O
PSE	NOUN	O	O
on	ADP	O	O
the	DET	O	O
stationary	ADJ	O	O
test	NOUN	O	O
with	ADP	O	O
footplates,	NOUN	O	O
with	ADP	O	O
between	ADP	O	O
group	NOUN	O	O
differences	NOUN	O	O
at	ADP	O	O
Day	NOUN	O	O
30	NUM	O	O
(PSE	NUM	O	O
vs.	CCONJ	O	O
PLA:	NOUN	O	O
28.96	NUM	O	O
+/-	SYM	O	O
2.08	NUM	O	O
vs.	CCONJ	O	O
28.09	NUM	O	O
+/-	SYM	O	O
1.92	NUM	O	O
hits;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.040)	NOUN	O	O
and	CCONJ	O	O
Day	NOUN	O	O
90	NUM	O	O
(PSE	NUM	O	O
vs.	CCONJ	O	O
PLA:	NOUN	O	O
28.42	NUM	O	O
+/-	SYM	O	O
2.54	NUM	O	O
vs.	CCONJ	O	O
27.02	NUM	O	O
+/-	SYM	O	O
3.55	NUM	O	O
hits;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.002).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
Clinical	ADJ	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
apatinib	ADP	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
as	ADP	O	O
the	DET	O	O
late-line	NOUN	O	O
treatment.	NOUN	O	O

At	ADP	O	O
the	DET	O	O
3-month	NOUN	O	O
follow-up	NOUN	O	O
visit,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
improvements	NOUN	O	O
in	ADP	O	O
adherence	NOUN	O	B-outcome
to	PART	O	O
the	DET	O	O
MD	NOUN	O	O
and	CCONJ	O	O
diet	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	O
2.2	NUM	O	O
and	CCONJ	O	O
2.5	NUM	O	O
points,	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
baseline	NOUN	O	O
visit,	NOUN	O	O
respectively,	NOUN	O	O
in	ADP	O	O
favour	NOUN	O	O
of	ADP	O	O
the	DET	O	O
IG.	NOUN	O	O

Only	ADV	O	O
PPI	NOUN	O	O
therapy	NOUN	O	O
significantly	ADV	O	O
decreased	VERB	O	O
the	DET	O	O
VAS	NOUN	O	O
scores,	NOUN	O	O
suggesting	VERB	O	O
the	DET	O	O
improvement	NOUN	O	O
of	ADP	O	O
taste	NOUN	O	B-outcome
perception	NOUN	O	I-outcome
.	PUNCT	O	O
Moreover,	NOUN	O	O
PPI	NOUN	O	O
therapy	NOUN	O	O
significantly	ADV	O	O
decreased	VERB	O	O
recognition	NOUN	O	O
thresholds	NOUN	O	O
for	ADP	O	O
bitter	NOUN	O	B-outcome
taste	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
anterior	ADJ	O	O
tongue	NOUN	O	O
(chorda	NUM	O	O
tympani	NOUN	O	O
nerve	NOUN	O	O
area)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
thresholds	NOUN	O	O
in	ADP	O	O
the	DET	O	O
posterior	ADJ	O	O
tongue	NOUN	O	O
(glossopharyngeal	PUNCT	O	O
nerve	NOUN	O	O
area)	NOUN	O	O
for	ADP	O	O
salty,	ADJ	O	B-outcome
sour,	NOUN	O	B-outcome
and	CCONJ	O	Seperator
bitter	NOUN	O	B-outcome
tastes	NOUN	O	E1-outcome
.	PUNCT	O	O
By	ADP	O	O
contrast,	NOUN	O	O
H2-blocker	NOUN	O	O
therapy	NOUN	O	O
caused	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
changes	NOUN	O	O
of	ADP	O	O
thresholds	NOUN	O	O
in	ADP	O	O
the	DET	O	O
anterior	ADJ	O	O
tongue,	ADV	O	O
but	CCONJ	O	O
improved	VERB	O	O
the	DET	O	O
threshold	NOUN	O	O
{only}	NOUN	O	O
for	ADP	O	O
bitter	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
posterior	ADJ	O	O
tongue,	ADV	O	O
the	DET	O	O
value	NOUN	O	O
of	ADP	O	O
which	ADP	O	O
was	VERB	O	O
however	ADV	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
PPI	NOUN	O	O
group.	VERB	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
role	NOUN	O	O
of	ADP	O	O
0.2%	NOUN	O	O
bio-adhesive	ADJ	O	O
chlorhexidine	NOUN	O	O
gel	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
alveolar	ADJ	O	B-outcome
osteitis	NOUN	O	I-outcome
after	ADP	O	O
surgical	ADJ	O	O
removal	NOUN	O	O
of	ADP	O	O
mandibular	ADJ	O	O
third	ADJ	O	O
molars	NOUN	O	O
which	ADP	O	O
causes	NOUN	O	O
extra	ADJ	O	O
monetary	ADJ	O	O
burden	NOUN	O	O
on	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
form	NOUN	O	O
of	ADP	O	O
several	ADJ	O	O
follow	VERB	O	O
up	ADP	O	O
visits..	NOUN	O	O
METHODS:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
in	ADP	O	O
the	DET	O	O
Dental	ADJ	O	O
Section,	NOUN	O	O
Ayub	ADP	O	O
Medical	ADJ	O	O
College,	PUNCT	O	O
Abbottabad.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/13	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
groups	NOUN	O	O
and	CCONJ	O	O
health	NOUN	O	B-outcome
education	NOUN	O	I-outcome
duration	NOUN	O	I-outcome
times	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
on	ADP	O	O
reduced	VERB	O	O
HbA1c	NOUN	O	B-outcome
concentration	NOUN	O	O
and	CCONJ	O	O
increased	VERB	O	O
the	DET	O	O
total	ADJ	O	O
score	NOUN	O	O
of	ADP	O	O
Self-Efficacy	NOUN	O	B-outcome
(P	NUM	O	O
<.05).	NOUN	O	O

In	ADP	O	B-outcome
vitro	ADV	O	I-outcome
fertilization	NOUN	O	I-outcome
(IVF)	NOUN	O	I-outcome
/	SYM	O	O
intracytoplasmic	ADJ	O	B-outcome
sperm	NOUN	O	I-outcome
injection	NOUN	O	I-outcome
(ICSI)	NUM	O	I-outcome
outcomes	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

Journal-Name:Zhong	ADJ	O	O
nan	VERB	O	O
da	NOUN	O	O
xue	NOUN	O	O
xue	NOUN	O	O
bao.	ADP	O	O

This	DET	O	O
assessment,	NOUN	O	O
part	NOUN	O	O
of	ADP	O	O
the	DET	O	O
BabyGel	NOUN	O	O
Pilot	NOUN	O	O
study,	NOUN	O	O
evaluated	VERB	O	O
the	DET	O	O
acceptability	NOUN	O	O
of	ADP	O	O
the	DET	O	O
'Newborn	NUM	O	O
Moments	NOUN	O	O
for	ADP	O	O
Hand	NOUN	O	O
Hygiene	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Home'	NOUN	O	O
poster.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Clinical	ADJ	O	O
Trial,	NOUN	O	O
Phase	NOUN	O	O
III	NUM	O	O

The	DET	O	O
conventional	ADJ	O	O
pulmonary	ADJ	O	O
rehabilitation	NOUN	O	O
treatments,	ADV	O	O
including	VERB	O	O
pursed	VERB	O	O
lips	NOUN	O	O
breathing	VERB	O	O
(PLB)	NOUN	O	O
and	CCONJ	O	O
abdominal	ADJ	O	O
breathing	VERB	O	O
training,	NOUN	O	O
were	VERB	O	O
applied	VERB	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Citrus	NOUN	O	O
Aurantium	NOUN	O	O
and	CCONJ	O	O
caffeine	NOUN	O	O
complex	NOUN	O	O
versus	CCONJ	O	O
placebo	NOUN	O	O
on	ADP	O	O
biomarkers	NOUN	O	O
of	ADP	O	O
metabolism	NOUN	O	B-outcome
:	PUNCT	O	O
a	DET	O	O
double	ADV	O	O
blind	PUNCT	O	O
crossover	NOUN	O	O
design.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
burden	NOUN	O	O
of	ADP	O	O
chronic	ADJ	O	O
obstructive	ADJ	O	O
lung	NOUN	O	O
disease	NOUN	O	O
(COPD)	NUM	O	O
is	VERB	O	O
increasing	VERB	O	O
in	ADP	O	O
women,	NOUN	O	O
with	ADP	O	O
recent	ADJ	O	O
evidence	NOUN	O	O
suggesting	VERB	O	O
gender	NOUN	O	O
differences	NOUN	O	O
in	ADP	O	O
disease	NOUN	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
potentially	ADV	O	O
in	ADP	O	O
treatment	NOUN	O	O
outcomes.	ADJ	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
2	NUM	O	O
similarly	ADV	O	O
designed	VERB	O	O
studies	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
episodic	NOUN	O	O
migraine	NOUN	O	O
(6	ADV	O	O
months)	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
study	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
migraine	NOUN	O	O
(3	NOUN	O	O
months),	NOUN	O	O
patients	NOUN	O	O
randomized	VERB	O	O
in	ADP	O	O
a	DET	O	O
1:1:2	NOUN	O	O
ratio	NOUN	O	O
received	VERB	O	O
a	DET	O	O
subcutaneous	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
galcanezumab	NOUN	O	O
120	NUM	O	O
mg/month	ADV	O	O
(after	PUNCT	O	O
an	DET	O	O
initial	ADJ	O	O
loading	VERB	O	O
dose	NOUN	O	O
of	ADP	O	O
240	NUM	O	O
mg)	NOUN	O	O
or	CCONJ	O	O
240	NUM	O	O
mg/month	ADV	O	O
or	CCONJ	O	O
placebo.	NOUN	O	O

The	DET	O	O
cumulative	ADJ	O	O
opioid	NOUN	O	B-outcome
requirement	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
in	ADP	O	O
group	NOUN	O	O
O	NOUN	O	O
at	ADP	O	O
6,	NOUN	O	O
12,	NUM	O	O
24,	NUM	O	O
and	CCONJ	O	O
48	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
surgery.	VERB	O	O
(	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Neonatal	ADJ	O	O
sepsis	NOUN	O	O
is	VERB	O	O
a	DET	O	O
major	ADJ	O	O
cause	ADP	O	O
of	ADP	O	O
mortality	NOUN	O	O
worldwide,	NOUN	O	O
with	ADP	O	O
most	DET	O	O
deaths	NOUN	O	O
occurring	VERB	O	O
in	ADP	O	O
low-income	NOUN	O	O
countries.	NUM	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
French	NOUN	O	O
National	ADJ	O	O
Cancer	NOUN	O	O
Institute;	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT00937456	NOUN	O	O
.).	NOUN	O	O

RESULTS:	NOUN	O	O
L-Methylfolate	NOUN	O	O
was	VERB	O	O
well	ADV	O	O
tolerated	VERB	O	B-outcome
,	PUNCT	O	O
with	ADP	O	O
no	DET	O	O
significant	ADJ	O	O
effect	NOUN	O	O
over	ADP	O	O
placebo	NOUN	O	O
except	ADP	O	O
improvement	NOUN	O	O
from	ADP	O	O
abnormal	ADJ	O	O
measures	NOUN	O	O
on	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
adaptive	ADJ	O	O
dimension	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Adult	NOUN	O	O
ADHD	NOUN	O	B-outcome
Self-report	NOUN	O	O
scale	NOUN	O	O
(chi	PUNCT	O	O
=	SYM	O	O
4.36,	ADP	O	O
P	NOUN	O	O
=	SYM	O	O
0.04).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Additionally,	NOUN	O	O
both	CCONJ	O	O
groups	NOUN	O	O
had	VERB	O	O
similar	ADJ	O	O
safety	NOUN	O	O
profile.	NOUN	O	O

We	PRON	O	O
investigated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
negative	ADJ	O	O
pressure	NOUN	O	O
wound	NOUN	O	O
therapy	NOUN	O	O
(NPWT)	PUNCT	O	O
on	ADP	O	O
short-	NOUN	O	O
and	CCONJ	O	O
long-term	NOUN	O	O
wound	NOUN	O	O
outcomes	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
pancreatectomy.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
cross-over	NOUN	O	O
study	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
on	ADP	O	O
premature	ADJ	O	O
infants	NOUN	O	O
in	ADP	O	O
NICU.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
direct	ADJ	O	O
and	CCONJ	O	O
video	ADJ	O	O
groups	NOUN	O	O
performed	VERB	O	O
2	NUM	O	O
handling	VERB	O	B-outcome
activities	NOUN	O	O
significantly	ADV	O	O
better	ADJ	O	O
than	ADP	O	O
the	DET	O	O
written-pictorial	ADJ	O	O
group.	VERB	O	O

Journal-Name:BMC	NOUN	O	O
gastroenterology	NOUN	O	O

Title:	NOUN	O	O
Omadacycline	NOUN	O	O
for	ADP	O	O
Community-Acquired	VERB	O	O
Bacterial	ADJ	O	O
Pneumonia.	NOUN	O	O

However,	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
total	ADJ	O	O
RES	NOUN	O	O
and	CCONJ	O	O
complete	ADJ	O	O
root	NOUN	O	B-outcome
coverage	NOUN	O	I-outcome
rate	NOUN	O	O
(p	PUNCT	O	O
>	SYM	O	O
0.05).	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
tramadol	NOUN	O	O
patient-controlled	VERB	O	O
analgesia	NOUN	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
24th	ADJ	O	O
hour.	NOUN	O	O

The	DET	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
was	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
weeks	NOUN	O	O
by	ADP	O	O
TaqMan(R)	PUNCT	O	O
Low	ADJ	O	O
Density	NOUN	O	O
Array.	NOUN	O	O

Control	NOUN	O	O
ICUs	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
12;	NUM	O	O
789	NUM	O	O
participants)	NOUN	O	O
delivered	VERB	O	O
usual	ADJ	O	O
care	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
intervention	NOUN	O	O
periods.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/27	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Only	ADV	O	O
4	NUM	O	O
children	NOUN	O	O
in	ADP	O	O
each	DET	O	O
arm	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
to	PART	O	O
have	VERB	O	O
heart	NOUN	O	B-outcome
diseases	NOUN	O	I-outcome
,	PUNCT	O	O
with	ADP	O	O
prevalence	NOUN	O	O
of	ADP	O	O
(0.17/1000	PUNCT	O	O
and	CCONJ	O	O
0.16/1000),	NUM	O	O
respectively,	NOUN	O	O
after	ADP	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
echocardiography	NOUN	O	O
evaluation.	ADV	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
PAR-G	NOUN	O	O
and	CCONJ	O	O
1PO-G,	NOUN	O	O
respectively	ADV	O	O
there	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
reductions	NOUN	O	O
in	ADP	O	O
slow	ADJ	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(SVC)	PUNCT	O	I-outcome
(p=0.0007	PUNCT	O	O
vs.	CCONJ	O	O
p<0.0001),	NOUN	O	O
inspiratory	ADJ	O	B-outcome
reserve	NOUN	O	I-outcome
volume	NOUN	O	I-outcome
(IRV)	NUM	O	I-outcome
(p=0.0016	NOUN	O	O
vs.	CCONJ	O	O
p=0.0026),	NOUN	O	O
and	CCONJ	O	O
forced	VERB	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(FVC)	PUNCT	O	I-outcome
(p=0.0013	NOUN	O	O
vs.	CCONJ	O	O
p<0.0001)	NOUN	O	O
and	CCONJ	O	O
expiratory	ADJ	O	B-outcome
reserve	NOUN	O	I-outcome
volume	NOUN	O	I-outcome
(ERV)	NUM	O	I-outcome
was	VERB	O	O
maintained	VERB	O	O
only	ADV	O	O
for	ADP	O	O
the	DET	O	O
PAR-G	NOUN	O	O
(p=0.4446	PUNCT	O	O
vs.	CCONJ	O	O
p=0.0191).	NOUN	O	O

The	DET	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
composite	NOUN	O	O
outcome	NOUN	O	O
event	NOUN	O	O
was	VERB	O	O
74%	NUM	O	O
lower	ADJ	O	O
with	ADP	O	O
caplacizumab	NOUN	O	O
than	ADP	O	O
with	ADP	O	O
placebo	NOUN	O	O
(12%	NUM	O	O
vs.	CCONJ	O	O
49%,	NOUN	O	O
P<0.001).	NUM	O	O

The	DET	O	O
difference	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
was	VERB	O	O
significant	ADJ	O	O
(p=.045).	NOUN	O	O

Additionally,	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
also	ADV	O	O
documented	VERB	O	O
during	ADP	O	O
the	DET	O	O
period	NOUN	O	O
of	ADP	O	O
the	DET	O	O
treatment.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study,	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Multicenter	NOUN	O	O
Study,	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O
Research	NOUN	O	O
Support,	NOUN	O	O
Non-U.S.	NOUN	O	O
Gov't,	NOUN	O	O

Department	NOUN	O	O
of	ADP	O	O
Pharmacy	NOUN	O	O
Practice,	NOUN	O	O
Sri	NOUN	O	O
Adichunchanagiri	NOUN	O	O
College	NOUN	O	O
of	ADP	O	O
Pharmacy,	NOUN	O	O
B.	NOUN	O	O
G.	NOUN	O	O
Nagara,	NOUN	O	O
Karnataka,	NOUN	O	O
India.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/25	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
correlations	NOUN	O	O
anxiety	NOUN	O	B-outcome
versus	CCONJ	O	O
heart	NOUN	O	B-outcome
variables	NOUN	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
versus	CCONJ	O	O
heart	NOUN	O	B-outcome
variables	NOUN	O	O
were	VERB	O	O
established	VERB	O	O
using	VERB	O	O
Spearman	NOUN	O	O
correlation	NOUN	O	O
test.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
hemorrhage	NOUN	O	O
control	NOUN	O	O
of	ADP	O	O
Surgiflo	NOUN	O	O
Haemostatic	ADJ	O	O
Matrix	NOUN	O	O
and	CCONJ	O	O
absorbable	ADJ	O	O
gelatin	NOUN	O	O
sponge	NOUN	O	O
in	ADP	O	O
posterior	ADJ	O	O
lumbar	ADJ	O	O
surgery:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
study.	NOUN	O	O

Maintenance	NOUN	O	O
of	ADP	O	O
effect	NOUN	O	O
during	ADP	O	O
the	DET	O	O
double-blind	ADJ	O	O
phase	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
based	VERB	O	O
on	ADP	O	O
a	DET	O	O
comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
percentages	NOUN	O	O
of	ADP	O	O
galcanezumab-	NOUN	O	O
and	CCONJ	O	O
placebo-treated	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
maintenance	NOUN	O	O
of	ADP	O	O
30,	NUM	O	O
50,	NOUN	O	O
75,	NUM	O	O
and	CCONJ	O	O
100%	NOUN	O	O
response	NOUN	O	B-outcome
(defined	NUM	O	O
as	ADP	O	O
>/=30,	NOUN	O	O
>/=50,	ADP	O	O
>/=75,	NOUN	O	O
and	CCONJ	O	O
100%	NOUN	O	O
reduction	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
in	ADP	O	O
monthly	ADV	O	O
migraine	NOUN	O	O
headache	NOUN	O	O
days	NOUN	O	O
[MHD])	NOUN	O	O
at	ADP	O	O
an	DET	O	O
individual	ADJ	O	O
patient	NOUN	O	O
level.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Magnetic	ADJ	O	O
Resonance	NOUN	O	O
Imaging	VERB	O	O
vs	CCONJ	O	O
Conventional	ADJ	O	O
Treat-to-Target	NOUN	O	O
Strategies	NOUN	O	O
on	ADP	O	O
Disease	NOUN	O	B-outcome
Activity	NOUN	O	I-outcome
Remission	NOUN	O	I-outcome
and	CCONJ	O	O
Radiographic	ADJ	O	B-outcome
Progression	NOUN	O	I-outcome
in	ADP	O	O
Rheumatoid	NOUN	O	O
Arthritis:	NOUN	O	O
The	DET	O	O
IMAGINE-RA	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

Journal-Name:Lipids	NOUN	O	O
in	ADP	O	O
health	NOUN	O	O
and	CCONJ	O	O
disease	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
amount	NOUN	O	O
of	ADP	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
and	CCONJ	O	O
autologous	ADJ	O	O
blood	NOUN	O	B-outcome
transfusion	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups,	NOUN	O	O
and	CCONJ	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

FINDINGS:	ADJ	O	O
We	PRON	O	O
recruited	VERB	O	O
2203	NUM	O	O
participants	NOUN	O	O
between	ADP	O	O
May	NOUN	O	O
7,	NUM	O	O
2014,	NUM	O	O
and	CCONJ	O	O
Sept	ADV	O	O
28,	NUM	O	O
2017,	NUM	O	O
of	ADP	O	O
whom	ADP	O	O
1099	NUM	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
lactoferrin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
1104	NUM	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/20	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
1	NUM	O	O
year	NOUN	O	O
MACE	NOUN	O	B-outcome
rates	NOUN	O	O
are	VERB	O	O
comparable	ADJ	O	O
in	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
elective	ADJ	O	O
coronary	ADJ	O	O
revascularization	NOUN	O	O
using	VERB	O	O
sirolimus	NOUN	O	O
eluting	VERB	O	O
polymer-free	ADJ	O	O
and	CCONJ	O	O
biodegradable	ADJ	O	O
polymer	NOUN	O	O
stents.	NOUN	O	O

The	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
low	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
weight	NOUN	O	I-outcome
(LBW)	NUM	O	I-outcome
was	VERB	O	O
also	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
three-dose	NOUN	O	O
(3.5%)	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
two-dose	NOUN	O	O
(12.2%)	NUM	O	O
group	NOUN	O	O
(aOR,	ADV	O	O
0.15;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.04-0.63);	NUM	O	O
however,	ADV	O	O
the	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
maternal	ADJ	O	B-outcome
anaemia	NOUN	O	I-outcome
,	PUNCT	O	O
pre-term	NOUN	O	B-outcome
births	NOUN	O	I-outcome
,	PUNCT	O	O
clinical	ADJ	O	B-outcome
malaria	NOUN	O	I-outcome
and	CCONJ	O	O
SP	NOUN	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
were	VERB	O	O
similar	ADJ	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
arms	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
simvastatin	NOUN	O	O
administration	NOUN	O	O
to	PART	O	O
cold	NOUN	O	O
storage	NOUN	O	O
solution	NOUN	O	O
of	ADP	O	O
explanted	VERB	O	O
whole	ADJ	O	O
liver	NOUN	O	O
grafts	NOUN	O	O
for	ADP	O	O
facing	VERB	O	O
ischemia/reperfusion	NOUN	O	O
injury	NOUN	O	O
in	ADP	O	O
an	DET	O	O
area	NOUN	O	O
with	ADP	O	O
a	DET	O	O
low	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
deceased	VERB	O	O
donation:	NOUN	O	O
a	DET	O	O
monocentric	ADP	O	O
randomized	VERB	O	O
controlled	VERB	O	O
double-blinded	VERB	O	O
phase	NOUN	O	O
2	NUM	O	O
study.	NOUN	O	O

Daily	ADJ	O	O
vitD(3)	NOUN	O	O
+	SYM	O	O
PBA	NOUN	O	O
for	ADP	O	O
16	NUM	O	O
weeks	NOUN	O	O
was	VERB	O	O
well-tolerated	VERB	O	O
and	CCONJ	O	O
effectively	ADV	O	O
improved	VERB	O	O
vitD(3)	NOUN	O	B-outcome
status	NOUN	O	O
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
reduce	VERB	O	O
viral	ADJ	O	B-outcome
load	NOUN	O	I-outcome
,	PUNCT	O	O
restore	VERB	O	O
peripheral	ADJ	O	B-outcome
T	NOUN	O	I-outcome
cell	NOUN	O	I-outcome
counts	NOUN	O	I-outcome
or	CCONJ	O	O
improve	VERB	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
(BMI)	PUNCT	O	I-outcome
or	CCONJ	O	O
middle-upper-arm	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
(MUAC)	NUM	O	I-outcome
in	ADP	O	O
HIV	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
slow	ADJ	O	O
progressive	ADJ	O	O
disease.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/06	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
two	NUM	O	O
intravenous	ADJ	O	O
(IV)	NUM	O	O
TXA	NOUN	O	O
regimens	NOUN	O	O
(a	PUNCT	O	O
three-hour	NOUN	O	O
two-dose	NOUN	O	O
(short-TXA)	PUNCT	O	O
and	CCONJ	O	O
11-hour	NOUN	O	O
four-dose	NOUN	O	O
(long-TXA))	PUNCT	O	O
were	VERB	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
placebo	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
perioperative	ADJ	O	O
real	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(RBL,	NOUN	O	O
between	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
day	NOUN	O	O
3	NUM	O	O
postoperatively)	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
THA	NOUN	O	O
who	ADP	O	O
receive	VERB	O	O
rivaroxaban	ADJ	O	O
as	ADP	O	O
thromboprophylaxis.	NOUN	O	O

On	ADP	O	O
the	DET	O	O
first	ADV	O	O
day	NOUN	O	O
before	ADP	O	O
surgery,	NOUN	O	O
the	DET	O	O
patient's	NOUN	O	O
general	ADJ	O	O
data	NOUN	O	O
were	VERB	O	O
collected	VERB	O	O
and	CCONJ	O	O
the	DET	O	O
Pittsburgh	NOUN	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
index	NOUN	O	O
(PSQI)	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
patient's	NOUN	O	O
sleep	NOUN	O	B-outcome
status	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
past	NOUN	O	O
month.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Australian	ADJ	O	O
and	CCONJ	O	O
New	ADJ	O	O
Zealand	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
Registry	NOUN	O	O
(	PUNCT	O	O
ACTRN12616001434482	NOUN	O	O
).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
assay	NOUN	O	O
range	NOUN	O	O
was	VERB	O	O
0.9-30	NUM	O	O
mg/L	NOUN	O	O
with	ADP	O	O
accuracy	NOUN	O	O
within	ADP	O	O
91%-99%	NOUN	O	O
and	CCONJ	O	O
coefficients	NOUN	O	O
of	ADP	O	O
variation	NOUN	O	O
ranging	VERB	O	O
from	ADP	O	O
1.2%	NOUN	O	O
to	PART	O	O
3.6%.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7807333	NUM	O	O

Title:	NOUN	O	O
Combined	VERB	O	O
phacoemulsification	NOUN	O	O
and	CCONJ	O	O
viscocanalostomy	NOUN	O	O
with	ADP	O	O
Ologen	NOUN	O	O
implant	NOUN	O	O
versus	CCONJ	O	O
combined	VERB	O	O
phacoemulsification	NOUN	O	O
and	CCONJ	O	O
viscocanalostomy.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
time,	NOUN	O	O
it	PRON	O	O
was	VERB	O	O
presented	VERB	O	O
that	ADP	O	O
pelvic	ADJ	O	B-outcome
floor	NOUN	O	I-outcome
muscles	NOUN	O	I-outcome
(PFM)	PUNCT	O	I-outcome
asymmetry	NOUN	O	I-outcome
visible	ADJ	O	O
in	ADP	O	O
ultrasonography	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
corrected	VERB	O	O
by	ADP	O	O
this	DET	O	O
specific	ADJ	O	O
exercise.	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
group	NOUN	O	O
C,	NOUN	O	O
serum	NOUN	O	O
norepinephrines	NOUN	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
D	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
(t=13.276,	NUM	O	O
16.027,	NUM	O	O
14.319,	NUM	O	O
12.771,	NOUN	O	O
12.296,	NOUN	O	O
respectively;	NOUN	O	O
all	DET	O	O
P<0.05)	NOUN	O	O
at	ADP	O	O
T(1),	NOUN	O	O
T(2),	NOUN	O	O
T(3),	NOUN	O	O
T(4),	NOUN	O	O
T(5).And	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
between	ADP	O	O
these	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
T(0),	NOUN	O	O
T(6),	NOUN	O	O
T(7),	NOUN	O	O
T(8)(all	NOUN	O	O
P>0.05).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Patients	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
for	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
12	NUM	O	O
weeks.	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
SuperPATH	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
longer	ADJ	O	O
(	PUNCT	O	O
t=4.470,	NOUN	O	O
P=0.000),	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
incision	NOUN	O	B-outcome
was	VERB	O	O
shorter	ADJ	O	O
(	PUNCT	O	O
t=-2.168,	NOUN	O	O
P=0.041).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

As	ADP	O	O
hydrogen	NOUN	O	O
gas	NOUN	O	O
was	VERB	O	O
recently	ADV	O	O
reported	VERB	O	O
to	PART	O	O
activate	VERB	O	O
PGC1alpha,	NOUN	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
investigated	VERB	O	O
whether	ADP	O	O
it	PRON	O	O
restores	NOUN	O	O
exhausted	VERB	O	O
CD8+	NOUN	O	B-outcome
T	NOUN	O	I-outcome
cells	NOUN	O	I-outcome
to	PART	O	O
improve	VERB	O	O
prognosis	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
stage	NOUN	O	O
IV	NUM	O	O
colorectal	ADJ	O	O
cancer.	NOUN	O	O

Wohlfert	ADP	O	O
TM,	NOUN	O	O
Miller	NOUN	O	O
KC.	NOUN	O	O

PMID:	NOUN	O	O
31615781	NUM	O	O

Title:	NOUN	O	O
[Effect	ADJ	O	O
of	ADP	O	O
dexmedetomidine	NOUN	O	O
on	ADP	O	O
perioperative	ADJ	O	O
stress	NOUN	O	B-outcome
and	CCONJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
radical	NOUN	O	O
resection	NOUN	O	O
of	ADP	O	O
esophageal	ADJ	O	O
cancer	NOUN	O	O
under	ADP	O	O
combined	VERB	O	O
thoracoscope	NOUN	O	O
and	CCONJ	O	O
laparoscope].	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

This	DET	O	O
aims	NOUN	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
combined	VERB	O	O
use	NOUN	O	O
of	ADP	O	O
radial	ADJ	O	O
extracorporeal	ADJ	O	O
shock	NOUN	O	O
wave	NOUN	O	O
therapy	NOUN	O	O
(rESWT)	NOUN	O	O
and	CCONJ	O	O
conventional	ADJ	O	O
rehabilitation	NOUN	O	O
therapy	NOUN	O	O
on	ADP	O	O
postoperative	ADJ	O	O
rehabilitation	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
spastic	ADJ	O	O
cerebral	ADJ	O	O
palsy.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Title:	NOUN	O	O
Cardiometabolic	ADJ	O	B-outcome
Health	NOUN	O	I-outcome
in	ADP	O	O
Relation	NOUN	O	O
to	PART	O	O
Lifestyle	NOUN	O	O
and	CCONJ	O	O
Body	NOUN	O	O
Weight	NOUN	O	O
Changes	NOUN	O	O
3(-)8	ADJ	O	O
Years	NOUN	O	O
Earlier.	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
dry	ADJ	O	O
needling	VERB	O	O
using	VERB	O	O
sterile	ADJ	O	O
stainless-steel	NOUN	O	O
acupuncture	NOUN	O	O
needles	NOUN	O	O
of	ADP	O	O
0.25	NUM	O	O
x	SYM	O	O
40	NUM	O	O
mm	NOUN	O	O
and	CCONJ	O	O
0.25	NUM	O	O
x	SYM	O	O
25	NUM	O	O
mm	NOUN	O	O
dimensions.	NOUN	O	O

After	ADP	O	O
30	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
dark	ADJ	O	O
chocolate	NOUN	O	O
intake,	NOUN	O	O
an	DET	O	O
increased	VERB	O	O
antioxidant	NOUN	O	B-outcome
power	NOUN	O	I-outcome
was	VERB	O	O
found	VERB	O	O
in	ADP	O	O
elite	ADP	O	O
athletes	NOUN	O	O
assuming	VERB	O	O
dark	ADJ	O	O
chocolate.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Gua	NOUN	O	O
Sha	NOUN	O	O
appears	NOUN	O	O
to	PART	O	O
be	VERB	O	O
an	DET	O	O
acceptable	ADJ	O	B-outcome
,	PUNCT	O	O
safe,	NOUN	O	O
and	CCONJ	O	O
effective	ADJ	O	O
treatment	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
indicated	VERB	O	O
the	DET	O	O
pilates	NOUN	O	O
exercises	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
valuable	ADJ	O	O
for	ADP	O	O
improvement	NOUN	O	O
of	ADP	O	O
CKD	NOUN	O	O
patients'	NOUN	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/13	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
noninvasive	ADJ	O	O
breathing	VERB	O	O
unit	NOUN	O	O
after	ADP	O	O
treatment,	NOUN	O	O
rhodiola+noninvasive	ADJ	O	O
breathing	VERB	O	O
unit	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
elevated	VERB	O	O
levels	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
SOD	NOUN	O	B-outcome
,	PUNCT	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
level	NOUN	O	O
decreased	VERB	O	O
P<0.05,	NOUN	O	O
and	CCONJ	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
serum	NOUN	O	O
SOD	NOUN	O	B-outcome
levels	NOUN	O	O
drop,	NOUN	O	O
the	DET	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
levels	NOUN	O	O
P<0.05,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
after	ADP	O	O
rhodiola	NOUN	O	O
rosea	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
compared,	NOUN	O	O
rhodiola+noninvasive	ADJ	O	O
breathing	VERB	O	O
unit	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
elevated	VERB	O	O
levels	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
SOD	NOUN	O	B-outcome
,	PUNCT	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
level	NOUN	O	O
decreased	VERB	O	O
P<0.05.	NOUN	O	O

Efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
results	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Japanese	NOUN	O	O
subgroup	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
East	ADV	O	O
Asian	ADJ	O	O
subgroup	NOUN	O	O
(which	ADV	O	O
included	VERB	O	O
patients	NOUN	O	O
from	ADP	O	O
Japan,	NOUN	O	O
Taiwan,	DET	O	O
and	CCONJ	O	O
South	NOUN	O	O
Korea)	ADJ	O	O
were	VERB	O	O
consistent	ADJ	O	O
with	ADP	O	O
the	DET	O	O
overall	ADJ	O	O
study	NOUN	O	O
population.	ADV	O	O

Eligible	ADJ	O	O
adults	NOUN	O	O
from	ADP	O	O
132	NUM	O	O
sites	NOUN	O	O
in	ADP	O	O
17	NUM	O	O
countries	NOUN	O	O
with	ADP	O	O
previously	ADV	O	O
untreated	VERB	O	O
CD30-positive	ADJ	O	O
peripheral	ADJ	O	O
T-cell	NOUN	O	O
lymphomas	NOUN	O	O
(targeting	VERB	O	O
75%	NUM	O	O
with	ADP	O	O
systemic	ADJ	O	O
anaplastic	ADJ	O	O
large	ADJ	O	O
cell	NOUN	O	O
lymphoma)	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
1:1	ADJ	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
A+CHP	ADV	O	O
or	CCONJ	O	O
CHOP	VERB	O	O
for	ADP	O	O
six	NUM	O	O
or	CCONJ	O	O
eight	NUM	O	O
21-day	NOUN	O	O
cycles.	NUM	O	O

FUNDING:	NOUN	O	O
Bristol-Myers	NOUN	O	O
Squibb.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
German	NOUN	O	O
register	NOUN	O	O
of	ADP	O	O
clinical	ADJ	O	O
studies:	NOUN	O	O
DRKS00000622	NOUN	O	O
.	PUNCT	O	O

Echocardiography	NOUN	O	O
was	VERB	O	O
analysed	VERB	O	O
off-line	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
after	ADP	O	O
3,	NOUN	O	O
6	NUM	O	O
and	CCONJ	O	O
12	NUM	O	O
months	NOUN	O	O
by	ADP	O	O
investigators	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
blinded	VERB	O	O
to	PART	O	O
clinical	ADJ	O	O
data.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
sample	NOUN	O	O
of	ADP	O	O
2262	NUM	O	O
male	NOUN	O	O
truckers	NOUN	O	O
registered	VERB	O	O
in	ADP	O	O
the	DET	O	O
North	NOUN	O	O
Star	NOUN	O	O
Alliance	NOUN	O	O
electronic	ADJ	O	O
health	NOUN	O	O
record	NOUN	O	O
system	NOUN	O	O
who,	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
these	DET	O	O
records,	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
testing	VERB	O	O
for	ADP	O	O
HIV	NOUN	O	O
regularly	ADV	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
three	NUM	O	O
study	NOUN	O	O
groups	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
they	PRON	O	O
were	VERB	O	O
sent	ADJ	O	O
text	VERB	O	O
messages	NOUN	O	O
about	ADV	O	O
the	DET	O	O
availability	NOUN	O	O
of	ADP	O	O
(1)	PUNCT	O	O
oral	ADJ	O	O
HIV	NOUN	O	O
self-test	NOUN	O	O
kits	NOUN	O	O
at	ADP	O	O
all	DET	O	O
8	NUM	O	O
North	NOUN	O	O
Star	NOUN	O	O
Alliance	NOUN	O	O
Kenya	PROPN	O	O
clinics	NOUN	O	O
that	ADP	O	O
was	VERB	O	O
sent	ADJ	O	O
three	NUM	O	O
times	NOUN	O	O
(intervention),	NOUN	O	O
(2)	PUNCT	O	O
HIV	NOUN	O	O
testing	VERB	O	O
in	ADP	O	O
general	ADJ	O	O
(not	ADV	O	O
self-testing)	NOUN	O	O
at	ADP	O	O
all	DET	O	O
North	NOUN	O	O
Star	NOUN	O	O
Alliance	NOUN	O	O
clinics	NOUN	O	O
sent	ADJ	O	O
three	NUM	O	O
times	NOUN	O	O
(enhanced	VERB	O	O
standard	ADJ	O	O
of	ADP	O	O
care	NOUN	O	O
[SOC]),	ADJ	O	O
or	CCONJ	O	O
(3)	PUNCT	O	O
HIV	NOUN	O	O
testing	VERB	O	O
in	ADP	O	O
general	ADJ	O	O
(not	ADV	O	O
self-testing)	NOUN	O	O
at	ADP	O	O
all	DET	O	O
North	NOUN	O	O
Star	NOUN	O	O
Alliance	NOUN	O	O
clinics	NOUN	O	O
sent	ADJ	O	O
one	NUM	O	O
time	NOUN	O	O
(SOC).	ADV	O	O

These	DET	O	O
reductions	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
79%	NUM	O	O
lower	ADJ	O	O
mean	NOUN	O	O
annualized	VERB	O	O
attack	NOUN	O	B-outcome
rate	NOUN	O	O
than	ADP	O	O
that	ADP	O	O
observed	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
(exploratory	NUM	O	O
efficacy	NOUN	O	O
end	NOUN	O	O
point).	NOUN	O	O

Complete	ADJ	O	O
diet	NOUN	O	O
collections	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
for	ADP	O	O
nitrogen	NOUN	O	O
(for	PUNCT	O	O
protein),	NOUN	O	O
fat,	ADP	O	O
energy,	NOUN	O	O
and	CCONJ	O	O
carbohydrate	NOUN	O	O
by	ADP	O	O
difference.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
further	ADV	O	O
define	NOUN	O	O
the	DET	O	O
role	NOUN	O	O
of	ADP	O	O
a	DET	O	O
fixed	VERB	O	O
combination	NOUN	O	O
halobetasol	NOUN	O	O
propionate	NOUN	O	O
0.01%	NOUN	O	O
and	CCONJ	O	O
tazarotene	NOUN	O	O
0.045%	NUM	O	O
(HP/TAZ)	PUNCT	O	O
lotion	NOUN	O	O
in	ADP	O	O
moderate-to-severe	ADV	O	O
plaque	NOUN	O	O
psoriasis	NOUN	O	O
using	VERB	O	O
the	DET	O	O
IGAxBSA	NOUN	O	O
composite	NOUN	O	O
tool.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
.	PUNCT	O	O
For	ADP	O	O
the	DET	O	O
safety	NOUN	O	O
assessment,	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
recorded	VERB	O	O
during	ADP	O	O
the	DET	O	O
study	NOUN	O	O
period.	NOUN	O	O

FINDINGS:	ADJ	O	O
Between	ADP	O	O
May	NOUN	O	O
12,	NUM	O	O
2015,	NUM	O	O
and	CCONJ	O	O
Aug	NOUN	O	O
4,	NOUN	O	O
2016,	NUM	O	O
184	NUM	O	O
overweight	NUM	O	O
or	CCONJ	O	O
obese	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
non-alcoholic	ADJ	O	O
steatohepatitis	NOUN	O	O
were	VERB	O	O
screened	VERB	O	O
for	ADP	O	O
study	NOUN	O	O
inclusion.	NOUN	O	O

This	DET	O	O
indicates	NOUN	O	O
that	ADP	O	O
changing	VERB	O	O
lifestyle	NOUN	O	B-outcome
is	VERB	O	O
an	DET	O	O
important	ADJ	O	O
first	ADV	O	O
step,	NOUN	O	O
but	CCONJ	O	O
maintaining	VERB	O	O
this	DET	O	O
change	NOUN	O	O
is	VERB	O	O
needed	VERB	O	O
for	ADP	O	O
improving	VERB	O	O
cardiometabolic	ADJ	O	B-outcome
health	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
long-term.	NOUN	O	O

Superoxide	NOUN	O	B-outcome
dismutase	NOUN	O	I-outcome
activity	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
elevated	VERB	O	O
after	ADP	O	O
exercise	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.002)	NUM	O	O
in	ADP	O	O
placebo	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
AA.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
sources	NOUN	O	O
of	ADP	O	O
fish	NOUN	O	O
and	CCONJ	O	O
camelina	NOUN	O	O
sativa	NOUN	O	O
oil	NOUN	O	O
on	ADP	O	O
immune	ADJ	O	O
cell	NOUN	O	O
and	CCONJ	O	O
adipose	ADJ	O	O
tissue	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
in	ADP	O	O
subjects	NOUN	O	O
with	ADP	O	O
abnormal	ADJ	O	O
fasting	VERB	O	O
glucose	NOUN	O	O
metabolism:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

The	DET	O	O
plasma	NOUN	O	O
concentrations	NOUN	O	O
of	ADP	O	O
netupitant	ADJ	O	B-outcome
and	CCONJ	O	Seperator
its	NUM	O	X
metabolites	NOUN	O	S1-outcome
increased	VERB	O	O
with	ADP	O	O
the	DET	O	O
dose	NOUN	O	O
increase	NOUN	O	O
from	ADP	O	O
30	NUM	O	O
mg	NOUN	O	O
to	PART	O	O
300	NUM	O	O
mg.	NOUN	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
all	DET	O	O
time	NOUN	O	O
points,	NOUN	O	O
tramadol	NOUN	O	B-outcome
consumption	NOUN	O	O
of	ADP	O	O
the	DET	O	O
OSTAP	NOUN	O	O
group	NOUN	O	O
remained	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
Sham	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
basic	ADJ	O	O
antianginal	ADJ	O	O
therapy	NOUN	O	O
was	VERB	O	O
allowed	VERB	O	O
to	PART	O	O
use	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups:	NOUN	O	O
beta-blockers,	NOUN	O	O
calcium	NOUN	O	O
antagonists,	NOUN	O	O
ATE	NOUN	O	O
inhibitors	NOUN	O	O
/	SYM	O	O
angiotensin	NOUN	O	O
II	NUM	O	O
receptor	NOUN	O	O
blockers,	NOUN	O	O
statins,	NOUN	O	O
acetylsalicylic	ADJ	O	O
acid,	NOUN	O	O
blockers	NOUN	O	O
of	ADP	O	O
P2Y12	NOUN	O	O
receptor	NOUN	O	O
platelets.	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
We	PRON	O	O
included	VERB	O	O
88	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
stable	ADJ	O	O
form	NOUN	O	O
of	ADP	O	O
CHD,	NUM	O	O
who	ADP	O	O
were	VERB	O	O
going	VERB	O	O
to	PART	O	O
pass	NOUN	O	O
the	DET	O	O
elective	ADJ	O	O
PCI,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

Title:	NOUN	O	O
Use	PUNCT	O	O
of	ADP	O	O
a	DET	O	O
robotic	ADJ	O	O
walking	VERB	O	O
aid	VERB	O	O
in	ADP	O	O
rehabilitation	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
fear	ADJ	O	B-outcome
of	ADP	O	I-outcome
falling	VERB	O	I-outcome
is	VERB	O	O
feasible	ADJ	O	B-outcome
and	CCONJ	O	O
acceptable	ADJ	O	B-outcome
from	ADP	O	O
the	DET	O	O
end	NOUN	O	O
user's	ADJ	O	O
perspective:	NOUN	O	O
A	DET	O	O
randomised	VERB	O	O
comparative	ADJ	O	O
study.	NOUN	O	O

PC	NOUN	O	O
significantly	ADV	O	O
lowered	VERB	O	O
sweat	NOUN	O	B-outcome
rate	NOUN	O	O
(PC	NOUN	O	O
=	SYM	O	O
1.02	NUM	O	O
+/-	SYM	O	O
0.31	NUM	O	O
L	NOUN	O	O
.	PUNCT	O	O

No	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
between	ADP	O	O
the	DET	O	O
direct	ADJ	O	O
and	CCONJ	O	O
video	ADJ	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
NCT,	NOUN	O	O
NCT03134690.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101476450	NUM	O	O

RESULTS:	NOUN	O	O
Non-esterified	VERB	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
net	ADJ	O	O
area	NOUN	O	O
under	ADP	O	O
curve	NOUN	O	O
(AUC)	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
by	ADP	O	O
97	NUM	O	O
+/-	SYM	O	O
38	NUM	O	O
mumol/Lx270	NOUN	O	O
min	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.024)	NOUN	O	O
after	ADP	O	O
breakfast	NOUN	O	O
but	CCONJ	O	O
reduced	VERB	O	O
by	ADP	O	O
141	NUM	O	O
+/-	SYM	O	O
33	NUM	O	O
mumol/Lx180	NOUN	O	O
min	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.001)	NUM	O	O
after	ADP	O	O
lunch	NOUN	O	O
on	ADP	O	O
the	DET	O	O
CRHP	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
CD	NOUN	O	O
diet.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
40	NUM	O	O
eligible	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
a	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(received	PUNCT	O	O
BZSF	NOUN	O	O
and	CCONJ	O	O
ceftriaxone)	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(received	PUNCT	O	O
ceftriaxone	NOUN	O	O
alone).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/03/27	ADV	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

CM	NOUN	O	O
had	VERB	O	O
a	DET	O	O
more	ADV	O	O
positive	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
strength	NOUN	O	B-outcome
development	NOUN	O	O
and	CCONJ	O	O
should	VERB	O	O
be	VERB	O	O
considered	VERB	O	O
an	DET	O	O
appropriate	ADJ	O	O
post-exercise	NOUN	O	O
recovery	NOUN	O	O
supplement	NOUN	O	O
for	ADP	O	O
adolescents.	NOUN	O	O

An	DET	O	O
equivalent	ADJ	O	O
volume	NOUN	O	O
of	ADP	O	O
normal	ADJ	O	O
saline	NOUN	O	O
was	VERB	O	O
administered	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Fifty-five	ADJ	O	O
women	NOUN	O	O
in	ADP	O	O
5	NUM	O	O
village	NOUN	O	O
clusters	NOUN	O	O
received	VERB	O	O
the	DET	O	O
ABHR	NOUN	O	O
and	CCONJ	O	O
used	VERB	O	O
it	PRON	O	O
from	ADP	O	O
birth	NOUN	O	O
to	PART	O	O
3	NUM	O	O
months	NOUN	O	O
postnatally,	NOUN	O	O
with	ADP	O	O
use	NOUN	O	O
guided	VERB	O	O
by	ADP	O	O
the	DET	O	O
new	ADJ	O	O
poster.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101643584	NUM	O	O

BACKGROUND:	NOUN	O	O
Ascorbic	ADJ	O	O
acid	NOUN	O	O
is	VERB	O	O
a	DET	O	O
water-soluble	ADJ	O	O
chain	NOUN	O	O
breaking	VERB	O	O
antioxidant.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/28	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

The	DET	O	O
160	NUM	O	O
patients	NOUN	O	O
fulfilled	VERB	O	O
the	DET	O	O
study	NOUN	O	O
requirements.	NOUN	O	O

PsycINFO	NOUN	O	O
Database	NOUN	O	O
Record	NOUN	O	O
(c)	PUNCT	O	O
2018	NUM	O	O
APA,	NOUN	O	O
all	DET	O	O
rights	NOUN	O	O
reserved).	NOUN	O	O

Preoperatively,	ADJ	O	O
all	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
clinically	ADV	O	O
(	NOUN	O	O
Kujala	NOUN	O	O
score	NOUN	O	O
questionnaire])	ADP	O	O
and	CCONJ	O	O
radiologically.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
consumption	NOUN	O	B-outcome
of	ADP	O	O
postoperative	ADJ	O	O
rescued	NOUN	O	O
sufentanil	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
Dex	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
Control	NOUN	O	O
group	NOUN	O	O
(56.3	NOUN	O	O
+/-	SYM	O	O
9.4	NUM	O	O
vs	CCONJ	O	O
65.9	NUM	O	O
+/-	SYM	O	O
10.7	NUM	O	O
mug).	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101273480	NUM	O	O

The	DET	O	O
mean	NOUN	O	O
value	NOUN	O	O
of	ADP	O	O
all	DET	O	O
measured	VERB	O	O
hematology	NOUN	O	B-outcome
variables	NOUN	O	O
remained	VERB	O	O
within	ADP	O	O
the	DET	O	O
reference	NOUN	O	O
values	NOUN	O	O
in	ADP	O	O
all	DET	O	O
study	NOUN	O	O
subject	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
significant	ADJ	O	O
changes	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
blood	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
or	CCONJ	O	O
lipid	NOUN	O	B-outcome
values.	NUM	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
100	NUM	O	O
children	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
constipation	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study,	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Multicenter	NOUN	O	O
Study,	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O
Research	NOUN	O	O
Support,	NOUN	O	O
U.S.	PROPN	O	O
Gov't,	NOUN	O	O
Non-P.H.S.,	VERB	O	O

METHODS:	NOUN	O	O
Seventy	NOUN	O	O
non-dialysis	NOUN	O	O
CKD-MBD	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
kidney	NOUN	O	O
deficiency	NOUN	O	O
and	CCONJ	O	O
dampness-heat	NOUN	O	O
syndrome	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(n=35)	PUNCT	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(n=35).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
In	ADP	O	O
high-risk	NOUN	O	O
ambulatory	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
cancer,	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
rivaroxaban	ADJ	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
a	DET	O	O
significantly	ADV	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
venous	ADJ	O	B-outcome
thromboembolism	NOUN	O	I-outcome
or	CCONJ	O	O
death	NOUN	O	B-outcome
due	ADJ	O	I-outcome
to	PART	O	I-outcome
venous	ADJ	O	I-outcome
thromboembolism	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
180-day	NOUN	O	O
trial	NOUN	O	O
period.	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
transthoracic	ADJ	O	O
open	ADJ	O	O
esophagectomy	NOUN	O	O
(open	NUM	O	O
procedure)	NOUN	O	O
or	CCONJ	O	O
hybrid	NOUN	O	O
minimally	ADV	O	O
invasive	ADJ	O	O
esophagectomy	NOUN	O	O
(hybrid	NOUN	O	O
procedure).	NOUN	O	O

After	ADP	O	O
the	DET	O	O
intervention,	ADP	O	O
only	ADV	O	O
the	DET	O	O
exercise	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
a	DET	O	O
significantly	ADV	O	O
lower	ADJ	O	O
BMI	NOUN	O	B-outcome
z-score	NOUN	O	O
than	ADP	O	O
the	DET	O	O
baseline	NOUN	O	O
score	NOUN	O	O
by	ADP	O	O
about	ADV	O	O
0.1	NUM	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.03),	NUM	O	O
but	CCONJ	O	O
no	DET	O	O
significant	ADJ	O	O
group	NOUN	O	O
by	ADP	O	O
time	NOUN	O	O
interaction	NOUN	O	O
effects	NOUN	O	O
were	VERB	O	O
observed.	NOUN	O	O

A	DET	O	O
masked	VERB	O	O
evaluator	NOUN	O	O
assessed	VERB	O	O
parent	NOUN	O	O
performance	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
parents	NOUN	O	O
rated	VERB	O	O
instructional	ADJ	O	B-outcome
effectiveness.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Despite	ADP	O	O
the	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
some	DET	O	O
cytotoxic	ADJ	O	B-outcome
cells	NOUN	O	I-outcome
(CTLs)	NUM	O	I-outcome
and	CCONJ	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
the	DET	O	O
proportion	NOUN	O	O
of	ADP	O	O
T	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
lymphocytes	NOUN	O	I-outcome
(Tregs)	NUM	O	I-outcome
to	PART	O	I-outcome
cytotoxic	ADJ	O	I-outcome
lymphocytes	NOUN	O	I-outcome
(CTLs)	NUM	O	I-outcome
,	PUNCT	O	O
supplementation	NOUN	O	O
with	ADP	O	O
LTE	NOUN	O	O
seems	NOUN	O	O
to	PART	O	O
exert	NOUN	O	O
a	DET	O	O
beneficial	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
a	DET	O	O
disrupted	VERB	O	O
Th1/Th2	NOUN	O	O
balance	NOUN	O	O
in	ADP	O	O
elite	ADP	O	O
athletes,	NOUN	O	O
as	ADP	O	O
shown	VERB	O	O
by	ADP	O	O
the	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
interleukin	NOUN	O	B-outcome
10	NUM	O	I-outcome
(IL-10)	PUNCT	O	I-outcome
concentration.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968555	NUM	O	O

METHODS:	NOUN	O	O
Utilizing	VERB	O	O
a	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled,	NOUN	O	O
parallel	ADJ	O	O
design,	NOUN	O	O
healthy,	NOUN	O	O
recreationally-active	ADJ	O	O
men	NOUN	O	O
and	CCONJ	O	O
women	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
142)	NOUN	O	O
received	VERB	O	O
900	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
PSE	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
(PLA)	PUNCT	O	O
daily	ADJ	O	O
for	ADP	O	O
90	NUM	O	O
days.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/22	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
Harris	ADV	O	O
and	CCONJ	O	O
VAS	NOUN	O	O
scores	NOUN	O	O
of	ADP	O	O
SuperPATH	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
and	CCONJ	O	O
3	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
were	VERB	O	O
better	ADJ	O	O
than	ADP	O	O
those	DET	O	O
of	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(	PUNCT	O	O
P<0.05).	NOUN	O	O

However,	ADV	O	O
few	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
explored	VERB	O	O
the	DET	O	O
application	NOUN	O	O
of	ADP	O	O
OPEP	NOUN	O	O
in	ADP	O	O
surgery	NOUN	O	O
lung	NOUN	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
underwent	VERB	O	O
lobectomy.	NOUN	O	O

After	ADP	O	O
a	DET	O	O
10-min	NOUN	O	O
rest,	NOUN	O	O
they	PRON	O	O
exercised	VERB	O	O
to	PART	O	O
a	DET	O	O
Trec	ADV	O	O
of	ADP	O	O
39.5	NUM	O	O
degrees	NOUN	O	O
C.	NOUN	O	O
Subsequently,	NOUN	O	O
they	PRON	O	O
underwent	VERB	O	O
CWI	NOUN	O	O
(9.99	PUNCT	O	O
+/-	SYM	O	O
0.03	NUM	O	O
degrees	NOUN	O	O
C)	NOUN	O	O
until	ADP	O	O
Trec	ADV	O	O
reached	VERB	O	O
38	NUM	O	O
degrees	NOUN	O	O
C.	NOUN	O	O
On	ADP	O	O
control	NOUN	O	O
(CON)	NOUN	O	O
days,	NOUN	O	O
the	DET	O	O
same	ADJ	O	O
procedures	NOUN	O	O
occurred	VERB	O	O
without	ADP	O	O
the	DET	O	O
15-min	NOUN	O	O
PC	NOUN	O	O
intervention.	NOUN	O	O

BACKGROUND:	NOUN	O	O
To	PART	O	O
study	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
the	DET	O	O
biodegradable	ADJ	O	O
collagen	NOUN	O	O
implant	NOUN	O	O
Ologen(R)	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjuvant	NOUN	O	O
in	ADP	O	O
phaco-viscocanalostomy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
coexisting	VERB	O	O
cataract	NOUN	O	O
and	CCONJ	O	O
primary	ADJ	O	O
open	ADJ	O	O
angle	NOUN	O	O
glaucoma.	NOUN	O	O

Among	ADP	O	O
the	DET	O	O
108	NUM	O	O
participants	NOUN	O	O
enrolled,	NOUN	O	O
37,	NUM	O	O
34,	NUM	O	O
and	CCONJ	O	O
37	NUM	O	O
received	VERB	O	O
Avaxim,	NOUN	O	O
Epaxal,	NOUN	O	O
and	CCONJ	O	O
Havrix,	NOUN	O	O
respectively.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

The	DET	O	O
intervention	NOUN	O	O
period	NOUN	O	O
lasted	VERB	O	O
30	NUM	O	O
days	NOUN	O	O
(1	NOUN	O	O
session	NOUN	O	O
every	DET	O	O
10	NUM	O	O
days).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Micronutrient	NOUN	O	O
deficiencies	NOUN	O	O
are	VERB	O	O
common	ADJ	O	O
during	ADP	O	O
pregnancy,	NOUN	O	O
especially	ADV	O	O
in	ADP	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
from	ADP	O	O
economically	ADV	O	O
disadvantaged	NOUN	O	O
settings	NOUN	O	O
where	ADP	O	O
diets	NOUN	O	O
with	ADP	O	O
low	ADJ	O	O
content	NOUN	O	O
of	ADP	O	O
minerals	NOUN	O	O
and	CCONJ	O	O
vitamins	NOUN	O	O
are	VERB	O	O
consumed.	NOUN	O	O

Comparison	NOUN	O	O
of	ADP	O	O
percentage	NOUN	O	O
of	ADP	O	O
respondents	NOUN	O	O
fitting	VERB	O	O
into	ADP	O	O
body	NOUN	O	O
posture	ADJ	O	O
norms	NOUN	O	O
clearly	ADV	O	O
indicates	NOUN	O	O
higher	ADJ	O	O
value	NOUN	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
classified	VERB	O	O
as	ADP	O	O
active.	ADJ	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
This	DET	O	O
was	VERB	O	O
a	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
unblinded	VERB	O	O
study.	NOUN	O	O

In	ADP	O	O
this	DET	O	O
open-label,	ADV	O	O
randomized,	NOUN	O	O
prospective,	NOUN	O	O
multicenter	NOUN	O	O
study,	NOUN	O	O
108	NUM	O	O
children	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
randomized	VERB	O	O
to	PART	O	O
receive	VERB	O	O
a	DET	O	O
pediatric	ADJ	O	O
form	NOUN	O	O
of	ADP	O	O
Avaxim,	NOUN	O	O
Epaxal,	NOUN	O	O
or	CCONJ	O	O
Havrix.	NOUN	O	O

Journal-Name:Lancet	NOUN	O	O
(London,	PUNCT	O	O
England)	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
neuromuscular	ADJ	O	O
electrical	ADJ	O	O
stimulation	NOUN	O	O
(NMES)	NUM	O	O
therapy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
urinary	ADJ	O	O
incontinence	NOUN	O	O
after	ADP	O	O
stroke	NOUN	O	O
(UIAS).	NOUN	O	O

As	ADP	O	O
shown	VERB	O	O
by	ADP	O	O
subjective	ADJ	O	O
symptoms	NOUN	O	B-outcome
,	PUNCT	O	O
the	DET	O	O
results	NOUN	O	O
in	ADP	O	O
95%	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
were	VERB	O	O
rated	VERB	O	O
as	ADP	O	O
good	ADJ	O	O
or	CCONJ	O	O
very	ADV	O	O
good.	NOUN	O	O

RESULTS:	NOUN	O	O
PC	NOUN	O	O
lowered	VERB	O	O
body	NOUN	O	B-outcome
heat	NOUN	O	I-outcome
storage	NOUN	O	I-outcome
and	CCONJ	O	O
rectal	ADJ	O	B-outcome
temperature	NOUN	O	I-outcome
by	ADP	O	O
15.7	NUM	O	O
+/-	SYM	O	O
15.0	NUM	O	O
W	NOUN	O	O
.	PUNCT	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
controlled,	NOUN	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
on	ADP	O	O
62	NUM	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
referred	VERB	O	O
to	PART	O	O
health	NOUN	O	O
centers	NOUN	O	O
of	ADP	O	O
Isfahan,	CCONJ	O	O
Iran.	NOUN	O	O

Oxidant/antioxidant	NOUN	O	B-outcome
status	NOUN	O	O
and	CCONJ	O	O
markers	NOUN	O	O
of	ADP	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
were	VERB	O	O
evaluated	VERB	O	O
in	ADP	O	O
24	NUM	O	O
elite	ADP	O	O
football	NOUN	O	O
players	NOUN	O	O
and	CCONJ	O	O
15	NUM	O	O
controls.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
lung	NOUN	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
forced	VERB	O	B-outcome
expiratory	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
in	ADP	O	Seperator
1	NUM	O	I-outcome
second	ADJ	O	I-outcome
(FEV1)	NOUN	O	I-outcome
and	CCONJ	O	O
ratio	NOUN	O	B-outcome
between	ADP	O	Seperator
FEV1	NOUN	O	I-outcome
and	CCONJ	O	Seperator
forced	VERB	O	I-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(FEV1/FVC)	PUNCT	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
secondary	ADJ	O	O
endpoints	NOUN	O	O
included	VERB	O	O
the	DET	O	O
symptom	NOUN	O	B-outcome
improvements,	NOUN	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
clinical	ADJ	O	B-outcome
assessment	NOUN	O	I-outcome
score,	NOUN	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QoL)	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
assessed	VERB	O	O
with	ADP	O	O
Paediatric	ADJ	O	O
Allergic	ADJ	O	B-outcome
Disease	NOUN	O	I-outcome
Quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
Life	NOUN	O	I-outcome
Questionnaire	PROPN	O	O
(PADQLQ)	NUM	O	O
scores.	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
Achaogen	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
Biomedical	ADJ	O	O
Advanced	VERB	O	O
Research	NOUN	O	O
and	CCONJ	O	O
Development	NOUN	O	O
Authority;	NOUN	O	O
EPIC	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02486627.).	NOUN	O	O

Further	ADV	O	O
evaluation	NOUN	O	O
of	ADP	O	O
long-term	NOUN	O	O
cardiovascular	ADJ	O	O
effects	NOUN	O	O
is	VERB	O	O
needed.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Precooling	VERB	O	O
(PC)	PUNCT	O	O
before	ADP	O	O
exercise	NOUN	O	O
may	VERB	O	O
help	VERB	O	O
prevent	NOUN	O	O
severe	ADJ	O	O
hyperthermia	NOUN	O	O
and	CCONJ	O	O
exertional	ADJ	O	O
heatstroke	NOUN	O	O
(EHS).	PUNCT	O	O

Muscular	ADJ	O	B-outcome
strength	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
limbs	NOUN	O	O
at	ADP	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.02).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101307187	NUM	O	O

Patients	NOUN	O	O
with	ADP	O	O
clinical	ADJ	O	O
stage	NOUN	O	O
I-II	NUM	O	O
gastric	ADJ	O	O
cancer	NOUN	O	O
with	ADP	O	O
a	DET	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
of	ADP	O	O
25	NUM	O	O
and	CCONJ	O	O
over,	NOUN	O	O
who	ADP	O	O
undergo	NOUN	O	O
laparoscopic	ADJ	O	O
subtotal	ADJ	O	O
gastrectomy	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
eligible	ADJ	O	O
for	ADP	O	O
trial	NOUN	O	O
inclusion.	NOUN	O	O

h(-1),	NOUN	O	O
CON	NOUN	O	O
=	SYM	O	O
1.22	NUM	O	O
+/-	SYM	O	O
0.39	NUM	O	O
L	NOUN	O	O
.	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Sperm	NOUN	O	O
selection	NOUN	O	O
strategies	NOUN	O	O
aimed	VERB	O	O
at	ADP	O	O
improving	VERB	O	O
success	NOUN	O	O
rates	NOUN	O	O
of	ADP	O	O
intracytoplasmic	ADJ	O	O
sperm	NOUN	O	O
injection	NOUN	O	O
(ICSI)	NUM	O	O
include	VERB	O	O
binding	VERB	O	O
to	PART	O	O
hyaluronic	ADJ	O	O
acid	NOUN	O	O
(herein	NUM	O	O
termed	VERB	O	O
hyaluronan).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/09	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
60	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
1	NUM	O	O
of	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
Pre-administered	VERB	O	O
with	ADP	O	O
remifentanil	NOUN	O	O
before	ADP	O	O
propofol	NOUN	O	O
infusion	NOUN	O	O
(Group	PUNCT	O	O
R,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
and	CCONJ	O	O
co-administered	VERB	O	O
with	ADP	O	O
remifentanil	NOUN	O	O
with	ADP	O	O
propofol	NOUN	O	O
(Group	PUNCT	O	O
N,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
30).	NOUN	O	O

Results	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
adapted	VERB	O	O
and	CCONJ	O	O
shared	VERB	O	O
with	ADP	O	O
all	DET	O	O
stakeholders.	NOUN	O	O

Title:	NOUN	O	O
Rehabilitation	NOUN	O	O
treatment	NOUN	O	O
of	ADP	O	O
spastic	ADJ	O	O
cerebral	ADJ	O	O
palsy	NOUN	O	O
with	ADP	O	O
radial	ADJ	O	O
extracorporeal	ADJ	O	O
shock	NOUN	O	O
wave	NOUN	O	O
therapy	NOUN	O	O
and	CCONJ	O	O
rehabilitation	NOUN	O	O
therapy.	NOUN	O	O

Results	NOUN	O	O
suggest	VERB	O	O
there	PRON	O	O
is	VERB	O	O
value	NOUN	O	O
in	ADP	O	O
further	ADV	O	O
methodologically	ADV	O	O
rigorous	ADJ	O	O
investigations	NOUN	O	O
into	ADP	O	O
improving	VERB	O	O
community-based	VERB	O	O
health	NOUN	O	O
system	NOUN	O	O
functioning	VERB	O	O
through	ADP	O	O
a	DET	O	O
similar	ADJ	O	O
approach	NOUN	O	O
to	PART	O	O
community	NOUN	O	O
engagement.	NOUN	O	O

Introduction:	NOUN	O	O
Most	DET	O	O
medical	ADJ	O	O
schools	NOUN	O	O
teach	NOUN	O	O
cardiopulmonary	ADJ	O	O
resuscitation	NOUN	O	O
(CPR)	ADV	O	O
during	ADP	O	O
the	DET	O	O
final	ADJ	O	O
year	NOUN	O	O
in	ADP	O	O
course	NOUN	O	O
curriculum	NOUN	O	O
to	PART	O	O
prepare	NOUN	O	O
students	NOUN	O	O
to	PART	O	O
manage	NOUN	O	O
the	DET	O	O
first	ADV	O	O
minutes	NOUN	O	O
of	ADP	O	O
clinical	ADJ	O	O
emergencies.	ADP	O	O

Title:	NOUN	O	O
EYE	NOUN	O	O
LENS	NOUN	O	O
RADIATION	NOUN	O	O
EXPOSURE	NOUN	O	O
OF	ADP	O	O
WORKERS	NOUN	O	O
DURING	ADP	O	O
MEDICAL	VERB	O	O
INTERVENTIONAL	ADJ	O	O
PROCEDURES	NOUN	O	O
AND	CCONJ	O	O
SURGERY.	NOUN	O	O

The	DET	O	O
results	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
using	VERB	O	O
descriptive	ADJ	O	O
and	CCONJ	O	O
inferential	ADJ	O	O
statistical	ADJ	O	O
tests	NOUN	O	O
in	ADP	O	O
SPSS	ADV	O	O
software.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ISRCTN67852437	NOUN	O	O
,	PUNCT	O	O
registered	VERB	O	O
02/03/2015.	NUM	O	O

At	ADP	O	O
10	NUM	O	O
minutes	NOUN	O	O
after	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
atomization,	NOUN	O	O
the	DET	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
ventilator	NOUN	O	O
in	ADP	O	O
different	ADJ	O	O
preset	NOUN	O	O
VT	NOUN	O	O
groups	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
showed	VERB	O	O
by	ADP	O	O
simulated	VERB	O	O
water	NOUN	O	O
lung	NOUN	O	O
(mL:	PUNCT	O	O
649.67+/-5.03	NOUN	O	O
vs.	CCONJ	O	O
840.00+/-10.00	NOUN	O	O
at	ADP	O	O
650	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
preset	NOUN	O	O
VT	NOUN	O	O
and	CCONJ	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.05),	NUM	O	O
and	CCONJ	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
showed	VERB	O	O
by	ADP	O	O
simulated	VERB	O	O
water	NOUN	O	O
lung	NOUN	O	O
(mL:	PUNCT	O	O
1	NUM	O	O
270.33+/-11.06	NOUN	O	O
vs.	CCONJ	O	O
840.00+/-10.00	NOUN	O	O
at	ADP	O	O
650	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
preset	NOUN	O	O
VT	NOUN	O	O
and	CCONJ	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

BACKGROUND:	NOUN	O	O
Residual	ADJ	O	O
postoperative	ADJ	O	O
neuromuscular	ADJ	O	O
blockade	NOUN	O	O
is	VERB	O	O
an	DET	O	O
important	ADJ	O	O
clinical	ADJ	O	O
issue.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/08	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

At	ADP	O	O
enrolment,	NOUN	O	O
90	NUM	O	O
women	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
into	ADP	O	O
each	DET	O	O
intervention	NOUN	O	O
arm	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
a	DET	O	O
daily	ADJ	O	O
tablet	NOUN	O	O
of	ADP	O	O
200	NUM	O	O
mug	NUM	O	O
elemental	ADJ	O	O
selenium	NOUN	O	O
or	CCONJ	O	O
placebo.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
scheduled	VERB	O	O
for	ADP	O	O
CABG	NOUN	O	O
and	CCONJ	O	O
had	VERB	O	O
been	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
bilateral	ADJ	O	O
or	CCONJ	O	O
single	ADJ	O	O
internal-thoracic-artery	ADV	O	O
grafting,	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
between-group	NOUN	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
any	DET	O	Seperator
cause	ADP	O	I-outcome
at	ADP	O	O
10	NUM	O	O
years	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
analysis.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

At	ADP	O	O
the	DET	O	O
same	ADJ	O	O
time,	NOUN	O	O
both	CCONJ	O	O
groups	NOUN	O	O
showed	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
the	DET	O	O
serologic	ADJ	O	O
and	CCONJ	O	O
biochemical	ADJ	O	O
response	NOUN	O	B-outcome
.	PUNCT	O	O
Of	ADP	O	O
all	DET	O	O
patients,	NOUN	O	O
2	NUM	O	O
dropped	VERB	O	O
out	ADP	O	O
due	ADJ	O	O
to	PART	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
and	CCONJ	O	O
5	NUM	O	O
experienced	VERB	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
reactions	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSION:	NOUN	O	O
Both	CCONJ	O	O
capsules	NOUN	O	O
(ETV	NUM	O	O
or	CCONJ	O	O
TDF)	NOUN	O	O
were	VERB	O	O
equally	ADV	O	O
effective	ADJ	O	O
in	ADP	O	O
nucleos(t)ide-naive	ADJ	O	O
CHB	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
comparable	ADJ	O	O
side-effect	NOUN	O	B-outcome
profile	NOUN	O	O
even	ADV	O	O
in	ADP	O	O
a	DET	O	O
long-term	NOUN	O	O
of	ADP	O	O
144	NUM	O	O
weeks.	NOUN	O	O

Infants	NOUN	O	O
aged	VERB	O	O
4(-)12	NUM	O	O
weeks	NOUN	O	O
received	VERB	O	O
L.	NOUN	O	O
rhamnosus	NOUN	O	O
19070-2	NUM	O	O
and	CCONJ	O	O
L.	NOUN	O	O
reuteri	NOUN	O	O
12246	NUM	O	O
in	ADP	O	O
a	DET	O	O
daily	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
250	NUM	O	O
x	SYM	O	O
10(6)	NOUN	O	O
CFU,	NOUN	O	O
3.33	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
fructooligosaccharide,	DET	O	O
and	CCONJ	O	O
200	NUM	O	O
IU	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D(3)	NOUN	O	O
(84	PUNCT	O	O
infants,	NOUN	O	O
probiotic	ADJ	O	O
group)	ADJ	O	O
or	CCONJ	O	O
just	ADV	O	O
vitamin	NOUN	O	O
D(3)	NOUN	O	O
(84	PUNCT	O	O
infants,	NOUN	O	O
control	NOUN	O	O
group)	ADJ	O	O
for	ADP	O	O
28	NUM	O	O
days.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0373125	NUM	O	O

Repeated	VERB	O	O
measures	NOUN	O	O
ANOVA	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
groups	NOUN	O	O
over	ADP	O	O
time.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
Supplementation	NOUN	O	O
with	ADP	O	O
ascorbic	ADJ	O	O
acid	NOUN	O	O
prior	ADJ	O	O
exercise	NOUN	O	O
improves	NOUN	O	O
antioxidant	NOUN	O	B-outcome
power	NOUN	O	O
but	CCONJ	O	O
does	VERB	O	O
not	ADV	O	O
prevent	NOUN	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
.	PUNCT	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
evaluated	VERB	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
an	DET	O	O
exercise	NOUN	O	O
program	NOUN	O	O
on	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
in	ADP	O	O
older	ADJ	O	O
breast	NOUN	O	O
cancer	NOUN	O	O
survivors	NOUN	O	O
undergoing	VERB	O	O
aromatase	NOUN	O	O
inhibitor	NOUN	O	O
therapy.	NOUN	O	O

The	DET	O	O
main	ADJ	O	O
objective	ADP	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
at	ADP	O	O
grading	VERB	O	O
functional	ADJ	O	B-outcome
training	VERB	O	I-outcome
intensity	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
affected	VERB	O	O
upper	ADJ	O	O
limb	NOUN	O	O
in	ADP	O	O
older	ADJ	O	O
adults	NOUN	O	O
with	ADP	O	O
a	DET	O	O
chronic	ADJ	O	O
stroke	NOUN	O	O
and	CCONJ	O	O
secondarily	ADV	O	O
to	PART	O	O
explore	ADP	O	O
the	DET	O	O
clinical	ADJ	O	O
changes	NOUN	O	O
between	ADP	O	O
FT	NOUN	O	O
and	CCONJ	O	O
ST	NOUN	O	O
when	ADP	O	O
the	DET	O	O
intensity	NOUN	O	O
is	VERB	O	O
regulated	VERB	O	O
with	ADP	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	O
exertion].	NOUN	O	O
Patients	NOUN	O	O
and	CCONJ	O	O
methods:	NOUN	O	O
Twelve	NUM	O	O
participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
a	DET	O	O
FT	NOUN	O	O
or	CCONJ	O	O
ST	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
trained	VERB	O	O
their	ADJ	O	O
affected	VERB	O	O
upper	ADJ	O	O
limb	NOUN	O	O
(3	NOUN	O	O
times/week	DET	O	O
for	ADP	O	O
4	NUM	O	O
weeks)	NOUN	O	O
with	ADP	O	O
the	DET	O	O
intensity	NOUN	O	O
standardized	VERB	O	O
with	ADP	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	O
exertion].	NOUN	O	O
Feasibility	NOUN	O	B-outcome
was	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
adherence	NOUN	O	B-outcome
,	PUNCT	O	O
occurrence	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
comparison	NOUN	O	O
of	ADP	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
ratings	NOUN	O	O
between	ADP	O	O
groups.	NOUN	O	O

Title:	NOUN	O	O
[Comparison	NOUN	O	O
of	ADP	O	O
effects	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
anesthesia	NOUN	O	O
methods	NOUN	O	O
on	ADP	O	O
the	DET	O	O
first	ADV	O	O
night	NOUN	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
in	ADP	O	O
middle-aged	NOUN	O	O
and	CCONJ	O	O
elderly	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
surgery	NOUN	O	O
for	ADP	O	O
lower	ADJ	O	O
extremity	NOUN	O	O
varicose	ADJ	O	O
vein].	NOUN	O	O

RESULTS:	NOUN	O	O
(1)	PUNCT	O	O
Clinical	ADJ	O	O
research	NOUN	O	O
results:	NOUN	O	O
all	DET	O	O
77	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
final	ADJ	O	O
analysis,	NOUN	O	O
including	VERB	O	O
20	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
7	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
under	ADP	O	O
VCV	NOUN	O	O
mode,	NOUN	O	O
18	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
and	CCONJ	O	O
21	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
7	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
under	ADP	O	O
PCV	NOUN	O	O
mode	NOUN	O	O
and	CCONJ	O	O
18	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985213R	NOUN	O	O

DISCUSSION:	NOUN	O	O
The	DET	O	O
evidence	NOUN	O	O
for	ADP	O	O
cost-effectiveness	NOUN	O	O
at	ADP	O	O
12	NUM	O	O
months	NOUN	O	O
was	VERB	O	O
inconclusive.	ADJ	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
Baduanjin	NOUN	O	O
qigong	ADJ	O	O
combined	VERB	O	O
with	ADP	O	O
CBT	NOUN	O	O
on	ADP	O	O
physical	ADJ	O	B-outcome
fitness	ADP	O	I-outcome
and	CCONJ	O	O
psychological	ADJ	O	B-outcome
health	NOUN	O	I-outcome
of	ADP	O	O
elderly	NOUN	O	O
housebound.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0014162	NUM	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
45	NUM	O	O
menopausal	ADJ	O	O
participants	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

Background:	NOUN	O	O
Acne	NOUN	O	O
vulgaris	NOUN	O	O
(acne)	NUM	O	O
is	VERB	O	O
the	DET	O	O
most	DET	O	O
common	ADJ	O	O
dermatologic	ADJ	O	O
disease	NOUN	O	O
seen	VERB	O	O
in	ADP	O	O
a	DET	O	O
racially,	NOUN	O	O
geographically,	NOUN	O	O
politically,	NOUN	O	O
culturally,	NOUN	O	O
and	CCONJ	O	O
socioeconomically	ADV	O	O
diverse	ADJ	O	O
Hispanic	ADJ	O	O
population.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101090633	NUM	O	O

Three	NUM	O	O
group	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
SOD	NOUN	O	B-outcome
and	CCONJ	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
before	ADP	O	O
treatment	NOUN	O	O
P>0.05.	NOUN	O	O

Title:	NOUN	O	O
Increased	VERB	O	O
self-care	NOUN	O	B-outcome
activities	NOUN	O	O
and	CCONJ	O	O
glycemic	ADJ	O	B-outcome
control	NOUN	O	I-outcome
rate	NOUN	O	O
in	ADP	O	O
relation	NOUN	O	O
to	PART	O	O
health	NOUN	O	O
education	NOUN	O	O
via	ADP	O	O
Wechat	ADP	O	O
among	ADP	O	O
diabetes	NOUN	O	O
patients:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

PURPOSE:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
3	NUM	O	O
different	ADJ	O	O
methods	NOUN	O	O
for	ADP	O	O
delivering	VERB	O	O
instruction	NOUN	O	O
on	ADP	O	O
infant	NOUN	O	O
handling	VERB	O	O
to	PART	O	O
parents	NOUN	O	O
in	ADP	O	O
the	DET	O	O
neonatal	ADJ	O	O
intensive	ADJ	O	O
care	NOUN	O	O
unit	NOUN	O	O
(NICU).	NOUN	O	O

Eighty-three	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
pulmonary	ADJ	O	O
bullae	NOUN	O	O
(American	NUM	O	O
Society	NOUN	O	O
of	ADP	O	O
Anesthesiologists	NOUN	O	O
(ASA)	NOUN	O	O
I-III)	ADP	O	O
undergoing	VERB	O	O
lobectomy,	NOUN	O	O
with	ADP	O	O
general	ADJ	O	O
anaesthesia,	NOUN	O	O
were	VERB	O	O
included.	NOUN	O	O

We	PRON	O	O
developed	VERB	O	O
a	DET	O	O
moderate-intensity	NOUN	O	O
intervention	NOUN	O	O
program	NOUN	O	O
that	ADP	O	O
can	VERB	O	O
be	VERB	O	O
sustained	VERB	O	O
in	ADP	O	O
the	DET	O	O
real-world	NOUN	O	O
setting	VERB	O	O
and	CCONJ	O	O
is	VERB	O	O
practically	ADV	O	O
applicable	ADJ	O	O
to	PART	O	O
both	CCONJ	O	O
moderate	ADJ	O	O
and	CCONJ	O	O
severe	ADJ	O	O
obesity.	ADP	O	O

Journal-Name:The	ADJ	O	O
International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
oral	ADJ	O	O
&	CCONJ	O	O
maxillofacial	ADJ	O	O
implants	NOUN	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
a	DET	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
of	ADP	O	O
33.6	NUM	O	O
months,	NOUN	O	O
the	DET	O	O
median	ADJ	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
21.6	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
modified-FOLFIRINOX	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
12.8	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
gemcitabine	NOUN	O	O
group	NOUN	O	O
(stratified	PUNCT	O	O
hazard	NOUN	O	O
ratio	NOUN	O	O
for	ADP	O	O
cancer-related	VERB	O	B-outcome
event	NOUN	O	I-outcome
,	PUNCT	O	O
second	ADJ	O	B-outcome
cancer	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
death	NOUN	O	B-outcome
,	PUNCT	O	O
0.58;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.46	NUM	O	O
to	PART	O	O
0.73;	NOUN	O	O
P<0.001).	NUM	O	O

The	DET	O	O
mean	NOUN	O	O
time	NOUN	O	B-outcome
for	ADP	O	Seperator
completing	VERB	O	I-outcome
the	DET	O	Seperator
task	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
stabilization	NOUN	O	O
period	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
group	NOUN	O	O
I	NUM	O	O
and	CCONJ	O	O
group	NOUN	O	O
III	NUM	O	O
and	CCONJ	O	O
group	NOUN	O	O
II	NUM	O	O
and	CCONJ	O	O
group	NOUN	O	O
III,	NOUN	O	O
which	ADP	O	O
means	NOUN	O	O
that	ADP	O	O
the	DET	O	O
independent	ADJ	O	O
training	VERB	O	O
method	NOUN	O	O
was	VERB	O	O
inferior	ADJ	O	O
to	PART	O	O
the	DET	O	O
other	ADJ	O	O
methods	NOUN	O	O
(group	PUNCT	O	O
I	NUM	O	O
vs.	CCONJ	O	O
group	NOUN	O	O
II	NUM	O	O
vs.	CCONJ	O	O
group	NOUN	O	O
III:	NOUN	O	O
187.38	NUM	O	O
vs.	CCONJ	O	O
187.07	NUM	O	O
vs.	CCONJ	O	O
253.47	NUM	O	O
seconds,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.001).	PUNCT	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
develop	VERB	O	O
an	DET	O	O
intervention	NOUN	O	O
protocol	NOUN	O	O
for	ADP	O	O
children's	NOUN	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
risk	NOUN	O	O
behaviors,	NOUN	O	O
and	CCONJ	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
protocol.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/13	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

No	DET	O	O
complications	NOUN	O	B-outcome
were	VERB	O	O
observed	VERB	O	O
during	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

The	DET	O	O
most	DET	O	O
preferred	VERB	O	B-outcome
respirator	NOUN	O	O
type	NOUN	O	O
was	VERB	O	O
the	DET	O	O
valve-type	NOUN	O	O
(10	NOUN	O	O
persons,	NOUN	O	O
45.5%).	NUM	O	O

In	ADP	O	O
addition,	NOUN	O	O
they	PRON	O	O
also	ADV	O	O
underwent	VERB	O	O
verum	NOUN	O	O
or	CCONJ	O	O
sham	NOUN	O	O
TENS	NOUN	O	O
30	NUM	O	O
min	NOUN	O	O
daily,	NOUN	O	O
3	NUM	O	O
times	NOUN	O	O
weekly	ADV	O	O
for	ADP	O	O
4	NUM	O	O
weeks.	NOUN	O	O

METHODS:	NOUN	O	O
Patients	NOUN	O	O
received	VERB	O	O
either	CCONJ	O	O
60	NUM	O	O
mg	NOUN	O	O
denosumab	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
32)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
31)	NOUN	O	O
every	DET	O	O
6	NUM	O	O
months	NOUN	O	O
for	ADP	O	O
12	NUM	O	O
months.	NOUN	O	O

PMID:	NOUN	O	O
31597637	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8900488	NUM	O	O

Poor	ADJ	O	O
nutritional	ADJ	O	O
status	NOUN	O	O
is	VERB	O	O
common	ADJ	O	O
among	ADP	O	O
human	NOUN	O	O
immunodeficiency	NOUN	O	O
virus	NOUN	O	O
(HIV)-infected	VERB	O	O
patients	NOUN	O	O
including	VERB	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
(vitD(3))	NOUN	O	O
deficiency.	NOUN	O	O

Subgroup	NOUN	O	O
analysis	NOUN	O	O
revealed	VERB	O	O
that	ADP	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
differences	NOUN	O	O
in	ADP	O	O
mean	NOUN	O	O
maximum	NOUN	O	O
grip	NOUN	O	O
value	NOUN	O	O
recovery	NOUN	O	O
between	ADP	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
rocuronium	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
treated	VERB	O	O
with	ADP	O	O
cisatracurium	NOUN	O	O
when	ADP	O	O
TOFr	NOUN	O	O
was	VERB	O	O
0.7,	NUM	O	O
0.8,	NOUN	O	O
and	CCONJ	O	O
0.9	NUM	O	O
or	CCONJ	O	O
when	ADP	O	O
the	DET	O	O
TOFr	NOUN	O	O
was	VERB	O	O
0.25	NUM	O	O
after	ADP	O	O
60	NUM	O	O
minutes	NOUN	O	O
(all	PUNCT	O	O
P	NOUN	O	O
>.05).	NUM	O	O

In	ADP	O	O
the	DET	O	O
2nd	ADJ	O	O
group	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
which	ADP	O	O
also	ADV	O	O
contained	VERB	O	O
22	NUM	O	O
children	NOUN	O	O
and	CCONJ	O	O
autologous	ADJ	O	O
gracilis	NOUN	O	O
graft	NOUN	O	O
was	VERB	O	O
used.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/09	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

FINDINGS:	ADJ	O	O
Between	ADP	O	O
July	NOUN	O	O
31,	NUM	O	O
2014,	NUM	O	O
and	CCONJ	O	O
March	NOUN	O	O
14,	NUM	O	O
2016,	NUM	O	O
656	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
ixazomib	NOUN	O	O
maintenance	NOUN	O	O
therapy	NOUN	O	O
(n=395)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
(n=261).	NOUN	O	O

Journal-Name:Nutrition	NOUN	O	O
&	CCONJ	O	O
diabetes	NOUN	O	O

Employees	NOUN	O	O
aged	VERB	O	O
18-65	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
no	DET	O	O
self-reported	VERB	O	O
medical	ADJ	O	O
contraindications	NOUN	O	O
to	PART	O	O
physical	ADJ	O	O
activity	NOUN	O	O
were	VERB	O	O
included.	NOUN	O	O

A	DET	O	O
primary	ADJ	O	O
school	NOUN	O	O
in	ADP	O	O
Changsha	ADV	O	O
city	NOUN	O	O
was	VERB	O	O
selected	VERB	O	O
by	ADP	O	O
random	NOUN	O	O
cluster	NOUN	O	O
sampling.	VERB	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
protocol-defined	VERB	O	O
decrease	NOUN	O	O
in	ADP	O	O
the	DET	O	O
hemoglobin	NOUN	O	B-outcome
level	NOUN	O	O
occurred	VERB	O	O
in	ADP	O	O
4	NUM	O	O
of	ADP	O	O
166	NUM	O	O
patients	NOUN	O	O
(2.4%;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.9	NUM	O	O
to	PART	O	O
6.0)	ADP	O	O
in	ADP	O	O
the	DET	O	O
tafenoquine	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
1	NUM	O	O
of	ADP	O	O
85	NUM	O	O
patients	NOUN	O	O
(1.2%;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.2	NUM	O	O
to	PART	O	O
6.4)	ADP	O	O
in	ADP	O	O
the	DET	O	O
primaquine	NOUN	O	O
group,	NOUN	O	O
for	ADP	O	O
a	DET	O	O
between-group	NOUN	O	O
difference	NOUN	O	O
of	ADP	O	O
1.2	NUM	O	O
percentage	NOUN	O	O
points	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
-4.2	NUM	O	O
to	PART	O	O
5.0).	NOUN	O	O

T	NOUN	O	O
Self-rating	VERB	O	O
depression	NOUN	O	B-outcome
scale	NOUN	O	O
(SDS)	PUNCT	O	O
and	CCONJ	O	O
self-rating	VERB	O	O
anxiety	NOUN	O	B-outcome
scale	NOUN	O	O
SAS	NUM	O	O
scores	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rhodiola	NOUN	O	O
rosea+non-invasive	ADJ	O	O
ventilator	NOUN	O	O
group	NOUN	O	O
decreased	VERB	O	O
after	ADP	O	O
treatment	NOUN	O	O
P<0.05	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
non-invasive	ADJ	O	O
ventilator	NOUN	O	O
group.	VERB	O	O
[	PUNCT	O	O

Title:	NOUN	O	O
[Effects	NOUN	O	O
of	ADP	O	O
rhodiola	NOUN	O	O
rosea	NOUN	O	O
on	ADP	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
and	CCONJ	O	O
negative	ADJ	O	B-outcome
emotional	ADJ	O	I-outcome
states	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
obstructive	ADJ	O	O
sleep	NOUN	O	O
apnea].	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

In	ADP	O	O
the	DET	O	O
present	ADJ	O	O
post	ADV	O	O
hoc	NOUN	O	O
analysis,	NOUN	O	O
patients	NOUN	O	O
who	ADP	O	O
continued	NOUN	O	O
to	PART	O	O
perform	NOUN	O	O
daily	ADJ	O	O
home	NOUN	O	O
spirometry	NOUN	O	O
and	CCONJ	O	O
completed	VERB	O	O
at	ADP	O	O
least	ADV	O	O
one	NUM	O	O
measurement	NOUN	O	O
per	ADP	O	O
week	NOUN	O	O
for	ADP	O	O
a	DET	O	O
56-day	NOUN	O	O
period	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
a	DET	O	O
moderate	ADJ	O	O
or	CCONJ	O	O
severe	ADJ	O	O
exacerbation	NOUN	O	O
were	VERB	O	O
included.	NOUN	O	O

Further	ADV	O	O
studies	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
validate	NOUN	O	O
the	DET	O	O
current	ADJ	O	O
observations.	NOUN	O	O

Randomisation	NOUN	O	O
was	VERB	O	O
stratified	VERB	O	O
by	ADP	O	O
induction	NOUN	O	O
regimen,	NOUN	O	O
pre-induction	NOUN	O	O
disease	NOUN	O	O
stage,	VERB	O	O
and	CCONJ	O	O
response	NOUN	O	O
post-transplantation.	NOUN	O	O

Supplementation	NOUN	O	O
with	ADP	O	O
oral	ADJ	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
can	VERB	O	O
favor	NOUN	O	O
the	DET	O	O
state	NOUN	O	O
of	ADP	O	O
iron	NOUN	O	O
metabolism,	VERB	O	O
and	CCONJ	O	O
testosterone	NOUN	O	O
and	CCONJ	O	O
cortisol	NOUN	O	O
as	ADP	O	O
an	DET	O	O
indicator	NOUN	O	O
of	ADP	O	O
muscle	NOUN	O	O
recovery	NOUN	O	O
of	ADP	O	O
the	DET	O	O
athlete	NOUN	O	O
with	ADP	O	O
a	DET	O	O
deficiency.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(p=0.3).	PUNCT	O	O

Most	DET	O	O
studies	NOUN	O	O
assessing	VERB	O	O
PZQ	NOUN	O	O
efficacy	NOUN	O	O
have	VERB	O	O
used	VERB	O	O
relatively	ADV	O	O
insensitive	ADJ	O	O
parasitological	ADJ	O	O
diagnostics,	ADJ	O	O
such	ADJ	O	O
as	ADP	O	O
the	DET	O	O
Kato-Katz	NOUN	O	O
(KK)	NOUN	O	O
and	CCONJ	O	O
urine-filtration	NOUN	O	O
methods,	NOUN	O	O
thereby	ADV	O	O
overestimating	VERB	O	O
cure	NOUN	O	O
rates	NOUN	O	O
(CRs).	PUNCT	O	O

The	DET	O	O
intervention	NOUN	O	O
arm	NOUN	O	O
received	VERB	O	O
a	DET	O	O
single	ADJ	O	O
mass	NOUN	O	O
drug	NOUN	O	O
administration	NOUN	O	O
of	ADP	O	O
azithromycin.	NOUN	O	O

Journal-Name:Nigerian	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Study	NOUN	O	O
2	NUM	O	O
tested	VERB	O	O
2-week	NOUN	O	O
smartphone-based	VERB	O	O
Monitor	NOUN	O	O
+	SYM	O	O
Accept	ADV	O	O
and	CCONJ	O	O
Monitor	NOUN	O	O
Only	ADV	O	O
interventions	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
an	DET	O	O
active	ADJ	O	O
control	NOUN	O	O
training.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101238455	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Injecting	VERB	O	O
a	DET	O	O
long	ADV	O	O
acting	VERB	O	O
steroid	NOUN	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
practice	NOUN	O	O
to	PART	O	O
alleviate	NOUN	O	O
the	DET	O	O
symptoms	NOUN	O	O
of	ADP	O	O
osteoarthritic	ADJ	O	O
knee.	NOUN	O	O

EG	NOUN	O	O
patients	NOUN	O	O
completed	VERB	O	O
ExMI	NOUN	O	O
therapy.	NOUN	O	O

Data	NOUN	O	O
were	VERB	O	O
from	ADP	O	O
review	NOUN	O	O
of	ADP	O	O
notes	NOUN	O	O
and	CCONJ	O	O
minutes	NOUN	O	O
from	ADP	O	O
meetings,	NOUN	O	O
and	CCONJ	O	O
discussions	NOUN	O	O
with	ADP	O	O
each	DET	O	O
CBO	NOUN	O	O
on	ADP	O	O
value	NOUN	O	O
added	VERB	O	O
by	ADP	O	O
intervention	NOUN	O	O
elements	NOUN	O	O
and	CCONJ	O	O
on	ADP	O	O
impact	NOUN	O	O
of	ADP	O	O
the	DET	O	O
project.	NOUN	O	O

Medical	ADJ	O	O
sciences	NOUN	O	O

BACKGROUND:	NOUN	O	O
Research	NOUN	O	O
has	VERB	O	O
demonstrated	VERB	O	O
that	ADP	O	O
low	ADJ	O	O
fermentable	ADJ	O	O
oligiosaccharide,	NOUN	O	O
disaccharide,	NOUN	O	O
monosaccharide	NOUN	O	O
and	CCONJ	O	O
polyol	NOUN	O	O
(FODMAP)	PUNCT	O	O
diets	NOUN	O	O
improve	VERB	O	O
gastrointestinal	ADJ	O	O
(GI)	NOUN	O	O
symptoms	NOUN	O	O
in	ADP	O	O
irritable	ADJ	O	O
bowel	NOUN	O	O
syndrome	NOUN	O	O
sufferers.	NOUN	O	O

Importance:	NOUN	O	O
Multimodal	ADP	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
is	VERB	O	O
widely	ADV	O	O
used	VERB	O	O
but	CCONJ	O	O
lacks	NOUN	O	O
evidence	NOUN	O	O
of	ADP	O	O
benefit.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

At	ADP	O	O
2	NUM	O	O
years	NOUN	O	O
follow-up,	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
intraocular	ADJ	O	B-outcome
pressure(IOP)	NOUN	O	I-outcome
level	NOUN	O	O
was	VERB	O	O
statistically	ADV	O	O
significantly	ADV	O	O
decreased	VERB	O	O
in	ADP	O	O
the	DET	O	O
OloPhacovisco	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.02)	NUM	O	O
and	CCONJ	O	O
complete	ADJ	O	O
success	NOUN	O	B-outcome
occurred	VERB	O	O
in	ADP	O	O
23	NUM	O	O
eyes	NOUN	O	O
(59.0%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
Phacovisco	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
32	NUM	O	O
eyes	NOUN	O	O
(80.0%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
OloPhacovisco	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
potential	ADJ	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
an	DET	O	O
active,	ADJ	O	O
music-instruction	NOUN	O	O
intervention	NOUN	O	O
in	ADP	O	O
improving	VERB	O	O
psychological	ADJ	O	B-outcome
health	NOUN	O	I-outcome
and	CCONJ	O	O
social	ADJ	O	B-outcome
functioning	VERB	O	I-outcome
among	ADP	O	O
Veterans	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
moderate	ADJ	O	O
to	PART	O	O
severe	ADJ	O	O
PTSD.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101266132	NUM	O	O

Most	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
mild;	NOUN	O	O
the	DET	O	O
most	DET	O	O
common	ADJ	O	O
events	NOUN	O	O
were	VERB	O	O
diarrhoea	NOUN	O	B-outcome
in	ADP	O	O
eight	NUM	O	O
(16%)	PUNCT	O	O
of	ADP	O	O
49	NUM	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
pegbelfermin	NOUN	O	O
and	CCONJ	O	O
two	NUM	O	O
(8%)	NOUN	O	O
of	ADP	O	O
26	NUM	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
and	CCONJ	O	O
nausea	NOUN	O	B-outcome
in	ADP	O	O
seven	NUM	O	O
(14%)	PUNCT	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
pegbelfermin	NOUN	O	O
and	CCONJ	O	O
two	NUM	O	O
(8%)	NOUN	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
placebo.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/19	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/09	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

METHODS:	NOUN	O	O
The	DET	O	O
present	ADJ	O	O
double-blind	ADJ	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
included	VERB	O	O
women	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
home	NOUN	O	O
deliveries	NOUN	O	O
in	ADP	O	O
Chitral	ADJ	O	O
district,	NOUN	O	O
Khyber	NOUN	O	O
Pakhtunkhwa	NOUN	O	O
province,	NOUN	O	O
Pakistan,	NOUN	O	O
after	ADP	O	O
presenting	VERB	O	O
at	ADP	O	O
healthcare	NOUN	O	O
facilities	NOUN	O	O
during	ADP	O	O
the	DET	O	O
third	ADJ	O	O
trimester	NOUN	O	O
of	ADP	O	O
pregnancy	NOUN	O	O
between	ADP	O	O
May	NOUN	O	O
28,	NUM	O	O
2012,	NUM	O	O
and	CCONJ	O	O
November	NOUN	O	O
27,	NUM	O	O
2014.	NUM	O	O

In	ADP	O	O
the	DET	O	O
dry	ADJ	O	O
needling	VERB	O	O
group,	NOUN	O	O
all	DET	O	O
the	DET	O	O
effect	NOUN	O	O
sizes	NOUN	O	O
for	ADP	O	O
headache	NOUN	O	O
variables	NOUN	O	O
were	VERB	O	O
large.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101281800	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Fifty-three	NUM	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
spine	NOUN	O	O
surgery	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
control	NOUN	O	O
group	NOUN	O	O
(group	PUNCT	O	O
C,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
26)	NOUN	O	O
and	CCONJ	O	O
transcutaneous	ADJ	O	O
electrical	ADJ	O	O
acupoint	NOUN	O	O
stimulation	NOUN	O	O
group	NOUN	O	O
(group	PUNCT	O	O
TEAS,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
27).	NOUN	O	O

There	PRON	O	O
is	VERB	O	O
a	DET	O	O
paucity	NOUN	O	O
of	ADP	O	O
evidence	NOUN	O	O
on	ADP	O	O
interventions	NOUN	O	O
that	ADP	O	O
might	VERB	O	O
provide	VERB	O	O
cardio-protection.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

RESULTS:	NOUN	O	O
Between	ADP	O	O
September	NOUN	O	O
2014	NUM	O	O
and	CCONJ	O	O
October	ADJ	O	O
2015,	NUM	O	O
we	PRON	O	O
recruited	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
assigned	VERB	O	O
37	NUM	O	O
clusters	NOUN	O	O
(from	PUNCT	O	O
nine	NUM	O	O
organisations;	NOUN	O	O
mean	NOUN	O	O
clusters	NOUN	O	O
per	ADP	O	O
organisation	NOUN	O	O
=	SYM	O	O
four)	NOUN	O	O
and	CCONJ	O	O
853	NUM	O	O
participants	NOUN	O	O
to	PART	O	O
the	DET	O	O
intervention	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
19	NUM	O	O
with	ADP	O	O
457	NUM	O	O
participants)	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
18	NUM	O	O
with	ADP	O	O
396	NUM	O	O
participants).	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Title:	NOUN	O	O
Alcohol	NOUN	O	O
pictorial	ADJ	O	O
health	NOUN	O	O
warning	VERB	O	O
labels:	NOUN	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
self-affirmation	NOUN	O	O
and	CCONJ	O	O
health	NOUN	O	O
warning	VERB	O	O
severity.	DET	O	O

Journal-Name:Medicine	NOUN	O	O

Data	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
using	VERB	O	O
1-way	NOUN	O	O
repeated-measures	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
variance	NOUN	O	O
for	ADP	O	O
each	DET	O	O
outcome	NOUN	O	O
measure.	NOUN	O	O

FUNDING:	NOUN	O	O
UK	PROPN	O	O
National	ADJ	O	O
Institute	NOUN	O	O
for	ADP	O	O
Health	NOUN	O	O
Research	NOUN	O	O
Health	NOUN	O	O
Technology	NOUN	O	O
Assessment	NOUN	O	O
programme	NOUN	O	O
(10/57/49).	NUM	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
current	ADJ	O	O
controlled	VERB	O	O
trials	NOUN	O	O
PHRC/HC/32/15.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Complications	NOUN	O	O
related	VERB	O	O
to	PART	O	O
concurrent	ADJ	O	O
chemoradiotherapy	NOUN	O	O
(CCRT)	NUM	O	O
such	ADJ	O	O
as	ADP	O	O
acute	ADJ	O	O
radiation-induced	VERB	O	O
esophagitis	NOUN	O	O
(ARIE)	NUM	O	O
may	VERB	O	O
cause	ADP	O	O
significant	ADJ	O	O
morbidity	NOUN	O	O
and	CCONJ	O	O
unplanned	VERB	O	O
treatment	NOUN	O	O
delays	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
non-small	ADJ	O	O
cell	NOUN	O	O
lung	NOUN	O	O
cancer	NOUN	O	O
(NSCLC).	PUNCT	O	O

Title:	NOUN	O	O
Seafood	NOUN	O	O
Consumption,	NOUN	O	O
Omega-3	NOUN	O	O
Fatty	ADJ	O	O
Acids	NOUN	O	O
Intake,	NOUN	O	O
and	CCONJ	O	O
Life-Time	NOUN	O	O
Prevalence	NOUN	O	O
of	ADP	O	O
Depression	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
PREDIMED-Plus	NOUN	O	O
Trial.	NOUN	O	O

These	DET	O	O
contextual	ADJ	O	O
factors	NOUN	O	O
interacted	VERB	O	O
with	ADP	O	O
the	DET	O	O
implemented	VERB	O	O
training	VERB	O	O
to	PART	O	O
influence	NOUN	O	O
knowledge	NOUN	O	O
about	ADV	O	O
pharmacological	ADJ	O	O
treatments	NOUN	O	O
and	CCONJ	O	O
symptoms	NOUN	O	O
of	ADP	O	O
mental	ADJ	O	O
illness,	NOUN	O	O
confidence	NOUN	O	O
in	ADP	O	O
providing	VERB	O	O
treatment,	NOUN	O	O
negative	ADJ	O	O
beliefs	NOUN	O	O
about	ADV	O	O
certain	ADJ	O	O
mental	ADJ	O	O
health	NOUN	O	O
conditions,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
understanding	VERB	O	O
of	ADP	O	O
the	DET	O	O
role	NOUN	O	O
of	ADP	O	O
PCPs	NOUN	O	O
in	ADP	O	O
mental	ADJ	O	O
health	NOUN	O	O
care	NOUN	O	O
delivery.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0313225	NUM	O	O

Journal-Name:	NOUN	O	O
BMJ	NOUN	O	O
(Clinical	ADJ	O	O
research	NOUN	O	O
ed.)	NOUN	O	O

Journal-Name:Respiratory	NUM	O	O
research	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT02571361.	NOUN	O	O

Journal-Name:International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
environmental	ADJ	O	O
research	NOUN	O	O
and	CCONJ	O	O
public	ADJ	O	O
health	NOUN	O	O

Title:	NOUN	O	O
[A	PUNCT	O	O
comparison	NOUN	O	O
study	NOUN	O	O
of	ADP	O	O
cognitive-behavioral	ADJ	O	O
therapy	NOUN	O	O
alone	ADJ	O	O
versus	CCONJ	O	O
combination	NOUN	O	O
with	ADP	O	O
tapered	VERB	O	O
hypnotic	ADJ	O	O
agents	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
insomnia].	NOUN	O	O

Functional	ADJ	O	B-outcome
outcome	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
improved	VERB	O	O
compared	VERB	O	O
to	PART	O	O
baseline	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
groups	NOUN	O	O
until	ADP	O	O
six	NUM	O	O
weeks	NOUN	O	O
however,	ADV	O	O
in	ADP	O	O
the	DET	O	O
triamcinolone	NOUN	O	O
group,	NOUN	O	O
it	PRON	O	O
was	VERB	O	O
significant	ADJ	O	O
until	ADP	O	O
twelve	NUM	O	O
weeks.	NOUN	O	O

Generally,	NOUN	O	O
UI	NOUN	O	O
becomes	NOUN	O	O
more	ADV	O	O
severe	ADJ	O	O
with	ADP	O	O
age.	ADJ	O	O

Methods:	NOUN	O	O
This	DET	O	O
was	VERB	O	O
a	DET	O	O
prospective	ADJ	O	O
study.	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
STEMI	NOUN	O	O
presenting	VERB	O	O
within	ADP	O	O
6	NUM	O	O
hours	NOUN	O	O
of	ADP	O	O
symptoms,	NOUN	O	O
adjunctive	ADJ	O	O
low-dose	NOUN	O	O
intracoronary	ADJ	O	O
alteplase	NOUN	O	O
given	VERB	O	O
during	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
percutaneous	ADJ	O	O
intervention	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
reduce	VERB	O	O
microvascular	ADJ	O	B-outcome
obstruction	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
study	NOUN	O	O
findings	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
this	DET	O	O
treatment.	NOUN	O	O

All	DET	O	O
children	NOUN	O	O
returned	VERB	O	O
to	PART	O	O
full	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
.	PUNCT	O	O
Similar	ADJ	O	O
results	NOUN	O	O
were	VERB	O	O
obtained	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
2nd	ADJ	O	O
group,	NOUN	O	O
where	ADP	O	O
MPFL	NOUN	O	O
was	VERB	O	O
reconstructed	VERB	O	O
with	ADP	O	O
ipsilateral	ADJ	O	O
gracilis	NOUN	O	O
tendon.	ADV	O	O
[	PUNCT	O	O

Eligible	ADJ	O	O
women	NOUN	O	O
(aged	PUNCT	O	O
18-43	NUM	O	O
years)	NOUN	O	O
had	VERB	O	O
a	DET	O	O
body-mass	NOUN	O	O
index	NOUN	O	O
of	ADP	O	O
19-35	NUM	O	O
kg/m(2)	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
follicle-stimulating	VERB	O	O
hormone	NOUN	O	O
(FSH)	PUNCT	O	O
concentration	NOUN	O	O
of	ADP	O	O
3.0-20.0	NUM	O	O
mIU/mL	NOUN	O	O
or,	NOUN	O	O
if	ADP	O	O
no	DET	O	O
FSH	NOUN	O	O
measurement	NOUN	O	O
was	VERB	O	O
available,	NOUN	O	O
an	DET	O	O
anti-mullerian	ADJ	O	O
hormone	NOUN	O	O
concentration	NOUN	O	O
of	ADP	O	O
at	ADP	O	O
least	ADV	O	O
1.5	NUM	O	O
pmol/L.	NOUN	O	O
Eligible	ADJ	O	O
men	NOUN	O	O
(aged	PUNCT	O	O
18-55	NUM	O	O
years)	NOUN	O	O
had	VERB	O	O
not	ADV	O	O
had	VERB	O	O
a	DET	O	O
vasovasostomy	NOUN	O	O
or	CCONJ	O	O
been	VERB	O	O
treated	VERB	O	O
for	ADP	O	O
cancer	NOUN	O	O
in	ADP	O	O
the	DET	O	O
24	NUM	O	O
months	NOUN	O	O
before	ADP	O	O
recruitment	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
able,	NOUN	O	O
after	ADP	O	O
at	ADP	O	O
least	ADV	O	O
3	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
sexual	ADJ	O	O
abstinence,	NOUN	O	O
to	PART	O	O
produce	VERB	O	O
freshly	ADV	O	O
ejaculated	VERB	O	O
sperm	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
cycle.	NOUN	O	O

END	NOUN	O	O
POINTS:	NOUN	O	O
Primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
MACE	NOUN	O	B-outcome
at	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
and	CCONJ	O	O
secondary	ADJ	O	O
end	NOUN	O	O
points	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
were	VERB	O	O
cardiac	ADJ	O	B-outcome
death	NOUN	O	I-outcome
,	PUNCT	O	O
urgent	ADJ	O	O
target	NOUN	O	O
lesion	NOUN	O	B-outcome
revascularization	NOUN	O	I-outcome
,	PUNCT	O	O
acute	ADJ	O	B-outcome
coronary	ADJ	O	I-outcome
syndrome	NOUN	O	I-outcome
,	PUNCT	O	O
stroke	NOUN	O	B-outcome
and	CCONJ	O	O
in-stent	NOUN	O	B-outcome
re-stenosis	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
204	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
between	ADP	O	O
January	NOUN	O	O
2013	NUM	O	O
to	PART	O	O
July	NOUN	O	O
2014,	NUM	O	O
91	NUM	O	O
in	ADP	O	O
the	DET	O	O
polymer-free	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
113	NUM	O	O
in	ADP	O	O
the	DET	O	O
biodegradable	ADJ	O	O
polymer	NOUN	O	O
group.	VERB	O	O

Handgrip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
increase	NOUN	O	O
was	VERB	O	O
also	ADV	O	O
observed	VERB	O	O
after	ADP	O	O
HIIT	NOUN	O	O
(p=.002),	PUNCT	O	O
but	CCONJ	O	O
no	DET	O	O
differences	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
with	ADP	O	O
MIIT	NOUN	O	O
and	CCONJ	O	O
CG.	NOUN	O	O

Patients	NOUN	O	O
with	ADP	O	O
coexisting	VERB	O	O
cataract	NOUN	O	O
and	CCONJ	O	O
glaucoma	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
phaco-viscocanalostomy	NOUN	O	O
(Phacovisco	PUNCT	O	O
group)	ADJ	O	O
(39	ADV	O	O
eyes)	NOUN	O	O
or	CCONJ	O	O
phaco-viscocanalostomy	NOUN	O	O
with	ADP	O	O
Ologen(R)	NOUN	O	O
implant	NOUN	O	O
(OloPhacovisco	NUM	O	O
group)	ADJ	O	O
(40	NOUN	O	O
eyes).	ADJ	O	O

The	DET	O	O
OSTAP	NOUN	O	O
block	VERB	O	O
is	VERB	O	O
a	DET	O	O
promising	VERB	O	O
technique	NOUN	O	O
for	ADP	O	O
producing	VERB	O	O
effective	ADJ	O	O
and	CCONJ	O	O
prolonged	VERB	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
laparoscopic	ADJ	O	O
hysterectomy	NOUN	O	O
surgeries.	NUM	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
health	NOUN	O	B-outcome
,	PUNCT	O	O
mental	ADJ	O	B-outcome
wellbeing	VERB	O	I-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
work	NOUN	O	B-outcome
absenteeism	NOUN	O	I-outcome
and	CCONJ	O	Seperator
presenteeism	NOUN	O	S1-outcome
,	PUNCT	O	O
and	CCONJ	O	O
use	NOUN	O	B-outcome
of	ADP	O	I-outcome
healthcare	NOUN	O	I-outcome
resources	NOUN	O	I-outcome
.	PUNCT	O	O
Cost-effectiveness,	NOUN	O	O
cost-benefit	NOUN	O	O
and	CCONJ	O	O
mediation	NOUN	O	O
analyses	NOUN	O	O
were	VERB	O	O
conducted.	NOUN	O	O

RESULTS:	NOUN	O	O
Thirty-five	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
AG	NOUN	O	O
and	CCONJ	O	O
thirty-four	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
CG.	NOUN	O	O

Journal-Name:Anticancer	NOUN	O	O
research	NOUN	O	O

Primary	ADJ	O	O
endpoint:	NOUN	O	O
the	DET	O	O
change	NOUN	O	O
in	ADP	O	O
plasma	NOUN	O	O
HIV-1	NOUN	O	B-outcome
comparing	VERB	O	O
week	NOUN	O	O
0	NUM	O	O
to	PART	O	O
16	NUM	O	O
using	VERB	O	O
modified	VERB	O	O
intention-to-treat	NOUN	O	O
(mITT,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
197)	NOUN	O	O
and	CCONJ	O	O
per-protocol	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
173)	NOUN	O	O
analyses.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

intrauterine	ADJ	O	B-outcome
adhesions	NOUN	O	I-outcome
were	VERB	O	O
staged	VERB	O	O
as	ADP	O	O
mild	ADJ	O	O
in	ADP	O	O
4	NUM	O	O
patients	NOUN	O	O
(14.28%)	PUNCT	O	O
and	CCONJ	O	O
moderate	ADJ	O	O
in	ADP	O	O
2	NUM	O	O
patients	NOUN	O	O
(7.14%)	NUM	O	O
in	ADP	O	O
group	NOUN	O	O
2	NUM	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
American	ADJ	O	O
Fertility	NOUN	O	O
Society	NOUN	O	O
classification	NOUN	O	O
of	ADP	O	O
IUAs.	NOUN	O	O

Stroke	NOUN	O	B-outcome
volume	NOUN	O	I-outcome
index	NOUN	O	O
(SVI)	PUNCT	O	O
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
cycle	NOUN	O	I-outcome
efficiency	NOUN	O	O
(CCE)	PUNCT	O	O
showed	VERB	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
SM	NOUN	O	O
but	CCONJ	O	O
a	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
S	NOUN	O	O
(Ptime*group<0.0001).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

SHORE	DET	O	O
data	NOUN	O	O
were	VERB	O	O
retrospectively	ADV	O	O
analyzed	VERB	O	O
to	PART	O	O
identify	NOUN	O	O
baseline	NOUN	O	O
patient	NOUN	O	O
characteristics	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
early	ADJ	O	O
clinically	ADV	O	O
significant	ADJ	O	O
improvements	NOUN	O	O
in	ADP	O	O
visual	ADJ	O	B-outcome
acuity	NOUN	O	I-outcome
(VA)	NOUN	O	I-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
improvement	NOUN	O	O
to	PART	O	O
a	DET	O	O
Snellen	NOUN	O	O
equivalent	ADJ	O	O
of	ADP	O	O
20/40	NOUN	O	O
or	CCONJ	O	O
better	ADJ	O	O
vision	NOUN	O	B-outcome
(>/=	PUNCT	O	O
69	NUM	O	O
Early	ADJ	O	O
Treatment	NOUN	O	O
Diabetic	ADJ	O	B-outcome
Retinopathy	NOUN	O	I-outcome
Study	NOUN	O	O
(ETDRS)	NOUN	O	O
letters)	NOUN	O	O
or	CCONJ	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
best-corrected	VERB	O	B-outcome
visual	ADJ	O	I-outcome
acuity	NOUN	O	I-outcome
(BCVA)	NUM	O	I-outcome
of	ADP	O	O
15	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
ETDRS	NOUN	O	O
letters	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
within	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
initiation.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9812598	NUM	O	O

Conclusion:	NOUN	O	O
Peer	NOUN	O	O
support	NOUN	O	O
for	ADP	O	O
education	NOUN	O	O
intervention	NOUN	O	O
seemed	VERB	O	O
beneficial	ADJ	O	O
for	ADP	O	O
diabetic	ADJ	O	B-outcome
control	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
combination	NOUN	O	O
of	ADP	O	O
education	NOUN	O	O
and	CCONJ	O	O
effect	NOUN	O	O
evaluation	NOUN	O	O
was	VERB	O	O
important	ADJ	O	O
in	ADP	O	O
the	DET	O	O
evaluation	NOUN	O	O
of	ADP	O	O
diabetes	NOUN	O	B-outcome
prevention	NOUN	O	I-outcome
and	CCONJ	O	Seperator
control	NOUN	O	S1-outcome
.	PUNCT	O	O
Peer	NOUN	O	O
support	NOUN	O	O
education	NOUN	O	O
also	ADV	O	O
benefited	VERB	O	O
the	DET	O	O
blood	NOUN	O	B-outcome
glucose	NOUN	O	I-outcome
control	NOUN	O	I-outcome
in	ADP	O	O
general	ADJ	O	O
population.	ADV	O	O

CONCLUSIONS:	NOUN	O	O
Rather	ADV	O	O
than	ADP	O	O
being	VERB	O	O
a	DET	O	O
time	NOUN	O	O
of	ADP	O	O
optimism,	ADV	O	O
a	DET	O	O
third	ADJ	O	O
of	ADP	O	O
low	ADJ	O	O
caste	NOUN	O	O
girls	NOUN	O	O
in	ADP	O	O
rural	ADJ	O	O
north,	NOUN	O	O
Karnataka	NOUN	O	O
have	VERB	O	O
limited	VERB	O	O
hope	NOUN	O	O
for	ADP	O	O
the	DET	O	O
future,	NOUN	O	O
with	ADP	O	O
some	DET	O	O
contemplating	VERB	O	O
suicide.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
arm	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
of	ADP	O	O
ocular	ADJ	O	B-outcome
infection	NOUN	O	I-outcome
12	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.004)	NOUN	O	O
but	CCONJ	O	O
no	DET	O	O
change	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
arm.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
0.6%	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
conventional	ADJ	O	O
60	NUM	O	O
mg	NOUN	O	O
loading	VERB	O	O
dose	NOUN	O	O
(LD)	NOUN	O	O
and	CCONJ	O	O
lower	ADJ	O	O
30	NUM	O	O
mg	NOUN	O	O
LD	NOUN	O	O
groups	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
not	ADV	O	O
significant).	NOUN	O	O

INTRODUCTION:	NOUN	O	O
The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
research	NOUN	O	O
was	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
Herbst	NOUN	O	O
appliance	NOUN	O	O
therapy	NOUN	O	O
using	VERB	O	O
incremental	ADJ	O	O
vs	CCONJ	O	O
maximum	NOUN	O	O
advancement	ADJ	O	O
in	ADP	O	O
late	ADJ	O	O
adolescent	NOUN	O	O
and	CCONJ	O	O
young	ADJ	O	O
adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
Class	NOUN	O	O
II	NUM	O	O
skeletal	ADJ	O	O
malocclusion.	NOUN	O	O

PURPOSE:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
3-dimensional	ADJ	O	O
epithelial	ADJ	O	O
remodeling	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
myopic	ADJ	O	O
laser	NOUN	O	O
in	ADP	O	O
situ	ADV	O	O
keratomileusis	NOUN	O	O
(LASIK)	PUNCT	O	O
versus	CCONJ	O	O
small	ADJ	O	O
incision	NOUN	O	O
lenticule	NOUN	O	O
extraction	NOUN	O	O
(SMILE).	NOUN	O	O

We	PRON	O	O
previously	ADV	O	O
conducted	VERB	O	O
a	DET	O	O
regional	ADJ	O	O
study	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Quebec's	NOUN	O	O
Eastern	NOUN	O	O
Townships	NOUN	O	O
region,	NOUN	O	O
the	DET	O	O
PromoVac	NOUN	O	O
Study,	NOUN	O	O
to	PART	O	O
test	NOUN	O	O
a	DET	O	O
new	ADJ	O	O
educational	ADJ	O	O
intervention,	ADP	O	O
based	VERB	O	O
on	ADP	O	O
motivational	ADJ	O	O
interviewing	VERB	O	O
techniques,	NOUN	O	O
aimed	VERB	O	O
at	ADP	O	O
promoting	VERB	O	O
infant	NOUN	O	B-outcome
vaccination	NOUN	O	I-outcome
.	PUNCT	O	O
This	DET	O	O
first	ADV	O	O
study	NOUN	O	O
evidenced	VERB	O	O
that	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
led	VERB	O	O
to	PART	O	O
a	DET	O	O
marked	VERB	O	O
increase	NOUN	O	O
in	ADP	O	O
mothers'	ADJ	O	O
intention	NOUN	O	B-outcome
to	PART	O	O
vaccinate,	ADP	O	O
and	CCONJ	O	O
vaccine	NOUN	O	B-outcome
coverage	NOUN	O	O
in	ADP	O	O
their	ADJ	O	O
infants.	NOUN	O	O

MAIN	ADJ	O	O
OUTCOME	NOUN	O	O
MEASURES:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
measure	NOUN	O	O
was	VERB	O	O
a	DET	O	O
composite	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
perinatal	ADJ	O	I-outcome
outcomes	NOUN	O	I-outcome
:	PUNCT	O	O
perinatal	ADJ	O	B-outcome
death	NOUN	O	I-outcome
,	PUNCT	O	O
Apgar	PROPN	O	B-outcome
score	NOUN	O	I-outcome
<4,	NOUN	O	O
impaired	VERB	O	B-outcome
consciousness	NOUN	O	I-outcome
,	PUNCT	O	O
asphyxia	NOUN	O	B-outcome
,	PUNCT	O	O
seizures	NOUN	O	B-outcome
,	PUNCT	O	O
assisted	VERB	O	B-outcome
ventilation	NOUN	O	I-outcome
,	PUNCT	O	O
septicaemia	NOUN	O	B-outcome
,	PUNCT	O	O
meningitis	NOUN	O	B-outcome
,	PUNCT	O	O
bronchopulmonary	ADJ	O	B-outcome
dysplasia	NOUN	O	I-outcome
,	PUNCT	O	O
intraventricular	ADJ	O	B-outcome
haemorrhage	NOUN	O	I-outcome
,	PUNCT	O	O
periventricular	ADJ	O	B-outcome
leukomalacia	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
necrotising	VERB	O	B-outcome
enterocolitis	NOUN	O	I-outcome
.	PUNCT	O	O
Secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
two	NUM	O	O
composite	NOUN	O	O
measures	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
maternal	ADJ	O	I-outcome
morbidity	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
spontaneous	ADJ	O	B-outcome
labour	NOUN	O	I-outcome
and	CCONJ	O	Seperator
birth	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Between	ADP	O	O
1	NUM	O	O
February	ADJ	O	O
2015	NUM	O	O
and	CCONJ	O	O
29	NUM	O	O
February	ADJ	O	O
2016,	NUM	O	O
60	NUM	O	O
midwifery	NOUN	O	O
practices	NOUN	O	O
enrolled	VERB	O	O
13	NUM	O	O
520	NUM	O	O
women	NOUN	O	O
in	ADP	O	O
mid-pregnancy	NOUN	O	O
(mean	NUM	O	O
22.8	NUM	O	O
(SD	NOUN	O	O
2.4)	NUM	O	O
weeks'	ADP	O	O
gestation).	NOUN	O	O

Postoperative	ADJ	O	O
intravenous	ADJ	O	O
patient-controlled	VERB	O	O
analgesia(PCA)	ADV	O	O
was	VERB	O	O
performed	VERB	O	O
in	ADP	O	O
all	DET	O	O
patients,	NOUN	O	O
with	ADP	O	O
background	NOUN	O	O
doses	NOUN	O	O
of	ADP	O	O
sufentanil	NOUN	O	O
0.04	NUM	O	O
mug.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Combination	NOUN	O	O
of	ADP	O	O
Paracetamol	NOUN	O	O
(Acetaminophen)	ADV	O	O
and	CCONJ	O	O
Ibuprofen	NOUN	O	O
vs	CCONJ	O	O
Either	CCONJ	O	O
Alone	ADJ	O	O
on	ADP	O	O
Patient-Controlled	VERB	O	O
Morphine	NOUN	O	B-outcome
Consumption	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
First	ADV	O	O
24	NUM	O	O
Hours	NOUN	O	O
After	ADP	O	O
Total	ADJ	O	O
Hip	NOUN	O	O
Arthroplasty:	NOUN	O	O
The	DET	O	O
PANSAID	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

The	DET	O	O
proposed	VERB	O	O
trial	NOUN	O	O
aims	NOUN	O	O
to	PART	O	O
provide	VERB	O	O
evidence	NOUN	O	O
for	ADP	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
repellent	NOUN	O	O
distributed	VERB	O	O
through	ADP	O	O
VHVs	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
malaria	NOUN	O	B-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
is	VERB	O	O
an	DET	O	O
open	ADJ	O	O
stepped-wedge	NOUN	O	O
cluster-randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
randomised	VERB	O	O
at	ADP	O	O
the	DET	O	O
village	NOUN	O	O
level.	NOUN	O	O

For	ADP	O	O
SAT,	NOUN	O	O
39	NUM	O	O
samples	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
8,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
10,	NUM	O	O
n	NOUN	O	O
=	SYM	O	O
9,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
12,	NUM	O	O
respectively)	NOUN	O	O
were	VERB	O	O
available.	NOUN	O	O

Devices	NOUN	O	O
that	ADP	O	O
promote	VERB	O	O
interaction	NOUN	O	O
with	ADP	O	O
tasks	NOUN	O	O
on	ADP	O	O
computers	NOUN	O	O
can	VERB	O	O
enhance	NOUN	O	O
performance	NOUN	O	O
and	CCONJ	O	O
lead	NOUN	O	O
to	PART	O	O
greater	ADJ	O	O
independence	NOUN	O	O
and	CCONJ	O	O
utilization	NOUN	O	O
of	ADP	O	O
technology.	NOUN	O	O

METHODS:	NOUN	O	O
Cross-sectional	ADJ	O	O
survey	NOUN	O	O
of	ADP	O	O
1191	NUM	O	O
low	ADJ	O	O
caste	NOUN	O	O
girls	NOUN	O	O
in	ADP	O	O
two	NUM	O	O
districts	NOUN	O	O
in	ADP	O	O
north	NOUN	O	O
Karnataka,	NOUN	O	O
conducted	VERB	O	O
as	ADP	O	O
part	NOUN	O	O
of	ADP	O	O
a	DET	O	O
cluster	NOUN	O	O
randomised-control	NOUN	O	O
trial.	NOUN	O	O

Journal-Name:Croatian	NOUN	O	O
medical	ADJ	O	O
journal	ADJ	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
progressive,	NOUN	O	O
refractory,	ADV	O	O
or	CCONJ	O	O
symptomatic	ADJ	O	O
desmoid	NOUN	O	O
tumors,	NOUN	O	O
sorafenib	NOUN	O	O
significantly	ADV	O	O
prolonged	VERB	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
and	CCONJ	O	O
induced	VERB	O	O
durable	ADJ	O	O
responses.	NOUN	O	O
(	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/26	VERB	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Tumor	NOUN	O	O
specimens	NOUN	O	O
and	CCONJ	O	O
clinical	ADJ	O	O
information	NOUN	O	O
were	VERB	O	O
collected	VERB	O	O
from	ADP	O	O
patients	NOUN	O	O
enrolled	VERB	O	O
in	ADP	O	O
CLASSIC	ADJ	O	O
trial,	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
study	NOUN	O	O
of	ADP	O	O
capecitabine	NOUN	O	O
plus	CCONJ	O	O
oxaliplatin-based	VERB	O	O
adjuvant	NOUN	O	O
chemotherapy.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
46	NUM	O	O
eligible	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
tinnitus	NOUN	O	O
were	VERB	O	O
entered	VERB	O	O
and	CCONJ	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

The	DET	O	O
IRSN	NOUN	O	O
dosemeter	NOUN	O	O
model	NOUN	O	O
was	VERB	O	O
considered	VERB	O	O
the	DET	O	O
most	DET	O	O
convenient	ADJ	O	B-outcome
.	PUNCT	O	O

The	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
on	ADP	O	O
250	NUM	O	O
mg/day	NOUN	O	O
of	ADP	O	O
elemental	ADJ	O	O
Mg	NOUN	O	O
for	ADP	O	O
three	NUM	O	O
months	NOUN	O	O
while	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
receive	VERB	O	O
any	DET	O	O
type	NOUN	O	O
of	ADP	O	O
supplements	NOUN	O	O
throughout	ADV	O	O
the	DET	O	O
intervention	NOUN	O	O
period.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Ologen(R)	NOUN	O	O
implant	NOUN	O	O
improved	VERB	O	O
the	DET	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
of	ADP	O	O
phaco-viscocanalostomy.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Ovarian	ADJ	O	O
hyperstimulation	NOUN	O	O
syndrome	NOUN	O	O
remains	NOUN	O	O
a	DET	O	O
serious	ADJ	O	O
complication	NOUN	O	O
during	ADP	O	O
in	ADP	O	O
vitro	ADV	O	O
fertilization	NOUN	O	O
cycles	NOUN	O	O
if	ADP	O	O
high	ADJ	O	O
dose	NOUN	O	O
human	NOUN	O	O
chorionic	ADJ	O	O
gonadotropin	NOUN	O	O
(hCG)	PUNCT	O	O
is	VERB	O	O
used	VERB	O	O
to	PART	O	O
trigger	ADP	O	O
ovulation	NOUN	O	O
in	ADP	O	O
high	ADJ	O	O
responder	VERB	O	O
patients.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Dexmedetomidine	NOUN	O	O
(Dex),	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjuvant,	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
reported	VERB	O	O
to	PART	O	O
prolong	NOUN	O	O
the	DET	O	O
duration	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
analgesia	NOUN	O	O
when	ADP	O	O
adding	VERB	O	O
to	PART	O	O
local	ADJ	O	O
anesthetic.	NOUN	O	O

Results	NOUN	O	O
indicate	VERB	O	O
that	ADP	O	O
WPI	NOUN	O	O
itself	PRON	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
improved	VERB	O	O
cognitive	ADJ	O	B-outcome
function	NOUN	O	I-outcome
but	CCONJ	O	O
some	DET	O	O
evidence	NOUN	O	O
of	ADP	O	O
benefit	NUM	O	O
of	ADP	O	O
SPI	NOUN	O	O
for	ADP	O	O
females	NOUN	O	O
was	VERB	O	O
found.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
[Effectiveness	ADV	O	O
of	ADP	O	O
a	DET	O	O
self-administered	VERB	O	O
rehabilitation	NOUN	O	O
program	NOUN	O	O
for	ADP	O	O
shoulder	NOUN	O	O
pain	NOUN	O	O
syndrome	NOUN	O	O
in	ADP	O	O
primary	ADJ	O	O
health	NOUN	O	O
care].	NOUN	O	O

The	DET	O	O
main	ADJ	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
eight	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
supplementation	NOUN	O	O
with	ADP	O	O
3000	NUM	O	O
IU/day	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
on	ADP	O	O
the	DET	O	O
hematological	ADJ	O	B-outcome
and	CCONJ	O	O
iron	NOUN	O	B-outcome
metabolism	NOUN	O	I-outcome
profile,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
on	ADP	O	O
the	DET	O	O
analytical	ADJ	O	O
values	NOUN	O	O
of	ADP	O	O
testosterone	NOUN	O	B-outcome
and	CCONJ	O	O
cortisol	NOUN	O	B-outcome
on	ADP	O	O
elite	ADP	O	O
male	NOUN	O	O
traditional	ADJ	O	O
rowers.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

The	DET	O	O
average	NOUN	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
operating	VERB	O	I-outcome
procedure	NOUN	O	I-outcome
was	VERB	O	O
1	NUM	O	O
hour	NOUN	O	O
and	CCONJ	O	O
35	NUM	O	O
minutes.	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
single-blind	NOUN	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
(evaluators)	NUM	O	O
with	ADP	O	O
an	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(self-administered	VERB	O	O
rehabilitation)	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(standard	PUNCT	O	O
physical	ADJ	O	O
therapy)	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
in	ADP	O	O
271	NUM	O	O
adult	NOUN	O	O
patients	NOUN	O	O
aged	VERB	O	O
18	NUM	O	O
or	CCONJ	O	O
older	ADJ	O	O
with	ADP	O	O
unilateral	ADJ	O	O
shoulder	NOUN	O	O
pain	NOUN	O	O
lasting	VERB	O	O
more	ADV	O	O
than	ADP	O	O
six	NUM	O	O
weeks	NOUN	O	O
and	CCONJ	O	O
less	ADV	O	O
than	ADP	O	O
three	NUM	O	O
months.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
ETView	NOUN	O	O
tracheoscopic	ADJ	O	O
ventilation	NOUN	O	O
tube	NOUN	O	O
(TVT)	NOUN	O	O
is	VERB	O	O
a	DET	O	O
tracheal	ADJ	O	O
tube	NOUN	O	O
(TT)	NOUN	O	O
incorporating	VERB	O	O
a	DET	O	O
video	ADJ	O	O
camera	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
light	NOUN	O	O
source	NOUN	O	O
in	ADP	O	O
its	ADJ	O	O
tip.	NOUN	O	O

Mindfulness	ADV	O	O
meditation	NOUN	O	O
interventions-which	NOUN	O	O
train	NOUN	O	O
skills	NOUN	O	O
in	ADP	O	O
monitoring	VERB	O	O
present-moment	ADJ	O	O
experiences	NOUN	O	O
with	ADP	O	O
a	DET	O	O
lens	NOUN	O	O
of	ADP	O	O
acceptance-have	VERB	O	O
shown	VERB	O	O
promise	NOUN	O	O
for	ADP	O	O
increasing	VERB	O	O
positive	ADJ	O	O
emotions.	NOUN	O	O

PURPOSE:	NOUN	O	O
Clinical	ADJ	O	O
implications	NOUN	O	O
of	ADP	O	O
single	ADJ	O	O
patient	NOUN	O	O
classifier	NOUN	O	O
(SPC)	NUM	O	O
and	CCONJ	O	O
microsatellite	NOUN	O	O
instability	NOUN	O	O
(MSI)	NOUN	O	O
in	ADP	O	O
stage	NOUN	O	O
II/III	NOUN	O	O
gastric	ADJ	O	O
cancer	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
reported.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Double-Blind	ADJ	O	O
Placebo-Controlled	VERB	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
Evaluating	VERB	O	O
the	DET	O	O
Effect	NOUN	O	O
of	ADP	O	O
Polyphenol-Rich	ADV	O	O
Herbal	ADJ	O	O
Congee	ADP	O	O
on	ADP	O	O
Bone	NOUN	O	B-outcome
Turnover	ADV	O	I-outcome
Markers	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Perimenopausal	ADJ	O	O
and	CCONJ	O	O
Menopausal	ADJ	O	O
Women.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
strength	NOUN	O	O
and	CCONJ	O	O
conditioning	VERB	O	O
research	NOUN	O	O

Responding	VERB	O	O
patients	NOUN	O	O
received	VERB	O	O
decitabine	NOUN	O	O
as	ADP	O	O
consolidation	NOUN	O	O
therapy	NOUN	O	O
on	ADP	O	O
a	DET	O	O
5-day	NOUN	O	O
schedule	NOUN	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
24	NUM	O	O
cycles.	NUM	O	O

METHODS:	NOUN	O	O
Forty-two	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
skeletal	ADJ	O	O
Class	NOUN	O	O
II	NUM	O	O
malocclusion	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
cast-splint	NOUN	O	O
Herbst	NOUN	O	O
appliances.	NUM	O	O

Similarly,	NOUN	O	O
no	DET	O	O
clinical	ADJ	O	O
or	CCONJ	O	O
statistical	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
noted	VERB	O	O
for	ADP	O	O
skeletal	ADJ	O	B-outcome
changes:	NOUN	O	O
ANB	NOUN	O	B-outcome
angle	NOUN	O	I-outcome
(PT,	NOUN	O	O
-1.51	NUM	O	O
degrees	NOUN	O	O
;	PUNCT	O	O
FT,	NOUN	O	O
-1.25	NUM	O	O
degrees	NOUN	O	O
;	PUNCT	O	O
P	NOUN	O	O
=	SYM	O	O
0.828;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-0.68,	ADP	O	O
0.849),	NUM	O	O
pogonion-sella	NOUN	O	B-outcome
vertical	ADJ	O	I-outcome
(PT,	NOUN	O	O
3.25	NUM	O	O
mm;	NOUN	O	O
FT,	NOUN	O	O
3.35	NUM	O	O
mm)	NOUN	O	O
or	CCONJ	O	O
A-sella	ADP	O	B-outcome
vertical	ADJ	O	I-outcome
(PT,	NOUN	O	O
1.28	NUM	O	O
mm;	NOUN	O	O
FT,	NOUN	O	O
1.06	NUM	O	O
mm).	NOUN	O	O

We	PRON	O	O
have	VERB	O	O
developed	VERB	O	O
a	DET	O	O
drug-capture	NOUN	O	O
assay	NOUN	O	O
(using	VERB	O	O
drug	NOUN	O	O
target)	NOUN	O	O
to	PART	O	O
measure	NOUN	O	O
belatacept	ADV	O	O
in	ADP	O	O
serum	NOUN	O	O
and	CCONJ	O	O
applied	VERB	O	O
this	DET	O	O
assay	NOUN	O	O
in	ADP	O	O
a	DET	O	O
pharmacokinetic	ADJ	O	O
study	NOUN	O	O
in	ADP	O	O
renal	ADJ	O	O
transplant	NOUN	O	O
recipients.	NOUN	O	O

PURPOSE:	NOUN	O	O
To	PART	O	O
study	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
Kangfuxin	NOUN	O	O
liquid	ADV	O	O
combined	VERB	O	O
with	ADP	O	O
Garlicin	NOUN	O	O
Capsules	NOUN	O	O
in	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
recurrent	ADP	O	O
oral	ADJ	O	O
ulcer	NOUN	O	O
(ROU)	NUM	O	O
and	CCONJ	O	O
on	ADP	O	O
immunological	ADJ	O	B-outcome
regulation	NOUN	O	I-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
This	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
study	NOUN	O	O
prospectively	ADV	O	O
enrolled	VERB	O	O
204	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
ROU	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Title:	NOUN	O	O
Enteral	ADJ	O	O
lactoferrin	NOUN	O	O
supplementation	NOUN	O	O
for	ADP	O	O
very	ADV	O	O
preterm	NOUN	O	O
infants:	NOUN	O	O
a	DET	O	O
randomised	VERB	O	O
placebo-controlled	VERB	O	O
trial.	NOUN	O	O

In	ADP	O	O
conclusion,	NOUN	O	O
the	DET	O	O
multifactorial	ADJ	O	O
intervention	NOUN	O	O
performed	VERB	O	O
could	VERB	O	O
improve	VERB	O	O
adherence	NOUN	O	B-outcome
to	PART	O	O
the	DET	O	O
MD	NOUN	O	O
and	CCONJ	O	O
diet	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
T2DM.	NOUN	O	O

Therefore,	NOUN	O	O
evidence	NOUN	O	O
is	VERB	O	O
scarce	NOUN	O	O
on	ADP	O	O
what	DET	O	O
conditions	NOUN	O	O
play	VERB	O	O
a	DET	O	O
role	NOUN	O	O
in	ADP	O	O
successful	ADJ	O	O
implementation	NOUN	O	O
and	CCONJ	O	O
how	ADP	O	O
they	PRON	O	O
interact.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/08	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

We	PRON	O	O
hope	NOUN	O	O
to	PART	O	O
show	VERB	O	O
the	DET	O	O
oncologic	ADJ	O	O
benefits	NOUN	O	O
of	ADP	O	O
deep	ADJ	O	O
NMB	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
moderate	ADJ	O	O
NMB	NOUN	O	O
during	ADP	O	O
subtotal	ADJ	O	O
gastrectomy.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
A	DET	O	O
Multifactorial	ADJ	O	O
Intervention	NOUN	O	O
in	ADP	O	O
Increasing	VERB	O	O
Adherence	NOUN	O	B-outcome
to	PART	O	O
the	DET	O	O
Mediterranean	NOUN	O	O
Diet	NOUN	O	O
among	ADP	O	O
Patients	NOUN	O	O
with	ADP	O	O
Diabetes	NOUN	O	O
Mellitus	NOUN	O	O
Type	NOUN	O	O
2:	NUM	O	O
A	DET	O	O
Controlled	VERB	O	O
and	CCONJ	O	O
Randomized	VERB	O	O
Study	NOUN	O	O
(EMID	PUNCT	O	O
Study).	NOUN	O	O

Registered	VERB	O	O
August	NOUN	O	O
7,	NUM	O	O
2015	NUM	O	O
-	PUNCT	O	O
retrospectively	ADV	O	O
registered.	NOUN	O	O

MEASUREMENTS:	NOUN	O	O
Peak	NOUN	O	B-outcome
muscle	NOUN	O	I-outcome
activation	NOUN	O	I-outcome
(in	NUM	O	O
percentage	NOUN	O	O
of	ADP	O	O
maximal	ADJ	O	O
voluntary	ADJ	O	O
isometric	ADJ	O	O
contraction	NOUN	O	O
[%MVIC])	ADP	O	O
in	ADP	O	O
the	DET	O	O
lower	ADJ	O	O
limbs	NOUN	O	O
during	ADP	O	O
gait	NOUN	O	O
was	VERB	O	O
measured	VERB	O	O
by	ADP	O	O
means	NOUN	O	O
of	ADP	O	O
surface	NOUN	O	O
electromyography,	NOUN	O	O
electrogoniometry,	NOUN	O	O
and	CCONJ	O	O
foot	NOUN	O	O
contact	NOUN	O	O
switches.	NUM	O	O

BACKGROUND/OBJECTIVES:	NOUN	O	O
Molecular	ADJ	O	O
mechanisms	NOUN	O	O
linking	VERB	O	O
fish	NOUN	O	O
and	CCONJ	O	O
vegetable	ADJ	O	O
oil	NOUN	O	O
intakes	NOUN	O	O
to	PART	O	O
their	ADJ	O	O
healthy	ADJ	O	O
metabolic	ADJ	O	O
effects	NOUN	O	O
may	VERB	O	O
involve	NOUN	O	O
attenuation	NOUN	O	O
of	ADP	O	O
inflammation.	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
fit	NOUN	O	O
factors	NOUN	O	O
among	ADP	O	O
healthcare	NOUN	O	O
providers	NOUN	O	O
working	VERB	O	O
in	ADP	O	O
the	DET	O	O
Emergency	NOUN	O	O
Department	NOUN	O	O
Center	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
training	VERB	O	O
with	ADP	O	O
three	NUM	O	O
types	NOUN	O	O
of	ADP	O	O
N95	NOUN	O	O
and	CCONJ	O	O
higher	ADJ	O	O
filter	NOUN	O	O
respirators.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
statistical	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
on	ADP	O	O
the	DET	O	O
other	ADJ	O	O
outcome	NOUN	O	O
measures.	NOUN	O	O

RES	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
two	NUM	O	O
calibrated	VERB	O	O
blind	PUNCT	O	O
periodontists	NOUN	O	O
one	NUM	O	O
year	NOUN	O	O
after	ADP	O	O
the	DET	O	O
treatment.	NOUN	O	O

Therefore,	NOUN	O	O
this	DET	O	O
study	NOUN	O	O
determined	VERB	O	O
if	ADP	O	O
PC	NOUN	O	O
affected	VERB	O	O
rectal	ADJ	O	B-outcome
temperature	NOUN	O	I-outcome
(Trec)	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
heat	NOUN	O	I-outcome
storage	NOUN	O	I-outcome
,	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
ratings	NOUN	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
(RPE),	NOUN	O	O
thermal	ADJ	O	B-outcome
sensation	NOUN	O	I-outcome
,	PUNCT	O	O
sweat	NOUN	O	B-outcome
rate,	NOUN	O	O
and	CCONJ	O	O
postexercise	NOUN	O	O
cold-water	NOUN	O	O
immersion	NOUN	O	O
(CWI)	NUM	O	O
rectal	ADJ	O	B-outcome
temperature	NOUN	O	I-outcome
cooling	VERB	O	O
rates.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Two	NUM	O	O
hundred	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
RA	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
remission	NOUN	O	O
(disease	NUM	O	O
activity	NOUN	O	O
score	NOUN	O	O
in	ADP	O	O
28	NUM	O	O
joints-C-reactive	NOUN	O	O
protein	NOUN	O	O
[DAS28-CRP]	NOUN	O	O
<3.2	ADJ	O	O
and	CCONJ	O	O
no	DET	O	O
swollen	NOUN	O	O
joints)	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
between	ADP	O	O
April	NOUN	O	O
2012	NUM	O	O
and	CCONJ	O	O
June	NOUN	O	O
2015.	NUM	O	O

The	DET	O	O
most	DET	O	O
relevant	ADJ	O	O
combination	NOUN	O	O
was	VERB	O	O
good	ADJ	O	O
quality	NOUN	O	O
implementation	NOUN	O	O
of	ADP	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
breaks	NOUN	O	I-outcome
,	PUNCT	O	O
implemented	VERB	O	O
by	ADP	O	O
teachers	NOUN	O	O
with	ADP	O	O
a	DET	O	O
high	ADJ	O	O
self-efficacy	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
a	DET	O	O
good	ADJ	O	O
previous	ADJ	O	O
knowledge	NOUN	O	B-outcome
about	ADV	O	O
the	DET	O	O
intervention.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
order	NOUN	O	O
of	ADP	O	O
treatment,	NOUN	O	O
27	NUM	O	O
cases	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
short-segment	ADP	O	O
fixation	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
vertebral	ADJ	O	O
reconstruction,	NOUN	O	O
26	NUM	O	O
cases	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
short-segment	ADP	O	O
fixation.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968551	NUM	O	O

The	DET	O	O
response	NOUN	O	O
was	VERB	O	O
independent	ADJ	O	O
of	ADP	O	O
the	DET	O	O
degree	NOUN	O	O
of	ADP	O	O
hypermobility.	NUM	O	O

As	ADP	O	O
a	DET	O	O
comparison	NOUN	O	O
control,	NOUN	O	O
26	NUM	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
comparable	ADJ	O	O
clinical	ADJ	O	O
baseline	NOUN	O	O
characteristics	NOUN	O	O
including	VERB	O	O
age,	NOUN	O	O
sex,	NOUN	O	O
Eastern	NOUN	O	O
Cooperative	ADJ	O	O
Oncology	NOUN	O	O
Group	NOUN	O	O
(ECOG)	NOUN	O	O
score,	NOUN	O	O
pathological	ADJ	O	O
type,	NOUN	O	O
carcinoembryonic	ADJ	O	O
antigen	NOUN	O	O
(CEA)	NOUN	O	O
level,	NOUN	O	O
tumor	NOUN	O	O
location,	NOUN	O	O
number	NOUN	O	O
and	CCONJ	O	O
location(s)	NOUN	O	O
of	ADP	O	O
metastasis,	NOUN	O	O
and	CCONJ	O	O
previous	ADJ	O	O
chemotherapies	NOUN	O	O
were	VERB	O	O
subject	NOUN	O	O
to	PART	O	O
observation.	ADV	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
personality	NOUN	O	O
and	CCONJ	O	O
social	ADJ	O	O
psychology	NOUN	O	O

RESULTS:	NOUN	O	O
By	ADP	O	O
December	NOUN	O	O
31,	NUM	O	O
2017,	NUM	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
261	NUM	O	O
of	ADP	O	O
the	DET	O	O
347	NUM	O	O
men	NOUN	O	O
in	ADP	O	O
the	DET	O	O
radical-prostatectomy	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
292	NUM	O	O
of	ADP	O	O
the	DET	O	O
348	NUM	O	O
men	NOUN	O	O
in	ADP	O	O
the	DET	O	O
watchful-waiting	VERB	O	O
group	NOUN	O	O
had	VERB	O	O
died	VERB	O	B-outcome
;	PUNCT	O	O
71	NUM	O	O
deaths	NOUN	O	B-outcome
in	PUNCT	O	X
the	DET	O	X
radical-prostatectomy	NOUN	O	X
group	NOUN	O	X
and	CCONJ	O	X
110	NUM	O	X
in	ADP	O	X
the	DET	O	X
watchful-waiting	VERB	O	X
group	NOUN	O	X
were	NOUN	O	X
due	ADJ	O	I-outcome
to	PART	O	I-outcome
prostate	NOUN	O	I-outcome
cancer	NOUN	O	I-outcome
(relative	ADJ	O	O
risk,	NOUN	O	O
0.55;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.41	NUM	O	O
to	PART	O	O
0.74;	NOUN	O	O
P<0.001;	ADJ	O	O
absolute	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
risk,	NOUN	O	O
11.7	NUM	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
5.2	NUM	O	O
to	PART	O	O
18.2).	NUM	O	O

ClinicalTrials.gov:NCT01485562.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0404312	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

BACKGROUND:	NOUN	O	O
Counterforce	NOUN	O	O
orthoses	NOUN	O	O
are	VERB	O	O
used	VERB	O	O
to	PART	O	O
manage	NOUN	O	O
lateral	ADJ	O	O
elbow	NOUN	O	O
tendinopathy,	ADJ	O	O
and	CCONJ	O	O
their	ADJ	O	O
effectiveness	NOUN	O	O
in	ADP	O	O
improving	VERB	O	O
motor	NOUN	O	O
function	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
documented.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
were	VERB	O	O
comparable	ADJ	O	O
for	ADP	O	O
preoperative	ADJ	O	O
SAI	NOUN	O	O
scores	NOUN	O	O
(P&gt;0.05);	NOUN	O	O
The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sedation	NOUN	O	O
group	NOUN	O	O
appeared	VERB	O	O
to	PART	O	O
have	VERB	O	O
lower	ADJ	O	O
intraoprative	ADJ	O	O
SAI	NOUN	O	O
scores,	NOUN	O	O
but	CCONJ	O	O
this	DET	O	O
difference	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(P=0.05).	NOUN	O	O

Transcutaneous	ADJ	O	O
electrical	ADJ	O	O
acupoint	NOUN	O	O
stimulation	NOUN	O	O
(TEAS)	NUM	O	O
is	VERB	O	O
a	DET	O	O
emerging	VERB	O	O
treatment	NOUN	O	O
which	ADP	O	O
combines	NOUN	O	O
transcutaneous	ADJ	O	O
electrical	ADJ	O	O
nerve	NOUN	O	O
stimulation	NOUN	O	O
with	ADP	O	O
traditional	ADJ	O	O
acupoint	NOUN	O	O
therapy.	NOUN	O	O

Prevention	NOUN	O	O
of	ADP	O	O
body	NOUN	O	O
posture	ADJ	O	O
abnormalities	NOUN	O	O
is	VERB	O	O
worth	ADP	O	O
promoting	VERB	O	O
in	ADP	O	O
groups	NOUN	O	O
of	ADP	O	O
children,	NOUN	O	O
also	ADV	O	O
with	ADP	O	O
various	ADJ	O	O
diseases	NOUN	O	O
including	VERB	O	O
asthma	NOUN	O	O
and	CCONJ	O	O
allergies	NOUN	O	O
symptoms.	NOUN	O	O

Whey	NOUN	O	O
protein	NOUN	O	O
is	VERB	O	O
rich	ADJ	O	O
in	ADP	O	O
the	DET	O	O
branched-chain	NOUN	O	O
amino	ADJ	O	O
acids,	NOUN	O	O
L-leucine,	ADJ	O	O
L-isoleucine	NOUN	O	O
and	CCONJ	O	O
L-valine.	NOUN	O	O

Title:	NOUN	O	O
Dark	NOUN	O	O
Chocolate	NOUN	O	O
Intake	NOUN	O	O
Positively	ADV	O	O
Modulates	NOUN	O	O
Redox	NOUN	O	B-outcome
Status	NOUN	O	O
and	CCONJ	O	O
Markers	NOUN	O	O
of	ADP	O	O
Muscular	ADJ	O	B-outcome
Damage	NOUN	O	I-outcome
in	ADP	O	O
Elite	ADP	O	O
Football	NOUN	O	O
Athletes:	ADJ	O	O
A	DET	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Study.	NOUN	O	O

METHODS:	NOUN	O	O
Sixty	NUM	O	O
patients	NOUN	O	O
scheduled	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
elective	ADJ	O	O
ileostomy	NOUN	O	O
closure	NOUN	O	O
under	ADP	O	O
epidural	ADJ	O	O
anesthesia	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
propofol	NOUN	O	O
sedation	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(n=30).	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sedation	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
a	DET	O	O
loading	VERB	O	O
dose	NOUN	O	O
of	ADP	O	O
propofol	NOUN	O	O
of	ADP	O	O
0.6	NUM	O	O
mg.kg(-	NOUN	O	O
1).	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

DESIGN:	NOUN	O	O
Double	ADV	O	O
blind,	NOUN	O	O
parallel	ADJ	O	O
group,	NOUN	O	O
placebo	NOUN	O	O
controlled,	NOUN	O	O
multicentre	NOUN	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Yoga	NOUN	O	O
positively	ADV	O	O
affected	VERB	O	O
depression	NOUN	O	B-outcome
and	CCONJ	O	O
blood	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
premenstrual	NOUN	O	O
syndrome	NOUN	O	O
in	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
visual	ADJ	O	O
analog	NOUN	O	O
scale	NOUN	O	O
(VAS)	PUNCT	O	O
scores	NOUN	O	O
during	ADP	O	O
movement,	NOUN	O	O
the	DET	O	O
tramadol	NOUN	O	B-outcome
consumption	NOUN	O	O
at	ADP	O	O
the	DET	O	O
1st,	NUM	O	O
4th,	NUM	O	O
and	CCONJ	O	O
12th	ADJ	O	O
postoperative	ADJ	O	O
hours,	NOUN	O	O
and	CCONJ	O	O
nausea	NOUN	O	B-outcome
scores	NOUN	O	O
at	ADP	O	O
the	DET	O	O
24th	ADJ	O	O
hour	NOUN	O	O
postoperatively.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Main	ADJ	O	O
outcome	NOUN	O	O
measures	NOUN	O	O
were	VERB	O	O
best-corrected	VERB	O	B-outcome
visual	ADJ	O	I-outcome
acuity	NOUN	O	I-outcome
(BCVA)	NUM	O	I-outcome
gain	VERB	O	O
of	ADP	O	O
15	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
ETDRS	NOUN	O	O
letters	NOUN	O	O
from	ADP	O	O
baseline,	NOUN	O	O
Snellen	NOUN	O	O
equivalent	ADJ	O	O
of	ADP	O	O
20/40	NOUN	O	O
or	CCONJ	O	O
better	ADJ	O	O
vision	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
baseline	NOUN	O	O
factors	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
early	ADJ	O	O
clinically	ADV	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
best-corrected	VERB	O	B-outcome
visual	ADJ	O	I-outcome
acuity	NOUN	O	I-outcome
(BCVA)	NUM	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
The	DET	O	O
median	ADJ	O	O
time	NOUN	O	B-outcome
for	ADP	O	Seperator
patients	NOUN	O	I-outcome
to	PART	O	I-outcome
achieve	NOUN	O	I-outcome
a	DET	O	Seperator
best-corrected	VERB	O	I-outcome
visual	ADJ	O	I-outcome
acuity	NOUN	O	I-outcome
(BCVA)	NUM	O	I-outcome
of	ADP	O	O
20/40	NOUN	O	O
or	CCONJ	O	O
better	ADJ	O	O
was	VERB	O	O
59	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
median	ADJ	O	O
time	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
to	PART	O	O
gain	VERB	O	O
15	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
{	NOUN	O	O
Early	ADJ	O	O
Treatment	NOUN	O	O
Diabetic	ADJ	O	B-outcome
Retinopathy	NOUN	O	I-outcome
Study	NOUN	O	O
(ETDRS)]}	PUNCT	O	O
letters	NOUN	O	O
was	VERB	O	O
63	NUM	O	O
days.	NOUN	O	O

SIM	NOUN	O	O
group	NOUN	O	O
learned	VERB	O	O
the	DET	O	O
AHA	NOUN	O	O
guidelines	NOUN	O	O
for	ADP	O	O
high-quality	NOUN	O	O
CPR	NOUN	O	O
via	ADP	O	O
an	DET	O	O
hour	NOUN	O	O
session	NOUN	O	O
that	ADP	O	O
included	VERB	O	O
a	DET	O	O
PowerPoint	NOUN	O	O
lecture	ADJ	O	O
with	ADP	O	O
training	VERB	O	O
on	ADP	O	O
a	DET	O	O
high-fidelity	NOUN	O	O
simulator.	NOUN	O	O

Clinical	ADJ	O	O
and	CCONJ	O	O
radiographic	ADJ	O	O
assessments	NOUN	O	O
of	ADP	O	O
abutments	NOUN	O	B-outcome
and	CCONJ	O	O
crowns	VERB	O	B-outcome
,	PUNCT	O	O
peri-implant	ADJ	O	B-outcome
mucosa	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
marginal	ADJ	O	B-outcome
bone	NOUN	O	I-outcome
levels	NOUN	O	O
were	VERB	O	O
recorded.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
neuron-specific	ADJ	O	B-outcome
enolase	NOUN	O	I-outcome
and	CCONJ	O	O
S100	NOUN	O	B-outcome
protein	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
occurrences	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
recorded.	NOUN	O	O

DISCUSSION:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
case	NOUN	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
Provincial	ADJ	O	O
RCT	NOUN	O	O
be	VERB	O	O
confirmed,	NOUN	O	O
serious	ADJ	O	O
consideration	NOUN	O	O
should	VERB	O	O
then	ADV	O	O
be	VERB	O	O
given	VERB	O	O
by	ADP	O	O
Ministry	NOUN	O	O
of	ADP	O	O
Health	NOUN	O	O
authorities	NOUN	O	O
to	PART	O	O
the	DET	O	O
possible	ADJ	O	O
implementation	NOUN	O	O
of	ADP	O	O
MI-based	VERB	O	O
strategies	NOUN	O	O
across	ADP	O	O
provincial	ADJ	O	O
maternity	NOUN	O	O
wards.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8008349	NUM	O	O

SAEs	NOUN	O	B-outcome
after	ADP	O	O
the	DET	O	O
1st	ADJ	O	O
and	CCONJ	O	O
2nd	ADJ	O	O
doses	NOUN	O	O
were	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
2	NUM	O	O
participants	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
participant,	NOUN	O	O
respectively,	NOUN	O	O
but	CCONJ	O	O
none	NUM	O	O
was	VERB	O	O
assessed	VERB	O	O
as	ADP	O	O
being	VERB	O	O
related	VERB	O	O
to	PART	O	O
vaccination.	ADV	O	O

METHODS:	NOUN	O	O
Single	NOUN	O	O
centre	NOUN	O	O
prospective	ADJ	O	O
open	ADJ	O	O
labeled	VERB	O	O
randomised	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
cervical	ADJ	O	O
spine	NOUN	O	O
phantom	NOUN	O	O
was	VERB	O	O
prepared	VERB	O	O
using	VERB	O	O
a	DET	O	O
cervical	ADJ	O	O
spine	NOUN	O	O
model	NOUN	O	O
immersed	VERB	O	O
in	ADP	O	O
a	DET	O	O
mixture	NOUN	O	O
of	ADP	O	O
gelatin	NOUN	O	O
and	CCONJ	O	O
psyllium	NOUN	O	O
husk.	NOUN	O	O

Group	NOUN	O	O
B	NOUN	O	O
(scleral	ADJ	O	O
group)	ADJ	O	O
included	VERB	O	O
124	NUM	O	O
cases	NOUN	O	O
(127	NUM	O	O
eyes),	NOUN	O	O
using	VERB	O	O
the	DET	O	O
sclera	NOUN	O	O
as	ADP	O	O
allograft.	NOUN	O	O

The	DET	O	O
e-cigarette	NOUN	O	O
group	NOUN	O	O
reported	VERB	O	O
greater	ADJ	O	O
declines	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
cough	NOUN	O	B-outcome
and	CCONJ	O	O
phlegm	NOUN	O	B-outcome
production	NOUN	O	I-outcome
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
52	NUM	O	O
weeks	NOUN	O	O
than	ADP	O	O
did	VERB	O	O
the	DET	O	O
nicotine-replacement	ADJ	O	O
group	NOUN	O	O
(relative	ADJ	O	O
risk	NOUN	O	O
for	ADP	O	O
cough,	ADV	O	O
0.8;	NUM	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.6	NUM	O	O
to	PART	O	O
0.9;	NUM	O	O
relative	ADJ	O	O
risk	NOUN	O	O
for	ADP	O	O
phlegm,	NOUN	O	O
0.7;	NUM	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.6	NUM	O	O
to	PART	O	O
0.9).	NUM	O	O

The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
aimed	VERB	O	O
to	PART	O	O
observe	NOUN	O	O
the	DET	O	O
curative	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
device-guided	VERB	O	O
rehabilitation	NOUN	O	O
on	ADP	O	O
respiratory	ADJ	O	O
functions	NOUN	O	O
in	ADP	O	O
stable	ADJ	O	O
COPD	NOUN	O	O
patients.	NOUN	O	O

Title:	NOUN	O	O
Effects	NOUN	O	O
of	ADP	O	O
Grape	NOUN	O	O
Pomace	NOUN	O	O
Polyphenolic	ADJ	O	O
Extract	NOUN	O	O
(Taurisolo((R)))	PUNCT	O	O
in	ADP	O	O
Reducing	VERB	O	O
Trimethylamine	NOUN	O	B-outcome
N-oxide	NOUN	O	I-outcome
(TMAO)	NOUN	O	I-outcome
Serum	NOUN	O	O
Levels	NOUN	O	O
in	ADP	O	O
Humans:	NOUN	O	O
Preliminary	ADJ	O	O
Results	NOUN	O	O
from	ADP	O	O
a	DET	O	O
Randomized,	NOUN	O	O
Placebo-Controlled,	NOUN	O	O
Cross-Over	NOUN	O	O
Study.	NOUN	O	O

Title:	NOUN	O	O
[Effects	NOUN	O	O
of	ADP	O	O
berberine	NOUN	O	O
on	ADP	O	O
the	DET	O	O
serum	NOUN	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
levels	NOUN	O	O
and	CCONJ	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
mellitus].	NOUN	O	O

The	DET	O	O
relationship	NOUN	O	O
between	ADP	O	O
serum	NOUN	O	O
25(OH)vitamin	NOUN	O	O
D3	NOUN	O	O
concentration	NOUN	O	O
and	CCONJ	O	O
waist	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
supports	NOUN	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
having	VERB	O	O
a	DET	O	O
protective	ADJ	O	O
role	NOUN	O	O
in	ADP	O	O
the	DET	O	O
current	ADJ	O	O
setting,	ADV	O	O
since	ADP	O	O
waist	NOUN	O	O
size	NOUN	O	O
is	VERB	O	O
directly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
cardiovascular	ADJ	O	O
and	CCONJ	O	O
metabolic	ADJ	O	O
diseases.	NOUN	O	O

The	DET	O	O
ergogenic	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
betaA	NOUN	O	O
has	VERB	O	O
also	ADV	O	O
been	VERB	O	O
demonstrated	VERB	O	O
for	ADP	O	O
2000-m	NUM	O	O
rowing	VERB	O	O
performance	NOUN	O	O
prompting	VERB	O	O
interest	NOUN	O	O
in	ADP	O	O
whether	ADP	O	O
betaA	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
beneficial	ADJ	O	O
for	ADP	O	O
sustained	VERB	O	O
aerobic	ADJ	O	O
exercise.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Journal-Name:Reproductive	ADJ	O	O
health	NOUN	O	O

Survival	NOUN	O	O
analyses	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
via	ADP	O	O
the	DET	O	O
Kaplan-Meier	NOUN	O	O
method.	NOUN	O	O

Differences	NOUN	O	O
between	ADP	O	O
treatment	NOUN	O	O
arms,	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
principle,	NOUN	O	O
were	VERB	O	O
adjusted	VERB	O	O
for	ADP	O	O
covariates	NOUN	O	O
and	CCONJ	O	O
missing	VERB	O	O
data	NOUN	O	O
were	VERB	O	O
handled	VERB	O	O
using	VERB	O	O
multiple	ADJ	O	O
imputation.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

BACKGROUND:	NOUN	O	O
Post-traumatic	ADJ	O	O
Stress	NOUN	O	O
Disorder	NOUN	O	O
(PTSD)	ADV	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
sequelae	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	O
combat-related	VERB	O	O
emotional	ADJ	O	O
trauma	NOUN	O	O
that	ADP	O	O
is	VERB	O	O
often	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
significantly	ADV	O	O
reduced	VERB	O	O
quality	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
in	ADP	O	O
afflicted	VERB	O	O
veterans.	NUM	O	O

Proton	NOUN	O	O
pump	NOUN	O	O
inhibitor	NOUN	O	O
(PPI)	NOUN	O	O
is	VERB	O	O
a	DET	O	O
useful	ADJ	O	O
drug	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
LPR,	VERB	O	O
but	CCONJ	O	O
its	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
hypogeusia	NOUN	O	O
is	VERB	O	O
not	ADV	O	O
known.	NOUN	O	O

An	DET	O	O
in	ADP	O	O
vitro	ADV	O	O
study	NOUN	O	O
also	ADV	O	O
confirmed	VERB	O	O
that	ADP	O	O
polyphenol	NOUN	O	O
extracts	NOUN	O	O
significantly	ADV	O	O
decreased	VERB	O	O
oxidative	ADJ	O	O
stress	NOUN	O	O
in	ADP	O	O
murine	ADJ	O	O
myoblast	NOUN	O	O
cell	NOUN	O	O
line	NOUN	O	O
C2C12-derived.	NOUN	O	O

RESULTS:	NOUN	O	O
We	PRON	O	O
randomized	VERB	O	O
210	NUM	O	O
participants,	NOUN	O	O
and	CCONJ	O	O
197	NUM	O	O
completed	VERB	O	O
the	DET	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
his	ADJ	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
test	NOUN	O	O
our	ADJ	O	O
hypothesis	NOUN	O	O
that	ADP	O	O
5	NUM	O	O
mug	NUM	O	O
Dex	NOUN	O	O
could	VERB	O	O
enhance	NOUN	O	O
the	DET	O	O
efficiency	NOUN	O	O
of	ADP	O	O
intrathecal	ADJ	O	O
bupivacaine	NOUN	O	O
and	CCONJ	O	O
reduce	VERB	O	O
the	DET	O	O
dose	NOUN	O	B-outcome
requirement	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
bupivacaine	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
cesarean	NOUN	O	O
section.	NOUN	O	O

Containing	VERB	O	O
dominantly	ADV	O	O
EPA,	NOUN	O	O
it	PRON	O	O
is	VERB	O	O
considered	VERB	O	O
to	PART	O	O
be	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
lowering	VERB	O	O
lipids,	NOUN	O	O
foremost	ADJ	O	O
serum	NOUN	O	O
triglycerides	NOUN	O	O
and	CCONJ	O	O
LDL	NOUN	O	O
cholesterol.	NOUN	O	O

PARTICIPANTS:	NOUN	O	O
Twenty-five	NUM	O	O
children	NOUN	O	O
with	ADP	O	O
DCD	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
the	DET	O	O
KT	NOUN	O	O
group	NOUN	O	O
(mean	NUM	O	O
age	NOUN	O	O
=	SYM	O	O
7.97	NUM	O	O
years)	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(mean	NUM	O	O
age	NOUN	O	O
=	SYM	O	O
8.04	NUM	O	O
years).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
Role	NOUN	O	O
Of	ADP	O	O
0.2%	NOUN	O	O
Bio-Adhesive	ADJ	O	O
Chlorhexidine	NOUN	O	O
Gel	NOUN	O	O
In	ADP	O	O
Reducing	VERB	O	O
Incidence	NOUN	O	O
Of	ADP	O	O
Alveolar	ADJ	O	B-outcome
Osteitis	NOUN	O	I-outcome
.	PUNCT	O	O

Adjuvant	NOUN	O	O
chemotherapy	NOUN	O	O
using	VERB	O	O
S-1	NOUN	O	O
was	VERB	O	O
administered	VERB	O	O
for	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
to	PART	O	O
patients	NOUN	O	O
with	ADP	O	O
curative	ADJ	O	O
resection	NOUN	O	O
who	ADP	O	O
fully	ADV	O	O
recovered	VERB	O	O
within	ADP	O	O
10	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
surgery	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
arms.	ADJ	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
how	ADP	O	O
high-dose	NOUN	O	O
ecabet	NOUN	O	O
sodium	NOUN	O	O
affects	NOUN	O	O
low-dose	NOUN	O	O
aspirin-induced	VERB	O	O
small	ADJ	O	O
intestinal	ADJ	O	O
mucosal	ADJ	O	O
injury	NOUN	O	O
in	ADP	O	O
healthy	ADJ	O	O
volunteers.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/13	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

A	DET	O	O
administration	NOUN	O	O
of	ADP	O	O
GLN	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
grade	NOUN	O	O
2	NUM	O	O
or	CCONJ	O	O
3	NUM	O	O
acute	ADJ	O	O
radiation-induced	VERB	O	O
esophagitis	NOUN	O	B-outcome
(ARIE)	NUM	O	O
(6.7%	NUM	O	O
vs	CCONJ	O	O
53.4%	NUM	O	O
for	ADP	O	O
Gln+	NOUN	O	O
vs	CCONJ	O	O
Gln-;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.004).	ADP	O	O

The	DET	O	O
BMI	NOUN	O	B-outcome
z-score	NOUN	O	O
of	ADP	O	O
the	DET	O	O
overall	ADJ	O	O
completers	NOUN	O	O
decreased	VERB	O	O
by	ADP	O	O
about	ADV	O	O
0.05	NUM	O	O
after	ADP	O	O
the	DET	O	O
16-week	NOUN	O	O
intervention	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.02).	NOUN	O	O

The	DET	O	O
deadline	NOUN	O	O
for	ADP	O	O
follow-up	NOUN	O	O
was	VERB	O	O
June	NOUN	O	O
2017	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
thromboembolism	NOUN	O	B-outcome
events	NOUN	O	O
within	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
was	VERB	O	O
counted.	NOUN	O	O

A	DET	O	O
transition	NOUN	O	O
to	PART	O	O
oral	ADJ	O	O
omadacycline	NOUN	O	O
(300	PUNCT	O	O
mg	NOUN	O	O
every	DET	O	O
24	NUM	O	O
hours)	NOUN	O	O
or	CCONJ	O	O
oral	ADJ	O	O
linezolid	NOUN	O	O
(600	NUM	O	O
mg	NOUN	O	O
every	DET	O	O
12	NUM	O	O
hours)	NOUN	O	O
was	VERB	O	O
allowed	VERB	O	O
after	ADP	O	O
3	NUM	O	O
days;	NOUN	O	O
the	DET	O	O
total	ADJ	O	O
treatment	NOUN	O	O
duration	NOUN	O	O
was	VERB	O	O
7	NUM	O	O
to	PART	O	O
14	NUM	O	O
days.	NOUN	O	O

Title:	NOUN	O	O
[Evaluation	NOUN	O	O
of	ADP	O	O
intervention	NOUN	O	O
program	NOUN	O	O
for	ADP	O	O
risk	NOUN	O	O
behaviors	NOUN	O	O
of	ADP	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
among	ADP	O	O
school	NOUN	O	O
age	NOUN	O	O
children].	NOUN	O	O

Journal-Name:National	ADJ	O	O
Bureau	PROPN	O	O
of	ADP	O	O
Economic	ADJ	O	O
Research	NOUN	O	O
bulletin	NOUN	O	O
on	ADP	O	O
aging	VERB	O	O
and	CCONJ	O	O
health	NOUN	O	O

Main	ADJ	O	O
parameters	NOUN	O	O
setting	VERB	O	O
of	ADP	O	O
respirator:	NOUN	O	O
the	DET	O	O
predetermined	VERB	O	O
tidal	DET	O	O
volume	NOUN	O	O
(VT)	NOUN	O	O
was	VERB	O	O
set	NOUN	O	O
at	ADP	O	O
500	NUM	O	O
mL	NOUN	O	O
in	ADP	O	O
the	DET	O	O
VCV	NOUN	O	O
group;	ADJ	O	O
the	DET	O	O
preset	NOUN	O	O
pressure	NOUN	O	O
was	VERB	O	O
regulated,	NOUN	O	O
so	ADV	O	O
that	ADP	O	O
when	ADP	O	O
the	DET	O	O
atomizer	NOUN	O	O
was	VERB	O	O
connected	VERB	O	O
to	PART	O	O
the	DET	O	O
atomization	NOUN	O	O
device,	NOUN	O	O
the	DET	O	O
VT	NOUN	O	O
was	VERB	O	O
nearly	ADV	O	O
equal	ADJ	O	O
to	PART	O	O
or	CCONJ	O	O
slightly	ADV	O	O
larger	ADJ	O	O
than	ADP	O	O
500	NUM	O	O
mL	NOUN	O	O
in	ADP	O	O
the	DET	O	O
PCV	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Blood	NOUN	O	O
samples	NOUN	O	O
were	VERB	O	O
obtained	VERB	O	O
from	ADP	O	O
the	DET	O	O
antecubital	ADJ	O	O
vein	NOUN	O	O
before	ADP	O	O
each	DET	O	O
exercise	NOUN	O	O
test,	NUM	O	O
1	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
completing	VERB	O	O
the	DET	O	O
test,	NUM	O	O
and	CCONJ	O	O
after	ADP	O	O
a	DET	O	O
24-h	NOUN	O	O
recovery.	NOUN	O	O

Title:	NOUN	O	O
Medial	ADJ	O	O
patellofemoral	ADJ	O	O
ligament	NOUN	O	O
reconstruction	NOUN	O	O
in	ADP	O	O
children:	NOUN	O	O
A	DET	O	O
comparative	ADJ	O	O
randomized	VERB	O	O
short-term	NOUN	O	O
study	NOUN	O	O
of	ADP	O	O
fascia	NOUN	O	O
lata	NOUN	O	O
allograft	NOUN	O	O
and	CCONJ	O	O
gracilis	NOUN	O	O
tendon	NOUN	O	O
autograft	NOUN	O	O
reconstruction.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/22	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal-Name:Respiratory	NUM	O	O
research	NOUN	O	O

Results:	NOUN	O	O
The	DET	O	O
glycemic	ADJ	O	B-outcome
control	NOUN	O	I-outcome
rate	NOUN	O	O
of	ADP	O	O
intervention	NOUN	O	O
group	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
and	CCONJ	O	O
people	NOUN	O	O
with	ADP	O	O
impaired	VERB	O	O
glucose	NOUN	O	O
tolerance	NOUN	O	O
(72.2%	NOUN	O	O
and	CCONJ	O	O
71.4%)	NUM	O	O
were	VERB	O	O
higher	ADJ	O	O
than	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(43.6%	PUNCT	O	O
and	CCONJ	O	O
26.7%),	NOUN	O	O
but	CCONJ	O	O
the	DET	O	O
unchanged	VERB	O	B-outcome
rate	NOUN	O	O
of	ADP	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(13.9%	NOUN	O	O
and	CCONJ	O	O
0.0%)	NUM	O	O
were	VERB	O	O
lower	ADJ	O	O
than	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(42.3%	PUNCT	O	O
and	CCONJ	O	O
73.3%).	NUM	O	O

respectively	ADV	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.450).	NUM	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
methylene	NOUN	O	O
blue	ADJ	O	O
localization	NOUN	O	O
group,	NOUN	O	O
3	NUM	O	O
patients	NOUN	O	O
had	VERB	O	O
localization	NOUN	O	B-outcome
failure	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
the	DET	O	O
intrathoracic	NOUN	O	O
diffusion	NOUN	O	O
of	ADP	O	O
methylene	NOUN	O	O
blue,	ADP	O	O
and	CCONJ	O	O
the	DET	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
93.61%.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Scorpion	NOUN	O	O
envenomation	NOUN	O	O
and	CCONJ	O	O
its	ADJ	O	O
consequences	NOUN	O	O
represented	VERB	O	O
a	DET	O	O
serious	ADJ	O	O
healthcare	NOUN	O	O
problem	ADP	O	O
in	ADP	O	O
Upper	NOUN	O	O
Egypt	NOUN	O	O
and	CCONJ	O	O
considered	VERB	O	O
to	PART	O	O
be	VERB	O	O
an	DET	O	O
important	ADJ	O	O
cause	ADP	O	O
of	ADP	O	O
life-threatening	VERB	O	O
emergency	NOUN	O	O
particularly	ADV	O	O
in	ADP	O	O
children.	NOUN	O	O

RESULTS:	NOUN	O	O
No	DET	O	O
significant	ADJ	O	O
operative	ADJ	O	O
or	CCONJ	O	O
postoperative	ADJ	O	O
complications	NOUN	O	B-outcome
(other	PUNCT	O	O
than	ADP	O	O
failure)	NOUN	O	O
were	VERB	O	O
encountered	VERB	O	O
in	ADP	O	O
either	CCONJ	O	O
group.	VERB	O	O

All	DET	O	O
outcomes	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
6-week,	NUM	O	O
and	CCONJ	O	O
12-week	NOUN	O	O
treatment.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

OBJECTIVE:	NOUN	O	O
Primary	ADJ	O	O
objective	ADP	O	O
was	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
atorvastatin	NOUN	O	O
40mg	NOUN	O	O
vs	CCONJ	O	O
80mg	NOUN	O	O
on	ADP	O	O
LDL-C	NOUN	O	B-outcome
in	ADP	O	O
Indian	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
atherosclerotic	ADJ	O	O
dyslipidemia.	NOUN	O	O

Following	VERB	O	O
baseline	NOUN	O	O
measures,	NOUN	O	O
two	NUM	O	O
study	NOUN	O	O
intervals	NOUN	O	O
occurred	VERB	O	O
with	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
receiving	VERB	O	O
live	ADJ	O	O
music	ADJ	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
interval	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
no	DET	O	O
music	ADJ	O	O
during	ADP	O	O
the	DET	O	O
second	ADJ	O	O
interval;	NOUN	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
no	DET	O	O
music	ADJ	O	O
during	ADP	O	O
both	CCONJ	O	O
intervals.	NOUN	O	O

For	ADP	O	O
the	DET	O	O
statistical	ADJ	O	O
analyses,	NOUN	O	O
the	DET	O	O
IBM	NOUN	O	O
SPSS	ADV	O	O
Statistics	NOUN	O	O
22	NUM	O	O
(IBM	NUM	O	O
SPSS,	ADJ	O	O
Turkey)	NOUN	O	O
program	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
findings	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

Women	NOUN	O	O
with	ADP	O	O
premenstrual	NOUN	O	O
syndrome	NOUN	O	O
(PMS)	NOUN	O	O
often	ADV	O	O
complain	NOUN	O	O
about	ADV	O	O
depression	NOUN	O	O
when	ADP	O	O
their	ADJ	O	O
menstrual	ADJ	O	O
cycle	NOUN	O	O
begins.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968555	NUM	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
traditional	ADJ	O	O
respiratory	ADJ	O	O
training	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
device-guided	VERB	O	O
pulmonary	ADJ	O	O
rehabilitation	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
the	DET	O	O
respiratory	ADJ	O	B-outcome
muscle	NOUN	O	I-outcome
function	NOUN	O	I-outcome
and	CCONJ	O	O
athletic	ADJ	O	B-outcome
ability	NOUN	O	I-outcome
in	ADP	O	O
stable	ADJ	O	O
COPD	NOUN	O	O
patients.	NOUN	O	O

Following	VERB	O	O
a	DET	O	O
review	NOUN	O	O
of	ADP	O	O
the	DET	O	O
information,	NOUN	O	O
attendees	NOUN	O	O
proposed	VERB	O	O
actions	NOUN	O	O
to	PART	O	O
strengthen	ADV	O	O
community-based	VERB	O	O
health	NOUN	O	O
services	NOUN	O	O
in	ADP	O	O
their	ADJ	O	O
community.	ADJ	O	O

RESULTS:	NOUN	O	O
Forty-four	NUM	O	O
individuals	NOUN	O	O
under	ADP	O	O
hazardous	ADJ	O	O
or	CCONJ	O	O
harmful	ADJ	O	O
alcohol	NOUN	O	O
use	NOUN	O	O
completed	VERB	O	O
all	DET	O	O
phases	NOUN	O	O
of	ADP	O	O
the	DET	O	O
research.	NOUN	O	O

We	PRON	O	O
investigated	VERB	O	O
whether	ADP	O	O
oral	ADJ	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
is	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
intravenous	ADJ	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
for	ADP	O	O
this	DET	O	O
indication.	ADV	O	O

BACKGROUND:	NOUN	O	O
Magnesium	NOUN	O	O
(Mg)	NOUN	O	O
supplementation	NOUN	O	O
may	VERB	O	O
help	VERB	O	O
control	NOUN	O	O
glycemic	ADJ	O	O
response	NOUN	O	O
among	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
(T2D)	NOUN	O	O
patients.	NOUN	O	O

Although	ADP	O	O
the	DET	O	O
reductions	NOUN	O	O
in	ADP	O	O
weight	NOUN	O	B-outcome
and	CCONJ	O	O
body	NOUN	O	B-outcome
fat	NOUN	O	I-outcome
were	VERB	O	O
comparable	ADJ	O	O
in	ADP	O	O
IS	VERB	O	O
and	CCONJ	O	O
IR	NOUN	O	O
groups,	NOUN	O	O
only	ADV	O	O
women	NOUN	O	O
with	ADP	O	O
IR	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
concentration	NOUN	O	O
as	ADP	O	O
a	DET	O	O
result	VERB	O	O
of	ADP	O	O
all	DET	O	O
interventions.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9433361	NUM	O	O

Twenty	NUM	O	O
seven	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
failed	VERB	O	O
at	ADP	O	O
least	ADV	O	O
2	NUM	O	O
lines	NOUN	O	O
chemotherapy	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
apatinib	ADP	O	O
(500	PUNCT	O	O
mg/day).	NOUN	O	O

The	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
interleukin	NOUN	O	B-outcome
2	NUM	O	I-outcome
(IL-2)	NOUN	O	I-outcome
,	PUNCT	O	O
interleukin	NOUN	O	B-outcome
4	NUM	O	I-outcome
(IL-4)	PUNCT	O	I-outcome
,	PUNCT	O	O
interleukin	NOUN	O	B-outcome
10	NUM	O	I-outcome
(IL-10)	PUNCT	O	I-outcome
,	PUNCT	O	O
interferon	NOUN	O	B-outcome
gamma	NOUN	O	I-outcome
(INF-)	PUNCT	O	I-outcome
and	CCONJ	O	O
total	ADJ	O	O
antioxidant	NOUN	O	B-outcome
capacity	NOUN	O	O
(TAC)	ADP	O	O
were	VERB	O	O
determined	VERB	O	O
with	ADP	O	O
commercially	ADV	O	O
available	ADJ	O	O
diagnostic	ADJ	O	O
kits.	NOUN	O	O

No	DET	O	O
therapeutic	ADJ	O	O
intervention	NOUN	O	O
was	VERB	O	O
applied	VERB	O	O
to	PART	O	O
the	DET	O	O
CG.	NOUN	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
whether	ADP	O	O
an	DET	O	O
ultrasound	NOUN	O	O
(US)-guided	PUNCT	O	O
oblique	ADJ	O	O
subcostal	ADJ	O	O
transversus	NOUN	O	O
abdominis	NOUN	O	O
plane	ADJ	O	O
(OSTAP)	PUNCT	O	O
block	VERB	O	O
would	VERB	O	O
improve	VERB	O	O
the	DET	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
scores	NOUN	O	O
and	CCONJ	O	O
decrease	NOUN	O	O
the	DET	O	O
tramadol	NOUN	O	B-outcome
consumption	NOUN	O	O
after	ADP	O	O
a	DET	O	O
laparoscopic	ADJ	O	O
hysterectomy.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
15th	NOUN	O	O
day	NOUN	O	O
after	ADP	O	O
surgery,	NOUN	O	O
drainage	NOUN	O	O
by	ADP	O	O
the	DET	O	O
incision	NOUN	O	O
was	VERB	O	O
1.53	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
was	VERB	O	O
2.11	NUM	O	O
(p=0.440),	PUNCT	O	O
30th	ADV	O	O
days	NOUN	O	O
after	ADP	O	O
drainage	NOUN	O	O
by	ADP	O	O
incision	NOUN	O	O
was	VERB	O	O
0.71	NUM	O	O
and	CCONJ	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
was	VERB	O	O
0.84	NUM	O	O
(p=0.787).	PUNCT	O	O

FINDINGS:	ADJ	O	O
Between	ADP	O	O
Feb	NOUN	O	O
28,	NUM	O	O
2013,	NUM	O	O
and	CCONJ	O	O
April	NOUN	O	O
12,	NUM	O	O
2018,	NUM	O	O
71	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled.	NOUN	O	O

As	ADP	O	O
obesity	NOUN	O	O
is	VERB	O	O
recognised	VERB	O	O
as	ADP	O	O
a	DET	O	O
contributing	VERB	O	O
factor	NOUN	O	O
when	ADP	O	O
developing	VERB	O	O
various	ADJ	O	O
health	NOUN	O	O
threatening	VERB	O	O
chronic	ADJ	O	O
diseases,	NOUN	O	O
prevention	NOUN	O	O
initiatives	NOUN	O	O
focusing	VERB	O	O
on	ADP	O	O
weight	NOUN	O	O
loss	NOUN	O	O
are	VERB	O	O
becoming	VERB	O	O
more	ADV	O	O
important.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Randomized,	NOUN	O	O
placebo-controlled,	NOUN	O	O
factorial	ADJ	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
among	ADP	O	O
120	NUM	O	O
patients	NOUN	O	O
aged	VERB	O	O
60	NUM	O	O
years	NOUN	O	O
or	CCONJ	O	O
older	ADJ	O	O
undergoing	VERB	O	O
on-pump	NOUN	O	O
coronary	ADJ	O	O
artery	NOUN	O	O
bypass	NOUN	O	O
graft	NOUN	O	O
(CABG)	PUNCT	O	O
surgery	NOUN	O	O
or	CCONJ	O	O
combined	VERB	O	O
CABG/valve	NUM	O	O
surgeries	NOUN	O	O
at	ADP	O	O
a	DET	O	O
US	PROPN	O	O
center.	NOUN	O	O

Operator-reported	VERB	O	O
aspiration	NOUN	O	B-outcome
occurred	VERB	O	O
during	ADP	O	O
2.5%	NOUN	O	O
of	ADP	O	O
intubations	NOUN	O	O
in	ADP	O	O
the	DET	O	O
bag-mask	ADJ	O	O
ventilation	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
during	ADP	O	O
4.0%	NOUN	O	O
in	ADP	O	O
the	DET	O	O
no-ventilation	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.41).	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
composite	NOUN	O	O
of	ADP	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
any	DET	O	Seperator
cause	ADP	O	I-outcome
,	PUNCT	O	O
myocardial	ADJ	O	B-outcome
infarction	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
stroke	NOUN	O	B-outcome
was	VERB	O	O
a	DET	O	O
secondary	ADJ	O	O
outcome.	NOUN	O	O

Journal-Name:Respiratory	NUM	O	O
research	NOUN	O	O

In	ADP	O	O
the	DET	O	O
SHM	NOUN	O	O
group,	NOUN	O	O
it	PRON	O	O
was	VERB	O	O
22,	NUM	O	O
3,	NOUN	O	O
and	CCONJ	O	O
5	NUM	O	O
cases	NOUN	O	O
respectively.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101474849	NUM	O	O

Title:	NOUN	O	O
Prospective,	NOUN	O	O
randomized,	NOUN	O	O
double-blinded,	NOUN	O	O
placebo-controlled	VERB	O	O
study	NOUN	O	O
on	ADP	O	O
safety	NOUN	O	O
and	CCONJ	O	O
tolerability	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
krill	NOUN	O	O
powder	NOUN	O	O
product	NOUN	O	O
in	ADP	O	O
overweight	NUM	O	O
subjects	NOUN	O	O
with	ADP	O	O
moderately	ADV	O	O
elevated	VERB	O	O
blood	NOUN	O	O
pressure.	NOUN	O	O

Title:	NOUN	O	O
Induction	NOUN	O	O
chronomodulated	VERB	O	O
chemotherapy	NOUN	O	O
plus	CCONJ	O	O
radiotherapy	NOUN	O	O
for	ADP	O	O
nasopharyngeal	ADJ	O	O
carcinoma:	NOUN	O	O
A	DET	O	O
Phase	NOUN	O	O
II	NUM	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
study.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
incidences	NOUN	O	O
of	ADP	O	O
bradycardia	NOUN	O	B-outcome
and	CCONJ	O	O
hypoxemia	NOUN	O	B-outcome
in	ADP	O	O
either	CCONJ	O	O
of	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
during	ADP	O	O
study	NOUN	O	O
observation.	ADV	O	O

The	DET	O	O
World	NOUN	O	O
Health	NOUN	O	O
Organisation	NOUN	O	O
(WHO)	NOUN	O	O
'5	PUNCT	O	O
Moments	NOUN	O	O
for	ADP	O	O
Hand	NOUN	O	O
Hygiene'	NUM	O	O
poster	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
used	VERB	O	O
to	PART	O	O
reduce	VERB	O	O
hospital-acquired	VERB	O	O
infections,	NOUN	O	O
but	CCONJ	O	O
there	PRON	O	O
is	VERB	O	O
no	DET	O	O
similar	ADJ	O	O
tool	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
community-acquired	VERB	O	O
newborn	NOUN	O	O
infections	NOUN	O	O
in	ADP	O	O
low-resource	ADJ	O	O
settings.	NOUN	O	O

Safety,	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
(AEs),	PUNCT	O	O
and	CCONJ	O	O
cutaneous	ADJ	O	O
tolerability	NOUN	O	B-outcome
were	VERB	O	O
evaluated	VERB	O	O
throughout	ADV	O	O
using	VERB	O	O
a	DET	O	O
4-point	NOUN	O	O
scale	NOUN	O	O
where	ADP	O	O
0=none	ADJ	O	O
and	CCONJ	O	O
3=severe.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/27	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Differences	NOUN	O	O
between	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
each	DET	O	O
time	NOUN	O	O
showed	VERB	O	O
no	DET	O	O
statistical	ADJ	O	O
significance	NOUN	O	O
(p	PUNCT	O	O
>	SYM	O	O
0.05).	NOUN	O	O

The	DET	O	O
drug	NOUN	O	O
Simvastatin	NOUN	O	O
may	VERB	O	O
help	VERB	O	O
to	PART	O	O
protect	VERB	O	O
donor	NOUN	O	O
livers	NOUN	O	O
against	ADP	O	O
this	DET	O	O
damage	NOUN	O	O
and	CCONJ	O	O
improve	VERB	O	O
outcomes	NOUN	O	O
for	ADP	O	O
transplant	NOUN	O	O
recipients.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
ability	NOUN	O	O
to	PART	O	O
generate	NOUN	O	O
high	ADJ	O	O
levels	NOUN	O	O
of	ADP	O	O
power	NOUN	O	O
is	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
key	ADJ	O	O
factors	NOUN	O	O
determining	VERB	O	O
success	NOUN	O	O
in	ADP	O	O
many	DET	O	O
sport	ADJ	O	O
disciplines.	ADJ	O	O

Registered	VERB	O	O
5	NUM	O	O
October	ADJ	O	O
2015.	NUM	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
use	NOUN	O	O
of	ADP	O	O
colorings	NOUN	O	O
in	ADP	O	O
eye	NOUN	O	O
drops	NOUN	O	O
can	VERB	O	O
help	VERB	O	O
distinguishing	VERB	O	O
the	DET	O	O
vials	NOUN	O	O
and	CCONJ	O	O
preventing	VERB	O	O
misidentification	NOUN	O	B-outcome
.	PUNCT	O	O

Journal-Name:Zhonghua	NOUN	O	O
nei	ADV	O	O
ke	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/19	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
KT	NOUN	O	O
group	NOUN	O	O
demonstrated	VERB	O	O
26.87%MVIC	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
=	SYM	O	O
26.87,	NOUN	O	O
7.11)	NUM	O	O
higher	ADJ	O	O
gastrocnemius	NOUN	O	O
medialis	NOUN	O	O
muscle	NOUN	O	O
peak	NOUN	O	O
activation	NOUN	O	O
during	ADP	O	O
mid	NOUN	O	O
stance	NOUN	O	O
phase	NOUN	O	O
at	ADP	O	O
post-test	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101266132	NUM	O	O

SETTING:	NOUN	O	O
People's	NOUN	O	O
Hospital	NOUN	O	O
of	ADP	O	O
Guanghan,	NOUN	O	O
China.	NOUN	O	O

RESULTS:	NOUN	O	O
Among	ADP	O	O
the	DET	O	O
1054	NUM	O	O
participants	NOUN	O	O
(527	NUM	O	O
in	ADP	O	O
each	DET	O	O
group),	NOUN	O	O
end-point	NOUN	O	O
data	NOUN	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
1015	NUM	O	O
(96.3%).	NUM	O	O

Pain	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
was	VERB	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
visual	ADJ	O	O
scale	NOUN	O	O
before	ADP	O	O
treatment,	NOUN	O	O
1	NUM	O	O
h	NOUN	O	O
after	ADP	O	O
consuming	VERB	O	O
the	DET	O	O
drug	NOUN	O	O
(for	PUNCT	O	O
24	NUM	O	O
h)	ADV	O	O
and	CCONJ	O	O
48	NUM	O	O
h	NOUN	O	O
after	ADP	O	O
the	DET	O	O
onset	NOUN	O	O
of	ADP	O	O
drug.	NOUN	O	O

To	PART	O	O
compare	NOUN	O	O
students'	NOUN	O	O
MCF	NOUN	O	O
experiences	NOUN	O	O
we	PRON	O	O
sent	ADJ	O	O
out	ADP	O	O
an	DET	O	O
electronic	ADJ	O	O
survey	NOUN	O	O
afterward	ADJ	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
following	VERB	O	O
using	VERB	O	O
a	DET	O	O
0-100	NUM	O	O
sliding	VERB	O	O
scale:	NOUN	O	O
overall	ADJ	O	O
satisfaction	NOUN	O	B-outcome
with	ADP	O	O
the	DET	O	O
meeting;	ADJ	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
communication	NOUN	O	B-outcome
;	PUNCT	O	O
the	DET	O	O
helpfulness	ADV	O	O
of	ADP	O	O
the	DET	O	O
meeting;	ADJ	O	O
their	ADJ	O	O
stress	NOUN	O	B-outcome
levels,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
convenience	NOUN	O	B-outcome
of	ADP	O	O
their	ADJ	O	O
meeting	VERB	O	O
location.	ADV	O	O

The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
8	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
Shilajit	ADJ	O	O
supplementation	NOUN	O	O
at	ADP	O	O
250	NUM	O	O
mg.d(-	NOUN	O	O
1)	NUM	O	O
(low	PUNCT	O	O
dose)	ADJ	O	O
and	CCONJ	O	O
500	NUM	O	O
mg.d(-	NOUN	O	O
1)	NUM	O	O
(high	PUNCT	O	O
dose)	ADJ	O	O
versus	CCONJ	O	O
placebo	NOUN	O	O
on	ADP	O	O
maximal	ADJ	O	B-outcome
voluntary	ADJ	O	I-outcome
isometric	ADJ	O	I-outcome
contraction	NOUN	O	I-outcome
(MVIC)	NOUN	O	I-outcome
strength,	NOUN	O	O
concentric	ADJ	O	B-outcome
peak	NOUN	O	I-outcome
torque	ADV	O	I-outcome
,	PUNCT	O	O
fatigue-induced	VERB	O	O
percent	NOUN	O	O
decline	NOUN	O	O
in	ADP	O	O
strength	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
serum	NOUN	O	O
hydroxyproline	NOUN	O	B-outcome
(HYP)	NOUN	O	I-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
Sixty-three	NUM	O	O
recreationally-active	ADJ	O	O
men	NOUN	O	O
([Formula:	PUNCT	O	O
see	NOUN	O	O
text	NOUN	O	O
+/-	SYM	O	O
SD:	NOUN	O	O
21.2	NUM	O	O
+/-	SYM	O	O
2.4	NUM	O	O
yr.;	NOUN	O	O

The	DET	O	O
administration	NOUN	O	O
of	ADP	O	O
NMES	NOUN	O	O
or	CCONJ	O	O
sham	NOUN	O	O
NMES,	NOUN	O	O
as	ADP	O	O
intervention,	ADP	O	O
was	VERB	O	O
performed	VERB	O	O
for	ADP	O	O
an	DET	O	O
8-week	NOUN	O	O
period	NOUN	O	O
treatment,	NOUN	O	O
and	CCONJ	O	O
4-week	NOUN	O	O
period	NOUN	O	O
follow-up.	PUNCT	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
The	DET	O	O
use	NOUN	O	B-outcome
of	ADP	O	I-outcome
resources	NOUN	O	I-outcome
,	PUNCT	O	O
costs	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality-adjusted	VERB	O	O
life-years	NOUN	O	O
(QALYs)	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
at	ADP	O	O
six	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
one	NUM	O	O
year.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

In	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
the	DET	O	O
routine	ADJ	O	O
care.	NOUN	O	O

These	DET	O	O
findings	NOUN	O	O
will	VERB	O	O
inform	NOUN	O	O
future	NOUN	O	O
mass	NOUN	O	O
drug	NOUN	O	O
administration	NOUN	O	O
policy	NOUN	O	O
and	CCONJ	O	O
shed	ADJ	O	O
light	NOUN	O	O
on	ADP	O	O
position	NOUN	O	O
of	ADP	O	O
novel	ADJ	O	O
diagnostic	ADJ	O	O
tools	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
schistosomiasis	NOUN	O	O
control	NOUN	O	O
strategies.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
high-dose	NOUN	O	O
intraoperative	ADJ	O	O
remifentanil	NOUN	O	O
on	ADP	O	O
postoperative	ADJ	O	B-outcome
sore	ADV	O	I-outcome
throat	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
study:	NOUN	O	O
A	DET	O	O
CONSORT	NOUN	O	O
compliant	ADJ	O	O
article.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/13	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Studies	NOUN	O	O
have	VERB	O	O
reported	VERB	O	O
that	ADP	O	O
uterine	ADJ	O	O
contractions	NOUN	O	O
(UC)	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
embryo	NOUN	O	O
transfer	NOUN	O	O
(ET)	NOUN	O	O
were	VERB	O	O
inversely	ADV	O	O
related	VERB	O	O
to	PART	O	O
implantation	NOUN	O	O
and	CCONJ	O	O
pregnancy	NOUN	O	O
rate,	NOUN	O	O
hence	ADV	O	O
reducing	VERB	O	O
the	DET	O	O
success	NOUN	O	O
of	ADP	O	O
IVF	NOUN	O	O
treatments.	NOUN	O	O

Hyperpigmentation	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
reduced	VERB	O	O
progressively	ADV	O	O
with	ADP	O	O
treatment.	NOUN	O	O

Conclusion:	NOUN	O	O
Berberine	NOUN	O	O
improves	NOUN	O	O
diabetic	ADJ	O	O
kidney	NOUN	O	O
disease	NOUN	O	O
by	ADP	O	O
reducing	VERB	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
serum	NOUN	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
and	CCONJ	O	O
serum	NOUN	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
in	ADP	O	O
T2DM	NOUN	O	O
patients,	NOUN	O	O
and	CCONJ	O	O
it	PRON	O	O
was	VERB	O	O
safe.	NOUN	O	O

Day	NOUN	O	O
1)	NUM	O	O
and	CCONJ	O	O
dexamethasone	NOUN	O	O
(9.9	PUNCT	O	O
mg	NOUN	O	O
i.v.	NOUN	O	O

Saliva	ADJ	O	O
3-methoxy-4-hydroxyphenylglycol	NOUN	O	B-outcome
(MHPG)	NOUN	O	I-outcome
,	PUNCT	O	O
a	DET	O	O
major	ADJ	O	O
product	NOUN	O	O
of	ADP	O	O
noradrenaline	NOUN	O	O
breakdown	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
representative	ADJ	O	O
marker	NOUN	O	O
of	ADP	O	O
sympathetic	ADJ	O	B-outcome
nerve	NOUN	O	I-outcome
activity	NOUN	O	I-outcome
,	PUNCT	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
just	ADV	O	O
after	ADP	O	O
the	DET	O	O
TSST	NOUN	O	O
in	ADP	O	O
the	DET	O	O
active	ADJ	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
berberine	NOUN	O	O
on	ADP	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
(UACR)	PUNCT	O	I-outcome
and	CCONJ	O	O
serum	NOUN	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
(Cys	NOUN	O	I-outcome
C)	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
mellitus	NOUN	O	O
(T2DM).	VERB	O	O

Interventions:	NOUN	O	O
Patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
1:1	ADJ	O	O
(stratified	PUNCT	O	O
by	ADP	O	O
cardiac	ADJ	O	O
vs	CCONJ	O	O
noncardiac	ADJ	O	O
surgery	NOUN	O	O
and	CCONJ	O	O
positive	ADJ	O	O
vs	CCONJ	O	O
negative	ADJ	O	O
recent	ADJ	O	O
fall	NOUN	O	O
history)	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
EEG-guided	VERB	O	O
anesthetic	ADJ	O	O
administration	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
614)	NUM	O	O
or	CCONJ	O	O
usual	ADJ	O	O
anesthetic	ADJ	O	O
care	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
618).	NOUN	O	O

Methods:	NOUN	O	O
Fifty-one	NUM	O	O
participants	NOUN	O	O
with	ADP	O	O
PFOA	NOUN	O	O
(66%	NOUN	O	O
women,	NOUN	O	O
mean	NOUN	O	O
+/-	SYM	O	O
SD	NOUN	O	O
age	NOUN	O	O
57	NUM	O	O
+/-	SYM	O	O
10	NUM	O	O
years,	NOUN	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
(BMI)	PUNCT	O	O
27	NUM	O	O
+/-	SYM	O	O
6	NUM	O	O
kg/m(2)),	NUM	O	O
and	CCONJ	O	O
23	NUM	O	O
controls	NOUN	O	O
(56%	PUNCT	O	O
women,	NOUN	O	O
age	NOUN	O	O
56	NUM	O	O
+/-	SYM	O	O
9	NUM	O	O
years,	NOUN	O	O
BMI	NOUN	O	O
24	NUM	O	O
+/-	SYM	O	O
4	NUM	O	O
kg/m(2))	NOUN	O	O
had	VERB	O	O
ankle	NOUN	O	O
dorsiflexion	NOUN	O	O
measured	VERB	O	O
using	VERB	O	O
the	DET	O	O
knee-to-wall	NOUN	O	O
test,	NUM	O	O
foot	NOUN	O	O
mobility,	NOUN	O	O
calculated	VERB	O	O
as	ADP	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
midfoot	NOUN	O	O
height	NOUN	O	O
or	CCONJ	O	O
width	NOUN	O	O
between	ADP	O	O
non-weightbearing	VERB	O	O
and	CCONJ	O	O
weightbearing,	NOUN	O	O
and	CCONJ	O	O
static	ADJ	O	O
foot	NOUN	O	O
posture	ADJ	O	O
characterized	VERB	O	O
utilizing	VERB	O	O
the	DET	O	O
Foot	NOUN	O	O
Posture	ADJ	O	O
Index.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

The	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
high	ADJ	O	O
dose,	NOUN	O	O
low	ADJ	O	O
dose,	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(each	PUNCT	O	O
group:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
21).	ADJ	O	O

SETTING:	NOUN	O	O
University	NOUN	O	O
hospital	NOUN	O	O
between	ADP	O	O
2010	NUM	O	O
and	CCONJ	O	O
2014.	NUM	O	O

But	CCONJ	O	O
in	ADP	O	O
practice,	NOUN	O	O
we	PRON	O	O
found	VERB	O	O
a	DET	O	O
lot	NOUN	O	O
of	ADP	O	O
problems	NOUN	O	O
in	ADP	O	O
using	VERB	O	O
the	DET	O	O
ointment.	NOUN	O	O

DISCUSSION:	NOUN	O	O
This	DET	O	O
project	NOUN	O	O
will	VERB	O	O
contribute	NOUN	O	O
much	DET	O	O
needed	VERB	O	O
evidence	NOUN	O	O
on	ADP	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
an	DET	O	O
electronic	ADJ	O	O
wellbeing	VERB	O	O
intervention	NOUN	O	O
for	ADP	O	O
Indigenous	ADJ	O	O
people	NOUN	O	O
with	ADP	O	O
ESKD	NOUN	O	O
-	PUNCT	O	O
a	DET	O	O
group	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
distress	NOUN	O	O
is	VERB	O	O
likely	ADV	O	O
to	PART	O	O
be	VERB	O	O
unacceptably	ADV	O	O
high,	ADP	O	O
yet	ADV	O	O
relatively	ADV	O	O
untreated.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101604552	NUM	O	O

2018;17(12):1290-1296.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Title:	NOUN	O	O
Impact	NOUN	O	O
of	ADP	O	O
pharmacotherapeutic	ADJ	O	O
education	NOUN	O	O
on	ADP	O	O
medication	NOUN	O	O
adherence	NOUN	O	B-outcome
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
outcomes	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
mellitus:	NOUN	O	O
a	DET	O	O
prospective,	NOUN	O	O
randomized	VERB	O	O
study.	NOUN	O	O

However,	ADV	O	O
the	DET	O	O
employees	NOUN	O	O
were	VERB	O	O
influenced	VERB	O	O
by	ADP	O	O
several	ADJ	O	O
factors,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
their	ADJ	O	O
own	ADJ	O	O
health	NOUN	O	O
and	CCONJ	O	O
weight	NOUN	O	O
loss,	NOUN	O	O
the	DET	O	O
pressure	NOUN	O	O
from	ADP	O	O
the	DET	O	O
environment	NOUN	O	O
and	CCONJ	O	O
their	ADJ	O	O
struggle	NOUN	O	O
for	ADP	O	O
recognition.	ADV	O	O

BACKGROUND:	NOUN	O	O
Pegbelfermin	NOUN	O	O
(BMS-986036),	PUNCT	O	O
a	DET	O	O
PEGylated	VERB	O	O
human	NOUN	O	O
fibroblast	NOUN	O	O
growth	NOUN	O	O
factor	NOUN	O	O
21	NUM	O	O
(FGF21)	PUNCT	O	O
analogue,	NOUN	O	O
has	VERB	O	O
previously	ADV	O	O
been	VERB	O	O
shown	VERB	O	O
to	PART	O	O
improve	VERB	O	O
markers	NOUN	O	O
of	ADP	O	O
metabolism	NOUN	O	O
and	CCONJ	O	O
liver	NOUN	O	O
fibrosis	NOUN	O	O
in	ADP	O	O
obese	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes.	NOUN	O	O

Registered	VERB	O	O
1	NUM	O	O
May	NOUN	O	O
2017	NUM	O	O
-	PUNCT	O	O
Retrospectively	ADV	O	O
registered,	VERB	O	O
http://www.clinicaltrial.gov	NOUN	O	O
/	SYM	O	O
NCT03134690.	NOUN	O	O

Patients	NOUN	O	O
with	ADP	O	O
laryngopharyngeal	ADJ	O	O
reflux	NOUN	O	O
(LPR)	ADV	O	O
were	VERB	O	O
reported	VERB	O	O
to	PART	O	O
suffer	NOUN	O	O
from	ADP	O	O
hypogeusia	NOUN	O	O
that	ADP	O	O
affects	NOUN	O	O
quality	NOUN	O	O
of	ADP	O	O
life.	NOUN	O	O

Journal-Name:Kathmandu	NOUN	O	O
University	NOUN	O	O
medical	ADJ	O	O
journal	ADJ	O	O
(KUMJ)	NOUN	O	O

Among	ADP	O	O
participants	NOUN	O	O
with	ADP	O	O
1-year	NOUN	O	O
abstinence,	NOUN	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
e-cigarette	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
more	ADV	O	O
likely	ADV	O	O
than	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
nicotine-replacement	ADJ	O	O
group	NOUN	O	O
to	PART	O	O
use	NOUN	O	B-outcome
their	ADJ	O	Seperator
assigned	VERB	O	I-outcome
product	NOUN	O	I-outcome
at	ADP	O	O
52	NUM	O	O
weeks	NOUN	O	O
(80%	PUNCT	O	O
[63	NOUN	O	O
of	ADP	O	O
79	NUM	O	O
participants	NOUN	O	O
vs.	CCONJ	O	O
9%	NOUN	O	O
[4	PUNCT	O	O
of	ADP	O	O
44	NUM	O	O
participants]).	ADJ	O	O

Title:	NOUN	O	O
Is	VERB	O	O
the	DET	O	O
transdermal	ADJ	O	O
fentanyl	NOUN	O	O
patch	NOUN	O	O
an	DET	O	O
efficient	ADJ	O	O
way	NOUN	O	O
to	PART	O	O
achieve	NOUN	O	O
acute	ADJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
control	NOUN	O	I-outcome
?:	ADJ	O	O

INTERVENTION:	NOUN	O	O
KT	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
KT	NOUN	O	O
application	NOUN	O	O
to	PART	O	O
the	DET	O	O
quadriceps	NOUN	O	O
and	CCONJ	O	O
gastrocnemius	NOUN	O	O
muscles	NOUN	O	O
whereas	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
no	DET	O	O
intervention.	NOUN	O	O

Clinical	ADJ	O	O
data	NOUN	O	O
and	CCONJ	O	O
biological	ADJ	O	O
parameters	NOUN	O	O
were	VERB	O	O
detected	VERB	O	O
and	CCONJ	O	O
recorded.	NOUN	O	O

The	DET	O	O
resulting	VERB	O	O
data	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
calculate	NOUN	O	O
the	DET	O	O
metabolizable	ADJ	O	O
energy	NOUN	O	O
of	ADP	O	O
cashews	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
digestibility	NOUN	O	O
of	ADP	O	O
macronutrients.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
iso-caloric	ADJ	O	O
CRHP/CD	NOUN	O	O
diets	NOUN	O	O
contained	VERB	O	O
31/54	NOUN	O	O
E%	NOUN	O	O
from	ADP	O	O
carbohydrate,	ADP	O	O
29/16	NOUN	O	O
E%	NOUN	O	O
energy	NOUN	O	O
from	ADP	O	O
protein	NOUN	O	O
and	CCONJ	O	O
40/30	NOUN	O	O
E%	NOUN	O	O
from	ADP	O	O
fat,	ADP	O	O
respectively.	NOUN	O	O

Either	CCONJ	O	O
low-dose	NOUN	O	O
or	CCONJ	O	O
standard-dose	NOUN	O	O
MDCT	NOUN	O	O
protocol	NOUN	O	O
was	VERB	O	O
performed,	NOUN	O	O
the	DET	O	O
experience	NOUN	O	O
of	ADP	O	O
otolaryngologist	NOUN	O	O
had	VERB	O	O
decreased	VERB	O	O
complication	NOUN	O	B-outcome
after	ADP	O	O
surgeries.	NUM	O	O

Journal-Name:The	ADJ	O	O
heart	NOUN	O	O
surgery	NOUN	O	O
forum	NOUN	O	O

At	ADP	O	O
3	NUM	O	O
years,	NOUN	O	O
the	DET	O	O
mean	NOUN	O	O
marginal	ADJ	O	B-outcome
bone	NOUN	O	I-outcome
level	NOUN	O	O
(MBL)	NOUN	O	O
change	NOUN	O	O
at	ADP	O	O
CI,	NOUN	O	O
FI,	NOUN	O	O
and	CCONJ	O	O
PS	NOUN	O	O
implants	NOUN	O	O
was	VERB	O	O
-0.12,	NOUN	O	O
-1.02,	NOUN	O	O
and	CCONJ	O	O
-1.04	NUM	O	O
mm,	NOUN	O	O
respectively	ADV	O	O
(P	NUM	O	O
=	SYM	O	O
.014).	PUNCT	O	O
"	PUNCT	O	O

APN	NOUN	O	O
and	CCONJ	O	O
AdipoR1	VERB	O	O
levels	NOUN	O	O
may	VERB	O	O
influence	NOUN	O	O
glucose	NOUN	O	O
and	CCONJ	O	O
lipid	NOUN	O	O
metabolism	NOUN	O	O
in	ADP	O	O
T2DM	NOUN	O	O
patients.	NOUN	O	O

2)	NOUN	O	O
Methods:	NOUN	O	O
a	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
parallel	ADJ	O	O
pilot	NOUN	O	O
study	NOUN	O	O
of	ADP	O	O
4.5	NUM	O	O
g	NOUN	O	O
administration	NOUN	O	O
of	ADP	O	O
Spirulina	NOUN	O	O
maxima	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
for	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
in	ADP	O	O
16	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
systemic	ADJ	O	O
arterial	ADJ	O	O
hypertension	NOUN	O	O
(SAH)	PUNCT	O	O
undergoing	VERB	O	O
treatment	NOUN	O	O
with	ADP	O	O
angiotensin-converting	VERB	O	O
enzyme	NOUN	O	O
(ACE)	NOUN	O	O
inhibitors	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
on	ADP	O	O
endothelial	ADJ	O	B-outcome
damage	NOUN	O	I-outcome
and	CCONJ	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
indicators.	NOUN	O	O

Taking	VERB	O	O
effective	ADJ	O	O
preventive	ADJ	O	O
measures	NOUN	O	O
is	VERB	O	O
particularly	ADV	O	O
important	ADJ	O	O
for	ADP	O	O
control	NOUN	O	O
of	ADP	O	O
HFMD	NOUN	O	O
infection.	NOUN	O	O

Vitamin	NOUN	O	O
D	NOUN	O	O
and	CCONJ	O	O
probiotic	ADJ	O	O
co-supplementation	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
testosterone	NOUN	O	B-outcome
(beta	NUM	O	O
-	PUNCT	O	O
0.19	NUM	O	O
ng/mL;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
0.28,	NUM	O	O
-	PUNCT	O	O
0.10;	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.001),	NUM	O	O
hirsutism	NOUN	O	B-outcome
(beta	NUM	O	O
-	PUNCT	O	O
0.95;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
1.39,	NUM	O	O
-	PUNCT	O	O
0.51;	ADP	O	O
P	NOUN	O	O
<	SYM	O	O
0.001),	NUM	O	O
high-sensitivity	NOUN	O	B-outcome
C-reactive	ADJ	O	I-outcome
protein	NOUN	O	I-outcome
(hs-CRP)	NOUN	O	I-outcome
(beta	NUM	O	O
-	PUNCT	O	O
0.67	NUM	O	O
mg/L;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
0.97,	NUM	O	O
-	PUNCT	O	O
0.38;	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.001)	NUM	O	O
and	CCONJ	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
levels	NOUN	O	O
(beta	NUM	O	O
-	PUNCT	O	O
0.25	NUM	O	O
mumol/L;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
0.40,	NUM	O	O
-	PUNCT	O	O
0.10;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.001),	NUM	O	O
and	CCONJ	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
antioxidant	NOUN	O	B-outcome
capacity	NOUN	O	O
(TAC)	ADP	O	O
(beta	NUM	O	O
82.81	NUM	O	O
mmol/L;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
42.86,	ADP	O	O
122.75;	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.001)	NUM	O	O
and	CCONJ	O	O
total	ADJ	O	O
glutathione	NOUN	O	B-outcome
(GSH)	PUNCT	O	I-outcome
levels	NOUN	O	O
(beta	NUM	O	O
40.42	NUM	O	O
mumol/L;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
4.69,	ADJ	O	O
76.19;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.02),	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
placebo.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
deaths	NOUN	O	B-outcome
,	PUNCT	O	O
discontinuations	NOUN	O	B-outcome
due	ADJ	O	I-outcome
to	PART	O	I-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
treatment-related	VERB	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
INTERPRETATION:	CCONJ	O	O
Treatment	NOUN	O	O
with	ADP	O	O
subcutaneously	ADV	O	O
administered	VERB	O	O
pegbelfermin	NOUN	O	O
for	ADP	O	O
16	NUM	O	O
weeks	NOUN	O	O
was	VERB	O	O
generally	ADV	O	O
well	ADV	O	O
tolerated	VERB	O	O
and	CCONJ	O	O
significantly	ADV	O	O
reduced	VERB	O	O
hepatic	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
non-alcoholic	ADJ	O	O
steatohepatitis.	NOUN	O	O

In	ADP	O	O
a	DET	O	O
prespecified	VERB	O	O
supportive	ADJ	O	O
analysis	NOUN	O	O
involving	VERB	O	O
the	DET	O	O
same	ADJ	O	O
population,	NOUN	O	O
the	DET	O	O
same	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
assessed	VERB	O	O
during	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
period	NOUN	O	O
(first	PUNCT	O	O
receipt	NOUN	O	O
of	ADP	O	O
trial	NOUN	O	O
agent	NOUN	O	O
to	PART	O	O
last	NOUN	O	O
dose	NOUN	O	O
plus	CCONJ	O	O
2	NUM	O	O
days).	NOUN	O	O

Results:	NOUN	O	O
:	PUNCT	O	O
Among	ADP	O	O
207	NUM	O	O
cases	NOUN	O	O
followed	VERB	O	O
till	ADV	O	O
delivery,	NOUN	O	O
the	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
parasitaemia	NOUN	O	B-outcome
was	VERB	O	O
lower	ADJ	O	O
in	ADP	O	O
three-dose	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
two-dose	NOUN	O	O
group	NOUN	O	O
for	ADP	O	O
both	CCONJ	O	O
peripheral	ADJ	O	B-outcome
(9.3%	NOUN	O	X
versus	CCONJ	O	X
27.8%)	NOUN	O	X
and	CCONJ	O	Seperator
placental	ADJ	O	B-outcome
(10.6%	NOUN	O	X
versus	CCONJ	O	X
25.6%)	NOUN	O	X
parasitaemia	NOUN	O	E1-outcome
.	PUNCT	O	O
The	DET	O	O
adjusted	VERB	O	O
odds	NOUN	O	O
ratios	NOUN	O	O
(aOR)	NOUN	O	O
were	VERB	O	O
0.15	NUM	O	O
[95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
(CI),	ADJ	O	O
0.05	NUM	O	O
-	PUNCT	O	O
0.45	NUM	O	O
and	CCONJ	O	O
0.17	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
0.06-0.51),	NOUN	O	O
respectively.	NOUN	O	O

Fourteen	NUM	O	O
performed	VERB	O	O
a	DET	O	O
16-week	NOUN	O	O
resistance	NOUN	O	O
training	VERB	O	O
(RT)	NOUN	O	O
intervention,	ADP	O	O
9	NUM	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
a	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
waitlist	ADJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
a	DET	O	O
New	ADJ	O	O
Crosslinked	VERB	O	O
Hyaluronan	NOUN	O	O
Gel	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Prevention	NOUN	O	O
of	ADP	O	O
Intrauterine	NOUN	O	B-outcome
Adhesions	NOUN	O	I-outcome
.	PUNCT	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
green	ADV	O	O
tea	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
standard	ADJ	O	O
antimicrobial	ADJ	O	O
treatment	NOUN	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
uncomplicated	VERB	O	O
cystitis.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/27	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/17	ADP	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
Two	NUM	O	O
co-primary	ADJ	O	O
outcomes:	NOUN	O	O
24-hour	NOUN	O	O
morphine	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
using	VERB	O	O
patient-controlled	VERB	O	O
analgesia	NOUN	O	O
in	ADP	O	O
pairwise	NOUN	O	O
comparisons	NOUN	O	O
between	ADP	O	O
the	DET	O	O
4	NUM	O	O
groups	NOUN	O	O
(multiplicity-adjusted	PUNCT	O	O
thresholds	NOUN	O	O
for	ADP	O	O
statistical	ADJ	O	O
significance,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.0042;	NUM	O	O
minimal	ADJ	O	O
clinically	ADV	O	O
important	ADJ	O	O
difference,	NOUN	O	O
10	NUM	O	O
mg),	NOUN	O	O
and	CCONJ	O	O
proportion	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
1	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(SAEs)	NOUN	O	I-outcome
within	ADP	O	O
90	NUM	O	O
days	NOUN	O	O
(multiplicity-adjusted	PUNCT	O	O
thresholds	NOUN	O	O
for	ADP	O	O
statistical	ADJ	O	O
significance,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.025).	PUNCT	O	O

The	DET	O	O
"shell"	NOUN	O	B-outcome
phenomenon	NOUN	O	I-outcome
and	CCONJ	O	O
surgery	NOUN	O	O
complications	NOUN	O	B-outcome
were	VERB	O	O
observed	VERB	O	O
at	ADP	O	O
the	DET	O	O
same	ADJ	O	O
time.	NOUN	O	O

One	NUM	O	O
group	NOUN	O	O
underwent	VERB	O	O
thoracic	ADJ	O	O
drainage	NOUN	O	O
by	ADP	O	O
the	DET	O	O
same	ADJ	O	O
intercostal	ADJ	O	O
space	NOUN	O	O
of	ADP	O	O
thoracotomy	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
other	ADJ	O	O
by	ADP	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
approach.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
explore	ADP	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
propofol	NOUN	O	O
sedation	NOUN	O	O
on	ADP	O	O
psychological	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
surgery	NOUN	O	O
under	ADP	O	O
epidural	ADJ	O	O
anesthesia.	NOUN	O	O

Patients	NOUN	O	O
from	ADP	O	O
the	DET	O	O
1st	ADJ	O	O
group	NOUN	O	O
were	VERB	O	O
to	PART	O	O
take	NOUN	O	O
nicorandil	NOUN	O	O
2	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
day	NOUN	O	O
before	ADP	O	O
the	DET	O	O
PCI	NOUN	O	O
at	ADP	O	O
the	DET	O	O
30	NUM	O	O
mg/day	NOUN	O	O
dose,	NOUN	O	O
then	ADV	O	O
20	NUM	O	O
mg	NOUN	O	O
orally	ADV	O	O
2	NUM	O	O
hours	NOUN	O	O
just	ADV	O	O
before	ADP	O	O
PCI,	NOUN	O	O
and	CCONJ	O	O
one	NUM	O	O
more	ADV	O	O
time	NOUN	O	O
6	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
the	DET	O	O
PCI	NOUN	O	O
-	PUNCT	O	O
10	NUM	O	O
mg	NOUN	O	O
nicorandil.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
preoperative	ADJ	O	O
MDCT	NOUN	O	O
images	NOUN	O	O
for	ADP	O	O
standard-dose	NOUN	O	O
protocol	NOUN	O	O
had	VERB	O	O
better	ADJ	O	O
quality	NOUN	O	B-outcome
than	ADP	O	O
low-dose	NOUN	O	O
protocol	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.001,	PUNCT	O	O
q	NOUN	O	O
=	SYM	O	O
4.57).	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
Paratek	NOUN	O	O
Pharmaceuticals;	NOUN	O	O
OASIS-1	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02378480	NOUN	O	O
.).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/26	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/20	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Household	NOUN	O	B-outcome
food	NOUN	O	I-outcome
purchasing	VERB	O	I-outcome
behaviour	NOUN	O	I-outcome
,	PUNCT	O	O
three	NUM	O	O
24-h	NOUN	O	O
food	NOUN	O	B-outcome
recalls,	NOUN	O	O
Tucker's	NOUN	O	O
semi-quantitative	ADJ	O	O
food	NOUN	O	B-outcome
frequency	NOUN	O	I-outcome
questionnaire	NOUN	O	O
(FFQ)],	NOUN	O	O
and	CCONJ	O	O
weight	NOUN	O	B-outcome
were	VERB	O	O
assessed	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
8	NUM	O	O
weeks.	NOUN	O	O

No	DET	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
evolution	NOUN	O	O
of	ADP	O	O
the	DET	O	O
other	ADJ	O	O
scores	NOUN	O	O
assessed	VERB	O	O
were	VERB	O	O
observed	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

RESULTS:	NOUN	O	O
Totally,	NOUN	O	O
135	NUM	O	O
infants	NOUN	O	O
in	ADP	O	O
three	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
studied	VERB	O	O
and	CCONJ	O	O
the	DET	O	O
results	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
minimum	NOUN	O	O
and	CCONJ	O	O
maximum	NOUN	O	O
gastric	ADJ	O	B-outcome
residual	ADJ	O	I-outcome
volumes	NOUN	O	I-outcome
were	VERB	O	O
in	ADP	O	O
prone	NOUN	O	O
(6.49	NOUN	O	O
+/-	SYM	O	O
8.25	NUM	O	O
ML)	NOUN	O	O
and	CCONJ	O	O
supine	NOUN	O	O
(12.59	NUM	O	O
+/-	SYM	O	O
11.9	NUM	O	O
ML)	NOUN	O	O
positions,	NOUN	O	O
respectively.	NOUN	O	O

TRIAL	NOUN	O	O
FUNDING:	NOUN	O	O
Medical	ADJ	O	O
Research	NOUN	O	O
Council/	NOUN	O	O
Wellcome	ADP	O	O
Trust/	NOUN	O	O
DfID	NOUN	O	O
(Global	NUM	O	O
Health	NOUN	O	O
Trials	NOUN	O	O
Scheme).	NOUN	O	O

METHODS/DESIGN:	NOUN	O	O
Eligible	ADJ	O	O
and	CCONJ	O	O
consenting	VERB	O	O
women	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
two	NUM	O	O
treatments	NOUN	O	O
(one	NOUN	O	O
cycle	NOUN	O	O
of	ADP	O	O
a	DET	O	O
GnRH	NOUN	O	O
agonist	NOUN	O	O
or	CCONJ	O	O
two	NUM	O	O
cycles	NOUN	O	O
of	ADP	O	O
a	DET	O	O
GnRH	NOUN	O	O
agonist)	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
IVF/ICSI	NOUN	O	O
using	VERB	O	O
a	DET	O	O
table	ADJ	O	O
of	ADP	O	O
random	NOUN	O	O
numbers.	NOUN	O	O

This	DET	O	O
interaction	NOUN	O	O
is	VERB	O	O
capable	ADJ	O	O
of	ADP	O	O
creating	VERB	O	O
toxic	ADJ	O	O
species	NOUN	O	O
that	ADP	O	O
generate	NOUN	O	O
cell	NOUN	O	O
death.	ADP	O	O

Helicobacter	NOUN	O	O
pylori	NOUN	O	O
(Hp)	NUM	O	O
drug	NOUN	O	O
resistant	ADJ	O	O
rate	NOUN	O	O
to	PART	O	O
clarithromycin	NOUN	O	O
(CLA)	PUNCT	O	O
has	VERB	O	O
increased	VERB	O	O
to	PART	O	O
20%	NUM	O	O
to	PART	O	O
50%,	NOUN	O	O
which	ADP	O	O
cause	ADP	O	O
concerns	NOUN	O	O
regarding	VERB	O	O
its	ADJ	O	O
effectiveness	NOUN	O	O
in	ADP	O	O
eradicating	VERB	O	O
Hp,	NOUN	O	O
we	PRON	O	O
aim	ADP	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
cost-effectiveness	NOUN	O	O
of	ADP	O	O
CLA-based	VERB	O	O
versus	CCONJ	O	O
furazolidone	NOUN	O	O
(FZD)-based	VERB	O	O
quadruple	ADJ	O	O
therapy,	NOUN	O	O
and	CCONJ	O	O
assess	NOUN	O	O
factors	NOUN	O	O
that	ADP	O	O
affect	NOUN	O	O
anti-Hp	ADP	O	O
efficacy.	NOUN	O	O

It	PRON	O	O
is	VERB	O	O
recommended	VERB	O	O
its	ADJ	O	O
teaching	VERB	O	O
to	PART	O	O
mothers	NOUN	O	O
and	CCONJ	O	O
its	ADJ	O	O
application	NOUN	O	O
in	ADP	O	O
the	DET	O	O
home	NOUN	O	O
environment.	NOUN	O	O

METHODOLOGY:	NOUN	O	O
In	ADP	O	O
total,	ADJ	O	O
237	NUM	O	O
samples	NOUN	O	O
were	VERB	O	O
analysed	VERB	O	O
from	ADP	O	O
28	NUM	O	O
DFUs,	NOUN	O	O
collected	VERB	O	O
at	ADP	O	O
fortnightly	ADV	O	O
intervals	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
or	CCONJ	O	O
until	ADP	O	O
healing.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
findings	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
routine	ADJ	O	O
ultrasonography	NOUN	O	O
in	ADP	O	O
the	DET	O	O
third	ADJ	O	O
trimester	NOUN	O	O
for	ADP	O	O
low	ADJ	O	O
risk	NOUN	O	O
pregnancies.	NOUN	O	O

Vitamin	NOUN	O	O
D	NOUN	O	O
is	VERB	O	O
involved	VERB	O	O
in	ADP	O	O
bone	NOUN	O	O
metabolism	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
many	DET	O	O
various	ADJ	O	O
extra-skeletal	ADJ	O	O
diseases	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
malabsorption	NOUN	O	O
syndromes,	NOUN	O	O
cardiovascular	ADJ	O	O
and	CCONJ	O	O
metabolic	ADJ	O	O
diseases,	NOUN	O	O
cancer,	NOUN	O	O
and	CCONJ	O	O
autoimmune	ADJ	O	O
and	CCONJ	O	O
neurological	ADJ	O	O
diseases.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968547	NUM	O	O

No	DET	O	O
significant	ADJ	O	O
effects	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
for	ADP	O	O
sprint	NOUN	O	B-outcome
variables	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
0.05)	NUM	O	O
with	ADP	O	O
comparable	ADJ	O	O
values	NOUN	O	O
at	ADP	O	O
T3	NOUN	O	O
for	ADP	O	O
mean	NOUN	O	O
distance	NOUN	O	B-outcome
(betaA1:	NOUN	O	O
163.9	NUM	O	O
+/-	SYM	O	O
3.8	NUM	O	O
m;	NOUN	O	O
betaA2:	NOUN	O	O
161.2	NUM	O	O
+/-	SYM	O	O
3.5	NUM	O	O
m;	NOUN	O	O
PL:	NOUN	O	O
162.7	NUM	O	O
+/-	SYM	O	O
3.6	NUM	O	O
m),	NOUN	O	O
average	NOUN	O	O
power	NOUN	O	B-outcome
(betaA1:	NOUN	O	O
352.7	NUM	O	O
+/-	SYM	O	O
14.5	NUM	O	O
W;	ADP	O	O
betaA2:	NOUN	O	O
342.2	NUM	O	O
+/-	SYM	O	O
13.5	NUM	O	O
W;	ADP	O	O
PL:	NOUN	O	O
348.2	NUM	O	O
+/-	SYM	O	O
13.9	NUM	O	O
W)	NOUN	O	O
and	CCONJ	O	O
lactate	VERB	O	B-outcome
(betaA1:	NOUN	O	O
10.0	NUM	O	O
+/-	SYM	O	O
0.9	NUM	O	O
mmol.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
ophthalmology	NOUN	O	O

A	DET	O	O
randomized,	NOUN	O	O
placebo-controlled,	NOUN	O	O
cross-over	NOUN	O	O
trial	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
Trimethylamine	NOUN	O	B-outcome
N-oxide	NOUN	O	I-outcome
(TMAO)	NOUN	O	I-outcome
-reducing	VERB	O	O
effect	NOUN	O	O
of	ADP	O	O
Taurisolo((R)).	NOUN	O	O

The	DET	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
preoperative	ADJ	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
changes	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
statistically	ADV	O	O
significant,	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
techniques	NOUN	O	O
at	ADP	O	O
any	DET	O	O
given	VERB	O	O
time	NOUN	O	O
studied.	NOUN	O	O

All	DET	O	O
canals	NOUN	O	O
were	VERB	O	O
cleaned	VERB	O	O
and	CCONJ	O	O
shaped	VERB	O	O
with	ADP	O	O
Reciproc	NOUN	O	O
instruments,	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
used	VERB	O	O
with	ADP	O	O
a	DET	O	O
micro	ADJ	O	O
motor	NOUN	O	O
(VDW,	PUNCT	O	O
Munich	ADJ	O	O
Germany).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
CAP	NOUN	O	O
hospitalized	VERB	O	O
to	PART	O	O
non-ICU	NOUN	O	O
wards,	NOUN	O	O
erythromycin	NOUN	O	O
use	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
68%	NUM	O	O
increased	VERB	O	O
risk	NOUN	O	O
of	ADP	O	O
hospital-acquired	VERB	O	O
cardiac	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
mainly	ADV	O	O
heart	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
.	PUNCT	O	O
Levofloxacin	NOUN	O	B-outcome
and	CCONJ	O	O
moxifloxacin	NOUN	O	B-outcome
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
heart	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
.	PUNCT	O	O
Although	ADP	O	O
our	ADJ	O	O
study	NOUN	O	O
does	VERB	O	O
not	ADV	O	O
fully	ADV	O	O
exclude	NOUN	O	O
confounding	VERB	O	O
bias,	NOUN	O	O
findings	NOUN	O	O
remained	VERB	O	O
largely	ADV	O	O
unchanged	VERB	O	O
in	ADP	O	O
crude,	NOUN	O	O
adjusted,	NOUN	O	O
and	CCONJ	O	O
sensitivity	NOUN	O	O
analyses.	NOUN	O	O

Journal-Name:	NOUN	O	O
BMJ	NOUN	O	O
(Clinical	ADJ	O	O
research	NOUN	O	O
ed.)	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/06	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Nurse-Led	NOUN	O	O
Preventive	ADJ	O	O
Psychological	ADJ	O	O
Intervention	NOUN	O	O
on	ADP	O	O
Symptoms	NOUN	O	O
of	ADP	O	O
Posttraumatic	ADJ	O	B-outcome
Stress	NOUN	O	I-outcome
Disorder	NOUN	O	O
Among	ADP	O	O
Critically	ADV	O	O
Ill	NOUN	O	O
Patients:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

Objective:The	NOUN	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
rhodiola	NOUN	O	O
rosea	NOUN	O	O
on	ADP	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
,	PUNCT	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
depression	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
OSA.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
sclerotherapy	NOUN	O	O
versus	CCONJ	O	O
cyanoacrylate	VERB	O	O
injection	NOUN	O	O
for	ADP	O	O
management	NOUN	O	O
of	ADP	O	O
actively	ADV	O	O
bleeding	VERB	O	O
esophageal	ADJ	O	O
varices	NOUN	O	O
in	ADP	O	O
cirrhotic	ADJ	O	O
patients.	NOUN	O	O

The	DET	O	O
efficacy	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
Pittsburgh	NOUN	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
index	NOUN	O	O
(PSQI)],	NOUN	O	O
Beck	NOUN	O	O
depression	NOUN	O	B-outcome
index	NOUN	O	O
(BDI)	NOUN	O	O
,	PUNCT	O	O
Beck	NOUN	O	O
anxiety	NOUN	O	B-outcome
inventory	ADJ	O	O
(BAI)	NOUN	O	O
and	CCONJ	O	O
sleep	NOUN	O	B-outcome
diary	ADP	O	O
variables	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
middle	ADJ	O	O
and	CCONJ	O	O
end	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
how	ADP	O	O
body	NOUN	O	O
posture	ADJ	O	O
is	VERB	O	O
shaped	VERB	O	O
in	ADP	O	O
children	NOUN	O	O
diagnosed	VERB	O	O
with	ADP	O	O
asthma	NOUN	O	O
symptoms	NOUN	O	O
and	CCONJ	O	O
whether	ADP	O	O
body	NOUN	O	O
posture	ADJ	O	O
is	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
PA.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
and	CCONJ	O	O
compare	NOUN	O	O
the	DET	O	O
short-term	NOUN	O	O
effects	NOUN	O	O
of	ADP	O	O
rigid	NOUN	O	O
and	CCONJ	O	O
Kinesio	NOUN	O	O
taping	VERB	O	O
on	ADP	O	O
scapular	ADJ	O	B-outcome
dyskinesis	NOUN	O	I-outcome
,	PUNCT	O	O
scapular	ADJ	O	B-outcome
upward	ADJ	O	I-outcome
rotation	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
pectoralis	NOUN	O	B-outcome
minor	ADJ	O	I-outcome
length	NOUN	O	I-outcome
in	ADP	O	O
asymptomatic	ADJ	O	O
overhead	ADP	O	O
athletes.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

A	DET	O	O
dietary	ADJ	O	O
calcium	NOUN	O	O
intake	NOUN	O	O
of	ADP	O	O
1	NUM	O	O
g	NOUN	O	O
per	ADP	O	O
day	NOUN	O	O
was	VERB	O	O
advised,	NOUN	O	O
but	CCONJ	O	O
calcium	NOUN	O	O
supplements	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
provided.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Mean	NOUN	O	O
lung	NOUN	O	B-outcome
function	NOUN	O	I-outcome
starts	NOUN	O	O
to	PART	O	O
decline	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
the	DET	O	O
first	ADV	O	O
reported	VERB	O	O
symptoms	NOUN	O	O
of	ADP	O	O
an	DET	O	O
exacerbation,	NOUN	O	O
and	CCONJ	O	O
does	VERB	O	O
not	ADV	O	O
recover	NOUN	O	O
to	PART	O	O
pre-exacerbation	NOUN	O	O
levels	NOUN	O	O
8	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
the	DET	O	O
event.	NOUN	O	O

CONCLUSION:	NOUN	O	O
In	ADP	O	O
Indian	NOUN	O	O
patients,	NOUN	O	O
30	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
loading	VERB	O	O
is	VERB	O	O
as	ADP	O	O
effective	ADJ	O	O
as	ADP	O	O
60	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
with	ADP	O	O
significantly	ADV	O	O
less	ADV	O	O
minor	ADJ	O	B-outcome
bleeding	VERB	O	I-outcome
.	PUNCT	O	O

Vanderbilt	NOUN	O	O
University	NOUN	O	O
Medical	ADJ	O	O
Center,	NOUN	O	O
Nashville,	NOUN	O	O
TN.	NOUN	O	O

Low	ADJ	O	O
DHA	NOUN	O	O
intakes	NOUN	O	O
might	VERB	O	O
explain	NOUN	O	O
subtle	ADJ	O	O
neurological	ADJ	O	B-outcome
deficits	NOUN	O	I-outcome
in	ADP	O	O
PKU.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101654770	NUM	O	O

Journal-Name:BMC	NOUN	O	O
neurology	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Resuscitation	NOUN	O	O
Strategy	NOUN	O	O
Targeting	VERB	O	O
Peripheral	ADJ	O	O
Perfusion	NOUN	O	O
Status	NOUN	O	O
vs	CCONJ	O	O
Serum	NOUN	O	O
Lactate	NOUN	O	O
Levels	NOUN	O	O
on	ADP	O	O
28-Day	ADP	O	O
Mortality	NOUN	O	B-outcome
Among	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Septic	ADJ	O	O
Shock:	NOUN	O	O
The	DET	O	O
ANDROMEDA-SHOCK	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

The	DET	O	O
elbow	NOUN	O	O
sleeve	NOUN	O	O
yielded	VERB	O	O
better	ADJ	O	O
scores	NOUN	O	O
than	ADP	O	O
no	DET	O	O
orthosis	NOUN	O	O
for	ADP	O	O
the	DET	O	O
following	VERB	O	O
outcomes:	NOUN	O	O
joint	NOUN	O	B-outcome
position	NOUN	O	I-outcome
reproduction	NOUN	O	I-outcome
score	NOUN	O	O
at	ADP	O	O
110	NUM	O	O
degrees	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.001),	PUNCT	O	O
pain	NOUN	O	B-outcome
(P	NUM	O	O
<	SYM	O	O
.001),	PUNCT	O	O
and	CCONJ	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.012).	PUNCT	O	O

For	ADP	O	O
the	DET	O	O
safety	NOUN	O	O
evaluation,	NOUN	O	O
laboratory	NOUN	O	O
examinations	NOUN	O	O
including	VERB	O	O
complete	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
count	NOUN	O	I-outcome
,	PUNCT	O	O
liver	NOUN	O	B-outcome
function	NOUN	O	I-outcome
test,	NUM	O	O
renal	ADJ	O	B-outcome
function	NOUN	O	I-outcome
test,	NUM	O	O
blood	NOUN	O	B-outcome
coagulation	NOUN	O	I-outcome
test,	NUM	O	O
inflammation	NOUN	O	B-outcome
test,	NUM	O	O
and	CCONJ	O	O
urine	NOUN	O	B-outcome
analysis	NOUN	O	I-outcome
will	VERB	O	O
be	VERB	O	O
conducted	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
taking	VERB	O	O
the	DET	O	O
medications.	NOUN	O	O

At	ADP	O	O
the	DET	O	O
test-of-cure	NOUN	O	O
visit,	NOUN	O	O
composite	NOUN	O	O
cure	NOUN	O	B-outcome
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
81.7%	NUM	O	O
(156	NUM	O	O
of	ADP	O	O
191	NUM	O	O
patients)	NOUN	O	O
and	CCONJ	O	O
70.1%	NUM	O	O
(138	NOUN	O	O
of	ADP	O	O
197	NUM	O	O
patients),	NOUN	O	O
respectively	ADV	O	O
(difference,	ADV	O	O
11.6	NUM	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
2.7	NUM	O	O
to	PART	O	O
20.3).	PUNCT	O	O

Clinicians	NOUN	O	O
may	VERB	O	O
find	ADP	O	O
these	DET	O	O
helpful	ADJ	O	O
when	ADP	O	O
considering	VERB	O	O
the	DET	O	O
likelihood	NOUN	O	O
of	ADP	O	O
achieving	VERB	O	O
early	ADJ	O	O
clinically	ADV	O	O
significant	ADJ	O	O
visual	ADJ	O	B-outcome
acuity	NOUN	O	I-outcome
(VA)	NOUN	O	I-outcome
improvements	NOUN	O	O
with	ADP	O	O
ranibizumab	ADJ	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
RVO.	NOUN	O	O

Serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
reactions	NOUN	O	I-outcome
such	ADJ	O	O
as	ADP	O	O
acute	ADJ	O	B-outcome
appendicitis	NOUN	O	I-outcome
and	CCONJ	O	O
acute	ADJ	O	B-outcome
viral	ADJ	O	I-outcome
gastroenteritis	NOUN	O	I-outcome
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
BT-11	NOUN	O	O
group4	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
placebo	NOUN	O	O
group,	NOUN	O	O
respectively.	NOUN	O	O

The	DET	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
length	NOUN	O	B-outcome
of	ADP	O	I-outcome
stay	NOUN	O	I-outcome
,	PUNCT	O	O
length	NOUN	O	B-outcome
of	ADP	O	I-outcome
incision	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
perioperative	ADJ	O	O
complications	NOUN	O	B-outcome
related	VERB	O	O
to	PART	O	O
operation	NOUN	O	O
were	VERB	O	O
recorded.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
a	DET	O	O
crossover	NOUN	O	O
design	NOUN	O	O
with	ADP	O	O
a	DET	O	O
1	NUM	O	O
wk.	DET	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

It	PRON	O	O
may	VERB	O	O
be	VERB	O	O
a	DET	O	O
more	ADV	O	O
acceptable	ADJ	O	O
and	CCONJ	O	O
viable	ADJ	O	O
option	NOUN	O	O
for	ADP	O	O
the	DET	O	O
common	ADJ	O	O
man.	NOUN	O	O

Satisfactory	ADJ	O	O
compliance	NOUN	O	B-outcome
with	ADP	O	O
mask	NOUN	O	O
application	NOUN	O	O
was	VERB	O	O
40%	NUM	O	O
in	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
vs.	CCONJ	O	O
73.3%	NUM	O	O
in	ADP	O	O
DEX	NOUN	O	O
group	NOUN	O	O
(P<0.05).	NOUN	O	O

Title:	NOUN	O	O
Cluster	NOUN	O	O
randomized	VERB	O	O
evaluation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Nia	NOUN	O	O
Project:	NOUN	O	O
study	NOUN	O	O
protocol.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

white	ADP	O	B-outcome
spot	NOUN	O	I-outcome
lesions	NOUN	O	I-outcome
were	VERB	O	O
assessed	VERB	O	O
using	VERB	O	O
a	DET	O	O
laser	NOUN	O	O
fluorescence	NOUN	O	O
device	NOUN	O	O
(	NOUN	O	O
DIAGNOdent	ADJ	O	O
pen],	NOUN	O	O
Kavo,	NOUN	O	O
Germany)	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
characterized	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
immediately	ADV	O	O
following	VERB	O	O
resin	NOUN	O	O
infiltration	NOUN	O	O
application	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
a	DET	O	O
6-month	NOUN	O	O
follow-up.	PUNCT	O	O

Journal-Name:International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
gynaecology	NOUN	O	O
and	CCONJ	O	O
obstetrics:	NOUN	O	O
the	DET	O	O
official	ADJ	O	O
organ	NOUN	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Federation	NOUN	O	O
of	ADP	O	O
Gynaecology	NOUN	O	O
and	CCONJ	O	O
Obstetrics	NOUN	O	O

The	DET	O	O
tear	NUM	O	O
levels	NOUN	O	O
of	ADP	O	O
matrix	NOUN	O	B-outcome
metalloproteinase	NOUN	O	I-outcome
(MMP)-9	PUNCT	O	I-outcome
and	CCONJ	O	O
serotonin	NOUN	O	B-outcome
were	VERB	O	O
measured	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
at	ADP	O	O
1	NUM	O	O
month	NOUN	O	O
after	ADP	O	O
injection.	ADV	O	O

Last	ADV	O	O
and	CCONJ	O	O
baseline	NOUN	O	O
observation	NOUN	O	O
carried	VERB	O	O
forward	ADV	O	O
method	NOUN	O	O
(LOCF,	PUNCT	O	O
BOCF)	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
as	ADP	O	O
sensitivity	NOUN	O	O
analysis.	NOUN	O	O

CONCLUSION:	NOUN	O	O
CART	NOUN	O	O
showed	VERB	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
(HRV)	NUM	O	I-outcome
parameters	NOUN	O	O
indicating	VERB	O	O
vagal	ADJ	O	O
dominance	NOUN	O	O
in	ADP	O	O
middle-aged	NOUN	O	O
hypertensive	ADJ	O	O
women.	NOUN	O	O

We	PRON	O	O
observed	VERB	O	O
no	DET	O	O
differences	NOUN	O	O
among	ADP	O	O
groups	NOUN	O	O
for	ADP	O	O
the	DET	O	O
change	NOUN	O	O
in	ADP	O	O
the	DET	O	O
pectoralis	NOUN	O	B-outcome
minor	ADJ	O	I-outcome
index	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

The	DET	O	O
safety	NOUN	O	O
profile	NOUN	O	O
of	ADP	O	O
netupitant	ADJ	O	O
was	VERB	O	O
comparable	ADJ	O	O
in	ADP	O	O
the	DET	O	O
three	NUM	O	O
arms.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Relevant	ADJ	O	O
participants'	NOUN	O	O
data	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
collected	VERB	O	O
at	ADP	O	O
enrolment	ADJ	O	O
and	CCONJ	O	O
at	ADP	O	O
delivery.	VERB	O	O

BACKGROUND:	NOUN	O	O
Exacerbations	NOUN	O	O
of	ADP	O	O
chronic	ADJ	O	O
obstructive	ADJ	O	O
pulmonary	ADJ	O	O
disease	NOUN	O	O
(COPD)	NUM	O	O
are	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
loss	NOUN	O	O
of	ADP	O	O
lung	NOUN	O	O
function	NOUN	O	O
and	CCONJ	O	O
poor	ADJ	O	O
outcomes	NOUN	O	O
for	ADP	O	O
patients.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
[Effects	NOUN	O	O
of	ADP	O	O
aerosol	NOUN	O	O
inhalation	NOUN	O	O
on	ADP	O	O
respiratory	ADJ	O	B-outcome
mechanical	ADJ	O	I-outcome
parameters	NOUN	O	O
under	ADP	O	O
different	ADJ	O	O
ventilation	NOUN	O	O
patterns	NOUN	O	O
and	CCONJ	O	O
ventilator	NOUN	O	O
parameters].	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
1548	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
bilateral	ADJ	O	O
internal-thoracic-artery	ADV	O	O
grafting	VERB	O	O
(the	NOUN	O	O
bilateral-graft	NOUN	O	O
group)	ADJ	O	O
and	CCONJ	O	O
1554	NUM	O	O
to	PART	O	O
undergo	NOUN	O	O
single	ADJ	O	O
internal-thoracic-artery	ADV	O	O
grafting	VERB	O	O
(the	NOUN	O	O
single-graft	NOUN	O	O
group).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/28	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Japanese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
oncology	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Journal-Name:Panminerva	NOUN	O	O
medica	NOUN	O	O

Emphasis	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
placed	VERB	O	O
on	ADP	O	O
TKA	NOUN	O	O
pain	NOUN	O	O
management	NOUN	O	O
for	ADP	O	O
postoperative	ADJ	O	O
care	NOUN	O	O
and	CCONJ	O	O
during	ADP	O	O
rehabilitation.	ADV	O	O

OBJECTIVE::	NOUN	O	O
With	ADP	O	O
increasing	VERB	O	O
incorporation	NOUN	O	O
of	ADP	O	O
MRI	NOUN	O	O
in	ADP	O	O
radiotherapy,	NOUN	O	O
we	PRON	O	O
investigate	NOUN	O	O
two	NUM	O	O
MRI	NOUN	O	O
sequences	NOUN	O	O
for	ADP	O	O
prostate	NOUN	O	O
delineation	NOUN	O	O
in	ADP	O	O
radiographer-led	VERB	O	O
image	NOUN	O	O
guidance.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Crohn's	NOUN	O	O
disease	NOUN	O	O
(CD)	NOUN	O	O
is	VERB	O	O
a	DET	O	O
highly	ADV	O	O
prevalent	ADJ	O	O
inflammatory	ADJ	O	O
bowel	NOUN	O	O
disease	NOUN	O	O
(IBD),	PUNCT	O	O
characterized	VERB	O	O
by	ADP	O	O
recurring	VERB	O	O
flares	NOUN	O	O
altered	VERB	O	O
by	ADP	O	O
periods	NOUN	O	O
of	ADP	O	O
inactive	ADJ	O	O
disease	NOUN	O	O
and	CCONJ	O	O
remission,	NOUN	O	O
affecting	VERB	O	O
physical	ADJ	O	O
and	CCONJ	O	O
psychological	ADJ	O	O
aspects	NOUN	O	O
and	CCONJ	O	O
quality	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
(QoL).	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
445	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned:	NOUN	O	O
222	NUM	O	O
to	PART	O	O
the	DET	O	O
early-start	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
223	NUM	O	O
to	PART	O	O
the	DET	O	O
delayed-start	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968567	NUM	O	O

METHODS:	NOUN	O	O
This	DET	O	O
multicenter,	NOUN	O	O
double-blind,	NOUN	O	O
double-dummy,	NOUN	O	O
parallel	ADJ	O	O
group,	NOUN	O	O
randomized,	NOUN	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
in	ADP	O	O
Ethiopia,	ADV	O	O
Peru,	ADP	O	O
Brazil,	NOUN	O	O
Cambodia,	NOUN	O	O
Thailand,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
Philippines.	NOUN	O	O

Title:	NOUN	O	O
School-based	VERB	O	O
surveillance	NOUN	O	O
for	ADP	O	O
detection	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	B-outcome
pharyngitis	NOUN	O	I-outcome
,	PUNCT	O	O
rheumatic	ADJ	O	B-outcome
fever/rheumatic	ADJ	O	I-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
in	ADP	O	O
Shimla	NOUN	O	O
district,	NOUN	O	O
Himachal	NOUN	O	O
Pradesh,	NOUN	O	O
India-A	NOUN	O	O
cluster	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Implementation	NOUN	O	O
methods:	NOUN	O	O
how	ADP	O	O
and	CCONJ	O	O
when	ADP	O	O
the	DET	O	O
components	NOUN	O	O
were	VERB	O	O
implemented	VERB	O	B-outcome
in	ADP	O	O
schools.	NOUN	O	O

Nonetheless,	NOUN	O	O
the	DET	O	O
positive	ADJ	O	O
results	NOUN	O	O
achieved	NOUN	O	O
in	ADP	O	O
the	DET	O	O
area	NOUN	O	O
of	ADP	O	O
functionality	NOUN	O	O
of	ADP	O	O
the	DET	O	O
CHW	NOUN	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
community	NOUN	O	O
structure	NOUN	O	O
capacity	NOUN	O	O
are	VERB	O	O
encouraging.	NOUN	O	O

Including	VERB	O	O
men	NOUN	O	O
in	ADP	O	O
preconception	NOUN	O	O
health	NOUN	O	O
policy	NOUN	O	O
guidelines	NOUN	O	O
and	CCONJ	O	O
identifying	VERB	O	O
suitable	ADJ	O	O
actors	NOUN	O	O
for	ADP	O	O
care	NOUN	O	O
provision	NOUN	O	O
would	VERB	O	O
be	VERB	O	O
important	ADJ	O	O
first	ADV	O	O
steps.	NOUN	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Initially,	NOUN	O	O
56	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
four	NUM	O	O
groups;	NOUN	O	O
control	NOUN	O	O
group	NOUN	O	O
(n=12),	PUNCT	O	O
single-dose	NOUN	O	O
(n=16),	NOUN	O	O
repeated-dose	NOUN	O	O
(n=12)	PUNCT	O	O
and	CCONJ	O	O
continuous	ADJ	O	O
infusion	NOUN	O	O
(n=16)	PUNCT	O	O
RSB	NOUN	O	O
analgesia	NOUN	O	O
groups.	NOUN	O	O

Local	ADJ	O	O
cutaneous	ADJ	O	O
safety	NOUN	O	O
and	CCONJ	O	O
tolerability	NOUN	O	B-outcome
assessments	NOUN	O	O
were	VERB	O	O
generally	ADV	O	O
mild-to-moderate	ADJ	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
improved	VERB	O	O
by	ADP	O	O
week	NOUN	O	O
12.	NUM	O	O

To	PART	O	O
combat	NOUN	O	O
this	DET	O	O
problem,	NOUN	O	O
investigators	NOUN	O	O
have	VERB	O	O
attempted	VERB	O	O
to	PART	O	O
withhold	ADV	O	O
angiotensin-converting	VERB	O	O
enzyme	NOUN	O	O
inhibitors	NOUN	O	O
(ACEi)	NUM	O	O
and	CCONJ	O	O
angiotensin	NOUN	O	O
receptor	NOUN	O	O
blockers	NOUN	O	O
(ARB)	NOUN	O	O
preoperatively,	ADJ	O	O
or	CCONJ	O	O
evaluated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
induction	NOUN	O	O
agents	NOUN	O	O
in	ADP	O	O
conferring	VERB	O	O
greater	ADJ	O	O
hemodynamic	ADJ	O	O
stability.	NOUN	O	O

Repeated	VERB	O	O
measures	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
variance	NOUN	O	O
(RMANOVA)	PUNCT	O	O
demonstrated	VERB	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
over	ADP	O	O
time	NOUN	O	O
for	ADP	O	O
the	DET	O	O
Schirmer	NOUN	O	O
I	NUM	O	O
test	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.002),	NUM	O	O
corneal	ADJ	O	B-outcome
fluorescein	NOUN	O	I-outcome
staining	VERB	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.025),	NUM	O	O
ocular	ADJ	O	B-outcome
surface	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
index](p	NOUN	O	O
=	SYM	O	O
0.020),	NUM	O	O
and	CCONJ	O	O
frequency	NOUN	O	O
of	ADP	O	O
lubricants	NOUN	O	B-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.029).	NUM	O	O

When	ADP	O	O
the	DET	O	O
patient	NOUN	O	O
left	ADV	O	O
the	DET	O	O
postanesthesia	NOUN	O	O
care	NOUN	O	O
unit,	ADP	O	O
all	DET	O	O
had	VERB	O	O
sore	ADV	O	B-outcome
throat	NOUN	O	I-outcome
and	CCONJ	O	O
26/15/25	VERB	O	O
patients	NOUN	O	O
in	ADP	O	O
VDT/VST/DT	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
hoarseness	VERB	O	B-outcome
.	PUNCT	O	O
All	DET	O	O
had	VERB	O	O
good	ADJ	O	O
outcomes	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
surgical	ADJ	O	I-outcome
operations	NOUN	O	I-outcome
.We	PUNCT	O	O
found	VERB	O	O
the	DET	O	O
ETView	NOUN	O	O
tube	NOUN	O	O
to	PART	O	O
be	VERB	O	O
helpful	ADJ	O	B-outcome
in	ADP	O	O
the	DET	O	O
endotracheal	ADJ	O	O
intubation	NOUN	O	O
and	CCONJ	O	O
continuous	ADJ	O	O
surveillance	NOUN	O	O
of	ADP	O	O
tube	NOUN	O	O
position	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
video-assisted	VERB	O	O
thoracoscopic	ADJ	O	O
lobectomy.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
159	NUM	O	O
American	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Anesthesiologists	NOUN	O	O
(ASA)	NOUN	O	O
physical	ADJ	O	O
status	NOUN	O	O
I	NUM	O	O
to	PART	O	O
III	NUM	O	O
patients	NOUN	O	O
scheduled	VERB	O	O
for	ADP	O	O
primary	ADJ	O	O
TKA	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
three	NUM	O	O
study	NOUN	O	O
groups.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
a	DET	O	O
double-blind	ADJ	O	O
trial,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
(in	NUM	O	O
a	DET	O	O
1:1	ADJ	O	O
ratio)	NOUN	O	O
adults	NOUN	O	O
with	ADP	O	O
community-acquired	VERB	O	O
bacterial	ADJ	O	O
pneumonia	NOUN	O	O
(Pneumonia	NOUN	O	O
Severity	NOUN	O	O
Index	NOUN	O	O
risk	NOUN	O	O
class	NOUN	O	O
II,	NOUN	O	O
III,	NOUN	O	O
or	CCONJ	O	O
IV)	NUM	O	O
to	PART	O	O
receive	VERB	O	O
omadacycline	NOUN	O	O
(100	NUM	O	O
mg	NOUN	O	O
intravenously	ADV	O	O
every	DET	O	O
12	NUM	O	O
hours	NOUN	O	O
for	ADP	O	O
two	NUM	O	O
doses,	ADJ	O	O
then	ADV	O	O
100	NUM	O	O
mg	NOUN	O	O
intravenously	ADV	O	O
every	DET	O	O
24	NUM	O	O
hours),	NOUN	O	O
or	CCONJ	O	O
moxifloxacin	NOUN	O	O
(400	NUM	O	O
mg	NOUN	O	O
intravenously	ADV	O	O
every	DET	O	O
24	NUM	O	O
hours).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

PMID:	NOUN	O	O
31618286	NUM	O	O

After	ADP	O	O
an	DET	O	O
anesthetic	ADJ	O	O
induction,	NOUN	O	O
bolus	NOUN	O	O
of	ADP	O	O
rocuronium	NOUN	O	O
0.1	NUM	O	O
mg/kg	NOUN	O	O
was	VERB	O	O
injected	VERB	O	O
when	ADP	O	O
it	PRON	O	O
was	VERB	O	O
needed	VERB	O	O
(for	PUNCT	O	O
patient	NOUN	O	O
involuntary	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
or	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
request	NOUN	O	O
of	ADP	O	O
the	DET	O	O
surgeon)	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
B,	NOUN	O	O
and	CCONJ	O	O
5	NUM	O	O
mcg/kg/min	NOUN	O	O
of	ADP	O	O
rocuronium	NOUN	O	O
were	VERB	O	O
infused	VERB	O	O
in	ADP	O	O
group	NOUN	O	O
I	NUM	O	O
study	NOUN	O	O
participants.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
is	VERB	O	O
defined	VERB	O	O
as	ADP	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
individuals	NOUN	O	O
positive	ADJ	O	O
for	ADP	O	O
Plasmodium	NOUN	O	B-outcome
falciparum	NOUN	O	I-outcome
and	CCONJ	O	Seperator
Plasmodium	NOUN	O	B-outcome
vivax	NOUN	O	I-outcome
infections	NOUN	O	E1-outcome
diagnosed	VERB	O	O
by	ADP	O	O
a	DET	O	O
rapid	ADJ	O	O
diagnostic	ADJ	O	O
test.	NOUN	O	O

RESULTS:	NOUN	O	O
Data	NOUN	O	O
from	ADP	O	O
55	NUM	O	O
of	ADP	O	O
the	DET	O	O
62	NUM	O	O
participants	NOUN	O	O
were	VERB	O	O
analyzed.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
instances	NOUN	O	O
of	ADP	O	O
urgent	ADJ	O	O
target	NOUN	O	O
lesion	NOUN	O	B-outcome
re-vascularisation	NOUN	O	I-outcome
or	CCONJ	O	O
definite	ADP	O	O
stent	NOUN	O	B-outcome
thrombosis	NOUN	O	I-outcome
in	ADP	O	O
either	CCONJ	O	O
groups.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
develop	VERB	O	O
a	DET	O	O
multidisciplinary	ADJ	O	O
lifestyle	NOUN	O	O
intervention	NOUN	O	O
program	NOUN	O	O
targeted	VERB	O	O
at	ADP	O	O
children	NOUN	O	O
and	CCONJ	O	O
adolescents	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
to	PART	O	O
severe	ADJ	O	O
obesity,	ADJ	O	O
and	CCONJ	O	O
assess	NOUN	O	O
the	DET	O	O
additional	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
exercise	NOUN	O	O
intervention	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
to	PART	O	O
usual	ADJ	O	O
care.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
the	DET	O	O
post	ADV	O	O
procedure	NOUN	O	O
creatinine	NOUN	O	B-outcome
values	NOUN	O	O
at	ADP	O	O
24h	NOUN	O	O
(p=0.013),	NOUN	O	O
48h	NOUN	O	O
(p=0.015),	PUNCT	O	O
2	NUM	O	O
weeks	NOUN	O	O
(p=0.003),	NOUN	O	O
6	NUM	O	O
weeks	NOUN	O	O
(p=0.003)	NOUN	O	O
and	CCONJ	O	O
post	ADV	O	O
procedure	NOUN	O	O
glomerular	ADJ	O	B-outcome
filtration	NOUN	O	I-outcome
rate	NOUN	O	I-outcome
(eGFR)	NOUN	O	I-outcome
values	NOUN	O	O
at	ADP	O	O
24h	NOUN	O	O
(p=0.026),	NOUN	O	O
48h	NOUN	O	O
(p=0.044),	PUNCT	O	O
2	NUM	O	O
weeks	NOUN	O	O
(p=0.015)	NUM	O	O
and	CCONJ	O	O
6	NUM	O	O
weeks	NOUN	O	O
(p=0.011)	NOUN	O	O
in	ADP	O	O
study	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
control	NOUN	O	O
group.	VERB	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
proportions	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
reporting	VERB	O	O
local	ADJ	O	B-outcome
solicited	VERB	O	I-outcome
AEs	NOUN	O	I-outcome
,	PUNCT	O	O
systemic	ADJ	O	B-outcome
solicited	VERB	O	I-outcome
AEs	NOUN	O	I-outcome
,	PUNCT	O	O
unsolicited	VERB	O	B-outcome
AEs	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
SAEs	NOUN	O	B-outcome
among	ADP	O	O
the	DET	O	O
3	NUM	O	O
vaccine	NOUN	O	O
groups	NOUN	O	O
after	ADP	O	O
the	DET	O	O
1st	ADJ	O	O
and	CCONJ	O	O
2nd	ADJ	O	O
doses.	NOUN	O	O

RESULTS:	NOUN	O	O
Eleven	NUM	O	O
out	ADP	O	O
of	ADP	O	O
fifty	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
group	NOUN	O	O
developed	VERB	O	O
contrast	NOUN	O	B-outcome
induced	VERB	O	I-outcome
nephropathy	NOUN	O	I-outcome
(CIN)	NOUN	O	I-outcome
(22%)	PUNCT	O	O
compared	VERB	O	O
to	PART	O	O
eighteen	NUM	O	O
out	ADP	O	O
of	ADP	O	O
the	DET	O	O
fifty	NUM	O	O
control	NOUN	O	O
patients	NOUN	O	O
(36%)	NOUN	O	O
(p=0.123).	PUNCT	O	O

CONCLUSIONS:	NOUN	O	O
Systematic	ADJ	O	O
pelvic	ADJ	O	O
and	CCONJ	O	O
paraaortic	ADJ	O	O
lymphadenectomy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
ovarian	ADJ	O	O
cancer	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
undergone	VERB	O	O
intraabdominal	ADJ	O	O
macroscopically	ADV	O	O
complete	ADJ	O	O
resection	NOUN	O	O
and	CCONJ	O	O
had	VERB	O	O
normal	ADJ	O	O
lymph	NOUN	O	O
nodes	NOUN	O	O
both	CCONJ	O	O
before	ADP	O	O
and	CCONJ	O	O
during	ADP	O	O
surgery	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
longer	ADJ	O	O
overall	ADJ	O	B-outcome
or	CCONJ	O	Seperator
progression-free	ADJ	O	B-outcome
survival	NOUN	O	E1-outcome
than	ADP	O	O
no	DET	O	O
lymphadenectomy	NOUN	O	O
and	CCONJ	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
higher	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
complications	NOUN	O	B-outcome
.	PUNCT	O	O
(Funded	PUNCT	O	O
by	ADP	O	O
Deutsche	NOUN	O	O
Forschungsgemeinschaft	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
Austrian	ADJ	O	O
Science	NOUN	O	O
Fund;	NOUN	O	O
LION	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT00712218.).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Importance:	NOUN	O	O
There	PRON	O	O
are	VERB	O	O
currently	ADV	O	O
no	DET	O	O
proven	VERB	O	O
treatments	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
mild	ADJ	O	O
cognitive	ADJ	O	O
impairment	NOUN	O	O
and	CCONJ	O	O
dementia.	NOUN	O	O

All	DET	O	O
primary	ADJ	O	O
and	CCONJ	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
8-week	NOUN	O	O
treatment,	NOUN	O	O
and	CCONJ	O	O
4-week	NOUN	O	O
follow-up.	PUNCT	O	O

Regarding	VERB	O	O
the	DET	O	O
composite	NOUN	O	O
outcome	NOUN	O	O
of	ADP	O	O
death	NOUN	O	B-outcome
,	PUNCT	O	O
myocardial	ADJ	O	B-outcome
infarction	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
stroke	NOUN	O	B-outcome
,	PUNCT	O	O
there	PRON	O	O
were	VERB	O	O
385	NUM	O	O
patients	NOUN	O	O
(24.9%)	PUNCT	O	O
with	ADP	O	O
an	DET	O	O
event	NOUN	O	O
in	ADP	O	O
the	DET	O	O
bilateral-graft	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
425	NUM	O	O
patients	NOUN	O	O
(27.3%)	NOUN	O	O
with	ADP	O	O
an	DET	O	O
event	NOUN	O	O
in	ADP	O	O
the	DET	O	O
single-graft	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.90;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.79	NUM	O	O
to	PART	O	O
1.03).	ADP	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ISRCTN10894523	NOUN	O	O
.	PUNCT	O	O

Title:	NOUN	O	O
Iodoform	NOUN	O	O
Vs	NUM	O	O
Calcium	NOUN	O	O
Hydroxide/Zinc	NOUN	O	O
Oxide	NOUN	O	O
based	VERB	O	O
pastes:	ADJ	O	O
12-month	NOUN	O	O
findings	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9206499	NUM	O	O

The	DET	O	O
relative	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
SAE	ADP	O	B-outcome
was	VERB	O	O
1.44	NUM	O	O
(97.5%	NUM	O	O
CI,	NOUN	O	O
0.79	NUM	O	O
to	PART	O	O
2.64;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.18).	NUM	O	O

Retrospectively	ADV	O	O
registered:	NOUN	O	O
December	NOUN	O	O
3,	NOUN	O	O
2010,	NUM	O	O
(	PUNCT	O	O
http://www.drks.de/drks_web/setLocale_EN.do	NOUN	O	O
).	NOUN	O	O

Results:	NOUN	O	O
Recruitment	NOUN	O	O
stopped	VERB	O	O
on	ADP	O	O
December	NOUN	O	O
21,	NUM	O	O
2017,	NUM	O	O
because	ADP	O	O
conditional	ADJ	O	O
power	NOUN	O	O
for	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
a	DET	O	O
prespecified	VERB	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
first	ADV	O	O
267	NUM	O	O
randomized	VERB	O	O
participants	NOUN	O	O
was	VERB	O	O
less	ADV	O	O
than	ADP	O	O
30%	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
(futility	NOUN	O	O
criterion).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
findings	NOUN	O	O
provide	VERB	O	O
new	ADJ	O	O
insights	NOUN	O	O
on	ADP	O	O
the	DET	O	O
effects	NOUN	O	O
and	CCONJ	O	O
mechanisms	NOUN	O	O
of	ADP	O	O
a	DET	O	O
MBI	NOUN	O	O
on	ADP	O	O
aMCI	NOUN	O	O
symptoms.	NOUN	O	O

No	DET	O	O
robotic	ADJ	O	O
rehabilitation	NOUN	O	O
session	NOUN	O	O
had	VERB	O	O
to	PART	O	O
be	VERB	O	O
replaced	VERB	O	B-outcome
by	ADP	O	O
conventional	ADJ	O	O
rehabilitation.	ADV	O	O

Journal-Name:Zhongguo	NOUN	O	O
xiu	NOUN	O	O
fu	ADP	O	O
chong	ADJ	O	O
jian	NOUN	O	O
wai	CCONJ	O	O
ke	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Zhongguo	NOUN	O	O
xiufu	VERB	O	O
chongjian	NOUN	O	O
waike	ADP	O	O
zazhi	NOUN	O	O
=	SYM	O	O
Chinese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
reparative	ADJ	O	O
and	CCONJ	O	O
reconstructive	ADJ	O	O
surgery	NOUN	O	O

Registered	VERB	O	O
19.7.2018.	NOUN	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
a	DET	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
of	ADP	O	O
7.5	NUM	O	O
years	NOUN	O	O
(range,	NOUN	O	O
1.3-9.6	NUM	O	O
years),	NOUN	O	O
7-year	NOUN	O	O
biochemical	ADJ	O	B-outcome
failure-free	ADJ	O	I-outcome
survival	NOUN	O	I-outcome
(BCFFS)	NUM	O	I-outcome
was	VERB	O	O
76.2%	NUM	O	O
for	ADP	O	O
the	DET	O	O
MHF	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
46.2%	NUM	O	O
for	ADP	O	O
the	DET	O	O
EHF	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.005).	NUM	O	O

School	NOUN	O	O
physical	ADJ	O	O
education	NOUN	O	O
(PE)	NOUN	O	O
is	VERB	O	O
an	DET	O	O
important	ADJ	O	O
existing	VERB	O	O
network	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
participation	NOUN	O	O
in	ADP	O	O
physical	ADJ	O	O
activity	NOUN	O	O
beyond	ADP	O	O
school	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
promoted	VERB	O	O
to	PART	O	O
the	DET	O	O
captive	ADJ	O	O
young	ADJ	O	O
people.	NOUN	O	O

We	PRON	O	O
will	VERB	O	O
compare	NOUN	O	O
3-month,	NUM	O	O
6-month,	NUM	O	O
and	CCONJ	O	O
12-month	NOUN	O	O
graft	NOUN	O	B-outcome
survival	NOUN	O	I-outcome
after	ADP	O	O
LT,	NOUN	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
identify	NOUN	O	O
a	DET	O	O
significant	ADJ	O	O
relation	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
homogenous	ADJ	O	O
groups	NOUN	O	O
of	ADP	O	O
LT	NOUN	O	O
patients.	NOUN	O	O

The	DET	O	O
outcomes	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
clinically	ADV	O	O
and	CCONJ	O	O
radiographically	ADV	O	O
according	ADJ	O	O
to	PART	O	O
specific	ADJ	O	O
criteria.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
therefore	ADV	O	O
investigated	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
betaA	NOUN	O	O
dosing	VERB	O	O
strategies	NOUN	O	O
on	ADP	O	O
30-min	NOUN	O	O
rowing	VERB	O	B-outcome
and	CCONJ	O	Seperator
subsequent	NOUN	O	X
sprint	NOUN	O	B-outcome
performance	NOUN	O	E1-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
Following	VERB	O	O
University	NOUN	O	O
Ethics	NOUN	O	O
approval,	NOUN	O	O
twenty-seven	VERB	O	O
healthy,	NOUN	O	O
male	NOUN	O	O
rowers	NOUN	O	O
(age:	NOUN	O	O
24	NUM	O	O
+/-	SYM	O	O
2	NUM	O	O
years;	NOUN	O	O
body-height:	NOUN	O	O
1.81	NUM	O	O
+/-	SYM	O	O
0.02	NUM	O	O
m;	NOUN	O	O
body-mass:	NOUN	O	O
82.3	NUM	O	O
+/-	SYM	O	O
2.5	NUM	O	O
kg;	NOUN	O	O
body-fat:	NOUN	O	O
14.2	NUM	O	O
+/-	SYM	O	O
1.0%)	NUM	O	O
were	VERB	O	O
randomised	VERB	O	O
in	ADP	O	O
a	DET	O	O
double-blind	ADJ	O	O
manner	NOUN	O	O
to	PART	O	O
4	NUM	O	O
weeks	NOUN	O	O
of:	NOUN	O	O
i)	ADJ	O	O
betaA	NOUN	O	O
(2.4	NOUN	O	O
g.d(-	NOUN	O	O
1),	NUM	O	O
betaA1);	NOUN	O	O
ii)	ADP	O	O
matched	VERB	O	O
total	ADJ	O	O
betaA	NOUN	O	O
(4.8	NOUN	O	O
g	NOUN	O	O
on	ADP	O	O
alternate	VERB	O	O
days,	NOUN	O	O
betaA2);	VERB	O	O
or	CCONJ	O	O
iii)	NOUN	O	O
cornflour	NOUN	O	O
placebo	NOUN	O	O
(2.4	NOUN	O	O
g.d(-	NOUN	O	O
1),	NUM	O	O
PL).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
progressive	ADJ	O	O
muscle	NOUN	O	O
relaxation	NOUN	O	O
on	ADP	O	O
cancer	NOUN	O	O
patients'	NOUN	O	O
self-efficacy	NOUN	O	B-outcome
.	PUNCT	O	O

This	DET	O	O
sample	NOUN	O	O
size	NOUN	O	O
achieves	NOUN	O	O
90%	VERB	O	O
power	NOUN	O	O
to	PART	O	O
detect	VERB	O	O
a	DET	O	O
difference	NOUN	O	O
of	ADP	O	O
14.6%	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
survival	NOUN	O	O
using	VERB	O	O
a	DET	O	O
one-sided	VERB	O	O
binomial	ADJ	O	O
test.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/17	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Injection	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
was	VERB	O	O
reported	VERB	O	O
by	ADP	O	O
11	NUM	O	O
of	ADP	O	O
28	NUM	O	O
(39%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Group	NOUN	O	O
N	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
2	NUM	O	O
of	ADP	O	O
28	NUM	O	O
(7%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
Group	NOUN	O	O
R	NOUN	O	O
(difference	NOUN	O	O
in	ADP	O	O
proportion:	ADJ	O	O
32%,	NOUN	O	O
95%	NOUN	O	O
CI:	NOUN	O	O
10-51%,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.01).	PUNCT	O	O

Title:	NOUN	O	O
Low	ADJ	O	O
dose	NOUN	O	O
human	NOUN	O	O
chorionic	ADJ	O	O
gonadotropin	NOUN	O	O
administration	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
gonadotropin	NOUN	O	O
releasing-hormone	NOUN	O	O
agonist	NOUN	O	O
trigger	ADP	O	O
versus	CCONJ	O	O
35	NUM	O	O
h	NOUN	O	O
later	ADV	O	O
in	ADP	O	O
women	NOUN	O	O
at	ADP	O	O
high	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
developing	VERB	O	O
ovarian	ADJ	O	O
hyperstimulation	NOUN	O	O
syndrome	NOUN	O	O
-	PUNCT	O	O
a	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
double-blind	ADJ	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Acute	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
plus	CCONJ	O	O
ATLG	NOUN	O	O
after	ADP	O	O
myeloablative	ADJ	O	O
allogeneic	ADJ	O	O
haemopoietic	ADJ	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
stem-cell	NOUN	O	O
transplantation	NOUN	O	O
from	ADP	O	O
HLA-identical	ADJ	O	O
siblings	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
leukaemia	NOUN	O	O
in	ADP	O	O
remission:	NOUN	O	O
final	ADJ	O	O
results	NOUN	O	O
of	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
and	CCONJ	O	O
long-term	NOUN	O	O
outcome	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
a	DET	O	O
phase	NOUN	O	O
3	NUM	O	O
randomised	VERB	O	O
study.	NOUN	O	O

Dipirona	NOUN	O	O
and	CCONJ	O	O
tramadol	NOUN	O	O
doses	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
groups	NOUN	O	O
(p=0.201	NOUN	O	O
and	CCONJ	O	O
p=0.341).	NOUN	O	O

Registered	VERB	O	O
on	ADP	O	O
3rd	ADJ	O	O
September	NOUN	O	O
2018,	NUM	O	O
https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=3571.	ADV	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
a	DET	O	O
deep	ADJ	O	O
NMB	NOUN	O	O
group	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
moderate	ADJ	O	O
NMB	NOUN	O	O
group	NOUN	O	O
with	ADP	O	O
a	DET	O	O
1:1	ADJ	O	O
ratio.	NOUN	O	O

Impressions	NOUN	O	B-outcome
from	ADP	O	O
the	DET	O	O
counselling	VERB	O	O
were	VERB	O	O
also	ADV	O	O
assessed	VERB	O	O
at	ADP	O	O
follow-up.	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
albumin	NOUN	O	B-outcome
levels	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(p	PUNCT	O	O
?	PUNCT	O	O

Journal-Name:Terapevticheskii	NOUN	O	O
arkhiv	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ISRCTN27083228	NOUN	O	O

Treatment	NOUN	O	B-outcome
success	NOUN	O	I-outcome
was	VERB	O	O
achieved	NOUN	O	O
by	ADP	O	O
19.6%	NOUN	O	O
of	ADP	O	O
subjects	NOUN	O	O
by	ADP	O	O
week	NOUN	O	O
12,	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
12.7%	NUM	O	O
on	ADP	O	O
vehicle	NOUN	O	O
(P=0.015).	NUM	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
prevention	NOUN	O	O
of	ADP	O	O
the	DET	O	O
complications	NOUN	O	O
during	ADP	O	O
the	DET	O	O
percutaneous	ADJ	O	O
myocardial	ADJ	O	O
revascularization	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
considered	VERB	O	O
with	ADP	O	O
the	DET	O	O
position	NOUN	O	O
of	ADP	O	O
the	DET	O	O
most	DET	O	O
suitable	ADJ	O	O
pharmacological	ADJ	O	O
support.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
objective	ADP	O	O
was	VERB	O	O
to	PART	O	O
show	VERB	O	O
the	DET	O	O
noninferiority	NOUN	O	O
of	ADP	O	O
plazomicin	NOUN	O	O
to	PART	O	O
meropenem	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
complicated	VERB	O	O
UTIs,	ADP	O	O
including	VERB	O	O
acute	ADJ	O	O
pyelonephritis,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
noninferiority	NOUN	O	O
margin	ADP	O	O
of	ADP	O	O
15	NUM	O	O
percentage	NOUN	O	O
points.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/07/01	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

We	PRON	O	O
observed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
decrease	NOUN	O	O
in	ADP	O	O
absolute	ADJ	O	O
hepatic	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
receiving	VERB	O	O
10	NUM	O	O
mg	NOUN	O	O
pegbelfermin	NOUN	O	O
daily	ADJ	O	O
(-6.8%	PUNCT	O	O
vs	CCONJ	O	O
-1.3%;	NOUN	O	O
p=0.0004)	ADV	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
receiving	VERB	O	O
20	NUM	O	O
mg	NOUN	O	O
pegbelfermin	NOUN	O	O
weekly	ADV	O	O
(-5.2%	NUM	O	O
vs	CCONJ	O	O
-1.3%;	NOUN	O	O
p=0.008)	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

BACKGROUND:	NOUN	O	O
and	CCONJ	O	O
purpose:	NOUN	O	O
Different	ADJ	O	O
in	ADP	O	O
vitro	ADV	O	O
studies	NOUN	O	O
have	VERB	O	O
reported	VERB	O	O
the	DET	O	O
antimicrobial	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
green	ADV	O	O
tea	NOUN	O	O
catechins	NOUN	O	O
and	CCONJ	O	O
also	ADV	O	O
their	ADJ	O	O
synergistic	ADJ	O	O
effects	NOUN	O	O
with	ADP	O	O
trimethoprim-sulfamethoxazole	NOUN	O	O
against	ADP	O	O
E.	NOUN	O	O
coli.	NOUN	O	O

These	DET	O	O
findings	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
this	DET	O	O
psychological	ADJ	O	O
intervention.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
for	ADP	O	O
compression	NOUN	O	B-outcome
rate	NOUN	O	O
or	CCONJ	O	O
recoil	NOUN	O	B-outcome
between	ADP	O	O
groups.	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
lactulose,	NOUN	O	O
while	ADP	O	O
the	DET	O	O
subjects	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
placebo	NOUN	O	O
intervention.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Lacunar	ADV	O	O
infarction	NOUN	O	O
of	ADP	O	O
SAI	NOUN	O	O
have	VERB	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
than	ADP	O	O
MAIs,	ADP	O	O
while	ADP	O	O
non-lacunar	NOUN	O	O
infarction	NOUN	O	O
of	ADP	O	O
SAI	NOUN	O	O
might	VERB	O	O
have	VERB	O	O
similar	ADJ	O	O
risk	NOUN	O	O
as	ADP	O	O
MAIs.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
SHAPE-2	NOUN	O	O
study	NOUN	O	O
is	VERB	O	O
a	DET	O	O
three-armed	VERB	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
conducted	VERB	O	O
in	ADP	O	O
2012-2013	NUM	O	O
in	ADP	O	O
the	DET	O	O
Netherlands.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
comparative	ADJ	O	O
study	NOUN	O	O
between	ADP	O	O
intravenous	ADJ	O	O
and	CCONJ	O	O
intramuscular	ADJ	O	O
scorpion	NOUN	O	O
antivenom	NOUN	O	O
regimens	NOUN	O	O
in	ADP	O	O
children.	NOUN	O	O

In	ADP	O	O
part	NOUN	O	O
A	DET	O	O
of	ADP	O	O
the	DET	O	O
trial,	NOUN	O	O
patients	NOUN	O	O
without	ADP	O	O
recent	ADJ	O	O
porphyria	NOUN	O	O
attacks	NOUN	O	O
(i.e.,	PUNCT	O	O
no	DET	O	O
attacks	NOUN	O	O
in	ADP	O	O
the	DET	O	O
6	NUM	O	O
months	NOUN	O	O
before	ADP	O	O
baseline)	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
a	DET	O	O
single	ADJ	O	O
subcutaneous	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
one	NUM	O	O
of	ADP	O	O
five	NUM	O	O
ascending	VERB	O	O
doses	NOUN	O	O
of	ADP	O	O
givosiran	NOUN	O	O
(0.035,	NOUN	O	O
0.10,	NUM	O	O
0.35,	NUM	O	O
1.0,	NOUN	O	O
or	CCONJ	O	O
2.5	NUM	O	O
mg	NOUN	O	O
per	ADP	O	O
kilogram	NOUN	O	O
of	ADP	O	O
body	NOUN	O	O
weight)	VERB	O	O
or	CCONJ	O	O
placebo.	NOUN	O	O

RESULTS:	NOUN	O	O
Both	CCONJ	O	O
the	DET	O	O
ALS	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG)	NOUN	O	O
showed	VERB	O	O
better	ADJ	O	O
performance	NOUN	O	B-outcome
on	ADP	O	O
the	DET	O	O
computer	NOUN	O	O
task	NOUN	O	O
when	ADP	O	O
using	VERB	O	O
the	DET	O	O
touchscreen	NUM	O	O
device,	NOUN	O	O
but	CCONJ	O	O
there	PRON	O	O
was	VERB	O	O
limited	VERB	O	O
transfer	NOUN	O	B-outcome
of	ADP	O	O
performance	NOUN	O	O
onto	ADP	O	O
the	DET	O	O
task	NOUN	O	O
performed	VERB	O	O
on	ADP	O	O
the	DET	O	O
Finger	NOUN	O	O
Motion	NOUN	O	O
control	NOUN	O	O
or	CCONJ	O	O
motion	NOUN	O	O
tracking.	NOUN	O	O

The	DET	O	O
sample	NOUN	O	O
had	VERB	O	O
180	NUM	O	O
individuals	NOUN	O	O
with	ADP	O	O
a	DET	O	O
pattern	NOUN	O	O
of	ADP	O	O
hazardous	ADJ	O	O
or	CCONJ	O	O
harmful	ADJ	O	O
alcohol	NOUN	O	O
use,	NOUN	O	O
recruited	VERB	O	O
in	ADP	O	O
a	DET	O	O
Basic	ADJ	O	O
Health	NOUN	O	O
Unit	NOUN	O	O
in	ADP	O	O
the	DET	O	O
city	NOUN	O	O
of	ADP	O	O
Sao	NOUN	O	O
Paulo.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
had	VERB	O	O
intravenous	ADJ	O	O
patient-controlled	VERB	O	O
analgesia	NOUN	O	O
(PCA)	PUNCT	O	O
with	ADP	O	O
10	NUM	O	O
mug/kg	NOUN	O	O
of	ADP	O	O
fentanyl	NOUN	O	O
for	ADP	O	O
48	NUM	O	O
hours.	DET	O	O

Compared	VERB	O	O
with	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
rhodiola	NOUN	O	O
treatment	NOUN	O	O
group,	NOUN	O	O
Self-rating	VERB	O	O
depression	NOUN	O	B-outcome
scale	NOUN	O	O
(SDS)	PUNCT	O	O
and	CCONJ	O	O
self-rating	VERB	O	O
anxiety	NOUN	O	B-outcome
scale	NOUN	O	O
SAS	NUM	O	O
scores	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rhodiola+non-invasive	ADJ	O	O
breathing	VERB	O	O
group	NOUN	O	O
decreased	VERB	O	O
after	ADP	O	O
treatment	NOUN	O	O
P<0.05.	NOUN	O	O

RESULTS:	NOUN	O	O
Better	ADJ	O	O
scores	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
with	ADP	O	O
the	DET	O	O
forearm	NOUN	O	O
band,	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
no	DET	O	O
orthosis,	NUM	O	O
for	ADP	O	O
multiple	ADJ	O	O
outcomes	NOUN	O	O
including	VERB	O	O
joint	NOUN	O	B-outcome
position	NOUN	O	I-outcome
reproduction	NOUN	O	I-outcome
score	NOUN	O	O
at	ADP	O	O
70	NUM	O	O
degrees	NOUN	O	O
of	ADP	O	O
elbow	NOUN	O	O
flexion	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.006),	PUNCT	O	O
pain	NOUN	O	B-outcome
(P	NUM	O	O
<	SYM	O	O
.001),	PUNCT	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.01),	PUNCT	O	O
and	CCONJ	O	O
dexterity	NOUN	O	B-outcome
(P	NUM	O	O
<	SYM	O	O
.001).	PUNCT	O	O

Pain	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
were	VERB	O	O
evaluated	VERB	O	O
too.	NOUN	O	O

The	DET	O	O
number	NOUN	O	O
needed	VERB	O	O
to	PART	O	O
treat	NOUN	O	O
to	PART	O	O
avert	NOUN	O	O
one	NUM	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
any	DET	O	Seperator
cause	ADP	O	I-outcome
was	VERB	O	O
8.4.	NOUN	O	O

Thus,	NOUN	O	O
branched-chain	NOUN	O	O
amino	ADJ	O	O
acids	NOUN	O	O
may,	NOUN	O	O
at	ADP	O	O
least	ADV	O	O
in	ADP	O	O
part,	NOUN	O	O
mediate	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
whey	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
energy	NOUN	O	O
intake	NOUN	O	O
and/or	CCONJ	O	O
blood	NOUN	O	O
glucose.	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
treatment,	NOUN	O	O
NES	NOUN	O	O
showed	VERB	O	O
greater	ADJ	O	O
effectiveness	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
the	DET	O	O
severity	NOUN	O	O
of	ADP	O	O
nausea	NOUN	O	B-outcome
(P	NUM	O	O
=	SYM	O	O
.02),	PUNCT	O	O
and	CCONJ	O	O
vomiting	VERB	O	B-outcome
(P	NUM	O	O
=	SYM	O	O
.04),	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
the	DET	O	O
appetite	NOUN	O	B-outcome
improvement	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.02),	PUNCT	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
sham	NOUN	O	O
NES.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Maintenance	NOUN	O	O
therapy	NOUN	O	O
following	VERB	O	O
autologous	ADJ	O	O
stem	NOUN	O	O
cell	NOUN	O	O
transplantation	NOUN	O	O
(ASCT)	PUNCT	O	O
can	VERB	O	O
delay	NOUN	O	O
disease	NOUN	O	O
progression	NOUN	O	O
and	CCONJ	O	O
prolong	NOUN	O	O
survival	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
multiple	ADJ	O	O
myeloma.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Journal-Name:Nan	NOUN	O	O
fang	NOUN	O	O
yi	ADP	O	O
ke	NOUN	O	O
da	NOUN	O	O
xue	NOUN	O	O
xue	NOUN	O	O
bao	NOUN	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
Southern	NOUN	O	O
Medical	ADJ	O	O
University	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
5	NUM	O	O
cases	NOUN	O	O
of	ADP	O	O
"shell"	NOUN	O	B-outcome
phenomenon	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
4	NUM	O	O
cases	NOUN	O	O
of	ADP	O	O
nonunion	NOUN	O	B-outcome
at	ADP	O	O
last	NOUN	O	O
follow-up,	ADP	O	O
23	NUM	O	O
cases	NOUN	O	O
of	ADP	O	O
"shell"	NOUN	O	B-outcome
phenomenon	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
19	NUM	O	O
cases	NOUN	O	O
of	ADP	O	O
nonunion	NOUN	O	B-outcome
at	ADP	O	O
last	NOUN	O	O
follow-up;	ADP	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
P<0.05).	NOUN	O	O

Title:	NOUN	O	O
Novel	ADJ	O	O
Tretinoin	NOUN	O	O
0.05%	NUM	O	O
Lotion	NOUN	O	O
for	ADP	O	O
Once-Daily	NOUN	O	O
Treatment	NOUN	O	O
of	ADP	O	O
Moderate-to-Severe	NOUN	O	O
Acne	NOUN	O	O
Vulgaris	NOUN	O	O
in	ADP	O	O
a	DET	O	O
Hispanic	ADJ	O	O
Population	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/29	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/15	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Conclusion	NOUN	O	O
Intra-articular	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
Triamcinolone	NOUN	O	O
acetenoid	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
symptoms	NOUN	O	B-outcome
control	NOUN	O	I-outcome
and	CCONJ	O	O
improving	VERB	O	O
functional	ADJ	O	B-outcome
outcome	NOUN	O	O
in	ADP	O	O
clinically	ADV	O	O
diagnosed	VERB	O	O
osteoarthritis	NOUN	O	O
of	ADP	O	O
knees	NOUN	O	O
in	ADP	O	O
community	NOUN	O	O
set	NOUN	O	O
up	ADP	O	O
during	ADP	O	O
health	NOUN	O	O
camps.	NOUN	O	O

Title:	NOUN	O	O
Single	NOUN	O	O
Patient	NOUN	O	O
Classifier	NOUN	O	O
Assay,	NOUN	O	O
Microsatellite	NOUN	O	O
Instability,	ADJ	O	O
and	CCONJ	O	O
Epstein-Barr	NOUN	O	O
Virus	NOUN	O	O
Status	NOUN	O	O
Predict	NOUN	O	O
Clinical	ADJ	O	O
Outcomes	NOUN	O	O
in	ADP	O	O
Stage	NOUN	O	O
II/III	NOUN	O	O
Gastric	ADJ	O	O
Cancer:	NOUN	O	O
Results	NOUN	O	O
from	ADP	O	O
CLASSIC	ADJ	O	O
Trial.	NOUN	O	O

The	DET	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
achieve	NOUN	O	I-outcome
1-lung	ADV	O	I-outcome
ventilation	NOUN	O	I-outcome
with	ADP	O	O
the	DET	O	O
VDT	NOUN	O	O
was	VERB	O	O
58.5	NUM	O	O
+/-	SYM	O	O
21.5	NUM	O	O
(mean	NUM	O	O
+/-	SYM	O	O
SD)	NOUN	O	O
seconds,	NOUN	O	O
the	DET	O	O
VST	NOUN	O	O
was	VERB	O	O
38.2	NUM	O	O
+/-	SYM	O	O
10.1	NUM	O	O
(mean	NUM	O	O
+/-	SYM	O	O
SD)	NOUN	O	O
seconds,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
DT	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
195.5	NUM	O	O
+/-	SYM	O	O
40.3	NUM	O	O
(mean	NUM	O	O
+/-	SYM	O	O
SD)	NOUN	O	O
seconds.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
3	NUM	O	O
sessions	NOUN	O	O
per	ADP	O	O
week	NOUN	O	O
of	ADP	O	O
SPT	NOUN	O	O
for	ADP	O	O
8	NUM	O	O
weeks.	NOUN	O	O

The	DET	O	O
effectiveness	NOUN	O	O
is	VERB	O	O
satisfactory.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101213729	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
82	NUM	O	O
older	ADJ	O	O
adults	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
3	NUM	O	O
groups:	NOUN	O	O
a	DET	O	O
HIIT	NOUN	O	O
group	NOUN	O	O
(n=28),	NOUN	O	O
a	DET	O	O
continuous	ADJ	O	O
intensity	NOUN	O	O
training	VERB	O	O
group	NOUN	O	O
(MIIT	NOUN	O	O
group,	NOUN	O	O
n=27),	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG,	NOUN	O	O
n=27).	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
Department	NOUN	O	O
of	ADP	O	O
Veterans	NOUN	O	O
Affairs	NOUN	O	O
Cooperative	ADJ	O	O
Studies	NOUN	O	O
Program;	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT01265550.).	NOUN	O	O

Journal-Name:Nan	NOUN	O	O
fang	NOUN	O	O
yi	ADP	O	O
ke	NOUN	O	O
da	NOUN	O	O
xue	NOUN	O	O
xue	NOUN	O	O
bao	NOUN	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
Southern	NOUN	O	O
Medical	ADJ	O	O
University	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/09/01	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Participants	NOUN	O	O
underwent	VERB	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
depression	NOUN	O	B-outcome
evaluation,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
measurements	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervals	NOUN	O	B-outcome
between	ADP	O	Seperator
consecutive	ADJ	O	I-outcome
heartbeats	NOUN	O	I-outcome
or	CCONJ	O	O
RR	NOUN	O	B-outcome
intervals	NOUN	O	I-outcome
for	ADP	O	O
the	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
HRV	NOUN	O	B-outcome
at	ADP	O	O
the	DET	O	O
first	ADV	O	O
and	CCONJ	O	O
the	DET	O	O
last	NOUN	O	O
weeks	NOUN	O	O
of	ADP	O	O
hospitalization	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
preterms.	NOUN	O	O

The	DET	O	O
therapeutic	ADJ	O	O
benefits	NOUN	O	O
of	ADP	O	O
LOWFODMAP	NOUN	O	O
diets	NOUN	O	O
in	ADP	O	O
recreational	ADJ	O	O
and	CCONJ	O	O
trained	VERB	O	O
athletes	NOUN	O	O
during	ADP	O	O
sustained	VERB	O	O
training	VERB	O	O
periods	NOUN	O	O
warrants	NOUN	O	O
further	ADV	O	O
investigation.	NOUN	O	O

Journal-Name:JSLS	NOUN	O	O
:	PUNCT	O	O
Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
Society	NOUN	O	O
of	ADP	O	O
Laparoendoscopic	ADJ	O	O
Surgeons	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

When	ADP	O	O
the	DET	O	O
endometrium	NOUN	O	B-outcome
thickness	NOUN	O	I-outcome
reached	VERB	O	O
>/=7	ADJ	O	O
mm,	NOUN	O	O
embryo	NOUN	O	O
transfer	NOUN	O	O
was	VERB	O	O
done.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
test	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
Gua	NOUN	O	O
Sha	NOUN	O	O
therapy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/27	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

BACKGROUND:	NOUN	O	O
Mental	ADJ	O	O
health	NOUN	O	O
disorders	NOUN	O	O
among	ADP	O	O
adolescents	NOUN	O	O
have	VERB	O	O
emerged	VERB	O	O
as	ADP	O	O
a	DET	O	O
major	ADJ	O	O
public	ADJ	O	O
health	NOUN	O	O
issue	NOUN	O	O
in	ADP	O	O
many	DET	O	O
low	ADJ	O	O
and	CCONJ	O	O
middle-income	NOUN	O	O
countries,	NOUN	O	O
including	VERB	O	O
India.	NOUN	O	O

LESSONS	NOUN	O	O
LEARNED:	NOUN	O	O
It	PRON	O	O
is	VERB	O	O
feasible	ADJ	O	O
to	PART	O	O
engage	NOUN	O	O
and	CCONJ	O	O
maintain	NOUN	O	O
a	DET	O	O
network	NOUN	O	O
of	ADP	O	O
CBOs	NOUN	O	O
linked	VERB	O	O
with	ADP	O	O
a	DET	O	O
local	ADJ	O	O
health	NOUN	O	O
system.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
Numeric	ADJ	O	O
rating	VERB	O	O
scale	NOUN	O	O
of	ADP	O	O
group	NOUN	O	O
O	NOUN	O	O
in	ADP	O	O
the	DET	O	O
PACU	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
(P	NUM	O	O
<.05);	NOUN	O	O
fewer	ADJ	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
O	NOUN	O	O
required	VERB	O	O
additional	ADJ	O	O
fentanyl	NOUN	O	B-outcome
boluses	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
PACU	NOUN	O	O
(P	NUM	O	O
<.05).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Treatment	NOUN	O	O
of	ADP	O	O
Plasmodium	NOUN	O	O
vivax	NOUN	O	O
malaria	NOUN	O	O
requires	NOUN	O	O
the	DET	O	O
clearing	VERB	O	O
of	ADP	O	O
asexual	ADJ	O	O
parasites,	NOUN	O	O
but	CCONJ	O	O
relapse	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
prevented	VERB	O	O
only	ADV	O	O
if	ADP	O	O
dormant	ADJ	O	O
hypnozoites	NOUN	O	O
are	VERB	O	O
cleared	VERB	O	O
from	ADP	O	O
the	DET	O	O
liver	NOUN	O	O
(a	PUNCT	O	O
treatment	NOUN	O	O
termed	VERB	O	O
"radical	ADJ	O	O
cure").	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101303164	NUM	O	O

Patient	NOUN	O	O
survival	NOUN	O	O
of	ADP	O	O
SPC-prognosis	NOUN	O	O
was	VERB	O	O
well	ADV	O	O
stratified	VERB	O	O
regardless	ADV	O	O
of	ADP	O	O
EBV	NOUN	O	O
status	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
microsatellite	NOUN	O	O
stable	ADJ	O	O
(MSS)	PUNCT	O	O
group,	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
in	ADP	O	O
MSI-high	NOUN	O	O
group.	VERB	O	O

Appropriate	ADJ	O	O
interim	ADJ	O	O
analyses	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
conducted	VERB	O	O
by	ADP	O	O
a	DET	O	O
data	NOUN	O	O
monitoring	VERB	O	O
and	CCONJ	O	O
ethics	NOUN	O	O
committee	NOUN	O	O
(DMEC),	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
final	ADJ	O	O
test	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
an	DET	O	O
intention-to-treat	NOUN	O	O
analysis.	NOUN	O	O

Title:	NOUN	O	O
Resin-modified	VERB	O	O
glass	NOUN	O	O
ionomer	NOUN	O	O
cement	NOUN	O	O
vs	CCONJ	O	O
composite	NOUN	O	O
for	ADP	O	O
orthodontic	ADJ	O	O
bonding:	NOUN	O	O
A	DET	O	O
multicenter,	NOUN	O	O
single-blind,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Head	NOUN	O	O
to	PART	O	O
head	NOUN	O	O
trials	NOUN	O	O
of	ADP	O	O
clinical	ADJ	O	O
outcomes	NOUN	O	O
of	ADP	O	O
sirolimus	NOUN	O	O
eluting	VERB	O	O
polymer	NOUN	O	O
free	ADJ	O	O
vs.	CCONJ	O	O
biodegradable	ADJ	O	O
polymer	NOUN	O	O
stents	NOUN	O	O
are	VERB	O	O
lacking.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Equivalence	NOUN	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Exhausted	VERB	O	O
cluster	NOUN	O	O
of	ADP	O	O
differentiation	NOUN	O	O
(CD)8+	NOUN	O	O
T	NOUN	O	O
cells	NOUN	O	O
lose	NOUN	O	O
immunological	ADJ	O	O
activity	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
mitochondrial	ADJ	O	O
dysfunction	NOUN	O	O
caused	VERB	O	O
by	ADP	O	O
peroxisome	NOUN	O	O
proliferatoractivated	VERB	O	O
receptor	NOUN	O	O
gamma	NOUN	O	O
coactivator	NOUN	O	O
1alpha	NOUN	O	O
(PGC1alpha)	NOUN	O	O
inactivation,	NOUN	O	O
resulting	VERB	O	O
in	ADP	O	O
a	DET	O	O
poor	ADJ	O	O
prognosis	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
cancer.	NOUN	O	O

PURPOSE:	NOUN	O	O
Trachoma,	ADP	O	O
caused	VERB	O	O
by	ADP	O	O
repeated	VERB	O	O
ocular	ADJ	O	O
infection	NOUN	O	O
with	ADP	O	O
Chlamydia	NOUN	O	O
trachomatis,	NOUN	O	O
is	VERB	O	O
the	DET	O	O
leading	VERB	O	O
infectious	ADJ	O	O
cause	ADP	O	O
of	ADP	O	O
blindness	NOUN	O	O
worldwide	ADJ	O	O
and	CCONJ	O	O
is	VERB	O	O
targeted	VERB	O	O
for	ADP	O	O
elimination	NOUN	O	O
as	ADP	O	O
a	DET	O	O
public	ADJ	O	O
health	NOUN	O	O
problem.	NOUN	O	O

Secondary	ADJ	O	O
objectives	NOUN	O	O
were	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
atorvastatin	NOUN	O	O
40mg	NOUN	O	O
vs	CCONJ	O	O
80mg	NOUN	O	O
on	ADP	O	O
HDL-C	NOUN	O	B-outcome
and	CCONJ	O	O
triglycerides	NOUN	O	B-outcome
and	CCONJ	O	O
also	ADV	O	O
comparing	VERB	O	O
of	ADP	O	O
side	NOUN	O	B-outcome
effects	NOUN	O	I-outcome
(	PUNCT	O	O
myopathy	NOUN	O	B-outcome
,	PUNCT	O	O
hepatotoxicity	NOUN	O	B-outcome
and	CCONJ	O	O
new	ADJ	O	B-outcome
onset	NOUN	O	I-outcome
diabetes	NOUN	O	I-outcome
mellitus	NOUN	O	I-outcome
)	PUNCT	O	O
of	ADP	O	O
both	CCONJ	O	O
doses.	NOUN	O	O

2015;35(3):	NUM	O	O
R17-R34).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
main	ADJ	O	O
finding	VERB	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
is	VERB	O	O
that	ADP	O	O
CAF	NOUN	O	O
ingestion	NOUN	O	O
increases	NOUN	O	O
movement	NOUN	O	B-outcome
velocity	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
bar	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
eccentric	ADJ	O	O
phase	NOUN	O	O
of	ADP	O	O
the	DET	O	O
movement,	NOUN	O	O
what	DET	O	O
results	NOUN	O	O
in	ADP	O	O
shortening	VERB	O	O
of	ADP	O	O
the	DET	O	O
time	NOUN	O	B-outcome
under	ADP	O	Seperator
tension	NOUN	O	I-outcome
(TUT)	PUNCT	O	I-outcome
needed	VERB	O	O
for	ADP	O	O
performing	VERB	O	O
a	DET	O	O
specific	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
repetitions,	NOUN	O	O
without	ADP	O	O
decreasing	VERB	O	O
power	NOUN	O	B-outcome
and	CCONJ	O	O
velocity	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
CON	NOUN	O	O
phase	NOUN	O	O
of	ADP	O	O
the	DET	O	O
movement.	NOUN	O	O

J	NOUN	O	O
Drugs	NOUN	O	O
Dermatol.	NOUN	O	O

Results:	NOUN	O	O
Among	ADP	O	O
559	NUM	O	O
randomized	VERB	O	O
participants	NOUN	O	O
(mean	NUM	O	O
age,	NOUN	O	O
67	NUM	O	O
years;	NOUN	O	O
277	NUM	O	O
[50%]	NUM	O	O
women),	NOUN	O	O
556	NUM	O	O
(99.5%)	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
trial	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
analysis.	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
blood	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
(MBP),	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
SpO2	NOUN	O	B-outcome
,	PUNCT	O	O
Observer's	NOUN	O	O
Assessment	NOUN	O	O
of	ADP	O	O
Alertness	ADP	O	B-outcome
/	SYM	O	O
Sedation	NOUN	O	B-outcome
(OAA/S)],	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
indicators	NOUN	O	O
of	ADP	O	O
psychological	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
of	ADP	O	O
brain	NOUN	O	O
functional	ADJ	O	O
state	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
(including	PUNCT	O	O
the	DET	O	O
wavelet	NOUN	O	B-outcome
index	NOUN	O	O
[WLi],	NOUN	O	O
anxiety	NOUN	O	B-outcome
index	NOUN	O	O
[ANXi],	NOUN	O	O
comfortable	ADJ	O	B-outcome
index	NOUN	O	O
[CFi]	PUNCT	O	O
and	CCONJ	O	O
pain	NOUN	O	B-outcome
index	NOUN	O	O
[Pi])	NOUN	O	O
were	VERB	O	O
recorded	VERB	O	O
at	ADP	O	O
5	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
entering	VERB	O	O
the	DET	O	O
operating	VERB	O	O
room	NOUN	O	O
(T0),	PUNCT	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
lumbar	ADJ	O	O
puncture	NOUN	O	O
(T1)	NOUN	O	O
and	CCONJ	O	O
change	NOUN	O	O
to	PART	O	O
supine	NOUN	O	O
position	NOUN	O	O
after	ADP	O	O
the	DET	O	O
puncture	NOUN	O	O
(T2),	PUNCT	O	O
at	ADP	O	O
20	NUM	O	O
s	NOUN	O	O
(T3),	PUNCT	O	O
40	NUM	O	O
s	NOUN	O	O
(T4),	PUNCT	O	O
and	CCONJ	O	O
60	NUM	O	O
s	NOUN	O	O
(T5)	NUM	O	O
after	ADP	O	O
intravenous	ADJ	O	O
administration,	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
2	NUM	O	O
min	NOUN	O	O
(T6),	PUNCT	O	O
4	NUM	O	O
min	NOUN	O	O
(T5),	PUNCT	O	O
6	NUM	O	O
min	NOUN	O	O
(T8),	PUNCT	O	O
8	NUM	O	O
min	NOUN	O	O
(T9),	PUNCT	O	O
10	NUM	O	O
min	NOUN	O	O
(T10)	NUM	O	O
and	CCONJ	O	O
40	NUM	O	O
min	NOUN	O	O
(T11)	ADP	O	O
after	ADP	O	O
skin	NOUN	O	O
incision.	ADV	O	O

Repeated-measures	NOUN	O	O
ANOVA	NOUN	O	O
with	ADP	O	O
group	NOUN	O	O
factor	NOUN	O	O
(GC	NOUN	O	O
and	CCONJ	O	O
GVD3)	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
if	ADP	O	O
the	DET	O	O
interaction	NOUN	O	O
of	ADP	O	O
the	DET	O	O
different	ADJ	O	O
values	NOUN	O	O
was	VERB	O	O
the	DET	O	O
same	ADJ	O	O
or	CCONJ	O	O
different	ADJ	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
throughout	ADV	O	O
the	DET	O	O
study	NOUN	O	O
(time	NOUN	O	O
x	SYM	O	O
group)	ADJ	O	O
after	ADP	O	O
vitamin	NOUN	O	O
D3	NOUN	O	O
treatment.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
Mindfulness-Based	VERB	O	O
Cognitive	ADJ	O	O
Therapy	NOUN	O	O
(MBCT)	NUM	O	O
on	ADP	O	O
the	DET	O	O
Illness	NOUN	O	B-outcome
Perception	NOUN	O	I-outcome
(IP)	NOUN	O	I-outcome
and	CCONJ	O	O
Psychological	ADJ	O	B-outcome
Symptoms	NOUN	O	I-outcome
(PS)	NOUN	O	I-outcome
for	ADP	O	O
Patients	NOUN	O	O
in	ADP	O	O
primary	ADJ	O	O
care	NOUN	O	O
with	ADP	O	O
an	DET	O	O
active	ADJ	O	O
symptom	NOUN	O	O
of	ADP	O	O
Rheumatoid	NOUN	O	O
Arthritis	NOUN	O	O
(RA).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
long-term	NOUN	O	O
efficacy	NOUN	O	O
of	ADP	O	O
tenofovir	NOUN	O	O
and	CCONJ	O	O
entecavir	NOUN	O	O
in	ADP	O	O
nucleos(t)ide	NOUN	O	O
analogue-naive	ADJ	O	O
HBeAg-positive	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
hepatitis	NOUN	O	O
B:	NOUN	O	O
A	DET	O	O
large,	ADV	O	O
multicentre,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trials.	NOUN	O	O

RESULTS:	NOUN	O	O
menthol	NOUN	O	O
chewing	VERB	O	O
gum	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
the	DET	O	O
intensity	NOUN	O	O
(p	PUNCT	O	O
<0.001),	NOUN	O	O
with	ADP	O	O
Cohen's	NOUN	O	O
medium-effect	NOUN	O	O
d,	NOUN	O	O
and	CCONJ	O	O
thirst	ADV	O	B-outcome
discomfort	NOUN	O	I-outcome
(p	PUNCT	O	O
<0.001),	NOUN	O	O
with	ADP	O	O
a	DET	O	O
large-effect	NOUN	O	O
Cohen's	NOUN	O	O
d.	NOUN	O	O
CONCLUSION:	NOUN	O	O
menthol	NOUN	O	O
chewing	VERB	O	O
gum	NOUN	O	O
was	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
reducing	VERB	O	O
the	DET	O	O
intensity	NOUN	O	B-outcome
and	CCONJ	O	Seperator
discomfort	NOUN	O	B-outcome
of	ADP	O	I-outcome
preoperative	ADJ	O	I-outcome
thirst	ADV	O	E3-outcome
.	PUNCT	O	O
The	DET	O	O
strategy	NOUN	O	O
proved	VERB	O	O
to	PART	O	O
be	VERB	O	O
an	DET	O	O
innovative,	NOUN	O	O
feasible	ADJ	O	B-outcome
and	CCONJ	O	O
safe	ADJ	O	O
option	NOUN	O	O
in	ADP	O	O
the	DET	O	O
use	NOUN	O	O
for	ADP	O	O
the	DET	O	O
surgical	ADJ	O	O
patient,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
the	DET	O	O
preoperative	ADJ	O	O
thirst,	NOUN	O	O
in	ADP	O	O
elective	ADJ	O	O
surgeries.	NUM	O	O

Also	ADV	O	O
the	DET	O	O
frequency	NOUN	O	O
of	ADP	O	O
the	DET	O	O
troponin	NOUN	O	B-outcome
increase	NOUN	O	O
above	ADP	O	O
the	DET	O	O
UNL(upper	ADP	O	O
normal	ADJ	O	O
level)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
nicorandal	ADJ	O	O
group,	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.03)	NUM	O	O
lower	ADJ	O	O
(in	NUM	O	O
62%	NUM	O	O
of	ADP	O	O
cases	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
85%	NOUN	O	O
of	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group).	NOUN	O	O

Title:	NOUN	O	O
"We	NOUN	O	O
have	VERB	O	O
to	PART	O	O
clean	NOUN	O	O
ourselves	NOUN	O	O
to	PART	O	O
ensure	NOUN	O	O
that	ADP	O	O
our	ADJ	O	O
children	NOUN	O	O
are	VERB	O	O
healthy	ADJ	O	O
and	CCONJ	O	O
beautiful":	ADJ	O	O
findings	NOUN	O	O
from	ADP	O	O
a	DET	O	O
qualitative	ADJ	O	O
assessment	NOUN	O	O
of	ADP	O	O
a	DET	O	O
hand	NOUN	O	O
hygiene	NOUN	O	O
poster	NOUN	O	O
in	ADP	O	O
rural	ADJ	O	O
Uganda.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
a	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
contralateral	ADJ	O	O
eye	NOUN	O	O
study	NOUN	O	O
of	ADP	O	O
LASIK	NOUN	O	O
versus	CCONJ	O	O
SMILE	NOUN	O	O
procedures,	NOUN	O	O
21	NUM	O	O
consecutive	ADJ	O	O
patients	NOUN	O	O
(42	VERB	O	O
eyes)	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
with	ADP	O	O
corneal	ADJ	O	O
epithelial	ADJ	O	O
mapping	VERB	O	O
by	ADP	O	O
anterior	ADJ	O	O
segment	NOUN	O	O
optical	ADJ	O	O
coherence	NOUN	O	O
tomography	NOUN	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
2	NUM	O	O
years.	NOUN	O	O

The	DET	O	O
subjects	NOUN	O	O
in	ADP	O	O
D1	NOUN	O	O
and	CCONJ	O	O
D2	NOUN	O	O
groups	NOUN	O	O
must	VERB	O	O
consume	NOUN	O	O
the	DET	O	O
congee	ADP	O	O
containing	VERB	O	O
the	DET	O	O
combined	VERB	O	O
extract	NOUN	O	O
of	ADP	O	O
M.	NOUN	O	O
alba	NOUN	O	O
and	CCONJ	O	O
P.	NOUN	O	O
odoratum	NOUN	O	O
leaves	NOUN	O	O
at	ADP	O	O
doses	NOUN	O	O
of	ADP	O	O
50	NUM	O	O
and	CCONJ	O	O
1500	NUM	O	O
mg/day,	NOUN	O	O
respectively.	NOUN	O	O

Single-step	NUM	O	O
advancement	ADJ	O	O
was	VERB	O	O
achieved	NOUN	O	O
in	ADP	O	O
the	DET	O	O
MA	NOUN	O	O
group	NOUN	O	O
until	ADP	O	O
an	DET	O	O
edge-to-edge	NOUN	O	O
incisor	NOUN	O	O
relationship	NOUN	O	O
or	CCONJ	O	O
an	DET	O	O
overcorrected	VERB	O	O
Class	NOUN	O	O
I	NUM	O	O
molar	ADJ	O	O
relationship	NOUN	O	O
was	VERB	O	O
obtained.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/22	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Respiratory	ADJ	O	O
mechanical	ADJ	O	O
indices	NOUN	O	O
[	PUNCT	O	O
peak	NOUN	O	B-outcome
airway	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
(Ppeak)	ADP	O	I-outcome
,	PUNCT	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
(VTi)	NOUN	O	I-outcome
,	PUNCT	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
(VTe)	NOUN	O	I-outcome
were	VERB	O	O
recorded	VERB	O	O
before	ADP	O	O
atomization	NOUN	O	O
(atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
was	VERB	O	O
0)	NOUN	O	O
and	CCONJ	O	O
10	NUM	O	O
minutes	NOUN	O	O
after	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
atomization	NOUN	O	O
under	ADP	O	O
the	DET	O	O
condition	NOUN	O	O
of	ADP	O	O
7	NUM	O	O
L/min	NOUN	O	O
and	CCONJ	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
respectively.	NOUN	O	O
(	PUNCT	O	O

RESULTS:	NOUN	O	O
Among	ADP	O	O
all	DET	O	O
the	DET	O	O
250	NUM	O	O
patients	NOUN	O	O
examined	VERB	O	O
156	NUM	O	O
women	NOUN	O	O
were	VERB	O	O
eligible	ADJ	O	O
for	ADP	O	O
study	NOUN	O	O
and	CCONJ	O	O
finally	ADV	O	O
120	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
allocated	VERB	O	O
to	PART	O	O
intervention	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
60)	ADP	O	O
and	CCONJ	O	O
control	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
60)	ADP	O	O
groups.	NOUN	O	O

The	DET	O	O
between-group	NOUN	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
was	VERB	O	O
not	ADV	O	O
significant	ADJ	O	O
(146	PUNCT	O	O
of	ADP	O	O
527	NUM	O	O
participants	NOUN	O	O
[27.7%]	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intravenous	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
138	NUM	O	O
of	ADP	O	O
527	NUM	O	O
[26.2%]	NOUN	O	O
in	ADP	O	O
the	DET	O	O
oral	ADJ	O	O
group;	ADJ	O	O
P=0.58).	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION	NOUN	O	O
NUMBER:	NOUN	O	O
www.clinicaltrials.gov	NOUN	O	O
NCT02011958.	NOUN	O	O

Data	NOUN	O	O
collection	NOUN	O	O
instruments	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
demographic	ADJ	O	O
information	NOUN	O	O
and	CCONJ	O	O
Strategies	NOUN	O	O
Used	VERB	O	O
by	ADP	O	O
People	NOUN	O	O
to	PART	O	O
Promote	NOUN	O	O
Health	NOUN	O	O
questionnaires.	ADP	O	O

Journal-Name:Zhongguo	NOUN	O	O
fei	ADV	O	O
ai	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Chinese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
lung	NOUN	O	O
cancer	NOUN	O	O

MAIN	ADJ	O	O
OUTCOME	NOUN	O	O
MEASURES:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
Roland-Morris	NOUN	O	O
Disability	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(RMDQ)	NOUN	O	O
score	NOUN	O	O
(range	PUNCT	O	O
0-24)	NOUN	O	O
at	ADP	O	O
one	NUM	O	O
year	NOUN	O	O
follow-up	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intention	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
population.	ADV	O	O

PMID:	NOUN	O	O
31609293	NUM	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
analyze	NOUN	O	O
the	DET	O	O
response	NOUN	O	O
of	ADP	O	O
selected	VERB	O	O
components	NOUN	O	O
of	ADP	O	O
the	DET	O	O
immune	ADJ	O	O
system	NOUN	O	O
in	ADP	O	O
rowers	NOUN	O	O
to	PART	O	O
maximal	ADJ	O	O
physical	ADJ	O	O
exercise,	NOUN	O	O
and	CCONJ	O	O
to	PART	O	O
verify	NOUN	O	O
if	ADP	O	O
this	DET	O	O
response	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
modulated	VERB	O	O
by	ADP	O	O
supplementation	NOUN	O	O
with	ADP	O	O
L-theanine.	NUM	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
NCT03288623.	NOUN	O	O

The	DET	O	O
appointment	ADJ	O	O
of	ADP	O	O
the	DET	O	O
oral	ADJ	O	O
form	NOUN	O	O
of	ADP	O	O
nicorandil	NOUN	O	O
(Cordinic,	PUNCT	O	O
PIQ-FHARMA	NOUN	O	O
LLC)	NOUN	O	O
for	ADP	O	O
2	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
day	NOUN	O	O
before	ADP	O	O
PCI	NOUN	O	O
30	NUM	O	O
mg/day,	NOUN	O	O
then	ADV	O	O
20	NUM	O	O
mg	NOUN	O	O
2	NUM	O	O
hours	NOUN	O	O
before	ADP	O	O
the	DET	O	O
PCI	NOUN	O	O
and	CCONJ	O	O
10	NUM	O	O
mg	NOUN	O	O
after	ADP	O	O
6	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
the	DET	O	O
surgery	NOUN	O	O
reduces	NOUN	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
intraoperative	ADJ	O	O
myocardial	ADJ	O	B-outcome
damage	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
obtained	VERB	O	O
data	NOUN	O	O
give	ADJ	O	O
an	DET	O	O
opportunity	NOUN	O	O
to	PART	O	O
extend	NOUN	O	O
the	DET	O	O
indications	NOUN	O	O
for	ADP	O	O
nicorandil's	NOUN	O	O
appointment	ADJ	O	O
in	ADP	O	O
the	DET	O	O
drug	NOUN	O	O
support	NOUN	O	O
during	ADP	O	O
PCI	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
stable	ADJ	O	O
coronary	ADJ	O	O
artery	NOUN	O	O
disease.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

However,	ADV	O	O
individuals	NOUN	O	O
who	ADP	O	O
met	VERB	O	O
in-person	NOUN	O	O
with	ADP	O	O
a	DET	O	O
faculty	NOUN	O	O
member	NOUN	O	O
rated	VERB	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
communication	NOUN	O	B-outcome
higher	ADJ	O	O
than	ADP	O	O
those	DET	O	O
who	ADP	O	O
met	VERB	O	O
via	ADP	O	O
videoconference	NOUN	O	O
(p=0.0002),	PUNCT	O	O
while	ADP	O	O
those	DET	O	O
who	ADP	O	O
met	VERB	O	O
online	ADP	O	O
rated	VERB	O	O
convenience	NOUN	O	B-outcome
higher	ADJ	O	O
than	ADP	O	O
those	DET	O	O
who	ADP	O	O
met	VERB	O	O
in-person	NOUN	O	O
(p<0.0001).	PUNCT	O	O

There	PRON	O	O
was	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different	ADJ	O	O
in	ADP	O	O
the	DET	O	O
patient	NOUN	O	O
satisfaction	NOUN	O	B-outcome
of	ADP	O	O
analgesia,	NOUN	O	O
incidence	NOUN	O	O
of	ADP	O	O
side	NOUN	O	B-outcome
effects	NOUN	O	I-outcome
,	PUNCT	O	O
neonatal	ADJ	O	B-outcome
outcomes	NOUN	O	O
and	CCONJ	O	O
neurological	ADJ	O	B-outcome
deficit	ADP	O	I-outcome
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHOD:	NOUN	O	O
Thirty	NUM	O	O
individuals	NOUN	O	O
with	ADP	O	O
ALS	NOUN	O	O
(18	NOUN	O	O
men	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
women,	NOUN	O	O
mean	NOUN	O	O
age	NOUN	O	O
59	NUM	O	O
years,	NOUN	O	O
range	NOUN	O	O
44-74	NUM	O	O
years)	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
26,	NUM	O	O
(minimum	NUM	O	O
score	NOUN	O	O
of	ADP	O	O
14	NUM	O	O
and	CCONJ	O	O
maximum	NOUN	O	O
41)	NOUN	O	O
on	ADP	O	O
the	DET	O	O
Revised	VERB	O	O
Amyotrophic	ADJ	O	O
Lateral	ADJ	O	O
Sclerosis	NOUN	O	O
Functional	ADJ	O	O
Rating	VERB	O	O
Scale	NOUN	O	O
(ALSFRS-R)	NUM	O	O
and	CCONJ	O	O
30	NUM	O	O
healthy	ADJ	O	O
controls	NOUN	O	O
matched	VERB	O	O
for	ADP	O	O
age	NOUN	O	O
and	CCONJ	O	O
gender,	NOUN	O	O
participated.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

At	ADP	O	O
+25d,	NUM	O	O
post-exercise	NOUN	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(p=0.01)	PUNCT	O	O
and	CCONJ	O	O
physiological	ADJ	O	B-outcome
strain	NOUN	O	I-outcome
index	NOUN	O	O
(p<0.05)	NOUN	O	O
but	CCONJ	O	O
neither	CCONJ	O	O
Tre	PUNCT	O	B-outcome
(p=0.18)	NOUN	O	O
nor	CCONJ	O	O
sweat	NOUN	O	B-outcome
rate	NOUN	O	O
(p=0.44)	NOUN	O	O
were	VERB	O	O
lower	ADJ	O	O
in	ADP	O	O
IHE	NOUN	O	O
vs.	CCONJ	O	O
CON.	NOUN	O	O

Sixty	NUM	O	O
patients,	NOUN	O	O
aged	VERB	O	O
50-70,	NOUN	O	O
undergoing	VERB	O	O
elective	ADJ	O	O
surgery	NOUN	O	O
for	ADP	O	O
unilateral	ADJ	O	O
lower	ADJ	O	O
extremity	NOUN	O	O
varicose	ADJ	O	O
vein	NOUN	O	O
at	ADP	O	O
Ningbo	NOUN	O	O
No.2	NOUN	O	O
Hospital,	ADJ	O	O
with	ADP	O	O
American	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Anesthesiologists	NOUN	O	O
(ASA)	NOUN	O	O
grade	NOUN	O	O
or	CCONJ	O	O
,	PUNCT	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
two	NUM	O	O
groups	NOUN	O	O
(n=30),	NOUN	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
spinal	ADJ	O	O
anesthesia	NOUN	O	O
group.	VERB	O	O

A	DET	O	O
representative	ADJ	O	O
from	ADP	O	O
the	DET	O	O
municipality,	ADJ	O	O
the	DET	O	O
manager	NOUN	O	O
at	ADP	O	O
a	DET	O	O
home-care	NOUN	O	O
centre,	NOUN	O	O
the	DET	O	O
project	NOUN	O	O
manager	NOUN	O	O
of	ADP	O	O
the	DET	O	O
weight	NOUN	O	O
loss	NOUN	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
six	NUM	O	O
health-care	NOUN	O	O
workers	NOUN	O	O
were	VERB	O	O
interviewed	VERB	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
a	DET	O	O
one-year	NOUN	O	O
weight	NOUN	O	O
loss	NOUN	O	O
intervention	NOUN	O	O
at	ADP	O	O
the	DET	O	O
workplace.	ADV	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
360	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
required	VERB	O	O
after	ADP	O	O
considering	VERB	O	O
ineligible	ADJ	O	O
cases.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

PMID:	NOUN	O	O
31597020	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101238455	NUM	O	O

Funded	VERB	O	O
by	ADP	O	O
GlaxoSmithKline	NOUN	O	O
and	CCONJ	O	O
Medicines	NOUN	O	O
for	ADP	O	O
Malaria	NOUN	O	O
Venture;	NOUN	O	O
GATHER	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02216123	NOUN	O	O
.).	NOUN	O	O

Journal-Name:Reproductive	ADJ	O	O
biology	NOUN	O	O
and	CCONJ	O	O
endocrinology	NOUN	O	O
:	PUNCT	O	O
RB&E	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Ginger	NOUN	O	O
and	CCONJ	O	O
Novafen	NOUN	O	O
on	ADP	O	O
menstrual	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
:	PUNCT	O	O
A	DET	O	O
cross-over	NOUN	O	O
trial.	NOUN	O	O

Nausea	NOUN	O	B-outcome
scores	NOUN	O	O
at	ADP	O	O
the	DET	O	O
24th	ADJ	O	O
postoperative	ADJ	O	O
hour	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
OSTAP	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
Sham	NOUN	O	O
group	NOUN	O	O
CONCLUSION::	ADJ	O	O
We	PRON	O	O
concluded	VERB	O	O
that	ADP	O	O
bilateral	ADJ	O	O
US-guided	VERB	O	O
OSTAP	NOUN	O	O
blocks	NOUN	O	O
reduced	VERB	O	O
24th	ADJ	O	O
hour	NOUN	O	O
tramadol	NOUN	O	B-outcome
requirements	NOUN	O	O
and	CCONJ	O	O
VAS	NOUN	O	O
scores	NOUN	O	O
after	ADP	O	O
laparoscopic	ADJ	O	O
hysterectomy.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/19	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

A	DET	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
has	VERB	O	O
begun	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
neoadjuvant	ADJ	O	O
chemotherapy	NOUN	O	O
using	VERB	O	O
gemcitabine	NOUN	O	O
and	CCONJ	O	O
S-1	NOUN	O	O
with	ADP	O	O
upfront	ADP	O	O
surgery	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
planned	VERB	O	O
resection	NOUN	O	O
of	ADP	O	O
pancreatic	ADJ	O	O
cancer.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Comparing	VERB	O	O
the	DET	O	O
groups,	NOUN	O	O
the	DET	O	O
slow	ADJ	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(p=0.0027)	ADP	O	O
and	CCONJ	O	O
forced	VERB	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(p=0.0028)	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
treatments,	ADV	O	O
while	ADP	O	O
the	DET	O	O
PAR-G	NOUN	O	O
showed	VERB	O	O
smaller	ADJ	O	O
declines	NOUN	O	O
in	ADP	O	O
these	DET	O	O
capacities.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101627676	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
pain	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
,	PUNCT	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
visual	ADJ	O	O
analog	NOUN	O	O
scale	NOUN	O	O
(VAS).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101088661	NUM	O	O

Results:	NOUN	O	O
One	NUM	O	O
month	NOUN	O	O
after	ADP	O	O
induction	NOUN	O	O
chemotherapy,	NOUN	O	O
the	DET	O	O
overall	ADJ	O	O
response	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
96.7%	NUM	O	O
in	ADP	O	O
the	DET	O	O
CC	NOUN	O	O
group	NOUN	O	O
versus	CCONJ	O	O
73.3%	NUM	O	O
in	ADP	O	O
the	DET	O	O
RC	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.011).	NUM	O	O

CONCLUSIONS:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
survival	NOUN	O	B-outcome
without	ADP	O	O
moderate	ADJ	O	O
or	CCONJ	O	O
severe	ADJ	O	O
neurodevelopmental	ADJ	O	B-outcome
disability	NOUN	O	I-outcome
at	ADP	O	O
24	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
very	ADV	O	O
preterm	NOUN	O	O
or	CCONJ	O	O
very-low-birth-weight	NOUN	O	O
infants	NOUN	O	O
with	ADP	O	O
a	DET	O	O
strategy	NOUN	O	O
of	ADP	O	O
advancing	VERB	O	O
milk	NOUN	O	O
feeding	VERB	O	O
volumes	NOUN	O	O
in	ADP	O	O
daily	ADJ	O	O
increments	NOUN	O	O
of	ADP	O	O
30	NUM	O	O
ml	NOUN	O	O
per	ADP	O	O
kilogram	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
18	NUM	O	O
ml	NOUN	O	O
per	ADP	O	O
kilogram.	NOUN	O	O
(	PUNCT	O	O

Less	ADV	O	O
onerous	ADJ	O	O
PT	NOUN	O	O
wear	ADJ	O	O
regimens	NOUN	O	O
may	VERB	O	O
therefore	ADV	O	O
be	VERB	O	O
a	DET	O	O
viable	ADJ	O	O
alternative	ADJ	O	O
to	PART	O	O
FT	NOUN	O	O
wear	ADJ	O	O
of	ADP	O	O
removable	ADJ	O	O
functional	ADJ	O	O
appliances.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/04	PUNCT	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal-Name:Medicine	NOUN	O	O

Postmenopausal	NOUN	O	O
overweight	NUM	O	O
women	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
a	DET	O	O
diet	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
97),	NOUN	O	O
exercise	NOUN	O	O
plus	CCONJ	O	O
diet	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
98)	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
48).	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
study	NOUN	O	O
of	ADP	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
a	DET	O	O
therapeutic	ADJ	O	O
education	NOUN	O	O
program	NOUN	O	O
on	ADP	O	O
patients	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
chronic	ADJ	O	O
low-back	NOUN	O	O
pain	NOUN	O	O
who	ADP	O	O
are	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
transcutaneous	ADJ	O	O
electrical	ADJ	O	O
nerve	NOUN	O	O
stimulation.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985213R	NOUN	O	O

The	DET	O	O
intervention	NOUN	O	O
strategy	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
higher	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
induction	NOUN	O	B-outcome
of	ADP	O	I-outcome
labour	NOUN	O	I-outcome
(1.16,	NOUN	O	O
1.04	NUM	O	O
to	PART	O	O
1.30)	NUM	O	O
and	CCONJ	O	O
a	DET	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
augmentation	NOUN	O	B-outcome
of	ADP	O	I-outcome
labour	NOUN	O	I-outcome
(0.78,	NOUN	O	O
0.71	NUM	O	O
to	PART	O	O
0.85).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9308586	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/07	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
10-week	NOUN	O	O
treatment,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
NMES	NOUN	O	O
therapy	NOUN	O	O
showed	VERB	O	O
better	ADJ	O	O
efficacy	NOUN	O	O
in	ADP	O	O
primary	ADJ	O	O
endpoints	NOUN	O	O
of	ADP	O	O
urodynamic	ADJ	O	B-outcome
values	NOUN	O	O
(P	NUM	O	O
<.01)	NOUN	O	O
and	CCONJ	O	O
Overactive	ADJ	O	B-outcome
Bladder	NOUN	O	I-outcome
Symptom	NOUN	O	I-outcome
Score	NOUN	O	O
(P	NUM	O	O
<.01),	PUNCT	O	O
and	CCONJ	O	O
secondary	ADJ	O	O
endpoints	NOUN	O	O
of	ADP	O	O
International	ADJ	O	O
Consultation	NOUN	O	O
on	ADP	O	O
Incontinence	NOUN	O	B-outcome
Questionnaire-Short	NOUN	O	O
Form	NOUN	O	O
(ICIQ-SF)	NUM	O	O
(P	NUM	O	O
<.01)	NOUN	O	O
and	CCONJ	O	O
Barthel	PROPN	O	O
Index	NOUN	O	O
(BI)	NOUN	O	O
(P	NUM	O	O
<.01),	PUNCT	O	O
compared	VERB	O	O
with	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
sham	NOUN	O	O
NMES.	NOUN	O	O

These	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
methylene	NOUN	O	O
blue	ADJ	O	O
localization	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
47),	NUM	O	O
and	CCONJ	O	O
modified	VERB	O	O
localization	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
32),	NUM	O	O
where	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
preoperative	ADJ	O	O
localization	NOUN	O	O
of	ADP	O	O
the	DET	O	O
small	ADJ	O	O
nodules	NOUN	O	O
by	ADP	O	O
CT-guided	VERB	O	O
placing	VERB	O	O
wire	NOUN	O	O
and	CCONJ	O	O
intrapleural	ADJ	O	O
fibrin	NOUN	O	O
glue	ADJ	O	O
near	ADV	O	O
the	DET	O	O
nodule	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
days	NOUN	O	O
before	ADP	O	O
the	DET	O	O
operation.	ADV	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
MRSA	NOUN	O	B-outcome
infection	NOUN	O	I-outcome
as	ADP	O	O
defined	VERB	O	O
according	ADJ	O	O
to	PART	O	O
Centers	NOUN	O	O
for	ADP	O	O
Disease	NOUN	O	O
Control	NOUN	O	O
and	CCONJ	O	O
Prevention	NOUN	O	O
(CDC)	NUM	O	O
criteria.	NOUN	O	O

The	DET	O	O
wider	ADP	O	O
use	NOUN	O	O
of	ADP	O	O
PICSI,	NOUN	O	O
therefore,	NOUN	O	O
is	VERB	O	O
not	ADV	O	O
recommended	VERB	O	O
at	ADP	O	O
present.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0372541	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/22	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
between	ADP	O	O
group	NOUN	O	O
difference	NOUN	O	O
in	ADP	O	O
child	NOUN	O	O
reported	VERB	O	O
pain	NOUN	O	B-outcome
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
12	NUM	O	O
months	NOUN	O	O
as	ADP	O	O
assessed	VERB	O	O
using	VERB	O	O
the	DET	O	O
Wong	ADP	O	O
Baker	NOUN	O	O
faces	NOUN	O	O
pain	NOUN	O	B-outcome
scale].	NOUN	O	O
Secondary	ADJ	O	O
endpoints	NOUN	O	O
were	VERB	O	O
parent	NOUN	O	O
reported	VERB	O	O
pain	NOUN	O	B-outcome
(100	NUM	O	O
mm	NOUN	O	O
visual	ADJ	O	O
analogue	NOUN	O	O
scale),	NOUN	O	O
parent	NOUN	O	O
reported	VERB	O	O
function	NOUN	O	B-outcome
(	NOUN	O	O
child	NOUN	O	O
health	NOUN	O	B-outcome
assessment	NOUN	O	O
questionnaire]),	ADP	O	O
child	NOUN	O	O
reported	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(	NOUN	O	O
child	NOUN	O	O
health	NOUN	O	B-outcome
utility	NOUN	O	O
9-dimensional	ADJ	O	O
assessment]),	NOUN	O	O
coordination	NOUN	O	B-outcome
(	NOUN	O	O
movement	NOUN	O	B-outcome
assessment	NOUN	O	O
battery	NOUN	O	O
for	ADP	O	O
children	NOUN	O	O
version	NOUN	O	O
2])	ADJ	O	O
and	CCONJ	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
(handheld	NUM	O	O
dynamometer).	NOUN	O	O

To	PART	O	O
study	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
rural	ADJ	O	O
county	NOUN	O	O
hospital	NOUN	O	O
vision	NOUN	O	O
centers	NOUN	O	O
(VC)	NOUN	O	O
on	ADP	O	O
self-reported	VERB	O	O
glasses	NOUN	O	B-outcome
ownership	NOUN	O	I-outcome
and	CCONJ	O	O
wearing	VERB	O	B-outcome
behavior	NOUN	O	I-outcome
(primary	PUNCT	O	O
outcome)	PUNCT	O	O
among	ADP	O	O
rural	ADJ	O	O
children	NOUN	O	O
in	ADP	O	O
China,	NOUN	O	O
we	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
cluster-randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
at	ADP	O	O
a	DET	O	O
VC	NOUN	O	O
in	ADP	O	O
the	DET	O	O
government	NOUN	O	O
hospital	NOUN	O	O
of	ADP	O	O
Qinan	ADP	O	O
County,	NOUN	O	O
a	DET	O	O
nationally-designated	VERB	O	O
poor	ADJ	O	O
county.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

The	DET	O	O
2nd	ADJ	O	O
dose	NOUN	O	O
was	VERB	O	O
administered	VERB	O	O
after	ADP	O	O
an	DET	O	O
interval	NOUN	O	O
of	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Journal-Name:Lancet	NOUN	O	O
(London,	PUNCT	O	O
England)	NOUN	O	O

Having	VERB	O	O
no	DET	O	O
hope	NOUN	O	O
for	ADP	O	O
the	DET	O	O
future	NOUN	O	O
was	VERB	O	O
independently	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
range	NOUN	O	O
of	ADP	O	O
factors,	NOUN	O	O
including	VERB	O	O
recent	ADJ	O	O
"eve-teasing"	PUNCT	O	O
(AOR	NUM	O	O
1.5	NUM	O	O
(1.0-2.4)),	NUM	O	O
being	VERB	O	O
engaged	VERB	O	O
(AOR	NUM	O	O
2.9	NUM	O	O
(0.9-9.7)),	PUNCT	O	O
not	ADV	O	O
participating	VERB	O	O
in	ADP	O	O
groups	NOUN	O	O
(AOR	NUM	O	O
0.5	NUM	O	O
(0.4-0.6))	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
lack	NOUN	O	O
of	ADP	O	O
emotional	ADJ	O	O
support	NOUN	O	O
(AOR	NUM	O	O
0.6	NUM	O	O
(0.4-0.7)).	NUM	O	O

Title:	NOUN	O	O
Oral	ADJ	O	O
glutamine	NOUN	O	O
supplements	NOUN	O	O
reduce	VERB	O	O
concurrent	ADJ	O	O
chemoradiotherapy-induced	VERB	O	O
esophagitis	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
non-small	ADJ	O	O
cell	NOUN	O	O
lung	NOUN	O	O
cancer.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Pre-	NOUN	O	O
and	CCONJ	O	O
co-administration	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
in	ADP	O	O
target-controlled	VERB	O	O
propofol	NOUN	O	O
and	CCONJ	O	O
remifentanil	NOUN	O	O
anesthesia	NOUN	O	O
are	VERB	O	O
the	DET	O	O
most	DET	O	O
common	ADJ	O	O
methods	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
study,	NOUN	O	O
60	NUM	O	O
children	NOUN	O	O
of	ADP	O	O
American	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Anesthesiology	NOUN	O	O
classification	NOUN	O	O
(ASA	PUNCT	O	O
I-II),	ADJ	O	O
aged	VERB	O	O
2-9	NUM	O	O
years,	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
two	NUM	O	O
equal	ADJ	O	O
groups.	NOUN	O	O

After	ADP	O	O
the	DET	O	O
self-affirmation	NOUN	O	O
manipulation	NOUN	O	O
was	VERB	O	O
administered,	NOUN	O	O
we	PRON	O	O
tracked	VERB	O	O
participants'	NOUN	O	O
eye	NOUN	O	B-outcome
movements	NOUN	O	I-outcome
while	ADP	O	O
they	PRON	O	O
viewed	VERB	O	O
images	NOUN	O	O
of	ADP	O	O
six	NUM	O	O
moderately-severe	ADV	O	O
and	CCONJ	O	O
six	NUM	O	O
highly-severe	ADJ	O	O
pictorial	ADJ	O	O
health	NOUN	O	O
warning	VERB	O	O
labels	NOUN	O	O
presented	VERB	O	O
on	ADP	O	O
large	ADJ	O	O
beer	NOUN	O	O
cans.	NUM	O	O

The	DET	O	O
optimal	ADJ	O	O
duration	NOUN	O	O
of	ADP	O	O
maintenance	NOUN	O	O
of	ADP	O	O
the	DET	O	O
ACB	NOUN	O	O
is	VERB	O	O
still	ADV	O	O
questionable.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
at	ADP	O	O
ClinicalTrials.gov,	NOUN	O	O
no.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

As	ADP	O	O
a	DET	O	O
result	VERB	O	O
of	ADP	O	O
better	ADJ	O	O
wound	NOUN	O	O
healing	VERB	O	B-outcome
,	PUNCT	O	O
the	DET	O	O
EMD-added	VERB	O	O
group	NOUN	O	O
exhibited	VERB	O	O
better	ADJ	O	O
results	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
the	DET	O	O
harmony	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
mucogingival	NOUN	O	I-outcome
junction	NOUN	O	I-outcome
between	ADP	O	Seperator
adjacent	ADJ	O	I-outcome
teeth	NOUN	O	I-outcome
.	PUNCT	O	O
This	DET	O	O
paper	NOUN	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
split-mouth	NOUN	O	O
study	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
SCTG+CAF	NUM	O	O
and	CCONJ	O	O
SCTG+CAF+EMD	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
using	VERB	O	O
RES	NOUN	O	O
in	ADP	O	O
bilateral	ADJ	O	O
canines.	NOUN	O	O

Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
was	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
questionnaires	NOUN	O	O
SF36,	NOUN	O	O
EORTC	ADJ	O	O
QLQ-C30,	ADV	O	O
and	CCONJ	O	O
EORTC	ADJ	O	O
QLQ-BR23	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
three,	NOUN	O	O
six,	ADV	O	O
and	CCONJ	O	O
nine	NUM	O	O
months.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
objectively	ADV	O	O
measured	VERB	O	O
mean	NOUN	O	O
steps/day	NOUN	O	B-outcome
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
using	VERB	O	O
a	DET	O	O
validated	VERB	O	O
pedometer	NOUN	O	O
(Yamax	NOUN	O	O
Digi-Walker	NOUN	O	O
CW-701)	NOUN	O	O
over	ADP	O	O
7	NUM	O	O
days,	NOUN	O	O
assessed	VERB	O	O
with	ADP	O	O
intention	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
analysis.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968551	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101474849	NUM	O	O

AIMS:	VERB	O	O
Cementless	NOUN	O	O
primary	ADJ	O	O
total	ADJ	O	O
hip	NOUN	O	O
arthroplasty	NOUN	O	O
(THA)	NUM	O	O
is	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
risks	NOUN	O	O
of	ADP	O	O
bleeding	VERB	O	O
and	CCONJ	O	O
thromboembolism.	NOUN	O	O

Result:There	NOUN	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
SDS	NOUN	O	O
and	CCONJ	O	O
SAS	NOUN	O	O
scores	NOUN	O	O
between	ADP	O	O
the	DET	O	O
three	NUM	O	O
groups	NOUN	O	O
P>0.05.	NOUN	O	O
[	PUNCT	O	O

Similarly,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
with	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
resting	VERB	O	B-outcome
pain	NOUN	O	I-outcome
scores	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.94	PUNCT	O	O
for	ADP	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.16	NUM	O	O
for	ADP	O	O
leg	NOUN	O	O
pain)	NOUN	O	O
and	CCONJ	O	O
movement	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
scores	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.52	PUNCT	O	O
for	ADP	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.56	NUM	O	O
for	ADP	O	O
leg	NOUN	O	O
pain).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/04	VERB	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

The	DET	O	O
dry	ADJ	O	O
needling	VERB	O	O
was	VERB	O	O
applied	VERB	O	O
in	ADP	O	O
active	ADJ	O	O
trigger	ADP	O	O
points	NOUN	O	O
located	VERB	O	O
in	ADP	O	O
the	DET	O	O
musculature	NOUN	O	O
of	ADP	O	O
the	DET	O	O
head	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
neck.	NOUN	O	O

Title:	NOUN	O	O
Music	ADJ	O	O
therapy	NOUN	O	O
intervention	NOUN	O	O
in	ADP	O	O
cardiac	ADJ	O	B-outcome
autonomic	ADJ	O	I-outcome
modulation	NOUN	O	I-outcome
,	PUNCT	O	O
anxiety	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
in	ADP	O	O
mothers	NOUN	O	O
of	ADP	O	O
preterms:	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Palo	NOUN	O	O
Alto,	NOUN	O	O
CA,	NOUN	O	O
USA.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
performance	NOUN	O	B-outcome
score	NOUN	O	O
in	ADP	O	O
test-1	NOUN	O	O
was	VERB	O	O
62.5	NUM	O	O
+/-	SYM	O	O
10.1	NUM	O	O
points	NOUN	O	O
in	ADP	O	O
the	DET	O	O
training	VERB	O	O
group	NOUN	O	O
and	CCONJ	O	O
62.3	NUM	O	O
+/-	SYM	O	O
4.1	NUM	O	O
points	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
[95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
(95%	PUNCT	O	O
CI)	NOUN	O	O
-5.5	VERB	O	O
to	PART	O	O
5.8;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.954].	PUNCT	O	O
In	ADP	O	O
test-2,	NOUN	O	O
the	DET	O	O
mean	NOUN	O	O
score	NOUN	O	O
was	VERB	O	O
86.8	NUM	O	O
+/-	SYM	O	O
6.5	NUM	O	O
points	NOUN	O	O
and	CCONJ	O	O
59.9	NUM	O	O
+/-	SYM	O	O
4.4	NUM	O	O
points	NOUN	O	O
in	ADP	O	O
the	DET	O	O
training	VERB	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups,	NOUN	O	O
respectively	ADV	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
21.9-31.8;	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
.001).	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
24-week,	NUM	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
phase	NOUN	O	O
3	NUM	O	O
study,	NOUN	O	O
225	NUM	O	O
patients,	NOUN	O	O
142	NUM	O	O
of	ADP	O	O
which	ADP	O	O
were	VERB	O	O
East	ADV	O	O
Asian	ADJ	O	O
(63.4%),	NOUN	O	O
were	VERB	O	O
enrolled:	NOUN	O	O
Japan	ADP	O	O
(n	NOUN	O	O
=	SYM	O	O
114),	NOUN	O	O
South	NOUN	O	O
Korea	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
20),	NUM	O	O
Taiwan	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
8),	NUM	O	O
the	DET	O	O
Czech	NOUN	O	O
Republic	ADJ	O	O
(n	NOUN	O	O
=	SYM	O	O
42),	NUM	O	O
and	CCONJ	O	O
Poland	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
40).	NOUN	O	O

PSE	NOUN	O	O
was	VERB	O	O
well	ADV	O	O
tolerated	VERB	O	B-outcome
as	ADP	O	O
evidenced	VERB	O	O
by	ADP	O	O
no	DET	O	O
effects	NOUN	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
blood	NOUN	O	B-outcome
safety	NOUN	O	O
panels.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/28	NUM	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/03	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

PARTICIPANTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
twenty-eight	NOUN	O	O
hypertensive	ADJ	O	O
(Stage	NOUN	O	O
1	NUM	O	O
and	CCONJ	O	O
2)	NOUN	O	O
sedentary	ADJ	O	O
women	NOUN	O	O
(Age	PUNCT	O	O
40.54+/-4.2	NOUN	O	O
yrs;	NOUN	O	O
Height	NOUN	O	O
155.14+/-5.4cm;	NOUN	O	O
Weight	NOUN	O	O
70.96+/-10.2kg;	NUM	O	O
BMI	NOUN	O	O
29.6+/-4.4;	NUM	O	O
Duration	NOUN	O	O
of	ADP	O	O
HTN:	NOUN	O	O
6.43+/-2.5	ADP	O	O
yrs)	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
for	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

Of	ADP	O	O
these,	NOUN	O	O
64	NUM	O	O
(85%)	NOUN	O	O
vs	CCONJ	O	O
83	NUM	O	O
(88%),	NOUN	O	O
respectively,	NOUN	O	O
reached	VERB	O	O
the	DET	O	O
primary	ADJ	O	O
clinical	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
(risk	NOUN	O	O
difference,	NOUN	O	O
-4.8%	NUM	O	O
[1-sided	VERB	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-13.6%	NOUN	O	O
to	PART	O	O
+	SYM	O	O
infinity;	NOUN	O	O
1-sided	VERB	O	O
P	NOUN	O	O
=	SYM	O	O
.19])	PUNCT	O	O
and	CCONJ	O	O
49	NUM	O	O
(66%)	ADV	O	O
vs	CCONJ	O	O
58	NUM	O	O
(62%),	NOUN	O	O
respectively,	NOUN	O	O
reached	VERB	O	O
the	DET	O	O
primary	ADJ	O	O
radiographic	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
(risk	NOUN	O	O
difference,	NOUN	O	O
4.7%	NOUN	O	O
[1-sided	VERB	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-7.0%	NUM	O	O
to	PART	O	O
+	SYM	O	O
infinity;	NOUN	O	O
1-sided	VERB	O	O
P	NOUN	O	O
=	SYM	O	O
.25).	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
metastatic	ADJ	O	O
pancreatic	ADJ	O	O
cancer,	NOUN	O	O
combination	NOUN	O	O
chemotherapy	NOUN	O	O
with	ADP	O	O
fluorouracil,	NOUN	O	O
leucovorin,	NOUN	O	O
irinotecan,	NOUN	O	O
and	CCONJ	O	O
oxaliplatin	NOUN	O	O
(FOLFIRINOX)	NUM	O	O
leads	NOUN	O	O
to	PART	O	O
longer	ADJ	O	O
overall	ADJ	O	O
survival	NOUN	O	O
than	ADP	O	O
gemcitabine	NOUN	O	O
therapy.	NOUN	O	O

Future	NOUN	O	O
randomized	VERB	O	O
trials	NOUN	O	O
with	ADP	O	O
longer-term	NOUN	O	O
outcomes	NOUN	O	O
that	ADP	O	O
include	VERB	O	O
sensorimotor	NOUN	O	O
mechanisms	NOUN	O	O
might	VERB	O	O
enhance	NOUN	O	O
our	ADJ	O	O
understanding	VERB	O	O
of	ADP	O	O
the	DET	O	O
comparative	ADJ	O	O
effectiveness.	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
lactulose	ADV	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
Chinese	NOUN	O	O
children	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
constipation.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Title:	NOUN	O	O
Pre-administration	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
in	ADP	O	O
target-controlled	VERB	O	O
propofol	NOUN	O	O
and	CCONJ	O	O
remifentanil	NOUN	O	O
anesthesia	NOUN	O	O
prolongs	NOUN	O	O
anesthesia	NOUN	O	B-outcome
induction	NOUN	O	I-outcome
in	ADP	O	O
neurosurgical	ADJ	O	O
patients:	NOUN	O	O
A	DET	O	O
double-blind	ADJ	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Importance:	NOUN	O	O
High-quality	NOUN	O	O
dietary	ADJ	O	O
patterns	NOUN	O	O
may	VERB	O	O
help	VERB	O	O
prevent	NOUN	O	O
chronic	ADJ	O	O
disease,	NOUN	O	O
but	CCONJ	O	O
limited	VERB	O	O
data	NOUN	O	O
exist	VERB	O	O
from	ADP	O	O
randomized	VERB	O	O
trials	NOUN	O	O
about	ADV	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
nutritional	ADJ	O	O
and	CCONJ	O	O
behavioral	ADJ	O	O
interventions	NOUN	O	O
on	ADP	O	O
dietary	ADJ	O	O
changes.	NOUN	O	O

Title:	NOUN	O	O
Preventive	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
galcanezumab	NOUN	O	O
in	ADP	O	O
adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
episodic	NOUN	O	O
or	CCONJ	O	O
chronic	ADJ	O	O
migraine	NOUN	O	O
are	VERB	O	O
persistent:	NOUN	O	O
data	NOUN	O	O
from	ADP	O	O
the	DET	O	O
phase	NOUN	O	O
3,	NOUN	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
EVOLVE-1,	NOUN	O	O
EVOLVE-2,	NOUN	O	O
and	CCONJ	O	O
REGAIN	NOUN	O	O
studies.	NOUN	O	O

Interestingly,	NOUN	O	O
the	DET	O	O
main	ADJ	O	O
determinant	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
was	VERB	O	O
the	DET	O	O
waist	NOUN	O	O
circumference.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
at	ADP	O	O
infertility	NOUN	O	O
department	NOUN	O	O
of	ADP	O	O
Royan	NOUN	O	O
Institute	NOUN	O	O
from	ADP	O	O
January	NOUN	O	O
2017	NUM	O	O
to	PART	O	O
June	NOUN	O	O
2018.	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Moderate-intensity	NOUN	O	O
combined	VERB	O	O
aerobic	ADJ	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
training	VERB	O	O
is	VERB	O	O
safe	ADJ	O	O
in	ADP	O	O
physically	ADV	O	O
unfit	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
quiescent	ADJ	O	O
Inflammatory	ADJ	O	O
Bowel	NOUN	O	O
Disease	NOUN	O	O
and	CCONJ	O	O
can	VERB	O	O
quickly	NOUN	O	O
achieve	NOUN	O	O
favourable	ADJ	O	O
body	NOUN	O	B-outcome
compositional	ADJ	O	I-outcome
changes	NOUN	O	O
without	ADP	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
.	PUNCT	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
at	ADP	O	O
ClinicalTrials.gov;	NOUN	O	O
Trial	NOUN	O	O
number:	NOUN	O	O
NCT02463916	NOUN	O	O
.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
there	PRON	O	O
is	VERB	O	O
good	ADJ	O	O
concordance	NOUN	O	O
between	ADP	O	O
radiographers	NOUN	O	O
across	ADP	O	O
all	DET	O	O
imaging	VERB	O	O
modalities.	NOUN	O	O

Metabolic	ADJ	O	B-outcome
pathways	NOUN	O	O
involving	VERB	O	O
lysine	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
phytochemicals	NOUN	O	B-outcome
were	VERB	O	O
also	ADV	O	O
modulated	VERB	O	O
by	ADP	O	O
navy	ADJ	O	O
bean	NOUN	O	O
intake	NOUN	O	O
in	ADP	O	O
CRC	NOUN	O	O
survivors.	NOUN	O	O

Journal-Name:Cornea	NOUN	O	O

BACKGROUND:	NOUN	O	O
Levodopa	NOUN	O	O
is	VERB	O	O
the	DET	O	O
main	ADJ	O	O
treatment	NOUN	O	O
for	ADP	O	O
symptoms	NOUN	O	O
of	ADP	O	O
Parkinson's	NOUN	O	O
disease.	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
3	NUM	O	O
groups,	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
tube	NOUN	O	O
ETView	NOUN	O	O
double-lumen	NOUN	O	O
tube	NOUN	O	O
(VDT),	NUM	O	O
ETView	NOUN	O	O
single-lumen	NOUN	O	O
tube	NOUN	O	O
(VST),	PUNCT	O	O
or	CCONJ	O	O
traditional	ADJ	O	O
double	ADV	O	O
lumen	NOUN	O	O
tube	NOUN	O	O
(DT).All	PUNCT	O	O
83	NUM	O	O
patients'	NOUN	O	O
intubations	NOUN	O	O
were	VERB	O	O
successful	ADJ	O	O
to	PART	O	O
achieve	NOUN	O	B-outcome
1-lung	ADV	O	I-outcome
ventilation	NOUN	O	I-outcome
:	PUNCT	O	O
74	NUM	O	O
patients	NOUN	O	O
at	ADP	O	O
the	DET	O	O
first	ADV	O	O
attempt	NOUN	O	O
(22/26	NOUN	O	O
in	ADP	O	O
VDT,	NUM	O	O
26/28	NOUN	O	O
in	ADP	O	O
VST,	NUM	O	O
26/29	NOUN	O	O
in	ADP	O	O
DT	NOUN	O	O
group)	ADJ	O	O
and	CCONJ	O	O
9	NUM	O	O
patients	NOUN	O	O
at	ADP	O	O
the	DET	O	O
second	ADJ	O	O
attempt.	NOUN	O	O

The	DET	O	O
changes	NOUN	O	O
in	ADP	O	O
respiratory	ADJ	O	B-outcome
mechanical	ADJ	O	I-outcome
indexes	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
under	ADP	O	O
different	ADJ	O	O
ventilation	NOUN	O	O
patterns	NOUN	O	O
and	CCONJ	O	O
ventilator	NOUN	O	O
parameters	NOUN	O	O
of	ADP	O	O
0	NUM	O	O
(only	ADV	O	O
connected	VERB	O	O
with	ADP	O	O
atomizing	VERB	O	O
device),	NOUN	O	O
5,	ADJ	O	O
7,	NUM	O	O
9	NUM	O	O
L/min	NOUN	O	O
atomizing	VERB	O	O
oxygen	NOUN	O	O
flow.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/26	VERB	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Results:	NOUN	O	O
At	ADP	O	O
week	NOUN	O	O
12,	NUM	O	O
mean	NOUN	O	O
percent	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
inflammatory	ADJ	O	O
and	CCONJ	O	O
noninflammatory	ADJ	O	O
lesion	NOUN	O	B-outcome
counts	NOUN	O	O
were	VERB	O	O
60.1%	NUM	O	O
and	CCONJ	O	O
53.0%,	NUM	O	O
respectively,	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
51.1%	NUM	O	O
and	CCONJ	O	O
38.7%	NUM	O	O
with	ADP	O	O
vehicle	NOUN	O	O
(P</=0.001)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
Hispanic	ADJ	O	O
population.	ADV	O	O

The	DET	O	O
population	NOUN	O	O
pharmacokinetic	ADJ	O	O
model	NOUN	O	O
visualized	VERB	O	O
both	CCONJ	O	O
measured	VERB	O	O
and	CCONJ	O	O
predicted	VERB	O	O
concentrations.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/31	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Title:	NOUN	O	O
Multivitamin	NOUN	O	O
and	CCONJ	O	O
Mineral	NOUN	O	O
Supplementation	NOUN	O	O
Containing	VERB	O	O
Phytonutrients	NOUN	O	O
Scavenges	NOUN	O	O
Reactive	ADJ	O	O
Oxygen	NOUN	O	O
Species	NOUN	O	O
in	ADP	O	O
Healthy	NOUN	O	O
Subjects:	NOUN	O	O
A	DET	O	O
Randomized,	NOUN	O	O
Double-Blinded,	NOUN	O	O
Placebo-Controlled	VERB	O	O
Trial.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100967802	NUM	O	O

Finally,	NOUN	O	O
participants	NOUN	O	O
reported	VERB	O	O
their	ADJ	O	O
self-efficacy	NOUN	O	B-outcome
to	PART	O	O
drink	NOUN	O	O
less	ADV	O	O
and	CCONJ	O	O
their	ADJ	O	O
alcohol	NOUN	O	B-outcome
use	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
clear	ADJ	O	O
evidence	NOUN	O	O
that	ADP	O	O
enhancing	VERB	O	O
self-affirmation	NOUN	O	O
influenced	VERB	O	O
any	DET	O	O
outcome.	NOUN	O	O

No	DET	O	O
significant	ADJ	O	O
effect	NOUN	O	O
over	ADP	O	O
24	NUM	O	O
h	NOUN	O	O
or	CCONJ	O	O
qualitative	ADJ	O	O
feelings	NOUN	O	O
of	ADP	O	O
satiety	NOUN	O	B-outcome
were	VERB	O	O
observed.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Unhealthy	NOUN	O	O
foods	NOUN	O	O
are	VERB	O	O
promoted	VERB	O	O
heavily,	NOUN	O	O
through	ADP	O	O
food	NOUN	O	O
company	DET	O	O
sponsorship	NOUN	O	O
of	ADP	O	O
elite	ADP	O	O
sport,	NOUN	O	O
resulting	VERB	O	O
in	ADP	O	O
extensive	ADJ	O	O
exposure	NOUN	O	O
among	ADP	O	O
young	ADJ	O	O
adults	NOUN	O	O
who	ADP	O	O
are	VERB	O	O
avid	NOUN	O	O
sport	ADJ	O	O
spectators.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Study	NOUN	O	O
design	NOUN	O	O
20	NUM	O	O
participants	NOUN	O	O
with	ADP	O	O
psychomotor	NOUN	O	O
disadaptation	NOUN	O	O
admitted	VERB	O	O
to	PART	O	O
an	DET	O	O
academic	ADJ	O	O
rehabilitation	NOUN	O	O
ward	NOUN	O	O
were	VERB	O	O
randomised	VERB	O	O
to	PART	O	O
receive	VERB	O	O
physiotherapist	NOUN	O	O
care	NOUN	O	O
supported	VERB	O	O
by	ADP	O	O
the	DET	O	O
SafeWalker(R)	ADV	O	O
robotic	ADJ	O	O
walking	VERB	O	O
aid	VERB	O	O
or	CCONJ	O	O
standard	ADJ	O	O
care	NOUN	O	O
only,	NOUN	O	O
for	ADP	O	O
ten	NUM	O	O
days.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/01/25	VERB	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
phase	NOUN	O	O
1	NUM	O	O
trial	NOUN	O	O
of	ADP	O	O
givosiran	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
intermittent	ADJ	O	O
porphyria.	NOUN	O	O

DISCUSSION:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
will	VERB	O	O
make	VERB	O	O
a	DET	O	O
unique	ADJ	O	O
contribution	NOUN	O	O
to	PART	O	O
the	DET	O	O
literature	NOUN	O	O
by	ADP	O	O
testing	VERB	O	O
a	DET	O	O
theory-based	VERB	O	O
intervention	NOUN	O	O
delivered	VERB	O	O
by	ADP	O	O
PE	NOUN	O	O
teachers	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
school	NOUN	O	O
students'	NOUN	O	O
participation	NOUN	O	B-outcome
in	ADP	O	O
out-of-school	NOUN	O	O
physical	ADJ	O	O
activity.	NOUN	O	O

The	DET	O	O
results	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
the	DET	O	O
menopausal	ADJ	O	O
women	NOUN	O	O
in	ADP	O	O
D2	NOUN	O	O
group	NOUN	O	O
increased	VERB	O	O
serum	NOUN	O	O
alkaline	ADJ	O	B-outcome
phosphatase	NOUN	O	I-outcome
,	PUNCT	O	O
osteocalcin	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
total	ADJ	O	O
phenolic	NOUN	O	B-outcome
compounds	NOUN	O	O
content	NOUN	O	O
but	CCONJ	O	O
decreased	VERB	O	O
CTX	NOUN	O	B-outcome
level.	NOUN	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
completed	VERB	O	O
+25d	NOUN	O	O
in	ADP	O	O
the	DET	O	O
hot	ADJ	O	O
condition.	NOUN	O	O

The	DET	O	O
exercise	NOUN	O	O
session	NOUN	O	O
attendance	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
62%	NUM	O	O
for	ADP	O	O
HIIT	NOUN	O	O
(288/465)	NOUN	O	O
and	CCONJ	O	O
75%	NUM	O	O
for	ADP	O	O
MICT	NOUN	O	O
(320/429),	NOUN	O	O
with	ADP	O	O
62%	NUM	O	O
of	ADP	O	O
HIIT	NOUN	O	O
participants	NOUN	O	O
(8/13)	ADP	O	O
and	CCONJ	O	O
67%	ADJ	O	O
of	ADP	O	O
MICT	NOUN	O	O
participants	NOUN	O	O
(8/12)	PUNCT	O	O
completing	VERB	O	O
at	ADP	O	O
least	ADV	O	O
24	NUM	O	O
of	ADP	O	O
36	NUM	O	O
sessions.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/20	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

CONCLUSION:	NOUN	O	O
Muscle	NOUN	O	O
relaxation	NOUN	O	O
can	VERB	O	O
enhance	NOUN	O	O
self-efficacy	NOUN	O	B-outcome
of	ADP	O	O
cancer	NOUN	O	O
patients.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
involving	VERB	O	O
confirmed	VERB	O	O
HIV-positive	ADJ	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
at	ADP	O	O
the	DET	O	O
Lagos	NOUN	O	O
University	NOUN	O	O
Teaching	VERB	O	O
Hospital	NOUN	O	O
(LUTH)	NUM	O	O
between	ADP	O	O
September	NOUN	O	O
2018	NUM	O	O
and	CCONJ	O	O
February	ADJ	O	O
2019.	NUM	O	O

The	DET	O	O
test	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
significantly	ADV	O	O
better	ADJ	O	O
results	NOUN	O	O
than	ADP	O	O
the	DET	O	O
control	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
soft	NOUN	O	B-outcome
tissue	NOUN	O	I-outcome
texture	NOUN	O	I-outcome
and	CCONJ	O	O
mucogingival	NOUN	O	B-outcome
junction	NOUN	O	I-outcome
alignment	ADP	O	I-outcome
results	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Our	ADJ	O	O
results	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
EHF	NOUN	O	O
is	VERB	O	O
potentially	ADV	O	O
inferior	ADJ	O	O
to	PART	O	O
that	ADP	O	O
of	ADP	O	O
MHF	NOUN	O	O
and	CCONJ	O	O
that	ADP	O	O
further	ADV	O	O
studies	NOUN	O	O
are	VERB	O	O
warranted,	VERB	O	O
therefore,	NOUN	O	O
to	PART	O	O
confirm	NOUN	O	O
these	DET	O	O
findings.	NOUN	O	O

PURPOSE:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
corneal	ADJ	O	B-outcome
endothelial	ADJ	O	I-outcome
cell	NOUN	O	I-outcome
density	NOUN	O	I-outcome
(ECD)	NOUN	O	I-outcome
and	CCONJ	O	Seperator
morphology	NOUN	O	S3-outcome
2	NUM	O	O
years	NOUN	O	O
after	ADP	O	O
phacoemulsification	NOUN	O	O
in	ADP	O	O
subjects	NOUN	O	O
from	ADP	O	O
the	DET	O	O
COMPASS	NOUN	O	O
trial	NOUN	O	O
(ClinicalTrials.gov,	PUNCT	O	O
NCT01085357)	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
mild-to-moderate	ADJ	O	O
primary	ADJ	O	O
open-angle	NOUN	O	O
glaucoma	NOUN	O	O
and	CCONJ	O	O
visually	ADV	O	O
significant	ADJ	O	O
cataracts.	VERB	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	B-outcome
success	NOUN	O	I-outcome
with	ADP	O	O
surgery	NOUN	O	O
(18	NOUN	O	O
of	ADP	O	O
27	NUM	O	O
patients,	NOUN	O	O
67%)	NUM	O	O
was	VERB	O	O
significantly	ADV	O	O
superior	ADJ	O	O
to	PART	O	O
that	ADP	O	O
with	ADP	O	O
active	ADJ	O	O
medical	ADJ	O	O
treatment	NOUN	O	O
(7	NOUN	O	O
of	ADP	O	O
25	NUM	O	O
patients,	NOUN	O	O
28%;	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.007)	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
medical	ADJ	O	O
treatment	NOUN	O	O
(3	NOUN	O	O
of	ADP	O	O
26	NUM	O	O
patients,	NOUN	O	O
12%;	NUM	O	O
P<0.001).	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Whilst	ADP	O	O
daily	ADJ	O	O
betaA	NOUN	O	O
may	VERB	O	O
confer	VERB	O	O
individual	ADJ	O	O
benefits,	NOUN	O	O
these	DET	O	O
results	NOUN	O	O
demonstrate	VERB	O	O
limited	VERB	O	O
impact	NOUN	O	O
of	ADP	O	O
betaA	NOUN	O	O
(irrespective	PUNCT	O	O
of	ADP	O	O
dosing	VERB	O	O
strategy)	NOUN	O	O
on	ADP	O	O
30-min	NOUN	O	O
rowing	VERB	O	B-outcome
or	CCONJ	O	Seperator
subsequent	NOUN	O	X
sprint	NOUN	O	B-outcome
performance	NOUN	O	E1-outcome
.	PUNCT	O	O
Further	ADV	O	O
investigation	NOUN	O	O
of	ADP	O	O
betaA	NOUN	O	O
dosage	NOUN	O	O
>	SYM	O	O
2.4	NUM	O	O
g.d(-	NOUN	O	O
1)	NUM	O	O
and/or	CCONJ	O	O
chronic	ADJ	O	O
intervention	NOUN	O	O
periods	NOUN	O	O
(>	PUNCT	O	O
4-8	NUM	O	O
weeks)	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
warranted	VERB	O	O
based	VERB	O	O
on	ADP	O	O
within-group	NOUN	O	O
observations.	NOUN	O	O

Title:	NOUN	O	O
Effects	NOUN	O	O
of	ADP	O	O
ascorbic	ADJ	O	O
acid	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
markers	NOUN	O	O
in	ADP	O	O
healthy	ADJ	O	O
women	NOUN	O	O
following	VERB	O	O
a	DET	O	O
single	ADJ	O	O
bout	NOUN	O	O
of	ADP	O	O
exercise.	NOUN	O	O

Selenium	NOUN	O	O
is	VERB	O	O
a	DET	O	O
non-metallic	ADJ	O	O
chemical	ADJ	O	O
element	NOUN	O	O
of	ADP	O	O
great	ADJ	O	O
importance	NOUN	O	O
to	PART	O	O
human	NOUN	O	O
health.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
music	ADJ	O	O
therapy	NOUN	O	O
intervention	NOUN	O	O
on	ADP	O	O
the	DET	O	O
autonomic	ADJ	O	O
control	NOUN	O	O
of	ADP	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
,	PUNCT	O	O
anxiety	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
in	ADP	O	O
mothers.	NOUN	O	O

Omadacycline	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
moxifloxacin	NOUN	O	O
for	ADP	O	O
early	ADJ	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
(81.1%	PUNCT	O	O
and	CCONJ	O	O
82.7%,	NUM	O	O
respectively;	NOUN	O	O
difference,	NOUN	O	O
-1.6	ADJ	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
-7.1	NUM	O	O
to	PART	O	O
3.8),	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
rates	NOUN	O	O
of	ADP	O	O
investigator-assessed	VERB	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
at	ADP	O	O
the	DET	O	O
post-treatment	NOUN	O	O
evaluation	NOUN	O	O
were	VERB	O	O
87.6%	NUM	O	O
and	CCONJ	O	O
85.1%,	NUM	O	O
respectively	ADV	O	O
(difference,	ADV	O	O
2.5	NUM	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-2.4	NOUN	O	O
to	PART	O	O
7.4).	NOUN	O	O

Several	ADJ	O	O
small	ADJ	O	O
trials	NOUN	O	O
have	VERB	O	O
suggested	VERB	O	O
that	ADP	O	O
supplementing	VERB	O	O
the	DET	O	O
enteral	ADJ	O	O
diet	NOUN	O	O
of	ADP	O	O
very	ADV	O	O
preterm	NOUN	O	O
infants	NOUN	O	O
with	ADP	O	O
lactoferrin,	NOUN	O	O
an	DET	O	O
antimicrobial	ADJ	O	O
protein	NOUN	O	O
processed	VERB	O	O
from	ADP	O	O
cow's	NOUN	O	O
milk,	NOUN	O	O
prevents	NOUN	O	O
infections	NOUN	O	O
and	CCONJ	O	O
associated	VERB	O	O
complications.	NOUN	O	O

At	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
follow	VERB	O	O
up,	NOUN	O	O
few	ADJ	O	O
patients	NOUN	O	O
reported	VERB	O	O
myalgia	NOUN	O	B-outcome
(2	PUNCT	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
7	NUM	O	O
in	ADP	O	O
Group	NOUN	O	O
B).	NOUN	O	O

It	PRON	O	O
has	VERB	O	O
been	VERB	O	O
reported	VERB	O	O
that	ADP	O	O
the	DET	O	O
intensity	NOUN	O	B-outcome
of	ADP	O	I-outcome
pain	NOUN	O	I-outcome
from	ADP	O	O
dysmenorrhea	ADJ	O	O
decreased	VERB	O	O
in	ADP	O	O
the	DET	O	O
Novafen	NOUN	O	O
and	CCONJ	O	O
Ginger	NOUN	O	O
groups.	NOUN	O	O

The	DET	O	O
admission	NOUN	O	O
of	ADP	O	O
prolonged	VERB	O	O
form	NOUN	O	O
of	ADP	O	O
nitrates	NOUN	O	O
before	ADP	O	O
the	DET	O	O
PCI	NOUN	O	O
was	VERB	O	O
allowed	VERB	O	O
in	ADP	O	O
the	DET	O	O
second	ADJ	O	O
group.	VERB	O	O

A	DET	O	O
transition	NOUN	O	O
to	PART	O	O
oral	ADJ	O	O
omadacycline	NOUN	O	O
(300	PUNCT	O	O
mg	NOUN	O	O
every	DET	O	O
24	NUM	O	O
hours)	NOUN	O	O
or	CCONJ	O	O
moxifloxacin	NOUN	O	O
(400	NUM	O	O
mg	NOUN	O	O
every	DET	O	O
24	NUM	O	O
hours),	NOUN	O	O
respectively,	NOUN	O	O
was	VERB	O	O
allowed	VERB	O	O
after	ADP	O	O
3	NUM	O	O
days;	NOUN	O	O
the	DET	O	O
total	ADJ	O	O
treatment	NOUN	O	O
duration	NOUN	O	O
was	VERB	O	O
7	NUM	O	O
to	PART	O	O
14	NUM	O	O
days.	NOUN	O	O

But	CCONJ	O	O
persistent	ADJ	O	O
CNLDO	NOUN	O	O
in	ADP	O	O
older	ADJ	O	O
children	NOUN	O	O
makes	NOUN	O	O
the	DET	O	O
success	NOUN	O	O
rate	NOUN	O	O
rapidly	ADV	O	O
decreased	VERB	O	O
due	ADJ	O	O
to	PART	O	O
long-term	NOUN	O	O
chronic	ADJ	O	O
inflammation.	NOUN	O	O

Group	NOUN	O	O
receiving	VERB	O	O
placebo	NOUN	O	O
had	VERB	O	O
pain	NOUN	O	B-outcome
relief	NOUN	O	I-outcome
only	ADV	O	O
for	ADP	O	O
first	ADV	O	O
two	NUM	O	O
weeks.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
was	VERB	O	O
a	DET	O	O
prospective	ADJ	O	O
single	ADJ	O	O
blind	PUNCT	O	O
randomized	VERB	O	O
sham	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
where	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
coronary	ADJ	O	O
angioplasty	NOUN	O	O
with	ADP	O	O
stage	NOUN	O	O
III	NUM	O	O
chronic	ADJ	O	O
kidney	NOUN	O	O
disease	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
sham	NOUN	O	O
preconditioning	VERB	O	O
and	CCONJ	O	O
remote	ADV	O	O
ischemic	ADJ	O	O
preconditioning.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

However,	ADV	O	O
the	DET	O	O
underlying	VERB	O	O
mechanisms	NOUN	O	O
and	CCONJ	O	O
effective	ADJ	O	O
therapeutic	ADJ	O	O
targets	NOUN	O	O
are	VERB	O	O
still	ADV	O	O
unclear.	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
equally	ADV	O	O
and	CCONJ	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
a	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
50)	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
50).	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
Lymphadenectomy	NOUN	O	O
in	ADP	O	O
Patients	NOUN	O	O
with	ADP	O	O
Advanced	VERB	O	O
Ovarian	ADJ	O	O
Neoplasms.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
aims	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
repeated	VERB	O	O
PZQ	NOUN	O	O
treatments	NOUN	O	O
against	ADP	O	O
Schistosoma	NOUN	O	B-outcome
mansoni	NOUN	O	I-outcome
infection	NOUN	O	I-outcome
in	ADP	O	O
school-aged	VERB	O	O
children	NOUN	O	O
in	ADP	O	O
Cote	NOUN	O	O
d'Ivoire	NOUN	O	O
using	VERB	O	O
the	DET	O	O
traditional	ADJ	O	O
KK	NOUN	O	O
technique,	ADV	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
more	ADV	O	O
sensitive	ADJ	O	O
antigen-	NOUN	O	O
and	CCONJ	O	O
DNA-detection	NOUN	O	O
methods.	NOUN	O	O

Tafenoquine	NOUN	O	O
is	VERB	O	O
a	DET	O	O
single-dose	NOUN	O	O
8-aminoquinoline	NOUN	O	O
that	ADP	O	O
has	VERB	O	O
recently	ADV	O	O
been	VERB	O	O
registered	VERB	O	O
for	ADP	O	O
the	DET	O	O
radical	NOUN	O	O
cure	NOUN	O	O
of	ADP	O	O
P.	NOUN	O	O
vivax.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
312	NUM	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
recorded	VERB	O	O
in	ADP	O	O
110	NUM	O	O
patients.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
multivariate	ADJ	O	O
analysis	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
lower	ADJ	O	O
nodal	NOUN	O	O
stage,	VERB	O	O
the	DET	O	O
presence	NOUN	O	O
of	ADP	O	O
squamous	ADJ	O	O
cell	NOUN	O	O
carcinoma	NOUN	O	O
(SCC),	NUM	O	O
a	DET	O	O
broader	ADJ	O	O
surgical	ADJ	O	O
resection	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
SCC,	NUM	O	O
and	CCONJ	O	O
being	VERB	O	O
female	NOUN	O	O
with	ADP	O	O
non-SCC	CCONJ	O	O
were	VERB	O	O
significantly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
longer	ADJ	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(DFS)	NOUN	O	I-outcome
.	PUNCT	O	O
Lower	ADJ	O	O
nodal	NOUN	O	O
stage	NOUN	O	O
and	CCONJ	O	O
smaller	ADJ	O	O
tumor	NOUN	O	O
size	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
an	DET	O	O
improved	VERB	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
.	PUNCT	O	O
Compared	VERB	O	O
to	PART	O	O
Other	ADJ	O	O
International,	PUNCT	O	O
enrollment	NOUN	O	O
in	ADP	O	O
East	ADV	O	O
Asia	PROPN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
an	DET	O	O
improved	VERB	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
non-SCC.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

For	ADP	O	O
both	CCONJ	O	O
end	NOUN	O	O
points,	NOUN	O	O
the	DET	O	O
noninferiority	NOUN	O	O
margin	ADP	O	O
was	VERB	O	O
10	NUM	O	O
percentage	NOUN	O	O
points.	NOUN	O	O

These	DET	O	O
findings	NOUN	O	O
were	VERB	O	O
true	ADJ	O	O
irrespective	ADJ	O	O
of	ADP	O	O
the	DET	O	O
type	NOUN	O	O
of	ADP	O	O
resection	NOUN	O	O
performed.	NOUN	O	O

After	ADP	O	O
6	NUM	O	O
months,	NOUN	O	O
RA	NOUN	O	B-outcome
and	CCONJ	O	Seperator
RV	NOUN	O	B-outcome
area	NOUN	O	E1-outcome
,	PUNCT	O	O
RV	NOUN	O	B-outcome
thickness	NOUN	O	I-outcome
tricuspid	NOUN	O	I-outcome
regurgitation	NOUN	O	I-outcome
velocity	NOUN	O	I-outcome
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
reduction.	NOUN	O	O

Late	ADJ	O	O
first-trimester	NOUN	O	O
high	ADJ	O	O
adherence	NOUN	O	O
to	PART	O	O
the	DET	O	O
predefined	VERB	O	O
six	NUM	O	O
food	NOUN	O	O
targets	NOUN	O	O
is	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
gestational	ADJ	O	B-outcome
diabetes	NOUN	O	I-outcome
mellitus	NOUN	O	I-outcome
(GDM)	NOUN	O	I-outcome
,	PUNCT	O	O
emergency	NOUN	O	B-outcome
C-section	NOUN	O	I-outcome
,	PUNCT	O	O
perineal	ADJ	O	B-outcome
trauma	NOUN	O	I-outcome
,	PUNCT	O	O
pregnancy-induced	VERB	O	B-outcome
hypertension	NOUN	O	I-outcome
and	CCONJ	O	Seperator
preeclampsia	NOUN	O	I-outcome
,	PUNCT	O	O
prematurity	NOUN	O	B-outcome
,	PUNCT	O	O
large-for-gestational-age	NOUN	O	B-outcome
,	PUNCT	O	O
and/or	CCONJ	O	O
small-for-gestational-age	NOUN	O	B-outcome
,	PUNCT	O	O
urinary	ADJ	O	B-outcome
tract	NOUN	O	I-outcome
infections	NOUN	O	I-outcome
(UTI)	NUM	O	I-outcome
,	PUNCT	O	O
prematurity	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
small-for-gestational-age	NOUN	O	B-outcome
(SGA)	PUNCT	O	I-outcome
newborns.	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
two-dose	NOUN	O	O
versus	CCONJ	O	O
three-dose	NOUN	O	O
sulphadoxine-pyrimethamine	NOUN	O	O
in	ADP	O	O
preventing	VERB	O	O
adverse	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
outcomes	NOUN	O	I-outcome
in	ADP	O	O
Nigeria.	NOUN	O	O

In	ADP	O	O
group	NOUN	O	O
B,	NOUN	O	O
although	ADP	O	O
the	DET	O	O
median	ADJ	O	O
number	NOUN	O	O
[range]	NOUN	O	O
of	ADP	O	O
lesions	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
first	ADV	O	O
tertile	ADJ	O	O
of	ADP	O	O
the	DET	O	O
small	ADJ	O	O
intestine	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
increase	NOUN	O	O
two	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
low-dose	NOUN	O	O
aspirin	NOUN	O	O
administration	NOUN	O	O
(baseline:	PUNCT	O	O
0	NUM	O	O
[0-4],	NOUN	O	O
after:	NOUN	O	O
1.5	NUM	O	O
[0-8];	PUNCT	O	O
p	NOUN	O	O
=	SYM	O	O
0.2969),	NOUN	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
lesions	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
second	ADJ	O	O
and	CCONJ	O	O
third	ADJ	O	O
tertiles	NOUN	O	O
of	ADP	O	O
the	DET	O	O
small	ADJ	O	O
intestine	NOUN	O	O
increased	VERB	O	O
significantly	ADV	O	O
(baseline:	PUNCT	O	O
0	NUM	O	O
[0-5],	PUNCT	O	O
after:	NOUN	O	O
2	NUM	O	O
[0-15];	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.0469).	NUM	O	O

Journal-Name:JAMA	NOUN	O	O

SUMMARY	NOUN	O	O
OF	ADP	O	O
KEY	NOUN	O	O
POINTS:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
a	DET	O	O
case-series	NOUN	O	O
report	NOUN	O	O
using	VERB	O	O
data	NOUN	O	O
previously	ADV	O	O
collected	VERB	O	O
for	ADP	O	O
a	DET	O	O
discontinued	VERB	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial,	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
participants	NOUN	O	O
received	VERB	O	O
hippotherapy	NOUN	O	O
or	CCONJ	O	O
standard	ADJ	O	O
outpatient	ADJ	O	O
clinic	ADJ	O	O
PT	NOUN	O	O
for	ADP	O	O
a	DET	O	O
12-week	NOUN	O	O
treatment	NOUN	O	O
period.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Large	ADJ	O	O
scale	NOUN	O	O
administration	NOUN	O	O
of	ADP	O	O
the	DET	O	O
anthelminthic	ADJ	O	O
drug	NOUN	O	O
praziquantel	NOUN	O	O
(PZQ)	NOUN	O	O
to	PART	O	O
at-risk	NOUN	O	O
populations	NOUN	O	O
is	VERB	O	O
the	DET	O	O
cornerstone	NOUN	O	O
of	ADP	O	O
schistosomiasis	NOUN	O	O
control,	NOUN	O	O
although	ADP	O	O
persisting	VERB	O	O
high	ADJ	O	O
prevalence	NOUN	O	O
of	ADP	O	O
infections	NOUN	O	O
in	ADP	O	O
some	DET	O	O
areas	NOUN	O	O
and	CCONJ	O	O
growing	VERB	O	O
concerns	NOUN	O	O
of	ADP	O	O
PZQ	NOUN	O	O
resistance	NOUN	O	O
have	VERB	O	O
revealed	VERB	O	O
the	DET	O	O
limitations	NOUN	O	O
of	ADP	O	O
this	DET	O	O
strategy.	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Participants	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
not	ADV	O	O
already	ADV	O	O
taking	VERB	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
supplements	NOUN	O	O
received	VERB	O	O
cholecalciferol	NOUN	O	O
before	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
began	VERB	O	O
(a	PUNCT	O	O
single	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
2.5	NUM	O	O
mg)	NOUN	O	O
and	CCONJ	O	O
during	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
(1.25	NOUN	O	O
mg	NOUN	O	O
per	ADP	O	O
month).	NOUN	O	O

Jitter	NOUN	O	O
plots	NOUN	O	O
of	ADP	O	O
the	DET	O	O
individual	ADJ	O	O
SFS24	ADJ	O	O
values	NOUN	O	O
versus	CCONJ	O	O
plasma	NOUN	O	O
NT	NOUN	O	O
concentrations	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
correlated	VERB	O	O
in	ADP	O	O
benign	ADJ	O	O
and	CCONJ	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
(r=-0.284,	NUM	O	O
p=0.028).	NOUN	O	O

Moderately	ADV	O	O
vitamin	NOUN	O	O
B12-deficient	NOUN	O	O
participants	NOUN	O	O
aged	VERB	O	O
between	ADP	O	O
45	NUM	O	O
and	CCONJ	O	O
75	NUM	O	O
years	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
56)	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
into	ADP	O	O
this	DET	O	O
randomised	VERB	O	O
controlled	VERB	O	O
crossover	NOUN	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/18	NOUN	O	O
06:00'	NUM	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
120	NUM	O	O
each.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/03	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Outcomes	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
on	ADP	O	O
a	DET	O	O
simulated	VERB	O	O
cardiac	ADJ	O	O
arrest	NOUN	O	O
case	NOUN	O	O
adapted	VERB	O	O
from	ADP	O	O
the	DET	O	O
AHA	NOUN	O	O
Advanced	VERB	O	O
Cardiac	ADJ	O	O
Life	NOUN	O	O
Support	NOUN	O	O
(ACLS)	PUNCT	O	O
SimMan(R)	ADV	O	O
Scenario	NOUN	O	O
manual.	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
inhaled	VERB	O	O
hydrogen	NOUN	O	O
gas	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
h/day	NOUN	O	O
at	ADP	O	O
their	ADJ	O	O
own	ADJ	O	O
homes	NOUN	O	O
and	CCONJ	O	O
received	VERB	O	O
chemotherapy	NOUN	O	O
at	ADP	O	O
the	DET	O	O
Tamana	NOUN	O	O
Regional	ADJ	O	O
Health	NOUN	O	O
Medical	ADJ	O	O
Center	NOUN	O	O
(Tamana,	NUM	O	O
Kumamoto,	ADJ	O	O
Japan).	NOUN	O	O

Objective:To	NOUN	O	O
investigate	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
LOPasparaginase	NOUN	O	O
+	SYM	O	O
vincristine	ADV	O	O
+	SYM	O	O
dexamethasone	NOUN	O	O
chemotherapy	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
radiotherapy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
nasal	ADJ	O	O
NK/T	NOUN	O	O
cell	NOUN	O	O
lymphoma.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
+/-	SYM	O	O
SD	NOUN	O	O
of	ADP	O	O
total	ADJ	O	O
induction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
was	VERB	O	O
180.5	NUM	O	O
+/-	SYM	O	O
49.0	NUM	O	O
s	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
N	NOUN	O	O
and	CCONJ	O	O
246.3	NUM	O	O
+/-	SYM	O	O
64.7	NUM	O	O
s	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
R	NOUN	O	O
(mean	NUM	O	O
difference:	NOUN	O	O
65.8	NUM	O	O
seconds;	NOUN	O	O
95%	NOUN	O	O
CI:	NOUN	O	O
35.0-96.5	NUM	O	O
s,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.01).	PUNCT	O	O

Compared	VERB	O	O
with	ADP	O	O
group	NOUN	O	O
C,	NOUN	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
(VAS	PUNCT	O	O
score>/=4)	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
D	NOUN	O	O
was	VERB	O	O
obviously	ADV	O	O
less	ADV	O	O
at	ADP	O	O
T(6),	NOUN	O	O
T(7),	NOUN	O	O
T(8)(10	NOUN	O	O
vs	CCONJ	O	O
20,	NUM	O	O
4	NUM	O	O
vs	CCONJ	O	O
12,	NUM	O	O
3	NUM	O	O
vs	CCONJ	O	O
10;	NUM	O	O
chi(2)=4.762,	NOUN	O	O
4.762,	NOUN	O	O
4.332,	PUNCT	O	O
respectively;	NOUN	O	O
all	DET	O	O
P<0.05).	NOUN	O	O

Journal-Name:Beijing	VERB	O	O
da	NOUN	O	O
xue	NOUN	O	O
xue	NOUN	O	O
bao.	ADP	O	O

RBR-3x7gz8	NOUN	O	O
).	NOUN	O	O

Time	NOUN	O	B-outcome
to	PART	O	I-outcome
Bispectral	ADJ	O	I-outcome
index	NOUN	O	I-outcome
(BIS)	PUNCT	O	I-outcome
60	NUM	O	I-outcome
and	CCONJ	O	O
rocuronium	NOUN	O	B-outcome
onset	NOUN	O	I-outcome
time	NOUN	O	I-outcome
were	VERB	O	O
longer	ADJ	O	O
in	ADP	O	O
the	DET	O	O
Group	NOUN	O	O
R	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01	NUM	O	O
and	CCONJ	O	O
P	NOUN	O	O
<	SYM	O	O
.01,	PUNCT	O	O
respectively).	NOUN	O	O

+25d	NOUN	O	O
post-exercise	NOUN	O	O
epinephrine	NOUN	O	B-outcome
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
CON	NOUN	O	O
vs.	CCONJ	O	O
IHE	NOUN	O	O
(p=0.04).	PUNCT	O	O

Title:	NOUN	O	O
The	DET	O	O
Effects	NOUN	O	O
of	ADP	O	O
Tai	NOUN	O	O
Chi	NOUN	O	O
on	ADP	O	O
Heart	NOUN	O	B-outcome
Rate	NOUN	O	I-outcome
Variability	NOUN	O	I-outcome
in	ADP	O	O
Older	ADJ	O	O
Chinese	NOUN	O	O
Individuals	NOUN	O	O
with	ADP	O	O
Depression.	NOUN	O	O

On	ADP	O	O
the	DET	O	O
same	ADJ	O	O
task,	NOUN	O	O
average	NOUN	O	O
reaction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
improved	VERB	O	O
(treatment	NUM	O	O
effect,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.036)	NUM	O	O
with	ADP	O	O
PSE	NOUN	O	O
at	ADP	O	O
Day	NOUN	O	O
7	NUM	O	O
(PSE	NUM	O	O
vs.	CCONJ	O	O
PLA:	NOUN	O	O
0.5896	NUM	O	O
+/-	SYM	O	O
0.060	NUM	O	O
vs.	CCONJ	O	O
0.6141	NUM	O	O
+/-	SYM	O	O
0.073	NUM	O	O
s;	ADP	O	O
p	NOUN	O	O
=	SYM	O	O
0.049)	NOUN	O	O
and	CCONJ	O	O
Day	NOUN	O	O
30	NUM	O	O
(PSE	NUM	O	O
vs.	CCONJ	O	O
PLA:	NOUN	O	O
0.5811	NUM	O	O
+/-	SYM	O	O
0.068	NUM	O	O
vs.	CCONJ	O	O
0.6033	NUM	O	O
+/-	SYM	O	O
0.055	NUM	O	O
s;	ADP	O	O
p	NOUN	O	O
=	SYM	O	O
0.049).	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/10	PUNCT	O	O
06:00'	NUM	O	O

The	DET	O	O
remifentanil	NOUN	O	O
effective	ADJ	O	O
concentration	NOUN	O	B-outcome
(EC50)	PUNCT	O	O
of	ADP	O	O
that	ADP	O	O
suppressed	VERB	O	O
responses	NOUN	O	O
to	PART	O	O
extubation	NOUN	O	O
during	ADP	O	O
anesthetic	ADJ	O	O
emergence	NOUN	O	O
was	VERB	O	O
1.20	NUM	O	O
ng/mL	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
TEAS,	NOUN	O	O
a	DET	O	O
value	NOUN	O	O
that	ADP	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
the	DET	O	O
1.64	NUM	O	O
ng/mL	NOUN	O	O
needed	VERB	O	O
by	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
C.The	ADJ	O	O
TEAS	NOUN	O	O
can	VERB	O	O
enhance	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
on	ADP	O	O
suppressing	VERB	O	O
responses	NOUN	O	B-outcome
to	PART	O	O
tracheal	ADJ	O	O
extubation	NOUN	O	O
in	ADP	O	O
elderly	NOUN	O	O
patients,	NOUN	O	O
the	DET	O	O
effective	ADJ	O	O
concentration	NOUN	O	B-outcome
(EC50)	PUNCT	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
can	VERB	O	O
reduce	VERB	O	O
approximately	ADV	O	O
27%	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
group	NOUN	O	O
C.	NOUN	O	O

Zero"	NOUN	O	O
marginal	ADJ	O	B-outcome
bone	NOUN	O	I-outcome
level	NOUN	O	O
(MBL)	NOUN	O	O
loss	NOUN	O	O
or	CCONJ	O	O
gain	VERB	O	O
was	VERB	O	O
measured	VERB	O	O
over	ADP	O	O
the	DET	O	O
3-year	NOUN	O	O
period	NOUN	O	O
at	ADP	O	O
72.1%	NUM	O	O
CI,	NOUN	O	O
3.0%	NOUN	O	O
FI,	NOUN	O	O
and	CCONJ	O	O
16.6%	NUM	O	O
PS	NOUN	O	O
implants.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
ovarian	ADJ	O	O
research	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
contrast	NOUN	O	B-outcome
induced	VERB	O	I-outcome
nephropathy	NOUN	O	I-outcome
(CIN)	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
the	DET	O	O
maximum	NOUN	O	O
improvement	NOUN	O	O
in	ADP	O	O
eGFR	NOUN	O	B-outcome
,	PUNCT	O	O
maximum	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
creatinine	NOUN	O	B-outcome
and	CCONJ	O	O
composite	NOUN	O	O
of	ADP	O	O
requirement	NOUN	O	O
of	ADP	O	O
hemodialysis	NOUN	O	B-outcome
,	PUNCT	O	O
death	NOUN	O	B-outcome
and	CCONJ	O	O
rehospitalization	NOUN	O	B-outcome
for	ADP	O	Seperator
heart	NOUN	O	I-outcome
failure	NOUN	O	I-outcome
up	ADP	O	O
to	PART	O	O
6	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
PCI.	NOUN	O	O

In	ADP	O	O
this	DET	O	O
study	NOUN	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
98	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
MMC	NOUN	O	O
and	CCONJ	O	O
hydrocephalus	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
equal	ADJ	O	O
groups.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
on	ADP	O	O
46	NUM	O	O
patients	NOUN	O	O
scheduled	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
THR.	NOUN	O	O

Treatments	NOUN	O	O
for	ADP	O	O
PPI-refractory	ADJ	O	O
heartburn	ADP	O	O
are	VERB	O	O
of	ADP	O	O
unproven	VERB	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
focus	NOUN	O	O
on	ADP	O	O
controlling	VERB	O	O
gastroesophageal	ADJ	O	O
reflux	NOUN	O	O
with	ADP	O	O
reflux-reducing	VERB	O	O
medication	NOUN	O	O
(e.g.,	NOUN	O	O
baclofen)	NOUN	O	O
or	CCONJ	O	O
antireflux	NOUN	O	O
surgery	NOUN	O	O
or	CCONJ	O	O
on	ADP	O	O
dampening	VERB	O	O
visceral	ADJ	O	O
hypersensitivity	NOUN	O	O
with	ADP	O	O
neuromodulators	NOUN	O	O
(e.g.,	NOUN	O	O
desipramine).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Tranexamic	ADJ	O	O
acid	NOUN	O	O
(TXA)	NOUN	O	O
is	VERB	O	O
an	DET	O	O
efficient	ADJ	O	O
antifibrinolytic	ADJ	O	O
agent,	NOUN	O	O
but	CCONJ	O	O
the	DET	O	O
mode	NOUN	O	O
and	CCONJ	O	O
timing	VERB	O	O
of	ADP	O	O
its	ADJ	O	O
administration	NOUN	O	O
remain	VERB	O	O
controversial.	NOUN	O	O

Further,	NOUN	O	O
amongst	ADP	O	O
all	DET	O	O
views,	NOUN	O	O
LAO	NOUN	O	O
views	NOUN	O	O
have	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
emitted	VERB	O	O
radiation	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
Non	NOUN	O	O
LAO	NOUN	O	O
views	NOUN	O	O
and	CCONJ	O	O
need	NOUN	O	O
more	ADV	O	O
radiation	NOUN	O	O
protection.	NOUN	O	O

Moreover,	NOUN	O	O
gastrocnemius	NOUN	O	B-outcome
medialis	NOUN	O	I-outcome
and	CCONJ	O	Seperator
biceps	VERB	O	B-outcome
femoris	NOUN	O	I-outcome
muscle	NOUN	O	I-outcome
peak	NOUN	O	I-outcome
activation	NOUN	O	E3-outcome
during	ADP	O	O
loading	VERB	O	O
response	NOUN	O	O
decreased	VERB	O	O
by	ADP	O	O
8.36%MVIC	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
=	SYM	O	O
2.71,	NUM	O	O
14.02)	ADJ	O	O
and	CCONJ	O	O
3.54%MVIC	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
=	SYM	O	O
1.08,	NUM	O	O
6.01),	ADP	O	O
respectively,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
overtime.	ADJ	O	O

Work-related	VERB	O	B-outcome
fear	ADJ	O	I-outcome
of	ADP	O	I-outcome
pain	NOUN	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
Combined-	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.003)	NUM	O	O
and	CCONJ	O	O
Exercise-arm	NUM	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.002).	NUM	O	O

A	DET	O	O
diet	NOUN	O	O
enriched	VERB	O	O
in	ADP	O	O
CSO,	NOUN	O	O
a	DET	O	O
rich	ADJ	O	O
source	NOUN	O	O
of	ADP	O	O
alpha-linolenic	ADJ	O	O
acid	NOUN	O	O
(ALA),	PUNCT	O	O
decreased	VERB	O	O
PBMC	NOUN	O	O
IFNG	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
0.01).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
demineralized	VERB	O	B-outcome
lesions	NOUN	O	I-outcome
was	VERB	O	O
24%;	NUM	O	O
but	CCONJ	O	O
when	ADP	O	O
the	DET	O	O
esthetic	ADJ	O	B-outcome
impact	NOUN	O	O
was	VERB	O	O
taken	VERB	O	O
into	ADP	O	O
account,	NOUN	O	O
this	DET	O	O
was	VERB	O	O
considerably	ADV	O	O
lower	ADJ	O	O
(9%).	NUM	O	O

Title:	NOUN	O	O
Rivaroxaban	NOUN	O	O
for	ADP	O	O
Thromboprophylaxis	NOUN	O	O
in	ADP	O	O
High-Risk	NOUN	O	O
Ambulatory	ADJ	O	O
Patients	NOUN	O	O
with	ADP	O	O
Cancer.	ADV	O	O

CONCLUSIONS:	NOUN	O	O
Oral	ADJ	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
intravenous	ADJ	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
when	ADP	O	O
used	VERB	O	O
during	ADP	O	O
the	DET	O	O
first	ADV	O	O
6	NUM	O	O
weeks	NOUN	O	O
for	ADP	O	O
complex	NOUN	O	O
orthopedic	ADJ	O	O
infection,	NOUN	O	O
as	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
treatment	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
at	ADP	O	O
1	NUM	O	O
year.	NOUN	O	O
(	PUNCT	O	O

Prot.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

The	DET	O	O
results	NOUN	O	O
have	VERB	O	O
contributed	VERB	O	O
to	PART	O	O
the	DET	O	O
establishing	VERB	O	O
of	ADP	O	O
an	DET	O	O
HA	NOUN	O	O
vaccination	NOUN	O	O
policy	NOUN	O	O
in	ADP	O	O
Korea	NOUN	O	O
and	CCONJ	O	O
will	VERB	O	O
be	VERB	O	O
informative	NOUN	O	O
to	PART	O	O
countries	NOUN	O	O
that	ADP	O	O
plan	NOUN	O	O
to	PART	O	O
initiate	VERB	O	O
vaccination	NOUN	O	O
programs	NOUN	O	O
against	ADP	O	O
HAV.	NOUN	O	O

ATLG	NOUN	O	O
was	VERB	O	O
descriptively	ADV	O	O
superior	ADJ	O	O
to	PART	O	O
non-ATLG	NOUN	O	O
at	ADP	O	O
24	NUM	O	O
months	NOUN	O	O
for	ADP	O	O
physical	ADJ	O	B-outcome
function	NOUN	O	I-outcome
(points	NOUN	O	O
estimate	ADP	O	O
-14.8	NUM	O	O
[95%	NOUN	O	O
CI	NOUN	O	O
-26.4	NUM	O	O
to	PART	O	O
-3.1];	NUM	O	O
p=0.014)	NOUN	O	O
and	CCONJ	O	O
social	ADJ	O	B-outcome
function	NOUN	O	I-outcome
(-19.1	NOUN	O	O
[-38.0	NOUN	O	O
to	PART	O	O
-0.2];	NUM	O	O
p=0.047),	NOUN	O	O
gastrointestinal	ADJ	O	B-outcome
side-effects	NOUN	O	I-outcome
(8.8	PUNCT	O	O
[2.5-15.1];	NOUN	O	O
p=0.008)	NUM	O	O
and	CCONJ	O	O
effect	NOUN	O	O
on	ADP	O	O
family	NOUN	O	O
(13.5	NUM	O	O
[1.2-25.8];	SYM	O	O
p=0.032).	NOUN	O	O

CONCLUSION:	NOUN	O	O
In	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
primary	ADJ	O	O
cementless	NOUN	O	O
THA,	NOUN	O	O
using	VERB	O	O
a	DET	O	O
posterior	ADJ	O	O
approach,	NOUN	O	O
who	ADP	O	O
are	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
rivaroxaban	ADJ	O	O
for	ADP	O	O
thromboembolic	ADJ	O	O
prophylaxis,	NOUN	O	O
short-	NOUN	O	O
and	CCONJ	O	O
long-TXA	NOUN	O	O
IV	NUM	O	O
protocols	NOUN	O	O
are	VERB	O	O
significantly	ADV	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
placebo	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
perioperative	ADJ	O	O
real	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(RBL),	PUNCT	O	O
without	ADP	O	O
any	DET	O	O
thromboembolic	ADJ	O	B-outcome
complications	NOUN	O	I-outcome
.	PUNCT	O	O
Non-inferiority	NOUN	O	O
of	ADP	O	O
a	DET	O	O
short-	NOUN	O	O
versus	CCONJ	O	O
a	DET	O	O
long-TXA	NOUN	O	O
protocol	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
perioperative	ADJ	O	O
real	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(RBL)	PUNCT	O	O
was	VERB	O	O
supported	VERB	O	O
in	ADP	O	O
a	DET	O	O
secondary	ADJ	O	O
analysis.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
posttraumatic	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
(PTSD)	ADV	O	I-outcome
symptom	NOUN	O	I-outcome
severity	NOUN	O	I-outcome
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
(treatment	NUM	O	O
effect	NOUN	O	O
estimate	ADP	O	O
[difference	ADP	O	O
in	ADP	O	O
differences	NOUN	O	O
of	ADP	O	O
-0.03	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-2.58	NUM	O	O
to	PART	O	O
2.52];	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.98).	NUM	O	O

METHODS:	NOUN	O	O
Baltimore	NOUN	O	O
CONNECT	NOUN	O	O
involved	VERB	O	O
22	NUM	O	O
CBOs	NOUN	O	O
in	ADP	O	O
East	ADV	O	O
Baltimore	NOUN	O	O
randomized	VERB	O	O
to	PART	O	O
a	DET	O	O
co-developed	VERB	O	O
intervention	NOUN	O	O
bundle	NOUN	O	O
versus	CCONJ	O	O
control.	NOUN	O	O

Title:	NOUN	O	O
Piloting	VERB	O	O
a	DET	O	O
participatory,	ADJ	O	O
community-based	VERB	O	O
health	NOUN	O	O
information	NOUN	O	O
system	NOUN	O	O
for	ADP	O	O
strengthening	VERB	O	O
community-based	VERB	O	O
health	NOUN	O	O
services:	NOUN	O	O
findings	NOUN	O	O
of	ADP	O	O
a	DET	O	O
cluster-randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
in	ADP	O	O
the	DET	O	O
slums	NOUN	O	O
of	ADP	O	O
Freetown,	NOUN	O	O
Sierra	NOUN	O	O
Leone.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
was	VERB	O	O
21.83	NUM	O	O
+/-	SYM	O	O
2.07	NUM	O	O
years.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
Clinical	ADJ	O	O
research	NOUN	O	O
on	ADP	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
Bosinji	NOUN	O	O
for	ADP	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
with	ADP	O	O
radiculopathy	ADJ	O	O
caused	VERB	O	O
by	ADP	O	O
herniated	VERB	O	O
intervertebral	ADJ	O	O
disc	NOUN	O	O
of	ADP	O	O
the	DET	O	O
lumbar	ADJ	O	O
spine:	NOUN	O	O
A	DET	O	O
protocol	NOUN	O	O
for	ADP	O	O
a	DET	O	O
multicenter,	NOUN	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
equivalence	NOUN	O	O
trial.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
19	NUM	O	O
cases	NOUN	O	O
were	VERB	O	O
successfully	ADV	O	O
hemostatic	ADJ	O	B-outcome
in	ADP	O	O
3	NUM	O	O
minutes,	NOUN	O	O
4	NUM	O	O
cases	NOUN	O	O
were	VERB	O	O
successful	ADJ	O	O
in	ADP	O	O
5	NUM	O	O
minutes,	NOUN	O	O
and	CCONJ	O	O
7	NUM	O	O
cases	NOUN	O	O
were	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
hemostasis.	NOUN	O	O

Title:	NOUN	O	O
Intraduodenal	ADJ	O	O
Administration	NOUN	O	O
of	ADP	O	O
L-Valine	NOUN	O	O
Has	NOUN	O	O
No	DET	O	O
Effect	NOUN	O	O
on	ADP	O	O
Antropyloroduodenal	ADJ	O	B-outcome
Pressures	NOUN	O	I-outcome
,	PUNCT	O	O
Plasma	NOUN	O	O
Cholecystokinin	NOUN	O	B-outcome
Concentrations	NOUN	O	O
or	CCONJ	O	O
Energy	NOUN	O	B-outcome
Intake	NOUN	O	I-outcome
in	ADP	O	O
Healthy,	NOUN	O	O
Lean	ADJ	O	O
Men.	NOUN	O	O

Amnestic	ADJ	O	O
mild	ADJ	O	O
cognitive	ADJ	O	O
impairment	NOUN	O	O
(aMCI),	ADJ	O	O
an	DET	O	O
Alzheimer's	NOUN	O	O
disease	NOUN	O	O
prodrome,	ADJ	O	O
is	VERB	O	O
characterized	VERB	O	O
by	ADP	O	O
cognitive	ADJ	O	O
and	CCONJ	O	O
psychological	ADJ	O	O
symptoms,	NOUN	O	O
the	DET	O	O
latter	NOUN	O	O
aggravating	VERB	O	O
prognosis.	NOUN	O	O

Results:	NOUN	O	O
Overall,	NOUN	O	O
402	NUM	O	O
patients	NOUN	O	O
(30	NOUN	O	O
mg:	ADV	O	O
134;	NUM	O	O
100	NUM	O	O
mg:	ADV	O	O
135;	NUM	O	O
300	NUM	O	O
mg:	ADV	O	O
133)	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
and	CCONJ	O	O
evaluable	ADJ	O	O
for	ADP	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety.	ADJ	O	O

Journal-Name:Lancet	NOUN	O	O
(London,	PUNCT	O	O
England)	NOUN	O	O

BACKGROUND:	NOUN	O	O
Congenital	ADJ	O	O
nasolacrimal	ADJ	O	O
duct	NOUN	O	O
obstruction	NOUN	O	O
(CNLDO)	PUNCT	O	O
is	VERB	O	O
common	ADJ	O	O
and.	NOUN	O	O

After	ADP	O	O
in	ADP	O	O
vitro	ADV	O	O
GI	NOUN	O	O
digestion,	NOUN	O	O
intestinal	ADJ	O	O
bioaccessibility	NOUN	O	O
of	ADP	O	O
RSV	NOUN	O	O
was	VERB	O	O
92.3%.	NOUN	O	O

In	ADP	O	O
intervention	NOUN	O	O
arm,	ADJ	O	O
one	NUM	O	O
child	NOUN	O	O
had	VERB	O	O
rheumatic	ADJ	O	B-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(RHD)	PUNCT	O	I-outcome
while	ADP	O	O
three	NUM	O	O
had	VERB	O	O
congenital	ADJ	O	B-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
;	PUNCT	O	O
in	ADP	O	O
control	NOUN	O	O
arm,	ADJ	O	O
one	NUM	O	O
child	NOUN	O	O
had	VERB	O	O
congenital	ADJ	O	B-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
and	CCONJ	O	O
three	NUM	O	O
had	VERB	O	O
rheumatic	ADJ	O	B-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(RHD)	PUNCT	O	I-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
School	NOUN	O	O
based	VERB	O	O
surveillance	NOUN	O	O
had	VERB	O	O
higher	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
suspecting	VERB	O	O
children	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	B-outcome
pharyngitis	NOUN	O	I-outcome
and	CCONJ	O	O
or	CCONJ	O	O
rheumatic	ADJ	O	B-outcome
fever/rheumatic	ADJ	O	I-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(RF/RHD)	NOUN	O	I-outcome
although	ADP	O	O
with	ADP	O	O
low	ADJ	O	O
specificity.	NOUN	O	O

RESULTS:	NOUN	O	O
There	PRON	O	O
were	VERB	O	O
positive	ADJ	O	O
associations	NOUN	O	O
among	ADP	O	O
SPC,	NOUN	O	O
MSI,	ADV	O	O
and	CCONJ	O	O
EBV	NOUN	O	O
statuses	NOUN	O	O
among	ADP	O	O
586	NUM	O	O
patients.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
used	VERB	O	O
data	NOUN	O	O
from	ADP	O	O
the	DET	O	O
Fluid	NOUN	O	O
Lavage	NOUN	O	O
of	ADP	O	O
Open	ADJ	O	O
Wounds	NOUN	O	O
trial	NOUN	O	O
to	PART	O	O
determine,	NOUN	O	O
in	ADP	O	O
1560	NUM	O	O
open	ADJ	O	O
fracture	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
surgical	ADJ	O	O
repair,	ADJ	O	O
the	DET	O	O
association	NOUN	O	O
between	ADP	O	O
Somatic	ADJ	O	O
PreOccupation	NOUN	O	O
and	CCONJ	O	O
Coping	VERB	O	O
(captured	PUNCT	O	O
by	ADP	O	O
the	DET	O	O
SPOC	NOUN	O	O
questionnaire)	NOUN	O	O
and	CCONJ	O	O
recovery	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
yr.	PUNCT	O	O

The	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
was	VERB	O	O
parallel	ADJ	O	O
to	PART	O	O
the	DET	O	O
improvement	NOUN	O	O
of	ADP	O	O
insulin	NOUN	O	B-outcome
resistance	NOUN	O	I-outcome
parameters.	NOUN	O	O

No	DET	O	O
additional	ADJ	O	O
side	NOUN	O	B-outcome
effect	NOUN	O	I-outcome
was	VERB	O	O
observed	VERB	O	O
by	ADP	O	O
adding	VERB	O	O
spinal	ADJ	O	O
Dex.	NOUN	O	O

All	DET	O	O
groups	NOUN	O	O
perceived	VERB	O	O
the	DET	O	O
instruction	NOUN	O	O
as	ADP	O	O
effective.	ADJ	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
general	ADJ	O	O
score	NOUN	O	O
of	ADP	O	O
the	DET	O	O
depression	NOUN	O	B-outcome
after	ADP	O	O
yoga	NOUN	O	O
intervention	NOUN	O	O
was	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P<0.036)	NUM	O	O
and	CCONJ	O	O
yoga	NOUN	O	O
group	NOUN	O	O
before	ADP	O	O
intervention	NOUN	O	O
(P<0.001).	NOUN	O	O

CONCLUSION:	NOUN	O	O
In	ADP	O	O
second-line	NOUN	O	O
treatment	NOUN	O	O
for	ADP	O	O
metastatic	ADJ	O	O
colorectal	ADJ	O	O
cancer,	NOUN	O	O
mFOLFOX6	NOUN	O	O
or	CCONJ	O	O
FOLFIRI	NOUN	O	O
with	ADP	O	O
erlotinib	NOUN	O	O
in	ADP	O	O
a	DET	O	O
sequence-dependent	ADJ	O	O
fashion	NOUN	O	O
is	VERB	O	O
not	ADV	O	O
feasible	ADJ	O	O
despite	ADP	O	O
potential	ADJ	O	O
promising	VERB	O	O
activity.	NOUN	O	O

Findings	NOUN	O	O
may	VERB	O	O
also	ADV	O	O
be	VERB	O	O
used	VERB	O	O
by	ADP	O	O
decision-makers	NOUN	O	O
interested	VERB	O	O
in	ADP	O	O
implementing	VERB	O	O
the	DET	O	O
mhGAP-IG	NOUN	O	O
training	VERB	O	O
in	ADP	O	O
other	ADJ	O	O
LMICs.	VERB	O	O

The	DET	O	O
secondary	ADJ	O	O
end	NOUN	O	O
points	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
comparable	ADJ	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups-	NOUN	O	O
Death	NOUN	O	B-outcome
-	PUNCT	O	O
1	NUM	O	O
of	ADP	O	O
85(1.17%)	NUM	O	O
vs.	CCONJ	O	O
2	NUM	O	O
of	ADP	O	O
98(2.04%),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.646,	NUM	O	O
Stroke	NOUN	O	B-outcome
0	NUM	O	O
of	ADP	O	O
85	NUM	O	O
vs.	CCONJ	O	O
2	NUM	O	O
of	ADP	O	O
98(2.04%),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.185	NUM	O	O
and	CCONJ	O	O
acute	ADJ	O	B-outcome
coronary	ADJ	O	I-outcome
syndrome	NOUN	O	I-outcome
-	PUNCT	O	O
2	NUM	O	O
of	ADP	O	O
85(2.35%)	NUM	O	O
vs.	CCONJ	O	O
1	NUM	O	O
of	ADP	O	O
98(1.02%),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.204.	NUM	O	O

L(-	NOUN	O	O
1))	NOUN	O	O
was	VERB	O	O
monitored	VERB	O	O
pre-post	NOUN	O	O
time-trial	ADJ	O	O
and	CCONJ	O	O
following	VERB	O	O
maximal	ADJ	O	O
sprint	NOUN	O	O
efforts.	NOUN	O	O

Patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
found	VERB	O	O
that	ADP	O	O
the	DET	O	O
rehabilitation	NOUN	O	O
sessions	NOUN	O	O
were	VERB	O	O
easier	NOUN	O	B-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.048).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
Health	NOUN	O	O
Technology	NOUN	O	O
Assessment	NOUN	O	O
Programme	NOUN	O	O
of	ADP	O	O
the	DET	O	O
National	ADJ	O	O
Institute	NOUN	O	O
for	ADP	O	O
Health	NOUN	O	O
Research;	NOUN	O	O
SIFT	NOUN	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials	NOUN	O	O
number,	ADV	O	O
ISRCTN76463425.).	NUM	O	O

Journal-Name:Nutrients	NOUN	O	O

The	DET	O	O
APPAC	NOUN	O	O
II	NUM	O	O
trial	NOUN	O	O
aims	NOUN	O	O
to	PART	O	O
add	NOUN	O	O
clinical	ADJ	O	O
evidence	NOUN	O	O
on	ADP	O	O
the	DET	O	O
debated	VERB	O	O
role	NOUN	O	O
of	ADP	O	O
antibiotics	NOUN	O	O
as	ADP	O	O
the	DET	O	O
first-line	NOUN	O	O
treatment	NOUN	O	O
for	ADP	O	O
a	DET	O	O
CT-confirmed	VERB	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
to	PART	O	O
optimise	NOUN	O	O
the	DET	O	O
non-operative	ADJ	O	O
treatment	NOUN	O	O
for	ADP	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis.	NOUN	O	O

CONCLUSION:	NOUN	O	O
These	DET	O	O
results	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
toric	ADJ	O	O
contact	NOUN	O	O
lenses	NOUN	O	O
provided	ADJ	O	O
improved	VERB	O	O
objective	ADP	O	O
measures	NOUN	O	O
of	ADP	O	O
vision	NOUN	O	B-outcome
in	ADP	O	O
a	DET	O	O
low-to-moderate	NOUN	O	O
astigmatic	ADJ	O	O
population.	ADV	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
1	NUM	O	O
of	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
Group	NOUN	O	O
1	NUM	O	O
patients	NOUN	O	O
received	VERB	O	O
curettage	NOUN	O	O
plus	CCONJ	O	O
NCH	NOUN	O	O
gel	NOUN	O	O
(intervention	PUNCT	O	O
group),	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
2	NUM	O	O
patients	NOUN	O	O
received	VERB	O	O
curettage	NOUN	O	O
alone	ADJ	O	O
(control	PUNCT	O	O
group).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/16	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/07	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

We	PRON	O	O
calculated	VERB	O	O
cause-specific	ADJ	O	O
hazard	NOUN	O	O
ratio's	NOUN	O	O
(HR's)	NUM	O	O
for	ADP	O	O
effects	NOUN	O	O
of	ADP	O	O
time-dependent	ADJ	O	O
macrolide	NOUN	O	B-outcome
and	CCONJ	O	O
fluoroquinolone	ADJ	O	B-outcome
exposure	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
beta-lactam	NOUN	O	O
monotherapy	NOUN	O	O
on	ADP	O	O
cardiac	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
new	ADJ	O	O
or	CCONJ	O	O
worsening	VERB	O	O
heart	NOUN	O	B-outcome
failure,	NOUN	O	I-outcome
arrhythmia,	NOUN	O	B-outcome
or	CCONJ	O	Seperator
myocardial	ADJ	O	B-outcome
ischemia	NOUN	O	I-outcome
during	ADP	O	I-outcome
hospitalization	NOUN	O	E2-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Cardiac	ADJ	O	B-outcome
events	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
146	NUM	O	O
(6.9%)	NUM	O	O
of	ADP	O	O
2107	NUM	O	O
patients,	NOUN	O	O
including	VERB	O	O
heart	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
(n	NOUN	O	O
=	SYM	O	O
101,	NOUN	O	O
4.8%),	NOUN	O	O
arrhythmia	NOUN	O	B-outcome
(n	NOUN	O	O
=	SYM	O	O
53,	NOUN	O	O
2.5%),	NUM	O	O
and	CCONJ	O	O
myocardial	ADJ	O	B-outcome
ischemia	NOUN	O	I-outcome
(n	NOUN	O	O
=	SYM	O	O
14,	NUM	O	O
0.7%).	NUM	O	O

This	DET	O	O
study	NOUN	O	O
explores	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
sponsorship	NOUN	O	O
of	ADP	O	O
an	DET	O	O
elite	ADP	O	O
sporting	VERB	O	O
event	NOUN	O	O
by:	NOUN	O	O
(A)	PUNCT	O	O
non-food	NOUN	O	O
brands	NOUN	O	O
(control),	PUNCT	O	O
(B)	PUNCT	O	O
unhealthy	NOUN	O	O
food	NOUN	O	O
brands,	NOUN	O	O
(C)	NOUN	O	O
healthier	ADJ	O	O
food	NOUN	O	O
brands,	NOUN	O	O
or	CCONJ	O	O
(D)	NOUN	O	O
an	DET	O	O
obesity	NOUN	O	O
prevention	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O
campaign	ADV	O	O
on	ADP	O	O
young	ADJ	O	O
adults'	NOUN	O	O
brand	NOUN	O	B-outcome
awareness	ADV	O	I-outcome
,	PUNCT	O	O
attitudes	NOUN	O	B-outcome
,	PUNCT	O	O
image	NOUN	O	B-outcome
perceptions	NOUN	O	I-outcome
,	PUNCT	O	O
event-sponsor	NOUN	O	B-outcome
fit	NOUN	O	I-outcome
perceptions	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
preference	NOUN	O	B-outcome
for	ADP	O	O
food	NOUN	O	O
sponsors'	ADJ	O	O
products.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Total	ADJ	O	O
knee	NOUN	O	O
arthroplasty	NOUN	O	O
(TKA)	ADV	O	O
is	VERB	O	O
a	DET	O	O
surgical	ADJ	O	O
procedure	NOUN	O	O
to	PART	O	O
replace	NOUN	O	O
the	DET	O	O
weight-bearing	VERB	O	O
surfaces	NOUN	O	O
of	ADP	O	O
the	DET	O	O
knee	NOUN	O	O
joint	NOUN	O	O
to	PART	O	O
relieve	NOUN	O	O
pain	NOUN	O	O
and	CCONJ	O	O
disability.	NOUN	O	O

It	PRON	O	O
aims	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
late	ADJ	O	O
first-trimester	NOUN	O	O
(>12	NOUN	O	O
gestational	ADJ	O	O
weeks)	NOUN	O	O
degree	NOUN	O	O
of	ADP	O	O
adherence	NOUN	O	O
to	PART	O	O
a	DET	O	O
MedDiet	NOUN	O	O
pattern-based	VERB	O	O
on	ADP	O	O
six	NUM	O	O
food	NOUN	O	O
targets-on	NOUN	O	O
a	DET	O	O
composite	NOUN	O	O
of	ADP	O	O
materno-foetal	ADJ	O	O
outcomes	NOUN	O	O
(CMFCs).	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
ambulatory	ADJ	O	O
adults	NOUN	O	O
with	ADP	O	O
hypertension,	NOUN	O	O
treating	VERB	O	O
to	PART	O	O
a	DET	O	O
systolic	ADJ	O	O
blood	NOUN	O	O
pressure	NOUN	O	O
goal	NOUN	O	O
of	ADP	O	O
less	ADV	O	O
than	ADP	O	O
120	NUM	O	O
mm	NOUN	O	O
Hg	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
a	DET	O	O
goal	NOUN	O	O
of	ADP	O	O
less	ADV	O	O
than	ADP	O	O
140	NUM	O	O
mm	NOUN	O	O
Hg	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
probable	ADJ	O	O
dementia	NOUN	O	B-outcome
.	PUNCT	O	O
Because	ADP	O	O
of	ADP	O	O
early	ADJ	O	O
study	NOUN	O	O
termination	NOUN	O	O
and	CCONJ	O	O
fewer	ADJ	O	O
than	ADP	O	O
expected	VERB	O	O
cases	NOUN	O	O
of	ADP	O	O
dementia,	NOUN	O	O
the	DET	O	O
study	NOUN	O	O
may	VERB	O	O
have	VERB	O	O
been	VERB	O	O
underpowered	VERB	O	O
for	ADP	O	O
this	DET	O	O
end	NOUN	O	O
point.	NOUN	O	O

However,	ADV	O	O
these	DET	O	O
results	NOUN	O	O
can	AUX	O	O
not	ADV	O	O
be	VERB	O	O
representative	ADJ	O	O
of	ADP	O	O
a	DET	O	O
heavy	ADJ	O	O
workload	ADP	O	O
or	CCONJ	O	O
incident	ADJ	O	O
situations	NOUN	O	O
for	ADP	O	O
which	ADP	O	O
radiation	NOUN	O	O
exposure	NOUN	O	O
to	PART	O	O
the	DET	O	O
eye-lens	NOUN	O	O
could	VERB	O	O
exceed	NOUN	O	O
this	DET	O	O
limit.	NOUN	O	O

As	ADP	O	O
we	PRON	O	O
now	ADV	O	O
know	NOUN	O	O
that	ADP	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
for	ADP	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis	NOUN	O	O
is	VERB	O	O
feasible	ADJ	O	O
and	CCONJ	O	O
safe,	NOUN	O	O
further	ADV	O	O
studies	NOUN	O	O
evaluating	VERB	O	O
optimisation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
antibiotic	ADJ	O	O
treatment	NOUN	O	O
regarding	VERB	O	O
both	CCONJ	O	O
antibiotic	ADJ	O	O
spectrum	NOUN	O	O
and	CCONJ	O	O
shorter	ADJ	O	O
hospital	NOUN	O	O
stay	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
antibiotics	NOUN	O	O
as	ADP	O	O
the	DET	O	O
first-line	NOUN	O	O
treatment	NOUN	O	O
for	ADP	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis.	NOUN	O	O

INTERVENTIONS:	NOUN	O	O
60	NUM	O	O
midwifery	NOUN	O	O
practices	NOUN	O	O
offered	VERB	O	O
usual	ADJ	O	O
care	NOUN	O	O
(serial	ADJ	O	O
fundal	ADJ	O	O
height	NOUN	O	O
measurements	NOUN	O	O
with	ADP	O	O
clinically	ADV	O	O
indicated	VERB	O	O
ultrasonography).	NUM	O	O

Total	ADJ	O	O
treatment	NOUN	O	B-outcome
times	NOUN	O	I-outcome
were	VERB	O	O
9.7	NUM	O	O
+/-	SYM	O	O
1.1	NUM	O	O
months	NOUN	O	O
for	ADP	O	O
the	DET	O	O
IA	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
9.5	NUM	O	O
+/-	SYM	O	O
1.1	NUM	O	O
months	NOUN	O	O
for	ADP	O	O
the	DET	O	O
MA	NOUN	O	O
group.	VERB	O	O

Biochemical	ADJ	O	B-outcome
failure	NOUN	O	I-outcome
tended	ADP	O	O
to	PART	O	O
be	VERB	O	O
a	DET	O	O
late	ADJ	O	O
event	NOUN	O	O
with	ADP	O	O
a	DET	O	O
median	ADJ	O	O
time	NOUN	O	O
to	PART	O	O
occurrence	NOUN	O	O
of	ADP	O	O
5	NUM	O	O
years.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

Also,	ADJ	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
LF	NOUN	O	O
decreased	VERB	O	O
ICAM1	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Journal-Name:Revista	NOUN	O	O
da	NOUN	O	O
Associacao	NOUN	O	O
Medica	NOUN	O	O
Brasileira	NOUN	O	O
(1992)	PUNCT	O	O

CONCLUSIONS:	NOUN	O	O
Our	ADJ	O	O
evidence	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
the	DET	O	O
brief	ADJ	O	O
group	NOUN	O	O
intervention	NOUN	O	O
performed	VERB	O	O
by	ADP	O	O
the	DET	O	O
nurse	ADJ	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
health	NOUN	O	O
care	NOUN	O	O
context	NOUN	O	O
was	VERB	O	O
effective	ADJ	O	O
to	PART	O	O
reduce	VERB	O	O
alcohol	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
in	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
patterns	NOUN	O	O
of	ADP	O	O
hazardous	ADJ	O	O
or	CCONJ	O	O
harmful	ADJ	O	O
use.	PUNCT	O	O

Operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
and	CCONJ	O	O
difficulty	NOUN	O	B-outcome
of	ADP	O	O
finding	VERB	O	O
the	DET	O	O
specimen	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
modified	VERB	O	O
localization	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
methylene	NOUN	O	O
blue	ADJ	O	O
localization	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
clusters	NOUN	O	O
(1:1)	NOUN	O	O
using	VERB	O	O
a	DET	O	O
computer	NOUN	O	O
generated	VERB	O	O
random	NOUN	O	O
sequence.	NOUN	O	O

The	DET	O	O
overarching	VERB	O	O
study	NOUN	O	O
aim	ADP	O	O
was	VERB	O	O
to	PART	O	O
understand	ADP	O	O
how	ADP	O	O
schools	NOUN	O	O
implemented	VERB	O	B-outcome
the	DET	O	O
AS:Sk	NUM	O	O
intervention,	ADP	O	O
with	ADP	O	O
a	DET	O	O
specific	ADJ	O	O
focus	NOUN	O	O
on	ADP	O	O
the	DET	O	O
frequency	NOUN	O	O
of	ADP	O	O
intervention	NOUN	O	B-outcome
component	NOUN	O	I-outcome
implementation	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
how	ADP	O	O
the	DET	O	O
components	NOUN	O	O
were	VERB	O	O
incorporated	VERB	O	B-outcome
into	ADP	O	O
the	DET	O	O
school	NOUN	O	O
day.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
obesity	NOUN	O	O
has	VERB	O	O
increased	VERB	O	O
significantly	ADV	O	O
worldwide	ADJ	O	O
within	ADP	O	O
the	DET	O	O
last	NOUN	O	O
decade.	NOUN	O	O

The	DET	O	O
patients'	NOUN	O	O
preoperative	ADJ	O	O
and	CCONJ	O	O
intraoperative	ADJ	O	O
anxiety	NOUN	O	B-outcome
scores	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
with	ADP	O	O
the	DET	O	O
State	NOUN	O	O
Anxiety	NOUN	O	B-outcome
Inventory	ADJ	O	O
(SAI)	NUM	O	O
on	ADP	O	O
the	DET	O	O
day	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
on	ADP	O	O
the	DET	O	O
first	ADV	O	O
day	NOUN	O	O
after	ADP	O	O
the	DET	O	O
surgery,	NOUN	O	O
respectively.	NOUN	O	O

Background	NOUN	O	O
Knee	NOUN	O	O
pain	NOUN	O	O
is	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
common	ADJ	O	O
complaints	NOUN	O	O
patients	NOUN	O	O
present	ADJ	O	O
with	ADP	O	O
in	ADP	O	O
any	DET	O	O
community	NOUN	O	O
based	VERB	O	O
health	NOUN	O	O
camps	NOUN	O	O
and	CCONJ	O	O
Osteoarthritis	NOUN	O	O
of	ADP	O	O
knee	NOUN	O	O
is	VERB	O	O
a	DET	O	O
usual	ADJ	O	O
diagnosis.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study	NOUN	O	O

Twenty-three	NUM	O	O
survivors	NOUN	O	O
of	ADP	O	O
BC	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
analysis.	NOUN	O	O

2)	NOUN	O	O
Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
results	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
subjective	ADJ	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
(SQ)	ADV	O	I-outcome
,	PUNCT	O	O
sleep	NOUN	O	B-outcome
onset	NOUN	O	I-outcome
latency	NOUN	O	I-outcome
(SOL)	NOUN	O	I-outcome
,	PUNCT	O	O
sleep	NOUN	O	B-outcome
efficiency	NOUN	O	I-outcome
(SE)	NOUN	O	I-outcome
,	PUNCT	O	O
sleep	NOUN	O	B-outcome
disturbance	NOUN	O	I-outcome
(SD)	NOUN	O	I-outcome
and	CCONJ	O	O
used	VERB	O	O
sleep	NOUN	O	B-outcome
medication	NOUN	O	I-outcome
(USM)	PUNCT	O	O
in	ADP	O	O
PSQI	NOUN	O	O
in	ADP	O	O
combination	NOUN	O	O
group	NOUN	O	O
significantly	ADV	O	O
decreased	VERB	O	O
at	ADP	O	O
week	NOUN	O	O
4	NUM	O	O
and	CCONJ	O	O
8	NUM	O	O
(all	PUNCT	O	O
P<0.05)	NOUN	O	O
.	PUNCT	O	O

Palo	NOUN	O	O
Alto,	NOUN	O	O
CA,	NOUN	O	O
USA.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
2-arm	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
(RCT)	NUM	O	O
enrolled	VERB	O	O
86	NUM	O	O
eligible	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
CUR	NOUN	O	O
following	VERB	O	O
TBI.	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
also	ADV	O	O
recorded	VERB	O	O
during	ADP	O	O
the	DET	O	O
study	NOUN	O	O
period.	NOUN	O	O

Recent	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
demonstrated	VERB	O	O
that	ADP	O	O
the	DET	O	O
energy	NOUN	O	O
provided	ADJ	O	O
by	ADP	O	O
several	ADJ	O	O
tree	NOUN	O	O
nuts	NOUN	O	O
is	VERB	O	O
less	ADV	O	O
than	ADP	O	O
that	ADP	O	O
predicted	VERB	O	O
by	ADP	O	O
the	DET	O	O
Atwater	ADV	O	O
factors,	NOUN	O	O
though	ADP	O	O
energy	NOUN	O	O
available	ADJ	O	O
from	ADP	O	O
cashews	NOUN	O	O
has	VERB	O	O
never	ADV	O	O
been	VERB	O	O
assessed.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Registration	NOUN	O	O
name:	NOUN	O	O
Virtual	ADJ	O	O
Task	NOUN	O	O
in	ADP	O	O
Amyotrophic	ADJ	O	O
Lateral	ADJ	O	O
Sclerosis;	NOUN	O	O
Registration	NOUN	O	O
number:	NOUN	O	O
NCT03113630	NOUN	O	O
;	PUNCT	O	O
retrospectively	ADV	O	O
registered	VERB	O	O
on	ADP	O	O
04/13/2017.	NUM	O	O

The	DET	O	O
capacity	NOUN	O	O
of	ADP	O	O
HMCs	NOUN	O	O
and	CCONJ	O	O
WDCs	NOUN	O	O
to	PART	O	O
engage	NOUN	O	O
with	ADP	O	O
the	DET	O	O
local	ADJ	O	O
health	NOUN	O	O
system	NOUN	O	O
was	VERB	O	O
also	ADV	O	O
measured	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
endline.	NOUN	O	O

Title:	NOUN	O	O
Combined	VERB	O	O
intravenous	ADJ	O	O
and	CCONJ	O	O
intra-articular	ADJ	O	O
tranexamic	ADJ	O	O
acid	NOUN	O	O
administration	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
knee	NOUN	O	O
arthroplasty	NOUN	O	O
for	ADP	O	O
preventing	VERB	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
and	CCONJ	O	O
hyperfibrinolysis	NOUN	O	B-outcome
:	PUNCT	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

No	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
occurred.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

A	DET	O	O
series	NOUN	O	O
of	ADP	O	O
multivariable	ADJ	O	O
analyses	NOUN	O	O
will	VERB	O	O
also	ADV	O	O
be	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
to	PART	O	O
identify	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
for	ADP	O	O
several	ADJ	O	O
possible	ADJ	O	O
confounders	NOUN	O	O
of	ADP	O	O
the	DET	O	O
major	ADJ	O	O
pregnancy	NOUN	O	B-outcome
outcomes	NOUN	O	I-outcome
and	CCONJ	O	O
HIV	NOUN	O	B-outcome
disease	NOUN	O	I-outcome
progression	NOUN	O	I-outcome
.	PUNCT	O	O
Statistical	ADJ	O	O
significance	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
defined	VERB	O	O
as	ADP	O	O
P	NOUN	O	O
<	SYM	O	O
.05.	PUNCT	O	O

GnRH-agonist	NOUN	O	O
trigger	ADP	O	O
and	CCONJ	O	O
adjuvant	NOUN	O	O
low	ADJ	O	O
dose	NOUN	O	O
hCG	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
proposed	VERB	O	O
to	PART	O	O
improve	VERB	O	O
birth	NOUN	O	O
rates,	NOUN	O	O
but	CCONJ	O	O
timing	VERB	O	O
of	ADP	O	O
this	DET	O	O
hCG	NOUN	O	O
support	NOUN	O	O
to	PART	O	O
corpus	NOUN	O	O
luteum	NOUN	O	O
function	NOUN	O	O
has	VERB	O	O
never	ADV	O	O
been	VERB	O	O
fully	ADV	O	O
described.	NOUN	O	O

The	DET	O	O
hypothesis	NOUN	O	O
was	VERB	O	O
that	ADP	O	O
PFM	NOUN	O	O
asymmetry	NOUN	O	O
may	VERB	O	O
have	VERB	O	O
a	DET	O	O
functional	ADJ	O	O
reason	NOUN	O	O
related	VERB	O	O
to	PART	O	O
lumbopelvic	NOUN	O	O
complex	NOUN	O	O
misalignment.	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
participant-reported	VERB	O	O
treatment	NOUN	O	B-outcome
usage	NOUN	O	I-outcome
and	CCONJ	O	O
respiratory	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
886	NUM	O	O
participants	NOUN	O	O
underwent	VERB	O	O
randomization.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
psychology	NOUN	O	O

RESULTS:	NOUN	O	O
Most	DET	O	O
mothers	NOUN	O	O
reported	VERB	O	O
that	ADP	O	O
they	PRON	O	O
understood	VERB	O	B-outcome
the	DET	O	O
message	NOUN	O	O
in	ADP	O	O
the	DET	O	O
poster	NOUN	O	O
("The	ADJ	O	O
picture	NOUN	O	O
shows	NOUN	O	O
me	NOUN	O	O
you	NOUN	O	O
must	VERB	O	O
use	NOUN	O	O
these	DET	O	O
drugs	NOUN	O	O
to	PART	O	O
keep	NOUN	O	O
your	ADP	O	O
baby	NOUN	O	O
healthy")	DET	O	O
and	CCONJ	O	O
that	ADP	O	O
they	PRON	O	O
could	VERB	O	O
adhere	ADV	O	B-outcome
to	PART	O	O
the	DET	O	O
moments	NOUN	O	O
from	ADP	O	O
the	DET	O	O
poster.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

The	DET	O	O
duration	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
lasted	VERB	O	O
for	ADP	O	O
8	NUM	O	O
weeks.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
depression	NOUN	O	B-outcome
levels	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

After	ADP	O	O
the	DET	O	O
operation,	NOUN	O	O
intravenous	ADJ	O	O
fentanyl	NOUN	O	O
infusion	NOUN	O	O
(25	NOUN	O	O
mug/h)	NOUN	O	O
was	VERB	O	O
begun	NOUN	O	O
with	ADP	O	O
loading	VERB	O	O
dose	NOUN	O	O
25	NUM	O	O
mug	NUM	O	O
in	ADP	O	O
the	DET	O	O
IV	NUM	O	O
group	NOUN	O	O
and	CCONJ	O	O
only	ADV	O	O
normal	ADJ	O	O
saline	NOUN	O	O
in	ADP	O	O
the	DET	O	O
TFP	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
diastolic	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
decreased	VERB	O	O
significantly	ADV	O	O
after	ADP	O	O
yoga	NOUN	O	O
intervention	NOUN	O	O
(P<0.029).	NOUN	O	O

Grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
was	VERB	O	O
tested	VERB	O	O
in	ADP	O	O
all	DET	O	O
patients	NOUN	O	O
using	VERB	O	O
an	DET	O	O
electronic	ADJ	O	O
device	NOUN	O	O
before	ADP	O	O
anesthesia	NOUN	O	O
and	CCONJ	O	O
when	ADP	O	O
TOFr	NOUN	O	O
values	NOUN	O	O
of	ADP	O	O
0.7,	NUM	O	O
0.8,	NOUN	O	O
and	CCONJ	O	O
0.9,	NUM	O	O
and	CCONJ	O	O
an	DET	O	O
hour	NOUN	O	O
later	ADV	O	O
of	ADP	O	O
TOFr	NOUN	O	O
value	NOUN	O	O
of	ADP	O	O
0.25.	NUM	O	O

Retrospectively	ADV	O	O
registered	VERB	O	O
on	ADP	O	O
November	NOUN	O	O
17,	NUM	O	O
2017.	NUM	O	O

TPI	NOUN	O	O
or	CCONJ	O	O
EMLA	NOUN	O	O
treatments	NOUN	O	O
decreased	VERB	O	O
shoulder	NOUN	O	O
pain	NOUN	O	O
irrespective	ADJ	O	O
of	ADP	O	O
exercise	NOUN	O	O
habit	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.001	NUM	O	O
and	CCONJ	O	O
P	NOUN	O	O
<	SYM	O	O
.001,	PUNCT	O	O
respectively),	NOUN	O	O
but	CCONJ	O	O
decreased	VERB	O	O
overall	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
only	ADV	O	O
in	ADP	O	O
patients	NOUN	O	O
without	ADP	O	O
exercise	NOUN	O	O
habit	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.019).	PUNCT	O	O

Methods:	NOUN	O	O
A	DET	O	O
child	NOUN	O	O
survival	NOUN	O	O
project	NOUN	O	O
was	VERB	O	O
implemented	VERB	O	O
in	ADP	O	O
10	NUM	O	O
slum	NOUN	O	O
communities,	NOUN	O	O
which	ADP	O	O
were	VERB	O	O
then	ADV	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
intervention	NOUN	O	O
(PCBHIS)	NUM	O	O
and	CCONJ	O	O
comparison	NOUN	O	O
areas.	NOUN	O	O

The	DET	O	O
statistical	ADJ	O	O
analysis	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
there	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
total	ADJ	O	O
dose	NOUN	O	B-outcome
of	ADP	O	O
used	VERB	O	O
gonadotropins	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
0.001),	NUM	O	O
stimulation	NOUN	O	B-outcome
duration	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
0.001),	NUM	O	O
number	NOUN	O	O
of	ADP	O	O
retrieved	VERB	O	B-outcome
oocytes	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
0.01)	NUM	O	O
and	CCONJ	O	O
top	ADV	O	O
quality	NOUN	O	O
embryo	NOUN	O	B-outcome
(P	NUM	O	O
<	SYM	O	O
0.001)	NUM	O	O
and	CCONJ	O	O
also	ADV	O	O
cancellation	NOUN	O	B-outcome
(P	NUM	O	O
=	SYM	O	O
0.002)	NUM	O	O
and	CCONJ	O	O
fertilization	NOUN	O	B-outcome
rates	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.002).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Journal-Name:JAMA	NOUN	O	O

In	ADP	O	O
the	DET	O	O
bilateral-graft	NOUN	O	O
group,	NOUN	O	O
13.9%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
only	ADV	O	O
a	DET	O	O
single	ADJ	O	O
internal-thoracic-artery	ADV	O	O
graft,	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
single-graft	NOUN	O	O
group,	NOUN	O	O
21.8%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
also	ADV	O	O
received	VERB	O	O
a	DET	O	O
radial-artery	NOUN	O	O
graft.	VERB	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
poster	NOUN	O	O
was	VERB	O	O
well-received	VERB	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
participants	NOUN	O	O
reported	VERB	O	O
compliance	NOUN	O	B-outcome
with	ADP	O	O
the	DET	O	O
moments	NOUN	O	O
for	ADP	O	O
hand	NOUN	O	O
hygiene	NOUN	O	O
(although	NUM	O	O
the	DET	O	O
full	ADJ	O	O
body	NOUN	O	O
wipe	NOUN	O	O
of	ADP	O	O
the	DET	O	O
baby	NOUN	O	O
has	VERB	O	O
since	ADP	O	O
been	VERB	O	O
removed).	ADP	O	O

CONCLUSIONS:	NOUN	O	O
Our	ADJ	O	O
findings	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
the	DET	O	O
active,	ADJ	O	O
music-instruction	NOUN	O	O
program	NOUN	O	O
holds	NOUN	O	O
promise	NOUN	O	O
as	ADP	O	O
a	DET	O	O
complementary	ADJ	O	O
means	NOUN	O	O
of	ADP	O	O
ameliorating	VERB	O	O
PTSD	NOUN	O	B-outcome
and	CCONJ	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
among	ADP	O	O
this	DET	O	O
population.	ADV	O	O

METHODS:	NOUN	O	O
CD80	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
trap	NOUN	O	O
belatacept	ADV	O	O
onto	ADP	O	O
streptavidin-coated	VERB	O	O
wells.	NOUN	O	O

Background:	NOUN	O	O
Although	ADP	O	O
community	NOUN	O	O
engagement	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
promoted	VERB	O	O
as	ADP	O	O
a	DET	O	O
strategy	NOUN	O	O
for	ADP	O	O
health	NOUN	O	O
systems	NOUN	O	O
strengthening,	ADP	O	O
there	PRON	O	O
is	VERB	O	O
need	NOUN	O	O
for	ADP	O	O
more	ADV	O	O
evidence	NOUN	O	O
for	ADP	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
this	DET	O	O
approach.	NOUN	O	O

These	DET	O	O
effects	NOUN	O	O
were	VERB	O	O
absent	ADJ	O	O
in	ADP	O	O
AA	NOUN	O	O
cohort.	NOUN	O	O

Predilution	NOUN	O	O
extended	VERB	O	O
the	DET	O	O
measurement	NOUN	O	O
range	NOUN	O	O
to	PART	O	O
130	NUM	O	O
mg/L	NOUN	O	O
with	ADP	O	O
an	DET	O	O
accuracy	NOUN	O	O
of	ADP	O	O
90%	VERB	O	O
and	CCONJ	O	O
coefficients	NOUN	O	O
of	ADP	O	O
variation	NOUN	O	O
of	ADP	O	O
3.8%.	NUM	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
lower	ADJ	O	O
loading	VERB	O	O
dose	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
with	ADP	O	O
conventional	ADJ	O	O
loading	VERB	O	O
dose	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
in	ADP	O	O
Indian	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
percutaneous	ADJ	O	O
coronary	ADJ	O	O
interventions.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
wei	NUM	O	O
zhong	PUNCT	O	O
bing	VERB	O	O
ji	ADP	O	O
jiu	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O

Moderate	ADP	O	O
intake	NOUN	O	O
of	ADP	O	O
total	ADJ	O	O
LC	ADP	O	O
omega-3	NOUN	O	O
PUFA	NOUN	O	O
(approximately	ADV	O	O
0.5(-)1	NUM	O	O
g/day)	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
lower	ADJ	O	O
prevalence	NOUN	O	O
of	ADP	O	O
depression	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSION:	NOUN	O	O
In	ADP	O	O
our	ADJ	O	O
study,	NOUN	O	O
moderate	ADJ	O	O
fish	NOUN	O	O
and	CCONJ	O	O
LC	ADP	O	O
omega-3	NOUN	O	O
PUFA	NOUN	O	O
intake,	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
high	ADJ	O	O
intake,	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
lower	ADJ	O	O
odds	NOUN	O	O
of	ADP	O	O
depression	NOUN	O	B-outcome
suggesting	VERB	O	O
a	DET	O	O
U-shaped	NOUN	O	O
relationship.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
(+/-SD)	NOUN	O	O
of	ADP	O	O
the	DET	O	O
60	NUM	O	O
participants	NOUN	O	O
was	VERB	O	O
27.5+/-5.0	NUM	O	O
years,	NOUN	O	O
spherical	ADJ	O	O
refractive	ADJ	O	O
error	NOUN	O	O
was	VERB	O	O
-3.68+/-2.01	NUM	O	O
D,	ADJ	O	O
and	CCONJ	O	O
cylinder	NOUN	O	O
was	VERB	O	O
-1.28+/-0.36	ADJ	O	O
D.	NOUN	O	O
High-	ADV	O	O
and	CCONJ	O	O
low-contrast	NOUN	O	O
visual	ADJ	O	B-outcome
acuities	NOUN	O	I-outcome
with	ADP	O	O
toric	ADJ	O	O
lenses	NOUN	O	O
were	VERB	O	O
better	ADJ	O	O
than	ADP	O	O
with	ADP	O	O
spherical	ADJ	O	O
lenses	NOUN	O	O
at	ADP	O	O
both	CCONJ	O	O
fitting	VERB	O	O
(toric	ADJ	O	O
high-contrast:	PUNCT	O	O
-0.065+/-0.078	NUM	O	O
and	CCONJ	O	O
low-contrast:	NOUN	O	O
0.133+/-0.103	NUM	O	O
vs.	CCONJ	O	O
spherical	ADJ	O	O
high-contrast:	PUNCT	O	O
0.001+/-0.104	NUM	O	O
and	CCONJ	O	O
low-contrast:	NOUN	O	O
0.224+/-0.107)	NOUN	O	O
and	CCONJ	O	O
follow-up	NOUN	O	O
(toric	ADJ	O	O
high-contrast:	PUNCT	O	O
-0.083+/-0.087	NOUN	O	O
and	CCONJ	O	O
low-contrast:	NOUN	O	O
0.108+/-0.107	NUM	O	O
vs.	CCONJ	O	O
spherical	ADJ	O	O
high-contrast:	PUNCT	O	O
-0.015+/-0.095	VERB	O	O
and	CCONJ	O	O
low-contrast:	NOUN	O	O
0.211+/-0.104)	NOUN	O	O
(all	PUNCT	O	O
P<0.0001).	NOUN	O	O

All	DET	O	O
the	DET	O	O
cases	NOUN	O	O
of	ADP	O	O
OHSS	ADP	O	O
in	ADP	O	O
Group	NOUN	O	O
2	NUM	O	O
were	VERB	O	O
moderate	ADJ	O	O
while	ADP	O	O
the	DET	O	O
one	NUM	O	O
case	NOUN	O	O
of	ADP	O	O
OHSS	ADP	O	O
in	ADP	O	O
Group	NOUN	O	O
1	NUM	O	O
was	VERB	O	O
mild.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrials.gov,	NOUN	O	O
NCT03112083	NOUN	O	O
,	PUNCT	O	O
retrospectively	ADV	O	O
registered.	NOUN	O	O

The	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
activation	NOUN	O	O
type:	NOUN	O	O
incremental	ADJ	O	O
advancement	ADJ	O	O
(IA)	NOUN	O	O
and	CCONJ	O	O
maximum	NOUN	O	O
advancement	ADJ	O	O
(MA).	PUNCT	O	O

METHODS:	NOUN	O	O
This	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
study	NOUN	O	O
included	VERB	O	O
409	NUM	O	O
subjects	NOUN	O	O
(496	PUNCT	O	O
eyes)	NOUN	O	O
older	ADJ	O	O
than	ADP	O	O
1-year-old	NOUN	O	O
with	ADP	O	O
persistent	ADJ	O	O
CNLDO	NOUN	O	O
in	ADP	O	O
southwest	NOUN	O	O
China,	NOUN	O	O
and	CCONJ	O	O
classified	VERB	O	O
into	ADP	O	O
3	NUM	O	O
groups:	NOUN	O	O
96	NUM	O	O
cases	NOUN	O	O
(123	PUNCT	O	O
eyes)	NOUN	O	O
were	VERB	O	O
the	DET	O	O
tobramycin/dexamethasone	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
group	NOUN	O	O
(drops	PUNCT	O	O
group),	NOUN	O	O
88	NUM	O	O
cases	NOUN	O	O
(104	NUM	O	O
eyes)	NOUN	O	O
were	VERB	O	O
the	DET	O	O
tobramycin/dexamethasone	NOUN	O	O
ointment	NOUN	O	O
group	NOUN	O	O
(ointment	NUM	O	O
group),	NOUN	O	O
and	CCONJ	O	O
225	NUM	O	O
cases	NOUN	O	O
(269	PUNCT	O	O
eyes)	NOUN	O	O
were	VERB	O	O
control	NOUN	O	O
group	NOUN	O	O
which	ADP	O	O
probing	VERB	O	O
with	ADP	O	O
normal	ADJ	O	O
saline	NOUN	O	O
(NS	PUNCT	O	O
group).	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
Mitochondria-Targeted	VERB	O	O
Metabolic	ADJ	O	O
Tubular	ADJ	O	O
Injury	NOUN	O	O
in	ADP	O	O
Diabetic	ADJ	O	O
Kidney	NOUN	O	O
Disease.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
5	NUM	O	O
PCBHIS	NOUN	O	O
communities,	NOUN	O	O
the	DET	O	O
findings	NOUN	O	O
from	ADP	O	O
monthly	ADV	O	O
reports	NOUN	O	O
submitted	VERB	O	O
by	ADP	O	O
community	NOUN	O	O
health	NOUN	O	O
workers	NOUN	O	O
(CHWs)	PUNCT	O	O
and	CCONJ	O	O
verbal	ADV	O	O
autopsy	NOUN	O	O
findings	NOUN	O	O
for	ADP	O	O
deaths	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
who	ADP	O	O
died	VERB	O	O
before	ADP	O	O
reaching	VERB	O	O
5	NUM	O	O
years	NOUN	O	O
of	ADP	O	O
age,	NOUN	O	O
were	VERB	O	O
processed	VERB	O	O
and	CCONJ	O	O
shared	VERB	O	O
at	ADP	O	O
bimonthly	ADV	O	O
meetings	NOUN	O	O
in	ADP	O	O
each	DET	O	O
community.	ADJ	O	O

SHM	NOUN	O	O
is	VERB	O	O
a	DET	O	O
safe	ADJ	O	O
and	CCONJ	O	O
effective	ADJ	O	O
hemostatic	ADJ	O	B-outcome
agent	NOUN	O	O
in	ADP	O	O
lumbar	ADJ	O	O
posterior	ADJ	O	O
surgery.	VERB	O	O

Data	NOUN	O	O
was	VERB	O	O
collected	VERB	O	O
by	ADP	O	O
semi-structured	VERB	O	O
interviews	NOUN	O	O
between	ADP	O	O
March	NOUN	O	O
and	CCONJ	O	O
April	NOUN	O	O
2016.	NUM	O	O

Interventions:	NOUN	O	O
Patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
a	DET	O	O
step-by-step	NOUN	O	O
resuscitation	NOUN	O	O
protocol	NOUN	O	O
aimed	VERB	O	O
at	ADP	O	O
either	CCONJ	O	O
normalizing	VERB	O	O
capillary	NOUN	O	O
refill	NOUN	O	O
time	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
212)	NOUN	O	O
or	CCONJ	O	O
normalizing	VERB	O	O
or	CCONJ	O	O
decreasing	VERB	O	O
lactate	VERB	O	O
levels	NOUN	O	O
at	ADP	O	O
rates	NOUN	O	O
greater	ADJ	O	O
than	ADP	O	O
20%	NUM	O	O
per	ADP	O	O
2	NUM	O	O
hours	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
212),	NUM	O	O
during	ADP	O	O
an	DET	O	O
8-hour	NOUN	O	O
intervention	NOUN	O	O
period.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Four	NUM	O	O
of	ADP	O	O
the	DET	O	O
6	NUM	O	O
care-seeking	VERB	O	O
behaviors	NOUN	O	O
judged	VERB	O	O
to	PART	O	O
be	VERB	O	O
amenable	ADJ	O	O
to	PART	O	O
promotion	NOUN	O	O
by	ADP	O	O
CHWs	NOUN	O	O
improved	VERB	O	O
more	ADV	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
area	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
area,	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
was	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(treatment	NUM	O	O
of	ADP	O	O
diarrhea	NOUN	O	O
with	ADP	O	O
ORS	NOUN	O	O
and	CCONJ	O	O
zinc).	NUM	O	O

BACKGROUND:	NOUN	O	O
Shilajit	ADJ	O	O
is	VERB	O	O
a	DET	O	O
safe,	NOUN	O	O
fluvic	NOUN	O	O
mineral	NOUN	O	O
complex	NOUN	O	O
exudate	NOUN	O	O
that	ADP	O	O
is	VERB	O	O
common	ADJ	O	O
to	PART	O	O
Ayurvedic	NOUN	O	O
medicine	NOUN	O	O
and	CCONJ	O	O
is	VERB	O	O
composed	VERB	O	O
of	ADP	O	O
fulvic	NOUN	O	O
acids,	NOUN	O	O
dibenzo-alpha-pyrones,	NOUN	O	O
proteins,	NOUN	O	O
and	CCONJ	O	O
minerals.	NOUN	O	O

INTRODUCTION:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
2-arm	NOUN	O	O
parallel	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
dentoalveolar	ADJ	O	B-outcome
and	CCONJ	O	O
skeletal	ADJ	O	B-outcome
changes	NOUN	O	O
achieved	NOUN	O	O
with	ADP	O	O
Twin-block	NOUN	O	O
appliance	NOUN	O	O
therapy	NOUN	O	O
prescribed	VERB	O	O
on	ADP	O	O
either	CCONJ	O	O
a	DET	O	O
part-	NOUN	O	O
or	CCONJ	O	O
full-time	NOUN	O	O
basis	NOUN	O	O
for	ADP	O	O
12	NUM	O	O
months.	NOUN	O	O

AIM:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
pharmacotherapeutic	ADJ	O	O
education	NOUN	O	O
on	ADP	O	O
30-day	NOUN	O	O
post-discharge	NOUN	O	O
medication	NOUN	O	O
adherence	NOUN	O	B-outcome
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
outcomes	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
mellitus	NOUN	O	O
(T2DM).	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
Action	NOUN	O	O
of	ADP	O	O
antimicrobial	ADJ	O	O
photodynamic	ADJ	O	O
therapy	NOUN	O	O
with	ADP	O	O
red	ADJ	O	O
leds	NOUN	O	O
in	ADP	O	O
microorganisms	NOUN	O	O
related	VERB	O	O
to	PART	O	O
halitose:	NOUN	O	O
Controlled	VERB	O	O
and	CCONJ	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

SETTING:	NOUN	O	O
Athletic	ADJ	O	O
training	VERB	O	O
rooms.	NOUN	O	O

Amla	NOUN	O	O
extract	NOUN	O	O
(500	PUNCT	O	O
mg)	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
matching	VERB	O	O
placebo	NOUN	O	O
capsule	NOUN	O	O
was	VERB	O	O
administered	VERB	O	O
twice	ADV	O	O
daily	ADJ	O	O
for	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
to	PART	O	O
the	DET	O	O
respective	ADJ	O	O
group	NOUN	O	O
of	ADP	O	O
patients.	NOUN	O	O

Therefore,	NOUN	O	O
we	PRON	O	O
investigated	VERB	O	O
the	DET	O	O
induction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
of	ADP	O	O
anesthesia	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
type	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
administration	NOUN	O	O
in	ADP	O	O
target-controlled	VERB	O	O
anesthesia.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
prespecified	VERB	O	O
intervention-period	NOUN	O	O
analysis,	NOUN	O	O
the	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
occurred	VERB	O	O
in	ADP	O	O
11	NUM	O	O
patients	NOUN	O	O
(2.6%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
rivaroxaban	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
27	NUM	O	O
(6.4%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.40;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.20	NUM	O	O
to	PART	O	O
0.80).	NOUN	O	O

The	DET	O	O
first	ADV	O	O
40	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
allocated	VERB	O	O
equally	ADV	O	O
to	PART	O	O
the	DET	O	O
two	NUM	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
by	ADP	O	O
computer-generated	VERB	O	O
block	VERB	O	O
randomisation	NOUN	O	O
(block	NOUN	O	O
size	NOUN	O	O
40),	NOUN	O	O
after	ADP	O	O
which	ADP	O	O
a	DET	O	O
response-adaptive	ADJ	O	O
randomisation	NOUN	O	O
algorithm	NOUN	O	O
used	VERB	O	O
all	DET	O	O
previous	ADJ	O	O
patients'	NOUN	O	O
treatment	NOUN	O	O
and	CCONJ	O	O
response	NOUN	O	O
data	NOUN	O	O
to	PART	O	O
decide	NOUN	O	O
the	DET	O	O
allocation	NOUN	O	O
of	ADP	O	O
each	DET	O	O
following	VERB	O	O
patient	NOUN	O	O
favouring	VERB	O	O
the	DET	O	O
group	NOUN	O	O
with	ADP	O	O
superior	ADJ	O	O
response.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ISRCTN17975376	ADJ	O	O
(Registered	PUNCT	O	O
19/09/2014).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Caplacizumab,	NOUN	O	O
an	DET	O	O
anti-von	NOUN	O	O
Willebrand	NOUN	O	O
factor	NOUN	O	O
humanized,	NOUN	O	O
bivalent	ADJ	O	O
variable-domain-only	ADV	O	O
immunoglobulin	NOUN	O	O
fragment,	NOUN	O	O
inhibits	NOUN	O	O
interaction	NOUN	O	O
between	ADP	O	O
von	ADP	O	O
Willebrand	NOUN	O	O
factor	NOUN	O	O
multimers	NOUN	O	O
and	CCONJ	O	O
platelets.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/16	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

METHODS:	NOUN	O	O
FLAME	NOUN	O	O
was	VERB	O	O
a	DET	O	O
52-week	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
severe-to-very-severe	NOUN	O	O
COPD	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
history	NOUN	O	O
of	ADP	O	O
exacerbations.	NOUN	O	O

This	DET	O	O
anatomically	ADV	O	O
high-fidelity	NOUN	O	O
simulator	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
have	VERB	O	O
any	DET	O	O
advantages	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
conventional	ADJ	O	O
dry	ADJ	O	O
simulators.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
part	NOUN	O	O
of	ADP	O	O
an	DET	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
process	NOUN	O	O
evaluation	NOUN	O	O
including	VERB	O	O
24	NUM	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
27	NUM	O	O
control	NOUN	O	O
classes.	NOUN	O	O

Title:	NOUN	O	O
Intermittent	ADJ	O	O
exercise-heat	NOUN	O	O
exposures	NOUN	O	O
and	CCONJ	O	O
intense	ADJ	O	O
physical	ADJ	O	O
activity	NOUN	O	O
sustain	NOUN	O	O
heat	NOUN	O	B-outcome
acclimation	NOUN	O	I-outcome
adaptations.	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
NES	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
NES	NOUN	O	O
intervention,	ADP	O	O
while	ADP	O	O
the	DET	O	O
subjects	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sham	NOUN	O	O
group	NOUN	O	O
underwent	VERB	O	O
sham	NOUN	O	O
NES.	NOUN	O	O

Title:	NOUN	O	O
Pathways	NOUN	O	O
leading	VERB	O	O
to	PART	O	O
success	NOUN	O	O
and	CCONJ	O	O
non-success:	NOUN	O	O
a	DET	O	O
process	NOUN	O	O
evaluation	NOUN	O	O
of	ADP	O	O
a	DET	O	O
cluster	NOUN	O	O
randomized	VERB	O	O
physical	ADJ	O	O
activity	NOUN	O	O
health	NOUN	O	O
promotion	NOUN	O	O
program	NOUN	O	O
applying	VERB	O	O
fuzzy-set	ADP	O	O
qualitative	ADJ	O	O
comparative	ADJ	O	O
analysis.	NOUN	O	O

BACKGROUND/AIMS:	NOUN	O	O
Diabetic	ADJ	O	O
kidney	NOUN	O	O
disease	NOUN	O	O
(DKD)	PUNCT	O	O
is	VERB	O	O
a	DET	O	O
leading	VERB	O	O
cause	ADP	O	O
of	ADP	O	O
end-stage	NOUN	O	O
renal	ADJ	O	O
disease	NOUN	O	O
(ESRD)	NOUN	O	O
worldwide,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
importance	NOUN	O	O
of	ADP	O	O
tubular	ADJ	O	O
injury	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
highlighted	VERB	O	O
in	ADP	O	O
recent	ADJ	O	O
years.	NOUN	O	O

OBJECTIVES:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
routine	ADJ	O	O
ultrasonography	NOUN	O	O
in	ADP	O	O
the	DET	O	O
third	ADJ	O	O
trimester	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
adverse	ADJ	O	B-outcome
perinatal	ADJ	O	I-outcome
outcomes	NOUN	O	O
in	ADP	O	O
low	ADJ	O	O
risk	NOUN	O	O
pregnancies	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
usual	ADJ	O	O
care	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
this	DET	O	O
policy	NOUN	O	O
on	ADP	O	O
maternal	ADJ	O	B-outcome
outcomes	NOUN	O	O
and	CCONJ	O	O
obstetric	ADP	O	B-outcome
interventions	NOUN	O	I-outcome
.	PUNCT	O	O
DESIGN:	NOUN	O	O
Pragmatic,	NOUN	O	O
multicentre,	NOUN	O	O
stepped	VERB	O	O
wedge	NOUN	O	O
cluster	NOUN	O	O
randomised	VERB	O	O
trial.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
if	ADP	O	O
a	DET	O	O
peripheral	ADJ	O	O
perfusion-targeted	VERB	O	O
resuscitation	NOUN	O	O
during	ADP	O	O
early	ADJ	O	O
septic	ADJ	O	O
shock	NOUN	O	O
in	ADP	O	O
adults	NOUN	O	O
is	VERB	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
a	DET	O	O
lactate	VERB	O	O
level-targeted	VERB	O	O
resuscitation	NOUN	O	O
for	ADP	O	O
reducing	VERB	O	O
mortality	NOUN	O	B-outcome
.	PUNCT	O	O
Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Multicenter,	NOUN	O	O
randomized	VERB	O	O
trial	NOUN	O	O
conducted	VERB	O	O
at	ADP	O	O
28	NUM	O	O
intensive	ADJ	O	O
care	NOUN	O	O
units	NOUN	O	O
in	ADP	O	O
5	NUM	O	O
countries.	NUM	O	O

The	DET	O	O
most	DET	O	O
common	ADJ	O	O
grade	NOUN	O	O
3-4	NUM	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
neutropenic	ADJ	O	B-outcome
fever	NOUN	O	I-outcome
(seven	PUNCT	O	O
patients	NOUN	O	O
[25%]	NUM	O	O
in	ADP	O	O
the	DET	O	O
5-day	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
14	NUM	O	O
[33%]	NUM	O	O
in	ADP	O	O
the	DET	O	O
10-day	NOUN	O	O
group)	ADJ	O	O
and	CCONJ	O	O
infection	NOUN	O	B-outcome
(five	NUM	O	O
[18%]	NUM	O	O
and	CCONJ	O	O
16	NUM	O	O
[37%],	ADV	O	O
respectively).	NOUN	O	O

The	DET	O	O
sham	NOUN	O	O
dry	ADJ	O	O
needling	VERB	O	O
procedure	NOUN	O	O
was	VERB	O	O
applied	VERB	O	O
into	ADP	O	O
the	DET	O	O
adipose	ADJ	O	O
tissue	NOUN	O	O
located	VERB	O	O
at	ADP	O	O
any	DET	O	O
area	NOUN	O	O
where	ADP	O	O
an	DET	O	O
active	ADJ	O	O
trigger	ADP	O	O
point	NOUN	O	O
was	VERB	O	O
absent.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
athletic	ADJ	O	O
training	VERB	O	O

Conclusions:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
implemented	VERB	O	O
in	ADP	O	O
challenging	VERB	O	O
circumstances.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Title:	NOUN	O	O
Once-Daily	NOUN	O	O
Plazomicin	NOUN	O	O
for	ADP	O	O
Complicated	VERB	O	O
Urinary	ADJ	O	O
Tract	NOUN	O	O
Infections.	ADV	O	O

Purpose:	NOUN	O	O
Intensity	NOUN	O	O
of	ADP	O	O
a	DET	O	O
training	VERB	O	O
program	NOUN	O	O
is	VERB	O	O
a	DET	O	O
critical	ADJ	O	O
variable	ADJ	O	O
in	ADP	O	O
treatment	NOUN	O	O
gains	NOUN	O	O
poststroke,	NOUN	O	O
but	CCONJ	O	O
there	PRON	O	O
are	VERB	O	O
no	DET	O	O
guidelines	NOUN	O	O
to	PART	O	O
adequately	ADV	O	O
dose	NOUN	O	O
the	DET	O	O
intensity	NOUN	O	O
of	ADP	O	O
functional	ADJ	O	O
training	VERB	O	O
(FT);	NOUN	O	O
the	DET	O	O
recommended	VERB	O	O
type	NOUN	O	O
of	ADP	O	O
training	VERB	O	O
to	PART	O	O
promote	VERB	O	O
poststroke	NOUN	O	O
recovery.	NOUN	O	O

RESULTS:	NOUN	O	O
Plazomicin	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
meropenem	NOUN	O	O
with	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
the	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
end	NOUN	O	O
points.	NOUN	O	O

Web-based	VERB	O	O
randomisation	NOUN	O	O
minimised	VERB	O	O
for	ADP	O	O
recruitment	NOUN	O	O
site,	NOUN	O	O
gestation	NOUN	O	O
(completed	VERB	O	O
weeks),	NOUN	O	O
sex,	NOUN	O	O
and	CCONJ	O	O
single	ADJ	O	O
versus	CCONJ	O	O
multifetal	ADJ	O	O
pregnancy.	NOUN	O	O

AIMS:	VERB	O	O
Adductor	NOUN	O	O
canal	NOUN	O	O
block	VERB	O	O
(ACB)	PUNCT	O	O
has	VERB	O	O
emerged	VERB	O	O
as	ADP	O	O
an	DET	O	O
alternative	ADJ	O	O
to	PART	O	O
femoral	ADJ	O	O
nerve	NOUN	O	O
block	VERB	O	O
(FNB)	PUNCT	O	O
for	ADP	O	O
analgesia	NOUN	O	O
after	ADP	O	O
total	ADJ	O	O
knee	NOUN	O	O
arthroplasty	NOUN	O	O
(TKA).	NOUN	O	O

No	DET	O	O
major	ADJ	O	O
safety	NOUN	O	O
concerns	NOUN	O	O
related	VERB	O	O
to	PART	O	O
the	DET	O	O
study	NOUN	O	O
medication	NOUN	O	O
were	VERB	O	O
identified.	NOUN	O	O

Title:	NOUN	O	O
Brentuximab	NOUN	O	O
vedotin	NOUN	O	O
with	ADP	O	O
chemotherapy	NOUN	O	O
for	ADP	O	O
CD30-positive	ADJ	O	O
peripheral	ADJ	O	O
T-cell	NOUN	O	O
lymphoma	NOUN	O	O
(ECHELON-2):	NUM	O	O
a	DET	O	O
global,	ADJ	O	O
double-blind,	NOUN	O	O
randomised,	NOUN	O	O
phase	NOUN	O	O
3	NUM	O	O
trial.	NOUN	O	O

INTERPRETATION:	CCONJ	O	O
The	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
ATLG	NOUN	O	O
to	PART	O	O
standard	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
improves	NOUN	O	O
the	DET	O	O
probability	NOUN	O	O
of	ADP	O	O
surviving	VERB	O	B-outcome
without	ADP	O	O
disease	NOUN	O	B-outcome
relapse	NOUN	O	I-outcome
and	CCONJ	O	O
cGVHD	ADP	O	B-outcome
after	ADP	O	O
myeloablative	ADJ	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
stem-cell	NOUN	O	O
transplantation	NOUN	O	O
from	ADP	O	O
an	DET	O	O
HLA-identical	ADJ	O	O
sibling	VERB	O	O
donor	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
leukaemia	NOUN	O	O
in	ADP	O	O
remission.	ADV	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
slightly	ADV	O	O
higher	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
ovarian	ADJ	O	B-outcome
hyperstimulation	NOUN	O	I-outcome
syndrome	NOUN	O	I-outcome
(OHSS)	NUM	O	I-outcome
in	ADP	O	O
Group	NOUN	O	O
2	NUM	O	O
compared	VERB	O	O
to	PART	O	O
Group	NOUN	O	O
1	NUM	O	O
although	ADP	O	O
the	DET	O	O
difference	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(3/31,	NOUN	O	O
9.7%	NOUN	O	O
versus	CCONJ	O	O
1/26,	NOUN	O	O
3.8%).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

One	NUM	O	O
hundred	NUM	O	O
and	CCONJ	O	O
fourteen	NUM	O	O
obese	NOUN	O	O
women	NOUN	O	O
aged	VERB	O	O
from	ADP	O	O
18	NUM	O	O
to	PART	O	O
40	NUM	O	O
years	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
insulin	NOUN	O	O
sensitive	ADJ	O	O
(IS)	NOUN	O	O
and	CCONJ	O	O
insulin	NOUN	O	O
resistant	ADJ	O	O
(IR)	PUNCT	O	O
groups	NOUN	O	O
and	CCONJ	O	O
received	VERB	O	O
a	DET	O	O
low	ADJ	O	O
calorie	NOUN	O	O
diet	NOUN	O	O
(LC),	NUM	O	O
or	CCONJ	O	O
an	DET	O	O
isocaloric	ADJ	O	O
diet	NOUN	O	O
and	CCONJ	O	O
500	NUM	O	O
mg	NOUN	O	O
metformin	NOUN	O	O
twice	ADV	O	O
daily	ADJ	O	O
(IM),	PUNCT	O	O
or	CCONJ	O	O
isocaloric	ADJ	O	O
diet	NOUN	O	O
with	ADP	O	O
120	NUM	O	O
mg	NOUN	O	O
orlistat	NOUN	O	O
three	NUM	O	O
times	NOUN	O	O
daily	ADJ	O	O
(IO).	PUNCT	O	O

Title:	NOUN	O	O
The	DET	O	O
periprocedural	ADJ	O	O
myocardial	ADJ	O	B-outcome
damage	NOUN	O	I-outcome
prevention	NOUN	O	O
during	ADP	O	O
elective	ADJ	O	O
percutaneous	ADJ	O	O
coronary	ADJ	O	O
intervention	NOUN	O	O
as	ADP	O	O
a	DET	O	O
result	VERB	O	O
of	ADP	O	O
pharmacological	ADJ	O	O
preconditioning	VERB	O	O
with	ADP	O	O
an	DET	O	O
oral	ADJ	O	O
form	NOUN	O	O
of	ADP	O	O
nicorandil	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
stable	ADJ	O	O
coronary	ADJ	O	O
artery	NOUN	O	O
disease.	NOUN	O	O

Results:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
194	NUM	O	O
children	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
study:	NOUN	O	O
98	NUM	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group;	ADJ	O	O
96	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group;	ADJ	O	O
96	NUM	O	O
(49.5%)	NOUN	O	O
boys	NOUN	O	O
and	CCONJ	O	O
98	NUM	O	O
(50.5%)	PUNCT	O	O
girls	NOUN	O	O
between	ADP	O	O
7	NUM	O	O
and	CCONJ	O	O
8	NUM	O	O
years	NOUN	O	O
old.	NUM	O	O

In	ADP	O	O
the	DET	O	O
analyses	NOUN	O	O
of	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group	NOUN	O	O
the	DET	O	O
Wilcoxon	NOUN	O	O
test	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
used.	NOUN	O	O

Method:Sixty	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
nasal	ADJ	O	O
NK/T	NOUN	O	O
cell	NOUN	O	O
lymphoma	NOUN	O	O
admitted	VERB	O	O
to	PART	O	O
our	ADJ	O	O
hospital	NOUN	O	O
from	ADP	O	O
February	ADJ	O	O
2012	NUM	O	O
to	PART	O	O
February	ADJ	O	O
2016	NUM	O	O
were	VERB	O	O
selected	VERB	O	O
as	ADP	O	O
the	DET	O	O
study	NOUN	O	O
subject.	NOUN	O	O

Journal-Name:Anticancer	NOUN	O	O
research	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Patients	NOUN	O	O
received	VERB	O	O
triple	NOUN	O	O
therapy	NOUN	O	O
(long-acting	VERB	O	O
muscarinic	ADJ	O	O
antagonist	NOUN	O	O
and	CCONJ	O	O
long-acting	VERB	O	O
beta2-agonist/inhaled	VERB	O	O
corticosteroid	NOUN	O	O
[ICS])	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
weeks,	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
continue	NOUN	O	O
triple	NOUN	O	O
therapy	NOUN	O	O
or	CCONJ	O	O
stepwise	ADV	O	O
withdrawal	NOUN	O	O
of	ADP	O	O
the	DET	O	O
ICS	NOUN	O	O
(dual	PUNCT	O	O
bronchodilator	NOUN	O	O
group).	NOUN	O	O

Mean	NOUN	O	O
compression	NOUN	O	B-outcome
fraction	NOUN	O	I-outcome
was	VERB	O	O
0.724	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
[0.699-0.751])	PUNCT	O	O
for	ADP	O	O
SIM	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
0.679	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
[0.655-0.702])	PUNCT	O	O
for	ADP	O	O
STD,	NUM	O	O
p=0.01.	NOUN	O	O

A	DET	O	O
general	ADJ	O	O
linear	ADJ	O	O
mixed	VERB	O	O
model	NOUN	O	O
was	VERB	O	O
applied	VERB	O	O
to	PART	O	O
test	NOUN	O	O
the	DET	O	O
intervention	NOUN	O	O
effect	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
16-week	NOUN	O	O
intervention	NOUN	O	O
(T2,	NUM	O	O
n	NOUN	O	O
=	SYM	O	O
338)	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
three-month	NOUN	O	O
follow-up	NOUN	O	O
(T3,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
311).	NOUN	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
8-week	NOUN	O	O
treatment,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
achieve	NOUN	O	O
better	ADJ	O	O
outcomes	NOUN	O	O
in	ADP	O	O
post-voiding	VERB	O	B-outcome
residual	ADJ	O	I-outcome
urine	NOUN	O	I-outcome
volume	NOUN	O	I-outcome
(PV-VRU)	PUNCT	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.66),	PUNCT	O	O
voided	VERB	O	B-outcome
volume	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.59),	PUNCT	O	O
maximum	NOUN	O	B-outcome
urinary	ADJ	O	I-outcome
flow	NOUN	O	I-outcome
rate	NOUN	O	O
(Qmax)	PUNCT	O	O
(P	NUM	O	O
=	SYM	O	O
.53),	ADP	O	O
and	CCONJ	O	O
Barthel	PROPN	O	O
Index	NOUN	O	O
(BI)	NOUN	O	O
scores	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.67),	NOUN	O	O
than	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

During	ADP	O	O
the	DET	O	O
16-week	NOUN	O	O
intervention,	ADP	O	O
intervention	NOUN	O	O
participants	NOUN	O	O
watched	VERB	O	O
ten	NUM	O	O
video	ADJ	O	O
lessons	NOUN	O	O
at	ADP	O	O
home	NOUN	O	O
and	CCONJ	O	O
joined	VERB	O	O
ten	NUM	O	O
peer	NOUN	O	O
support	NOUN	O	O
group	NOUN	O	O
teleconferences.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Title:	NOUN	O	O
A	DET	O	O
high-fidelity	NOUN	O	O
simulator	NOUN	O	O
for	ADP	O	O
needle	NOUN	O	O
cricothyroidotomy	NOUN	O	O
training	VERB	O	O
is	VERB	O	O
not	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
increased	VERB	O	O
proficiency	NOUN	O	B-outcome
compared	VERB	O	O
with	ADP	O	O
conventional	ADJ	O	O
simulators:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
study.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
a	DET	O	O
3-day	NOUN	O	O
course	NOUN	O	O
of	ADP	O	O
chloroquine	NOUN	O	O
(total	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
1500	NUM	O	O
mg).	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9422756	NUM	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
196	NUM	O	O
patients	NOUN	O	O
(98	NOUN	O	O
per	ADP	O	O
group)	ADJ	O	O
are	VERB	O	O
required.	NOUN	O	O

Methods	NOUN	O	O
Forty-Four	NOUN	O	O
children	NOUN	O	O
(2.3+/-0.9	NUM	O	O
years)	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
intravenous	ADJ	O	O
sufentanil	NOUN	O	O
(1	NOUN	O	O
mug/kg)	NOUN	O	O
and	CCONJ	O	O
midazolam	NOUN	O	O
(0.2	NOUN	O	O
mg/kg)	NOUN	O	O
(Group	PUNCT	O	O
SM)	NOUN	O	O
or	CCONJ	O	O
2.0	NUM	O	O
minimal	ADJ	O	O
alveolar	ADJ	O	O
concentration	NOUN	O	O
(MAC)	NOUN	O	O
sevoflurane	NOUN	O	O
(Group	PUNCT	O	O
S)	ADV	O	O
to	PART	O	O
complete	ADJ	O	O
induction	NOUN	O	O
after	ADP	O	O
sedation	NOUN	O	O
was	VERB	O	O
obtained	VERB	O	O
with	ADP	O	O
2.0	NUM	O	O
MAC	NOUN	O	O
sevoflurane.	NOUN	O	O

METHODS:	NOUN	O	O
Cricothyroidotomy-naive	ADJ	O	O
residents	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
2	NUM	O	O
groups,	NOUN	O	O
including	VERB	O	O
simulation	NOUN	O	O
training	VERB	O	O
with	ADP	O	O
a	DET	O	O
conventional	ADJ	O	O
simulator	NOUN	O	O
(Group	PUNCT	O	O
C)	NOUN	O	O
and	CCONJ	O	O
with	ADP	O	O
a	DET	O	O
high-fidelity	NOUN	O	O
simulator	NOUN	O	O
(Group	PUNCT	O	O
3D).	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/17	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal-Name:BMC	NOUN	O	O
surgery	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
during	ADP	O	O
hemostatic	ADJ	O	O
process	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
(P	NUM	O	O
<.001).	NUM	O	O

Title:	NOUN	O	O
Mothers	NOUN	O	O
In	ADP	O	O
Motion	NOUN	O	O
intervention	NOUN	O	O
effect	NOUN	O	O
on	ADP	O	O
psychosocial	ADJ	O	B-outcome
health	NOUN	O	I-outcome
in	ADP	O	O
young,	NOUN	O	O
low-income	NOUN	O	O
women	NOUN	O	O
with	ADP	O	O
overweight	NUM	O	O
or	CCONJ	O	O
obesity.	ADP	O	O

Patients	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
remission	NOUN	O	O
and	CCONJ	O	O
physically	ADV	O	O
inactive	ADJ	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
25	NUM	O	O
+/-	SYM	O	O
6.5	NUM	O	O
years	NOUN	O	O
and	CCONJ	O	O
Body	NOUN	O	O
Mass	NOUN	O	O
Index	NOUN	O	O
of	ADP	O	O
28.9	NUM	O	O
+/-	SYM	O	O
3.8	NUM	O	O
were	VERB	O	O
recruited	VERB	O	O
from	ADP	O	O
a	DET	O	O
dedicated	VERB	O	O
Inflammatory	ADJ	O	O
Bowel	NOUN	O	O
Disease	NOUN	O	O
clinic.	ADJ	O	O

BACKGROUND:	NOUN	O	O
Recently,	NOUN	O	O
a	DET	O	O
novel	ADJ	O	O
approach	NOUN	O	O
with	ADP	O	O
delaying	VERB	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
controlled	VERB	O	O
ovarian	ADJ	O	O
stimulation	NOUN	O	O
along	ADV	O	O
with	ADP	O	O
gonadotropin-releasing	VERB	O	O
hormone	NOUN	O	O
(GnRH)	NUM	O	O
antagonist	NOUN	O	O
pretreatment	NOUN	O	O
for	ADP	O	O
7	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
estrogen	NOUN	O	O
priming	VERB	O	O
for	ADP	O	O
further	ADV	O	O
suppression	NOUN	O	O
of	ADP	O	O
endogenous	ADJ	O	O
follicle	NOUN	O	O
stimulating	VERB	O	O
hormone	NOUN	O	O
(FSH)	PUNCT	O	O
during	ADP	O	O
the	DET	O	O
early	ADJ	O	O
follicular	ADJ	O	O
phase,	NOUN	O	O
resulting	VERB	O	O
in	ADP	O	O
more	ADV	O	O
FSH-responsive	ADJ	O	O
follicles	NOUN	O	O
and	CCONJ	O	O
thus	ADV	O	O
improving	VERB	O	O
synchronous	NOUN	O	O
follicular	ADJ	O	O
development	NOUN	O	O
was	VERB	O	O
introduced.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
number	NOUN	O	O
of	ADP	O	O
adherent	ADJ	O	B-outcome
patients	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(57/64	NOUN	O	O
[89.9%]	NOUN	O	O
vs	CCONJ	O	O
41/61	NOUN	O	O
[67.2%];	ADP	O	O
chi2	NOUN	O	O
test,	NUM	O	O
P=0.003].	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
in	ADP	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
experienced	VERB	O	O
adverse	ADJ	O	B-outcome
outcomes	NOUN	O	I-outcome
(31/64	NOUN	O	O
[48.4%]	NOUN	O	O
vs	CCONJ	O	O
36/61	NOUN	O	O
[59.0%];	NOUN	O	O
chi2	NOUN	O	O
test,	NUM	O	O
P=0.236).	NOUN	O	O

However,	ADV	O	O
most	DET	O	O
studies	NOUN	O	O
assessing	VERB	O	O
implementation	NOUN	O	O
success	NOUN	O	O
focus	NOUN	O	O
on	ADP	O	O
only	ADV	O	O
one	NUM	O	O
condition,	NOUN	O	O
although	ADP	O	O
more	ADV	O	O
conditions	NOUN	O	O
influence	NOUN	O	O
this	DET	O	O
process.	NOUN	O	O

METHODS:	NOUN	O	O
One	NUM	O	O
hundred	NUM	O	O
patients	NOUN	O	O
presented	VERB	O	O
to	PART	O	O
the	DET	O	O
emergency	NOUN	O	O
department	NOUN	O	O
of	ADP	O	O
Assiut	NOUN	O	O
University	NOUN	O	O
Children	NOUN	O	O
Hospital	NOUN	O	O
with	ADP	O	O
a	DET	O	O
history	NOUN	O	O
of	ADP	O	O
scorpion	NOUN	O	O
sting	VERB	O	O
aged	VERB	O	O
less	ADV	O	O
than	ADP	O	O
18	NUM	O	O
years	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
our	ADJ	O	O
randomized	VERB	O	O
comparative	ADJ	O	O
trial	NOUN	O	O
during	ADP	O	O
2016.	NUM	O	O

The	DET	O	O
degree	NOUN	O	O
to	PART	O	O
which	ADP	O	O
individuals	NOUN	O	O
change	NOUN	O	O
their	ADJ	O	O
lifestyle	NOUN	O	B-outcome
in	ADP	O	O
response	NOUN	O	O
to	PART	O	O
interventions	NOUN	O	O
differs	NOUN	O	O
and	CCONJ	O	O
this	DET	O	O
variation	NOUN	O	O
could	VERB	O	O
affect	NOUN	O	O
cardiometabolic	ADJ	O	B-outcome
health	NOUN	O	I-outcome
.	PUNCT	O	O
We	PRON	O	O
examined	VERB	O	O
if	ADP	O	O
changes	NOUN	O	O
in	ADP	O	O
dietary	ADJ	O	B-outcome
intake	NOUN	O	I-outcome
,	PUNCT	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
and	CCONJ	O	O
weight	NOUN	O	B-outcome
of	ADP	O	O
obese	NOUN	O	O
infertile	NOUN	O	O
women	NOUN	O	O
during	ADP	O	O
the	DET	O	O
first	ADV	O	O
six	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
the	DET	O	O
LIFEstyle	NOUN	O	O
trial	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
cardiometabolic	ADJ	O	B-outcome
health	NOUN	O	I-outcome
3(-)8	ADJ	O	O
years	NOUN	O	O
later	ADV	O	O
(N	PUNCT	O	O
=	SYM	O	O
50(-)78).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Significant	ADJ	O	O
treatment	NOUN	O	O
x	SYM	O	O
time	NOUN	O	O
effects	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
for	ADP	O	O
postprandial	ADJ	O	O
glucose	NOUN	O	B-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.004)	NOUN	O	O
for	ADP	O	O
RS	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
placebo,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
trend	NOUN	O	O
for	ADP	O	O
higher	ADJ	O	O
C-peptide	ADJ	O	B-outcome
concentrations	NOUN	O	O
following	VERB	O	O
RS.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

There	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
24	NUM	O	O
hours	NOUN	O	O
increment	NOUN	O	O
in	ADP	O	O
highly	ADV	O	B-outcome
sensitive	ADJ	O	I-outcome
troponin	NOUN	O	I-outcome
(HS-Tp)	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
it	PRON	O	O
was	VERB	O	O
higher	ADJ	O	O
(112	NUM	O	O
ng/l)	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
nicorandil	NOUN	O	O
group	NOUN	O	O
(67	PUNCT	O	O
ng/l),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.03.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

DFUs	NOUN	O	O
which	ADP	O	O
failed	VERB	O	O
to	PART	O	O
heal	NOUN	O	O
during	ADP	O	O
the	DET	O	O
study	NOUN	O	O
period	NOUN	O	O
(20/28,	PUNCT	O	O
71.4	NUM	O	O
%)	PUNCT	O	O
were	VERB	O	O
more	ADV	O	O
likely	ADV	O	O
to	PART	O	O
be	VERB	O	O
persistently	ADV	O	O
colonized	VERB	O	O
with	ADP	O	O
a	DET	O	O
heterogeneous	ADJ	O	O
community	NOUN	O	O
of	ADP	O	O
micro-organisms	NOUN	O	O
including	VERB	O	O
anaerobes	NOUN	O	O
and	CCONJ	O	O
Enterobacteriaceae	NOUN	O	O
(log-likelihood	NUM	O	O
ratio	NOUN	O	O
9.56,	NOUN	O	O
P=0.008).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Visceral	ADJ	O	O
leishmaniasis	NOUN	O	O
(VL)	PUNCT	O	O
in	ADP	O	O
human	NOUN	O	O
immunodeficiency	NOUN	O	O
virus	NOUN	O	O
(HIV)	PUNCT	O	O
co-infected	VERB	O	O
patients	NOUN	O	O
requires	NOUN	O	O
special	ADJ	O	O
case	NOUN	O	O
management.	NOUN	O	O

Eligible	ADJ	O	O
women	NOUN	O	O
were	VERB	O	O
undergoing	VERB	O	O
IVF	NOUN	O	O
(fresh-embryo	NUM	O	O
or	CCONJ	O	O
frozen-embryo	NOUN	O	O
transfer),	NOUN	O	O
with	ADP	O	O
no	DET	O	O
recent	ADJ	O	O
exposure	NOUN	O	O
to	PART	O	O
disruptive	ADJ	O	O
intrauterine	ADJ	O	O
instrumentation	NOUN	O	O
(e.g.,	NOUN	O	O
hysteroscopy).	NOUN	O	O

In	ADP	O	O
our	ADJ	O	O
adjusted	VERB	O	O
multivariable	ADJ	O	O
regression	NOUN	O	O
models,	NOUN	O	O
SPOC	NOUN	O	O
scores	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
weeks	NOUN	O	O
post-surgery	NOUN	O	O
accounted	VERB	O	O
for	ADP	O	O
10%	ADP	O	O
of	ADP	O	O
the	DET	O	O
variation	NOUN	O	O
in	ADP	O	O
short	ADJ	O	O
form-12	NOUN	O	O
physical	ADJ	O	B-outcome
component	NOUN	O	O
summary	NOUN	O	O
scores	NOUN	O	O
and	CCONJ	O	O
14%	NOUN	O	O
of	ADP	O	O
short	ADJ	O	O
form-12	NOUN	O	O
mental	ADJ	O	B-outcome
component	NOUN	O	O
summary	NOUN	O	O
scores	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
yr.	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101599229	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

BACKGROUND:	NOUN	O	O
Health	NOUN	O	O
promotion	NOUN	O	O
programs	NOUN	O	O
can	VERB	O	O
only	ADV	O	O
lead	NOUN	O	O
to	PART	O	O
improvements	NOUN	O	O
in	ADP	O	O
health	NOUN	O	O
outcomes	NOUN	O	O
if	ADP	O	O
they	PRON	O	O
are	VERB	O	O
effectively	ADV	O	O
implemented.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Nutritional	ADJ	O	O
and	CCONJ	O	O
Behavioral	ADJ	O	O
Intervention	NOUN	O	O
on	ADP	O	O
Energy-Reduced	VERB	O	O
Mediterranean	NOUN	O	O
Diet	NOUN	O	O
Adherence	NOUN	O	B-outcome
Among	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Metabolic	ADJ	O	O
Syndrome:	NOUN	O	O
Interim	NOUN	O	O
Analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
PREDIMED-Plus	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

Extended	VERB	O	O
follow-up	NOUN	O	O
(median	PUNCT	O	O
5.9	NUM	O	O
years	NOUN	O	O
[IQR	PUNCT	O	O
1.7-7.9])	NUM	O	O
confirmed	VERB	O	O
a	DET	O	O
lower	ADJ	O	O
5-year	ADJ	O	O
chronic	ADJ	O	B-outcome
graft-versus-host	ADV	O	I-outcome
disease	NOUN	O	I-outcome
(cGVHD)	NOUN	O	I-outcome
incidence	NOUN	O	O
(30.0%	PUNCT	O	O
[95%	NOUN	O	O
CI	NOUN	O	O
21.4-41.9	NOUN	O	O
vs	CCONJ	O	O
69.1%	PUNCT	O	O
[59.1-80.1];	NOUN	O	O
analysis	NOUN	O	O
for	ADP	O	O
entire	ADJ	O	O
follow-up,	ADP	O	O
p<0.001),	NOUN	O	O
no	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
relapses	NOUN	O	B-outcome
(35.4%	NUM	O	O
[26.4-47.5]	NOUN	O	O
vs	CCONJ	O	O
22.5%	NUM	O	O
[14.6-34.7];	NOUN	O	O
p=0.09),	ADJ	O	O
improved	VERB	O	O
cGVHD-free	ADJ	O	B-outcome
and	CCONJ	O	Seperator
relapse-free	ADJ	O	I-outcome
survival	NOUN	O	I-outcome
(cGRFS)	SYM	O	I-outcome
(34.3%	PUNCT	O	O
[24.2-44.5]	NOUN	O	O
vs	CCONJ	O	O
13.9%	NUM	O	O
[7.1-22.9];	NOUN	O	O
p=0.005),	NOUN	O	O
and	CCONJ	O	O
fewer	ADJ	O	O
patients	NOUN	O	O
still	ADV	O	O
in	ADP	O	O
immunosuppression	NOUN	O	B-outcome
(9.6%	NOUN	O	O
vs	CCONJ	O	O
28.3%;	NOUN	O	O
p=0.017)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
ATLG	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
non-ATLG	NOUN	O	O
group.	VERB	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
RSB	NOUN	O	O
analgesia	NOUN	O	O
significantly	ADV	O	O
enhanced	VERB	O	O
the	DET	O	O
SFS24	ADJ	O	O
scores	NOUN	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
groups	NOUN	O	O
(p=0.001).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Schools	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
identified	VERB	O	O
as	ADP	O	O
key	ADJ	O	O
environments	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
child	NOUN	O	O
physical	ADJ	O	O
activity	NOUN	O	O
(PA).	NUM	O	O

Survival	NOUN	O	B-outcome
without	ADP	O	O
moderate	ADJ	O	O
or	CCONJ	O	O
severe	ADJ	O	O
neurodevelopmental	ADJ	O	B-outcome
disability	NOUN	O	I-outcome
at	ADP	O	O
24	NUM	O	O
months	NOUN	O	O
occurred	VERB	O	O
in	ADP	O	O
802	NUM	O	O
of	ADP	O	O
1224	NUM	O	O
infants	NOUN	O	O
(65.5%)	PUNCT	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
faster	ADJ	O	O
increment	NOUN	O	O
and	CCONJ	O	O
848	NUM	O	O
of	ADP	O	O
1246	NUM	O	O
(68.1%)	PUNCT	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
slower	NOUN	O	O
increment	NOUN	O	O
(adjusted	PUNCT	O	O
risk	NOUN	O	O
ratio,	NOUN	O	O
0.96;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.92	NUM	O	O
to	PART	O	O
1.01;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.16).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101566341	NUM	O	O

Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QoL)	NOUN	O	I-outcome
,	PUNCT	O	O
assessed	VERB	O	O
using	VERB	O	O
European	NOUN	O	O
Organisation	NOUN	O	O
for	ADP	O	O
Research	NOUN	O	O
and	CCONJ	O	O
Treatment	NOUN	O	O
of	ADP	O	O
Cancer	NOUN	O	O
QLQ-C30	NOUN	O	O
and	CCONJ	O	O
QLQ-HDC29	NOUN	O	O
questionnaires,	NOUN	O	O
was	VERB	O	O
an	DET	O	O
unpublished	VERB	O	O
secondary	ADJ	O	O
endpoint,	VERB	O	O
which	ADP	O	O
we	PRON	O	O
now	ADV	O	O
report	NOUN	O	O
here.	NOUN	O	O

The	DET	O	O
rowers	NOUN	O	O
were	VERB	O	O
subjected	VERB	O	O
to	PART	O	O
blood	NOUN	O	O
tests	NOUN	O	O
at	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
(T1)	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
eight	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
(T2),	PUNCT	O	O
for	ADP	O	O
the	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
haematological	ADJ	O	B-outcome
and	CCONJ	O	O
hormonal	ADJ	O	B-outcome
values.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

These	DET	O	O
data	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
its	ADJ	O	O
routine	ADJ	O	O
use	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
late-onset	NOUN	O	O
infection	NOUN	O	O
and	CCONJ	O	O
associated	VERB	O	O
morbidity	NOUN	O	O
or	CCONJ	O	O
mortality	NOUN	O	O
in	ADP	O	O
very	ADV	O	O
preterm	NOUN	O	O
infants.	NOUN	O	O

The	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
short-term	NOUN	O	O
effects	NOUN	O	O
of	ADP	O	O
RS	NOUN	O	O
on	ADP	O	O
appetite	NOUN	O	B-outcome
,	PUNCT	O	O
satiety	NOUN	O	B-outcome
and	CCONJ	O	O
postprandial	ADJ	O	O
metabolism	NOUN	O	B-outcome
in	ADP	O	O
overweight/obese	NOUN	O	O
subjects.	NOUN	O	O

The	DET	O	O
mechanism	NOUN	O	O
behind	NOUN	O	O
this	DET	O	O
second-meal	ADJ	O	O
phenomenon	NOUN	O	O
of	ADP	O	O
CRHP	NOUN	O	O
diet	NOUN	O	O
on	ADP	O	O
important	ADJ	O	O
risk	NOUN	O	O
factors	NOUN	O	O
for	ADP	O	O
aggravating	VERB	O	O
T2DM	NOUN	O	O
and	CCONJ	O	O
cardiovascular	ADJ	O	O
disease	NOUN	O	O
awaits	NOUN	O	O
further	ADV	O	O
investigation.	NOUN	O	O

We	PRON	O	O
sought	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
a	DET	O	O
one-time	NOUN	O	O
azithromycin	NOUN	O	O
mass	NOUN	O	O
treatment	NOUN	O	O
would	VERB	O	O
reduce	VERB	O	O
trachomatous	ADJ	O	B-outcome
inflammation-follicular	ADJ	O	I-outcome
(TF)	NOUN	O	I-outcome
levels	NOUN	O	O
below	ADP	O	O
the	DET	O	O
elimination	NOUN	O	O
threshold	NOUN	O	O
of	ADP	O	O
5%	NOUN	O	O
in	ADP	O	O
communities	NOUN	O	O
with	ADP	O	O
disease	NOUN	O	O
prevalence	NOUN	O	O
between	ADP	O	O
5	NUM	O	O
and	CCONJ	O	O
9.9%.	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
achieved	NOUN	O	O
in	ADP	O	O
similar	ADJ	O	O
proportions	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
two	NUM	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
(12	PUNCT	O	O
[43%]	NUM	O	O
of	ADP	O	O
28	NUM	O	O
in	ADP	O	O
the	DET	O	O
5-day	NOUN	O	O
schedule	NOUN	O	O
group,	NOUN	O	O
95%	NOUN	O	O
credible	ADJ	O	O
interval	NOUN	O	O
26-60,	ADJ	O	O
and	CCONJ	O	O
17	NUM	O	O
[40%]	NUM	O	O
of	ADP	O	O
43	NUM	O	O
in	ADP	O	O
the	DET	O	O
10-day	NOUN	O	O
schedule	NOUN	O	O
group,	NOUN	O	O
26-54,	NOUN	O	O
p=0.78;	NOUN	O	O
difference	NOUN	O	O
3%,	NOUN	O	O
-21	NUM	O	O
to	PART	O	O
27).	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION	NOUN	O	O
NUMBER:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
(NCT03196791),	NOUN	O	O
date	NOUN	O	O
of	ADP	O	O
registration:	NOUN	O	O
October	ADJ	O	O
10,	NUM	O	O
2017.	NUM	O	O

The	DET	O	O
present	ADJ	O	O
design	NOUN	O	O
is	VERB	O	O
a	DET	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
that	ADP	O	O
uses	NOUN	O	O
the	DET	O	O
pre-test	NOUN	O	O
and	CCONJ	O	O
post-test	NOUN	O	O
design	NOUN	O	O
with	ADP	O	O
a	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

No	DET	O	O
venous	ADJ	O	B-outcome
or	CCONJ	O	Seperator
arterial	ADJ	O	I-outcome
thromboembolic	ADJ	O	I-outcome
complications	NOUN	O	I-outcome
were	VERB	O	O
reported.	NOUN	O	O

Vital	ADJ	O	O
status	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
known	VERB	O	O
for	ADP	O	O
2.3%	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
at	ADP	O	O
10	NUM	O	O
years.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
between-group	NOUN	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
wheezing	VERB	O	B-outcome
or	CCONJ	O	O
shortness	ADV	O	B-outcome
of	ADP	O	I-outcome
breath	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
E-cigarettes	NOUN	O	O
were	VERB	O	O
more	ADV	O	O
effective	ADJ	O	O
for	ADP	O	O
smoking	VERB	O	B-outcome
cessation	NOUN	O	I-outcome
than	ADP	O	O
nicotine-replacement	ADJ	O	O
therapy,	NOUN	O	O
when	ADP	O	O
both	CCONJ	O	O
products	NOUN	O	O
were	VERB	O	O
accompanied	VERB	O	O
by	ADP	O	O
behavioral	ADJ	O	O
support.	NOUN	O	O
(	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Conclusion:	NOUN	O	O
The	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
thoracolumbar	ADV	O	O
fracture	NOUN	O	O
with	ADP	O	O
short-segment	ADP	O	O
fixation	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
injured	VERB	O	O
vertebral	ADJ	O	O
reconstruction	NOUN	O	O
can	VERB	O	O
effectively	ADV	O	O
prevent	NOUN	O	O
the	DET	O	O
"shell"	NOUN	O	B-outcome
phenomenon	NOUN	O	I-outcome
,	PUNCT	O	O
which	ADP	O	O
is	VERB	O	O
conducive	ADJ	O	O
to	PART	O	O
maintaining	VERB	O	O
the	DET	O	O
height	NOUN	O	O
of	ADP	O	O
injured	VERB	O	O
vertebral	ADJ	O	O
and	CCONJ	O	O
improving	VERB	O	O
the	DET	O	O
long-term	NOUN	O	O
function.	ADJ	O	O

At	ADP	O	O
baseline,	NOUN	O	O
the	DET	O	O
ultrasonographic	ADJ	O	O
evaluation	NOUN	O	O
of	ADP	O	O
pelvic	ADJ	O	B-outcome
floor	NOUN	O	I-outcome
muscles	NOUN	O	I-outcome
(PFM)	PUNCT	O	I-outcome
performed	VERB	O	O
during	ADP	O	O
resting	VERB	O	O
and	CCONJ	O	O
during	ADP	O	O
voluntary	ADJ	O	O
pelvic	ADJ	O	O
muscles	NOUN	O	O
contraction	NOUN	O	O
showed	VERB	O	O
the	DET	O	O
right-left	NOUN	O	O
length	NOUN	O	O
asymmetry.	VERB	O	O

Title:	NOUN	O	O
Tobramycin/dexamethasone	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
as	ADP	O	O
a	DET	O	O
better	ADJ	O	O
choice	NOUN	O	O
for	ADP	O	O
lacrimal	ADJ	O	O
duct	NOUN	O	O
probing	VERB	O	O
in	ADP	O	O
persistent	ADJ	O	O
congenital	ADJ	O	O
nasolacrimal	ADJ	O	O
duct	NOUN	O	O
obstruction:	NOUN	O	O
A	DET	O	O
consort	NOUN	O	O
study.	NOUN	O	O

CONCLUSION:	NOUN	O	O
We	PRON	O	O
developed	VERB	O	O
a	DET	O	O
high-fidelity	NOUN	O	O
simulator	NOUN	O	O
for	ADP	O	O
cricothyroidotomy	NOUN	O	O
from	ADP	O	O
3D	NOUN	O	O
computed	VERB	O	O
tomography	NOUN	O	O
data	NOUN	O	O
using	VERB	O	O
a	DET	O	O
3D	NOUN	O	O
printer.	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
Bazhengsan	NOUN	O	O
formula	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
ceftriaxone	NOUN	O	O
for	ADP	O	O
female	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
uncomplicated	VERB	O	O
gonorrhea:	NOUN	O	O
A	DET	O	O
pilot	NOUN	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
children	NOUN	O	O
have	VERB	O	O
good	ADJ	O	O
recovery	NOUN	O	B-outcome
conditions	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
no	DET	O	O
obvious	ADJ	O	O
postoperative	ADJ	O	O
agitation	NOUN	O	B-outcome
and	CCONJ	O	O
respiratory	ADJ	O	B-outcome
depression	NOUN	O	I-outcome
after	ADP	O	O
DEX	NOUN	O	O
administration.	ADV	O	O

METHOD:	NOUN	O	O
This	DET	O	O
Study	NOUN	O	O
is	VERB	O	O
A	DET	O	O
Prospective,	NOUN	O	O
randomized,	NOUN	O	O
open-label,	ADV	O	O
comparative	ADJ	O	O
study.	NOUN	O	O

Participants	NOUN	O	O
redeemed	VERB	O	O
only	ADV	O	O
39%	NUM	O	O
(SD	NOUN	O	O
43%)	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
earned	VERB	O	O
points.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

The	DET	O	O
LOP	NOUN	O	O
regimen	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
the	DET	O	O
CHOPcyclophosphamide	NOUN	O	O
+	SYM	O	O
pirarubicin	NOUN	O	O
+	SYM	O	O
vincristine	ADV	O	O
+	SYM	O	O
dexamethasone	NOUN	O	O
regimen	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
in	ADP	O	O
group	NOUN	O	O
B.	NOUN	O	O
The	DET	O	O
short-term	NOUN	O	O
efficacy,	NOUN	O	O
long-term	NOUN	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
compared.	NOUN	O	O

Title:	NOUN	O	O
Partial	ADJ	O	O
thickness	NOUN	O	O
cornea	NOUN	O	O
tissue	NOUN	O	O
from	ADP	O	O
small	ADJ	O	O
incision	NOUN	O	O
lenticule	NOUN	O	O
extraction:	NOUN	O	O
A	DET	O	O
novel	ADJ	O	O
patch	NOUN	O	O
graft	NOUN	O	O
in	ADP	O	O
glaucoma	NOUN	O	O
drainage	NOUN	O	O
implant	NOUN	O	O
surgery.	VERB	O	O

The	DET	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
of	ADP	O	O
colored	VERB	O	O
eye	NOUN	O	O
drops	NOUN	O	O
was	VERB	O	O
88%	VERB	O	O
and,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
of	ADP	O	O
transparent,	ADJ	O	O
24%.	NUM	O	O

Among	ADP	O	O
the	DET	O	O
men	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
radical	NOUN	O	O
prostatectomy,	NOUN	O	O
extracapsular	ADJ	O	O
extension	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
prostate	NOUN	O	I-outcome
cancer	NOUN	O	I-outcome
that	ADP	O	O
was	VERB	O	O
5	NUM	O	O
times	NOUN	O	O
as	ADP	O	O
high	ADJ	O	O
as	ADP	O	O
that	ADP	O	O
among	ADP	O	O
men	NOUN	O	O
without	ADP	O	O
extracapsular	ADJ	O	O
extension,	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
Gleason	PROPN	O	O
score	NOUN	O	O
higher	ADJ	O	O
than	ADP	O	O
7	NUM	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
risk	NOUN	O	O
that	ADP	O	O
was	VERB	O	O
10	NUM	O	O
times	NOUN	O	O
as	ADP	O	O
high	ADJ	O	O
as	ADP	O	O
that	ADP	O	O
with	ADP	O	O
a	DET	O	O
score	NOUN	O	O
of	ADP	O	O
6	NUM	O	O
or	CCONJ	O	O
lower	ADJ	O	O
(scores	NOUN	O	O
range	NOUN	O	O
from	ADP	O	O
2	NUM	O	O
to	PART	O	O
10,	NUM	O	O
with	ADP	O	O
higher	ADJ	O	O
scores	NOUN	O	O
indicating	VERB	O	O
more	ADV	O	O
aggressive	ADJ	O	O
cancer).	NOUN	O	O

No	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
of	ADP	O	O
fasting	VERB	O	B-outcome
plasma	NOUN	O	I-outcome
glucose	NOUN	O	I-outcome
and	CCONJ	O	O
2-hour	NOUN	O	B-outcome
plasma	NOUN	O	I-outcome
glucose	NOUN	O	I-outcome
concentrations	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
between	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
months	NOUN	O	O
(P	NUM	O	O
>.05).	NUM	O	O

CTs	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
due	ADJ	O	O
to	PART	O	O
caries	NOUN	O	O
lesions	NOUN	O	O
in	ADP	O	O
70.4%	NUM	O	O
of	ADP	O	O
the	DET	O	O
cases	NOUN	O	O
and	CCONJ	O	O
due	ADJ	O	O
to	PART	O	O
trauma	NOUN	O	O
in	ADP	O	O
29.6%.	NUM	O	O

RS	NOUN	O	O
may	VERB	O	O
indeed	ADV	O	O
have	VERB	O	O
short-term	NOUN	O	O
beneficial	ADJ	O	O
effects	NOUN	O	O
in	ADP	O	O
obese	NOUN	O	O
individuals.	NOUN	O	O

No	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
second	ADJ	O	B-outcome
malignancies	NOUN	O	I-outcome
was	VERB	O	O
noted	VERB	O	O
with	ADP	O	O
ixazomib	NOUN	O	O
therapy	NOUN	O	O
(12	PUNCT	O	O
[3%]	NOUN	O	O
patients)	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
(eight	NUM	O	O
[3%]	NOUN	O	O
patients)	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
this	DET	O	O
analysis.	NOUN	O	O

The	DET	O	O
IV	NUM	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
received	VERB	O	O
a	DET	O	O
placebo	NOUN	O	O
patch.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Decolonization	NOUN	O	O
involved	VERB	O	O
chlorhexidine	NOUN	O	O
mouthwash,	NOUN	O	O
baths	NOUN	O	O
or	CCONJ	O	O
showers	NOUN	O	O
with	ADP	O	O
chlorhexidine,	NOUN	O	O
and	CCONJ	O	O
nasal	ADJ	O	O
mupirocin	NOUN	O	O
for	ADP	O	O
5	NUM	O	O
days	NOUN	O	O
twice	ADV	O	O
per	ADP	O	O
month	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
20	NUM	O	O
patients.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
multicenter,	NOUN	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
postdischarge	NOUN	O	O
hygiene	NOUN	O	O
education,	VERB	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
education	NOUN	O	O
plus	CCONJ	O	O
decolonization,	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
colonized	VERB	O	O
with	ADP	O	O
MRSA	NOUN	O	O
(carriers).	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Men	NOUN	O	O
with	ADP	O	O
clinically	ADV	O	O
detected,	NOUN	O	O
localized	VERB	O	O
prostate	NOUN	O	O
cancer	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
long	ADV	O	O
life	NOUN	O	O
expectancy	NOUN	O	O
benefited	VERB	O	O
from	ADP	O	O
radical	NOUN	O	O
prostatectomy,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
of	ADP	O	O
2.9	NUM	O	O
years	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
gained.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Hypomethylating	VERB	O	O
agents,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
decitabine,	NOUN	O	O
are	VERB	O	O
the	DET	O	O
standard	ADJ	O	O
of	ADP	O	O
care	NOUN	O	O
for	ADP	O	O
older	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
newly	ADV	O	O
diagnosed	VERB	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
leukaemia.	NOUN	O	O

Methylphenidate	NOUN	O	B-outcome
dosing	VERB	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
individuals	NOUN	O	O
on	ADP	O	O
L-methylfolate	NOUN	O	O
over	ADP	O	O
time	NOUN	O	O
(chi	PUNCT	O	O
=	SYM	O	O
7.35,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.007).	NUM	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
obtained	VERB	O	O
data	NOUN	O	O
shows	NOUN	O	O
the	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
of	ADP	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
highly	ADV	O	B-outcome
sensitive	ADJ	O	I-outcome
troponin	NOUN	O	I-outcome
(HS-Tp)	NOUN	O	I-outcome
in	ADP	O	O
24	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
PCI	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
no	DET	O	O
admission	NOUN	O	O
of	ADP	O	O
nicorandil	NOUN	O	O
(117	NUM	O	O
ng/l)	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
nicorandil	NOUN	O	O
group	NOUN	O	O
(73	NOUN	O	O
ng/l),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.04.	PUNCT	O	O

Full	ADJ	O	O
history,	NOUN	O	O
clinical	ADJ	O	O
examination,	NOUN	O	O
and	CCONJ	O	O
routine	ADJ	O	O
baseline	NOUN	O	O
investigations	NOUN	O	O
were	VERB	O	O
performed.	NOUN	O	O

PMID:	NOUN	O	O
31623051	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8410840	NUM	O	O

Eligible	ADJ	O	O
participants	NOUN	O	O
were	VERB	O	O
adults	NOUN	O	O
with	ADP	O	O
a	DET	O	O
confirmed	VERB	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
symptomatic	ADJ	O	O
multiple	ADJ	O	O
myeloma	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
International	ADJ	O	O
Myeloma	NOUN	O	O
Working	VERB	O	O
Group	NOUN	O	O
criteria	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
achieved	NOUN	O	O
at	ADP	O	O
least	ADV	O	O
a	DET	O	O
partial	ADJ	O	O
response	NOUN	O	O
after	ADP	O	O
undergoing	VERB	O	O
standard-of-care	NOUN	O	O
induction	NOUN	O	O
therapy	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
high-dose	NOUN	O	O
melphalan	NOUN	O	O
(200	NUM	O	O
mg/m(2))	NOUN	O	O
conditioning	VERB	O	O
and	CCONJ	O	O
single	ADJ	O	O
ASCT	NOUN	O	O
within	ADP	O	O
12	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
diagnosis.	NOUN	O	O

We	PRON	O	O
describe	NOUN	O	O
the	DET	O	O
first	ADV	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
to	PART	O	O
address	NOUN	O	O
both	CCONJ	O	O
chronic	ADJ	O	O
disease	NOUN	O	O
and	CCONJ	O	O
mental	ADJ	O	O
health	NOUN	O	O
in	ADP	O	O
Indigenous	ADJ	O	O
people	NOUN	O	O
with	ADP	O	O
ESKD,	ADJ	O	O
which	ADP	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
to	PART	O	O
test	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
culturally	ADV	O	O
adapted	VERB	O	O
e-mental	ADJ	O	O
health	NOUN	O	O
intervention	NOUN	O	O
in	ADP	O	O
this	DET	O	O
population.	ADV	O	O

Title:	NOUN	O	O
[Clinical	ADJ	O	O
observation	NOUN	O	O
of	ADP	O	O
LOP	NOUN	O	O
chemotherapy	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
radiotherapy	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
early	ADJ	O	O
nasal	ADJ	O	O
NK/T	NOUN	O	O
cell	NOUN	O	O
lymphoma].	NOUN	O	O

Title:	NOUN	O	O
Open-labeled	VERB	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
1-year	NOUN	O	O
clinical	ADJ	O	O
outcomes	NOUN	O	O
of	ADP	O	O
polymer-free	ADJ	O	O
sirolimus-eluting	VERB	O	O
coronary	ADJ	O	O
stents	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
biodegradable	ADJ	O	O
polymer-based	VERB	O	O
sirolimus-eluting	VERB	O	O
coronary	ADJ	O	O
stents.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Community-based	VERB	O	O
organizations	NOUN	O	O
(CBOs)	PUNCT	O	O
are	VERB	O	O
key	ADJ	O	O
partners	NOUN	O	O
in	ADP	O	O
supporting	VERB	O	O
care,	NOUN	O	O
but	CCONJ	O	O
health	NOUN	O	O
systems	NOUN	O	O
and	CCONJ	O	O
CBOs	NOUN	O	O
operate	NOUN	O	O
in	ADP	O	O
silos.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

RESULTS:	NOUN	O	O
Cumulative	ADJ	O	O
mean	NOUN	O	O
QALYs/mean	NOUN	O	O
costs	NOUN	O	B-outcome
of	ADP	O	I-outcome
health	NOUN	O	I-outcome
care	NOUN	O	I-outcome
service	NOUN	O	I-outcome
use	NOUN	O	I-outcome
and	CCONJ	O	Seperator
surgery	NOUN	O	I-outcome
per	ADP	O	O
patient	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
12	NUM	O	O
months	NOUN	O	O
were	VERB	O	O
estimated	VERB	O	O
as	ADP	O	O
0.640	NUM	O	O
(standard	PUNCT	O	O
error	NOUN	O	O
(se)	NOUN	O	O
0.024)/	NUM	O	O
pound3147	NOUN	O	O
(se	PUNCT	O	O
166)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
decompression	NOUN	O	O
arm,	ADJ	O	O
0.656	NUM	O	O
(se	PUNCT	O	O
0.020)/	NUM	O	O
pound2830	NOUN	O	O
(se	PUNCT	O	O
183)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
arthroscopy	NOUN	O	O
only	ADV	O	O
arm	NOUN	O	O
and	CCONJ	O	O
0.522	NUM	O	O
(se	PUNCT	O	O
0.029)/	NUM	O	O
pound1451	NOUN	O	O
(se	PUNCT	O	O
151)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
no	DET	O	O
treatment	NOUN	O	O
arm.	NOUN	O	O

Title:	NOUN	O	O
Halobetasol	NOUN	O	O
and	CCONJ	O	O
Tazarotene:	NOUN	O	O
Further	ADV	O	O
Defining	VERB	O	O
the	DET	O	O
Role	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Unique	ADJ	O	O
Fixed	VERB	O	O
Combination	NOUN	O	O
Topical	ADJ	O	O
Lotion	NOUN	O	O
in	ADP	O	O
Moderate-to-Severe	NOUN	O	O
Plaque	NOUN	O	O
Psoriasis	NOUN	O	O

Direct	ADJ	O	O
comparison	NOUN	O	O
between	ADP	O	O
both	CCONJ	O	O
interventions	NOUN	O	O
revealed	VERB	O	O
that	ADP	O	O
the	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
subcutaneous	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
was	VERB	O	O
statistically	ADV	O	O
significantly	ADV	O	O
larger	ADJ	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
that	ADP	O	O
combined	VERB	O	O
exercise	NOUN	O	O
with	ADP	O	O
diet:	NOUN	O	O
an	DET	O	O
additional	ADJ	O	O
10.6	NUM	O	O
cm(2)	NOUN	O	O
(95%CI	PUNCT	O	O
-18.7;	NUM	O	O
-	PUNCT	O	O
2.4)	NUM	O	O
was	VERB	O	O
lost	VERB	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
diet-only	ADV	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/01	ADP	O	O
06:01	NUM	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[pubmed]	PUNCT	O	O

CONCLUSION:	NOUN	O	O
Premedication	NOUN	O	O
with	ADP	O	O
intranasal	ADJ	O	O
DEX	NOUN	O	O
2	NUM	O	O
mug/kg	NOUN	O	O
for	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
dental	ADJ	O	O
rehabilitation	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
produces	NOUN	O	O
good	ADJ	O	O
preoperative	ADJ	O	O
sedation	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
sedation	NOUN	O	B-outcome
,	PUNCT	O	O
scores	NOUN	O	O
of	ADP	O	O
parental	ADJ	O	B-outcome
separation	NOUN	O	I-outcome
and	CCONJ	O	O
compliance	NOUN	O	B-outcome
with	ADP	O	O
the	DET	O	O
mask	NOUN	O	O
were	VERB	O	O
satisfied.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
group	NOUN	O	O
of	ADP	O	O
34	NUM	O	O
healthy	ADJ	O	O
volunteers	NOUN	O	O
was	VERB	O	O
presented	VERB	O	O
to	PART	O	O
two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
four	NUM	O	O
eye	NOUN	O	O
drops	NOUN	O	O
each.	NOUN	O	O

Plasma	NOUN	O	O
malondialdehyde	NOUN	O	B-outcome
did	VERB	O	O
not	ADV	O	O
change	NOUN	O	O
after	ADP	O	O
exercise	NOUN	O	O
in	ADP	O	O
placebo	NOUN	O	O
but	CCONJ	O	O
was	VERB	O	O
significantly	ADV	O	O
decreased	VERB	O	O
in	ADP	O	O
AA	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
include	VERB	O	O
any	DET	O	O
maternal	ADJ	O	O
or	CCONJ	O	O
fetal	ADJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
miscarriage	NOUN	O	B-outcome
,	PUNCT	O	O
pregnancy	NOUN	O	B-outcome
,	PUNCT	O	O
live	ADJ	O	B-outcome
births	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
neonatal	ADJ	O	B-outcome
outcomes.	ADJ	O	O

However,	ADV	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
receive	VERB	O	O
equi-anesthetic	ADJ	O	O
doses	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
propofol	NOUN	O	O
or	CCONJ	O	O
methohexital	ADJ	O	O
for	ADP	O	O
anesthetic	ADJ	O	O
induction.	NOUN	O	O

h(-	NOUN	O	O
1)	NUM	O	O
followed	VERB	O	O
by	ADP	O	O
a	DET	O	O
maintenance	NOUN	O	O
dose	NOUN	O	O
with	ADP	O	O
continuous	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
3	NUM	O	O
mg.kg(-	NOUN	O	O
1).	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
differences	NOUN	O	O
in	ADP	O	O
these	DET	O	O
results	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
demographic	ADJ	O	O
variables.	NUM	O	O

Interventions:	NOUN	O	O
Participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
a	DET	O	O
systolic	ADJ	O	O
blood	NOUN	O	O
pressure	NOUN	O	O
goal	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
less	ADV	O	O
than	ADP	O	O
120	NUM	O	O
mm	NOUN	O	O
Hg	NOUN	O	O
(intensive	NUM	O	O
treatment	NOUN	O	O
group;	ADJ	O	O
n	NOUN	O	O
=	SYM	O	O
4678)	NOUN	O	O
or	CCONJ	O	O
less	ADV	O	O
than	ADP	O	O
140	NUM	O	O
mm	NOUN	O	O
Hg	NOUN	O	O
(standard	PUNCT	O	O
treatment	NOUN	O	O
group;	ADJ	O	O
n	NOUN	O	O
=	SYM	O	O
4683).	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

We	PRON	O	O
divided	VERB	O	O
45	NUM	O	O
subjects	NOUN	O	O
into	ADP	O	O
3	NUM	O	O
groups:	NOUN	O	O
those	DET	O	O
with	ADP	O	O
expert	NOUN	O	O
proctoring	VERB	O	O
(group	PUNCT	O	O
I),	NOUN	O	O
those	DET	O	O
who	ADP	O	O
watched	VERB	O	O
only	ADV	O	O
an	DET	O	O
educational	ADJ	O	O
video	ADJ	O	O
(group	PUNCT	O	O
II),	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
with	ADP	O	O
independent	ADJ	O	O
training	VERB	O	O
(group	PUNCT	O	O
III;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
15	NUM	O	O
per	ADP	O	O
group).	NOUN	O	O

Two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
categorized	VERB	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
route	NOUN	O	O
of	ADP	O	O
administration	NOUN	O	O
of	ADP	O	O
scorpion	NOUN	O	O
antivenom;	NOUN	O	O
intramuscular	ADJ	O	O
and	CCONJ	O	O
intravenous	ADJ	O	O
with	ADP	O	O
50	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group.	VERB	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
therefore	ADV	O	O
to	PART	O	O
explore	ADP	O	O
reasons	NOUN	O	O
for	ADP	O	O
employee	NOUN	O	O
engagement	NOUN	O	O
in	ADP	O	O
weight	NOUN	O	O
loss	NOUN	O	O
projects	NOUN	O	O
at	ADP	O	O
the	DET	O	O
workplace	ADJ	O	O
and	CCONJ	O	O
the	DET	O	O
incentives	NOUN	O	O
a	DET	O	O
municipality,	ADJ	O	O
a	DET	O	O
manager	NOUN	O	O
at	ADP	O	O
a	DET	O	O
home-care	NOUN	O	O
centre,	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
project	NOUN	O	O
manager	NOUN	O	O
have	VERB	O	O
to	PART	O	O
launch	NOUN	O	O
such	ADJ	O	O
project.	NOUN	O	O

All	DET	O	O
subjects	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
submitted	VERB	O	O
to	PART	O	O
microbiological	ADJ	O	O
analysis	NOUN	O	O
and	CCONJ	O	O
evaluation	NOUN	O	O
with	ADP	O	O
Oral	ADJ	O	O
ChromaTM	NOUN	O	O
before,	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
treatment,	NOUN	O	O
7,	NUM	O	O
14,	NUM	O	O
and	CCONJ	O	O
30	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
treatment.	NOUN	O	O

The	DET	O	O
follow	VERB	O	O
up	ADP	O	O
period	NOUN	O	O
was	VERB	O	O
6	NUM	O	O
months.	NOUN	O	O

Title:	NOUN	O	O
Determinants	NOUN	O	O
of	ADP	O	O
Plasma	NOUN	O	O
Docosahexaenoic	NOUN	O	O
Acid	NOUN	O	O
Levels	NOUN	O	O
and	CCONJ	O	O
Their	ADJ	O	O
Relationship	NOUN	O	O
to	PART	O	O
Neurological	ADJ	O	B-outcome
and	CCONJ	O	Seperator
Cognitive	ADJ	O	B-outcome
Functions	NOUN	O	E1-outcome
in	ADP	O	O
PKU	NOUN	O	O
Patients:	NOUN	O	O
A	DET	O	O
Double	ADV	O	O
Blind	NOUN	O	O
Randomized	VERB	O	O
Supplementation	NOUN	O	O
Study.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Serum	NOUN	O	O
corticosterone	NOUN	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
D	NOUN	O	O
were	VERB	O	O
sharply	ADV	O	O
less	ADV	O	O
than	ADP	O	O
them	PRON	O	O
in	ADP	O	O
group	NOUN	O	O
C	NOUN	O	O
at	ADP	O	O
T(2),	NOUN	O	O
T(3),	NOUN	O	O
T(4),	NOUN	O	O
T(5)	ADJ	O	O
(t=16.364,	NUM	O	O
15.306,	NOUN	O	O
12.153,	NOUN	O	O
12.592,	NOUN	O	O
respectively;	NOUN	O	O
all	DET	O	O
P<0.05),	NOUN	O	O
but	CCONJ	O	O
at	ADP	O	O
T(0),	NOUN	O	O
T(1),	NOUN	O	O
T(6),	NOUN	O	O
T(7),	NOUN	O	O
T(8),	ADJ	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
between	ADP	O	O
these	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(all	PUNCT	O	O
P>0.05).	NOUN	O	O

Further	ADV	O	O
studies	NOUN	O	O
are	VERB	O	O
still	ADV	O	O
needed	VERB	O	O
to	PART	O	O
warrant	ADJ	O	O
the	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
designed	VERB	O	O
as	ADP	O	O
a	DET	O	O
prospective,	NOUN	O	O
delayed-entry	NOUN	O	O
randomized	VERB	O	O
pilot	NOUN	O	O
trial.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
self-administered	VERB	O	O
rehabilitation	NOUN	O	O
program	NOUN	O	O
showed	VERB	O	O
an	DET	O	O
adjusted	VERB	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
51%	NUM	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
54%	ADV	O	O
of	ADP	O	O
the	DET	O	O
standard	ADJ	O	O
physical	ADJ	O	O
therapy	NOUN	O	O
(p	PUNCT	O	O
>	SYM	O	O
0.05).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Based	VERB	O	O
on	ADP	O	O
this	DET	O	O
single-center	NOUN	O	O
prospective	ADJ	O	O
study,	NOUN	O	O
both	CCONJ	O	O
of	ADP	O	O
these	DET	O	O
therapies	NOUN	O	O
appear	VERB	O	O
to	PART	O	O
have	VERB	O	O
relatively	ADV	O	O
favorable	ADJ	O	O
outcomes,	NOUN	O	O
although	ADP	O	O
cyanoacrylate	VERB	O	O
injection	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
superior	ADJ	O	O
to	PART	O	O
sclerotherapy	NOUN	O	O
for	ADP	O	O
initial	ADJ	O	O
control	NOUN	O	O
of	ADP	O	O
active	ADJ	O	B-outcome
bleeding	VERB	O	I-outcome
.	PUNCT	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
[ClinicalTrials.gov	NUM	O	O
Identifier:	NOUN	O	O
NCT03388125	NOUN	O	O
]-Date	NUM	O	O
of	ADP	O	O
registration:	NOUN	O	O
January	NOUN	O	O
2,	NOUN	O	O
2018	NUM	O	O
"Retrospectively	ADV	O	O
registered".	NOUN	O	O

CONCLUSION:	NOUN	O	O
SPC,	NOUN	O	O
MSI,	ADV	O	O
and	CCONJ	O	O
EBV	NOUN	O	O
statuses	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
used	VERB	O	O
in	ADP	O	O
combination	NOUN	O	O
to	PART	O	O
predict	VERB	O	O
the	DET	O	O
prognosis	NOUN	O	O
and	CCONJ	O	O
responsiveness	NOUN	O	O
of	ADP	O	O
adjuvant	NOUN	O	O
chemotherapy	NOUN	O	O
for	ADP	O	O
stage	NOUN	O	O
II/III	NOUN	O	O
gastric	ADJ	O	O
cancer.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
neurology	NOUN	O	O

All	DET	O	O
centers	NOUN	O	O
had	VERB	O	O
to	PART	O	O
qualify	NOUN	O	O
with	ADP	O	O
regard	NOUN	O	O
to	PART	O	O
surgical	ADJ	O	O
skills	NOUN	O	O
before	ADP	O	O
participation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
trial.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
single-blind	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
performed.	NOUN	O	O

After	ADP	O	O
3,	NOUN	O	O
7,	NUM	O	O
and	CCONJ	O	O
10	NUM	O	O
months,	NOUN	O	O
a	DET	O	O
third	ADJ	O	O
of	ADP	O	O
the	DET	O	O
practices	NOUN	O	O
were	VERB	O	O
randomised	VERB	O	O
to	PART	O	O
the	DET	O	O
intervention	NOUN	O	O
strategy.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
33	NUM	O	O
(45%)	NOUN	O	O
female	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
average	NOUN	O	O
BMI	NOUN	O	O
was	VERB	O	O
27.6.	NUM	O	O

Successful	ADJ	O	B-outcome
spinal	ADJ	O	I-outcome
anesthesia	NOUN	O	I-outcome
was	VERB	O	O
defined	VERB	O	O
as	ADP	O	O
a	DET	O	O
T5	NOUN	O	O
sensory	ADJ	O	O
level	NOUN	O	O
achieved	NOUN	O	O
within	ADP	O	O
10	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
intrathecal	ADJ	O	O
drug	NOUN	O	O
administration	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
epidural	ADJ	O	O
supplement	NOUN	O	O
was	VERB	O	O
required	VERB	O	O
during	ADP	O	O
the	DET	O	O
surgery.	VERB	O	O

The	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
was	VERB	O	O
7.6%,	NUM	O	O
15.1%	NUM	O	O
and	CCONJ	O	O
15.3%	NUM	O	O
in	ADP	O	O
lacunar	NOUN	O	O
infarction	NOUN	O	O
of	ADP	O	O
SAI,	NUM	O	O
non-lacunar	NOUN	O	O
infarction	NOUN	O	O
of	ADP	O	O
SAI	NOUN	O	O
and	CCONJ	O	O
MAIs	NOUN	O	O
at	ADP	O	O
one	NUM	O	O
year,	ADV	O	O
respectively.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Conclusion:	NOUN	O	O
Our	ADJ	O	O
results	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
LCME-required	VERB	O	O
MCF	NOUN	O	O
sessions	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
successfully	ADV	O	O
conducted	VERB	O	O
via	ADP	O	O
web-based	VERB	O	O
programs	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
Google	NOUN	O	O
Hangouts	NOUN	O	O
without	ADP	O	O
jeopardizing	VERB	O	O
overall	ADJ	O	O
meeting	VERB	O	O
experience	NOUN	O	B-outcome
.	PUNCT	O	O
While	ADP	O	O
the	DET	O	O
convenience	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
meetings	NOUN	O	O
was	VERB	O	O
improved,	NOUN	O	O
it	PRON	O	O
is	VERB	O	O
also	ADV	O	O
important	ADJ	O	O
for	ADP	O	O
clerkship	NOUN	O	O
directors	NOUN	O	O
to	PART	O	O
note	NOUN	O	O
the	DET	O	O
perceived	VERB	O	O
deficit	ADP	O	O
in	ADP	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
communication	NOUN	O	B-outcome
with	ADP	O	O
videoconferencing.	NOUN	O	O

RESULTS:	NOUN	O	O
Participants	NOUN	O	O
in	ADP	O	O
MTG	NOUN	O	O
had	VERB	O	O
an	DET	O	O
average	NOUN	O	O
of	ADP	O	O
seven	NUM	O	O
sessions	NOUN	O	O
of	ADP	O	O
music	ADJ	O	O
therapy,	NOUN	O	O
and	CCONJ	O	O
showed	VERB	O	O
improvement	NOUN	O	O
in	ADP	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
depression	NOUN	O	B-outcome
scores	NOUN	O	O
and	CCONJ	O	O
autonomic	ADJ	O	B-outcome
indexes	NOUN	O	O
of	ADP	O	O
the	DET	O	O
time	NOUN	O	O
domain	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Palo	NOUN	O	O
Alto,	NOUN	O	O
CA,	NOUN	O	O
USA.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
2961	NUM	O	O
eligible	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
identified	VERB	O	O
from	ADP	O	O
September	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
January	NOUN	O	O
2017.	NUM	O	O

Two	NUM	O	O
events	NOUN	O	O
in	ADP	O	O
the	DET	O	O
lactoferrin	NOUN	O	O
group	NOUN	O	O
(one	NOUN	O	O
case	NOUN	O	O
of	ADP	O	O
blood	NOUN	O	B-outcome
in	ADP	O	Seperator
stool	NOUN	O	I-outcome
and	CCONJ	O	O
one	NUM	O	O
death	NOUN	O	B-outcome
after	ADP	O	O
intestinal	ADJ	O	O
perforation)	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
as	ADP	O	O
being	VERB	O	O
possibly	ADV	O	O
related	VERB	O	O
to	PART	O	O
the	DET	O	O
trial	NOUN	O	O
intervention.	NOUN	O	O

The	DET	O	O
results	NOUN	O	O
is	VERB	O	O
surprising,	NOUN	O	O
so	ADV	O	O
we	PRON	O	O
hope	NOUN	O	O
to	PART	O	O
do	VERB	O	O
some	DET	O	O
further	ADV	O	O
research	NOUN	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
prove	NOUN	O	O
it	PRON	O	O
is	VERB	O	O
worth	ADP	O	O
to	PART	O	O
clinical	ADJ	O	O
application.	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
treatment,	NOUN	O	O
the	DET	O	O
6-minute	NOUN	O	O
walk	NOUN	O	B-outcome
test	NOUN	O	O
(6MWT)],	NOUN	O	O
chronic	ADJ	O	B-outcome
obstructive	ADJ	O	I-outcome
pulmonary	ADJ	O	I-outcome
disease	NOUN	O	I-outcome
(COPD)	NUM	O	I-outcome
assessment	NOUN	O	O
test	NOUN	O	O
(CAT)],	NOUN	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
,	PUNCT	O	O
airflow	NOUN	O	B-outcome
obstruction	NOUN	O	I-outcome
,	PUNCT	O	O
dyspnea	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
exercise	NOUN	O	B-outcome
capacity	NOUN	O	I-outcome
(BODE)	NUM	O	O
index	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
increased	VERB	O	O
compared	VERB	O	O
with	ADP	O	O
pre-treatment	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
but	CCONJ	O	O
not	ADV	O	O
FVC%	NOUN	O	O
and	CCONJ	O	O
FEVl%.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Letter	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
A	DET	O	O
short-term	NOUN	O	O
LOWFODMAP	NOUN	O	O
diet	NOUN	O	O
under	ADP	O	O
free-living	VERB	O	O
conditions	NOUN	O	O
reduced	VERB	O	O
exercise-related	VERB	O	O
GI	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
and	CCONJ	O	O
improved	VERB	O	O
the	DET	O	O
perceived	VERB	O	O
ability	NOUN	O	B-outcome
to	PART	O	O
exercise	NOUN	O	O
in	ADP	O	O
otherwise	NOUN	O	O
healthy,	NOUN	O	O
recreational	ADJ	O	O
runners.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
in	ADP	O	O
the	DET	O	O
Australian	ADJ	O	O
New	ADJ	O	O
Zealand	NOUN	O	O
Clinical	ADJ	O	O
Trial	NOUN	O	O
Registry	NOUN	O	O
(ANZCTR)	NOUN	O	O
under	ADP	O	O
protocol	NOUN	O	O
number:	NOUN	O	O
ACTRN12617000449336.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Our	ADJ	O	O
study	NOUN	O	O
indicates	NOUN	O	O
that	ADP	O	O
mitochondrial	ADJ	O	B-outcome
damage	NOUN	O	I-outcome
could	VERB	O	O
be	VERB	O	O
the	DET	O	O
hallmark	NOUN	O	O
of	ADP	O	O
tubular	ADJ	O	O
injury	NOUN	O	O
in	ADP	O	O
DKD	NOUN	O	O
patients,	NOUN	O	O
and	CCONJ	O	O
this	DET	O	O
would	VERB	O	O
provide	VERB	O	O
a	DET	O	O
novel	ADJ	O	O
and	CCONJ	O	O
attractive	ADJ	O	O
therapeutic	ADJ	O	O
target	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
this	DET	O	O
disease.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
overall	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	B-outcome
sore	ADV	O	I-outcome
throat	NOUN	O	I-outcome
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
HR	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
LR	NOUN	O	O
group	NOUN	O	O
[33	NOUN	O	O
(72%)	PUNCT	O	O
vs	CCONJ	O	O
18	NUM	O	O
(39%),	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.022].	NUM	O	O
The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	B-outcome
sore	ADV	O	I-outcome
throat	NOUN	O	I-outcome
at	ADP	O	O
0,	NUM	O	O
2,	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
surgery	NOUN	O	O
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
HR	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
LR	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.001,	PUNCT	O	O
P	NOUN	O	O
=	SYM	O	O
.001,	PUNCT	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.001,	PUNCT	O	O
respectively).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

Therefore,	NOUN	O	O
28	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
selected	VERB	O	O
from	ADP	O	O
the	DET	O	O
diagnostic	ADJ	O	O
group.	VERB	O	O

The	DET	O	O
paired	VERB	O	O
sample	NOUN	O	O
t-test	NOUN	O	O
or	CCONJ	O	O
Wilcoxon	NOUN	O	O
test	NOUN	O	O
were	VERB	O	O
employed	VERB	O	O
to	PART	O	O
calculate	NOUN	O	O
the	DET	O	O
differences	NOUN	O	O
between	ADP	O	O
variables	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
music	ADJ	O	O
therapy	NOUN	O	O
intervention.	NOUN	O	O

However,	ADV	O	O
using	VERB	O	O
SMV	NOUN	O	O
may	VERB	O	O
have	VERB	O	O
superior	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
improving	VERB	O	O
muscle	NOUN	O	B-outcome
tone	NOUN	O	I-outcome
after	ADP	O	O
stroke.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

We	PRON	O	O
quantified	VERB	O	O
associations	NOUN	O	O
between	ADP	O	O
macrolide	NOUN	O	B-outcome
and	CCONJ	O	O
fluoroquinolone	ADJ	O	B-outcome
use	NOUN	O	O
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
events	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
hospitalized	VERB	O	O
with	ADP	O	O
CAP	NOUN	O	O
in	ADP	O	O
non-ICU	NOUN	O	O
wards.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

Microbiome	NOUN	O	O
profiles	NOUN	O	O
were	VERB	O	O
generated	VERB	O	O
by	ADP	O	O
16S	NOUN	O	O
rRNA	NOUN	O	O
gene	NOUN	O	O
sequence	NOUN	O	O
analysis,	NOUN	O	O
supplemented	VERB	O	O
by	ADP	O	O
targeted	VERB	O	O
nanopore	ADV	O	O
sequencing.	NOUN	O	O

These	DET	O	O
parameters	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
examined	VERB	O	O
in	ADP	O	O
20	NUM	O	O
healthy	ADJ	O	O
volunteers.	ADV	O	O

CONCLUSION:	NOUN	O	O
Pre-administration	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
in	ADP	O	O
target-controlled	VERB	O	O
propofol	NOUN	O	O
and	CCONJ	O	O
remifentanil	NOUN	O	O
anesthesia	NOUN	O	O
prolongs	NOUN	O	O
total	ADJ	O	O
induction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
about	ADV	O	O
35%	ADP	O	O
compared	VERB	O	O
to	PART	O	O
co-administration	NOUN	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
and	CCONJ	O	O
propofol	NOUN	O	O
by	ADP	O	O
decreased	VERB	O	O
CO.	NOUN	O	O

Whereas	ADP	O	O
rigid	NOUN	O	O
and	CCONJ	O	O
Kinesio	NOUN	O	O
taping	VERB	O	O
are	VERB	O	O
recommended	VERB	O	O
for	ADP	O	O
preventing	VERB	O	O
these	DET	O	O
injuries,	NOUN	O	O
high-level	NOUN	O	O
evidence	NOUN	O	O
from	ADP	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
is	VERB	O	O
still	ADV	O	O
needed.	NOUN	O	O

The	DET	O	O
remaining	VERB	O	O
78	NUM	O	O
patients	NOUN	O	O
underwent	VERB	O	O
randomization.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
combined	VERB	O	O
chemotherapy	NOUN	O	O
and	CCONJ	O	O
IMRTintensity	NOUN	O	O
modulated	VERB	O	O
conformal	ADJ	O	O
radiotherapy.	NOUN	O	O

Journal-Name:Upsala	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medical	ADJ	O	O
sciences	NOUN	O	O

2)	NOUN	O	O
Simulated	VERB	O	O
scuba	ADJ	O	O
test	NOUN	O	O
in	ADP	O	O
vitro:	ADP	O	O
the	DET	O	O
ventilator	NOUN	O	O
was	VERB	O	O
connected	VERB	O	O
to	PART	O	O
the	DET	O	O
simulated	VERB	O	O
scuba,	NOUN	O	O
and	CCONJ	O	O
an	DET	O	O
external	ADJ	O	O
mechanical	ADJ	O	O
ventilation	NOUN	O	O
model	NOUN	O	O
was	VERB	O	O
constructed.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

The	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
an	DET	O	O
information	NOUN	O	O
leaflet	NOUN	O	O
about	ADV	O	O
issues	NOUN	O	O
related	VERB	O	O
to	PART	O	O
alcohol	NOUN	O	O
consumption.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0224131	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
parasite	NOUN	O	B-outcome
clearance	NOUN	O	I-outcome
at	ADP	O	O
day	NOUN	O	O
29,	NUM	O	O
after	ADP	O	O
the	DET	O	O
first	ADV	O	O
round	ADJ	O	O
of	ADP	O	O
treatment.	NOUN	O	O

During	ADP	O	O
the	DET	O	O
follow-up	NOUN	O	O
period,	NOUN	O	O
2	NUM	O	O
children	NOUN	O	O
of	ADP	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
children	NOUN	O	O
of	ADP	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
lost	VERB	O	O
or	CCONJ	O	O
the	DET	O	O
outcome	NOUN	O	O
was	VERB	O	O
unknown.	NOUN	O	O

Resulting	VERB	O	O
data	NOUN	O	O
were	VERB	O	O
then	ADV	O	O
analyzed	VERB	O	O
using	VERB	O	O
t	NOUN	O	O
test,	NUM	O	O
Pearson	NOUN	O	O
chi-square	NOUN	O	O
test,	NUM	O	O
and	CCONJ	O	O
Fisher	ADV	O	O
exact	NOUN	O	O
test	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
outcomes	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Both	CCONJ	O	O
the	DET	O	O
regimens	NOUN	O	O
achieved	NOUN	O	O
therapeutic	ADJ	O	O
goals,	NOUN	O	O
however	ADV	O	O
DR	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
to	PART	O	O
be	VERB	O	O
superior	ADJ	O	O
as	ADP	O	O
it	PRON	O	O
achieved	NOUN	O	O
greater	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
cholesterol	NOUN	O	B-outcome
(TC)	NOUN	O	O
and	CCONJ	O	O
low	ADJ	O	B-outcome
density	NOUN	O	I-outcome
lipoprotein-cholesterol	NOUN	O	I-outcome
(LDL-C)	NOUN	O	I-outcome
.	PUNCT	O	O
Further,	NOUN	O	O
these	DET	O	O
findings	NOUN	O	O
are	VERB	O	O
substantiated	VERB	O	O
by	ADP	O	O
correlation	NOUN	O	O
of	ADP	O	O
lipid	NOUN	O	B-outcome
indices	NOUN	O	O
with	ADP	O	O
serum	NOUN	O	O
hydroxymethylglutaryl-CoA	NOUN	O	B-outcome
reductase	NOUN	O	I-outcome
enzyme	NOUN	O	I-outcome
(HMGCR)	PUNCT	O	I-outcome
levels.	NOUN	O	O

CONCLUSION:	NOUN	O	O
On	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
present	ADJ	O	O
results	NOUN	O	O
the	DET	O	O
delayed-start	NOUN	O	O
protocol	NOUN	O	O
in	ADP	O	O
poor	ADJ	O	O
responders	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
the	DET	O	O
fertilization	NOUN	O	B-outcome
rate	NOUN	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
embryos	NOUN	O	B-outcome
and	CCONJ	O	O
reduce	VERB	O	O
the	DET	O	O
cycle	NOUN	O	B-outcome
cancellation	NOUN	O	I-outcome
but	CCONJ	O	O
have	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
rate;	NOUN	O	O
however,	ADV	O	O
larger	ADJ	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
are	VERB	O	O
required	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
it	PRON	O	O
with	ADP	O	O
other	ADJ	O	O
protocols.	NOUN	O	O

Noggin	NOUN	O	B-outcome
was	VERB	O	O
measured,	NOUN	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
time	NOUN	O	O
in	ADP	O	O
thalassemia	ADP	O	O
patients,	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
12	NUM	O	O
months,	NOUN	O	O
using	VERB	O	O
a	DET	O	O
recently	ADV	O	O
developed	VERB	O	O
high	ADJ	O	O
sensitivity	NOUN	O	O
fluorescent	ADJ	O	O
immunoassay.	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
Simulation	NOUN	O	O
vs.	CCONJ	O	O
Standard	NOUN	O	O
Training	VERB	O	O
for	ADP	O	O
Teaching	VERB	O	O
Medical	ADJ	O	O
Students	NOUN	O	O
High-quality	NOUN	O	O
Cardiopulmonary	ADJ	O	O
Resuscitation.	NOUN	O	O

Although	ADP	O	O
there	PRON	O	O
are	VERB	O	O
studies	NOUN	O	O
confirming	VERB	O	O
ergogenic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
caffeine	NOUN	O	O
(CAF)	PUNCT	O	O
on	ADP	O	O
different	ADJ	O	O
physical	ADJ	O	O
and	CCONJ	O	O
mental	ADJ	O	O
abilities,	NOUN	O	O
much	DET	O	O
controversy	NOUN	O	O
remains	NOUN	O	O
about	ADV	O	O
its	ADJ	O	O
influence	NOUN	O	O
on	ADP	O	O
power.	NOUN	O	O

Interventions:	NOUN	O	O
Participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
treatment	NOUN	O	O
with	ADP	O	O
placebo	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
151),	NOUN	O	O
alteplase	NOUN	O	O
10	NUM	O	O
mg	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
144),	NUM	O	O
or	CCONJ	O	O
alteplase	NOUN	O	O
20	NUM	O	O
mg	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
145)	NOUN	O	O
by	ADP	O	O
manual	ADJ	O	O
infusion	NOUN	O	O
over	ADP	O	O
5	NUM	O	O
to	PART	O	O
10	NUM	O	O
minutes.	ADJ	O	O

CrCo-Ti	NOUN	O	O
rods	NOUN	O	O
provide	VERB	O	O
significant	ADJ	O	O
and	CCONJ	O	O
stable	ADJ	O	O
spinal	ADJ	O	B-outcome
correction	NOUN	O	I-outcome
,	PUNCT	O	O
especially	ADV	O	O
in	ADP	O	O
correction	NOUN	O	B-outcome
of	ADP	O	I-outcome
main	ADJ	O	I-outcome
curve	NOUN	O	I-outcome
.	PUNCT	O	O
This	DET	O	O
rate	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
patients'	NOUN	O	O
age	NOUN	O	O
and	CCONJ	O	O
type	NOUN	O	O
of	ADP	O	O
rod	NOUN	O	O
administered	VERB	O	O
but	CCONJ	O	O
not	ADV	O	O
gender.	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
For	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial,	NOUN	O	O
we	PRON	O	O
enrolled	VERB	O	O
50	NUM	O	O
CKD	NOUN	O	O
patients.	NOUN	O	O

Cost	NOUN	O	B-outcome
per	ADP	O	O
gained	VERB	O	O
QALY	NOUN	O	O
was	VERB	O	O
1704-7889	NUM	O	O
USD.	ADP	O	O

Patients	NOUN	O	O
with	ADP	O	O
diabetes	NOUN	O	O
or	CCONJ	O	O
glucose	NOUN	O	O
intolerance	NOUN	O	O
in	ADP	O	O
the	DET	O	O
education	NOUN	O	O
group	NOUN	O	O
improved	VERB	O	O
significantly	ADV	O	O
in	ADP	O	O
waist-to-hip	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
,	PUNCT	O	O
uric	ADJ	O	B-outcome
acid	NOUN	O	I-outcome
,	PUNCT	O	O
total	ADJ	O	B-outcome
cholesterol	NOUN	O	I-outcome
and	CCONJ	O	O
<	SYM	O	O
P	NOUN	O	O
0>	NOUN	O	O
HDL-C	NOUN	O	O
.	PUNCT	O	O
Glycemic	ADJ	O	B-outcome
hemoglobin	NOUN	O	I-outcome
level	NOUN	O	O
also	ADV	O	O
improved	VERB	O	O
significantly	ADV	O	O
in	ADP	O	O
diabetes	NOUN	O	O
patients	NOUN	O	O
of	ADP	O	O
the	DET	O	O
education	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

In	ADP	O	O
both	CCONJ	O	O
groups,	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
drug	NOUN	O	O
was	VERB	O	O
similar	ADJ	O	O
for	ADP	O	O
methicillin-susceptible	ADJ	O	O
and	CCONJ	O	O
methicillin-resistant	ADJ	O	O
Staphylococcus	NOUN	O	B-outcome
aureus	NOUN	O	I-outcome
infections	NOUN	O	I-outcome
.	PUNCT	O	O
Adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
48.3%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
omadacycline	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
45.7%	NUM	O	O
of	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
linezolid	NOUN	O	O
group;	ADJ	O	O
the	DET	O	O
most	DET	O	O
frequent	ADJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
gastrointestinal	ADJ	O	B-outcome
(in	NUM	O	O
18.0%	NUM	O	O
and	CCONJ	O	O
15.8%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
respective	ADJ	O	O
groups).	NOUN	O	O

Methods:	NOUN	O	O
Chemotherapy-naive	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
(1:1:1)	NUM	O	O
to	PART	O	O
a	DET	O	O
single	ADJ	O	O
oral	ADJ	O	O
netupitant	ADJ	O	O
30-,	NOUN	O	O
100-	NUM	O	O
or	CCONJ	O	O
300-mg	NUM	O	O
dose	NOUN	O	O
before	ADP	O	O
chemotherapy	NOUN	O	O
initiation.	ADV	O	O

Methods:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
114	NUM	O	O
T2DM	NOUN	O	O
inpatients	NOUN	O	O
or	CCONJ	O	O
outpatients,	ADV	O	O
including	VERB	O	O
46	NUM	O	O
males	NOUN	O	O
and	CCONJ	O	O
68	NUM	O	O
females	NOUN	O	O
aged	VERB	O	O
(55+/-14)	PUNCT	O	O
years	NOUN	O	O
between	ADP	O	O
January	NOUN	O	O
2015	NUM	O	O
and	CCONJ	O	O
January	NOUN	O	O
2016	NUM	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups:	NOUN	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(n=57)	NOUN	O	O
only	ADV	O	O
with	ADP	O	O
hypoglycemic	ADJ	O	O
agents,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(n=57)	NOUN	O	O
with	ADP	O	O
berberine	NOUN	O	O
(0.4	NOUN	O	O
g,	NOUN	O	O
3	NUM	O	O
times	NOUN	O	O
a	DET	O	O
day)	NOUN	O	O
on	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
from	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Right	NOUN	O	O
ventricular	ADJ	O	O
size	NOUN	O	O
and	CCONJ	O	O
function	NOUN	O	O
under	ADP	O	O
riociguat	NOUN	O	O
in	ADP	O	O
pulmonary	ADJ	O	O
arterial	ADJ	O	O
hypertension	NOUN	O	O
and	CCONJ	O	O
chronic	ADJ	O	O
thromboembolic	ADJ	O	O
pulmonary	ADJ	O	O
hypertension	NOUN	O	O
(the	NOUN	O	O
RIVER	NOUN	O	O
study).	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
shivering	VERB	O	B-outcome
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
HR	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
LR	NOUN	O	O
group	NOUN	O	O
[10	NOUN	O	O
(22%)	PUNCT	O	O
vs	CCONJ	O	O
2	NUM	O	O
(4%),	NOUN	O	O
difference	NOUN	O	O
17%,	NUM	O	O
95%	NOUN	O	O
CI	NOUN	O	O
2%-33%,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.027].	PUNCT	O	O
CONCLUSION:	NOUN	O	O
A	DET	O	O
relatively	ADV	O	O
large	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
intraoperative	ADJ	O	O
remifentanil	NOUN	O	O
increased	VERB	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	B-outcome
sore	ADV	O	I-outcome
throat	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
for	ADP	O	O
orthopedic	ADJ	O	O
surgery	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

Surgical	ADJ	O	O
quality	NOUN	O	O
assurance	NOUN	O	O
was	VERB	O	O
implemented	VERB	O	O
by	ADP	O	O
the	DET	O	O
credentialing	VERB	O	O
of	ADP	O	O
surgeons,	NOUN	O	O
standardization	NOUN	O	O
of	ADP	O	O
technique,	ADV	O	O
and	CCONJ	O	O
monitoring	VERB	O	O
of	ADP	O	O
performance.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
ophthalmology	NOUN	O	O

RESULTS:	NOUN	O	O
Over	ADP	O	O
17	NUM	O	O
months,	NOUN	O	O
53	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
for	ADP	O	O
eligibility	NOUN	O	O
and	CCONJ	O	O
36	NUM	O	O
(68%)	NOUN	O	O
were	VERB	O	O
randomised	VERB	O	O
(47%	NOUN	O	O
male;	NOUN	O	O
mean	NOUN	O	O
age	NOUN	O	O
36.9	NUM	O	O
[SD	NUM	O	O
11.2	VERB	O	O
years);	NOUN	O	O
13	NUM	O	O
to	PART	O	O
HIIT,	NOUN	O	O
12	NUM	O	O
to	PART	O	O
MICT,	NOUN	O	O
and	CCONJ	O	O
11	NUM	O	O
to	PART	O	O
control.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Exercise-heat	NOUN	O	O
exposures	NOUN	O	O
every	DET	O	O
fifth	ADJ	O	O
day	NOUN	O	O
for	ADP	O	O
25	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
regular	ADJ	O	O
intense	ADJ	O	O
physical	ADJ	O	O
activity	NOUN	O	O
after	ADP	O	O
HA	NOUN	O	O
sustained	VERB	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
and	CCONJ	O	O
Tre	PUNCT	O	B-outcome
adaptations	NOUN	O	O
and	CCONJ	O	O
reduced	VERB	O	O
perceptual	ADJ	O	B-outcome
and	CCONJ	O	Seperator
Physiological	ADJ	O	B-outcome
strain	NOUN	O	E1-outcome
during	ADP	O	O
exercise-heat	NOUN	O	O
stress	NOUN	O	O
approximately	ADV	O	O
1	NUM	O	O
month	NOUN	O	O
later.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
infectious	ADJ	O	O
diseases	NOUN	O	O

SETTING:	NOUN	O	O
Hospital	NOUN	O	O
outpatient	ADJ	O	O
clinics	NOUN	O	O
at	ADP	O	O
six	NUM	O	O
hospitals	NOUN	O	O
in	ADP	O	O
Norway.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Feeling	VERB	O	O
down,	ADJ	O	O
depressed	VERB	O	O
or	CCONJ	O	O
hopeless	ADV	O	O
was	VERB	O	O
independently	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
recent	ADJ	O	O
eve-teasing	VERB	O	O
(AOR	NUM	O	O
2.9	NUM	O	O
(1.6-5.4)),	NOUN	O	O
a	DET	O	O
harassing	VERB	O	O
or	CCONJ	O	O
abusive	ADJ	O	O
school	NOUN	O	O
environment	NOUN	O	O
(AOR	NUM	O	O
3.9	NUM	O	O
(1.8-8.2)),	NOUN	O	O
being	VERB	O	O
frequently	ADV	O	O
absent	ADJ	O	O
(AOR	NUM	O	O
2.8	NUM	O	O
(1.5-5.5))	PUNCT	O	O
or	CCONJ	O	O
having	VERB	O	O
dropped	VERB	O	O
out	ADP	O	O
of	ADP	O	O
school	NOUN	O	O
(AOR	NUM	O	O
2.1	NUM	O	O
(1.0-4.3)),	NOUN	O	O
and	CCONJ	O	O
living	VERB	O	O
in	ADP	O	O
Vijayapura	NOUN	O	O
district	ADP	O	O
(AOR	NUM	O	O
2.5	NUM	O	O
(1.6-4.1)).	NUM	O	O

Journal-Name:Medicine	NOUN	O	O

BACKGROUND:	NOUN	O	O
Induction	NOUN	O	O
of	ADP	O	O
delta	NOUN	O	O
aminolevulinic	ADJ	O	O
acid	NOUN	O	O
synthase	NOUN	O	O
1	NUM	O	O
(	PUNCT	O	O
ALAS1)	NOUN	O	O
gene	NOUN	O	O
expression	NOUN	O	O
and	CCONJ	O	O
accumulation	NOUN	O	O
of	ADP	O	O
neurotoxic	ADJ	O	O
intermediates	NOUN	O	O
result	VERB	O	O
in	ADP	O	O
neurovisceral	ADJ	O	O
attacks	NOUN	O	O
and	CCONJ	O	O
disease	NOUN	O	O
manifestations	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
intermittent	ADJ	O	O
porphyria,	ADV	O	O
a	DET	O	O
rare	ADJ	O	O
inherited	VERB	O	O
disease	NOUN	O	O
of	ADP	O	O
heme	NOUN	O	O
biosynthesis.	NOUN	O	O

Additionally	ADV	O	O
the	DET	O	O
authors	NOUN	O	O
evaluated	VERB	O	O
whether	ADP	O	O
CAF	NOUN	O	O
has	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
velocity	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
bar	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
eccentric	ADJ	O	O
(ECC)	PUNCT	O	O
phase	NOUN	O	O
(VEMEAN)	NUM	O	O
of	ADP	O	O
the	DET	O	O
bench	NOUN	O	O
press	NOUN	O	O
movement.	NOUN	O	O

Thus,	NOUN	O	O
PrimaVie(R)	NOUN	O	O
Shilajit	ADJ	O	O
supplementation	NOUN	O	O
at	ADP	O	O
500	NUM	O	O
mg.d(-	NOUN	O	O
1)	NUM	O	O
elicited	VERB	O	O
favorable	ADJ	O	O
muscle	NOUN	O	B-outcome
and	CCONJ	O	Seperator
connective	ADJ	O	B-outcome
tissue	NOUN	O	E1-outcome
adaptations.	NOUN	O	O

Primary	ADJ	O	O
outcome	NOUN	O	O
data	NOUN	O	O
for	ADP	O	O
2182	NUM	O	O
infants	NOUN	O	O
(1093	PUNCT	O	O
[99.5%]	NOUN	O	O
of	ADP	O	O
1098	NUM	O	O
in	ADP	O	O
the	DET	O	O
lactoferrin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
1089	NUM	O	O
[99.0]	NOUN	O	O
of	ADP	O	O
1101	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group)	ADJ	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
inclusion	NOUN	O	O
in	ADP	O	O
the	DET	O	O
modified	VERB	O	O
intention-to-treat	NOUN	O	O
analyses.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
explore	ADP	O	O
the	DET	O	O
surgical	ADJ	O	O
treatment	NOUN	O	O
strategy	NOUN	O	O
of	ADP	O	O
the	DET	O	O
vertebral	ADJ	O	O
"shell"	NOUN	O	O
after	ADP	O	O
thoracolumbar	ADV	O	O
fracture,	NOUN	O	O
and	CCONJ	O	O
provide	VERB	O	O
clinical	ADJ	O	O
reference	NOUN	O	O
for	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
of	ADP	O	O
"shell".	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

On	ADP	O	O
day	NOUN	O	O
28,	NUM	O	O
mean	NOUN	O	O
cry	NOUN	O	B-outcome
and	CCONJ	O	Seperator
fuss	NOUN	O	B-outcome
time	NOUN	O	E1-outcome
became	VERB	O	O
statistically	ADV	O	O
different:	NOUN	O	O
142	NUM	O	O
(89)	NOUN	O	O
vs.	CCONJ	O	O
199	NUM	O	O
(72),	PUNCT	O	O
respectively	ADV	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Also,	ADJ	O	O
safety	NOUN	O	O
parameters	NOUN	O	O
were	VERB	O	O
similar	ADJ	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Importance:	NOUN	O	O
Despite	ADP	O	O
guideline	NOUN	O	O
recommendations,	NOUN	O	O
many	DET	O	O
patients	NOUN	O	O
discontinue	NOUN	O	O
P2Y12	NOUN	O	O
inhibitor	NOUN	O	O
therapy	NOUN	O	O
earlier	ADJ	O	O
than	ADP	O	O
the	DET	O	O
recommended	VERB	O	O
1	NUM	O	O
year	NOUN	O	O
after	ADP	O	O
myocardial	ADJ	O	O
infarction	NOUN	O	O
(MI),	NOUN	O	O
and	CCONJ	O	O
higher-potency	NOUN	O	O
P2Y12	NOUN	O	O
inhibitors	NOUN	O	O
are	VERB	O	O
underutilized.	NOUN	O	O

RESULTS:	NOUN	O	O
Spearman	NOUN	O	O
rank	NOUN	O	O
correlation	NOUN	O	O
analysis	NOUN	O	O
indicated	VERB	O	O
that	ADP	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
correlation	NOUN	O	O
between	ADP	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
and	CCONJ	O	O
TOFr	NOUN	O	O
during	ADP	O	O
patient	NOUN	O	O
recovery	NOUN	O	O
from	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
(correlation	NUM	O	O
coefficient	NOUN	O	O
for	ADP	O	O
grip	NOUN	O	O
strength	NOUN	O	O
recovery	NOUN	O	O
[rs]	NOUN	O	O
=	SYM	O	O
0.886).	NUM	O	O

Postprandial	ADJ	O	O
qualitative	ADJ	O	O
appetite	NOUN	O	B-outcome
,	PUNCT	O	O
glucose	NOUN	O	B-outcome
,	PUNCT	O	O
insulin	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
GLP-1	NOUN	O	B-outcome
were	VERB	O	O
measured	VERB	O	O
every	DET	O	O
30	NUM	O	O
min	NOUN	O	O
for	ADP	O	O
7	NUM	O	O
h.	NOUN	O	O
Energy	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
values	NOUN	O	O
from	ADP	O	O
an	DET	O	O
ad	NOUN	O	O
libitum	ADV	O	O
dinner	NOUN	O	O
and	CCONJ	O	O
for	ADP	O	O
a	DET	O	O
24-h	NOUN	O	O
period	NOUN	O	O
were	VERB	O	O
assessed.	NOUN	O	O

Title:	NOUN	O	O
White	ADP	O	O
Sweet	ADJ	O	O
Potato	NOUN	O	O
as	ADP	O	O
Meal	ADJ	O	O
Replacement	NOUN	O	O
for	ADP	O	O
Overweight	NOUN	O	O
White-Collar	ADJ	O	O
Workers:	ADJ	O	O
A	DET	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial.	NOUN	O	O

We	PRON	O	O
discuss	NOUN	O	O
possible	ADJ	O	O
explanations	NOUN	O	O
for	ADP	O	O
this	DET	O	O
null	ADJ	O	O
effect,	NOUN	O	O
including	VERB	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
participants'	NOUN	O	O
low	ADJ	O	O
perceived	VERB	O	O
susceptibility	NOUN	O	O
to	PART	O	O
the	DET	O	O
risks	NOUN	O	O
shown	VERB	O	O
on	ADP	O	O
these	DET	O	O
pictorial	ADJ	O	O
health	NOUN	O	O
warning	VERB	O	O
labels.	NOUN	O	O

To	PART	O	O
evaluate	VERB	O	O
whether	ADP	O	O
all	DET	O	O
SAI	NOUN	O	O
had	VERB	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
than	ADP	O	O
MAIs	NOUN	O	O
in	ADP	O	O
minor	ADJ	O	O
stroke.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/17	ADP	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
Patients	NOUN	O	O
under	ADP	O	O
long-term	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
riociguat	NOUN	O	O
show	VERB	O	O
significantly	ADV	O	O
reduced	VERB	O	O
right	ADJ	O	B-outcome
heart	NOUN	O	I-outcome
size	NOUN	O	I-outcome
and	CCONJ	O	O
improved	VERB	O	O
RV	NOUN	O	B-outcome
function	NOUN	O	I-outcome
in	ADP	O	O
PAH	NOUN	O	O
and	CCONJ	O	O
CTEPH.	NOUN	O	O

Journal-Name:Italian	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
pediatrics	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Direct	ADJ	O	O
and	CCONJ	O	O
video	ADJ	O	O
instructions	NOUN	O	O
are	VERB	O	O
equally	ADV	O	O
effective	ADJ	O	O
in	ADP	O	O
teaching	VERB	O	O
parents	NOUN	O	O
to	PART	O	O
perform	NOUN	O	O
simple	NOUN	O	O
whole	ADJ	O	B-outcome
motor	NOUN	O	I-outcome
tasks	NOUN	O	O
in	ADP	O	O
the	DET	O	O
NICU,	ADJ	O	O
and	CCONJ	O	O
parents	NOUN	O	O
welcome	NOUN	O	B-outcome
the	DET	O	Seperator
instruction	NOUN	O	I-outcome
.	PUNCT	O	O

The	DET	O	O
aortic	ADJ	O	O
and	CCONJ	O	O
hepatic	ADJ	O	O
equivalence	NOUN	O	O
margins	NOUN	O	O
were	VERB	O	O
100	NUM	O	O
and	CCONJ	O	O
20	NUM	O	O
Hounsfield	NOUN	O	O
units,	NOUN	O	O
respectively.	NOUN	O	O

Title:	NOUN	O	O
Endoscopic	ADJ	O	O
injection	NOUN	O	O
sclerotherapy	NOUN	O	O
versus	CCONJ	O	O
N-Butyl-2	NOUN	O	O
Cyanoacrylate	NOUN	O	O
injection	NOUN	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
actively	ADV	O	O
bleeding	VERB	O	O
esophageal	ADJ	O	O
varices:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Bispectral	ADJ	O	O
index(BIS)	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
monitor	NOUN	O	O
the	DET	O	O
depth	NOUN	O	O
of	ADP	O	O
anesthesia	NOUN	O	O
and	CCONJ	O	O
maintained	VERB	O	O
between	ADP	O	O
45-60	NUM	O	O
during	ADP	O	O
operation.	ADV	O	O

0.05).	NOUN	O	O

Study	NOUN	O	O
participants	NOUN	O	O
were	VERB	O	O
admitted	VERB	O	O
30	NUM	O	O
minutes	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
ET	NOUN	O	O
and	CCONJ	O	O
given	VERB	O	O
either	CCONJ	O	O
tablet	NOUN	O	O
after	ADP	O	O
their	ADJ	O	O
baseline	NOUN	O	O
vital	ADJ	O	O
signs	NOUN	O	O
were	VERB	O	O
recorded.	NOUN	O	O

PURPOSE:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
rehydrating	VERB	O	B-outcome
efficacy	NOUN	O	O
of	ADP	O	O
MW	NOUN	O	O
after	ADP	O	O
exercise-induced	VERB	O	O
dehydration.	ADV	O	O

Similarly,	NOUN	O	O
adjusted	VERB	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
were	VERB	O	O
reduced	VERB	O	O
by	ADP	O	O
20.4%	NUM	O	O
(-	NOUN	O	O
6.3	NUM	O	O
points,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.02).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/30	ADP	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Conclusions:	NOUN	O	O
Albuminemia	NOUN	O	B-outcome
levels	NOUN	O	O
decreased	VERB	O	O
significantly	ADV	O	O
in	ADP	O	O
both	CCONJ	O	O
groups,	NOUN	O	O
and	CCONJ	O	O
this	DET	O	O
decrease	NOUN	O	O
was	VERB	O	O
more	ADV	O	O
marked	VERB	O	O
in	ADP	O	O
the	DET	O	O
EEN	NOUN	O	O
group.	VERB	O	O

Journal-Name:Revista	NOUN	O	O
de	ADP	O	O
la	NOUN	O	O
Facultad	ADV	O	O
de	ADP	O	O
Ciencias	NOUN	O	O
Medicas	NOUN	O	O
(Cordoba,	NUM	O	O
Argentina)	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
safety	NOUN	O	O
outcome	NOUN	O	O
was	VERB	O	O
a	DET	O	O
protocol-defined	VERB	O	O
decrease	NOUN	O	O
in	ADP	O	O
the	DET	O	O
hemoglobin	NOUN	O	B-outcome
level	NOUN	O	O
(>3.0	PUNCT	O	O
g	NOUN	O	O
per	ADP	O	O
deciliter	NOUN	O	O
or	CCONJ	O	O
>/=30%	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
or	CCONJ	O	O
to	PART	O	O
a	DET	O	O
level	NOUN	O	O
of	ADP	O	O
<6.0	CCONJ	O	O
g	NOUN	O	O
per	ADP	O	O
deciliter).	PUNCT	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
double-blind,	NOUN	O	O
randomized	VERB	O	O
trial	NOUN	O	O
involving	VERB	O	O
high-risk	NOUN	O	O
ambulatory	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
cancer	NOUN	O	O
(Khorana	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
>/=2,	NOUN	O	O
on	ADP	O	O
a	DET	O	O
scale	NOUN	O	O
from	ADP	O	O
0	NUM	O	O
to	PART	O	O
6,	NOUN	O	O
with	ADP	O	O
higher	ADJ	O	O
scores	NOUN	O	O
indicating	VERB	O	O
a	DET	O	O
higher	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
venous	ADJ	O	O
thromboembolism),	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
patients	NOUN	O	O
without	ADP	O	O
deep-vein	NOUN	O	O
thrombosis	NOUN	O	O
at	ADP	O	O
screening	VERB	O	O
to	PART	O	O
receive	VERB	O	O
rivaroxaban	ADJ	O	O
(at	NUM	O	O
a	DET	O	O
dose	NOUN	O	O
of	ADP	O	O
10	NUM	O	O
mg)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
daily	ADJ	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
180	NUM	O	O
days,	NOUN	O	O
with	ADP	O	O
screening	VERB	O	O
every	DET	O	O
8	NUM	O	O
weeks.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

By	ADP	O	O
week	NOUN	O	O
8,	NOUN	O	O
HP/TAZ	NOUN	O	O
lotion	NOUN	O	O
achieved	NOUN	O	O
a	DET	O	O
63.5%	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
mean	NOUN	O	O
IGAxBSA	NOUN	O	O
composite	NOUN	O	O
score	NOUN	O	O
(P<0.001	PUNCT	O	O
versus	CCONJ	O	O
TAZ	NOUN	O	O
and	CCONJ	O	O
vehicle),	NOUN	O	O
that	ADP	O	O
was	VERB	O	O
sustained	VERB	O	O
four	NUM	O	O
weeks	NOUN	O	O
posttreatment	NOUN	O	O
(P<0.001	PUNCT	O	O
versus	CCONJ	O	O
TAZ	NOUN	O	O
and	CCONJ	O	O
vehicle	NOUN	O	O
and	CCONJ	O	O
P=0.003	NOUN	O	O
versus	CCONJ	O	O
HP).	NOUN	O	O

The	DET	O	O
tear	NUM	O	O
serotonin	NOUN	O	B-outcome
level	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
was	VERB	O	O
reduced	VERB	O	O
from	ADP	O	O
2.76	NUM	O	O
+/-	SYM	O	O
0.34	NUM	O	O
to	PART	O	O
1.73	NUM	O	O
+/-	SYM	O	O
0.14	NUM	O	O
ng/mL	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.001).	NUM	O	O

Clinicaltrials.gov	NOUN	O	O
NCT01702974.	NOUN	O	O

MAIN	ADJ	O	O
OUTCOME	NOUN	O	O
MEASURES:	NOUN	O	O
Resting	VERB	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
was	VERB	O	O
measured	VERB	O	O
and	CCONJ	O	O
standard	ADJ	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
(HRV)	NUM	O	I-outcome
indices	NOUN	O	O
were	VERB	O	O
calculated	VERB	O	O
using	VERB	O	O
time	NOUN	O	O
domain	NOUN	O	O
(	PUNCT	O	O
SDNN	NOUN	O	B-outcome
,	PUNCT	O	O
pNN50	ADV	O	B-outcome
,	PUNCT	O	O
RMSSD	NOUN	O	B-outcome
)	PUNCT	O	O
and	CCONJ	O	O
frequency	NOUN	O	O
domain	NOUN	O	O
(	PUNCT	O	O
LFnu	ADP	O	B-outcome
,	PUNCT	O	O
HFnu	NOUN	O	B-outcome
,	PUNCT	O	O
LF/HF	ADV	O	B-outcome
and	CCONJ	O	O
TP	NOUN	O	B-outcome
)	PUNCT	O	O
analysis.	NOUN	O	O

BACKGROUND:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
Baduanjin	NOUN	O	O
qigong	ADJ	O	O
combined	VERB	O	O
with	ADP	O	O
cognitive-behavior	ADJ	O	O
therapy	NOUN	O	O
(CBT)	PUNCT	O	O
on	ADP	O	O
the	DET	O	O
physical	ADJ	O	B-outcome
fitness	ADP	O	I-outcome
and	CCONJ	O	O
psychological	ADJ	O	B-outcome
health	NOUN	O	I-outcome
of	ADP	O	O
elderly	NOUN	O	O
housebound.	NOUN	O	O

In	ADP	O	O
total,	ADJ	O	O
27	NUM	O	O
participants,	NOUN	O	O
inexperienced	VERB	O	O
in	ADP	O	O
spinal	ADJ	O	O
ultrasonography,	ADJ	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
allocated	VERB	O	O
to	PART	O	O
1	NUM	O	O
of	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
(training	VERB	O	O
group,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
18;	NUM	O	O
control	NOUN	O	O
group,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
9).	ADJ	O	O

A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
comparing	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
NPWT	NOUN	O	O
with	ADP	O	O
standard	ADJ	O	O
surgical	ADJ	O	O
dressing	VERB	O	O
(SSD)	PUNCT	O	O
on	ADP	O	O
wounds	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
in	ADP	O	O
265	NUM	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
open	ADJ	O	O
gastrointestinal	ADJ	O	O
resections	NOUN	O	O
from	ADP	O	O
2012	NUM	O	O
to	PART	O	O
2016.	NUM	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
6-minute	NOUN	O	O
walk	NOUN	O	B-outcome
test	NOUN	O	O
(6MWT)],	NOUN	O	O
chronic	ADJ	O	B-outcome
obstructive	ADJ	O	I-outcome
pulmonary	ADJ	O	I-outcome
disease	NOUN	O	I-outcome
(COPD)	NUM	O	I-outcome
assessment	NOUN	O	O
test	NOUN	O	O
(CAT)],	NOUN	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
,	PUNCT	O	O
airflow	NOUN	O	B-outcome
obstruction	NOUN	O	I-outcome
,	PUNCT	O	O
dyspnea	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
exercise	NOUN	O	B-outcome
capacity	NOUN	O	I-outcome
(BODE)	NUM	O	O
index].	ADJ	O	O
Besides,	NOUN	O	O
the	DET	O	O
pulmonary	ADJ	O	B-outcome
function	NOUN	O	I-outcome
(FVC%,	PUNCT	O	O
FEVl%)	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

The	DET	O	O
appearance	NOUN	O	B-outcome
,	PUNCT	O	O
graft	NOUN	O	B-outcome
,	PUNCT	O	O
conjunctiva	ADP	O	B-outcome
melting	VERB	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
tube	NOUN	O	B-outcome
exposure	NOUN	O	I-outcome
were	VERB	O	O
the	DET	O	O
primary	ADJ	O	O
observation	NOUN	O	O
points.	NOUN	O	O

Patients	NOUN	O	O
with	ADP	O	O
clinical	ADJ	O	O
improvement	NOUN	O	O
but	CCONJ	O	O
without	ADP	O	O
parasite	NOUN	O	O
clearance	NOUN	O	O
at	ADP	O	O
day	NOUN	O	O
29	NUM	O	O
received	VERB	O	O
a	DET	O	O
second	ADJ	O	O
round	ADJ	O	O
of	ADP	O	O
the	DET	O	O
allocated	VERB	O	O
treatment.	NOUN	O	O

Complete	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
,	PUNCT	O	O
complete	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
with	ADP	O	Seperator
incomplete	ADJ	O	I-outcome
platelet	NOUN	O	I-outcome
recovery	NOUN	O	I-outcome
(CRp)	NOUN	O	I-outcome
,	PUNCT	O	O
complete	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
with	ADP	O	Seperator
incomplete	ADJ	O	I-outcome
haematological	ADJ	O	I-outcome
recovery	NOUN	O	I-outcome
(CRi)	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
groups	NOUN	O	O
when	ADP	O	O
stratified	VERB	O	O
by	ADP	O	O
cytogenetics,	NOUN	O	O
de-novo	NOUN	O	O
versus	CCONJ	O	O
secondary	ADJ	O	O
or	CCONJ	O	O
therapy-related	VERB	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
leukaemia,	NOUN	O	O
or	CCONJ	O	O
TP53(mut)	ADJ	O	O
status.	NOUN	O	O

Title:	NOUN	O	O
[	PUNCT	O	O
Feasibility	NOUN	O	B-outcome
of	ADP	O	O
supraglottic	ADJ	O	O
tracheal	ADJ	O	O
tube	NOUN	O	O
ventilation	NOUN	O	O
during	ADP	O	O
painless	NOUN	O	O
fiberbronchoscopy].	NOUN	O	O

The	DET	O	O
treatment	NOUN	O	O
was	VERB	O	O
well	ADV	O	O
tolerated	VERB	O	B-outcome
,	PUNCT	O	O
without	ADP	O	O
side	NOUN	O	B-outcome
effects	NOUN	O	I-outcome
or	CCONJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
Thus,	NOUN	O	O
our	ADJ	O	O
WSP	NOUN	O	O
formula	NOUN	O	O
as	ADP	O	O
an	DET	O	O
MR	NOUN	O	O
can	VERB	O	O
facilitate	VERB	O	O
individual	ADJ	O	O
weight	NOUN	O	B-outcome
loss	NOUN	O	O
and	CCONJ	O	O
thus	ADV	O	O
has	VERB	O	O
commercial	ADJ	O	O
application	NOUN	O	O
in	ADP	O	O
the	DET	O	O
food	NOUN	O	O
industry.	VERB	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
scapular	ADJ	O	B-outcome
dyskinesis	NOUN	O	I-outcome
percentage	NOUN	O	O
(	PUNCT	O	O
P	NOUN	O	O
<	SYM	O	O
.05)	NOUN	O	O
decreased	VERB	O	O
and	CCONJ	O	O
the	DET	O	O
pectoralis	NOUN	O	B-outcome
minor	ADJ	O	I-outcome
index	NOUN	O	O
(	PUNCT	O	O
P	NOUN	O	O
<	SYM	O	O
.001)	PUNCT	O	O
increased	VERB	O	O
immediately	ADV	O	O
and	CCONJ	O	O
at	ADP	O	O
60	NUM	O	O
to	PART	O	O
72	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
taping	VERB	O	O
in	ADP	O	O
the	DET	O	O
rigid-taping	VERB	O	O
and	CCONJ	O	O
Kinesio-taping	VERB	O	O
groups.	NOUN	O	O

The	DET	O	O
aims	NOUN	O	O
of	ADP	O	O
our	ADJ	O	O
study	NOUN	O	O
were	VERB	O	O
to	PART	O	O
analyze	NOUN	O	O
not	ADV	O	O
only	ADV	O	O
the	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
daily	ADJ	O	O
vs.	CCONJ	O	O
monthly	ADV	O	O
administration	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
on	ADP	O	O
bone	NOUN	O	B-outcome
metabolism	NOUN	O	I-outcome
and	CCONJ	O	O
bone	NOUN	O	B-outcome
turnover	ADV	O	I-outcome
,	PUNCT	O	O
but	CCONJ	O	O
also	ADV	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
routes	NOUN	O	O
of	ADP	O	O
administration	NOUN	O	O
on	ADP	O	O
fat	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
in	ADP	O	O
a	DET	O	O
cohort	NOUN	O	O
of	ADP	O	O
adults	NOUN	O	O
with	ADP	O	O
low	ADJ	O	O
levels	NOUN	O	O
of	ADP	O	O
25(OH)	NUM	O	O
vitamin	NOUN	O	O
D3	NOUN	O	O
at	ADP	O	O
baseline.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
psychology	NOUN	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
previously	ADV	O	O
showed	VERB	O	O
that	ADP	O	O
human	NOUN	O	O
anti-T-lymphocyte	NOUN	O	O
globulin	NOUN	O	O
(ATLG)	ADV	O	O
plus	CCONJ	O	O
ciclosporin	NOUN	O	O
and	CCONJ	O	O
methotrexate	NOUN	O	O
given	VERB	O	O
to	PART	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
leukaemia	NOUN	O	O
in	ADP	O	O
remission,	NOUN	O	O
having	VERB	O	O
allogeneic	ADJ	O	O
haemopoietic	ADJ	O	O
stem-cell	NOUN	O	O
transplantation	NOUN	O	O
with	ADP	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
stem	NOUN	O	O
cells	NOUN	O	O
from	ADP	O	O
an	DET	O	O
HLA-identical	ADJ	O	O
sibling	VERB	O	O
donor	NOUN	O	O
after	ADP	O	O
myeloablative	ADJ	O	O
conditioning,	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
2-year	NOUN	O	O
chronic	ADJ	O	B-outcome
graft-versus-host	ADV	O	I-outcome
disease	NOUN	O	I-outcome
(cGVHD)	NOUN	O	I-outcome
incidence	NOUN	O	X
and	NOUN	O	X
severity	NOUN	O	S4-outcome
,	PUNCT	O	O
without	ADP	O	O
increasing	VERB	O	O
disease	NOUN	O	B-outcome
relapse	NOUN	O	I-outcome
and	CCONJ	O	O
infections	NOUN	O	O
,	PUNCT	O	O
and	CCONJ	O	O
improves	NOUN	O	O
cGVHD-free	ADJ	O	O
and	CCONJ	O	O
relapse-free	ADJ	O	O
survival	NOUN	O	O
(cGRFS)	SYM	O	O
.	PUNCT	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
an	DET	O	O
extended	VERB	O	O
follow-up	NOUN	O	O
study	NOUN	O	O
was	VERB	O	O
the	DET	O	O
assessment	NOUN	O	O
of	ADP	O	O
long-term	NOUN	O	O
outcomes,	NOUN	O	O
which	ADP	O	O
are,	NOUN	O	O
in	ADP	O	O
this	DET	O	O
context,	NOUN	O	O
scarcely	ADV	O	O
reported	VERB	O	O
in	ADP	O	O
the	DET	O	O
literature.	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
Delayed-Start	NOUN	O	O
Trial	NOUN	O	O
of	ADP	O	O
Levodopa	NOUN	O	O
in	ADP	O	O
Parkinson's	NOUN	O	O
Disease.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:The	ADJ	O	O
bone	NOUN	O	O
&	CCONJ	O	O
joint	NOUN	O	O
journal	ADJ	O	O

The	DET	O	O
postinduction	NOUN	O	O
systolic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.03),	PUNCT	O	O
diastolic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
.001)	PUNCT	O	O
and	CCONJ	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.03)	NUM	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
methohexital	ADJ	O	O
group.	VERB	O	O

Title:	NOUN	O	O
FOLFIRINOX	NOUN	O	O
or	CCONJ	O	O
Gemcitabine	NOUN	O	O
as	ADP	O	O
Adjuvant	NOUN	O	O
Therapy	NOUN	O	O
for	ADP	O	O
Pancreatic	ADJ	O	O
Cancer.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
1st	ADJ	O	O
group	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
operated	VERB	O	O
with	ADP	O	O
cadaver	ADV	O	O
allografts,	ADV	O	O
the	DET	O	O
Kujala	NOUN	O	O
score	ADJ	O	O
significantly	ADV	O	O
improved	VERB	O	O
from	ADP	O	O
73.91	NUM	O	O
points	NOUN	O	O
preoperatively	ADV	O	O
to	PART	O	O
94.50	NUM	O	O
points	NOUN	O	O
postoperatively	ADV	O	O
(P	NUM	O	O
<	SYM	O	O
.001).	PUNCT	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
beta-alanine	NOUN	O	O
dosing	VERB	O	O
strategies	NOUN	O	O
on	ADP	O	O
30-minute	NOUN	O	O
rowing	VERB	O	B-outcome
performance	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Participants,	NOUN	O	O
the	DET	O	O
study	NOUN	O	O
team	NOUN	O	O
administering	VERB	O	O
treatment,	NOUN	O	O
and	CCONJ	O	O
investigators	NOUN	O	O
analysing	VERB	O	O
outcomes	NOUN	O	O
(who	PUNCT	O	O
were	VERB	O	O
independent	ADJ	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
team	NOUN	O	O
and	CCONJ	O	O
had	VERB	O	O
no	DET	O	O
further	ADV	O	O
involvement)	NOUN	O	O
were	VERB	O	O
masked	VERB	O	O
to	PART	O	O
treatment	NOUN	O	O
groups.	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
perinatal	ADJ	O	I-outcome
outcomes	NOUN	O	I-outcome
was	VERB	O	O
1.7%	ADJ	O	O
(n=118)	NOUN	O	O
for	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
strategy	NOUN	O	O
and	CCONJ	O	O
1.8%	NOUN	O	O
(n=106)	NOUN	O	O
for	ADP	O	O
usual	ADJ	O	O
care.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
treatment	NOUN	O	B-outcome
success	NOUN	O	I-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
a	DET	O	O
decrease	NOUN	O	O
of	ADP	O	O
50%	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
in	ADP	O	O
the	DET	O	O
Gastroesophageal	NOUN	O	O
Reflux	NOUN	O	O
Disease	NOUN	O	O
(GERD)-Health	PUNCT	O	O
Related	VERB	O	O
Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
Life	NOUN	O	I-outcome
score	ADJ	O	O
(range,	NOUN	O	O
0	NUM	O	O
to	PART	O	O
50,	NOUN	O	O
with	ADP	O	O
higher	ADJ	O	O
scores	NOUN	O	O
indicating	VERB	O	O
worse	NOUN	O	O
symptoms)	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
year.	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
Medical	ADJ	O	O
versus	CCONJ	O	O
Surgical	ADJ	O	O
Treatment	NOUN	O	O
for	ADP	O	O
Refractory	ADJ	O	O
Heartburn.	NOUN	O	O

MATERIAL	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Three	NUM	O	O
hundred	NUM	O	O
thirty-two	NUM	O	O
Indian	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
elective	ADJ	O	O
percutaneous	ADJ	O	O
coronary	ADJ	O	O
intervention	NOUN	O	O
(PCI)	PUNCT	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

Total	ADJ	O	O
follow-up	NOUN	O	O
was	VERB	O	O
38.2	NUM	O	O
months,	NOUN	O	O
during	ADP	O	O
which	ADP	O	O
the	DET	O	O
median	ADJ	O	O
duration	NOUN	O	O
of	ADP	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
5.5	NUM	O	O
months	NOUN	O	O
(IQR	NUM	O	O
2.1-11.7)	NUM	O	O
in	ADP	O	O
the	DET	O	O
5-day	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
6.0	NUM	O	O
months	NOUN	O	O
(1.9-11.7)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
10-day	NOUN	O	O
group.	VERB	O	O

Reduction	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
hydroxymethylglutaryl-CoA	NOUN	O	B-outcome
reductase	NOUN	O	I-outcome
enzyme	NOUN	O	I-outcome
(HMGCR)	PUNCT	O	I-outcome
levels	NOUN	O	O
was	VERB	O	O
comparable	ADJ	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
groups	NOUN	O	O
(31.17%	PUNCT	O	O
vs	CCONJ	O	O
28.19%).	NOUN	O	O

DHA	NOUN	O	B-outcome
intakes	NOUN	O	O
up	ADP	O	O
to	PART	O	O
7	NUM	O	O
mg/kg	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
improve	VERB	O	O
neurological	ADJ	O	B-outcome
functions	NOUN	O	I-outcome
in	ADP	O	O
PKU	NOUN	O	O
children.	NOUN	O	O

Then	ADV	O	O
the	DET	O	O
3	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
subgroups	NOUN	O	O
by	ADP	O	O
age,	NOUN	O	O
12	NUM	O	O
to	PART	O	O
24	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
25	NUM	O	O
to	PART	O	O
36	NUM	O	O
months.	NOUN	O	O

Achaogen,	VERB	O	O
South	NOUN	O	O
San	NOUN	O	O
Francisco,	ADV	O	O
CA.	NOUN	O	O

Statistically	ADV	O	O
significant	ADJ	O	O
root	NOUN	O	B-outcome
coverage	NOUN	O	I-outcome
percentage	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
at	ADP	O	O
one	NUM	O	O
year	NOUN	O	O
post-treatment	NOUN	O	O
for	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8912748	NUM	O	O

179.8	NUM	O	O
+/-	SYM	O	O
6.3	NUM	O	O
cm;	NOUN	O	O
83.1	NUM	O	O
+/-	SYM	O	O
12.7	NUM	O	O
kg)	NOUN	O	O
volunteered	VERB	O	O
to	PART	O	O
participate	NOUN	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

Journal-Name:Marine	NOUN	O	O
drugs	NOUN	O	O

Some	DET	O	O
of	ADP	O	O
the	DET	O	O
earlier	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
reported	VERB	O	O
several,	ADJ	O	O
non-serious	ADJ	O	O
adverse	ADJ	O	O
events,	NOUN	O	O
mostly	ADV	O	O
related	VERB	O	O
to	PART	O	O
gastrointestinal	ADJ	O	O
tract,	NOUN	O	O
but	CCONJ	O	O
systematic	ADJ	O	O
sufficiently	ADV	O	O
powered	VERB	O	O
study	NOUN	O	O
on	ADP	O	O
safety	NOUN	O	O
is	VERB	O	O
lacking.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

INTRODUCTION:	NOUN	O	O
Noggin	NOUN	O	O
is	VERB	O	O
an	DET	O	O
antagonist	NOUN	O	O
of	ADP	O	O
bone	NOUN	O	O
morphogenetic	ADJ	O	O
proteins	NOUN	O	O
(BMPs)	PUNCT	O	O
and	CCONJ	O	O
has	VERB	O	O
a	DET	O	O
strong	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
osteogenesis.	NOUN	O	O

Furthermore,	NOUN	O	O
the	DET	O	O
24	NUM	O	O
elite	ADP	O	O
football	NOUN	O	O
players	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
a	DET	O	O
dark	ADJ	O	O
chocolate	NOUN	O	O
(>85%	NOUN	O	O
cocoa)	NOUN	O	O
intake	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
12)	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
12)	NOUN	O	O
for	ADP	O	O
30	NUM	O	O
days	NOUN	O	O
in	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
global	ADJ	O	O
health	NOUN	O	O

CONCLUSION:	NOUN	O	O
Oral	ADJ	O	O
supplementation	NOUN	O	O
with	ADP	O	O
3000	NUM	O	O
IU/day	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D3	NOUN	O	O
during	ADP	O	O
eight	NUM	O	O
weeks	NOUN	O	O
showed	VERB	O	O
to	PART	O	O
be	VERB	O	O
sufficient	ADJ	O	O
to	PART	O	O
prevent	NOUN	O	O
a	DET	O	O
decline	NOUN	O	O
in	ADP	O	O
hematological	ADJ	O	O
levels	NOUN	O	O
of	ADP	O	O
haemoglobin	NOUN	O	B-outcome
and	CCONJ	O	O
haematocrit	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
improve	VERB	O	O
transferrin	NOUN	O	B-outcome
of	ADP	O	O
25(OH)D	NUM	O	O
levels.	NOUN	O	O

The	DET	O	O
intercostal	ADJ	O	O
drainage	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
mean	NOUN	O	O
length	NOUN	O	B-outcome
of	ADP	O	I-outcome
hospital	NOUN	O	I-outcome
stay	NOUN	O	I-outcome
(p=0.527)	NOUN	O	O
and	CCONJ	O	O
drainage	NOUN	O	O
(p=0.547)	NOUN	O	O
of	ADP	O	O
4	NUM	O	O
days,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
and	CCONJ	O	O
5.5	NUM	O	O
days,	NOUN	O	O
respectively.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
performed	VERB	O	O
a	DET	O	O
phase	NOUN	O	O
3,	NOUN	O	O
prospective,	NOUN	O	O
double-blind,	NOUN	O	O
double-dummy,	NOUN	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
tafenoquine	NOUN	O	O
with	ADP	O	O
primaquine	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy.	NOUN	O	O

With	ADP	O	O
a	DET	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
of	ADP	O	O
31	NUM	O	O
months	NOUN	O	O
(IQR	NUM	O	O
27.3-35.7),	NOUN	O	O
we	PRON	O	O
observed	VERB	O	O
a	DET	O	O
28%	NUM	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
progression	NOUN	O	B-outcome
or	CCONJ	O	O
death	NOUN	O	B-outcome
with	ADP	O	O
ixazomib	NOUN	O	O
versus	CCONJ	O	O
placebo	NOUN	O	O
(median	PUNCT	O	O
PFS	NOUN	O	O
26.5	NUM	O	O
months	NOUN	O	O
[95%	NOUN	O	O
CI	NOUN	O	O
23.7-33.8	ADV	O	O
vs	CCONJ	O	O
21.3	NUM	O	O
months	NOUN	O	O
[18.0-24.7];	NOUN	O	O
hazard	NOUN	O	O
ratio	NOUN	O	O
0.72,	NUM	O	O
95%	NOUN	O	O
CI	NOUN	O	O
0.58-0.89;	NOUN	O	O
p=0.0023).	VERB	O	O

D-group	NOUN	O	O
received	VERB	O	O
a	DET	O	O
12-wk	NOUN	O	O
diet	NOUN	O	O
intervention	NOUN	O	O
within	ADP	O	O
primary	ADJ	O	O
health	NOUN	O	O
care	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
monthly	ADV	O	O
emails	NOUN	O	O
up	ADP	O	O
to	PART	O	O
the	DET	O	O
1-y	NOUN	O	O
follow-up.	PUNCT	O	O

intrauterine	ADJ	O	B-outcome
adhesions	NOUN	O	I-outcome
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
6	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
2,	NOUN	O	O
while	ADP	O	O
no	DET	O	O
intrauterine	ADJ	O	B-outcome
adhesions	NOUN	O	I-outcome
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
group	NOUN	O	O
1	NUM	O	O
(P	NUM	O	O
=	SYM	O	O
.007).	PUNCT	O	O

Title:	NOUN	O	O
[Effect	ADJ	O	O
of	ADP	O	O
Ronghuang	NOUN	O	O
Granule	NOUN	O	O
on	ADP	O	O
serum	NOUN	O	O
FGF23	NOUN	O	B-outcome
,	PUNCT	O	O
FGFRs	NOUN	O	B-outcome
and	CCONJ	O	O
Klotho	NOUN	O	B-outcome
in	ADP	O	O
non-dialysis	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
CKD-MBD	NOUN	O	O
and	CCONJ	O	O
kidney	NOUN	O	O
deficiency	NOUN	O	O
and	CCONJ	O	O
damp-heat	NOUN	O	O
syndrome].	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
randomized,	NOUN	O	O
double-blinded,	NOUN	O	O
placebo-controlled	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
on	ADP	O	O
60	NUM	O	O
subjects,	NOUN	O	O
aged	VERB	O	O
18-40	NUM	O	O
years	NOUN	O	O
old.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/21	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
success	NOUN	O	B-outcome
rates	NOUN	O	O
in	ADP	O	O
the	DET	O	O
tobramycin/dexamethasone	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
group	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
2	NUM	O	O
age	NOUN	O	O
subgroups	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
ointment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
NS	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
trigger	ADP	O	O
point	NOUN	O	O
dry	ADJ	O	O
needling	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
tension-type	NOUN	O	O
headache	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
and	CCONJ	O	O
safe	ADJ	O	O
in	ADP	O	O
reducing	VERB	O	O
headache	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
,	PUNCT	O	Seperator
frequency	NOUN	O	X
and	CCONJ	O	Seperator
duration	NOUN	O	S1-outcome
,	PUNCT	O	O
and	CCONJ	O	O
increasing	VERB	O	O
health-related	VERB	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
.	PUNCT	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
NCT03500861.	NOUN	O	O

It	PRON	O	O
can	VERB	O	O
improve	VERB	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
has	VERB	O	O
no	DET	O	O
adverse	ADJ	O	B-outcome
effect	NOUN	O	I-outcome
on	ADP	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
.	PUNCT	O	O

Under	ADP	O	O
PCV	NOUN	O	O
mode,	NOUN	O	O
with	ADP	O	O
the	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
oxygen	NOUN	O	O
atomization	NOUN	O	O
flow,	NOUN	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
was	VERB	O	O
decreased	VERB	O	O
gradually,	NOUN	O	O
and	CCONJ	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
was	VERB	O	O
increased	VERB	O	O
gradually,	NOUN	O	O
with	ADP	O	O
significant	ADJ	O	O
difference	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
those	DET	O	O
before	ADP	O	O
atomization	NOUN	O	O
when	ADP	O	O
the	DET	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
was	VERB	O	O
9	NUM	O	O
L/min	NOUN	O	O
[	PUNCT	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
(mL):	NOUN	O	O
322.78+/-17.75	NOUN	O	O
vs.	CCONJ	O	O
518.17+/-8.97,	NOUN	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
(mL):	NOUN	O	O
730.89+/-31.20	NOUN	O	O
vs.	CCONJ	O	O
519.00+/-9.06,	NOUN	O	O
both	CCONJ	O	O
P	NOUN	O	O
<	SYM	O	O
0.05].	NUM	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
change	NOUN	O	O
in	ADP	O	O
peak	NOUN	O	B-outcome
airway	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
at	ADP	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
that	ADP	O	O
before	ADP	O	O
atomization	NOUN	O	O
(cmH2O:	NOUN	O	O
21.44+/-2.23	PUNCT	O	O
vs.	CCONJ	O	O
21.39+/-2.55,	NUM	O	O
P	NOUN	O	O
>	SYM	O	O
0.05).	NOUN	O	O
(	PUNCT	O	O

Introduction:	NOUN	O	O
Acute	ADJ	O	O
pancreatitis	NOUN	O	O
(AP)	NOUN	O	O
is	VERB	O	O
an	DET	O	O
inflammatory	ADJ	O	O
disease	NOUN	O	O
of	ADP	O	O
the	DET	O	O
pancreas	NOUN	O	O
that	ADP	O	O
spans	NOUN	O	O
a	DET	O	O
wide	ADJ	O	O
range	NOUN	O	O
ranging	VERB	O	O
from	ADP	O	O
mild	ADJ	O	O
to	PART	O	O
critical	ADJ	O	O
forms.	NOUN	O	O

Title:	NOUN	O	O
[Effect	ADJ	O	O
of	ADP	O	O
Kangfuxin	NOUN	O	O
liquid	ADV	O	O
combined	VERB	O	O
with	ADP	O	O
Garlicin	NOUN	O	O
Capsules	NOUN	O	O
in	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
recurrent	ADP	O	O
oral	ADJ	O	O
ulcer	NOUN	O	O
and	CCONJ	O	O
on	ADP	O	O
immune	ADJ	O	B-outcome
regulation	NOUN	O	I-outcome
].	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
derived	VERB	O	O
data	NOUN	O	O
from	ADP	O	O
the	DET	O	O
imaging	VERB	O	O
subgroup	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Clopidogrel	NOUN	O	O
in	ADP	O	O
High-risk	NOUN	O	O
Patients	NOUN	O	O
with	ADP	O	O
Acute	ADJ	O	O
Nondisabling	VERB	O	O
Cerebrovascular	ADJ	O	O
Events	NOUN	O	O
(CHANCE)	PUNCT	O	O
trial.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
verify	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
brief	ADJ	O	O
group	NOUN	O	O
intervention,	ADP	O	O
performed	VERB	O	O
by	ADP	O	O
nurses,	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
the	DET	O	O
hazardous	ADJ	O	B-outcome
or	CCONJ	O	Seperator
harmful	ADJ	O	I-outcome
alcohol	NOUN	O	I-outcome
use	NOUN	O	I-outcome
in	ADP	O	O
users	NOUN	O	O
of	ADP	O	O
a	DET	O	O
primary	ADJ	O	O
health	NOUN	O	O
care	NOUN	O	O
service.	NOUN	O	O

kg(-1).h(-1)	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
C,	NOUN	O	O
and	CCONJ	O	O
sufentanil	NOUN	O	O
0.025	NUM	O	O
mug.kg(-1).h(-1)	NOUN	O	O
plus	CCONJ	O	O
dexmedetomidine	NOUN	O	O
0.1	NUM	O	O
mug.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
diet	NOUN	O	O
with	ADP	O	O
or	CCONJ	O	O
without	ADP	O	O
exercise	NOUN	O	O
on	ADP	O	O
abdominal	ADJ	O	O
fat	NOUN	O	O
</>	SYM	O	O
in	ADP	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
-	PUNCT	O	O
a	DET	O	O
randomised	VERB	O	O
trial.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
79	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
POCS	NOUN	O	O
and	CCONJ	O	O
35	NUM	O	O
healthy	ADJ	O	O
females	NOUN	O	O
were	VERB	O	O
included,	VERB	O	O
and	CCONJ	O	O
endometrial	ADJ	O	O
biopsies	NOUN	O	O
were	VERB	O	O
obtained.	NOUN	O	O

Title:	NOUN	O	O
Sorafenib	NOUN	O	O
for	ADP	O	O
Advanced	VERB	O	O
and	CCONJ	O	O
Refractory	ADJ	O	O
Desmoid	NOUN	O	O
Tumors.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9301647	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Statistical	ADJ	O	O
analysis	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
using	VERB	O	O
the	DET	O	O
Statistical	ADJ	O	O
Package	NOUN	O	O
for	ADP	O	O
the	DET	O	O
Social	ADJ	O	O
Sciences,	NOUN	O	O
version	NOUN	O	O
20.	NUM	O	O

The	DET	O	O
accumulation	NOUN	O	O
of	ADP	O	O
damaged	VERB	O	B-outcome
mtDNA	ADJ	O	I-outcome
and	CCONJ	O	O
fragmented	VERB	O	B-outcome
mitochondria	NOUN	O	I-outcome
resulted	VERB	O	O
in	ADP	O	O
increased	VERB	O	O
reactive	ADJ	O	B-outcome
oxygen	NOUN	O	I-outcome
species	NOUN	O	I-outcome
(ROS)	PUNCT	O	I-outcome
generation,	NOUN	O	O
activation	NOUN	O	O
of	ADP	O	O
apoptosis	NOUN	O	B-outcome
and	CCONJ	O	O
loss	NOUN	O	O
of	ADP	O	O
mitochondrial	ADJ	O	B-outcome
membrane	NOUN	O	I-outcome
potential	ADJ	O	I-outcome
(DeltaPsim)	NOUN	O	I-outcome
in	ADP	O	O
tubules	NOUN	O	O
and	CCONJ	O	O
PBMCs.	NOUN	O	O

This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
ClinicalTrials.gov,	NOUN	O	O
number	NOUN	O	O
NCT01786343.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Respiratory	ADJ	O	B-outcome
depression	NOUN	O	I-outcome
was	VERB	O	O
not	ADV	O	O
happened	NUM	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

Five	NUM	O	O
quasimonomorphic	ADJ	O	O
mononucleotide	NOUN	O	O
markers	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
tumor	NOUN	O	O
MSI	NOUN	O	O
status.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
72	NUM	O	O
children,	NOUN	O	O
ages	NOUN	O	O
4	NUM	O	O
to	PART	O	O
12	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
MA	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
a	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
a	DET	O	O
ratio	NOUN	O	O
of	ADP	O	O
1:1.	NUM	O	O

Title:	NOUN	O	O
The	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
pelvis	NOUN	O	O
reposition	NOUN	O	O
exercises	NOUN	O	O
on	ADP	O	O
pelvic	ADJ	O	B-outcome
floor	NOUN	O	I-outcome
muscles	NOUN	O	I-outcome
asymmetry	NOUN	O	I-outcome
:	PUNCT	O	O
A	DET	O	O
randomized	VERB	O	O
prospective	ADJ	O	O
study.	NOUN	O	O

This	DET	O	O
effect	NOUN	O	O
may	VERB	O	O
not	ADV	O	O
be	VERB	O	O
dose	NOUN	O	O
related	VERB	O	O
within	ADP	O	O
the	DET	O	O
studied	VERB	O	O
range.	ADJ	O	O

Title:	NOUN	O	O
Patient	NOUN	O	O
coping	VERB	O	O
and	CCONJ	O	O
expectations	NOUN	O	O
predict	VERB	O	O
recovery	NOUN	O	B-outcome
after	ADP	O	O
major	ADJ	O	O
orthopaedic	ADJ	O	O
trauma.	NOUN	O	O

The	DET	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
a	DET	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
TTP	NOUN	O	O
at	ADP	O	O
any	DET	O	O
time	NOUN	O	O
during	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
67%	ADJ	O	O
lower	ADJ	O	O
with	ADP	O	O
caplacizumab	NOUN	O	O
than	ADP	O	O
with	ADP	O	O
placebo	NOUN	O	O
(12%	NUM	O	O
vs.	CCONJ	O	O
38%,	NUM	O	O
P<0.001).	NUM	O	O

Therefore,	NOUN	O	O
continuous	ADJ	O	O
investigation	NOUN	O	O
of	ADP	O	O
effective	ADJ	O	O
interventions	NOUN	O	O
for	ADP	O	O
upper	ADJ	O	O
extremity	NOUN	O	O
functions	NOUN	O	O
after	ADP	O	O
stroke	NOUN	O	O
is	VERB	O	O
a	DET	O	O
necessity.	ADJ	O	O

The	DET	O	O
participants	NOUN	O	O
performed	VERB	O	O
a	DET	O	O
2000-m	NUM	O	O
test	NOUN	O	O
on	ADP	O	O
a	DET	O	O
rowing	VERB	O	O
ergometer	NOUN	O	O
at	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
(1st	NOUN	O	O
examination)	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
supplementation	NOUN	O	O
period	NOUN	O	O
(2nd	PUNCT	O	O
examination).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
aforementioned	VERB	O	O
results	NOUN	O	O
demonstrate	VERB	O	O
that	ADP	O	O
TKA	NOUN	O	O
is	VERB	O	O
an	DET	O	O
effective	ADJ	O	O
surgery,	NOUN	O	O
and	CCONJ	O	O
IV	NUM	O	O
plus	CCONJ	O	O
IA	NOUN	O	O
TXA	NOUN	O	O
injection	NOUN	O	O
functions	NOUN	O	O
more	ADV	O	O
effectively	ADV	O	O
in	ADP	O	O
reducing	VERB	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
and	CCONJ	O	O
fibrinolytic	ADJ	O	B-outcome
activity	NOUN	O	O
in	ADP	O	O
patients,	NOUN	O	O
which	ADP	O	O
is	VERB	O	O
a	DET	O	O
clinical	ADJ	O	O
factor	NOUN	O	O
of	ADP	O	O
occult	NOUN	O	O
hemorrhage.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
project	NOUN	O	O
manager	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
manager	NOUN	O	O
of	ADP	O	O
the	DET	O	O
home-care	NOUN	O	O
centre	NOUN	O	O
both	CCONJ	O	O
reflected	VERB	O	O
mainly	ADV	O	O
on	ADP	O	O
improvement	NOUN	O	O
of	ADP	O	O
the	DET	O	O
healthcare	NOUN	O	O
workers	NOUN	O	O
health.	NOUN	O	O

Endometriosis	NOUN	O	O
is	VERB	O	O
a	DET	O	O
classic	ADJ	O	O
indication	NOUN	O	O
for	ADP	O	O
IVF.	NUM	O	O

Group	NOUN	O	O
A	DET	O	O
(corneal	PUNCT	O	O
group)	ADJ	O	O
included	VERB	O	O
131	NUM	O	O
cases	NOUN	O	O
(135	ADV	O	O
eyes),	NOUN	O	O
receiving	VERB	O	O
the	DET	O	O
3	NUM	O	O
layers	NOUN	O	O
of	ADP	O	O
allogeneic	ADJ	O	O
cornea	NOUN	O	O
slices	NOUN	O	O
as	ADP	O	O
graft.	VERB	O	O

INCLUSION	NOUN	O	O
CRITERIA:	NOUN	O	O
Patients	NOUN	O	O
with	ADP	O	O
stable	ADJ	O	O
coronary	ADJ	O	O
artery	NOUN	O	O
disease	NOUN	O	O
or	CCONJ	O	O
recent	ADJ	O	O
acute	ADJ	O	O
coronary	ADJ	O	O
syndrome	NOUN	O	O
(	PUNCT	O	O
>1	NOUN	O	O
week	NOUN	O	O
from	ADP	O	O
the	DET	O	O
date	NOUN	O	O
of	ADP	O	O
STEMI),	NOUN	O	O
being	VERB	O	O
taken	VERB	O	O
up	ADP	O	O
for	ADP	O	O
elective	ADJ	O	O
angioplasty.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
gastroenterology	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT02257294.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7703942	NUM	O	O

All	DET	O	O
students	NOUN	O	O
managed	VERB	O	O
a	DET	O	O
simulated	VERB	O	O
cardiac	ADJ	O	O
arrest	NOUN	O	O
scenario	NOUN	O	O
with	ADP	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
AHA	NOUN	O	O
guidelines	NOUN	O	O
definition	NOUN	O	O
of	ADP	O	O
high-quality	NOUN	O	O
CPR	NOUN	O	O
(specifies	NOUN	O	O
metrics	NOUN	O	O
for	ADP	O	O
compression	NOUN	O	B-outcome
rate,	NOUN	O	X
depth	NOUN	O	I-outcome
,	PUNCT	O	O
recoil	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
compression	NOUN	O	B-outcome
fraction	NOUN	O	I-outcome
).	NOUN	O	O

The	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
atelectasis	NOUN	O	O
was	VERB	O	O
10%	ADP	O	O
for	ADP	O	O
the	DET	O	O
PAR-G	NOUN	O	O
and	CCONJ	O	O
30%	NOUN	O	O
for	ADP	O	O
the	DET	O	O
1PO-G	NUM	O	O
(p=0.0027).	NOUN	O	O

Topics	NOUN	O	O
of	ADP	O	O
discussion	NOUN	O	O
in	ADP	O	O
CHDRs	NOUN	O	O
focused	VERB	O	O
primarily	ADV	O	O
on	ADP	O	O
CHW	NOUN	O	O
functionality.	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
MIIT	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups,	NOUN	O	O
HIIT	NOUN	O	O
showed	VERB	O	O
improvements	NOUN	O	O
in	ADP	O	O
the	DET	O	O
SF-36	NOUN	O	O
domains:	NOUN	O	O
general	ADJ	O	B-outcome
health	NOUN	O	I-outcome
(p<.001	PUNCT	O	O
for	ADP	O	O
both)	NOUN	O	O
health	NOUN	O	B-outcome
changes	NOUN	O	O
(p<.001	PUNCT	O	O
for	ADP	O	O
both),	NOUN	O	O
vitality	NOUN	O	B-outcome
(p=.002	NUM	O	O
and	CCONJ	O	O
p=.001	NUM	O	O
respectively)	NOUN	O	O
and	CCONJ	O	O
physical	ADJ	O	B-outcome
functioning	VERB	O	I-outcome
(p=.036	PUNCT	O	O
and	CCONJ	O	O
p<.001	NOUN	O	O
respectively).	NOUN	O	O

METHODS:	NOUN	O	O
Forty-five	ADJ	O	O
adult,	NOUN	O	O
hypertensive	ADJ	O	O
patients	NOUN	O	O
taking	VERB	O	O
ACEi	NOUN	O	O
or	CCONJ	O	O
ARB	NOUN	O	O
and	CCONJ	O	O
scheduled	VERB	O	O
for	ADP	O	O
elective,	NOUN	O	O
noncardiac	ADJ	O	O
surgery	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Health	NOUN	O	O
education	NOUN	O	O
of	ADP	O	O
diabetic	ADJ	O	O
individuals	NOUN	O	O
via	ADP	O	O
Wechat	ADP	O	O
platform	NOUN	O	O
in	ADP	O	O
conjunction	NOUN	O	O
with	ADP	O	O
conventional	ADJ	O	O
diabetes	NOUN	O	O
treatment	NOUN	O	O
could	VERB	O	O
improve	VERB	O	O
glycemic	ADJ	O	B-outcome
control	NOUN	O	I-outcome
and	CCONJ	O	O
positively	ADV	O	O
influence	NOUN	O	O
other	ADJ	O	O
aspects	NOUN	O	O
of	ADP	O	O
diabetes	NOUN	O	O
self-care	NOUN	O	B-outcome
skills.	NOUN	O	O

These	DET	O	O
meetings	NOUN	O	O
were	VERB	O	O
held	NOUN	O	O
over	ADP	O	O
a	DET	O	O
period	NOUN	O	O
of	ADP	O	O
20	NUM	O	O
months	NOUN	O	O
from	ADP	O	O
July	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
March	NOUN	O	O
2017.	NUM	O	O

Therefore,	NOUN	O	O
the	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
use	NOUN	O	O
a	DET	O	O
combination	NOUN	O	O
of	ADP	O	O
methods	NOUN	O	O
to	PART	O	O
elicit	VERB	O	O
child	NOUN	O	O
and	CCONJ	O	O
teacher	NOUN	O	O
perceptions	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
acceptability	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
AS:Sk	NUM	O	O
intervention,	ADP	O	O
alongside	ADP	O	O
systematic	ADJ	O	O
researcher	ADP	O	O
observations.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/08	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
by	ADP	O	O
random	NOUN	O	O
allocation	NOUN	O	O
using	VERB	O	O
Ti-Ti	NOUN	O	O
rods	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
29)	NOUN	O	O
and	CCONJ	O	O
CrCo-Ti	NOUN	O	O
rods	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
alone	ADJ	O	O
difference	NOUN	O	O
among	ADP	O	O
them	PRON	O	O
in	ADP	O	O
the	DET	O	O
surgical	ADJ	O	O
procedure	NOUN	O	O
was	VERB	O	O
rod	NOUN	O	O
material	ADJ	O	O
(Ti-Ti	NOUN	O	O
or	CCONJ	O	O
CrCo-Ti	NOUN	O	O
rods)	ADJ	O	O
and	CCONJ	O	O
finally,	NOUN	O	O
radiological	ADJ	O	B-outcome
outcomes	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
preoperatively,	ADJ	O	O
postoperatively	ADV	O	O
and	CCONJ	O	O
at	ADP	O	O
last	NOUN	O	O
follow-up	NOUN	O	O
for	ADP	O	O
12	NUM	O	O
months.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/27	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
therapeutic	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
combined	VERB	O	O
treatment	NOUN	O	O
is	VERB	O	O
better	ADJ	O	O
than	ADP	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
alone	ADJ	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
PCOS.	NOUN	O	O

However,	ADV	O	O
data	NOUN	O	O
on	ADP	O	O
the	DET	O	O
optimal	ADJ	O	O
route	NOUN	O	O
of	ADP	O	O
administration	NOUN	O	O
are	VERB	O	O
not	ADV	O	O
consistent.	NOUN	O	O

Unchanged	VERB	O	B-outcome
rate,	NOUN	O	O
transfer	NOUN	O	B-outcome
rate	NOUN	O	O
of	ADP	O	O
patients,	NOUN	O	O
rate	NOUN	O	O
of	ADP	O	O
impaired	VERB	O	B-outcome
glucose	NOUN	O	I-outcome
tolerance	NOUN	O	I-outcome
,	PUNCT	O	O
turn	NOUN	O	B-outcome
normal	ADJ	O	I-outcome
rate	NOUN	O	O
and	CCONJ	O	O
other	ADJ	O	O
biochemical	ADJ	O	O
indicators	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
and	CCONJ	O	O
people	NOUN	O	O
with	ADP	O	O
impaired	VERB	O	O
glucose	NOUN	O	O
tolerance	NOUN	O	O
from	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
intervention	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
analyzed,	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
intervention	NOUN	O	O
effects	NOUN	O	O
of	ADP	O	O
peer	NOUN	O	O
support	NOUN	O	O
education	NOUN	O	O
mode.	VERB	O	O

The	DET	O	O
data	NOUN	O	O
were	VERB	O	O
collected	VERB	O	O
using	VERB	O	O
the	DET	O	O
revised	VERB	O	O
Illness	NOUN	O	B-outcome
Perception	NOUN	O	I-outcome
Questionnaire	PROPN	O	O
(IPQ-R)	NOUN	O	O
and	CCONJ	O	O
Depression	NOUN	O	B-outcome
Anxiety	NOUN	O	B-outcome
Stress	NOUN	O	B-outcome
Scales	NOUN	O	O
(DASS-21	NOUN	O	O
scores)	NOUN	O	O
which	ADP	O	O
were	VERB	O	O
completed	VERB	O	O
by	ADP	O	O
the	DET	O	O
participants.	NOUN	O	O

No	DET	O	O
changes	NOUN	O	O
were	VERB	O	O
detected	VERB	O	O
in	ADP	O	O
weight	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
"MyNutriCart"	NOUN	O	O
app	CCONJ	O	O
use	NOUN	O	O
led	VERB	O	O
to	PART	O	O
significant	ADJ	O	O
improvements	NOUN	O	O
in	ADP	O	O
food-related	VERB	O	B-outcome
behaviors	NOUN	O	I-outcome
compared	VERB	O	O
to	PART	O	O
baseline,	NOUN	O	O
with	ADP	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
Traditional	ADJ	O	O
group.	VERB	O	O

The	DET	O	O
mean	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
total	ADJ	O	B-outcome
cholesterol	NOUN	O	I-outcome
(TC)	NOUN	O	I-outcome
,	PUNCT	O	O
low	ADJ	O	B-outcome
density	NOUN	O	I-outcome
lipoprotein-cholesterol	NOUN	O	I-outcome
(LDL-C)	NOUN	O	I-outcome
and	CCONJ	O	O
non-high	ADJ	O	B-outcome
density	NOUN	O	I-outcome
lipoprotein-cholesterol	NOUN	O	I-outcome
(HDL-C)	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
DR	NOUN	O	O
group,	NOUN	O	O
whereas	ADP	O	O
mean	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
triglycerides	NOUN	O	B-outcome
(TG)	NOUN	O	I-outcome
and	CCONJ	O	O
increase	NOUN	O	O
in	ADP	O	O
non-high	ADJ	O	B-outcome
density	NOUN	O	I-outcome
lipoprotein-cholesterol	NOUN	O	I-outcome
(HDL-C)	NOUN	O	I-outcome
was	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
groups.	NOUN	O	O

The	DET	O	O
exercise	NOUN	O	O
protocol	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
performing	VERB	O	O
the	DET	O	O
bench	NOUN	O	O
press	NOUN	O	O
movement	NOUN	O	O
with	ADP	O	O
a	DET	O	O
load	NOUN	O	O
equal	ADJ	O	O
to	PART	O	O
70%1RM	NUM	O	O
with	ADP	O	O
maximal	ADJ	O	O
possible	ADJ	O	O
velocity	NOUN	O	O
(X/0/X/0).	NOUN	O	O

Total	ADJ	O	O
knee	NOUN	O	O
arthroplasty	NOUN	O	O
(TKA)	ADV	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
orthopedic	ADJ	O	O
surgery	NOUN	O	O
known	VERB	O	O
to	PART	O	O
be	VERB	O	O
very	ADV	O	O
painful.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
retrospectively	ADV	O	O
registered	VERB	O	O
on	ADP	O	O
20/12/2018	NUM	O	O
under	ADP	O	O
the	DET	O	O
number	NOUN	O	O
(	PUNCT	O	O
NCT03782051	NOUN	O	O
).	NOUN	O	O

Median	ADJ	O	O
24-hour	NOUN	O	O
morphine	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
was	VERB	O	O
20	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
0-148)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
PCM	NOUN	O	O
+	SYM	O	O
IBU	NOUN	O	O
group,	NOUN	O	O
36	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
0-166)	NUM	O	O
for	ADP	O	O
PCM	NOUN	O	O
alone,	NOUN	O	O
26	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
2-139)	NOUN	O	O
for	ADP	O	O
IBU	NOUN	O	O
alone,	NOUN	O	O
and	CCONJ	O	O
28	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
2-145)	NUM	O	O
for	ADP	O	O
HS-PCM	NOUN	O	O
+	SYM	O	O
IBU.	NOUN	O	O

Hagstrom,	NOUN	O	O
AD,	NOUN	O	O
Shorter,	NOUN	O	O
KA,	NOUN	O	O
and	CCONJ	O	O
Marshall,	NOUN	O	O
PWM.	NOUN	O	O

The	DET	O	O
task	NOUN	O	O
used	VERB	O	O
in	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
the	DET	O	O
Tube	NOUN	O	O
2	NUM	O	O
and	CCONJ	O	O
it	PRON	O	O
imitates	NOUN	O	O
a	DET	O	O
vesicourethral	ADJ	O	O
anastomosis	NOUN	O	O
in	ADP	O	O
robotic	ADJ	O	O
prostatectomy.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Training	VERB	O	O
on	ADP	O	O
wearing	VERB	O	O
an	DET	O	O
N95	NOUN	O	O
or	CCONJ	O	O
higher	ADJ	O	O
respirator	NOUN	O	O
improved	VERB	O	O
the	DET	O	O
protection	NOUN	O	B-outcome
performance	NOUN	O	O
of	ADP	O	O
respirators	NOUN	O	O
among	ADP	O	O
healthcare	NOUN	O	O
providers	NOUN	O	O
working	VERB	O	O
in	ADP	O	O
the	DET	O	O
EMC.	NOUN	O	O

The	DET	O	O
anti-HAV	NOUN	O	B-outcome
GMCs	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
Avaxim,	NOUN	O	O
Epaxal,	NOUN	O	O
and	CCONJ	O	O
Havrix	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
5868.4	NOUN	O	O
(95%	PUNCT	O	O
CI:	NOUN	O	O
4237.2-8126.6),	NOUN	O	O
1962.1	NOUN	O	O
(95%	PUNCT	O	O
CI:	NOUN	O	O
1298.0-2965.9),	NOUN	O	O
and	CCONJ	O	O
2232.9	NOUN	O	O
mIU/mL	NOUN	O	O
(95%	PUNCT	O	O
CI:	NOUN	O	O
1428.4-3490.4),	NOUN	O	O
respectively,	NOUN	O	O
after	ADP	O	O
administration	NOUN	O	O
of	ADP	O	O
2	NUM	O	O
doses	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.001).	PUNCT	O	O

After	ADP	O	O
simulation	NOUN	O	O
training,	NOUN	O	O
participants	NOUN	O	O
performed	VERB	O	O
cricothyroidotomy	NOUN	O	O
using	VERB	O	O
an	DET	O	O
ex	ADP	O	O
vivo	ADV	O	O
porcine	ADJ	O	O
larynx	ADJ	O	O
fitted	VERB	O	O
with	ADP	O	O
an	DET	O	O
endoscope	NOUN	O	O
to	PART	O	O
record	NOUN	O	O
the	DET	O	O
procedure.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101230586	NUM	O	O

Title:	NOUN	O	O
The	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
orlistat,	NOUN	O	O
metformin	NOUN	O	O
and	CCONJ	O	O
diet	NOUN	O	O
on	ADP	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
in	ADP	O	O
obeses	NOUN	O	O
women	NOUN	O	O
with	ADP	O	O
and	CCONJ	O	O
without	ADP	O	O
insulin	NOUN	O	O
resistance.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/28	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Following	VERB	O	O
the	DET	O	O
study,	NOUN	O	O
5	NUM	O	O
focus	NOUN	O	O
group	NOUN	O	O
discussions	NOUN	O	O
(FGDs)	PUNCT	O	O
were	VERB	O	O
conducted	VERB	O	O
consisting	VERB	O	O
of	ADP	O	O
6-8	NUM	O	O
purposively	ADV	O	O
sampled	VERB	O	O
participants	NOUN	O	O
from	ADP	O	O
intervention	NOUN	O	O
villages.	NUM	O	O

This	DET	O	O
study	NOUN	O	O
is	VERB	O	O
designed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
high-dose	NOUN	O	O
remifentanil	NOUN	O	O
on	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	B-outcome
sore	ADV	O	I-outcome
throat	NOUN	O	I-outcome
(POST)	NUM	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
after	ADP	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

The	DET	O	O
data	NOUN	O	O
sources	NOUN	O	O
were	VERB	O	O
pooled	VERB	O	O
to	PART	O	O
produce	VERB	O	O
the	DET	O	O
themes	NOUN	O	O
presented	VERB	O	O
in	ADP	O	O
the	DET	O	O
results	NOUN	O	O
section.	NOUN	O	O

RESULTS:	NOUN	O	O
Two	NUM	O	O
groups	NOUN	O	O
showed	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
baseline	NOUN	O	O
characteristics.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/23	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Peak	NOUN	O	O
FPPA	NOUN	O	O
was	VERB	O	O
determined	VERB	O	O
from	ADP	O	O
video	ADJ	O	O
recordings	NOUN	O	O
while	ADP	O	O
participants	NOUN	O	O
performed	VERB	O	O
5	NUM	O	O
single-leg	ADJ	O	O
squats.	NOUN	O	O

Little	ADJ	O	O
is	VERB	O	O
known	VERB	O	O
about	ADV	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
bracing	VERB	O	O
on	ADP	O	O
sensory	ADJ	O	O
function.	ADJ	O	O

Of	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
who	ADP	O	O
tested,	NOUN	O	O
64.5%	NUM	O	O
chose	NOUN	O	O
the	DET	O	O
self-test	NOUN	O	B-outcome
and	CCONJ	O	O
35.5%	NUM	O	O
chose	NOUN	O	O
the	DET	O	O
standard	ADJ	O	O
provider-administered	VERB	O	O
blood-based	VERB	O	O
HIV	NOUN	O	B-outcome
test	NOUN	O	I-outcome
.	PUNCT	O	O
Although	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
more	ADV	O	O
than	ADP	O	O
doubled	VERB	O	O
HIV	NOUN	O	B-outcome
testing	VERB	O	I-outcome
rates,	NOUN	O	O
because	ADP	O	O
HIV	NOUN	O	B-outcome
testing	VERB	O	I-outcome
rates	NOUN	O	O
were	VERB	O	O
so	ADV	O	O
low	ADJ	O	O
in	ADP	O	O
this	DET	O	O
population	NOUN	O	O
(by	NOUN	O	O
design	NOUN	O	O
as	ADP	O	O
we	PRON	O	O
selected	VERB	O	O
irregular	ADJ	O	O
testers),	NOUN	O	O
even	ADV	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
more	ADV	O	O
than	ADP	O	O
96%	ADJ	O	O
of	ADP	O	O
participants	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
test	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
Announcing	VERB	O	O
the	DET	O	O
availability	NOUN	O	O
of	ADP	O	O
HIV	NOUN	O	O
self-testing	VERB	O	O
via	ADP	O	O
text	VERB	O	O
message	NOUN	O	O
increased	VERB	O	O
HIV	NOUN	O	B-outcome
testing	VERB	O	I-outcome
rates	NOUN	O	O
among	ADP	O	O
truckers	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
not	ADV	O	O
regularly	ADV	O	O
accessing	VERB	O	O
HIV	NOUN	O	O
testing.	NOUN	O	O

T	NOUN	O	O
Self-rating	VERB	O	O
depression	NOUN	O	B-outcome
scale	NOUN	O	O
(SDS)	PUNCT	O	O
and	CCONJ	O	O
self-rating	VERB	O	O
anxiety	NOUN	O	B-outcome
scale	NOUN	O	O
SAS	NUM	O	O
scores	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rhodiola	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
increased	VERB	O	O
after	ADP	O	O
treatment	NOUN	O	O
P<0.05.	NOUN	O	O

RESULTS:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
in	ADP	O	O
patient	NOUN	O	O
characteristics,	ADJ	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
extubation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
and	CCONJ	O	O
recovery	NOUN	O	B-outcome
time	NOUN	O	I-outcome
.	PUNCT	O	O
Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
children	NOUN	O	O
in	ADP	O	O
control	NOUN	O	O
group,	NOUN	O	O
those	DET	O	O
in	ADP	O	O
DEX	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
more	ADV	O	O
sedated	VERB	O	B-outcome
when	ADP	O	O
they	PRON	O	O
were	VERB	O	O
separated	VERB	O	O
from	ADP	O	O
their	ADJ	O	O
parents	NOUN	O	O
(56.7%	PUNCT	O	O
vs.	CCONJ	O	O
26.7%,	NUM	O	O
P<0.05).	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
current	ADJ	O	O
article	NOUN	O	O
is	VERB	O	O
to	PART	O	O
present	ADJ	O	O
the	DET	O	O
protocol	NOUN	O	O
for	ADP	O	O
a	DET	O	O
PE	NOUN	O	O
teacher-delivered	VERB	O	O
theory-based	VERB	O	O
trial	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
secondary	ADJ	O	O
school	NOUN	O	O
students'	NOUN	O	O
participation	NOUN	O	B-outcome
in	ADP	O	O
physical	ADJ	O	O
activity	NOUN	O	O
out-of-school	NOUN	O	O
contexts.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0370522	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

The	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
control	NOUN	O	O
and	CCONJ	O	O
intervention.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
infectious	ADJ	O	O
diseases	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
RADPAD	NOUN	O	O
protection	NOUN	O	O
drape	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
radiation	NOUN	O	B-outcome
exposure	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
catheterization	NOUN	O	O
laboratory-First	NOUN	O	O
Indian	NOUN	O	O
study.	NOUN	O	O

Results:	NOUN	O	O
Among	ADP	O	O
11001	NUM	O	O
enrolled	VERB	O	O
patients	NOUN	O	O
(median	PUNCT	O	O
age,	NOUN	O	O
62	NUM	O	O
years;	NOUN	O	O
3459	NUM	O	O
[31%]	NUM	O	O
women),	NOUN	O	O
10102	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
discharged	VERB	O	O
with	ADP	O	O
prescriptions	NOUN	O	O
for	ADP	O	O
clopidogrel	NOUN	O	O
or	CCONJ	O	O
ticagrelor	ADV	O	O
(clopidogrel	NUM	O	O
prescribed	VERB	O	O
to	PART	O	O
2317	NUM	O	O
[36.0%]	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
2497	NUM	O	O
[54.7%]	NOUN	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group),	NOUN	O	O
4393	NUM	O	O
of	ADP	O	O
6135	NUM	O	O
patients	NOUN	O	O
(72%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
used	VERB	O	B-outcome
the	DET	O	Seperator
voucher	ADV	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
follow-up	NOUN	O	O
data	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
10802	NUM	O	O
patients	NOUN	O	O
(98.2%).	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101307187	NUM	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
change	NOUN	O	O
in	ADP	O	O
Coenzyme	NOUN	O	B-outcome
Q10	NOUN	O	I-outcome
(CoQ10)	PUNCT	O	I-outcome
level	NOUN	O	O
of	ADP	O	O
amla	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.2942)	NUM	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
groups	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.6744).	NUM	O	O

This	DET	O	O
study	NOUN	O	O
investigated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
yoga	NOUN	O	O
on	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
PMS	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
depression	NOUN	O	O
during	ADP	O	O
menstrual	ADJ	O	O
cycle.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
between-subjects	NOUN	O	O
web-based	VERB	O	O
experiment	NOUN	O	O
was	VERB	O	O
conducted,	VERB	O	O
consisting	VERB	O	O
of	ADP	O	O
four	NUM	O	O
sponsorship	NOUN	O	O
conditions	NOUN	O	O
(A	PUNCT	O	O
through	ADP	O	O
D)	NOUN	O	O
featuring	VERB	O	O
three	NUM	O	O
product	NOUN	O	O
categories	NOUN	O	O
within	ADP	O	O
each	DET	O	O
condition.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7903310	NUM	O	O

For	ADP	O	O
the	DET	O	O
first	ADV	O	O
3	NUM	O	O
groups,	NOUN	O	O
we	PRON	O	O
applied	VERB	O	O
tape	NOUN	O	O
to	PART	O	O
the	DET	O	O
shoulder	NOUN	O	O
and	CCONJ	O	O
scapular	ADJ	O	O
region.	NOUN	O	O

RESULTS:	NOUN	O	O
Supplementation	NOUN	O	O
with	ADP	O	O
L-theanine	NOUN	O	O
contributed	VERB	O	O
to	PART	O	O
a	DET	O	O
significant	ADJ	O	O
post-exercise	NOUN	O	O
decrease	NOUN	O	O
in	ADP	O	O
IL-10	NOUN	O	B-outcome
concentration,	NOUN	O	O
which	ADP	O	O
was	VERB	O	O
reflected	VERB	O	O
by	ADP	O	O
higher	ADJ	O	O
values	NOUN	O	O
of	ADP	O	O
IL-2	NOUN	O	B-outcome
to	PART	O	I-outcome
IL-10	NOUN	O	I-outcome
and	CCONJ	O	Seperator
IFN-gamma	NOUN	O	B-outcome
to	PART	O	I-outcome
IL-10	NOUN	O	I-outcome
ratios	NOUN	O	E1-outcome
.	PUNCT	O	O
Moreover,	NOUN	O	O
a	DET	O	O
significant	ADJ	O	O
post-recovery	NOUN	O	O
decrease	NOUN	O	O
in	ADP	O	O
cytotoxic	ADJ	O	B-outcome
lymphocyte	NOUN	O	I-outcome
(CTL)	PUNCT	O	I-outcome
count,	NOUN	O	O
T	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
lymphocyte	NOUN	O	I-outcome
(Treg)	NUM	O	I-outcome
to	PART	O	I-outcome
natural	ADJ	O	I-outcome
killer	NOUN	O	I-outcome
(NK)	ADV	O	I-outcome
and	CCONJ	O	Seperator
T	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
lymphocyte	NOUN	O	I-outcome
(Treg)	NUM	O	I-outcome
to	PART	O	I-outcome
cytotoxic	ADJ	O	I-outcome
lymphocyte	NOUN	O	I-outcome
(CTL)	PUNCT	O	I-outcome
ratios	NOUN	O	E1-outcome
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
supplemented	VERB	O	O
group.	VERB	O	O

RESULTS:	NOUN	O	O
All	DET	O	O
groups	NOUN	O	O
significantly	ADV	O	O
improved	VERB	O	O
handling	VERB	O	B-outcome
performance.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101238455	NUM	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
gender,	NOUN	O	O
age,	NOUN	O	O
body	NOUN	O	O
mass	NOUN	O	O
index,	NOUN	O	O
the	DET	O	O
type	NOUN	O	O
of	ADP	O	O
disease,	NOUN	O	O
complicating	VERB	O	O
diseases,	NOUN	O	O
and	CCONJ	O	O
American	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Anesthesiologists	NOUN	O	O
grading	VERB	O	O
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
P>0.05).	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

DESIGN:	NOUN	O	O
Randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Mean	NOUN	O	O
daily	ADJ	O	O
FEV1	NOUN	O	B-outcome
began	VERB	O	O
to	PART	O	O
decline	NOUN	O	O
from	ADP	O	O
approximately	ADV	O	O
2	NUM	O	O
weeks	NOUN	O	O
before	ADP	O	O
the	DET	O	O
onset	NOUN	O	O
of	ADP	O	O
symptoms	NOUN	O	O
of	ADP	O	O
an	DET	O	O
exacerbation,	NOUN	O	O
dropping	VERB	O	O
from	ADP	O	O
0.907	NUM	O	O
L	NOUN	O	O
(mean	NUM	O	O
Days	NOUN	O	O
-	PUNCT	O	O
56	NUM	O	O
to	PART	O	O
-	PUNCT	O	O
36	NUM	O	O
before	ADP	O	O
the	DET	O	O
exacerbation)	NOUN	O	O
to	PART	O	O
0.860	NUM	O	O
L	NOUN	O	O
on	ADP	O	O
the	DET	O	O
first	ADV	O	O
day	NOUN	O	O
of	ADP	O	O
the	DET	O	O
exacerbation.	ADJ	O	O

METHODS:	NOUN	O	O
Postprandial	ADJ	O	O
non-esterified	VERB	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
and	CCONJ	O	O
triglyceride	NOUN	O	B-outcome
responses	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
subjects	NOUN	O	O
with	ADP	O	O
T2DM	NOUN	O	O
by	ADP	O	O
comparing	VERB	O	O
a	DET	O	O
carbohydrate-reduced	VERB	O	O
high-protein	NOUN	O	O
(CRHP)	NOUN	O	O
diet	NOUN	O	O
with	ADP	O	O
a	DET	O	O
conventional	ADJ	O	O
diabetes	NOUN	O	O
(CD)	NOUN	O	O
diet	NOUN	O	O
in	ADP	O	O
an	DET	O	O
open-label,	ADV	O	O
randomized,	NOUN	O	O
cross-over	NOUN	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
MAIs,	ADP	O	O
lacunar	NOUN	O	O
infarction	NOUN	O	O
of	ADP	O	O
SAI	NOUN	O	O
had	VERB	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
[HR]	NOUN	O	O
0.41,	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI]	ADV	O	O
0.21-0.80,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.009),	NUM	O	O
but	CCONJ	O	O
not	ADV	O	O
in	ADP	O	O
non-lacunar	NOUN	O	O
infarction	NOUN	O	O
of	ADP	O	O
SAI	NOUN	O	O
(HR	NOUN	O	O
1.01,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
0.60-1.69,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.98).	NUM	O	O

Title:	NOUN	O	O
The	DET	O	O
acute	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
caffeine	NOUN	O	O
intake	NOUN	O	O
on	ADP	O	O
time	NOUN	O	B-outcome
under	ADP	O	Seperator
tension	NOUN	O	I-outcome
and	CCONJ	O	O
power	NOUN	O	B-outcome
generated	VERB	O	O
during	ADP	O	O
the	DET	O	O
bench	NOUN	O	O
press	NOUN	O	O
movement.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
support	NOUN	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
acceptability	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
exercise	NOUN	O	O
programmes	NOUN	O	O
and	CCONJ	O	O
trial	NOUN	O	O
procedures.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

As	ADP	O	O
well	ADV	O	O
as	ADP	O	O
receiving	VERB	O	O
usual	ADJ	O	O
care,	NOUN	O	O
women	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
strategy	NOUN	O	O
were	VERB	O	O
offered	VERB	O	O
two	NUM	O	O
routine	ADJ	O	O
biometry	NOUN	O	O
scans	NOUN	O	O
at	ADP	O	O
28-30	NUM	O	O
and	CCONJ	O	O
34-36	NUM	O	O
weeks'	ADP	O	O
gestation.	NOUN	O	O

To	PART	O	O
assess	NOUN	O	O
safety,	ADP	O	O
local	ADJ	O	B-outcome
solicited	VERB	O	I-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(AEs)	NOUN	O	I-outcome
,	PUNCT	O	O
systemic	ADJ	O	B-outcome
solicited	VERB	O	I-outcome
AEs	NOUN	O	I-outcome
,	PUNCT	O	O
unsolicited	VERB	O	B-outcome
AEs	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
serious	ADJ	O	B-outcome
AEs	NOUN	O	I-outcome
(SAEs)	NOUN	O	I-outcome
were	VERB	O	O
graded.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
6-year,	NUM	O	O
double-blind	ADJ	O	O
trial	NOUN	O	O
involving	VERB	O	O
2000	NUM	O	O
women	NOUN	O	O
with	ADP	O	O
osteopenia	NOUN	O	O
(defined	NUM	O	O
by	ADP	O	O
a	DET	O	O
T	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
-1.0	PUNCT	O	O
to	PART	O	O
-2.5	ADP	O	O
at	ADP	O	O
either	CCONJ	O	O
the	DET	O	O
total	ADJ	O	O
hip	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
femoral	ADJ	O	O
neck	NOUN	O	O
on	ADP	O	O
either	CCONJ	O	O
side)	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
65	NUM	O	O
years	NOUN	O	O
of	ADP	O	O
age	NOUN	O	O
or	CCONJ	O	O
older.	NOUN	O	O

Moreover,	NOUN	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
markers	NOUN	O	O
(	PUNCT	O	O
CK	NOUN	O	B-outcome
and	CCONJ	O	O
LDH	NOUN	O	B-outcome
,	PUNCT	O	O
p	NOUN	O	O
<	SYM	O	O
0.001)	NUM	O	O
was	VERB	O	O
observed.	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

BACKGROUND:	NOUN	O	O
Based	VERB	O	O
on	ADP	O	O
the	DET	O	O
encouraging	VERB	O	O
activity	NOUN	O	O
and	CCONJ	O	O
manageable	ADJ	O	O
safety	NOUN	O	O
profile	NOUN	O	O
observed	VERB	O	O
in	ADP	O	O
a	DET	O	O
phase	NOUN	O	O
1	NUM	O	O
study,	NOUN	O	O
the	DET	O	O
ECHELON-2	NOUN	O	O
trial	NOUN	O	O
was	VERB	O	O
initiated	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
brentuximab	NOUN	O	O
vedotin,	NOUN	O	O
cyclophosphamide,	NOUN	O	O
doxorubicin,	NOUN	O	O
and	CCONJ	O	O
prednisone	ADJ	O	O
(A+CHP)	NOUN	O	O
versus	CCONJ	O	O
cyclophosphamide,	NOUN	O	O
doxorubicin,	NOUN	O	O
vincristine,	NOUN	O	O
and	CCONJ	O	O
prednisone	ADJ	O	O
(CHOP)	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
CD30-positive	ADJ	O	O
peripheral	ADJ	O	O
T-cell	NOUN	O	O
lymphomas.	NOUN	O	O

The	DET	O	O
overall	ADJ	O	O
approach	NOUN	O	O
includes	NOUN	O	O
providing	VERB	O	O
universal	ADJ	O	O
access	NOUN	O	O
to	PART	O	O
diagnosis	NOUN	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
of	ADP	O	O
malaria,	NOUN	O	O
and	CCONJ	O	O
sustainable	ADJ	O	O
preventive	ADJ	O	O
measures,	NOUN	O	O
including	VERB	O	O
vector	NOUN	O	O
control.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/07	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Other	ADJ	O	O
outcomes	NOUN	O	O
include	VERB	O	O
gonadotrophin	NOUN	O	B-outcome
(Gn)	NUM	O	I-outcome
duration	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
total	ADJ	O	O
dose	NOUN	O	B-outcome
of	ADP	O	I-outcome
follicle-stimulating	VERB	O	I-outcome
hormone	NOUN	O	I-outcome
(FSH)	PUNCT	O	I-outcome
used,	NOUN	O	O
number	NOUN	O	O
of	ADP	O	O
oocytes	NOUN	O	B-outcome
retrieved	VERB	O	I-outcome
,	PUNCT	O	O
number	NOUN	O	O
of	ADP	O	O
embryos	NOUN	O	B-outcome
available	ADJ	O	I-outcome
for	ADP	O	Seperator
transfer	NOUN	O	I-outcome
,	PUNCT	O	O
implantation	NOUN	O	B-outcome
rate,	NOUN	O	O
the	DET	O	O
abortion	NOUN	O	B-outcome
rate,	NOUN	O	O
live	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
rate,	NOUN	O	O
and	CCONJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
moderate-to-severe	ADV	O	O
ovarian	ADJ	O	B-outcome
hyperstimulation	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
sample	NOUN	O	O
size	NOUN	O	O
of	ADP	O	O
this	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
estimated	VERB	O	O
to	PART	O	O
be	VERB	O	O
421	NUM	O	O
participants	NOUN	O	O
for	ADP	O	O
each	DET	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
arms.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/11	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
NCT02666872	NOUN	O	O
(Retrospectively	ADV	O	O
registered	VERB	O	O
as	ADP	O	O
January	NOUN	O	O
28,	NUM	O	O
2016).	NOUN	O	O

REGISTRATION:	NOUN	O	O
NCT02190630.	NOUN	O	O

The	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
SPOC	NOUN	O	O
scores	NOUN	O	O
to	PART	O	O
an	DET	O	O
adjusted	VERB	O	O
regression	NOUN	O	O
model	NOUN	O	O
to	PART	O	O
predict	VERB	O	O
pain	NOUN	O	B-outcome
interference	NOUN	O	I-outcome
improved	VERB	O	O
the	DET	O	O
concordance	NOUN	O	O
statistic	ADJ	O	O
from	ADP	O	O
0.66	NUM	O	O
to	PART	O	O
0.75,	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
greatest	ADV	O	O
risk	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
high	ADJ	O	O
SPOC	NOUN	O	O
scores	NOUN	O	O
(odds	NOUN	O	O
ratio:	NOUN	O	O
6.06;	NOUN	O	O
99%	ADV	O	O
CI:	NOUN	O	O
3.97-9.25;	NOUN	O	O
absolute	ADJ	O	O
risk	NOUN	O	O
increase:	NOUN	O	O
18.3%;	NOUN	O	O
95%	NOUN	O	O
CI:	NOUN	O	O
11.7%,	NUM	O	O
26.7%).	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101604552	NUM	O	O

According	ADJ	O	O
to	PART	O	O
several	ADJ	O	O
qualitative	ADJ	O	O
studies	NOUN	O	O
in	ADP	O	O
Africa,	NOUN	O	O
such	ADJ	O	O
pressures	NOUN	O	O
are	VERB	O	O
exacerbated	VERB	O	O
by	ADP	O	O
girls'	NOUN	O	O
lack	NOUN	O	O
of	ADP	O	O
knowledge	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
bodies,	NOUN	O	O
their	ADJ	O	O
rights,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
implications	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
decisions,	PUNCT	O	O
and	CCONJ	O	O
by	ADP	O	O
their	ADJ	O	O
inability	NOUN	O	O
to	PART	O	O
manage	NOUN	O	O
puberty	NOUN	O	O
and	CCONJ	O	O
adolescence	NOUN	O	O
safely	ADV	O	O
and	CCONJ	O	O
comfortably	ADV	O	O
with	ADP	O	O
appropriate	ADJ	O	O
menstrual	ADJ	O	O
health	NOUN	O	O
and	CCONJ	O	O
hygiene	NOUN	O	O
management	NOUN	O	O
(MHM)	NOUN	O	O
products.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
all-cause	NOUN	O	B-outcome
mortality	NOUN	O	I-outcome
at	ADP	O	O
28	NUM	O	O
days.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/26	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Title:	NOUN	O	O
Metabolizable	ADJ	O	O
Energy	NOUN	O	B-outcome
from	ADP	O	O
Cashew	NOUN	O	O
Nuts	NOUN	O	O
is	VERB	O	O
Less	ADV	O	O
than	ADP	O	O
that	ADP	O	O
Predicted	VERB	O	O
by	ADP	O	O
Atwater	ADV	O	O
Factors.	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
explore	ADP	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
music	ADJ	O	O
therapy/physical	ADJ	O	O
therapy	NOUN	O	O
co-treatment	NOUN	O	O
using	VERB	O	O
live	ADJ	O	O
music-supported	VERB	O	O
exercise	NOUN	O	O
on	ADP	O	O
pain	NOUN	O	B-outcome
and	CCONJ	O	O
exercise	NOUN	O	O
adherence	NOUN	O	B-outcome
during	ADP	O	O
a	DET	O	O
lower	ADJ	O	O
extremity	NOUN	O	O
pedaling	VERB	O	O
exercise	NOUN	O	O
to	PART	O	O
facilitate	VERB	O	O
range	NOUN	O	B-outcome
of	ADP	O	I-outcome
motion	NOUN	O	I-outcome
(ROM)	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
researcher	ADP	O	O
randomized	VERB	O	O
32	NUM	O	O
TKA	NOUN	O	O
inpatient	NOUN	O	O
rehabilitation	NOUN	O	O
participants	NOUN	O	O
to	PART	O	O
an	DET	O	O
intervention	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Conclusion:	NOUN	O	O
The	DET	O	O
combination	NOUN	O	O
of	ADP	O	O
parecoxib,	NOUN	O	O
TAP,	NOUN	O	O
and	CCONJ	O	O
PCIA	NOUN	O	O
pump	NOUN	O	O
could	VERB	O	O
significantly	ADV	O	O
reduce	VERB	O	O
patient	NOUN	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
and	CCONJ	O	O
enhance	NOUN	O	O
recovery	NOUN	O	B-outcome
.	PUNCT	O	O

The	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
6-month	NOUN	O	O
follow-up	NOUN	O	O
(	NOUN	O	O
DIAGNOdent	ADJ	O	O
pen	NOUN	O	O
values	NOUN	O	O
were	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
baseline	NOUN	O	O
values.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2984818R	ADV	O	O

Exacerbation	NOUN	O	O
onset	NOUN	O	O
was	VERB	O	O
the	DET	O	O
first	ADV	O	O
day	NOUN	O	O
of	ADP	O	O
a	DET	O	O
reported	VERB	O	O
symptom	NOUN	O	O
of	ADP	O	O
exacerbation.	ADJ	O	O

The	DET	O	O
baseline	NOUN	O	O
status	NOUN	O	O
of	ADP	O	O
knees	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
was	VERB	O	O
comparable	ADJ	O	O
at	ADP	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
study.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/08	ADP	O	O
00:00	NOUN	O	O
[revised]	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

We	PRON	O	O
used	VERB	O	O
descriptive	ADJ	O	O
analyses	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
the	DET	O	O
small	ADJ	O	O
sample	NOUN	O	O
size.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
linear	ADJ	O	O
association	NOUN	O	O
between	ADP	O	O
high,	ADP	O	O
moderate,	NOUN	O	O
and	CCONJ	O	O
low	ADJ	O	O
adherence,	ADV	O	O
and	CCONJ	O	O
a	DET	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
gestational	ADJ	O	B-outcome
diabetes	NOUN	O	I-outcome
mellitus	NOUN	O	I-outcome
(GDM)	NOUN	O	I-outcome
,	PUNCT	O	O
emergency	NOUN	O	B-outcome
C-section	NOUN	O	I-outcome
,	PUNCT	O	O
perineal	ADJ	O	B-outcome
trauma	NOUN	O	I-outcome
,	PUNCT	O	O
pregnancy-induced	VERB	O	B-outcome
hypertension	NOUN	O	I-outcome
and	CCONJ	O	O
preeclampsia	NOUN	O	B-outcome
,	PUNCT	O	O
prematurity	NOUN	O	B-outcome
,	PUNCT	O	O
large-for-gestational-age	NOUN	O	B-outcome
,	PUNCT	O	O
and/or	CCONJ	O	O
small-for-gestational-age	NOUN	O	B-outcome
,	PUNCT	O	O
urinary	ADJ	O	B-outcome
tract	NOUN	O	I-outcome
infections	NOUN	O	I-outcome
(UTI)	NUM	O	I-outcome
,	PUNCT	O	O
prematurity	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
small-for-gestational-age	NOUN	O	B-outcome
(SGA)	PUNCT	O	I-outcome
newborns	NOUN	O	O
(all	PUNCT	O	O
p	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Shanghai	NUM	O	O
kou	NOUN	O	O
qiang	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O
=	SYM	O	O
Shanghai	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
stomatology	ADV	O	O

In	ADP	O	O
conclusion,	NOUN	O	O
reductions	NOUN	O	O
in	ADP	O	O
snack	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
reduced	VERB	O	O
insulin	NOUN	O	B-outcome
resistance	NOUN	O	I-outcome
3(-)8	ADJ	O	O
years	NOUN	O	O
later,	ADV	O	O
but	CCONJ	O	O
adjustment	NOUN	O	O
for	ADP	O	O
current	ADJ	O	O
lifestyle	NOUN	O	B-outcome
reduced	VERB	O	O
these	DET	O	O
associations.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Hospitalized	VERB	O	O
patients	NOUN	O	O
who	ADP	O	O
are	VERB	O	O
colonized	VERB	O	O
with	ADP	O	O
methicillin-resistant	ADJ	O	O
Staphylococcus	NOUN	O	O
aureus	NOUN	O	O
(MRSA)	NOUN	O	O
are	VERB	O	O
at	ADP	O	O
high	ADJ	O	O
risk	NOUN	O	O
for	ADP	O	O
infection	NOUN	O	O
after	ADP	O	O
discharge.	ADJ	O	O

The	DET	O	O
arterial	ADJ	O	B-outcome
carbon	NOUN	O	I-outcome
dioxide	NOUN	O	I-outcome
partial	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
PaCO(2)	ADV	O	I-outcome
),	NUM	O	O
the	DET	O	O
time	NOUN	O	B-outcome
spent	VERB	O	I-outcome
in	ADP	O	Seperator
successful	ADJ	O	I-outcome
positioning	VERB	O	I-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
tube	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
endoscope	NOUN	O	B-outcome
indwelling	VERB	O	I-outcome
duration	NOUN	O	I-outcome
,	PUNCT	O	O
operative	ADJ	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
tube	NOUN	O	B-outcome
drawing	VERB	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
patients'	NOUN	O	O
awakening	VERB	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
satisfaction	NOUN	O	B-outcome
of	ADP	O	O
operators,	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
during	ADP	O	O
anesthesia,	NOUN	O	O
the	DET	O	O
numbers	NOUN	O	O
of	ADP	O	O
bucking	VERB	O	B-outcome
or	CCONJ	O	O
body	NOUN	O	B-outcome
moving	VERB	O	I-outcome
were	VERB	O	O
also	ADV	O	O
recorded.	NOUN	O	O

Title:	NOUN	O	O
Heart	NOUN	O	O
Rate	NOUN	O	O
Variability	NOUN	O	O
following	VERB	O	O
Combined	VERB	O	O
Aerobic	ADJ	O	O
and	CCONJ	O	O
Resistance	NOUN	O	O
Training	VERB	O	O
in	ADP	O	O
Sedentary	ADJ	O	O
Hypertensive	ADJ	O	O
Women:	NOUN	O	O
A	DET	O	O
Randomised	VERB	O	O
Control	NOUN	O	O
Trial.	NOUN	O	O

Patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Sham	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
an	DET	O	O
US-guided	VERB	O	O
bilateral	ADJ	O	O
OSTAP	NOUN	O	O
with	ADP	O	O
40	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
0.9%	NOUN	O	O
saline.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Repeated	VERB	O	O
doses	NOUN	O	O
of	ADP	O	O
Praziquantel	NOUN	O	O
in	ADP	O	O
Schistosomiasis	NOUN	O	O
Treatment	NOUN	O	O
(RePST)	NOUN	O	O
-	PUNCT	O	O
single	ADJ	O	O
versus	CCONJ	O	O
multiple	ADJ	O	O
praziquantel	NOUN	O	O
treatments	NOUN	O	O
in	ADP	O	O
school-aged	VERB	O	O
children	NOUN	O	O
in	ADP	O	O
Cote	NOUN	O	O
d'Ivoire:	PUNCT	O	O
a	DET	O	O
study	NOUN	O	O
protocol	NOUN	O	O
for	ADP	O	O
an	DET	O	O
open-label,	ADV	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Methods:	NOUN	O	O
Between	ADP	O	O
June	NOUN	O	O
2015	NUM	O	O
and	CCONJ	O	O
January	NOUN	O	O
2017,	NUM	O	O
53	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
high	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
vertebral	ADJ	O	O
"shell"	NOUN	O	O
after	ADP	O	O
thoracolumbar	ADV	O	O
fracture	NOUN	O	O
surgery	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
a	DET	O	O
prospective	ADJ	O	O
study	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
selection	NOUN	O	O
criteria.	NOUN	O	O

PMID:	NOUN	O	O
31623042	NUM	O	O

The	DET	O	O
tear	NUM	O	B-outcome
breakup	ADP	O	I-outcome
time	NOUN	O	I-outcome
(TBUT)	PUNCT	O	I-outcome
,	PUNCT	O	O
Schirmer	NOUN	O	O
test	NOUN	O	O
with	ADP	O	O
anesthesia,	NOUN	O	O
and	CCONJ	O	O
fluorescein	NOUN	O	B-outcome
staining	VERB	O	I-outcome
scores	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
preoperatively	ADV	O	O
and	CCONJ	O	O
postoperatively	ADV	O	O
on	ADP	O	O
days	NOUN	O	O
7,	NUM	O	O
14,	NUM	O	O
30	NUM	O	O
and	CCONJ	O	O
90.	NOUN	O	O

The	DET	O	O
drug	NOUN	O	B-outcome
cost	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
AG	NOUN	O	O
(4,413.60+/-1,772.35)	PUNCT	O	O
yen	ADV	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
CG	NOUN	O	O
(6,490.35+/-3,367.66)	PUNCT	O	O
yen	ADV	O	O
(P=0.01).	NUM	O	O

Title:	NOUN	O	O
Effects	NOUN	O	O
of	ADP	O	O
botulinum	NOUN	O	O
toxin	NOUN	O	O
type	NOUN	O	O
A	DET	O	O
on	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
dry	ADJ	O	O
eye	NOUN	O	O
disease	NOUN	O	O
and	CCONJ	O	O
tear	NUM	O	O
cytokines.	NUM	O	O

CONCLUSION:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
study	NOUN	O	O
comparing	VERB	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
CM	NOUN	O	O
and	CCONJ	O	O
CHO	NOUN	O	O
on	ADP	O	O
athletic	ADJ	O	O
outcomes	NOUN	O	O
in	ADP	O	O
an	DET	O	O
adolescent	NOUN	O	O
population	NOUN	O	O
in	ADP	O	O
a	DET	O	O
field-based	VERB	O	O
environment.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
ET	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
montelukast	NOUN	O	O
may	VERB	O	O
benefit	NUM	O	O
for	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
MA.	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9425194	NUM	O	O

RESULTS:	NOUN	O	O
With	ADP	O	O
a	DET	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
of	ADP	O	O
27.2	NUM	O	O
months,	NOUN	O	O
the	DET	O	O
2-year	NOUN	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
rate	NOUN	O	O
was	VERB	O	O
81%	NUM	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
69	NUM	O	O
to	PART	O	O
96)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sorafenib	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
36%	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
22	NUM	O	O
to	PART	O	O
57)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
for	ADP	O	O
progression	NOUN	O	B-outcome
or	CCONJ	O	O
death	NOUN	O	B-outcome
,	PUNCT	O	O
0.13;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.05	NUM	O	O
to	PART	O	O
0.31;	NOUN	O	O
P<0.001).	NUM	O	O

CONCLUSIONS:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
either	CCONJ	O	O
dental	ADJ	O	B-outcome
or	CCONJ	O	O
skeletal	ADJ	O	B-outcome
changes	NOUN	O	O
achieved	NOUN	O	O
with	ADP	O	O
PT	NOUN	O	O
or	CCONJ	O	O
FT	NOUN	O	O
wear	ADJ	O	O
of	ADP	O	O
a	DET	O	O
Twin-block	NOUN	O	O
appliance	NOUN	O	O
over	ADP	O	O
12	NUM	O	O
months.	NOUN	O	O

Los	NOUN	O	O
Angeles	NOUN	O	O
Biomedical	ADJ	O	O
Research	NOUN	O	O
Institute,	VERB	O	O
Los	NOUN	O	O
Angeles,	NOUN	O	O
CA	NOUN	O	O
dr.mckinnell@gmail.com.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
comparing	VERB	O	O
methohexital	ADJ	O	O
and	CCONJ	O	O
propofol	NOUN	O	O
for	ADP	O	O
induction	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
receiving	VERB	O	O
angiotensin	NOUN	O	O
axis	NOUN	O	O
blockade.	NOUN	O	O

Sterol	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
element-binding	VERB	O	I-outcome
protein-1	NOUN	O	I-outcome
expression	NOUN	O	I-outcome
was	VERB	O	O
inhibited	VERB	O	O
after	ADP	O	O
treatment,	NOUN	O	O
while	ADP	O	O
the	DET	O	O
inhibitory	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
combined	VERB	O	O
treatment	NOUN	O	O
were	VERB	O	O
stronger	ADJ	O	O
than	ADP	O	O
those	DET	O	O
of	ADP	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
alone.	NOUN	O	O

The	DET	O	O
main	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
the	DET	O	O
rate	NOUN	O	O
and	CCONJ	O	O
severity	NOUN	O	B-outcome
of	ADP	O	I-outcome
intrauterine	ADJ	O	B-outcome
adhesions	NOUN	O	E2-outcome
formation,	ADP	O	O
which	ADP	O	O
were	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
follow-up	NOUN	O	O
hysteroscopy	NOUN	O	O
performed	VERB	O	O
in	ADP	O	O
the	DET	O	O
ensuing	VERB	O	O
2-6	NUM	O	O
months.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
four	NUM	O	O
serious	ADJ	O	B-outcome
AEs	NOUN	O	I-outcome
(SAEs)	NOUN	O	I-outcome
reported	VERB	O	O
(two	NUM	O	O
each	DET	O	O
group)	ADJ	O	O
unrelated	VERB	O	O
to	PART	O	O
treatment.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Our	ADJ	O	O
results	NOUN	O	O
support	NOUN	O	O
the	DET	O	O
mechanisms	NOUN	O	O
occurring	VERB	O	O
with	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
of	ADP	O	O
the	DET	O	O
described	VERB	O	O
orthotic	ADJ	O	O
interventions.	NOUN	O	O

Cost-effectiveness	NOUN	O	O
ratios	NOUN	O	O
of	ADP	O	O
FZD	NOUN	O	O
and	CCONJ	O	O
CLA	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
0.75	NUM	O	O
and	CCONJ	O	O
1.02,	NOUN	O	O
and	CCONJ	O	O
incremental	ADJ	O	O
cost-effectiveness	NOUN	O	O
ratio	NOUN	O	O
of	ADP	O	O
FZD	NOUN	O	O
group	NOUN	O	O
over	ADP	O	O
CLA	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
-3.62.	NUM	O	O

28	NUM	O	O
received	VERB	O	O
decitabine	NOUN	O	O
for	ADP	O	O
5	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
43	NUM	O	O
for	ADP	O	O
10	NUM	O	O
days,	NOUN	O	O
and	CCONJ	O	O
all	DET	O	O
were	VERB	O	O
assessable	ADJ	O	O
for	ADP	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety.	ADJ	O	O

IQOS(TM)	NOUN	O	O
scored	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
subjective	ADJ	O	O
reward/satisfaction	NOUN	O	B-outcome
and	CCONJ	O	O
was	VERB	O	O
slightly	ADV	O	O
preferred	VERB	O	O
to	PART	O	O
the	DET	O	O
e-cigarette.	NOUN	O	O

Recently,	NOUN	O	O
we	PRON	O	O
revealed	VERB	O	O
that	ADP	O	O
beta-Eudesmol	NOUN	O	O
ingestion	NOUN	O	O
affected	VERB	O	O
autonomic	ADJ	O	O
nerve	NOUN	O	O
activity	NOUN	O	O
in	ADP	O	O
an	DET	O	O
animal	NOUN	O	O
model.	NOUN	O	O

Patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
IV	NUM	O	O
acetaminophen	ADV	O	O
had	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
delirium	NOUN	O	B-outcome
(10%	PUNCT	O	O
vs	CCONJ	O	O
28%	NUM	O	O
placebo;	ADV	O	O
difference,	NOUN	O	O
-18%	NOUN	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-32%	NOUN	O	O
to	PART	O	O
-5%];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.01;	PUNCT	O	O
HR,	NOUN	O	O
2.8	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
1.1-7.8]).	ADJ	O	O

Journal-Name:Medicine	NOUN	O	O

Owing	ADJ	O	O
to	PART	O	O
the	DET	O	O
multifactorial	ADJ	O	O
nature	NOUN	O	O
of	ADP	O	O
wound	NOUN	O	O
complications,	NOUN	O	O
it	PRON	O	O
is	VERB	O	O
yet	ADV	O	O
to	PART	O	O
be	VERB	O	O
determined	VERB	O	O
which	ADP	O	O
cohorts	NOUN	O	O
of	ADP	O	O
pancreatectomy	NOUN	O	O
patients	NOUN	O	O
will	VERB	O	O
benefit	NUM	O	O
from	ADP	O	O
NPWT.	ADV	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT02546765.	NOUN	O	O

This	DET	O	O
semi-experimental	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
using	VERB	O	O
a	DET	O	O
pretest-posttest	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Journal-Name:Medicine	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
expression	NOUN	O	O
level	NOUN	O	O
of	ADP	O	O
sterol	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
element-binding	VERB	O	I-outcome
protein-1	NOUN	O	I-outcome
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
PCOS	NOUN	O	O
patients	NOUN	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
healthy	ADJ	O	O
control.	NOUN	O	O

Retrospectively	ADV	O	O
registered	VERB	O	O
14th	NUM	O	O
October	ADJ	O	O
2016.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Progress	NOUN	O	O
in	ADP	O	O
community	NOUN	O	O
health	NOUN	O	O
partnerships	NOUN	O	O
:	PUNCT	O	O
research,	NOUN	O	O
education,	VERB	O	O
and	CCONJ	O	O
action	NOUN	O	O

To	PART	O	O
reach	NOUN	O	O
these	DET	O	O
goals,	NOUN	O	O
we	PRON	O	O
determined	VERB	O	O
that	ADP	O	O
we	PRON	O	O
needed	VERB	O	O
to	PART	O	O
recruit	NOUN	O	O
106	NUM	O	O
patients.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Truckers	NOUN	O	O
in	ADP	O	O
sub-Saharan	CCONJ	O	O
Africa	PROPN	O	O
are	VERB	O	O
at	ADP	O	O
higher	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
contracting	VERB	O	O
HIV	NOUN	O	O
than	ADP	O	O
the	DET	O	O
general	ADJ	O	O
population.	ADV	O	O

Title:	NOUN	O	O
A	DET	O	O
comparative	ADJ	O	O
study	NOUN	O	O
on	ADP	O	O
the	DET	O	O
prophylactic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
paracetamol	NOUN	O	O
and	CCONJ	O	O
dexmedetomidine	NOUN	O	O
for	ADP	O	O
controlling	VERB	O	O
hemodynamics	NOUN	O	B-outcome
during	ADP	O	O
surgery	NOUN	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
laparoscopic	ADJ	O	O
cholecystectomy.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
from	ADP	O	O
April	NOUN	O	O
to	PART	O	O
October	ADJ	O	O
2015	NUM	O	O
in	ADP	O	O
Tabriz,	ADJ	O	O
Iran.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Journal-Name:Oxidative	ADJ	O	O
medicine	NOUN	O	O
and	CCONJ	O	O
cellular	ADJ	O	O
longevity	NOUN	O	O

However,	ADV	O	O
this	DET	O	O
procedure	NOUN	O	O
is	VERB	O	O
inconvenient	ADJ	O	O
and	CCONJ	O	O
not	ADV	O	O
widely	ADV	O	O
adopted.	NOUN	O	O

Exercise	NOUN	O	O
can	VERB	O	O
produce	VERB	O	O
an	DET	O	O
imbalance	NOUN	O	O
between	ADP	O	O
ROS	NOUN	O	O
and	CCONJ	O	O
antioxidants,	NOUN	O	O
leading	VERB	O	O
to	PART	O	O
oxidative	ADJ	O	O
stress-related	VERB	O	O
tissue	NOUN	O	O
damages.	ADJ	O	O

Vaccine	NOUN	O	B-outcome
coverage	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
analyzed	VERB	O	O
using	VERB	O	O
Chi-squared	NOUN	O	O
distribution	NOUN	O	O
testing	VERB	O	O
and	CCONJ	O	O
logistic	ADJ	O	O
regression	NOUN	O	O
to	PART	O	O
identify	NOUN	O	O
determinant	NOUN	O	O
factors.	NOUN	O	O

Title:	NOUN	O	O
Suspension	NOUN	O	O
Training	VERB	O	O
HIIT	NOUN	O	O
Improves	NOUN	O	O
Gait	NOUN	O	B-outcome
Speed	NOUN	O	I-outcome
,	PUNCT	O	O
Strength	NOUN	O	B-outcome
and	CCONJ	O	O
Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
Life	NOUN	O	I-outcome
in	ADP	O	O
Older	ADJ	O	O
Adults.	NOUN	O	O

To	PART	O	O
address	NOUN	O	O
the	DET	O	O
growing	VERB	O	O
interest	NOUN	O	O
in	ADP	O	O
connecting	VERB	O	O
mental	ADJ	O	O
and	CCONJ	O	O
physical	ADJ	O	O
performance,	NOUN	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
examined	VERB	O	O
whether	ADP	O	O
the	DET	O	O
nootropic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
PSE	NOUN	O	O
translate	NOUN	O	O
into	ADP	O	O
changes	NOUN	O	O
in	ADP	O	O
reactive	ADJ	O	B-outcome
agility	NOUN	O	I-outcome
following	VERB	O	O
daily	ADJ	O	O
supplementation	NOUN	O	O
with	ADP	O	O
PSE.	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
VCV	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
PCV	NOUN	O	O
group	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
ventilation	NOUN	O	O
mode.	VERB	O	O

Interestingly,	NOUN	O	O
the	DET	O	O
increase	NOUN	O	O
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
term	NOUN	O	O
livebirth	ADJ	O	B-outcome
rate	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
significantly	ADV	O	O
between	ADP	O	O
PICSI	NOUN	O	O
(27.4%	NUM	O	O
[379/1381])	NOUN	O	O
and	CCONJ	O	O
ICSI	NOUN	O	O
(25.2%	PUNCT	O	O
[346/1371])	NUM	O	O
groups	NOUN	O	O
(odds	NOUN	O	O
ratio	NOUN	O	O
1.12,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
0.95-1.34;	NUM	O	O
p=0.18).	NOUN	O	O

Pretreatment	NOUN	O	O
and	CCONJ	O	O
day-of-debond	NOUN	O	O
digital	ADJ	O	O
photographic	ADJ	O	O
images	NOUN	O	O
were	VERB	O	O
taken	VERB	O	O
of	ADP	O	O
the	DET	O	O
teeth	NOUN	O	O
and	CCONJ	O	O
assessed	VERB	O	O
by	ADP	O	O
up	ADP	O	O
to	PART	O	O
5	NUM	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
3	NUM	O	O
lay	ADJ	O	O
assessors	NOUN	O	O
for	ADP	O	O
the	DET	O	O
presence	NOUN	O	O
or	CCONJ	O	O
absence	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
demineralized	VERB	O	B-outcome
lesions	NOUN	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
esthetic	ADJ	O	B-outcome
impact.	NOUN	O	O

The	DET	O	O
level	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
root	NOUN	O	I-outcome
canal	NOUN	O	I-outcome
filling	VERB	O	I-outcome
was	VERB	O	O
better	ADJ	O	O
in	ADP	O	O
the	DET	O	O
Calen(R)/ZO	NUM	O	O
group.	VERB	O	O

The	DET	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
time	NOUN	O	O
was	VERB	O	O
6.0	NUM	O	O
months	NOUN	O	O
(2.0-16.0	PUNCT	O	O
months).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
rate	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
years	NOUN	O	O
was	VERB	O	O
63.4%	NUM	O	O
in	ADP	O	O
the	DET	O	O
modified-FOLFIRINOX	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
48.6%	NUM	O	O
in	ADP	O	O
the	DET	O	O
gemcitabine	NOUN	O	O
group.	VERB	O	O

These	DET	O	O
findings	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
explained	VERB	O	O
by	ADP	O	O
a	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
indigestible	ADJ	O	O
carbohydrates	NOUN	O	O
available	ADJ	O	O
for	ADP	O	O
fermentation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
gut.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Among	ADP	O	O
2806	NUM	O	O
eligible	ADJ	O	O
children	NOUN	O	O
with	ADP	O	O
visiual	ADJ	O	O
impairment	NOUN	O	O
(visual	ADJ	O	O
acuity	NOUN	O	O
</=	NOUN	O	O
6/12	ADJ	O	O
in	ADP	O	O
either	CCONJ	O	O
eye),	NOUN	O	O
93	NUM	O	O
(3.31%)	PUNCT	O	O
were	VERB	O	O
lost	VERB	O	O
to	PART	O	O
follow-up,	ADP	O	O
leaving	VERB	O	O
2713	NUM	O	O
students	NOUN	O	O
(45.0%	NOUN	O	O
boys).	NUM	O	O

Hospitals	NOUN	O	O
randomized	VERB	O	O
to	PART	O	O
usual	ADJ	O	O
care	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
156	NUM	O	O
[4565	NOUN	O	O
patients])	NUM	O	O
did	VERB	O	O
not	ADV	O	O
provide	VERB	O	O
study	NOUN	O	O
vouchers.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

RESULTS:	NOUN	O	O
Eight	NUM	O	O
hundred	NUM	O	O
and	CCONJ	O	O
eighty-eight	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
WISDOM	NOUN	O	O
study	NOUN	O	O
had	VERB	O	O
a	DET	O	O
moderate/severe	ADV	O	O
exacerbation	NOUN	O	B-outcome
after	ADP	O	O
the	DET	O	O
complete	ADJ	O	O
ICS	NOUN	O	O
withdrawal	NOUN	O	O
visit;	NOUN	O	O
360	NUM	O	O
of	ADP	O	O
them	PRON	O	O
contributed	VERB	O	O
at	ADP	O	O
least	ADV	O	O
one	NUM	O	O
FEV1	NOUN	O	B-outcome
measure	NOUN	O	O
per	ADP	O	O
week	NOUN	O	O
for	ADP	O	O
the	DET	O	O
8	NUM	O	O
weeks	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
event	NOUN	O	O
and	CCONJ	O	O
are	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
analysis.	NOUN	O	O

The	DET	O	O
means	NOUN	O	O
and	CCONJ	O	O
CVs	NOUN	O	O
of	ADP	O	O
MEP	NOUN	O	B-outcome
amplitude	ADJ	O	I-outcome
in	ADP	O	O
all	DET	O	O
limbs	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
I.	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
train-of-four	ADV	O	B-outcome
(TOF)	ADV	O	I-outcome
counts	NOUN	O	I-outcome
from	ADP	O	O
30	NUM	O	O
to	PART	O	O
80	NUM	O	O
min	NOUN	O	O
of	ADP	O	O
operation	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
B.	NOUN	O	O
CONCLUSION:	NOUN	O	O
We	PRON	O	O
conclude	NOUN	O	O
that	ADP	O	O
the	DET	O	O
continuous	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
rocuronium	NOUN	O	O
effectively	ADV	O	O
inhibited	VERB	O	O
the	DET	O	O
involuntary	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
and	CCONJ	O	O
spontaneous	ADJ	O	B-outcome
respiration	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
patient	NOUN	O	O
while	ADP	O	O
enabling	VERB	O	O
MEP	NOUN	O	O
monitoring.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
WISDOM	NOUN	O	O
(ClinicalTrials.gov	ADV	O	O
number,	ADV	O	O
NCT00975195	NOUN	O	O
).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101627676	NUM	O	O

The	DET	O	O
Mediterranean	NOUN	O	O
diet	NOUN	O	O
(MD)	NOUN	O	O
is	VERB	O	O
recognized	VERB	O	O
as	ADP	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
healthiest	NOUN	O	O
dietary	ADJ	O	O
patterns	NOUN	O	O
and	CCONJ	O	O
has	VERB	O	O
benefits	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
improving	VERB	O	O
glycaemic	ADJ	O	O
control	NOUN	O	O
among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
(T2DM).	VERB	O	O

No	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
sclerotherapy	NOUN	O	O
and	CCONJ	O	O
cyanoacrylate	VERB	O	O
groups	NOUN	O	O
regarding	VERB	O	O
rebleeding	VERB	O	B-outcome
(26.79,	NUM	O	O
19.30%	NOUN	O	O
respectively,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.344),	NUM	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
hospital	NOUN	O	B-outcome
stay	NOUN	O	I-outcome
or	CCONJ	O	O
mortality	NOUN	O	B-outcome
rate	NOUN	O	O
were	VERB	O	O
observed.	NOUN	O	O

Navy	ADJ	O	O
bean	NOUN	O	O
consumption	NOUN	O	O
was	VERB	O	O
previously	ADV	O	O
shown	VERB	O	O
to	PART	O	O
modulate	NOUN	O	O
host	NOUN	O	O
and	CCONJ	O	O
microbiome	NOUN	O	O
metabolism,	VERB	O	O
and	CCONJ	O	O
this	DET	O	O
investigation	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
impact	NOUN	O	O
on	ADP	O	O
the	DET	O	O
human	NOUN	O	O
stool	NOUN	O	B-outcome
metabolome	NOUN	O	I-outcome
,	PUNCT	O	O
which	ADP	O	O
includes	NOUN	O	O
the	DET	O	O
presence	NOUN	O	O
of	ADP	O	O
navy	ADJ	O	B-outcome
bean	NOUN	O	I-outcome
metabolites	NOUN	O	I-outcome
.	PUNCT	O	O
This	DET	O	O
4-week,	NUM	O	O
randomized-controlled	VERB	O	O
trial	NOUN	O	O
with	ADP	O	O
overweight	NUM	O	O
and	CCONJ	O	O
obese	NOUN	O	O
CRC	NOUN	O	O
survivors	NOUN	O	O
involved	VERB	O	O
consumption	NOUN	O	O
of	ADP	O	O
1	NUM	O	O
meal	ADJ	O	O
and	CCONJ	O	O
1	NUM	O	O
snack	NOUN	O	O
daily.	NOUN	O	O

Muscular	ADJ	O	B-outcome
strength	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
limbs	NOUN	O	O
in	ADP	O	O
the	DET	O	O
RT	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.01).	NOUN	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
PICSI	NOUN	O	O
versus	CCONJ	O	O
standard	ADJ	O	O
ICSI	NOUN	O	O
for	ADP	O	O
improving	VERB	O	O
livebirth	ADJ	O	B-outcome
rates	NOUN	O	O
among	ADP	O	O
couples	NOUN	O	O
undergoing	VERB	O	O
fertility	NOUN	O	O
treatment.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

In	ADP	O	O
light	NOUN	O	O
of	ADP	O	O
this,	ADV	O	O
the	DET	O	O
present	ADJ	O	O
paper	NOUN	O	O
is	VERB	O	O
an	DET	O	O
attempt	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
positioning	VERB	O	O
on	ADP	O	O
gastric	ADJ	O	B-outcome
residual	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
in	ADP	O	O
premature	ADJ	O	O
infants	NOUN	O	O
in	ADP	O	O
NICU.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Perceived	VERB	O	O
ability	NOUN	O	B-outcome
to	PART	O	O
exercise	NOUN	O	B-outcome
(frequency,	NOUN	O	X
intensity	NOUN	O	I-outcome
and	CCONJ	O	Seperator
duration	NOUN	O	S1-outcome
)	PUNCT	O	O
in	ADP	O	O
relation	NOUN	O	O
to	PART	O	O
each	DET	O	O
dietary	ADJ	O	O
period	NOUN	O	O
was	VERB	O	O
also	ADV	O	O
rated	VERB	O	O
using	VERB	O	O
a	DET	O	O
visual	ADJ	O	O
analogue	NOUN	O	O
scale.	ADJ	O	O

Dietary	ADJ	O	O
fibre	NOUN	O	O
from	ADP	O	O
resistant	ADJ	O	O
starch	NOUN	O	O
(RS)	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
shown	VERB	O	O
to	PART	O	O
have	VERB	O	O
an	DET	O	O
impact	NOUN	O	O
on	ADP	O	O
food	NOUN	O	O
intake	NOUN	O	O
in	ADP	O	O
normal	ADJ	O	O
weight	NOUN	O	O
individuals,	ADJ	O	O
but	CCONJ	O	O
its	ADJ	O	O
role	NOUN	O	O
in	ADP	O	O
obesity	NOUN	O	O
is	VERB	O	O
unknown.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Process	NOUN	O	O
evaluations	NOUN	O	O
can	VERB	O	O
provide	VERB	O	O
information	NOUN	O	O
on	ADP	O	O
which	ADP	O	O
aspects	NOUN	O	O
of	ADP	O	O
an	DET	O	O
intervention	NOUN	O	O
were	VERB	O	O
delivered	VERB	O	O
and	CCONJ	O	O
how.	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
Evaluation	NOUN	O	O
of	ADP	O	O
Videoconference	NOUN	O	O
Meetings	NOUN	O	O
for	ADP	O	O
Medical	ADJ	O	O
Students'	NUM	O	O
Mid-clerkship	NOUN	O	O
Feedback	NOUN	O	O
Sessions.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/08/13	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
compare	NOUN	O	O
the	DET	O	O
hemostatic	ADJ	O	B-outcome
effect	NOUN	O	O
of	ADP	O	O
hematostatic	ADJ	O	O
agent	NOUN	O	O
Surgiflo	NOUN	O	O
and	CCONJ	O	O
absorbable	ADJ	O	O
gelatin	NOUN	O	O
sponge	NOUN	O	O
(AGS)	NOUN	O	O
in	ADP	O	O
posterior	ADJ	O	O
lumbar	ADJ	O	O
surgery.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9415084	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

1-year	NOUN	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
25%	NUM	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

Objectives	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
the	DET	O	O
acceptability	NOUN	O	B-outcome
and	CCONJ	O	O
feasibility	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
a	DET	O	O
robotic	ADJ	O	O
walking	VERB	O	O
aid	VERB	O	O
to	PART	O	O
support	NOUN	O	O
the	DET	O	O
work	NOUN	O	O
of	ADP	O	O
physiotherapists	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
fear	ADJ	O	B-outcome
of	ADP	O	I-outcome
falling	VERB	O	I-outcome
in	ADP	O	O
the	DET	O	O
rehabilitation	NOUN	O	O
of	ADP	O	O
elderly	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
'psychomotor	NOUN	O	O
disadaptation'	NOUN	O	O
(the	NOUN	O	O
most	DET	O	O
severe	ADJ	O	O
form	NOUN	O	O
of	ADP	O	O
post-fall	NOUN	O	O
syndrome).	NOUN	O	O

One-quarter	NOUN	O	O
were	VERB	O	O
African	ADV	O	O
American	ADJ	O	O
or	CCONJ	O	O
Black.	NOUN	O	O

Meanwhile,	NOUN	O	O
the	DET	O	O
correlation	NOUN	O	O
analysis	NOUN	O	O
and	CCONJ	O	O
multiple	ADJ	O	O
stepwise	ADV	O	O
regression	NOUN	O	O
analysis	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
analyze	NOUN	O	O
the	DET	O	O
association	NOUN	O	O
of	ADP	O	O
APN	NOUN	O	O
and	CCONJ	O	O
AdipoR1	VERB	O	O
with	ADP	O	O
clinical	ADJ	O	O
factors.	NOUN	O	O

RESULTS:	NOUN	O	O
Myocarditis	NOUN	O	B-outcome
,	PUNCT	O	O
encephalopathy	NOUN	O	B-outcome
,	PUNCT	O	O
cardiogenic	ADJ	O	B-outcome
shock	NOUN	O	I-outcome
,	PUNCT	O	O
ICU	NOUN	O	B-outcome
admission	NOUN	O	I-outcome
,	PUNCT	O	O
need	NOUN	O	B-outcome
for	ADP	O	Seperator
mechanical	ADJ	O	I-outcome
ventilation	NOUN	O	I-outcome
,	PUNCT	O	O
mean	NOUN	O	O
hospital	NOUN	O	B-outcome
stay	NOUN	O	I-outcome
and	CCONJ	O	O
mortality	NOUN	O	B-outcome
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
those	DET	O	O
received	VERB	O	O
intravenous	ADJ	O	O
antivenom	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
those	DET	O	O
received	VERB	O	O
intramuscular	ADJ	O	O
one.	PUNCT	O	O

Surgical	ADJ	O	O
site	NOUN	O	O
infection	NOUN	O	O
(SSI)	NOUN	O	O
and	CCONJ	O	O
incisional	ADJ	O	O
hernia	NOUN	O	O
are	VERB	O	O
common	ADJ	O	O
complications	NOUN	O	O
after	ADP	O	O
major	ADJ	O	O
pancreatectomy.	NOUN	O	O

Journal-Name:Lipids	NOUN	O	O
in	ADP	O	O
health	NOUN	O	O
and	CCONJ	O	O
disease	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
AG	NOUN	O	O
received	VERB	O	O
oscillating	VERB	O	O
positive	ADJ	O	O
expiratory	ADJ	O	O
pressure	NOUN	O	O
training	VERB	O	O
and	CCONJ	O	O
the	DET	O	O
CG	NOUN	O	O
underwent	VERB	O	O
standard	ADJ	O	O
perioperative	ADJ	O	O
treatment.	NOUN	O	O

The	DET	O	O
development	NOUN	O	O
of	ADP	O	O
complex	NOUN	O	O
communities,	NOUN	O	O
particularly	ADV	O	O
involving	VERB	O	O
Enterobacteriaceae	NOUN	O	O
and	CCONJ	O	O
strict	ADJ	O	O
anaerobes,	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
contributing	VERB	O	O
to	PART	O	O
poor	ADJ	O	O
outcomes	NOUN	O	O
in	ADP	O	O
DFUs	NOUN	O	O
and	CCONJ	O	O
requires	NOUN	O	O
further	ADV	O	O
investigation.	NOUN	O	O

Journal-Name:	NOUN	O	O
The	DET	O	O
journal	ADJ	O	O
of	ADP	O	O
contemporary	ADJ	O	O
dental	ADJ	O	O
practice	NOUN	O	O

However,	ADV	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
PICSI	NOUN	O	O
on	ADP	O	O
livebirth	ADJ	O	O
rates	NOUN	O	O
is	VERB	O	O
uncertain.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/17	NOUN	O	O
06:00'	NUM	O	O

In	ADP	O	O
this	DET	O	O
single-blind	NOUN	O	O
randomized	VERB	O	O
crossover	NOUN	O	O
study,	NOUN	O	O
overweight/obese	NOUN	O	O
healthy	ADJ	O	O
males	NOUN	O	O
consumed	VERB	O	O
a	DET	O	O
test	NOUN	O	O
breakfast	NOUN	O	O
and	CCONJ	O	O
lunch	NOUN	O	O
containing	VERB	O	O
either	CCONJ	O	O
48	NUM	O	O
g	NOUN	O	O
RS	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
placebo.	NOUN	O	O

One	NUM	O	O
eye	NOUN	O	O
needed	VERB	O	O
repair	NOUN	O	B-outcome
surgery	NOUN	O	I-outcome
.	PUNCT	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
statistical	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

AIM:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
curcumin	NOUN	O	O
gel	NOUN	O	O
as	ADP	O	O
local	ADJ	O	O
drug	NOUN	O	O
delivery	NOUN	O	O
post-scaling	VERB	O	O
and	CCONJ	O	O
root	NOUN	O	O
planing	VERB	O	O
and	CCONJ	O	O
its	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
clinical	ADJ	O	O
parameters	NOUN	O	O
like	ADP	O	O
plaque	NOUN	O	B-outcome
,	PUNCT	O	O
gingival	ADJ	O	B-outcome
scores,	NOUN	O	O
pocket	NOUN	O	B-outcome
depth	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
clinical	ADJ	O	B-outcome
attachment	NOUN	O	I-outcome
level	NOUN	O	I-outcome
(CAL)	NOUN	O	I-outcome
.	PUNCT	O	O
MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Ten	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
two	NUM	O	O
sites	NOUN	O	O
in	ADP	O	O
the	DET	O	O
contralateral	ADJ	O	O
quadrants	NOUN	O	O
having	VERB	O	O
probing	VERB	O	O
pocket	NOUN	O	O
depths	NOUN	O	O
(PPDs)	NOUN	O	O
of	ADP	O	O
>/=5	ADJ	O	O
mm	NOUN	O	O
were	VERB	O	O
selected.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9708388	NUM	O	O

OBJECTIVE:	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
menthol	NOUN	O	O
chewing	VERB	O	O
gum,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
relief	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intensity	NOUN	O	B-outcome
and	CCONJ	O	Seperator
discomfort	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	NOUN	O	X
surgical	ADJ	O	X
patient's	NOUN	O	X
thirst	ADV	O	E2-outcome
in	ADP	O	O
the	DET	O	O
preoperative	ADJ	O	O
period.	NOUN	O	O

Title:	NOUN	O	O
Examining	VERB	O	O
diabetic	ADJ	O	O
heel	NOUN	O	O
ulcers	NOUN	O	O
through	ADP	O	O
an	DET	O	O
ecological	ADJ	O	O
lens:	NOUN	O	O
microbial	ADJ	O	O
community	NOUN	O	O
dynamics	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
healing	VERB	O	O
and	CCONJ	O	O
infection.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
slight	NOUN	O	O
transient	ADJ	O	O
increases	NOUN	O	O
in	ADP	O	O
scaling	VERB	O	B-outcome
and	CCONJ	O	O
burning	VERB	O	B-outcome
over	ADP	O	O
the	DET	O	O
first	ADV	O	O
four	NUM	O	O
weeks.	NOUN	O	O

METHODS:	NOUN	O	O
ECHELON-2	NOUN	O	O
is	VERB	O	O
a	DET	O	O
double-blind,	NOUN	O	O
double-dummy,	NOUN	O	O
randomised,	NOUN	O	O
placebo-controlled,	NOUN	O	O
active-comparator	NOUN	O	O
phase	NOUN	O	O
3	NUM	O	O
study.	NOUN	O	O

Title:	NOUN	O	O
Grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
postoperative	ADJ	O	O
residual	ADJ	O	B-outcome
neuromuscular	ADJ	O	I-outcome
block	VERB	O	I-outcome
recovery	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9308586	NUM	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
retrospectively	ADV	O	O
registered	VERB	O	O
in	ADP	O	O
the	DET	O	O
Iranian	ADJ	O	O
website	ADV	O	O
(	PUNCT	O	O
www.irct.ir	NOUN	O	O
)	PUNCT	O	O
for	ADP	O	O
registration	NOUN	O	O
of	ADP	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
(	PUNCT	O	O
IRCT20170513033941N37	NOUN	O	O
).	NOUN	O	O

DISCUSSION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
will	VERB	O	O
provide	VERB	O	O
data	NOUN	O	O
on	ADP	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
repeated	VERB	O	O
PZQ	NOUN	O	O
treatment	NOUN	O	O
on	ADP	O	O
the	DET	O	O
clearance	NOUN	O	O
of	ADP	O	O
S.mansoni	NOUN	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
several	ADJ	O	O
diagnostic	ADJ	O	O
techniques.	NUM	O	O

RESULTS::	NOUN	O	O
There	PRON	O	O
is	VERB	O	O
good	ADJ	O	O
agreement	NOUN	O	O
when	ADP	O	O
comparing	VERB	O	O
radiographer	ADP	O	O
contours	NOUN	O	O
to	PART	O	O
the	DET	O	O
gold-standard	NOUN	O	O
for	ADP	O	O
all	DET	O	O
three	NUM	O	O
imaging	VERB	O	O
types	NOUN	O	O
with	ADP	O	O
Dice	NOUN	O	O
similarity	NOUN	O	O
co-efficient	NOUN	O	O
0.91-0.94,	NUM	O	O
Cohen's	NOUN	O	O
kappa	NOUN	O	O
0.85-0.91,	NUM	O	O
Hausdorff	NOUN	O	O
distance	NOUN	O	O
4.6-7.6	NUM	O	O
mm	NOUN	O	O
and	CCONJ	O	O
mean	NOUN	O	O
distance	NOUN	O	O
between	ADP	O	O
contours	NOUN	O	O
0.9-1.2	NUM	O	O
mm.	NOUN	O	O

The	DET	O	O
MMP-9	NOUN	O	B-outcome
conversion	NOUN	O	I-outcome
rate	NOUN	O	O
of	ADP	O	O
group	NOUN	O	O
A	DET	O	O
(76.92%)	PUNCT	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
of	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
(38.46%,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.005).	NUM	O	O

Results:	NOUN	O	O
Among	ADP	O	O
1458	NUM	O	O
enrolled	VERB	O	O
patients	NOUN	O	O
(mean	NUM	O	O
[SD]	PUNCT	O	O
age,	NOUN	O	O
58	NUM	O	O
[16]	PUNCT	O	O
years;	NOUN	O	O
599	NUM	O	O
women	NOUN	O	O
[41%]),	NOUN	O	O
1353	NUM	O	O
(93%)	PUNCT	O	O
completed	VERB	O	O
the	DET	O	O
study	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
final	ADJ	O	O
analysis.	NOUN	O	O

RESULTS:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
12-month	NOUN	O	O
follow-up	NOUN	O	O
showed	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
overall	ADJ	O	O
TF1-9	NOUN	O	B-outcome
prevalence	NOUN	O	O
by	ADP	O	O
balozi	NOUN	O	O
between	ADP	O	O
control	NOUN	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
arms.	ADJ	O	O

The	DET	O	O
associations	NOUN	O	O
between	ADP	O	O
any	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
continuous	ADJ	O	O
variables	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
tested	VERB	O	O
using	VERB	O	O
the	DET	O	O
t	NOUN	O	O
test	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
Mann-Whitney	NOUN	O	O
U	NOUN	O	O
test	NOUN	O	O
and	CCONJ	O	O
that	ADP	O	O
of	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
categorical	ADJ	O	O
variables	NOUN	O	O
with	ADP	O	O
chi-square	NOUN	O	O
or	CCONJ	O	O
Fishers	NOUN	O	O
exact	NOUN	O	O
test	NOUN	O	O
where	ADP	O	O
appropriate.	NOUN	O	O

DISCUSSION:	NOUN	O	O
Our	ADJ	O	O
study	NOUN	O	O
suggests	NOUN	O	O
a	DET	O	O
beneficial	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
oral	ADJ	O	O
glutamine	NOUN	O	O
supplementation	NOUN	O	O
for	ADP	O	O
the	DET	O	O
prevention	NOUN	O	O
from	ADP	O	O
radiation-induced	VERB	O	O
injury	NOUN	O	B-outcome
and	CCONJ	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
loss	NOUN	O	O
in	ADP	O	O
advanced	VERB	O	O
NSCLC	NOUN	O	O
patients	NOUN	O	O
who	ADP	O	O
receiving	VERB	O	O
CCRT.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
length	NOUN	O	B-outcome
of	ADP	O	I-outcome
hospital	NOUN	O	I-outcome
stay	NOUN	O	I-outcome
for	ADP	O	O
the	DET	O	O
intercostal	ADJ	O	O
drainage	NOUN	O	O
group	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intensive	ADJ	O	O
care	NOUN	O	O
unit	NOUN	O	O
was	VERB	O	O
1.5	NUM	O	O
day	NOUN	O	O
(1.0	PUNCT	O	O
to	PART	O	O
2.0	NUM	O	O
days)	NOUN	O	O
and	CCONJ	O	O
2.0	NUM	O	O
days	NOUN	O	O
(25.1	ADJ	O	O
to	PART	O	O
3.0	NUM	O	O
days)	NOUN	O	O
for	ADP	O	O
the	DET	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
group	NOUN	O	O
(p=0.060).	NUM	O	O

The	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
halted	VERB	O	O
after	ADP	O	O
an	DET	O	O
interim	ADJ	O	O
safety	NOUN	O	O
analysis	NOUN	O	O
(n=11)	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
excess	ADJ	O	O
grade	NOUN	O	O
3	NUM	O	O
neutropenia	NOUN	O	B-outcome
,	PUNCT	O	O
dose	NOUN	O	B-outcome
reductions	NOUN	O	I-outcome
and	CCONJ	O	O
treatment	NOUN	O	B-outcome
delays	NOUN	O	I-outcome
.	PUNCT	O	O
Grade	NOUN	O	O
3	NUM	O	O
or	CCONJ	O	O
4	NUM	O	O
neutropenia	NOUN	O	B-outcome
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
64%	NUM	O	O
of	ADP	O	O
patients.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

A	DET	O	O
high	ADJ	O	O
Gleason	PROPN	O	O
score	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
presence	NOUN	O	O
of	ADP	O	O
extracapsular	ADJ	O	O
extension	NOUN	O	O
in	ADP	O	O
the	DET	O	O
radical	NOUN	O	O
prostatectomy	NOUN	O	O
specimens	NOUN	O	O
were	VERB	O	O
highly	ADV	O	O
predictive	ADJ	O	O
of	ADP	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
prostate	NOUN	O	I-outcome
cancer	NOUN	O	I-outcome
.	PUNCT	O	O
(Funded	PUNCT	O	O
by	ADP	O	O
the	DET	O	O
Swedish	NOUN	O	O
Cancer	NOUN	O	O
Society	NOUN	O	O
and	CCONJ	O	O
others.).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8303003	NUM	O	O

In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
we	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
ixazomib	NOUN	O	O
as	ADP	O	O
maintenance	NOUN	O	O
therapy	NOUN	O	O
following	VERB	O	O
ASCT.	NOUN	O	O

One	NUM	O	O
patient	NOUN	O	O
in	ADP	O	O
the	DET	O	O
gemcitabine	NOUN	O	O
group	NOUN	O	O
died	VERB	O	B-outcome
from	ADP	O	O
toxic	ADJ	O	B-outcome
effects	NOUN	O	O
(	PUNCT	O	O
interstitial	ADJ	O	B-outcome
pneumonitis	NOUN	O	I-outcome
).	NOUN	O	O

Patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
D	NOUN	O	O
received	VERB	O	O
intravenous	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
dexmedetomidine(1	NOUN	O	O
mug/kg)	NOUN	O	O
20	NUM	O	O
min	NOUN	O	O
before	ADP	O	O
anesthesia	NOUN	O	O
induction,	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
intravenous	ADJ	O	O
pumping	VERB	O	O
of	ADP	O	O
dexmedetomidine(0.2	NOUN	O	O
mug.kg(-1).h(-1))	NOUN	O	O
intraoperatively.	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
for	ADP	O	O
the	DET	O	O
upper	ADJ	O	O
50th	ADJ	O	O
percentile	ADJ	O	O
group,	NOUN	O	O
the	DET	O	O
adjusted	VERB	O	O
mean	NOUN	O	O
post-supplementation	NOUN	O	O
baseline	NOUN	O	O
hydroxyproline	NOUN	O	B-outcome
(HYP)	NOUN	O	I-outcome
for	ADP	O	O
the	DET	O	O
high	ADJ	O	O
dose	NOUN	O	O
group	NOUN	O	O
(1.5	NOUN	O	O
+/-	SYM	O	O
0.3	NUM	O	O
mug.mL(-	NOUN	O	O
1))	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
than	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
low	ADJ	O	O
dose	NOUN	O	O
(2.4	NOUN	O	O
+/-	SYM	O	O
0.3	NUM	O	O
mug.mL(-	NOUN	O	O
1);	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.034)	NUM	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
(2.4	NOUN	O	O
+/-	SYM	O	O
0.3	NUM	O	O
mug.mL(-	NOUN	O	O
1),	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.024)	NOUN	O	O
groups.	NOUN	O	O

METHODS:	NOUN	O	O
Older	ADJ	O	O
breast	NOUN	O	O
cancer	NOUN	O	O
survivors	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups:	NOUN	O	O
combined	VERB	O	O
training:	NOUN	O	O
resistance	NOUN	O	O
+	SYM	O	O
aerobic	ADJ	O	O
exercise	NOUN	O	O
program	NOUN	O	O
for	ADP	O	O
nine	NUM	O	O
months	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
18)	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
18).	NUM	O	O

Cumulative	ADJ	O	O
opioid	NOUN	O	B-outcome
requirements	NOUN	O	I-outcome
after	ADP	O	O
48	NUM	O	O
hours	NOUN	O	O
were	VERB	O	O
similar	ADJ	O	O
between	ADP	O	O
the	DET	O	O
groups.	NOUN	O	O

Among	ADP	O	O
the	DET	O	O
440	NUM	O	O
patients	NOUN	O	O
randomized	VERB	O	O
(mean	NUM	O	O
age,	NOUN	O	O
60.5	NUM	O	O
years;	NOUN	O	O
15%	ADJ	O	O
women),	NOUN	O	O
the	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
achieved	NOUN	O	O
in	ADP	O	O
396	NUM	O	O
patients	NOUN	O	O
(90%),	NOUN	O	O
17	NUM	O	O
(3.9%)	NUM	O	O
withdrew,	ADJ	O	O
and	CCONJ	O	O
all	DET	O	O
others	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
to	PART	O	O
3	NUM	O	O
months.	NOUN	O	O

RESULTS:	NOUN	O	O
Truckers	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
more	ADV	O	O
likely	ADV	O	O
to	PART	O	O
test	NOUN	O	B-outcome
for	ADP	O	Seperator
HIV	NOUN	O	I-outcome
compared	VERB	O	O
to	PART	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
enhanced	VERB	O	O
SOC	NOUN	O	O
(OR	NOUN	O	O
=	SYM	O	O
2.7,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.009).	NUM	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

METHODS:	NOUN	O	O
APPAC	NOUN	O	O
II	NUM	O	O
trial	NOUN	O	O
is	VERB	O	O
a	DET	O	O
multicentre,	NOUN	O	O
open-label,	ADV	O	O
non-inferiority	NOUN	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
comparing	VERB	O	O
per	ADP	O	O
oral	ADJ	O	O
(p.o.)	NOUN	O	O

Adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
CT-scan	NOUN	O	O
diagnosed	VERB	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
nine	NUM	O	O
Finnish	NOUN	O	O
hospitals.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
hundred	NUM	O	O
of	ADP	O	O
healthy	ADJ	O	O
parturients	NOUN	O	O
undergoing	VERB	O	O
elective	ADJ	O	O
cesarean	NOUN	O	O
section	NOUN	O	O
under	ADP	O	O
combined	VERB	O	O
spinal-epidural	ADJ	O	O
anesthesia	NOUN	O	O
(CSEA)	PUNCT	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
this	DET	O	O
randomized,	NOUN	O	O
double-blinded,	NOUN	O	O
dose-ranging	VERB	O	O
study.	NOUN	O	O

J	NOUN	O	O
Strength	NOUN	O	O
Cond	ADP	O	O
Res	NOUN	O	O
33(1):	NOUN	O	O
225-233,	NUM	O	O
2019-Upper	NOUN	O	O
limb	NOUN	O	O
strength	NOUN	O	O
deficits	NOUN	O	O
are	VERB	O	O
frequently	ADV	O	O
observed	VERB	O	O
following	VERB	O	O
breast	NOUN	O	O
cancer	NOUN	O	O
(BC)	NOUN	O	O
and	CCONJ	O	O
its	ADJ	O	O
treatments.	NOUN	O	O

Title:	NOUN	O	O
IQOS(TM)	NOUN	O	O
vs.	CCONJ	O	O
e-Cigarette	NOUN	O	O
vs.	CCONJ	O	O
Tobacco	NOUN	O	O
Cigarette:	NOUN	O	O
A	DET	O	O
Direct	ADJ	O	O
Comparison	NOUN	O	O
of	ADP	O	O
Short-Term	NOUN	O	O
Effects	NOUN	O	O
after	ADP	O	O
Overnight-Abstinence.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0313225	NUM	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
80	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
neuro	VERB	O	O
intervention	NOUN	O	O
with	ADP	O	O
MEP	NOUN	O	O
monitoring	VERB	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

MPH-ER	NOUN	O	O
was	VERB	O	O
well	ADV	O	O
tolerated	VERB	O	B-outcome
.	PUNCT	O	O
Conclusion:	NOUN	O	O
Fluvoxamine	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
MPH-ER	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
refractory	ADJ	O	O
obsessive-compulsive	ADJ	O	O
disorder.	NOUN	O	O

Title:	NOUN	O	O
Study	NOUN	O	O
on	ADP	O	O
the	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
Polygala	NOUN	O	O
tenuifolia	NOUN	O	O
Willdenow	NOUN	O	O
root	NOUN	O	O
extract	NOUN	O	O
powder	NOUN	O	O
(BT-11)	NOUN	O	O
in	ADP	O	O
young	ADJ	O	O
person	NOUN	O	O
aged	VERB	O	O
from	ADP	O	O
9	NUM	O	O
to	PART	O	O
19	NUM	O	O
years	NOUN	O	O
old.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8610224	NUM	O	O

Grade	NOUN	O	O
3	NUM	O	O
systemic	ADJ	O	B-outcome
solicited	VERB	O	I-outcome
AE	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
5.4%	NOUN	O	O
and	CCONJ	O	O
2.9%	NOUN	O	O
of	ADP	O	O
the	DET	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Havrix	NOUN	O	O
group	NOUN	O	O
after	ADP	O	O
the	DET	O	O
1st	ADJ	O	O
and	CCONJ	O	O
2nd	ADJ	O	O
doses,	ADJ	O	O
respectively.	NOUN	O	O

After	ADP	O	O
eight	NUM	O	O
weeks,	NOUN	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
fat	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
,	PUNCT	O	O
wrist	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
,	PUNCT	O	O
thigh	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
,	PUNCT	O	O
calf	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
,	PUNCT	O	O
mid-arm	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
triceps	ADP	O	B-outcome
skinfolds	NOUN	O	I-outcome
decreased	VERB	O	O
significantly	ADV	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
groups.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
NCT01277302	NOUN	O	O
.	PUNCT	O	O

INTRODUCTION:	NOUN	O	O
Joint	NOUN	O	O
hypermobility	NOUN	O	O
is	VERB	O	O
common	ADJ	O	O
in	ADP	O	O
childhood	NOUN	O	O
and	CCONJ	O	O
can	VERB	O	O
be	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
musculoskeletal	ADJ	O	O
pain	NOUN	O	O
and	CCONJ	O	O
dysfunction.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8109496	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[pubmed]	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
patient	NOUN	O	O
involuntary	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
and	CCONJ	O	O
spontaneous	ADJ	O	B-outcome
respiration	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
mean	NOUN	O	O
MEP	NOUN	O	B-outcome
amplitude	ADJ	O	I-outcome
,	PUNCT	O	O
coefficient	NOUN	O	O
of	ADP	O	O
variation	NOUN	O	O
(CV),	NOUN	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
MEP	NOUN	O	B-outcome
stimulus	NOUN	O	I-outcome
change	NOUN	O	I-outcome
and	CCONJ	O	O
train-of-four	ADV	O	B-outcome
(TOF)	ADV	O	I-outcome
count	NOUN	O	I-outcome
were	VERB	O	O
compared.	NOUN	O	O

Moreover,	NOUN	O	O
the	DET	O	O
WSP-MR	NOUN	O	O
group	NOUN	O	O
demonstrated	VERB	O	O
a	DET	O	O
5%	NOUN	O	O
decrease	NOUN	O	O
in	ADP	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
fat	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
mid-arm	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
and	CCONJ	O	O
a	DET	O	O
3.5%	NOUN	O	O
decrease	NOUN	O	O
in	ADP	O	O
glycated	VERB	O	B-outcome
hemoglobin	NOUN	O	I-outcome
levels	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
psychopharmacology	NOUN	O	O

Thus,	NOUN	O	O
the	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
explore	ADP	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
the	DET	O	O
application	NOUN	O	O
of	ADP	O	O
OPEP	NOUN	O	O
device	NOUN	O	O
(acapella)	PUNCT	O	O
in	ADP	O	O
lung	NOUN	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
video-assisted	VERB	O	O
thorascopic	ADJ	O	O
surgery	NOUN	O	O
(VATS).	NOUN	O	O

The	DET	O	O
intention-to-treat	NOUN	O	O
analysis	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
definitive	ADJ	O	O
treatment	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
(oral	ADJ	O	O
group	NOUN	O	O
vs.	CCONJ	O	O
intravenous	ADJ	O	O
group)	ADJ	O	O
of	ADP	O	O
-1.4	NUM	O	O
percentage	NOUN	O	O
points	NOUN	O	O
(90%	PUNCT	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
-4.9	NUM	O	O
to	PART	O	O
2.2;	ADP	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-5.6	VERB	O	O
to	PART	O	O
2.9),	NUM	O	O
indicating	VERB	O	O
noninferiority.	ADJ	O	O

METHODS:	NOUN	O	O
Sixty-six	NUM	O	O
female	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
American	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Anesthesiologists	NOUN	O	O
I,	ADJ	O	O
II,	NOUN	O	O
or	CCONJ	O	O
III,	NOUN	O	O
aged	VERB	O	O
18	NUM	O	O
to	PART	O	O
65	NUM	O	O
years	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
scheduled	VERB	O	O
for	ADP	O	O
laparoscopic	ADJ	O	O
hysterectomy	NOUN	O	O
for	ADP	O	O
benign	ADJ	O	O
gynecologic	ADJ	O	O
pathologies	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
in	ADP	O	O
this	DET	O	O
randomized,	NOUN	O	O
controlled,	NOUN	O	O
observer-blinded	VERB	O	O
trial.	NOUN	O	O

All	DET	O	O
outcomes	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
2-week,	NUM	O	O
and	CCONJ	O	O
1-month	NOUN	O	O
follow-up	NOUN	O	O
period.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
Kinesio	NOUN	O	O
tape	NOUN	O	O
(KT)	NOUN	O	O
on	ADP	O	O
lower	ADJ	O	O
limb	NOUN	O	O
muscle	NOUN	O	B-outcome
activation	NOUN	O	I-outcome
pattern	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
developmental	ADJ	O	O
coordination	NOUN	O	O
disorder	ADP	O	O
(DCD)	NOUN	O	O
during	ADP	O	O
walking.	NOUN	O	O

The	DET	O	O
outcome	NOUN	O	O
assessor	NOUN	O	O
was	VERB	O	O
blinded;	NOUN	O	O
however,	ADV	O	O
it	PRON	O	O
was	VERB	O	O
not	ADV	O	O
feasible	ADJ	O	O
to	PART	O	O
blind	PUNCT	O	O
either	CCONJ	O	O
operator	NOUN	O	O
or	CCONJ	O	O
patients.	NOUN	O	O

Methods:	NOUN	O	O
By	ADP	O	O
theoretically	ADV	O	O
analyzing	VERB	O	O
the	DET	O	O
influential	ADJ	O	O
factors	NOUN	O	O
for	ADP	O	O
children's	NOUN	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
risk	NOUN	O	O
behaviors,	NOUN	O	O
children's	NOUN	O	O
cognitive	ADJ	O	O
development	NOUN	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
social	ADJ	O	O
learning	VERB	O	O
theory,	ADJ	O	O
an	DET	O	O
intervention	NOUN	O	O
protocol	NOUN	O	O
was	VERB	O	O
established	VERB	O	O
on	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
changing	VERB	O	O
the	DET	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
attribution	NOUN	O	O
and	CCONJ	O	O
negative	ADJ	O	O
information	NOUN	O	O
transmission	NOUN	O	O
of	ADP	O	O
risk	NOUN	O	O
behavior	NOUN	O	O
consequences.	NOUN	O	O

Primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
comparison	NOUN	O	O
of	ADP	O	O
mean	NOUN	O	O
change	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
hydroxymethylglutaryl-CoA	NOUN	O	B-outcome
reductase	NOUN	O	I-outcome
enzyme	NOUN	O	I-outcome
(HMGCR)	PUNCT	O	I-outcome
levels	NOUN	O	O
and	CCONJ	O	O
lipid	NOUN	O	O
indices	NOUN	O	O
of	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
and	CCONJ	O	O
their	ADJ	O	O
correlation	NOUN	O	O
with	ADP	O	O
each	DET	O	O
other.	NOUN	O	O

Serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
124	NUM	O	O
patients	NOUN	O	O
(20.2%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
guided	VERB	O	O
and	CCONJ	O	O
130	NUM	O	O
(21.0%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
.	PUNCT	O	O
Secondary	ADJ	O	O
end	NOUN	O	O
points	NOUN	O	O
included	VERB	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
and	CCONJ	O	O
safety.	ADJ	O	O

Results:	NOUN	O	O
After	ADP	O	O
intervention,	ADP	O	O
the	DET	O	O
observation	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
forced	VERB	O	B-outcome
expiratory	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
in	ADP	O	Seperator
1	NUM	O	I-outcome
second	ADJ	O	I-outcome
(FEV(1)	PUNCT	O	I-outcome
),	NUM	O	O
forced	VERB	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(FVC)	PUNCT	O	I-outcome
,	PUNCT	O	O
arterial	ADJ	O	B-outcome
partial	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
of	ADP	O	I-outcome
oxygen	NOUN	O	I-outcome
(PaO(2)	PUNCT	O	I-outcome
)	PUNCT	O	O
,	PUNCT	O	O
and	CCONJ	O	O
six-minute	NOUN	O	O
walk	NOUN	O	B-outcome
distance	NOUN	O	I-outcome
than	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P<0.05)	NOUN	O	O
,	PUNCT	O	O
while	ADP	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
in	ADP	O	O
FEV(1)/FVC	NOUN	O	B-outcome
and	CCONJ	O	O
partial	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
of	ADP	O	I-outcome
carbon	NOUN	O	I-outcome
dioxide	NOUN	O	I-outcome
(P>0.05)	PUNCT	O	O
.	PUNCT	O	O

One	NUM	O	O
patient	NOUN	O	O
(4%)	NUM	O	O
died	VERB	O	B-outcome
from	ADP	O	O
sepsis	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
context	NOUN	O	O
of	ADP	O	O
neutropenic	ADJ	O	B-outcome
fever	NOUN	O	I-outcome
,	PUNCT	O	O
infection	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
haemorrhage	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
5-day	NOUN	O	O
group,	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
10-day	NOUN	O	O
group	NOUN	O	O
six	NUM	O	O
patients	NOUN	O	O
(14%)	PUNCT	O	O
died	VERB	O	B-outcome
from	ADP	O	O
infection	NOUN	O	B-outcome
.	PUNCT	O	O
Early	ADJ	O	O
mortality	NOUN	O	B-outcome
was	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Journal-Name:The	ADJ	O	O
bone	NOUN	O	O
&	CCONJ	O	O
joint	NOUN	O	O
journal	ADJ	O	O

At	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
follow-up,	ADP	O	O
patients	NOUN	O	O
showed	VERB	O	O
normal	ADJ	O	O
levels	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D,	ADJ	O	O
with	ADP	O	O
increased	VERB	O	O
calcium	NOUN	O	B-outcome
levels	NOUN	O	I-outcome
and	CCONJ	O	O
decreased	VERB	O	O
bone	NOUN	O	B-outcome
turnover	ADV	O	I-outcome
.	PUNCT	O	O
Waist	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
also	ADV	O	O
decreased.	NOUN	O	O

The	DET	O	O
intended	VERB	O	O
sample	NOUN	O	O
size	NOUN	O	O
is	VERB	O	O
552	NUM	O	O
patients.	NOUN	O	O

Late-onset	NOUN	O	O
sepsis	NOUN	O	B-outcome
occurred	VERB	O	O
in	ADP	O	O
414	NUM	O	O
of	ADP	O	O
1389	NUM	O	O
infants	NOUN	O	O
(29.8%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
faster-increment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
434	NUM	O	O
of	ADP	O	O
1397	NUM	O	O
(31.1%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
slower-increment	ADJ	O	O
group	NOUN	O	O
(adjusted	PUNCT	O	O
risk	NOUN	O	O
ratio,	NOUN	O	O
0.96;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.86	NUM	O	O
to	PART	O	O
1.07).	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
all	DET	O	O
showed	VERB	O	O
elevated	VERB	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
23	NUM	O	I-outcome
(FGF23)	NOUN	O	I-outcome
,	PUNCT	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
receptor	NOUN	O	I-outcome
(FGFRs)	NOUN	O	I-outcome
and	CCONJ	O	O
Klotho	NOUN	O	B-outcome
protein	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
normal	ADJ	O	O
subjects	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.01);	NUM	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
23	NUM	O	I-outcome
(FGF23)	NOUN	O	I-outcome
,	PUNCT	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
receptor	NOUN	O	I-outcome
(FGFRs)	NOUN	O	I-outcome
and	CCONJ	O	O
Klotho	NOUN	O	B-outcome
levels	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
reduced	VERB	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.05)	NUM	O	O
but	CCONJ	O	O
remained	VERB	O	O
unchanged	VERB	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P&gt;0.05),	NOUN	O	O
showing	VERB	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/12	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
D-group	NOUN	O	O
increased	VERB	O	O
their	ADJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
more	ADV	O	O
than	ADP	O	O
the	DET	O	O
C-group	NOUN	O	O
at	ADP	O	O
12	NUM	O	O
wk.	DET	O	O

Reports	NOUN	O	O
of	ADP	O	O
CHW	NOUN	O	O
household	NOUN	O	O
contact	NOUN	O	O
and	CCONJ	O	O
assessments	NOUN	O	O
of	ADP	O	O
CHW	NOUN	O	O
quality	NOUN	O	O
were	VERB	O	O
obtained	VERB	O	O
in	ADP	O	O
the	DET	O	O
endline	NOUN	O	O
KPC	NOUN	O	O
household	NOUN	O	O
survey,	ADJ	O	O
and	CCONJ	O	O
household	NOUN	O	O
contacts	NOUN	O	O
measured	VERB	O	O
in	ADP	O	O
monthly	ADV	O	O
submitted	VERB	O	O
reports	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
tabulated.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
sought	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
a	DET	O	O
lower	ADJ	O	O
loading	VERB	O	O
dose	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
with	ADP	O	O
conventional	ADJ	O	O
loading	VERB	O	O
dose	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
in	ADP	O	O
Indian	NOUN	O	O
patients.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
2	NUM	O	O
weeks	NOUN	O	O
and	CCONJ	O	O
4	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
treatment,	NOUN	O	O
including	VERB	O	O
the	DET	O	O
modified	VERB	O	O
Ashworth	NOUN	O	O
Scale	NOUN	O	O
(MAS)	NOUN	O	O
score,	NOUN	O	O
Gross	NOUN	O	B-outcome
Motor	NOUN	O	I-outcome
Function	NOUN	O	I-outcome
Measure	NOUN	O	O
(GMFM)	NOUN	O	O
score,	NOUN	O	O
plantar	NOUN	O	B-outcome
area	NOUN	O	I-outcome
and	CCONJ	O	O
plantar	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

A	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
research	NOUN	O	O
is	VERB	O	O
a	DET	O	O
prospective	ADJ	O	O
comparative	ADJ	O	O
randomized	VERB	O	O
study.	NOUN	O	O

Within	ADP	O	O
30	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
surgery,	NOUN	O	O
4	NUM	O	O
patients	NOUN	O	O
(0.65%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
guided	VERB	O	O
group	NOUN	O	O
and	CCONJ	O	O
19	NUM	O	O
(3.07%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group	NOUN	O	O
died.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8610224	NUM	O	O

Title:	NOUN	O	O
Application	NOUN	O	O
of	ADP	O	O
intrapulmonary	ADJ	O	O
wire	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
intrapleural	ADJ	O	O
fibrin	NOUN	O	O
glue	ADJ	O	O
in	ADP	O	O
preoperative	ADJ	O	O
localization	NOUN	O	O
of	ADP	O	O
small	ADJ	O	O
pulmonary	ADJ	O	O
nodules.	NOUN	O	O

Title:	NOUN	O	O
[Surgical	ADJ	O	O
treatment	NOUN	O	O
strategy	NOUN	O	O
for	ADP	O	O
the	DET	O	O
"shell"	NOUN	O	O
phenomenon	NOUN	O	O
after	ADP	O	O
thoracolumbar	ADV	O	O
fracture].	NOUN	O	O

In	ADP	O	O
2	NUM	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trials	NOUN	O	O
(RCTs)	PUNCT	O	O
of	ADP	O	O
stressed	VERB	O	O
community	NOUN	O	O
adults,	ADP	O	O
mindfulness	ADV	O	O
skills	NOUN	O	O
were	VERB	O	O
dismantled	VERB	O	O
into	ADP	O	O
2	NUM	O	O
structurally	ADV	O	O
equivalent	ADJ	O	O
interventions:	NOUN	O	O
(a)	PUNCT	O	O
training	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
monitoring	VERB	O	O
and	CCONJ	O	O
acceptance	NOUN	O	O
(Monitor	NOUN	O	O
+	SYM	O	O
Accept)	DET	O	O
and	CCONJ	O	O
(b)	NUM	O	O
training	VERB	O	O
in	ADP	O	O
monitoring	VERB	O	O
only	ADV	O	O
(Monitor	NOUN	O	O
Only)	NOUN	O	O
without	ADP	O	O
acceptance	NOUN	O	O
training.	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
213	NUM	O	O
patients	NOUN	O	O
(95.1%)	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Moreover,	NOUN	O	O
the	DET	O	O
change	NOUN	O	O
in	ADP	O	O
ICAM1	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
correlated	VERB	O	O
positively	ADV	O	O
with	ADP	O	O
the	DET	O	O
intake	NOUN	O	O
of	ADP	O	O
FF	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
0.05)	NUM	O	O
and	CCONJ	O	O
negatively	ADV	O	O
with	ADP	O	O
the	DET	O	O
intake	NOUN	O	O
of	ADP	O	O
LF	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
0.05),	NUM	O	O
independently	ADV	O	O
of	ADP	O	O
study	NOUN	O	O
group.	VERB	O	O

We	PRON	O	O
designed	VERB	O	O
a	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
study	NOUN	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
glutamine	NOUN	O	O
(GLN)	NOUN	O	O
supplementation	NOUN	O	O
in	ADP	O	O
preventing	VERB	O	O
CCRT-induced	VERB	O	O
toxicities	NOUN	O	B-outcome
of	ADP	O	O
advanced	VERB	O	O
NSCLC	NOUN	O	O
patients.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Pregnancy	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
identified	VERB	O	O
as	ADP	O	O
a	DET	O	O
contributor	NOUN	O	O
to	PART	O	O
obesity.	ADP	O	O

This	DET	O	O
single-blind	NOUN	O	O
preliminary	ADJ	O	O
randomized-controlled	VERB	O	O
study	NOUN	O	O
investigated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
a	DET	O	O
MBI	NOUN	O	O
on	ADP	O	O
anxio-depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
memory	NOUN	O	B-outcome
,	PUNCT	O	O
compared	VERB	O	O
to	PART	O	O
a	DET	O	O
psychoeducation-based	VERB	O	O
intervention	NOUN	O	O
in	ADP	O	O
older	ADJ	O	O
adults	NOUN	O	O
with	ADP	O	O
aMCI.	ADJ	O	O

The	DET	O	O
assessors	NOUN	O	O
were	VERB	O	O
masked	VERB	O	O
as	ADP	O	O
to	PART	O	O
group	NOUN	O	O
allocation.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
effects	NOUN	O	O
for	ADP	O	O
pedaling	VERB	O	O
adherence	NOUN	O	B-outcome
.	PUNCT	O	O
Conclusions	NOUN	O	O
show	VERB	O	O
an	DET	O	O
important	ADJ	O	O
role	NOUN	O	O
for	ADP	O	O
live	ADJ	O	O
music	ADJ	O	O
therapy	NOUN	O	O
intervention	NOUN	O	O
on	ADP	O	O
observed	VERB	O	O
pain	NOUN	O	B-outcome
while	ADP	O	O
engaged	VERB	O	O
in	ADP	O	O
co-treatment	NOUN	O	O
during	ADP	O	O
this	DET	O	O
lower	ADJ	O	O
extremity	NOUN	O	O
ROM	NOUN	O	O
exercise.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
preintravenous	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
parecoxib,	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
transversus	NOUN	O	O
abdominis	NOUN	O	O
plane	ADJ	O	O
block	VERB	O	O
in	ADP	O	O
strategy	NOUN	O	O
of	ADP	O	O
enhanced	VERB	O	O
recovery	NOUN	O	B-outcome
after	ADP	O	O
radical	NOUN	O	O
resection	NOUN	O	O
of	ADP	O	O
colorectal	ADJ	O	O
cancer.	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
preliminary	ADJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
an	DET	O	O
ongoing	VERB	O	O
trial,	NOUN	O	O
an	DET	O	O
intervention	NOUN	O	O
that	ADP	O	O
encouraged	VERB	O	O
an	DET	O	O
energy-reduced	VERB	O	O
Mediterranean	NOUN	O	O
diet	NOUN	O	O
and	CCONJ	O	O
physical	ADJ	O	O
activity,	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
advice	NOUN	O	O
to	PART	O	O
follow	VERB	O	O
an	DET	O	O
energy-unrestricted	VERB	O	O
Mediterranean	NOUN	O	O
diet,	ADV	O	O
resulted	VERB	O	O
in	ADP	O	O
a	DET	O	O
significantly	ADV	O	O
greater	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
diet	NOUN	O	O
adherence	NOUN	O	B-outcome
after	ADP	O	O
12	NUM	O	O
months.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/11	NOUN	O	O
06:00'	NUM	O	O

Colorectal	ADJ	O	O
cancer	NOUN	O	O
(CRC)	NOUN	O	O
is	VERB	O	O
the	DET	O	O
third	ADJ	O	O
leading	VERB	O	O
cause	ADP	O	O
of	ADP	O	O
cancer-related	VERB	O	O
death	NOUN	O	O
in	ADP	O	O
the	DET	O	O
United	VERB	O	O
States	NOUN	O	O
and	CCONJ	O	O
emerging	VERB	O	O
evidence	NOUN	O	O
supports	NOUN	O	O
that	ADP	O	O
increased	VERB	O	O
consumption	NOUN	O	O
of	ADP	O	O
legumes,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
navy	ADJ	O	O
beans,	NOUN	O	O
can	VERB	O	O
reduce	VERB	O	O
risk.	NOUN	O	O

Title:	NOUN	O	O
Treatment	NOUN	O	B-outcome
response	NOUN	O	I-outcome
to	PART	O	O
indacaterol/glycopyrronium	NOUN	O	O
versus	CCONJ	O	O
salmeterol/fluticasone	NOUN	O	O
in	ADP	O	O
exacerbating	VERB	O	O
COPD	NOUN	O	O
patients	NOUN	O	O
by	ADP	O	O
gender:	NOUN	O	O
a	DET	O	O
post-hoc	NOUN	O	O
analysis	NOUN	O	O
in	ADP	O	O
the	DET	O	O
FLAME	NOUN	O	O
study.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Training	VERB	O	O
using	VERB	O	O
a	DET	O	O
gelatin-based	VERB	O	O
cervical	ADJ	O	O
spine	NOUN	O	O
phantom	NOUN	O	O
helps	ADJ	O	O
novices	NOUN	O	O
acquire	NOUN	O	O
the	DET	O	O
skills	NOUN	O	B-outcome
necessary	ADJ	O	O
to	PART	O	O
perform	NOUN	O	O
ultrasound-guided	VERB	O	O
cervical	ADJ	O	O
medial	ADJ	O	O
branch	NOUN	O	O
blocks.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTER:	NOUN	O	O
NCT01511276	NOUN	O	O
(clinicaltrials.gov),	PUNCT	O	O
prospectively	ADV	O	O
registered.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
A	DET	O	O
BCL	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
tear	NUM	O	B-outcome
film	NOUN	O	I-outcome
stability	NOUN	O	I-outcome
and	CCONJ	O	O
lessen	NOUN	O	O
dry	ADJ	O	B-outcome
eye	NOUN	O	I-outcome
discomfort	NOUN	O	I-outcome
immediately	ADV	O	O
after	ADP	O	O
phacoemulsification.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
cognitive	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
occurrence	NOUN	O	O
of	ADP	O	O
adjudicated	VERB	O	O
probable	ADJ	O	O
dementia	NOUN	O	B-outcome
.	PUNCT	O	O
Secondary	ADJ	O	O
cognitive	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
adjudicated	VERB	O	O
mild	ADJ	O	O
cognitive	ADJ	O	B-outcome
impairment	NOUN	O	I-outcome
and	CCONJ	O	O
a	DET	O	O
composite	NOUN	O	O
outcome	NOUN	O	O
of	ADP	O	O
mild	ADJ	O	O
cognitive	ADJ	O	B-outcome
impairment	NOUN	O	I-outcome
or	CCONJ	O	Seperator
probable	ADJ	O	I-outcome
dementia	NOUN	O	I-outcome
.	PUNCT	O	O
Results:	NOUN	O	O
Among	ADP	O	O
9361	NUM	O	O
randomized	VERB	O	O
participants	NOUN	O	O
(mean	NUM	O	O
age,	NOUN	O	O
67.9	NUM	O	O
years;	NOUN	O	O
3332	NUM	O	O
women	NOUN	O	O
[35.6%]),	NOUN	O	O
8563	NUM	O	O
(91.5%)	NOUN	O	O
completed	VERB	O	O
at	ADP	O	O
least	ADV	O	O
1	NUM	O	O
follow-up	NOUN	O	O
cognitive	ADJ	O	O
assessment.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
microbiologically	ADV	O	O
confirmed	VERB	O	O
or	CCONJ	O	O
clinically	ADV	O	O
suspected	VERB	O	O
late-onset	NOUN	O	O
infection	NOUN	O	B-outcome
(occurring	VERB	O	O
>72	PUNCT	O	O
h	NOUN	O	O
after	ADP	O	O
birth),	NOUN	O	O
which	ADP	O	O
was	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
all	DET	O	O
participants	NOUN	O	O
for	ADP	O	O
whom	ADP	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
data	NOUN	O	O
was	VERB	O	O
available	ADJ	O	O
by	ADP	O	O
calculating	VERB	O	O
the	DET	O	O
relative	ADJ	O	O
risk	NOUN	O	O
ratio	NOUN	O	O
with	ADP	O	O
95%	NOUN	O	O
CI	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

The	DET	O	O
effective	ADJ	O	O
concentration	NOUN	O	B-outcome
values	NOUN	O	O
for	ADP	O	O
remifentanil	NOUN	O	O
TCI	NOUN	O	O
were	VERB	O	O
determined	VERB	O	O
using	VERB	O	O
sequential	ADJ	O	O
method	NOUN	O	O
and	CCONJ	O	O
probit	NOUN	O	O
analysis.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/21	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
VAS	NOUN	O	O
scores	NOUN	O	O
and	CCONJ	O	O
recognition	NOUN	O	O
thresholds	NOUN	O	O
for	ADP	O	O
four	NUM	O	O
basic	ADJ	O	O
tastes	NOUN	O	B-outcome
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
before	ADP	O	O
treatment.	NOUN	O	O

We	PRON	O	O
investigated	VERB	O	O
whether	ADP	O	O
prophylactic	ADJ	O	O
use	NOUN	O	O
of	ADP	O	O
carvedilol	NOUN	O	O
can	VERB	O	O
prevent	NOUN	O	O
doxorubicin-induced	VERB	O	O
cardiotoxicity	NOUN	O	B-outcome
and	CCONJ	O	O
whether	ADP	O	O
any	DET	O	O
observed	VERB	O	O
effect	NOUN	O	O
is	VERB	O	O
dose	NOUN	O	O
related.	NOUN	O	O

The	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Standard	NOUN	O	O
Randomised	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O
Number	NOUN	O	O
88261002.	NUM	O	O

Oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
,	PUNCT	O	O
antioxidant	NOUN	O	B-outcome
status	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
were	VERB	O	O
assessed	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
30	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
chocolate	NOUN	O	O
intake.	VERB	O	O

CONCLUSIONS:	NOUN	O	O
A	DET	O	O
diet	NOUN	O	O
intervention	NOUN	O	O
that	ADP	O	O
produced	VERB	O	O
clinically	ADV	O	O
relevant	ADJ	O	O
postpartum	NOUN	O	O
weight	NOUN	O	O
loss	NOUN	O	O
also	ADV	O	O
resulted	VERB	O	O
in	ADP	O	O
increased	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
and	CCONJ	O	O
was	VERB	O	O
cost-effective.	ADJ	O	O

RESULTS:	NOUN	O	O
0.2%	NOUN	O	O
bio-adhesive	ADJ	O	O
chlorhexidine	NOUN	O	O
gel	NOUN	O	O
used	VERB	O	O
after	ADP	O	O
mandibular	ADJ	O	O
third	ADJ	O	O
molar	ADJ	O	O
removal	NOUN	O	O
reduced	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
alveolar	ADJ	O	B-outcome
osteitis	NOUN	O	I-outcome
by	ADP	O	O
10%	ADP	O	O
in	ADP	O	O
comparison	NOUN	O	O
to	PART	O	O
control	NOUN	O	O
group	NOUN	O	O
with	ADP	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference,	NOUN	O	O
i.e.,	NUM	O	O
p=0.044..	NOUN	O	O
CONCLUSIONS:	NOUN	O	O
2.3	NUM	O	O
times	NOUN	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
alveolar	ADJ	O	B-outcome
osteitis	NOUN	O	I-outcome
was	VERB	O	O
observed	VERB	O	O
after	ADP	O	O
use	NOUN	O	O
of	ADP	O	O
0.2%	NOUN	O	O
bio-adhesive	ADJ	O	O
chlorhexidine	NOUN	O	O
gel.	NOUN	O	O

CONSLUSIONS:	NOUN	O	O
Kangfuxin	NOUN	O	O
liquid	ADV	O	O
combined	VERB	O	O
with	ADP	O	O
Garlicin	NOUN	O	O
Capsules	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
the	DET	O	O
therapeutic	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
ROU	NOUN	O	O
and	CCONJ	O	O
repair	NOUN	O	B-outcome
of	ADP	O	I-outcome
local	ADJ	O	I-outcome
damaged	VERB	O	I-outcome
mucosa	NOUN	O	I-outcome
in	ADP	O	O
children,	NOUN	O	O
increasing	VERB	O	O
the	DET	O	O
immune	ADJ	O	O
function	NOUN	O	O
of	ADP	O	O
children.	NOUN	O	O

Some	DET	O	O
participants	NOUN	O	O
used	VERB	O	O
the	DET	O	O
information	NOUN	O	O
from	ADP	O	O
the	DET	O	O
poster	NOUN	O	O
to	PART	O	O
encourage	NOUN	O	B-outcome
other	ADJ	O	Seperator
caregivers	NOUN	O	I-outcome
to	PART	O	O
use	NOUN	O	O
the	DET	O	O
ABHR	NOUN	O	O
("after	NUM	O	O
explaining	VERB	O	O
to	PART	O	O
them,	NUM	O	O
they	PRON	O	O
liked	VERB	O	O
it").	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
for	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
10	NUM	O	O
days.	NOUN	O	O

Title:	NOUN	O	O
Preoperative	ADJ	O	O
celecoxib	NOUN	O	O
analgesia	NOUN	O	O
is	VERB	O	O
more	ADV	O	O
efficient	ADJ	O	O
and	CCONJ	O	O
equally	ADV	O	O
tolerated	VERB	O	B-outcome
compared	VERB	O	O
to	PART	O	O
postoperative	ADJ	O	O
celecoxib	NOUN	O	O
analgesia	NOUN	O	O
in	ADP	O	O
knee	NOUN	O	O
osteoarthritis	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
total	ADJ	O	O
knee	NOUN	O	O
arthroplasty:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
study.	NOUN	O	O

Subjects	NOUN	O	O
exercised	VERB	O	O
significantly	ADV	O	O
longer	ADJ	O	O
(PC	NOUN	O	O
=	SYM	O	O
66.7	NUM	O	O
+/-	SYM	O	O
16.3	NUM	O	O
min,	NOUN	O	O
CON	NOUN	O	O
=	SYM	O	O
45.7	NUM	O	O
+/-	SYM	O	O
9.5	NUM	O	O
min)	ADJ	O	O
and	CCONJ	O	O
at	ADP	O	O
lower	ADJ	O	O
rectal	ADJ	O	B-outcome
temperature	NOUN	O	I-outcome
(approximately	ADV	O	O
0.5	NUM	O	O
+/-	SYM	O	O
0.5	NUM	O	O
degrees	NOUN	O	O
C)	NOUN	O	O
and	CCONJ	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(approximately	ADV	O	O
10	NUM	O	O
+/-	SYM	O	O
7	NUM	O	O
bpm)	NOUN	O	O
following	VERB	O	O
PC.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985213R	NOUN	O	O

The	DET	O	O
intervention	NOUN	O	O
contained	VERB	O	O
35	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
cooked	VERB	O	O
navy	ADJ	O	O
bean	NOUN	O	O
or	CCONJ	O	O
macronutrient	ADJ	O	O
matched	VERB	O	O
meals	NOUN	O	O
and	CCONJ	O	O
snacks	NOUN	O	O
with	ADP	O	O
0	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
navy	ADJ	O	O
beans	NOUN	O	O
for	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
18).	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

In	ADP	O	O
addition,	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
a	DET	O	O
single	ADJ	O	O
300-mg	NUM	O	O
dose	NOUN	O	O
of	ADP	O	O
tafenoquine	NOUN	O	O
on	ADP	O	O
day	NOUN	O	O
1	NUM	O	O
or	CCONJ	O	O
2	NUM	O	O
(260	PUNCT	O	O
patients),	NOUN	O	O
placebo	NOUN	O	O
(133	NOUN	O	O
patients),	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
15-mg	NOUN	O	O
dose	NOUN	O	O
of	ADP	O	O
primaquine	NOUN	O	O
once	ADP	O	O
daily	ADJ	O	O
for	ADP	O	O
14	NUM	O	O
days	NOUN	O	O
(129	NUM	O	O
patients).	ADJ	O	O

The	DET	O	O
primary	ADJ	O	O
outcomes	NOUN	O	O
are	VERB	O	O
implantation	NOUN	O	B-outcome
and	CCONJ	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
rates.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Title:	NOUN	O	O
[Evaluation	NOUN	O	O
of	ADP	O	O
peer	NOUN	O	O
support	NOUN	O	O
education	NOUN	O	O
mode	NOUN	O	O
for	ADP	O	O
type	NOUN	O	B-outcome
2	NUM	O	I-outcome
diabetes	NOUN	O	I-outcome
control	NOUN	O	I-outcome
in	ADP	O	O
rural	ADJ	O	O
residents].	ADJ	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups:	NOUN	O	O
PAR-G	NOUN	O	O
(BiPAP	NOUN	O	O
in	ADP	O	O
PAR	NOUN	O	O
for	ADP	O	O
one	NUM	O	O
hour),	NOUN	O	O
and	CCONJ	O	O
1PO-G	NUM	O	O
(BIPAP	PUNCT	O	O
for	ADP	O	O
one	NUM	O	O
hour	NOUN	O	O
on	ADP	O	O
the	DET	O	O
1PO).	NUM	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
explore	ADP	O	O
the	DET	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
programmatic	ADJ	O	O
feasibility	NOUN	O	O
of	ADP	O	O
using	VERB	O	O
800	NUM	O	O
mug	NUM	O	O
of	ADP	O	O
sublingual	ADJ	O	O
misoprostol	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
and	CCONJ	O	O
treat	NOUN	O	O
postpartum	NOUN	O	B-outcome
hemorrhage	NOUN	O	I-outcome
(PPH)	PUNCT	O	I-outcome
during	ADP	O	O
home	NOUN	O	O
delivery.	VERB	O	O

Peri-implant	ADJ	O	O
mucosal	ADJ	O	O
stability	NOUN	O	O
was	VERB	O	O
generally	ADV	O	O
observed.	NOUN	O	O

Likewise,	NOUN	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
throughout	ADV	O	O
the	DET	O	O
study	NOUN	O	O
in	ADP	O	O
the	DET	O	O
group-by-time	NOUN	O	O
interaction	NOUN	O	O
and	CCONJ	O	O
changes	NOUN	O	O
of	ADP	O	O
haemoglobin	NOUN	O	B-outcome
(GC:	NUM	O	O
-2.89	NUM	O	O
+/-	SYM	O	O
2.29%	NOUN	O	O
vs.	CCONJ	O	O
VD3G:	NOUN	O	O
0.71	NUM	O	O
+/-	SYM	O	O
1.91%;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.009),	NUM	O	O
hematocrit	NOUN	O	B-outcome
(CG:	NUM	O	O
-1.57	NUM	O	O
+/-	SYM	O	O
2.49%	NOUN	O	O
vs.	CCONJ	O	O
VD3G:	NOUN	O	O
1.16	NUM	O	O
+/-	SYM	O	O
1.81%;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.019)	NUM	O	O
and	CCONJ	O	O
transferrin	NOUN	O	B-outcome
(CG:	NUM	O	O
0.67	NUM	O	O
+/-	SYM	O	O
4.88%	PUNCT	O	O
vs.	CCONJ	O	O
VD3G:	NOUN	O	O
6.51	NUM	O	O
+/-	SYM	O	O
4.36%;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.007).	NUM	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
double	ADV	O	O
blind,	NOUN	O	O
placebo	NOUN	O	O
controlled,	NOUN	O	O
multicenter	NOUN	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
Emblica	NOUN	O	O
officinalis	NOUN	O	O
extract	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
dyslipidemia.	NOUN	O	O

Result:The	NOUN	O	O
clinical	ADJ	O	O
manifestations	NOUN	O	O
of	ADP	O	O
60	NUM	O	O
patients	NOUN	O	O
mainly	ADV	O	O
included	VERB	O	O
nasal	ADJ	O	B-outcome
obstruction	NOUN	O	I-outcome
81.67%,	NOUN	O	O
accompanied	VERB	O	O
by	ADP	O	O
fever	NOUN	O	B-outcome
,	PUNCT	O	O
headache	NOUN	O	B-outcome
,	PUNCT	O	O
nosebleed	NOUN	O	B-outcome
and	CCONJ	O	O
runny	NOUN	O	B-outcome
nose	NOUN	O	I-outcome
.	PUNCT	O	O
Forty-one	NUM	O	O
patients68.33%	NOUN	O	O
had	VERB	O	O
only	ADV	O	O
one	NUM	O	O
site	NOUN	O	O
of	ADP	O	O
lesion	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
21	NUM	O	O
patients35.00%	NOUN	O	O
had	VERB	O	O
multiple	ADJ	O	O
sites	NOUN	O	O
of	ADP	O	O
lesions	NOUN	O	B-outcome
.	PUNCT	O	O
In	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
total	ADJ	O	O
remission	NOUN	O	B-outcome
rate,	NOUN	O	O
it	PRON	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
B93.33%	NOUN	O	O
vs.	CCONJ	O	O
66.67%,	NOUN	O	O
P<0.05.	NOUN	O	O

OBJECTIVES:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
if	ADP	O	O
intermittent	ADJ	O	O
exercise-heat	NOUN	O	O
exposures	NOUN	O	O
(IHE)	PUNCT	O	O
every	DET	O	O
fifth	ADJ	O	O
day	NOUN	O	O
sustain	NOUN	O	O
heat	NOUN	O	B-outcome
acclimation	NOUN	O	I-outcome
(HA)	PUNCT	O	I-outcome
adaptations	NOUN	O	O
25	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
initial	ADJ	O	O
HA.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Occupational	ADJ	O	O
radiation	NOUN	O	O
exposureis	NOUN	O	O
a	DET	O	O
growing	VERB	O	O
problem	ADP	O	O
due	ADJ	O	O
to	PART	O	O
increasing	VERB	O	O
number	NOUN	O	O
and	CCONJ	O	O
complexity	NOUN	O	O
of	ADP	O	O
interventional	ADJ	O	O
procedures.	NOUN	O	O

CONCLUSION:	NOUN	O	O
CrCo-Ti	NOUN	O	O
rods	NOUN	O	O
have	VERB	O	O
the	DET	O	O
ability	NOUN	O	O
to	PART	O	O
produce	VERB	O	O
higher	ADJ	O	O
correction	NOUN	O	B-outcome
rates	NOUN	O	O
in	ADP	O	O
AIS	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
Ti-Ti	NOUN	O	O
rod	NOUN	O	O
of	ADP	O	O
the	DET	O	O
same	ADJ	O	O
diameter.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
In	ADP	O	O
summary,	ADJ	O	O
the	DET	O	O
findings	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
NMES	NOUN	O	O
therapy	NOUN	O	O
may	VERB	O	O
not	ADV	O	O
benefit	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
CUR	NOUN	O	O
following	VERB	O	O
TBI.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Journal-Name:Zhongguo	NOUN	O	O
xiu	NOUN	O	O
fu	ADP	O	O
chong	ADJ	O	O
jian	NOUN	O	O
wai	CCONJ	O	O
ke	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Zhongguo	NOUN	O	O
xiufu	VERB	O	O
chongjian	NOUN	O	O
waike	ADP	O	O
zazhi	NOUN	O	O
=	SYM	O	O
Chinese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
reparative	ADJ	O	O
and	CCONJ	O	O
reconstructive	ADJ	O	O
surgery	NOUN	O	O

Fish	NOUN	O	O
and	CCONJ	O	O
seafood	NOUN	O	O
consumption	NOUN	O	O
and	CCONJ	O	O
omega-3	NOUN	O	O
PUFA	NOUN	O	O
intake	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
through	ADP	O	O
a	DET	O	O
validated	VERB	O	O
food-frequency	NOUN	O	O
questionnaire.	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
National	ADJ	O	O
Cancer	NOUN	O	O
Institute	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02066181	NOUN	O	O
.).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Patients	NOUN	O	O
receiving	VERB	O	O
dexmedetomidine	NOUN	O	O
vs	CCONJ	O	O
propofol	NOUN	O	O
had	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
delirium	NOUN	O	B-outcome
(17%	PUNCT	O	O
vs	CCONJ	O	O
21%;	NUM	O	O
difference,	NOUN	O	O
-4%	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-18%	NOUN	O	O
to	PART	O	O
10%];	ADJ	O	O
P	NOUN	O	O
=	SYM	O	O
.54;	PUNCT	O	O
HR,	NOUN	O	O
0.8	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
0.4-1.9]).	NUM	O	O

Results:	NOUN	O	O
The	DET	O	O
PFOA	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
less	ADV	O	O
ankle	NOUN	O	O
dorsiflexion	NOUN	O	O
(odds	NOUN	O	O
ratio	NOUN	O	O
6.7,	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
2.46-18.2),	NUM	O	O
greater	ADJ	O	O
midfoot	NOUN	O	O
height	NOUN	O	O
mobility	NOUN	O	O
(5.2,	NOUN	O	O
1.78-15.14)	ADJ	O	O
and	CCONJ	O	O
width	NOUN	O	O
mobility	NOUN	O	O
(4.3,	NOUN	O	O
1.33-14.39,	NUM	O	O
and	CCONJ	O	O
greater	ADJ	O	O
foot	NOUN	O	O
mobility	NOUN	O	O
magnitude	NOUN	O	O
(8.4,	NOUN	O	O
2.32-30.69)	NOUN	O	O
than	ADP	O	O
controls.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Implantation	NOUN	O	O
failure	NOUN	O	O
is	VERB	O	O
the	DET	O	O
main	ADJ	O	O
factor	NOUN	O	O
affecting	VERB	O	O
the	DET	O	O
success	NOUN	O	O
rate	NOUN	O	O
of	ADP	O	O
in	ADP	O	O
vitro	ADV	O	O
fertilization	NOUN	O	O
(IVF)	NOUN	O	O
procedures.	NOUN	O	O

A	DET	O	O
definitive	ADJ	O	O
trial	NOUN	O	O
is	VERB	O	O
warranted.	NOUN	O	O

This	DET	O	O
may	VERB	O	O
necessitate	NOUN	O	O
an	DET	O	O
alternative	ADJ	O	O
therapy	NOUN	O	O
for	ADP	O	O
this	DET	O	O
group	NOUN	O	O
of	ADP	O	O
patients.	NOUN	O	O

Title:	NOUN	O	O
Hybrid	NOUN	O	O
Minimally	ADV	O	O
Invasive	ADJ	O	O
Esophagectomy	NOUN	O	O
for	ADP	O	O
Esophageal	ADJ	O	O
Cancer.	ADV	O	O

The	DET	O	O
cumulative	ADJ	O	O
opioid	NOUN	O	B-outcome
dose	NOUN	O	I-outcome
administered	VERB	O	O
at	ADP	O	O
6,	NOUN	O	O
12,	NUM	O	O
24,	NUM	O	O
and	CCONJ	O	O
48	NUM	O	O
h	NOUN	O	O
after	ADP	O	O
surgery	NOUN	O	O
were	VERB	O	O
recorded.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Probing	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
tobramycin/dexamethasone	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
was	VERB	O	O
effective	ADJ	O	O
and	CCONJ	O	O
easy-to-perform	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
clinic,	NOUN	O	O
and	CCONJ	O	O
it	PRON	O	O
may	VERB	O	O
be	VERB	O	O
a	DET	O	O
better	ADJ	O	O
choice	NOUN	O	O
for	ADP	O	O
persistent	ADJ	O	O
CNLDO.	NOUN	O	O

Results:	NOUN	O	O
19	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
distributed	VERB	O	O
in	ADP	O	O
57.89%	NOUN	O	O
in	ADP	O	O
the	DET	O	O
G2	NOUN	O	O
and	CCONJ	O	O
42.11%	NOUN	O	O
in	ADP	O	O
the	DET	O	O
G1.	NOUN	O	O

The	DET	O	O
minimal	ADJ	O	O
clinically	ADV	O	O
important	ADJ	O	O
between	ADP	O	O
group	NOUN	O	O
difference	NOUN	O	O
in	ADP	O	O
mean	NOUN	O	O
Roland-Morris	NOUN	O	O
Disability	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(RMDQ)	NOUN	O	O
score	NOUN	O	O
was	VERB	O	O
predefined	VERB	O	O
as	ADP	O	O
4.	NUM	O	O

In	ADP	O	O
this	DET	O	O
post-hoc	NOUN	O	O
analysis,	NOUN	O	O
gender-based	VERB	O	O
baseline	NOUN	O	O
differences	NOUN	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
outcomes	NOUN	O	O
between	ADP	O	O
indacaterol/glycopyrronium	NOUN	O	O
110/50	NOUN	O	O
mug	NUM	O	O
once	ADP	O	O
daily	ADJ	O	O
(IND/GLY)	NOUN	O	O
and	CCONJ	O	O
salmeterol/fluticasone	NOUN	O	O
50/500	NOUN	O	O
twice	ADV	O	O
daily	ADJ	O	O
(SFC)	PUNCT	O	O
were	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
rate	NOUN	O	O
of	ADP	O	O
exacerbations	NOUN	O	B-outcome
,	PUNCT	O	O
time-to-first	ADV	O	B-outcome
exacerbation	NOUN	O	I-outcome
,	PUNCT	O	O
lung	NOUN	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
health	NOUN	O	B-outcome
status,	NOUN	O	O
and	CCONJ	O	O
rescue	NOUN	O	B-outcome
medication	NOUN	O	I-outcome
use	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
This	DET	O	O
post-hoc	NOUN	O	O
analysis	NOUN	O	O
included	VERB	O	O
2557	NUM	O	O
men	NOUN	O	O
and	CCONJ	O	O
805	NUM	O	O
women.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
significant	ADJ	O	O
pain	NOUN	O	B-outcome
relief	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
receiving	VERB	O	O
Triamcinolone	NOUN	O	O
at	ADP	O	O
two	NUM	O	O
and	CCONJ	O	O
six	NUM	O	O
week	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
in	ADP	O	O
twelve	NUM	O	O
weeks.	NOUN	O	O

However,	ADV	O	O
the	DET	O	O
higher	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
premature	ADJ	O	O
withdrawals	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
TENS	NOUN	O	O
group	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
due	ADJ	O	O
to	PART	O	O
early	ADJ	O	O
withdrawal	NOUN	O	B-outcome
of	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
did	VERB	O	O
not	ADV	O	O
experience	NOUN	O	O
improvement	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
symptoms.	NOUN	O	O

The	DET	O	O
contribution	NOUN	O	O
of	ADP	O	O
MAT	NOUN	O	O
components	NOUN	O	O
and	CCONJ	O	O
of	ADP	O	O
ruminations'	NOUN	O	O
reduction	NOUN	O	O
to	PART	O	O
intervention	NOUN	O	O
efficacy	NOUN	O	O
were	VERB	O	O
examined.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
acute	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
dietary	ADJ	O	O
carbohydrate	NOUN	O	O
reduction	NOUN	O	O
on	ADP	O	O
postprandial	ADJ	O	O
responses	NOUN	O	O
of	ADP	O	O
non-esterified	VERB	O	B-outcome
fatty	ADJ	O	I-outcome
acids	NOUN	O	I-outcome
and	CCONJ	O	O
triglycerides	NOUN	O	B-outcome
:	PUNCT	O	O
a	DET	O	O
randomized	VERB	O	O
trial.	NOUN	O	O

RESULTS:	NOUN	O	O
We	PRON	O	O
observed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
physical	ADJ	O	B-outcome
and	CCONJ	O	Seperator
task	ADJ	O	X
subscales	NOUN	O	X
of	ADP	O	X
the	NOUN	O	X
global	ADJ	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	E3-outcome
(GQoL)	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.01	NUM	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.04,	PUNCT	O	O
respectively)	NOUN	O	O
and	CCONJ	O	O
also	ADV	O	O
in	ADP	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
specific	ADJ	O	O
for	ADP	O	O
CD	NOUN	O	O
(P	NUM	O	O
</=.0001)	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
in	ADP	O	O
pain	NOUN	O	B-outcome
score	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.28).	PUNCT	O	O

Title:	NOUN	O	O
Bilateral	ADJ	O	O
versus	CCONJ	O	O
Single	NOUN	O	O
Internal-Thoracic-Artery	DET	O	O
Grafts	NOUN	O	O
at	ADP	O	O
10	NUM	O	O
Years.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study,	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Multicenter	NOUN	O	O
Study,	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O
Research	NOUN	O	O
Support,	NOUN	O	O
Non-U.S.	NOUN	O	O
Gov't,	NOUN	O	O

IRCT.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8900488	NUM	O	O

CLINICAL	ADJ	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Australian	ADJ	O	O
New	ADJ	O	O
Zealand	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
Registry	NOUN	O	O
(ANZCTR)	NOUN	O	O
registration	NOUN	O	O
number	NOUN	O	O
ACTRN12618000368235	ADJ	O	O
.	PUNCT	O	O

METHODS:	NOUN	O	O
Forty-four	NUM	O	O
adults	NOUN	O	O
with	ADP	O	O
Diagnostic	ADJ	O	O
and	CCONJ	O	O
Statistical	ADJ	O	O
Manual	ADJ	O	O
of	ADP	O	O
Mental	ADJ	O	O
Disorders,	NOUN	O	O
Fifth	NOUN	O	O
Edition	NOUN	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
ADHD	NOUN	O	O
participated	VERB	O	O
in	ADP	O	O
a	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled,	NOUN	O	O
12-week	NOUN	O	O
trial	NOUN	O	O
of	ADP	O	O
15	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
L-methylfolate	NOUN	O	O
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
osmotic-release	NOUN	O	O
oral	ADJ	O	O
system	NOUN	O	O
methylphenidate.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
split-mouth,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
low-level	NOUN	O	O
laser	NOUN	O	O
therapy	NOUN	O	O
(LLLT)	PUNCT	O	O
and	CCONJ	O	O
photodynamic	ADJ	O	O
therapy	NOUN	O	O
(PDT)	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunct	ADP	O	O
to	PART	O	O
scaling	VERB	O	O
and	CCONJ	O	O
root	NOUN	O	O
planing	VERB	O	O
(SRP)	NOUN	O	O
in	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
chronic	ADJ	O	O
periodontitis.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
and	CCONJ	O	O
other	ADJ	O	O
experimental	ADJ	O	O
and	CCONJ	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
confirmed	VERB	O	O
that	ADP	O	O
the	DET	O	O
administration	NOUN	O	O
of	ADP	O	O
the	DET	O	O
scorpion	NOUN	O	O
antivenom	NOUN	O	O
by	ADP	O	O
intravenous	ADJ	O	O
route	NOUN	O	O
has	VERB	O	O
a	DET	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
systemic	ADJ	O	O
toxicity	NOUN	O	B-outcome
,	PUNCT	O	O
a	DET	O	O
better	ADJ	O	O
outcome	NOUN	O	O
of	ADP	O	O
fatal	ADJ	O	B-outcome
complication	NOUN	O	O
resulted	VERB	O	O
from	ADP	O	O
envenomation	NOUN	O	O
especially	ADV	O	O
cardiogenic	ADJ	O	B-outcome
shock	NOUN	O	I-outcome
,	PUNCT	O	O
decreased	VERB	O	O
need	NOUN	O	B-outcome
for	ADP	O	Seperator
ICU	NOUN	O	I-outcome
facilities	NOUN	O	O
and	CCONJ	O	O
mechanical	ADJ	O	B-outcome
ventilation	NOUN	O	I-outcome
,	PUNCT	O	O
shorter	ADJ	O	O
hospital	NOUN	O	B-outcome
stay	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
better	ADJ	O	O
overall	ADJ	O	O
outcome	NOUN	O	O
than	ADP	O	O
the	DET	O	O
intramuscular	ADJ	O	O
route.	NOUN	O	O

Exclusion	NOUN	O	O
criteria	NOUN	O	O
were	VERB	O	O
presence	NOUN	O	O
of	ADP	O	O
a	DET	O	O
severe	ADJ	O	O
congenital	ADJ	O	O
anomaly,	NOUN	O	O
anticipated	VERB	O	O
enteral	ADJ	O	O
fasting	VERB	O	O
for	ADP	O	O
longer	ADJ	O	O
than	ADP	O	O
14	NUM	O	O
days,	NOUN	O	O
or	CCONJ	O	O
no	DET	O	O
realistic	ADJ	O	O
prospect	VERB	O	O
of	ADP	O	O
survival.	NOUN	O	O

kg(-1).h(-1)	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
D.	NOUN	O	O
The	DET	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
liquid	ADV	O	B-outcome
input	NOUN	O	I-outcome
and	CCONJ	O	Seperator
output	NOUN	O	S1-outcome
during	ADP	O	O
operation,	NOUN	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
patient	NOUN	O	O
controlled	VERB	O	O
analgesia	NOUN	O	B-outcome
(PCA)	PUNCT	O	O
pressings	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
were	VERB	O	O
recorded.	NOUN	O	O

For	ADP	O	O
normal	ADJ	O	O
breathing,	NOUN	O	O
the	DET	O	O
adequate	ADJ	O	O
protection	NOUN	O	B-outcome
rates	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
training	VERB	O	O
were	VERB	O	O
62	NUM	O	O
(0-100)	NUM	O	O
vs	CCONJ	O	O
100	NUM	O	O
(90-100)	NOUN	O	O
for	ADP	O	O
cup-type,	NOUN	O	O
100	NUM	O	O
(0-100)	NUM	O	O
vs	CCONJ	O	O
100	NUM	O	O
(100-100)	NOUN	O	O
for	ADP	O	O
fold-type,	NOUN	O	O
and	CCONJ	O	O
19	NUM	O	O
(0-100)	NUM	O	O
vs	CCONJ	O	O
100	NUM	O	O
(44-100)	NOUN	O	O
for	ADP	O	O
valve-type	NOUN	O	O
(all	PUNCT	O	O
P	NOUN	O	O
<	SYM	O	O
.05).	NUM	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
participated	VERB	O	O
in	ADP	O	O
the	DET	O	O
follow-up	NOUN	O	O
of	ADP	O	O
three	NUM	O	O
months.	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
responses	NOUN	O	B-outcome
are	VERB	O	O
ongoing.	NOUN	O	O

BACKGROUND:	NOUN	O	O
A	DET	O	O
lumbar	ADJ	O	O
herniated	VERB	O	O
intervertebral	ADJ	O	O
disc	NOUN	O	O
(LHIVD)	PUNCT	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
problem	ADP	O	O
that	ADP	O	O
usually	ADV	O	O
causes	NOUN	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
radiating	VERB	O	O
pain.	NOUN	O	O

Regression	NOUN	O	O
analyses	NOUN	O	O
were	VERB	O	O
conducted	VERB	O	O
to	PART	O	O
test	NOUN	O	O
for	ADP	O	O
differences	NOUN	O	O
by	ADP	O	O
sponsorship	NOUN	O	O
condition	NOUN	O	O
on	ADP	O	O
the	DET	O	O
respective	ADJ	O	O
outcome	NOUN	O	O
measures.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

No	DET	O	O
changes	NOUN	O	O
in	ADP	O	O
insulin	NOUN	O	B-outcome
or	CCONJ	O	O
triglycerides	NOUN	O	B-outcome
were	VERB	O	O
observed	VERB	O	O
during	ADP	O	O
the	DET	O	O
ingestion	NOUN	O	O
period.	NOUN	O	O

METHODS:	NOUN	O	O
(1)	PUNCT	O	O
Clinical	ADJ	O	O
research:	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
needed	VERB	O	O
sedative	NOUN	O	O
undergoing	VERB	O	O
mechanical	ADJ	O	O
ventilation	NOUN	O	O
admitted	VERB	O	O
to	PART	O	O
intensive	ADJ	O	O
care	NOUN	O	O
unit	NOUN	O	O
(ICU)	PUNCT	O	O
of	ADP	O	O
Qingdao	NOUN	O	O
Municipal	ADJ	O	O
Hospital	NOUN	O	O
from	ADP	O	O
January	NOUN	O	O
2016	NUM	O	O
to	PART	O	O
January	NOUN	O	O
2018	NUM	O	O
were	VERB	O	O
enrolled.	NOUN	O	O

No	DET	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
reported.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
nutritional	ADJ	O	O
and	CCONJ	O	O
physical	ADJ	O	O
activity	NOUN	O	O
education	NOUN	O	O
program	NOUN	O	O
on	ADP	O	O
dietary	ADJ	O	B-outcome
quality	NOUN	O	I-outcome
.	PUNCT	O	O
Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Preliminary	ADJ	O	O
exploratory	ADJ	O	O
interim	ADJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
an	DET	O	O
ongoing	VERB	O	O
randomized	VERB	O	O
trial.	NOUN	O	O

The	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
stopped	VERB	O	O
early	ADJ	O	O
for	ADP	O	O
benefit	NUM	O	O
on	ADP	O	O
its	ADJ	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
(a	PUNCT	O	O
composite	NOUN	O	O
of	ADP	O	O
cardiovascular	ADJ	O	B-outcome
events)	NOUN	O	O
and	CCONJ	O	O
all-cause	NOUN	O	B-outcome
mortality	NOUN	O	I-outcome
on	ADP	O	O
August	NOUN	O	O
20,	NUM	O	O
2015.	NUM	O	O

Title:	NOUN	O	O
A	DET	O	O
Feasibility	NOUN	O	O
RCT	NOUN	O	O
Evaluating	VERB	O	O
a	DET	O	O
Play-Informed,	NOUN	O	O
Caregiver-Implemented,	NOUN	O	O
Home-Based	VERB	O	O
Intervention	NOUN	O	O
to	PART	O	O
Improve	NOUN	O	O
the	DET	O	O
Play	NOUN	O	B-outcome
of	ADP	O	O
Children	NOUN	O	O
Who	ADP	O	O
Are	VERB	O	O
HIV	NOUN	O	O
Positive.	NOUN	O	O

Meal	ADJ	O	O
replacements	NOUN	O	O
(MRs)	NOUN	O	O
are	VERB	O	O
portion-	NOUN	O	O
and	CCONJ	O	O
calorie-controlled	VERB	O	O
meals,	ADJ	O	O
which	ADP	O	O
make	VERB	O	O
the	DET	O	O
food	NOUN	O	O
environment	NOUN	O	O
part	NOUN	O	O
of	ADP	O	O
an	DET	O	O
individual's	NOUN	O	O
weight	NOUN	O	O
loss	NOUN	O	O
regimen.	NOUN	O	O

After	ADP	O	O
consumption,	NOUN	O	O
participants	NOUN	O	O
were	VERB	O	O
monitored	VERB	O	O
throughout	ADV	O	O
a	DET	O	O
45-min	NOUN	O	O
ingestion	NOUN	O	O
period,	NOUN	O	O
then	ADV	O	O
completed	VERB	O	O
a	DET	O	O
repeated	VERB	O	O
Wingate	NOUN	O	O
protocol,	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
then	ADV	O	O
monitored	VERB	O	O
throughout	ADV	O	O
a	DET	O	O
45-min	NOUN	O	O
recovery	NOUN	O	O
period.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/24	NUM	O	O
06:00	ADP	O	O
[pubmed]	PUNCT	O	O

BACKGROUND:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
parallel-group	NOUN	O	O
trial,	NOUN	O	O
we	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
explore	ADP	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
trigger	ADP	O	O
point	NOUN	O	O
dry	ADJ	O	O
needling	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
tension-type	NOUN	O	O
headache	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
headache	NOUN	O	B-outcome
frequency,	NOUN	O	I-outcome
intensity	NOUN	O	I-outcome
and	CCONJ	O	Seperator
duration	NOUN	O	S1-outcome
,	PUNCT	O	O
and	CCONJ	O	O
improvement	NOUN	O	O
of	ADP	O	O
health-related	VERB	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
The	DET	O	O
168	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
2	NUM	O	O
neurology	NOUN	O	O
clinics	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
tension-type	NOUN	O	O
headache.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
cervical	ADJ	O	O
spine	NOUN	O	O
phantoms	NOUN	O	O
for	ADP	O	O
improving	VERB	O	O
resident	ADJ	O	O
proficiency	NOUN	O	B-outcome
in	ADP	O	O
performing	VERB	O	O
ultrasound-guided	VERB	O	O
cervical	ADJ	O	O
medial	ADJ	O	O
branch	NOUN	O	O
block:	NOUN	O	O
A	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
comparative	ADJ	O	O
study.	NOUN	O	O

Hence	ADV	O	O
this	DET	O	O
operative	ADJ	O	O
procedure	NOUN	O	O
is	VERB	O	O
worthy	NOUN	O	O
of	ADP	O	O
popularization.	ADV	O	O

Funded	VERB	O	O
by	ADP	O	O
Paratek	NOUN	O	O
Pharmaceuticals;	NOUN	O	O
OPTIC	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02531438	NOUN	O	O
.).	NOUN	O	O

Precooling,	NOUN	O	O
exertional	ADJ	O	O
heatstroke	NOUN	O	O
risk	NOUN	O	O
factors,	NOUN	O	O
and	CCONJ	O	O
postexercise	NOUN	O	O
cooling	VERB	O	O
rates.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
cure	NOUN	O	B-outcome
rate	NOUN	O	O
of	ADP	O	O
intense	ADJ	O	O
versus	CCONJ	O	O
standard	ADJ	O	O
treatment	NOUN	O	O
with	ADP	O	O
PZQ	NOUN	O	O
on	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
a	DET	O	O
confirmed	VERB	O	O
S.mansoni	NOUN	O	O
infection	NOUN	O	O
measured	VERB	O	O
by	ADP	O	O
KK.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Australian	ADJ	O	O
New	ADJ	O	O
Zealand	NOUN	O	O
Clinical	ADJ	O	O
Trial	NOUN	O	O
Registry;	NOUN	O	O
ACTRN12617000249358	ADP	O	O
;	PUNCT	O	O
Date	NOUN	O	O
registered:	NOUN	O	O
17/02/2017.	NOUN	O	O

METHOD:	NOUN	O	O
A	DET	O	O
prospective	ADJ	O	O
randomised,	NOUN	O	O
single	ADJ	O	O
centre	NOUN	O	O
parallel	ADJ	O	O
group	NOUN	O	O
trial	NOUN	O	O
comparing	VERB	O	O
an	DET	O	O
8-week	NOUN	O	O
individualised	VERB	O	O
multidisciplinary	ADJ	O	O
intervention	NOUN	O	O
programme	NOUN	O	O
(bespoke	PUNCT	O	O
physiotherapy	NOUN	O	O
and	CCONJ	O	O
occupational	ADJ	O	O
therapy	NOUN	O	O
in	ADP	O	O
the	DET	O	O
clinical,	ADJ	O	O
home	NOUN	O	O
and	CCONJ	O	O
school	NOUN	O	O
environment)	NOUN	O	O
with	ADP	O	O
current	ADJ	O	O
standard	ADJ	O	O
management	NOUN	O	O
(advice,	NOUN	O	O
information	NOUN	O	O
and	CCONJ	O	O
therapy	NOUN	O	O
referral	ADJ	O	O
if	ADP	O	O
deemed	VERB	O	O
necessary).	NOUN	O	O

87.3	NUM	O	O
+/-	SYM	O	O
7.7	NUM	O	O
kg)	NOUN	O	O
with	ADP	O	O
at	ADP	O	O
least	ADV	O	O
2	NUM	O	O
years	NOUN	O	O
of	ADP	O	O
experience	NOUN	O	O
in	ADP	O	O
resistance	NOUN	O	O
training.	NOUN	O	O

The	DET	O	O
area	NOUN	O	O
of	ADP	O	O
images	NOUN	O	O
that	ADP	O	O
give	ADJ	O	O
confidence	NOUN	O	O
for	ADP	O	O
sinus	NOUN	O	O
surgery	NOUN	O	O
at	ADP	O	O
one	NUM	O	O
time	NOUN	O	O
was	VERB	O	O
higher	ADJ	O	O
for	ADP	O	O
standard-dose	NOUN	O	O
MDCT	NOUN	O	O
protocol	NOUN	O	O
technique	NOUN	O	O
than	ADP	O	O
low-dose	NOUN	O	O
MDCT	NOUN	O	O
protocol	NOUN	O	O
method.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
APN	NOUN	O	O
and	CCONJ	O	O
AdipoR1	VERB	O	O
were	VERB	O	O
significantly	ADV	O	O
decreased	VERB	O	O
in	ADP	O	O
T2DM	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
T2DM	NOUN	O	O
+	SYM	O	O
MVC	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
NC	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
the	DET	O	O
lowest	ADV	O	O
value	NOUN	O	O
in	ADP	O	O
T2DM	NOUN	O	O
+	SYM	O	O
MVC	NOUN	O	O
group	NOUN	O	O
(all	PUNCT	O	O
P<0.01).	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
clinical	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
nursing	VERB	O	O
intervention	NOUN	O	O
for	ADP	O	O
respiratory	ADJ	O	O
function	NOUN	O	O
exercise	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
silicosis	NOUN	O	O
complicated	VERB	O	O
by	ADP	O	O
stable	ADJ	O	O
chronic	ADJ	O	O
obstructive	ADJ	O	O
pulmonary	ADJ	O	O
disease	NOUN	O	O
(COPD)	NUM	O	O
.	PUNCT	O	O

J.	NOUN	O	O
Radiol.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
antibiotic	ADJ	O	O
treatment	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
Modic	NOUN	O	O
changes	NOUN	O	O
(the	NOUN	O	O
AIM	NOUN	O	O
study):	NUM	O	O
double	ADV	O	O
blind,	NOUN	O	O
randomised,	NOUN	O	O
placebo	NOUN	O	O
controlled,	NOUN	O	O
multicentre	NOUN	O	O
trial.	NOUN	O	O

PURPOSE:	NOUN	O	O
This	DET	O	O
report	NOUN	O	O
assesses	NOUN	O	O
functional	ADJ	O	B-outcome
mobility	NOUN	O	I-outcome
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
neurological	ADJ	O	O
impairments	NOUN	O	O
and	CCONJ	O	O
documented	VERB	O	O
gross	ADJ	O	O
motor	NOUN	O	O
delays,	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
receiving	VERB	O	O
either	CCONJ	O	O
hippotherapy	NOUN	O	O
or	CCONJ	O	O
standard	ADJ	O	O
outpatient	ADJ	O	O
physical	ADJ	O	O
therapy	NOUN	O	O
(PT).	NUM	O	O

Weaknesses	NOUN	O	O
in	ADP	O	O
the	DET	O	O
CHW	NOUN	O	O
intervention	NOUN	O	O
severely	ADV	O	O
limited	VERB	O	O
the	DET	O	O
extent	NOUN	O	O
to	PART	O	O
which	ADP	O	O
the	DET	O	O
PCBHIS	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
used	VERB	O	O
to	PART	O	O
observe	NOUN	O	O
trends	NOUN	O	O
in	ADP	O	O
mortality	NOUN	O	O
and	CCONJ	O	O
morbidity.	NOUN	O	O

Villages	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
grouped	VERB	O	O
into	ADP	O	O
blocks,	NOUN	O	O
with	ADP	O	O
blocks	NOUN	O	O
transitioned	VERB	O	O
monthly	ADV	O	O
from	ADP	O	O
control	NOUN	O	O
(no	PUNCT	O	O
repellent)	NOUN	O	O
to	PART	O	O
intervention	NOUN	O	O
states	NOUN	O	O
(to	PUNCT	O	O
receive	VERB	O	O
repellent)	NOUN	O	O
across	ADP	O	O
14	NUM	O	O
monthly	ADV	O	O
intervals	NOUN	O	O
in	ADP	O	O
random	NOUN	O	O
order).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Phacoemulsification	NOUN	O	O
in	ADP	O	O
eyes	NOUN	O	O
with	ADP	O	O
mild-to-moderate	ADJ	O	O
primary	ADJ	O	O
open-angle	NOUN	O	O
glaucoma	NOUN	O	O
results	NOUN	O	O
in	ADP	O	O
early	ADJ	O	O
endothelial	ADJ	O	B-outcome
cell	NOUN	O	I-outcome
loss	NOUN	O	O
(ECL),	NUM	O	O
with	ADP	O	O
Endothelial	ADJ	O	B-outcome
Cell	NOUN	O	I-outcome
Density	NOUN	O	I-outcome
(ECD)	NOUN	O	I-outcome
stabilizing	VERB	O	O
after	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
effect	NOUN	O	O
on	ADP	O	O
other	ADJ	O	O
endothelial	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
markers	NOUN	O	O
up	ADP	O	O
to	PART	O	O
2	NUM	O	O
years	NOUN	O	O
postoperatively.	NOUN	O	O

METHODS:	NOUN	O	O
Ninety	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
ASA	NOUN	O	O
I	NUM	O	O
or	CCONJ	O	O
II,	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
cesarean	NOUN	O	O
section,	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
group	NOUN	O	O
D	NOUN	O	O
(bupivacaine	NUM	O	O
+	SYM	O	O
5	NUM	O	O
mug	NUM	O	O
Dex)	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
C	NOUN	O	O
(bupivacaine	NUM	O	O
+	SYM	O	O
the	DET	O	O
same	ADJ	O	O
volume	NOUN	O	O
of	ADP	O	O
saline).	ADJ	O	O

The	DET	O	O
6-month	NOUN	O	O
values	NOUN	O	O
of	ADP	O	O
the	DET	O	O
resin	NOUN	O	O
infiltration	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
statistically	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
those	DET	O	O
of	ADP	O	O
the	DET	O	O
fluoride	NOUN	O	O
varnish	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.028,	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Randomized,	NOUN	O	O
blinded,	NOUN	O	O
placebo-controlled,	NOUN	O	O
4-group	NOUN	O	O
trial	NOUN	O	O
in	ADP	O	O
6	NUM	O	O
Danish	NOUN	O	O
hospitals	NOUN	O	O
with	ADP	O	O
90-day	NOUN	O	O
follow-up	NOUN	O	O
that	ADP	O	O
included	VERB	O	O
556	NUM	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
total	ADJ	O	O
hip	NOUN	O	O
arthroplasty	NOUN	O	O
(THA)	NUM	O	O
from	ADP	O	O
December	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
October	ADJ	O	O
2017.	NUM	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
cost-effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
loyalty	NOUN	O	O
scheme	NOUN	O	O
based	VERB	O	O
intervention	NOUN	O	O
involving	VERB	O	O
rewards	NOUN	O	O
for	ADP	O	O
increasing	VERB	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
in	ADP	O	O
public	ADJ	O	O
sector	NOUN	O	O
employees.	NUM	O	O

Change	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
hydroxymethylglutaryl-CoA	NOUN	O	B-outcome
reductase	NOUN	O	I-outcome
enzyme	NOUN	O	I-outcome
(HMGCR)	PUNCT	O	I-outcome
levels	NOUN	O	O
correlated	VERB	O	O
more	ADV	O	O
with	ADP	O	O
change	NOUN	O	O
in	ADP	O	O
lipid	NOUN	O	B-outcome
indices	NOUN	O	O
of	ADP	O	O
DR	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
combination	NOUN	O	O
of	ADP	O	O
data	NOUN	O	O
sources	NOUN	O	O
revealed	VERB	O	O
four	NUM	O	O
themes	NOUN	O	O
and	CCONJ	O	O
16	NUM	O	O
sub-themes.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
done	NOUN	O	O
with	ADP	O	O
the	DET	O	O
goal	NOUN	O	O
of	ADP	O	O
comparing	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
Ginger	NOUN	O	O
and	CCONJ	O	O
Novafen	NOUN	O	O
on	ADP	O	O
the	DET	O	O
menstrual	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
.	PUNCT	O	O
MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
This	DET	O	O
crossover	NOUN	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
study	NOUN	O	O
was	VERB	O	O
done	NOUN	O	O
in	ADP	O	O
Iran	NOUN	O	O
on	ADP	O	O
168	NUM	O	O
single	ADJ	O	O
girl	NOUN	O	O
students	NOUN	O	O
18-26	NUM	O	O
years	NOUN	O	O
old	ADJ	O	O
in	ADP	O	O
Babol	NOUN	O	O
University	NOUN	O	O
of	ADP	O	O
Medical	ADJ	O	O
Sciences	NOUN	O	O
with	ADP	O	O
primary	ADJ	O	O
menstrual	ADJ	O	O
pain.	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
in-hospital	NOUN	O	O
delirium	NOUN	O	B-outcome
by	ADP	O	O
the	DET	O	O
Confusion	NOUN	O	O
Assessment	NOUN	O	O
Method.	NOUN	O	O

PMID:	NOUN	O	O
31618539	NUM	O	O

The	DET	O	O
exercise	NOUN	O	O
protocol	NOUN	O	O
promoted	VERB	O	O
slight	NOUN	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
,	PUNCT	O	O
reflected	VERB	O	O
in	ADP	O	O
significant	ADJ	O	O
increases	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
creatine	NOUN	O	B-outcome
kinase	NOUN	O	I-outcome
in	ADP	O	O
all	DET	O	O
subjects	NOUN	O	O
after	ADP	O	O
exercise.	NOUN	O	O

Journal-Name:American	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
orthodontics	NOUN	O	O
and	CCONJ	O	O
dentofacial	ADJ	O	O
orthopedics	NOUN	O	O
:	PUNCT	O	O
official	ADJ	O	O
publication	NOUN	O	O
of	ADP	O	O
the	DET	O	O
American	ADJ	O	O
Association	NOUN	O	O
of	ADP	O	O
Orthodontists,	NOUN	O	O
its	ADJ	O	O
constituent	ADP	O	O
societies,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
American	ADJ	O	O
Board	NOUN	O	O
of	ADP	O	O
Orthodontics	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

RESULTS:	NOUN	O	O
Of	ADP	O	O
the	DET	O	O
68	NUM	O	O
Veterans	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
self-	NOUN	O	O
or	CCONJ	O	O
provider-referred	VERB	O	O
to	PART	O	O
the	DET	O	O
program,	NOUN	O	O
25	NUM	O	O
(36.7%)	NUM	O	O
were	VERB	O	O
ineligible	ADJ	O	O
due	ADJ	O	O
to	PART	O	O
(i)	PUNCT	O	O
absence	NOUN	O	O
of	ADP	O	O
a	DET	O	O
PTSD	NOUN	O	O
diagnosis	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
3);	NOUN	O	O
participation	NOUN	O	O
in	ADP	O	O
ongoing	VERB	O	O
intense	ADJ	O	O
psychotherapy	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
4)	NOUN	O	O
or	CCONJ	O	O
inpatient	NOUN	O	O
substance	NOUN	O	O
abuse	NOUN	O	O
program	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
2);	NUM	O	O
current	ADJ	O	O
resident	ADJ	O	O
of	ADP	O	O
the	DET	O	O
Domiciliary	ADJ	O	O
(n	NOUN	O	O
=	SYM	O	O
8)	ADV	O	O
and	CCONJ	O	O
inability	NOUN	O	O
to	PART	O	O
participate	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
distance	NOUN	O	O
of	ADP	O	O
residence	NOUN	O	O
from	ADP	O	O
the	DET	O	O
VA	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
8).	NOUN	O	O

In	ADP	O	O
IHE	NOUN	O	O
only,	NOUN	O	O
post-exercise	NOUN	O	O
Tre	PUNCT	O	B-outcome
and	CCONJ	O	O
perceptual	ADJ	O	B-outcome
responses	NOUN	O	I-outcome
at	ADP	O	O
Post	ADV	O	O
HA	NOUN	O	O
and	CCONJ	O	O
+25d	NOUN	O	O
were	VERB	O	O
lower	ADJ	O	O
than	ADP	O	O
Pre	NOUN	O	O
HA	NOUN	O	O
(p</=0.01).	NUM	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Physical	ADJ	O	B-outcome
and	CCONJ	O	O
psychological	ADJ	O	B-outcome
statuses	NOUN	O	O
of	ADP	O	O
elderly	NOUN	O	O
housebound	VERB	O	O
were	VERB	O	O
significantly	ADV	O	O
improved	VERB	O	O
by	ADP	O	O
Baduanjin	NOUN	O	O
training	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
CBT.	NOUN	O	O

In	ADP	O	O
part	NOUN	O	O
B,	NOUN	O	O
patients	NOUN	O	O
without	ADP	O	O
recent	ADJ	O	O
attacks	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
once-monthly	ADV	O	O
injections	NOUN	O	O
of	ADP	O	O
one	NUM	O	O
of	ADP	O	O
two	NUM	O	O
doses	NOUN	O	O
of	ADP	O	O
givosiran	NOUN	O	O
(0.35	PUNCT	O	O
or	CCONJ	O	O
1.0	NUM	O	O
mg	NOUN	O	O
per	ADP	O	O
kilogram)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
(total	ADJ	O	O
of	ADP	O	O
two	NUM	O	O
injections	NOUN	O	O
28	NUM	O	O
days	NOUN	O	O
apart).	NOUN	O	O

In	ADP	O	O
group	NOUN	O	O
A	DET	O	O
simultaneous	ADJ	O	O
MMC	NOUN	O	O
repair	NOUN	O	O
and	CCONJ	O	O
VP	NOUN	O	O
shunting	VERB	O	O
was	VERB	O	O
performed	VERB	O	O
while	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
MMC	NOUN	O	O
repair	NOUN	O	O
was	VERB	O	O
done	NOUN	O	O
in	ADP	O	O
first	ADV	O	O
and	CCONJ	O	O
VP	NOUN	O	O
shunting	VERB	O	O
was	VERB	O	O
done	NOUN	O	O
two	NUM	O	O
weeks	NOUN	O	O
postoperatively..	NOUN	O	O
RESULTS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
study	NOUN	O	O
mean	NOUN	O	O
age	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
A	DET	O	O
was	VERB	O	O
1	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
SD+/-2.77	ADP	O	O
while	ADP	O	O
mean	NOUN	O	O
age	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
B	NOUN	O	O
was	VERB	O	O
1	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
SD+/-3.12.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
SuperPATH	NOUN	O	O
approach	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
hip	NOUN	O	O
arthroplasty	NOUN	O	O
(THA)	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
conventional	ADJ	O	O
posterolateral	ADJ	O	O
approach.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
LASIK	NOUN	O	O
group,	NOUN	O	O
central	ADJ	O	B-outcome
epithelial	ADJ	O	I-outcome
thickness	NOUN	O	I-outcome
increased	VERB	O	O
from	ADP	O	O
52.38	NUM	O	O
+/-	SYM	O	O
2.57	NUM	O	O
mum	NOUN	O	O
to	PART	O	O
57.00	NUM	O	O
+/-	SYM	O	O
4.23	NUM	O	O
mum	NOUN	O	O
and	CCONJ	O	O
remained	VERB	O	O
almost	ADV	O	O
stable	ADJ	O	O
at	ADP	O	O
this	DET	O	O
level	NOUN	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
24	NUM	O	O
months.	NOUN	O	O

Additionally,	NOUN	O	O
both	CCONJ	O	O
groups	NOUN	O	O
will	VERB	O	O
receive	VERB	O	O
the	DET	O	O
same	ADJ	O	O
acupuncture	NOUN	O	O
treatment	NOUN	O	O
once	ADP	O	O
a	DET	O	O
week	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
weeks	NOUN	O	O
as	ADP	O	O
a	DET	O	O
concurrent	ADJ	O	O
treatment.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrials.gov,	NOUN	O	O
NCT01465698	NOUN	O	O
November	NOUN	O	O
7,	NUM	O	O
2011	NUM	O	O
(prospective).	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
brief	ADJ	O	O
group	NOUN	O	O
intervention	NOUN	O	O
in	ADP	O	O
the	DET	O	O
harmful	ADJ	O	O
alcohol	NOUN	O	O
use	NOUN	O	O
in	ADP	O	O
primary	ADJ	O	O
health	NOUN	O	O
care.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7909660	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Hybrid	NOUN	O	O
surgery	NOUN	O	O
comprised	VERB	O	O
a	DET	O	O
two-field	NOUN	O	O
abdominal-thoracic	ADJ	O	O
operation	NOUN	O	O
(also	ADV	O	O
called	VERB	O	O
an	DET	O	O
Ivor-Lewis	NOUN	O	O
procedure)	NOUN	O	O
with	ADP	O	O
laparoscopic	ADJ	O	O
gastric	ADJ	O	O
mobilization	NOUN	O	O
and	CCONJ	O	O
open	ADJ	O	O
right	ADJ	O	O
thoracotomy.	NOUN	O	O

Conclusion:	NOUN	O	O
Nursing	VERB	O	O
intervention	NOUN	O	O
can	VERB	O	O
effectively	ADV	O	O
improve	VERB	O	O
forced	VERB	O	B-outcome
expiratory	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
in	ADP	O	Seperator
1	NUM	O	I-outcome
second	ADJ	O	I-outcome
(FEV(1)	PUNCT	O	I-outcome
,	PUNCT	O	O
forced	VERB	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(FVC)	PUNCT	O	I-outcome
,	PUNCT	O	O
arterial	ADJ	O	B-outcome
partial	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
of	ADP	O	I-outcome
oxygen	NOUN	O	I-outcome
(PaO(2)	PUNCT	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
6-minute	NOUN	O	O
walking	VERB	O	B-outcome
distance	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
silicosis	NOUN	O	O
complicated	VERB	O	O
by	ADP	O	O
stable	ADJ	O	O
COPD.	NOUN	O	O

High	ADJ	O	O
ECOG	NOUN	O	O
scores,	NOUN	O	O
cancer	NOUN	O	O
localization	NOUN	O	O
to	PART	O	O
the	DET	O	O
right	ADJ	O	O
side	NOUN	O	O
of	ADP	O	O
colon	NOUN	O	O
and	CCONJ	O	O
lymph	NOUN	O	O
node	NOUN	O	O
metastasis	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
increased	VERB	O	O
risk	NOUN	O	O
of	ADP	O	O
death	NOUN	O	B-outcome
and	CCONJ	O	O
all	DET	O	O
remained	VERB	O	O
independent	ADJ	O	O
factors	NOUN	O	O
affecting	VERB	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
most	DET	O	O
common	ADJ	O	O
grade	NOUN	O	O
3/4	PUNCT	O	O
treatment-related	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
hypertension	NOUN	O	B-outcome
and	CCONJ	O	O
hand-foot	NOUN	O	B-outcome
skin	NOUN	O	I-outcome
syndrome	NOUN	O	I-outcome
.	PUNCT	O	O
Apatinib	ADP	O	O
treatment	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
failed	VERB	O	O
chemotherapy	NOUN	O	O
achieved	NOUN	O	O
better	ADJ	O	O
disease	NOUN	O	B-outcome
control	NOUN	O	I-outcome
and	CCONJ	O	O
prolonged	VERB	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
relative	ADJ	O	O
to	PART	O	O
untreated	VERB	O	O
controls.	NOUN	O	O

Music	ADJ	O	O
therapy	NOUN	O	O
is	VERB	O	O
used	VERB	O	O
as	ADP	O	O
a	DET	O	O
nonpharmacologic	ADJ	O	O
intervention	NOUN	O	O
for	ADP	O	O
pain	NOUN	O	O
management	NOUN	O	O
and	CCONJ	O	O
to	PART	O	O
promote	VERB	O	O
rehabilitation	NOUN	O	O
exercise	NOUN	O	O
adherence.	NOUN	O	O

Title:	NOUN	O	O
Three-Year	ADP	O	O
Prospective	ADJ	O	O
Randomized	VERB	O	O
Comparative	ADJ	O	O
Assessment	NOUN	O	O
of	ADP	O	O
Anterior	ADJ	O	O
Maxillary	ADJ	O	O
Single	NOUN	O	O
Implants	NOUN	O	O
with	ADP	O	O
Different	ADJ	O	O
Abutment	NOUN	O	O
Interfaces.	NOUN	O	O

Advances	NOUN	O	O
in	ADP	O	O
knowledge:	NOUN	O	O
Our	ADJ	O	O
work	NOUN	O	O
is	VERB	O	O
relevant	ADJ	O	O
for	ADP	O	O
MRI	NOUN	O	O
sequence	NOUN	O	O
choice	NOUN	O	O
and	CCONJ	O	O
development	NOUN	O	O
of	ADP	O	O
the	DET	O	O
roles	NOUN	O	O
of	ADP	O	O
the	DET	O	O
interprofessional	ADJ	O	O
team	NOUN	O	O
in	ADP	O	O
the	DET	O	O
advancement	ADJ	O	O
of	ADP	O	O
MRI-guided	VERB	O	O
radiotherapy.	NOUN	O	O

METHODS:	NOUN	O	O
Patients	NOUN	O	O
who	ADP	O	O
started	VERB	O	O
riociguat	NOUN	O	O
treatment	NOUN	O	O
(1.0-2.5	NOUN	O	O
mg	NOUN	O	O
tid)	NOUN	O	O
within	ADP	O	O
the	DET	O	O
trials	NOUN	O	O
phase	NOUN	O	O
II,	NOUN	O	O
PATENT,	NOUN	O	O
PATENTplus,	NOUN	O	O
EAS,	NOUN	O	O
CHEST	NOUN	O	O
and	CCONJ	O	O
continued	NOUN	O	O
treatment	NOUN	O	O
for	ADP	O	O
3-12	NUM	O	O
months	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
Endometrial	ADJ	O	O
Scratching	VERB	O	O
before	ADP	O	O
In	ADP	O	O
Vitro	ADV	O	O
Fertilization.	NOUN	O	O

RESULTS:	NOUN	O	O
Compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
condition,	NOUN	O	O
unhealthy	NOUN	O	O
food	NOUN	O	O
sponsorship	NOUN	O	O
promoted	VERB	O	O
higher	ADJ	O	O
awareness	ADV	O	B-outcome
of,	NOUN	O	O
and	CCONJ	O	O
more	ADV	O	O
favourable	ADJ	O	O
attitudes	NOUN	O	B-outcome
towards,	NOUN	O	O
unhealthy	NOUN	O	O
food	NOUN	O	O
sponsor	ADP	O	O
brands.	NOUN	O	O

PURPOSE:	NOUN	O	O
The	DET	O	O
goal	NOUN	O	O
of	ADP	O	O
this	DET	O	O
investigation	NOUN	O	O
was	VERB	O	O
to	PART	O	O
define	NOUN	O	O
time-dependent	ADJ	O	O
peri-implant	ADJ	O	B-outcome
tissue	NOUN	O	I-outcome
changes	NOUN	O	O
at	ADP	O	O
implants	NOUN	O	O
with	ADP	O	O
different	ADJ	O	O
abutment	NOUN	O	O
interface	NOUN	O	O
designs.	VERB	O	O

Title:	NOUN	O	O
Changes	NOUN	O	O
in	ADP	O	O
Unilateral	ADJ	O	O
Upper	NOUN	O	B-outcome
Limb	NOUN	O	I-outcome
Muscular	ADJ	O	I-outcome
Strength	NOUN	O	I-outcome
and	CCONJ	O	O
Electromyographic	ADJ	O	B-outcome
Activity	NOUN	O	O
After	ADP	O	O
a	DET	O	O
16-Week	NOUN	O	O
Strength	NOUN	O	O
Training	VERB	O	O
Intervention	NOUN	O	O
in	ADP	O	O
Survivors	NOUN	O	O
of	ADP	O	O
Breast	NOUN	O	O
Cancer.	ADV	O	O

CONCLUSIONS:	NOUN	O	O
In	ADP	O	O
summary,	ADJ	O	O
we	PRON	O	O
demonstrated	VERB	O	O
that	ADP	O	O
10	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
NMES	NOUN	O	O
therapy	NOUN	O	O
was	VERB	O	O
efficacious	ADJ	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
UIAS.	NOUN	O	O

Importance:	NOUN	O	O
Intraoperative	ADJ	O	O
electroencephalogram	NOUN	O	O
(EEG)	PUNCT	O	O
waveform	NOUN	O	O
suppression,	NOUN	O	O
often	ADV	O	O
suggesting	VERB	O	O
excessive	ADJ	O	O
general	ADJ	O	O
anesthesia,	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
postoperative	ADJ	O	O
delirium.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101599229	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
research	NOUN	O	O
sample	NOUN	O	O
includes	NOUN	O	O
3489	NUM	O	O
girls,	ADJ	O	O
with	ADP	O	O
about	ADV	O	O
25	NUM	O	O
girls	NOUN	O	O
per	ADP	O	O
school	NOUN	O	O
on	ADP	O	O
average.	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Intra-abdominal	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
loss	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
larger	ADJ	O	O
in	ADP	O	O
the	DET	O	O
exercise	NOUN	O	O
plus	CCONJ	O	O
diet	NOUN	O	O
group	NOUN	O	O
(-	NOUN	O	O
3.8	NUM	O	O
cm(2),	ADV	O	O
95%CI	NOUN	O	O
-9.0;	PUNCT	O	O
1.3).	NUM	O	O

At	ADP	O	O
D29,	NOUN	O	O
intention-to-treat	NOUN	O	O
efficacy	NOUN	O	O
in	ADP	O	O
the	DET	O	O
AmBisome	NOUN	O	O
arm	NOUN	O	O
was	VERB	O	O
70%	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
45-87%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
unadjusted	VERB	O	O
analysis,	NOUN	O	O
and	CCONJ	O	O
50%	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
27-73%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
adjusted	VERB	O	O
analysis,	NOUN	O	O
while	ADP	O	O
in	ADP	O	O
the	DET	O	O
combination	NOUN	O	O
arm,	ADJ	O	O
it	PRON	O	O
was	VERB	O	O
81%	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
67-90%)	ADP	O	O
and	CCONJ	O	O
67%	ADJ	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
48-82%)	PUNCT	O	O
respectively.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Title:	NOUN	O	O
Caplacizumab	NOUN	O	O
Treatment	NOUN	O	O
for	ADP	O	O
Acquired	VERB	O	O
Thrombotic	ADJ	O	O
Thrombocytopenic	ADJ	O	O
Purpura.	NOUN	O	O

The	DET	O	O
SPT-SMV	NOUN	O	O
experimental	ADJ	O	O
group	NOUN	O	O
received	VERB	O	O
SMV	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
each	DET	O	O
SPT	NOUN	O	O
session.	NOUN	O	O

We	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
bilateral	ADJ	O	O
internal-thoracic-artery	ADV	O	O
grafts	NOUN	O	O
for	ADP	O	O
CABG.	NOUN	O	O

In	ADP	O	O
experimental	ADJ	O	O
group,	NOUN	O	O
patients	NOUN	O	O
received	VERB	O	O
delayed-start	NOUN	O	O
GnRH	NOUN	O	O
antagonist	NOUN	O	O
protocol	NOUN	O	O
with	ADP	O	O
estrogen	NOUN	O	O
priming	VERB	O	O
followed	VERB	O	O
by	ADP	O	O
early	ADJ	O	O
follicular-phase	NOUN	O	O
GnRH	NOUN	O	O
antagonist	NOUN	O	O
treatment	NOUN	O	O
for	ADP	O	O
7	NUM	O	O
days	NOUN	O	O
before	ADP	O	O
ovarian	ADJ	O	O
stimulation	NOUN	O	O
with	ADP	O	O
gonadotropin	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
control	NOUN	O	O
group,	NOUN	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
estrogen	NOUN	O	O
priming	VERB	O	O
antagonist	NOUN	O	O
protocol.	NOUN	O	O

SETTING:	NOUN	O	O
University	NOUN	O	O
laboratory	NOUN	O	O
setting.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
randomized	VERB	O	O
crossover	NOUN	O	O
study	NOUN	O	O
evaluated	VERB	O	O
23	NUM	O	O
healthcare	NOUN	O	O
providers.	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/28	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[pubmed]	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Guidelines	NOUN	O	O
recommend	NOUN	O	O
macrolides	NOUN	O	O
and	CCONJ	O	O
fluoroquinolones	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
hospitalized	VERB	O	O
with	ADP	O	O
community-acquired	VERB	O	O
pneumonia	NOUN	O	O
(CAP),	PUNCT	O	O
but	CCONJ	O	O
their	ADJ	O	O
use	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
cardiac	ADJ	O	O
events.	NOUN	O	O

SAI	NOUN	O	O
were	VERB	O	O
classified	VERB	O	O
as	ADP	O	O
lacunar	NOUN	O	O
infarction	NOUN	O	O
and	CCONJ	O	O
non-lacunar	NOUN	O	O
infarction.	NOUN	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
an	DET	O	O
ocular	ADJ	O	O
bandage	NOUN	O	O
contact	NOUN	O	O
lens	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
dry	ADJ	O	O
eye	NOUN	O	O
after	ADP	O	O
phacoemulsification.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

Use	PUNCT	O	O
of	ADP	O	O
hyaluronan-based	VERB	O	O
sperm	NOUN	O	O
selection	NOUN	O	O
for	ADP	O	O
ICSI	NOUN	O	O
(so-called	VERB	O	O
physiological	ADJ	O	O
ICSI	NOUN	O	O
[PICSI])	NOUN	O	O
is	VERB	O	O
reported	VERB	O	O
to	PART	O	O
reduce	VERB	O	O
the	DET	O	O
proportion	NOUN	O	O
of	ADP	O	O
pregnancies	NOUN	O	O
that	ADP	O	O
end	NOUN	O	O
in	ADP	O	O
miscarriage.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
of	ADP	O	O
this	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
rate.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Multicenter	NOUN	O	O
Study,	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O
Research	NOUN	O	O
Support,	NOUN	O	O
Non-U.S.	NOUN	O	O
Gov't,	NOUN	O	O

Method	NOUN	O	O
A	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
double	ADV	O	O
blind,	NOUN	O	O
placebo	NOUN	O	O
control	NOUN	O	O
trial	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
in	ADP	O	O
community	NOUN	O	O
after	ADP	O	O
obtaining	VERB	O	O
the	DET	O	O
ethical	ADJ	O	O
clearance	NOUN	O	O
from	ADP	O	O
the	DET	O	O
IRC.	NOUN	O	O

Finally,	NOUN	O	O
endometrial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
,	PUNCT	O	O
chemical,	ADJ	O	B-outcome
clinical,	ADJ	O	B-outcome
and	CCONJ	O	Seperator
ongoing	VERB	O	B-outcome
pregnancy	NOUN	O	E1-outcome
rates	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
two	NUM	O	O
groups.	NOUN	O	O

These	DET	O	O
meetings,	NOUN	O	O
called	VERB	O	O
Community	NOUN	O	O
Health	NOUN	O	O
Data	NOUN	O	O
Review	NOUN	O	O
(CHDR)	NUM	O	O
meetings,	NOUN	O	O
were	VERB	O	O
attended	VERB	O	O
by	ADP	O	O
community	NOUN	O	O
leaders,	NOUN	O	O
including	VERB	O	O
members	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Ward	NOUN	O	O
Development	NOUN	O	O
Committee	NOUN	O	O
(WDC)	ADJ	O	O
and	CCONJ	O	O
Health	NOUN	O	O
Management	NOUN	O	O
Committee	NOUN	O	O
(HMC),	NUM	O	O
by	ADP	O	O
the	DET	O	O
CHW	NOUN	O	O
Peer	NOUN	O	O
Supervisors,	NOUN	O	O
and	CCONJ	O	O
by	ADP	O	O
representatives	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Peripheral	ADJ	O	O
Health	NOUN	O	O
Unit.	NOUN	O	O

CONCLUSION:	NOUN	O	O
These	DET	O	O
data	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
a	DET	O	O
single	ADJ	O	O
round	ADJ	O	O
of	ADP	O	O
MDA	NOUN	O	O
may	VERB	O	O
not	ADV	O	O
be	VERB	O	O
sufficient	ADJ	O	O
to	PART	O	O
decrease	NOUN	O	O
trachomatous	ADJ	O	B-outcome
inflammation-follicular	ADJ	O	I-outcome
levels	NOUN	O	O
below	ADP	O	O
5%	NOUN	O	O
when	ADP	O	O
TF1-9	NOUN	O	O
is	VERB	O	O
between	ADP	O	O
5	NUM	O	O
and	CCONJ	O	O
9.9%	NOUN	O	O
at	ADP	O	O
baseline.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
cross-over	NOUN	O	O
trial	NOUN	O	O
of	ADP	O	O
eight	NUM	O	O
weeks	NOUN	O	O
combined	VERB	O	O
aerobic	ADJ	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
training	VERB	O	O
on	ADP	O	O
body	NOUN	O	B-outcome
composition	NOUN	O	I-outcome
assessed	VERB	O	O
by	ADP	O	O
Dual	ADJ	O	O
Energy	NOUN	O	O
X-ray	NOUN	O	O
Absorptiometry	NOUN	O	O
was	VERB	O	O
performed.	NOUN	O	O

A	DET	O	O
mindfulness-based	VERB	O	O
intervention	NOUN	O	O
(MBI)	NOUN	O	O
represents	NOUN	O	O
a	DET	O	O
promising	VERB	O	O
non-pharmacological	ADJ	O	O
framework	NOUN	O	O
for	ADP	O	O
Alzheimer's	NOUN	O	O
disease	NOUN	O	O
prevention.	NOUN	O	O

Similar	ADJ	O	O
changes	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
some	DET	O	O
slight	NOUN	O	O
or	CCONJ	O	O
more	ADV	O	O
serious	ADJ	O	O
unintentional	ADJ	O	O
injuries	NOUN	O	B-outcome
(P=0.030).	NUM	O	O

In	ADP	O	O
recent	ADJ	O	O
years,	NOUN	O	O
enamel	NOUN	O	O
matrix	NOUN	O	O
derivatives	NOUN	O	O
(EMDs)	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
used	VERB	O	O
for	ADP	O	O
their	ADJ	O	O
regenerative	ADJ	O	O
potential	ADJ	O	O
in	ADP	O	O
periodontics.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

It	PRON	O	O
was	VERB	O	O
also	ADV	O	O
registered	VERB	O	O
after	ADP	O	O
completion	NOUN	O	O
at	ADP	O	O
ClinicalTrials.gov	NOUN	O	O
(	PUNCT	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT03662165):	NOUN	O	O
https://clinicaltrials.gov/ct2/show/NCT03662165?term=NCT03662165&type=Intr&cond=H	NOUN	O	O
IV&rank=1	NUM	O	O

Conclusion:	NOUN	O	O
The	DET	O	O
approach	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
selecting	VERB	O	O
the	DET	O	O
patients	NOUN	O	O
participating	VERB	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
and	CCONJ	O	O
analyzing	VERB	O	O
the	DET	O	O
data	NOUN	O	O
in	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
allows	NOUN	O	O
us	PRON	O	O
to	PART	O	O
conclude	NOUN	O	O
that	ADP	O	O
cryotherapy	NOUN	O	O
is	VERB	O	O
an	DET	O	O
aid	VERB	O	O
of	ADP	O	O
clinical	ADJ	O	O
procedures	NOUN	O	O
to	PART	O	O
clean	NOUN	O	O
and	CCONJ	O	O
shape	NOUN	O	O
the	DET	O	O
canals	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
the	DET	O	O
occurrence	NOUN	O	O
of	ADP	O	O
postendodontic	ADJ	O	O
pain	NOUN	O	B-outcome
and	CCONJ	O	O
the	DET	O	O
need	NOUN	O	B-outcome
for	ADP	O	Seperator
medication	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
presenting	VERB	O	O
with	ADP	O	O
a	DET	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
vital	ADJ	O	O
pulp.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
proportion	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
reporting	VERB	O	O
severe	ADJ	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
a	DET	O	O
pain	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
between	ADP	O	O
7	NUM	O	O
and	CCONJ	O	O
10,	NUM	O	O
on	ADP	O	O
postoperative	ADJ	O	O
day	NOUN	O	O
number	NOUN	O	O
2	NUM	O	O
(POD	NOUN	O	O
2)	NOUN	O	O
were	VERB	O	O
21%	NUM	O	O
for	ADP	O	O
the	DET	O	O
single-shot	NOUN	O	O
group,	NOUN	O	O
14%	NOUN	O	O
for	ADP	O	O
the	DET	O	O
24-hour	NOUN	O	O
block	VERB	O	O
group,	NOUN	O	O
and	CCONJ	O	O
12%	NUM	O	O
for	ADP	O	O
the	DET	O	O
48-hour	NOUN	O	O
block	VERB	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.05).	NOUN	O	O

The	DET	O	O
same	ADJ	O	O
tools	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
at	ADP	O	O
two,	NOUN	O	O
six	NUM	O	O
and	CCONJ	O	O
at	ADP	O	O
twelve	NUM	O	O
weeks	NOUN	O	O
post	ADV	O	O
injection	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
functional	ADJ	O	B-outcome
outcome	NOUN	O	O
and	CCONJ	O	O
pain	NOUN	O	B-outcome
.	PUNCT	O	O
Result	NOUN	O	O
One	NUM	O	O
hundred	NUM	O	O
and	CCONJ	O	O
seventeen	ADV	O	O
patients	NOUN	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
analysis	NOUN	O	O
among	ADP	O	O
which,	NOUN	O	O
55(48.7%)	NUM	O	O
patients	NOUN	O	O
received	VERB	O	O
Triamcinolone	NOUN	O	O
and	CCONJ	O	O
58(51.3%)	NUM	O	O
received	VERB	O	O
placebo.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Preoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
also	ADV	O	O
exhibited	VERB	O	O
decreased	VERB	O	O
patient's	NOUN	O	O
global	ADJ	O	B-outcome
assessment	NOUN	O	I-outcome
(PGA)	PUNCT	O	O
score	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
2	NUM	O	O
hours,	NOUN	O	O
6	NUM	O	O
hours,	NOUN	O	O
12	NUM	O	O
hours,	NOUN	O	O
24	NUM	O	O
hours,	NOUN	O	O
and	CCONJ	O	O
48	NUM	O	O
hours	NOUN	O	O
post	ADV	O	O
operation.	ADV	O	O

At	ADP	O	O
23	NUM	O	O
years,	NOUN	O	O
a	DET	O	O
mean	NOUN	O	O
of	ADP	O	O
2.9	NUM	O	O
extra	ADJ	O	O
years	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
were	VERB	O	O
gained	VERB	O	O
with	ADP	O	O
radical	NOUN	O	O
prostatectomy.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Acute	ADJ	O	O
GU	NOUN	O	B-outcome
Toxicities	NOUN	O	I-outcome
were	VERB	O	O
more	ADV	O	O
common	ADJ	O	O
in	ADP	O	O
the	DET	O	O
MHF	NOUN	O	O
than	ADP	O	O
the	DET	O	O
EHF	NOUN	O	O
group	NOUN	O	O
(85	PUNCT	O	O
vs.	CCONJ	O	O
57%,	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.009),	NUM	O	O
but	CCONJ	O	O
late	ADJ	O	O
GI	NOUN	O	B-outcome
and	CCONJ	O	Seperator
GU	NOUN	O	B-outcome
toxicities	NOUN	O	E1-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
SMILE	NOUN	O	O
eyes,	NOUN	O	O
it	PRON	O	O
increased	VERB	O	O
from	ADP	O	O
52.52	NUM	O	O
+/-	SYM	O	O
3.01	NUM	O	O
mum	NOUN	O	O
to	PART	O	O
57.15	NUM	O	O
+/-	SYM	O	O
4.57	NUM	O	O
mum	NOUN	O	O
and	CCONJ	O	O
also	ADV	O	O
remained	VERB	O	O
stable	ADJ	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
24	NUM	O	O
months.	NOUN	O	O

Statistical	ADJ	O	O
analyses	NOUN	O	O
included	VERB	O	O
t	NOUN	O	O
tests,	NOUN	O	O
a	DET	O	O
Poisson	NOUN	O	O
regression	NOUN	O	O
model,	NOUN	O	O
and	CCONJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
covariance	NOUN	O	O
(ANCOVA)	NUM	O	O
using	VERB	O	O
STATA.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
found	VERB	O	O
that	ADP	O	O
lactulose	ADV	O	O
is	VERB	O	O
efficacious	ADJ	O	O
for	ADP	O	O
Chinese	NOUN	O	O
children	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
constipation	NOUN	O	O
after	ADP	O	O
6-weeks	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Single-dose	NUM	O	O
tafenoquine	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
a	DET	O	O
significantly	ADV	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
recurrence	NOUN	O	O
than	ADP	O	O
placebo	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
phenotypically	ADV	O	O
normal	ADJ	O	O
G6PD	NOUN	O	O
activity.	NOUN	O	O
(	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/07	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/20	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
647	NUM	O	O
patients	NOUN	O	O
underwent	VERB	O	O
randomization	NOUN	O	O
from	ADP	O	O
December	NOUN	O	O
2008	NUM	O	O
through	ADP	O	O
January	NOUN	O	O
2012,	NUM	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
lymphadenectomy	NOUN	O	O
(323	NUM	O	O
patients)	NOUN	O	O
or	CCONJ	O	O
not	ADV	O	O
undergo	NOUN	O	O
lymphadenectomy	NOUN	O	O
(324),	ADV	O	O
and	CCONJ	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
analysis.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

BACKGROUND:	NOUN	O	O
Amyotrophic	ADJ	O	O
Lateral	ADJ	O	O
Sclerosis	NOUN	O	O
(ALS)	PUNCT	O	O
is	VERB	O	O
a	DET	O	O
rapid	ADJ	O	O
progressive	ADJ	O	O
neurodegenerative	ADJ	O	O
disease,	NOUN	O	O
characterized	VERB	O	O
by	ADP	O	O
a	DET	O	O
selective	ADJ	O	O
loss	NOUN	O	O
of	ADP	O	O
motor	NOUN	O	O
neurons,	PUNCT	O	O
brain	NOUN	O	O
stem	NOUN	O	O
and	CCONJ	O	O
spinal	ADJ	O	O
cord	NOUN	O	O
which	ADP	O	O
leads	NOUN	O	O
to	PART	O	O
deterioration	NOUN	O	O
of	ADP	O	O
motor	NOUN	O	O
abilities.	NOUN	O	O

Journal-Name:The	ADJ	O	O
western	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
emergency	NOUN	O	O
medicine	NOUN	O	O

Electromyography-measured	VERB	O	O
eyestrain	NOUN	O	B-outcome
was	VERB	O	O
less	ADV	O	O
with	ADP	O	O
toric	ADJ	O	O
versus	CCONJ	O	O
spherical	ADJ	O	O
contact	NOUN	O	O
lenses	NOUN	O	O
at	ADP	O	O
fitting	VERB	O	O
(least-square	NOUN	O	O
ratio	NOUN	O	O
of	ADP	O	O
toric	ADJ	O	O
over	ADP	O	O
spherical=0.72;	NOUN	O	O
P=0.0019)	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
at	ADP	O	O
follow-up	NOUN	O	O
(ratio=0.86;	NUM	O	O
P=0.11).	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
study	NOUN	O	O
medication	NOUN	O	O
was	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
analyzing	VERB	O	O
lipid	NOUN	O	B-outcome
profile.	NOUN	O	O

To	PART	O	O
improve	VERB	O	O
the	DET	O	O
success	NOUN	O	O
rate,	NOUN	O	O
probing	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
tobramycin/dexamethasone	NOUN	O	O
ointment	NOUN	O	O
is	VERB	O	O
considered	VERB	O	O
effective.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/29	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
Perceived	VERB	O	O
Stress	NOUN	O	B-outcome
Scale],	NOUN	O	O
Center	NOUN	O	O
for	ADP	O	O
Epidemiologic	ADJ	O	O
Studies	NOUN	O	O
Depression	NOUN	O	B-outcome
Scale],	NOUN	O	O
and	CCONJ	O	O
Positive	ADJ	O	B-outcome
and	CCONJ	O	Seperator
Negative	ADJ	O	B-outcome
Affect	NOUN	O	E1-outcome
Scale	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
measure	NOUN	O	O
stress	NOUN	O	B-outcome
,	PUNCT	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
positive	ADJ	O	B-outcome
and	CCONJ	O	Seperator
negative	ADJ	O	B-outcome
affect	NOUN	O	E1-outcome
,	PUNCT	O	O
respectively.	NOUN	O	O

Relocating	VERB	O	O
away	ADJ	O	O
from	ADP	O	O
family	NOUN	O	O
and	CCONJ	O	O
country	NOUN	O	O
for	ADP	O	O
treatment,	NOUN	O	O
adjusting	VERB	O	O
to	PART	O	O
life	NOUN	O	O
with	ADP	O	O
a	DET	O	O
chronic	ADJ	O	O
condition	NOUN	O	O
and	CCONJ	O	O
time	NOUN	O	O
lost	VERB	O	O
to	PART	O	O
dialysis	NOUN	O	O
cause	ADP	O	O
grief	NOUN	O	O
and	CCONJ	O	O
sadness	ADV	O	O
which	ADP	O	O
have	VERB	O	O
immense	NOUN	O	O
impact	NOUN	O	O
on	ADP	O	O
quality	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
and	CCONJ	O	O
challenges	NOUN	O	O
treatment	NOUN	O	O
adherence.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Chronic	ADJ	O	O
obstructive	ADJ	O	O
pulmonary	ADJ	O	O
disease	NOUN	O	O
(COPD)	NUM	O	O
is	VERB	O	O
a	DET	O	O
serious	ADJ	O	O
lung	NOUN	O	O
disease	NOUN	O	O
for	ADP	O	O
individuals	NOUN	O	O
in	ADP	O	O
middle	ADJ	O	O
age	NOUN	O	O
and	CCONJ	O	O
especially	ADV	O	O
in	ADP	O	O
old	ADJ	O	O
people.	NOUN	O	O

The	DET	O	O
G1	NOUN	O	O
presented	VERB	O	O
a	DET	O	O
higher	ADJ	O	O
average	NOUN	O	O
hospital	NOUN	O	B-outcome
stay	NOUN	O	I-outcome
in	ADP	O	O
relation	NOUN	O	O
to	PART	O	O
the	DET	O	O
G2,	NOUN	O	O
such	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
significant	ADJ	O	O
(p>	NUM	O	O
0.05).	NOUN	O	O

The	DET	O	O
level	NOUN	O	O
of	ADP	O	O
activity	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
assessed	VERB	O	O
on	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
a	DET	O	O
questionnaire	NOUN	O	O
and	CCONJ	O	O
body	NOUN	O	O
posture	ADJ	O	O
assessments	NOUN	O	O
were	VERB	O	O
done	NOUN	O	O
using	VERB	O	O
a	DET	O	O
plumb	NOUN	O	O
line,	NOUN	O	O
pediscoliometer,	ADV	O	O
digital	ADJ	O	O
inclinometer.	NOUN	O	O

Before	ADP	O	O
crossover,	NOUN	O	O
the	DET	O	O
objective	ADP	O	O
response	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
33%	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
20	NUM	O	O
to	PART	O	O
48)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sorafenib	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
20%	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
8	NUM	O	O
to	PART	O	O
38)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
live	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
rates	NOUN	O	O
between	ADP	O	O
Group	NOUN	O	O
1	NUM	O	O
and	CCONJ	O	O
Group	NOUN	O	O
2	NUM	O	O
by	ADP	O	O
intention-to-treat	NOUN	O	O
(14/34,	PUNCT	O	O
41.2%	NUM	O	O
versus	CCONJ	O	O
21/37,	NUM	O	O
56.8%,	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.19)	NUM	O	O
or	CCONJ	O	O
per-protocol	NOUN	O	O
(14/26,	PUNCT	O	O
53.8%	NUM	O	O
versus	CCONJ	O	O
19/31,	ADV	O	O
61.3%,	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.57)	NUM	O	O
analyses.	NOUN	O	O

A	DET	O	O
follow-up	NOUN	O	O
extension	NOUN	O	O
was	VERB	O	O
then	ADV	O	O
done,	ADJ	O	O
with	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
cumulative	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
chronic	ADJ	O	B-outcome
graft-versus-host	ADV	O	I-outcome
disease	NOUN	O	I-outcome
(cGVHD)	NOUN	O	I-outcome
.	PUNCT	O	O
Enrolment	ADJ	O	O
has	VERB	O	O
been	VERB	O	O
completed	VERB	O	O
for	ADP	O	O
both	CCONJ	O	O
studies.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
HIV	NOUN	O	B-outcome
testing	VERB	O	I-outcome
between	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
enhanced	VERB	O	O
SOC	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
SOC	NOUN	O	O
groups.	NOUN	O	O

CONCLUSION:	NOUN	O	O
RADPAD	NOUN	O	O
significantly	ADV	O	O
reduces	NOUN	O	O
radiation	NOUN	O	B-outcome
exposure	NOUN	O	I-outcome
to	PART	O	O
the	DET	O	O
primary	ADJ	O	O
operator	NOUN	O	O
during	ADP	O	O
prolonged	VERB	O	O
complex	NOUN	O	O
PCI	NOUN	O	O
procedures.	NOUN	O	O

beta-Eudesmol,	NOUN	O	O
an	DET	O	O
oxygenated	VERB	O	O
sesquiterpene,	NOUN	O	O
is	VERB	O	O
reported	VERB	O	O
to	PART	O	O
accumulate	VERB	O	O
in	ADP	O	O
a	DET	O	O
particular	NOUN	O	O
hop	NOUN	O	O
cultivar.	NOUN	O	O

The	DET	O	O
tear	NUM	O	B-outcome
film	NOUN	O	I-outcome
break-up	NOUN	O	I-outcome
time	NOUN	O	I-outcome
was	VERB	O	O
higher	ADJ	O	O
at	ADP	O	O
2	NUM	O	O
weeks	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
1	NUM	O	O
month	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A.	PROPN	O	O
The	DET	O	O
Schirmer	NOUN	O	O
I	NUM	O	O
test	NOUN	O	O
and	CCONJ	O	O
ocular	ADJ	O	B-outcome
surface	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
index	NOUN	O	O
scores	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
better	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
2	NUM	O	O
months.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8216186	NUM	O	O

Mean	NOUN	O	O
central	ADJ	O	B-outcome
corneal	ADJ	O	I-outcome
thickness	NOUN	O	I-outcome
(CCT)	PUNCT	O	I-outcome
was	VERB	O	O
similar	ADJ	O	O
at	ADP	O	O
baseline	NOUN	O	O
(550	ADV	O	O
+/-	SYM	O	O
35	NUM	O	O
mum)	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
12	NUM	O	O
months	NOUN	O	O
(551	NOUN	O	O
+/-	SYM	O	O
37	NUM	O	O
mum)	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
months	NOUN	O	O
(555	NUM	O	O
+/-	SYM	O	O
35	NUM	O	O
mum).	NOUN	O	O

antibiotics	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
CT-scan	NOUN	O	O
confirmed	VERB	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis.	NOUN	O	O

Journal-Name:JAMA	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
phase	NOUN	O	O
II/III	NOUN	O	O
trial	NOUN	O	O
of	ADP	O	O
neoadjuvant	ADJ	O	O
chemotherapy	NOUN	O	O
with	ADP	O	O
gemcitabine	NOUN	O	O
and	CCONJ	O	O
S-1	NOUN	O	O
versus	CCONJ	O	O
upfront	ADP	O	O
surgery	NOUN	O	O
for	ADP	O	O
resectable	ADJ	O	O
pancreatic	ADJ	O	O
cancer	NOUN	O	O
(Prep-02/JSAP05).	NUM	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
Netherlands	NOUN	O	O
Organization	NOUN	O	O
for	ADP	O	O
Health	NOUN	O	O
Research	NOUN	O	O
and	CCONJ	O	O
Development	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
LEAP	NOUN	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials	NOUN	O	O
number,	ADV	O	O
ISRCTN30518857	NOUN	O	O
.).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8102988	NUM	O	O

Additionally,	NOUN	O	O
30	NUM	O	O
healthy	ADJ	O	O
people	NOUN	O	O
were	VERB	O	O
selected	VERB	O	O
as	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(NC	PUNCT	O	O
group).	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Trial	NOUN	O	O
registered	VERB	O	O
at	ADP	O	O
ClinicalTrials.gov	NOUN	O	O
with	ADP	O	O
protocol	NOUN	O	O
number	NOUN	O	O
Medical	ADJ	O	O
College	NOUN	O	O
of	ADP	O	O
Wisconsin	NOUN	O	O
PRO00019269	NOUN	O	O
on	ADP	O	O
11/29/2018	NOUN	O	O
(Retrospectively	ADV	O	O
registered).	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/11	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

In	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial,	NOUN	O	O
we	PRON	O	O
assessed	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
a	DET	O	O
WSP	NOUN	O	O
formula	NOUN	O	O
on	ADP	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
management	NOUN	O	O
in	ADP	O	O
58	NUM	O	O
white-collar	ADJ	O	O
workers	NOUN	O	O
through	ADP	O	O
MR	NOUN	O	O
to	PART	O	O
elucidate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
this	DET	O	O
WSP-MR	NOUN	O	O
on	ADP	O	O
factors	NOUN	O	O
leading	VERB	O	O
to	PART	O	O
overweight.	NOUN	O	O

The	DET	O	O
dose	NOUN	O	B-outcome
of	ADP	O	O
propofol	NOUN	O	O
and	CCONJ	O	O
remifentanil	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
statisticed.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
application	NOUN	O	O
of	ADP	O	O
preoperative	ADJ	O	O
localization	NOUN	O	O
of	ADP	O	O
small	ADJ	O	O
nodules	NOUN	O	O
by	ADP	O	O
placing	VERB	O	O
wire	NOUN	O	O
and	CCONJ	O	O
intrapleural	ADJ	O	O
fibrin	NOUN	O	O
glue	ADJ	O	O
improves	NOUN	O	O
the	DET	O	O
success	NOUN	O	O
[rate]	NOUN	O	O
of	ADP	O	O
resection	NOUN	O	B-outcome
,	PUNCT	O	O
reduces	NOUN	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
the	DET	O	O
operation	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
lowers	NOUN	O	O
the	DET	O	O
difficulty	NOUN	O	B-outcome
of	ADP	O	O
finding	VERB	O	O
pathological	ADJ	O	O
specimens	NOUN	O	O
after	ADP	O	O
the	DET	O	O
operation.	ADV	O	O

RESULTS:	NOUN	O	O
Both	CCONJ	O	O
groups	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
noggin	NOUN	O	B-outcome
serum	NOUN	O	O
levels	NOUN	O	O
(denosumab	PUNCT	O	O
p	NOUN	O	O
<	SYM	O	O
0.001;	NOUN	O	O
placebo	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.0001).	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/17	NOUN	O	O
06:00'	NUM	O	O

Clinical	ADJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/06	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
a	DET	O	O
12-week	NOUN	O	O
high-intensity	NOUN	O	O
interval	NOUN	O	O
exercise	NOUN	O	O
(HIIT)	NOUN	O	O
training	VERB	O	O
program	NOUN	O	O
involving	VERB	O	O
suspension	NOUN	O	O
exercises	NOUN	O	O
(TRX)	NOUN	O	O
on	ADP	O	O
the	DET	O	O
muscle	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
composition	NOUN	O	I-outcome
,	PUNCT	O	O
gait	NOUN	O	B-outcome
speed	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
of	ADP	O	O
older	ADJ	O	O
adults.	NOUN	O	O

This	DET	O	O
increase	NOUN	O	O
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
women	NOUN	O	O
who	ADP	O	O
conceived	VERB	O	O
in	ADP	O	O
PRP	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
value:	NOUN	O	O
0.031).	NUM	O	O

GovNCT01996241	NOUN	O	O
.	PUNCT	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
Of	ADP	O	O
Simultaneous	ADJ	O	O
Versus	CCONJ	O	O
Delayed	VERB	O	O
Ventriculoperitoneal	NOUN	O	O
Shunting	VERB	O	O
In	ADP	O	O
Patients	NOUN	O	O
Undergoing	VERB	O	O
Meningocoele	PROPN	O	O
Repair	NOUN	O	O
In	ADP	O	O
Terms	NOUN	O	O
Of	ADP	O	O
Infection	NOUN	O	B-outcome
.	PUNCT	O	O

OBJECTIVE:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
and	CCONJ	O	O
probiotic	ADJ	O	O
co-administration	NOUN	O	O
on	ADP	O	O
mental	ADJ	O	B-outcome
health	NOUN	O	I-outcome
,	PUNCT	O	O
hormonal	ADJ	O	B-outcome
,	PUNCT	O	O
inflammatory	ADJ	O	B-outcome
and	CCONJ	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
parameters	NOUN	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
polycystic	ADJ	O	O
ovary	NOUN	O	O
syndrome	NOUN	O	O
(PCOS).	PUNCT	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
randomized,	NOUN	O	O
crossover,	NOUN	O	O
counterbalanced	VERB	O	O
study,	NOUN	O	O
12	NUM	O	O
subjects	NOUN	O	O
(6	ADV	O	O
men,	NOUN	O	O
6	NUM	O	O
women;	ADJ	O	O
age	NOUN	O	O
=	SYM	O	O
22	NUM	O	O
+/-	SYM	O	O
2	NUM	O	O
yr;	NOUN	O	O
mass	NOUN	O	O
=	SYM	O	O
73.5	NUM	O	O
+/-	SYM	O	O
7.9	NUM	O	O
kg;	NOUN	O	O
height	NOUN	O	O
=	SYM	O	O
171	NUM	O	O
+/-	SYM	O	O
7	NUM	O	O
cm)	NOUN	O	O
underwent	VERB	O	O
15	NUM	O	O
min	NOUN	O	O
of	ADP	O	O
CWI	NOUN	O	O
(10.0	PUNCT	O	O
+/-	SYM	O	O
0.03	NUM	O	O
degrees	NOUN	O	O
C)	NOUN	O	O
in	ADP	O	O
an	DET	O	O
environmental	ADJ	O	O
chamber	NOUN	O	O
(38.6	PUNCT	O	O
+/-	SYM	O	O
0.6	NUM	O	O
degrees	NOUN	O	O
C;	NOUN	O	O
36	NUM	O	O
+/-	SYM	O	O
2%	NUM	O	O
humidity).	NOUN	O	O

Thermal	ADJ	O	B-outcome
sensation	NOUN	O	I-outcome
significantly	ADV	O	O
differed	VERB	O	O
between	ADP	O	O
conditions	NOUN	O	O
only	ADV	O	O
at	ADP	O	O
pre-exercise	NOUN	O	O
(PC	NOUN	O	O
=	SYM	O	O
3	NUM	O	O
+/-	SYM	O	O
1,	NOUN	O	O
CON	NOUN	O	O
=	SYM	O	O
5	NUM	O	O
+/-	SYM	O	O
0.5).DISCUSSION:	ADP	O	O
PC	NOUN	O	O
delayed	VERB	O	O
severe	ADJ	O	B-outcome
hyperthermia	NOUN	O	I-outcome
and	CCONJ	O	O
mitigated	VERB	O	O
dehydration	NOUN	O	B-outcome
without	ADP	O	O
affecting	VERB	O	O
thermal	ADJ	O	B-outcome
perception	NOUN	O	I-outcome
or	CCONJ	O	O
cooling	VERB	O	B-outcome
rates	NOUN	O	O
posthyperthermia.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
anteversion	NOUN	O	B-outcome
and	CCONJ	O	O
abduction	NOUN	O	B-outcome
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
P>0.05)	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
X-ray	NOUN	O	O
film	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
year.	NOUN	O	O

CONCLUSION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
presents	NOUN	O	O
novel	ADJ	O	O
and	CCONJ	O	O
important	ADJ	O	O
findings	NOUN	O	O
when	ADP	O	O
selecting	VERB	O	O
interaction	NOUN	O	O
devices	NOUN	O	O
for	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
ALS	NOUN	O	O
to	PART	O	O
access	NOUN	O	O
technology	NOUN	O	O
by	ADP	O	O
demonstrating	VERB	O	O
immediate	ADJ	O	O
performance	NOUN	O	B-outcome
benefits	NOUN	O	O
of	ADP	O	O
using	VERB	O	O
a	DET	O	O
touchscreen	NUM	O	O
device,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
improvement	NOUN	O	O
of	ADP	O	O
motor	NOUN	O	B-outcome
skills	NOUN	O	I-outcome
.	PUNCT	O	O
There	PRON	O	O
were	VERB	O	O
possible	ADJ	O	O
transferable	ADJ	O	O
skills	NOUN	O	O
obtained	VERB	O	O
when	ADP	O	O
using	VERB	O	O
virtual	ADJ	O	O
systems	NOUN	O	O
which	ADP	O	O
may	VERB	O	O
allow	ADP	O	O
flexibility	NOUN	O	O
and	CCONJ	O	O
enable	ADJ	O	O
individuals	NOUN	O	O
to	PART	O	O
maintain	NOUN	O	O
performance	NOUN	O	O
overtime.	ADJ	O	O

The	DET	O	O
corneal	ADJ	O	B-outcome
fluorescein	NOUN	O	I-outcome
staining	VERB	O	I-outcome
grades	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
until	ADP	O	O
4	NUM	O	O
months.	NOUN	O	O

Ethical	ADJ	O	O
approval	ADJ	O	O
for	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
obtained	VERB	O	O
from	ADP	O	O
the	DET	O	O
LUTH's	NOUN	O	O
Health	NOUN	O	O
Research	NOUN	O	O
and	CCONJ	O	O
Ethics	NOUN	O	O
Committee	NOUN	O	O
(Approval	NOUN	O	O
number:	NOUN	O	O
ADM/DCST/HREC/APP/2438;	NOUN	O	O
30th	ADV	O	O
August	NOUN	O	O
2018).	NUM	O	O

The	DET	O	O
postoperative	ADJ	O	O
mean	NOUN	O	B-outcome
arterial	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
(MAP)	NOUN	O	I-outcome
,	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
and	CCONJ	O	O
pulse	NOUN	O	B-outcome
oxygen	NOUN	O	I-outcome
saturation	NOUN	O	I-outcome
(SpO(2))	PUNCT	O	I-outcome
in	ADP	O	O
the	DET	O	O
ward	NOUN	O	O
were	VERB	O	O
recorded	VERB	O	O
with	ADP	O	O
a	DET	O	O
multi-function	NOUN	O	O
monitor	NOUN	O	O
on	ADP	O	O
first	ADV	O	O
night	NOUN	O	O
after	ADP	O	O
surgery.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Clinical	ADJ	O	O
Trial,	NOUN	O	O
Phase	NOUN	O	O
III	NUM	O	O

METHODS:	NOUN	O	O
One	NUM	O	O
hundred	NUM	O	O
twenty-four	NOUN	O	O
eligible	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
AGC	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.774)	NUM	O	O
difference,	NOUN	O	O
however,	ADV	O	O
between	ADP	O	O
the	DET	O	O
low	ADJ	O	O
dose	NOUN	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
groups.	NOUN	O	O

Results:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
general	ADJ	O	O
data	NOUN	O	O
and	CCONJ	O	O
Pittsburgh	NOUN	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
index	NOUN	O	O
scale	NOUN	O	O
scores	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
(all	PUNCT	O	O
P>0.05).	NOUN	O	O

Journal-Name:International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
environmental	ADJ	O	O
research	NOUN	O	O
and	CCONJ	O	O
public	ADJ	O	O
health	NOUN	O	O

Our	ADJ	O	O
results	NOUN	O	O
were	VERB	O	O
estimated	VERB	O	O
as	ADP	O	O
good	ADJ	O	O
or	CCONJ	O	O
very	ADV	O	O
good	ADJ	O	O
in	ADP	O	O
93%	ADJ	O	O
of	ADP	O	O
patients.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
This	DET	O	O
retrospective	ADJ	O	O
analysis	NOUN	O	O
found	VERB	O	O
that	ADP	O	O
better	ADJ	O	O
BCVA,	NOUN	O	O
greater	ADJ	O	O
total	ADJ	O	O
macular	ADJ	O	O
volume,	NOUN	O	O
and	CCONJ	O	O
presence	NOUN	O	O
of	ADP	O	O
subretinal	ADJ	O	O
fluid	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
more	ADV	O	O
rapid	ADJ	O	O
vision	NOUN	O	B-outcome
gains.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
formed	VERB	O	O
two	NUM	O	O
groups	NOUN	O	O
or	CCONJ	O	O
patients:	NOUN	O	O
the	DET	O	O
first	ADV	O	O
group	NOUN	O	O
involved	VERB	O	O
45	NUM	O	O
patients	NOUN	O	O
-	PUNCT	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
nicorandil	NOUN	O	O
(Cordinic,	PUNCT	O	O
PIQ-FHARMA	NOUN	O	O
LLC)	NOUN	O	O
(the	NOUN	O	O
main	ADJ	O	O
group)	ADJ	O	O
the	DET	O	O
other	ADJ	O	O
group	NOUN	O	O
included	VERB	O	O
43	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
treated	VERB	O	O
by	ADP	O	O
the	DET	O	O
standard	ADJ	O	O
therapy	NOUN	O	O
(the	NOUN	O	O
comparison	NOUN	O	O
group).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
QCA	NOUN	O	O
has	VERB	O	O
potential	ADJ	O	O
for	ADP	O	O
an	DET	O	O
in-depth	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
complex	NOUN	O	O
interventions	NOUN	O	O
as	ADP	O	O
it	PRON	O	O
can	VERB	O	O
rely	ADV	O	O
on	ADP	O	O
small	ADJ	O	O
to	PART	O	O
medium	NOUN	O	O
sample	NOUN	O	O
sizes	NOUN	O	O
and	CCONJ	O	O
analyze	NOUN	O	O
pathways	NOUN	O	O
to	PART	O	O
success	NOUN	O	O
and	CCONJ	O	O
non-success	NOUN	O	O
separately.	NOUN	O	O

The	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
CD3(+)	NOUN	O	B-outcome
,	PUNCT	O	O
CD4(+)	NOUN	O	B-outcome
,	PUNCT	O	O
CD4(+)/CD8(+)	NOUN	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
those	DET	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
after	ADP	O	O
treatment	NOUN	O	O
(P<0.05),	PUNCT	O	O
the	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
CD8+	NOUN	O	B-outcome
was	VERB	O	O
significant	ADJ	O	O
lower	ADJ	O	O
than	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
(P<0.05).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
retrospectively	ADV	O	O
with	ADP	O	O
ISRCTN	NOUN	O	O
(	PUNCT	O	O
ISRCTN86573140	VERB	O	O
).	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
tazarotene	NOUN	O	O
affords	NOUN	O	O
sustained	VERB	O	O
benefits	NOUN	O	O
posttreatment.	NOUN	O	O

Conditioning	VERB	O	O
regimens	NOUN	O	O
were	VERB	O	O
cyclophosphamide	NOUN	O	O
120	NUM	O	O
mg/kg	NOUN	O	O
with	ADP	O	O
either	CCONJ	O	O
total	ADJ	O	O
body	NOUN	O	O
irradiation	NOUN	O	O
(12	PUNCT	O	O
Gy)	NOUN	O	O
or	CCONJ	O	O
busulfan	NOUN	O	O
(12.8	NOUN	O	O
mg/kg	NOUN	O	O
intravenously	ADV	O	O
or	CCONJ	O	O
16	NUM	O	O
mg/kg	NOUN	O	O
orally),	NOUN	O	O
with	ADP	O	O
or	CCONJ	O	O
without	ADP	O	O
etoposide	NOUN	O	O
(30-60	NUM	O	O
mg/kg).	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
placebo,	NOUN	O	O
D1,	ADJ	O	O
and	CCONJ	O	O
D2	NOUN	O	O
groups,	NOUN	O	O
respectively.	NOUN	O	O

RESULTS:	NOUN	O	O
There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
with	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
the	DET	O	O
best-corrected	VERB	O	B-outcome
visual	ADJ	O	I-outcome
acuity	NOUN	O	I-outcome
(BCVA)	NUM	O	I-outcome
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
at	ADP	O	O
any	DET	O	O
time	NOUN	O	O
point.	NOUN	O	O

Adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
including	VERB	O	O
incidence	NOUN	O	O
and	CCONJ	O	O
severity	NOUN	O	B-outcome
of	ADP	O	I-outcome
febrile	NOUN	O	B-outcome
neutropenia	NOUN	O	E2-outcome
(41	NOUN	O	O
[18%]	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
A+CHP	ADV	O	O
group	NOUN	O	O
and	CCONJ	O	O
33	NUM	O	O
[15%]	NUM	O	O
in	ADP	O	O
the	DET	O	O
CHOP	VERB	O	O
group)	ADJ	O	O
and	CCONJ	O	O
peripheral	ADJ	O	B-outcome
neuropathy	NOUN	O	I-outcome
(117	NUM	O	O
[52%]	NUM	O	O
in	ADP	O	O
the	DET	O	O
A+CHP	ADV	O	O
group	NOUN	O	O
and	CCONJ	O	O
124	NUM	O	O
[55%]	NUM	O	O
in	ADP	O	O
the	DET	O	O
CHOP	VERB	O	O
group),	NOUN	O	O
were	VERB	O	O
similar	ADJ	O	O
between	ADP	O	O
groups.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

The	DET	O	O
final	ADJ	O	O
date	NOUN	O	O
for	ADP	O	O
follow-up	NOUN	O	O
of	ADP	O	O
cognitive	ADJ	O	O
outcomes	NOUN	O	O
was	VERB	O	O
July	NOUN	O	O
22,	NUM	O	O
2018.	NUM	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
per-protocol	NOUN	O	O
population,	NOUN	O	O
MRSA	NOUN	O	B-outcome
infection	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
98	NUM	O	O
of	ADP	O	O
1063	NUM	O	O
participants	NOUN	O	O
(9.2%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
education	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
67	NUM	O	O
of	ADP	O	O
1058	NUM	O	O
(6.3%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
decolonization	NOUN	O	O
group;	ADJ	O	O
84.8%	NUM	O	O
of	ADP	O	O
the	DET	O	O
MRSA	NOUN	O	B-outcome
infections	NOUN	O	I-outcome
led	VERB	O	O
to	PART	O	O
hospitalization	NOUN	O	B-outcome
.	PUNCT	O	O
Infection	NOUN	O	B-outcome
from	ADP	O	O
any	DET	O	O
cause	ADP	O	O
occurred	VERB	O	O
in	ADP	O	O
23.7%	NUM	O	O
of	ADP	O	O
the	DET	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
education	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
19.6%	NOUN	O	O
of	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
decolonization	NOUN	O	O
group;	ADJ	O	O
85.8%	NUM	O	O
of	ADP	O	O
the	DET	O	O
infections	NOUN	O	B-outcome
led	VERB	O	O
to	PART	O	O
hospitalization	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
hazard	NOUN	O	O
of	ADP	O	O
MRSA	NOUN	O	B-outcome
infection	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
decolonization	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
education	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.70;	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.52	NUM	O	O
to	PART	O	O
0.96;	NOUN	O	O
P=0.03;	NOUN	O	O
number	NOUN	O	O
needed	VERB	O	O
to	PART	O	O
treat	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
one	NUM	O	O
infection	NOUN	O	B-outcome
,	PUNCT	O	O
30;	NUM	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
18	NUM	O	O
to	PART	O	O
230);	NOUN	O	O
this	DET	O	O
lower	ADJ	O	O
hazard	NOUN	O	O
led	VERB	O	O
to	PART	O	O
a	DET	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
hospitalization	NOUN	O	B-outcome
due	ADJ	O	I-outcome
to	PART	O	I-outcome
MRSA	NOUN	O	I-outcome
infection	NOUN	O	I-outcome
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.71;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.51	NUM	O	O
to	PART	O	O
0.99).	PUNCT	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
majority	NOUN	O	O
(71%)	NUM	O	O
of	ADP	O	O
men	NOUN	O	O
wanted	VERB	O	B-outcome
children	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
future.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
of	ADP	O	O
the	DET	O	O
current	ADJ	O	O
study	NOUN	O	O
demonstrate	VERB	O	O
that	ADP	O	O
consumption	NOUN	O	O
of	ADP	O	O
900	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
PSE	NOUN	O	O
improved	VERB	O	O
specific	ADJ	O	O
measures	NOUN	O	O
of	ADP	O	O
reactive	ADJ	O	B-outcome
agility	NOUN	O	I-outcome
in	ADP	O	O
a	DET	O	O
young,	NOUN	O	O
active	ADJ	O	O
population.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Future	NOUN	O	O
research	NOUN	O	O
will	VERB	O	O
benefit	NUM	O	O
from	ADP	O	O
longer	ADJ	O	O
study	NOUN	O	O
durations	NOUN	O	O
with	ADP	O	O
larger	ADJ	O	O
numbers	NOUN	O	O
of	ADP	O	O
participants.	NOUN	O	O

Although	ADP	O	O
there	PRON	O	O
is	VERB	O	O
strong	ADJ	O	O
evidence	NOUN	O	O
that	ADP	O	O
topical	ADJ	O	O
repellents	NOUN	O	O
protect	VERB	O	O
against	ADP	O	O
mosquito	ADV	O	O
bites,	NOUN	O	O
evidence	NOUN	O	O
is	VERB	O	O
not	ADV	O	O
well	ADV	O	O
established	VERB	O	O
for	ADP	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
repellents	NOUN	O	O
distributed	VERB	O	O
as	ADP	O	O
part	NOUN	O	O
of	ADP	O	O
malaria	NOUN	O	O
control	NOUN	O	O
activities	NOUN	O	O
in	ADP	O	O
protecting	VERB	O	O
against	ADP	O	O
episodes	NOUN	O	O
of	ADP	O	O
malaria.	NOUN	O	O

By	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
10-year	NOUN	O	O
follow-up,	ADP	O	O
11	NUM	O	O
patients	NOUN	O	O
(36.7%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
CC	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
experienced	VERB	O	O
local	ADJ	O	B-outcome
recurrence	NOUN	O	I-outcome
versus	CCONJ	O	O
11	NUM	O	O
patients	NOUN	O	O
(36.7%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
RC	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
0.999).	NUM	O	O

Importance:	NOUN	O	O
Postoperative	ADJ	O	O
delirium	NOUN	O	O
is	VERB	O	O
common	ADJ	O	O
following	VERB	O	O
cardiac	ADJ	O	O
surgery	NOUN	O	O
and	CCONJ	O	O
may	VERB	O	O
be	VERB	O	O
affected	VERB	O	O
by	ADP	O	O
choice	NOUN	O	O
of	ADP	O	O
analgesic	ADP	O	O
and	CCONJ	O	O
sedative.	ADJ	O	O

Neither	CCONJ	O	O
coefficient	NOUN	O	O
of	ADP	O	O
variation	NOUN	O	O
nor	CCONJ	O	O
percentage	NOUN	O	O
of	ADP	O	O
hexagonal	ADJ	O	O
cells	NOUN	O	O
changed	VERB	O	O
significantly	ADV	O	O
from	ADP	O	O
baseline	NOUN	O	O
at	ADP	O	O
any	DET	O	O
time	NOUN	O	O
point.	NOUN	O	O

We	PRON	O	O
investigated	VERB	O	O
SPC	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
status	NOUN	O	O
of	ADP	O	O
MSI	NOUN	O	O
and	CCONJ	O	O
Epstein-Barr	NOUN	O	O
virus	NOUN	O	O
(EBV)	PUNCT	O	O
as	ADP	O	O
combinatory	ADJ	O	O
biomarkers	NOUN	O	O
to	PART	O	O
predict	VERB	O	O
the	DET	O	O
prognosis	NOUN	O	O
and	CCONJ	O	O
responsiveness	NOUN	O	O
of	ADP	O	O
adjuvant	NOUN	O	O
chemotherapy	NOUN	O	O
for	ADP	O	O
stage	NOUN	O	O
II/III	NOUN	O	O
gastric	ADJ	O	O
cancer.	NOUN	O	O

Interventions:	NOUN	O	O
Participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
receive	VERB	O	O
paracetamol	NOUN	O	O
(acetaminophen)	ADV	O	O
1000	NUM	O	O
mg	NOUN	O	O
plus	CCONJ	O	O
ibuprofen	NOUN	O	O
400	NUM	O	O
mg	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
136;	NUM	O	O
PCM	NOUN	O	O
+	SYM	O	O
IBU),	NOUN	O	O
paracetamol	NOUN	O	O
1000	NUM	O	O
mg	NOUN	O	O
plus	CCONJ	O	O
matched	VERB	O	O
placebo	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
142;	NUM	O	O
PCM),	NOUN	O	O
ibuprofen	NOUN	O	O
400	NUM	O	O
mg	NOUN	O	O
plus	CCONJ	O	O
matched	VERB	O	O
placebo	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
141;	NOUN	O	O
IBU),	NOUN	O	O
or	CCONJ	O	O
half-strength	NOUN	O	O
paracetamol	NOUN	O	O
500	NUM	O	O
mg	NOUN	O	O
plus	CCONJ	O	O
ibuprofen	NOUN	O	O
200	NUM	O	O
mg	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
140;	NUM	O	O
HS-PCM	NOUN	O	O
+	SYM	O	O
IBU)	ADJ	O	O
orally	ADV	O	O
every	DET	O	O
6	NUM	O	O
hours	NOUN	O	O
for	ADP	O	O
24	NUM	O	O
hours	NOUN	O	O
postoperatively,	NOUN	O	O
starting	VERB	O	O
1	NUM	O	O
hour	NOUN	O	O
before	ADP	O	O
surgery.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
R&D	NOUN	O	O
Unicancer	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT01526135	NOUN	O	O
;	PUNCT	O	O
EudraCT	NOUN	O	O
number,	ADV	O	O
2011-002026-52	NUM	O	O
.).	NOUN	O	O

Title:	NOUN	O	O
Green	NOUN	O	O
tea	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
for	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
uncomplicated	VERB	O	O
cystitis	NOUN	O	O
in	ADP	O	O
women:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
analgesic	ADP	O	O
efficacy	NOUN	O	O
of	ADP	O	O
oblique	ADJ	O	O
subcostal	ADJ	O	O
transversus	NOUN	O	O
abdominis	NOUN	O	O
plane	ADJ	O	O
block	VERB	O	O
after	ADP	O	O
laparoscopic	ADJ	O	O
hysterectomy:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
controlled,	NOUN	O	O
observer-blinded	VERB	O	O
study.	NOUN	O	O

The	DET	O	O
Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
Life	NOUN	O	I-outcome
Short	NOUN	O	O
Form	NOUN	O	O
(KDQOL-SF)	NUM	O	O
questionnaire	NOUN	O	O
was	VERB	O	O
completed	VERB	O	O
by	ADP	O	O
all	DET	O	O
participants	NOUN	O	O
at	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
and	CCONJ	O	O
two	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
completion	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervention.	NOUN	O	O

The	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
Bosinji,	ADP	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
herbal	ADJ	O	O
medicines	NOUN	O	O
used	VERB	O	O
for	ADP	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
radiating	VERB	O	O
pain	NOUN	O	O
in	ADP	O	O
patient	NOUN	O	O
with	ADP	O	O
LHIVD,	ADJ	O	O
has	VERB	O	O
been	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
several	ADJ	O	O
studies;	PUNCT	O	O
however,	ADV	O	O
little	DET	O	O
clinical	ADJ	O	O
evidence	NOUN	O	O
is	VERB	O	O
available	ADJ	O	O
owing	ADJ	O	O
to	PART	O	O
the	DET	O	O
methodological	ADJ	O	O
limitations	NOUN	O	O
in	ADP	O	O
previous	ADJ	O	O
studies.	NOUN	O	O

In	ADP	O	O
comparison	NOUN	O	O
to	PART	O	O
moderately-severe	ADV	O	O
health	NOUN	O	O
warnings,	ADP	O	O
highly-severe	ADJ	O	O
health	NOUN	O	O
warnings	NOUN	O	O
increased	VERB	O	O
avoidance	NOUN	O	B-outcome
and	CCONJ	O	O
reactance	NOUN	O	B-outcome
and	CCONJ	O	O
were	VERB	O	O
perceived	VERB	O	O
as	ADP	O	O
more	ADV	O	O
effective	ADJ	O	O
and	CCONJ	O	O
increased	VERB	O	O
motivation	NOUN	O	B-outcome
to	PART	O	O
drink	NOUN	O	O
less.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Participants	NOUN	O	O
completed	VERB	O	O
1	NUM	O	O
week	NOUN	O	O
of	ADP	O	O
pre-	ADJ	O	O
and	CCONJ	O	O
post-testing,	NOUN	O	O
and	CCONJ	O	O
4	NUM	O	O
days	NOUN	O	O
per	ADP	O	O
week	NOUN	O	O
of	ADP	O	O
strength	NOUN	O	O
and	CCONJ	O	O
conditioning	VERB	O	O
training	VERB	O	O
for	ADP	O	O
5	NUM	O	O
weeks.	NOUN	O	O

NCT01709253	NOUN	O	O
;	PUNCT	O	O
registered	VERB	O	O
October	ADJ	O	O
18,	NUM	O	O
2012;	NOUN	O	O
retrospectively	ADV	O	O
registered).	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
decolonization	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
lower	ADJ	O	O
likelihoods	NOUN	O	O
of	ADP	O	O
clinically	ADV	O	O
judged	VERB	O	O
infection	NOUN	O	B-outcome
from	ADP	O	O
any	DET	O	O
cause	ADP	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.83;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.70	NUM	O	O
to	PART	O	O
0.99)	NUM	O	O
and	CCONJ	O	O
infection-related	VERB	O	B-outcome
hospitalization	NOUN	O	I-outcome
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.76;	NUM	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.62	NUM	O	O
to	PART	O	O
0.93);	NUM	O	O
treatment	NOUN	O	O
effects	NOUN	O	O
for	ADP	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
interpreted	VERB	O	O
with	ADP	O	O
caution	NOUN	O	O
owing	ADJ	O	O
to	PART	O	O
a	DET	O	O
lack	NOUN	O	O
of	ADP	O	O
prespecified	VERB	O	O
adjustment	NOUN	O	O
for	ADP	O	O
multiple	ADJ	O	O
comparisons.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
in	ADP	O	O
96	NUM	O	O
sub-village	NOUN	O	O
units	NOUN	O	O
(balozis)	NUM	O	O
in	ADP	O	O
the	DET	O	O
Kongwa	NOUN	O	O
district	ADP	O	O
of	ADP	O	O
Tanzania	NOUN	O	O
which	ADP	O	O
were	VERB	O	O
predicted	VERB	O	O
from	ADP	O	O
prior	ADJ	O	O
prevalence	NOUN	O	O
surveys	NOUN	O	O
to	PART	O	O
have	VERB	O	O
TF	NOUN	O	O
between	ADP	O	O
5	NUM	O	O
and	CCONJ	O	O
9.9%.	NUM	O	O

The	DET	O	O
time	NOUN	O	O
required	VERB	O	O
for	ADP	O	O
a	DET	O	O
change	NOUN	O	O
in	ADP	O	O
TOFr	NOUN	O	O
values	NOUN	O	O
from	ADP	O	O
0.25	NUM	O	O
to	PART	O	O
0.75	NUM	O	O
and	CCONJ	O	O
0.9	NUM	O	O
was	VERB	O	O
evaluated.	NOUN	O	O

We	PRON	O	O
looked	VERB	O	O
at	ADP	O	O
HIV	NOUN	O	B-outcome
testing	VERB	O	I-outcome
over	ADP	O	O
a	DET	O	O
2-month	NOUN	O	O
study	NOUN	O	O
period	NOUN	O	O
following	VERB	O	O
the	DET	O	O
first	ADV	O	O
text.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Secondary	ADJ	O	O
analyses	NOUN	O	O
included	VERB	O	O
the	DET	O	O
progression	NOUN	O	B-outcome
of	ADP	O	O
symptoms,	NOUN	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
UPDRS	NOUN	O	O
score,	NOUN	O	O
between	ADP	O	O
weeks	NOUN	O	O
4	NUM	O	O
and	CCONJ	O	O
40	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
noninferiority	NOUN	O	O
of	ADP	O	O
early	ADJ	O	O
initiation	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
to	PART	O	O
delayed	VERB	O	O
initiation	NOUN	O	O
between	ADP	O	O
weeks	NOUN	O	O
44	NUM	O	O
and	CCONJ	O	O
80,	NUM	O	O
with	ADP	O	O
a	DET	O	O
noninferiority	NOUN	O	O
margin	ADP	O	O
of	ADP	O	O
0.055	NUM	O	O
points	NOUN	O	O
per	ADP	O	O
week.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

PSE	NOUN	O	O
also	ADV	O	O
significantly	ADV	O	O
increased	VERB	O	O
hits	NOUN	O	B-outcome
(treatment	NUM	O	O
effect,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.020)	NUM	O	O
at	ADP	O	O
Day	NOUN	O	O
30	NUM	O	O
(PSE	NUM	O	O
vs.	CCONJ	O	O
PLA:	NOUN	O	O
19.25	NUM	O	O
+/-	SYM	O	O
1.84	NUM	O	O
vs.	CCONJ	O	O
18.45	NUM	O	O
+/-	SYM	O	O
1.48	NUM	O	O
hits;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.007)	NOUN	O	O
and	CCONJ	O	O
Day	NOUN	O	O
90	NUM	O	O
(PSE	NUM	O	O
vs.	CCONJ	O	O
PLA:	NOUN	O	O
19.39	NUM	O	O
+/-	SYM	O	O
1.90	NUM	O	O
vs.	CCONJ	O	O
18.66	NUM	O	O
+/-	SYM	O	O
1.64	NUM	O	O
hits;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.026)	NUM	O	O
for	ADP	O	O
the	DET	O	O
multi-directional	ADJ	O	O
test	NOUN	O	O
with	ADP	O	O
footplates.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
alone,	NOUN	O	O
the	DET	O	O
combined	VERB	O	O
treatment	NOUN	O	O
improved	VERB	O	O
cervical	ADJ	O	B-outcome
mucus	NOUN	O	I-outcome
score,	NOUN	O	O
follicle	NOUN	O	B-outcome
development	NOUN	O	I-outcome
rate,	NOUN	O	O
single	ADJ	O	B-outcome
follicle	NOUN	O	I-outcome
ovulation	NOUN	O	I-outcome
rate,	NOUN	O	O
endometrial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
,	PUNCT	O	O
positive	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
three	NUM	O	B-outcome
lines	NOUN	O	I-outcome
sign	ADV	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
follicle-stimulating	VERB	O	B-outcome
hormone	NOUN	O	I-outcome
level.	NOUN	O	O

Journal-Name:PLoS	NOUN	O	O
neglected	VERB	O	O
tropical	ADJ	O	O
diseases	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

INTRODUCTION:	NOUN	O	O
Halitosis	NOUN	O	O
is	VERB	O	O
the	DET	O	O
term	NOUN	O	O
used	VERB	O	O
to	PART	O	O
describe	NOUN	O	O
any	DET	O	O
unpleasant	ADJ	O	O
odor	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
expired	VERB	O	O
air	NOUN	O	O
regardless	ADV	O	O
of	ADP	O	O
its	ADJ	O	O
source.	NOUN	O	O

NCT:	NOUN	O	O
03200197.	NUM	O	O

The	DET	O	O
degree	NOUN	O	O
of	ADP	O	O
injured	VERB	O	O
vertebra	NOUN	O	B-outcome
compression	NOUN	O	I-outcome
,	PUNCT	O	O
VAS	NOUN	O	O
score,	NOUN	O	O
and	CCONJ	O	O
Oswestry	NOUN	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(ODI)	NOUN	O	O
score	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
improved	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
at	ADP	O	O
immediate	ADJ	O	O
after	ADP	O	O
operation	NOUN	O	O
and	CCONJ	O	O
last	NOUN	O	O
follow-up	NOUN	O	O
(	PUNCT	O	O
P<0.05).	NOUN	O	O

In	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study,	NOUN	O	O
we	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
Trimethylamine	NOUN	O	B-outcome
N-oxide	NOUN	O	I-outcome
(TMAO)	NOUN	O	I-outcome
-reducing	VERB	O	O
effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
novel	ADJ	O	O
nutraceutical	ADJ	O	O
formulation	NOUN	O	O
containing	VERB	O	O
grape	NOUN	O	O
pomace	NOUN	O	O
extract	NOUN	O	O
in	ADP	O	O
humans	NOUN	O	O
(Taurisolo((R))).	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(IG)	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG).	NUM	O	O

Patients	NOUN	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
20	NUM	O	O
mg/m(2)	NOUN	O	O
decitabine	NOUN	O	O
intravenously	ADV	O	O
for	ADP	O	O
5	NUM	O	O
or	CCONJ	O	O
10	NUM	O	O
consecutive	ADJ	O	O
days	NOUN	O	O
as	ADP	O	O
induction	NOUN	O	O
therapy,	NOUN	O	O
every	DET	O	O
4-8	NUM	O	O
weeks	NOUN	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
three	NUM	O	O
cycles.	NUM	O	O

Compared	VERB	O	O
with	ADP	O	O
women	NOUN	O	O
whose	ADP	O	O
inability	NOUN	O	O
to	PART	O	O
procreate	VERB	O	O
is	VERB	O	O
caused	VERB	O	O
by	ADP	O	O
simple	NOUN	O	O
tubal	ADJ	O	O
infertility,	ADJ	O	O
women	NOUN	O	O
with	ADP	O	O
endometriosis	NOUN	O	O
often	ADV	O	O
have	VERB	O	O
lower	ADJ	O	O
pregnancy	NOUN	O	O
rates	NOUN	O	O
following	VERB	O	O
in	ADP	O	O
vitro	ADV	O	O
fertilization/intracytoplasmic	ADJ	O	O
sperm	NOUN	O	O
injection	NOUN	O	O
(IVF/ICSI).	NUM	O	O

We	PRON	O	O
profiled	VERB	O	O
the	DET	O	O
microbiome	NOUN	O	O
of	ADP	O	O
a	DET	O	O
longitudinal	ADJ	O	O
sample	NOUN	O	O
series	NOUN	O	O
of	ADP	O	O
28	NUM	O	O
people	NOUN	O	O
with	ADP	O	O
diabetes	NOUN	O	O
and	CCONJ	O	O
DFUs	NOUN	O	O
of	ADP	O	O
the	DET	O	O
heel	NOUN	O	O
in	ADP	O	O
an	DET	O	O
attempt	NOUN	O	O
to	PART	O	O
better	ADJ	O	O
characterize	NOUN	O	O
the	DET	O	O
relationship	NOUN	O	O
between	ADP	O	O
healing,	NOUN	O	O
infection	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
microbiome.	NOUN	O	O

Final	ADJ	O	O
outcome	NOUN	O	O
for	ADP	O	O
presence	NOUN	O	O
of	ADP	O	O
rheumatic	ADJ	O	B-outcome
fever/rheumatic	ADJ	O	I-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(RF/RHD)	NOUN	O	I-outcome
or	CCONJ	O	O
other	ADJ	O	O
heart	NOUN	O	B-outcome
Diseases	NOUN	O	I-outcome
was	VERB	O	O
recorded	VERB	O	O
after	ADP	O	O
examination	NOUN	O	O
at	ADP	O	O
nearest	ADJ	O	O
primary	ADJ	O	O
health	NOUN	O	O
centers	NOUN	O	O
and/or	CCONJ	O	O
at	ADP	O	O
Indira	NOUN	O	O
Gandhi	NOUN	O	O
Medical	ADJ	O	O
College	NOUN	O	O
Hospital,	ADJ	O	O
Shimla.	NOUN	O	O

As	ADP	O	O
predicted,	NOUN	O	O
across	ADP	O	O
2	NUM	O	O
RCTs,	NOUN	O	O
Monitor	NOUN	O	O
+	SYM	O	O
Accept	ADV	O	O
training	VERB	O	O
increased	VERB	O	O
positive	ADJ	O	B-outcome
affect	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
both	CCONJ	O	O
Monitor	NOUN	O	O
Only	ADV	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups.	NOUN	O	O

Title:	NOUN	O	O
Cost-effectiveness	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
a	DET	O	O
placebo-controlled	VERB	O	O
randomized	VERB	O	O
trial	NOUN	O	O
evaluating	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
arthroscopic	ADJ	O	O
subacromial	ADJ	O	O
decompression	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
subacromial	ADJ	O	O
shoulder	NOUN	O	O
pain.	NOUN	O	O

RESULTS:	NOUN	O	O
Following	VERB	O	O
similar	ADJ	O	O
dehydration	NOUN	O	O
(~	PUNCT	O	O
2%DeltaBW),	NUM	O	O
MW	NOUN	O	O
had	VERB	O	O
no	DET	O	O
differential	ADJ	O	O
(p	PUNCT	O	O
>	SYM	O	O
0.05)	NUM	O	O
impact	NOUN	O	O
on	ADP	O	O
any	DET	O	O
measure	NOUN	O	O
of	ADP	O	O
rehydration.	NOUN	O	O

Day	NOUN	O	O
1,	NOUN	O	O
8	NUM	O	O
mg	NOUN	O	O
orally	ADV	O	O
Days	NOUN	O	O
2-4).	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100967802	NUM	O	O

To	PART	O	O
evaluates	NOUN	O	O
the	DET	O	O
eye-lens	NOUN	O	O
radiation	NOUN	O	O
exposure	NOUN	O	O
of	ADP	O	O
workers	NOUN	O	O
during	ADP	O	O
medical	ADJ	O	O
interventional	ADJ	O	O
procedures	NOUN	O	O
and	CCONJ	O	O
surgery	NOUN	O	O
in	ADP	O	O
a	DET	O	O
military	ADJ	O	O
hospital	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
of	ADP	O	O
the	DET	O	O
equine	ADJ	O	O
veterinarians.	ADV	O	O

Our	ADJ	O	O
incentive	ADJ	O	O
level	NOUN	O	O
may	VERB	O	O
have	VERB	O	O
been	VERB	O	O
too	ADV	O	O
low	ADJ	O	O
to	PART	O	O
incentivise	NOUN	O	O
change,	NOUN	O	O
despite	ADP	O	O
being	VERB	O	O
designed	VERB	O	O
a	DET	O	O
priori	ADV	O	O
by	ADP	O	O
a	DET	O	O
Contingent	ADJ	O	O
Valuation	NOUN	O	O
Survey.	NOUN	O	O

The	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
pulmonary	ADJ	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
blood	NOUN	O	B-outcome
gas	NOUN	O	I-outcome
parameters,	NOUN	O	O
and	CCONJ	O	O
six-minute	NOUN	O	O
walk	NOUN	O	B-outcome
distance	NOUN	O	I-outcome
before	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
2	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
intervention.	NOUN	O	O

The	DET	O	O
first	ADV	O	B-outcome
out-of-bed	VERB	O	I-outcome
activity	NOUN	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
first	ADV	O	B-outcome
anus	NOUN	O	I-outcome
exhaust	ADV	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
hospital	NOUN	O	B-outcome
stay	NOUN	O	I-outcome
time	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
parecoxib	NOUN	O	O
+	SYM	O	O
TAP	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
shorter	ADJ	O	O
than	ADP	O	O
those	DET	O	O
of	ADP	O	O
the	DET	O	O
other	ADJ	O	O
groups,	NOUN	O	O
while	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
all	DET	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
the	DET	O	O
other	ADJ	O	O
groups.	NOUN	O	O

The	DET	O	O
test	NOUN	O	O
groups	NOUN	O	O
showed	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
reductions	NOUN	O	O
in	ADP	O	O
Gingival	ADJ	O	B-outcome
Index],	NOUN	O	O
probing	VERB	O	B-outcome
depth	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
clinical	ADJ	O	B-outcome
attachment	NOUN	O	I-outcome
level	NOUN	O	I-outcome
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
reductions	NOUN	O	O
in	ADP	O	O
Porphyromonas	NOUN	O	B-outcome
gingivalis	NOUN	O	I-outcome
and	CCONJ	O	O
Aggregatibacter	NOUN	O	B-outcome
actinomycetemcomitans	NOUN	O	I-outcome
counts	NOUN	O	O
at	ADP	O	O
1-,	NOUN	O	O
3-,	ADJ	O	O
6-,	NOUN	O	O
and	CCONJ	O	O
9-month	NOUN	O	O
follow-ups	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

RESULTS:	NOUN	O	O
Vitamin	NOUN	O	O
D	NOUN	O	O
and	CCONJ	O	O
probiotic	ADJ	O	O
co-supplementation,	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
placebo,	NOUN	O	O
significantly	ADV	O	O
improved	VERB	O	O
beck	NOUN	O	O
depression	NOUN	O	B-outcome
inventory	ADJ	O	O
[beta	NOUN	O	O
(difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
of	ADP	O	O
outcomes	NOUN	O	O
measures	NOUN	O	O
between	ADP	O	O
treatment	NOUN	O	O
groups)	NOUN	O	O
-	PUNCT	O	O
0.58;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
1.15,	ADP	O	O
-	PUNCT	O	O
0.02;	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.04],	NOUN	O	O
general	ADJ	O	B-outcome
health	NOUN	O	I-outcome
questionnaire	NOUN	O	O
scores	NOUN	O	O
(beta	NUM	O	O
-	PUNCT	O	O
0.93;	ADP	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
1.78,	ADP	O	O
-	PUNCT	O	O
0.08;	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.03)	NUM	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
,	PUNCT	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
stress	NOUN	O	B-outcome
scale	NOUN	O	O
scores	NOUN	O	O
(beta	NUM	O	O
-	PUNCT	O	O
0.90;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-	PUNCT	O	O
1.67,	PUNCT	O	O
-	PUNCT	O	O
0.13;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.02).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
We	PRON	O	O
found	VERB	O	O
that	ADP	O	O
hybrid	NOUN	O	O
minimally	ADV	O	O
invasive	ADJ	O	O
esophagectomy	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
a	DET	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
intraoperative	ADJ	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
major	ADJ	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
specifically	ADV	O	O
pulmonary	ADJ	O	B-outcome
complications	NOUN	O	I-outcome
,	PUNCT	O	O
than	ADP	O	O
open	ADJ	O	O
esophagectomy,	NOUN	O	O
without	ADP	O	O
compromising	VERB	O	O
overall	ADJ	O	B-outcome
and	CCONJ	O	Seperator
disease-free	ADJ	O	B-outcome
survival	NOUN	O	E1-outcome
over	ADP	O	O
a	DET	O	O
period	NOUN	O	O
of	ADP	O	O
3	NUM	O	O
years.	NOUN	O	O
(	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

BACKGROUND:	NOUN	O	O
Pharmacologic	ADJ	O	O
angiotensin	NOUN	O	O
axis	NOUN	O	O
blockade	NOUN	O	O
(AAB)	PUNCT	O	O
has	VERB	O	O
been	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
profound	NOUN	O	O
hypotension	NOUN	O	O
following	VERB	O	O
anesthetic	ADJ	O	O
induction	NOUN	O	O
with	ADP	O	O
propofol.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
immunogenicity	NOUN	O	B-outcome
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
3	NUM	O	O
inactivated	VERB	O	O
hepatitis	NOUN	O	O
A	DET	O	O
vaccines	NOUN	O	O
in	ADP	O	O
Korean	NOUN	O	O
children	NOUN	O	O
aged	VERB	O	O
12	NUM	O	O
to	PART	O	O
18	NUM	O	O
months:	NOUN	O	O
An	DET	O	O
open-label,	ADV	O	O
randomized,	NOUN	O	O
prospective,	NOUN	O	O
multicenter	NOUN	O	O
study.	NOUN	O	O

Music	ADJ	O	O
therapy	NOUN	O	O
sessions	NOUN	O	O
lasting	VERB	O	O
30-45	NUM	O	O
min	NOUN	O	O
were	VERB	O	O
individually	ADV	O	O
delivered	VERB	O	O
weekly	ADV	O	O
using	VERB	O	O
receptive	ADJ	O	O
techniques.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

BACKGROUND:	NOUN	O	O
Infections	NOUN	O	O
acquired	VERB	O	O
in	ADP	O	O
hospital	NOUN	O	O
are	VERB	O	O
an	DET	O	O
important	ADJ	O	O
cause	ADP	O	O
of	ADP	O	O
morbidity	NOUN	O	O
and	CCONJ	O	O
mortality	NOUN	O	O
in	ADP	O	O
very	ADV	O	O
preterm	NOUN	O	O
infants.	NOUN	O	O

BACKGROUND	NOUN	O	O
AND	CCONJ	O	O
PURPOSE:	NOUN	O	O
Self-efficacy	NOUN	O	O
is	VERB	O	O
considered	VERB	O	O
as	ADP	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
influential	ADJ	O	O
parameters	NOUN	O	O
affecting	VERB	O	O
the	DET	O	O
health	NOUN	O	O
of	ADP	O	O
patients.	NOUN	O	O

The	DET	O	O
white	ADP	O	O
sclera	NOUN	O	O
slice	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
seen	VERB	O	O
under	ADP	O	O
the	DET	O	O
conjunctiva,	NOUN	O	O
thereby	ADV	O	O
affecting	VERB	O	O
the	DET	O	O
cosmetic	ADJ	O	B-outcome
appearance	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSION:	NOUN	O	O
The	DET	O	O
cornea	NOUN	O	O
slice	NOUN	O	O
acquired	VERB	O	O
from	ADP	O	O
SMILE	NOUN	O	O
surgery	NOUN	O	O
can	VERB	O	O
effectively	ADV	O	O
prevent	NOUN	O	O
drainage	NOUN	O	B-outcome
tube	NOUN	O	I-outcome
exposure	NOUN	O	I-outcome
.	PUNCT	O	O
Moreover,	NOUN	O	O
it	PRON	O	O
is	VERB	O	O
easy	NOUN	O	B-outcome
to	PART	O	I-outcome
acquire	NOUN	O	I-outcome
,	PUNCT	O	O
safe,	NOUN	O	O
and	CCONJ	O	O
cheaper	ADV	O	B-outcome
,	PUNCT	O	O
giving	VERB	O	O
the	DET	O	O
patient	NOUN	O	O
a	DET	O	O
better	ADJ	O	O
cosmetic	ADJ	O	B-outcome
appearance	NOUN	O	I-outcome
.	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
therapeutic	ADJ	O	O
benefits	NOUN	O	O
of	ADP	O	O
soft	NOUN	O	O
non-manipulative	ADJ	O	O
osteopathic	ADJ	O	O
techniques	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
CD.	NOUN	O	O

For	ADP	O	O
flexion	NOUN	O	B-outcome
and	CCONJ	O	O
abduction	NOUN	O	B-outcome
activity,	ADP	O	O
SuperPATH	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
and	CCONJ	O	O
3	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
were	VERB	O	O
better	ADJ	O	O
than	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(	PUNCT	O	O
P<0.05),	NOUN	O	O
while	ADP	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
14	NUM	O	O
days,	NOUN	O	O
3	NUM	O	O
months,	NOUN	O	O
6	NUM	O	O
months,	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
year	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
(	PUNCT	O	O
P>0.05).	NOUN	O	O

Objective:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
whether	ADP	O	O
controlled	VERB	O	O
irrigation	NOUN	O	O
with	ADP	O	O
three	NUM	O	O
different	ADJ	O	O
irrigation	NOUN	O	O
regimens	NOUN	O	O
with	ADP	O	O
different	ADJ	O	O
temperature	NOUN	O	O
would	VERB	O	O
result	VERB	O	O
in	ADP	O	O
reduction	NOUN	O	O
of	ADP	O	O
post-endodontic	ADJ	O	O
pain	NOUN	O	B-outcome
after	ADP	O	O
one-visit	NOUN	O	O
root	NOUN	O	O
canal	NOUN	O	O
treatment	NOUN	O	O
(RCT).	NOUN	O	O

T	NOUN	O	O
Kujala	NOUN	O	O
score	ADJ	O	O
increased	VERB	O	O
from	ADP	O	O
70.77	NUM	O	O
points	NOUN	O	O
preoperatively	ADV	O	O
to	PART	O	O
94.32	NUM	O	O
postoperatively	ADV	O	O
(P	NUM	O	O
<	SYM	O	O
.001).	PUNCT	O	O

METHODS:	NOUN	O	O
Ten	NUM	O	O
physically	ADV	O	O
active	ADJ	O	O
males	NOUN	O	O
(25.1	ADJ	O	O
+/-	SYM	O	O
3.9	NUM	O	O
years;	NOUN	O	O
weight	NOUN	O	O
78.71	NUM	O	O
+/-	SYM	O	O
9.53	NUM	O	O
kg;	NOUN	O	O
height	NOUN	O	O
177.2	NUM	O	O
+/-	SYM	O	O
4.6	NUM	O	O
cm;	NOUN	O	O
body	NOUN	O	O
fat	NOUN	O	O
15.5	NUM	O	O
+/-	SYM	O	O
3.13%)	NUM	O	O
participated	VERB	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
We	PRON	O	O
conclude	NOUN	O	O
that	ADP	O	O
weight	NOUN	O	B-outcome
loss	NOUN	O	O
of	ADP	O	O
6-7%	ADJ	O	O
with	ADP	O	O
diet	NOUN	O	O
or	CCONJ	O	O
with	ADP	O	O
exercise	NOUN	O	O
plus	CCONJ	O	O
diet	NOUN	O	O
reduced	VERB	O	O
both	CCONJ	O	O
subcutaneous	ADJ	O	B-outcome
and	CCONJ	O	Seperator
intra-abdominal	ADJ	O	B-outcome
fat	NOUN	O	E1-outcome
.	PUNCT	O	O
Only	ADV	O	O
subcutaneous	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
statistically	ADV	O	O
significantly	ADV	O	O
reduced	VERB	O	O
to	PART	O	O
a	DET	O	O
larger	ADJ	O	O
extent	NOUN	O	O
when	ADP	O	O
exercise	NOUN	O	O
is	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
a	DET	O	O
small	ADJ	O	O
caloric	ADJ	O	O
restriction.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Complications	NOUN	O	B-outcome
were	VERB	O	O
comparable	ADJ	O	O
between	ADP	O	O
treatment	NOUN	O	O
groups.	NOUN	O	O

Title:	NOUN	O	O
Reduction	NOUN	O	O
of	ADP	O	O
postendodontic	ADJ	O	O
pain	NOUN	O	B-outcome
after	ADP	O	O
one-visit	NOUN	O	O
root	NOUN	O	O
canal	NOUN	O	O
treatment	NOUN	O	O
using	VERB	O	O
three	NUM	O	O
irrigating	VERB	O	O
regimens	NOUN	O	O
with	ADP	O	O
different	ADJ	O	O
temperature.	NOUN	O	O

Medication	NOUN	O	O
adherence	NOUN	O	B-outcome
and	CCONJ	O	O
occurrence	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
outcomes	NOUN	O	I-outcome
(	PUNCT	O	O
adverse	ADJ	O	B-outcome
drug	NOUN	O	I-outcome
reactions	NOUN	O	I-outcome
,	PUNCT	O	O
readmission	NOUN	O	B-outcome
,	PUNCT	O	O
emergency	NOUN	O	B-outcome
department	NOUN	O	I-outcome
visits	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
death	NOUN	O	B-outcome
)	PUNCT	O	O
were	VERB	O	O
assessed	VERB	O	O
at	ADP	O	O
the	DET	O	O
follow-up	NOUN	O	O
visit,	NOUN	O	O
30	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
discharge.	ADJ	O	O

Conclusion:	NOUN	O	O
Further	ADV	O	O
trials	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
optimal	ADJ	O	O
treatment	NOUN	O	O
protocols	NOUN	O	O
for	ADP	O	O
various	ADJ	O	O
UI	NOUN	O	O
types	NOUN	O	O
and	CCONJ	O	O
to	PART	O	O
evaluate	VERB	O	O
long-term	NOUN	O	O
outcomes	NOUN	O	O
of	ADP	O	O
the	DET	O	O
ExMI	NOUN	O	O
treatment.	NOUN	O	O

RESULTS:	NOUN	O	O
Fifty-two	NUM	O	O
eyes	NOUN	O	O
from	ADP	O	O
26	NUM	O	O
patients	NOUN	O	O
(mean	NUM	O	O
age,	NOUN	O	O
57.7	NUM	O	O
years)	NOUN	O	O
were	VERB	O	O
included.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

No	DET	O	O
significant	ADJ	O	O
ToP	NOUN	O	O
item	NOUN	O	O
changes	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
in	ADP	O	O
the	DET	O	O
conventional	ADJ	O	O
group.	VERB	O	O

CBT-i	NOUN	O	O
group	NOUN	O	O
is	VERB	O	O
superior	ADJ	O	O
in	ADP	O	O
improving	VERB	O	O
sleep	NOUN	O	B-outcome
onset	NOUN	O	I-outcome
latency	NOUN	O	I-outcome
(SOL)	NOUN	O	I-outcome
and	CCONJ	O	O
sleep	NOUN	O	B-outcome
efficiency	NOUN	O	I-outcome
(SE)	NOUN	O	I-outcome
.	PUNCT	O	O
Combination	NOUN	O	O
regimen	NOUN	O	O
in	ADP	O	O
our	ADJ	O	O
study	NOUN	O	O
can	VERB	O	O
significantly	ADV	O	O
reduce	VERB	O	O
the	DET	O	O
doses	NOUN	O	B-outcome
of	ADP	O	O
medication.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968547	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/27	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
MRI	NOUN	O	O
measures	NOUN	O	O
of	ADP	O	O
disease	NOUN	O	B-outcome
activity	NOUN	O	I-outcome
,	PUNCT	O	O
physical	ADJ	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
.	PUNCT	O	O
Results:	NOUN	O	O
Of	ADP	O	O
200	NUM	O	O
patients	NOUN	O	O
randomized	VERB	O	O
(133	NOUN	O	O
women	NOUN	O	O
[67%];	NOUN	O	O
mean	NOUN	O	O
[SD]	PUNCT	O	O
age,	NOUN	O	O
61.6	NUM	O	O
[10.5]	NOUN	O	O
years;	NOUN	O	O
median	ADJ	O	O
baseline	NOUN	O	O
DAS28-CRP,	NOUN	O	O
1.9	NUM	O	O
[interquartile	NOUN	O	O
range,	VERB	O	O
1.7-2.2];	NUM	O	O
van	NOUN	O	O
der	NOUN	O	O
Heijde-modified	VERB	O	O
Sharp	NOUN	O	O
score,	NOUN	O	O
18.0	NUM	O	O
[interquartile	NOUN	O	O
range,	VERB	O	O
7.0-42.5]),	NOUN	O	O
76	NUM	O	O
patients	NOUN	O	O
(76%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
MRI-guided	VERB	O	O
group	NOUN	O	O
and	CCONJ	O	O
95	NUM	O	O
(95%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
conventional	ADJ	O	O
group	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/18	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Within	ADP	O	O
24	NUM	O	O
h	NOUN	O	O
after	ADP	O	O
operation,	NOUN	O	O
the	DET	O	O
sufentanil	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
in	ADP	O	O
group	NOUN	O	O
D[(35.86+/-8.65)mug]was	NOUN	O	O
significantly	ADV	O	O
less	ADV	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
C[(59.53+/-15.26)	NOUN	O	O
mug,	NOUN	O	O
t=7.061,	NOUN	O	O
P<0.05],	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
patient	NOUN	O	O
controlled	VERB	O	O
analgesia	NOUN	O	B-outcome
pressing	VERB	O	O
in	ADP	O	O
group	NOUN	O	O
D(2.15+/-1.38)	NOUN	O	O
was	VERB	O	O
obviously	ADV	O	O
less	ADV	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
C(5.85+/-2.16,	NOUN	O	O
t=4.971,	NOUN	O	O
P<0.05).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
vector	NOUN	O	O
borne	NOUN	O	O
diseases	NOUN	O	O

After	ADP	O	O
12	NUM	O	O
months,	NOUN	O	O
patients	NOUN	O	O
receiving	VERB	O	O
riociguat	NOUN	O	O
therapy	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
right	ADJ	O	B-outcome
atrial	ADJ	O	I-outcome
(-	NOUN	O	X
2.6	NUM	O	X
+/-	SYM	O	X
4.4	NUM	O	X
cm2,	NOUN	O	X
95%	NOUN	O	X
CI	NOUN	O	X
-3.84,	NOUN	O	X
-	PUNCT	O	X
1.33;	NOUN	O	X
p	NOUN	O	X
<	SYM	O	X
0.001,	NUM	O	X
n	NOUN	O	X
=	SYM	O	X
49)	NOUN	O	X
and	CCONJ	O	Seperator
right	ADJ	O	B-outcome
ventricular	ADJ	O	I-outcome
(RV)	NOUN	O	I-outcome
area	NOUN	O	E1-outcome
(-	NOUN	O	O
3.5	NUM	O	O
+/-	SYM	O	O
5.2	NUM	O	O
cm2,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
-5.1,	NUM	O	O
-	PUNCT	O	O
1.9;	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.001;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
44),	NUM	O	O
RV	NOUN	O	B-outcome
thickness	NOUN	O	I-outcome
(-	NOUN	O	O
0.76	NUM	O	O
+/-	SYM	O	O
2.2	NUM	O	O
mm,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
-1.55,	NOUN	O	O
0.03;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
32),	NUM	O	O
and	CCONJ	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
TAPSE	NOUN	O	B-outcome
(2.95	NUM	O	O
+/-	SYM	O	O
4.78	NUM	O	O
mm,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
1.52,	NUM	O	O
4.39;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
45)	NOUN	O	O
and	CCONJ	O	O
RV	NOUN	O	B-outcome
fractional	ADJ	O	I-outcome
area	NOUN	O	I-outcome
change	NOUN	O	O
(8.12	PUNCT	O	O
+/-	SYM	O	O
8.87	NUM	O	O
mm,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
4.61,	NOUN	O	O
11.62;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
27).	NOUN	O	O

METHODS:	NOUN	O	O
Patients	NOUN	O	O
admitted	VERB	O	O
from	ADP	O	O
Weifang	NOUN	O	O
People's	NOUN	O	O
Hospital	NOUN	O	O
from	ADP	O	O
January	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
December	NOUN	O	O
2016	NUM	O	O
who	ADP	O	O
received	VERB	O	O
TKA	NOUN	O	O
were	VERB	O	O
injected	VERB	O	O
with	ADP	O	O
20	NUM	O	O
mg/kg	NOUN	O	O
TXA	NOUN	O	O
by	ADP	O	O
IV	NUM	O	O
before	ADP	O	O
TKA	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
50),	NOUN	O	O
3.0	NUM	O	O
g	NOUN	O	O
TXA	NOUN	O	O
by	ADP	O	O
IA	NOUN	O	O
after	ADP	O	O
TKA	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
50),	NOUN	O	O
or	CCONJ	O	O
combination	NOUN	O	O
of	ADP	O	O
20	NUM	O	O
mg/kg	NOUN	O	O
TXA	NOUN	O	O
by	ADP	O	O
IV	NUM	O	O
before	ADP	O	O
TKA	NOUN	O	O
and	CCONJ	O	O
3.0	NUM	O	O
g	NOUN	O	O
TXA	NOUN	O	O
by	ADP	O	O
IA	NOUN	O	O
after	ADP	O	O
TKA	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
50).	NOUN	O	O

Angle	NOUN	O	B-outcome
change	NOUN	O	I-outcome
was	VERB	O	O
3.29+/-6.60	NUM	O	O
for	ADP	O	O
kyphosis	NOUN	O	O
angle	NOUN	O	O
and	CCONJ	O	O
0.59+/-7.76	NUM	O	O
for	ADP	O	O
lordosis	NOUN	O	O
angle.	NOUN	O	O

T	NOUN	O	O
Diabetes	NOUN	O	O
Management	NOUN	O	O
Self-Efficacy	NOUN	O	B-outcome
Scale	NOUN	O	O
was	VERB	O	O
completed	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
6-month	NOUN	O	O
and	CCONJ	O	O
12-month.	NUM	O	O

Participants	NOUN	O	O
included	VERB	O	O
44	NUM	O	O
adults	NOUN	O	O
with	ADP	O	O
serotonin	NOUN	O	O
reuptake	NOUN	O	O
inhibitor	NOUN	O	O
treatment-refractory	NOUN	O	O
OCD	NOUN	O	O
and	CCONJ	O	O
they	PRON	O	O
received	VERB	O	O
a	DET	O	O
stable	ADJ	O	O
fluvoxamine	NOUN	O	O
pharmacotherapy	NOUN	O	O
with	ADP	O	O
Yale-Brown	NOUN	O	O
Obsessive	ADJ	O	B-outcome
Compulsive	ADJ	O	I-outcome
Scale	NOUN	O	O
(Y-BOCS)	NUM	O	O
scores	NOUN	O	O
higher	ADJ	O	O
than	ADP	O	O
20.	NUM	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
A	DET	O	O
phase	NOUN	O	O
II	NUM	O	O
trial	NOUN	O	O
(planned	PUNCT	O	O
n=58)	NOUN	O	O
using	VERB	O	O
second-line	NOUN	O	O
therapy	NOUN	O	O
for	ADP	O	O
metastatic	ADJ	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
with	ADP	O	O
either	CCONJ	O	O
oxaliplatin-based	VERB	O	O
(mFOLFOX6)	NOUN	O	O
or	CCONJ	O	O
irinotecan-based	VERB	O	O
(FOLFIRI)	NUM	O	O
combination	NOUN	O	O
chemotherapy	NOUN	O	O
and	CCONJ	O	O
100	NUM	O	O
mg	NOUN	O	O
erlotinib	NOUN	O	O
daily	ADJ	O	O
on	ADP	O	O
days	NOUN	O	O
3-8	NUM	O	O
after	ADP	O	O
each	DET	O	O
infusion	NOUN	O	O
(days	NUM	O	O
1	NUM	O	O
and	CCONJ	O	O
2)	NOUN	O	O
every	DET	O	O
14	NUM	O	O
days.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100884618	NUM	O	O

OBJECTIVE:	NOUN	O	O
Menstrual	ADJ	O	O
pain	NOUN	O	O
is	VERB	O	O
a	DET	O	O
periodic	ADJ	O	O
pain	NOUN	O	O
which	ADP	O	O
happens	NOUN	O	O
during	ADP	O	O
the	DET	O	O
days	NOUN	O	O
of	ADP	O	O
menses.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
aimed	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
prophylactic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
paracetamol	NOUN	O	O
and	CCONJ	O	O
dexmedetomidine	NOUN	O	O
for	ADP	O	O
controlling	VERB	O	O
hemodynamics	NOUN	O	B-outcome
during	ADP	O	O
surgery	NOUN	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
population	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
132	NUM	O	O
patients	NOUN	O	O
aged	VERB	O	O
18	NUM	O	O
to	PART	O	O
70	NUM	O	O
years	NOUN	O	O
and	CCONJ	O	O
from	ADP	O	O
both	CCONJ	O	O
genders,	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
candidates	NOUN	O	O
for	ADP	O	O
emergency	NOUN	O	O
cholecystectomy	NOUN	O	O
or	CCONJ	O	O
elective	ADJ	O	O
surgery.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9114501	NUM	O	O

Methods:	NOUN	O	O
This	DET	O	O
was	VERB	O	O
a	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
parallel-arm	NOUN	O	O
study	NOUN	O	O
of	ADP	O	O
70	NUM	O	O
fourth-year	NOUN	O	O
medical	ADJ	O	O
students	NOUN	O	O
to	PART	O	O
either	CCONJ	O	O
simulation	NOUN	O	O
(SIM)	NOUN	O	O
or	CCONJ	O	O
standard	ADJ	O	O
training	VERB	O	O
(STD)	PUNCT	O	O
over	ADP	O	O
an	DET	O	O
eight-month	NOUN	O	O
period.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101249598	NUM	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
intervention	NOUN	O	O
of	ADP	O	O
intensive	ADJ	O	O
education	NOUN	O	O
on	ADP	O	O
hand	NOUN	O	O
hygiene	NOUN	O	O
on	ADP	O	O
hand	NOUN	O	B-outcome
food	NOUN	O	I-outcome
mouth	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(HFMD)	PUNCT	O	I-outcome
.	PUNCT	O	O
We	PRON	O	O
randomized	VERB	O	O
64	NUM	O	O
villages	NOUN	O	O
into	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups	NOUN	O	O
in	ADP	O	O
Handan,	ADV	O	O
Hebei	NOUN	O	O
province,	NOUN	O	O
China.	NOUN	O	O

Sixteen	NUM	O	O
subjects	NOUN	O	O
with	ADP	O	O
well-controlled	VERB	O	O
T2DM	NOUN	O	O
(median	PUNCT	O	O
HbA1c	NOUN	O	O
47	NUM	O	O
mmol/mol,	NOUN	O	O
(37-67	NOUN	O	O
mmol/mol)	NOUN	O	O
and	CCONJ	O	O
BMI	NOUN	O	O
30	NUM	O	O
+/-	SYM	O	O
4.4	NUM	O	O
kg/m(2))	NOUN	O	O
participated	VERB	O	O
in	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
increasing	VERB	O	O
multidrug	NOUN	O	O
resistance	NOUN	O	O
among	ADP	O	O
gram-negative	ADJ	O	O
uropathogens	NOUN	O	O
necessitates	NOUN	O	O
new	ADJ	O	O
treatments	NOUN	O	O
for	ADP	O	O
serious	ADJ	O	O
infections.	NOUN	O	O

RESULTS:	NOUN	O	O
Endometrial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
increased	VERB	O	O
significantly	ADV	O	O
to	PART	O	O
8.67	NUM	O	O
+/-	SYM	O	O
0.64	NUM	O	O
in	ADP	O	O
PRP	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
controls	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.001).	NUM	O	O

In	ADP	O	O
the	DET	O	O
secondary	ADJ	O	O
analysis,	NOUN	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
Roland-Morris	NOUN	O	O
Disability	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(RMDQ)	NOUN	O	O
score	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
was	VERB	O	O
-2.3	NOUN	O	O
(-4.2	ADV	O	O
to-0.4,	NOUN	O	O
P=0.02)	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
1	NUM	O	O
Modic	NOUN	O	O
changes	NOUN	O	O
and	CCONJ	O	O
-0.1	ADV	O	O
(-2.7	NOUN	O	O
to	PART	O	O
2.6,	NOUN	O	O
P=0.95)	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
Modic	NOUN	O	O
changes.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Overall,	NOUN	O	O
the	DET	O	O
co-administration	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
and	CCONJ	O	O
probiotic	ADJ	O	O
for	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
to	PART	O	O
women	NOUN	O	O
with	ADP	O	O
PCOS	NOUN	O	O
had	VERB	O	O
beneficial	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
mental	ADJ	O	B-outcome
health	NOUN	O	I-outcome
parameters,	NOUN	O	O
serum	NOUN	O	O
total	ADJ	O	O
testosterone	NOUN	O	B-outcome
,	PUNCT	O	O
hirsutism	NOUN	O	B-outcome
,	PUNCT	O	O
high-sensitivity	NOUN	O	B-outcome
C-reactive	ADJ	O	I-outcome
protein	NOUN	O	I-outcome
(hs-CRP)	NOUN	O	I-outcome
,	PUNCT	O	O
plasma	NOUN	O	O
total	ADJ	O	O
antioxidant	NOUN	O	B-outcome
capacity	NOUN	O	O
(TAC),	NUM	O	O
glutathione	NOUN	O	B-outcome
(GSH)	PUNCT	O	I-outcome
and	CCONJ	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
levels.	NOUN	O	O

Further	ADV	O	O
process	NOUN	O	O
evaluations	NOUN	O	O
of	ADP	O	O
multi-component	ADJ	O	O
school-based	VERB	O	O
PA	NOUN	O	O
interventions	NOUN	O	O
are	VERB	O	O
warranted	VERB	O	O
to	PART	O	O
develop	VERB	O	O
the	DET	O	O
limited	VERB	O	O
evidence	NOUN	O	O
base.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
695	NUM	O	O
men	NOUN	O	O
with	ADP	O	O
localized	VERB	O	O
prostate	NOUN	O	O
cancer	NOUN	O	O
to	PART	O	O
watchful	ADJ	O	O
waiting	VERB	O	O
or	CCONJ	O	O
radical	NOUN	O	O
prostatectomy	NOUN	O	O
from	ADP	O	O
October	ADJ	O	O
1989	NUM	O	O
through	ADP	O	O
February	ADJ	O	O
1999	NUM	O	O
and	CCONJ	O	O
collected	VERB	O	O
follow-up	NOUN	O	O
data	NOUN	O	O
through	ADP	O	O
2017.	NUM	O	O

However,	ADV	O	O
anesthesia	NOUN	O	O
induction	NOUN	O	O
time	NOUN	O	O
by	ADP	O	O
timing	VERB	O	O
remifentanil	NOUN	O	O
administration	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
identified.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
independent	ADJ	O	O
t-test	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
total	ADJ	O	O
score	NOUN	O	O
of	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
and	CCONJ	O	O
its	ADJ	O	O
various	ADJ	O	O
dimensions	NOUN	O	O
(	PUNCT	O	O
vasomotor	NOUN	O	B-outcome
,	PUNCT	O	O
psychosocial	ADJ	O	B-outcome
,	PUNCT	O	O
physical	ADJ	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
sexual	ADJ	O	B-outcome
dimensions)	NOUN	O	O
after	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
between	ADP	O	O
the	DET	O	O
aromatherapy	NOUN	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
groups	NOUN	O	O
(P<0.001).	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
also	ADV	O	O
assessed	VERB	O	O
during	ADP	O	O
the	DET	O	O
period	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
demonstrates	NOUN	O	O
the	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
BT-11	NOUN	O	O
in	ADP	O	O
the	DET	O	O
adolescent	NOUN	O	O
by	ADP	O	O
showing	VERB	O	O
no	DET	O	O
apparent	ADJ	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
related	VERB	O	O
to	PART	O	O
it.	NOUN	O	O

Title:	NOUN	O	O
Evaluation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
a	DET	O	O
new	ADJ	O	O
hemostatic	ADJ	O	O
powder	NOUN	O	O
using	VERB	O	O
a	DET	O	O
quantitative	ADJ	O	O
surface	NOUN	O	B-outcome
bleeding	VERB	O	I-outcome
severity	NOUN	O	O
scale.	ADJ	O	O

METHODS:	NOUN	O	O
Eligible	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
aged	VERB	O	O
60	NUM	O	O
years	NOUN	O	O
or	CCONJ	O	O
older	ADJ	O	O
with	ADP	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
leukaemia	NOUN	O	O
but	CCONJ	O	O
unsuitable	ADJ	O	O
for	ADP	O	O
intensive	ADJ	O	O
chemotherapy	NOUN	O	O
(or	NUM	O	O
<60	NOUN	O	O
years	NOUN	O	O
if	ADP	O	O
unsuitable	ADJ	O	O
for	ADP	O	O
intensive	ADJ	O	O
chemotherapy	NOUN	O	O
with	ADP	O	O
an	DET	O	O
anthracycline	NOUN	O	O
plus	CCONJ	O	O
cytarabine).	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
length	NOUN	O	B-outcome
of	ADP	O	I-outcome
stay	NOUN	O	I-outcome
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
t=0.474,	NOUN	O	O
P=0.640).	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
7,	NUM	O	O
9,	NOUN	O	O
11,	NUM	O	O
13	NUM	O	O
or	CCONJ	O	O
15	NUM	O	O
mg	NOUN	O	O
intrathecal	ADJ	O	O
hyperbaric	ADJ	O	O
ropivacaine	NOUN	O	O
respectively.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
http://www.clinicaltrials.gov	NOUN	O	O
Unique	ADJ	O	O
identifier:	NOUN	O	O
NCT00979589	NOUN	O	O
.	PUNCT	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

BACKGROUND:	NOUN	O	O
Radical	ADJ	O	O
prostatectomy	NOUN	O	O
reduces	NOUN	O	O
mortality	NOUN	O	O
among	ADP	O	O
men	NOUN	O	O
with	ADP	O	O
clinically	ADV	O	O
detected	VERB	O	O
localized	VERB	O	O
prostate	NOUN	O	O
cancer,	NOUN	O	O
but	CCONJ	O	O
evidence	NOUN	O	O
from	ADP	O	O
randomized	VERB	O	O
trials	NOUN	O	O
with	ADP	O	O
long-term	NOUN	O	O
follow-up	NOUN	O	O
is	VERB	O	O
sparse.	NOUN	O	O

Title:	NOUN	O	O
Phase	NOUN	O	O
1	NUM	O	O
Trial	NOUN	O	O
of	ADP	O	O
an	DET	O	O
RNA	NOUN	O	O
Interference	NOUN	O	O
Therapy	NOUN	O	O
for	ADP	O	O
Acute	ADJ	O	O
Intermittent	ADJ	O	O
Porphyria.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/13	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
prognostic	ADJ	O	O
factor	NOUN	O	O
analysis	NOUN	O	O
in	ADP	O	O
NSCLC	NOUN	O	O
performed	VERB	O	O
on	ADP	O	O
data	NOUN	O	O
from	ADP	O	O
a	DET	O	O
large	ADJ	O	O
prospective	ADJ	O	O
study.	NOUN	O	O

METHODS:	NOUN	O	O
Clinical	ADJ	O	O
and	CCONJ	O	O
randomized	VERB	O	O
trial	NOUN	O	O
with	ADP	O	O
follow-up	NOUN	O	O
of	ADP	O	O
three	NUM	O	O
months.	NOUN	O	O

We	PRON	O	O
have	VERB	O	O
shown	VERB	O	O
that	ADP	O	O
a	DET	O	O
diet	NOUN	O	O
intervention	NOUN	O	O
postpartum	NOUN	O	O
produced	VERB	O	O
a	DET	O	O
2-y	NOUN	O	O
weight	NOUN	O	O
loss	NOUN	O	O
of	ADP	O	O
8%.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
analysis,	NOUN	O	O
the	DET	O	O
mean	NOUN	O	O
microvascular	ADJ	O	B-outcome
obstruction	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
the	DET	O	O
20-mg	NOUN	O	O
alteplase	NOUN	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
groups	NOUN	O	O
(3.5%	NOUN	O	O
vs	CCONJ	O	O
2.3%;	NOUN	O	O
estimated	VERB	O	O
difference,	NOUN	O	O
1.16%;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-0.08%	NOUN	O	O
to	PART	O	O
2.41%;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.32)	NOUN	O	O
nor	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
10-mg	NOUN	O	O
alteplase	NOUN	O	O
vs	CCONJ	O	O
placebo	NOUN	O	O
groups	NOUN	O	O
(2.6%	NOUN	O	O
vs	CCONJ	O	O
2.3%;	NOUN	O	O
estimated	VERB	O	O
difference,	NOUN	O	O
0.29%;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-0.76%	NUM	O	O
to	PART	O	O
1.35%;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.74).	PUNCT	O	O

Results	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
the	DET	O	O
participants	NOUN	O	O
was	VERB	O	O
85.2	NUM	O	O
years.	NOUN	O	O

The	DET	O	O
clinical	ADJ	O	O
value	NOUN	O	O
of	ADP	O	O
OPEP	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
widely	ADV	O	O
discussed	VERB	O	O
in	ADP	O	O
chronic	ADJ	O	O
obstructive	ADJ	O	O
pulmonary	ADJ	O	O
disease,	NOUN	O	O
bronchiectasis	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
pulmonary	ADJ	O	O
cyst.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/09/05	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Except	ADP	O	O
for	ADP	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
infarctions,	NOUN	O	O
size	NOUN	O	O
and	CCONJ	O	O
location	NOUN	O	O
should	VERB	O	O
also	ADV	O	O
be	VERB	O	O
considered	VERB	O	O
to	PART	O	O
stratify	NOUN	O	O
risk	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	O
recurrence	NOUN	O	O
in	ADP	O	O
minor	ADJ	O	O
stroke.	NOUN	O	O

Eligible	ADJ	O	O
infants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
(1:1)	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
enteral	ADJ	O	O
bovine	ADJ	O	O
lactoferrin	NOUN	O	O
(150	NUM	O	O
mg/kg	NOUN	O	O
per	ADP	O	O
day;	NOUN	O	O
maximum	NOUN	O	O
300	NUM	O	O
mg/day;	ADV	O	O
lactoferrin	NOUN	O	O
group)	ADJ	O	O
or	CCONJ	O	O
sucrose	NOUN	O	O
(same	NUM	O	O
dose;	NOUN	O	O
control	NOUN	O	O
group)	ADJ	O	O
once	ADP	O	O
daily	ADJ	O	O
until	ADP	O	O
34	NUM	O	O
weeks'	ADP	O	O
postmenstrual	NOUN	O	O
age.	ADJ	O	O

BACKGROUND:	NOUN	O	O
Endotracheal	ADP	O	O
intubation	NOUN	O	O
for	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
causes	NOUN	O	O
postoperative	ADJ	O	O
sore	ADV	O	O
throat	NOUN	O	O
(POST).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/31	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

No	DET	O	O
further	ADV	O	O
group	NOUN	O	O
differences	NOUN	O	O
were	VERB	O	O
found.	NOUN	O	O

Title:	NOUN	O	O
Bag-Mask	NOUN	O	O
Ventilation	NOUN	O	O
during	ADP	O	O
Tracheal	ADJ	O	O
Intubation	NOUN	O	O
of	ADP	O	O
Critically	ADV	O	O
Ill	NOUN	O	O
Adults.	NOUN	O	O

PATIENTS	NOUN	O	O
OR	CCONJ	O	O
OTHER	ADJ	O	O
PARTICIPANTS:	NOUN	O	O
Seventy-two	NUM	O	O
elite	ADP	O	O
asymptomatic	ADJ	O	O
overhead	ADP	O	O
athletes	NOUN	O	O
(age	NOUN	O	O
=	SYM	O	O
17.00	NUM	O	O
+/-	SYM	O	O
4.09	NUM	O	O
years,	NOUN	O	O
height	NOUN	O	O
=	SYM	O	O
1.75	NUM	O	O
+/-	SYM	O	O
0.11	NUM	O	O
m,	NOUN	O	O
mass	NOUN	O	O
=	SYM	O	O
67.26	NUM	O	O
+/-	SYM	O	O
15.25	NUM	O	O
kg,	NOUN	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
=	SYM	O	O
21.80	NUM	O	O
+/-	SYM	O	O
3.00).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0014171	NUM	O	O

Result/Key	NOUN	O	O
findings.	NOUN	O	O

Three	NUM	O	O
patients	NOUN	O	O
died	VERB	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
11	NUM	O	O
patients	NOUN	O	O
died	VERB	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
during	ADP	O	O
the	DET	O	O
3-year	NOUN	O	O
follow-up.	PUNCT	O	O

Findings	NOUN	O	O
will	VERB	O	O
contribute	NOUN	O	O
to	PART	O	O
a	DET	O	O
better	ADJ	O	O
understanding	VERB	O	O
of	ADP	O	O
the	DET	O	O
optimal	ADJ	O	O
distribution	NOUN	O	O
mechanisms	NOUN	O	O
of	ADP	O	O
repellent,	NOUN	O	O
context	NOUN	O	O
specific	ADJ	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
inform	NOUN	O	O
policy	NOUN	O	O
makers	NOUN	O	O
and	CCONJ	O	O
implementers	NOUN	O	O
of	ADP	O	O
malaria	NOUN	O	O
elimination	NOUN	O	O
programs	NOUN	O	O
in	ADP	O	O
the	DET	O	O
GMS.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
aim	ADP	O	O
was	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
if	ADP	O	O
serum	NOUN	O	O
25(OH)D	NUM	O	B-outcome
is	VERB	O	O
a	DET	O	O
predictor	NOUN	O	O
of	ADP	O	O
testosterone	NOUN	O	B-outcome
and	CCONJ	O	O
cortisol	NOUN	O	B-outcome
levels.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101090220	NUM	O	O

The	DET	O	O
subjects	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
ET	NOUN	O	O
plus	CCONJ	O	O
montelukast,	NOUN	O	O
while	ADP	O	O
the	DET	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
montelukast	NOUN	O	O
alone.	NOUN	O	O

Decompression	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
cost-effective	ADJ	O	O
in	ADP	O	O
the	DET	O	O
longer-term,	NOUN	O	O
but	CCONJ	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
analysis	NOUN	O	O
are	VERB	O	O
sensitive	ADJ	O	O
to	PART	O	O
the	DET	O	O
assumptions	NOUN	O	O
made	VERB	O	O
about	ADV	O	O
how	ADP	O	O
costs	NOUN	O	O
and	CCONJ	O	O
QALYs	NOUN	O	O
are	VERB	O	O
extrapolated	VERB	O	O
beyond	ADP	O	O
the	DET	O	O
follow-up	NOUN	O	O
of	ADP	O	O
the	DET	O	O
trial.	NOUN	O	O

The	DET	O	O
effects	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
by	ADP	O	O
the	DET	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
end	NOUN	O	I-outcome
the	DET	O	Seperator
task	NOUN	O	I-outcome
after	ADP	O	O
overcoming	VERB	O	O
the	DET	O	O
learning	VERB	O	O
curve	NOUN	O	O
which	ADP	O	O
is	VERB	O	O
determined	VERB	O	O
by	ADP	O	O
several	ADJ	O	O
performance	NOUN	O	B-outcome
parameters.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9424324	NUM	O	O

A	DET	O	O
nonsignificant	ADJ	O	O
elevation	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
norepinephrine	NOUN	O	B-outcome
and	CCONJ	O	O
epinephrine	NOUN	O	B-outcome
levels	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
methohexital	ADJ	O	O
group,	NOUN	O	O
while	ADP	O	O
serum	NOUN	O	O
arginine	NOUN	O	B-outcome
vasopressin	NOUN	O	I-outcome
and	CCONJ	O	O
angiotensin	NOUN	O	B-outcome
II	NUM	O	I-outcome
levels	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

Journal-Name:	NOUN	O	O
The	DET	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
We	PRON	O	O
have	VERB	O	O
developed	VERB	O	O
an	DET	O	O
automated,	VERB	O	O
accurate,	NOUN	O	O
and	CCONJ	O	O
precise	ADJ	O	O
assay	NOUN	O	O
for	ADP	O	O
the	DET	O	O
determination	NOUN	O	O
of	ADP	O	O
belatacept	ADV	O	O
serum	NOUN	O	O
concentrations.	NUM	O	O

Talbot	NOUN	O	O
Advisors,	NOUN	O	O
Anna	ADP	O	O
Maria,	NOUN	O	O
FL.	NOUN	O	O

Primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
the	DET	O	O
ratio	NOUN	O	B-outcome
of	ADP	O	I-outcome
operator	NOUN	O	I-outcome
received	VERB	O	I-outcome
dose	NOUN	O	I-outcome
in	PUNCT	O	X
mrem	NOUN	O	X
to	PART	O	I-outcome
total	ADJ	O	I-outcome
radiation	NOUN	O	I-outcome
in	ADP	O	O
Gyat	ADJ	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
procedure	NOUN	O	O
which	ADP	O	O
was	VERB	O	O
designated	VERB	O	O
''Relative	ADJ	O	O
operator	NOUN	O	O
exposure'',	NOUN	O	O
with	ADP	O	O
or	CCONJ	O	O
without	ADP	O	O
RADPAD.	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
in	ADP	O	O
a	DET	O	O
3:2	NOUN	O	O
ratio	NOUN	O	O
to	PART	O	O
oral	ADJ	O	O
ixazomib	NOUN	O	O
or	CCONJ	O	O
matching	VERB	O	O
placebo	NOUN	O	O
on	ADP	O	O
days	NOUN	O	O
1,	NOUN	O	O
8,	NOUN	O	O
and	CCONJ	O	O
15	NUM	O	O
in	ADP	O	O
28-day	NOUN	O	O
cycles	NOUN	O	O
for	ADP	O	O
2	NUM	O	O
years	NOUN	O	O
following	VERB	O	O
induction,	NOUN	O	O
high-dose	NOUN	O	O
therapy,	NOUN	O	O
and	CCONJ	O	O
transplantation.	ADV	O	O

Reactive	ADJ	O	B-outcome
agility	NOUN	O	I-outcome
,	PUNCT	O	O
our	ADJ	O	O
primary	ADJ	O	O
outcome,	ADJ	O	O
was	VERB	O	O
determined	VERB	O	O
by	ADP	O	O
measuring	VERB	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
hits	NOUN	O	B-outcome
and	CCONJ	O	O
average	NOUN	O	O
reaction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
(ART)	NOUN	O	O
on	ADP	O	O
a	DET	O	O
Makoto	NOUN	O	O
Arena	NOUN	O	O
II,	NOUN	O	O
a	DET	O	O
360(0)	NUM	O	O
audio-visual	ADJ	O	O
device	NOUN	O	O
that	ADP	O	O
measures	NOUN	O	O
stationary,	NOUN	O	B-outcome
lateral,	NOUN	O	B-outcome
and	CCONJ	O	Seperator
multi-directional	ADJ	O	B-outcome
active	ADJ	O	I-outcome
choice	NOUN	O	I-outcome
reaction	NOUN	O	I-outcome
performance	NOUN	O	E4-outcome
.	PUNCT	O	O
Safety	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
using	VERB	O	O
complete	ADJ	O	O
blood	NOUN	O	B-outcome
count	NOUN	O	I-outcome
,	PUNCT	O	O
comprehensive	ADJ	O	O
metabolic	ADJ	O	B-outcome
panel	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
blood	NOUN	O	B-outcome
lipids	NOUN	O	I-outcome
.	PUNCT	O	O
Measurements	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
on	ADP	O	O
days	NOUN	O	O
7,	NUM	O	O
30,	NUM	O	O
and	CCONJ	O	O
90	NUM	O	O
of	ADP	O	O
supplementation.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

However,	ADV	O	O
no	DET	O	O
studies	NOUN	O	O
have	VERB	O	O
yet	ADV	O	O
documented	VERB	O	O
the	DET	O	O
utility	NOUN	O	O
of	ADP	O	O
and	CCONJ	O	O
student	NOUN	O	O
response	NOUN	O	O
to	PART	O	O
videoconference	NOUN	O	O
meetings	NOUN	O	O
for	ADP	O	O
mid-clerkship	NOUN	O	O
feedback	NOUN	O	O
(MCF)	NOUN	O	O
sessions	NOUN	O	O
required	VERB	O	O
by	ADP	O	O
the	DET	O	O
Liaison	NOUN	O	O
Committee	NOUN	O	O
on	ADP	O	O
Medical	ADJ	O	O
Education	NOUN	O	O
(LCME).	NOUN	O	O

During	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
treatment	NOUN	O	O
period,	NOUN	O	O
three	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
died	VERB	O	B-outcome
.	PUNCT	O	O
One	NUM	O	O
patient	NOUN	O	O
in	ADP	O	O
the	DET	O	O
caplacizumab	NOUN	O	O
group	NOUN	O	O
died	VERB	O	B-outcome
from	ADP	O	O
cerebral	ADJ	O	O
ischemia	NOUN	O	O
after	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
period.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
lowest	ADV	O	O
oxygen	NOUN	O	B-outcome
saturation	NOUN	O	I-outcome
observed	VERB	O	O
during	ADP	O	O
the	DET	O	O
interval	NOUN	O	O
between	ADP	O	O
induction	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
minutes	NOUN	O	O
after	ADP	O	O
tracheal	ADJ	O	O
intubation.	ADV	O	O

The	DET	O	O
data	NOUN	O	O
was	VERB	O	O
analyzed	VERB	O	O
via	ADP	O	O
SPSS-21	NOUN	O	O
using	VERB	O	O
descriptive	ADJ	O	O
statistics	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
mean,	NOUN	O	O
standard	ADJ	O	O
deviation,	NOUN	O	O
and	CCONJ	O	O
frequency;	NOUN	O	O
and	CCONJ	O	O
inferential	ADJ	O	O
statistics	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
Chi	NOUN	O	O
Squared,	NOUN	O	O
Kruskal	NOUN	O	O
Wallis	NOUN	O	O
test,	NUM	O	O
and	CCONJ	O	O
Friedman	NOUN	O	O
test.	NOUN	O	O

Title:	NOUN	O	O
Cobalt	NOUN	O	O
chromium-Titanium	NOUN	O	O
rods	NOUN	O	O
versus	CCONJ	O	O
Titanium-Titanium	NOUN	O	O
rods	NOUN	O	O
for	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
adolescent	NOUN	O	O
idiopathic	ADJ	O	O
scoliosis;	ADJ	O	O
which	ADP	O	O
type	NOUN	O	O
of	ADP	O	O
rod	NOUN	O	O
has	VERB	O	O
better	ADJ	O	O
postoperative	ADJ	O	O
outcomes?	NOUN	O	O

The	DET	O	O
survey	NOUN	O	O
also	ADV	O	O
collected	VERB	O	O
data	NOUN	O	O
on	ADP	O	O
these	DET	O	O
demographic	ADJ	O	O
variables:	NOUN	O	O
the	DET	O	O
name	NOUN	O	O
of	ADP	O	O
the	DET	O	O
faculty	NOUN	O	O
member	NOUN	O	O
with	ADP	O	O
whom	ADP	O	O
the	DET	O	O
student	NOUN	O	O
met;	NOUN	O	O
student	NOUN	O	O
gender,	NOUN	O	O
age,	NOUN	O	O
and	CCONJ	O	O
interest	NOUN	O	O
in	ADP	O	O
EM;	NOUN	O	O
location	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
meeting;	ADJ	O	O
meeting-method	NOUN	O	O
preference;	ADJ	O	O
and	CCONJ	O	O
number	NOUN	O	O
of	ADP	O	O
EM	NOUN	O	O
shifts	NOUN	O	O
completed.	NOUN	O	O

For	ADP	O	O
dexmedetomidine	NOUN	O	O
vs	CCONJ	O	O
propofol,	NOUN	O	O
only	ADV	O	O
breakthrough	NOUN	O	O
analgesia	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
different	ADJ	O	O
(median,	NOUN	O	O
328.8	NUM	O	O
vs	CCONJ	O	O
397.5	NUM	O	O
microg;	NOUN	O	O
difference,	NOUN	O	O
-69	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-155	NUM	O	O
to	PART	O	O
-4];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.04).	PUNCT	O	O

The	DET	O	O
rates	NOUN	O	O
of	ADP	O	O
dyskinesia	ADJ	O	B-outcome
and	CCONJ	O	O
levodopa-related	VERB	O	O
fluctuations	NOUN	O	O
in	ADP	O	O
motor	NOUN	O	B-outcome
response	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
significantly	ADV	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/04	VERB	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

INTERPRETATION:	CCONJ	O	O
Enteral	ADJ	O	O
supplementation	NOUN	O	O
with	ADP	O	O
bovine	ADJ	O	O
lactoferrin	NOUN	O	O
does	VERB	O	O
not	ADV	O	O
reduce	VERB	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
late-onset	NOUN	O	O
infection	NOUN	O	B-outcome
in	ADP	O	O
very	ADV	O	O
preterm	NOUN	O	O
infants.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Both	CCONJ	O	O
drugs	NOUN	O	O
reduced	VERB	O	O
menstrual	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
.	PUNCT	O	O
Ginger	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
Novafen	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
relieving	VERB	O	O
pain	NOUN	O	B-outcome
in	ADP	O	O
girls	NOUN	O	O
with	ADP	O	O
primary	ADJ	O	O
dysmenorrhea	ADJ	O	O
.	PUNCT	O	O

Further	ADV	O	O
controlled	VERB	O	O
prospective	ADJ	O	O
studies	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
these	DET	O	O
results.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Prospectively	ADV	O	O
registered	VERB	O	O
at	ADP	O	O
ClinicalTrials.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
performance	NOUN	O	B-outcome
on	ADP	O	O
a	DET	O	O
computer	NOUN	O	O
task	NOUN	O	O
in	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
ALS	NOUN	O	O
using	VERB	O	O
three	NUM	O	O
different	ADJ	O	O
commonly	ADV	O	O
used	VERB	O	O
non-immersive	ADJ	O	O
devices.	ADJ	O	O

This	DET	O	O
was	VERB	O	O
an	DET	O	O
educational	ADJ	O	O
tool	NOUN	O	O
which	ADP	O	O
aimed	VERB	O	O
to	PART	O	O
remind	VERB	O	O
mothers	NOUN	O	O
in	ADP	O	O
rural	ADJ	O	O
Uganda	ADP	O	O
to	PART	O	O
clean	NOUN	O	O
their	ADJ	O	O
hands	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
neonatal	ADJ	O	O
infection.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/22	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
Effects	NOUN	O	O
of	ADP	O	O
Instruction	NOUN	O	O
on	ADP	O	O
Parent	NOUN	O	O
Competency	NOUN	O	B-outcome
During	ADP	O	O
Infant	NOUN	O	O
Handling	VERB	O	O
in	ADP	O	O
a	DET	O	O
Neonatal	ADJ	O	O
Intensive	ADJ	O	O
Care	NOUN	O	O
Unit.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/29	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
In	ADP	O	O
well-controlled	VERB	O	O
T2DM	NOUN	O	O
a	DET	O	O
modest	ADJ	O	O
reduction	NOUN	O	O
of	ADP	O	O
dietary	ADJ	O	O
carbohydrate	NOUN	O	O
with	ADP	O	O
a	DET	O	O
corresponding	VERB	O	O
increase	NOUN	O	O
in	ADP	O	O
protein	NOUN	O	O
and	CCONJ	O	O
fat	NOUN	O	O
acutely	ADV	O	O
reduced	VERB	O	O
postprandial	ADJ	O	O
serum	NOUN	O	O
non-esterified	VERB	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
suppression	NOUN	O	O
and	CCONJ	O	O
increased	VERB	O	O
serum	NOUN	O	O
triglyceride	NOUN	O	B-outcome
(TG)	NOUN	O	I-outcome
responses	NOUN	O	O
after	ADP	O	O
a	DET	O	O
breakfast	NOUN	O	O
meal	ADJ	O	O
but	CCONJ	O	O
had	VERB	O	O
the	DET	O	O
opposite	ADJ	O	O
effect	NOUN	O	O
after	ADP	O	O
a	DET	O	O
lunch	NOUN	O	O
meal.	NOUN	O	O

BACKGROUND/AIMS:	NOUN	O	O
The	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
adiponectin	NOUN	O	O
(APN)	NUM	O	O
and	CCONJ	O	O
adiponectin	NOUN	O	O
receptor	NOUN	O	O
1	NUM	O	O
(AdipoR1)	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
mellitus	NOUN	O	O
(T2DM)	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
macrovascular	ADJ	O	O
complications	NOUN	O	O
(MVC),	NUM	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
their	ADJ	O	O
correlation	NOUN	O	O
with	ADP	O	O
clinical	ADJ	O	O
parameters.	NOUN	O	O

METHODS:	NOUN	O	O
Participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
the	DET	O	O
CART	NOUN	O	O
group	NOUN	O	O
that	ADP	O	O
performed	VERB	O	O
combined	VERB	O	O
aerobic	ADJ	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
exercise	NOUN	O	O
of	ADP	O	O
moderate	ADJ	O	O
intensity	NOUN	O	O
[aerobic	NOUN	O	O
exercise	NOUN	O	O
50-80%	NUM	O	O
of	ADP	O	O
HRmax	NOUN	O	O
(maximum	NOUN	O	O
heart	NOUN	O	O
rate)	NOUN	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
exercises	NOUN	O	O
at	ADP	O	O
50-80%	NUM	O	O
of	ADP	O	O
1	NUM	O	O
Repetition	NOUN	O	O
Maximum	NOUN	O	O
(RM)],	NOUN	O	O
5	NUM	O	O
times/week	DET	O	O
for	ADP	O	O
4	NUM	O	O
weeks,	NOUN	O	O
or	CCONJ	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
that	ADP	O	O
followed	VERB	O	O
conventional	ADJ	O	O
treatment	NOUN	O	O
without	ADP	O	O
any	DET	O	O
supervised	VERB	O	O
exercise	NOUN	O	O
intervention.	NOUN	O	O

This	DET	O	O
will	VERB	O	O
help	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
if	ADP	O	O
routine	ADJ	O	O
selenium	NOUN	O	O
supplementation	NOUN	O	O
in	ADP	O	O
HIV-infected	VERB	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
will	VERB	O	O
contribute	NOUN	O	O
to	PART	O	O
the	DET	O	O
improvement	NOUN	O	O
in	ADP	O	O
the	DET	O	O
major	ADJ	O	O
adverse	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
outcomes	NOUN	O	I-outcome
such	ADJ	O	O
as	ADP	O	O
preterm	NOUN	O	B-outcome
birth	NOUN	O	I-outcome
and	CCONJ	O	O
low	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
weight	NOUN	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
HIV	NOUN	O	B-outcome
disease	NOUN	O	I-outcome
surrogate	ADJ	O	O
markers	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
CD4+	NOUN	O	B-outcome
cells	NOUN	O	I-outcome
count	NOUN	O	I-outcome
and	CCONJ	O	O
viral	ADJ	O	B-outcome
load	NOUN	O	I-outcome
.	PUNCT	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
PACTR,	ADJ	O	O
PACTR201809756724274.	NOUN	O	O

In	ADP	O	O
conclusion,	NOUN	O	O
cashews	NOUN	O	O
provide	VERB	O	O
fewer	ADJ	O	O
calories	NOUN	O	O
than	ADP	O	O
the	DET	O	O
values	NOUN	O	O
predicted	VERB	O	O
by	ADP	O	O
the	DET	O	O
Atwater	ADV	O	O
factors,	NOUN	O	O
as	ADP	O	O
found	VERB	O	O
on	ADP	O	O
current	ADJ	O	O
food	NOUN	O	O
labels.	NOUN	O	O

In	ADP	O	O
SAT,	NOUN	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
FF	NOUN	O	O
on	ADP	O	O
decreasing	VERB	O	O
IL1RN	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
was	VERB	O	O
significant	ADJ	O	O
(P	NUM	O	O
<	SYM	O	O
0.03).	NUM	O	O

PMP	NOUN	O	O
supplementation	NOUN	O	O
for	ADP	O	O
eight	NUM	O	O
weeks	NOUN	O	O
reduced	VERB	O	O
reactive	ADJ	O	B-outcome
oxygen	NOUN	O	I-outcome
species	NOUN	O	I-outcome
(ROS)	PUNCT	O	I-outcome
and	CCONJ	O	O
prevented	VERB	O	O
DNA	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
without	ADP	O	O
altering	VERB	O	O
endogenous	ADJ	O	O
antioxidant	NOUN	O	O
system.	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
388	NUM	O	O
subjects	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
analysis.	NOUN	O	O

MAIN	ADJ	O	O
OUTCOME	NOUN	O	O
MEASURE(S):	NOUN	O	O
We	PRON	O	O
evaluated	VERB	O	O
all	DET	O	O
groups	NOUN	O	O
for	ADP	O	O
observable	ADJ	O	O
scapular	ADJ	O	B-outcome
dyskinesis	NOUN	O	I-outcome
using	VERB	O	O
the	DET	O	O
scapular	ADJ	O	O
dyskinesis	NOUN	O	O
test,	NUM	O	O
scapular	ADJ	O	B-outcome
upward	ADJ	O	I-outcome
rotation	NOUN	O	I-outcome
using	VERB	O	O
a	DET	O	O
digital	ADJ	O	O
inclinometer,	NOUN	O	O
and	CCONJ	O	O
pectoralis	NOUN	O	B-outcome
minor	ADJ	O	I-outcome
length	NOUN	O	I-outcome
using	VERB	O	O
the	DET	O	O
pectoralis	NOUN	O	O
minor	ADJ	O	O
index	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
taping,	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
60	NUM	O	O
to	PART	O	O
72	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
taping.	NOUN	O	O

Baseline	NOUN	O	O
characteristics	NOUN	O	O
differed	VERB	O	O
between	ADP	O	O
genders,	NOUN	O	O
with	ADP	O	O
women	NOUN	O	O
being	VERB	O	O
younger,	NOUN	O	O
having	VERB	O	O
better	ADJ	O	O
lung	NOUN	O	O
function	NOUN	O	O
and	CCONJ	O	O
more	ADV	O	O
often	ADV	O	O
experiencing	VERB	O	O
>/=2	NOUN	O	O
exacerbations	NOUN	O	O
in	ADP	O	O
the	DET	O	O
previous	ADJ	O	O
year.	NOUN	O	O

Nervous	ADJ	O	O
tissues	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
less	ADV	O	O
prone	NOUN	O	O
to	PART	O	O
low	ADJ	O	O
DHA	NOUN	O	B-outcome
levels	NOUN	O	O
after	ADP	O	O
infancy,	ADJ	O	O
or	CCONJ	O	O
higher	ADJ	O	O
doses	NOUN	O	O
might	VERB	O	O
be	VERB	O	O
required	VERB	O	O
to	PART	O	O
impact	NOUN	O	O
neurological	ADJ	O	B-outcome
functions	NOUN	O	I-outcome
.	PUNCT	O	O
In	ADP	O	O
situations	NOUN	O	O
of	ADP	O	O
minimal	ADJ	O	O
dietary	ADJ	O	O
DHA,	NOUN	O	O
endogenous	ADJ	O	O
synthesis	NOUN	O	O
of	ADP	O	O
DHA	NOUN	O	O
from	ADP	O	O
alpha-linolenic	ADJ	O	O
acid	NOUN	O	O
could	VERB	O	O
relevantly	ADV	O	O
contribute	NOUN	O	O
to	PART	O	O
DHA	NOUN	O	B-outcome
status.	NOUN	O	O

At	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
4-week	NOUN	O	O
follow-up,	ADP	O	O
there	PRON	O	O
were	VERB	O	O
also	ADV	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
post-voiding	VERB	O	B-outcome
residual	ADJ	O	I-outcome
urine	NOUN	O	I-outcome
volume	NOUN	O	I-outcome
(PV-VRU)	PUNCT	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.42),	PUNCT	O	O
voided	VERB	O	B-outcome
volume	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.71),	PUNCT	O	O
maximum	NOUN	O	B-outcome
urinary	ADJ	O	I-outcome
flow	NOUN	O	I-outcome
rate	NOUN	O	O
(Qmax)	PUNCT	O	O
(P	NUM	O	O
=	SYM	O	O
.24),	PUNCT	O	O
and	CCONJ	O	O
Barthel	PROPN	O	O
Index	NOUN	O	O
(BI)	NOUN	O	O
scores	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.75)	ADP	O	O
between	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

To	PART	O	O
ensure	NOUN	O	O
adequate	ADJ	O	O
input	NOUN	O	O
and	CCONJ	O	O
secure	ADJ	O	O
implementation,	ADP	O	O
study	NOUN	O	O
design	NOUN	O	O
and	CCONJ	O	O
results	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
reviewed	VERB	O	O
with	ADP	O	O
relevant	ADJ	O	O
stakeholders,	NOUN	O	O
including	VERB	O	O
the	DET	O	O
children's	NOUN	O	O
families,	NOUN	O	O
and	CCONJ	O	O
provincial	ADJ	O	O
and	CCONJ	O	O
regional	ADJ	O	O
decision-makers.	NOUN	O	O

Measures	NOUN	O	O
included	VERB	O	O
a	DET	O	O
composite	NOUN	O	O
strength	NOUN	O	B-outcome
score	NOUN	O	O
(bench	NUM	O	O
press	NOUN	O	O
+	SYM	O	O
squat).	NOUN	O	O

FINDINGS:	ADJ	O	O
Between	ADP	O	O
Jan	NOUN	O	O
24,	NUM	O	O
2013,	NUM	O	O
and	CCONJ	O	O
Nov	NOUN	O	O
7,	NUM	O	O
2016,	NUM	O	O
601	NUM	O	O
patients	NOUN	O	O
assessed	VERB	O	O
for	ADP	O	O
eligibility,	NOUN	O	O
of	ADP	O	O
whom	ADP	O	O
452	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
226	NUM	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
both	CCONJ	O	O
the	DET	O	O
A+CHP	ADV	O	O
group	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
CHOP	VERB	O	O
group.	VERB	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
diet	NOUN	O	O
and	CCONJ	O	O
exercise	NOUN	O	O
plus	CCONJ	O	O
diet	NOUN	O	O
group	NOUN	O	O
lost	VERB	O	O
6.1	NUM	O	O
and	CCONJ	O	O
6.9%	NOUN	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
,	PUNCT	O	O
respectively.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Consequently,	NOUN	O	O
the	DET	O	O
overall	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
decreased	VERB	O	O
in	ADP	O	O
EMLA	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
TPI	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.023).	PUNCT	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
investigated	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
exercise	NOUN	O	O
training	VERB	O	O
(ET)	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
montelukast	NOUN	O	O
for	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
mild	ADJ	O	O
asthma	NOUN	O	O
(MA).	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8910750	NUM	O	O

The	DET	O	O
HIIT	NOUN	O	O
and	CCONJ	O	O
MICT	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
offered	VERB	O	O
three	NUM	O	O
exercise	NOUN	O	O
sessions	NOUN	O	O
per	ADP	O	O
week	NOUN	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
12	NUM	O	O
weeks.	NOUN	O	O

PMID:	NOUN	O	O
31618331	NUM	O	O

The	DET	O	O
drainage	NOUN	O	B-outcome
volume	NOUN	O	I-outcome
on	ADP	O	O
the	DET	O	O
1st	ADJ	O	O
day	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
2nd	ADJ	O	O
to	PART	O	O
4th	ADP	O	O
day	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
AGS	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
less	ADV	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.015,	PUNCT	O	O
P	NOUN	O	O
=	SYM	O	O
.010).	PUNCT	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
in	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
was	VERB	O	O
similar	ADJ	O	O
and	CCONJ	O	O
almost	ADV	O	O
equal	ADJ	O	O
to	PART	O	O
52	NUM	O	O
years;	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sex	NOUN	O	O
ratios	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

Segmental	ADJ	O	O
muscle	NOUN	O	O
vibration	NOUN	O	O
(SMV)	NOUN	O	O
is	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
interventions	NOUN	O	O
that	ADP	O	O
incorporate	VERB	O	O
sensory	ADJ	O	O
stimulation	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
motor	NOUN	O	O
cortical	ADJ	O	O
excitability.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Intensive	ADJ	O	O
vs	CCONJ	O	O
Standard	NOUN	O	O
Blood	NOUN	O	O
Pressure	NOUN	O	O
Control	NOUN	O	O
on	ADP	O	O
Probable	ADJ	O	O
Dementia	NOUN	O	B-outcome
:	PUNCT	O	O
A	DET	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

METHODS:	NOUN	O	O
An	DET	O	O
open-label,	ADV	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
conducted	VERB	O	O
in	ADP	O	O
school-aged	VERB	O	O
children	NOUN	O	O
(5	PUNCT	O	O
to	PART	O	O
18	NUM	O	O
years)	NOUN	O	O
from	ADP	O	O
the	DET	O	O
region	NOUN	O	O
of	ADP	O	O
Taabo,	ADP	O	O
Cote	NOUN	O	O
d'Ivoire,	NOUN	O	O
an	DET	O	O
area	NOUN	O	O
endemic	ADJ	O	O
for	ADP	O	O
S.	NOUN	O	O
mansoni.	NOUN	O	O

No	DET	O	O
clinically	ADV	O	O
significant	ADJ	O	O
alterations	NOUN	O	O
in	ADP	O	O
the	DET	O	O
alpha-	NOUN	O	B-outcome
and	CCONJ	O	Seperator
beta-	NOUN	O	B-outcome
diversity	NOUN	O	I-outcome
of	ADP	O	I-outcome
gut	NOUN	O	I-outcome
microbiota	NOUN	O	E4-outcome
and	CCONJ	O	O
associated	VERB	O	O
metabolic	ADJ	O	O
pathways	NOUN	O	O
were	VERB	O	O
evident.	NOUN	O	O

Blood	NOUN	O	O
samples	NOUN	O	O
were	VERB	O	O
taken	VERB	O	O
immediately	ADV	O	O
before,	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
and	CCONJ	O	O
30	NUM	O	O
min	NOUN	O	O
post-exercise	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
plasma	NOUN	O	O
albumin	NOUN	O	B-outcome
,	PUNCT	O	O
total	ADJ	O	O
protein	NOUN	O	B-outcome
,	PUNCT	O	O
glucose	NOUN	O	B-outcome
,	PUNCT	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
and	CCONJ	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
markers.	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
before	ADP	O	O
treatment,	NOUN	O	O
serum	NOUN	O	O
SOD	NOUN	O	B-outcome
level	NOUN	O	O
were	VERB	O	O
all	DET	O	O
increased	VERB	O	O
and	CCONJ	O	O
malondialdehyde	NOUN	O	B-outcome
(MDA)	NOUN	O	I-outcome
level	NOUN	O	O
were	VERB	O	O
all	DET	O	O
decreased	VERB	O	O
in	ADP	O	O
the	DET	O	O
three	NUM	O	O
groups	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
P<0.05.	NOUN	O	O

The	DET	O	O
main	ADJ	O	O
goal	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
caffeine	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
time	NOUN	O	B-outcome
under	ADP	O	Seperator
tension	NOUN	O	I-outcome
(TUT)	PUNCT	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
performed	VERB	O	O
repetitions	NOUN	O	B-outcome
(REP)	PUNCT	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
second	ADJ	O	O
objective	ADP	O	O
was	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
CAF	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
power	NOUN	O	B-outcome
(P)	NUM	O	I-outcome
and	CCONJ	O	O
movement	NOUN	O	B-outcome
velocity	NOUN	O	I-outcome
(V)	NUM	O	I-outcome
during	ADP	O	O
the	DET	O	O
bench	NOUN	O	O
press	NOUN	O	O
movement.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrial.gov	NOUN	O	O
:	PUNCT	O	O
NCT01015716	ADJ	O	O
,	PUNCT	O	O
registration	NOUN	O	O
data	NOUN	O	O
14.12.2010	NOUN	O	O
(Prospectively	ADV	O	O
registered).	ADP	O	O

(1)	PUNCT	O	O
Background:	NOUN	O	O
Spirulina	NOUN	O	O
(Arthrospira)	PUNCT	O	O
maxima	NOUN	O	O
has	VERB	O	O
shown	VERB	O	O
beneficial	ADJ	O	O
effects	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
being	VERB	O	O
anti-dyslipidemic,	NOUN	O	O
antiviral,	ADJ	O	O
antioxidant	NOUN	O	O
and	CCONJ	O	O
antihypertensive.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
5-minute	NOUN	O	O
SMV	NOUN	O	O
application	NOUN	O	O
along	ADV	O	O
with	ADP	O	O
supervised	VERB	O	O
physical	ADJ	O	O
therapy	NOUN	O	O
(SPT)	NUM	O	O
on	ADP	O	O
improving	VERB	O	O
activities	NOUN	O	B-outcome
of	ADP	O	I-outcome
daily	ADJ	O	I-outcome
living	VERB	O	I-outcome
and	CCONJ	O	O
motor	NOUN	O	B-outcome
recovery	NOUN	O	I-outcome
on	ADP	O	O
the	DET	O	O
hemiparetic	ADJ	O	O
upper	ADJ	O	O
extremity	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
stroke.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Our	ADJ	O	O
aim	ADP	O	O
is	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
multifactorial	ADJ	O	O
intervention	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
adherence	NOUN	O	O
to	PART	O	O
the	DET	O	O
MD,	ADV	O	O
diet	NOUN	O	O
quality	NOUN	O	O
and	CCONJ	O	O
biomedical	ADJ	O	O
parameters.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

BACKGROUND:	NOUN	O	O
Belatacept	NOUN	O	O
(Nulojix;	PUNCT	O	O
Bristol-Myers	NOUN	O	O
Squibb,	NOUN	O	O
New	ADJ	O	O
York,	ADJ	O	O
NY)	NOUN	O	O
is	VERB	O	O
a	DET	O	O
biological	ADJ	O	O
immunosuppressive	ADJ	O	O
drug	NOUN	O	O
used	VERB	O	O
for	ADP	O	O
the	DET	O	O
prophylaxis	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
rejection	NOUN	O	O
after	ADP	O	O
renal	ADJ	O	O
transplantation.	ADV	O	O

5-year	ADJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
,	PUNCT	O	O
relapse-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
non-relapse	VERB	O	B-outcome
mortality	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
significantly	ADV	O	O
between	ADP	O	O
groups.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Participants	NOUN	O	O
assigned	VERB	O	O
to	PART	O	O
both	CCONJ	O	O
conditions	NOUN	O	O
experienced	VERB	O	O
similar	ADJ	O	O
benefits	NOUN	O	O
regarding	VERB	O	O
anxio-depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
and	CCONJ	O	O
aging-related	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
.	PUNCT	O	O
General	NOUN	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
and	CCONJ	O	O
memory	NOUN	O	B-outcome
remained	VERB	O	O
unchanged.	NOUN	O	O

Intraoperative	ADJ	O	O
measures	NOUN	O	O
included	VERB	O	O
anesthetic	ADJ	O	B-outcome
concentration,	NOUN	O	O
EEG	NOUN	O	B-outcome
suppression	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
hypotension	NOUN	O	B-outcome
.	PUNCT	O	O
Adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
included	VERB	O	O
undesirable	ADJ	O	B-outcome
intraoperative	ADJ	O	I-outcome
movement	NOUN	O	I-outcome
,	PUNCT	O	O
intraoperative	ADJ	O	B-outcome
awareness	ADV	O	I-outcome
with	ADP	O	Seperator
recall	NOUN	O	I-outcome
,	PUNCT	O	O
postoperative	ADJ	O	O
nausea	NOUN	O	B-outcome
and	CCONJ	O	Seperator
vomiting	VERB	O	I-outcome
,	PUNCT	O	O
medical	ADJ	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
death	NOUN	O	B-outcome
.	PUNCT	O	O
Results:	NOUN	O	O
Of	ADP	O	O
the	DET	O	O
1232	NUM	O	O
randomized	VERB	O	O
patients	NOUN	O	O
(median	PUNCT	O	O
age,	NOUN	O	O
69	NUM	O	O
years	NOUN	O	O
[range,	NOUN	O	O
60	NUM	O	O
to	PART	O	O
95];	NOUN	O	O
563	NUM	O	O
women	NOUN	O	O
[45.7%]),	ADJ	O	O
1213	NUM	O	O
(98.5%)	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
for	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcome.	NOUN	O	O

If	ADP	O	O
patients	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
to	PART	O	O
have	VERB	O	O
reflux-related	VERB	O	O
heartburn,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
them	PRON	O	O
to	PART	O	O
receive	VERB	O	O
surgical	ADJ	O	O
treatment	NOUN	O	O
(laparoscopic	ADJ	O	O
Nissen	ADJ	O	O
fundoplication),	NOUN	O	O
active	ADJ	O	O
medical	ADJ	O	O
treatment	NOUN	O	O
(omeprazole	PUNCT	O	O
plus	CCONJ	O	O
baclofen,	NOUN	O	O
with	ADP	O	O
desipramine	NOUN	O	O
added	VERB	O	O
depending	VERB	O	O
on	ADP	O	O
symptoms),	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
medical	ADJ	O	O
treatment	NOUN	O	O
(omeprazole	PUNCT	O	O
plus	CCONJ	O	O
placebo).	NOUN	O	O

Slightly	ADV	O	O
over	ADP	O	O
one-quarter	NOUN	O	O
were	VERB	O	O
veterans	NOUN	O	O
of	ADP	O	O
the	DET	O	O
OEF/OIF	NOUN	O	O
wars.	ADV	O	O

There	PRON	O	O
was	VERB	O	O
also	ADV	O	O
a	DET	O	O
significant	ADJ	O	O
-decrease	NOUN	O	O
in	ADP	O	O
creatine	NOUN	O	B-outcome
phosphokinase-MB	NOUN	O	I-outcome
after	ADP	O	O
24	NUM	O	O
hours	NOUN	O	O
in	ADP	O	O
the	DET	O	O
nicorandil	NOUN	O	O
group	NOUN	O	O
(2.7	NOUN	O	O
ng/L)	NUM	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(2.0	NOUN	O	O
ng/L),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.008.	NUM	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT01206062.	NOUN	O	O

Journal-Name:The	ADJ	O	O
Tohoku	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
experimental	ADJ	O	O
medicine	NOUN	O	O

Information	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
useful	ADJ	O	O
for	ADP	O	O
educators,	NOUN	O	O
community	NOUN	O	O
stakeholders	NOUN	O	O
and	CCONJ	O	O
policy	NOUN	O	O
makers	NOUN	O	O
interested	VERB	O	O
in	ADP	O	O
developing	VERB	O	O
programs	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
students'	NOUN	O	O
out-of-school	NOUN	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
.	PUNCT	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ISRCTN39374060	NOUN	O	O
.	PUNCT	O	O

The	DET	O	O
smaller	ADJ	O	O
sample	NOUN	O	O
size	NOUN	O	O
for	ADP	O	O
women	NOUN	O	O
may	VERB	O	O
account	VERB	O	O
for	ADP	O	O
some	DET	O	O
observed	VERB	O	O
discrepancies	NOUN	O	O
in	ADP	O	O
treatment	NOUN	O	B-outcome
responses	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
Although	ADP	O	O
there	PRON	O	O
were	VERB	O	O
gender	NOUN	O	O
differences	NOUN	O	O
in	ADP	O	O
baseline	NOUN	O	O
characteristics,	ADJ	O	O
IND/GLY	NOUN	O	O
demonstrated	VERB	O	O
similar	ADJ	O	O
trends	NOUN	O	O
for	ADP	O	O
exacerbation	NOUN	O	B-outcome
prevention	NOUN	O	O
and	CCONJ	O	O
lung	NOUN	O	B-outcome
function	NOUN	O	I-outcome
improvement	NOUN	O	O
in	ADP	O	O
men	NOUN	O	O
and	CCONJ	O	O
women	NOUN	O	O
with	ADP	O	O
moderate-to-very-severe	NOUN	O	O
COPD	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
history	NOUN	O	O
of	ADP	O	O
exacerbations	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
SFC.	NOUN	O	O

The	DET	O	O
Physical	ADJ	O	O
Activity	NOUN	O	O
Loyalty	NOUN	O	O
Scheme	ADV	O	O
(PAL)	NOUN	O	O
intervention	NOUN	O	O
was	VERB	O	O
based	VERB	O	O
on	ADP	O	O
high-street	NOUN	O	O
loyalty	NOUN	O	O
cards	NOUN	O	O
where	ADP	O	O
participants	NOUN	O	O
earned	VERB	O	O
points	NOUN	O	O
for	ADP	O	O
minutes	NOUN	O	O
of	ADP	O	O
activity	NOUN	O	B-outcome
that	ADP	O	O
could	VERB	O	O
be	VERB	O	O
redeemed	VERB	O	O
for	ADP	O	O
rewards,	NOUN	O	O
complemented	VERB	O	O
by	ADP	O	O
evidence-based	VERB	O	O
behaviour	NOUN	O	O
change	NOUN	O	O
techniques.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

It	PRON	O	O
involves	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
a	DET	O	O
non-toxic	ADJ	O	O
dye,	PUNCT	O	O
called	VERB	O	O
photosensitizer	NOUN	O	O
(FS),	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
light	NOUN	O	O
source	NOUN	O	O
of	ADP	O	O
a	DET	O	O
specific	ADJ	O	O
wavelength	NOUN	O	O
in	ADP	O	O
the	DET	O	O
presence	NOUN	O	O
of	ADP	O	O
the	DET	O	O
environmental	ADJ	O	O
oxygen.	NOUN	O	O

The	DET	O	O
scores	NOUN	O	O
of	ADP	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
risk	NOUN	O	B-outcome
behavior	NOUN	O	I-outcome
before	ADP	O	O
intervention,	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
intervention,	ADP	O	O
and	CCONJ	O	O
the	DET	O	O
frequency	NOUN	O	O
before	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
intervention,	ADP	O	O
were	VERB	O	O
collected	VERB	O	O
and	CCONJ	O	O
compared.	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
in	ADP	O	O
a	DET	O	O
1:1	ADJ	O	O
ratio	NOUN	O	O
to	PART	O	O
either	CCONJ	O	O
endometrial	ADJ	O	O
scratching	VERB	O	O
(by	NOUN	O	O
pipelle	ADJ	O	O
biopsy	NOUN	O	O
between	ADP	O	O
day	NOUN	O	O
3	NUM	O	O
of	ADP	O	O
the	DET	O	O
cycle	NOUN	O	O
preceding	VERB	O	O
the	DET	O	O
embryo-transfer	NOUN	O	O
cycle	NOUN	O	O
and	CCONJ	O	O
day	NOUN	O	O
3	NUM	O	O
of	ADP	O	O
the	DET	O	O
embryo-transfer	NOUN	O	O
cycle)	NOUN	O	O
or	CCONJ	O	O
no	DET	O	O
intervention.	NOUN	O	O

Lean	ADJ	O	B-outcome
tissue	NOUN	O	I-outcome
mass	NOUN	O	I-outcome
increased	VERB	O	O
by	ADP	O	O
a	DET	O	O
median	ADJ	O	O
of	ADP	O	O
1.59	NUM	O	O
kg	NOUN	O	O
and	CCONJ	O	O
fat	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
decreased	VERB	O	O
by	ADP	O	O
a	DET	O	O
median	ADJ	O	O
of	ADP	O	O
1.52	NUM	O	O
kg	NOUN	O	O
in	ADP	O	O
the	DET	O	O
exercising	VERB	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101265111	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/11	NOUN	O	O
06:00'	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101212761	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
intraoperative	ADJ	O	O
or	CCONJ	O	O
postoperative	ADJ	O	O
complication	NOUN	O	B-outcome
of	ADP	O	O
grade	NOUN	O	O
II	NUM	O	O
or	CCONJ	O	O
higher	ADJ	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
Clavien-Dindo	NOUN	O	O
classification	NOUN	O	O
(indicating	VERB	O	O
major	ADJ	O	O
complication	NOUN	O	B-outcome
leading	VERB	O	O
to	PART	O	O
intervention)	NOUN	O	O
within	ADP	O	O
30	NUM	O	O
days.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/27	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Patients	NOUN	O	O
aged	VERB	O	O
11	NUM	O	O
years	NOUN	O	O
or	CCONJ	O	O
older,	ADV	O	O
in	ADP	O	O
the	DET	O	O
permanent	ADJ	O	O
dentition,	NOUN	O	O
and	CCONJ	O	O
about	ADV	O	O
to	PART	O	O
start	NOUN	O	O
fixed	VERB	O	O
orthodontic	ADJ	O	O
treatment	NOUN	O	O
in	ADP	O	O
these	DET	O	O
6	NUM	O	O
centers	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
have	VERB	O	O
either	CCONJ	O	O
resin-modified	VERB	O	O
glass	NOUN	O	O
ionomer	NOUN	O	O
cement	NOUN	O	O
or	CCONJ	O	O
light-cured	VERB	O	O
composite	NOUN	O	O
for	ADP	O	O
bonding	VERB	O	O
brackets,	NOUN	O	O
forward	ADV	O	O
of	ADP	O	O
the	DET	O	O
first	ADV	O	O
molars.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
the	DET	O	O
response	NOUN	O	B-outcome
rate	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
historical	ADJ	O	O
response	NOUN	O	O
rate.	NOUN	O	O


METHODS:	NOUN	O	O
In	ADP	O	O
a	DET	O	O
multicenter,	NOUN	O	O
randomized	VERB	O	O
trial	NOUN	O	O
conducted	VERB	O	O
in	ADP	O	O
seven	NUM	O	O
intensive	ADJ	O	O
care	NOUN	O	O
units	NOUN	O	O
in	ADP	O	O
the	DET	O	O
United	VERB	O	O
States,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
adults	NOUN	O	O
undergoing	VERB	O	O
tracheal	ADJ	O	O
intubation	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
ventilation	NOUN	O	O
with	ADP	O	O
a	DET	O	O
bag-mask	ADJ	O	O
device	NOUN	O	O
or	CCONJ	O	O
no	DET	O	O
ventilation	NOUN	O	O
between	ADP	O	O
induction	NOUN	O	O
and	CCONJ	O	O
laryngoscopy.	NOUN	O	O

21	NUM	O	O
patients	NOUN	O	O
(10.29%),	NOUN	O	O
were	VERB	O	O
lost	VERB	O	O
to	PART	O	O
follow	VERB	O	O
up.	ADV	O	O

Conjunctiva	NOUN	O	B-outcome
melted	VERB	O	I-outcome
and	CCONJ	O	O
drainage	NOUN	O	B-outcome
tube	NOUN	O	I-outcome
exposed	VERB	O	I-outcome
in	ADP	O	O
0	NUM	O	O
eyes	NOUN	O	O
(0%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
corneal	ADJ	O	O
graft	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
eyes	NOUN	O	O
(1.6%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
scleral	ADJ	O	O
group.	VERB	O	O

This	DET	O	O
paper's	ADJ	O	O
objective	ADP	O	O
is	VERB	O	O
to	PART	O	O
fill	NOUN	O	O
that	ADP	O	O
lack.	NOUN	O	O

PURPOSE:	NOUN	O	O
Many	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
demonstrated	VERB	O	O
the	DET	O	O
advantage	NOUN	O	O
of	ADP	O	O
maintaining	VERB	O	O
intraoperative	ADJ	O	O
deep	ADJ	O	O
neuromuscular	ADJ	O	O
block	VERB	O	O
(NMB)	ADV	O	O
with	ADP	O	O
sugammadex.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Under	ADP	O	O
the	DET	O	O
conditions	NOUN	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study,	NOUN	O	O
the	DET	O	O
95%	NOUN	O	O
effective	ADJ	O	O
dose	NOUN	O	B-outcome
of	ADP	O	O
intrathecal	ADJ	O	O
hyperbaric	ADJ	O	O
ropivacaine	NOUN	O	O
for	ADP	O	O
successful	ADJ	O	B-outcome
spinal	ADJ	O	I-outcome
anesthesia	NOUN	O	I-outcome
for	ADP	O	O
cesarean	NOUN	O	O
section	NOUN	O	O
in	ADP	O	O
healthy	ADJ	O	O
parturient	ADJ	O	O
receiving	VERB	O	O
prophylactic	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
phenylephrine	NOUN	O	O
was	VERB	O	O
15.2	NUM	O	O
mg.	NOUN	O	O

However,	ADV	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
low	ADJ	O	O
BMI,	NUM	O	O
the	DET	O	O
LBW	NOUN	O	O
protocol	NOUN	O	O
delivered	VERB	O	O
a	DET	O	O
significantly	ADV	O	O
higher	ADJ	O	O
dose	NOUN	O	B-outcome
than	ADP	O	O
the	DET	O	O
TBW	NOUN	O	O
protocol	NOUN	O	O
(620.7	PUNCT	O	O
vs	CCONJ	O	O
600.0	NUM	O	O
mg	NOUN	O	O
iodine/kg,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.001).	NUM	O	O

Ferric	ADJ	O	B-outcome
reducing	VERB	O	I-outcome
ability	NOUN	O	O
of	ADP	O	O
plasma	NOUN	O	O
and	CCONJ	O	O
vitamin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
levels	NOUN	O	O
in	ADP	O	O
AA	NOUN	O	O
cohort	NOUN	O	O
significantly	ADV	O	O
increased	VERB	O	O
after	ADP	O	O
exercise	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
generated	VERB	O	O
five	NUM	O	O
data	NOUN	O	O
sets.	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
no	DET	O	O
statistical	ADJ	O	O
significance	NOUN	O	O
between	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
for	ADP	O	O
any	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
detected.	NOUN	O	O

The	DET	O	O
risk	NOUN	O	O
ratio	NOUN	O	O
adjusted	VERB	O	O
for	ADP	O	O
minimisation	NOUN	O	O
factors	NOUN	O	O
was	VERB	O	O
0.95	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
0.86-1.04;	NUM	O	O
p=0.233).	NOUN	O	O

Journal-Name:Maturitas	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

antibiotic	ADJ	O	O
monotherapy	NOUN	O	O
with	ADP	O	O
intravenous	ADJ	O	O
(i.v.)	NOUN	O	O

Date	NOUN	O	O
of	ADP	O	O
registration:	NOUN	O	O
September	NOUN	O	O
2009.	NUM	O	O

p<0.001).	NOUN	O	O

Among	ADP	O	O
these,	NOUN	O	O
glasses	NOUN	O	B-outcome
ownership	NOUN	O	I-outcome
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
school	NOUN	O	O
year	NOUN	O	O
was	VERB	O	O
68.6%	NUM	O	O
among	ADP	O	O
1252	NUM	O	O
treatment	NOUN	O	O
group	NOUN	O	O
students	NOUN	O	O
(82	PUNCT	O	O
schools),	NOUN	O	O
and	CCONJ	O	O
26.4%	NUM	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.01)	NUM	O	O
among	ADP	O	O
1461	NUM	O	O
controls	NOUN	O	O
(82	PUNCT	O	O
schools).	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
observe	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
Ronghuang	NOUN	O	O
granule	NOUN	O	O
on	ADP	O	O
serum	NOUN	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
23	NUM	O	I-outcome
(FGF23)	NOUN	O	I-outcome
,	PUNCT	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
receptor	NOUN	O	I-outcome
(FGFRs)	NOUN	O	I-outcome
and	CCONJ	O	O
Klotho	NOUN	O	B-outcome
protein	NOUN	O	I-outcome
levels	NOUN	O	O
in	ADP	O	O
non-dialysis	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
kidney	NOUN	O	O
disease-mineral	ADJ	O	O
and	CCONJ	O	O
bone	NOUN	O	O
disorder	ADP	O	O
(CKD-MBD)	NOUN	O	O
and	CCONJ	O	O
kidney	NOUN	O	O
deficiency	NOUN	O	O
and	CCONJ	O	O
damp	NOUN	O	O
heat	NOUN	O	O
syndrome.	NOUN	O	O

We	PRON	O	O
performed	VERB	O	O
a	DET	O	O
subset	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
73	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
pancreatectomy.	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
blinded	VERB	O	O
randomized	VERB	O	O
trial,	NOUN	O	O
70	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
four	NUM	O	O
500mg	NOUN	O	O
capsules	NOUN	O	O
of	ADP	O	O
green	ADV	O	O
tea	NOUN	O	O
or	CCONJ	O	O
starch	NOUN	O	O
as	ADP	O	O
placebo	NOUN	O	O
daily	ADJ	O	O
for	ADP	O	O
three	NUM	O	O
days	NOUN	O	O
along	ADV	O	O
with	ADP	O	O
trimethoprim-sulfamethoxazole.	NUM	O	O

Results	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Active	ADJ	O	O
Schools:	NOUN	O	O
Skelmersdale	NOUN	O	O
(AS:Sk)	PUNCT	O	O
multi-component	ADJ	O	O
pilot	NOUN	O	O
intervention	NOUN	O	O
indicated	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
positive	ADJ	O	O
change	NOUN	O	O
to	PART	O	O
child	NOUN	O	O
PA	NOUN	O	O
levels.	NOUN	O	O

Achaogen,	VERB	O	O
South	NOUN	O	O
San	NOUN	O	O
Francisco,	ADV	O	O
CA.	NOUN	O	O

RESULTS:	NOUN	O	O
Ulcer	NOUN	O	B-outcome
healing	VERB	O	I-outcome
time	NOUN	O	I-outcome
(3.5+/-0.6)	NOUN	O	O
d,	NOUN	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
pain	NOUN	O	I-outcome
(3.1+/-0.3)d	PUNCT	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
were	VERB	O	O
shorter	ADJ	O	O
than	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
(P<0.05);	NOUN	O	O
treatment	NOUN	O	O
efficiency	NOUN	O	O
was	VERB	O	O
96.08%	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A,	NOUN	O	O
88.24%	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
B(	NOUN	O	O
chi(2)=6.264,	ADV	O	O
P<0.05).	NOUN	O	O

CONCLUSION:	NOUN	O	O
In	ADP	O	O
low	ADJ	O	O
risk	NOUN	O	O
pregnancies,	NOUN	O	O
routine	ADJ	O	O
ultrasonography	NOUN	O	O
in	ADP	O	O
the	DET	O	O
third	ADJ	O	O
trimester	NOUN	O	O
along	ADV	O	O
with	ADP	O	O
clinically	ADV	O	O
indicated	VERB	O	O
ultrasonography	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
higher	ADJ	O	O
antenatal	ADJ	O	O
detection	NOUN	O	O
of	ADP	O	O
small	ADJ	O	B-outcome
for	ADP	O	Seperator
gestational	ADJ	O	I-outcome
age	NOUN	O	I-outcome
fetuses	NOUN	O	I-outcome
but	CCONJ	O	O
not	ADV	O	O
with	ADP	O	O
a	DET	O	O
reduced	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
perinatal	ADJ	O	I-outcome
outcomes	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
usual	ADJ	O	O
care	NOUN	O	O
alone.	NOUN	O	O

The	DET	O	O
selected	VERB	O	O
subjects	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
3	NUM	O	O
groups:	NOUN	O	O
G1:	NOUN	O	O
aPDT;	NOUN	O	O
G2:	NOUN	O	O
scraper,	ADV	O	O
and	CCONJ	O	O
G3:	NOUN	O	O
aPDT	NOUN	O	O
and	CCONJ	O	O
scraper.	NOUN	O	O

Phytonutrients	NOUN	O	O
and	CCONJ	O	O
vitamin	NOUN	O	O
and	CCONJ	O	O
mineral	NOUN	O	O
supplementation	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
reported	VERB	O	O
to	PART	O	O
provide	VERB	O	O
increased	VERB	O	O
antioxidant	NOUN	O	O
capacity	NOUN	O	O
in	ADP	O	O
humans;	NOUN	O	O
however,	ADV	O	O
there	PRON	O	O
is	VERB	O	O
still	ADV	O	O
controversy.	NOUN	O	O

INTERVENTIONS:	NOUN	O	O
Patients	NOUN	O	O
were	VERB	O	O
randomised	VERB	O	O
to	PART	O	O
three	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
oral	ADJ	O	O
treatment	NOUN	O	O
with	ADP	O	O
either	CCONJ	O	O
750	NUM	O	O
mg	NOUN	O	O
amoxicillin	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
three	NUM	O	O
times	NOUN	O	O
daily.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
survival	NOUN	O	B-outcome
without	ADP	O	O
moderate	ADJ	O	O
or	CCONJ	O	O
severe	ADJ	O	O
neurodevelopmental	ADJ	O	B-outcome
disability	NOUN	O	I-outcome
at	ADP	O	O
24	NUM	O	O
months.	NOUN	O	O

Asthma	NOUN	O	O
among	ADP	O	O
children	NOUN	O	O
and	CCONJ	O	O
adolescents,	NOUN	O	O
its	ADJ	O	O
relations	NOUN	O	O
with	ADP	O	O
physical	ADJ	O	O
activity	NOUN	O	O
(PA)	NOUN	O	O
and	CCONJ	O	O
PA	NOUN	O	O
relations	NOUN	O	O
with	ADP	O	O
body	NOUN	O	O
posture	ADJ	O	O
were	VERB	O	O
and	CCONJ	O	O
are	VERB	O	O
still	ADV	O	O
being	VERB	O	O
investigated.	NOUN	O	O

The	DET	O	O
poster	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
adapted	VERB	O	O
into	ADP	O	O
a	DET	O	O
sticker	NOUN	O	O
format	NUM	O	O
on	ADP	O	O
the	DET	O	O
ABHR	NOUN	O	O
bottle.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/21	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

METHODS:	NOUN	O	O
A	DET	O	O
cluster	NOUN	O	O
randomised	VERB	O	O
wait-list	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
in	ADP	O	O
public	ADJ	O	O
sector	NOUN	O	O
organisations	NOUN	O	O
in	ADP	O	O
Northern	NOUN	O	O
Ireland.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/27	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

In	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
performed	VERB	O	O
relaxation	NOUN	O	O
techniques	NOUN	O	O
once	ADP	O	O
a	DET	O	O
day	NOUN	O	O
for	ADP	O	O
30min	NOUN	O	O
over	ADP	O	O
two	NUM	O	O
months.	NOUN	O	O

ED95	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
bupivacaine	NOUN	O	O
was	VERB	O	O
calculated	VERB	O	O
using	VERB	O	O
logistic	ADJ	O	O
regression	NOUN	O	O
model.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/20	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

OUTCOME	NOUN	O	O
MEASURES:	NOUN	O	O
Image	NOUN	O	O
analysis	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
by	ADP	O	O
the	DET	O	O
workstation.	ADV	O	O
[	PUNCT	O	O

We	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
prognostic	ADJ	O	O
value	NOUN	O	O
of	ADP	O	O
histopathological	ADJ	O	O
measures	NOUN	O	O
with	ADP	O	O
a	DET	O	O
Cox	NOUN	O	O
proportional-hazards	NOUN	O	O
model.	NOUN	O	O

The	DET	O	O
1-year	NOUN	O	O
abstinence	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
18.0%	NUM	O	O
in	ADP	O	O
the	DET	O	O
e-cigarette	NOUN	O	O
group,	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
9.9%	NOUN	O	O
in	ADP	O	O
the	DET	O	O
nicotine-replacement	ADJ	O	O
group	NOUN	O	O
(relative	ADJ	O	O
risk,	NOUN	O	O
1.83;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
1.30	NUM	O	O
to	PART	O	O
2.58;	NOUN	O	O
P<0.001).	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101150032	NUM	O	O

However,	ADV	O	O
there	PRON	O	O
is	VERB	O	O
a	DET	O	O
paucity	NOUN	O	O
of	ADP	O	O
research	NOUN	O	O
exploring	VERB	O	O
the	DET	O	O
potential	ADJ	O	O
benefit	NUM	O	O
of	ADP	O	O
FODMAP	ADV	O	O
strategies	NOUN	O	O
to	PART	O	O
support	NOUN	O	O
healthy,	NOUN	O	O
recreational	ADJ	O	O
athletes	NOUN	O	O
who	ADP	O	O
experience	NOUN	O	O
GI	NOUN	O	O
issues	NOUN	O	O
during	ADP	O	O
training.	NOUN	O	O

SafeWalker(R)	ADV	O	O
supports	NOUN	O	O
the	DET	O	O
body	NOUN	O	O
weight	NOUN	O	O
whilst	ADP	O	O
securing	VERB	O	O
postural	ADJ	O	O
stability	NOUN	O	O
without	ADP	O	O
relying	VERB	O	O
on	ADP	O	O
upper	ADJ	O	O
body	NOUN	O	O
strength	NOUN	O	O
or	CCONJ	O	O
high	ADJ	O	O
cognitive	ADJ	O	O
demand.	NOUN	O	O

The	DET	O	O
number	NOUN	O	O
of	ADP	O	O
women	NOUN	O	O
that	ADP	O	O
would	VERB	O	O
need	NOUN	O	O
to	PART	O	O
be	VERB	O	O
treated	VERB	O	O
to	PART	O	O
prevent	NOUN	O	O
the	DET	O	O
occurrence	NOUN	O	O
of	ADP	O	O
a	DET	O	O
fracture	NOUN	O	O
in	ADP	O	O
1	NUM	O	O
woman	NOUN	O	O
was	VERB	O	O
15.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal-Name:Brazilian	ADP	O	O
oral	ADJ	O	O
research	NOUN	O	O

When	ADP	O	O
sex	NOUN	O	O
was	VERB	O	O
considered,	VERB	O	O
females	NOUN	O	O
had	VERB	O	O
lower	ADJ	O	O
urine	NOUN	O	B-outcome
volume	NOUN	O	I-outcome
[UV]	NOUN	O	I-outcome
,	PUNCT	O	O
elevated	VERB	O	O
urine	NOUN	O	B-outcome
osmolality	NOUN	O	I-outcome
(UOsm)	PUNCT	O	I-outcome
(p	PUNCT	O	O
<	SYM	O	O
0.05),	NUM	O	O
trends	NOUN	O	O
for	ADP	O	O
higher	ADJ	O	O
Delta	NOUN	O	O
Body	NOUN	O	B-outcome
Weight	NOUN	O	I-outcome
[BW]	NOUN	O	I-outcome
),	NUM	O	O
urine	NOUN	O	B-outcome
specific	ADJ	O	I-outcome
gravity	NOUN	O	I-outcome
[USG]	NOUN	O	I-outcome
,	PUNCT	O	O
but	CCONJ	O	O
similar	ADJ	O	O
salivary	ADJ	O	B-outcome
osmolality	NOUN	O	I-outcome
(SOsm)	PUNCT	O	I-outcome
.	PUNCT	O	O
Analysis	NOUN	O	O
of	ADP	O	O
beverages	NOUN	O	O
and	CCONJ	O	O
urine	NOUN	O	O
for	ADP	O	O
antioxidant	NOUN	O	B-outcome
potential	ADJ	O	I-outcome
(AP)	NOUN	O	I-outcome
revealed	VERB	O	O
a	DET	O	O
four-fold	NOUN	O	O
greater	ADJ	O	O
antioxidant	NOUN	O	B-outcome
potential	ADJ	O	I-outcome
(AP)	NOUN	O	I-outcome
in	ADP	O	O
MW,	NOUN	O	O
which	ADP	O	O
increased	VERB	O	O
peak	NOUN	O	O
urine	NOUN	O	O
antioxidant	NOUN	O	B-outcome
potential	ADJ	O	I-outcome
(AP)	NOUN	O	I-outcome
(9.4	NOUN	O	O
+/-	SYM	O	O
0.7	NUM	O	O
vs.	CCONJ	O	O
7.6	NUM	O	O
+/-	SYM	O	O
1.0	NUM	O	O
mmol,	NOUN	O	O
MW	NOUN	O	O
vs.	CCONJ	O	O
control,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

In	ADP	O	O
this	DET	O	O
study	NOUN	O	O
(APEX,	PUNCT	O	O
Part	NOUN	O	O
I),	NOUN	O	O
we	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
efficacy/safety	NOUN	O	O
outcomes	NOUN	O	O
of	ADP	O	O
DMF	NOUN	O	O
in	ADP	O	O
a	DET	O	O
predominantly	ADV	O	O
East	ADV	O	O
Asian	ADJ	O	O
population	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
RRMS.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Electroencephalography-Guided	VERB	O	O
Anesthetic	ADJ	O	O
Administration	NOUN	O	O
on	ADP	O	O
Postoperative	ADJ	O	O
Delirium	NOUN	O	B-outcome
Among	ADP	O	O
Older	ADJ	O	O
Adults	NOUN	O	O
Undergoing	VERB	O	O
Major	ADP	O	O
Surgery:	NOUN	O	O
The	DET	O	O
ENGAGES	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
total	ADJ	O	O
cohort	NOUN	O	O
at	ADP	O	O
one	NUM	O	O
year,	ADV	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
Roland-Morris	NOUN	O	O
Disability	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(RMDQ)	NOUN	O	O
score	NOUN	O	O
between	ADP	O	O
the	DET	O	O
amoxicillin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
-1.6	ADJ	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
-3.1	NUM	O	O
to	PART	O	O
0.0,	NOUN	O	O
P=0.04).	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
first	ADV	O	O
night	NOUN	O	O
of	ADP	O	O
total	ADJ	O	B-outcome
sleep	NOUN	O	I-outcome
time	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
spinal	ADJ	O	O
anesthesia	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
shorter[(357.2+/-83.4)min	NOUN	O	O
vs	CCONJ	O	O
(275.1+/-64.8)min,	NOUN	O	O
t=-9.635,	NUM	O	O
P<0.05],	NOUN	O	O
while	ADP	O	O
the	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
wakefulness	ADV	O	B-outcome
,	PUNCT	O	O
total	ADJ	O	B-outcome
sleep	NOUN	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
overall	ADJ	O	B-outcome
sleep	NOUN	O	I-outcome
quality	NOUN	O	I-outcome
,	PUNCT	O	O
daytime	NOUN	O	B-outcome
mood	NOUN	O	I-outcome
and	CCONJ	O	O
daytime	NOUN	O	B-outcome
physical	ADJ	O	I-outcome
function	NOUN	O	I-outcome
were	VERB	O	O
significantly	ADV	O	O
higher[(25.9%,	NOUN	O	O
22.2%,	NUM	O	O
25.9%,	NUM	O	O
18.5%18.5%)	NUM	O	O
vs	CCONJ	O	O
(51.7%,	NUM	O	O
51.7%,	NOUN	O	O
55.2%,	NUM	O	O
48.3%44.8%),	NOUN	O	O
chi(2)=3.901,	NOUN	O	O
5.192,	NOUN	O	O
4.941,	NUM	O	O
5.523	NOUN	O	O
and	CCONJ	O	O
4.437,	NUM	O	O
all	DET	O	O
P<0.05],	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
cases	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
urinary	ADJ	O	B-outcome
retention	NOUN	O	I-outcome
and	CCONJ	O	O
lower	ADJ	O	B-outcome
limb	NOUN	O	I-outcome
discomfort	NOUN	O	I-outcome
were	VERB	O	O
significantly	ADV	O	O
higher[(8	ADV	O	O
and	CCONJ	O	O
6)	NOUN	O	O
vs	CCONJ	O	O
(1	NOUN	O	O
and	CCONJ	O	O
0),	NUM	O	O
all	DET	O	O
P<0.05].	NOUN	O	O
Conclusion:	NOUN	O	O
Both	CCONJ	O	O
anesthesia	NOUN	O	O
methods	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
safely	ADV	O	O
and	CCONJ	O	O
effectively	ADV	O	O
applied	VERB	O	O
to	PART	O	O
middle-aged	NOUN	O	O
and	CCONJ	O	O
elderly	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
lower	ADJ	O	O
extremity	NOUN	O	O
varicose	ADJ	O	O
veins	NOUN	O	O
surgery,	NOUN	O	O
but	CCONJ	O	O
patients	NOUN	O	O
with	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
show	VERB	O	O
fewer	ADJ	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
on	ADP	O	O
the	DET	O	O
first	ADV	O	O
night	NOUN	O	O
after	ADP	O	O
surgery	NOUN	O	O
and	CCONJ	O	O
have	VERB	O	O
better	ADJ	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
.	PUNCT	O	O

Clinical	ADJ	O	O
safety	NOUN	O	O
assessment	NOUN	O	O
failed	VERB	O	O
to	PART	O	O
show	VERB	O	O
toxicity	NOUN	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
.	PUNCT	O	O
Therefore,	NOUN	O	O
herbal	ADJ	O	O
congee	ADP	O	O
containing	VERB	O	O
the	DET	O	O
combined	VERB	O	O
extract	NOUN	O	O
of	ADP	O	O
M.	NOUN	O	O
alba	NOUN	O	O
and	CCONJ	O	O
P.	NOUN	O	O
odoratum	NOUN	O	O
leaves	NOUN	O	O
is	VERB	O	O
the	DET	O	O
potential	ADJ	O	O
functional	ADJ	O	O
food	NOUN	O	O
that	ADP	O	O
can	VERB	O	O
decrease	NOUN	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
osteoporosis.	NOUN	O	O

A	DET	O	O
community-based	VERB	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
on	ADP	O	O
the	DET	O	O
selected	VERB	O	O
students	NOUN	O	O
once	ADP	O	O
a	DET	O	O
week	NOUN	O	O
for	ADP	O	O
5	NUM	O	O
consecutive	ADJ	O	O
weeks.	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
12-month	NOUN	O	O
change	NOUN	O	O
in	ADP	O	O
adherence	NOUN	O	B-outcome
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
energy-reduced	VERB	O	O
Mediterranean	NOUN	O	O
diet	NOUN	O	O
(er-MedDiet)	PUNCT	O	O
score	NOUN	O	O
(range,	NOUN	O	O
0-17;	NUM	O	O
higher	ADJ	O	O
scores	NOUN	O	O
indicate	VERB	O	O
greater	ADJ	O	O
adherence;	ADJ	O	O
minimal	ADJ	O	O
clinically	ADV	O	O
important	ADJ	O	O
difference,	NOUN	O	O
1	NUM	O	O
point).	NOUN	O	O

Catheter	NOUN	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
analyzed	VERB	O	O
as	ADP	O	O
a	DET	O	O
secondary	ADJ	O	O
end	NOUN	O	O
point,	NOUN	O	O
were	VERB	O	O
more	ADV	O	O
common	ADJ	O	O
in	ADP	O	O
the	DET	O	O
intravenous	ADJ	O	O
group	NOUN	O	O
(9.4%	PUNCT	O	O
vs.	CCONJ	O	O
1.0%).	NOUN	O	O

Patients	NOUN	O	O
who	ADP	O	O
enrolled	VERB	O	O
in	ADP	O	O
SHORE	DET	O	O
fulfilled	VERB	O	O
eligibility	NOUN	O	O
criteria	NOUN	O	O
per	ADP	O	O
protocol	NOUN	O	O
(N	PUNCT	O	O
=	SYM	O	O
202).	NUM	O	O

T	NOUN	O	O
Numeric	ADJ	O	O
rating	VERB	O	O
scale	NOUN	O	O
(NRS)	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
pain	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
post-anesthesia	NOUN	O	O
care	NOUN	O	O
unit	NOUN	O	O
(PACU).	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
amount	NOUN	O	O
of	ADP	O	O
microvascular	ADJ	O	B-outcome
obstruction	NOUN	O	I-outcome
(%	PUNCT	O	O
left	ADV	O	B-outcome
ventricular	ADJ	O	I-outcome
mass	NOUN	O	I-outcome
)	PUNCT	O	O
demonstrated	VERB	O	O
by	ADP	O	O
contrast-enhanced	VERB	O	O
cardiac	ADJ	O	O
magnetic	ADJ	O	O
resonance	NOUN	O	O
imaging	VERB	O	O
(MRI)	PUNCT	O	O
conducted	VERB	O	O
from	ADP	O	O
days	NOUN	O	O
2	NUM	O	O
through	ADP	O	O
7	NUM	O	O
after	ADP	O	O
enrollment.	NOUN	O	O

The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
the	DET	O	O
combined	VERB	O	O
intervention	NOUN	O	O
exceeded	VERB	O	O
that	ADP	O	O
of	ADP	O	O
CBT	NOUN	O	O
or	CCONJ	O	O
Baduanjin	NOUN	O	O
alone.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Dyslipidemia	NOUN	O	O
is	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
most	DET	O	O
frequently	ADV	O	O
implicated	VERB	O	O
risk	NOUN	O	O
factors	NOUN	O	O
for	ADP	O	O
development	NOUN	O	O
of	ADP	O	O
atherosclerosis.	NOUN	O	O

Pre-	NOUN	O	O
to	PART	O	O
postintervention	NOUN	O	O
overall	ADJ	O	O
Test	NOUN	O	O
of	ADP	O	O
Playfulness	ADV	O	B-outcome
(ToP)	ADV	O	O
scores	NOUN	O	O
improved	VERB	O	O
marginally	ADV	O	O
for	ADP	O	O
the	DET	O	O
PICIHBI	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
12)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
conventional	ADJ	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
12).	ADV	O	O

In	ADP	O	O
this	DET	O	O
study	NOUN	O	O
62	NUM	O	O
subjects	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
selected	VERB	O	O
for	ADP	O	O
the	DET	O	O
yoga	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups.	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
Vanderbilt	NOUN	O	O
Institute	NOUN	O	O
for	ADP	O	O
Clinical	ADJ	O	O
and	CCONJ	O	O
Translational	ADJ	O	O
Research	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
PreVent	ADJ	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT03026322.).	NOUN	O	O

Couples	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
(1:1)	NOUN	O	O
with	ADP	O	O
an	DET	O	O
online	ADP	O	O
system	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
PICSI	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
standard	ADJ	O	O
ICSI	NOUN	O	O
procedure.	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

In	ADP	O	O
the	DET	O	O
other	ADJ	O	O
group,	NOUN	O	O
each	DET	O	O
had	VERB	O	O
a	DET	O	O
different	ADJ	O	O
color.	ADV	O	O

A	DET	O	O
single	ADJ	O	O
trained	VERB	O	O
operator	NOUN	O	O
performed	VERB	O	O
the	DET	O	O
CT	NOUN	O	O
in	ADP	O	O
a	DET	O	O
single	ADJ	O	O
visit	NOUN	O	O
in	ADP	O	O
cases	NOUN	O	O
without	ADP	O	O
periapical	ADJ	O	O
or	CCONJ	O	O
interradicular	ADJ	O	O
radiolucency	NOUN	O	O
(PIR)	PUNCT	O	O
or	CCONJ	O	O
in	ADP	O	O
multiple	ADJ	O	O
visits	NOUN	O	O
in	ADP	O	O
cases	NOUN	O	O
with	ADP	O	O
PIR.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
median	ADJ	O	O
plasma	NOUN	O	O
Nitrotyrosine	NOUN	O	B-outcome
(NT)	NOUN	O	I-outcome
concentrations	NOUN	O	O
(pg/ml)	NUM	O	O
following	VERB	O	O
surgery	NOUN	O	O
(POP1)	PUNCT	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
cancer	NOUN	O	O
versus	CCONJ	O	O
patients	NOUN	O	O
with	ADP	O	O
benign	ADJ	O	O
disease	NOUN	O	O
(5.3	NOUN	O	O
vs.	CCONJ	O	O
7.6,	NOUN	O	O
p=0.008).	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
lack	NOUN	O	O
of	ADP	O	O
surveillance	NOUN	O	O
system	NOUN	O	O
is	VERB	O	O
a	DET	O	O
major	ADJ	O	O
barrier	NOUN	O	O
in	ADP	O	O
prevention	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
of	ADP	O	O
rheumatic	ADJ	O	O
fever/rheumatic	ADJ	O	O
heart	NOUN	O	O
disease	NOUN	O	O
(RF/RHD).	PUNCT	O	O

Ten	NUM	O	O
SAEs	NOUN	O	B-outcome
were	VERB	O	O
observed	VERB	O	O
within	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
period,	NOUN	O	O
and	CCONJ	O	O
4	NUM	O	O
deaths	NOUN	O	B-outcome
unrelated	VERB	O	O
to	PART	O	O
the	DET	O	O
study	NOUN	O	O
medication.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

BACKGROUND:	NOUN	O	O
Single	NOUN	O	O
acute	ADJ	O	O
infarction	NOUN	O	O
(SAI)	NUM	O	O
usually	ADV	O	O
had	VERB	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	O
recurrence	NOUN	O	O
than	ADP	O	O
multiple	ADJ	O	O
acute	ADJ	O	O
infarctions	NOUN	O	O
(MAIs)	ADV	O	O
in	ADP	O	O
minor	ADJ	O	O
stroke.	NOUN	O	O

The	DET	O	O
44	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
into	ADP	O	O
a	DET	O	O
study	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
22	NUM	O	O
patiencs	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group.	VERB	O	O

In	ADP	O	O
the	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point,	NOUN	O	O
the	DET	O	O
noninferiority	NOUN	O	O
margin	ADP	O	O
was	VERB	O	O
7.5	NUM	O	O
percentage	NOUN	O	O
points.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
ovarian	ADJ	O	O
research	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

Secondary	ADJ	O	O
analyses	NOUN	O	O
and	CCONJ	O	O
sensitivity	NOUN	O	O
analyses	NOUN	O	O
supported	VERB	O	O
this	DET	O	O
finding.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
this	DET	O	O
study	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
entecavir	NOUN	O	O
and	CCONJ	O	O
tenofovir	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
treatment-naive	ADJ	O	O
HBV	NOUN	O	O
e	NOUN	O	O
antigen	NOUN	O	O
(HBeAg)-positive	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
hepatitis	NOUN	O	O
B	NOUN	O	O
(CHB)	NOUN	O	O
for	ADP	O	O
144	NUM	O	O
weeks.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
the	DET	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
first	ADV	O	I-outcome
occurrence	NOUN	O	I-outcome
of	ADP	O	I-outcome
a	DET	O	Seperator
nonvertebral	ADJ	O	I-outcome
or	CCONJ	O	Seperator
vertebral	ADJ	O	I-outcome
fragility	NOUN	O	I-outcome
fracture	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
At	ADP	O	O
baseline,	NOUN	O	O
the	DET	O	O
mean	NOUN	O	O
(+/-SD)	NOUN	O	O
age	NOUN	O	O
was	VERB	O	O
71+/-5	NOUN	O	O
years,	NOUN	O	O
the	DET	O	O
T	NOUN	O	O
score	NOUN	O	O
at	ADP	O	O
the	DET	O	O
femoral	ADJ	O	O
neck	NOUN	O	O
was	VERB	O	O
-1.6+/-0.5,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
median	ADJ	O	O
10-year	NOUN	O	O
risk	NOUN	O	O
of	ADP	O	O
hip	NOUN	O	O
fracture	NOUN	O	O
was	VERB	O	O
2.3%.	NUM	O	O

The	DET	O	O
duration	NOUN	O	O
of	ADP	O	O
total	ADJ	O	B-outcome
hospital	NOUN	O	I-outcome
stay	NOUN	O	I-outcome
and	CCONJ	O	O
postoperative	ADJ	O	B-outcome
hospital	NOUN	O	I-outcome
stay	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
AG	NOUN	O	O
(10.86+/-5.64,	ADV	O	O
5.09+/-4.55)	NOUN	O	O
d	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
shorter	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
CG	NOUN	O	O
(10.86+/-5.64,	ADV	O	O
5.09+/-4.55)	NOUN	O	O
d	NOUN	O	O
(P=0.01,	PUNCT	O	O
P=0.01).	NOUN	O	O

Therefore,	NOUN	O	O
a	DET	O	O
novel	ADJ	O	O
system	NOUN	O	O
for	ADP	O	O
patient	NOUN	O	O
classification	NOUN	O	O
(category	PUNCT	O	O
14)	PUNCT	O	O
was	VERB	O	O
developed	VERB	O	O
in	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
these	DET	O	O
two	NUM	O	O
indices	NOUN	O	O
to	PART	O	O
assist	NOUN	O	O
in	ADP	O	O
predicting	VERB	O	O
the	DET	O	O
prognosis	NOUN	O	O
and	CCONJ	O	O
therapeutic	ADJ	O	O
response.	NOUN	O	O

Journal-Name:American	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
orthodontics	NOUN	O	O
and	CCONJ	O	O
dentofacial	ADJ	O	O
orthopedics	NOUN	O	O
:	PUNCT	O	O
official	ADJ	O	O
publication	NOUN	O	O
of	ADP	O	O
the	DET	O	O
American	ADJ	O	O
Association	NOUN	O	O
of	ADP	O	O
Orthodontists,	NOUN	O	O
its	ADJ	O	O
constituent	ADP	O	O
societies,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
American	ADJ	O	O
Board	NOUN	O	O
of	ADP	O	O
Orthodontics	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
improvements	NOUN	O	O
in	ADP	O	O
household	NOUN	O	O
purchasing	VERB	O	B-outcome
of	ADP	O	I-outcome
vegetables	NOUN	O	I-outcome
and	CCONJ	O	Seperator
whole	ADJ	O	I-outcome
grains	NOUN	O	S2-outcome
,	PUNCT	O	O
in	ADP	O	O
individual	ADJ	O	O
intakes	NOUN	O	B-outcome
of	ADP	O	I-outcome
refined	VERB	O	I-outcome
grains	NOUN	O	I-outcome
,	PUNCT	O	Seperator
healthy	ADJ	O	I-outcome
proteins	NOUN	O	S2-outcome
,	PUNCT	O	O
whole-fat	PUNCT	O	O
dairies	NOUN	O	O
,	PUNCT	O	O
legumes	NOUN	O	O
,	PUNCT	O	O
100%	NOUN	O	O
fruit	NOUN	O	O
juices	NOUN	O	O
,	PUNCT	O	O
and	CCONJ	O	O
sweets	NOUN	O	O
and	CCONJ	O	O
snacks	NOUN	O	O
;	PUNCT	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
individual	ADJ	O	O
frequency	NOUN	O	O
of	ADP	O	O
intake	NOUN	O	B-outcome
of	ADP	O	I-outcome
fruits	NOUN	O	I-outcome
and	CCONJ	O	Seperator
cold	NOUN	O	I-outcome
cuts/cured	VERB	O	I-outcome
meats	NOUN	O	S2-outcome
within	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/01	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Recruitment	NOUN	O	O
was	VERB	O	O
stopped	VERB	O	O
after	ADP	O	O
inclusion	NOUN	O	O
of	ADP	O	O
19	NUM	O	O
and	CCONJ	O	O
39	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
monotherapy	NOUN	O	O
and	CCONJ	O	O
combination	NOUN	O	O
arms	NOUN	O	O
respectively,	NOUN	O	O
as	ADP	O	O
per	ADP	O	O
pre-specified	VERB	O	O
stopping	VERB	O	O
rules.	NUM	O	O

Three	NUM	O	O
models	NOUN	O	O
of	ADP	O	O
eye-lens	NOUN	O	O
dosemeters	NOUN	O	O
(Dosilab,	PUNCT	O	O
Landauer	NOUN	O	O
and	CCONJ	O	O
IRSN)	NUM	O	O
were	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
term	NOUN	O	O
of	ADP	O	O
ergonomics	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
annual	NOUN	O	O
estimation	NOUN	O	O
of	ADP	O	O
eye-lens	NOUN	O	B-outcome
doses	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
reach	NOUN	O	O
the	DET	O	O
annual	NOUN	O	O
dose	NOUN	O	O
limit	NOUN	O	O
of	ADP	O	O
20	NUM	O	O
mSv	NOUN	O	O
revised	VERB	O	O
by	ADP	O	O
the	DET	O	O
ICRP,	ADP	O	O
ranged	VERB	O	O
from	ADP	O	O
0.00	NUM	O	O
to	PART	O	O
18.12	NUM	O	O
mSv	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
of	ADP	O	O
0.96	NUM	O	O
+/-	SYM	O	O
2.28	NUM	O	O
mSv.	ADJ	O	O

RESULTS:	NOUN	O	O
119	NUM	O	O
children	NOUN	O	O
aged	VERB	O	O
5	NUM	O	O
to	PART	O	O
16	NUM	O	O
years,	NOUN	O	O
with	ADP	O	O
symptomatic	ADJ	O	O
hypermobility	NOUN	O	O
were	VERB	O	O
randomised	VERB	O	O
to	PART	O	O
receive	VERB	O	O
an	DET	O	O
individualised	VERB	O	O
multidisciplinary	ADJ	O	O
intervention	NOUN	O	O
(I)	PUNCT	O	O
(n	NOUN	O	O
=	SYM	O	O
59)	NOUN	O	O
or	CCONJ	O	O
standard	ADJ	O	O
management	NOUN	O	O
(S)	PUNCT	O	O
(n	NOUN	O	O
=	SYM	O	O
60).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/18	NOUN	O	O
06:00'	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
hospitalized	VERB	O	B-outcome
death	NOUN	O	I-outcome
,	PUNCT	O	O
severe	ADJ	O	B-outcome
disability	NOUN	O	I-outcome
at	ADP	O	O
15	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
age,	NOUN	O	O
neonatal	ADJ	O	B-outcome
behavioral	ADJ	O	I-outcome
neurological	ADJ	O	I-outcome
assessment	NOUN	O	O
(NBNA)	NOUN	O	O
score	NOUN	O	O
at	ADP	O	O
28	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
age,	NOUN	O	O
and	CCONJ	O	O
Bayley	PROPN	O	O
scales	NOUN	O	O
of	ADP	O	O
infant	NOUN	O	B-outcome
development	NOUN	O	I-outcome
(BSID)	NUM	O	O
score	NOUN	O	O
(including	PUNCT	O	O
mental	ADJ	O	B-outcome
development	NOUN	O	I-outcome
index	NOUN	O	O
(MDI)	NOUN	O	O
score	NOUN	O	O
and	CCONJ	O	O
psychomotor	NOUN	O	B-outcome
development	NOUN	O	I-outcome
index	NOUN	O	O
(PDI)	PUNCT	O	O
score)	NOUN	O	O
at	ADP	O	O
15	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
age	NOUN	O	O
at	ADP	O	O
follow-up.	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Vaccination	NOUN	O	O
has	VERB	O	O
a	DET	O	O
huge	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O
impact.	NOUN	O	O

Title:	NOUN	O	O
Tafenoquine	NOUN	O	O
versus	CCONJ	O	O
Primaquine	NOUN	O	O
to	PART	O	O
Prevent	NOUN	O	O
Relapse	NOUN	O	B-outcome
of	ADP	O	O
Plasmodium	NOUN	O	O
vivax	NOUN	O	O
Malaria.	NOUN	O	O

T	NOUN	O	O
Yale-Brown	NOUN	O	O
Obsessive	ADJ	O	B-outcome
Compulsive	ADJ	O	I-outcome
Scale	NOUN	O	O
(Y-BOCS)],	NOUN	O	O
Hamilton	ADV	O	O
Anxiety	NOUN	O	B-outcome
Scale	NOUN	O	O
(HAMA)	PUNCT	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
efficacy,	NOUN	O	O
Pittsburgh	NOUN	O	O
Sleep	NOUN	O	B-outcome
Quality	NOUN	O	I-outcome
Index	NOUN	O	O
(PSQI)	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
Treatment	NOUN	O	O
Emergent	ADJ	O	O
Symptom	NOUN	O	O
Scale	NOUN	O	O
(TESS)	ADP	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
side	NOUN	O	B-outcome
effects	NOUN	O	I-outcome
.	PUNCT	O	O
Data	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
in	ADP	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
sample.	NOUN	O	O

Three	NUM	O	O
patients	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
complete	ADJ	O	O
the	DET	O	O
study,	NOUN	O	O
leaving	VERB	O	O
156	NUM	O	O
patients	NOUN	O	O
for	ADP	O	O
final	ADJ	O	O
analysis.	NOUN	O	O

In	ADP	O	O
one	NUM	O	O
group,	NOUN	O	O
all	DET	O	O
four	NUM	O	O
eye	NOUN	O	O
drops	NOUN	O	O
were	VERB	O	O
transparent.	NOUN	O	O

Changes	NOUN	O	O
in	ADP	O	O
unilateral	ADJ	O	O
upper	ADJ	O	B-outcome
limb	NOUN	O	I-outcome
muscular	ADJ	O	I-outcome
strength	NOUN	O	I-outcome
and	CCONJ	O	O
Electromyographic	ADJ	O	B-outcome
Activity	NOUN	O	I-outcome
after	ADP	O	O
a	DET	O	O
16-week	NOUN	O	O
strength	NOUN	O	O
training	VERB	O	O
intervention	NOUN	O	O
in	ADP	O	O
survivors	NOUN	O	O
of	ADP	O	O
breast	NOUN	O	O
cancer.	NOUN	O	O

Aortic	ADJ	O	O
enhancement	NOUN	O	B-outcome
during	ADP	O	O
the	DET	O	O
hepatic	ADJ	O	O
arterial	ADJ	O	O
phase	NOUN	O	O
and	CCONJ	O	O
hepatic	ADJ	O	O
enhancement	NOUN	O	O
during	ADP	O	O
the	DET	O	O
portal	NOUN	O	O
venous	ADJ	O	O
phase	NOUN	O	O
was	VERB	O	O
compared.	NOUN	O	O

Feasibility	NOUN	O	B-outcome
outcomes	NOUN	O	O
included	VERB	O	O
rates	NOUN	O	O
of	ADP	O	O
recruitment	NOUN	O	B-outcome
,	PUNCT	O	O
retention	NOUN	O	B-outcome
,	PUNCT	O	O
outcome	NOUN	O	B-outcome
completion	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
exercise	NOUN	O	B-outcome
attendance	NOUN	O	I-outcome
.	PUNCT	O	O
Data	NOUN	O	O
were	VERB	O	O
collected	VERB	O	O
on	ADP	O	O
cardiorespiratory	ADJ	O	B-outcome
fitness	ADP	O	I-outcome
(e.g.,	NOUN	O	O
peak	NOUN	O	B-outcome
oxygen	NOUN	O	I-outcome
uptake	NOUN	O	I-outcome
),	NUM	O	O
disease	NOUN	O	B-outcome
activity	NOUN	O	I-outcome
,	PUNCT	O	O
fatigue	NOUN	O	B-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
intervention	NOUN	O	O
acceptability	NOUN	O	B-outcome
(via	PUNCT	O	O
interviews).	NUM	O	O

BACKGROUND:	NOUN	O	O
Omadacycline,	NOUN	O	O
a	DET	O	O
new	ADJ	O	O
once-daily	ADV	O	O
aminomethylcycline	NOUN	O	O
antibiotic	ADJ	O	O
agent	NOUN	O	O
that	ADP	O	O
can	VERB	O	O
be	VERB	O	O
administered	VERB	O	O
intravenously	ADV	O	O
or	CCONJ	O	O
orally,	NOUN	O	O
reaches	NOUN	O	O
high	ADJ	O	O
concentrations	NOUN	O	O
in	ADP	O	O
pulmonary	ADJ	O	O
tissues	NOUN	O	O
and	CCONJ	O	O
is	VERB	O	O
active	ADJ	O	O
against	ADP	O	O
common	ADJ	O	O
pathogens	NOUN	O	O
that	ADP	O	O
cause	ADP	O	O
community-acquired	VERB	O	O
bacterial	ADJ	O	O
pneumonia.	NOUN	O	O

Awareness	ADV	O	B-outcome
about	ADV	O	Seperator
fertility	NOUN	O	I-outcome
and	CCONJ	O	O
lifestyle-related	VERB	O	B-outcome
factors	NOUN	O	I-outcome
were	VERB	O	O
the	DET	O	O
main	ADJ	O	O
outcomes,	NOUN	O	O
measured	VERB	O	O
through	ADP	O	O
a	DET	O	O
questionnaire	NOUN	O	O
before	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
through	ADP	O	O
a	DET	O	O
telephone	NOUN	O	O
survey	NOUN	O	O
after	ADP	O	O
three	NUM	O	O
months.	NOUN	O	O

Electromyography	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
objectively	ADV	O	O
evaluate	VERB	O	O
eyestrain	NOUN	O	B-outcome
.	PUNCT	O	O
Linear	ADJ	O	O
mixed	VERB	O	O
models	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
differences	NOUN	O	O
between	ADP	O	O
toric	ADJ	O	O
and	CCONJ	O	O
spherical	ADJ	O	O
contact	NOUN	O	O
lenses.	ADJ	O	O

In	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
no	DET	O	O
changes	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
with	ADP	O	O
the	DET	O	O
exception	NOUN	O	O
of	ADP	O	O
an	DET	O	O
increase	NOUN	O	O
of	ADP	O	O
sNox2-dp	PUNCT	O	B-outcome
,	PUNCT	O	O
H2O2	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
myoglobin	NOUN	O	B-outcome
.	PUNCT	O	O
A	DET	O	O
simple	NOUN	O	O
linear	ADJ	O	O
regression	NOUN	O	O
analysis	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
sNox2-dp	PUNCT	O	B-outcome
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
biomarker	NOUN	O	O
release	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.001).	NUM	O	O

PATIENTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
97	NUM	O	O
patients	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
LBP.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
136	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
FS	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
and	CCONJ	O	O
then	ADV	O	O
were	VERB	O	O
equally	ADV	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
a	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
68)	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
sham	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
68).	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Preoperative	ADJ	O	O
administration	NOUN	O	O
of	ADP	O	O
celecoxib	NOUN	O	O
exhibits	NOUN	O	O
better	ADJ	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
equal	ADJ	O	O
safety	NOUN	O	O
profiles	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
postoperative	ADJ	O	O
administration	NOUN	O	O
of	ADP	O	O
celecoxib	NOUN	O	O
in	ADP	O	O
knee	NOUN	O	O
OA	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
TKA.	NOUN	O	O

Further	ADV	O	O
studies	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
multiple	ADJ	O	O
arterial	ADJ	O	O
grafts	NOUN	O	O
provide	VERB	O	O
better	ADJ	O	O
outcomes	NOUN	O	O
than	ADP	O	O
a	DET	O	O
single	ADJ	O	O
internal-thoracic-artery	ADV	O	O
graft.	VERB	O	O
(	PUNCT	O	O

Journal-Name:BMC	NOUN	O	O
psychology	NOUN	O	O

RESULTS:	NOUN	O	O
Forced	VERB	O	B-outcome
vital	ADJ	O	I-outcome
capacity	NOUN	O	I-outcome
(FVC)	PUNCT	O	I-outcome
,	PUNCT	O	O
maximum	NOUN	O	B-outcome
voluntary	ADJ	O	I-outcome
ventilation	NOUN	O	I-outcome
(MVV)	PUNCT	O	I-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
self-reported	VERB	O	O
health	NOUN	O	B-outcome
status	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
increased	VERB	O	O
(P	NUM	O	O
<	SYM	O	O
.05)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
receiving	VERB	O	O
joint	NOUN	O	O
Baduanjin	NOUN	O	O
and	CCONJ	O	O
CBT	NOUN	O	O
intervention	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
months,	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
Baduanjin	NOUN	O	O
only	ADV	O	O
group	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
CBT	NOUN	O	O
only	ADV	O	O
group.	VERB	O	O

Journal-Name:Medicine	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
verum	NOUN	O	O
TENS	NOUN	O	O
may	VERB	O	O
benefit	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
tinnitus	NOUN	O	O
after	ADP	O	O
4	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
assigned	VERB	O	O
the	DET	O	O
following	VERB	O	O
registry	NOUN	O	O
number:	NOUN	O	O
NCT03006406	NOUN	O	O
.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/18	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

However,	ADV	O	O
no	DET	O	O
differences	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
group-by-time	NOUN	O	O
interaction	NOUN	O	O
of	ADP	O	O
the	DET	O	O
hormonal	ADJ	O	B-outcome
parameters	NOUN	O	O
(p	PUNCT	O	O
>	SYM	O	O
0.05).	NOUN	O	O

Of	ADP	O	O
these,	NOUN	O	O
95	NUM	O	O
(52%)	PUNCT	O	O
patients	NOUN	O	O
were	VERB	O	O
excluded	VERB	O	O
because	ADP	O	O
they	PRON	O	O
no	DET	O	O
longer	ADJ	O	O
met	VERB	O	O
study	NOUN	O	O
criteria	NOUN	O	O
and	CCONJ	O	O
80	NUM	O	O
(43%)	NUM	O	O
patients	NOUN	O	O
entered	VERB	O	O
the	DET	O	O
placebo	NOUN	O	O
lead-in	NOUN	O	O
phase.	NOUN	O	O

We	PRON	O	O
describe	NOUN	O	O
an	DET	O	O
operations	NOUN	O	O
research	NOUN	O	O
(OR)	NOUN	O	O
Study	NOUN	O	O
and	CCONJ	O	O
assessment	NOUN	O	O
of	ADP	O	O
one	NUM	O	O
form	NOUN	O	O
of	ADP	O	O
community	NOUN	O	O
engagement,	NOUN	O	O
the	DET	O	O
development	NOUN	O	O
and	CCONJ	O	O
implementation	NOUN	O	O
of	ADP	O	O
a	DET	O	O
participatory	NOUN	O	O
community-based	VERB	O	O
health	NOUN	O	O
information	NOUN	O	O
system	NOUN	O	O
(PCBHIS),	NUM	O	O
in	ADP	O	O
slum	NOUN	O	O
communities	NOUN	O	O
in	ADP	O	O
Freetown,	NOUN	O	O
Sierra	NOUN	O	O
Leone.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
mean	NOUN	O	O
velocity	NOUN	O	O
during	ADP	O	O
the	DET	O	O
eccentric	ADJ	O	O
phase	NOUN	O	O
of	ADP	O	O
movement	NOUN	O	O
(0.690	NOUN	O	O
m/s	NOUN	O	O
in	ADP	O	O
the	DET	O	O
GCAF	NOUN	O	O
to	PART	O	O
0.609	NUM	O	O
in	ADP	O	O
GCON	NOUN	O	O
with	ADP	O	O
p	NOUN	O	O
=	SYM	O	O
0.002).	NUM	O	O

Key	NOUN	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
a	DET	O	O
composite	NOUN	O	O
of	ADP	O	O
TTP-related	VERB	O	B-outcome
death	NOUN	O	I-outcome
,	PUNCT	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
TTP,	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
thromboembolic	ADJ	O	B-outcome
event	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
treatment	NOUN	O	O
period;	NOUN	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
TTP	NOUN	O	O
at	ADP	O	O
any	DET	O	O
time	NOUN	O	O
during	ADP	O	O
the	DET	O	O
trial;	NOUN	O	O
refractory	ADJ	O	B-outcome
TTP	NOUN	O	I-outcome
;	PUNCT	O	O
and	CCONJ	O	O
normalization	NOUN	O	B-outcome
of	ADP	O	I-outcome
organ-damage	NOUN	O	I-outcome
markers.	NOUN	O	O

SETTING:	NOUN	O	O
60	NUM	O	O
midwifery	NOUN	O	O
practices	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Netherlands.	NOUN	O	O

These	DET	O	O
results	NOUN	O	O
show	VERB	O	O
that	ADP	O	O
the	DET	O	O
amla	NOUN	O	O
extract	NOUN	O	O
used	VERB	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
is	VERB	O	O
potentially	ADV	O	O
a	DET	O	O
hypoglycaemic	ADJ	O	O
as	ADP	O	O
well.	NOUN	O	O

The	DET	O	O
CD8+	NOUN	O	O
T	NOUN	O	O
cells	NOUN	O	O
were	VERB	O	O
isolated	VERB	O	O
from	ADP	O	O
the	DET	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
and	CCONJ	O	O
their	ADJ	O	O
phenotype	NOUN	O	O
was	VERB	O	O
analyzed	VERB	O	O
by	ADP	O	O
flow	NOUN	O	O
cytometry.	VERB	O	O

Periods	NOUN	O	O
of	ADP	O	O
unilateral	ADJ	O	O
strength	NOUN	O	O
training	VERB	O	O
should	VERB	O	O
be	VERB	O	O
implemented	VERB	O	O
into	ADP	O	O
periodized	VERB	O	O
RT	NOUN	O	O
programs	NOUN	O	O
in	ADP	O	O
this	DET	O	O
cohort.	NOUN	O	O

In	ADP	O	O
this	DET	O	O
randomized,	NOUN	O	O
prospective	ADJ	O	O
trial,	NOUN	O	O
we	PRON	O	O
explore	ADP	O	O
differences	NOUN	O	O
in	ADP	O	O
live	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
rates	NOUN	O	O
and	CCONJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
ovarian	ADJ	O	B-outcome
hyperstimulation	NOUN	O	I-outcome
syndrome	NOUN	O	I-outcome
(OHSS)	NUM	O	I-outcome
in	ADP	O	O
high-responder	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
in	ADP	O	O
vitro	ADV	O	O
fertilization	NOUN	O	O
(IVF)	NOUN	O	O
receiving	VERB	O	O
low	ADJ	O	O
dose	NOUN	O	O
hCG	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
GnRH-agonist	NOUN	O	O
(dual	PUNCT	O	O
trigger)	NOUN	O	O
or	CCONJ	O	O
hCG	NOUN	O	O
adjuvant	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
oocyte	NOUN	O	O
retrieval.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/14	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Therefore,	NOUN	O	O
it	PRON	O	O
can	VERB	O	O
be	VERB	O	O
concluded	VERB	O	O
that	ADP	O	O
MBCT	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
on	ADP	O	O
illness	NOUN	O	B-outcome
perceptions	NOUN	O	I-outcome
and	CCONJ	O	O
psychological	ADJ	O	B-outcome
syndrome	NOUN	O	I-outcome
and	CCONJ	O	O
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
as	ADP	O	O
an	DET	O	O
MBI	NOUN	O	O
method	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
the	DET	O	O
illness	NOUN	O	B-outcome
perceptions	NOUN	O	I-outcome
in	ADP	O	O
people	NOUN	O	O
with	ADP	O	O
RA.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
multidisciplinary	ADJ	O	O
intervention	NOUN	O	O
strategy	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
symptomatic	ADJ	O	O
joint	NOUN	O	O
hypermobility	NOUN	O	O
in	ADP	O	O
childhood:	NOUN	O	O
a	DET	O	O
randomised,	NOUN	O	O
single	ADJ	O	O
Centre	NOUN	O	O
parallel	ADJ	O	O
group	NOUN	O	O
trial	NOUN	O	O
(The	ADJ	O	O
Bendy	NOUN	O	O
Study).	NOUN	O	O

Before	ADP	O	O
program	NOUN	O	O
implementation,	ADP	O	O
the	DET	O	O
schools	NOUN	O	O
were	VERB	O	O
stratified	VERB	O	O
by	ADP	O	O
sub-county	NOUN	O	O
and	CCONJ	O	O
randomized	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
four	NUM	O	O
study	NOUN	O	O
arms	NOUN	O	O
(35	VERB	O	O
schools	NOUN	O	O
per	ADP	O	O
arm):	ADJ	O	O
1)	NUM	O	O
control,	NOUN	O	O
2)	NOUN	O	O
disposable	ADJ	O	O
sanitary	ADJ	O	O
pads	NOUN	O	O
distribution,	NOUN	O	O
2)	NOUN	O	O
reproductive	ADJ	O	O
health	NOUN	O	O
education,	VERB	O	O
and	CCONJ	O	O
4)	NOUN	O	O
sanitary	ADJ	O	O
pad	NOUN	O	O
distribution	NOUN	O	O
and	CCONJ	O	O
reproductive	ADJ	O	O
health	NOUN	O	O
education.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
Health	NOUN	O	O
Research	NOUN	O	O
Council	NOUN	O	O
of	ADP	O	O
New	ADJ	O	O
Zealand;	NOUN	O	O
Australian	ADJ	O	O
New	ADJ	O	O
Zealand	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
Registry	NOUN	O	O
number,	ADV	O	O
ACTRN12609000593235	NOUN	O	O
.).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/06/14	PUNCT	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

The	DET	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
analgesia	NOUN	O	I-outcome
was	VERB	O	O
230.5	NUM	O	O
+/-	SYM	O	O
40.5	NUM	O	O
minutes	NOUN	O	O
in	ADP	O	O
Dex	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
145.1	NUM	O	O
+/-	SYM	O	O
28.5	NUM	O	O
minutes	NOUN	O	O
in	ADP	O	O
Control	NOUN	O	O
group,	NOUN	O	O
respectively	ADV	O	O
(P	NUM	O	O
<	SYM	O	O
.001).	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/08/29	PUNCT	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

RESULTS:	NOUN	O	O
Significant	ADJ	O	O
time	NOUN	O	O
x	SYM	O	O
group	NOUN	O	O
interactions	NOUN	O	O
and	CCONJ	O	O
moderate	ADJ	O	O
to	PART	O	O
high	ADJ	O	O
effect	NOUN	O	O
sizes	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
for	ADP	O	O
physical	ADJ	O	B-outcome
functioning	VERB	O	I-outcome
,	PUNCT	O	O
physical	ADJ	O	B-outcome
health	NOUN	O	I-outcome
,	PUNCT	O	O
bodily	ADV	O	B-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
general	ADJ	O	B-outcome
health	NOUN	O	I-outcome
perception	NOUN	O	I-outcome
,	PUNCT	O	O
vitality	NOUN	O	B-outcome
,	PUNCT	O	O
social	ADJ	O	B-outcome
functioning	VERB	O	I-outcome
,	PUNCT	O	O
fatigue	NOUN	O	B-outcome
,	PUNCT	O	O
sleep	NOUN	O	B-outcome
disturbance	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
image	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
upset	ADV	O	B-outcome
by	ADP	O	O
hair	NOUN	O	O
loss,	NOUN	O	O
favoring	VERB	O	O
the	DET	O	O
exercise	NOUN	O	O
group.	VERB	O	O

For	ADP	O	O
a	DET	O	O
better	ADJ	O	O
application	NOUN	O	O
of	ADP	O	O
TXA	NOUN	O	O
function,	ADP	O	O
we	PRON	O	O
explored	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
intravenous	ADJ	O	O
injection	NOUN	O	O
(IV)	NUM	O	O
of	ADP	O	O
TXA	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
intra-articular	ADJ	O	O
injection	NOUN	O	O
(IA)	NOUN	O	O
of	ADP	O	O
TXA	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
after	ADP	O	O
TKA.	NOUN	O	O

Short-	ADV	O	O
and	CCONJ	O	O
long-term	NOUN	O	O
wound	NOUN	O	B-outcome
complications	NOUN	O	I-outcome
were	VERB	O	O
not	ADV	O	O
improved	VERB	O	O
with	ADP	O	O
NPWT.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101224380	NUM	O	O

antibiotic	ADJ	O	O
therapy	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
p.o.	NOUN	O	O

Haematology	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
red	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
cell	NOUN	O	I-outcome
count	NOUN	O	I-outcome
and	CCONJ	O	O
haematocrit	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
AGS	NOUN	O	O
group	NOUN	O	O
before	ADP	O	O
operation	NOUN	O	O
were	VERB	O	O
lower	ADJ	O	O
than	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.039,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.029),	PUNCT	O	O
but	CCONJ	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
(P	NUM	O	O
>.05).	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/07	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Median	ADJ	O	O
end-tidal	ADP	O	O
volatile	ADP	O	O
anesthetic	ADJ	O	B-outcome
concentration	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
guided	VERB	O	O
group	NOUN	O	O
than	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group	NOUN	O	O
(0.69	NUM	O	O
vs	CCONJ	O	O
0.80	NUM	O	O
minimum	NOUN	O	O
alveolar	ADJ	O	B-outcome
concentration;	NOUN	O	O
difference,	NOUN	O	O
-0.11	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-0.13	NUM	O	O
to	PART	O	O
-0.10),	NOUN	O	O
and	CCONJ	O	O
median	ADJ	O	O
cumulative	ADJ	O	O
time	NOUN	O	B-outcome
with	ADP	O	Seperator
EEG	NOUN	O	I-outcome
suppression	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
(7	NOUN	O	O
vs	CCONJ	O	O
13	NUM	O	O
minutes;	NOUN	O	O
difference,	NOUN	O	O
-6.0	ADJ	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-9.9	NUM	O	O
to	PART	O	O
-2.1]).	NUM	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
6	NUM	O	O
weeks,	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
weeks,	NOUN	O	O
UGPRF	NOUN	O	O
showed	VERB	O	O
more	ADV	O	O
promising	VERB	O	O
outcome	NOUN	O	O
results	NOUN	O	O
in	ADP	O	O
pain	NOUN	O	B-outcome
relief	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
VAS	NOUN	O	O
(P	NUM	O	O
<.01),	PUNCT	O	O
improvement	NOUN	O	O
of	ADP	O	O
shoulder	NOUN	O	B-outcome
disorder	ADP	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
and	CCONJ	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(SPADI)	NOUN	O	O
score	NOUN	O	O
(	PUNCT	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
P	NOUN	O	O
<.01;	NUM	O	O
disability	NOUN	O	B-outcome
,	PUNCT	O	O
P	NOUN	O	O
<.01;	NUM	O	O
total,	ADJ	O	O
P	NOUN	O	O
<.01),	PUNCT	O	O
and	CCONJ	O	O
enhancement	NOUN	O	O
of	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
Short	NOUN	O	O
Form-36	NOUN	O	O
questionnaire	NOUN	O	O
(SF-36)	NOUN	O	O
scale	NOUN	O	O
(PCS,	NOUN	O	O
P	NOUN	O	O
<.01;	NUM	O	O
MCS,	NOUN	O	O
P	NOUN	O	O
<.01),	PUNCT	O	O
compared	VERB	O	O
with	ADP	O	O
sham	NOUN	O	O
UGPRF	NOUN	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Desmoid	NOUN	O	O
tumors	NOUN	O	O
(also	ADV	O	O
referred	VERB	O	O
to	PART	O	O
as	ADP	O	O
aggressive	ADJ	O	O
fibromatosis)	NOUN	O	O
are	VERB	O	O
connective	ADJ	O	O
tissue	NOUN	O	O
neoplasms	NOUN	O	O
that	ADP	O	O
can	VERB	O	O
arise	VERB	O	O
in	ADP	O	O
any	DET	O	O
anatomical	ADJ	O	O
location	NOUN	O	O
and	CCONJ	O	O
infiltrate	NOUN	O	O
the	DET	O	O
mesentery,	NOUN	O	O
neurovascular	ADJ	O	O
structures,	NOUN	O	O
and	CCONJ	O	O
visceral	ADJ	O	O
organs.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/09	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Surveys	NOUN	O	O
with	ADP	O	O
established	VERB	O	O
validity	NOUN	O	O
and	CCONJ	O	O
reliability	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
measure	NOUN	O	O
self-efficacy	NOUN	O	B-outcome
to	PART	O	O
cope	NOUN	O	O
with	ADP	O	O
stress,	NOUN	O	O
emotional	ADJ	O	O
coping	VERB	O	B-outcome
response,	NOUN	O	O
and	CCONJ	O	O
social	ADJ	O	B-outcome
support	NOUN	O	I-outcome
for	ADP	O	O
stress	NOUN	O	O
management.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
live	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
1364	NUM	O	O
women	NOUN	O	O
underwent	VERB	O	O
randomization.	NOUN	O	O

Estimates	NOUN	O	O
from	ADP	O	O
regression-adjusted	VERB	O	O
treatment	NOUN	O	O
effects	NOUN	O	O
indicate	VERB	O	O
that	ADP	O	O
the	DET	O	O
average	NOUN	O	O
PTSD	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
score	NOUN	O	O
was	VERB	O	O
reduced	VERB	O	O
by	ADP	O	O
9.7	NUM	O	O
points	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.01),	NUM	O	O
or	CCONJ	O	O
14.3%	NUM	O	O
from	ADP	O	O
pre-	ADJ	O	O
to	PART	O	O
post-intervention.	ADJ	O	O

KT	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
incorporated	VERB	O	O
into	ADP	O	O
gait	NOUN	O	O
re-education	NOUN	O	O
programmes	NOUN	O	O
to	PART	O	O
facilitate	VERB	O	O
muscle	NOUN	O	O
contraction	NOUN	O	O
in	ADP	O	O
these	DET	O	O
children.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
any	DET	O	Seperator
cause	ADP	O	I-outcome
at	ADP	O	O
10	NUM	O	O
years.	NOUN	O	O

Pain	NOUN	O	B-outcome
VAS	NOUN	O	O
scores	NOUN	O	O
at	ADP	O	O
rest	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
flexion	NOUN	O	O
were	VERB	O	O
both	CCONJ	O	O
lower	ADJ	O	O
in	ADP	O	O
preoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
2	NUM	O	O
hours,	NOUN	O	O
6	NUM	O	O
hours,	NOUN	O	O
12	NUM	O	O
hours,	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
hours	NOUN	O	O
post	ADV	O	O
operation.	ADV	O	O

Study	NOUN	O	O
models	NOUN	O	O
and	CCONJ	O	O
cephalograms	NOUN	O	O
were	VERB	O	O
taken	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
12	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

wash-out	ADP	O	O
period,	NOUN	O	O
19	NUM	O	O
healthy	ADJ	O	O
women	NOUN	O	O
performed	VERB	O	O
30	NUM	O	O
min	NOUN	O	O
moderate-intensity	NOUN	O	O
cycling	VERB	O	O
after	ADP	O	O
ingesting	VERB	O	O
1000	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
ascorbic	ADJ	O	O
acid	NOUN	O	O
(AA)	NOUN	O	O
or	CCONJ	O	O
placebo.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
studied	VERB	O	O
40	NUM	O	O
morbidly	ADV	O	O
obese	NOUN	O	O
individuals	NOUN	O	O
aged	VERB	O	O
between	ADP	O	O
25	NUM	O	O
and	CCONJ	O	O
55	NUM	O	O
years	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
pulmonary	ADJ	O	O
function	NOUN	O	O
test	NOUN	O	O
and	CCONJ	O	O
chest	NOUN	O	O
X-ray	NOUN	O	O
preoperatively,	ADJ	O	O
and	CCONJ	O	O
on	ADP	O	O
the	DET	O	O
day	NOUN	O	O
of	ADP	O	O
discharge	NOUN	O	O
(2nd	PUNCT	O	O
day	NOUN	O	O
after	ADP	O	O
surgery).	NOUN	O	O

Furthermore,	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups,	NOUN	O	O
mean	NOUN	O	B-outcome
arterial	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
and	CCONJ	O	O
preoperative	ADJ	O	O
PR	NOUN	O	B-outcome
interval	NOUN	O	I-outcome
were	VERB	O	O
similar	ADJ	O	O
at	ADP	O	O
various	ADJ	O	O
times.	NOUN	O	O

Such	ADJ	O	O
information	NOUN	O	O
provides	NOUN	O	O
important	ADJ	O	O
knowledge	NOUN	O	O
that	ADP	O	O
may	VERB	O	O
help	VERB	O	O
to	PART	O	O
inform	NOUN	O	O
decisions	NOUN	O	O
of	ADP	O	O
municipalities,	NOUN	O	O
employers	NOUN	O	O
and	CCONJ	O	O
other	ADJ	O	O
public	ADJ	O	O
health	NOUN	O	O
decision	NOUN	O	O
makers,	NOUN	O	O
when	ADP	O	O
and	CCONJ	O	O
if	ADP	O	O
implementing	VERB	O	O
weight	NOUN	O	O
loss	NOUN	O	O
interventions.	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
consumed	VERB	O	O
either	CCONJ	O	O
two	NUM	O	O
packs	NOUN	O	O
a	DET	O	O
day	NOUN	O	O
for	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
132	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
WSP	NOUN	O	O
(WSP-MR	PUNCT	O	O
group)	ADJ	O	O
or	CCONJ	O	O
a	DET	O	O
normal	ADJ	O	O
diet	NOUN	O	O
daily	ADJ	O	O
(non-WSP	PUNCT	O	O
group)	ADJ	O	O
for	ADP	O	O
eight	NUM	O	O
weeks.	NOUN	O	O

METHODS:	NOUN	O	O
Subjects	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
receive	VERB	O	O
HP	NOUN	O	O
(256	NUM	O	O
subjects)	NOUN	O	O
or	CCONJ	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
(132	NUM	O	O
subjects)	NOUN	O	O
for	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
minimal,	ADJ	O	O
mild,	NOUN	O	O
or	CCONJ	O	O
moderate	ADJ	O	O
bleeding	VERB	O	B-outcome
at	ADP	O	O
20	NUM	O	O
investigational	ADJ	O	O
sites.	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
verify	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
aPDT	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
halitosis	NOUN	O	O
by	ADP	O	O
evaluating	VERB	O	O
the	DET	O	O
formation	NOUN	O	O
of	ADP	O	O
volatile	ADP	O	O
sulphur	NOUN	O	O
compounds	NOUN	O	O
with	ADP	O	O
gas	NOUN	O	O
chromatography	NOUN	O	O
and	CCONJ	O	O
microbiological	ADJ	O	O
analysis	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment.	NOUN	O	O

Thus,	NOUN	O	O
a	DET	O	O
double-blinded	VERB	O	O
randomized,	NOUN	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
nifedipine,	NOUN	O	O
a	DET	O	O
calcium	NOUN	O	O
channel	NOUN	O	O
blocker	NOUN	O	O
with	ADP	O	O
potent	ADJ	O	O
smooth	NOUN	O	O
muscle	NOUN	O	O
relaxing	VERB	O	O
activity	NOUN	O	O
and	CCONJ	O	O
an	DET	O	O
excellent	ADJ	O	O
safety	NOUN	O	O
profile,	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
the	DET	O	O
outcome	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
ET	NOUN	O	O
treatments.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
crossover,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial,	NOUN	O	O
elbow	NOUN	O	B-outcome
proprioception	NOUN	O	I-outcome
,	PUNCT	O	O
pain	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
,	PUNCT	O	O
pain-free	ADJ	O	B-outcome
grip	NOUN	O	I-outcome
strength	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
finger	NOUN	O	B-outcome
dexterity	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
in	ADP	O	O
50	NUM	O	O
participants	NOUN	O	O
with	ADP	O	O
a	DET	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
lateral	ADJ	O	O
elbow	NOUN	O	O
tendinopathy.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9425194	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

In	ADP	O	O
contrast,	NOUN	O	O
children	NOUN	O	O
reported	VERB	O	O
that	ADP	O	O
the	DET	O	O
activities	NOUN	O	O
outside	ADP	O	O
of	ADP	O	O
the	DET	O	O
classroom	NOUN	O	O
were	VERB	O	O
preferred	VERB	O	B-outcome
.	PUNCT	O	O
Future	NOUN	O	O
school-based	VERB	O	O
PA	NOUN	O	O
interventions	NOUN	O	O
should	VERB	O	O
aim	ADP	O	O
to	PART	O	O
achieve	NOUN	O	O
a	DET	O	O
balance	NOUN	O	O
between	ADP	O	O
routine	ADJ	O	O
PA	NOUN	O	O
at	ADP	O	O
a	DET	O	O
set	NOUN	O	O
time	NOUN	O	O
and	CCONJ	O	O
PA	NOUN	O	O
that	ADP	O	O
is	VERB	O	O
flexible	ADJ	O	O
and	CCONJ	O	O
adaptable.	NOUN	O	O

Title:	NOUN	O	O
Proton	NOUN	O	O
Pump	ADV	O	O
Inhibitor	NOUN	O	O
Ameliorates	NOUN	O	O
Taste	NOUN	O	B-outcome
Disturbance	NOUN	O	I-outcome
among	ADP	O	O
Patients	NOUN	O	O
with	ADP	O	O
Laryngopharyngeal	ADJ	O	O
Reflux:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Study.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/12	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
normal	ADJ	O	O
G6PD	NOUN	O	O
enzyme	NOUN	O	O
activity,	ADP	O	O
the	DET	O	O
decline	NOUN	O	O
in	ADP	O	O
hemoglobin	NOUN	O	B-outcome
level	NOUN	O	O
with	ADP	O	O
tafenoquine	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
significantly	ADV	O	O
from	ADP	O	O
that	ADP	O	O
with	ADP	O	O
primaquine.	NOUN	O	O

If	ADP	O	O
endometrial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
failed	VERB	O	O
to	PART	O	O
increase	NOUN	O	O
after	ADP	O	O
48	NUM	O	O
h,	NOUN	O	O
PRP	NOUN	O	O
infusion	NOUN	O	O
was	VERB	O	O
repeated	VERB	O	O
in	ADP	O	O
the	DET	O	O
same	ADJ	O	O
cycle.	NOUN	O	O

All	DET	O	O
the	DET	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
biochemical	ADJ	O	O
parameters	NOUN	O	O
were	VERB	O	O
routinely	ADV	O	O
evaluated	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment.	NOUN	O	O

Title:	NOUN	O	O
Physiological,	ADJ	O	O
hyaluronan-selected	VERB	O	O
intracytoplasmic	ADJ	O	O
sperm	NOUN	O	O
injection	NOUN	O	O
for	ADP	O	O
infertility	NOUN	O	O
treatment	NOUN	O	O
(HABSelect):	NOUN	O	O
a	DET	O	O
parallel,	ADV	O	O
two-group,	NOUN	O	O
randomised	VERB	O	O
trial.	NOUN	O	O

Journal-Name:The	ADJ	O	O
bone	NOUN	O	O
&	CCONJ	O	O
joint	NOUN	O	O
journal	ADJ	O	O

Journal-Name:JAMA	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
if	ADP	O	O
a	DET	O	O
combination	NOUN	O	O
of	ADP	O	O
a	DET	O	O
lower	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
AmBisome	NOUN	O	O
with	ADP	O	O
miltefosine	NOUN	O	O
would	VERB	O	O
show	VERB	O	O
acceptable	ADJ	O	O
efficacy	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Evaluation	NOUN	O	O
of	ADP	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
as	ADP	O	O
an	DET	O	O
additional	ADJ	O	O
strategy	NOUN	O	O
to	PART	O	O
evaluate	VERB	O	O
postoperative	ADJ	O	O
residual	ADJ	O	B-outcome
neuromuscular	ADJ	O	I-outcome
blockade	NOUN	O	I-outcome
.	PUNCT	O	O

DISCUSSION:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
trial	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
used	VERB	O	O
to	PART	O	O
establish	NOUN	O	O
clinical	ADJ	O	O
evidence	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
Bosinji	NOUN	O	O
with	ADP	O	O
acupuncture	NOUN	O	O
treatment	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
LHIVD.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Low-Dose	NOUN	O	O
Intracoronary	ADJ	O	O
Alteplase	NOUN	O	O
During	ADP	O	O
Primary	ADJ	O	O
Percutaneous	ADJ	O	O
Coronary	ADJ	O	O
Intervention	NOUN	O	O
on	ADP	O	O
Microvascular	ADJ	O	B-outcome
Obstruction	NOUN	O	I-outcome
in	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Acute	ADJ	O	O
Myocardial	ADJ	O	O
Infarction:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

We	PRON	O	O
assessed	VERB	O	O
a	DET	O	O
composite	NOUN	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
of	ADP	O	O
complete	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
,	PUNCT	O	O
complete	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
with	ADP	O	Seperator
incomplete	ADJ	O	I-outcome
platelet	NOUN	O	I-outcome
recovery	NOUN	O	I-outcome
(CRp)	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
complete	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
with	ADP	O	Seperator
incomplete	ADJ	O	I-outcome
haematological	ADJ	O	I-outcome
recovery	NOUN	O	I-outcome
(CRi)	NOUN	O	I-outcome
achieved	NOUN	O	O
at	ADP	O	O
any	DET	O	O
time	NOUN	O	O
and	CCONJ	O	O
assessed	VERB	O	O
by	ADP	O	O
intention	NOUN	O	O
to	PART	O	O
treat.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Hence,	NOUN	O	O
we	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
identify	NOUN	O	O
which	ADP	O	O
combinations	NOUN	O	O
of	ADP	O	O
teacher	NOUN	O	O
and	CCONJ	O	O
implementation	NOUN	O	O
process	NOUN	O	O
characteristics	NOUN	O	O
affected	VERB	O	O
the	DET	O	O
emotional	ADJ	O	B-outcome
and	CCONJ	O	Seperator
social	ADJ	O	I-outcome
school	NOUN	O	I-outcome
experience	NOUN	O	I-outcome
(SCE)	PUNCT	O	I-outcome
of	ADP	O	O
pupils	NOUN	O	O
participating	VERB	O	O
in	ADP	O	O
a	DET	O	O
school-based	VERB	O	O
health	NOUN	O	O
promotion	NOUN	O	O
program.	NOUN	O	O

Objective:	NOUN	O	O
Netupitant	ADJ	O	O
is	VERB	O	O
a	DET	O	O
novel,	ADV	O	O
selective	ADJ	O	O
neurokinin-1	NOUN	O	O
receptor	NOUN	O	O
antagonist	NOUN	O	O
used	VERB	O	O
for	ADP	O	O
prevention	NOUN	O	O
of	ADP	O	O
chemotherapy-induced	VERB	O	O
nausea	NOUN	O	O
and	CCONJ	O	O
vomiting,	NOUN	O	O
a	DET	O	O
distressing	VERB	O	O
side	NOUN	O	O
effect	NOUN	O	O
of	ADP	O	O
chemotherapy.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
early	ADJ	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
survival	NOUN	O	B-outcome
with	ADP	O	O
improvement	NOUN	O	O
in	ADP	O	O
at	ADP	O	O
least	ADV	O	O
two	NUM	O	O
of	ADP	O	O
four	NUM	O	O
symptoms	NOUN	O	B-outcome
(	PUNCT	O	O
cough	NOUN	O	B-outcome
,	PUNCT	O	O
sputum	NOUN	O	B-outcome
production	NOUN	O	I-outcome
,	PUNCT	O	O
pleuritic	ADJ	O	B-outcome
chest	NOUN	O	I-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
dyspnea	NOUN	O	B-outcome
)	PUNCT	O	O
and	CCONJ	O	O
no	DET	O	O
worsening	VERB	O	O
of	ADP	O	O
symptoms	NOUN	O	B-outcome
at	ADP	O	O
72	NUM	O	O
to	PART	O	O
120	NUM	O	O
hours,	NOUN	O	O
without	ADP	O	O
receipt	NOUN	O	O
of	ADP	O	O
rescue	NOUN	O	B-outcome
antibacterial	ADJ	O	I-outcome
therapy	NOUN	O	I-outcome
.	PUNCT	O	O
A	DET	O	O
secondary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
investigator-assessed	VERB	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
at	ADP	O	O
a	DET	O	O
post-treatment	NOUN	O	O
evaluation	NOUN	O	O
5	NUM	O	O
to	PART	O	O
10	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
the	DET	O	O
last	NOUN	O	O
dose,	NOUN	O	O
with	ADP	O	O
clinical	ADJ	O	O
response	NOUN	O	O
defined	VERB	O	O
as	ADP	O	O
resolution	NOUN	O	O
or	CCONJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
signs	NOUN	O	B-outcome
or	CCONJ	O	O
symptoms	NOUN	O	B-outcome
to	PART	O	O
the	DET	O	O
extent	NOUN	O	O
that	ADP	O	O
further	ADV	O	O
antibacterial	ADJ	O	O
therapy	NOUN	O	O
was	VERB	O	O
unnecessary.	VERB	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
2048	NUM	O	O
were	VERB	O	O
approached	VERB	O	O
for	ADP	O	O
participation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
ICU,	ADJ	O	O
of	ADP	O	O
which	ADP	O	O
1458	NUM	O	O
provided	ADJ	O	O
informed	VERB	O	O
consent.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/28	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
authors	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
find	ADP	O	O
any	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
all	DET	O	O
measured	VERB	O	O
variables	NOUN	O	O
for	ADP	O	O
the	DET	O	O
CG	NOUN	O	O
at	ADP	O	O
the	DET	O	O
initial	ADJ	O	O
and	CCONJ	O	O
final	ADJ	O	O
assessments.	NOUN	O	O

The	DET	O	O
nasopharyngeal	ADJ	O	O
temperature	NOUN	O	O
was	VERB	O	O
maintained	VERB	O	O
at	ADP	O	O
33.0-34.5	NUM	O	O
centigrade	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
rectal	ADJ	O	O
temperature	NOUN	O	O
was	VERB	O	O
maintained	VERB	O	O
at	ADP	O	O
34.5-35.0	NUM	O	O
centigrade.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
between-group	NOUN	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rates	NOUN	O	O
of	ADP	O	O
ongoing	VERB	O	B-outcome
pregnancy	NOUN	O	I-outcome
,	PUNCT	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
,	PUNCT	O	O
multiple	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
,	PUNCT	O	O
ectopic	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
miscarriage	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
median	ADJ	O	O
score	NOUN	O	O
for	ADP	O	O
pain	NOUN	O	B-outcome
from	ADP	O	O
endometrial	ADJ	O	O
scratching	VERB	O	O
(on	PUNCT	O	O
a	DET	O	O
scale	NOUN	O	O
of	ADP	O	O
0	NUM	O	O
to	PART	O	O
10,	NUM	O	O
with	ADP	O	O
higher	ADJ	O	O
scores	NOUN	O	O
indicating	VERB	O	O
worse	NOUN	O	O
pain)	NOUN	O	O
was	VERB	O	O
3.5	NUM	O	O
(interquartile	NUM	O	O
range,	VERB	O	O
1.9	NUM	O	O
to	PART	O	O
6.0).	NOUN	O	O

The	DET	O	O
Ocular	ADJ	O	B-outcome
Surface	NOUN	O	I-outcome
Disease	NOUN	O	I-outcome
Index	NOUN	O	O
(OSDI)	NOUN	O	O
questionnaire,	NOUN	O	O
evaluation	NOUN	O	O
of	ADP	O	O
subjective	ADJ	O	O
symptoms	NOUN	O	B-outcome
and	CCONJ	O	O
evaluation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
best-corrected	VERB	O	B-outcome
visual	ADJ	O	I-outcome
acuity	NOUN	O	I-outcome
(BCVA)	NUM	O	I-outcome
were	VERB	O	O
conducted	VERB	O	O
preoperatively	ADV	O	O
and	CCONJ	O	O
postoperatively	ADV	O	O
on	ADP	O	O
days	NOUN	O	O
1,	NOUN	O	O
7,	NUM	O	O
14,	NUM	O	O
30	NUM	O	O
and	CCONJ	O	O
90.	NOUN	O	O

3)	NOUN	O	O
Results:	NOUN	O	O
There	PRON	O	O
were	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05)	NUM	O	O
decreases	NOUN	O	O
in	ADP	O	O
systolic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
sVCAM-1	NOUN	O	B-outcome
,	PUNCT	O	O
sE-selectin	NOUN	O	B-outcome
and	CCONJ	O	O
endothelin-1	NOUN	O	B-outcome
levels,	NOUN	O	O
and	CCONJ	O	O
increases	NOUN	O	O
in	ADP	O	O
glutathione	NOUN	O	B-outcome
peroxidase	NOUN	O	I-outcome
activity	NOUN	O	I-outcome
and	CCONJ	O	O
oxidized	VERB	O	B-outcome
glutathione	NOUN	O	I-outcome
levels.	NOUN	O	O
(	PUNCT	O	O

These	DET	O	O
and	CCONJ	O	O
other	ADJ	O	O
related	VERB	O	O
markers	NOUN	O	O
(holotranscobalamin,	NUM	O	O
methylmalonic	ADJ	O	O
acid	NOUN	O	O
and	CCONJ	O	O
homocysteine)	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
linked	VERB	O	O
with	ADP	O	O
cognitive	ADJ	O	O
health.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Journal-Name:Clinical	ADJ	O	O
interventions	NOUN	O	O
in	ADP	O	O
aging	VERB	O	O

Patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
after	ADP	O	O
the	DET	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
resectable	ADJ	O	O
or	CCONJ	O	O
borderline	NOUN	O	O
resectable	ADJ	O	O
by	ADP	O	O
portal	NOUN	O	O
vein	NOUN	O	O
involvement	NOUN	O	O
pancreatic	ADJ	O	O
cancer	NOUN	O	O
with	ADP	O	O
histological	ADJ	O	O
confirmation.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
pilot	NOUN	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
effectiveness	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
transcutaneous	ADJ	O	O
electrical	ADJ	O	O
nerve	NOUN	O	O
stimulation	NOUN	O	O
(TENS)	PUNCT	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
tinnitus.	NOUN	O	O

Although	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
successfully	ADV	O	O
altered	VERB	O	O
several	ADJ	O	O
hypothesised	VERB	O	O
mediating	VERB	O	O
constructs	NOUN	O	O
it	PRON	O	O
did	VERB	O	O
not	ADV	O	O
translate	NOUN	O	O
into	ADP	O	O
long-term	NOUN	O	O
behaviour	NOUN	O	O
change.	NOUN	O	O

Subpopulations	NOUN	O	O
of	ADP	O	O
T	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
lymphocytes	NOUN	O	I-outcome
(Tregs)	NUM	O	I-outcome
(	PUNCT	O	O
CD4+	NOUN	O	B-outcome
/	SYM	O	O
CD25+	DET	O	B-outcome
/	SYM	O	O
CD127-	NUM	O	B-outcome
),	NUM	O	O
cytotoxic	ADJ	O	B-outcome
lymphocytes	NOUN	O	I-outcome
(CTLs)	NUM	O	I-outcome
(	PUNCT	O	O
CD8+	NOUN	O	B-outcome
/	SYM	O	O
TCRalphabeta+	PUNCT	O	B-outcome
),	NUM	O	O
natural	ADJ	O	B-outcome
killer	NOUN	O	I-outcome
(NK)	ADV	O	I-outcome
cells	NOUN	O	I-outcome
(	PUNCT	O	O
CD3-	ADJ	O	B-outcome
/	SYM	O	O
CD16+	NOUN	O	B-outcome
/	SYM	O	O
CD56+	NOUN	O	B-outcome
)	PUNCT	O	O
and	CCONJ	O	O
TCRdeltagamma-positive	ADJ	O	B-outcome
(Tdeltagamma)	NUM	O	I-outcome
cells	NOUN	O	I-outcome
were	VERB	O	O
determined	VERB	O	O
by	ADP	O	O
means	NOUN	O	O
of	ADP	O	O
flow	NOUN	O	O
cytometry.	VERB	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
is	VERB	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
;	PUNCT	O	O
secondary	ADJ	O	O
endpoints	NOUN	O	O
include	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
resection	NOUN	O	B-outcome
rate,	NOUN	O	O
recurrence-free	PUNCT	O	B-outcome
survival	NOUN	O	I-outcome
,	PUNCT	O	O
residual	ADJ	O	B-outcome
tumor	NOUN	O	I-outcome
status	NOUN	O	I-outcome
,	PUNCT	O	O
nodal	NOUN	O	B-outcome
metastases	NOUN	O	I-outcome
and	CCONJ	O	O
tumor	NOUN	O	B-outcome
marker	NOUN	O	I-outcome
kinetics	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
target	NOUN	O	O
sample	NOUN	O	O
size	NOUN	O	O
was	VERB	O	O
required	VERB	O	O
to	PART	O	O
be	VERB	O	O
at	ADP	O	O
least	ADV	O	O
163	NUM	O	O
(alpha-error	NOUN	O	O
0.05;	NOUN	O	O
power	NOUN	O	O
0.8)	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
arms.	ADJ	O	O

Journal-Name:Taiwanese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
obstetrics	NOUN	O	O
&	CCONJ	O	O
gynecology	NOUN	O	O

While	ADP	O	O
30%	NOUN	O	O
report	NOUN	O	O
working	VERB	O	O
full	ADJ	O	O
or	CCONJ	O	O
part	NOUN	O	O
time,	NOUN	O	O
45%	ADJ	O	O
were	VERB	O	O
retired	VERB	O	O
due	ADJ	O	O
to	PART	O	O
disability.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/28	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
results	NOUN	O	O
indicate	VERB	O	O
that	ADP	O	O
these	DET	O	O
vaccines	NOUN	O	O
were	VERB	O	O
safe	ADJ	O	O
and	CCONJ	O	O
immunogenic	ADJ	O	B-outcome
in	ADP	O	O
ethnic	ADJ	O	O
Korean	NOUN	O	O
children.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
event	NOUN	O	I-outcome
such	ADJ	O	O
as	ADP	O	O
arrhythmia,	NOUN	O	O
large	ADJ	O	O
vein	NOUN	O	O
thrombosis	NOUN	O	O
or	CCONJ	O	O
irreducible	ADJ	O	O
hypotension	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups,	NOUN	O	O
and	CCONJ	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
general	ADJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
such	ADJ	O	O
as	ADP	O	O
sinus	NOUN	O	B-outcome
bradycardia	NOUN	O	I-outcome
,	PUNCT	O	O
scleredema	NOUN	O	B-outcome
,	PUNCT	O	O
blood	NOUN	O	B-outcome
glucose	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
systemic	ADJ	O	B-outcome
infection	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
[16.7%	ADP	O	O
(3/18)	PUNCT	O	O
vs.	CCONJ	O	O
11.1%	NUM	O	O
(2/18),	PUNCT	O	O
5.6%	NOUN	O	O
(1/18)	PUNCT	O	O
vs.	CCONJ	O	O
5.6%	NOUN	O	O
(1/18),	NUM	O	O
22.2%	NUM	O	O
(4/18)	PUNCT	O	O
vs.	CCONJ	O	O
11.1%	NUM	O	O
(2/18),	PUNCT	O	O
5.6%	NOUN	O	O
(1/18)	PUNCT	O	O
vs.	CCONJ	O	O
5.6%	NOUN	O	O
(1/18),	NUM	O	O
all	DET	O	O
P	NOUN	O	O
>	SYM	O	O
0.05].	NUM	O	O
CONCLUSIONS:	NOUN	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
could	VERB	O	O
significantly	ADV	O	O
increase	NOUN	O	O
the	DET	O	O
neonatal	ADJ	O	B-outcome
behavioral	ADJ	O	I-outcome
neurological	ADJ	O	I-outcome
assessment	NOUN	O	O
score	NOUN	O	O
at	ADP	O	O
28	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
birth	NOUN	O	O
and	CCONJ	O	O
Bayley	PROPN	O	O
scales	NOUN	O	O
of	ADP	O	O
infant	NOUN	O	B-outcome
development	NOUN	O	I-outcome
score	NOUN	O	O
at	ADP	O	O
15	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
age,	NOUN	O	O
reduce	VERB	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
disability	NOUN	O	I-outcome
in	ADP	O	O
moderate	ADJ	O	O
and	CCONJ	O	O
severe	ADJ	O	O
HIE	NOUN	O	O
children,	NOUN	O	O
but	CCONJ	O	O
it	PRON	O	O
was	VERB	O	O
not	ADV	O	O
be	VERB	O	O
proved	VERB	O	O
that	ADP	O	O
SBH	NOUN	O	O
could	VERB	O	O
reduce	VERB	O	O
the	DET	O	O
mortality	NOUN	O	B-outcome
.	PUNCT	O	O
Compared	VERB	O	O
with	ADP	O	O
routine	ADJ	O	O
treatment,	NOUN	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
had	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
superiority	NOUN	O	O
on	ADP	O	O
improving	VERB	O	O
the	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
neuron-specific	ADJ	O	B-outcome
enolase	NOUN	O	I-outcome
and	CCONJ	O	O
S100	NOUN	O	B-outcome
protein	NOUN	O	I-outcome
,	PUNCT	O	O
suggesting	VERB	O	O
that	ADP	O	O
SBH	NOUN	O	O
could	VERB	O	O
not	ADV	O	O
protect	VERB	O	O
the	DET	O	O
brain	NOUN	O	O
by	ADP	O	O
inhibiting	VERB	O	O
the	DET	O	O
apoptosis	NOUN	O	O
of	ADP	O	O
nerve	NOUN	O	O
cells	NOUN	O	O
and	CCONJ	O	O
promoting	VERB	O	O
the	DET	O	O
repair	NOUN	O	O
of	ADP	O	O
nerve	NOUN	O	O
cells.	NOUN	O	O

Both	CCONJ	O	O
MRI	NOUN	O	O
sequences	NOUN	O	O
scored	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
compared	VERB	O	O
to	PART	O	O
CT	NOUN	O	O
for	ADP	O	O
image	NOUN	O	O
quality	NOUN	O	O
and	CCONJ	O	O
confidence	NOUN	O	O
in	ADP	O	O
contouring,	NOUN	O	O
particularly	ADV	O	O
T2*W.	NOUN	O	O
This	DET	O	O
was	VERB	O	O
also	ADV	O	O
reflected	VERB	O	O
in	ADP	O	O
the	DET	O	O
shorter	ADJ	O	O
time	NOUN	O	O
for	ADP	O	O
contouring,	NOUN	O	O
measuring	VERB	O	O
15.4,	NOUN	O	O
9.6	NUM	O	O
and	CCONJ	O	O
9.8	NUM	O	O
min	NOUN	O	O
for	ADP	O	O
CT,	NOUN	O	O
T2W	NOUN	O	O
and	CCONJ	O	O
T2*W	NOUN	O	O
MRI	NOUN	O	O
respectively.	NOUN	O	O

All	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
three	NUM	O	O
groups,	NOUN	O	O
each	DET	O	O
using	VERB	O	O
a	DET	O	O
different	ADJ	O	O
device	NOUN	O	O
system	NOUN	O	O
(motion	NOUN	O	O
tracking,	PUNCT	O	O
finger	NOUN	O	O
motion	NOUN	O	O
control	NOUN	O	O
or	CCONJ	O	O
touchscreen)	ADV	O	O
to	PART	O	O
perform	NOUN	O	O
three	NUM	O	O
task	NOUN	O	O
phases	NOUN	O	O
(	PUNCT	O	O
acquisition	NOUN	O	B-outcome
,	PUNCT	O	O
retention	NOUN	O	B-outcome
and	CCONJ	O	O
transfer	NOUN	O	B-outcome
).	NOUN	O	O

And	CCONJ	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
mean	NOUN	O	B-outcome
arterial	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
,	PUNCT	O	O
pulse	NOUN	O	B-outcome
oxygen	NOUN	O	I-outcome
saturation	NOUN	O	I-outcome
and	CCONJ	O	O
bispectral	ADJ	O	O
index	NOUN	O	O
(BIS)	PUNCT	O	O
every	DET	O	O
2	NUM	O	O
hours	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
from	ADP	O	O
20:	NOUN	O	O
00	NUM	O	O
(the	NOUN	O	O
first	ADV	O	O
day)	NOUN	O	O
to	PART	O	O
6:	ADP	O	O
00	NUM	O	O
(the	NOUN	O	O
second	ADJ	O	O
day)(all	NOUN	O	O
P>0.05).	NOUN	O	O

During	ADP	O	O
the	DET	O	O
final	ADJ	O	O
week	NOUN	O	O
of	ADP	O	O
each	DET	O	O
intervention	NOUN	O	O
phase,	NOUN	O	O
subjects	NOUN	O	O
collected	VERB	O	O
all	DET	O	O
feces	NOUN	O	O
and	CCONJ	O	O
urine	NOUN	O	O
produced,	NOUN	O	O
and	CCONJ	O	O
these	DET	O	O
were	VERB	O	O
also	ADV	O	O
analyzed	VERB	O	O
for	ADP	O	O
nitrogen	NOUN	O	B-outcome
(feces	NOUN	O	O
and	CCONJ	O	O
urine),	NOUN	O	O
energy	NOUN	O	B-outcome
(feces	NOUN	O	O
and	CCONJ	O	O
urine),	NOUN	O	O
and	CCONJ	O	O
fat	NOUN	O	B-outcome
(feces).	NOUN	O	O

Cost	NOUN	O	O
is	VERB	O	O
frequently	ADV	O	O
cited	VERB	O	O
as	ADP	O	O
an	DET	O	O
explanation	NOUN	O	O
for	ADP	O	O
both	CCONJ	O	O
of	ADP	O	O
these	DET	O	O
observations.	NOUN	O	O

Barriers	NOUN	O	O
were	VERB	O	O
regrouped	VERB	O	O
into	ADP	O	O
five	NUM	O	O
categories:	NOUN	O	O
structural	ADJ	O	O
factors	NOUN	O	O
(e.g.,	NOUN	O	O
policies,	NOUN	O	O
social	ADJ	O	O
context,	NOUN	O	O
local	ADJ	O	O
workforce	ADP	O	O
development,	NOUN	O	O
and	CCONJ	O	O
physical	ADJ	O	O
aspects	NOUN	O	O
of	ADP	O	O
the	DET	O	O
environment),	NOUN	O	O
organizational	ADJ	O	O
factors	NOUN	O	O
(e.g.,	NOUN	O	O
logistical	ADJ	O	O
issues	NOUN	O	O
for	ADP	O	O
the	DET	O	O
provision	NOUN	O	O
of	ADP	O	O
care	NOUN	O	O
and	CCONJ	O	O
collaboration	NOUN	O	O
within	ADP	O	O
and	CCONJ	O	O
across	ADP	O	O
healthcare	NOUN	O	O
organizations),	NOUN	O	O
provider	NOUN	O	O
factors	NOUN	O	O
(e.g.,	NOUN	O	O
previous	ADJ	O	O
mental	ADJ	O	O
health	NOUN	O	O
experience	NOUN	O	O
and	CCONJ	O	O
personal	ADJ	O	O
characteristics),	NOUN	O	O
patient	NOUN	O	O
factors	NOUN	O	O
(e.g.,	NOUN	O	O
beliefs	NOUN	O	O
about	ADV	O	O
the	DET	O	O
health	NOUN	O	O
system	NOUN	O	O
and	CCONJ	O	O
healthcare	NOUN	O	O
professionals,	NOUN	O	O
and	CCONJ	O	O
motivation	NOUN	O	O
to	PART	O	O
seek	NOUN	O	O
care),	NOUN	O	O
and	CCONJ	O	O
innovation	NOUN	O	O
factors	NOUN	O	O
(e.g.,	NOUN	O	O
training	VERB	O	O
characteristics).	NOUN	O	O

Primary	ADJ	O	O
efficacy	NOUN	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
composite	NOUN	O	O
of	ADP	O	O
in-hospital	NOUN	O	B-outcome
death	NOUN	O	I-outcome
and	CCONJ	O	O
stent	NOUN	O	B-outcome
thrombosis	NOUN	O	I-outcome
at	ADP	O	O
96	NUM	O	O
h,	NOUN	O	O
while	ADP	O	O
safety	NOUN	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
in-hospital	NOUN	O	B-outcome
bleeding	VERB	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
The	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
in	ADP	O	O
their	ADJ	O	O
baseline	NOUN	O	O
characteristics.	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
pain	NOUN	O	B-outcome
scale	NOUN	O	O
values	NOUN	O	O
on	ADP	O	O
first	ADV	O	O
postoperative	ADJ	O	O
was	VERB	O	O
4.24	NUM	O	O
in	ADP	O	O
the	DET	O	O
drainage	NOUN	O	O
by	ADP	O	O
the	DET	O	O
same	ADJ	O	O
intercostal	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
3.95	NUM	O	O
in	ADP	O	O
the	DET	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
(p=0.733).	PUNCT	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
degree	NOUN	O	O
of	ADP	O	O
injured	VERB	O	O
vertebra	NOUN	O	B-outcome
compression	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
immediate	ADJ	O	O
after	ADP	O	O
operation	NOUN	O	O
(	PUNCT	O	O
P>0.05),	NOUN	O	O
but	CCONJ	O	O
which	ADP	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
last	NOUN	O	O
follow-up	NOUN	O	O
(	PUNCT	O	O
P<0.05).	NOUN	O	O

Mean	NOUN	O	O
change	NOUN	O	O
in	ADP	O	O
cry	NOUN	O	B-outcome
and	CCONJ	O	Seperator
fuss	NOUN	O	B-outcome
time	NOUN	O	E1-outcome
from	ADP	O	O
day	NOUN	O	O
0	NUM	O	O
through	ADP	O	O
day	NOUN	O	O
28	NUM	O	O
was	VERB	O	O
-163	NUM	O	O
(99)	NOUN	O	O
minutes	NOUN	O	O
in	ADP	O	O
the	DET	O	O
probiotic	ADJ	O	O
and	CCONJ	O	O
-116	NUM	O	O
(94)	NOUN	O	O
minutes	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.019).	NUM	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Brazilian	NOUN	O	O
Registry	NOUN	O	O
of	ADP	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
(no.	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

In	ADP	O	O
addition,	NOUN	O	O
the	DET	O	O
total	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(TBL),	NUM	O	O
hidden	NOUN	O	B-outcome
blood	NOUN	O	I-outcome
loss	NOUN	O	I-outcome
(HBL)	PUNCT	O	I-outcome
,	PUNCT	O	O
maximum	NOUN	O	O
hemoglobin	NOUN	O	B-outcome
(Hb)	PUNCT	O	I-outcome
drop,	NOUN	O	O
fibrinolytic	ADJ	O	B-outcome
activity,	ADP	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
incidence	NOUN	O	O
of	ADP	O	O
thromboembolism	NOUN	O	B-outcome
were	VERB	O	O
measured.	NOUN	O	O

METHOD:	NOUN	O	O
The	DET	O	O
double-blind	ADJ	O	O
study	NOUN	O	O
included	VERB	O	O
20	NUM	O	O
members	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Polish	ADV	O	O
Rowing	VERB	O	O
Team.	NOUN	O	O

This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
designed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
muscle	NOUN	O	O
relaxation	NOUN	O	O
during	ADP	O	O
laparoscopic	ADJ	O	O
subtotal	ADJ	O	O
gastrectomy	NOUN	O	O
on	ADP	O	O
the	DET	O	O
oncological	ADJ	O	O
benefits,	NOUN	O	O
particularly	ADV	O	O
in	ADP	O	O
obese	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
gastric	ADJ	O	O
cancer.	NOUN	O	O

We	PRON	O	O
explored	VERB	O	O
characteristics	NOUN	O	O
of	ADP	O	O
NSCLC	NOUN	O	O
that	ADP	O	O
could	VERB	O	O
predict	VERB	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(DFS)	NOUN	O	I-outcome
and	CCONJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
using	VERB	O	O
Cox	NOUN	O	O
regression	NOUN	O	O
models.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
cancer	NOUN	O	O
research	NOUN	O	O
and	CCONJ	O	O
therapeutics	NOUN	O	O

Journal-Name:	NOUN	O	O
Revista	NOUN	O	O
latino-americana	NOUN	O	O
de	ADP	O	O
enfermagem	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
baseline	NOUN	O	O
data	NOUN	O	O
of	ADP	O	O
gender,	NOUN	O	O
gestational	ADJ	O	O
age,	NOUN	O	O
birth	NOUN	O	O
weight,	NOUN	O	O
age,	NOUN	O	O
5-minure	NOUN	O	O
Apgar	PROPN	O	O
score	NOUN	O	O
or	CCONJ	O	O
SNAPPE	NOUN	O	O
II	NUM	O	O
score	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups,	NOUN	O	O
indicating	VERB	O	O
that	ADP	O	O
the	DET	O	O
baseline	NOUN	O	O
data	NOUN	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
balanced	VERB	O	O
and	CCONJ	O	O
comparable.	NOUN	O	O

Yi	NOUN	O	O
xue	NOUN	O	O
ban	NOUN	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
Central	ADJ	O	O
South	NOUN	O	O
University.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
and	CCONJ	O	O
cost-effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
loyalty	NOUN	O	O
scheme	NOUN	O	O
for	ADP	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
behaviour	NOUN	O	O
change	NOUN	O	O
maintenance:	NOUN	O	O
results	NOUN	O	O
from	ADP	O	O
a	DET	O	O
cluster	NOUN	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101217089	NUM	O	O

A	DET	O	O
P	NOUN	O	O
value	NOUN	O	O
of	ADP	O	O
less	ADV	O	O
than	ADP	O	O
.05	NUM	O	O
was	VERB	O	O
considered	VERB	O	O
statistically	ADV	O	O
significant.	NOUN	O	O

Journal-Name:International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
sports	NOUN	O	O
medicine	NOUN	O	O

Background	NOUN	O	O
Very	ADV	O	O
little	DET	O	O
research	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
done	NOUN	O	O
to	PART	O	O
simultaneously	ADV	O	O
investigate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
Tai	NOUN	O	O
Chi	NOUN	O	O
(TC)	NOUN	O	O
on	ADP	O	O
depression	NOUN	O	O
and	CCONJ	O	O
heart	NOUN	O	O
rate	NOUN	O	O
variability	NOUN	O	O
(HRV).	NOUN	O	O

Eighty	PROPN	O	O
percent	NOUN	O	O
of	ADP	O	O
CI	NOUN	O	O
implants,	NOUN	O	O
61%	NUM	O	O
of	ADP	O	O
FI	NOUN	O	O
implants,	NOUN	O	O
and	CCONJ	O	O
84%	NOUN	O	O
of	ADP	O	O
PS	NOUN	O	O
implants	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
to	PART	O	O
have	VERB	O	O
a	DET	O	O
clinically	ADV	O	O
stable	ADJ	O	O
peri-implant	ADJ	O	B-outcome
mucosal	ADJ	O	I-outcome
zenith	ADP	O	I-outcome
position	NOUN	O	I-outcome
with	ADP	O	O
less	ADV	O	O
than	ADP	O	O
0.5	NUM	O	O
mm	NOUN	O	O
of	ADP	O	O
measured	VERB	O	O
recession.	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
the	DET	O	O
groups	NOUN	O	O
were	VERB	O	O
dichotomized	VERB	O	O
at	ADP	O	O
the	DET	O	O
50th	ADJ	O	O
percentile	ADJ	O	O
based	VERB	O	O
on	ADP	O	O
pre-supplementation	NOUN	O	O
MVIC	NOUN	O	O
and	CCONJ	O	O
baseline	NOUN	O	O
HYP.	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
incident	ADJ	O	O
delirium	NOUN	O	B-outcome
during	ADP	O	O
postoperative	ADJ	O	O
days	NOUN	O	O
1	NUM	O	O
through	ADP	O	O
5.	NUM	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
74	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
have	VERB	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
radiating	VERB	O	O
pain	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
LHIVD	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
recruited	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Those	DET	O	O
in	ADP	O	O
the	DET	O	O
training	VERB	O	O
group	NOUN	O	O
received	VERB	O	O
a	DET	O	O
further	ADV	O	O
individual	ADJ	O	O
3-hour	NOUN	O	O
training	VERB	O	O
session,	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
tested	VERB	O	O
again	ADV	O	O
after	ADP	O	O
1	NUM	O	O
week	NOUN	O	O
(test-2).	PUNCT	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
overall	ADJ	O	O
remission	NOUN	O	B-outcome
rate	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
(3.7%	PUNCT	O	O
vs	CCONJ	O	O
0%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.322).	NUM	O	O

Self-reported	VERB	O	O
life-time	NOUN	O	O
medical	ADJ	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
depression	NOUN	O	B-outcome
or	CCONJ	O	O
use	NOUN	O	B-outcome
of	ADP	O	I-outcome
antidepressants	NOUN	O	I-outcome
was	VERB	O	O
considered	VERB	O	O
as	ADP	O	O
outcome.	NOUN	O	O

AIM:	NOUN	O	O
The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
prove	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
pharmacological	ADJ	O	O
preconditioning	VERB	O	O
caused	VERB	O	O
by	ADP	O	O
nicorandil	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
stable	ADJ	O	O
coronary	ADJ	O	O
heart	NOUN	O	O
disease	NOUN	O	O
(CHD)	PUNCT	O	O
during	ADP	O	O
the	DET	O	O
elective	ADJ	O	O
percutaneous	ADJ	O	O
coronary	ADJ	O	O
intervention	NOUN	O	O
(PCI).	PUNCT	O	O

Systemic	ADJ	O	O
hemodynamic	ADJ	O	B-outcome
data	NOUN	O	O
recorded	VERB	O	O
by	ADP	O	O
PRAM	NOUN	O	O
included	VERB	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
systolic	ADJ	O	B-outcome
(SBP)	PUNCT	O	I-outcome
and	NUM	O	X
mean	NOUN	O	X
(MBP)	PUNCT	O	X
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
stroke	NOUN	O	B-outcome
volume	NOUN	O	I-outcome
index	NOUN	O	O
(SVI),	PUNCT	O	O
cardiac	ADJ	O	B-outcome
index	NOUN	O	O
(CI),	ADJ	O	O
systemic	ADJ	O	B-outcome
vascular	ADJ	O	I-outcome
resistance	NOUN	O	I-outcome
index	NOUN	O	O
(SVRI),	PUNCT	O	O
the	DET	O	O
maximal	ADJ	O	O
slope	NOUN	O	O
of	ADP	O	O
systolic	ADJ	O	B-outcome
upstroke	NOUN	O	I-outcome
(dp/dtmax)	NUM	O	O
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
cycle	NOUN	O	I-outcome
efficiency	NOUN	O	O
(CCE)	PUNCT	O	O
after	ADP	O	O
sedation	NOUN	O	O
obtained,	NOUN	O	O
1,	NOUN	O	O
2,	NOUN	O	O
5	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
induction	NOUN	O	O
achieved,	NOUN	O	O
1,	NOUN	O	O
2,	NOUN	O	O
5	NUM	O	O
and	CCONJ	O	O
10	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
intubation.	ADV	O	O

METHODS:	NOUN	O	O
Current	ADJ	O	O
soft	NOUN	O	O
contact	NOUN	O	O
lens	NOUN	O	O
wearers	NOUN	O	O
with	ADP	O	O
-0.75	NUM	O	O
to	PART	O	O
-1.75	NUM	O	O
D	NOUN	O	O
astigmatism	NOUN	O	O
in	ADP	O	O
each	DET	O	O
eye	NOUN	O	O
were	VERB	O	O
binocularly	ADV	O	O
fitted	VERB	O	O
with	ADP	O	O
toric	ADJ	O	O
(1-Day	PUNCT	O	O
ACUVUE	NOUN	O	O
MOIST	NOUN	O	O
for	ADP	O	O
astigmatism)	NOUN	O	O
and	CCONJ	O	O
spherical	ADJ	O	O
(1-Day	PUNCT	O	O
ACUVUE	NOUN	O	O
MOIST)	ADP	O	O
contact	NOUN	O	O
lenses	NOUN	O	O
in	ADP	O	O
random	NOUN	O	O
order.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
position	NOUN	O	O
on	ADP	O	O
gastric	ADJ	O	B-outcome
residual	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
of	ADP	O	O
premature	ADJ	O	O
infants	NOUN	O	O
in	ADP	O	O
NICU.	NOUN	O	O

The	DET	O	O
study	NOUN	O	O
participants	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
randomly	ADV	O	O
into	ADP	O	O
two	NUM	O	O
groups:	NOUN	O	O
the	DET	O	O
supplemented	VERB	O	O
group	NOUN	O	O
ingested	VERB	O	O
caffeine	NOUN	O	O
before	ADP	O	O
exercise	NOUN	O	O
(GCAF),	NOUN	O	O
while	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
given	VERB	O	O
a	DET	O	O
placebo	NOUN	O	O
(GCON).	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT02406677.	NOUN	O	O

Methods:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
prospective	ADJ	O	O
study,	NOUN	O	O
one	NUM	O	O
hundred	NUM	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
radical	NOUN	O	O
resection	NOUN	O	O
of	ADP	O	O
esophageal	ADJ	O	O
cancer	NOUN	O	O
in	ADP	O	O
Affiliated	VERB	O	O
Cancer	NOUN	O	O
Hospital	NOUN	O	O
of	ADP	O	O
Zhengzhou	NOUN	O	O
University	NOUN	O	O
from	ADP	O	O
January	NOUN	O	O
2016	NUM	O	O
to	PART	O	O
October	ADJ	O	O
2017,	NUM	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(group	PUNCT	O	O
C)	NOUN	O	O
and	CCONJ	O	O
dexmedetomidine	NOUN	O	O
group	NOUN	O	O
(group	PUNCT	O	O
D),	NOUN	O	O
n=50.	ADJ	O	O

Preliminary	ADJ	O	O
evidence	NOUN	O	O
suggests	NOUN	O	O
that	ADP	O	O
patients'	NOUN	O	O
beliefs	NOUN	O	O
and	CCONJ	O	O
perceptions	NOUN	O	O
may	VERB	O	O
influence	NOUN	O	O
their	ADJ	O	O
prognosis.	NOUN	O	O

Journal-Name:Cellular	ADJ	O	O
physiology	NOUN	O	O
and	CCONJ	O	O
biochemistry	NOUN	O	O
:	PUNCT	O	O
international	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
experimental	ADJ	O	O
cellular	ADJ	O	O
physiology,	NOUN	O	O
biochemistry,	ADP	O	O
and	CCONJ	O	O
pharmacology	NOUN	O	O

Main	ADJ	O	O
parameters	NOUN	O	O
setting	VERB	O	O
of	ADP	O	O
respirator:	NOUN	O	O
VCV	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
given	VERB	O	O
450,	NOUN	O	O
550,	NOUN	O	O
650	NUM	O	O
mL	NOUN	O	O
preset	NOUN	O	O
VT,	NOUN	O	O
and	CCONJ	O	O
PCV	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
given	VERB	O	O
12,	NUM	O	O
16,	NOUN	O	O
20	NUM	O	O
cmH2O	NOUN	O	O
(1	NOUN	O	O
cmH2O	NOUN	O	O
=	SYM	O	O
0.098	NUM	O	O
kPa)	NOUN	O	O
preset	NOUN	O	O
suction	NOUN	O	O
pressure.	NOUN	O	O

Statistical	ADJ	O	O
analyses	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
using	VERB	O	O
SPSS	ADV	O	O
version	NOUN	O	O
23.0	NUM	O	O
for	ADP	O	O
Windows.	NOUN	O	O

Each	DET	O	O
quadrant	ADJ	O	O
was	VERB	O	O
categorized	VERB	O	O
into	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(SRP	PUNCT	O	O
alone;	NOUN	O	O
two	NUM	O	O
quadrants	NOUN	O	O
per	ADP	O	O
patient),	NOUN	O	O
test	NOUN	O	O
group	NOUN	O	O
1	NUM	O	O
(SRP	PUNCT	O	O
+	SYM	O	O
PDT),	NOUN	O	O
and	CCONJ	O	O
test	NOUN	O	O
group	NOUN	O	O
2	NUM	O	O
(SRP	PUNCT	O	O
+	SYM	O	O
LLLT.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/19	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Kinesio	NOUN	O	O
taping	VERB	O	O
on	ADP	O	O
electromyographic	ADJ	O	O
activity	NOUN	O	O
of	ADP	O	O
leg	NOUN	O	O
muscles	NOUN	O	O
during	ADP	O	O
gait	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
developmental	ADJ	O	O
coordination	NOUN	O	O
disorder:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Fluvoxamine	NOUN	O	O
and	CCONJ	O	O
MPH-ER	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
to	PART	O	O
the	DET	O	O
study	NOUN	O	O
group,	NOUN	O	O
while	ADP	O	O
fluvoxamine	NOUN	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
8	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
course.	NOUN	O	O
[	PUNCT	O	O

All	DET	O	O
subjects	NOUN	O	O
(20-45	NOUN	O	O
years	NOUN	O	O
old),	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
frequently	ADV	O	O
referred	VERB	O	O
to	PART	O	O
the	DET	O	O
private	ADJ	O	O
obstetrics	NOUN	O	O
and	CCONJ	O	O
gynecology	NOUN	O	O
clinics,	NOUN	O	O
were	VERB	O	O
initially	ADV	O	O
monitored	VERB	O	O
for	ADP	O	O
PMS	NOUN	O	O
and	CCONJ	O	O
depression.	NOUN	O	O

We	PRON	O	O
analyzed	VERB	O	O
44	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
hypovitaminosis	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
six	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
different	ADJ	O	O
regimens	NOUN	O	O
of	ADP	O	O
administration:	NOUN	O	O
seven	NUM	O	O
drops	NOUN	O	O
(1750	NOUN	O	O
IU)/day	NOUN	O	O
vs.	CCONJ	O	O
50,000	NUM	O	O
IU/month.	NOUN	O	O

No	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
noted	VERB	O	O
between	ADP	O	O
carvedilol	NOUN	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
the	DET	O	O
development	NOUN	O	O
of	ADP	O	O
diastolic	ADJ	O	B-outcome
dysfunction	NOUN	O	I-outcome
,	PUNCT	O	O
clinically	ADV	O	B-outcome
overt	ADJ	O	I-outcome
heart	NOUN	O	I-outcome
failure	NOUN	O	I-outcome
or	CCONJ	O	O
death	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
Carvedilol	NOUN	O	O
might	VERB	O	O
prevent	NOUN	O	O
deterioration	NOUN	O	O
in	ADP	O	O
left	ADV	O	B-outcome
ventricular	ADJ	O	I-outcome
ejection	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
(LVEF)	PUNCT	O	I-outcome
in	ADP	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
doxorubicin.	NOUN	O	O

These	DET	O	O
metabolites	NOUN	O	B-outcome
and	CCONJ	O	O
metabolic	ADJ	O	B-outcome
pathways	NOUN	O	O
represent	NOUN	O	O
an	DET	O	O
acute	ADJ	O	O
response	NOUN	O	O
to	PART	O	O
increased	VERB	O	O
navy	ADJ	O	O
bean	NOUN	O	O
intake,	NOUN	O	O
which	ADP	O	O
merit	NOUN	O	O
further	ADV	O	O
investigation	NOUN	O	O
for	ADP	O	O
improving	VERB	O	O
colonic	ADJ	O	O
health	NOUN	O	O
after	ADP	O	O
long-term	NOUN	O	O
consumption.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101090633	NUM	O	O

Journal-Name:Reproductive	ADJ	O	O
health	NOUN	O	O

At	ADP	O	O
6	NUM	O	O
months,	NOUN	O	O
only	ADV	O	O
one	NUM	O	O
of	ADP	O	O
116	NUM	O	O
patients	NOUN	O	O
(1%)	NOUN	O	O
assigned	VERB	O	O
to	PART	O	O
carvedilol	NOUN	O	O
had	VERB	O	O
an	DET	O	O
left	ADV	O	B-outcome
ventricular	ADJ	O	I-outcome
ejection	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
(LVEF)	PUNCT	O	I-outcome
<50%	PUNCT	O	O
compared	VERB	O	O
to	PART	O	O
four	NUM	O	O
of	ADP	O	O
the	DET	O	O
38	NUM	O	O
assigned	VERB	O	O
to	PART	O	O
placebo	NOUN	O	O
(11%),	NOUN	O	O
(p=0.013).	PUNCT	O	O

The	DET	O	O
incidences	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
pulmonary	ADJ	O	B-outcome
complications	NOUN	O	I-outcome
(PPCs)	PUNCT	O	I-outcome
and	CCONJ	O	O
atelectasis	NOUN	O	O
(2.9%,	NOUN	O	O
0.0%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
AG	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
CG	NOUN	O	O
(20.6%,	NUM	O	O
14.7%)(P=0.03,	NOUN	O	O
P=0.03).	NOUN	O	O

Title:	NOUN	O	O
Does	VERB	O	O
the	DET	O	O
"delayed	PUNCT	O	O
start"	ADJ	O	O
protocol	NOUN	O	O
with	ADP	O	O
gonadotropin-releasing	VERB	O	O
hormone	NOUN	O	O
antagonist	NOUN	O	O
improve	VERB	O	O
the	DET	O	O
pregnancy	NOUN	O	B-outcome
outcome	NOUN	O	O
in	ADP	O	O
Bologna	NOUN	O	O
poor	ADJ	O	O
responders?	NOUN	O	O

Mean	NOUN	O	O
of	ADP	O	O
deformity	NOUN	O	B-outcome
correction	NOUN	O	I-outcome
rate	NOUN	O	O
was	VERB	O	O
91.49+/-10.67%	ADJ	O	O
using	VERB	O	O
CrCo-Ti	NOUN	O	O
rods	NOUN	O	O
versus	CCONJ	O	O
81.86+/-9.88%	NOUN	O	O
using	VERB	O	O
Ti-Ti	NOUN	O	O
rods	NOUN	O	O
(P-value=0.01).	PUNCT	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
National	ADJ	O	O
Institute	NOUN	O	O
for	ADP	O	O
Health	NOUN	O	O
Research	NOUN	O	O
and	CCONJ	O	O
Cancer	NOUN	O	O
Research	NOUN	O	O
UK;	ADJ	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials	NOUN	O	O
number,	ADV	O	O
ISRCTN60477608	ADP	O	O
.).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Total	ADJ	O	O
hip	NOUN	O	O
replacement	NOUN	O	O
(THR)	PUNCT	O	O
is	VERB	O	O
often	ADV	O	O
accompanied	VERB	O	O
by	ADP	O	O
severe	ADJ	O	O
postoperative	ADJ	O	O
pain.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Postprandial	ADJ	O	O
non-esterified	VERB	O	O
fatty	ADJ	O	O
acid	NOUN	O	O
(NEFA)	NUM	O	O
and	CCONJ	O	O
triglyceride	NOUN	O	O
(TG)	NOUN	O	O
responses	NOUN	O	O
are	VERB	O	O
increased	VERB	O	O
in	ADP	O	O
subjects	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
mellitus	NOUN	O	O
(T2DM)	NOUN	O	O
and	CCONJ	O	O
may	VERB	O	O
impair	NOUN	O	O
insulin	NOUN	O	O
action	NOUN	O	O
and	CCONJ	O	O
increase	NOUN	O	O
risk	NOUN	O	O
of	ADP	O	O
cardiovascular	ADJ	O	O
disease	NOUN	O	O
and	CCONJ	O	O
death.	ADP	O	O

Reduction	NOUN	O	O
in	ADP	O	O
radiation	NOUN	O	O
dose	NOUN	O	O
may	VERB	O	O
lead	NOUN	O	O
to	PART	O	O
a	DET	O	O
compromise	VERB	O	O
in	ADP	O	O
quality	NOUN	O	O
of	ADP	O	O
MDCT	NOUN	O	O
images	NOUN	O	O
and	CCONJ	O	O
have	VERB	O	O
chances	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
complications.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Exhaled	VERB	O	B-outcome
CO	NOUN	O	I-outcome
(eCO)	PUNCT	O	I-outcome
measurements	NOUN	O	O
and	CCONJ	O	O
questionnaires	NOUN	O	O
were	VERB	O	O
repeatedly	ADV	O	O
administered	VERB	O	O
throughout	ADV	O	O
the	DET	O	O
session.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
influence	NOUN	O	O
of	ADP	O	O
orlistat	NOUN	O	O
(IO),	PUNCT	O	O
metformin	NOUN	O	O
(IM),	PUNCT	O	O
or	CCONJ	O	O
calorie-restricted	VERB	O	O
diet	NOUN	O	O
(LC)	NOUN	O	O
on	ADP	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
,	PUNCT	O	O
with	ADP	O	O
special	ADJ	O	O
respect	NOUN	O	O
to	PART	O	O
insulin-resistance	NOUN	O	O
status.	NOUN	O	O

Journal-Name:The	ADJ	O	O
British	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
radiology	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
very	ADV	O	O
preterm	NOUN	O	O
or	CCONJ	O	O
very-low-birth-weight	NOUN	O	O
infants	NOUN	O	O
to	PART	O	O
daily	ADJ	O	O
milk	NOUN	O	O
increments	NOUN	O	O
of	ADP	O	O
30	NUM	O	O
ml	NOUN	O	O
per	ADP	O	O
kilogram	NOUN	O	O
of	ADP	O	O
body	NOUN	O	O
weight	NOUN	O	O
(faster	PUNCT	O	O
increment)	NOUN	O	O
or	CCONJ	O	O
18	NUM	O	O
ml	NOUN	O	O
per	ADP	O	O
kilogram	NOUN	O	O
(slower	NUM	O	O
increment)	NOUN	O	O
until	ADP	O	O
reaching	VERB	O	O
full	ADJ	O	O
feeding	VERB	O	O
volumes.	ADP	O	O

Mean	NOUN	O	O
blood	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
(MBP)	PUNCT	O	I-outcome
,	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
SpO2	NOUN	O	B-outcome
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
points	NOUN	O	O
from	ADP	O	O
T6	NOUN	O	O
to	PART	O	O
T10	NOUN	O	O
and	CCONJ	O	O
Observer's	NOUN	O	O
Assessment	NOUN	O	O
of	ADP	O	O
Alertness	ADP	O	B-outcome
/	SYM	O	O
Sedation	NOUN	O	B-outcome
(OAA/S)],	NOUN	O	O
wavelet	NOUN	O	B-outcome
index	NOUN	O	O
[WLi],	NOUN	O	O
anxiety	NOUN	O	B-outcome
index	NOUN	O	O
[ANXi],	NOUN	O	O
comfortable	ADJ	O	B-outcome
index	NOUN	O	O
[CFi],	PUNCT	O	O
and	CCONJ	O	O
pain	NOUN	O	B-outcome
index	NOUN	O	O
[Pi]	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
points	NOUN	O	O
from	ADP	O	O
T6	NOUN	O	O
to	PART	O	O
T11	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
sedation	NOUN	O	O
group	NOUN	O	O
(all	PUNCT	O	O
P	NOUN	O	O
&lt;	NOUN	O	O
0.05),	NUM	O	O
and	CCONJ	O	O
these	DET	O	O
parameters	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
the	DET	O	O
other	ADJ	O	O
time	NOUN	O	O
points	NOUN	O	O
(all	PUNCT	O	O
P&gt;0.05).	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
similarity	NOUN	O	O
of	ADP	O	O
the	DET	O	O
simulators	NOUN	O	O
to	PART	O	O
the	DET	O	O
porcine	ADJ	O	O
larynx	ADJ	O	O
(P	NUM	O	O
=	SYM	O	O
.81).	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101627676	NUM	O	O

RESULTS:	NOUN	O	O
Statistically	ADV	O	O
significant	ADJ	O	O
and	CCONJ	O	O
different	ADJ	O	O
increases	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
group-by-time	NOUN	O	O
interaction	NOUN	O	O
of	ADP	O	O
25(OH)D	NUM	O	O
in	ADP	O	O
VD3G	PUNCT	O	O
in	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
CG	NOUN	O	O
during	ADP	O	O
the	DET	O	O
study	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.001;	NOUN	O	O
VD3G	PUNCT	O	O
(T1:	NUM	O	O
26.24	NUM	O	O
+/-	SYM	O	O
8.18	NUM	O	O
ng/mL	NOUN	O	O
vs.	CCONJ	O	O
T2:	NOUN	O	O
48.12	NUM	O	O
+/-	SYM	O	O
10.88	NUM	O	O
ng/mL)	NOUN	O	O
vs	CCONJ	O	O
CG	NOUN	O	O
(T1:	NUM	O	O
30.76	NUM	O	O
+/-	SYM	O	O
6.95	NUM	O	O
ng/mL	NOUN	O	O
vs.	CCONJ	O	O
T2:	NOUN	O	O
35.14	NUM	O	O
+/-	SYM	O	O
7.96	NUM	O	O
ng/mL).	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
single-center	NOUN	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
at	ADP	O	O
the	DET	O	O
Medical	ADJ	O	O
Department	NOUN	O	O
of	ADP	O	O
University	NOUN	O	O
Hospital	NOUN	O	O
Dubrava,	NOUN	O	O
Zagreb,	ADJ	O	O
between	ADP	O	O
April	NOUN	O	O
and	CCONJ	O	O
June	NOUN	O	O
2018.	NUM	O	O

Digestibility	NOUN	O	O
of	ADP	O	O
energy,	NOUN	O	O
fat,	ADP	O	O
protein,	NOUN	O	O
and	CCONJ	O	O
carbohydrate	NOUN	O	O
was	VERB	O	O
lower	ADJ	O	O
for	ADP	O	O
the	DET	O	O
cashew-containing	VERB	O	O
diet	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
diet	NOUN	O	O
(92.9%	NOUN	O	O
vs.	CCONJ	O	O
94.9%,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.0001	NUM	O	O
for	ADP	O	O
energy;	ADP	O	O
96.1%	NOUN	O	O
vs.	CCONJ	O	O
97.8%,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.0009	NUM	O	O
for	ADP	O	O
fat;	NOUN	O	O
90.1%	NOUN	O	O
vs.	CCONJ	O	O
91.2%,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.0012	NUM	O	O
for	ADP	O	O
protein;	NOUN	O	O
92.9%	ADJ	O	O
vs.	CCONJ	O	O
94.9%,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.0001	NUM	O	O
for	ADP	O	O
carbohydrate;	NOUN	O	O
for	ADP	O	O
the	DET	O	O
cashew-containing	VERB	O	O
diet	NOUN	O	O
vs.	CCONJ	O	O
the	DET	O	O
control	NOUN	O	O
diet,	ADV	O	O
respectively).	NOUN	O	O

Within	ADP	O	O
7	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
surgery	NOUN	O	O
(or,	NOUN	O	O
if	ADP	O	O
the	DET	O	O
infection	NOUN	O	O
was	VERB	O	O
being	VERB	O	O
managed	VERB	O	O
without	ADP	O	O
surgery,	NOUN	O	O
within	ADP	O	O
7	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
antibiotic	ADJ	O	O
treatment),	NOUN	O	O
participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
intravenous	ADJ	O	O
or	CCONJ	O	O
oral	ADJ	O	O
antibiotics	NOUN	O	O
to	PART	O	O
complete	ADJ	O	O
the	DET	O	O
first	ADV	O	O
6	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
therapy.	NOUN	O	O

High	ADJ	O	O
adherence	NOUN	O	O
was	VERB	O	O
defined	VERB	O	O
as	ADP	O	O
complying	VERB	O	O
with	ADP	O	O
5(-)6	NOUN	O	O
targets;	NOUN	O	O
moderate	ADJ	O	O
adherence	NOUN	O	O
2(-)4	NOUN	O	O
targets;	NOUN	O	O
low	ADJ	O	O
adherence	NOUN	O	O
0(-)1	ADP	O	O
targets.	NOUN	O	O

The	DET	O	O
pancreaticoduodectomy	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
68	NUM	O	O
per	ADP	O	O
cent,	ADJ	O	O
whereas	ADP	O	O
27	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
of	ADP	O	O
patients	NOUN	O	O
underwent	VERB	O	O
distal	ADJ	O	B-outcome
or	CCONJ	O	Seperator
subtotal	ADJ	O	I-outcome
pancreatectomy	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
4	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
total	ADJ	O	O
pancreatectomy	NOUN	O	B-outcome
.	PUNCT	O	O
Incisional	ADJ	O	B-outcome
hernia	NOUN	O	I-outcome
rates	NOUN	O	O
were	VERB	O	O
32	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
and	CCONJ	O	O
14	NUM	O	O
per	ADP	O	O
cent	NUM	O	O
between	ADP	O	O
the	DET	O	O
SSD	NOUN	O	O
and	CCONJ	O	O
NPWT	NOUN	O	O
groups,	NOUN	O	O
respectively	ADV	O	O
(P	NUM	O	O
=	SYM	O	O
0.067).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Further	ADV	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
causes	NOUN	O	O
of	ADP	O	O
this	DET	O	O
asymmetry	NOUN	O	O
may	VERB	O	O
lead	NOUN	O	O
to	PART	O	O
more	ADV	O	O
accurate	ADJ	O	O
treatment	NOUN	O	O
of	ADP	O	O
PFM	NOUN	O	O
dysfunctions.	NOUN	O	O

Undesirable	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
137	NUM	O	O
patients	NOUN	O	O
(22.3%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
guided	VERB	O	O
and	CCONJ	O	O
95	NUM	O	O
(15.4%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/02	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Necrotizing	VERB	O	B-outcome
enterocolitis	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
70	NUM	O	O
of	ADP	O	O
1394	NUM	O	O
infants	NOUN	O	O
(5.0%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
faster-increment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
78	NUM	O	O
of	ADP	O	O
1399	NUM	O	O
(5.6%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
slower-increment	ADJ	O	O
group	NOUN	O	O
(adjusted	PUNCT	O	O
risk	NOUN	O	O
ratio,	NOUN	O	O
0.88;	NUM	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.68	NUM	O	O
to	PART	O	O
1.16).	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
delayed-start	NOUN	O	O
GnRH	NOUN	O	O
antagonist	NOUN	O	O
protocol	NOUN	O	O
and	CCONJ	O	O
standard	ADJ	O	O
GnRH	NOUN	O	O
antagonist	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
poor	ADJ	O	O
ovarian	ADJ	O	O
response	NOUN	O	O
(POR)	NOUN	O	O
undergoing	VERB	O	O
in	ADP	O	O
vitro	ADV	O	O
fertilization	NOUN	O	O
(IVF)/	NOUN	O	O
intracytoplasmic	ADJ	O	O
sperm	NOUN	O	O
injection	NOUN	O	O
(ICSI).	NUM	O	O

The	DET	O	O
range	NOUN	O	B-outcome
of	ADP	O	I-outcome
motion	NOUN	O	I-outcome
,	PUNCT	O	O
functional	ADJ	O	B-outcome
score	NOUN	O	O
(	NOUN	O	O
Harris	NOUN	O	O
score]),	ADJ	O	O
visual	ADJ	O	O
analogue	NOUN	O	O
scale	NOUN	O	O
(VAS)	PUNCT	O	O
score,	NOUN	O	O
and	CCONJ	O	O
prosthesis	NOUN	O	B-outcome
position	NOUN	O	I-outcome
were	VERB	O	O
recorded.	NOUN	O	O

We	PRON	O	O
will	VERB	O	O
also	ADV	O	O
assess	NOUN	O	O
teachers'	ADV	O	O
autonomy-supportive	ADJ	O	B-outcome
techniques	NOUN	O	I-outcome
and	CCONJ	O	Seperator
behaviours	NOUN	O	S1-outcome
by	ADP	O	O
observation.	ADV	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
prospective	ADJ	O	O
study,	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
intractable	ADJ	O	O
DED	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
a	DET	O	O
BTX-A	NOUN	O	O
(group	PUNCT	O	O
A)	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(group	PUNCT	O	O
B).	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

Therefore,	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
natural	ADJ	O	O
herbal	ADJ	O	O
medicine,	ADJ	O	O
non-synthetic	ADJ	O	O
drug,	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
primary	ADJ	O	B-outcome
dysmenorrhea	ADJ	O	I-outcome
is	VERB	O	O
recommended.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
application	NOUN	O	O
of	ADP	O	O
KT	NOUN	O	O
on	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
DCD	NOUN	O	O
had	VERB	O	O
an	DET	O	O
increased	VERB	O	O
gastrocnemius	NOUN	O	B-outcome
medialis	NOUN	O	I-outcome
muscle	NOUN	O	I-outcome
activation	NOUN	O	I-outcome
during	ADP	O	O
stance	NOUN	O	O
phase.	NOUN	O	O

Mixed	VERB	O	O
model	NOUN	O	O
ANOVAs	NOUN	O	O
and	CCONJ	O	O
ANCOVAs	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
statistically	ADV	O	O
analyze	NOUN	O	O
the	DET	O	O
dependent	ADJ	O	O
variables	NOUN	O	O
for	ADP	O	O
the	DET	O	O
total	ADJ	O	O
groups	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
21	NUM	O	O
per	ADP	O	O
group)	ADJ	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
dichotomized	VERB	O	O
groups.	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
assessed	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
ultrasound-guided	VERB	O	O
pulsed	VERB	O	O
radiofrequency	NOUN	O	O
(UGPRF)	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
frozen	NOUN	O	O
shoulder	NOUN	O	O
(FS).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
definitive	ADJ	O	O
treatment	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
within	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
after	ADP	O	O
randomization.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Title:	NOUN	O	O
Announcing	VERB	O	O
the	DET	O	O
availability	NOUN	O	O
of	ADP	O	O
oral	ADJ	O	O
HIV	NOUN	O	O
self-test	NOUN	O	O
kits	NOUN	O	O
via	ADP	O	O
text	VERB	O	O
message	NOUN	O	O
to	PART	O	O
increase	NOUN	O	O
HIV	NOUN	O	O
testing	VERB	O	O
among	ADP	O	O
hard-to-reach	ADJ	O	O
truckers	NOUN	O	O
in	ADP	O	O
Kenya:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Each	DET	O	O
diet	NOUN	O	O
was	VERB	O	O
consumed	VERB	O	O
on	ADP	O	O
two	NUM	O	O
consecutive	ADJ	O	O
days,	NOUN	O	O
separated	VERB	O	O
by	ADP	O	O
a	DET	O	O
wash-out	ADP	O	O
period.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
intraoperatively	ADV	O	O
randomly	ADV	O	O
assigned	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
newly	ADV	O	O
diagnosed	VERB	O	O
advanced	VERB	O	O
ovarian	ADJ	O	O
cancer	NOUN	O	O
(International	ADJ	O	O
Federation	NOUN	O	O
of	ADP	O	O
Gynecology	NOUN	O	O
and	CCONJ	O	O
Obstetrics	NOUN	O	O
stage	NOUN	O	O
IIB	NOUN	O	O
through	ADP	O	O
IV)	NUM	O	O
who	ADP	O	O
had	VERB	O	O
undergone	VERB	O	O
macroscopically	ADV	O	O
complete	ADJ	O	O
resection	NOUN	O	O
and	CCONJ	O	O
had	VERB	O	O
normal	ADJ	O	O
lymph	NOUN	O	O
nodes	NOUN	O	O
both	CCONJ	O	O
before	ADP	O	O
and	CCONJ	O	O
during	ADP	O	O
surgery	NOUN	O	O
to	PART	O	O
either	CCONJ	O	O
undergo	NOUN	O	O
or	CCONJ	O	O
not	ADV	O	O
undergo	NOUN	O	O
lymphadenectomy.	NOUN	O	O

Exposure	NOUN	O	O
to	PART	O	O
sponsorship	NOUN	O	O
for	ADP	O	O
healthier	ADJ	O	O
foods	NOUN	O	O
produced	VERB	O	O
similar	ADJ	O	O
sponsorship	NOUN	O	O
effects	NOUN	O	O
for	ADP	O	O
healthier	ADJ	O	O
food	NOUN	O	O
sponsor	ADP	O	O
brands,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
prompting	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
the	DET	O	O
proportion	NOUN	O	O
of	ADP	O	O
young	ADJ	O	O
adults	NOUN	O	O
showing	VERB	O	O
a	DET	O	O
preference	NOUN	O	B-outcome
for	ADP	O	O
these	DET	O	O
products.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
cyclophosphamide	NOUN	O	O
750	NUM	O	O
mg/m(2)	NOUN	O	O
and	CCONJ	O	O
doxorubicin	NOUN	O	O
50	NUM	O	O
mg/m(2)	NOUN	O	O
on	ADP	O	O
day	NOUN	O	O
1	NUM	O	O
of	ADP	O	O
each	DET	O	O
cycle	NOUN	O	O
intravenously	ADV	O	O
and	CCONJ	O	O
prednisone	ADJ	O	O
100	NUM	O	O
mg	NOUN	O	O
once	ADP	O	O
daily	ADJ	O	O
on	ADP	O	O
days	NOUN	O	O
1	NUM	O	O
to	PART	O	O
5	NUM	O	O
of	ADP	O	O
each	DET	O	O
cycle	NOUN	O	O
orally,	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
either	CCONJ	O	O
brentuximab	NOUN	O	O
vedotin	NOUN	O	O
1.8	NUM	O	O
mg/kg	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
placebo	NOUN	O	O
form	NOUN	O	O
of	ADP	O	O
vincristine	ADV	O	O
intravenously	ADV	O	O
(A+CHP	PUNCT	O	O
group)	ADJ	O	O
or	CCONJ	O	O
vincristine	ADV	O	O
1.4	NUM	O	O
mg/m(2)	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
placebo	NOUN	O	O
form	NOUN	O	O
of	ADP	O	O
brentuximab	NOUN	O	O
vedotin	NOUN	O	O
intravenously	ADV	O	O
(CHOP	PUNCT	O	O
group)	ADJ	O	O
on	ADP	O	O
day	NOUN	O	O
1	NUM	O	O
of	ADP	O	O
each	DET	O	O
cycle.	NOUN	O	O

PMID:	NOUN	O	O
31597806	NUM	O	O

BACKGROUD:	NOUN	O	O
The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
trigger	ADP	O	O
point	NOUN	O	O
injection	NOUN	O	O
(TPI)	NOUN	O	O
and	CCONJ	O	O
eutectic	ADJ	O	O
mixture	NOUN	O	O
local	ADJ	O	O
anesthetics	NOUN	O	O
(EMLA)	NUM	O	O
cream	NOUN	O	O
on	ADP	O	O
the	DET	O	O
postoperative	ADJ	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
total	ADJ	O	O
laparoscopic	ADJ	O	O
hysterectomy.	NOUN	O	O

The	DET	O	O
new	ADJ	O	O
lotion	NOUN	O	O
formulation	NOUN	O	O
was	VERB	O	O
well-	NOUN	O	B-outcome
tolerated	VERB	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
all	DET	O	O
treatment-related	VERB	O	B-outcome
AEs	NOUN	O	I-outcome
were	VERB	O	O
both	CCONJ	O	O
mild	ADJ	O	O
and	CCONJ	O	O
transient	ADJ	O	O
in	ADP	O	O
nature.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Few	ADJ	O	O
patients	NOUN	O	O
maintained	VERB	O	O
>/=75%	NUM	O	O
response	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
Treatment	NOUN	O	O
with	ADP	O	O
galcanezumab	NOUN	O	O
120	NUM	O	O
mg	NOUN	O	O
or	CCONJ	O	O
240	NUM	O	O
mg	NOUN	O	O
demonstrated	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
and	CCONJ	O	O
clinically	ADV	O	O
meaningful	ADJ	O	O
persistence	NOUN	O	O
of	ADP	O	O
effect	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
episodic	NOUN	O	O
migraine	NOUN	O	O
(>/=3	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
consecutive	ADJ	O	O
months)	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
migraine	NOUN	O	O
(for	PUNCT	O	O
3	NUM	O	O
months).	NOUN	O	O

Furthermore,	NOUN	O	O
no	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
related	VERB	O	O
to	PART	O	O
NES	NOUN	O	O
treatment	NOUN	O	O
were	VERB	O	O
detected.	NOUN	O	O

From	ADP	O	O
January	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
June	NOUN	O	O
2017,	NUM	O	O
42	NUM	O	O
children	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
to	PART	O	O
severe	ADJ	O	O
HIE	NOUN	O	O
in	ADP	O	O
the	DET	O	O
neonatal	ADJ	O	O
intensive	ADJ	O	O
care	NOUN	O	O
unit	NOUN	O	O
(NICU)	NUM	O	O
of	ADP	O	O
the	DET	O	O
First	ADV	O	O
Affiliated	VERB	O	O
Hospital	NOUN	O	O
of	ADP	O	O
Bengbu	NOUN	O	O
Medical	ADJ	O	O
College	NOUN	O	O
were	VERB	O	O
enrolled,	NOUN	O	O
and	CCONJ	O	O
they	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
after	ADP	O	O
obtaining	VERB	O	O
the	DET	O	O
consent	NOUN	O	O
of	ADP	O	O
the	DET	O	O
guardian	ADJ	O	O
of	ADP	O	O
the	DET	O	O
children.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Intraoperative	ADJ	O	O
propofol	NOUN	O	O
sedation	NOUN	O	O
can	VERB	O	O
alleviate	NOUN	O	O
the	DET	O	O
patients'	NOUN	O	O
anxiety	NOUN	O	B-outcome
,	PUNCT	O	O
improve	VERB	O	O
the	DET	O	O
comfort	NOUN	O	B-outcome
level,	NOUN	O	O
and	CCONJ	O	O
lessen	NOUN	O	O
physiological	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
during	ADP	O	O
surgeries	NOUN	O	O
under	ADP	O	O
epidural	ADJ	O	O
anesthesia.	NOUN	O	O

However,	ADV	O	O
limited	VERB	O	O
studies	NOUN	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
association	NOUN	O	O
of	ADP	O	O
health	NOUN	O	O
education	NOUN	O	O
via	ADP	O	O
Wechat	ADP	O	O
platform	NOUN	O	O
on	ADP	O	O
increased	VERB	O	O
the	DET	O	O
basic	ADJ	O	O
self-care	NOUN	O	O
skills	NOUN	O	O
and	CCONJ	O	O
glycemic	ADJ	O	O
control	NOUN	O	O
rate	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes.	NOUN	O	O

The	DET	O	O
response	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
18%.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
suggested	VERB	O	O
that	ADP	O	O
normal	ADJ	O	O
recommended	VERB	O	O
dosages	NOUN	O	O
of	ADP	O	O
100	NUM	O	O
mg	NOUN	O	O
CA	NOUN	O	O
+	SYM	O	O
100	NUM	O	O
mg	NOUN	O	O
C	NOUN	O	O
is	VERB	O	O
sufficient	ADJ	O	O
to	PART	O	O
promote	VERB	O	O
glucose	NOUN	O	B-outcome
sparing	VERB	O	O
at	ADP	O	O
rest,	NOUN	O	O
with	ADP	O	O
modest	ADJ	O	O
increases	NOUN	O	O
in	ADP	O	O
SNS	NOUN	O	B-outcome
activity	NOUN	O	I-outcome
;	PUNCT	O	O
however,	ADV	O	O
the	DET	O	O
individual	ADJ	O	O
role	NOUN	O	O
of	ADP	O	O
CA	NOUN	O	O
or	CCONJ	O	O
C	NOUN	O	O
in	ADP	O	O
this	DET	O	O
response	NOUN	O	O
can	AUX	O	O
not	ADV	O	O
be	VERB	O	O
determined.	NOUN	O	O

CONCLUSION:	NOUN	O	O
BTX-A	NOUN	O	O
injection	NOUN	O	O
into	ADP	O	O
the	DET	O	O
medial	ADJ	O	O
part	NOUN	O	O
of	ADP	O	O
eyelid	NOUN	O	O
improves	NOUN	O	O
dry	ADJ	O	B-outcome
eye	NOUN	O	I-outcome
signs	NOUN	O	I-outcome
and	CCONJ	O	Seperator
symptoms	NOUN	O	S2-outcome
and	CCONJ	O	O
reduces	NOUN	O	O
tear	NUM	O	O
cytokine	NOUN	O	B-outcome
levels.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Title:	NOUN	O	O
Effects	NOUN	O	O
of	ADP	O	O
selenium	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
pregnancy	NOUN	O	B-outcome
outcome	NOUN	O	I-outcome
and	CCONJ	O	O
disease	NOUN	O	B-outcome
progression	NOUN	O	I-outcome
in	ADP	O	O
HIV-infected	VERB	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
in	ADP	O	O
Lagos,	NOUN	O	O
Nigeria:	NOUN	O	O
Study	NOUN	O	O
protocol	NOUN	O	O
for	ADP	O	O
a	DET	O	O
randomised,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
trial.	NOUN	O	O

A	DET	O	O
2015	NUM	O	O
review.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Title:	NOUN	O	O
The	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
Shilajit	ADJ	O	O
supplementation	NOUN	O	O
on	ADP	O	O
fatigue-induced	VERB	O	O
decreases	NOUN	O	O
in	ADP	O	O
muscular	ADJ	O	B-outcome
strength	NOUN	O	I-outcome
and	CCONJ	O	O
serum	NOUN	O	O
hydroxyproline	NOUN	O	B-outcome
levels.	NOUN	O	O

County	NOUN	O	O
hospital-based	VERB	O	O
vision	NOUN	O	O
centers	NOUN	O	O
appear	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
delivering	VERB	O	O
childrens'	NOUN	O	O
glasses	NOUN	O	O
in	ADP	O	O
rural	ADJ	O	O
China.	NOUN	O	O

We	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
on	ADP	O	O
ADHD	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
self-report	NOUN	O	O
on	ADP	O	O
the	DET	O	O
Behavior	NOUN	O	O
Rating	VERB	O	O
Inventory	ADJ	O	O
of	ADP	O	O
Executive	NOUN	O	B-outcome
Function	NOUN	O	I-outcome
of	ADP	O	O
executive	ADJ	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
methylphenidate	NOUN	O	B-outcome
dosing	VERB	O	I-outcome
,	PUNCT	O	O
neuropsychological	ADJ	O	B-outcome
test	NOUN	O	O
measures,	NOUN	O	O
the	DET	O	O
Adult	NOUN	O	O
ADHD	NOUN	O	B-outcome
Self-report	NOUN	O	O
scale],	NUM	O	O
emotional	ADJ	O	B-outcome
dysregulation	NOUN	O	I-outcome
,	PUNCT	O	O
social	ADJ	O	B-outcome
adjustment	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
work	NOUN	O	B-outcome
productivity	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
moderating	VERB	O	O
effects	NOUN	O	O
of	ADP	O	O
body	NOUN	O	O
mass	NOUN	O	O
index,	NOUN	O	O
autoantibodies	NOUN	O	O
to	PART	O	O
folate	NOUN	O	O
receptors,	NOUN	O	O
and	CCONJ	O	O
select	NOUN	O	O
genetic	ADJ	O	O
polymorphisms.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
AGS	NOUN	O	O
group,	NOUN	O	O
allogeneic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
was	VERB	O	O
infused	VERB	O	O
in	ADP	O	O
1	NUM	O	O
case	NOUN	O	O
during	ADP	O	O
operation,	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
allogeneic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
was	VERB	O	O
infused	VERB	O	O
in	ADP	O	O
the	DET	O	O
other	ADJ	O	O
patients.	NOUN	O	O

Balozis	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
arms.	ADJ	O	O

Electronic	ADJ	O	O
address:	NOUN	O	O
cedar@stanford.edu.	VERB	O	O

P	NOUN	O	O
<.05)	NOUN	O	O
CONCLUSIONS::	NOUN	O	O
A	DET	O	O
single	ADJ	O	O
bolus	NOUN	O	O
injection	NOUN	O	O
of	ADP	O	O
oxycodone	NOUN	O	O
is	VERB	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
of	ADP	O	O
fentanyl	NOUN	O	O
in	ADP	O	O
the	DET	O	O
acute	ADJ	O	O
phase	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
after	ADP	O	O
THR.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/21	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Additional	ADJ	O	O
implications	NOUN	O	O
and	CCONJ	O	O
limitations	NOUN	O	O
are	VERB	O	O
discussed.	NOUN	O	O

Significance	ADV	O	O
testing	VERB	O	O
for	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
based	VERB	O	O
on	ADP	O	O
1-sided	VERB	O	O
testing.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/07/06	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
TENS	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
LBP	NOUN	O	O
when	ADP	O	O
associated	VERB	O	O
to	PART	O	O
a	DET	O	O
therapeutic	ADJ	O	O
education	NOUN	O	O
program	NOUN	O	O
(TEP).	PUNCT	O	O

Child	NOUN	O	O
engagement:	NOUN	O	O
enjoyment	ADJ	O	O
and	CCONJ	O	O
positive	ADJ	O	O
behaviour.	NOUN	O	O

To	PART	O	O
address	NOUN	O	O
these	DET	O	O
lacunas,	NOUN	O	O
a	DET	O	O
training	VERB	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
Mental	ADJ	O	O
Health	NOUN	O	O
Gap	NOUN	O	O
Action	NOUN	O	O
Programme	NOUN	O	O
(mhGAP)	NOUN	O	O
Intervention	NOUN	O	O
Guide	NOUN	O	O
(IG)	NOUN	O	O
was	VERB	O	O
offered	VERB	O	O
to	PART	O	O
PCPs	NOUN	O	O
working	VERB	O	O
in	ADP	O	O
the	DET	O	O
Greater	ADJ	O	O
Tunis	NOUN	O	O
area	NOUN	O	O
between	ADP	O	O
February	ADJ	O	O
and	CCONJ	O	O
April	NOUN	O	O
2016.	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Rigid	ADV	O	O
or	CCONJ	O	O
Kinesio	NOUN	O	O
taping	VERB	O	O
of	ADP	O	O
the	DET	O	O
shoulder	NOUN	O	O
and	CCONJ	O	O
scapular	ADJ	O	O
region	NOUN	O	O
improved	VERB	O	O
scapular	ADJ	O	B-outcome
dyskinesis	NOUN	O	I-outcome
and	CCONJ	O	O
pectoralis	NOUN	O	B-outcome
minor	ADJ	O	I-outcome
length	NOUN	O	I-outcome
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
alter	NOUN	O	O
scapular	ADJ	O	B-outcome
upward	ADJ	O	I-outcome
rotation	NOUN	O	I-outcome
.	PUNCT	O	O
Short-term	NOUN	O	O
rigid	NOUN	O	O
and	CCONJ	O	O
Kinesio	NOUN	O	O
taping	VERB	O	O
may	VERB	O	O
help	VERB	O	O
improve	VERB	O	O
scapular	ADJ	O	B-outcome
dyskinesis	NOUN	O	I-outcome
and	CCONJ	O	O
pectoralis	NOUN	O	B-outcome
minor	ADJ	O	I-outcome
length	NOUN	O	I-outcome
in	ADP	O	O
overhead	ADP	O	O
athletes.	ADV	O	O

T	NOUN	O	O
test	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
differences	NOUN	O	O
between	ADP	O	O
two	NUM	O	O
groups,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
results	NOUN	O	O
were	VERB	O	O
corrected	VERB	O	O
using	VERB	O	O
Bonferroni	NOUN	O	O
method.	NOUN	O	O

After	ADP	O	O
interventions,	NOUN	O	O
the	DET	O	O
exercise	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
lower	ADJ	O	O
percentage	NOUN	O	O
body	NOUN	O	B-outcome
fat	NOUN	O	I-outcome
(%BF)	ADV	O	O
and	CCONJ	O	O
cardiometabolic	ADJ	O	B-outcome
risk	NOUN	O	O
markers,	NOUN	O	O
and	CCONJ	O	O
higher	ADJ	O	O
lean	ADJ	O	B-outcome
body	NOUN	O	I-outcome
mass	NOUN	O	I-outcome
(LM)	NUM	O	I-outcome
and	CCONJ	O	O
leg	NOUN	O	B-outcome
muscle	NOUN	O	I-outcome
strength	NOUN	O	I-outcome
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

We	PRON	O	O
used	VERB	O	O
fuzzy-set	ADP	O	O
qualitative	ADJ	O	O
comparative	ADJ	O	O
analysis	NOUN	O	O
(fsQCA)	PUNCT	O	O
to	PART	O	O
identify	NOUN	O	O
combinations	NOUN	O	O
of	ADP	O	O
conditions	NOUN	O	O
that	ADP	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
either	CCONJ	O	O
an	DET	O	O
increase	NOUN	O	O
or	CCONJ	O	O
no	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
the	DET	O	O
outcome	NOUN	O	O
emotional	ADJ	O	B-outcome
and	CCONJ	O	Seperator
social	ADJ	O	I-outcome
school	NOUN	O	I-outcome
experience	NOUN	O	I-outcome
(SCE)	PUNCT	O	I-outcome
in	ADP	O	O
comparison	NOUN	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
20	NUM	O	O
months	NOUN	O	O
post	ADV	O	O
intervention.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
Data	NOUN	O	O
regarding	VERB	O	O
efficacy	NOUN	O	O
comparison	NOUN	O	O
of	ADP	O	O
daily	ADJ	O	O
regimen	NOUN	O	O
(DR)	NOUN	O	O
versus	CCONJ	O	O
every	DET	O	O
other	ADJ	O	O
day	NOUN	O	O
regimen	NOUN	O	O
(EODR)	NUM	O	O
atorvastatin	NOUN	O	O
therapy	NOUN	O	O
is	VERB	O	O
not	ADV	O	O
validated	VERB	O	O
by	ADP	O	O
estimation	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
hydroxymethylglutaryl-CoA	NOUN	O	O
reductase	NOUN	O	O
(HMGCR)	PUNCT	O	O
levels	NOUN	O	O
and	CCONJ	O	O
HMGCR	ADV	O	O
correlation	NOUN	O	O
with	ADP	O	O
lipid	NOUN	O	O
indices.	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
employed	VERB	O	O
a	DET	O	O
prospective,	NOUN	O	O
randomized	VERB	O	O
study	NOUN	O	O
design	NOUN	O	O
to	PART	O	O
assess	NOUN	O	O
student's	NUM	O	O
learning	VERB	O	B-outcome
curve.	ADJ	O	O

Title:	NOUN	O	O
Oral	ADJ	O	O
ixazomib	NOUN	O	O
maintenance	NOUN	O	O
following	VERB	O	O
autologous	ADJ	O	O
stem	NOUN	O	O
cell	NOUN	O	O
transplantation	NOUN	O	O
(TOURMALINE-MM3):	NUM	O	O
a	DET	O	O
double-blind,	NOUN	O	O
randomised,	NOUN	O	O
placebo-controlled	VERB	O	O
phase	NOUN	O	O
3	NUM	O	O
trial.	NOUN	O	O

Here,	NOUN	O	O
we	PRON	O	O
describe	NOUN	O	O
a	DET	O	O
simple	NOUN	O	O
method	NOUN	O	O
for	ADP	O	O
creating	VERB	O	O
a	DET	O	O
cervical	ADJ	O	O
spine	NOUN	O	O
phantom	NOUN	O	O
and	CCONJ	O	O
investigate	NOUN	O	O
whether	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
a	DET	O	O
gelatin-based	VERB	O	O
phantom	NOUN	O	O
is	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
improved	VERB	O	O
proficiency	NOUN	O	B-outcome
in	ADP	O	O
performing	VERB	O	O
ultrasound-guided	VERB	O	O
cervical	ADJ	O	O
medial	ADJ	O	O
branch	NOUN	O	O
block.	NOUN	O	O

In	ADP	O	O
contrast,	NOUN	O	O
all	DET	O	O
active	ADJ	O	O
interventions	NOUN	O	O
in	ADP	O	O
Studies	NOUN	O	O
1	NUM	O	O
and	CCONJ	O	O
2	NUM	O	O
decreased	VERB	O	O
negative	ADJ	O	B-outcome
affect	NOUN	O	I-outcome
.	PUNCT	O	O
These	DET	O	O
studies	NOUN	O	O
provide	VERB	O	O
the	DET	O	O
first	ADV	O	O
experimental	ADJ	O	O
evidence	NOUN	O	O
that	ADP	O	O
developing	VERB	O	O
an	DET	O	O
orientation	NOUN	O	O
of	ADP	O	O
acceptance	NOUN	O	O
toward	ADP	O	O
present-moment	ADJ	O	O
experiences	NOUN	O	O
is	VERB	O	O
a	DET	O	O
central	ADJ	O	O
mechanism	NOUN	O	O
of	ADP	O	O
mindfulness	ADV	O	O
interventions	NOUN	O	O
for	ADP	O	O
boosting	VERB	O	O
positive	ADJ	O	B-outcome
emotions	NOUN	O	I-outcome
in	ADP	O	O
daily	ADJ	O	O
life.	NOUN	O	O
(	PUNCT	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
21	NUM	O	O
patients	NOUN	O	O
(10.9%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
bag-mask	ADJ	O	O
ventilation	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
severe	ADJ	O	B-outcome
hypoxemia	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
45	NUM	O	O
patients	NOUN	O	O
(22.8%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
no-ventilation	NOUN	O	O
group	NOUN	O	O
(relative	ADJ	O	O
risk,	NOUN	O	O
0.48;	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.30	NUM	O	O
to	PART	O	O
0.77).	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint,	VERB	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
according	ADJ	O	O
to	PART	O	O
blinded	VERB	O	O
independent	ADJ	O	O
central	ADJ	O	O
review,	ADJ	O	O
was	VERB	O	O
analysed	VERB	O	O
by	ADP	O	O
intent-to-treat.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

In	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group,	NOUN	O	O
1	NUM	O	O
case	NOUN	O	O
had	VERB	O	O
incision	NOUN	O	B-outcome
fat	NOUN	O	I-outcome
liquefaction	NOUN	O	I-outcome
and	CCONJ	O	O
4	NUM	O	O
cases	NOUN	O	O
had	VERB	O	O
bone	NOUN	O	B-outcome
cement	NOUN	O	I-outcome
leakage	NOUN	O	I-outcome
;	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
2	NUM	O	O
cases	NOUN	O	O
had	VERB	O	O
screw	NOUN	O	B-outcome
loosening	VERB	O	I-outcome
and	CCONJ	O	O
1	NUM	O	O
case	NOUN	O	O
had	VERB	O	O
unilateral	ADJ	O	O
connecting	VERB	O	O
rod	NOUN	O	B-outcome
rupture	NOUN	O	I-outcome
;	PUNCT	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
complications	NOUN	O	B-outcome
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
chi	NOUN	O	O
(2)=0.504,	ADV	O	O
P=0.478).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/28	NUM	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
Acute	ADJ	O	O
Effect	NOUN	O	O
of	ADP	O	O
Resistant	ADJ	O	O
Starch	NOUN	O	O
on	ADP	O	O
Food	NOUN	O	B-outcome
Intake	NOUN	O	I-outcome
,	PUNCT	O	O
Appetite	ADV	O	B-outcome
and	CCONJ	O	O
Satiety	NOUN	O	B-outcome
in	ADP	O	O
Overweight/Obese	NOUN	O	O
Males.	NOUN	O	O

All	DET	O	O
the	DET	O	O
included	VERB	O	O
patients	NOUN	O	O
were	VERB	O	O
equally	ADV	O	O
and	CCONJ	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
a	DET	O	O
verum	NOUN	O	O
TENS	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
sham	NOUN	O	O
TENS	NOUN	O	O
group,	NOUN	O	O
each	DET	O	O
group	NOUN	O	O
23	NUM	O	O
participants.	NOUN	O	O

Efficacy	NOUN	O	O
assessments	NOUN	O	O
using	VERB	O	O
the	DET	O	O
validated	VERB	O	O
IGAxBSA	NOUN	O	O
composite	NOUN	O	O
tool.	NOUN	O	O

Diagnostic	ADJ	O	O
criteria	NOUN	O	O
for	ADP	O	O
the	DET	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
RA	NOUN	O	O
were	VERB	O	O
all	DET	O	O
patients	NOUN	O	O
with	ADP	O	O
RA	NOUN	O	O
who	ADP	O	O
visited	VERB	O	O
the	DET	O	O
clinic	ADJ	O	O
of	ADP	O	O
Jam	NOUN	O	O
Rheumatology	NOUN	O	O
Centers	NOUN	O	O
and	CCONJ	O	O
met	VERB	O	O
other	ADJ	O	O
inclusion	NOUN	O	O
criteria	NOUN	O	O
in	ADP	O	O
Mashhad	ADJ	O	O
in	ADP	O	O
the	DET	O	O
spring	VERB	O	O
of	ADP	O	O
2018.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Baseline	NOUN	O	O
characteristics	NOUN	O	O
were	VERB	O	O
detectable	ADJ	O	O
viral	ADJ	O	O
loads	NOUN	O	O
(median	PUNCT	O	O
7897	NUM	O	O
copies/mL),	NOUN	O	O
low	ADJ	O	O
CD4(+)	NOUN	O	O
(median	PUNCT	O	O
410	NUM	O	O
cells/microL),	NOUN	O	O
and	CCONJ	O	O
elevated	VERB	O	O
CD8(+)	NOUN	O	O
(median	PUNCT	O	O
930	NUM	O	O
cells/microL)	NOUN	O	O
T	NOUN	O	O
cell	NOUN	O	O
counts.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
baseline	NOUN	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
outcome	NOUN	O	O
of	ADP	O	O
ovarian	ADJ	O	O
stimulation	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
metabolizable	ADJ	O	O
energy	NOUN	O	O
in	ADP	O	O
cashew	NOUN	O	O
nuts.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0421110	NUM	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
on	ADP	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
tranexamic	ADJ	O	O
acid	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
rivaroxaban	ADJ	O	O
thromboprophylaxis	NOUN	O	O
in	ADP	O	O
reducing	VERB	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
after	ADP	O	O
primary	ADJ	O	O
cementless	NOUN	O	O
total	ADJ	O	O
hip	NOUN	O	O
arthroplasty.	NOUN	O	O

Subjects	NOUN	O	O
practiced	VERB	O	O
yoga	NOUN	O	O
over	ADP	O	O
two	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
three	NUM	O	O
sessions,	DET	O	O
the	DET	O	O
duration	NOUN	O	O
of	ADP	O	O
each	DET	O	O
session	NOUN	O	O
was	VERB	O	O
60min.	NOUN	O	O

Results:	NOUN	O	O
Participant	ADJ	O	O
retention	NOUN	O	O
was	VERB	O	O
100%	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Most	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
women	NOUN	O	O
(>88%),	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
35.3	NUM	O	O
years,	NOUN	O	O
more	ADV	O	O
than	ADP	O	O
a	DET	O	O
high	ADJ	O	O
school	NOUN	O	O
education	NOUN	O	O
(>80%),	NOUN	O	O
a	DET	O	O
family	NOUN	O	O
composition	NOUN	O	O
of	ADP	O	O
at	ADP	O	O
least	ADV	O	O
three	NUM	O	O
members,	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
mean	NOUN	O	O
baseline	NOUN	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
(BMI)	PUNCT	O	O
of	ADP	O	O
34.5	NUM	O	O
kg/m(2).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Equivalence	NOUN	O	O
Trial	NOUN	O	O

Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Two-year,	ADV	O	O
randomized,	NOUN	O	O
multicenter	NOUN	O	O
trial	NOUN	O	O
conducted	VERB	O	O
at	ADP	O	O
9	NUM	O	O
hospitals	NOUN	O	O
in	ADP	O	O
Denmark.	NOUN	O	O

RESULTS:	NOUN	O	O
There	PRON	O	O
were	VERB	O	O
49	NUM	O	O
patients	NOUN	O	O
allocated	VERB	O	O
to	PART	O	O
receive	VERB	O	O
misoprostol	NOUN	O	O
and	CCONJ	O	O
38	NUM	O	O
allocated	VERB	O	O
to	PART	O	O
receive	VERB	O	O
placebo;	ADV	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
a	DET	O	O
20	NUM	O	O
g/L	NOUN	O	O
decrease	NOUN	O	O
in	ADP	O	O
hemoglobin	NOUN	O	B-outcome
was	VERB	O	O
similar	ADJ	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
(20/43	NOUN	O	O
[47%]	NUM	O	O
vs	CCONJ	O	O
19/33	NOUN	O	O
[58%],	NOUN	O	O
respectively;	NOUN	O	O
P=0.335).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Adjuvant	NOUN	O	O
therapy	NOUN	O	O
with	ADP	O	O
a	DET	O	O
modified	VERB	O	O
FOLFIRINOX	NOUN	O	O
regimen	NOUN	O	O
led	VERB	O	O
to	PART	O	O
significantly	ADV	O	O
longer	ADJ	O	O
survival	NOUN	O	B-outcome
than	ADP	O	O
gemcitabine	NOUN	O	O
among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
resected	VERB	O	O
pancreatic	ADJ	O	O
cancer,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
expense	NOUN	O	O
of	ADP	O	O
a	DET	O	O
higher	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
toxic	ADJ	O	B-outcome
effects.	NOUN	O	O
(	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
whether	ADP	O	O
informing	VERB	O	O
truckers	NOUN	O	O
who	ADP	O	O
do	VERB	O	O
not	ADV	O	O
test	NOUN	O	O
for	ADP	O	O
HIV	NOUN	O	O
regularly	ADV	O	O
about	ADV	O	O
the	DET	O	O
availability	NOUN	O	O
of	ADP	O	O
HIV	NOUN	O	O
self-testing	VERB	O	O
kits	NOUN	O	O
at	ADP	O	O
roadside	NOUN	O	O
wellness	NOUN	O	O
centers	NOUN	O	O
in	ADP	O	O
Kenya	PROPN	O	O
using	VERB	O	O
text	VERB	O	O
messages	NOUN	O	O
would	VERB	O	O
increase	NOUN	O	O
HIV	NOUN	O	B-outcome
testing	VERB	O	I-outcome
rates	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
current	ADJ	O	O
program	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
they	PRON	O	O
are	VERB	O	O
sent	ADJ	O	O
text	VERB	O	O
messages	NOUN	O	O
about	ADV	O	O
the	DET	O	O
availability	NOUN	O	O
of	ADP	O	O
HIV	NOUN	O	O
testing	VERB	O	O
in	ADP	O	O
general.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Methods:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
60	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
silicosis	NOUN	O	O
complicated	VERB	O	O
by	ADP	O	O
stable	ADJ	O	O
COPD	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
hospitalized	VERB	O	O
in	ADP	O	O
Department	NOUN	O	O
of	ADP	O	O
Occupational	ADJ	O	O
Diseases,	NOUN	O	O
Laigang	NOUN	O	O
Hospital	NOUN	O	O
Affiliated	VERB	O	O
to	PART	O	O
Taishan	NOUN	O	O
Medical	ADJ	O	O
College,	PUNCT	O	O
from	ADP	O	O
August	NOUN	O	O
2017	NUM	O	O
to	PART	O	O
April	NOUN	O	O
2018	NUM	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
observation	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
30	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group.	VERB	O	O

FUNDING:	NOUN	O	O
Millennium	NOUN	O	O
Pharmaceuticals,	ADJ	O	O
a	DET	O	O
wholly	ADV	O	O
owned	VERB	O	O
subsidiary	NOUN	O	O
of	ADP	O	O
Takeda	NOUN	O	O
Pharmaceutical	NOUN	O	O
Company.	NOUN	O	O

Title:	NOUN	O	O
Using	VERB	O	O
physical	ADJ	O	O
education	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
out-of	ADP	O	O
school	NOUN	O	O
physical	ADJ	O	O
activity	NOUN	O	O
in	ADP	O	O
lower	ADJ	O	O
secondary	ADJ	O	O
school	NOUN	O	O
students	NOUN	O	O
-	PUNCT	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
protocol.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Bisphosphonates	NOUN	O	O
prevent	NOUN	O	O
fractures	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
osteoporosis,	PRON	O	O
but	CCONJ	O	O
their	ADJ	O	O
efficacy	NOUN	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
osteopenia	NOUN	O	O
is	VERB	O	O
unknown.	NOUN	O	O

At	ADP	O	O
these	DET	O	O
time	NOUN	O	O
points:	NOUN	O	O
T(0)(the	NOUN	O	O
day	NOUN	O	O
before	ADP	O	O
operation),	NOUN	O	O
T(1)(immediate	NOUN	O	O
before	ADP	O	O
anesthesia	NOUN	O	O
induction),	NOUN	O	O
T(2)(1	NOUN	O	O
h	NOUN	O	O
after	ADP	O	O
emergence),	NOUN	O	O
T(3)(24	NOUN	O	O
h	NOUN	O	O
after	ADP	O	O
operation),	NOUN	O	O
T(4)(3	NOUN	O	O
d	NOUN	O	O
after	ADP	O	O
operation),	NOUN	O	O
T(5)(7	NOUN	O	O
d	NOUN	O	O
after	ADP	O	O
operation),	NOUN	O	O
T(6)(one	PRON	O	O
month	NOUN	O	O
after	ADP	O	O
operation),	NOUN	O	O
T(7)(3	NOUN	O	O
months	NOUN	O	O
after	ADP	O	O
operation)	NOUN	O	O
and	CCONJ	O	O
T(8)(6	NOUN	O	O
month	NOUN	O	O
after	ADP	O	O
operation)	NOUN	O	O
,	PUNCT	O	O
venous	ADJ	O	O
blood	NOUN	O	O
samples	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
were	VERB	O	O
collected	VERB	O	O
for	ADP	O	O
detection	NOUN	O	O
of	ADP	O	O
epinephrine	NOUN	O	B-outcome
,	PUNCT	O	O
norepinephrine	NOUN	O	B-outcome
and	CCONJ	O	O
corticosterone	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
pain	NOUN	O	B-outcome
visual	ADJ	O	O
analogue	NOUN	O	O
scale(VSA)	NUM	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
pain	NOUN	O	B-outcome
levels	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
at	ADP	O	O
T(2),	NOUN	O	O
T(3),	NOUN	O	O
T(4),	NOUN	O	O
T(5),	NOUN	O	O
T(6),	NOUN	O	O
T(7),	NOUN	O	O
T(8).	NOUN	O	O

For	ADP	O	O
the	DET	O	O
evaluation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
association	NOUN	O	O
of	ADP	O	O
the	DET	O	O
categorical	ADJ	O	O
variables	NOUN	O	O
the	DET	O	O
Chi-square	NOUN	O	O
test	NOUN	O	O
and	CCONJ	O	O
Fisher's	NOUN	O	O
Exact	NOUN	O	O
Test	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
used.	NOUN	O	O

Journal-Name:Revista	NOUN	O	O
de	ADP	O	O
saude	NOUN	O	O
publica	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
also	ADV	O	O
major	ADJ	O	O
re-structuring	VERB	O	O
of	ADP	O	O
several	ADJ	O	O
organisations	NOUN	O	O
which	ADP	O	O
presented	VERB	O	O
significant	ADJ	O	O
implementation	NOUN	O	O
challenges,	NOUN	O	O
and	CCONJ	O	O
technical	ADJ	O	O
limitations.	NOUN	O	O

DESIGN:	NOUN	O	O
A	DET	O	O
parallel	ADJ	O	O
group	NOUN	O	O
trial	NOUN	O	O
with	ADP	O	O
follow-up	NOUN	O	O
METHODS::	NOUN	O	O
Thirty	NUM	O	O
young	ADJ	O	O
women	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
experimental	ADJ	O	O
(n	NOUN	O	O
=	SYM	O	O
15)	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
15).	NOUN	O	O

Amer.).	NOUN	O	O

Physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
participation	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
variable,	NOUN	O	O
and	CCONJ	O	O
psychological	ADJ	O	O
mediators	NOUN	O	O
from	ADP	O	O
the	DET	O	O
trans-contextual	ADJ	O	O
model	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
pre-trial,	ADJ	O	O
post-trial,	ADJ	O	O
and	CCONJ	O	O
at	ADP	O	O
one-,	NOUN	O	O
three-	NOUN	O	O
and	CCONJ	O	O
six-months	NOUN	O	O
post-trial.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Upper	NOUN	O	O
extremity	NOUN	O	O
functional	ADJ	O	O
impairments	NOUN	O	O
are	VERB	O	O
common	ADJ	O	O
consequences	NOUN	O	O
of	ADP	O	O
stroke.	NOUN	O	O

The	DET	O	O
children	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
for	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
6	NUM	O	O
weeks.	NOUN	O	O

Hence,	NOUN	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
aims	NOUN	O	O
to	PART	O	O
establish	NOUN	O	O
the	DET	O	O
clinical	ADJ	O	O
evidence	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
Bosinji	NOUN	O	O
in	ADP	O	O
improving	VERB	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
function	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
in	ADP	O	O
LHIVD	NOUN	O	O
patients.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/26	VERB	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Implementation	NOUN	O	O
of	ADP	O	O
multi-component	ADJ	O	O
PA	NOUN	O	O
interventions	NOUN	O	O
within	ADP	O	O
schools	NOUN	O	O
is	VERB	O	O
advocated	VERB	O	O
but	CCONJ	O	O
research	NOUN	O	O
has	VERB	O	O
showed	VERB	O	O
that	ADP	O	O
they	PRON	O	O
may	VERB	O	O
not	ADV	O	O
always	ADV	O	O
be	VERB	O	O
effective	ADJ	O	O
at	ADP	O	O
increasing	VERB	O	O
child	NOUN	O	O
PA.	NOUN	O	O

Mean	NOUN	O	O
arterial	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
(MAP),	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
peripheral	ADJ	O	B-outcome
capillary	NOUN	O	I-outcome
oxygen	NOUN	O	I-outcome
saturation	NOUN	O	I-outcome
SpO(2)	NOUN	O	I-outcome
,	PUNCT	O	O
partial	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
of	ADP	O	I-outcome
exhaled	VERB	O	I-outcome
carbon	NOUN	O	I-outcome
dioxide	NOUN	O	I-outcome
P(ET)CO(2)	NOUN	O	I-outcome
and	CCONJ	O	O
bispectral	ADJ	O	O
index	NOUN	O	O
(BIS)	PUNCT	O	O
were	VERB	O	O
recorded	VERB	O	O
after	ADP	O	O
entering	VERB	O	O
the	DET	O	O
operating	VERB	O	O
room(T(0)),	NOUN	O	O
after	ADP	O	O
anesthesia	NOUN	O	O
induction(T(1)),	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
inserting	VERB	O	O
laryngeal	ADJ	O	O
mask	NOUN	O	O
airway	NOUN	O	O
or	CCONJ	O	O
tracheal	ADJ	O	O
tube(T(2)),	NOUN	O	O
fiberbronchoscopy	NOUN	O	O
inserting(T(3)),	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
operation(T(4)),	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
recovery	NOUN	O	O
of	ADP	O	O
patients'	NOUN	O	O
consciousness(T(5)).	NOUN	O	O

Of	ADP	O	O
10	NUM	O	O
key	ADJ	O	O
secondary	ADJ	O	O
end	NOUN	O	O
points,	NOUN	O	O
8	NUM	O	O
were	VERB	O	O
null	ADJ	O	O
and	CCONJ	O	O
2	NUM	O	O
showed	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
benefit	NUM	O	O
for	ADP	O	O
the	DET	O	O
MRI	NOUN	O	O
treat-to-target	NOUN	O	O
group.	VERB	O	O

During	ADP	O	O
pre-supplementation	NOUN	O	O
testing,	NOUN	O	O
the	DET	O	O
subjects	NOUN	O	O
performed	VERB	O	O
2	NUM	O	O
pretest	NOUN	O	O
MVICs,	NOUN	O	O
2	NUM	O	O
sets	NOUN	O	O
of	ADP	O	O
50	NUM	O	O
maximal,	ADJ	O	O
bilateral,	ADP	O	O
concentric	ADJ	O	O
isokinetic	ADJ	O	O
leg	NOUN	O	O
extensions	NOUN	O	O
at	ADP	O	O
180	NUM	O	O
degrees	NOUN	O	O
.s(-	PUNCT	O	O
1)	NUM	O	O
separated	VERB	O	O
by	ADP	O	O
2-min	NOUN	O	O
of	ADP	O	O
rest,	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
posttest	NOUN	O	O
MVICs.	ADJ	O	O

The	DET	O	O
RADPAD	NOUN	O	O
is	VERB	O	O
a	DET	O	O
lead-free	ADJ	O	O
sterile	ADJ	O	O
drape	NOUN	O	O
containing	VERB	O	O
bismuth	NOUN	O	O
and	CCONJ	O	O
barium	NOUN	O	O
that	ADP	O	O
reduces	NOUN	O	O
scatter	NOUN	O	O
radiation	NOUN	O	O
during	ADP	O	O
fluoroscopic	ADJ	O	O
procedures.	NOUN	O	O

The	DET	O	O
odds	NOUN	O	O
ratios	NOUN	O	O
(95%	PUNCT	O	O
CI)	NOUN	O	O
for	ADP	O	O
gestational	ADJ	O	B-outcome
diabetes	NOUN	O	I-outcome
mellitus	NOUN	O	I-outcome
(GDM)	NOUN	O	I-outcome
and	CCONJ	O	O
CMFCs	NOUN	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
a	DET	O	O
high	ADJ	O	O
adherence	NOUN	O	O
were	VERB	O	O
0.35((0.18(-)0.67),	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.002)	NUM	O	O
and	CCONJ	O	O
0.23((0.11(-)0.48),	PUNCT	O	O
p	NOUN	O	O
<	SYM	O	O
0.001),	NUM	O	O
respectively.	NOUN	O	O

Moreover,	NOUN	O	O
further	ADV	O	O
studies	NOUN	O	O
should	VERB	O	O
allow	ADP	O	O
assessments	NOUN	O	O
of	ADP	O	O
the	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
pegbelfermin	NOUN	O	O
in	ADP	O	O
a	DET	O	O
larger	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
patients.	NOUN	O	O

Conclusion:	NOUN	O	O
Perioperative	ADJ	O	O
application	NOUN	O	O
of	ADP	O	O
dexmedetomidine	NOUN	O	O
can	VERB	O	O
effectively	ADV	O	O
decrease	NOUN	O	O
the	DET	O	O
perioperative	ADJ	O	O
stress	NOUN	O	B-outcome
response,	NOUN	O	O
obviously	ADV	O	O
cut	ADJ	O	O
down	ADJ	O	O
the	DET	O	O
perioperative	ADJ	O	O
opioid	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
prevent	NOUN	O	O
the	DET	O	O
transition	NOUN	O	O
from	ADP	O	O
postoperative	ADJ	O	O
acute	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
to	PART	O	O
chronic	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
radical	NOUN	O	O
resection	NOUN	O	O
of	ADP	O	O
esophageal	ADJ	O	O
cancer	NOUN	O	O
under	ADP	O	O
combined	VERB	O	O
thoracoscope	NOUN	O	O
and	CCONJ	O	O
laparoscope.	NOUN	O	O

Conclusion:	NOUN	O	O
Therapeutic	ADJ	O	O
radiographer	ADP	O	O
prostate	NOUN	O	O
contours	NOUN	O	O
are	VERB	O	O
more	ADV	O	O
accurate,	NOUN	O	O
show	VERB	O	O
less	ADV	O	O
interobserver	ADV	O	O
variability	NOUN	O	O
and	CCONJ	O	O
are	VERB	O	O
more	ADV	O	O
confidently	ADV	O	O
and	CCONJ	O	O
quickly	NOUN	O	O
outlined	VERB	O	O
on	ADP	O	O
MRI	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
CT,	NOUN	O	O
particularly	ADV	O	O
using	VERB	O	O
T2*W	NOUN	O	O
MRI.	NOUN	O	O

The	DET	O	O
first	ADV	O	O
lotion	NOUN	O	O
formulation	NOUN	O	O
of	ADP	O	O
tretinoin	NOUN	O	O
was	VERB	O	O
developed	VERB	O	O
using	VERB	O	O
novel	ADJ	O	O
polymerized	VERB	O	O
emulsion	NOUN	O	O
technology	NOUN	O	O
to	PART	O	O
provide	VERB	O	O
an	DET	O	O
important	ADJ	O	O
alternative	ADJ	O	O
option	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
these	DET	O	O
acne	NOUN	O	O
patients	NOUN	O	O
who	ADP	O	O
may	VERB	O	O
be	VERB	O	O
sensitive	ADJ	O	O
to	PART	O	O
the	DET	O	O
irritant	NOUN	O	O
effects	NOUN	O	O
of	ADP	O	O
other	ADJ	O	O
tretinoin	NOUN	O	O
formulations.	VERB	O	O

Pain	NOUN	O	B-outcome
visual	ADJ	O	O
analog	NOUN	O	O
scale	NOUN	O	O
(VAS),	NUM	O	O
patient's	NOUN	O	O
global	ADJ	O	B-outcome
assessment	NOUN	O	I-outcome
(PGA),	PUNCT	O	O
flexional	ADJ	O	B-outcome
angles	NOUN	O	I-outcome
,	PUNCT	O	O
patient-controlled	VERB	O	O
analgesia	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
,	PUNCT	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
receiving	VERB	O	O
pethidine	NOUN	O	B-outcome
,	PUNCT	O	O
pethidine	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
assessed.	NOUN	O	O

Interpretation	NOUN	O	O
&	CCONJ	O	O
conclusion:	NOUN	O	O
:	PUNCT	O	O
Addition	NOUN	O	O
of	ADP	O	O
a	DET	O	O
third	ADJ	O	O
SP	NOUN	O	O
dose	NOUN	O	O
to	PART	O	O
the	DET	O	O
standard	ADJ	O	O
two-dose	NOUN	O	O
SP	NOUN	O	O
for	ADP	O	O
IPTp	NOUN	O	O
led	VERB	O	O
to	PART	O	O
improved	VERB	O	O
reductions	NOUN	O	O
in	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
some	DET	O	O
adverse	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
outcomes	NOUN	O	I-outcome
.	PUNCT	O	O

The	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
albuminemia	NOUN	O	B-outcome
had	VERB	O	O
a	DET	O	O
direct	ADJ	O	O
correlation	NOUN	O	O
with	ADP	O	O
CRP	NOUN	O	O
levels,	NOUN	O	O
which	ADP	O	O
were	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
G1.	NOUN	O	O

We	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
comparative	ADJ	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
high-fidelity	NOUN	O	O
simulation	NOUN	O	O
training	VERB	O	O
vs.	CCONJ	O	O
standard	ADJ	O	O
manikin	NOUN	O	O
training	VERB	O	O
for	ADP	O	O
teaching	VERB	O	O
medical	ADJ	O	O
students	NOUN	O	O
the	DET	O	O
American	ADJ	O	O
Heart	NOUN	O	O
Association	NOUN	O	O
(AHA)	NUM	O	O
guidelines	NOUN	O	O
for	ADP	O	O
high-quality	NOUN	O	O
CPR.	NOUN	O	O

Both	CCONJ	O	O
T2W	NOUN	O	O
and	CCONJ	O	O
T2*W	NOUN	O	O
MRI	NOUN	O	O
show	VERB	O	O
reduced	VERB	O	O
interobserver	ADV	O	O
variability	NOUN	O	O
and	CCONJ	O	O
improved	VERB	O	O
accuracy	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
CT,	NOUN	O	O
this	DET	O	O
was	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
for	ADP	O	O
T2*W	NOUN	O	O
imaging	VERB	O	O
compared	VERB	O	O
to	PART	O	O
CT	NOUN	O	O
across	ADP	O	O
all	DET	O	O
four	NUM	O	O
comparison	NOUN	O	O
metrics.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
evaluated	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
amla	NOUN	O	O
(Emblica	NUM	O	O
officinalis)	NOUN	O	O
extract	NOUN	O	O
(composed	PUNCT	O	O
of	ADP	O	O
polyphenols,	NOUN	O	O
triterpenoids,	NOUN	O	O
oils	NOUN	O	O
etc.	NOUN	O	O

Conclusion	NOUN	O	O
We	PRON	O	O
demonstrated	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
acceptability	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
a	DET	O	O
robotic	ADJ	O	O
walking	VERB	O	O
aid	VERB	O	O
from	ADP	O	O
the	DET	O	O
perspective	ADJ	O	O
of	ADP	O	O
both	CCONJ	O	O
older	ADJ	O	O
individuals	NOUN	O	O
and	CCONJ	O	O
physiotherapists.	NOUN	O	O

The	DET	O	O
study	NOUN	O	O
included	VERB	O	O
204	NUM	O	O
subjects	NOUN	O	O
between	ADP	O	O
25(-)70	ADJ	O	O
years	NOUN	O	O
with	ADP	O	O
T2DM.	NOUN	O	O

INTERPRETATION:	CCONJ	O	O
Ixazomib	NUM	O	O
maintenance	NOUN	O	O
prolongs	NOUN	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(PFS)	NOUN	O	I-outcome
and	CCONJ	O	O
represents	NOUN	O	O
an	DET	O	O
additional	ADJ	O	O
option	NOUN	O	O
for	ADP	O	O
post-transplant	NOUN	O	O
maintenance	NOUN	O	O
therapy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
newly	ADV	O	O
diagnosed	VERB	O	O
multiple	ADJ	O	O
myeloma.	ADV	O	O

Journal-Name:Nutrients	NOUN	O	O

At	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
pain,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
200	NUM	O	O
mg	NOUN	O	O
capsule	NOUN	O	O
was	VERB	O	O
given	VERB	O	O
every	DET	O	O
6	NUM	O	O
h	NOUN	O	O
for	ADP	O	O
two	NUM	O	O
serial	ADJ	O	O
cycles.	NUM	O	O

Conclusion:Rhodiola	NOUN	O	O
may	VERB	O	O
improve	VERB	O	O
the	DET	O	O
negative	ADJ	O	B-outcome
emotions	NOUN	O	I-outcome
such	ADJ	O	O
as	ADP	O	O
anxiety	NOUN	O	B-outcome
and	CCONJ	O	O
depression	NOUN	O	B-outcome
by	ADP	O	O
inhibiting	VERB	O	O
oxygen	NOUN	O	B-outcome
free	ADJ	O	I-outcome
radicals	NOUN	O	I-outcome
and	CCONJ	O	O
lipid	NOUN	O	B-outcome
peroxidation	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
OSA.	NOUN	O	O

Therefore,	NOUN	O	O
denosumab	NOUN	O	O
possibly	ADV	O	O
regulates	NOUN	O	O
noggin	NOUN	O	B-outcome
and	CCONJ	O	O
favours	NOUN	O	O
bone	NOUN	O	O
turnover	ADV	O	O
in	ADP	O	O
TDT	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
osteoporosis	NOUN	O	O
through	ADP	O	O
a	DET	O	O
novel	ADJ	O	O
mechanism	NOUN	O	O
of	ADP	O	O
action.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7511141	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/21	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
Kaplan-Meier	NOUN	O	O
estimated	VERB	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
free	ADJ	O	O
from	ADP	O	O
recurrence	NOUN	O	B-outcome
at	ADP	O	O
6	NUM	O	O
months,	NOUN	O	O
defined	VERB	O	O
as	ADP	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
clearance	NOUN	O	O
without	ADP	O	O
recurrent	ADP	O	O
parasitemia.	NOUN	O	O

Serum	NOUN	O	O
cytokines	NOUN	O	O
were	VERB	O	O
quantified,	NOUN	O	O
and	CCONJ	O	O
microbiota	NOUN	O	O
assessed	VERB	O	O
using	VERB	O	O
metagenomic	ADJ	O	O
sequencing.	NOUN	O	O

INTERVENTIONS:	NOUN	O	O
Patients	NOUN	O	O
were	VERB	O	O
subjected	VERB	O	O
to	PART	O	O
low-dose	NOUN	O	O
preoperative	ADJ	O	O
protocols	NOUN	O	O
of	ADP	O	O
MDCT	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
144;	NUM	O	O
ldMDCT	NOUN	O	O
group)	ADJ	O	O
or	CCONJ	O	O
standard-dose	NOUN	O	O
preoperative	ADJ	O	O
protocols	NOUN	O	O
of	ADP	O	O
MDCT	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
144;	NUM	O	O
sdMDCT	NOUN	O	O
group).	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
undetectable	ADJ	O	O
MEP	NOUN	O	B-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
as	ADP	O	O
measured	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
OSTAP	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
a	DET	O	O
bilateral	ADJ	O	O
OSTAP	NOUN	O	O
block	VERB	O	O
with	ADP	O	O
40	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
0.375%	NUM	O	O
bupivacaine	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
Sham	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
an	DET	O	O
US-guided	VERB	O	O
bilateral	ADJ	O	O
OSTAP	NOUN	O	O
with	ADP	O	O
40	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
0.9%	NOUN	O	O
saline.	NOUN	O	O

Despite	ADP	O	O
growing	VERB	O	O
interest	NOUN	O	O
in	ADP	O	O
natural	ADJ	O	O
rehydrating	VERB	O	O
beverages,	NOUN	O	O
no	DET	O	O
study	NOUN	O	O
has	VERB	O	O
examined	VERB	O	O
maple	NOUN	O	O
water	NOUN	O	O
(MW).	PUNCT	O	O

Journal-Name:Nutrients	NOUN	O	O

However,	ADV	O	O
although	ADP	O	O
it	PRON	O	O
was	VERB	O	O
not	ADV	O	O
sufficient	ADJ	O	O
to	PART	O	O
enhance	NOUN	O	O
muscle	NOUN	O	O
recovery	NOUN	O	O
observed	VERB	O	O
by	ADP	O	O
testosterone	NOUN	O	B-outcome
and	CCONJ	O	O
cortisol	NOUN	O	B-outcome
responses,	NOUN	O	O
it	PRON	O	O
was	VERB	O	O
observed	VERB	O	O
that	ADP	O	O
serum	NOUN	O	O
25(OH)D	NUM	O	B-outcome
levels	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
a	DET	O	O
predictor	NOUN	O	O
of	ADP	O	O
anabolic	ADJ	O	B-outcome
and	CCONJ	O	O
catabolic	ADJ	O	B-outcome
hormones.	NUM	O	O

Conclusion	NOUN	O	O
PRAM	NOUN	O	O
provides	NOUN	O	O
meaningful	ADJ	O	O
and	CCONJ	O	O
direct	ADJ	O	O
monitoring	VERB	O	O
of	ADP	O	O
hemodynamics	NOUN	O	O
and	CCONJ	O	O
cardiac	ADJ	O	O
efficiency	NOUN	O	O
during	ADP	O	O
the	DET	O	O
dynamic	ADJ	O	O
period	NOUN	O	O
of	ADP	O	O
anesthetic	ADJ	O	O
induction	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
cardiac	ADJ	O	O
surgery.	VERB	O	O

The	DET	O	O
results	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
scores	NOUN	O	O
of	ADP	O	O
pre-test	NOUN	O	O
(before	NUM	O	O
MBI)	NOUN	O	O
and	CCONJ	O	O
post-test	NOUN	O	O
(after	PUNCT	O	O
MBI)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
and	CCONJ	O	O
MBCT	NOUN	O	O
had	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
the	DET	O	O
perception	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
disease	NOUN	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
psychological	ADJ	O	B-outcome
syndrome	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
volume	NOUN	O	O
controlled	VERB	O	O
ventilation	NOUN	O	O
(VCV)	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
pressure	NOUN	O	O
controlled	VERB	O	O
ventilation	NOUN	O	O
(PCV)	NOUN	O	O
group	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
random	NOUN	O	O
number	NOUN	O	O
table.	ADJ	O	O

Title:	NOUN	O	O
Baseline	NOUN	O	O
characteristics	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
early	ADJ	O	O
visual	ADJ	O	B-outcome
acuity	NOUN	O	I-outcome
gains	NOUN	O	O
after	ADP	O	O
ranibizumab	ADJ	O	O
treatment	NOUN	O	O
for	ADP	O	O
retinal	ADJ	O	O
vein	NOUN	O	O
occlusion.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

METHODS:	NOUN	O	O
Eighty-two	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
T1-3bN0M0	NOUN	O	O
prostate	NOUN	O	O
cancer	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
not	ADV	O	O
received	VERB	O	O
androgen-deprivation	NOUN	O	O
therapy	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
five	NUM	O	O
arms:	NOUN	O	O
Arm	NOUN	O	O
1,	NOUN	O	O
60	NUM	O	O
cobalt	NOUN	O	O
gray	NOUN	O	O
equivalent	ADJ	O	O
(CGE)/20	NOUN	O	O
fractions/5	NOUN	O	O
weeks;	ADP	O	O
Arm	NOUN	O	O
2,	NOUN	O	O
54	NUM	O	O
CGE/15	NOUN	O	O
fractions/5	NOUN	O	O
weeks;	ADP	O	O
Arm	NOUN	O	O
3,	NOUN	O	O
47	NUM	O	O
CGE/10	NOUN	O	O
fractions/5	NOUN	O	O
weeks;	ADP	O	O
Arm	NOUN	O	O
4,	NOUN	O	O
35	NUM	O	O
CGE/5	NOUN	O	O
fractions/2.5	NUM	O	O
weeks;	ADP	O	O
and	CCONJ	O	O
Arm	NOUN	O	O
5,	ADJ	O	O
35	NUM	O	O
CGE/5	NOUN	O	O
fractions/4	NOUN	O	O
weeks.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
neurology	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Most	DET	O	O
fractures	NOUN	O	O
in	ADP	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
occur	VERB	O	O
in	ADP	O	O
those	DET	O	O
with	ADP	O	O
osteopenia,	NOUN	O	O
so	ADV	O	O
therapies	NOUN	O	O
that	ADP	O	O
are	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
osteopenia	NOUN	O	O
are	VERB	O	O
needed.	NOUN	O	O

The	DET	O	O
main	ADJ	O	O
group	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
90	NUM	O	O
children	NOUN	O	O
diagnosed	VERB	O	O
with	ADP	O	O
asthma	NOUN	O	O
and	CCONJ	O	O
allergies	NOUN	O	O
symptoms	NOUN	O	O
age	NOUN	O	O
9	NUM	O	O
to	PART	O	O
12	NUM	O	O
years	NOUN	O	O
old	ADJ	O	O
(x	PUNCT	O	O
=	SYM	O	O
10.75	NUM	O	O
+/-	SYM	O	O
1.08).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Few	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
conducted	VERB	O	O
on	ADP	O	O
the	DET	O	O
utility	NOUN	O	O
of	ADP	O	O
cervical	ADJ	O	O
spine	NOUN	O	O
phantoms	NOUN	O	O
for	ADP	O	O
practicing	VERB	O	O
cervical	ADJ	O	O
procedures.	NOUN	O	O

Significant	ADJ	O	O
correlations	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
between	ADP	O	O
depression	NOUN	O	B-outcome
and	CCONJ	O	O
parasympathetic	ADJ	O	B-outcome
modulation	NOUN	O	I-outcome
using	VERB	O	O
linear	ADJ	O	O
(r	NUM	O	O
=	SYM	O	O
-	PUNCT	O	O
0.687;	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.028)	NUM	O	O
and	CCONJ	O	O
nonlinear	ADJ	O	O
analyses	NOUN	O	O
(r	NUM	O	O
=	SYM	O	O
-	PUNCT	O	O
0.689;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.027)	NUM	O	O
in	ADP	O	O
MTG.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/17	NOUN	O	O
06:00'	NUM	O	O

However,	ADV	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
bacteriological	ADJ	O	B-outcome
cure	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.34),	PUNCT	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.11),	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
between	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

RESULTS:	NOUN	O	O
For	ADP	O	O
the	DET	O	O
upper	ADJ	O	O
50th	ADJ	O	O
percentile	ADJ	O	O
group,	NOUN	O	O
the	DET	O	O
post-supplementation	NOUN	O	O
adjusted	VERB	O	O
mean	NOUN	O	O
percent	NOUN	O	O
decline	NOUN	O	O
in	ADP	O	O
maximal	ADJ	O	B-outcome
voluntary	ADJ	O	I-outcome
isometric	ADJ	O	I-outcome
contraction	NOUN	O	I-outcome
(MVIC)	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
for	ADP	O	O
the	DET	O	O
high	ADJ	O	O
dose	NOUN	O	O
group	NOUN	O	O
(8.9	PUNCT	O	O
+/-	SYM	O	O
2.3%)	NUM	O	O
than	ADP	O	O
the	DET	O	O
low	ADJ	O	O
dose	NOUN	O	O
(17.0	PUNCT	O	O
+/-	SYM	O	O
2.4%;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.022)	NUM	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
(16.0	PUNCT	O	O
+/-	SYM	O	O
2.4%;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.044)	NUM	O	O
groups.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
between-group	NOUN	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
change	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
week	NOUN	O	O
80	NUM	O	O
in	ADP	O	O
the	DET	O	O
total	ADJ	O	O
score	NOUN	O	O
on	ADP	O	O
the	DET	O	O
Unified	VERB	O	O
Parkinson's	NOUN	O	B-outcome
Disease	NOUN	O	I-outcome
Rating	VERB	O	O
Scale	NOUN	O	O
(UPDRS;	PUNCT	O	O
scores	NOUN	O	O
range	NOUN	O	O
from	ADP	O	O
0	NUM	O	O
to	PART	O	O
176,	NOUN	O	O
with	ADP	O	O
higher	ADJ	O	O
scores	NOUN	O	O
signifying	VERB	O	O
more	ADV	O	O
severe	ADJ	O	O
disease).	NOUN	O	O

When	ADP	O	O
comparing	VERB	O	O
survey	NOUN	O	O
responses	NOUN	O	O
between	ADP	O	O
individuals	NOUN	O	O
who	ADP	O	O
met	VERB	O	O
online	ADP	O	O
and	CCONJ	O	O
in	ADP	O	O
person,	NOUN	O	O
we	PRON	O	O
did	VERB	O	O
not	ADV	O	O
detect	VERB	O	O
a	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
demographics	NOUN	O	O
with	ADP	O	O
the	DET	O	O
exception	NOUN	O	O
of	ADP	O	O
preferred	VERB	O	O
meeting	VERB	O	O
method	NOUN	O	O
(p=0.0225).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Five	NUM	O	O
minutes	NOUN	O	O
before	ADP	O	O
taking	VERB	O	O
the	DET	O	O
Trier	NOUN	O	O
Social	ADJ	O	O
Stress	NOUN	O	O
Test	NOUN	O	O
(TSST)	NUM	O	O
as	ADP	O	O
a	DET	O	O
mental	ADJ	O	O
stressor,	NOUN	O	O
participants	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group	NOUN	O	O
ingested	VERB	O	O
a	DET	O	O
beverage	ADP	O	O
containing	VERB	O	O
beta-Eudesmol,	NOUN	O	O
the	DET	O	O
active	ADJ	O	O
beverage,	CCONJ	O	O
or	CCONJ	O	O
a	DET	O	O
placebo	NOUN	O	O
beverage	ADP	O	O
that	ADP	O	O
did	VERB	O	O
not	ADV	O	O
contain	NOUN	O	O
beta-Eudesmol.	NOUN	O	O

The	DET	O	O
treatment	NOUN	O	O
lasted	VERB	O	O
for	ADP	O	O
2	NUM	O	O
weeks.	NOUN	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
Curcumin	NOUN	O	O
as	ADP	O	O
an	DET	O	O
Adjunct	ADP	O	O
to	PART	O	O
Scaling	VERB	O	O
and	CCONJ	O	O
Root	ADJ	O	O
Planing	VERB	O	O
in	ADP	O	O
Chronic	ADJ	O	O
Periodontitis	NOUN	O	O
Patients:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

The	DET	O	O
upper	ADJ	O	O
boundary	NOUN	O	O
of	ADP	O	O
the	DET	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval,	ADP	O	O
when	ADP	O	O
comparing	VERB	O	O
short	ADJ	O	O
and	CCONJ	O	O
long	ADV	O	O
protocols,	NOUN	O	O
was	VERB	O	O
below	ADP	O	O
the	DET	O	O
pre-specified	VERB	O	O
margin	ADP	O	O
of	ADP	O	O
non-inferiority	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.027).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O
Research	NOUN	O	O
Support,	NOUN	O	O
Non-U.S.	NOUN	O	O
Gov't,	NOUN	O	O

They	PRON	O	O
had	VERB	O	O
lost	VERB	O	O
their	ADJ	O	O
ability	NOUN	O	O
to	PART	O	O
perform	NOUN	O	O
some	DET	O	O
basic	ADJ	O	O
living	VERB	O	O
activities.	NOUN	O	O

ID:	NOUN	O	O
ISRCTN13021107].	NUM	O	O

All	DET	O	O
men	NOUN	O	O
received	VERB	O	O
standard	ADJ	O	O
care,	NOUN	O	O
and	CCONJ	O	O
men	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(IG)	NOUN	O	O
also	ADV	O	O
received	VERB	O	O
oral	ADJ	O	O
and	CCONJ	O	O
written	ADP	O	O
RLP-based	VERB	O	O
information	NOUN	O	O
about	ADV	O	O
lifestyle	NOUN	O	O
and	CCONJ	O	O
fertility.	NOUN	O	O

Time	NOUN	O	B-outcome
to	PART	O	I-outcome
emergency	NOUN	O	I-outcome
medical	ADJ	O	I-outcome
services	NOUN	O	I-outcome
(EMS)	NUM	O	I-outcome
activation	NOUN	O	I-outcome
was	VERB	O	O
24.7	NUM	O	O
seconds	NOUN	O	O
(s)	PUNCT	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
[15.7-40.8])	NOUN	O	O
for	ADP	O	O
SIM	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
79.5	NUM	O	O
s	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
[44.8-119.6])	PUNCT	O	O
for	ADP	O	O
STD	NOUN	O	O
group,	NOUN	O	O
p=0.007.	NUM	O	O

Therefore,	NOUN	O	O
in	ADP	O	O
this	DET	O	O
setting,	ADV	O	O
ATLG	NOUN	O	O
plus	CCONJ	O	O
standard	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
preferred	VERB	O	O
over	ADP	O	O
the	DET	O	O
standard	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
alone.	NOUN	O	O

We	PRON	O	O
hypothesized	VERB	O	O
that	ADP	O	O
this	DET	O	O
high-fidelity	NOUN	O	O
cricothyroidotomy	NOUN	O	O
simulator	NOUN	O	O
results	NOUN	O	O
in	ADP	O	O
increased	VERB	O	O
proficiency	NOUN	O	B-outcome
for	ADP	O	O
needle	NOUN	O	O
cricothyroidotomy	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
conventional	ADJ	O	O
simulators.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Omadacycline	NOUN	O	O
also	ADV	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
linezolid	NOUN	O	O
with	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
investigator-assessed	VERB	O	O
clinical	ADJ	O	B-outcome
response	NOUN	O	I-outcome
at	ADP	O	O
the	DET	O	O
post-treatment	NOUN	O	O
evaluation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
modified	VERB	O	O
intention-to-treat	NOUN	O	O
population	NOUN	O	O
(rate	NOUN	O	O
of	ADP	O	O
response,	NOUN	O	O
86.1%	NUM	O	O
and	CCONJ	O	O
83.6%,	NUM	O	O
respectively;	NOUN	O	O
difference,	NOUN	O	O
2.5	NUM	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-3.2	NUM	O	O
to	PART	O	O
8.2)	NUM	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
clinical	ADJ	O	O
per-protocol	NOUN	O	O
population	NOUN	O	O
(96.3%	PUNCT	O	O
and	CCONJ	O	O
93.5%,	NOUN	O	O
respectively;	NOUN	O	O
difference,	NOUN	O	O
2.8	NUM	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-1.0	PUNCT	O	O
to	PART	O	O
6.9).	ADP	O	O

The	DET	O	O
amount	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
was	VERB	O	O
measured	VERB	O	O
on	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
visual	ADJ	O	O
analog	NOUN	O	O
scale,	NOUN	O	O
arterial	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
at	ADP	O	O
recovery	NOUN	O	O
and	CCONJ	O	O
4,	NOUN	O	O
12,	NUM	O	O
and	CCONJ	O	O
24	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
surgery.	VERB	O	O

Journal-Name:Pediatric	ADJ	O	O
physical	ADJ	O	O
therapy	NOUN	O	O
:	PUNCT	O	O
the	DET	O	O
official	ADJ	O	O
publication	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Section	NOUN	O	O
on	ADP	O	O
Pediatrics	NOUN	O	O
of	ADP	O	O
the	DET	O	O
American	ADJ	O	O
Physical	ADJ	O	O
Therapy	NOUN	O	O
Association	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/09/21	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Secondary	ADJ	O	O
endpoints	NOUN	O	O
include	VERB	O	O
post-intervention	NOUN	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
late	ADJ	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
acute	ADJ	O	O
appendicitis	NOUN	O	O
after	ADP	O	O
one	NUM	O	O
year,	ADV	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
hospital	NOUN	O	I-outcome
stay	NOUN	O	I-outcome
,	PUNCT	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
sick	NOUN	O	B-outcome
leave	NOUN	O	I-outcome
and	CCONJ	O	O
treatment	NOUN	O	B-outcome
costs	NOUN	O	I-outcome
.	PUNCT	O	O
Primary	ADJ	O	O
endpoint	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
evaluated	VERB	O	O
in	ADP	O	O
two	NUM	O	O
stages:	NOUN	O	O
point	NOUN	O	O
estimates	NOUN	O	O
with	ADP	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
(CI)	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
calculated	VERB	O	O
for	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
and	CCONJ	O	O
proportion	NOUN	O	O
difference	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
with	ADP	O	O
95%	NOUN	O	O
CI	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
calculated	VERB	O	O
and	CCONJ	O	O
evaluated	VERB	O	O
based	VERB	O	O
on	ADP	O	O
6	NUM	O	O
percentage	NOUN	O	O
point	NOUN	O	O
non-inferiority	NOUN	O	O
margin.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

The	DET	O	O
use	NOUN	O	O
of	ADP	O	O
cadaver	ADV	O	O
allograft	NOUN	O	O
spares	NOUN	O	O
the	DET	O	O
hamstring	VERB	O	B-outcome
muscles	NOUN	O	I-outcome
and	CCONJ	O	O
reduces	NOUN	O	O
the	DET	O	O
time	NOUN	O	B-outcome
of	ADP	O	I-outcome
surgery	NOUN	O	I-outcome
.	PUNCT	O	O
Therefore,	NOUN	O	O
such	ADJ	O	O
study	NOUN	O	O
appears	NOUN	O	O
to	PART	O	O
be	VERB	O	O
useful	ADJ	O	O
because	ADP	O	O
it	PRON	O	O
provides	NOUN	O	O
valuable	ADJ	O	O
information	NOUN	O	O
that	ADP	O	O
would	VERB	O	O
help	VERB	O	O
to	PART	O	O
guide	NOUN	O	O
treatment	NOUN	O	O
of	ADP	O	O
this	DET	O	O
condition	NOUN	O	O
in	ADP	O	O
children.	NOUN	O	O

In	ADP	O	O
part	NOUN	O	O
C,	NOUN	O	O
all	DET	O	O
6	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
once-monthly	ADV	O	O
injections	NOUN	O	O
of	ADP	O	O
givosiran	NOUN	O	O
had	VERB	O	O
sustained	VERB	O	O
reductions	NOUN	O	O
in	ADP	O	O
ALAS1	NOUN	O	B-outcome
messenger	NOUN	O	I-outcome
RNA	NOUN	O	I-outcome
(mRNA)	ADV	O	I-outcome
,	PUNCT	O	O
delta	NOUN	O	B-outcome
aminolevulinic	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
porphobilinogen	NOUN	O	B-outcome
levels	NOUN	O	O
to	PART	O	O
near	ADV	O	O
normal.	NOUN	O	O

The	DET	O	O
hazard	NOUN	O	O
ratio	NOUN	O	O
for	ADP	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
recurrence	NOUN	O	B-outcome
was	VERB	O	O
0.30	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
0.22	NUM	O	O
to	PART	O	O
0.40)	NUM	O	O
with	ADP	O	O
tafenoquine	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
(P<0.001)	PUNCT	O	O
and	CCONJ	O	O
0.26	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
0.18	NUM	O	O
to	PART	O	O
0.39)	NOUN	O	O
with	ADP	O	O
primaquine	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
(P<0.001).	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Results:	NOUN	O	O
During	ADP	O	O
the	DET	O	O
study	NOUN	O	O
period,	NOUN	O	O
133	NUM	O	O
third-year	NOUN	O	O
medical	ADJ	O	O
students	NOUN	O	O
responded	VERB	O	O
to	PART	O	O
the	DET	O	O
survey.	NOUN	O	O

Title:	NOUN	O	O
Resin	NOUN	O	O
infiltration	NOUN	O	O
technique	NOUN	O	O
and	CCONJ	O	O
fluoride	NOUN	O	O
varnish	NOUN	O	O
on	ADP	O	O
white	ADP	O	O
spot	NOUN	O	O
lesions	NOUN	O	O
in	ADP	O	O
children:	NOUN	O	O
Preliminary	ADJ	O	O
findings	NOUN	O	O
of	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
normalization	NOUN	O	I-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
platelet	NOUN	O	I-outcome
count	NOUN	O	I-outcome
,	PUNCT	O	O
with	ADP	O	O
discontinuation	NOUN	O	O
of	ADP	O	O
daily	ADJ	O	O
plasma	NOUN	O	O
exchange	NOUN	O	O
within	ADP	O	O
5	NUM	O	O
days	NOUN	O	O
thereafter.	NOUN	O	O

However,	ADV	O	O
no	DET	O	O
condition	NOUN	O	O
x	SYM	O	O
time	NOUN	O	O
interactions	NOUN	O	O
were	VERB	O	O
observed.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
simultaneous	ADJ	O	O
vs	CCONJ	O	O
delayed	VERB	O	O
ventriculoperitoneal	ADJ	O	O
shunting	VERB	O	O
in	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
myelomeningocele	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
infection	NOUN	O	B-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
This	DET	O	O
Randomized	VERB	O	O
Control	NOUN	O	O
Trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
at	ADP	O	O
department	NOUN	O	O
of	ADP	O	O
Neurosurgery,	NOUN	O	O
Ayub	ADP	O	O
Medical	ADJ	O	O
College,	PUNCT	O	O
Abbottabad	ADV	O	O
from	ADP	O	O
7th	NOUN	O	O
March	NOUN	O	O
to	PART	O	O
7th	NOUN	O	O
June	NOUN	O	O
2016.	NUM	O	O

All	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
parenteral	ADJ	O	O
intramuscular	ADJ	O	O
therapy	NOUN	O	O
of	ADP	O	O
1	NUM	O	O
ml	NOUN	O	O
Vitamin	NOUN	O	O
B12	NOUN	O	O
weekly	ADV	O	O
for	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
4	NUM	O	O
weeks.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
relaxation	NOUN	O	O
techniques	NOUN	O	O
on	ADP	O	O
self-efficacy	NOUN	O	B-outcome
of	ADP	O	O
patients	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
cancer.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Results:	NOUN	O	O
The	DET	O	O
hysteroscopic	ADJ	O	O
findings	NOUN	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
20	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
1	NUM	O	O
and	CCONJ	O	O
28	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
2.	NUM	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
during	ADP	O	O
the	DET	O	O
hospital	NOUN	O	O
stay	NOUN	O	O
received	VERB	O	O
the	DET	O	O
usual	ADJ	O	O
diabetes	NOUN	O	O
education.	NOUN	O	O

Approval	ADJ	O	O
from	ADP	O	O
ethical	ADJ	O	O
committee	NOUN	O	O
was	VERB	O	O
obtained.	NOUN	O	O

METHODS:	NOUN	O	O
Ninety-six	NUM	O	O
parents	NOUN	O	O
in	ADP	O	O
the	DET	O	O
NICU	NOUN	O	O
received	VERB	O	O
instruction.	NOUN	O	O

Assessment	NOUN	O	O
of	ADP	O	O
plaque	NOUN	O	B-outcome
index	NOUN	O	O
(PI)],	NOUN	O	O
gingival	ADJ	O	B-outcome
index	NOUN	O	O
(GI)],	NUM	O	O
probing	VERB	O	B-outcome
pocket	NOUN	O	I-outcome
depth	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
clinical	ADJ	O	B-outcome
attachment	NOUN	O	I-outcome
levels	NOUN	O	I-outcome
(CAL)	NOUN	O	I-outcome
were	VERB	O	O
done	NOUN	O	O
at	ADP	O	O
the	DET	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
4th	ADP	O	O
week.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
FOLFIRI/erlotinib	NOUN	O	O
arm	NOUN	O	O
met	VERB	O	O
the	DET	O	O
pre-specified	VERB	O	O
response	NOUN	O	B-outcome
rate	NOUN	O	O
criteria	NOUN	O	O
of	ADP	O	O
at	ADP	O	O
least	ADV	O	O
10%	ADP	O	O
to	PART	O	O
expand	NOUN	O	O
accrual	ADJ	O	O
to	PART	O	O
the	DET	O	O
intended	VERB	O	O
sample	NOUN	O	O
size.	NOUN	O	O

Two	NUM	O	O
patients	NOUN	O	O
presented	VERB	O	O
a	DET	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
event	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
study	NOUN	O	O
(one	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group)	ADJ	O	O
but	CCONJ	O	O
non-attributable	ADJ	O	O
to	PART	O	O
the	DET	O	O
treatment	NOUN	O	O
studied.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
IBU-alone	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
HS-PCM	NOUN	O	O
+	SYM	O	O
IBU	NOUN	O	O
(2	PUNCT	O	O
mg	NOUN	O	O
[99.6%	NOUN	O	O
CI,	NOUN	O	O
-10	NUM	O	O
to	PART	O	O
7];	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.81).	PUNCT	O	O

BTX-A	NOUN	O	O
is	VERB	O	O
thus	ADV	O	O
a	DET	O	O
potential	ADJ	O	O
treatment	NOUN	O	O
option	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
intractable	ADJ	O	O
DED.	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

Efficacy	NOUN	O	O
of	ADP	O	O
school-based	VERB	O	O
surveillance	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
for	ADP	O	O
detection	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	B-outcome
pharyngitis	NOUN	O	I-outcome
and	CCONJ	O	O
rheumatic	ADJ	O	B-outcome
fever/rheumatic	ADJ	O	I-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(RF/RHD)	NOUN	O	I-outcome
in	ADP	O	O
Shimla	NOUN	O	O
district,	NOUN	O	O
HP.	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	B-outcome
sore	ADV	O	I-outcome
throat	NOUN	O	I-outcome
was	VERB	O	O
monitored	VERB	O	O
at	ADP	O	O
0,	NUM	O	O
2,	NOUN	O	O
4,	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
hours	NOUN	O	O
postoperatively.	NOUN	O	O

Compliance	NOUN	O	B-outcome
rates	NOUN	O	O
varied	VERB	O	O
between	ADP	O	O
intervention-arms.	NOUN	O	O

Decreases	NOUN	O	O
in	ADP	O	O
savory	ADJ	O	B-outcome
and	CCONJ	O	Seperator
sweet	ADJ	O	I-outcome
snack	NOUN	O	I-outcome
intake	NOUN	O	I-outcome
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
lower	ADJ	O	O
HOMA-IR	ADV	O	B-outcome
3(-)8	ADJ	O	O
years	NOUN	O	O
later,	ADV	O	O
but	CCONJ	O	O
these	DET	O	O
associations	NOUN	O	O
disappeared	VERB	O	O
after	ADP	O	O
adjustment	NOUN	O	O
for	ADP	O	O
current	ADJ	O	O
lifestyle.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/15	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
Using	VERB	O	O
misoprostol	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
postpartum	NOUN	O	O
hemorrhage	NOUN	O	O
in	ADP	O	O
home	NOUN	O	O
deliveries	NOUN	O	O
attended	VERB	O	O
by	ADP	O	O
traditional	ADJ	O	O
birth	NOUN	O	O
attendants.	NOUN	O	O

No	DET	O	O
patients	NOUN	O	O
reported	VERB	O	O
intraoperative	ADJ	O	B-outcome
awareness	ADV	O	I-outcome
.	PUNCT	O	O
Postoperative	ADJ	O	O
nausea	NOUN	O	B-outcome
and	CCONJ	O	Seperator
vomiting	VERB	O	I-outcome
was	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
48	NUM	O	O
patients	NOUN	O	O
(7.8%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
guided	VERB	O	O
and	CCONJ	O	O
55	NUM	O	O
patients	NOUN	O	O
(8.9%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

After	ADP	O	O
surgery,	NOUN	O	O
the	DET	O	O
intraocular	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
significantly	ADV	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

Biochemical	ADJ	O	O
parameters	NOUN	O	O
including	VERB	O	O
fasting	VERB	O	B-outcome
plasma	NOUN	O	I-outcome
glucose	NOUN	O	I-outcome
(FPG)	NOUN	O	I-outcome
,	PUNCT	O	O
2-hour	NOUN	O	B-outcome
plasma	NOUN	O	I-outcome
glucose	NOUN	O	I-outcome
(2hPG)	PUNCT	O	I-outcome
,	PUNCT	O	O
glycosylated	VERB	O	B-outcome
hemoglobin	NOUN	O	I-outcome
A1c	ADV	O	I-outcome
(HbA1c)	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
among	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
6-month	NOUN	O	O
and	CCONJ	O	O
12-month.	NUM	O	O
[	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/18	NOUN	O	O
06:00'	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/09	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Toxicon	NOUN	O	O
:	PUNCT	O	O
official	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
on	ADP	O	O
Toxinology	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

While	ADP	O	O
Atorvastatin	ADP	O	O
80mg	NOUN	O	O
results	NOUN	O	O
in	ADP	O	O
LDL	NOUN	O	B-outcome
reduction	NOUN	O	O
as	ADP	O	O
50.11+/-15.85	NUM	O	O
&	CCONJ	O	O
52.30+/-13.72.	NOUN	O	O

All	DET	O	O
together	ADV	O	O
219	NUM	O	O
women	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
within	ADP	O	O
each	DET	O	O
sub-study,	NOUN	O	O
of	ADP	O	O
whom	ADP	O	O
74	NUM	O	O
and	CCONJ	O	O
68%	NUM	O	O
had	VERB	O	O
adequate	ADJ	O	O
questionnaire	NOUN	O	O
data	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
and	CCONJ	O	O
12	NUM	O	O
months,	NOUN	O	O
respectively.	NOUN	O	O

AmBisome	NOUN	O	O
monotherapy	NOUN	O	O
at	ADP	O	O
40	NUM	O	O
mg/kg	NOUN	O	O
is	VERB	O	O
recommended	VERB	O	O
by	ADP	O	O
the	DET	O	O
World	NOUN	O	O
Health	NOUN	O	O
Organization.	NOUN	O	O

The	DET	O	O
endpoints	NOUN	O	O
were	VERB	O	O
radiation-induced	VERB	O	O
esophagitis	NOUN	O	B-outcome
,	PUNCT	O	O
mucositis	NOUN	O	B-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
loss,	NOUN	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
and	CCONJ	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
The	DET	O	O
60	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
NSCLC	NOUN	O	O
included	VERB	O	O
42	NUM	O	O
men	NOUN	O	O
and	CCONJ	O	O
18	NUM	O	O
women	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
+/-	SYM	O	O
standard	ADJ	O	O
deviation	NOUN	O	O
of	ADP	O	O
60.3	NUM	O	O
years	NOUN	O	O
+/-	SYM	O	O
18.2	NUM	O	O
(range,	NOUN	O	O
44-78	NUM	O	O
years).At	NOUN	O	O
a	DET	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
of	ADP	O	O
26.4	NUM	O	O
months	NOUN	O	O
(range	PUNCT	O	O
10.4-32.2),	NOUN	O	O
all	DET	O	O
patients	NOUN	O	O
tolerated	VERB	O	B-outcome
GLN	NOUN	O	O
well.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
24th	ADJ	O	O
hour	NOUN	O	O
tramadol	NOUN	O	B-outcome
consumption.	NOUN	O	O

as	ADP	O	O
found	VERB	O	O
in	ADP	O	O
the	DET	O	O
fresh	ADJ	O	O
wild	ADJ	O	O
amla	NOUN	O	O
fruit)	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
dyslipidemia.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
study	NOUN	O	O
whether	ADP	O	O
oxycodone	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
an	DET	O	O
effective	ADJ	O	O
alternative	ADJ	O	O
for	ADP	O	O
fentanyl	NOUN	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
early	ADJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
after	ADP	O	O
total	ADJ	O	O
hip	NOUN	O	O
replacement.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
intention-to-treat	NOUN	O	O
population	NOUN	O	O
included	VERB	O	O
386	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
omadacycline	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
388	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
moxifloxacin	NOUN	O	O
group.	VERB	O	O

METHODS:	NOUN	O	O
Sixty-nine	NUM	O	O
patients	NOUN	O	O
receiving	VERB	O	O
VATS	NOUN	O	O
lobectomy	NOUN	O	O
in	ADP	O	O
Department	NOUN	O	O
of	ADP	O	O
Thoracic	ADJ	O	O
Surgery,	NOUN	O	O
West	ADP	O	O
China	NOUN	O	O
Hospital,	ADJ	O	O
Sichuan	NOUN	O	O
University	NOUN	O	O
from	ADP	O	O
September	NOUN	O	O
15,	NUM	O	O
2017	NUM	O	O
to	PART	O	O
January	NOUN	O	O
15,	NUM	O	O
2018	NUM	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
the	DET	O	O
acapella	ADP	O	O
group	NOUN	O	O
(AG)	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG).	NUM	O	O

Title:	NOUN	O	O
Body	NOUN	O	O
posture	ADJ	O	O
and	CCONJ	O	O
physical	ADJ	O	O
activity	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
diagnosed	VERB	O	O
with	ADP	O	O
asthma	NOUN	O	O
and	CCONJ	O	O
allergies	NOUN	O	O
symptoms:	NOUN	O	O
A	DET	O	O
report	NOUN	O	O
from	ADP	O	O
randomized	VERB	O	O
observational	ADJ	O	O
studies.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

After	ADP	O	O
adjustment	NOUN	O	O
for	ADP	O	O
confounders,	NOUN	O	O
the	DET	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
significant	ADJ	O	O
(odds	NOUN	O	O
ratio	NOUN	O	O
0.88,	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
0.70	NUM	O	O
to	PART	O	O
1.20).	NOUN	O	O

However,	ADV	O	O
knowledge	NOUN	O	O
about	ADV	O	O
their	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
hemodynamics	NOUN	O	O
and	CCONJ	O	O
cardiac	ADJ	O	O
efficiency	NOUN	O	O
remains	NOUN	O	O
limited	VERB	O	O
due	ADJ	O	O
largely	ADV	O	O
to	PART	O	O
the	DET	O	O
lack	NOUN	O	O
of	ADP	O	O
direct	ADJ	O	O
monitoring	VERB	O	O
method.	NOUN	O	O

Results:	NOUN	O	O
HP/TAZ	NOUN	O	O
lotion	NOUN	O	O
demonstrated	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
superiority	NOUN	O	O
at	ADP	O	O
week	NOUN	O	O
8	NUM	O	O
(versus	NOUN	O	O
TAZ	NOUN	O	O
and	CCONJ	O	O
vehicle)	NOUN	O	O
and	CCONJ	O	O
week	NOUN	O	O
12	NUM	O	O
(versus	NOUN	O	O
HP,	NOUN	O	O
TAZ,	NOUN	O	O
and	CCONJ	O	O
vehicle).	NOUN	O	O

Journal-Name:The	ADJ	O	O
Lancet.	NOUN	O	O

Various	ADJ	O	O
pharmacological	ADJ	O	O
agents,	NOUN	O	O
with	ADP	O	O
the	DET	O	O
exception	NOUN	O	O
of	ADP	O	O
calcium	NOUN	O	O
channel	NOUN	O	O
blockers,	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
investigated	VERB	O	O
to	PART	O	O
improve	VERB	O	O
ET	NOUN	O	O
outcomes	NOUN	O	O
by	ADP	O	O
reducing	VERB	O	O
UC.	ADJ	O	O

Title:	NOUN	O	O
Spirometric	ADJ	O	B-outcome
changes	NOUN	O	O
during	ADP	O	O
exacerbations	NOUN	O	O
of	ADP	O	O
COPD:	NOUN	O	O
a	DET	O	O
post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
WISDOM	NOUN	O	O
trial.	NOUN	O	O

The	DET	O	O
current	ADJ	O	O
study	NOUN	O	O
combined	VERB	O	O
hedonic	ADJ	O	O
liking	VERB	O	O
with	ADP	O	O
non-hypothetical	ADJ	O	O
experimental	ADJ	O	O
auctions	NOUN	O	O
to	PART	O	O
measure	NOUN	O	O
consumer	NOUN	O	O
preferences	NOUN	O	B-outcome
for	ADP	O	O
bitter	NOUN	O	O
tasting	VERB	O	O
food	NOUN	O	O
and	CCONJ	O	O
identify	NOUN	O	O
individual	ADJ	O	O
socio-demographic	ADJ	O	O
and	CCONJ	O	O
psychographic	ADJ	O	O
characteristics	NOUN	O	O
that	ADP	O	O
influence	NOUN	O	O
bitter	NOUN	O	B-outcome
aversion	NOUN	O	I-outcome
.	PUNCT	O	O
Furthermore,	NOUN	O	O
the	DET	O	O
research	NOUN	O	O
analyzed	VERB	O	O
whether	ADP	O	O
consumer	NOUN	O	O
preferences	NOUN	O	B-outcome
for	ADP	O	O
bitter	NOUN	O	O
food	NOUN	O	O
were	VERB	O	O
influenced	VERB	O	O
by	ADP	O	O
sensory	ADJ	O	O
and	CCONJ	O	O
health-related	VERB	O	O
information.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968551	NUM	O	O

Furthermore,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
between	ADP	O	O
all	DET	O	O
measured	VERB	O	O
variables	NOUN	O	O
for	ADP	O	O
the	DET	O	O
EG	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
CG	NOUN	O	O
at	ADP	O	O
the	DET	O	O
final	ADJ	O	O
assessment.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
173	NUM	O	O
with	ADP	O	O
complete	ADJ	O	O
before-and	CCONJ	O	O
after-digital	ADJ	O	O
images	NOUN	O	O
of	ADP	O	O
the	DET	O	O
teeth.	NOUN	O	O

In	ADP	O	O
23	NUM	O	O
research	NOUN	O	O
centers	NOUN	O	O
in	ADP	O	O
Spain,	ADV	O	O
6874	NUM	O	O
men	NOUN	O	O
and	CCONJ	O	O
women	NOUN	O	O
aged	VERB	O	O
55	NUM	O	O
to	PART	O	O
75	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
metabolic	ADJ	O	O
syndrome	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
cardiovascular	ADJ	O	O
disease	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
between	ADP	O	O
September	NOUN	O	O
2013	NUM	O	O
and	CCONJ	O	O
December	NOUN	O	O
2016,	NUM	O	O
with	ADP	O	O
final	ADJ	O	O
data	NOUN	O	O
collection	NOUN	O	O
in	ADP	O	O
March	NOUN	O	O
2019.	NUM	O	O

Patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
dimethyldiguanide	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
clomifene	NOUN	O	O
citrate,	NOUN	O	O
while	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
alone.	NOUN	O	O

This	DET	O	O
8-week	NOUN	O	O
trial	NOUN	O	O
includes	NOUN	O	O
four	NUM	O	O
two-weekly	NOUN	O	O
standard	ADJ	O	O
doses	NOUN	O	O
of	ADP	O	O
PZQ	NOUN	O	O
in	ADP	O	O
the	DET	O	O
"intense	PUNCT	O	O
treatment"	NOUN	O	O
intervention	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
one	NUM	O	O
standard	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
PZQ	NOUN	O	O
in	ADP	O	O
the	DET	O	O
"standard	VERB	O	O
treatment"	NOUN	O	O
control	NOUN	O	O
group.	VERB	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/15	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

AIMS:	VERB	O	O
The	DET	O	O
aims	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
were	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
use	NOUN	O	B-outcome
of	ADP	O	I-outcome
resources	NOUN	O	I-outcome
,	PUNCT	O	O
costs	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
outcomes	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
subacromial	ADJ	O	O
decompression,	NOUN	O	O
arthroscopy	NOUN	O	O
only	ADV	O	O
(placebo	PUNCT	O	O
surgery),	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
treatment	NOUN	O	O
for	ADP	O	O
subacromial	ADJ	O	O
pain	NOUN	O	O
in	ADP	O	O
the	DET	O	O
United	VERB	O	O
Kingdom	NOUN	O	O
National	ADJ	O	O
Health	NOUN	O	O
Service	NOUN	O	O
(NHS),	NUM	O	O
and	CCONJ	O	O
to	PART	O	O
estimate	ADP	O	O
their	ADJ	O	O
cost-effectiveness.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ISRCTN	NOUN	O	O
99322160	NUM	O	O
,	PUNCT	O	O
01/10/2018.	NUM	O	O

Background:	NOUN	O	O
A	DET	O	O
unique	ADJ	O	O
fixed	VERB	O	O
combination	NOUN	O	O
halobetasol	NOUN	O	O
propionate	NOUN	O	O
0.01%	NOUN	O	O
and	CCONJ	O	O
tazarotene	NOUN	O	O
0.045%	NUM	O	O
(HP/TAZ)	PUNCT	O	O
lotion	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
shown	VERB	O	O
to	PART	O	O
be	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
psoriasis	NOUN	O	O
using	VERB	O	O
Investigator	NOUN	O	O
Global	NOUN	O	O
Assessment	NOUN	O	O
(IGA)	NOUN	O	O
tools	NOUN	O	O
to	PART	O	O
assess	NOUN	O	O
erythema,	ADJ	O	O
plaque	NOUN	O	O
elevation,	NOUN	O	O
and	CCONJ	O	O
scaling.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

As	ADP	O	O
compared	VERB	O	O
to	PART	O	O
inhalational	ADJ	O	O
sevoflurane,	ADJ	O	O
intravenous	ADJ	O	O
sufentanil-midazolam	NOUN	O	O
exerts	NOUN	O	O
more	ADV	O	O
favorable	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
systemic	ADJ	O	B-outcome
hemodynamics	NOUN	O	I-outcome
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
efficiency	NOUN	O	O
during	ADP	O	O
anesthetic	ADJ	O	O
induction	NOUN	O	O
in	ADP	O	O
this	DET	O	O
group	NOUN	O	O
of	ADP	O	O
patients.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome,	ADJ	O	O
hemoglobin	NOUN	O	B-outcome
decrease	NOUN	O	O
of	ADP	O	O
20	NUM	O	O
g/L	NOUN	O	O
or	CCONJ	O	O
greater	ADJ	O	O
from	ADP	O	O
pre-	ADJ	O	O
to	PART	O	O
post-delivery	NOUN	O	O
assessment,	NOUN	O	O
was	VERB	O	O
compared	VERB	O	O
on	ADP	O	O
a	DET	O	O
modified	VERB	O	O
intention-to-treat	NOUN	O	O
basis.	NUM	O	O

For	ADP	O	O
the	DET	O	O
project	NOUN	O	O
manager,	NOUN	O	O
achieving	VERB	O	O
good	ADJ	O	O
scientific	ADJ	O	O
results	NOUN	O	O
was	VERB	O	O
highlighted	VERB	O	O
as	ADP	O	O
well.	NOUN	O	O

RESULTS:	NOUN	O	O
Of	ADP	O	O
the	DET	O	O
1218	NUM	O	O
open	ADJ	O	O
fracture	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
complete	ADJ	O	O
data	NOUN	O	O
available	ADJ	O	O
for	ADP	O	O
analysis,	NOUN	O	O
813	NUM	O	O
(66.7%)	NUM	O	O
reported	VERB	O	O
moderate	ADJ	O	O
to	PART	O	O
extreme	NOUN	O	O
pain	NOUN	O	B-outcome
at	ADP	O	O
1	NUM	O	O
yr.	PUNCT	O	O

There	PRON	O	O
is	VERB	O	O
no	DET	O	O
standard	ADJ	O	O
of	ADP	O	O
care.	NOUN	O	O

Title:	NOUN	O	O
Observation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
curative	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
device-guided	VERB	O	O
rehabilitation	NOUN	O	O
on	ADP	O	O
respiratory	ADJ	O	B-outcome
function	NOUN	O	I-outcome
in	ADP	O	O
stable	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
obstructive	ADJ	O	O
pulmonary	ADJ	O	O
disease.	NOUN	O	O

AIM	NOUN	O	O
OF	ADP	O	O
THE	DET	O	O
STUDY:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
BT-11	NOUN	O	O
in	ADP	O	O
human	NOUN	O	O
aged	VERB	O	O
from	ADP	O	O
9	NUM	O	O
to	PART	O	O
19	NUM	O	O
years	NOUN	O	O
old.	NUM	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
volunteers	NOUN	O	O
had	VERB	O	O
a	DET	O	O
level	NOUN	O	O
of	ADP	O	O
education	NOUN	O	O
from	ADP	O	O
incomplete	ADJ	O	O
junior	NOUN	O	O
school	NOUN	O	O
to	PART	O	O
complete	ADJ	O	O
graduate	NOUN	O	O
course,	NOUN	O	O
with	ADP	O	O
16	NUM	O	O
males	NOUN	O	O
(48%)	NOUN	O	O
and	CCONJ	O	O
18	NUM	O	O
females	NOUN	O	O
(52%),	PUNCT	O	O
age	NOUN	O	O
range	NOUN	O	O
of	ADP	O	O
21	NUM	O	O
to	PART	O	O
87	NUM	O	O
years.	NOUN	O	O

Objective:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
ExMI	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
stress	NOUN	O	O
UI	NOUN	O	O
in	ADP	O	O
women.	NOUN	O	O

Among	ADP	O	O
healthy	ADJ	O	O
children,	NOUN	O	O
percentages	NOUN	O	O
of	ADP	O	O
the	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
active	ADJ	O	O
children	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
inactive	ADJ	O	O
children.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

Anti-CT694	NOUN	O	B-outcome
responses	NOUN	O	I-outcome
increased	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
study	NOUN	O	O
arms	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.009	NUM	O	O
for	ADP	O	O
control	NOUN	O	O
arm	NOUN	O	O
and	CCONJ	O	O
p	NOUN	O	O
=	SYM	O	O
0.04	NUM	O	O
for	ADP	O	O
treatment	NOUN	O	O
arm).	ADP	O	O

The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
pilates	NOUN	O	O
exercises	NOUN	O	O
on	ADP	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
of	ADP	O	O
CKD	NOUN	O	O
patients.	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
23	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
parts	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
B	NOUN	O	O
and	CCONJ	O	O
17	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
part	NOUN	O	O
C	NOUN	O	O
underwent	VERB	O	O
randomization.	NOUN	O	O

Maintaining	VERB	O	O
vaccine	NOUN	O	O
coverage	NOUN	O	O
is	VERB	O	O
key	ADJ	O	O
to	PART	O	O
avoid	NOUN	O	O
the	DET	O	O
devastating	VERB	O	O
consequences	NOUN	O	O
of	ADP	O	O
resurgence.	NOUN	O	O

Scapular	ADJ	O	B-outcome
upward	ADJ	O	I-outcome
rotation	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
change	NOUN	O	O
after	ADP	O	O
taping	VERB	O	O
in	ADP	O	O
any	DET	O	O
group	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0135043	NUM	O	O

Regression	NOUN	O	O
models	NOUN	O	O
that	ADP	O	O
show	VERB	O	O
the	DET	O	O
collaborative	ADJ	O	O
relationship	NOUN	O	O
between	ADP	O	O
mother	NOUN	O	O
and	CCONJ	O	O
child,	NOUN	O	O
and	CCONJ	O	O
their	ADJ	O	O
reciprocity	NOUN	O	O
in	ADP	O	O
the	DET	O	O
process	NOUN	O	O
of	ADP	O	O
adaptation	NOUN	O	O
were	VERB	O	O
proposed.	NOUN	O	O

Title:	NOUN	O	O
High-intensity	NOUN	O	O
interval	NOUN	O	O
training	VERB	O	O
and	CCONJ	O	O
moderate-intensity	NOUN	O	O
continuous	ADJ	O	O
training	VERB	O	O
in	ADP	O	O
adults	NOUN	O	O
with	ADP	O	O
Crohn's	NOUN	O	O
disease:	NOUN	O	O
a	DET	O	O
pilot	NOUN	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O


It	PRON	O	O
has	VERB	O	O
proven	VERB	O	O
properties	NOUN	O	O
like	ADP	O	O
anti-inflammatory,	NOUN	O	O
antioxidant,	NOUN	O	O
antimicrobial,	ADJ	O	O
hepatoprotective,	NOUN	O	O
immunostimulant,	NOUN	O	O
antiseptic,	NOUN	O	O
antimutagenic,	VERB	O	O
and	CCONJ	O	O
it	PRON	O	O
also	ADV	O	O
accelerates	NOUN	O	O
wound	NOUN	O	O
healing.	NOUN	O	O

Self-reported	VERB	O	O
pain	NOUN	O	B-outcome
measures,	NOUN	O	O
observed	VERB	O	O
pain	NOUN	O	B-outcome
measures,	NOUN	O	O
and	CCONJ	O	O
observed	VERB	O	O
measures	NOUN	O	O
of	ADP	O	O
pedaling	VERB	O	O
adherence	NOUN	O	B-outcome
were	VERB	O	O
collected	VERB	O	O
for	ADP	O	O
each	DET	O	O
participant.	NOUN	O	O

The	DET	O	O
current	ADJ	O	O
randomized,	NOUN	O	O
cross-over	NOUN	O	O
behavioral	ADJ	O	O
trial	NOUN	O	O
tried	VERB	O	O
to	PART	O	O
bridge	NOUN	O	O
the	DET	O	O
latter	NOUN	O	O
gaps.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
tretinoin	NOUN	O	O
0.05%	NUM	O	O
lotion	NOUN	O	O
in	ADP	O	O
treating	VERB	O	O
moderate-to-severe	ADV	O	O
acne	NOUN	O	O
in	ADP	O	O
a	DET	O	O
Hispanic	ADJ	O	O
population.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Consumption	NOUN	O	O
of	ADP	O	O
WPI	NOUN	O	O
significantly	ADV	O	O
improved	VERB	O	O
active	ADJ	O	B-outcome
B12	NOUN	O	I-outcome
and	CCONJ	O	O
folate	NOUN	O	B-outcome
status	NOUN	O	O
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
direct	ADJ	O	O
improvements	NOUN	O	O
in	ADP	O	O
cognitive	ADJ	O	B-outcome
function	NOUN	O	I-outcome
.	PUNCT	O	O
However,	ADV	O	O
there	PRON	O	O
was	VERB	O	O
evidence	NOUN	O	O
of	ADP	O	O
improvement	NOUN	O	O
in	ADP	O	O
reaction	NOUN	O	B-outcome
time	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.02)	NUM	O	O
and	CCONJ	O	O
reasoning	VERB	O	B-outcome
speed	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.04)	NUM	O	O
in	ADP	O	O
the	DET	O	O
SPI	NOUN	O	O
condition	NOUN	O	O
for	ADP	O	O
females.	ADP	O	O

The	DET	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
rates	NOUN	O	O
at	ADP	O	O
1,	NOUN	O	O
5,	ADJ	O	O
and	CCONJ	O	O
10	NUM	O	O
years	NOUN	O	O
were	VERB	O	O
96.7%,	NOUN	O	O
53.3%,	NUM	O	O
and	CCONJ	O	O
43.3%,	NUM	O	O
respectively,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
CC	NOUN	O	O
group,	NOUN	O	O
and	CCONJ	O	O
96.7%,	NOUN	O	O
43.3%,	NUM	O	O
and	CCONJ	O	O
33.3%,	NUM	O	O
respectively,	NOUN	O	O
in	ADP	O	O
the	DET	O	O
RC	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.346).	NOUN	O	O

Osmotic-release	NOUN	O	O
oral	ADJ	O	O
system	NOUN	O	O
methylphenidate	NOUN	O	O
was	VERB	O	O
dose	NOUN	O	O
optimized	VERB	O	O
over	ADP	O	O
the	DET	O	O
first	ADV	O	O
6	NUM	O	O
weeks.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/12	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Results:	NOUN	O	O
The	DET	O	O
improvement	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Yale-Brown	NOUN	O	O
Obsessive	ADJ	O	B-outcome
Compulsive	ADJ	O	I-outcome
Scale	NOUN	O	O
(Y-BOCS)	NUM	O	O
total	ADJ	O	O
score,	NOUN	O	O
Yale-Brown	NOUN	O	O
Obsessive	ADJ	O	B-outcome
Compulsive	ADJ	O	I-outcome
Scale	NOUN	O	O
(Y-BOCS)	NUM	O	O
obsession	NOUN	O	B-outcome
subscale	NOUN	O	O
score	NOUN	O	O
and	CCONJ	O	O
Hamilton	ADV	O	O
Anxiety	NOUN	O	B-outcome
Scale	NOUN	O	O
(HAMA)	PUNCT	O	O
score	NOUN	O	O
were	VERB	O	O
more	ADV	O	O
prominent	ADJ	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P<0.001).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/08	ADP	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

CONCLUSION:	NOUN	O	O
PRP	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
improving	VERB	O	O
the	DET	O	O
endometrial	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
possibly	ADV	O	O
pregnancy	NOUN	O	B-outcome
outcomes	NOUN	O	I-outcome
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
a	DET	O	O
thin	ADJ	O	O
endometrium.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
pain	NOUN	O	B-outcome
scores	NOUN	O	O
of	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
reduced	VERB	O	O
after	ADP	O	O
treatment,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
difference	NOUN	O	O
was	VERB	O	O
significant	ADJ	O	O
between	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
group	NOUN	O	O
B	NOUN	O	O
[(1.1+/-0.4)	NOUN	O	O
vs	CCONJ	O	O
(3.2+/-	PUNCT	O	O
0.6)	NUM	O	O
(P<0.05).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
These	DET	O	O
findings	NOUN	O	O
call	ADV	O	O
into	ADP	O	O
question	NOUN	O	O
the	DET	O	O
validity	NOUN	O	O
of	ADP	O	O
the	DET	O	O
self-affirmation	NOUN	O	O
manipulation,	NOUN	O	O
which	ADP	O	O
is	VERB	O	O
purported	VERB	O	O
to	PART	O	O
reduce	VERB	O	O
defensive	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
to	PART	O	O
threatening	VERB	O	O
warnings.	NOUN	O	O

The	DET	O	O
TBW	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
251)	NOUN	O	O
was	VERB	O	O
injected	VERB	O	O
with	ADP	O	O
600	NUM	O	O
mg	NOUN	O	O
iodine/kg	DET	O	O
TBW.	NOUN	O	O

Functional	ADJ	O	B-outcome
outcomes	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
DHA	NOUN	O	O
status	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
remained	VERB	O	O
unchanged	VERB	O	O
by	ADP	O	O
supplementation.	NOUN	O	O

During	ADP	O	O
each	DET	O	O
session,	NOUN	O	O
participants	NOUN	O	O
used	VERB	O	O
one	NUM	O	O
of	ADP	O	O
three	NUM	O	O
products	NOUN	O	O
(cigarette,	PUNCT	O	O
e-cigarette,	PUNCT	O	O
or	CCONJ	O	O
IQOS(TM))	NOUN	O	O
for	ADP	O	O
five	NUM	O	O
minutes.	ADJ	O	O

Eligible	ADJ	O	O
participants	NOUN	O	O
are	VERB	O	O
HIV-infected	VERB	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
aged	VERB	O	O
15	NUM	O	O
to	PART	O	O
49	NUM	O	O
years	NOUN	O	O
and	CCONJ	O	O
have	VERB	O	O
a	DET	O	O
singleton	NOUN	O	O
gestation	NOUN	O	O
at	ADP	O	O
14	NUM	O	O
to	PART	O	O
27	NUM	O	O
weeks'	ADP	O	O
gestation.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
an	DET	O	O
MRI-guided	VERB	O	O
treat-to-target	NOUN	O	O
strategy	NOUN	O	O
vs	CCONJ	O	O
a	DET	O	O
conventional	ADJ	O	O
clinical	ADJ	O	O
treat-to-target	NOUN	O	O
strategy	NOUN	O	O
improves	NOUN	O	O
outcomes	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
RA	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
remission.	ADV	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
higher	ADJ	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
regarding	VERB	O	O
complete	ADJ	O	O
success	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
that	ADP	O	O
received	VERB	O	O
Ologen(R)	NOUN	O	O
implant	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.04).	NUM	O	O

No	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
reported	VERB	O	O
between	ADP	O	O
dietary	ADJ	O	O
conditions	NOUN	O	O
for	ADP	O	O
plasma	NOUN	O	O
intestinal	ADJ	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
binding	VERB	O	I-outcome
protein	NOUN	O	I-outcome
(I-FABP)	ADV	O	I-outcome
(P	NUM	O	O
>	SYM	O	O
0.05).	NOUN	O	O

Title:	NOUN	O	O
Optimising	VERB	O	O
the	DET	O	O
antibiotic	ADJ	O	O
treatment	NOUN	O	O
of	ADP	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis:	NOUN	O	O
a	DET	O	O
protocol	NOUN	O	O
for	ADP	O	O
a	DET	O	O
multicentre	NOUN	O	O
randomised	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
(APPAC	PUNCT	O	O
II	NUM	O	O
trial).	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
aim	ADP	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
non-inferiority	NOUN	O	O
of	ADP	O	O
the	DET	O	O
reduction	NOUN	O	O
of	ADP	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
short	ADJ	O	O
protocol	NOUN	O	O
versus	CCONJ	O	O
the	DET	O	O
long	ADV	O	O
protocol.	NOUN	O	O

Title:	NOUN	O	O
Process	NOUN	O	O
evaluation	NOUN	O	O
of	ADP	O	O
a	DET	O	O
pilot	NOUN	O	O
multi-component	ADJ	O	O
physical	ADJ	O	O
activity	NOUN	O	O
intervention	NOUN	O	O
-	PUNCT	O	O
active	ADJ	O	O
schools:	NOUN	O	O
Skelmersdale.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
study	NOUN	O	O
also	ADV	O	O
examines	NOUN	O	O
the	DET	O	O
cost	NOUN	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
this	DET	O	O
therapy	NOUN	O	O
in	ADP	O	O
this	DET	O	O
setting	VERB	O	O
through	ADP	O	O
examination	NOUN	O	O
of	ADP	O	O
health	NOUN	O	O
care	NOUN	O	O
service	NOUN	O	O
utilisation	NOUN	O	O
across	ADP	O	O
groups	NOUN	O	O
during	ADP	O	O
the	DET	O	O
first	ADV	O	O
3	NUM	O	O
months.	NOUN	O	O

Overall	ADV	O	O
incidence	NOUN	O	O
of	ADP	O	O
total	ADJ	O	O
side	NOUN	O	B-outcome
effects	NOUN	O	I-outcome
in	ADP	O	O
FZD	NOUN	O	O
and	CCONJ	O	O
CLA	NOUN	O	O
groups	NOUN	O	O
was	VERB	O	O
19.57%	NUM	O	O
and	CCONJ	O	O
13.98%,	NOUN	O	O
and	CCONJ	O	O
their	ADJ	O	O
severe	ADJ	O	B-outcome
side	NOUN	O	I-outcome
effects	NOUN	O	I-outcome
were	VERB	O	O
3.26%	NOUN	O	O
and	CCONJ	O	O
2.15%,	NUM	O	O
respectively	ADV	O	O
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

The	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
included	VERB	O	O
102	NUM	O	O
healthy	ADJ	O	O
children	NOUN	O	O
at	ADP	O	O
the	DET	O	O
similar	ADJ	O	O
age	NOUN	O	O
(x	PUNCT	O	O
=	SYM	O	O
10.64	NUM	O	O
+/-	SYM	O	O
1.1).	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
Effects	NOUN	O	O
of	ADP	O	O
Adiponectin	NOUN	O	O
and	CCONJ	O	O
Adiponectin	NOUN	O	O
Receptor	NOUN	O	O
1	NUM	O	O
Levels	NOUN	O	O
on	ADP	O	O
Macrovascular	ADJ	O	O
Complications	NOUN	O	O
Among	ADP	O	O
Patients	NOUN	O	O
with	ADP	O	O
Type	NOUN	O	O
2	NUM	O	O
Diabetes	NOUN	O	O
Mellitus.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
of	ADP	O	O
grade	NOUN	O	O
3	NUM	O	O
or	CCONJ	O	O
4	NUM	O	O
occurred	VERB	O	O
in	ADP	O	O
75.9%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
modified-FOLFIRINOX	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
52.9%	NUM	O	O
of	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
gemcitabine	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
disease	NOUN	O	B-outcome
control	NOUN	O	I-outcome
rate	NOUN	O	O
of	ADP	O	O
the	DET	O	O
apatinib	ADP	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
better	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
of	ADP	O	O
the	DET	O	O
observation	NOUN	O	O
group	NOUN	O	O
(70.4%	NUM	O	O
vs	CCONJ	O	O
26.9%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.002).	PUNCT	O	O

Objective:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
a	DET	O	O
nurse-led	VERB	O	O
preventive,	ADJ	O	O
complex	NOUN	O	O
psychological	ADJ	O	O
intervention,	ADP	O	O
initiated	VERB	O	O
in	ADP	O	O
the	DET	O	O
ICU,	ADJ	O	O
reduces	NOUN	O	O
patient-reported	VERB	O	O
posttraumatic	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
(PTSD)	ADV	O	I-outcome
symptom	NOUN	O	I-outcome
severity	NOUN	O	I-outcome
at	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Methods:	NOUN	O	O
From	ADP	O	O
March	NOUN	O	O
2017	NUM	O	O
to	PART	O	O
June	NOUN	O	O
2018,	NUM	O	O
third-year	NOUN	O	O
medical	ADJ	O	O
students	NOUN	O	O
rotating	VERB	O	O
through	ADP	O	O
the	DET	O	O
mandatory,	NOUN	O	O
four-week	NOUN	O	O
emergency	NOUN	O	O
medicine	NOUN	O	O
(EM)	NOUN	O	O
clerkship	NOUN	O	O
at	ADP	O	O
a	DET	O	O
single	ADJ	O	O
medical	ADJ	O	O
school	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
either	CCONJ	O	O
to	PART	O	O
a	DET	O	O
web-based	VERB	O	O
videoconference	NOUN	O	O
meeting	VERB	O	O
via	ADP	O	O
Google	NOUN	O	O
Hangouts,	NOUN	O	O
or	CCONJ	O	O
to	PART	O	O
a	DET	O	O
traditional	ADJ	O	O
in-person	NOUN	O	O
meeting	VERB	O	O
for	ADP	O	O
their	ADJ	O	O
MCF	NOUN	O	O
session.	NOUN	O	O

Depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
were	VERB	O	O
collected	VERB	O	O
by	ADP	O	O
the	DET	O	O
Beck	NOUN	O	O
Depression	NOUN	O	O
Inventory-II].	ADP	O	O
Logistic	ADJ	O	O
regression	NOUN	O	O
models	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
estimate	ADP	O	O
the	DET	O	O
association	NOUN	O	O
between	ADP	O	O
seafood	NOUN	O	O
products	NOUN	O	O
and	CCONJ	O	O
omega-3	NOUN	O	O
PUFA	NOUN	O	O
consumption	NOUN	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
.	PUNCT	O	O
Multiple	ADJ	O	O
linear	ADJ	O	O
regression	NOUN	O	O
models	NOUN	O	O
were	VERB	O	O
fitted	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
association	NOUN	O	O
between	ADP	O	O
fish	NOUN	O	O
and	CCONJ	O	O
long-chain	NOUN	O	O
(LC)	NOUN	O	O
omega-3	NOUN	O	O
PUFA	NOUN	O	O
intake	NOUN	O	O
and	CCONJ	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Out	ADP	O	O
of	ADP	O	O
6587	NUM	O	O
participants,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
1367	NUM	O	O
cases	NOUN	O	O
of	ADP	O	O
depression	NOUN	O	B-outcome
.	PUNCT	O	O
Total	ADJ	O	O
seafood	NOUN	O	O
consumption	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
depression	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
odds	NOUN	O	O
ratios	NOUN	O	O
(ORs)	NOUN	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
intervals	NOUN	O	O
(CIs))	NUM	O	O
for	ADP	O	O
the	DET	O	O
2nd,	NUM	O	O
3rd,	NUM	O	O
and	CCONJ	O	O
4th	ADP	O	O
quintiles	NOUN	O	O
of	ADP	O	O
consumption	NOUN	O	O
of	ADP	O	O
fatty	ADJ	O	O
fish	NOUN	O	O
were	VERB	O	O
0.77	NUM	O	O
(0.63(-)0.94),	PUNCT	O	O
0.71	NUM	O	O
(0.58(-)0.87),	PUNCT	O	O
and	CCONJ	O	O
0.78	NUM	O	O
(0.64(-)0.96),	NUM	O	O
respectively,	NOUN	O	O
and	CCONJ	O	O
p	NOUN	O	O
for	ADP	O	O
trend	NOUN	O	O
=	SYM	O	O
0.759.	NUM	O	O

Interventions:	NOUN	O	O
Patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
1	NUM	O	O
of	ADP	O	O
4	NUM	O	O
groups	NOUN	O	O
receiving	VERB	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
with	ADP	O	O
IV	NUM	O	O
acetaminophen	ADV	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
every	DET	O	O
6	NUM	O	O
hours	NOUN	O	O
for	ADP	O	O
48	NUM	O	O
hours	NOUN	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
sedation	NOUN	O	O
with	ADP	O	O
dexmedetomidine	NOUN	O	O
or	CCONJ	O	O
propofol	NOUN	O	O
starting	VERB	O	O
at	ADP	O	O
chest	NOUN	O	O
closure	NOUN	O	O
and	CCONJ	O	O
continued	NOUN	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
6	NUM	O	O
hours	NOUN	O	O
(acetaminophen	ADV	O	O
and	CCONJ	O	O
dexmedetomidine:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
29;	NUM	O	O
placebo	NOUN	O	O
and	CCONJ	O	O
dexmedetomidine:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
30;	NUM	O	O
acetaminophen	ADV	O	O
and	CCONJ	O	O
propofol:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
31;	NOUN	O	O
placebo	NOUN	O	O
and	CCONJ	O	O
propofol:	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
30).	NOUN	O	O

The	DET	O	O
scores	NOUN	O	O
for	ADP	O	O
the	DET	O	O
HMCs	NOUN	O	O
improved	VERB	O	O
less	ADV	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
area	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
area	NOUN	O	O
for	ADP	O	O
all	DET	O	O
six	NUM	O	O
components,	NOUN	O	O
but	CCONJ	O	O
none	NUM	O	O
of	ADP	O	O
these	DET	O	O
differences	NOUN	O	O
were	VERB	O	O
statistically	ADV	O	O
significant.	NOUN	O	O

Patients	NOUN	O	O
of	ADP	O	O
ldMDCT	NOUN	O	O
group	NOUN	O	O
with	ADP	O	O
large	ADJ	O	O
growth	NOUN	O	O
of	ADP	O	O
nasal	ADJ	O	O
polyps	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.03,	PUNCT	O	O
q	NOUN	O	O
=	SYM	O	O
5.35)	NOUN	O	O
and	CCONJ	O	O
complete	ADJ	O	O
opacification	NOUN	O	O
of	ADP	O	O
sinuses	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.03,	PUNCT	O	O
q	NOUN	O	O
=	SYM	O	O
7.94)	NUM	O	O
had	VERB	O	O
complications	NOUN	O	B-outcome
after	ADP	O	O
sinus	NOUN	O	O
surgeries.	NUM	O	O

Title:	NOUN	O	O
[Can	NOUN	O	O
Perioperative	ADJ	O	O
Oscillating	VERB	O	O
Positive	ADJ	O	O
Expiratory	ADJ	O	O
Pressure	NOUN	O	O
Practice	NOUN	O	O
Enhance	NOUN	O	O
Recovery	NOUN	O	B-outcome
in	ADP	O	O
Lung	NOUN	O	O
Cancer	NOUN	O	O
Patients	NOUN	O	O
Undergoing	VERB	O	O
Thorascopic	ADJ	O	O
Lobectomy?	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study	NOUN	O	O

Poor	ADJ	O	O
ovarian	ADJ	O	O
response	NOUN	O	O
was	VERB	O	O
defined	VERB	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
Bologna	NOUN	O	O
criteria.	NOUN	O	O

Researchers	NOUN	O	O
were	VERB	O	O
masked	VERB	O	O
to	PART	O	O
allocation,	NOUN	O	O
but	CCONJ	O	O
participants	NOUN	O	O
were	VERB	O	O
not.	ADV	O	O

Interventions:	NOUN	O	O
Twenty	NUM	O	O
four	NUM	O	O
ICUs	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
1:1	ADJ	O	O
to	PART	O	O
the	DET	O	O
intervention	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
the	DET	O	O
Surgiflo	NOUN	O	O
Haemostatic	ADJ	O	O
Matrix	NOUN	O	O
(SHM)	NOUN	O	O
group	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
AGS	NOUN	O	O
group	NOUN	O	O
(AGS)	NOUN	O	O
by	ADP	O	O
computer-generated	VERB	O	O
randomization	NOUN	O	O
codes.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

There	PRON	O	O
is	VERB	O	O
a	DET	O	O
need	NOUN	O	O
of	ADP	O	O
future	NOUN	O	O
studies	NOUN	O	O
to	PART	O	O
demonstrate	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
the	DET	O	O
proposed	VERB	O	O
intervention	NOUN	O	O
in	ADP	O	O
endemic	ADJ	O	O
regions	NOUN	O	O
of	ADP	O	O
the	DET	O	O
state.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9420934	NUM	O	O

There	PRON	O	O
are	VERB	O	O
no	DET	O	O
specific	ADJ	O	O
treatment	NOUN	O	O
drugs	NOUN	O	O
and	CCONJ	O	O
vaccine	NOUN	O	O
for	ADP	O	O
Hand	NOUN	O	O
Foot	NOUN	O	O
and	CCONJ	O	O
Mouth	NOUN	O	O
Disease	NOUN	O	O
(HFMD).	PUNCT	O	O

The	DET	O	O
median	ADJ	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(PFS)	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
longer	ADJ	O	O
for	ADP	O	O
apatinib	ADP	O	O
group	NOUN	O	O
than	ADP	O	O
for	ADP	O	O
observation	NOUN	O	O
group	NOUN	O	O
(2.0	NOUN	O	O
vs.	CCONJ	O	O
1.1	NUM	O	O
months;	NOUN	O	O
HR	NOUN	O	O
=	SYM	O	O
3.88;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
1.91-7.88;	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.001).	PUNCT	O	O

This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
describe	NOUN	O	O
the	DET	O	O
playfulness	ADV	O	B-outcome
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
HIV	NOUN	O	O
and	CCONJ	O	O
PHE	NOUN	O	O
on	ADP	O	O
HAART	NOUN	O	O
living	VERB	O	O
in	ADP	O	O
challenging	VERB	O	O
socioeconomic	ADJ	O	O
areas	NOUN	O	O
in	ADP	O	O
South	NOUN	O	O
Africa	PROPN	O	O
aged	VERB	O	O
6	NUM	O	O
months	NOUN	O	O
to	PART	O	O
8	NUM	O	O
years	NOUN	O	O
and	CCONJ	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
preliminary	ADJ	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
play-informed,	NOUN	O	O
caregiver-implemented,	NOUN	O	O
home-based	VERB	O	O
intervention	NOUN	O	O
(PICIHBI)	NOUN	O	O
for	ADP	O	O
improving	VERB	O	O
play.	NOUN	O	O

Serum,	NOUN	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
mononuclear	ADJ	O	O
cells	NOUN	O	O
(PBMCs)	PUNCT	O	O
and	CCONJ	O	O
kidney	NOUN	O	O
biopsy	NOUN	O	O
specimens	NOUN	O	O
were	VERB	O	O
obtained	VERB	O	O
from	ADP	O	O
participants.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered,	VERB	O	O
number	NOUN	O	O
ISRCTN99214271.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/23	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Parents,	NOUN	O	O
caregivers,	NOUN	O	O
and	CCONJ	O	O
outcome	NOUN	O	O
assessors	NOUN	O	O
were	VERB	O	O
unaware	VERB	O	O
of	ADP	O	O
group	NOUN	O	O
assignment.	NOUN	O	O

Outcomes	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
in	ADP	O	O
3	NUM	O	O
randomized	VERB	O	O
conditions	NOUN	O	O
(no	PUNCT	O	O
brace,	NOUN	O	O
forearm	NOUN	O	O
band,	NOUN	O	O
or	CCONJ	O	O
elbow	NOUN	O	O
sleeve).	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
septic	ADJ	O	O
shock,	ADJ	O	O
a	DET	O	O
resuscitation	NOUN	O	O
strategy	NOUN	O	O
targeting	VERB	O	O
normalization	NOUN	O	O
of	ADP	O	O
capillary	NOUN	O	O
refill	NOUN	O	O
time,	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
a	DET	O	O
strategy	NOUN	O	O
targeting	VERB	O	O
serum	NOUN	O	O
lactate	VERB	O	O
levels,	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
reduce	VERB	O	O
all-cause	NOUN	O	O
28-day	NOUN	O	O
mortality	NOUN	O	B-outcome
.	PUNCT	O	O
Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT03078712.	NOUN	O	O

BACKGROUND:	NOUN	O	O
In	ADP	O	O
acquired	VERB	O	O
thrombotic	ADJ	O	O
thrombocytopenic	ADJ	O	O
purpura	NOUN	O	O
(TTP),	PUNCT	O	O
an	DET	O	O
immune-mediated	VERB	O	O
deficiency	NOUN	O	O
of	ADP	O	O
the	DET	O	O
von	ADP	O	O
Willebrand	NOUN	O	O
factor-cleaving	VERB	O	O
protease	NOUN	O	O
ADAMTS13	NOUN	O	O
allows	NOUN	O	O
unrestrained	VERB	O	O
adhesion	NOUN	O	O
of	ADP	O	O
von	ADP	O	O
Willebrand	NOUN	O	O
factor	NOUN	O	O
multimers	NOUN	O	O
to	PART	O	O
platelets	NOUN	O	O
and	CCONJ	O	O
microthrombosis,	NOUN	O	O
which	ADP	O	O
result	VERB	O	O
in	ADP	O	O
thrombocytopenia,	NOUN	O	O
hemolytic	ADJ	O	O
anemia,	NOUN	O	O
and	CCONJ	O	O
tissue	NOUN	O	O
ischemia.	NOUN	O	O

The	DET	O	O
IG	NOUN	O	O
participants	NOUN	O	O
additionally	ADV	O	O
took	VERB	O	O
part	NOUN	O	O
in	ADP	O	O
a	DET	O	O
food	NOUN	O	O
workshop,	NOUN	O	O
five	NUM	O	O
walks	VERB	O	O
and	CCONJ	O	O
received	VERB	O	O
a	DET	O	O
smartphone	NOUN	O	O
application	NOUN	O	O
for	ADP	O	O
three	NUM	O	O
months.	NOUN	O	O

The	DET	O	O
eye-lens	NOUN	O	O
dosemeters	NOUN	O	O
were	VERB	O	O
placed	VERB	O	O
near	ADV	O	O
the	DET	O	O
eye	NOUN	O	O
closest	ADV	O	O
to	PART	O	O
the	DET	O	O
radiation	NOUN	O	O
source	NOUN	O	O
(Carinou,	NOUN	O	O
E.,	NOUN	O	O
Ferrari,	NOUN	O	O
P.,	NOUN	O	O
Bjelac,	NOUN	O	O
O.	ADV	O	O
C.,	NOUN	O	O
Gingaume,	NOUN	O	O
M.,	NOUN	O	O
Merce,	NOUN	O	O
M.	NOUN	O	O
S.	NOUN	O	O
and	CCONJ	O	O
O'Connor,	NOUN	O	O
U.	NOUN	O	O
Eye	NOUN	O	O
lens	NOUN	O	O
monitoring	VERB	O	O
for	ADP	O	O
interventional	ADJ	O	O
radiology	NOUN	O	O
personnel:	NOUN	O	O
dosemeters,	NOUN	O	O
calibration	NOUN	O	O
and	CCONJ	O	O
practical	ADJ	O	O
aspects	NOUN	O	O
of	ADP	O	O
H	NOUN	O	O
p	NOUN	O	O
(3)	PUNCT	O	O
monitoring.	NOUN	O	O

Title:	NOUN	O	O
Navy	ADJ	O	O
Beans	NOUN	O	O
Impact	NOUN	O	O
the	DET	O	O
Stool	NOUN	O	B-outcome
Metabolome	NOUN	O	I-outcome
and	CCONJ	O	O
Metabolic	ADJ	O	B-outcome
Pathways	NOUN	O	O
for	ADP	O	O
Colon	NOUN	O	O
Health	NOUN	O	O
in	ADP	O	O
Cancer	NOUN	O	O
Survivors.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Main	ADJ	O	O
outcome	NOUN	O	O
measures	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
acceptability	NOUN	O	B-outcome
of	ADP	O	O
rehabilitation	NOUN	O	O
sessions	NOUN	O	O
at	ADP	O	O
five	NUM	O	O
and	CCONJ	O	O
ten	NUM	O	O
days	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
(i)	PUNCT	O	O
questionnaires	NOUN	O	O
completed	VERB	O	O
by	ADP	O	O
patient	NOUN	O	O
and	CCONJ	O	O
physiotherapist,	NOUN	O	O
(ii)	PUNCT	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
steps	NOUN	O	B-outcome
performed	VERB	O	O
during	ADP	O	O
sessions,	DET	O	O
(iii)	NUM	O	O
replacement	NOUN	O	B-outcome
of	ADP	O	O
a	DET	O	O
robotic	ADJ	O	O
session	NOUN	O	O
by	ADP	O	O
a	DET	O	O
conventional	ADJ	O	O
one.	PUNCT	O	O

The	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
TEAS	NOUN	O	O
on	ADP	O	O
the	DET	O	O
effective	ADJ	O	O
concentration	NOUN	O	B-outcome
(EC50)	PUNCT	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
suppressing	VERB	O	O
tracheal	ADJ	O	O
extubation	NOUN	O	O
response	NOUN	O	O
in	ADP	O	O
elderly	NOUN	O	O
patients.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
hand	NOUN	O	O
washing	VERB	O	O
and	CCONJ	O	O
personal	ADJ	O	O
hygiene	NOUN	O	O
on	ADP	O	O
hand	NOUN	O	B-outcome
food	NOUN	O	I-outcome
mouth	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
:	PUNCT	O	O
A	DET	O	O
community	NOUN	O	O
intervention	NOUN	O	O
study.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
trial	NOUN	O	O
will	VERB	O	O
adopt	NOUN	O	O
a	DET	O	O
waitlist-control	NOUN	O	O
design	NOUN	O	O
with	ADP	O	O
cluster-randomization	NOUN	O	O
by	ADP	O	O
school.	NOUN	O	O

DHA	NOUN	O	O
supplementation	NOUN	O	O
increased	VERB	O	O
plasma	NOUN	O	O
glycerophospholipid	ADP	O	B-outcome
DHA	NOUN	O	I-outcome
proportional	ADJ	O	O
to	PART	O	O
dose	NOUN	O	O
by	ADP	O	O
0.4%	NOUN	O	O
DHA	NOUN	O	O
per	ADP	O	O
1	NUM	O	O
mg	NOUN	O	O
intake/kg	ADJ	O	O
bodyweight.	NOUN	O	O

Within	ADP	O	O
groups,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
also	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
at	ADP	O	O
different	ADJ	O	O
times	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.05).The	NUM	O	O
rESWT	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
rehabilitation	NOUN	O	O
can	VERB	O	O
quickly	NOUN	O	O
and	CCONJ	O	O
effectively	ADV	O	O
relieve	NOUN	O	O
paralysis	NOUN	O	B-outcome
of	ADP	O	O
lower	ADJ	O	O
extremities,	NOUN	O	O
reduce	VERB	O	O
the	DET	O	O
tension	NOUN	O	B-outcome
of	ADP	O	I-outcome
hamstrings	NOUN	O	I-outcome
and	CCONJ	O	Seperator
calf	NOUN	O	I-outcome
muscles	NOUN	O	S2-outcome
,	PUNCT	O	O
relieve	NOUN	O	O
muscle	NOUN	O	B-outcome
spasm	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
rapidly	ADV	O	O
improve	VERB	O	O
limb	NOUN	O	B-outcome
function	NOUN	O	I-outcome
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
spastic	ADJ	O	O
cerebral	ADJ	O	O
palsy.	NOUN	O	O

METHODS:	NOUN	O	O
Using	VERB	O	O
a	DET	O	O
single-blind,	NOUN	O	O
counterbalanced,	NOUN	O	O
crossover	NOUN	O	O
design,	NOUN	O	O
we	PRON	O	O
compared	VERB	O	O
the	DET	O	O
rehydrating	VERB	O	B-outcome
efficacy	NOUN	O	O
of	ADP	O	O
MW	NOUN	O	O
vs.	CCONJ	O	O
maple-flavored	VERB	O	O
bottled	VERB	O	O
water	NOUN	O	O
(control)	NUM	O	O
in	ADP	O	O
26	NUM	O	O
young	ADJ	O	O
healthy	ADJ	O	O
(22	NOUN	O	O
+/-	SYM	O	O
4	NUM	O	O
yrs.,	ADP	O	O

BMI	NOUN	O	B-outcome
,	PUNCT	O	O
blood	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
composition	NOUN	O	I-outcome
,	PUNCT	O	O
pulse	NOUN	O	B-outcome
wave	NOUN	O	I-outcome
velocity	NOUN	O	I-outcome
,	PUNCT	O	O
glycemic	ADJ	O	B-outcome
parameters	NOUN	O	O
and	CCONJ	O	O
lipid	NOUN	O	B-outcome
profile	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
3(-)8	ADJ	O	O
years	NOUN	O	O
after	ADP	O	O
randomization.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
Amla	NOUN	O	O
extract	NOUN	O	O
has	VERB	O	O
shown	VERB	O	O
significant	ADJ	O	O
potential	ADJ	O	O
in	ADP	O	O
reducing	VERB	O	O
total	ADJ	O	O
cholesterol	NOUN	O	B-outcome
(TC)	NOUN	O	O
and	CCONJ	O	O
triglyceride	NOUN	O	B-outcome
(TG)	NOUN	O	I-outcome
levels	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
lipid	NOUN	O	B-outcome
ratios	NOUN	O	I-outcome
,	PUNCT	O	O
atherogenic	ADJ	O	B-outcome
index	NOUN	O	O
of	ADP	O	O
the	DET	O	O
plasma	NOUN	O	O
(AIP)	NUM	O	O
and	CCONJ	O	O
apoB/apo	NOUN	O	B-outcome
A-I	NOUN	O	I-outcome
in	ADP	O	O
dyslipidemic	ADJ	O	O
persons	NOUN	O	O
and	CCONJ	O	O
thus	ADV	O	O
has	VERB	O	O
scope	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
general	ADJ	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
diabetic	ADJ	O	O
dyslipidemia.	NOUN	O	O

We	PRON	O	O
assessed	VERB	O	O
the	DET	O	O
associations	NOUN	O	O
between	ADP	O	O
infarction	NOUN	O	O
patterns	NOUN	O	O
and	CCONJ	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
using	VERB	O	O
multivariable	ADJ	O	O
Cox	NOUN	O	O
regression	NOUN	O	O
models.	NOUN	O	O

No	DET	O	O
other	ADJ	O	O
associations	NOUN	O	O
between	ADP	O	O
changes	NOUN	O	O
in	ADP	O	O
lifestyle	NOUN	O	B-outcome
or	CCONJ	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
first	ADV	O	O
six	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
randomization	NOUN	O	O
with	ADP	O	O
cardiovascular	ADJ	O	B-outcome
health	NOUN	O	I-outcome
3(-)8	ADJ	O	O
years	NOUN	O	O
later	ADV	O	O
were	VERB	O	O
observed.	NOUN	O	O

Title:	NOUN	O	O
Cardiac	ADJ	O	O
events	NOUN	O	O
after	ADP	O	O
macrolides	NOUN	O	O
or	CCONJ	O	O
fluoroquinolones	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
hospitalized	VERB	O	O
for	ADP	O	O
community-acquired	VERB	O	O
pneumonia:	NOUN	O	O
post-hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
a	DET	O	O
cluster-randomized	VERB	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Radical	ADJ	O	O
Prostatectomy	NOUN	O	O
or	CCONJ	O	O
Watchful	ADJ	O	O
Waiting	VERB	O	O
in	ADP	O	O
Prostate	NOUN	O	O
Cancer	NOUN	O	O
-	PUNCT	O	O
29-Year	NOUN	O	O
Follow-up.	NOUN	O	O

Title:	NOUN	O	O
Omadacycline	NOUN	O	O
for	ADP	O	O
Acute	ADJ	O	O
Bacterial	ADJ	O	O
Skin	NOUN	O	O
and	CCONJ	O	O
Skin-Structure	NOUN	O	O
Infections.	ADV	O	O

In	ADP	O	O
a	DET	O	O
double-blind	ADJ	O	O
multicentric	ADJ	O	O
trial,	NOUN	O	O
109	NUM	O	O
PKU	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
DHA	NOUN	O	O
doses	NOUN	O	O
from	ADP	O	O
0	NUM	O	O
to	PART	O	O
7	NUM	O	O
mg/kg&amp;day	NOUN	O	O
for	ADP	O	O
six	NUM	O	O
months.	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
organ	NOUN	O	B-outcome
dysfunction	NOUN	O	I-outcome
at	ADP	O	O
72	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
randomization,	NOUN	O	O
as	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
Sequential	ADJ	O	O
Organ	NOUN	O	B-outcome
Failure	NOUN	O	I-outcome
Assessment	NOUN	O	O
(SOFA)	NOUN	O	O
score	NOUN	O	O
(range,	NOUN	O	O
0	NUM	O	O
[best]	NOUN	O	O
to	PART	O	O
24	NUM	O	O
[worst]);	PUNCT	O	O
death	NOUN	O	B-outcome
within	ADP	O	O
90	NUM	O	O
days;	NOUN	O	O
mechanical	ADJ	O	B-outcome
ventilation-,	NOUN	O	I-outcome
renal	ADJ	O	B-outcome
replacement	NOUN	O	I-outcome
therapy-,	PUNCT	O	I-outcome
and	CCONJ	O	Seperator
vasopressor-	ADJ	O	B-outcome
free	ADJ	O	I-outcome
days	NOUN	O	E2-outcome
within	ADP	O	O
28	NUM	O	O
days;	NOUN	O	O
intensive	ADJ	O	B-outcome
care	NOUN	O	I-outcome
unit	NOUN	O	I-outcome
and	CCONJ	O	Seperator
hospital	NOUN	O	I-outcome
length	NOUN	O	I-outcome
of	ADP	O	I-outcome
stay	NOUN	O	I-outcome
.	PUNCT	O	O
Results:	NOUN	O	O
Among	ADP	O	O
424	NUM	O	O
patients	NOUN	O	O
randomized	VERB	O	O
(mean	NUM	O	O
age,	NOUN	O	O
63	NUM	O	O
years;	NOUN	O	O
226	NUM	O	O
[53%]	NUM	O	O
women),	NOUN	O	O
416	NUM	O	O
(98%)	ADV	O	O
completed	VERB	O	O
the	DET	O	O
trial.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101273946	NUM	O	O

As	ADP	O	O
the	DET	O	O
method	NOUN	O	O
of	ADP	O	O
blind	PUNCT	O	O
randomization	NOUN	O	O
envelope	NOUN	O	O
method	NOUN	O	O
was	VERB	O	O
used.	NOUN	O	O

RESULTS:	NOUN	O	O
Gastrocnemius	NOUN	O	B-outcome
medialis	NOUN	O	I-outcome
activation	NOUN	O	I-outcome
during	ADP	O	O
mid	NOUN	O	O
stance	NOUN	O	O
(23.46%MVIC,	NOUN	O	O
95%	NOUN	O	O
CI	NOUN	O	O
=	SYM	O	O
-32.53,	NOUN	O	O
-14.39)	NOUN	O	O
and	CCONJ	O	O
late	ADJ	O	O
stance	NOUN	O	O
phases	NOUN	O	O
(3.25%MVIC,	NUM	O	O
95%	NOUN	O	O
CI	NOUN	O	O
=	SYM	O	O
-5.67,	NOUN	O	O
-0.81)	NUM	O	O
of	ADP	O	O
gait	NOUN	O	O
increased	VERB	O	O
after	ADP	O	O
the	DET	O	O
application	NOUN	O	O
of	ADP	O	O
KT	NOUN	O	O
in	ADP	O	O
the	DET	O	O
KT	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
baseline	NOUN	O	O
values.	NUM	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
transcutaneous	ADJ	O	O
electrical	ADJ	O	O
acupoint	NOUN	O	O
stimulation	NOUN	O	O
on	ADP	O	O
the	DET	O	O
effective	ADJ	O	O
concentration	NOUN	O	B-outcome
(EC50)	PUNCT	O	O
of	ADP	O	O
remifentanil	NOUN	O	O
suppressing	VERB	O	O
responses	NOUN	O	B-outcome
to	PART	O	O
tracheal	ADJ	O	O
extubation	NOUN	O	O
in	ADP	O	O
elderly	NOUN	O	O
patients.	NOUN	O	O

METHODS:	NOUN	O	O
Sixteen	NUM	O	O
healthy	ADJ	O	O
volunteers	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
in	ADP	O	O
a	DET	O	O
crossover	NOUN	O	O
design	NOUN	O	O
manner	NOUN	O	O
to	PART	O	O
either	CCONJ	O	O
a	DET	O	O
LOWFODMAP	NOUN	O	O
(16.06	NOUN	O	O
+/-	SYM	O	O
1.79	NUM	O	O
g.d(-	NOUN	O	O
1))	NOUN	O	O
or	CCONJ	O	O
HIGHFODMAP	ADV	O	O
(38.65	PUNCT	O	O
+/-	SYM	O	O
6.66	NUM	O	O
g.d(-	NOUN	O	O
1))	NOUN	O	O
diet	NOUN	O	O
for	ADP	O	O
7	NUM	O	O
days,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
one	NUM	O	O
week	NOUN	O	O
washout	ADV	O	O
period	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
a	DET	O	O
further	ADV	O	O
7	NUM	O	O
days	NOUN	O	O
on	ADP	O	O
the	DET	O	O
alternate	VERB	O	O
diet.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
schools	NOUN	O	O
in	ADP	O	O
district	ADP	O	O
Shimla	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
controlled	VERB	O	O
arm	NOUN	O	O
(442	NUM	O	O
vs.	CCONJ	O	O
441	NUM	O	O
schools).	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
two	NUM	O	O
treatment	NOUN	O	O
groups	NOUN	O	O
for	ADP	O	O
dry	ADJ	O	O
needling	VERB	O	O
or	CCONJ	O	O
sham	NOUN	O	O
dry	ADJ	O	O
needling,	NOUN	O	O
delivered	VERB	O	O
in	ADP	O	O
3	NUM	O	O
sessions	NOUN	O	O
a	DET	O	O
week	NOUN	O	O
for	ADP	O	O
2	NUM	O	O
weeks.	NOUN	O	O

This	DET	O	O
double-blind,	NOUN	O	O
randomized,	NOUN	O	O
Phase	NOUN	O	O
II	NUM	O	O
study	NOUN	O	O
investigated	VERB	O	O
the	DET	O	O
dose-response	NOUN	O	O
of	ADP	O	O
oral	ADJ	O	O
netupitant	ADJ	O	O
in	ADP	O	O
Japanese	NOUN	O	O
patients	NOUN	O	O
receiving	VERB	O	O
highly	ADV	O	O
emetogenic	ADJ	O	O
chemotherapy.	NOUN	O	O

For	ADP	O	O
that	ADP	O	O
highly	ADV	O	O
selected	VERB	O	O
subgroup,	NOUN	O	O
surgery	NOUN	O	O
was	VERB	O	O
superior	ADJ	O	O
to	PART	O	O
medical	ADJ	O	O
treatment.	NOUN	O	O
(	PUNCT	O	O

None	NUM	O	O
of	ADP	O	O
the	DET	O	O
findings	NOUN	O	O
that	ADP	O	O
favored	VERB	O	O
the	DET	O	O
comparison	NOUN	O	O
area	NOUN	O	O
were	VERB	O	O
statistically	ADV	O	O
significant.	NOUN	O	O

Data	NOUN	O	O
analysis	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
using	VERB	O	O
Chi-square,	NOUN	O	O
independent	ADJ	O	O
t-test,	NOUN	O	O
and	CCONJ	O	O
paired	VERB	O	O
t-test.	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
two	NUM	O	O
groups	NOUN	O	O
receiving	VERB	O	O
the	DET	O	O
drugs	NOUN	O	O
Novafen	NOUN	O	O
and	CCONJ	O	O
Ginger.	NOUN	O	O

Compared	VERB	O	O
to	PART	O	O
MIIT	NOUN	O	O
and	CCONJ	O	O
CG,	NOUN	O	O
participants	NOUN	O	O
of	ADP	O	O
the	DET	O	O
HIIT	NOUN	O	O
group	NOUN	O	O
showed	VERB	O	O
significant	ADJ	O	O
post-intervention	NOUN	O	O
improvements	NOUN	O	O
in	ADP	O	O
BMI	NOUN	O	B-outcome
(p=.002	NUM	O	O
and	CCONJ	O	O
p<.001,	NOUN	O	O
respectively)	NOUN	O	O
and	CCONJ	O	O
gait	NOUN	O	B-outcome
speed	NOUN	O	I-outcome
(p<.001	PUNCT	O	O
for	ADP	O	O
both).	NUM	O	O

Additional	ADJ	O	O
studies	NOUN	O	O
that	ADP	O	O
use	NOUN	O	O
liver	NOUN	O	O
biopsies	NOUN	O	O
would	VERB	O	O
allow	ADP	O	O
for	ADP	O	O
the	DET	O	O
assessment	NOUN	O	O
of	ADP	O	O
pegbelfermin's	NOUN	O	O
effects	NOUN	O	O
on	ADP	O	O
liver	NOUN	O	O
histology.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101150032	NUM	O	O

Further	ADV	O	O
rigorous	ADJ	O	O
studies	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
and	CCONJ	O	O
extend	NOUN	O	O
these	DET	O	O
results.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
segmental	ADJ	O	O
muscle	NOUN	O	O
vibration	NOUN	O	O
on	ADP	O	O
upper	ADJ	O	B-outcome
extremity	NOUN	O	I-outcome
functional	ADJ	O	I-outcome
ability	NOUN	O	I-outcome
poststroke:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
(SD)	NOUN	O	O
er-MedDiet	NUM	O	O
score	NOUN	O	O
was	VERB	O	O
8.5	NUM	O	O
(2.6)	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
13.2	NUM	O	O
(2.7)	NOUN	O	O
at	ADP	O	O
12	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(increase,	NOUN	O	O
4.7	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
4.6-4.8])	NOUN	O	O
and	CCONJ	O	O
8.6	NUM	O	O
(2.7)	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
11.1	NUM	O	O
(2.8)	NOUN	O	O
at	ADP	O	O
12	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(increase,	NOUN	O	O
2.5	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
2.3-2.6])	NUM	O	O
(between-group	NOUN	O	O
difference,	NOUN	O	O
2.2	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
2.1-2.4];	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
.001).	PUNCT	O	O

The	DET	O	O
number	NOUN	O	O
of	ADP	O	O
minor	ADJ	O	O
unintentional	ADJ	O	O
injuries	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
decreased	VERB	O	O
from	ADP	O	O
119	NUM	O	O
to	PART	O	O
56,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
suffering	VERB	O	O
2	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
injuries	NOUN	O	O
dropped	VERB	O	O
from	ADP	O	O
34	NUM	O	O
to	PART	O	O
10	NUM	O	O
(P<0.001)	PUNCT	O	O
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
the	DET	O	O
intervention,	ADP	O	O
while	ADP	O	O
both	CCONJ	O	O
of	ADP	O	O
them	PRON	O	O
were	VERB	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P=0.011).	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/10	ADV	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

CONCLUSIONS:	NOUN	O	O
Ronghuang	NOUN	O	O
granule	NOUN	O	O
improves	NOUN	O	O
the	DET	O	O
clinical	ADJ	O	O
symptoms	NOUN	O	B-outcome
of	ADP	O	O
non-dialysis	NOUN	O	O
CKD-MBD	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
kidney	NOUN	O	O
deficiency	NOUN	O	O
and	CCONJ	O	O
dampness	NOUN	O	O
heat	NOUN	O	O
syndrome	NOUN	O	O
by	ADP	O	O
reducing	VERB	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
23	NUM	O	I-outcome
(FGF23)	NOUN	O	I-outcome
,	PUNCT	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
receptor	NOUN	O	I-outcome
(FGFRs)	NOUN	O	I-outcome
and	CCONJ	O	O
Klotho	NOUN	O	B-outcome
,	PUNCT	O	O
improving	VERB	O	O
calcium	NOUN	O	B-outcome
and	CCONJ	O	Seperator
phosphorus	NOUN	O	I-outcome
metabolism	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
inhibiting	VERB	O	O
secondary	ADJ	O	B-outcome
hyperparathyroidism	NOUN	O	I-outcome
.	PUNCT	O	O

Few	ADJ	O	O
galcanezumab-treated	VERB	O	O
patients	NOUN	O	O
maintained	VERB	O	O
100%	NOUN	O	O
response	NOUN	O	B-outcome
.	PUNCT	O	O
In	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
migraine,	ADJ	O	O
29%	NUM	O	O
of	ADP	O	O
galcanezumab-treated	VERB	O	O
patients	NOUN	O	O
maintained	VERB	O	O
>/=30%	NOUN	O	O
response	NOUN	O	B-outcome
all	DET	O	O
3	NUM	O	O
months	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
16%	NUM	O	O
of	ADP	O	O
placebo	NOUN	O	O
patients	NOUN	O	O
while	ADP	O	O
>/=50%	ADV	O	O
response	NOUN	O	B-outcome
was	VERB	O	O
maintained	VERB	O	O
in	ADP	O	O
16.8	NUM	O	O
and	CCONJ	O	O
14.6%	NOUN	O	O
of	ADP	O	O
galcanezumab-treated	VERB	O	O
patients	NOUN	O	O
(120	NUM	O	O
mg	NOUN	O	O
and	CCONJ	O	O
240	NUM	O	O
mg)	NOUN	O	O
and	CCONJ	O	O
was	VERB	O	O
greater	ADJ	O	O
than	ADP	O	O
placebo	NOUN	O	O
(6.3%;	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.001).	NUM	O	O

We	PRON	O	O
therefore	ADV	O	O
assessed	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
PPI	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
histamine	NOUN	O	O
H2	NOUN	O	O
receptor	NOUN	O	O
antagonist	NOUN	O	O
(H2	NUM	O	O
blocker)	NOUN	O	O
on	ADP	O	O
hypogeusia	NOUN	O	B-outcome
among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
LPR.	NOUN	O	O

Registered	VERB	O	O
June	NOUN	O	O
16,	NOUN	O	O
2015.	NUM	O	O

Minor	ADJ	O	B-outcome
bleeding	VERB	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
[Bleeding	VERB	O	O
Academic	ADJ	O	O
Research	NOUN	O	O
Consortium	NOUN	O	O
1,	NOUN	O	O
A	DET	O	O
=	SYM	O	O
6.63%	NOUN	O	O
vs	CCONJ	O	O
B	NOUN	O	O
=	SYM	O	O
1.81%,	NUM	O	O
odds	NOUN	O	O
ratio	NOUN	O	O
(OR)	NOUN	O	O
=	SYM	O	O
3.86,	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
(CI)	NOUN	O	O
=	SYM	O	O
1.06-14.08,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.05].	NUM	O	O
Major	ADP	O	B-outcome
bleeding	VERB	O	I-outcome
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
(A	PUNCT	O	O
=	SYM	O	O
3.61%,	NUM	O	O
vs	CCONJ	O	O
B	NOUN	O	O
=	SYM	O	O
1.81%,	NUM	O	O
OR	CCONJ	O	O
=	SYM	O	O
2.04,	ADV	O	O
95%	NOUN	O	O
CI	NOUN	O	O
=	SYM	O	O
0.50-8.29,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.50).	NUM	O	O

CONCLUSION:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
clear	ADJ	O	O
benefit	NUM	O	O
of	ADP	O	O
the	DET	O	O
24-hour	NOUN	O	O
or	CCONJ	O	O
48-hour	NOUN	O	O
infusions	NOUN	O	O
over	ADP	O	O
the	DET	O	O
single-shot	NOUN	O	O
ACB	NOUN	O	O
for	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
apatinib	ADP	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
for	ADP	O	O
whom	ADP	O	O
at	ADP	O	O
least	ADV	O	O
two	NUM	O	O
lines	NOUN	O	O
of	ADP	O	O
prior	ADJ	O	O
chemotherapy	NOUN	O	O
had	VERB	O	O
failed.	NOUN	O	O

Twelve	NUM	O	O
weeks	NOUN	O	O
later,	ADV	O	O
permanent	ADJ	O	O
crowns	VERB	O	O
were	VERB	O	O
placed	VERB	O	O
on	ADP	O	O
patient-specific	ADJ	O	O
abutments	NOUN	O	O
and	CCONJ	O	O
evaluated	VERB	O	O
at	ADP	O	O
6,	NOUN	O	O
12,	NUM	O	O
and	CCONJ	O	O
36	NUM	O	O
months	NOUN	O	O
following	VERB	O	O
implant	NOUN	O	O
placement.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/17	ADP	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
gender,	NOUN	O	O
age,	NOUN	O	O
injury	NOUN	O	O
cause,	NOUN	O	O
Denis	NOUN	O	O
classification,	NOUN	O	O
fracture	NOUN	O	O
segment,	NOUN	O	O
the	DET	O	O
degree	NOUN	O	O
of	ADP	O	O
injured	VERB	O	O
vertebra	NOUN	O	O
compression,	NOUN	O	O
bone	NOUN	O	O
mineral	NOUN	O	O
density,	NOUN	O	O
and	CCONJ	O	O
American	ADJ	O	O
Spinal	ADJ	O	O
Cord	NOUN	O	O
Injury	NOUN	O	O
Association	NOUN	O	O
(ASIA)	NUM	O	O
classification	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
P>0.05).	NOUN	O	O

The	DET	O	O
allocation	NOUN	O	O
sequence	NOUN	O	O
was	VERB	O	O
concealed	VERB	O	O
by	ADP	O	O
using	VERB	O	O
a	DET	O	O
computer	NOUN	O	O
generated	VERB	O	O
number	NOUN	O	O
on	ADP	O	O
the	DET	O	O
prescription.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
Mindfulness-Based	VERB	O	O
Cognitive	ADJ	O	O
Therapy	NOUN	O	O
on	ADP	O	O
the	DET	O	O
illness	NOUN	O	B-outcome
perception	NOUN	O	I-outcome
and	CCONJ	O	O
Psychological	ADJ	O	B-outcome
Symptoms	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
Rheumatoid	NOUN	O	O
Arthritis.	NOUN	O	O

Some	DET	O	O
cycles	NOUN	O	O
are	VERB	O	O
cancelled	VERB	O	O
due	ADJ	O	O
to	PART	O	O
inadequate	ADJ	O	O
endometrial	ADJ	O	O
growth	NOUN	O	O
in	ADP	O	O
ART.	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
and	CCONJ	O	O
standard	ADJ	O	O
deviation	NOUN	O	O
of	ADP	O	O
variables	NOUN	O	O
were	VERB	O	O
obtained	VERB	O	O
and	CCONJ	O	O
the	DET	O	O
normality	NOUN	O	O
of	ADP	O	O
data	NOUN	O	O
was	VERB	O	O
analyzed	VERB	O	O
using	VERB	O	O
the	DET	O	O
Kolmogorov-Smirnov	NOUN	O	O
test.	NOUN	O	O

In	ADP	O	O
conclusion,	NOUN	O	O
our	ADJ	O	O
data	NOUN	O	O
show	VERB	O	O
that	ADP	O	O
Taurisolo((R))	NOUN	O	O
may	VERB	O	O
represent	NOUN	O	O
a	DET	O	O
novel	ADJ	O	O
and	CCONJ	O	O
useful	ADJ	O	O
natural	ADJ	O	O
remedy	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
prognostic	ADJ	O	O
markers	NOUN	O	O
for	ADP	O	O
incident	ADJ	O	O
cardiovascular	ADJ	O	O
events.	NOUN	O	O

Hydrocephalus	NOUN	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
condition	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
myelomeningocele.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
comparison	NOUN	O	O
was	VERB	O	O
the	DET	O	O
alteplase	NOUN	O	O
20-mg	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
the	DET	O	O
placebo	NOUN	O	O
group;	ADJ	O	O
if	ADP	O	O
not	ADV	O	O
significant,	NOUN	O	O
the	DET	O	O
alteplase	NOUN	O	O
10-mg	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
considered	VERB	O	O
a	DET	O	O
secondary	ADJ	O	O
analysis.	NOUN	O	O

Cite	NOUN	O	O
this	DET	O	O
article:	NOUN	O	O
Bone	NOUN	O	O
Joint	NOUN	O	O
J	NOUN	O	O
2019;101-B:340-347	ADP	O	O

RESULTS:	NOUN	O	O
Plasma	NOUN	O	O
albumin	NOUN	O	B-outcome
and	CCONJ	O	O
total	ADJ	O	O
protein	NOUN	O	B-outcome
levels	NOUN	O	O
increased	VERB	O	O
immediately	ADV	O	O
after	ADP	O	O
exercise	NOUN	O	O
in	ADP	O	O
placebo	NOUN	O	O
alongside	ADP	O	O
slight	NOUN	O	O
reductions	NOUN	O	O
in	ADP	O	O
glucose	NOUN	O	B-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.001).	NUM	O	O

Journal-Name:Nutrients	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
clinicaltrials.gov,	NOUN	O	O
NCT02518165	NOUN	O	O
.	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

No	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
either	CCONJ	O	O
group.	VERB	O	O

Clinical	ADJ	O	O
trial	NOUN	O	O
registration:	NOUN	O	O
JapicCTI-142	NOUN	O	O
483.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
60	NUM	O	O
cases	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
during	ADP	O	O
August	NOUN	O	O
2016	NUM	O	O
and	CCONJ	O	O
June	NOUN	O	O
2017	NUM	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
inclusion	NOUN	O	O
and	CCONJ	O	O
exclusion	NOUN	O	O
criteria.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/22	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

OBJECTIVE:	NOUN	O	O
Compare	NOUN	O	O
the	DET	O	O
outcome	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	B-outcome
deformity	NOUN	O	I-outcome
correction	NOUN	O	I-outcome
between	ADP	O	O
Ti-Ti	NOUN	O	O
and	CCONJ	O	O
CrCo-Ti	NOUN	O	O
rods	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
Adolescent	NOUN	O	O
Idiopathic	ADJ	O	O
Scoliosis	NOUN	O	O
(AIS)	NOUN	O	O
using	VERB	O	O
rods	NOUN	O	O
mentioned	VERB	O	O
with	ADP	O	O
all	DET	O	O
pedicle	NOUN	O	O
screws	NOUN	O	O
and	CCONJ	O	O
translation	NOUN	O	O
technique.	NOUN	O	O

Interventions:	NOUN	O	O
Patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
(1:1)	NOUN	O	O
to	PART	O	O
an	DET	O	O
MRI-guided	VERB	O	O
vs	CCONJ	O	O
a	DET	O	O
conventional	ADJ	O	O
treat-to-target	NOUN	O	O
strategy.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
CM	NOUN	O	O
group	NOUN	O	O
(12.3%	NUM	O	O
increase)	NOUN	O	O
had	VERB	O	O
significantly	ADV	O	O
greater	ADJ	O	O
improvements	NOUN	O	O
in	ADP	O	O
composite	NOUN	O	O
strength	NOUN	O	B-outcome
from	ADP	O	O
pre-	ADJ	O	O
to	PART	O	O
post-test	NOUN	O	O
than	ADP	O	O
CHO	NOUN	O	O
(2.7%	NOUN	O	O
increase).	NOUN	O	O

Importance:	NOUN	O	O
A	DET	O	O
meta-analysis	NOUN	O	O
of	ADP	O	O
outcomes	NOUN	O	O
during	ADP	O	O
the	DET	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
intensive	ADJ	O	O
care	NOUN	O	O
unit	NOUN	O	O
(ICU)	PUNCT	O	O
discharge	NOUN	O	O
indicate	VERB	O	O
a	DET	O	O
prevalence	NOUN	O	O
for	ADP	O	O
clinically	ADV	O	O
important	ADJ	O	O
posttraumatic	ADJ	O	O
stress	NOUN	O	O
disorder	ADP	O	O
(PTSD)	ADV	O	O
symptoms	NOUN	O	O
of	ADP	O	O
25%.	NUM	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
Ayub	ADP	O	O
Medical	ADJ	O	O
College,	PUNCT	O	O
Abbottabad	ADV	O	O
:	PUNCT	O	O
JAMC	NOUN	O	O

Participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
participated	VERB	O	O
in	ADP	O	O
a	DET	O	O
24-week	NUM	O	O
TC	NOUN	O	O
training	VERB	O	O
program	NOUN	O	O
(three	NUM	O	O
60-min	NOUN	O	O
sessions	NOUN	O	O
per	ADP	O	O
week),	NOUN	O	O
whereas	ADP	O	O
individuals	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
maintained	VERB	O	O
their	ADJ	O	O
unaltered	VERB	O	O
lifestyle.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/19	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/22	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Age	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
endothelial	ADJ	O	B-outcome
cell	NOUN	O	I-outcome
loss	NOUN	O	O
(ECL)	ADV	O	O
after	ADP	O	O
cataract	NOUN	O	O
surgery	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.02),	NUM	O	O
but	CCONJ	O	O
baseline	NOUN	O	O
intraocular	ADJ	O	O
pressure,	NOUN	O	O
number	NOUN	O	O
of	ADP	O	O
glaucoma	NOUN	O	B-outcome
medications	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
central	ADJ	O	B-outcome
corneal	ADJ	O	I-outcome
thickness	NOUN	O	I-outcome
(CCT)	PUNCT	O	I-outcome
were	VERB	O	O
not.	ADV	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
designed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
ascorbic	ADJ	O	O
acid	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
circulating	VERB	O	O
biomarkers	NOUN	O	O
of	ADP	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
and	CCONJ	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
following	VERB	O	O
a	DET	O	O
single	ADJ	O	O
bout	NOUN	O	O
of	ADP	O	O
exercise.	NOUN	O	O

Background	NOUN	O	O
and	CCONJ	O	O
Objectives:	ADJ	O	O
The	DET	O	O
authors	NOUN	O	O
sought	NOUN	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
a	DET	O	O
new	ADJ	O	O
crosslinked	VERB	O	O
hyaluronan	ADJ	O	O
(NCH)	PUNCT	O	O
gel	NOUN	O	O
on	ADP	O	O
the	DET	O	O
prevention	NOUN	O	O
of	ADP	O	O
intrauterine	ADJ	O	B-outcome
adhesions	NOUN	O	I-outcome
(IUAs)	NUM	O	I-outcome
in	ADP	O	O
women	NOUN	O	O
underwent	VERB	O	O
curettage	NOUN	O	O
in	ADP	O	O
the	DET	O	O
second	ADJ	O	O
trimester.	NOUN	O	O

Background/aim:	NOUN	O	O
In	ADP	O	O
South	NOUN	O	O
Africa,	NOUN	O	O
contextual	ADJ	O	O
factors	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
identified	VERB	O	O
as	ADP	O	O
barriers	NOUN	O	O
to	PART	O	O
outdoor,	NOUN	O	O
unstructured	VERB	O	O
play.	NOUN	O	O

These	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
at	ADP	O	O
17	NUM	O	O
medical	ADJ	O	O
centres	NOUN	O	O
in	ADP	O	O
the	DET	O	O
USA.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101291488	NUM	O	O

Journal-Name:Lancet	NOUN	O	O
(London,	PUNCT	O	O
England)	NOUN	O	O

In	ADP	O	O
this	DET	O	O
phase	NOUN	O	O
2a	NOUN	O	O
study,	NOUN	O	O
we	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
pegbelfermin	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
non-alcoholic	ADJ	O	O
steatohepatitis.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
performed	VERB	O	O
a	DET	O	O
multicenter,	NOUN	O	O
open-label,	ADV	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
involving	VERB	O	O
patients	NOUN	O	O
18	NUM	O	O
to	PART	O	O
75	NUM	O	O
years	NOUN	O	O
of	ADP	O	O
age	NOUN	O	O
with	ADP	O	O
resectable	ADJ	O	O
cancer	NOUN	O	O
of	ADP	O	O
the	DET	O	O
middle	ADJ	O	O
or	CCONJ	O	O
lower	ADJ	O	O
third	ADJ	O	O
of	ADP	O	O
the	DET	O	O
esophagus.	NOUN	O	O

Participants	NOUN	O	O
rated	VERB	O	O
their	ADJ	O	O
gastrointestinal	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
on	ADP	O	O
an	DET	O	O
adapted	VERB	O	O
version	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Irritable	ADJ	O	B-outcome
Bowel	NOUN	O	I-outcome
Syndrome-Severity	NOUN	O	I-outcome
Scoring	VERB	O	O
System	NOUN	O	O
(IBS-SSS)	PUNCT	O	O
questionnaire	NOUN	O	O
before	ADP	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
each	DET	O	O
dietary	ADJ	O	O
period.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101248897	NUM	O	O

Methods:	NOUN	O	O
Between	ADP	O	O
June	NOUN	O	O
2016	NUM	O	O
and	CCONJ	O	O
September	NOUN	O	O
2017,	NUM	O	O
60	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
curettage	NOUN	O	O
for	ADP	O	O
retained	VERB	O	O
placental	ADJ	O	O
tissue	NOUN	O	O
after	ADP	O	O
medically	ADV	O	O
induced	VERB	O	O
or	CCONJ	O	O
spontaneous	ADJ	O	O
pregnancy	NOUN	O	O
loss	NOUN	O	O
in	ADP	O	O
the	DET	O	O
second	ADJ	O	O
trimester	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
randomized,	NOUN	O	O
single-blinded,	NOUN	O	O
and	CCONJ	O	O
controlled	VERB	O	O
study,	NOUN	O	O
total	ADJ	O	O
75	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
TPI	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
25),	NUM	O	O
EMLA	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
25),	NUM	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
25).	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
incremental	ADJ	O	O
vs	CCONJ	O	O
maximum	NOUN	O	O
bite	NOUN	O	O
advancement	ADJ	O	O
during	ADP	O	O
Herbst	NOUN	O	O
appliance	NOUN	O	O
therapy	NOUN	O	O
in	ADP	O	O
late	ADJ	O	O
adolescent	NOUN	O	O
and	CCONJ	O	O
young	ADJ	O	O
adult	NOUN	O	O
patients.	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
The	DET	O	O
primary	ADJ	O	O
clinical	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
posttraumatic	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
(PTSD)	ADV	O	I-outcome
symptom	NOUN	O	I-outcome
severity	NOUN	O	I-outcome
among	ADP	O	O
survivors	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
measured	VERB	O	O
using	VERB	O	O
the	DET	O	O
posttraumatic	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
(PTSD)	ADV	O	I-outcome
symptom	NOUN	O	I-outcome
severity	NOUN	O	I-outcome
Scale-Self-Report	NOUN	O	O
questionnaire	NOUN	O	O
(score	PUNCT	O	O
range,	VERB	O	O
0-51,	NUM	O	O
with	ADP	O	O
higher	ADJ	O	O
scores	NOUN	O	O
indicating	VERB	O	O
greater	ADJ	O	O
symptom	NOUN	O	O
severity;	ADV	O	O
the	DET	O	O
minimal	ADJ	O	O
clinically	ADV	O	O
important	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
considered	VERB	O	O
to	PART	O	O
be	VERB	O	O
4.2	NUM	O	O
points).	NOUN	O	O

Ixazomib	NUM	O	O
is	VERB	O	O
ideally	ADV	O	O
suited	VERB	O	O
for	ADP	O	O
maintenance	NOUN	O	O
therapy	NOUN	O	O
given	VERB	O	O
its	ADJ	O	O
convenient	ADJ	O	O
once-weekly	NOUN	O	O
oral	ADJ	O	O
dosing	VERB	O	O
and	CCONJ	O	O
low	ADJ	O	O
toxicity	NOUN	O	O
profile.	NOUN	O	O

Title:	NOUN	O	O
Spirulina	NOUN	O	O
maxima	NOUN	O	O
Decreases	NOUN	O	O
Endothelial	ADJ	O	B-outcome
Damage	NOUN	O	I-outcome
and	CCONJ	O	O
Oxidative	ADJ	O	B-outcome
Stress	NOUN	O	I-outcome
Indicators	NOUN	O	O
in	ADP	O	O
Patients	NOUN	O	O
with	ADP	O	O
Systemic	ADJ	O	O
Arterial	ADJ	O	O
Hypertension:	NOUN	O	O
Results	NOUN	O	O
from	ADP	O	O
Exploratory	ADJ	O	O
Controlled	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

PURPOSE:	NOUN	O	O
The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
is	VERB	O	O
to	PART	O	O
translate	NOUN	O	O
laboratory-based	VERB	O	O
research	NOUN	O	O
on	ADP	O	O
beverage-based	VERB	O	O
supplements	NOUN	O	O
to	PART	O	O
a	DET	O	O
naturalistic,	VERB	O	O
field	NOUN	O	O
setting	VERB	O	O
in	ADP	O	O
adolescent	NOUN	O	O
athletes.	ADV	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
mixed-methods	NOUN	O	O
pilot	NOUN	O	O
trial,	NOUN	O	O
participants	NOUN	O	O
with	ADP	O	O
quiescent	ADJ	O	O
or	CCONJ	O	O
mildly-active	ADJ	O	O
CD	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
1:1:1	ADJ	O	O
to	PART	O	O
HIIT,	NOUN	O	O
MICT	NOUN	O	O
or	CCONJ	O	O
usual	ADJ	O	O
care	NOUN	O	O
control,	NOUN	O	O
and	CCONJ	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
Ca	NOUN	O	B-outcome
,	PUNCT	O	O
P	NOUN	O	B-outcome
,	PUNCT	O	O
parathyroid	NOUN	O	B-outcome
hormone	NOUN	O	I-outcome
(iPTH)	NUM	O	I-outcome
,	PUNCT	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
23	NUM	O	I-outcome
(FGF23)	NOUN	O	I-outcome
,	PUNCT	O	O
fibroblast	NOUN	O	B-outcome
growth	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
receptor	NOUN	O	I-outcome
(FGFRs)	NOUN	O	I-outcome
and	CCONJ	O	O
Klotho	NOUN	O	B-outcome
proteins	NOUN	O	I-outcome
were	VERB	O	O
detected	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment.	NOUN	O	O

Chlorhexidine	NOUN	O	O
is	VERB	O	O
most	DET	O	O
widely	ADV	O	O
used	VERB	O	O
antiseptic	ADJ	O	O
which	ADP	O	O
is	VERB	O	O
thought	VERB	O	O
to	PART	O	O
be	VERB	O	O
helpful	ADJ	O	O
to	PART	O	O
prevent	NOUN	O	O
alveolar	ADJ	O	O
osteitis.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Liver	NOUN	O	O
transplantation	NOUN	O	O
is	VERB	O	O
the	DET	O	O
best	ADP	O	O
treatment	NOUN	O	O
for	ADP	O	O
end-stage	NOUN	O	O
liver	NOUN	O	O
disease.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcome	NOUN	O	O
composite	NOUN	O	O
of	ADP	O	O
requirement	NOUN	O	O
of	ADP	O	O
hemodialysis	NOUN	O	B-outcome
,	PUNCT	O	O
death	NOUN	O	B-outcome
and	CCONJ	O	O
rehospitalization	NOUN	O	B-outcome
for	ADP	O	Seperator
heart	NOUN	O	I-outcome
failure	NOUN	O	I-outcome
was	VERB	O	O
not	ADV	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(p:	NUM	O	O
0.646).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/06	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

As	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group,	NOUN	O	O
women	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
zoledronate	ADJ	O	O
had	VERB	O	O
a	DET	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
nonvertebral	ADJ	O	B-outcome
fragility	NOUN	O	I-outcome
fractures	NOUN	O	I-outcome
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.66;	NOUN	O	O
P=0.001),	NOUN	O	O
symptomatic	ADJ	O	B-outcome
fractures	NOUN	O	I-outcome
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.73;	NOUN	O	O
P=0.003),	NOUN	O	O
vertebral	ADJ	O	B-outcome
fractures	NOUN	O	I-outcome
(odds	NOUN	O	O
ratio,	NOUN	O	O
0.45;	NOUN	O	O
P=0.002),	NOUN	O	O
and	CCONJ	O	O
height	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(P<0.001).	NOUN	O	O

After	ADP	O	O
the	DET	O	O
12-week	NOUN	O	O
treatments,	ADV	O	O
the	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
examined	VERB	O	O
for	ADP	O	O
changes	NOUN	O	O
of	ADP	O	O
TCM	NOUN	O	O
syndromes.	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

The	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
BT-11	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
elucidated	VERB	O	O
in	ADP	O	O
younger	ADJ	O	O
person	NOUN	O	O
further.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
analysis	NOUN	O	O
at	ADP	O	O
10	NUM	O	O
years,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
315	NUM	O	O
deaths	NOUN	O	B-outcome
(20.3%	ADV	O	O
of	ADP	O	O
the	DET	O	O
patients)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
bilateral-graft	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
329	NUM	O	O
deaths	NOUN	O	O
(21.2%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
single-graft	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.96;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.82	NUM	O	O
to	PART	O	O
1.12;	NOUN	O	O
P=0.62).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Median	ADJ	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
48.2	NUM	O	O
months	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
35.2-not	NOUN	O	O
evaluable)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
A+CHP	ADV	O	O
group	NOUN	O	O
and	CCONJ	O	O
20.8	NUM	O	O
months	NOUN	O	O
(12.7-47.6)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
CHOP	VERB	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
0.71	NUM	O	O
[95%	NOUN	O	O
CI	NOUN	O	O
0.54-0.93],	NOUN	O	O
p=0.0110).	NOUN	O	O

In	ADP	O	B-outcome
stent	NOUN	O	I-outcome
re-stenosis	NOUN	O	I-outcome
was	VERB	O	O
found	VERB	O	O
in	ADP	O	O
7	NUM	O	O
of	ADP	O	O
85(8.2%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
polymer-free	ADJ	O	O
group	NOUN	O	O
vs.	CCONJ	O	O
6	NUM	O	O
of	ADP	O	O
98(6.12%)	ADP	O	O
in	ADP	O	O
the	DET	O	O
biodegradable	ADJ	O	O
polymer	NOUN	O	O
group.	VERB	O	O

During	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
period,	NOUN	O	O
rivaroxaban	ADJ	O	O
led	VERB	O	O
to	PART	O	O
a	DET	O	O
substantially	ADV	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
such	ADJ	O	O
events,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
low	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
major	ADJ	O	B-outcome
bleeding	VERB	O	I-outcome
.	PUNCT	O	O
(Funded	PUNCT	O	O
by	ADP	O	O
Janssen	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
CASSINI	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02555878.).	NOUN	O	O

Basis	NOUN	O	O
for	ADP	O	O
sample	NOUN	O	O
size	NOUN	O	O
calculation	NOUN	O	O
was	VERB	O	O
the	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
MACE	NOUN	O	O
from	ADP	O	O
the	DET	O	O
ISAR	NOUN	O	O
TEST	NOUN	O	O
3	NUM	O	O
trial	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
the	DET	O	O
absolute	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
10.25%	NOUN	O	O
with	ADP	O	O
a	DET	O	O
standard	ADJ	O	O
deviation	NOUN	O	O
of	ADP	O	O
0.24.	NUM	O	O

More	ADV	O	O
focus	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
put	NOUN	O	O
into	ADP	O	O
an	DET	O	O
education	NOUN	O	O
tool	NOUN	O	O
for	ADP	O	O
other	ADJ	O	O
caregivers	NOUN	O	O
who	ADP	O	O
wish	NOUN	O	O
to	PART	O	O
hold	NOUN	O	O
the	DET	O	O
baby.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/18	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
toxicity	NOUN	O	B-outcome
was	VERB	O	O
manageable.	NOUN	O	O

RESULTS:	NOUN	O	O
24	NUM	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Traditional	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
27	NUM	O	O
in	ADP	O	O
the	DET	O	O
App	NOUN	O	O
group	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

BACKGROUND:	NOUN	O	O
To	PART	O	O
combat	NOUN	O	O
emerging	VERB	O	O
drug	NOUN	O	O
resistance	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Greater	ADJ	O	O
Mekong	NOUN	O	O
Sub-region	NOUN	O	O
(GMS)	NUM	O	O
the	DET	O	O
World	NOUN	O	O
Health	NOUN	O	O
Organization	NOUN	O	O
and	CCONJ	O	O
GMS	NOUN	O	O
countries	NOUN	O	O
have	VERB	O	O
committed	VERB	O	O
to	PART	O	O
eliminating	VERB	O	O
malaria	NOUN	O	O
in	ADP	O	O
the	DET	O	O
region	NOUN	O	O
by	ADP	O	O
2030.	NUM	O	O

It	PRON	O	O
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
that,	NOUN	O	O
as	ADP	O	O
CRP	NOUN	O	B-outcome
levels	NOUN	O	O
increased,	NOUN	O	O
albumin	NOUN	O	B-outcome
levels	NOUN	O	O
decreased	VERB	O	O
significantly	ADV	O	O
(p	PUNCT	O	O
<0.01).	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Pair-matched	VERB	O	O
participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(CON;	PUNCT	O	O
n=7)	VERB	O	O
that	ADP	O	O
exercised	VERB	O	O
in	ADP	O	O
a	DET	O	O
temperate	NOUN	O	O
environment	NOUN	O	O
(24	NOUN	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
21%RH)	NUM	O	O
or	CCONJ	O	O
IHE	NOUN	O	O
group	NOUN	O	O
(n=9)	PUNCT	O	O
that	ADP	O	O
exercised	VERB	O	O
in	ADP	O	O
a	DET	O	O
hot	ADJ	O	O
environment	NOUN	O	O
(40	NOUN	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
40%RH)	NUM	O	O
every	DET	O	O
fifth	ADJ	O	O
day	NOUN	O	O
for	ADP	O	O
25	NUM	O	O
days	NOUN	O	O
following	VERB	O	O
HA	NOUN	O	O
(+25d)	NOUN	O	O
with	ADP	O	O
out-of-laboratory	ADP	O	O
exercise	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
and	CCONJ	O	Seperator
duration	NOUN	O	S1-outcome
recorded.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8610224	NUM	O	O

CONCLUSION:	NOUN	O	O
Electrolyte-containing	VERB	O	O
MW,	NOUN	O	O
was	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
effectiveness	NOUN	O	O
to	PART	O	O
water,	NOUN	O	O
but	CCONJ	O	O
has	VERB	O	O
antioxidant	NOUN	O	B-outcome
properties.	NOUN	O	O

INTERVENTIONS:	NOUN	O	O
Routine	ADJ	O	O
care	NOUN	O	O
(TENS	PUNCT	O	O
group)	ADJ	O	O
or	CCONJ	O	O
routine	ADJ	O	O
care	NOUN	O	O
plus	CCONJ	O	O
a	DET	O	O
therapeutic	ADJ	O	O
education	NOUN	O	O
program	NOUN	O	O
(TENS-TEP	NUM	O	O
group)	ADJ	O	O
based	VERB	O	O
on	ADP	O	O
consultation	NOUN	O	O
support	NOUN	O	O
by	ADP	O	O
a	DET	O	O
pain	NOUN	O	O
resource	NOUN	O	O
nurse.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
multi-center,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
of	ADP	O	O
the	DET	O	O
application	NOUN	O	O
of	ADP	O	O
a	DET	O	O
shortened	VERB	O	O
protocol	NOUN	O	O
of	ADP	O	O
long-acting	VERB	O	O
Triptorelin	NOUN	O	O
down-regulated	VERB	O	O
prior	ADJ	O	O
to	PART	O	O
IVF/ICSI	NOUN	O	O
among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
endometriosis:	NOUN	O	O
A	DET	O	O
protocol.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

FINDINGS:	ADJ	O	O
In	ADP	O	O
the	DET	O	O
original	ADJ	O	O
study,	NOUN	O	O
from	ADP	O	O
Dec	NOUN	O	O
14,	NUM	O	O
2006,	NUM	O	O
to	PART	O	O
Feb	NOUN	O	O
2,	NOUN	O	O
2012,	NUM	O	O
161	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
155	NUM	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
the	DET	O	O
ATLG	NOUN	O	O
group	NOUN	O	O
(n=83)	PUNCT	O	O
or	CCONJ	O	O
to	PART	O	O
the	DET	O	O
non-ATLG	NOUN	O	O
group	NOUN	O	O
(n=72).	NOUN	O	O

Safety,	NOUN	O	O
pharmacokinetic,	VERB	O	O
pharmacodynamic,	VERB	O	O
and	CCONJ	O	O
exploratory	ADJ	O	O
efficacy	NOUN	O	O
outcomes	NOUN	O	O
were	VERB	O	O
evaluated.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Comparative	ADJ	O	O
Study	NOUN	O	O

We	PRON	O	O
observed	VERB	O	O
a	DET	O	O
trend	NOUN	O	O
toward	ADP	O	O
decreased	VERB	O	O
incisional	ADJ	O	B-outcome
hernia	NOUN	O	I-outcome
rates	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
NPWT.	ADV	O	O

LEVEL	NOUN	O	O
OF	ADP	O	O
EVIDENCE:	NOUN	O	O
III.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
observe	NOUN	O	O
the	DET	O	O
preoperative	ADJ	O	O
sedation	NOUN	O	B-outcome
,	PUNCT	O	O
the	DET	O	O
status	NOUN	O	B-outcome
of	ADP	O	I-outcome
separation	NOUN	O	I-outcome
from	ADP	O	I-outcome
parents	NOUN	O	I-outcome
,	PUNCT	O	O
compliance	NOUN	O	B-outcome
with	ADP	O	O
the	DET	O	O
mask,	NOUN	O	O
hemodynamic	ADJ	O	B-outcome
parameters	NOUN	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
agitation	NOUN	O	B-outcome
of	ADP	O	O
intranasal	ADJ	O	O
dexmedetomidine	NOUN	O	O
(DEX)	NOUN	O	O
premedication	NOUN	O	O
on	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
dental	ADJ	O	O
rehabilitation	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
immediate	ADJ	O	O
sensorimotor	NOUN	O	B-outcome
effects	NOUN	O	O
of	ADP	O	O
elbow	NOUN	O	O
orthoses	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
lateral	ADJ	O	O
elbow	NOUN	O	O
tendinopathy:	NOUN	O	O
a	DET	O	O
prospective	ADJ	O	O
crossover	NOUN	O	O
study.	NOUN	O	O

Interim	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
a	DET	O	O
randomized,	NOUN	O	O
double	ADV	O	O
blinded,	NOUN	O	O
placebo-controlled	VERB	O	O
trial.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
seem	VERB	O	O
to	PART	O	O
indicate	VERB	O	O
that	ADP	O	O
using	VERB	O	O
krill	NOUN	O	O
powder	NOUN	O	O
as	ADP	O	O
a	DET	O	O
source	NOUN	O	O
for	ADP	O	O
EPA	NOUN	O	O
and	CCONJ	O	O
DHA	NOUN	O	O
is	VERB	O	O
safe	ADJ	O	O
in	ADP	O	O
therapeutic	ADJ	O	O
dose	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
let	NOUN	O	O
alone	ADJ	O	O
serious	ADJ	O	O
ones,	NOUN	O	O
is	VERB	O	O
low.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
enrolled	VERB	O	O
subjects	NOUN	O	O
was	VERB	O	O
51	NUM	O	O
years	NOUN	O	O
old	ADJ	O	O
[range:	NOUN	O	O
22	NUM	O	O
to	PART	O	O
76].	NUM	O	O
The	DET	O	O
majority	NOUN	O	O
was	VERB	O	O
male	NOUN	O	O
(90%).	PUNCT	O	O

DESIGN:	NOUN	O	O
Randomized	VERB	O	O
and	CCONJ	O	O
blinded	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

OBJECTIVES:	NOUN	O	O
To	PART	O	O
compare	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
toric	ADJ	O	O
versus	CCONJ	O	O
spherical	ADJ	O	O
soft	NOUN	O	O
contact	NOUN	O	O
lenses	NOUN	O	O
on	ADP	O	O
objective	ADP	O	O
measures	NOUN	O	O
of	ADP	O	O
visual	ADJ	O	B-outcome
performance	NOUN	O	O
using	VERB	O	O
visual	ADJ	O	O
acuity	NOUN	O	O
and	CCONJ	O	O
electromyography	NOUN	O	O
of	ADP	O	O
the	DET	O	O
orbicularis	NOUN	O	O
oculi	NOUN	O	O
muscle.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Major	ADP	O	B-outcome
bleeding	VERB	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
8	NUM	O	O
of	ADP	O	O
405	NUM	O	O
patients	NOUN	O	O
(2.0%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
rivaroxaban	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
4	NUM	O	O
of	ADP	O	O
404	NUM	O	O
(1.0%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
1.96;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.59	NUM	O	O
to	PART	O	O
6.49).	ADP	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
National	ADJ	O	O
Institute	NOUN	O	O
for	ADP	O	O
Health	NOUN	O	O
Research;	NOUN	O	O
OVIVA	NOUN	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials	NOUN	O	O
number,	ADV	O	O
ISRCTN91566927	NOUN	O	O
.).	NOUN	O	O

Suicidal	NOUN	O	O
ideation	NOUN	O	O
was	VERB	O	O
independently	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
sexual	ADJ	O	O
abuse	NOUN	O	O
(AOR	NUM	O	O
11.9	NUM	O	O
(3.0-47.0))	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
lack	NOUN	O	O
of	ADP	O	O
parental	ADJ	O	O
emotional	ADJ	O	O
support	NOUN	O	O
(AOR	NUM	O	O
0.2	NUM	O	O
(0.1-0.5)).	NUM	O	O

Dual	ADJ	O	O
trigger	ADP	O	O
may	VERB	O	O
be	VERB	O	O
preferable	ADJ	O	O
to	PART	O	O
reduce	VERB	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
OHSS.	NOUN	O	O

BACKGROUND/AIM:	NOUN	O	O
Our	ADJ	O	O
hypothesis	NOUN	O	O
was	VERB	O	O
that	ADP	O	O
rectus	ADJ	O	O
sheath	NOUN	O	O
block	VERB	O	O
(RSB)	NOUN	O	O
analgesia	NOUN	O	O
could	VERB	O	O
enhance	NOUN	O	O
satisfaction	NOUN	O	B-outcome
following	VERB	O	O
midline	NOUN	O	O
laparotomy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
benign	ADJ	O	O
disease	NOUN	O	O
and	CCONJ	O	O
cancer	NOUN	O	O
patients.	NOUN	O	O

For	ADP	O	O
the	DET	O	O
representative	ADJ	O	O
of	ADP	O	O
the	DET	O	O
municipality	NOUN	O	O
the	DET	O	O
possible	ADJ	O	O
economical	ADJ	O	O
gain	VERB	O	O
of	ADP	O	O
the	DET	O	O
project	NOUN	O	O
was	VERB	O	O
in	ADP	O	O
focus.	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
GlaxoSmithKline	NOUN	O	O
and	CCONJ	O	O
Medicines	NOUN	O	O
for	ADP	O	O
Malaria	NOUN	O	O
Venture;	NOUN	O	O
DETECTIVE	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT01376167	NOUN	O	O
.).	NOUN	O	O

It	PRON	O	O
impacts	NOUN	O	O
physical,	NOUN	O	O
mental,	NOUN	O	O
and	CCONJ	O	O
social	ADJ	O	O
functioning	VERB	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
the	DET	O	O
quality	NOUN	O	O
of	ADP	O	O
life,	ADJ	O	O
often	ADV	O	O
leading	VERB	O	O
to	PART	O	O
depression.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
double-blind	ADJ	O	O
trial,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
adults	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
bacterial	ADJ	O	O
skin	NOUN	O	O
and	CCONJ	O	O
skin-structure	NOUN	O	O
infections	NOUN	O	O
(in	NUM	O	O
a	DET	O	O
1:1	ADJ	O	O
ratio)	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
omadacycline	NOUN	O	O
(100	NUM	O	O
mg	NOUN	O	O
given	VERB	O	O
intravenously	ADV	O	O
every	DET	O	O
12	NUM	O	O
hours	NOUN	O	O
for	ADP	O	O
two	NUM	O	O
doses,	ADJ	O	O
then	ADV	O	O
100	NUM	O	O
mg	NOUN	O	O
given	VERB	O	O
intravenously	ADV	O	O
every	DET	O	O
24	NUM	O	O
hours)	NOUN	O	O
or	CCONJ	O	O
linezolid	NOUN	O	O
(600	NUM	O	O
mg	NOUN	O	O
given	VERB	O	O
intravenously	ADV	O	O
every	DET	O	O
12	NUM	O	O
hours).	NOUN	O	O

Treatment	NOUN	O	O
included	VERB	O	O
weekly	ADV	O	O
behavioral	ADJ	O	O
support	NOUN	O	O
for	ADP	O	O
at	ADP	O	O
least	ADV	O	O
4	NUM	O	O
weeks.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Under	ADP	O	O
the	DET	O	O
VCV	NOUN	O	O
mode,	NOUN	O	O
the	DET	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
outside	ADP	O	O
the	DET	O	O
atomization	NOUN	O	O
could	VERB	O	O
lead	NOUN	O	O
to	PART	O	O
the	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
patient	NOUN	O	O
side,	NOUN	O	O
while	ADP	O	O
under	ADP	O	O
the	DET	O	O
PCV	NOUN	O	O
mode,	NOUN	O	O
the	DET	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
and	CCONJ	O	O
peak	NOUN	O	B-outcome
airway	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
patient	NOUN	O	O
side	NOUN	O	O
had	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
change.	NOUN	O	O

Clinical	ADJ	O	B-outcome
attachment	NOUN	O	I-outcome
level	NOUN	O	I-outcome
was	VERB	O	O
improved	VERB	O	O
but	CCONJ	O	O
the	DET	O	O
results	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
statically	ADV	O	O
significant.	NOUN	O	O

Gastrointestinal	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
(	PUNCT	O	O
flatulence	NOUN	O	B-outcome
,	PUNCT	O	O
(	PUNCT	O	O
heartburn	ADP	O	B-outcome
and	CCONJ	O	O
diarrhea	NOUN	O	B-outcome
)	PUNCT	O	O
were	VERB	O	O
the	DET	O	O
most	DET	O	O
commonly	ADV	O	O
reported	VERB	O	O
among	ADP	O	O
those	DET	O	O
probably	ADV	O	O
related	VERB	O	O
to	PART	O	O
the	DET	O	O
test	NOUN	O	O
products.	NOUN	O	O

Lifestyle	NOUN	O	B-outcome
was	VERB	O	O
assessed	VERB	O	O
using	VERB	O	O
questionnaires	NOUN	O	O
and	CCONJ	O	O
weight	NOUN	O	B-outcome
was	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
3	NUM	O	O
and	CCONJ	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
randomization.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Before	ADP	O	O
and	CCONJ	O	O
at	ADP	O	O
2	NUM	O	O
weeks,	NOUN	O	O
1	NUM	O	O
month,	NOUN	O	O
2	NUM	O	O
months,	NOUN	O	O
and	CCONJ	O	O
4	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
injection,	NOUN	O	O
dry	ADJ	O	B-outcome
eye	NOUN	O	I-outcome
signs	NOUN	O	I-outcome
;	PUNCT	O	O
tear	NUM	O	B-outcome
film	NOUN	O	I-outcome
break-up	NOUN	O	I-outcome
time	NOUN	O	I-outcome
(TBUT)	PUNCT	O	I-outcome
,	PUNCT	O	O
Schirmer	NOUN	O	O
I	NUM	O	O
test],	NUM	O	O
corneal	ADJ	O	B-outcome
fluorescein	NOUN	O	I-outcome
staining	VERB	O	I-outcome
(CFS)	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
symptoms	NOUN	O	B-outcome
;	PUNCT	O	O
ocular	ADJ	O	B-outcome
surface	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
index	NOUN	O	O
(OSDI)];	NOUN	O	O
and	CCONJ	O	O
frequency	NOUN	O	O
of	ADP	O	O
lubricants	NOUN	O	B-outcome
were	VERB	O	O
assessed.	NOUN	O	O

Journal-Name:Cellular	ADJ	O	O
physiology	NOUN	O	O
and	CCONJ	O	O
biochemistry	NOUN	O	O
:	PUNCT	O	O
international	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
experimental	ADJ	O	O
cellular	ADJ	O	O
physiology,	NOUN	O	O
biochemistry,	ADP	O	O
and	CCONJ	O	O
pharmacology	NOUN	O	O

Conclusions:	NOUN	O	O
HP/TAZ	NOUN	O	O
lotion	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
significant	ADJ	O	O
and	CCONJ	O	O
rapid	ADJ	O	O
reductions	NOUN	O	O
in	ADP	O	O
disease	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
as	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
IGAxBSA	NOUN	O	O
composite	NOUN	O	O
tool.	NOUN	O	O

PURPOSE/BACKGROUND:	NOUN	O	O
Interventions	NOUN	O	O
for	ADP	O	O
attention-deficit/hyperactivity	NOUN	O	O
disorder	ADP	O	O
(ADHD)	NUM	O	O
may	VERB	O	O
be	VERB	O	O
inadequate	ADJ	O	O
for	ADP	O	O
some	DET	O	O
patients.	NOUN	O	O

We	PRON	O	O
report	NOUN	O	O
unpublished	VERB	O	O
data	NOUN	O	O
on	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QoL)	NOUN	O	I-outcome
from	ADP	O	O
the	DET	O	O
original	ADJ	O	O
study	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
results	NOUN	O	O
of	ADP	O	O
a	DET	O	O
follow-up	NOUN	O	O
extension.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
both	CCONJ	O	O
the	DET	O	O
Ober	NOUN	O	O
and	CCONJ	O	O
Thomas	NOUN	O	O
tests	NOUN	O	O
were	VERB	O	O
positive	ADJ	O	O
at	ADP	O	O
baseline	NOUN	O	O
in	ADP	O	O
most	DET	O	O
subjects.	NOUN	O	O

A	DET	O	O
number	NOUN	O	O
of	ADP	O	O
preventive	ADJ	O	O
methods	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
tried.	NOUN	O	O

However,	ADV	O	O
it	PRON	O	O
is	VERB	O	O
unknown	VERB	O	O
if	ADP	O	O
these	DET	O	O
characteristics	NOUN	O	O
are	VERB	O	O
evident	ADJ	O	O
in	ADP	O	O
people	NOUN	O	O
with	ADP	O	O
PF	NOUN	O	O
osteoarthritis	NOUN	O	O
(OA),	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
pain-free	ADJ	O	O
older	ADJ	O	O
adults.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
changes	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
supplemented	VERB	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
10),	NUM	O	O
receiving	VERB	O	O
150	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
L-theanine	NOUN	O	O
extract	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
weeks,	NOUN	O	O
or	CCONJ	O	O
to	PART	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
10).	NOUN	O	O

All	DET	O	O
rural	ADJ	O	O
primary	ADJ	O	O
schools	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
164)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
county	NOUN	O	O
were	VERB	O	O
invited	VERB	O	O
to	PART	O	O
participate.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
design	NOUN	O	O
for	ADP	O	O
the	DET	O	O
evaluation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Nia	NOUN	O	O
Project	NOUN	O	O
is	VERB	O	O
a	DET	O	O
longitudinal,	ADJ	O	O
cluster-randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
consisting	VERB	O	O
of	ADP	O	O
a	DET	O	O
baseline	NOUN	O	O
survey	NOUN	O	O
with	ADP	O	O
a	DET	O	O
cohort	NOUN	O	O
of	ADP	O	O
Class	NOUN	O	O
7	NUM	O	O
girls,	ADJ	O	O
a	DET	O	O
school	NOUN	O	O
quality	NOUN	O	O
survey,	ADJ	O	O
qualitative	ADJ	O	O
data	NOUN	O	O
collection,	NOUN	O	O
school	NOUN	O	O
attendance	NOUN	O	O
tracking,	PUNCT	O	O
and	CCONJ	O	O
an	DET	O	O
endline	NOUN	O	O
survey	NOUN	O	O
at	ADP	O	O
the	DET	O	O
completion	NOUN	O	O
of	ADP	O	O
the	DET	O	O
18-month	NOUN	O	O
intervention	NOUN	O	O
period	NOUN	O	O
with	ADP	O	O
the	DET	O	O
same	ADJ	O	O
cohort.	NOUN	O	O

Control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
general	ADJ	O	O
education.	NOUN	O	O

Additionally,	NOUN	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
regarding	VERB	O	O
all	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
detected	VERB	O	O
between	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

The	DET	O	O
change	NOUN	O	O
in	ADP	O	O
Unified	VERB	O	O
Parkinson's	NOUN	O	B-outcome
Disease	NOUN	O	I-outcome
Rating	VERB	O	O
Scale	NOUN	O	O
(UPDRS)	NUM	O	O
score	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
week	NOUN	O	O
80	NUM	O	O
was	VERB	O	O
-1.0+/-13.1	NOUN	O	O
points	NOUN	O	O
and	CCONJ	O	O
-2.0+/-13.0	NOUN	O	O
points,	NOUN	O	O
respectively	ADV	O	O
(difference,	ADV	O	O
1.0	NUM	O	O
point;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
-1.5	NUM	O	O
to	PART	O	O
3.5;	NOUN	O	O
P=0.44);	NOUN	O	O
this	DET	O	O
finding	VERB	O	O
of	ADP	O	O
no	DET	O	O
significant	ADJ	O	O
between-group	NOUN	O	O
difference	NOUN	O	O
at	ADP	O	O
week	NOUN	O	O
80	NUM	O	O
implies	NOUN	O	O
that	ADP	O	O
levodopa	NOUN	O	O
had	VERB	O	O
no	DET	O	O
disease-modifying	VERB	O	O
effect.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100940562	NUM	O	O

Metabolic	ADJ	O	B-outcome
function	NOUN	O	I-outcome
was	VERB	O	O
measured	VERB	O	O
through	ADP	O	O
blood	NOUN	O	O
glucose	NOUN	O	B-outcome
,	PUNCT	O	O
plasma	NOUN	O	O
insulin	NOUN	O	B-outcome
,	PUNCT	O	O
plasma	NOUN	O	O
triglycerides	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
plasma	NOUN	O	O
catecholamines	NOUN	O	B-outcome
:	PUNCT	O	O
epinephrine	NOUN	O	B-outcome
(E)	NUM	O	I-outcome
and	CCONJ	O	O
norepinephrine	NOUN	O	B-outcome
(NE)	NOUN	O	I-outcome
.	PUNCT	O	O
Biomarkers	NOUN	O	O
were	VERB	O	O
taken	VERB	O	O
at	ADP	O	O
four	NUM	O	O
different	ADJ	O	O
time	NOUN	O	O
points;	NOUN	O	O
Ingestion	NOUN	O	O
period:	NOUN	O	O
baseline	NOUN	O	O
(I1),	ADV	O	O
post-ingestion	NOUN	O	O
period	NOUN	O	O
(I2);	PUNCT	O	O
Recovery	NOUN	O	O
period:	NOUN	O	O
immediately	ADV	O	O
post-exercise	NOUN	O	O
(R1),	PUNCT	O	O
post-recovery	NOUN	O	O
period	NOUN	O	O
(R2).	NOUN	O	O

Gains	NOUN	O	O
in	ADP	O	O
motor	NOUN	O	B-outcome
function	NOUN	O	I-outcome
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
undergoing	VERB	O	O
therapy,	NOUN	O	O
regardless	ADV	O	O
of	ADP	O	O
its	ADJ	O	O
type,	NOUN	O	O
might	VERB	O	O
be	VERB	O	O
a	DET	O	O
sufficient	ADJ	O	O
stimulus	NOUN	O	O
to	PART	O	O
produce	VERB	O	O
gains	NOUN	O	O
when	ADP	O	O
intensity	NOUN	O	O
is	VERB	O	O
adequately	ADV	O	O
adjusted.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
RSB	NOUN	O	O
analgesia	NOUN	O	O
could	VERB	O	O
significantly	ADV	O	O
enhance	NOUN	O	O
patient	NOUN	O	O
satisfaction	NOUN	O	B-outcome
following	VERB	O	O
midline	NOUN	O	O
laparotomy.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Today,	NOUN	O	O
the	DET	O	O
ever-expanding	VERB	O	O
technology	NOUN	O	O
is	VERB	O	O
inevitably	ADV	O	O
shadowing	VERB	O	O
on	ADP	O	O
all	DET	O	O
aspects	NOUN	O	O
of	ADP	O	O
human	NOUN	O	O
life.	NOUN	O	O

Our	ADJ	O	O
primary	ADJ	O	O
aim	ADP	O	O
was	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
in	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
setting	VERB	O	O
whether	ADP	O	O
diets	NOUN	O	O
enriched	VERB	O	O
in	ADP	O	O
fatty	ADJ	O	O
fish	NOUN	O	O
(FF),	NUM	O	O
lean	ADJ	O	O
fish	NOUN	O	O
(LF)	NOUN	O	O
or	CCONJ	O	O
ALA-rich	ADJ	O	O
camelina	NOUN	O	O
sativa	NOUN	O	O
oil	NOUN	O	O
(CSO)	PUNCT	O	O
differ	VERB	O	O
in	ADP	O	O
their	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
the	DET	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
response	NOUN	O	O
of	ADP	O	O
selected	VERB	O	O
inflammation-related	VERB	O	O
genes	NOUN	O	O
in	ADP	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
mononuclear	ADJ	O	O
cells	NOUN	O	O
(PBMCs)	PUNCT	O	O
and	CCONJ	O	O
subcutaneous	ADJ	O	O
adipose	ADJ	O	O
tissue	NOUN	O	O
(SAT)	PUNCT	O	O
in	ADP	O	O
subjects	NOUN	O	O
with	ADP	O	O
impaired	VERB	O	O
fasting	VERB	O	O
glucose.	NOUN	O	O

Conclusions:	NOUN	O	O
No	DET	O	O
dose-response	NOUN	O	O
relationship	NOUN	O	O
of	ADP	O	O
netupitant	ADJ	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
overall	ADJ	O	O
complete	ADJ	O	B-outcome
response	NOUN	O	I-outcome
rate	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
the	DET	O	O
correlation	NOUN	O	O
between	ADP	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
and	CCONJ	O	O
train-of-four	ADV	O	O
ratio	NOUN	O	O
(TOFr)	NOUN	O	O
to	PART	O	O
examine	NOUN	O	O
whether	ADP	O	O
assessing	VERB	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
clinically	ADV	O	O
to	PART	O	O
monitor	NOUN	O	O
residual	ADJ	O	B-outcome
neuromuscular	ADJ	O	I-outcome
blockade	NOUN	O	I-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
One	NUM	O	O
hundred	NUM	O	O
twenty	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
ASA	NOUN	O	O
I	NUM	O	O
or	CCONJ	O	O
II	NUM	O	O
scheduled	VERB	O	O
for	ADP	O	O
laparoscopic	ADJ	O	O
cholecystectomy	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

Determining	VERB	O	O
whether	ADP	O	O
levodopa	NOUN	O	O
also	ADV	O	O
has	VERB	O	O
a	DET	O	O
disease-modifying	VERB	O	O
effect	NOUN	O	O
could	VERB	O	O
provide	VERB	O	O
guidance	NOUN	O	O
as	ADP	O	O
to	PART	O	O
when	ADP	O	O
in	ADP	O	O
the	DET	O	O
course	NOUN	O	O
of	ADP	O	O
the	DET	O	O
disease	NOUN	O	O
the	DET	O	O
treatment	NOUN	O	O
with	ADP	O	O
this	DET	O	O
drug	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
initiated.	NOUN	O	O

Results:	NOUN	O	O
Patients	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
1	NUM	O	O
year.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
when	ADP	O	O
baseline	NOUN	O	O
(	NOUN	O	O
DIAGNOdent	ADJ	O	O
pen	NOUN	O	O
(DD)	NOUN	O	O
values	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
(P	NUM	O	O
>	SYM	O	O
0.05).	NOUN	O	O

RESULTS:	NOUN	O	O
Thirty-four	NUM	O	O
patients	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
delayed-release	NOUN	O	O
dimethyl	NOUN	O	O
fumarate	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
relapsing-remitting	VERB	O	O
multiple	ADJ	O	O
sclerosis	NOUN	O	O
from	ADP	O	O
East	ADV	O	O
Asia	PROPN	O	O
and	CCONJ	O	O
other	ADJ	O	O
countries.	NUM	O	O

The	DET	O	O
study	NOUN	O	O
involved	VERB	O	O
192	NUM	O	O
children.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

PE	NOUN	O	O
teachers	NOUN	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
intervention	NOUN	O	O
condition	NOUN	O	O
will	VERB	O	O
receive	VERB	O	O
a	DET	O	O
two-week,	NOUN	O	O
12-h	NOUN	O	O
training	VERB	O	O
program	NOUN	O	O
comprising	VERB	O	O
basic	ADJ	O	O
information	NOUN	O	O
on	ADP	O	O
how	ADP	O	O
to	PART	O	O
promote	VERB	O	O
out-of-school	NOUN	O	O
physical	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
and	CCONJ	O	O
theory-based	VERB	O	O
training	VERB	O	O
on	ADP	O	O
strategies	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
students'	NOUN	O	O
autonomous	ADJ	O	O
motivation	NOUN	O	B-outcome
toward	ADP	O	O
physical	ADJ	O	O
activity.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Negative	ADJ	O	O
Pressure	NOUN	O	O
Wound	NOUN	O	O
Therapy	NOUN	O	O
on	ADP	O	O
Wound	NOUN	O	B-outcome
Complications	NOUN	O	I-outcome
Post-Pancreatectomy.	NOUN	O	O

INTRODUCTION:	NOUN	O	O
N95	NOUN	O	O
or	CCONJ	O	O
higher	ADJ	O	O
filtering	VERB	O	O
respirators	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
recommended	VERB	O	O
in	ADP	O	O
healthcare	NOUN	O	O
settings,	NOUN	O	O
although	ADP	O	O
there	PRON	O	O
is	VERB	O	O
still	ADV	O	O
a	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
infection	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
the	DET	O	O
improper	NOUN	O	O
selection	NOUN	O	O
and	CCONJ	O	O
wearing	VERB	O	O
of	ADP	O	O
respirators.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Soft,	NOUN	O	O
non-manipulative	ADJ	O	O
osteopathic	ADJ	O	O
treatment	NOUN	O	O
is	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
improving	VERB	O	O
overall	ADJ	O	B-outcome
and	CCONJ	O	Seperator
physical-related	VERB	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	E3-outcome
in	ADP	O	O
CD	NOUN	O	O
patients,	NOUN	O	O
regardless	ADV	O	O
of	ADP	O	O
the	DET	O	O
phase	NOUN	O	O
of	ADP	O	O
the	DET	O	O
disease.	NOUN	O	O

Thirty	NUM	O	O
patients	NOUN	O	O
(50%)	PUNCT	O	O
received	VERB	O	O
prophylactic	ADJ	O	O
powdered	VERB	O	O
GLN	NOUN	O	O
orally	ADV	O	O
at	ADP	O	O
a	DET	O	O
dose	NOUN	O	O
of	ADP	O	O
10	NUM	O	O
g/8	NOUN	O	O
h.	NOUN	O	O
The	DET	O	O
prescribed	VERB	O	O
radiation	NOUN	O	O
dose	NOUN	O	O
to	PART	O	O
the	DET	O	O
planning	VERB	O	O
target	NOUN	O	O
volume	NOUN	O	O
was	VERB	O	O
30	NUM	O	O
Gy	NOUN	O	O
in	ADP	O	O
2-Gy	NUM	O	O
fractions.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
endpoints	NOUN	O	O
are	VERB	O	O
surgeon's	PUNCT	O	O
surgical	ADJ	O	B-outcome
condition	NOUN	O	I-outcome
score,	NOUN	O	O
patient's	NOUN	O	O
sedation	NOUN	O	B-outcome
score,	NOUN	O	O
and	CCONJ	O	O
surgical	ADJ	O	O
outcomes	NOUN	O	O
including	VERB	O	O
peak	NOUN	O	B-outcome
inspiratory	ADJ	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
morbidity	NOUN	O	B-outcome
.	PUNCT	O	O
DISCUSSION:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
study	NOUN	O	O
that	ADP	O	O
compares	NOUN	O	O
deep	ADJ	O	O
NMB	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
NMB	NOUN	O	O
during	ADP	O	O
laparoscopic	ADJ	O	O
gastrectomy	NOUN	O	O
in	ADP	O	O
obese	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
gastric	ADJ	O	O
cancer.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/18	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

This	DET	O	O
study	NOUN	O	O
suggests	NOUN	O	O
that	ADP	O	O
epithelial	ADJ	O	O
remodeling	VERB	O	O
may	VERB	O	O
correlate	VERB	O	O
with	ADP	O	O
relative	ADJ	O	O
curvature	NOUN	O	O
changes	NOUN	O	O
resulting	VERB	O	O
after	ADP	O	O
both	CCONJ	O	O
techniques,	NOUN	O	O
rather	ADV	O	O
than	ADP	O	O
the	DET	O	O
obvious	ADJ	O	O
difference	NOUN	O	O
of	ADP	O	O
subepithelial	ADJ	O	O
corneal	ADJ	O	O
denervation	NOUN	O	O
changes.	NOUN	O	O

Title:	NOUN	O	O
Preventive	ADJ	O	O
effect	NOUN	O	O
of	ADP	O	O
ecabet	NOUN	O	O
sodium	NOUN	O	O
on	ADP	O	O
low-dose	NOUN	O	O
aspirin-induced	VERB	O	O
small	ADJ	O	B-outcome
intestinal	ADJ	O	I-outcome
mucosal	ADJ	O	I-outcome
injury	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
pilot	NOUN	O	O
study.	NOUN	O	O

Journal-Name:Nigerian	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

However,	ADV	O	O
this	DET	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
report	NOUN	O	O
about	ADV	O	O
the	DET	O	O
effects	NOUN	O	O
on	ADP	O	O
indicators	NOUN	O	O
of	ADP	O	O
endothelial	ADJ	O	B-outcome
damage	NOUN	O	I-outcome
.	PUNCT	O	O
More	ADV	O	O
research	NOUN	O	O
in	ADP	O	O
this	DET	O	O
field	NOUN	O	O
is	VERB	O	O
necessary	ADJ	O	O
to	PART	O	O
gain	VERB	O	O
an	DET	O	O
insight	NOUN	O	O
into	ADP	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
Spirulina	NOUN	O	O
on	ADP	O	O
these	DET	O	O
indicators.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

We	PRON	O	O
found	VERB	O	O
that	ADP	O	O
the	DET	O	O
two	NUM	O	O
regimens	NOUN	O	O
were	VERB	O	O
equivalent;	NOUN	O	O
36	NUM	O	O
out	ADP	O	O
of	ADP	O	O
44	NUM	O	O
patients	NOUN	O	O
reached	VERB	O	O
the	DET	O	O
normal	ADJ	O	O
range	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
after	ADP	O	O
six	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/18	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Current	ADJ	O	O
management	NOUN	O	O
is	VERB	O	O
delivered	VERB	O	O
by	ADP	O	O
a	DET	O	O
multidisciplinary	ADJ	O	O
team,	NOUN	O	O
but	CCONJ	O	O
evidence	NOUN	O	O
of	ADP	O	O
effectiveness	NOUN	O	O
is	VERB	O	O
limited.	NOUN	O	O

Age,	NOUN	O	O
sex,	NOUN	O	O
type	NOUN	O	O
of	ADP	O	O
femoral	ADJ	O	O
prosthesis,	ADV	O	O
and	CCONJ	O	O
the	DET	O	O
injection	NOUN	O	O
method	NOUN	O	O
of	ADP	O	O
TXA	NOUN	O	O
were	VERB	O	O
risk	NOUN	O	O
factors	NOUN	O	O
for	ADP	O	O
HBL	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
after	ADP	O	O
receiving	VERB	O	O
TKA.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8910750	NUM	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

Thus,	NOUN	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
with	ADP	O	O
the	DET	O	O
aim	ADP	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
lavender	NOUN	O	O
aromatherapy	NOUN	O	O
on	ADP	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
of	ADP	O	O
postmenopausal	ADJ	O	O
women.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Otherwise,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
marginal	ADJ	O	O
benefits	NOUN	O	O
for	ADP	O	O
keeping	VERB	O	O
the	DET	O	O
indwelling	VERB	O	O
catheter	NOUN	O	O
for	ADP	O	O
48	NUM	O	O
hours	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
reducing	VERB	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
pain	NOUN	O	B-outcome
and	CCONJ	O	O
improving	VERB	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
pain	NOUN	O	I-outcome
management	NOUN	O	I-outcome
.	PUNCT	O	O
However,	ADV	O	O
all	DET	O	O
three	NUM	O	O
groups	NOUN	O	O
had	VERB	O	O
similar	ADJ	O	O
opioid	NOUN	O	B-outcome
usage	NOUN	O	I-outcome
,	PUNCT	O	O
length	NOUN	O	B-outcome
of	ADP	O	I-outcome
hospital	NOUN	O	I-outcome
stay	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
functional	ADJ	O	B-outcome
outcomes.	ADJ	O	O

Despite	ADP	O	O
their	ADJ	O	O
growing	VERB	O	O
demographics	NOUN	O	O
in	ADP	O	O
the	DET	O	O
US,	ADP	O	O
there	PRON	O	O
are	VERB	O	O
few	ADJ	O	O
studies	NOUN	O	O
evaluating	VERB	O	O
acne	NOUN	O	O
treatment	NOUN	O	O
in	ADP	O	O
this	DET	O	O
population.	ADV	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
age,	NOUN	O	O
MAS	NOUN	O	O
score,	NOUN	O	O
and	CCONJ	O	O
GMFM	NOUN	O	O
score	NOUN	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
before	ADP	O	O
treatment.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
modified	VERB	O	O
localization	NOUN	O	O
group,	NOUN	O	O
all	DET	O	O
32	NUM	O	O
patients	NOUN	O	O
succeeded	VERB	O	O
in	ADP	O	O
the	DET	O	O
localization	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
was	VERB	O	O
100%.	ADP	O	O

Children	NOUN	O	O
with	ADP	O	O
spastic	ADJ	O	O
cerebral	ADJ	O	O
palsy	NOUN	O	O
6	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
multistage	NOUN	O	O
surgery	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(received	PUNCT	O	O
rESWT	NOUN	O	O
and	CCONJ	O	O
conventional	ADJ	O	O
rehabilitation	NOUN	O	O
therapy)	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(received	PUNCT	O	O
conventional	ADJ	O	O
rehabilitation	NOUN	O	O
only).	NUM	O	O

Overjets	NOUN	O	B-outcome
were	VERB	O	O
reduced	VERB	O	O
by	ADP	O	O
7	NUM	O	O
mm	NOUN	O	O
(SD,	NOUN	O	O
2.92)	NUM	O	O
in	ADP	O	O
the	DET	O	O
PT	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
6.5	NUM	O	O
mm	NOUN	O	O
(SD,	NOUN	O	O
2.62)	NUM	O	O
in	ADP	O	O
the	DET	O	O
FT	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
no	DET	O	O
statistical	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.587;	NUM	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-1.01,	NOUN	O	O
1.78).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

At	ADP	O	O
4,	NOUN	O	O
8,	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
treatment,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
significantly	ADV	O	O
lowered	VERB	O	O
scores	NOUN	O	O
of	ADP	O	O
TCM	NOUN	O	B-outcome
syndromes	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
score	NOUN	O	O
before	ADP	O	O
treatment	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.05	NUM	O	O
or	CCONJ	O	O
0.01),	NUM	O	O
while	ADP	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
of	ADP	O	O
the	DET	O	O
scores	NOUN	O	O
occurred	VERB	O	O
only	ADV	O	O
at	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.05);	NUM	O	O
at	ADP	O	O
each	DET	O	O
of	ADP	O	O
the	DET	O	O
time	NOUN	O	O
points,	NOUN	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
significantly	ADV	O	O
greater	ADJ	O	O
reductions	NOUN	O	O
in	ADP	O	O
the	DET	O	O
score	NOUN	O	O
than	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.01).	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
UGPRF,	NOUN	O	O
while	ADP	O	O
the	DET	O	O
subjects	NOUN	O	O
in	ADP	O	O
the	DET	O	O
sham	NOUN	O	O
group	NOUN	O	O
underwent	VERB	O	O
sham	NOUN	O	O
UGPRF.	NOUN	O	O

The	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
only	ADV	O	O
differ	VERB	O	O
by	ADP	O	O
the	DET	O	O
Simvastatin	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
administration	NOUN	O	O
regimen	NOUN	O	O
while	ADP	O	O
following	VERB	O	O
the	DET	O	O
same	ADJ	O	O
procedure,	NOUN	O	O
with	ADP	O	O
identical	ADJ	O	O
surgical	ADJ	O	O
instruments,	NOUN	O	O
and	CCONJ	O	O
medical	ADJ	O	O
and	CCONJ	O	O
nursing	VERB	O	O
skilled	VERB	O	O
staff.	NOUN	O	O

Sporting	VERB	O	O
organisations	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
encouraged	VERB	O	O
to	PART	O	O
seek	NOUN	O	O
sponsorship	NOUN	O	O
from	ADP	O	O
companies	NOUN	O	O
who	ADP	O	O
produce	VERB	O	O
healthier	ADJ	O	O
food	NOUN	O	O
brands	NOUN	O	O
and	CCONJ	O	O
government-funded	VERB	O	O
social	ADJ	O	O
marketing	VERB	O	O
campaigns.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Additionally	ADV	O	O
mean	NOUN	O	O
radiation	NOUN	O	B-outcome
dose	NOUN	O	I-outcome
per	ADP	O	O
shoot	NOUN	O	O
of	ADP	O	O
recorded	VERB	O	O
Left	ADV	O	O
anterior	ADJ	O	O
oblique	ADJ	O	O
(LAO)	NOUN	O	O
oriented	VERB	O	O
projections	NOUN	O	O
was	VERB	O	O
34.4+/-15.7mGyvs	NUM	O	O
24.9+/-12.9	NUM	O	O
mGy	NOUN	O	O
for	ADP	O	O
a	DET	O	O
non	ADJ	O	O
LAO	NOUN	O	O
oriented	VERB	O	O
projection.	NOUN	O	O
(	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

IR	NOUN	O	O
premenopausal	ADJ	O	O
women	NOUN	O	O
show	VERB	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
serum	NOUN	O	O
concentrations	NOUN	O	O
regardless	ADV	O	O
the	DET	O	O
method	NOUN	O	O
of	ADP	O	O
intervention.	NOUN	O	O

In	ADP	O	O
conclusion,	NOUN	O	O
PPI	NOUN	O	O
could	VERB	O	O
ameliorate	VERB	O	O
hypogeusia	NOUN	O	B-outcome
by	ADP	O	O
improving	VERB	O	O
bitter,	NOUN	O	B-outcome
salty,	ADJ	O	B-outcome
and	CCONJ	O	Seperator
sour	NOUN	O	B-outcome
tastes	NOUN	O	E1-outcome
among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
LPR.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Medication	NOUN	O	O
Co-payment	ADJ	O	O
Vouchers	NOUN	O	O
on	ADP	O	O
P2Y12	NOUN	O	B-outcome
Inhibitor	NOUN	O	I-outcome
Use	PUNCT	O	I-outcome
and	CCONJ	O	O
Major	ADP	O	B-outcome
Adverse	ADJ	O	I-outcome
Cardiovascular	ADJ	O	I-outcome
Events	NOUN	O	I-outcome
Among	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Myocardial	ADJ	O	O
Infarction:	NOUN	O	O
The	DET	O	O
ARTEMIS	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/28	NUM	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

For	ADP	O	O
normal	ADJ	O	O
breathing,	NOUN	O	O
fit	NOUN	O	B-outcome
factors	NOUN	O	I-outcome
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
training	VERB	O	O
were	VERB	O	O
121	NUM	O	O
(10-185)	NUM	O	O
vs	CCONJ	O	O
192	NUM	O	O
(161-200)	PUNCT	O	O
for	ADP	O	O
cup-type,	NOUN	O	O
200	NUM	O	O
(39-200)	NOUN	O	O
vs	CCONJ	O	O
200	NUM	O	O
(200-200)	NOUN	O	O
for	ADP	O	O
fold-type,	NOUN	O	O
and	CCONJ	O	O
85	NUM	O	O
(18-157)	PUNCT	O	O
vs	CCONJ	O	O
173	NUM	O	O
(117-200)	PUNCT	O	O
for	ADP	O	O
valve-type.	NOUN	O	O

INTERPRETATION:	CCONJ	O	O
In	ADP	O	O
older	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
newly	ADV	O	O
diagnosed	VERB	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
leukaemia,	NOUN	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
by	ADP	O	O
the	DET	O	O
5-day	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
10-day	NOUN	O	O
decitabine	NOUN	O	O
schedule.	NOUN	O	O

Complications	NOUN	O	B-outcome
,	PUNCT	O	O
for	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
similar	ADJ	O	O
with	ADP	O	O
30%	NOUN	O	O
in	ADP	O	O
proposed	VERB	O	O
drainage	NOUN	O	O
and	CCONJ	O	O
25%	NUM	O	O
in	ADP	O	O
traditional	ADJ	O	O
approach	NOUN	O	O
(p=0.723).	PUNCT	O	O

One	NUM	O	O
participant	ADJ	O	O
was	VERB	O	O
lost	VERB	O	B-outcome
to	PART	O	I-outcome
follow-up	NOUN	O	I-outcome
.	PUNCT	O	O
Outcome	NOUN	O	B-outcome
completion	NOUN	O	I-outcome
rates	NOUN	O	O
ranged	VERB	O	O
from	ADP	O	O
89	NUM	O	O
to	PART	O	O
97%.	NUM	O	O

Title:	NOUN	O	O
[Efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
selective	ADJ	O	O
brain	NOUN	O	O
hypothermia	NOUN	O	O
therapy	NOUN	O	O
on	ADP	O	O
neonatal	ADJ	O	O
hypoxic-ischemic	ADJ	O	O
encephalopathy].	NOUN	O	O

The	DET	O	O
assay	NOUN	O	O
was	VERB	O	O
applied	VERB	O	O
in	ADP	O	O
a	DET	O	O
pilot	NOUN	O	O
pharmacokinetic	ADJ	O	O
study	NOUN	O	O
in	ADP	O	O
renal	ADJ	O	O
transplanted	VERB	O	O
patients	NOUN	O	O
receiving	VERB	O	O
belatacept	ADV	O	O
infusions.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Endothelial	ADJ	O	B-outcome
Cell	NOUN	O	I-outcome
Density	NOUN	O	I-outcome
(ECD)	NOUN	O	I-outcome
,	PUNCT	O	O
coefficient	NOUN	O	O
of	ADP	O	O
variation,	NOUN	O	O
and	CCONJ	O	O
percentage	NOUN	O	O
of	ADP	O	O
hexagonal	ADJ	O	B-outcome
cells	NOUN	O	I-outcome
were	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
a	DET	O	O
central	ADJ	O	O
image	NOUN	O	O
analysis	NOUN	O	O
reading	VERB	O	O
center	NOUN	O	O
and	CCONJ	O	O
central	ADJ	O	B-outcome
corneal	ADJ	O	I-outcome
thickness	NOUN	O	I-outcome
(CCT)	PUNCT	O	I-outcome
was	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
ultrasound	NOUN	O	O
pachymetry.	VERB	O	O

After	ADP	O	O
each	DET	O	O
fitting	VERB	O	O
and	CCONJ	O	O
at	ADP	O	O
1-week	NOUN	O	O
follow-up,	ADP	O	O
high-	ADV	O	O
and	CCONJ	O	O
low-contrast	NOUN	O	O
visual	ADJ	O	B-outcome
acuities	NOUN	O	I-outcome
were	VERB	O	O
measured.	NOUN	O	O

Results:	NOUN	O	O
P(ET)CO(2)	NOUN	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
at	ADP	O	O
T(0),	NOUN	O	O
T(1),	NOUN	O	O
T(2),	NOUN	O	O
T(3),	NOUN	O	O
T(4),	NOUN	O	O
T(5)	ADJ	O	O
were	VERB	O	O
(36.9+/-4.1),	NOUN	O	O
(36.3+/-4.7),	NOUN	O	O
(38.1+/-5.6),	NOUN	O	O
(40.4+/-4.0),	NOUN	O	O
(48.8+/-7.7),	NOUN	O	O
(45.3+/-7.6)	NOUN	O	O
mmHg,	NOUN	O	O
P(ET)CO(2)	NOUN	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
were	VERB	O	O
(38.6+/-4.4),	NOUN	O	O
(37.8+/-5.6),	ADV	O	O
(37.8+/-5.4),	NOUN	O	O
(37.4+/-6.7),	NOUN	O	O
(43.3+/-12.2),	PUNCT	O	O
(43.5+/-8.0)	PUNCT	O	O
mmHg,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
operation,	NOUN	O	O
the	DET	O	O
P(ET)CO(2)	NOUN	O	B-outcome
at	ADP	O	O
T(4)	NOUN	O	O
and	CCONJ	O	O
T(5)	ADJ	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
at	ADP	O	O
T(0)	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
group	NOUN	O	O
B	NOUN	O	O
(F=14.582,	NOUN	O	O
12.651,	ADV	O	O
all	DET	O	O
P<0.05).	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O

Four	NUM	O	O
infants	NOUN	O	O
had	VERB	O	O
consent	NOUN	O	O
withdrawn	VERB	O	O
or	CCONJ	O	O
unconfirmed,	NOUN	O	O
leaving	VERB	O	O
1098	NUM	O	O
infants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
lactoferrin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
1101	NUM	O	O
in	ADP	O	O
the	DET	O	O
sucrose	NOUN	O	O
group.	VERB	O	O

CONCLUSION:	NOUN	O	O
Significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
MBLs	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
at	ADP	O	O
different	ADJ	O	O
implant	NOUN	O	O
interfaces.	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Our	ADJ	O	O
mixed	VERB	O	O
results	NOUN	O	O
pose	NOUN	O	O
challenges	NOUN	O	O
that	ADP	O	O
are	VERB	O	O
too	ADV	O	O
infrequently	ADV	O	O
exposed	VERB	O	O
in	ADP	O	O
public	ADJ	O	O
heath	NOUN	O	O
intervention	NOUN	O	O
trials.	NOUN	O	O

The	DET	O	O
patient's	NOUN	O	O
satisfaction	NOUN	O	B-outcome
with	ADP	O	O
anesthesia	NOUN	O	O
was	VERB	O	O
assessed	VERB	O	O
with	ADP	O	O
the	DET	O	O
Visual	ADJ	O	O
Analog	NOUN	O	O
Scale	NOUN	O	O
(VAS)	PUNCT	O	O
score	NOUN	O	O
on	ADP	O	O
the	DET	O	O
first	ADV	O	O
day	NOUN	O	O
after	ADP	O	O
the	DET	O	O
operation.	ADV	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
the	DET	O	O
cost-efficacy	NOUN	O	O
of	ADP	O	O
furazolidone-based	VERB	O	O
versus	CCONJ	O	O
clarithromycin-based	VERB	O	O
quadruple	ADJ	O	O
therapy	NOUN	O	O
in	ADP	O	O
initial	ADJ	O	O
treatment	NOUN	O	O
of	ADP	O	O
Helicobacter	NOUN	O	O
pylori	NOUN	O	O
infection	NOUN	O	O
in	ADP	O	O
a	DET	O	O
variable	ADJ	O	O
clarithromycin	NOUN	O	O
drug-resistant	ADJ	O	O
region,	NOUN	O	O
a	DET	O	O
single-center,	NOUN	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
open-label	NOUN	O	O
study.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968555	NUM	O	O

However,	ADV	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
social	ADJ	O	B-outcome
support	NOUN	O	I-outcome
for	ADP	O	O
stress	NOUN	O	O
management	NOUN	O	O
and	CCONJ	O	O
negative	ADJ	O	B-outcome
affect	NOUN	O	I-outcome
between	ADP	O	O
these	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Title:	NOUN	O	O
Pilates	NOUN	O	O
exercises	NOUN	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
kidney	NOUN	O	O
disease.	NOUN	O	O

Results:	NOUN	O	O
All	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
12-18	NUM	O	O
months	NOUN	O	O
with	ADP	O	O
an	DET	O	O
average	NOUN	O	O
of	ADP	O	O
14.4	NUM	O	O
months.	NOUN	O	O

All	DET	O	O
secondary	ADJ	O	O
endpoints	NOUN	O	O
were	VERB	O	O
met.	NOUN	O	O

Between	ADP	O	O
weeks	NOUN	O	O
4	NUM	O	O
and	CCONJ	O	O
40,	NUM	O	O
the	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
progression	NOUN	O	B-outcome
of	ADP	O	O
symptoms,	NOUN	O	O
as	ADP	O	O
measured	VERB	O	O
in	ADP	O	O
Unified	VERB	O	O
Parkinson's	NOUN	O	B-outcome
Disease	NOUN	O	I-outcome
Rating	VERB	O	O
Scale	NOUN	O	O
(UPDRS)	NUM	O	O
points	NOUN	O	O
per	ADP	O	O
week,	NOUN	O	O
was	VERB	O	O
0.04+/-0.23	NOUN	O	O
in	ADP	O	O
the	DET	O	O
early-start	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
0.06+/-0.34	NOUN	O	O
in	ADP	O	O
the	DET	O	O
delayed-start	NOUN	O	O
group	NOUN	O	O
(difference,	ADV	O	O
-0.02;	ADP	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
-0.07	NUM	O	O
to	PART	O	O
0.03).	NUM	O	O

Hydrocephalus	NOUN	O	O
is	VERB	O	O
seen	VERB	O	O
in	ADP	O	O
11.8%	NUM	O	O
of	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
Myelomeningocele	NOUN	O	O
(MMC).	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

After	ADP	O	O
administration	NOUN	O	O
of	ADP	O	O
2	NUM	O	O
doses,	ADJ	O	O
the	DET	O	O
seropositivity	NOUN	O	O
rates	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Avaxim,	NOUN	O	O
Epaxal,	NOUN	O	O
and	CCONJ	O	O
Havrix	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
all	DET	O	O
100%	NOUN	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
intervals	NOUN	O	O
[CIs]:	NOUN	O	O
99.0-100,	NOUN	O	O
98.9-100,	NOUN	O	O
and	CCONJ	O	O
99.0-100,	NOUN	O	O
respectively;	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.001).	PUNCT	O	O

In	ADP	O	O
addition,	NOUN	O	O
post-training,	NOUN	O	O
participants	NOUN	O	O
still	ADV	O	O
felt	ADP	O	O
uncomfortable	ADJ	O	O
with	ADP	O	O
certain	ADJ	O	O
aspects	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
some	DET	O	O
mental	ADJ	O	O
health	NOUN	O	O
conditions.	NOUN	O	O

HIV	NOUN	O	O
self-testing	VERB	O	O
may	VERB	O	O
be	VERB	O	O
a	DET	O	O
way	NOUN	O	O
to	PART	O	O
increase	NOUN	O	O
testing	VERB	O	O
rates	NOUN	O	O
in	ADP	O	O
this	DET	O	O
high-risk	NOUN	O	O
population.	ADV	O	O

Journal-Name:Japanese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
oncology	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
assess	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
three	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
antibiotic	ADJ	O	O
treatment	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain,	NOUN	O	O
previous	ADJ	O	O
disc	NOUN	O	O
herniation,	NOUN	O	O
and	CCONJ	O	O
vertebral	ADJ	O	O
endplate	NOUN	O	O
changes	NOUN	O	O
(Modic	NUM	O	O
changes).	NUM	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
NCT02323412.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O

Before	ADP	O	O
clinicians	NOUN	O	O
can	VERB	O	O
advocate	NOUN	O	O
PC	NOUN	O	O
as	ADP	O	O
an	DET	O	O
EHS	NOUN	O	O
prevention	NOUN	O	O
strategy,	NOUN	O	O
it	PRON	O	O
must	VERB	O	O
effectively	ADV	O	O
mitigate	NOUN	O	O
factors	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
EHS	NOUN	O	O
development	NOUN	O	O
while	ADP	O	O
not	ADV	O	O
lessening	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
EHS	NOUN	O	O
treatment.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
82	NUM	O	O
children	NOUN	O	O
with	ADP	O	O
spastic	ADJ	O	O
cerebral	ADJ	O	O
palsy	NOUN	O	O
were	VERB	O	O
recruited,	NOUN	O	O
including	VERB	O	O
43	NUM	O	O
children	NOUN	O	O
in	ADP	O	O
treatment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
39	NUM	O	O
children	NOUN	O	O
in	ADP	O	O
control	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101160020	NUM	O	O

Gastric	ADJ	O	B-outcome
residual	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
before	ADP	O	O
and	CCONJ	O	O
one	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
feeding	VERB	O	O
was	VERB	O	O
measured	VERB	O	O
and	CCONJ	O	O
recorded	VERB	O	O
for	ADP	O	O
three	NUM	O	O
positions	NOUN	O	O
including	VERB	O	O
right-lateral,	NOUN	O	O
left-lateral,	NOUN	O	O
and	CCONJ	O	O
prone.	NOUN	O	O

The	DET	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
for	ADP	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
aortic	ADJ	O	O
and	CCONJ	O	O
hepatic	ADJ	O	O
enhancement	NOUN	O	B-outcome
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
protocols	NOUN	O	O
was	VERB	O	O
within	ADP	O	O
the	DET	O	O
range	NOUN	O	O
of	ADP	O	O
the	DET	O	O
predetermined	VERB	O	O
equivalence	NOUN	O	O
margins	NOUN	O	O
in	ADP	O	O
all	DET	O	O
BMI	NOUN	O	O
subgroups.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

This	DET	O	O
follows	NOUN	O	O
a	DET	O	O
4-week	NOUN	O	O
baseline	NOUN	O	O
period	NOUN	O	O
where	ADP	O	O
all	DET	O	O
villages	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
receive	VERB	O	O
repellent.	NOUN	O	O

No	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
recorded	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

No	DET	O	O
change	NOUN	O	O
in	ADP	O	O
Pgp3-specific	NOUN	O	B-outcome
antibody	NOUN	O	I-outcome
responses	NOUN	O	I-outcome
were	VERB	O	O
observed	VERB	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
or	CCONJ	O	O
treatment	NOUN	O	O
arms.	ADJ	O	O

RESULTS:	NOUN	O	O
CART	NOUN	O	O
group	NOUN	O	O
demonstrated	VERB	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
HFnu	NOUN	O	B-outcome
,	PUNCT	O	O
TP	NOUN	O	B-outcome
,	PUNCT	O	O
SDNN	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
RMSSD	NOUN	O	B-outcome
,	PUNCT	O	O
(p<0.05)	NOUN	O	O
along	ADV	O	O
with	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
decrease	NOUN	O	O
in	ADP	O	O
LFnu	ADP	O	B-outcome
,	PUNCT	O	O
LF/HF	ADV	O	B-outcome
ratio	NOUN	O	I-outcome
,	PUNCT	O	O
systolic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
diastolic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
(p<0.05).	NOUN	O	O

MATERIAL	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
The	DET	O	O
safety	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
in	ADP	O	O
randomly	ADV	O	O
assigned	VERB	O	O
subjects	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
the	DET	O	O
test	NOUN	O	O
products	NOUN	O	O
(61	NOUN	O	O
subjects	NOUN	O	O
in	ADP	O	O
BT-11	NOUN	O	O
300mg	NUM	O	O
daily	ADJ	O	O
or	CCONJ	O	O
60	NUM	O	O
subjects	NOUN	O	O
in	ADP	O	O
matching	VERB	O	O
placebo)	NOUN	O	O
for	ADP	O	O
12	NUM	O	O
weeks.	NOUN	O	O

We	PRON	O	O
used	VERB	O	O
minimally	ADV	O	O
invasive	ADJ	O	O
technique	NOUN	O	O
pressure	NOUN	O	O
recording	VERB	O	O
analytical	ADJ	O	O
method	NOUN	O	O
(PRAM)	NUM	O	O
to	PART	O	O
directly	ADV	O	O
monitor	NOUN	O	O
hemodynamics	NOUN	O	B-outcome
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
efficiency	NOUN	O	O
and	CCONJ	O	O
compared	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
anesthetic	ADJ	O	O
regimens	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
ventricular	ADJ	O	O
septal	ADJ	O	O
defect	NOUN	O	O
repair.	NOUN	O	O

Results	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
disseminated	VERB	O	O
through	ADP	O	O
workshops,	NOUN	O	O
conferences	NOUN	O	O
and	CCONJ	O	O
peer-reviewed	VERB	O	O
publications.	NOUN	O	O

The	DET	O	O
presence	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
uncomplicated	VERB	O	O
cystitis	NOUN	O	O
symptoms	NOUN	O	O
was	VERB	O	O
recorded	VERB	O	O
and	CCONJ	O	O
urinalysis	ADV	O	O
was	VERB	O	O
performed.	NOUN	O	O

Our	ADJ	O	O
finding	VERB	O	O
that	ADP	O	O
highly-severe	ADJ	O	O
health	NOUN	O	O
warnings	NOUN	O	O
increase	NOUN	O	O
avoidance	NOUN	O	B-outcome
and	CCONJ	O	O
reactance	NOUN	O	B-outcome
but	CCONJ	O	O
are	VERB	O	O
also	ADV	O	O
perceived	VERB	O	O
as	ADP	O	O
being	VERB	O	O
more	ADV	O	O
effective	ADJ	O	O
and	CCONJ	O	O
more	ADV	O	O
likely	ADV	O	O
to	PART	O	O
motivate	NOUN	O	B-outcome
people	NOUN	O	O
to	PART	O	O
drink	NOUN	O	O
less	ADV	O	O
will	VERB	O	O
inform	NOUN	O	O
future	NOUN	O	O
health	NOUN	O	O
warning	VERB	O	O
design	NOUN	O	O
and	CCONJ	O	O
have	VERB	O	O
implications	NOUN	O	O
for	ADP	O	O
health	NOUN	O	O
warning	VERB	O	O
label	NOUN	O	O
theory.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Conclusions	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
indicated	VERB	O	O
that	ADP	O	O
TC	NOUN	O	O
may	VERB	O	O
alleviate	NOUN	O	O
depression	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
elderly	NOUN	O	O
through	ADP	O	O
modulating	VERB	O	O
autonomous	ADJ	O	O
nervous	ADJ	O	O
system	NOUN	O	O
or	CCONJ	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
parameters.	NOUN	O	O

The	DET	O	O
same	ADJ	O	O
evaluation	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
18	NUM	O	O
to	PART	O	O
30	NUM	O	O
months	NOUN	O	O
postoperatively	ADV	O	O
to	PART	O	O
estimate	ADP	O	O
the	DET	O	O
results	NOUN	O	O
of	ADP	O	O
our	ADJ	O	O
treatment.	NOUN	O	O

Our	ADJ	O	O
findings	NOUN	O	O
confirm	NOUN	O	O
that	ADP	O	O
lactobacilli	NOUN	O	O
decrease	NOUN	O	O
cry	NOUN	O	B-outcome
and	CCONJ	O	Seperator
fuss	NOUN	O	B-outcome
time	NOUN	O	E1-outcome
and	CCONJ	O	O
provide	VERB	O	O
a	DET	O	O
dietary	ADJ	O	B-outcome
support	NOUN	O	I-outcome
in	ADP	O	O
exclusively	ADV	O	O
breastfed	NOUN	O	O
infants	NOUN	O	O
with	ADP	O	O
colic.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
patients	NOUN	O	O
scheduled	VERB	O	O
for	ADP	O	O
CABG	NOUN	O	O
to	PART	O	O
undergo	NOUN	O	O
bilateral	ADJ	O	O
or	CCONJ	O	O
single	ADJ	O	O
internal-thoracic-artery	ADV	O	O
grafting.	NOUN	O	O

Accumulating	VERB	O	O
evidence	NOUN	O	O
suggests	NOUN	O	O
that	ADP	O	O
some	DET	O	O
single	ADJ	O	O
strains	NOUN	O	O
of	ADP	O	O
lactobacilli	NOUN	O	O
may	VERB	O	O
play	VERB	O	O
a	DET	O	O
positive	ADJ	O	O
dietary	ADJ	O	O
role	NOUN	O	O
in	ADP	O	O
attenuation	NOUN	O	O
of	ADP	O	O
colic	ADJ	O	O
in	ADP	O	O
exclusively	ADV	O	O
breastfed	NOUN	O	O
infants.	NOUN	O	O

We	PRON	O	O
hypothesized	VERB	O	O
that	ADP	O	O
Dex	NOUN	O	O
could	VERB	O	O
enhance	NOUN	O	O
the	DET	O	O
efficiency	NOUN	O	O
of	ADP	O	O
intrathecal	ADJ	O	O
bupivacaine	NOUN	O	O
for	ADP	O	O
spinal	ADJ	O	O
anesthesia	NOUN	O	O
in	ADP	O	O
cesarean	NOUN	O	O
section.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Importance:	NOUN	O	O
Microvascular	ADJ	O	O
obstruction	NOUN	O	O
commonly	ADV	O	O
affects	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
ST-segment	NOUN	O	O
elevation	NOUN	O	O
myocardial	ADJ	O	O
infarction	NOUN	O	O
(STEMI)	PUNCT	O	O
and	CCONJ	O	O
is	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
adverse	ADJ	O	O
outcomes.	ADJ	O	O

In	ADP	O	O
the	DET	O	O
PRP	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
40),	NOUN	O	O
in	ADP	O	O
addition	NOUN	O	O
to	PART	O	O
HRT,	NOUN	O	O
0.5-1	NUM	O	O
cc	NOUN	O	O
of	ADP	O	O
PRP	NOUN	O	O
was	VERB	O	O
infused	VERB	O	O
into	ADP	O	O
the	DET	O	O
uterine	ADJ	O	O
cavity	NOUN	O	O
on	ADP	O	O
the	DET	O	O
13th	ADJ	O	O
day	NOUN	O	O
of	ADP	O	O
HRT	NOUN	O	O
cycle.	NOUN	O	O

In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
we	PRON	O	O
showed	VERB	O	O
that	ADP	O	O
supplementation	NOUN	O	O
with	ADP	O	O
a	DET	O	O
PMP	NOUN	O	O
significantly	ADV	O	O
improved	VERB	O	O
reactive	ADJ	O	B-outcome
oxygen	NOUN	O	I-outcome
species	NOUN	O	I-outcome
(ROS)	PUNCT	O	I-outcome
scavenging	VERB	O	O
activity	NOUN	O	O
and	CCONJ	O	O
prevented	VERB	O	O
DNA	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
.	PUNCT	O	O
However,	ADV	O	O
additional	ADJ	O	O
research	NOUN	O	O
is	VERB	O	O
still	ADV	O	O
needed	VERB	O	O
to	PART	O	O
further	ADV	O	O
identify	NOUN	O	O
mechanisms	NOUN	O	O
of	ADP	O	O
actions	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
role	NOUN	O	O
of	ADP	O	O
circulating	VERB	O	O
phytonutrient	NOUN	O	O
metabolites.	NOUN	O	O

Thus,	NOUN	O	O
krill	NOUN	O	O
powder	NOUN	O	O
has	VERB	O	O
a	DET	O	O
lot	NOUN	O	O
of	ADP	O	O
potential	ADJ	O	O
in	ADP	O	O
improving	VERB	O	O
lipid	NOUN	O	O
and	CCONJ	O	O
metabolic	ADJ	O	O
profile	NOUN	O	O
and	CCONJ	O	O
reinforcing	VERB	O	O
the	DET	O	O
activity	NOUN	O	O
of	ADP	O	O
the	DET	O	O
antioxidant	NOUN	O	O
system.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

Bivariate	NOUN	O	O
and	CCONJ	O	O
multivariate	ADJ	O	O
logistic	ADJ	O	O
regression	NOUN	O	O
analysis	NOUN	O	O
assessed	VERB	O	O
correlates	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
indicators	NOUN	O	O
of	ADP	O	O
psychological	ADJ	O	O
distress.	NOUN	O	O

Netupitant	ADJ	O	O
was	VERB	O	O
well	ADV	O	O
tolerated	VERB	O	B-outcome
at	ADP	O	O
all	DET	O	O
doses	NOUN	O	O
without	ADP	O	O
clinically	ADV	O	O
harmful	ADJ	O	O
safety	NOUN	O	O
signals	NOUN	O	O
observed.	NOUN	O	O

A	DET	O	O
range	NOUN	O	O
of	ADP	O	O
studies	NOUN	O	O
showed	VERB	O	O
confusing	VERB	O	O
data	NOUN	O	O
about	ADV	O	O
the	DET	O	O
relationship	NOUN	O	O
between	ADP	O	O
obesity,	ADJ	O	O
weight	NOUN	O	O
reduction	NOUN	O	O
and	CCONJ	O	O
circulating	VERB	O	O
total	ADJ	O	O
insulin-like	ADJ	O	O
growth	NOUN	O	O
factor	NOUN	O	O
-1	NUM	O	O
(IGF-1).	PUNCT	O	O

Methods:	NOUN	O	O
Between	ADP	O	O
March	NOUN	O	O
2017	NUM	O	O
and	CCONJ	O	O
May	NOUN	O	O
2017,	NUM	O	O
24	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
planned	VERB	O	O
to	PART	O	O
have	VERB	O	O
a	DET	O	O
unilateral	ADJ	O	O
THA	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
and	CCONJ	O	O
randomized	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

INTRODUCTION:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
we	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
demineralized	VERB	O	B-outcome
lesions	NOUN	O	I-outcome
and	CCONJ	O	O
bond	NOUN	O	B-outcome
failures	NOUN	O	I-outcome
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
wearing	VERB	O	O
fixed	VERB	O	O
orthodontic	ADJ	O	O
appliances	NOUN	O	O
bonded	VERB	O	O
with	ADP	O	O
either	CCONJ	O	O
light-cured	VERB	O	O
resin-modified	VERB	O	O
glass	NOUN	O	O
ionomer	NOUN	O	O
cement	NOUN	O	O
or	CCONJ	O	O
light-cured	VERB	O	O
composite.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Few	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
described	VERB	O	O
belatacept	ADV	O	O
pharmacokinetics,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
therapeutic	ADJ	O	O
drug	NOUN	O	O
monitoring	VERB	O	O
has	VERB	O	O
not	ADV	O	O
been	VERB	O	O
investigated.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
chronomodulated	VERB	O	O
chemotherapy	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30,	NUM	O	O
CC	NOUN	O	O
group)	ADJ	O	O
received	VERB	O	O
cisplatin	NOUN	O	O
at	ADP	O	O
80	NUM	O	O
mg/m(2)	NOUN	O	O
through	ADP	O	O
intravenous	ADJ	O	O
infusion	NOUN	O	O
from	ADP	O	O
10:00	NOUN	O	O
to	PART	O	O
22:00	NOUN	O	O
and	CCONJ	O	O
5-fluorouracil	NOUN	O	O
(5-FU)	NOUN	O	O
at	ADP	O	O
1000	NUM	O	O
mg/m(2)	NOUN	O	O
plus	CCONJ	O	O
citrovorum	NOUN	O	O
factor	NOUN	O	O
at	ADP	O	O
200	NUM	O	O
mg/m(2)	NOUN	O	O
from	ADP	O	O
22:00	NOUN	O	O
to	PART	O	O
10:00	NOUN	O	O
each	DET	O	O
day	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
days.	NOUN	O	O

Among	ADP	O	O
the	DET	O	O
men	NOUN	O	O
in	ADP	O	O
the	DET	O	O
IG,	NOUN	O	O
76%	NUM	O	O
had	VERB	O	O
a	DET	O	O
positive	ADJ	O	B-outcome
experience	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
counselling,	NOUN	O	O
and	CCONJ	O	O
77%	NUM	O	O
had	VERB	O	O
received	VERB	O	B-outcome
new	ADJ	O	I-outcome
information	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSION:	NOUN	O	O
The	DET	O	O
intervention	NOUN	O	O
managed	VERB	O	O
to	PART	O	O
increase	NOUN	O	O
different	ADJ	O	O
aspects	NOUN	O	O
of	ADP	O	O
men's	NOUN	O	O
fertility	NOUN	O	B-outcome
awareness	ADV	O	I-outcome
.	PUNCT	O	O
In	ADP	O	O
the	DET	O	O
future,	NOUN	O	O
the	DET	O	O
format	NUM	O	O
for	ADP	O	O
preconception	NOUN	O	O
care	NOUN	O	O
for	ADP	O	O
men	NOUN	O	O
needs	NOUN	O	O
further	ADV	O	O
development.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
FLAME	NOUN	O	O
study.	NOUN	O	O

During	ADP	O	O
operations,	NUM	O	O
the	DET	O	O
ETView	NOUN	O	O
tubes	NOUN	O	O
provided	ADJ	O	O
continuous	ADJ	O	B-outcome
airway	NOUN	O	I-outcome
visualization	NOUN	O	I-outcome
in	ADP	O	O
all	DET	O	O
patients;	NOUN	O	O
a	DET	O	O
good	ADJ	O	O
view	NOUN	O	B-outcome
was	VERB	O	O
obtained	VERB	O	O
in	ADP	O	O
24/25	VERB	O	O
patients	NOUN	O	O
in	ADP	O	O
VDT/VST,	ADJ	O	O
moderate	ADJ	O	O
in	ADP	O	O
4/12	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
VDT/VST,	ADJ	O	O
and	CCONJ	O	O
poor	ADJ	O	O
in	ADP	O	O
1/1	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
VDT/VST.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

13	NUM	O	O
046	NUM	O	O
women	NOUN	O	O
(intervention	PUNCT	O	O
n=7067,	NOUN	O	O
usual	ADJ	O	O
care	NOUN	O	O
n=5979)	NOUN	O	O
with	ADP	O	O
data	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
national	ADJ	O	O
Dutch	NOUN	O	O
perinatal	ADJ	O	O
registry	NOUN	O	O
or	CCONJ	O	O
hospital	NOUN	O	O
records	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
analyses.	NOUN	O	O

Peripheral	ADJ	O	O
perfusion-targeted	VERB	O	O
resuscitation	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
less	ADV	O	O
organ	NOUN	O	B-outcome
dysfunction	NOUN	O	I-outcome
at	ADP	O	O
72	NUM	O	O
hours	NOUN	O	O
(mean	NUM	O	O
SOFA	NOUN	O	O
score,	NOUN	O	O
5.6	NUM	O	O
[SD,	NOUN	O	O
4.3	PUNCT	O	O
vs	CCONJ	O	O
6.6	NUM	O	O
[SD,	NOUN	O	O
4.7];	NUM	O	O
mean	NOUN	O	O
difference,	NOUN	O	O
-1.00	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-1.97	NUM	O	O
to	PART	O	O
-0.02];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.045).	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
is	VERB	O	O
the	DET	O	O
number	NOUN	O	O
of	ADP	O	O
harvested	VERB	O	B-outcome
lymph	NOUN	O	I-outcome
nodes	NOUN	O	I-outcome
,	PUNCT	O	O
which	ADP	O	O
is	VERB	O	O
a	DET	O	O
critical	ADJ	O	O
index	NOUN	O	O
of	ADP	O	O
the	DET	O	O
quality	NOUN	O	O
of	ADP	O	O
surgery	NOUN	O	O
in	ADP	O	O
gastric	ADJ	O	O
cancer	NOUN	O	O
treatment.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
gastroenterology	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
evaluated	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
nerve	NOUN	O	O
electrical	ADJ	O	O
stimulation	NOUN	O	O
(NES)	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
chemotherapy-induced	VERB	O	O
nausea	NOUN	O	B-outcome
and	CCONJ	O	O
vomiting	VERB	O	B-outcome
(CINV)	PUNCT	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
gastric	ADJ	O	O
cancer	NOUN	O	O
(AGC).	PUNCT	O	O

Krill-derived	VERB	O	O
protein	NOUN	O	O
hydrolysates/peptides	NOUN	O	O
may	VERB	O	O
have	VERB	O	O
positive	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
blood	NOUN	O	O
pressure	NOUN	O	O
and	CCONJ	O	O
astaxanthin	ADP	O	O
has	VERB	O	O
anti-oxidative	ADJ	O	O
and	CCONJ	O	O
anti-inflammatory	ADJ	O	O
properties.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/18	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101510759	NUM	O	O

Title:	NOUN	O	O
Remote	ADV	O	O
ischemic	ADJ	O	O
preconditioning	VERB	O	O
for	ADP	O	O
prevention	NOUN	O	O
of	ADP	O	O
contrast	NOUN	O	B-outcome
induced	VERB	O	I-outcome
nephropathy	NOUN	O	I-outcome
-Insights	NUM	O	O
from	ADP	O	O
an	DET	O	O
Indian	NOUN	O	O
study.	NOUN	O	O

Several	ADJ	O	O
approved	VERB	O	O
inactivated	VERB	O	O
hepatitis	NOUN	O	O
A	DET	O	O
(HA)	PUNCT	O	O
vaccines	NOUN	O	O
are	VERB	O	O
available	ADJ	O	O
in	ADP	O	O
Korea.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/23	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
TFP	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
received	VERB	O	O
a	DET	O	O
single	ADJ	O	O
TFP	NOUN	O	O
25	NUM	O	O
mug/	NOUN	O	O
h	NOUN	O	O
to	PART	O	O
the	DET	O	O
anterior	ADJ	O	O
chest	NOUN	O	O
wall	NOUN	O	O
14	NUM	O	O
h	NOUN	O	O
before	ADP	O	O
operation.	ADV	O	O

However,	ADV	O	O
the	DET	O	O
combination	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
a	DET	O	O
clinically	ADV	O	O
important	ADJ	O	O
improvement	NOUN	O	O
over	ADP	O	O
ibuprofen	NOUN	O	O
alone,	NOUN	O	O
suggesting	VERB	O	O
that	ADP	O	O
ibuprofen	NOUN	O	O
alone	ADJ	O	O
may	VERB	O	O
be	VERB	O	O
a	DET	O	O
reasonable	ADJ	O	O
option	NOUN	O	O
for	ADP	O	O
early	ADJ	O	O
postoperative	ADJ	O	O
oral	ADJ	O	O
analgesia.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

0.05).	NOUN	O	O

In	ADP	O	O
the	DET	O	O
Province	NOUN	O	O
of	ADP	O	O
Quebec,	NOUN	O	O
vaccine	NOUN	O	O
coverage	NOUN	O	O
in	ADP	O	O
young	ADJ	O	O
children	NOUN	O	O
are	VERB	O	O
sub-optimal,	ADJ	O	O
mostly	ADV	O	O
due	ADJ	O	O
to	PART	O	O
ambivalence	NOUN	O	O
toward	ADP	O	O
vaccine	NOUN	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy.	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
neuromuscular	ADJ	O	O
electrical	ADJ	O	O
stimulation	NOUN	O	O
(NMES)	NUM	O	O
therapy	NOUN	O	O
for	ADP	O	O
chronic	ADJ	O	O
urinary	ADJ	O	O
retention	NOUN	O	O
(CUR)	NOUN	O	O
following	VERB	O	O
traumatic	ADJ	O	O
brain	NOUN	O	O
injury	NOUN	O	O
(TBI).	PUNCT	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
probiotics	NOUN	O	O
on	ADP	O	O
glycemic	ADJ	O	O
index.	NOUN	O	O

Final	ADJ	O	O
date	NOUN	O	O
of	ADP	O	O
follow-up	NOUN	O	O
was	VERB	O	O
January	NOUN	O	O
1,	NOUN	O	O
2018.	NUM	O	O

These	DET	O	O
findings	NOUN	O	O
were	VERB	O	O
potentially	ADV	O	O
explained	VERB	O	O
by	ADP	O	O
within-group	NOUN	O	O
significance	NOUN	O	O
for	ADP	O	O
the	DET	O	O
same	ADJ	O	O
variables	NOUN	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
10	NUM	O	O
min	NOUN	O	O
split	ADJ	O	O
(P	NUM	O	O
</=	NOUN	O	O
0.01),	NUM	O	O
and	CCONJ	O	O
for	ADP	O	O
distance	NOUN	O	O
covered	VERB	O	O
(P	NUM	O	O
=	SYM	O	O
0.01)	NUM	O	O
in	ADP	O	O
the	DET	O	O
second	ADJ	O	O
10-min	NOUN	O	O
split.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
median	ADJ	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
normalization	NOUN	O	I-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
platelet	NOUN	O	I-outcome
count	NOUN	O	I-outcome
was	VERB	O	O
shorter	ADJ	O	O
with	ADP	O	O
caplacizumab	NOUN	O	O
than	ADP	O	O
with	ADP	O	O
placebo	NOUN	O	O
(2.69	NUM	O	O
days	NOUN	O	O
[95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
{CI},	NOUN	O	O
1.89	NUM	O	O
to	PART	O	O
2.83	NOUN	O	O
vs.	CCONJ	O	O
2.88	NUM	O	O
days	NOUN	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
2.68	NUM	O	O
to	PART	O	O
3.56],	NOUN	O	O
P=0.01),	NOUN	O	O
and	CCONJ	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
caplacizumab	NOUN	O	O
were	VERB	O	O
1.55	NUM	O	O
times	NOUN	O	O
as	ADP	O	O
likely	ADV	O	O
to	PART	O	O
have	VERB	O	O
a	DET	O	O
normalization	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
platelet	NOUN	O	I-outcome
count	NOUN	O	I-outcome
as	ADP	O	O
those	DET	O	O
who	ADP	O	O
received	VERB	O	O
placebo.	NOUN	O	O

Results	NOUN	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
(HR)	NOUN	O	I-outcome
,	PUNCT	O	O
systemic	ADJ	O	B-outcome
vascular	ADJ	O	I-outcome
resistance	NOUN	O	I-outcome
index	NOUN	O	O
(SVRI)	PUNCT	O	O
showed	VERB	O	O
a	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
SM	NOUN	O	O
but	CCONJ	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
S	NOUN	O	O
(Ptime*group<0.0001)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
period.	NOUN	O	O

Hydration	NOUN	O	B-outcome
indicators	NOUN	O	O
(	PUNCT	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
(BW)	NOUN	O	I-outcome
,	PUNCT	O	O
salivary	ADJ	O	B-outcome
and	CCONJ	O	Seperator
urine	NOUN	O	B-outcome
osmolality	NOUN	O	E1-outcome
[SOsm/UOsm],	ADP	O	O
urine	NOUN	O	B-outcome
specific	ADJ	O	I-outcome
gravity	NOUN	O	I-outcome
[USG]	NOUN	O	I-outcome
,	PUNCT	O	O
urine	NOUN	O	B-outcome
volume	NOUN	O	I-outcome
[UV]	NOUN	O	I-outcome
,	PUNCT	O	O
urine	NOUN	O	B-outcome
color	NOUN	O	I-outcome
[UC]	NOUN	O	I-outcome
),	NUM	O	O
thirst	ADV	O	B-outcome
,	PUNCT	O	O
fatigue	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
recovery	NOUN	O	B-outcome
(	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
[HR)	PUNCT	O	I-outcome
],	NOUN	O	O
and	CCONJ	O	O
HR	NOUN	O	B-outcome
variability	NOUN	O	I-outcome
[HRV]	NOUN	O	I-outcome
)	PUNCT	O	O
were	VERB	O	O
taken	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
post-exercise,	NOUN	O	O
0.5,	NOUN	O	O
1,	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
h	NOUN	O	O
post-consumption	NOUN	O	O
of	ADP	O	O
1	NUM	O	O
L	NOUN	O	O
of	ADP	O	O
MW	NOUN	O	O
or	CCONJ	O	O
control.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
95%	NOUN	O	O
effective	ADJ	O	O
dose	NOUN	O	B-outcome
of	ADP	O	O
intrathecal	ADJ	O	O
ropivacaine	NOUN	O	O
with	ADP	O	O
5	NUM	O	O
mug	NUM	O	O
sufentanil	NOUN	O	O
for	ADP	O	O
successful	ADJ	O	O
anesthesia	NOUN	O	O
was	VERB	O	O
15.2	NUM	O	O
mg	NOUN	O	O
(95%CI,	NOUN	O	O
13.5-18.8	NUM	O	O
mg),	NOUN	O	O
when	ADP	O	O
receiving	VERB	O	O
prophylactic	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
phenylephrine.	NOUN	O	O

The	DET	O	O
plasma	NOUN	O	O
concentrations	NOUN	O	O
of	ADP	O	O
the	DET	O	O
NT	NOUN	O	O
marker	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
just	ADV	O	O
before,	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
and	CCONJ	O	O
24	NUM	O	O
h	NOUN	O	O
after	ADP	O	O
operation.	ADV	O	O

Changes	NOUN	O	O
in	ADP	O	O
the	DET	O	O
100-mm	NOUN	O	O
visual	ADJ	O	O
analogue	NOUN	O	O
scale	NOUN	O	O
(VAS)	PUNCT	O	O
for	ADP	O	O
low	ADJ	O	B-outcome
back	ADP	O	I-outcome
pain	NOUN	O	I-outcome
after	ADP	O	O
6	NUM	O	O
weeks	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
assessed	VERB	O	O
as	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcome.	NOUN	O	O

Safety	NOUN	O	O
was	VERB	O	O
assessed	VERB	O	O
in	ADP	O	O
all	DET	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
at	ADP	O	O
least	ADV	O	O
one	NUM	O	O
dose	NOUN	O	O
of	ADP	O	O
ixazomib	NOUN	O	O
or	CCONJ	O	O
placebo,	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
treatment	NOUN	O	O
actually	ADV	O	O
received.	NOUN	O	O

While	ADP	O	O
the	DET	O	O
mhGAP-IG	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
used	VERB	O	O
extensively	ADV	O	O
in	ADP	O	O
low-	ADJ	O	O
and	CCONJ	O	O
middle-income	NOUN	O	O
countries	NOUN	O	O
(LMICs)	PUNCT	O	O
to	PART	O	O
help	VERB	O	O
build	ADP	O	O
non-specialists'	NOUN	O	O
mental	ADJ	O	O
health	NOUN	O	O
capacity,	NOUN	O	O
little	DET	O	O
research	NOUN	O	O
has	VERB	O	O
focused	VERB	O	O
on	ADP	O	O
how	ADP	O	O
contextual	ADJ	O	O
factors	NOUN	O	O
interact	VERB	O	O
with	ADP	O	O
the	DET	O	O
implemented	VERB	O	O
training	VERB	O	O
program	NOUN	O	O
to	PART	O	O
influence	NOUN	O	O
its	ADJ	O	O
expected	VERB	O	O
outcomes.	ADJ	O	O

Secondary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
emergency	NOUN	O	I-outcome
medical	ADJ	O	I-outcome
services	NOUN	O	I-outcome
(EMS)	NUM	O	I-outcome
activation	NOUN	O	I-outcome
.	PUNCT	O	O
We	PRON	O	O
analyzed	VERB	O	O
data	NOUN	O	O
via	ADP	O	O
Kruskal-Wallis	NOUN	O	O
rank	NOUN	O	O
sum	NOUN	O	O
test.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
presented	VERB	O	O
with	ADP	O	O
a	DET	O	O
vital	ADJ	O	O
maxillary	ADJ	O	O
or	CCONJ	O	O
mandibular	ADJ	O	O
molar,	ADV	O	O
premolar,	ADV	O	O
or	CCONJ	O	O
front	NOUN	O	O
teeth	NOUN	O	O
designated	VERB	O	O
for	ADP	O	O
intentional	ADJ	O	O
endodontic	ADJ	O	O
RCT	NOUN	O	O
for	ADP	O	O
prosthetic	ADJ	O	O
reasons.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Incidence	NOUN	O	O
of	ADP	O	O
end	NOUN	O	O
stage	NOUN	O	O
kidney	NOUN	O	O
disease	NOUN	O	O
(ESKD)	PUNCT	O	O
for	ADP	O	O
Indigenous	ADJ	O	O
Australians	NOUN	O	O
is	VERB	O	O
especially	ADV	O	O
high	ADJ	O	O
in	ADP	O	O
remote	ADV	O	O
and	CCONJ	O	O
very	ADV	O	O
remote	ADV	O	O
areas	NOUN	O	O
of	ADP	O	O
Australia	PROPN	O	O
(18	NOUN	O	O
and	CCONJ	O	O
20	NUM	O	O
times	NOUN	O	O
the	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
comparable	ADJ	O	O
non-Indigenous	ADJ	O	O
people).	NOUN	O	O

Both	CCONJ	O	O
intervention	NOUN	O	O
groups	NOUN	O	O
aimed	VERB	O	O
for	ADP	O	O
equivalent	ADJ	O	O
weight	NOUN	O	O
loss	NOUN	O	O
(6-7%)	NUM	O	O
following	VERB	O	O
a	DET	O	O
calorie-restricted	VERB	O	O
diet	NOUN	O	O
(diet	NOUN	O	O
group)	ADJ	O	O
or	CCONJ	O	O
a	DET	O	O
partly	ADV	O	O
supervised	VERB	O	O
intensive	ADJ	O	O
exercise	NOUN	O	O
programme	NOUN	O	O
(4	NOUN	O	O
h	NOUN	O	O
per	ADP	O	O
week)	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
a	DET	O	O
small	ADJ	O	O
caloric	ADJ	O	O
restriction	NOUN	O	O
(exercise	PUNCT	O	O
plus	CCONJ	O	O
diet	NOUN	O	O
group).	NOUN	O	O

Objective:	NOUN	O	O
Investigate	NOUN	O	O
beneficial	ADJ	O	O
and	CCONJ	O	O
harmful	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
4	NUM	O	O
nonopioid	NOUN	O	O
analgesics	NOUN	O	O
regimens.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Study	NOUN	O	O
design:	NOUN	O	O
Controlled	VERB	O	O
laboratory	NOUN	O	O
study;	ADJ	O	O
cross-sectional	ADJ	O	O
design.	NOUN	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
AHRQ	NOUN	O	O
Healthcare-Associated	VERB	O	O
Infections	NOUN	O	O
Program	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT01209234	NOUN	O	O
.).	NOUN	O	O

When	ADP	O	O
the	DET	O	O
intensity	NOUN	O	O
of	ADP	O	O
pain	NOUN	O	B-outcome
was	VERB	O	O
taken	VERB	O	O
into	ADP	O	O
consideration	NOUN	O	O
in	ADP	O	O
the	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
EG,	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
significantly	ADV	O	O
greater	ADJ	O	O
increment	NOUN	O	O
in	ADP	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
specific	ADJ	O	O
for	ADP	O	O
CD	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
people	NOUN	O	O
without	ADP	O	O
pain	NOUN	O	B-outcome
than	ADP	O	O
in	ADP	O	O
those	DET	O	O
with	ADP	O	O
pain	NOUN	O	B-outcome
(P	NUM	O	O
=	SYM	O	O
.02)	PUNCT	O	O
The	DET	O	O
improvements	NOUN	O	O
in	ADP	O	O
global	ADJ	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(GQoL)	NOUN	O	I-outcome
were	VERB	O	O
independent	ADJ	O	O
from	ADP	O	O
the	DET	O	O
disease	NOUN	O	O
status	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.16).	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
and	CCONJ	O	O
procedure	NOUN	O	B-outcome
time	NOUN	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
secondary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
a	DET	O	O
subjective	ADJ	O	O
measure	NOUN	O	O
of	ADP	O	O
the	DET	O	O
similarity	NOUN	O	O
of	ADP	O	O
the	DET	O	O
simulator	NOUN	O	O
to	PART	O	O
the	DET	O	O
porcine	ADJ	O	O
larynx.	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
equally	ADV	O	O
divided	VERB	O	O
the	DET	O	O
NES	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
sham	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
evaluated	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
two-dose	NOUN	O	O
versus	CCONJ	O	O
three-dose	NOUN	O	O
of	ADP	O	O
SP	NOUN	O	O
for	ADP	O	O
IPTp-SP	NOUN	O	O
in	ADP	O	O
the	DET	O	O
prevention	NOUN	O	O
of	ADP	O	O
low	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
weight	NOUN	O	I-outcome
(LBW)	NUM	O	I-outcome
and	CCONJ	O	O
malaria	NOUN	O	B-outcome
parasitaemia	NOUN	O	I-outcome
.	PUNCT	O	O
Methods:	NOUN	O	O
:	PUNCT	O	O
An	DET	O	O
open,	ADV	O	O
randomized,	NOUN	O	O
controlled,	NOUN	O	O
longitudinal	ADJ	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
in	ADP	O	O
a	DET	O	O
secondary	ADJ	O	O
level	NOUN	O	O
hospital	NOUN	O	O
in	ADP	O	O
Nsukka	NUM	O	O
region	NOUN	O	O
of	ADP	O	O
Enugu	NOUN	O	O
State,	VERB	O	O
Nigeria.	NOUN	O	O

In	ADP	O	O
this	DET	O	O
regard,	NOUN	O	O
proper	ADJ	O	O
positioning	VERB	O	O
is	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
key	ADJ	O	O
measures	NOUN	O	O
that	ADP	O	O
is	VERB	O	O
done	NOUN	O	O
by	ADP	O	O
nurses;	NOUN	O	O
still	ADV	O	O
there	PRON	O	O
is	VERB	O	O
a	DET	O	O
paucity	NOUN	O	O
of	ADP	O	O
studies	NOUN	O	O
in	ADP	O	O
this	DET	O	O
field	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
results	NOUN	O	O
of	ADP	O	O
these	DET	O	O
few	ADJ	O	O
studies	NOUN	O	O
are	VERB	O	O
an	DET	O	O
area	NOUN	O	O
of	ADP	O	O
ongoing	VERB	O	O
debates.	NOUN	O	O

METHODS:	NOUN	O	O
Ninety-two	NUM	O	O
patients	NOUN	O	O
scheduled	VERB	O	O
for	ADP	O	O
orthopedic	ADJ	O	O
lower	ADJ	O	O
extremity	NOUN	O	O
surgery	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
into	ADP	O	O
1	NUM	O	O
of	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Regression-adjusted	VERB	O	O
difference	NOUN	O	O
in	ADP	O	O
means	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
examine	NOUN	O	O
the	DET	O	O
intervention's	NOUN	O	O
effectiveness	NOUN	O	O
with	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
PTSD	NOUN	O	B-outcome
symptomatology	NOUN	O	I-outcome
(primary	PUNCT	O	O
outcome)	PUNCT	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
depression	NOUN	O	B-outcome
,	PUNCT	O	O
perceptions	NOUN	O	B-outcome
of	ADP	O	I-outcome
cognitive	ADJ	O	I-outcome
failures	NOUN	O	I-outcome
,	PUNCT	O	O
social	ADJ	O	B-outcome
functioning	VERB	O	I-outcome
and	CCONJ	O	O
isolation	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
health-related	VERB	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(secondary	PUNCT	O	O
outcomes).	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/15	NOUN	O	O
06:00	ADP	O	O
[pubmed]	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9308586	NUM	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
37	NUM	O	O
patients	NOUN	O	O
(36%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
hybrid-procedure	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
a	DET	O	O
major	ADJ	O	O
intraoperative	ADJ	O	O
or	CCONJ	O	O
postoperative	ADJ	O	O
complication	NOUN	O	B-outcome
,	PUNCT	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
67	NUM	O	O
(64%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
open-procedure	NOUN	O	O
group	NOUN	O	O
(odds	NOUN	O	O
ratio,	NOUN	O	O
0.31;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
0.18	NUM	O	O
to	PART	O	O
0.55;	NOUN	O	O
P<0.001).	NUM	O	O

The	DET	O	O
prophylactic	ADJ	O	O
phenylephrine	NOUN	O	O
infusion	NOUN	O	O
(50	PUNCT	O	O
mug/min)	NOUN	O	O
was	VERB	O	O
initiated	VERB	O	O
immediately	ADV	O	O
at	ADP	O	O
the	DET	O	O
same	ADJ	O	O
time	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
injection.	ADV	O	O

ClinicalTrials.gov	NOUN	O	O
number:	NOUN	O	O
NCT01782326	NOUN	O	O
.	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Modelling	VERB	O	O
of	ADP	O	O
the	DET	O	O
predicted	VERB	O	O
species	NOUN	O	O
interactions	NOUN	O	O
in	ADP	O	O
a	DET	O	O
single	ADJ	O	O
DFU	NOUN	O	O
with	ADP	O	O
high	ADJ	O	O
diversity	NOUN	O	O
indicated	VERB	O	O
that	ADP	O	O
networks	NOUN	O	O
of	ADP	O	O
metabolic	ADJ	O	O
interactions	NOUN	O	O
may	VERB	O	O
exist	VERB	O	O
that	ADP	O	O
contribute	NOUN	O	O
to	PART	O	O
the	DET	O	O
formation	NOUN	O	O
of	ADP	O	O
stable	ADJ	O	O
communities.	NOUN	O	O

Health	NOUN	O	O
sciences	NOUN	O	O

Missing	VERB	O	O
end-point	NOUN	O	O
data	NOUN	O	O
(39	ADV	O	O
participants,	NOUN	O	O
3.7%)	NUM	O	O
were	VERB	O	O
imputed.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O

BACKGROUND:	NOUN	O	O
Overweight	NOUN	O	O
and	CCONJ	O	O
metabolic	ADJ	O	O
problems	NOUN	O	O
now	ADV	O	O
add	NOUN	O	O
to	PART	O	O
the	DET	O	O
burden	NOUN	O	O
of	ADP	O	O
illness	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
Inflammatory	ADJ	O	O
Bowel	NOUN	O	O
Disease.	NOUN	O	O

Of	ADP	O	O
the	DET	O	O
560	NUM	O	O
total	ADJ	O	O
metabolites	NOUN	O	B-outcome
identified	VERB	O	O
from	ADP	O	O
the	DET	O	O
cooked	VERB	O	O
navy	ADJ	O	O
beans,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
237	NUM	O	O
possible	ADJ	O	O
navy	ADJ	O	B-outcome
bean-derived	VERB	O	I-outcome
metabolites	NOUN	O	I-outcome
that	ADP	O	O
were	VERB	O	O
identified	VERB	O	O
in	ADP	O	O
the	DET	O	O
stool	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
consuming	VERB	O	O
navy	ADJ	O	O
beans,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
N-methylpipecolate	NOUN	O	B-outcome
,	PUNCT	O	O
2-aminoadipate	NOUN	O	B-outcome
,	PUNCT	O	O
piperidine	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
vanillate	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
microbial	ADJ	O	O
metabolism	NOUN	O	B-outcome
of	ADP	O	I-outcome
amino	ADJ	O	I-outcome
acids	NOUN	O	I-outcome
and	CCONJ	O	Seperator
fatty	ADJ	O	I-outcome
acids	NOUN	O	S2-outcome
were	VERB	O	O
also	ADV	O	O
identified	VERB	O	O
in	ADP	O	O
stool	NOUN	O	O
after	ADP	O	O
4	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
navy	ADJ	O	O
bean	NOUN	O	O
intake	NOUN	O	O
including	VERB	O	O
cadaverine	NOUN	O	B-outcome
,	PUNCT	O	O
hydantoin-5	NOUN	O	B-outcome
propionic	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
,	PUNCT	O	O
4-hydroxyphenylacetate	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
caprylate	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
stool	NOUN	O	O
relative	ADJ	O	O
abundance	NOUN	O	O
of	ADP	O	O
ophthalmate	NUM	O	B-outcome
increased	VERB	O	O
5.25-fold	NOUN	O	O
for	ADP	O	O
navy	ADJ	O	O
bean	NOUN	O	O
consumers	NOUN	O	O
that	ADP	O	O
can	VERB	O	O
indicate	VERB	O	O
glutathione	NOUN	O	O
regulation,	NOUN	O	O
and	CCONJ	O	O
involving	VERB	O	O
cancer	NOUN	O	O
control	NOUN	O	O
mechanisms	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
detoxification	NOUN	O	O
of	ADP	O	O
xenobiotics,	NOUN	O	O
antioxidant	NOUN	O	O
defense,	NOUN	O	O
proliferation,	NOUN	O	O
and	CCONJ	O	O
apoptosis.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
surgery	NOUN	O	O

Observers	NOUN	O	O
recorded	VERB	O	O
time	NOUN	O	O
taken	VERB	O	O
for	ADP	O	O
contouring	VERB	O	O
and	CCONJ	O	O
scored	VERB	O	O
image	NOUN	O	O
quality	NOUN	O	O
and	CCONJ	O	O
confidence	NOUN	O	O
in	ADP	O	O
contouring.	NOUN	O	O

FUNDING:	NOUN	O	O
University	NOUN	O	O
of	ADP	O	O
Texas	ADP	O	O
MD	NOUN	O	O
Anderson	NOUN	O	O
Cancer	NOUN	O	O
Center	NOUN	O	O
and	CCONJ	O	O
National	ADJ	O	O
Cancer	NOUN	O	O
Institute	NOUN	O	O
Specialized	VERB	O	O
Programs	NOUN	O	O
of	ADP	O	O
Research	NOUN	O	O
Excellence.	NOUN	O	O

Journal-Name:	NOUN	O	O
Einstein	NOUN	O	O
(Sao	ADV	O	O
Paulo,	NOUN	O	O
Brazil)	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
intervention	NOUN	O	O
effects	NOUN	O	O
of	ADP	O	O
peer	NOUN	O	O
support	NOUN	O	O
education	NOUN	O	O
mode	NOUN	O	O
for	ADP	O	O
type	NOUN	O	B-outcome
2	NUM	O	I-outcome
diabetes	NOUN	O	I-outcome
control	NOUN	O	I-outcome
in	ADP	O	O
rural	ADJ	O	O
residents.	NOUN	O	O

m(-2)	NOUN	O	O
and	CCONJ	O	O
0.42	NUM	O	O
+/-	SYM	O	O
0.40	NUM	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
respectively,	NOUN	O	O
before	ADP	O	O
exercise.	NOUN	O	O

RESULTS:	NOUN	O	O
Significant	ADJ	O	O
difference	NOUN	O	O
of	ADP	O	O
HbA1c	NOUN	O	B-outcome
concentration	NOUN	O	O
and	CCONJ	O	O
Self-Efficacy	NOUN	O	B-outcome
were	VERB	O	O
found	VERB	O	O
between	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups	NOUN	O	O
at	ADP	O	O
6-month	NOUN	O	O
and	CCONJ	O	O
12-month	NOUN	O	O
(P	NUM	O	O
<.05).	NOUN	O	O

Activities	NOUN	O	B-outcome
of	ADP	O	I-outcome
daily	ADJ	O	I-outcome
living	VERB	O	I-outcome
(ADL)	PUNCT	O	I-outcome
,	PUNCT	O	O
self-evaluated	VERB	O	O
loneliness	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
level	NOUN	O	O
of	ADP	O	O
depression	NOUN	O	B-outcome
were	VERB	O	O
significantly	ADV	O	O
lowered	VERB	O	O
(P	NUM	O	O
<	SYM	O	O
.05)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
group	NOUN	O	O
receiving	VERB	O	O
joint	NOUN	O	O
Baduanjin	NOUN	O	O
and	CCONJ	O	O
CBT	NOUN	O	O
intervention	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
months,	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
Baduanjin	NOUN	O	O
only	ADV	O	O
group	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
CBT	NOUN	O	O
only	ADV	O	O
group.	VERB	O	O

A	DET	O	O
25%	NUM	O	O
and	CCONJ	O	O
50%	NUM	O	O
improvement	NOUN	O	O
in	ADP	O	O
IGAxBSA	NOUN	O	O
was	VERB	O	O
achieved	NOUN	O	O
within	ADP	O	O
1.9	NUM	O	O
and	CCONJ	O	O
4.6	NUM	O	O
weeks,	NOUN	O	O
respectively,	NOUN	O	O
and	CCONJ	O	O
47.5%	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
achieved	NOUN	O	O
IGAxBSA-75	NOUN	O	O
by	ADP	O	O
week	NOUN	O	O
8.	NUM	O	O

BACKGROUND:	NOUN	O	O
Primary	ADJ	O	O
care	NOUN	O	O
physicians	NOUN	O	O
(PCPs)	PUNCT	O	O
working	VERB	O	O
in	ADP	O	O
mental	ADJ	O	O
health	NOUN	O	O
care	NOUN	O	O
in	ADP	O	O
Tunisia	NOUN	O	O
often	ADV	O	O
lack	NOUN	O	O
knowledge	NOUN	O	O
and	CCONJ	O	O
skills	NOUN	O	O
needed	VERB	O	O
to	PART	O	O
adequately	ADV	O	O
address	NOUN	O	O
mental	ADJ	O	O
health-related	VERB	O	O
issues.	NOUN	O	O

Journal-Name:	NOUN	O	O
Revista	NOUN	O	O
da	NOUN	O	O
Associacao	NOUN	O	O
Medica	NOUN	O	O
Brasileira	NOUN	O	O
(1992)	PUNCT	O	O

On	ADP	O	O
the	DET	O	O
other	ADJ	O	O
hand,	NOUN	O	O
plasma	NOUN	O	O
C-reactive	ADJ	O	B-outcome
protein	NOUN	O	I-outcome
and	CCONJ	O	O
lactate	VERB	O	B-outcome
dehydrogenase	NOUN	O	I-outcome
remained	VERB	O	O
unchanged.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

We	PRON	O	O
collected	VERB	O	O
6484	NUM	O	O
questionnaires,	NOUN	O	O
including	VERB	O	O
3583	NUM	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
[response	NOUN	O	O
rate:	NOUN	O	O
96%	ADJ	O	O
(3583/3726)	NOUN	O	O
and	CCONJ	O	O
2901	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
[response	NOUN	O	O
rate:	NOUN	O	O
90%	VERB	O	O
(2901/3224)].	NOUN	O	O
We	PRON	O	O
observed	VERB	O	O
that	ADP	O	O
hand	NOUN	O	B-outcome
washing	VERB	O	I-outcome
habit	NOUN	O	I-outcome
of	ADP	O	O
children	NOUN	O	O
and	CCONJ	O	O
parent,	NOUN	O	O
knowledge	NOUN	O	B-outcome
of	ADP	O	I-outcome
hand	NOUN	O	I-outcome
food	NOUN	O	I-outcome
mouth	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
of	ADP	O	O
parents,	NOUN	O	O
children's	NOUN	O	O
daily	ADJ	O	O
cleaning	VERB	O	B-outcome
habits	NOUN	O	I-outcome
scores	NOUN	O	O
improved	VERB	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
higher	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
year	NOUN	O	O
1	NUM	O	O
(April	NOUN	O	O
1-July	ADJ	O	O
31,	NUM	O	O
2011)and	NOUN	O	O
year	NOUN	O	O
2	NUM	O	O
(April	NOUN	O	O
1-July	ADJ	O	O
31,	NUM	O	O
2012).	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
safety	NOUN	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
major	ADJ	O	B-outcome
bleeding	VERB	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Of	ADP	O	O
1080	NUM	O	O
enrolled	VERB	O	O
patients,	NOUN	O	O
49	NUM	O	O
(4.5%)	NOUN	O	O
had	VERB	O	O
thrombosis	NOUN	O	O
at	ADP	O	O
screening	VERB	O	O
and	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
undergo	NOUN	O	O
randomization.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
double-blind	ADJ	O	O
study	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
doxorubicin,	NOUN	O	O
comparing	VERB	O	O
placebo	NOUN	O	O
(n=38)	NOUN	O	O
with	ADP	O	O
different	ADJ	O	O
doses	NOUN	O	O
of	ADP	O	O
carvedilol	NOUN	O	O
[6.25mg/day	PUNCT	O	O
(n=41),	NOUN	O	O
12.5mg/day	NUM	O	O
(n=38)	NOUN	O	O
or	CCONJ	O	O
25mg/day	NOUN	O	O
(n=37)].	NUM	O	O
The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
the	DET	O	O
measured	VERB	O	O
change	NOUN	O	O
in	ADP	O	O
left	ADV	O	B-outcome
ventricular	ADJ	O	I-outcome
ejection	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
(LVEF)	PUNCT	O	I-outcome
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
6	NUM	O	O
months.	NOUN	O	O

This	DET	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
a	DET	O	O
structured	VERB	O	O
multidisciplinary,	NOUN	O	O
multisite	NOUN	O	O
intervention	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
improved	VERB	O	O
clinical	ADJ	O	O
outcomes	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
standard	ADJ	O	O
care.	NOUN	O	O

Therefore,	NOUN	O	O
it	PRON	O	O
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
as	ADP	O	O
an	DET	O	O
alternative	ADJ	O	O
method	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
are	VERB	O	O
willing	VERB	O	O
to	PART	O	O
use	NOUN	O	O
this	DET	O	O
technique.	NOUN	O	O

We	PRON	O	O
followed	VERB	O	O
a	DET	O	O
standard	ADJ	O	O
general	ADJ	O	O
anesthetic	ADJ	O	O
technique,	ADV	O	O
with	ADP	O	O
endotracheal	ADJ	O	O
intubation.	ADV	O	O

FGDs	NOUN	O	O
were	VERB	O	O
audio-recorded,	NOUN	O	O
transcribed	VERB	O	O
then	ADV	O	O
translated	VERB	O	O
into	ADP	O	O
English.	NOUN	O	O

Similarly,	NOUN	O	O
time-to-first	ADV	O	B-outcome
moderate/severe	ADV	O	I-outcome
exacerbation	NOUN	O	I-outcome
was	VERB	O	O
also	ADV	O	O
delayed	VERB	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
[95%	NOUN	O	O
CI]:	ADP	O	O
0.79	NUM	O	O
[0.70-0.89]	ADJ	O	O
and	CCONJ	O	O
0.76	NUM	O	O
[0.63-0.91]	NOUN	O	O
in	ADP	O	O
men	NOUN	O	O
and	CCONJ	O	O
women,	NOUN	O	O
respectively).	NOUN	O	O

Up	NOUN	O	O
to	PART	O	O
50%	NUM	O	O
of	ADP	O	O
reproductive-age	NOUN	O	O
women	NOUN	O	O
suffer	NOUN	O	O
from	ADP	O	O
pelvic	ADJ	O	O
pain.	NOUN	O	O

This	DET	O	O
is	VERB	O	O
a	DET	O	O
post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
St.	NOUN	O	O
Carlos	NOUN	O	O
gestational	ADJ	O	O
diabetes	NOUN	O	O
mellitus	NOUN	O	O
(GDM)	NOUN	O	O
Prevention	NOUN	O	O
Study.	NOUN	O	O

The	DET	O	O
evaluation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Nia	NOUN	O	O
Project	NOUN	O	O
is	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
first	ADV	O	O
to	PART	O	O
analyze	NOUN	O	O
the	DET	O	O
individual	ADJ	O	O
and	CCONJ	O	O
combined	VERB	O	O
contributions	NOUN	O	O
of	ADP	O	O
sanitary	ADJ	O	O
pads	NOUN	O	O
and	CCONJ	O	O
provision	NOUN	O	O
of	ADP	O	O
comprehensive	ADJ	O	O
reproductive	ADJ	O	O
health	NOUN	O	O
education	NOUN	O	O
on	ADP	O	O
girls'	NOUN	O	O
education	NOUN	O	B-outcome
and	CCONJ	O	O
reproductive	ADJ	O	B-outcome
health	NOUN	O	I-outcome
outcomes.	ADJ	O	O

Results	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
used	VERB	O	O
to	PART	O	O
tailor	ADV	O	O
structural,	ADJ	O	O
organizational,	ADJ	O	O
provider,	NOUN	O	O
patient,	NOUN	O	O
and	CCONJ	O	O
innovation	NOUN	O	O
factors	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
future	NOUN	O	O
implementations	NOUN	O	O
of	ADP	O	O
the	DET	O	O
mhGAP-based	VERB	O	O
training	VERB	O	O
in	ADP	O	O
Tunisia.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
The	DET	O	O
project	NOUN	O	O
is	VERB	O	O
approved	VERB	O	O
by	ADP	O	O
Iranian	ADJ	O	O
Registry	NOUN	O	O
of	ADP	O	O
Clinical	ADJ	O	O
Trial	NOUN	O	O
with	ADP	O	O
no.	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Initial	ADJ	O	O
forward	ADV	O	O
movement	NOUN	O	O
in	ADP	O	O
the	DET	O	O
IA	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
4	NUM	O	O
to	PART	O	O
5	NUM	O	O
mm	NOUN	O	O
and	CCONJ	O	O
was	VERB	O	O
followed	VERB	O	O
by	ADP	O	O
subsequent	ADJ	O	O
bimonthly	ADV	O	O
advancements	NOUN	O	O
of	ADP	O	O
2	NUM	O	O
mm.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
Ayub	ADP	O	O
Medical	ADJ	O	O
College,	PUNCT	O	O
Abbottabad	ADV	O	O
:	PUNCT	O	O
JAMC	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
science	NOUN	O	O
and	CCONJ	O	O
medicine	NOUN	O	O
in	ADP	O	O
sport	ADJ	O	O

Journal-Name:Radiation	NOUN	O	O
protection	NOUN	O	O
dosimetry	NOUN	O	O

Follow-on	NOUN	O	O
oral	ADJ	O	O
antibiotics	NOUN	O	O
were	VERB	O	O
permitted	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
revealed	VERB	O	O
that	ADP	O	O
teachers	NOUN	O	O
believed	VERB	O	O
classroom	NOUN	O	O
based	VERB	O	O
activities	NOUN	O	O
were	VERB	O	O
most	DET	O	O
feasible	ADJ	O	B-outcome
and	CCONJ	O	O
acceptable	ADJ	O	B-outcome
due	ADJ	O	O
to	PART	O	O
the	DET	O	O
reduced	VERB	O	O
implementation	NOUN	O	O
barriers	NOUN	O	O
of	ADP	O	O
sufficient	ADJ	O	O
time	NOUN	O	O
and	CCONJ	O	O
space.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/26	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

However,	ADV	O	O
these	DET	O	O
do	VERB	O	O
not	ADV	O	O
consider	NOUN	O	O
changes	NOUN	O	O
in	ADP	O	O
Body	NOUN	O	O
Surface	NOUN	O	O
Area	NOUN	O	O
(BSA)].	NOUN	O	O
The	DET	O	O
IGAxBSA	NOUN	O	O
composite	NOUN	O	O
tool	NOUN	O	O
is	VERB	O	O
a	DET	O	O
simple,	NOUN	O	O
effective,	NUM	O	O
validated	VERB	O	O
alternative	ADJ	O	O
for	ADP	O	O
measuring	VERB	O	O
improvement	NOUN	O	O
in	ADP	O	O
psoriasis	NOUN	O	O
severity.	DET	O	O

Title:	NOUN	O	O
To	PART	O	O
study	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
high	ADJ	O	O
dose	NOUN	O	O
Atorvastatin	ADP	O	O
40mg	NOUN	O	O
versus	CCONJ	O	O
80mg	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
dyslipidemia.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Plasma	NOUN	O	O
Nitrotyrosine	NOUN	O	B-outcome
(NT)	NOUN	O	I-outcome
concentrations	NOUN	O	O
versus	CCONJ	O	O
patient	NOUN	O	O
satisfaction	NOUN	O	O
following	VERB	O	O
surgery	NOUN	O	O
are	VERB	O	O
significantly	ADV	O	O
correlated	VERB	O	O
in	ADP	O	O
benign	ADJ	O	O
disease	NOUN	O	O
and	CCONJ	O	O
cancer.	NOUN	O	O

The	DET	O	O
majority	NOUN	O	O
of	ADP	O	O
AEs	NOUN	O	B-outcome
were	VERB	O	O
mild	ADJ	O	O
and	CCONJ	O	O
transient.	NOUN	O	O

Methods:	NOUN	O	O
Post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
212	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
moderate-to-severe	ADV	O	O
plaque	NOUN	O	O
psoriasis	NOUN	O	O
randomized	VERB	O	O
(2:2:2:1)	NUM	O	O
to	PART	O	O
HP/TAZ	NOUN	O	O
lotion,	NOUN	O	O
HP,	NOUN	O	O
TAZ,	NOUN	O	O
or	CCONJ	O	O
vehicle	NOUN	O	O
once-daily	ADV	O	O
for	ADP	O	O
8	NUM	O	O
weeks,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
4-week	NOUN	O	O
posttreatment	NOUN	O	O
follow-up.	PUNCT	O	O

Overall,	NOUN	O	O
the	DET	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
24)	NOUN	O	O
had	VERB	O	O
a	DET	O	O
median	ADJ	O	O
score	NOUN	O	O
of	ADP	O	O
0	NUM	O	O
(lowest	NUM	O	O
item	NOUN	O	O
score)	NOUN	O	O
on	ADP	O	O
nine	NUM	O	O
of	ADP	O	O
24	NUM	O	O
Test	NOUN	O	O
of	ADP	O	O
Playfulness	ADV	O	B-outcome
(ToP)	ADV	O	O
items	NOUN	O	O
and	CCONJ	O	O
only	ADV	O	O
had	VERB	O	O
a	DET	O	O
median	ADJ	O	O
score	NOUN	O	O
of	ADP	O	O
3	NUM	O	O
(highest	NUM	O	O
score)	NOUN	O	O
on	ADP	O	O
two	NUM	O	O
items.	NOUN	O	O

In	ADP	O	O
FZD	NOUN	O	O
group,	NOUN	O	O
92	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
FZD	NOUN	O	O
plus	CCONJ	O	O
esomeprazole,	NOUN	O	O
bismuth	NOUN	O	O
potassium	NOUN	O	O
citrate,	NOUN	O	O
and	CCONJ	O	O
amoxicillin	NOUN	O	O
for	ADP	O	O
14	NUM	O	O
days.	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

The	DET	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
rate	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
years	NOUN	O	O
was	VERB	O	O
39.7%	NUM	O	O
in	ADP	O	O
the	DET	O	O
modified-FOLFIRINOX	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
21.4%	NUM	O	O
in	ADP	O	O
the	DET	O	O
gemcitabine	NOUN	O	O
group.	VERB	O	O

Randomisation	NOUN	O	O
was	VERB	O	O
stratified	VERB	O	O
by	ADP	O	O
histological	ADJ	O	O
subtype	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
local	ADJ	O	O
pathology	NOUN	O	O
assessment	NOUN	O	O
and	CCONJ	O	O
by	ADP	O	O
international	ADJ	O	O
prognostic	ADJ	O	O
index	NOUN	O	O
score.	NOUN	O	O

Complications	NOUN	O	B-outcome
regarding	VERB	O	O
opioids	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/27	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Difference	NOUN	O	O
in	ADP	O	O
detection	NOUN	O	O
rate	NOUN	O	O
between	ADP	O	O
intervention	NOUN	O	O
arm	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
arm	NOUN	O	O
was	VERB	O	O
compared	VERB	O	O
using	VERB	O	O
Z	NOUN	O	O
test.	NOUN	O	O

Title:	NOUN	O	O
Can	VERB	O	O
Reproductive	ADJ	O	O
Life	NOUN	O	O
Plan-based	VERB	O	O
counselling	VERB	O	O
increase	NOUN	O	O
men's	NOUN	O	O
fertility	NOUN	O	B-outcome
awareness	ADV	O	I-outcome
?	PUNCT	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Following	VERB	O	O
8	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
supplementation,	NOUN	O	O
the	DET	O	O
subjects	NOUN	O	O
repeated	VERB	O	O
the	DET	O	O
pre-supplementation	NOUN	O	O
testing	VERB	O	O
procedures.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Based	VERB	O	O
on	ADP	O	O
our	ADJ	O	O
pre-clinical	ADJ	O	O
data,	NOUN	O	O
we	PRON	O	O
hypothesized	VERB	O	O
that	ADP	O	O
sequencing	VERB	O	O
chemotherapy	NOUN	O	O
with	ADP	O	O
erlotinib	NOUN	O	O
would	VERB	O	O
increase	NOUN	O	O
the	DET	O	O
tumor	NOUN	O	O
response	NOUN	O	B-outcome
rate	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
metastatic	ADJ	O	O
colorectal	ADJ	O	O
cancer.	NOUN	O	O

Data	NOUN	O	O
elicited	VERB	O	O
from	ADP	O	O
18	NUM	O	O
participating	VERB	O	O
children	NOUN	O	O
via	ADP	O	O
a	DET	O	O
write	NOUN	O	O
draw,	NOUN	O	O
show	VERB	O	O
and	CCONJ	O	O
tell	NOUN	O	O
task	NOUN	O	O
included,	VERB	O	O
frequency	NOUN	O	O
counts	NOUN	O	O
of	ADP	O	O
most	DET	O	O
enjoyable	ADJ	O	O
intervention	NOUN	O	O
components,	NOUN	O	O
drawings,	ADJ	O	O
and	CCONJ	O	O
verbatim	ADV	O	O
data.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
researchregistry4264	ADP	O	O
dated	VERB	O	O
1	NUM	O	O
March	NOUN	O	O
2016	NUM	O	O
(www.researchregistry.com).	PUNCT	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
performed	VERB	O	O
a	DET	O	O
prospective	ADJ	O	O
phase	NOUN	O	O
II	NUM	O	O
study	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
acute	ADJ	O	O
toxicity	NOUN	O	B-outcome
among	ADP	O	O
five	NUM	O	O
different	ADJ	O	O
hypofractionated	VERB	O	O
schedules	NOUN	O	O
using	VERB	O	O
proton	NOUN	O	O
therapy.	NOUN	O	O

Better	ADJ	O	O
baseline	NOUN	O	O
BCVA	NOUN	O	O
(>	PUNCT	O	O
50	NUM	O	O
ETDRS	NOUN	O	O
letters/Snellen	NOUN	O	O
equivalent	ADJ	O	O
>/=	NOUN	O	O
20/100),	NUM	O	O
greater	ADJ	O	O
baseline	NOUN	O	O
total	ADJ	O	O
macular	ADJ	O	O
volume	NOUN	O	O
(>	PUNCT	O	O
9.99	NUM	O	O
mm(3)),	NOUN	O	O
and	CCONJ	O	O
presence	NOUN	O	O
of	ADP	O	O
subretinal	ADJ	O	O
fluid	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
were	VERB	O	O
all	DET	O	O
associated	VERB	O	O
with	ADP	O	O
early	ADJ	O	O
improvement	NOUN	O	O
to	PART	O	O
20/40	NOUN	O	O
or	CCONJ	O	O
better	ADJ	O	O
vision	NOUN	O	B-outcome
(	NOUN	O	O
Early	ADJ	O	O
Treatment	NOUN	O	O
Diabetic	ADJ	O	B-outcome
Retinopathy	NOUN	O	I-outcome
Study	NOUN	O	O
(ETDRS)	NOUN	O	O
equivalent	ADJ	O	O
>/=	NOUN	O	O
69	NUM	O	O
letters;	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
.0001,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.02,	NOUN	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.03,	PUNCT	O	O
respectively).	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
operated	VERB	O	O
in	ADP	O	O
two	NUM	O	O
orthopedic	ADJ	O	O
centers.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
L-theanine	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
the	DET	O	O
immune	ADJ	O	O
system	NOUN	O	O
of	ADP	O	O
athletes	NOUN	O	O
exposed	VERB	O	O
to	PART	O	O
strenuous	NOUN	O	O
physical	ADJ	O	O
exercise.	NOUN	O	O

Transcripts	NOUN	O	O
were	VERB	O	O
inductively	ADV	O	O
coded	VERB	O	O
using	VERB	O	O
ATLAS.ti(R)	NOUN	O	O
and	CCONJ	O	O
qualitatively	ADV	O	O
analysed	VERB	O	O
using	VERB	O	O
thematic	ADJ	O	O
content	NOUN	O	O
analysis.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

Patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
non-invasive	ADJ	O	O
ventilator	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
continuous	ADJ	O	O
positive	ADJ	O	O
airway	NOUN	O	O
pressure	NOUN	O	O
CPAP	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
months,	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
rhodiola	NOUN	O	O
rosea+non-invasive	ADJ	O	O
ventilator	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
oral	ADJ	O	O
rhodiola	NOUN	O	O
capsules	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
on	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
CPAP,	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
rhodiola	NOUN	O	O
rosea	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
pure	ADJ	O	O
oral	ADJ	O	O
rhodiola	NOUN	O	O
capsules	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
months.	NOUN	O	O

Results:	NOUN	O	O
Students	NOUN	O	O
in	ADP	O	O
the	DET	O	O
SIM	NOUN	O	O
group	NOUN	O	O
performed	VERB	O	O
CPR	NOUN	O	O
that	ADP	O	O
more	ADV	O	O
closely	ADV	O	O
adhered	VERB	O	B-outcome
to	PART	O	O
the	DET	O	O
AHA	NOUN	O	O
guidelines	NOUN	O	O
of	ADP	O	O
compression	NOUN	O	B-outcome
depth	NOUN	O	I-outcome
and	CCONJ	O	O
compression	NOUN	O	B-outcome
fraction	NOUN	O	I-outcome
.	PUNCT	O	O
Mean	NOUN	O	O
compression	NOUN	O	B-outcome
depth	NOUN	O	I-outcome
was	VERB	O	O
4.57	NUM	O	O
centimeters	NOUN	O	O
(cm)	PUNCT	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI]	ADV	O	O
[4.30-4.82])	ADP	O	O
for	ADP	O	O
SIM	NOUN	O	O
and	CCONJ	O	O
3.89	NUM	O	O
cm	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
[3.50-4.27])	NOUN	O	O
for	ADP	O	O
STD,	NUM	O	O
p=0.02.	NOUN	O	O

CONCLUSION:	NOUN	O	O
In	ADP	O	O
conclusion,	NOUN	O	O
higher	ADJ	O	O
noggin	NOUN	O	B-outcome
levels	NOUN	O	O
reflected	VERB	O	O
more	ADV	O	O
BMP	NOUN	O	O
inhibition,	NOUN	O	O
since	ADP	O	O
our	ADJ	O	O
assay	NOUN	O	O
detects	NOUN	O	O
free	ADJ	O	O
bioactive	ADJ	O	O
noggin	NOUN	O	B-outcome
,	PUNCT	O	O
which	ADP	O	O
in	ADP	O	O
turn	NOUN	O	O
impaired	VERB	O	O
bone	NOUN	O	O
formation	NOUN	O	O
in	ADP	O	O
placebo	NOUN	O	O
group.	VERB	O	O

h(-	NOUN	O	O
1)	NUM	O	O
given	VERB	O	O
after	ADP	O	O
the	DET	O	O
Observer's	NOUN	O	O
Assessment	NOUN	O	O
of	ADP	O	O
Alertness	ADP	O	B-outcome
/	SYM	O	O
Sedation	NOUN	O	B-outcome
(OAA/S)	PUNCT	O	O
score	NOUN	O	O
reached	VERB	O	O
2-3.	NOUN	O	O

At	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
endline,	NOUN	O	O
knowledge,	NOUN	O	O
practice	NOUN	O	O
and	CCONJ	O	O
coverage	NOUN	O	O
(KPC)	NOUN	O	O
surveys	NOUN	O	O
measured	VERB	O	O
household	NOUN	O	O
health-related	VERB	O	O
behaviors	NOUN	O	O
and	CCONJ	O	O
care-seeking	VERB	O	O
behaviors.	DET	O	O

RESULTS:	NOUN	O	O
All	DET	O	O
the	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
at	ADP	O	O
least	ADV	O	O
1	NUM	O	O
month.	NOUN	O	O

Perceived	VERB	O	O
exercise	NOUN	O	B-outcome
frequency	NOUN	O	X
(z	NOUN	O	X
=	SYM	O	X
2.309,	PUNCT	O	X
P	NOUN	O	X
=	SYM	O	X
0.02)	NUM	O	X
and	NOUN	O	X
intensity	NOUN	O	I-outcome
(z	NOUN	O	O
=	SYM	O	O
2.687,	ADJ	O	O
P	NOUN	O	O
=	SYM	O	O
0.007)	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
improved	VERB	O	O
following	VERB	O	O
a	DET	O	O
short-term	NOUN	O	O
LOWFODMAP	NOUN	O	O
approach	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
HIGHFODMAP.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
nonvertebral	ADJ	O	B-outcome
or	CCONJ	O	Seperator
vertebral	ADJ	O	B-outcome
fragility	NOUN	O	I-outcome
fractures	NOUN	O	E2-outcome
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
osteopenia	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
zoledronate	ADJ	O	O
than	ADP	O	O
in	ADP	O	O
women	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
placebo.	NOUN	O	O
(	PUNCT	O	O

After	ADP	O	O
3	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
treatment,	NOUN	O	O
the	DET	O	O
serum	NOUN	O	O
neuron-specific	ADJ	O	B-outcome
enolase	NOUN	O	I-outcome
and	CCONJ	O	O
S100	NOUN	O	B-outcome
protein	NOUN	O	I-outcome
levels	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
decreased	VERB	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
those	DET	O	O
before	ADP	O	O
treatment	NOUN	O	O
[NSE	PUNCT	O	O
(mug/L):	NOUN	O	O
30.15+/-15.18	NUM	O	O
vs.	CCONJ	O	O
31.32+/-14.75,	NUM	O	O
S100	NOUN	O	O
(ng/L):	NOUN	O	O
387.5	NUM	O	O
(273.3,	PUNCT	O	O
573.0)	NUM	O	O
vs.	CCONJ	O	O
890.0	NUM	O	O
(590.5,	NOUN	O	O
1	NUM	O	O
162.5)	NUM	O	O
in	ADP	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group;	ADJ	O	O
NSE	NOUN	O	O
(mug/L):	NOUN	O	O
29.09+/-16.22	NUM	O	O
vs.	CCONJ	O	O
32.25+/-15.43,	NUM	O	O
S100	NOUN	O	O
(ng/L):	NOUN	O	O
402.5	NUM	O	O
(302.2,	NOUN	O	O
580.5)	NUM	O	O
vs.	CCONJ	O	O
842.0	NUM	O	O
(462.3,	PUNCT	O	O
1	NUM	O	O
200.5)	NUM	O	O
in	ADP	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group,	NOUN	O	O
all	DET	O	O
P	NOUN	O	O
<	SYM	O	O
0.05].	NUM	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
neuron-specific	ADJ	O	B-outcome
enolase	NOUN	O	I-outcome
or	CCONJ	O	O
S100	NOUN	O	B-outcome
protein	NOUN	O	I-outcome
level	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(all	PUNCT	O	O
P	NOUN	O	O
>	SYM	O	O
0.05).	NOUN	O	O

Patients	NOUN	O	O
received	VERB	O	O
IV	NUM	O	O
plus	CCONJ	O	O
IA	NOUN	O	O
TXA	NOUN	O	O
has	VERB	O	O
decreased	VERB	O	O
total	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(TBL),	NUM	O	O
hidden	NOUN	O	B-outcome
blood	NOUN	O	I-outcome
loss	NOUN	O	I-outcome
(HBL)	PUNCT	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
maximum	NOUN	O	O
hemoglobin	NOUN	O	B-outcome
(Hb)	PUNCT	O	I-outcome
drop	NOUN	O	O
than	ADP	O	O
those	DET	O	O
received	VERB	O	O
IV	NUM	O	O
TXA-alone	NOUN	O	O
and	CCONJ	O	O
IA	NOUN	O	O
TXA-alone,	NOUN	O	O
with	ADP	O	O
reductions	NOUN	O	O
in	ADP	O	O
FDP	NOUN	O	B-outcome
and	CCONJ	O	O
D-dimer	NOUN	O	B-outcome
,	PUNCT	O	O
indicating	VERB	O	O
that	ADP	O	O
IV	NUM	O	O
plus	CCONJ	O	O
IA	NOUN	O	O
TXA	NOUN	O	O
injection	NOUN	O	O
is	VERB	O	O
superior	ADJ	O	O
to	PART	O	O
prevent	NOUN	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
and	CCONJ	O	O
hyperfibrinolysis	NOUN	O	B-outcome
during	ADP	O	O
TKA.	NOUN	O	O

Before	ADP	O	O
treatment,	NOUN	O	O
2	NUM	O	O
weeks	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
month	NOUN	O	O
after	ADP	O	O
treatment,	NOUN	O	O
the	DET	O	O
Gross	NOUN	O	B-outcome
Motor	NOUN	O	I-outcome
Function	NOUN	O	I-outcome
Measure	ADJ	O	X
(GMFM)],	NOUN	O	X
modified	VERB	O	X
Ashworth	NOUN	O	X
Scale	NOUN	O	X
(MAS)]	PUNCT	O	X
of	ADP	O	I-outcome
the	DET	O	Seperator
hamstrings	NOUN	O	I-outcome
and	CCONJ	O	Seperator
triceps	ADP	O	I-outcome
,	PUNCT	O	O
plantar	NOUN	O	B-outcome
area	NOUN	O	I-outcome
and	CCONJ	O	O
plantar	NOUN	O	B-outcome
pressure	NOUN	O	I-outcome
were	VERB	O	O
examined	VERB	O	O
for	ADP	O	O
efficacy	NOUN	O	O
assessment.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
patient-level	NOUN	O	O
meta-analysis,	NOUN	O	O
the	DET	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
free	ADJ	O	O
from	ADP	O	O
recurrence	NOUN	O	B-outcome
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
was	VERB	O	O
67.0%	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
61.0	NUM	O	O
to	PART	O	O
72.3)	NUM	O	O
among	ADP	O	O
the	DET	O	O
426	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
tafenoquine	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
72.8%	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
65.6	NUM	O	O
to	PART	O	O
78.8)	NUM	O	O
among	ADP	O	O
the	DET	O	O
214	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
primaquine	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
AG	NOUN	O	O
had	VERB	O	O
better	ADJ	O	O
forced	VERB	O	B-outcome
expiratory	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
first	ADV	O	O
second	ADJ	O	O
and	CCONJ	O	O
peak	NOUN	O	B-outcome
expiratory	ADJ	O	I-outcome
flow	NOUN	O	I-outcome
[(1.50+/-0.32)	NOUN	O	O
L,(252.06+/-75.27)	NOUN	O	O
L/min	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
CG	NOUN	O	O
[(1.34+/-0.19)	NOUN	O	O
L,	NOUN	O	O
(216.94+/-49.72)	PUNCT	O	O
L/min	NOUN	O	O
(P=0.03,	NUM	O	O
P=0.03)	NOUN	O	O
at	ADP	O	O
discharge.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Both	CCONJ	O	O
effects	NOUN	O	O
remained	VERB	O	O
significant	ADJ	O	O
after	ADP	O	O
controlling	VERB	O	O
for	ADP	O	O
preferred	VERB	O	O
meeting	VERB	O	O
method	NOUN	O	O
(p<0.0001	NOUN	O	O
and	CCONJ	O	O
p=0.0003,	NOUN	O	O
respectively)	NOUN	O	O
and	CCONJ	O	O
among	ADP	O	O
EM-bound	ADP	O	O
students	NOUN	O	O
(p=.0423	PUNCT	O	O
and	CCONJ	O	O
p<0.0110,	NOUN	O	O
respectively).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

The	DET	O	O
total	ADJ	O	O
irradiation	NOUN	O	O
dose	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group	NOUN	O	O
was	VERB	O	O
70	NUM	O	O
Gy	NOUN	O	O
for	ADP	O	O
the	DET	O	O
whole	ADJ	O	O
nasopharynx.	NOUN	O	O

However,	ADV	O	O
data	NOUN	O	O
from	ADP	O	O
randomized	VERB	O	O
trials	NOUN	O	O
are	VERB	O	O
limited.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

The	DET	O	O
follow-up	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
during	ADP	O	O
the	DET	O	O
first	ADV	O	O
five	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
evaluation	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
at	ADP	O	O
two	NUM	O	O
different	ADJ	O	O
times.	NOUN	O	O

PROTOCOL:	NOUN	O	O
The	DET	O	O
protocol	NOUN	O	O
is	VERB	O	O
available	ADJ	O	O
from	ADP	O	O
the	DET	O	O
corresponding	VERB	O	O
author	NOUN	O	O
on	ADP	O	O
request.	NOUN	O	O

Evidence	NOUN	O	O
of	ADP	O	O
Lack	NOUN	O	O
of	ADP	O	O
Benefit	NOUN	O	O
From	ADP	O	O
a	DET	O	O
Double-Blind,	NOUN	O	O
Placebo-Controlled,	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

During	ADP	O	O
a	DET	O	O
total	ADJ	O	O
median	ADJ	O	O
follow-up	NOUN	O	O
of	ADP	O	O
5.11	NUM	O	O
years,	NOUN	O	O
adjudicated	VERB	O	O
probable	ADJ	O	O
dementia	NOUN	O	B-outcome
occurred	VERB	O	O
in	ADP	O	O
149	NUM	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intensive	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
176	NUM	O	O
in	ADP	O	O
the	DET	O	O
standard	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(7.2	NOUN	O	O
vs	CCONJ	O	O
8.6	NUM	O	O
cases	NOUN	O	O
per	ADP	O	O
1000	NUM	O	O
person-years;	NOUN	O	O
hazard	NOUN	O	O
ratio	NOUN	O	O
[HR],	PUNCT	O	O
0.83;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.67-1.04).	ADV	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Netherlands	NOUN	O	O
Trial	NOUN	O	O
Register	NOUN	O	O
NTR4367.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/06	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Notably,	NOUN	O	O
10	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
L-leucine	NOUN	O	O
or	CCONJ	O	O
L-isoleucine,	ADJ	O	O
administered	VERB	O	O
intragastrically	ADV	O	O
before	ADP	O	O
a	DET	O	O
mixed-nutrient	ADJ	O	O
drink,	NOUN	O	O
lowered	VERB	O	O
postprandial	ADJ	O	O
blood	NOUN	O	O
glucose,	NOUN	O	O
and	CCONJ	O	O
intraduodenal	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
L-leucine	NOUN	O	O
(at	NUM	O	O
a	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
0.45	NUM	O	O
kcal/min,	NOUN	O	O
total:	NOUN	O	O
9.9	NUM	O	O
g)	NOUN	O	O
lowered	VERB	O	O
fasting	VERB	O	O
blood	NOUN	O	O
glucose	NOUN	O	O
and	CCONJ	O	O
reduced	VERB	O	O
energy	NOUN	O	O
intake	NOUN	O	O
from	ADP	O	O
a	DET	O	O
subsequent	ADJ	O	O
meal.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/29	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

From	ADP	O	O
weeks	NOUN	O	O
12	NUM	O	O
-	PUNCT	O	O
24,	NUM	O	O
the	DET	O	O
total	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
gadolinium-enhancing	VERB	O	B-outcome
(Gd(+))	NUM	O	I-outcome
lesions	NOUN	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
by	ADP	O	O
84%	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.0001)	NUM	O	O
in	ADP	O	O
DMF	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
placebo.	NOUN	O	O

Subjects	NOUN	O	O
and	CCONJ	O	O
Methods:	NOUN	O	O
Among	ADP	O	O
the	DET	O	O
children	NOUN	O	O
referred	VERB	O	O
to	PART	O	O
the	DET	O	O
our	ADJ	O	O
University,	ADJ	O	O
Faculty	NOUN	O	O
of	ADP	O	O
Dentistry,	PUNCT	O	O
Department	NOUN	O	O
of	ADP	O	O
Pediatric	ADJ	O	O
Dentistry,	PUNCT	O	O
23	NUM	O	O
aged	VERB	O	O
between	ADP	O	O
8-14	NUM	O	O
with	ADP	O	O
81	NUM	O	O
anterior	ADJ	O	O
white	ADP	O	B-outcome
spot	NOUN	O	I-outcome
lesions	NOUN	O	I-outcome
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
study.	NOUN	O	O

METHOD:	NOUN	O	O
59	NUM	O	O
patients	NOUN	O	O
operated	VERB	O	O
for	ADP	O	O
spinal	ADJ	O	O
deformity	NOUN	O	O
(Lenke	NOUN	O	O
1	NUM	O	O
or	CCONJ	O	O
2)	NOUN	O	O
AIS.	NOUN	O	O

The	DET	O	O
postprandial	ADJ	O	O
insulin	NOUN	O	B-outcome
and	CCONJ	O	O
GLP-1	NOUN	O	B-outcome
responses	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0210174	NUM	O	O

We	PRON	O	O
compared	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
these	DET	O	O
two	NUM	O	O
schedules.	NOUN	O	O

MBCT	NOUN	O	O
as	ADP	O	O
an	DET	O	O
evidence-based	VERB	O	O
psychotherapeutic	ADJ	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
Mindfulness-Based	VERB	O	O
Intervention	NOUN	O	O
(MBI),	PUNCT	O	O
is	VERB	O	O
an	DET	O	O
8-week	NOUN	O	O
course	NOUN	O	O
developed	VERB	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
relapsing	VERB	O	O
depression	NOUN	O	O
that	ADP	O	O
integrates	NOUN	O	O
mindfulness	ADV	O	O
meditation	NOUN	O	O
practices	NOUN	O	O
and	CCONJ	O	O
cognitive	ADJ	O	O
therapy.	NOUN	O	O

The	DET	O	O
assay	NOUN	O	O
was	VERB	O	O
successfully	ADV	O	O
applied	VERB	O	O
in	ADP	O	O
a	DET	O	O
pharmacokinetic	ADJ	O	O
study	NOUN	O	O
in	ADP	O	O
renal	ADJ	O	O
transplant	NOUN	O	O
recipients	NOUN	O	O
receiving	VERB	O	O
belatacept	ADV	O	O
infusions.	NOUN	O	O

The	DET	O	O
pattern	NOUN	O	O
of	ADP	O	O
FEV1	NOUN	O	B-outcome
changes	NOUN	O	O
around	ADP	O	O
exacerbations	NOUN	O	O
was	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
the	DET	O	O
triple	NOUN	O	O
therapy	NOUN	O	O
and	CCONJ	O	O
dual	ADJ	O	O
bronchodilator	NOUN	O	O
groups,	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
similar	ADJ	O	O
pattern	NOUN	O	O
was	VERB	O	O
seen	VERB	O	O
in	ADP	O	O
moderate	ADJ	O	O
and	CCONJ	O	O
severe	ADJ	O	O
exacerbations	NOUN	O	O
when	ADP	O	O
analysed	VERB	O	O
separately.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Endometriosis	NOUN	O	O
is	VERB	O	O
the	DET	O	O
major	ADJ	O	O
cause	ADP	O	O
of	ADP	O	O
progressive	ADJ	O	O
pelvic	ADJ	O	O
pain	NOUN	O	O
and	CCONJ	O	O
subfertility.	ADJ	O	O

In	ADP	O	O
addition,	NOUN	O	O
lavender	NOUN	O	O
essential	ADJ	O	O
oil	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
shown	VERB	O	O
to	PART	O	O
have	VERB	O	O
positive	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
some	DET	O	O
symptoms	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
menopause.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Significant	ADJ	O	O
improvements	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
Ca	NOUN	O	B-outcome
,	PUNCT	O	O
P	NOUN	O	B-outcome
and	CCONJ	O	O
iPTH	NOUN	O	B-outcome
levels	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
at	ADP	O	O
4,	NOUN	O	O
8,	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
weeks	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.05)	NUM	O	O
but	CCONJ	O	O
only	ADV	O	O
at	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
&lt;	NOUN	O	O
0.05).	NOUN	O	O

Journal-Name:Yonsei	NOUN	O	O
medical	ADJ	O	O
journal	ADJ	O	O

However,	ADV	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
study	NOUN	O	O
protocols	NOUN	O	O
to	PART	O	O
ensure	NOUN	O	O
patient	NOUN	O	O
safety,	ADP	O	O
these	DET	O	O
randomised	VERB	O	O
studies	NOUN	O	O
used	VERB	O	O
mainly	ADV	O	O
broad-spectrum	NOUN	O	O
intravenous	ADJ	O	O
antibiotics	NOUN	O	O
requiring	VERB	O	O
additional	ADJ	O	O
hospital	NOUN	O	O
resources	NOUN	O	O
and	CCONJ	O	O
prolonged	VERB	O	O
hospital	NOUN	O	O
stay.	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/10	PUNCT	O	O
06:00'	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Recent	ADJ	O	O
studies	NOUN	O	O
have	VERB	O	O
shown	VERB	O	O
that	ADP	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
is	VERB	O	O
both	CCONJ	O	O
safe	ADJ	O	O
and	CCONJ	O	O
cost-effective	ADJ	O	O
for	ADP	O	O
a	DET	O	O
CT-scan	NOUN	O	O
confirmed	VERB	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis.	NOUN	O	O

INTRODUCTION:	NOUN	O	O
Deficient	ADJ	O	O
levels	NOUN	O	O
of	ADP	O	O
25-hydroxyvitamin	NOUN	O	O
D	NOUN	O	O
(25(OH)D)	NUM	O	O
(<30	PUNCT	O	O
ng/mL)	NOUN	O	O
may	VERB	O	O
compromise	VERB	O	O
health	NOUN	O	O
and	CCONJ	O	O
athletic	ADJ	O	O
performance.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
open-label	NOUN	O	O
study	NOUN	O	O
of	ADP	O	O
single	ADJ	O	O
injection	NOUN	O	O
versus	CCONJ	O	O
continuous	ADJ	O	O
adductor	NOUN	O	O
canal	NOUN	O	O
block	VERB	O	O
for	ADP	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
after	ADP	O	O
total	ADJ	O	O
knee	NOUN	O	O
arthroplasty.	NOUN	O	O

MATERIAL	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Thirty-six	NUM	O	O
elite	ADP	O	O
male	NOUN	O	O
rowers	NOUN	O	O
(27	PUNCT	O	O
+/-	SYM	O	O
6	NUM	O	O
years)	NOUN	O	O
were	VERB	O	O
assigned	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
randomly:	NOUN	O	O
1)	NUM	O	O
Control	NOUN	O	O
group	NOUN	O	O
(CG,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
18,	NUM	O	O
height:	NOUN	O	O
181.05	NUM	O	O
+/-	SYM	O	O
3.39	NUM	O	O
cm	NOUN	O	O
and	CCONJ	O	O
body	NOUN	O	O
mass:	NOUN	O	O
77.02	NUM	O	O
+/-	SYM	O	O
7.55	NUM	O	O
kg),	NOUN	O	O
2)	NOUN	O	O
Group	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
3,000	NUM	O	O
IU	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D3/day	NOUN	O	O
(VD3G,	NOUN	O	O
s	NOUN	O	O
=	SYM	O	O
18,	NUM	O	O
height:	NOUN	O	O
179.70	NUM	O	O
+/-	SYM	O	O
9.07	NUM	O	O
cm	NOUN	O	O
and	CCONJ	O	O
body	NOUN	O	O
mass:	NOUN	O	O
76.19	NUM	O	O
+/-	SYM	O	O
10.07	NUM	O	O
kg).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/06	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Group	NOUN	O	O
A	DET	O	O
consisted	VERB	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
Atorvastatin	ADP	O	O
40mg	NOUN	O	O
daily	ADJ	O	O
and	CCONJ	O	O
Group	NOUN	O	O
B	NOUN	O	O
Atorvastatin	ADP	O	O
80mg	NOUN	O	O
daily.	NOUN	O	O

Title:	NOUN	O	O
Precooling,	NOUN	O	O
Exertional	ADJ	O	O
Heatstroke	NOUN	O	O
Risk	NOUN	O	O
Factors,	NOUN	O	O
and	CCONJ	O	O
Postexercise	ADV	O	O
Cooling	VERB	O	O
Rates.	NOUN	O	O

Cost	NOUN	O	O
and	CCONJ	O	O
resource	NOUN	O	O
savings	NOUN	O	O
of	ADP	O	O
using	VERB	O	O
the	DET	O	O
app	CCONJ	O	O
compared	VERB	O	O
to	PART	O	O
face-to-face	NUM	O	O
counseling	VERB	O	O
may	VERB	O	O
make	VERB	O	O
it	PRON	O	O
a	DET	O	O
good	ADJ	O	O
option	NOUN	O	O
for	ADP	O	O
interventionists.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

J	NOUN	O	O
Drugs	NOUN	O	O
Dermatol.	NOUN	O	O

We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
double-blinded,	NOUN	O	O
randomized,	NOUN	O	O
and	CCONJ	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
in	ADP	O	O
Addis	NOUN	O	O
Ababa,	NOUN	O	O
Ethiopia,	ADV	O	O
to	PART	O	O
investigate	NOUN	O	O
if	ADP	O	O
daily	ADJ	O	O
nutritional	ADJ	O	O
supplementation	NOUN	O	O
with	ADP	O	O
vitD(3)	NOUN	O	O
(5000	NUM	O	O
IU)	NOUN	O	O
and	CCONJ	O	O
phenylbutyrate	NOUN	O	O
(PBA,	PUNCT	O	O
2	NUM	O	O
x	SYM	O	O
500	NUM	O	O
mg)	NOUN	O	O
could	VERB	O	O
mediate	VERB	O	O
beneficial	ADJ	O	O
effects	NOUN	O	O
in	ADP	O	O
treatment-naive	ADJ	O	O
HIV	NOUN	O	O
patients.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
For	ADP	O	O
high	ADJ	O	O
responder	VERB	O	O
patients	NOUN	O	O
receiving	VERB	O	O
GnRH-agonist	NOUN	O	O
trigger,	ADV	O	O
low	ADJ	O	O
dose	NOUN	O	O
hCG	NOUN	O	O
supplementation	NOUN	O	O
allowed	VERB	O	O
high	ADJ	O	O
pregnancy	NOUN	O	B-outcome
rates	NOUN	O	O
after	ADP	O	O
fresh	ADJ	O	O
embryo	NOUN	O	O
transfer,	NOUN	O	O
regardless	ADV	O	O
of	ADP	O	O
whether	ADP	O	O
it	PRON	O	O
was	VERB	O	O
given	VERB	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
trigger	ADP	O	O
or	CCONJ	O	O
at	ADP	O	O
oocyte	NOUN	O	O
retrieval.	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
group	NOUN	O	O
B,	NOUN	O	O
30	NUM	O	O
cases	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group.	VERB	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
fit	NOUN	O	B-outcome
factor	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
overall	ADJ	O	B-outcome
fit	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
,	PUNCT	O	O
adequate	ADJ	O	O
protection	NOUN	O	B-outcome
rate,	NOUN	O	O
and	CCONJ	O	O
respiratory	ADJ	O	O
preference	NOUN	O	B-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Fit	NOUN	O	B-outcome
factors	NOUN	O	I-outcome
,	PUNCT	O	O
overall	ADJ	O	B-outcome
fit	NOUN	O	I-outcome
factor	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
adequate	ADJ	O	B-outcome
protection	NOUN	O	I-outcome
rate	NOUN	O	O
were	VERB	O	O
higher	ADJ	O	O
after	ADP	O	O
training	VERB	O	O
than	ADP	O	O
before	ADP	O	O
training	VERB	O	O
for	ADP	O	O
the	DET	O	O
3	NUM	O	O
types	NOUN	O	O
of	ADP	O	O
respirators	NOUN	O	O
(all	PUNCT	O	O
P	NOUN	O	O
<	SYM	O	O
.05).	NUM	O	O

RESULTS:	NOUN	O	O
More	ADV	O	O
than	ADP	O	O
one	NUM	O	O
third	ADJ	O	O
of	ADP	O	O
girls	NOUN	O	O
(35.1%)	PUNCT	O	O
reported	VERB	O	O
having	VERB	O	O
no	DET	O	O
hope	NOUN	O	O
for	ADP	O	O
the	DET	O	O
future.	NOUN	O	O

At	ADP	O	O
6	NUM	O	O
months,	NOUN	O	O
the	DET	O	O
mean	NOUN	O	O
Posttraumatic	ADJ	O	B-outcome
Stress	NOUN	O	I-outcome
Disorder	NOUN	O	I-outcome
(PTSD)	ADV	O	I-outcome
Symptom	NOUN	O	I-outcome
Scale]-Self-Report	ADJ	O	O
questionnaire	NOUN	O	O
score	NOUN	O	O
in	ADP	O	O
intervention	NOUN	O	O
ICUs	NOUN	O	O
was	VERB	O	O
11.8	NUM	O	O
(baseline	NUM	O	O
period)	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
11.5	NUM	O	O
(intervention	PUNCT	O	O
period)	NOUN	O	O
(difference,	ADV	O	O
-0.40	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-2.46	NUM	O	O
to	PART	O	O
1.67])	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
control	NOUN	O	O
ICUs,	ADP	O	O
10.1	NUM	O	O
(baseline	NUM	O	O
period)	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
10.2	NUM	O	O
(intervention	PUNCT	O	O
period)	NOUN	O	O
(difference,	ADV	O	O
0.06	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-1.74	NUM	O	O
to	PART	O	O
1.85])	NOUN	O	O
between	ADP	O	O
periods.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
female	NOUN	O	O
healthcare	NOUN	O	O
workers	NOUN	O	O
with	ADP	O	O
recurrent	ADP	O	O
non-specific	ADJ	O	O
LBP	NOUN	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
four	NUM	O	O
study-arms:	NOUN	O	O
Combined	VERB	O	O
neuromuscular	ADJ	O	O
exercise	NOUN	O	O
and	CCONJ	O	O
back	ADP	O	O
care	NOUN	O	O
counseling;	VERB	O	O
Exercise;	NOUN	O	O
Counseling;	VERB	O	O
and	CCONJ	O	O
no	DET	O	O
intervention	NOUN	O	O
Control.	NOUN	O	O

Yoga	NOUN	O	O
decreased	VERB	O	O
the	DET	O	O
state	NOUN	O	O
of	ADP	O	O
depression	NOUN	O	B-outcome
and	CCONJ	O	O
diastolic	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
subjects	NOUN	O	O
with	ADP	O	O
PMS	NOUN	O	O
complaining	VERB	O	O
from	ADP	O	O
depression.	NOUN	O	O

The	DET	O	O
95%	NOUN	O	O
effective	ADJ	O	O
dose	NOUN	O	B-outcome
was	VERB	O	O
calculated	VERB	O	O
with	ADP	O	O
Probit	NOUN	O	O
analysis.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Multidisciplinary	ADJ	O	O
interventions	NOUN	O	O
among	ADP	O	O
these	DET	O	O
workers	NOUN	O	O
have	VERB	O	O
improved	VERB	O	O
fear	ADJ	O	O
avoidance	NOUN	O	O
beliefs	NOUN	O	B-outcome
,	PUNCT	O	O
but	CCONJ	O	O
not	ADV	O	O
low	ADJ	O	B-outcome
back	ADP	O	I-outcome
pain	NOUN	O	I-outcome
(LBP)	PUNCT	O	I-outcome
and	CCONJ	O	O
related	VERB	O	O
sickness	NOUN	O	B-outcome
absences	NOUN	O	I-outcome
,	PUNCT	O	O
cost-effectiveness	NOUN	O	O
studies	NOUN	O	O
are	VERB	O	O
scarce.	NOUN	O	O

Rate	NOUN	O	O
of	ADP	O	O
main	ADJ	O	B-outcome
curve	NOUN	O	I-outcome
correction	NOUN	O	I-outcome
was	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different	ADJ	O	O
considering	VERB	O	O
patients'	NOUN	O	O
gender	NOUN	O	O
(P-value0.657).	NUM	O	O

Adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
were	VERB	O	O
analyzed	VERB	O	O
by	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
rate,	NOUN	O	O
type,	NOUN	O	O
and	CCONJ	O	O
severity.	DET	O	O

Journal-Name:Anticancer	NOUN	O	O
research	NOUN	O	O

We	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
usefulness	ADJ	O	O
of	ADP	O	O
the	DET	O	O
single/double	ADJ	O	O
ETView	NOUN	O	O
TVT	NOUN	O	O
in	ADP	O	O
monitoring	VERB	O	O
the	DET	O	O
tracheal	ADJ	O	O
tube	NOUN	O	O
position	NOUN	O	O
during	ADP	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
undergoing	VERB	O	O
video-assisted	VERB	O	O
thoracoscopic	ADJ	O	O
lobectomy.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Thus,	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
BiPAP	ADJ	O	O
in	ADP	O	O
PAR	NOUN	O	O
can	VERB	O	O
promote	VERB	O	O
restoration	NOUN	O	O
of	ADP	O	O
expiratory	ADJ	O	B-outcome
reserve	NOUN	O	I-outcome
volume	NOUN	O	I-outcome
and	CCONJ	O	O
contribute	NOUN	O	O
to	PART	O	O
the	DET	O	O
reduction	NOUN	O	O
of	ADP	O	O
atelectasis.	NOUN	O	O

Objective	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
clinical	ADJ	O	O
outcome	NOUN	O	O
of	ADP	O	O
injecting	VERB	O	O
Triamcinolone	NOUN	O	O
acetenoid	NOUN	O	O
in	ADP	O	O
osteoarthritis	NOUN	O	O
of	ADP	O	O
knee	NOUN	O	O
in	ADP	O	O
a	DET	O	O
community	NOUN	O	O
set	NOUN	O	O
up	ADP	O	O
over	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
double-blind	ADJ	O	O
placebo	NOUN	O	O
control	NOUN	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/06	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Comparing	VERB	O	O
MRI	NOUN	O	O
sequences	NOUN	O	O
reveals	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
interobserver	ADV	O	O
variability	NOUN	O	O
and	CCONJ	O	O
significantly	ADV	O	O
improved	VERB	O	O
accuracy	NOUN	O	O
on	ADP	O	O
T2*W	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
T2W	NOUN	O	O
MRI	NOUN	O	O
for	ADP	O	O
DSC	NOUN	O	O
and	CCONJ	O	O
Cohen's	NOUN	O	O
kappa.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Various	ADJ	O	O
studies	NOUN	O	O
indicate	VERB	O	O
the	DET	O	O
negative	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
menopausal	ADJ	O	O
symptoms	NOUN	O	O
and	CCONJ	O	O
complications	NOUN	O	O
on	ADP	O	O
the	DET	O	O
quality	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
(QOL)	PUNCT	O	O
of	ADP	O	O
women.	NOUN	O	O

Before	ADP	O	O
treatment,	NOUN	O	O
the	DET	O	O
average	NOUN	O	O
pain	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
in	ADP	O	O
Novafen	NOUN	O	O
and	CCONJ	O	O
Ginger	NOUN	O	O
users	NOUN	O	O
were	VERB	O	O
7.12	NUM	O	O
+/-	SYM	O	O
2.32	NUM	O	O
and	CCONJ	O	O
7.60	NUM	O	O
+/-	SYM	O	O
1.84,	NUM	O	O
respectively	ADV	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment	NOUN	O	O
pain	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
decreased	VERB	O	O
to	PART	O	O
3.10	NUM	O	O
+/-	SYM	O	O
2.69	NUM	O	O
and	CCONJ	O	O
2.97	NUM	O	O
+/-	SYM	O	O
2.69,	NUM	O	O
respectively.	NOUN	O	O

METHOD:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial,	NOUN	O	O
with	ADP	O	O
102	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
preoperative	ADJ	O	O
period,	NOUN	O	O
randomized	VERB	O	O
in	ADP	O	O
a	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
usual	ADJ	O	O
care,	NOUN	O	O
and	CCONJ	O	O
an	DET	O	O
experimental	ADJ	O	O
group,	NOUN	O	O
which	ADP	O	O
received	VERB	O	O
menthol	NOUN	O	O
gum,	NOUN	O	O
which	ADP	O	O
was	VERB	O	O
the	DET	O	O
study	NOUN	O	O
treatment	NOUN	O	O
variable.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

OBJECTIVE:	NOUN	O	O
Deterioration	NOUN	O	O
in	ADP	O	O
ventricular	ADJ	O	O
function	NOUN	O	O
is	VERB	O	O
often	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
anthracyclines	NOUN	O	O
for	ADP	O	O
cancer.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Non-esterified	VERB	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
and	CCONJ	O	O
triglyceride	NOUN	O	B-outcome
were	VERB	O	O
evaluated	VERB	O	O
following	VERB	O	O
breakfast	NOUN	O	O
and	CCONJ	O	O
lunch.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
a	DET	O	O
multicenter	NOUN	O	O
(6	ADV	O	O
centers:	NOUN	O	O
2	NUM	O	O
teaching	VERB	O	O
hospitals,	NOUN	O	O
4	NUM	O	O
specialist	NOUN	O	O
orthodontic	ADJ	O	O
practices),	NOUN	O	O
single-blinded,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
with	ADP	O	O
2	NUM	O	O
parallel	ADJ	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Spirometry,	ADV	O	O
SF-36	NUM	O	O
health	NOUN	O	O
survey	NOUN	O	O
of	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
Lawton	NOUN	O	O
and	CCONJ	O	O
Brody	NOUN	O	O
Instrumental	ADJ	O	O
Activities	NOUN	O	B-outcome
of	ADP	O	I-outcome
Daily	ADJ	O	I-outcome
Living	VERB	O	I-outcome
Scale	NOUN	O	O
(IADL)	NUM	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
collect	NOUN	O	O
physical	ADJ	O	B-outcome
health	NOUN	O	I-outcome
data,	NOUN	O	O
and	CCONJ	O	O
self-evaluation	NOUN	O	O
of	ADP	O	O
overall	ADJ	O	B-outcome
health	NOUN	O	I-outcome
status,	NOUN	O	O
self-evaluation	NOUN	O	O
of	ADP	O	O
loneliness	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
short-form	NOUN	O	O
geriatric	ADJ	O	O
depression	NOUN	O	B-outcome
scale	NOUN	O	O
(GDS-15)	ADV	O	O
were	VERB	O	O
used	VERB	O	O
to	PART	O	O
collect	NOUN	O	O
mental	ADJ	O	B-outcome
health	NOUN	O	I-outcome
data	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
3	NUM	O	O
months,	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
intervention.	NOUN	O	O

Teacher	NOUN	O	O
verbatim	ADV	O	O
data	NOUN	O	O
was	VERB	O	O
collected	VERB	O	O
from	ADP	O	O
3	NUM	O	O
interviews,	ADJ	O	O
and	CCONJ	O	O
18	NUM	O	O
researcher	ADP	O	O
observations	NOUN	O	O
were	VERB	O	O
recorded	VERB	O	O
using	VERB	O	O
field	NOUN	O	O
notes.	ADV	O	O

Overall,	NOUN	O	O
throat	NOUN	O	B-outcome
or	CCONJ	O	Seperator
mouth	NOUN	O	I-outcome
irritation	NOUN	O	I-outcome
was	VERB	O	O
reported	VERB	O	O
more	ADV	O	O
frequently	ADV	O	O
in	ADP	O	O
the	DET	O	O
e-cigarette	NOUN	O	O
group	NOUN	O	O
(65.3%,	PUNCT	O	O
vs.	CCONJ	O	O
51.2%	NUM	O	O
in	ADP	O	O
the	DET	O	O
nicotine-replacement	ADJ	O	O
group)	ADJ	O	O
and	CCONJ	O	O
nausea	NOUN	O	B-outcome
more	ADV	O	O
frequently	ADV	O	O
in	ADP	O	O
the	DET	O	O
nicotine-replacement	ADJ	O	O
group	NOUN	O	O
(37.9%,	PUNCT	O	O
vs.	CCONJ	O	O
31.3%	NUM	O	O
in	ADP	O	O
the	DET	O	O
e-cigarette	NOUN	O	O
group).	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
injected	VERB	O	O
with	ADP	O	O
BTX-A	NOUN	O	O
or	CCONJ	O	O
normal	ADJ	O	O
saline	NOUN	O	O
in	ADP	O	O
the	DET	O	O
medial	ADJ	O	O
part	NOUN	O	O
of	ADP	O	O
the	DET	O	O
upper	ADJ	O	O
and	CCONJ	O	O
lower	ADJ	O	O
eyelids.	NOUN	O	O

METHODS:	NOUN	O	O
Sixteen	NUM	O	O
non-heat	NOUN	O	O
acclimatized	VERB	O	O
men	NOUN	O	O
heat	NOUN	O	O
acclimated	VERB	O	O
during	ADP	O	O
10-11	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
exercise	NOUN	O	O
in	ADP	O	O
the	DET	O	O
heat	NOUN	O	O
(40	NOUN	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
40%	NUM	O	O
RH).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Similar	ADJ	O	O
results	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
CyPass	NOUN	O	O
micro-stent	ADJ	O	O
implantation	NOUN	O	O
accompanying	VERB	O	O
phacoemulsification.	NOUN	O	O

The	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
had	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.01)	NUM	O	O
of	ADP	O	O
about	ADV	O	O
10	NUM	O	O
points	NOUN	O	O
in	ADP	O	O
Audit	NOUN	O	O
score	NOUN	O	O
after	ADP	O	O
the	DET	O	O
brief	ADJ	O	O
group	NOUN	O	O
intervention	NOUN	O	O
[before	NOUN	O	O
BGI	NOUN	O	O
=	SYM	O	O
15.89	NUM	O	O
(SD	NOUN	O	O
=	SYM	O	O
6.62)	ADP	O	O
-	PUNCT	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
;	PUNCT	O	O
after	ADP	O	O
BGI	NOUN	O	O
=	SYM	O	O
6.40	NUM	O	O
(SD	NOUN	O	O
=	SYM	O	O
5.05)	NOUN	O	O
-	PUNCT	O	O
low	ADJ	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
maintaining	VERB	O	O
the	DET	O	O
low	ADJ	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
in	ADP	O	O
follow-up	NOUN	O	O
[6.69	NOUN	O	O
(SD	NOUN	O	O
=	SYM	O	O
6.38)	NOUN	O	O
-	PUNCT	O	O
low	ADJ	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
].	NOUN	O	O
The	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
(p	PUNCT	O	O
</=	NOUN	O	O
0.01)	NUM	O	O
of	ADP	O	O
about	ADV	O	O
three	NUM	O	O
points	NOUN	O	O
in	ADP	O	O
Audit	NOUN	O	O
score	NOUN	O	O
[before	NOUN	O	O
BGI	NOUN	O	O
=	SYM	O	O
13.11	NUM	O	O
(SD	NOUN	O	O
=	SYM	O	O
4.54)	NOUN	O	O
-	PUNCT	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
;	PUNCT	O	O
after	ADP	O	O
BGI	NOUN	O	O
=	SYM	O	O
9.83	NUM	O	O
(SD	NOUN	O	O
=	SYM	O	O
5.54)	NUM	O	O
-	PUNCT	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
and	CCONJ	O	O
in	ADP	O	O
follow-up	NOUN	O	O
presented	VERB	O	O
the	DET	O	O
mean	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
13.00	NUM	O	O
(SD	NOUN	O	O
=	SYM	O	O
5.70),	NUM	O	O
indicative	ADJ	O	O
of	ADP	O	O
hazardous	ADJ	O	B-outcome
use	NOUN	O	I-outcome
.	PUNCT	O	O
Differences	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(experimental	ADJ	O	O
group	NOUN	O	O
versus	CCONJ	O	O
control	NOUN	O	O
group)	ADJ	O	O
in	ADP	O	O
reduction	NOUN	O	O
of	ADP	O	O
consumption	NOUN	O	B-outcome
were	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(p	PUNCT	O	O
</=	NOUN	O	O
0.01).	NOUN	O	O

Clinical	ADJ	O	O
changes	NOUN	O	O
were	VERB	O	O
defined	VERB	O	O
as	ADP	O	O
improvements	NOUN	O	O
on	ADP	O	O
the	DET	O	O
Fugl-Meyer	NOUN	O	O
motor	NOUN	O	B-outcome
assessment	NOUN	O	O
(FMA)	NOUN	O	O
and	CCONJ	O	O
Wolf	NOUN	O	O
motor	NOUN	O	B-outcome
function	NOUN	O	I-outcome
test	NOUN	O	O
(WMFT)].	PUNCT	O	O
Results:	NOUN	O	O
All	DET	O	O
participants	NOUN	O	O
adhered	VERB	O	O
to	PART	O	O
FT/ST	ADV	O	O
without	ADP	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
comparable	ADJ	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
ratings	NOUN	O	O
were	VERB	O	O
noted	VERB	O	O
between	ADP	O	O
groups	NOUN	O	O
throughout	ADV	O	O
the	DET	O	O
training	VERB	O	O
(P>/=0.42).	NUM	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
60	NUM	O	O
T2DM	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
presence	NOUN	O	O
of	ADP	O	O
MVC:	NOUN	O	O
T2DM	NOUN	O	O
+	SYM	O	O
MVC	NOUN	O	O
group	NOUN	O	O
(n=30)	NUM	O	O
and	CCONJ	O	O
T2DM	NOUN	O	O
group	NOUN	O	O
(n=30).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/16	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Title:	NOUN	O	O
Foot	NOUN	O	O
and	CCONJ	O	O
ankle	NOUN	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
dynamic	ADJ	O	O
knee	NOUN	O	O
valgus	NOUN	O	O
in	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
patellofemoral	ADJ	O	O
osteoarthritis.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
generated	VERB	O	O
power	NOUN	O	B-outcome
and	CCONJ	O	O
velocity	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
CON	NOUN	O	O
phase	NOUN	O	O
of	ADP	O	O
the	DET	O	O
movement	NOUN	O	O
between	ADP	O	O
the	DET	O	O
GCAF	NOUN	O	O
and	CCONJ	O	O
GCON.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
referred	VERB	O	O
to	PART	O	O
VA	NOUN	O	O
gastroenterology	NOUN	O	O
clinics	NOUN	O	O
for	ADP	O	O
PPI-refractory	ADJ	O	O
heartburn,	NOUN	O	O
systematic	ADJ	O	O
workup	NOUN	O	O
revealed	VERB	O	O
truly	ADV	O	O
PPI-refractory	ADJ	O	O
and	CCONJ	O	O
reflux-related	VERB	O	O
heartburn	ADP	O	O
in	ADP	O	O
a	DET	O	O
minority	NOUN	O	O
of	ADP	O	O
patients.	NOUN	O	O

However,	ADV	O	O
self-testing	VERB	O	O
is	VERB	O	O
only	ADV	O	O
a	DET	O	O
partial	ADJ	O	O
solution	NOUN	O	O
to	PART	O	O
increasing	VERB	O	O
testing	VERB	O	B-outcome
rates	NOUN	O	O
in	ADP	O	O
this	DET	O	O
hard	NOUN	O	O
to	PART	O	O
reach	NOUN	O	O
population.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/15	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:The	ADJ	O	O
western	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
emergency	NOUN	O	O
medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100891112	NUM	O	O

The	DET	O	O
median	ADJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
54.4	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
modified-FOLFIRINOX	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
35.0	NUM	O	O
months	NOUN	O	O
in	ADP	O	O
the	DET	O	O
gemcitabine	NOUN	O	O
group	NOUN	O	O
(stratified	PUNCT	O	O
hazard	NOUN	O	O
ratio	NOUN	O	O
for	ADP	O	O
death	NOUN	O	B-outcome
,	PUNCT	O	O
0.64;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.48	NUM	O	O
to	PART	O	O
0.86;	NOUN	O	O
P=0.003).	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
critically	ADV	O	O
ill	ADJ	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
ICU,	ADJ	O	O
a	DET	O	O
nurse-led	VERB	O	O
preventive,	ADJ	O	O
complex	NOUN	O	O
psychological	ADJ	O	O
intervention	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
reduce	VERB	O	O
patient-reported	VERB	O	O
posttraumatic	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
disorder	ADP	O	I-outcome
(PTSD)	ADV	O	I-outcome
symptom	NOUN	O	I-outcome
severity	NOUN	O	I-outcome
at	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Clinical	ADJ	O	O
interventions	NOUN	O	O
to	PART	O	O
address	NOUN	O	O
greater	ADJ	O	O
foot	NOUN	O	O
mobility	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
relevant	ADJ	O	O
for	ADP	O	O
PFOA.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/26	VERB	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Methods:	NOUN	O	O
This	DET	O	O
was	VERB	O	O
a	DET	O	O
prospective	ADJ	O	O
study	NOUN	O	O
conducted	VERB	O	O
from	ADP	O	O
November	NOUN	O	O
2017	NUM	O	O
to	PART	O	O
March	NOUN	O	O
2018.	NUM	O	O

Further	ADV	O	O
study	NOUN	O	O
of	ADP	O	O
pegbelfermin	NOUN	O	O
is	VERB	O	O
warranted	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
non-alcoholic	ADJ	O	O
steatohepatitis.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
music	ADJ	O	O
therapy	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/08/02	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

BACKGROUND:	NOUN	O	O
Multiple	ADJ	O	O
arterial	ADJ	O	O
grafts	NOUN	O	O
may	VERB	O	O
result	VERB	O	O
in	ADP	O	O
longer	ADJ	O	O
survival	NOUN	O	O
than	ADP	O	O
single	ADJ	O	O
arterial	ADJ	O	O
grafts	NOUN	O	O
after	ADP	O	O
coronary-artery	NOUN	O	O
bypass	NOUN	O	O
grafting	VERB	O	O
(CABG)	PUNCT	O	O
surgery.	VERB	O	O

In	ADP	O	O
Group	NOUN	O	O
A	DET	O	O
(12%)	NUM	O	O
patients	NOUN	O	O
had	VERB	O	O
infection	NOUN	O	B-outcome
and	CCONJ	O	O
(88%)	NOUN	O	O
whereas	ADP	O	O
in	ADP	O	O
Group	NOUN	O	O
B	NOUN	O	O
(20%)	NOUN	O	O
patients	NOUN	O	O
had	VERB	O	O
infection	NOUN	O	B-outcome
and	CCONJ	O	O
(80%)	NOUN	O	O
patients	NOUN	O	O
did	VERB	O	O
n't	ADV	O	O
had	VERB	O	O
infection	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
Simultaneous	ADJ	O	O
VP	NOUN	O	O
shunting	VERB	O	O
was	VERB	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
delayed	VERB	O	O
VP	NOUN	O	O
shunting	VERB	O	O
in	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
myelomeningocele	NOUN	O	O
in	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
infection	NOUN	O	B-outcome
.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

All	DET	O	O
the	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
traditional	ADJ	O	O
Chinese	NOUN	O	O
medicine	NOUN	O	O
retention	NOUN	O	O
enema,	ADP	O	O
and	CCONJ	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
additional	ADJ	O	O
Ronghuang	NOUN	O	O
granule	NOUN	O	O
treatment	NOUN	O	O
(3	NOUN	O	O
times	NOUN	O	O
a	DET	O	O
day).	NOUN	O	O

This	DET	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
experimental	ADJ	O	O
evidence	NOUN	O	O
of	ADP	O	O
beta-Eudesmol	NOUN	O	O
effect	NOUN	O	O
for	ADP	O	O
mental	ADJ	O	O
stress	NOUN	O	O
in	ADP	O	O
human.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8102988	NUM	O	O

Furthermore,	NOUN	O	O
glycolysis	NOUN	O	B-outcome
and	CCONJ	O	O
tricarboxylic	ADJ	O	B-outcome
acid	NOUN	O	I-outcome
(TCA)	PUNCT	O	I-outcome
cycle	NOUN	O	I-outcome
was	VERB	O	O
perturbed,	NOUN	O	O
and	CCONJ	O	O
increased	VERB	O	O
dihydroxyacetone	NOUN	O	B-outcome
phosphate	NOUN	O	I-outcome
(DHAP)	NUM	O	I-outcome
and	CCONJ	O	O
decreased	VERB	O	O
succinyl-CoA	NOUN	O	B-outcome
synthetase	NOUN	O	I-outcome
(SCS)	PUNCT	O	I-outcome
respectively	ADV	O	O
in	ADP	O	O
these	DET	O	O
two	NUM	O	O
metabolic	ADJ	O	O
pathways	NOUN	O	O
were	VERB	O	O
identified	VERB	O	O
as	ADP	O	O
potential	ADJ	O	O
biomarkers	NOUN	O	O
for	ADP	O	O
tubular	ADJ	O	O
injury	NOUN	O	O
in	ADP	O	O
DKD.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
physiology	NOUN	O	O
and	CCONJ	O	O
pharmacology	NOUN	O	O
:	PUNCT	O	O
an	DET	O	O
official	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
Polish	ADV	O	O
Physiological	ADJ	O	O
Society	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0332203	NUM	O	O

Title:	NOUN	O	O
Effects	NOUN	O	O
of	ADP	O	O
Vitamin	NOUN	O	O
D	NOUN	O	O
Supplementation	NOUN	O	O
on	ADP	O	O
Haematological	ADJ	O	B-outcome
Values	NOUN	O	O
and	CCONJ	O	O
Muscle	NOUN	O	B-outcome
Recovery	NOUN	O	I-outcome
in	ADP	O	O
Elite	ADP	O	O
Male	NOUN	O	O
Traditional	ADJ	O	O
Rowers.	NOUN	O	O

The	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(G1)	PUNCT	O	O
was	VERB	O	O
indicated	VERB	O	O
from	ADP	O	O
the	DET	O	O
entrance	NOUN	O	O
a	DET	O	O
diet	NOUN	O	O
hyperproteic	NOUN	O	O
low	ADJ	O	O
in	ADP	O	O
colecistokinetics	NOUN	O	O
diet,	ADV	O	O
and	CCONJ	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(G2)	NUM	O	O
nothing	VERB	O	O
by	ADP	O	O
mouth.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
double-blind,	NOUN	O	O
controlled	VERB	O	O
trial,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
145	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
TTP	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
caplacizumab	NOUN	O	O
(10-mg	NOUN	O	O
intravenous	ADJ	O	O
loading	VERB	O	O
bolus,	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
10	NUM	O	O
mg	NOUN	O	O
daily	ADJ	O	O
subcutaneously)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
during	ADP	O	O
plasma	NOUN	O	O
exchange	NOUN	O	O
and	CCONJ	O	O
for	ADP	O	O
30	NUM	O	O
days	NOUN	O	O
thereafter.	NOUN	O	O

After	ADP	O	O
adjusting	VERB	O	O
for	ADP	O	O
pancreatic	ADJ	O	O
fistula	NOUN	O	O
and	CCONJ	O	O
delayed	VERB	O	O
gastric	ADJ	O	O
emptying,	NOUN	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
observed.	NOUN	O	O

The	DET	O	O
implantation	NOUN	O	B-outcome
rate	NOUN	O	O
and	CCONJ	O	O
per-cycle	NOUN	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
rate	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
PRP	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.002	NUM	O	O
and	CCONJ	O	O
0.044,	NOUN	O	O
respectively	ADV	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.002).	NUM	O	O

Samples	NOUN	O	O
were	VERB	O	O
stable	ADJ	O	O
during	ADP	O	O
storage	NOUN	O	O
at	ADP	O	O
4	NUM	O	O
degrees	NOUN	O	O
C	NOUN	O	O
for	ADP	O	O
15	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
during	ADP	O	O
2	NUM	O	O
freeze-thaw	NOUN	O	O
cycles.	NUM	O	O

In	ADP	O	O
this	DET	O	O
clinical	ADJ	O	O
trial,	NOUN	O	O
we	PRON	O	O
evaluated	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
platelet-rich	NOUN	O	O
plasma	NOUN	O	O
(PRP)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
thin	ADJ	O	O
endometrium.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
In	ADP	O	O
view	NOUN	O	O
of	ADP	O	O
the	DET	O	O
high	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
polycystic	ADJ	O	O
ovary	NOUN	O	O
syndrome	NOUN	O	O
(PCOS)	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
unsatisfactory	ADJ	O	O
therapeutic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
dimethyldiguanide	NOUN	O	O
or	CCONJ	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
alone,	NOUN	O	O
our	ADJ	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
therapeutic	ADJ	O	O
effects	NOUN	O	O
of	ADP	O	O
dimethyldiguanide	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
clomifene	NOUN	O	O
citrate	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
PCOS.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8611905	NUM	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

L(-	NOUN	O	O
1)).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101147696	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
safety	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
absolute	ADJ	O	O
change	NOUN	O	O
in	ADP	O	O
hepatic	ADJ	O	B-outcome
fat	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
after	ADP	O	O
16	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Other	ADJ	O	O
potential	ADJ	O	O
moments	NOUN	O	O
for	ADP	O	O
hand	NOUN	O	B-outcome
hygiene	NOUN	O	I-outcome
were	VERB	O	O
introduced	VERB	O	O
by	ADP	O	O
participants,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
after	ADP	O	O
tending	VERB	O	O
to	PART	O	O
domestic	ADJ	O	O
animals	NOUN	O	O
and	CCONJ	O	O
gardening.	NOUN	O	O

The	DET	O	O
relationship	NOUN	O	O
of	ADP	O	O
marginal	ADJ	O	O
bone	NOUN	O	O
responses	NOUN	O	O
and	CCONJ	O	O
peri-implant	ADJ	O	O
mucosal	ADJ	O	O
stability	NOUN	O	O
requires	NOUN	O	O
further	ADV	O	O
evaluation.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

Patients	NOUN	O	O
and	CCONJ	O	O
Methods:	NOUN	O	O
Between	ADP	O	O
2003	NUM	O	O
and	CCONJ	O	O
2004,	NUM	O	O
60	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
pathologically	ADV	O	O
confirmed	VERB	O	O
NPC	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
and	CCONJ	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
two	NUM	O	O
groups.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
NCT01839708	NOUN	O	O
;	PUNCT	O	O
registered	VERB	O	O
February	ADJ	O	O
28,	NUM	O	O
2013.	NUM	O	O

The	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
which	ADP	O	O
was	VERB	O	O
conducted	VERB	O	O
before	ADP	O	O
PCI	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
the	DET	O	O
surgery.	VERB	O	O

Considerations	NOUN	O	O
for	ADP	O	O
feasibility	NOUN	O	O
and	CCONJ	O	O
effectiveness,	NOUN	O	O
including	VERB	O	O
barriers	NOUN	O	O
to	PART	O	O
attendance,	NOUN	O	O
are	VERB	O	O
discussed.	NOUN	O	O

However,	ADV	O	O
higher	ADJ	O	O
frequencies	NOUN	O	O
of	ADP	O	O
all	DET	O	O
adverse	ADJ	O	B-outcome
outcomes	NOUN	O	I-outcome
were	VERB	O	O
consistently	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

METHODS:	NOUN	O	O
From	ADP	O	O
October	ADJ	O	O
2015	NUM	O	O
to	PART	O	O
December	NOUN	O	O
2017,	NUM	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
79	NUM	O	O
patients,	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
preoperative	ADJ	O	O
localization	NOUN	O	O
of	ADP	O	O
small	ADJ	O	O
pulmonary	ADJ	O	O
nodules	NOUN	O	O
and	CCONJ	O	O
surgical	ADJ	O	O
treatment	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Department	NOUN	O	O
of	ADP	O	O
Thoracic	ADJ	O	O
Surgery	NOUN	O	O
of	ADP	O	O
Hohhot	NOUN	O	O
First	ADV	O	O
Hospital,	ADJ	O	O
were	VERB	O	O
enrolled	VERB	O	O
into	ADP	O	O
this	DET	O	O
study.	NOUN	O	O

EBV-encoded	VERB	O	O
small	ADJ	O	O
RNA	NOUN	O	O
in	ADP	O	O
situ	ADV	O	O
hybridization	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
to	PART	O	O
define	NOUN	O	O
EBV	NOUN	O	O
status.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
was	VERB	O	O
a	DET	O	O
post-hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
a	DET	O	O
cluster-randomized	VERB	O	O
trial	NOUN	O	O
as	ADP	O	O
a	DET	O	O
cohort	NOUN	O	O
study;	ADJ	O	O
including	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
working	VERB	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
CAP	NOUN	O	O
admitted	VERB	O	O
to	PART	O	O
non-ICU	NOUN	O	O
wards	NOUN	O	O
without	ADP	O	O
a	DET	O	O
cardiac	ADJ	O	O
event	NOUN	O	O
on	ADP	O	O
admission.	NOUN	O	O

The	DET	O	O
physiological	ADJ	O	B-outcome
adaptive	ADJ	O	I-outcome
mode	NOUN	O	I-outcome
(	PUNCT	O	O
activity	NOUN	O	B-outcome
and	CCONJ	O	O
exercise	NOUN	O	B-outcome
and	CCONJ	O	O
neonatal	ADJ	O	B-outcome
nutrition	NOUN	O	I-outcome
)	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
interdependence	NOUN	O	B-outcome
adaptive	ADJ	O	I-outcome
mode	NOUN	O	I-outcome
(appropriate	NOUN	O	O
affection	NOUN	O	B-outcome
and	CCONJ	O	O
proper	ADJ	O	O
development	NOUN	O	B-outcome
);	PUNCT	O	O
and	CCONJ	O	O
statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
in	ADP	O	O
favor	NOUN	O	O
of	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
the	DET	O	O
combination	NOUN	O	O
therapy	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experiment	NOUN	O	O
group	NOUN	O	O
could	VERB	O	O
significantly	ADV	O	O
improve	VERB	O	O
the	DET	O	O
6MWT	ADV	O	O
(P	NUM	O	O
=	SYM	O	O
.0094),	NUM	O	O
CAT	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.0071)	PUNCT	O	O
and	CCONJ	O	O
BODE	NOUN	O	O
index	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.0064)	PUNCT	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
the	DET	O	O
changes	NOUN	O	O
of	ADP	O	O
6MWT	ADV	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
CAT	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
and	CCONJ	O	O
BODE	NOUN	O	O
index	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01)	PUNCT	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
major	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
cardiovascular	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(MACE)	PUNCT	O	I-outcome
at	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
between	ADP	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
usual	ADJ	O	O
care	NOUN	O	O
groups	NOUN	O	O
(unadjusted	VERB	O	O
cumulative	ADJ	O	O
incidence,	NOUN	O	O
10.2%	NUM	O	O
vs	CCONJ	O	O
10.6%;	ADJ	O	O
P	NOUN	O	O
=	SYM	O	O
.65;	NUM	O	O
adjusted	VERB	O	O
difference,	NOUN	O	O
0.66%	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-0.73%	ADV	O	O
to	PART	O	O
2.06%];	ADJ	O	O
adjusted	VERB	O	O
hazard	NOUN	O	O
ratio,	NOUN	O	O
1.07	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
0.93	NUM	O	O
to	PART	O	O
1.25]).	ADJ	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

A	DET	O	O
sociodemographic	ADJ	O	O
questionnaire	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
Alcohol	NOUN	O	B-outcome
Use	PUNCT	O	I-outcome
Disorders	NOUN	O	I-outcome
Identification	NOUN	O	O
Test	NOUN	O	O
(Audit)	PUNCT	O	O
were	VERB	O	O
applied.	NOUN	O	O

RESULTS:	NOUN	O	O
Methohexital	ADJ	O	O
resulted	VERB	O	O
in	ADP	O	O
less	ADV	O	O
hypotension	NOUN	O	B-outcome
compared	VERB	O	O
with	ADP	O	O
propofol	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.01),	PUNCT	O	O
although	ADP	O	O
the	DET	O	O
degree	NOUN	O	O
of	ADP	O	O
refractory	ADJ	O	B-outcome
hypotension	NOUN	O	I-outcome
was	VERB	O	O
similar	ADJ	O	O
(P	NUM	O	O
=	SYM	O	O
.37).	PUNCT	O	O

The	DET	O	O
eligible	ADJ	O	O
women	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
an	DET	O	O
experimental	ADJ	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups.	NOUN	O	O

RESULTS:	NOUN	O	O
Among	ADP	O	O
the	DET	O	O
401	NUM	O	O
patients	NOUN	O	O
enrolled,	NOUN	O	O
the	DET	O	O
median	ADJ	O	O
lowest	ADV	O	O
oxygen	NOUN	O	B-outcome
saturation	NOUN	O	I-outcome
was	VERB	O	O
96%	ADJ	O	O
(interquartile	NUM	O	O
range,	VERB	O	O
87	NUM	O	O
to	PART	O	O
99)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
bag-mask	ADJ	O	O
ventilation	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
93%	ADJ	O	O
(interquartile	NUM	O	O
range,	VERB	O	O
81	NUM	O	O
to	PART	O	O
99)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
no-ventilation	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.01).	NOUN	O	O

Title:	NOUN	O	O
National	ADJ	O	O
quality	NOUN	O	O
improvement	NOUN	O	O
programmes	NOUN	O	O
need	NOUN	O	O
time	NOUN	O	O
and	CCONJ	O	O
resources	NOUN	O	O
to	PART	O	O
have	VERB	O	O
an	DET	O	O
impact.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/15	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
all	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
required	VERB	O	O
to	PART	O	O
undergo	NOUN	O	O
indwelling	VERB	O	O
urinary	ADJ	O	O
catheter	NOUN	O	O
throughout	ADV	O	O
the	DET	O	O
study	NOUN	O	O
period.	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
THA,	NOUN	O	O
paracetamol	NOUN	O	O
plus	CCONJ	O	O
ibuprofen	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
morphine	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
paracetamol	NOUN	O	O
alone	ADJ	O	O
in	ADP	O	O
the	DET	O	O
first	ADV	O	O
24	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
surgery;	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
SAEs	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
pooled	VERB	O	O
groups	NOUN	O	O
receiving	VERB	O	O
ibuprofen	NOUN	O	O
alone	ADJ	O	O
vs	CCONJ	O	O
with	ADP	O	O
paracetamol	NOUN	O	O
alone.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Drainage	NOUN	O	O
by	ADP	O	O
the	DET	O	O
same	ADJ	O	O
thoracotomy	NOUN	O	O
intercostal	ADJ	O	O
space	NOUN	O	O
was	VERB	O	O
feasible	ADJ	O	O
and	CCONJ	O	O
results	NOUN	O	O
30	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
surgery	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
inferior	ADJ	O	O
to	PART	O	O
those	DET	O	O
of	ADP	O	O
the	DET	O	O
traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
approach.	NOUN	O	O

['2018/12/21	NOUN	O	O
06:00'	NUM	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
effective	ADJ	O	O
teaching	VERB	O	O
methods	NOUN	O	O
to	PART	O	O
achieve	NOUN	O	O
skill	ADV	O	B-outcome
acquisition	NOUN	O	O
using	VERB	O	O
a	DET	O	O
robotic	ADJ	O	O
virtual	ADJ	O	O
reality	NOUN	O	O
simulator:	NOUN	O	O
Expert	NOUN	O	O
proctoring	VERB	O	O
versus	CCONJ	O	O
an	DET	O	O
educational	ADJ	O	O
video	ADJ	O	O
versus	CCONJ	O	O
independent	ADJ	O	O
training.	NOUN	O	O

Title:	NOUN	O	O
Daily	ADJ	O	O
Nutritional	ADJ	O	O
Supplementation	NOUN	O	O
with	ADP	O	O
Vitamin	NOUN	O	O
D(3)	NOUN	O	O
and	CCONJ	O	O
Phenylbutyrate	NOUN	O	O
to	PART	O	O
Treatment-Naive	ADJ	O	O
HIV	NOUN	O	O
Patients	NOUN	O	O
Tested	VERB	O	O
in	ADP	O	O
a	DET	O	O
Randomized	VERB	O	O
Placebo-Controlled	VERB	O	O
Trial.	NOUN	O	O

To	PART	O	O
analyze	NOUN	O	O
if	ADP	O	O
25(OH)D	NUM	O	O
was	VERB	O	O
a	DET	O	O
good	ADJ	O	O
predictor	NOUN	O	O
of	ADP	O	O
testosterone	NOUN	O	B-outcome
,	PUNCT	O	O
cortisol	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
testosterone/cortisol	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
a	DET	O	O
stepwise	ADV	O	O
regression	NOUN	O	O
model	NOUN	O	O
was	VERB	O	O
performed.	NOUN	O	O

Title:	NOUN	O	O
Promoting	VERB	O	O
vaccination	NOUN	O	O
in	ADP	O	O
the	DET	O	O
province	NOUN	O	O
of	ADP	O	O
Quebec:	ADV	O	O
the	DET	O	O
PromoVaQ	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
protocol.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
double-blind,	NOUN	O	O
phase	NOUN	O	O
3	NUM	O	O
trial,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
87	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
progressive,	NOUN	O	O
symptomatic,	NOUN	O	O
or	CCONJ	O	O
recurrent	ADP	O	O
desmoid	NOUN	O	O
tumors	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
sorafenib	NOUN	O	O
(400-mg	NOUN	O	O
tablet	NOUN	O	O
once	ADP	O	O
daily)	CCONJ	O	O
or	CCONJ	O	O
matching	VERB	O	O
placebo.	NOUN	O	O

Among	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
lymphadenectomy,	NOUN	O	O
the	DET	O	O
median	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
removed	VERB	O	O
nodes	NOUN	O	B-outcome
was	VERB	O	O
57	NUM	O	O
(35	VERB	O	O
pelvic	ADJ	O	O
and	CCONJ	O	O
22	NUM	O	O
paraaortic	ADJ	O	O
nodes).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/11	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

METHODS:	NOUN	O	O
Healthy	NOUN	O	O
volunteers	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
randomly	ADV	O	O
into	ADP	O	O
one	NUM	O	O
of	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
with	ADP	O	O
the	DET	O	O
following	VERB	O	O
drug	NOUN	O	O
regimens	NOUN	O	O
for	ADP	O	O
2	NUM	O	O
weeks:	NOUN	O	O
group	NOUN	O	O
A,	NOUN	O	O
low-dose	NOUN	O	O
aspirin	NOUN	O	O
once	ADP	O	O
per	ADP	O	O
day	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
B,	NOUN	O	O
low-dose	NOUN	O	O
aspirin	NOUN	O	O
and	CCONJ	O	O
4.0	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
ecabet	NOUN	O	O
sodium.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
daily	ADJ	O	O
stool	NOUN	O	B-outcome
frequency.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
selected	VERB	O	O
to	PART	O	O
receive	VERB	O	O
standard	ADJ	O	O
anesthesia	NOUN	O	O
induction	NOUN	O	O
with	ADP	O	O
either	CCONJ	O	O
0.6	NUM	O	O
mg.kg	NOUN	O	O
rocuronium	NOUN	O	O
or	CCONJ	O	O
0.2	NUM	O	O
mg.kg	NOUN	O	O
cisatracurium.	NOUN	O	O

h(-1)),	NOUN	O	O
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
affect	NOUN	O	O
ratings	NOUN	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
or	CCONJ	O	O
CWI	NOUN	O	O
cooling	VERB	O	B-outcome
rates	NOUN	O	O
(PC	NOUN	O	O
=	SYM	O	O
0.18	NUM	O	O
+/-	SYM	O	O
0.14	NUM	O	O
degrees	NOUN	O	O
C	NOUN	O	O
.	PUNCT	O	O

METHODS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
designed	VERB	O	O
as	ADP	O	O
a	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
sham	NOUN	O	O
control	NOUN	O	O
trial.	NOUN	O	O

Tafenoquine	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
asymptomatic	ADJ	O	O
declines	NOUN	O	O
in	ADP	O	O
hemoglobin	NOUN	O	O
levels,	NOUN	O	O
which	ADP	O	O
resolved	VERB	O	O
without	ADP	O	O
intervention.	NOUN	O	O

MACE	NOUN	O	B-outcome
at	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
were	VERB	O	O
comparable	ADJ	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
groups	NOUN	O	O
3	NUM	O	O
of	ADP	O	O
85(3.52%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
polymer-free	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
3	NUM	O	O
of	ADP	O	O
98(3.06%)	ADV	O	O
in	ADP	O	O
the	DET	O	O
biodegradable	ADJ	O	O
polymer	NOUN	O	O
group,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.859.	NUM	O	O

Curcumin	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
as	ADP	O	O
an	DET	O	O
effective	ADJ	O	O
alternative	ADJ	O	O
local	ADJ	O	O
drug	NOUN	O	O
delivery	NOUN	O	O
agent.	NOUN	O	O

Further	ADV	O	O
studies	NOUN	O	O
with	ADP	O	O
larger	ADJ	O	O
sample	NOUN	O	O
sizes	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
these	DET	O	O
findings.	NOUN	O	O

Subepithelial	ADJ	O	O
connective	ADJ	O	O
tissue	NOUN	O	O
grafts	NOUN	O	O
(SCTGs)	NOUN	O	O
with	ADP	O	O
a	DET	O	O
coronally	ADV	O	O
advanced	VERB	O	O
flap	NOUN	O	O
(CAF)	PUNCT	O	O
are	VERB	O	O
accepted	VERB	O	O
as	ADP	O	O
the	DET	O	O
gold	NOUN	O	O
standard	ADJ	O	O
for	ADP	O	O
covering	VERB	O	O
denuded	VERB	O	O
root	NOUN	O	O
surfaces.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
1307333	NUM	O	O

Objectives:	ADJ	O	O
To	PART	O	O
compare	NOUN	O	O
foot	NOUN	O	O
and	CCONJ	O	O
ankle	NOUN	O	O
mobility,	NOUN	O	O
foot	NOUN	O	O
posture,	NOUN	O	O
and	CCONJ	O	O
dynamic	ADJ	O	O
knee	NOUN	O	O
valgus,	NOUN	O	O
measured	VERB	O	O
as	ADP	O	O
the	DET	O	O
frontal	ADJ	O	O
plane	ADJ	O	O
projection	NOUN	O	O
angle	NOUN	O	O
(FPPA)	PUNCT	O	O
during	ADP	O	O
single-leg	ADJ	O	O
squatting,	NOUN	O	O
between	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
and	CCONJ	O	O
without	ADP	O	O
PFOA.	NOUN	O	O

We	PRON	O	O
hypothesize	NOUN	O	O
that	ADP	O	O
school	NOUN	O	O
students	NOUN	O	O
receiving	VERB	O	O
the	DET	O	O
teacher-delivered	VERB	O	O
intervention	NOUN	O	O
to	PART	O	O
promote	VERB	O	O
autonomous	ADJ	O	O
motivation	NOUN	O	O
toward	ADP	O	O
physical	ADJ	O	O
activity	NOUN	O	O
will	VERB	O	O
exhibit	NOUN	O	O
greater	ADJ	O	O
participation	NOUN	O	B-outcome
in	ADP	O	O
physical	ADJ	O	O
activities	NOUN	O	O
outside	ADP	O	O
of	ADP	O	O
school,	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
students	NOUN	O	O
receiving	VERB	O	O
a	DET	O	O
control	NOUN	O	O
intervention.	NOUN	O	O

The	DET	O	O
prevalence	NOUN	O	O
of	ADP	O	O
halitosis	NOUN	O	O
in	ADP	O	O
the	DET	O	O
population	NOUN	O	O
is	VERB	O	O
approximately	ADV	O	O
30%,	NUM	O	O
of	ADP	O	O
which	ADP	O	O
80	NUM	O	O
to	PART	O	O
90%	VERB	O	O
of	ADP	O	O
the	DET	O	O
cases	NOUN	O	O
originate	ADJ	O	O
in	ADP	O	O
the	DET	O	O
oral	ADJ	O	O
cavity	NOUN	O	O
resulting	VERB	O	O
from	ADP	O	O
proteolytic	ADJ	O	O
degradation	NOUN	O	O
by	ADP	O	O
gram	NOUN	O	O
negative	ADJ	O	O
anaerobic	ADJ	O	O
bacteria.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
high-dose	NOUN	O	O
remifentanil	NOUN	O	O
(HR)	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
46),	NOUN	O	O
remifentanil	NOUN	O	O
was	VERB	O	O
infused	VERB	O	O
at	ADP	O	O
a	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
0.25	NUM	O	O
mug/kg/min	NOUN	O	O
and	CCONJ	O	O
subsequently	ADV	O	O
increased	VERB	O	O
or	CCONJ	O	O
decreased	VERB	O	O
by	ADP	O	O
0.05	NUM	O	O
mug/kg/min	NOUN	O	O
per	ADP	O	O
clinical	ADJ	O	O
demand.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
post-voiding	VERB	O	B-outcome
residual	ADJ	O	I-outcome
urine	NOUN	O	I-outcome
volume	NOUN	O	I-outcome
(PV-VRU)	PUNCT	O	I-outcome
.	PUNCT	O	O
The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
the	DET	O	O
voided	VERB	O	B-outcome
volume	NOUN	O	I-outcome
,	PUNCT	O	O
maximum	NOUN	O	B-outcome
urinary	ADJ	O	I-outcome
flow	NOUN	O	I-outcome
rate	NOUN	O	O
(Qmax),	NUM	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
Barthel	PROPN	O	O
Index	NOUN	O	O
(BI)	NOUN	O	O
scale.	ADJ	O	O

MAIN	ADJ	O	O
OUTCOME	NOUN	O	O
MEASURES:	NOUN	O	O
EIFEL	NOUN	O	O
and	CCONJ	O	O
Dallas	NOUN	O	O
Pain	NOUN	O	B-outcome
Questionnaire	NOUN	O	O
scores.	NOUN	O	O

Minor	ADJ	O	O
stroke	NOUN	O	O
were	VERB	O	O
categorized	VERB	O	O
into	ADP	O	O
SAI	NOUN	O	O
and	CCONJ	O	O
MAIs	NOUN	O	O
by	ADP	O	O
infarction	NOUN	O	O
numbers	NOUN	O	O
in	ADP	O	O
diffusion	NOUN	O	O
weighted	VERB	O	O
imaging.	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
nausea	NOUN	O	B-outcome
,	PUNCT	O	O
vomiting	VERB	O	B-outcome
,	PUNCT	O	O
drowsiness	ADV	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
headache	NOUN	O	B-outcome
was	VERB	O	O
similar	ADJ	O	O
between	ADP	O	O
the	DET	O	O
groups.	NOUN	O	O

Participants	NOUN	O	O
completed	VERB	O	O
a	DET	O	O
laboratory	NOUN	O	O
30-min	NOUN	O	O
rowing	VERB	O	O
time-trial,	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
3x30-seconds	NOUN	O	O
(s)	PUNCT	O	O
maximal	ADJ	O	O
sprint	NOUN	O	O
efforts	NOUN	O	O
at	ADP	O	O
days	NOUN	O	O
0,	NUM	O	O
14	NUM	O	O
and	CCONJ	O	O
28	NUM	O	O
(T1-T3).	PUNCT	O	O

After	ADP	O	O
suitable	ADJ	O	O
training,	NOUN	O	O
patients	NOUN	O	O
performed	VERB	O	O
daily	ADJ	O	O
spirometry	NOUN	O	O
at	ADP	O	O
home	NOUN	O	O
using	VERB	O	O
a	DET	O	O
portable,	NOUN	O	O
battery-operated	VERB	O	O
spirometer.	NOUN	O	O

Patient-reported	VERB	O	O
persistence	NOUN	O	B-outcome
with	ADP	O	O
P2Y12	NOUN	O	O
inhibitors	NOUN	O	O
at	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
was	VERB	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(unadjusted	VERB	O	O
rates,	NOUN	O	O
5340/6135	ADJ	O	O
[87.0%]	NOUN	O	O
vs	CCONJ	O	O
3324/3967	PUNCT	O	O
[83.8%],	NOUN	O	O
respectively;	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
.001;	NOUN	O	O
adjusted	VERB	O	O
difference,	NOUN	O	O
2.3%	NOUN	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
0.4%	NOUN	O	O
to	PART	O	O
4.1%];	NOUN	O	O
adjusted	VERB	O	O
odds	NOUN	O	O
ratio,	NOUN	O	O
1.19	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
1.02	NUM	O	O
to	PART	O	O
1.40]).	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
nerve	NOUN	O	O
electrical	ADJ	O	O
stimulation	NOUN	O	O
for	ADP	O	O
treating	VERB	O	O
chemotherapy-induced	VERB	O	O
nausea	NOUN	O	B-outcome
and	CCONJ	O	O
vomiting	VERB	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
gastric	ADJ	O	O
cancer:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Intervention	NOUN	O	O
ICUs	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
12;	NUM	O	O
669	NUM	O	O
participants)	NOUN	O	O
delivered	VERB	O	O
usual	ADJ	O	O
care	NOUN	O	O
during	ADP	O	O
a	DET	O	O
baseline	NOUN	O	O
period	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
an	DET	O	O
intervention	NOUN	O	O
period.	NOUN	O	O

It	PRON	O	O
correlates	NOUN	O	O
well	ADV	O	O
with	ADP	O	O
the	DET	O	O
Psoriasis	NOUN	O	O
Area	NOUN	O	O
and	CCONJ	O	O
Severity	NOUN	O	O
Index	NOUN	O	O
(PASI)	PUNCT	O	O
and	CCONJ	O	O
demonstrates	NOUN	O	O
sensitivity	NOUN	O	O
to	PART	O	O
changes	NOUN	O	O
from	ADP	O	O
baseline	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
both	CCONJ	O	O
mild	ADJ	O	O
and	CCONJ	O	O
moderately	ADV	O	O
severe	ADJ	O	O
disease.	NOUN	O	O

Mitochondrial	ADJ	O	B-outcome
fragmentation	NOUN	O	I-outcome
was	VERB	O	O
specifically	ADV	O	O
presented	VERB	O	O
in	ADP	O	O
tubules,	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
in	ADP	O	O
podocytes	NOUN	O	O
of	ADP	O	O
DKD	NOUN	O	O
patients.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Omadacycline	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
moxifloxacin	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
community-acquired	VERB	O	O
bacterial	ADJ	O	O
pneumonia	NOUN	O	O
in	ADP	O	O
adults.	NOUN	O	O
(	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

To	PART	O	O
compare	NOUN	O	O
the	DET	O	O
means	NOUN	O	O
the	DET	O	O
student	NOUN	O	O
t	NOUN	O	O
test	NOUN	O	O
and	CCONJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
variance	NOUN	O	O
(ANOVA)	NUM	O	O
will	VERB	O	O
be	VERB	O	O
used	VERB	O	O
and	CCONJ	O	O
to	PART	O	O
analyse	NOUN	O	O
the	DET	O	O
correlation	NOUN	O	O
between	ADP	O	O
the	DET	O	O
continuous	ADJ	O	O
variables	NOUN	O	O
the	DET	O	O
correlation	NOUN	O	O
test	NOUN	O	O
by	ADP	O	O
Pearson	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
applied.	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
neuromuscular	ADJ	O	O
electrical	ADJ	O	O
stimulation	NOUN	O	O
therapy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
urinary	ADJ	O	O
incontinence	NOUN	O	O
after	ADP	O	O
stroke:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
sham	NOUN	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Traditional	ADJ	O	O
chest	NOUN	O	O
drainage	NOUN	O	O
versus	CCONJ	O	O
drainage	NOUN	O	O
by	ADP	O	O
thoracotomy:	NOUN	O	O
a	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
study.	NOUN	O	O

So	ADV	O	O
we	PRON	O	O
tried	VERB	O	O
tobramycin/dexamethasone	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
as	ADP	O	O
a	DET	O	O
replacement.	NOUN	O	O

Title:	NOUN	O	O
Hydrogen	NOUN	O	O
gas	NOUN	O	O
restores	NOUN	O	O
exhausted	VERB	O	O
CD8+	NOUN	O	B-outcome
T	NOUN	O	I-outcome
cells	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
prognosis.	NOUN	O	O

Constant	NOUN	O	O
score	NOUN	O	O
for	ADP	O	O
function	NOUN	O	B-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
using	VERB	O	O
SF-36],	NOUN	O	O
simple	NOUN	O	O
shoulder	NOUN	O	O
test	NOUN	O	O
(SST)	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
Disabilities	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
Arm	NOUN	O	I-outcome
,	PUNCT	O	Seperator
Shoulder	ADV	O	I-outcome
,	PUNCT	O	Seperator
and	CCONJ	O	Seperator
Hand	NOUN	O	S3-outcome
(DASH)	NUM	O	O
score	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
calculated	VERB	O	O
at	ADP	O	O
six,	ADV	O	O
12	NUM	O	O
and	CCONJ	O	O
24	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
follow-up.	PUNCT	O	O

Fisher's	NOUN	O	O
exact	NOUN	O	O
test	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
verify	NOUN	O	O
the	DET	O	O
differences	NOUN	O	O
between	ADP	O	O
categorical	ADJ	O	O
variables.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODS:	NOUN	O	O
From	ADP	O	O
September	NOUN	O	O
2014	NUM	O	O
to	PART	O	O
September	NOUN	O	O
2015,	NUM	O	O
60	NUM	O	O
patients	NOUN	O	O
diagnosed	VERB	O	O
with	ADP	O	O
NSCLC	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
to	PART	O	O
the	DET	O	O
study.	NOUN	O	O

These	DET	O	O
results	NOUN	O	O
indicate	VERB	O	O
that	ADP	O	O
polyphenol-rich	ADJ	O	O
nutrient	NOUN	O	O
supplementation	NOUN	O	O
by	ADP	O	O
means	NOUN	O	O
of	ADP	O	O
dark	ADJ	O	O
chocolate	NOUN	O	O
positively	ADV	O	O
modulates	NOUN	O	O
redox	NOUN	O	B-outcome
status	NOUN	O	O
and	CCONJ	O	O
reduced	VERB	O	O
exercise-induced	VERB	O	O
muscular	ADJ	O	B-outcome
injury	NOUN	O	I-outcome
biomarkers	NOUN	O	O
in	ADP	O	O
elite	ADP	O	O
football	NOUN	O	O
athletes.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/28	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Of	ADP	O	O
the	DET	O	O
185	NUM	O	O
enrolled	VERB	O	O
patients,	NOUN	O	O
180	NUM	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9113221	NUM	O	O

a	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

No	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
0.05)	NUM	O	O
among	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
regarding	VERB	O	O
degree	NOUN	O	O
or	CCONJ	O	O
duration	NOUN	O	O
of	ADP	O	O
pain	NOUN	O	B-outcome
.	PUNCT	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
0.05)	NUM	O	O
among	ADP	O	O
the	DET	O	O
4(o)C	NOUN	O	O
and	CCONJ	O	O
2.5(o)C	CCONJ	O	O
groups.	NOUN	O	O

However,	ADV	O	O
there	PRON	O	O
are	VERB	O	O
limited	VERB	O	O
data	NOUN	O	O
on	ADP	O	O
the	DET	O	O
time	NOUN	O	O
course	NOUN	O	O
of	ADP	O	O
changes	NOUN	O	O
in	ADP	O	O
forced	VERB	O	O
expiratory	ADJ	O	O
volume	NOUN	O	O
in	ADP	O	O
1	NUM	O	O
s	NOUN	O	O
(FEV1)	NOUN	O	O
preceding	VERB	O	O
the	DET	O	O
first	ADV	O	O
reported	VERB	O	O
symptom	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
an	DET	O	O
exacerbation.	ADJ	O	O

Journal-Name:Oxidative	ADJ	O	O
medicine	NOUN	O	O
and	CCONJ	O	O
cellular	ADJ	O	O
longevity	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
selected	VERB	O	O
based	VERB	O	O
on	ADP	O	O
specific	ADJ	O	O
inclusion	NOUN	O	O
and	CCONJ	O	O
exclusion	NOUN	O	O
criteria,	NOUN	O	O
and	CCONJ	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups:	NOUN	O	O
Group	NOUN	O	O
1	NUM	O	O
(G1)	PUNCT	O	O
-	PUNCT	O	O
iodoform	NOUN	O	O
paste	NOUN	O	O
(iodoform	NUM	O	O
+	SYM	O	O
camphorated	VERB	O	O
parachlorophenol	NOUN	O	O
+	SYM	O	O
ointment	NOUN	O	O
comprising	VERB	O	O
prednisolone	NOUN	O	O
acetate	NOUN	O	O
5.0	NUM	O	O
mg	NOUN	O	O
and	CCONJ	O	O
rifamycin	NOUN	O	O
1.5	NUM	O	O
mg);	NOUN	O	O
Group	NOUN	O	O
2	NUM	O	O
(G2)	NUM	O	O
-	PUNCT	O	O
Calen(R)/ZO	NUM	O	O
paste.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

2019;18(1):32-38.	NUM	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
Intravenous	ADJ	O	O
Acetaminophen	ADV	O	O
vs	CCONJ	O	O
Placebo	NOUN	O	O
Combined	VERB	O	O
With	ADP	O	O
Propofol	NOUN	O	O
or	CCONJ	O	O
Dexmedetomidine	NOUN	O	O
on	ADP	O	O
Postoperative	ADJ	O	O
Delirium	NOUN	O	B-outcome
Among	ADP	O	O
Older	ADJ	O	O
Patients	NOUN	O	O
Following	VERB	O	O
Cardiac	ADJ	O	O
Surgery:	NOUN	O	O
The	DET	O	O
DEXACET	NOUN	O	O
Randomized	VERB	O	O
Clinical	ADJ	O	O
Trial.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
groups	NOUN	O	O
and	CCONJ	O	O
received	VERB	O	O
the	DET	O	O
study	NOUN	O	O
drug	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
analyses.	NOUN	O	O

The	DET	O	O
reported	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
as	ADP	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
and	CCONJ	O	O
haematological	ADJ	O	B-outcome
safety	NOUN	O	O
parameters	NOUN	O	O
and	CCONJ	O	O
changes	NOUN	O	O
in	ADP	O	O
systolic	ADJ	O	B-outcome
and	CCONJ	O	Seperator
diastolic	ADJ	O	B-outcome
pressure	NOUN	O	E1-outcome
and	CCONJ	O	O
blood	NOUN	O	O
total	ADJ	O	O
and	CCONJ	O	O
lipoprotein	NOUN	O	B-outcome
lipids	NOUN	O	B-outcome
were	VERB	O	O
measured	VERB	O	O
as	ADP	O	O
secondary	ADJ	O	O
end	NOUN	O	O
points.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

The	DET	O	O
treatment	NOUN	O	O
sessions	NOUN	O	O
lasted	VERB	O	O
for	ADP	O	O
15	NUM	O	O
minutes,	NOUN	O	O
and	CCONJ	O	O
occurred	VERB	O	O
three	NUM	O	O
times	NOUN	O	O
a	DET	O	O
week,	NOUN	O	O
for	ADP	O	O
4	NUM	O	O
weeks.	NOUN	O	O

Collectively,	NOUN	O	O
the	DET	O	O
present	ADJ	O	O
results	NOUN	O	O
suggested	VERB	O	O
that	ADP	O	O
hydrogen	NOUN	O	O
gas	NOUN	O	O
reverses	NOUN	O	O
imbalances	NOUN	O	O
toward	ADP	O	O
PD1+	NOUN	O	B-outcome
CD8+	NOUN	O	I-outcome
T	NOUN	O	I-outcome
cells	NOUN	O	I-outcome
to	PART	O	O
provide	VERB	O	O
an	DET	O	O
improved	VERB	O	O
prognosis.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
divided	VERB	O	O
529	NUM	O	O
patients	NOUN	O	O
(279	PUNCT	O	O
men,	NOUN	O	O
250	NUM	O	O
women;	ADJ	O	O
median	ADJ	O	O
age,	NOUN	O	O
66	NUM	O	O
years)	NOUN	O	O
scheduled	VERB	O	O
for	ADP	O	O
hepatic	ADJ	O	O
dynamic	ADJ	O	O
computed	VERB	O	O
tomography	NOUN	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Self-reported	VERB	O	O
responses	NOUN	O	B-outcome
to	PART	O	O
the	DET	O	O
pictorial	ADJ	O	O
health	NOUN	O	O
warning	VERB	O	O
labels	NOUN	O	O
were	VERB	O	O
then	ADV	O	O
measured,	NOUN	O	O
including	VERB	O	O
avoidance	NOUN	O	B-outcome
,	PUNCT	O	O
reactance	NOUN	O	B-outcome
,	PUNCT	O	O
effectiveness,	NOUN	O	O
susceptibility	NOUN	O	B-outcome
and	CCONJ	O	O
motivation	NOUN	O	B-outcome
to	PART	O	O
drink	NOUN	O	O
less.	NOUN	O	O

The	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
underwent	VERB	O	O
the	DET	O	O
Brief	ADP	O	O
Group	NOUN	O	O
Intervention,	VERB	O	O
which	ADP	O	O
had	VERB	O	O
four	NUM	O	O
group	NOUN	O	O
sessions,	DET	O	O
with	ADP	O	O
weekly	ADV	O	O
meetings.	NOUN	O	O

Intensive	ADJ	O	O
physical	ADJ	O	O
exercise	NOUN	O	O
may	VERB	O	O
cause	ADP	O	O
increase	NOUN	O	O
oxidative	ADJ	O	O
stress	NOUN	O	O
and	CCONJ	O	O
muscular	ADJ	O	O
injury	NOUN	O	O
in	ADP	O	O
elite	ADP	O	O
football	NOUN	O	O
athletes.	ADV	O	O

Therefore,	NOUN	O	O
exercise	NOUN	O	O
training	VERB	O	O
in	ADP	O	O
combined	VERB	O	O
form	NOUN	O	O
(aerobic	PUNCT	O	O
and	CCONJ	O	O
resistance)	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
incorporated	VERB	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
programs	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
hypertension	NOUN	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
augment	ADP	O	O
improvement	NOUN	O	O
in	ADP	O	O
their	ADJ	O	O
cardiac	ADJ	O	O
autonomic	ADJ	O	O
control.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
that	ADP	O	O
were	VERB	O	O
operated	VERB	O	O
returned	VERB	O	O
to	PART	O	O
full	ADJ	O	B-outcome
activity	NOUN	O	I-outcome
.	PUNCT	O	O
However,	ADV	O	O
median	ADJ	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
operation	NOUN	O	I-outcome
was	VERB	O	O
longer	ADJ	O	O
and	CCONJ	O	O
lasted	VERB	O	O
1	NUM	O	O
hour	NOUN	O	O
and	CCONJ	O	O
55	NUM	O	O
minutes.	ADJ	O	O

Fifty	NUM	O	O
patients	NOUN	O	O
(56%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
amoxicillin	NOUN	O	O
group	NOUN	O	O
experienced	VERB	O	O
at	ADP	O	O
least	ADV	O	O
one	NUM	O	O
drug	NOUN	O	O
related	VERB	O	O
adverse	ADJ	O	B-outcome
event	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
31	NUM	O	O
(34%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/02/01	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Pilot	NOUN	O	O
study.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Krill	NOUN	O	O
powder	NOUN	O	O
is	VERB	O	O
rich	ADJ	O	O
in	ADP	O	O
bioactive	ADJ	O	O
ingredients	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
eicosapentaenoic	ADJ	O	O
acid	NOUN	O	O
(EPA),	NOUN	O	O
docosahexaenoic	VERB	O	O
acid	NOUN	O	O
(DHA),	PUNCT	O	O
phospholipids,	NOUN	O	O
protein	NOUN	O	O
and	CCONJ	O	O
astaxanthin.	NOUN	O	O

A	DET	O	O
3-way	NOUN	O	O
repeated	VERB	O	O
measures	NOUN	O	O
ANOVA	NOUN	O	O
was	VERB	O	O
employed	VERB	O	O
for	ADP	O	O
main	ADJ	O	O
analyses,	NOUN	O	O
with	ADP	O	O
Bonferonni	NOUN	O	O
post-hoc	NOUN	O	O
assessment	NOUN	O	O
(P	NUM	O	O
</=	NOUN	O	O
0.05).	NOUN	O	O

The	DET	O	O
intervention	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
guided	VERB	O	O
by	ADP	O	O
the	DET	O	O
trans-contextual	ADJ	O	O
model	NOUN	O	O
explaining	VERB	O	O
the	DET	O	O
processes	NOUN	O	O
by	ADP	O	O
which	ADP	O	O
PE	NOUN	O	O
teachers'	ADV	O	O
support	NOUN	O	O
for	ADP	O	O
autonomous	ADJ	O	O
motivation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
classroom	NOUN	O	O
promotes	NOUN	O	O
students'	NOUN	O	O
motivation	NOUN	O	B-outcome
to	PART	O	O
engage	NOUN	O	O
in	ADP	O	O
out-of-school	NOUN	O	O
physical	ADJ	O	O
activity.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
follow-up	NOUN	O	O
study,	NOUN	O	O
which	ADP	O	O
started	VERB	O	O
on	ADP	O	O
Feb	NOUN	O	O
7,	NUM	O	O
2017,	NUM	O	O
and	CCONJ	O	O
was	VERB	O	O
completed	VERB	O	O
on	ADP	O	O
June	NOUN	O	O
30,	NUM	O	O
2017,	NUM	O	O
61	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
ATLG	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
53	NUM	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
non-ATLG	NOUN	O	O
group.	VERB	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
The	DET	O	O
120	NUM	O	O
elderly	NOUN	O	O
housebound	VERB	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
3	NUM	O	O
intervention	NOUN	O	O
groups:	NOUN	O	O
Baduanjin	NOUN	O	O
training,	NOUN	O	O
Baduanjin	NOUN	O	O
training	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
CBT,	NOUN	O	O
and	CCONJ	O	O
CBT.	NOUN	O	O

STD	NOUN	O	O
group	NOUN	O	O
learned	VERB	O	O
identical	ADJ	O	O
content	NOUN	O	O
using	VERB	O	O
a	DET	O	O
low-fidelity	NOUN	O	O
Resusci	NOUN	O	O
Anne(R)	ADJ	O	O
CPR	NOUN	O	O
manikin.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
enrolled	VERB	O	O
adults	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
being	VERB	O	O
treated	VERB	O	O
for	ADP	O	O
bone	NOUN	O	O
or	CCONJ	O	O
joint	NOUN	O	O
infection	NOUN	O	O
at	ADP	O	O
26	NUM	O	O
U.K.	ADJ	O	O
centers.	NOUN	O	O

Title:	NOUN	O	O
Long-term	NOUN	O	O
results	NOUN	O	O
of	ADP	O	O
a	DET	O	O
phase	NOUN	O	O
II	NUM	O	O
study	NOUN	O	O
of	ADP	O	O
hypofractionated	VERB	O	O
proton	NOUN	O	O
therapy	NOUN	O	O
for	ADP	O	O
prostate	NOUN	O	O
cancer:	NOUN	O	O
moderate	ADJ	O	O
versus	CCONJ	O	O
extreme	NOUN	O	O
hypofractionation.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
intensive	ADJ	O	O
blood	NOUN	O	O
pressure	NOUN	O	O
control	NOUN	O	O
on	ADP	O	O
risk	NOUN	O	O
of	ADP	O	O
dementia	NOUN	O	B-outcome
.	PUNCT	O	O
Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
conducted	VERB	O	O
at	ADP	O	O
102	NUM	O	O
sites	NOUN	O	O
in	ADP	O	O
the	DET	O	O
United	VERB	O	O
States	NOUN	O	O
and	CCONJ	O	O
Puerto	NOUN	O	O
Rico	NOUN	O	O
among	ADP	O	O
adults	NOUN	O	O
aged	VERB	O	O
50	NUM	O	O
years	NOUN	O	O
or	CCONJ	O	O
older	ADJ	O	O
with	ADP	O	O
hypertension	NOUN	O	O
but	CCONJ	O	O
without	ADP	O	O
diabetes	NOUN	O	O
or	CCONJ	O	O
history	NOUN	O	O
of	ADP	O	O
stroke.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968547	NUM	O	O

This	DET	O	O
study	NOUN	O	O
will	VERB	O	O
assess	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
selenium	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
major	ADJ	O	O
pregnancy	NOUN	O	B-outcome
outcomes	NOUN	O	I-outcome
and	CCONJ	O	O
disease	NOUN	O	B-outcome
progression	NOUN	O	I-outcome
among	ADP	O	O
HIV-infected	VERB	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
in	ADP	O	O
Lagos,	NOUN	O	O
Nigeria.	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Young	ADJ	O	O
adults	NOUN	O	O
in	ADP	O	O
the	DET	O	O
age	NOUN	O	O
group	NOUN	O	O
between	ADP	O	O
18	NUM	O	O
and	CCONJ	O	O
25	NUM	O	O
years	NOUN	O	O
with	ADP	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
halitosis	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
research.	NOUN	O	O

Primary	ADJ	O	O
outcome	NOUN	O	O
data	NOUN	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
249	NUM	O	O
(54.4%)	NUM	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
236	NUM	O	O
(59.6%)	NOUN	O	O
control	NOUN	O	O
participants.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/16	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Dehydration	NOUN	O	O
impairs	NOUN	O	O
physiological	ADJ	O	O
function	NOUN	O	O
and	CCONJ	O	O
physical	ADJ	O	O
performance,	NOUN	O	O
thus	ADV	O	O
understanding	VERB	O	O
effective	ADJ	O	O
rehydration	NOUN	O	O
strategies	NOUN	O	O
is	VERB	O	O
paramount.	NOUN	O	O

Title:	NOUN	O	O
Prophylactic	ADJ	O	O
use	NOUN	O	O
of	ADP	O	O
carvedilol	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
ventricular	ADJ	O	B-outcome
dysfunction	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
cancer	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
doxorubicin.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
data	NOUN	O	O
collection	NOUN	O	O
tools	NOUN	O	O
were	VERB	O	O
the	DET	O	O
Menopause-Specific	ADJ	O	O
Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
Life	NOUN	O	I-outcome
Questionnaire	PROPN	O	O
(MENQOL)	NUM	O	O
and	CCONJ	O	O
a	DET	O	O
demographic	ADJ	O	O
characteristics	NOUN	O	O
questionnaire.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Multidetector	NOUN	O	O
computed	VERB	O	O
tomography	NOUN	O	O
(MDCT)	NUM	O	O
images	NOUN	O	O
for	ADP	O	O
rhinosinusitis	NOUN	O	O
may	VERB	O	O
have	VERB	O	O
a	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
radiation	NOUN	O	O
hazards.	NOUN	O	O

Flushing	VERB	O	B-outcome
and	CCONJ	O	O
flushing-related	VERB	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
gastrointestinal	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
related	VERB	O	O
to	PART	O	O
DMF	NOUN	O	O
treatment.	NOUN	O	O

Athens	NOUN	O	O
Insomnia	NOUN	O	B-outcome
Scale	NOUN	O	O
(AIS)	NOUN	O	O
was	VERB	O	O
recorded	VERB	O	O
at	ADP	O	O
18:	NOUN	O	O
00	NUM	O	O
at	ADP	O	O
the	DET	O	O
second	ADJ	O	O
day	NOUN	O	O
after	ADP	O	O
surgery.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome,	ADJ	O	O
perioperative	ADJ	O	O
real	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(RBL),	PUNCT	O	O
was	VERB	O	O
evaluated	VERB	O	O
at	ADP	O	O
72	NUM	O	O
hours	NOUN	O	O
postoperatively.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
original	ADJ	O	O
open-label	NOUN	O	O
study,	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
and	CCONJ	O	O
lymphoblastic	ADJ	O	O
leukaemia	NOUN	O	O
in	ADP	O	O
first	ADV	O	O
or	CCONJ	O	O
subsequent	ADJ	O	O
remission,	NOUN	O	O
having	VERB	O	O
sibling	VERB	O	O
HLA-identical	ADJ	O	O
allogeneic	ADJ	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
stem-cell	NOUN	O	O
transplantation,	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
(1:1)	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
ATLG	NOUN	O	O
plus	CCONJ	O	O
standard	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
with	ADP	O	O
ciclosporin	NOUN	O	O
and	CCONJ	O	O
short-term	NOUN	O	O
methotrexate	NOUN	O	O
(ATLG	PUNCT	O	O
group)	ADJ	O	O
or	CCONJ	O	O
standard	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
without	ADP	O	O
ATLG	NOUN	O	O
(non-ATLG	PUNCT	O	O
group).	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
efficacy	NOUN	O	O
endpoints	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
Tinnitus	NOUN	O	B-outcome
Handicap	NOUN	O	I-outcome
Inventory	ADJ	O	O
(THI)],	NOUN	O	O
12-Item	NOUN	O	O
Short	NOUN	O	O
Form	NOUN	O	O
Health	NOUN	O	B-outcome
Survey	NOUN	O	O
(SF-12)	NOUN	O	O
questionnaire],	NUM	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
All	DET	O	O
outcome	NOUN	O	O
efficacy	NOUN	O	O
endpoints	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
4	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Only	ADV	O	O
3	NUM	O	O
(4.4%)	NUM	O	O
Veterans	NOUN	O	O
declined	VERB	O	O
participation	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
lack	NOUN	O	O
of	ADP	O	O
interest.	NOUN	O	O

BACKGROUND:	NOUN	O	O
beta-alanine	NOUN	O	O
(betaA)	NOUN	O	O
supplementation	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
shown	VERB	O	O
to	PART	O	O
increase	NOUN	O	O
intramuscular	ADJ	O	O
carnosine	NOUN	O	O
content	NOUN	O	O
and	CCONJ	O	O
subsequent	ADJ	O	O
high-intensity	NOUN	O	O
performance	NOUN	O	O
in	ADP	O	O
events	NOUN	O	O
lasting	VERB	O	O
<	SYM	O	O
4	NUM	O	O
minutes	NOUN	O	O
(min),	NOUN	O	O
which	ADP	O	O
may	VERB	O	O
be	VERB	O	O
dependent	ADJ	O	O
on	ADP	O	O
total,	ADJ	O	O
as	ADP	O	O
opposed	VERB	O	O
to	PART	O	O
daily,	NOUN	O	O
dose.	NOUN	O	O

Title:	NOUN	O	O
Treatment	NOUN	O	O
with	ADP	O	O
a	DET	O	O
5-day	NOUN	O	O
versus	CCONJ	O	O
a	DET	O	O
10-day	NOUN	O	O
schedule	NOUN	O	O
of	ADP	O	O
decitabine	NOUN	O	O
in	ADP	O	O
older	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
newly	ADV	O	O
diagnosed	VERB	O	O
acute	ADJ	O	O
myeloid	NOUN	O	O
leukaemia:	NOUN	O	O
a	DET	O	O
randomised	VERB	O	O
phase	NOUN	O	O
2	NUM	O	O
trial.	NOUN	O	O

Tafenoquine	NOUN	O	O
showed	VERB	O	O
efficacy	NOUN	O	O
for	ADP	O	O
the	DET	O	O
radical	NOUN	O	O
cure	NOUN	O	B-outcome
of	ADP	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
malaria,	NOUN	O	O
although	ADP	O	O
tafenoquine	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
shown	VERB	O	O
to	PART	O	O
be	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
primaquine.	NOUN	O	O
(	PUNCT	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
combined	VERB	O	O
aerobic	ADJ	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
training	VERB	O	O
(CART)	PUNCT	O	O
on	ADP	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
in	ADP	O	O
sedentary,	ADJ	O	O
hypertensive	ADJ	O	O
women.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Total	ADJ	O	O
distance	NOUN	O	B-outcome
(m),	PUNCT	O	O
average	NOUN	O	O
power	NOUN	O	B-outcome
(W),	NUM	O	O
relative	ADJ	O	O
average	NOUN	O	O
power	NOUN	O	B-outcome
(W.kg(-	PUNCT	O	O
1)),	NOUN	O	O
cardio-respiratory	NOUN	O	B-outcome
measures	NOUN	O	O
and	CCONJ	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
were	VERB	O	O
assessed	VERB	O	O
for	ADP	O	O
each	DET	O	O
10-min	NOUN	O	O
split.	NOUN	O	O

Title:	NOUN	O	O
Lactulose	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
Chinese	NOUN	O	O
children	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
constipation:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized-controlled	VERB	O	O
trial	NOUN	O	O
pilot	NOUN	O	O
study	NOUN	O	O
examining	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
extracorporeal	ADJ	O	O
magnetic	ADJ	O	O
innervation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
stress	NOUN	O	O
urinary	ADJ	O	O
incontinence	NOUN	O	O
in	ADP	O	O
women.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

They	PRON	O	O
then	ADV	O	O
underwent	VERB	O	O
ET	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
observed	VERB	O	O
for	ADP	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
for	ADP	O	O
another	DET	O	O
30	NUM	O	O
minutes	NOUN	O	O
post-ET.	NOUN	O	O

Treated	VERB	O	O
teeth	NOUN	O	O
were	VERB	O	O
restored	VERB	O	O
with	ADP	O	O
composite	NOUN	O	O
resin	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
the	DET	O	O
root	NOUN	O	O
canal	NOUN	O	O
filling.	NOUN	O	O

Quantitative	ADJ	O	O
fit	NOUN	O	O
tests	NOUN	O	O
(QNFTs)	PUNCT	O	O
were	VERB	O	O
performed	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
training	VERB	O	O
using	VERB	O	O
three	NUM	O	O
types	NOUN	O	O
of	ADP	O	O
N95	NOUN	O	O
or	CCONJ	O	O
higher	ADJ	O	O
filter	NOUN	O	O
respirators	NOUN	O	O
(cup-type,	NOUN	O	O
fold-type,	NOUN	O	O
valve-type).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101153627	NUM	O	O

Additionally,	NOUN	O	O
a	DET	O	O
39%	NUM	O	O
reduction	NOUN	O	O
in	ADP	O	O
atherogenic	ADJ	O	B-outcome
index	NOUN	O	O
of	ADP	O	O
the	DET	O	O
plasma	NOUN	O	O
(AIP)	NUM	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.0177)	NUM	O	O
was	VERB	O	O
also	ADV	O	O
noted	VERB	O	O
in	ADP	O	O
amla	NOUN	O	O
group.	VERB	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
at	ADP	O	O
clinicaltrials.gov	NOUN	O	O
ID:	NOUN	O	O
NCT02472951.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
number	NOUN	O	O
of	ADP	O	O
school	NOUN	O	O
children	NOUN	O	O
reported	VERB	O	O
from	ADP	O	O
intervention	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
in	ADP	O	O
control	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
suspected	VERB	O	O
symptoms	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	B-outcome
pharyngitis	NOUN	O	I-outcome
and	CCONJ	O	O
or	CCONJ	O	O
rheumatic	ADJ	O	B-outcome
fever/rheumatic	ADJ	O	I-outcome
heart	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(RF/RHD)	NOUN	O	I-outcome
were	VERB	O	O
65	NUM	O	O
(2.84/1000)	NOUN	O	O
and	CCONJ	O	O
15	NUM	O	O
(0.60/1000),	NOUN	O	O
respectively	ADV	O	O
(p<0.01).	NOUN	O	O

DESIGN:	NOUN	O	O
Randomized,	NOUN	O	O
double-blind	ADJ	O	O
(patients	NOUN	O	O
and	CCONJ	O	O
evaluators	NOUN	O	O
blind),	NOUN	O	O
controlled,	NOUN	O	O
trial.	NOUN	O	O

Journal-Name:The	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
headache	NOUN	O	O
and	CCONJ	O	O
pain	NOUN	O	O

Vaccination	NOUN	O	O
coverage	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
assessed	VERB	O	O
at	ADP	O	O
3-years	NOUN	O	O
of	ADP	O	O
age,	NOUN	O	O
thus	ADV	O	O
the	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
expected	VERB	O	O
to	PART	O	O
be	VERB	O	O
completed	VERB	O	O
in	ADP	O	O
March	NOUN	O	O
2019.	NUM	O	O

We	PRON	O	O
deductively	ADV	O	O
selected	VERB	O	O
five	NUM	O	O
conditions	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
Consolidated	VERB	O	O
Framework	NOUN	O	O
for	ADP	O	O
Implementation	NOUN	O	O
Research:	NOUN	O	O
teachers'	ADV	O	O
perceived	VERB	O	O
self-efficacy	NOUN	O	B-outcome
,	PUNCT	O	O
teachers'	ADV	O	O
expectations	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
benefits	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervention,	ADP	O	O
teachers'	ADV	O	O
previous	ADJ	O	O
knowledge	NOUN	O	B-outcome
about	ADV	O	O
the	DET	O	O
intervention,	ADP	O	O
dosage	NOUN	O	B-outcome
of	ADP	O	I-outcome
physical	ADJ	O	I-outcome
activity	NOUN	O	I-outcome
breaks	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
implementation	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
We	PRON	O	O
identified	VERB	O	O
five	NUM	O	O
different	ADJ	O	O
pathways	NOUN	O	O
that	ADP	O	O
led	VERB	O	O
to	PART	O	O
no	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
the	DET	O	O
pupils'	NOUN	O	O
outcome	NOUN	O	O
(parameters	NOUN	O	O
of	ADP	O	O
fit:	ADP	O	O
consistency	NOUN	O	O
94%,	PUNCT	O	O
coverage	NOUN	O	O
66%).	NOUN	O	O

Demographic	ADJ	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
hormonal	ADJ	O	O
profiles	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
trigger	ADP	O	O
point	NOUN	O	O
dry	ADJ	O	O
needling	VERB	O	O
versus	CCONJ	O	O
sham	NOUN	O	O
needling	VERB	O	O
for	ADP	O	O
chronic	ADJ	O	O
tension-type	NOUN	O	O
headache.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
120	NUM	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
intervention	NOUN	O	O
(health	NOUN	O	O
education	NOUN	O	O
by	ADP	O	O
Wechat	ADP	O	O
platform	NOUN	O	O
plus	CCONJ	O	O
usual	ADJ	O	O
care)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(usual	ADJ	O	O
care).	NOUN	O	O

The	DET	O	O
same	ADJ	O	O
multidisciplinary	ADJ	O	O
protocol	NOUN	O	O
for	ADP	O	O
detecting	VERB	O	O
and	CCONJ	O	O
managing	VERB	O	O
fetal	ADJ	O	O
growth	NOUN	O	O
restriction	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
strategies.	NOUN	O	O

Prerandomization	NOUN	O	O
procedures	NOUN	O	O
excluded	VERB	O	O
288	NUM	O	O
patients:	NOUN	O	O
42	NUM	O	O
had	VERB	O	O
relief	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
heartburn	ADP	O	O
during	ADP	O	O
the	DET	O	O
2-week	NOUN	O	O
omeprazole	NOUN	O	O
trial,	NOUN	O	O
70	NUM	O	O
did	VERB	O	O
not	ADV	O	O
complete	ADJ	O	O
trial	NOUN	O	O
procedures,	NOUN	O	O
54	NUM	O	O
were	VERB	O	O
excluded	VERB	O	O
for	ADP	O	O
other	ADJ	O	O
reasons,	NOUN	O	O
23	NUM	O	O
had	VERB	O	O
non-GERD	NOUN	O	O
esophageal	ADJ	O	O
disorders,	NOUN	O	O
and	CCONJ	O	O
99	NUM	O	O
had	VERB	O	O
functional	ADJ	O	O
heartburn	ADP	O	O
(not	ADV	O	O
due	ADJ	O	O
to	PART	O	O
GERD	NOUN	O	O
or	CCONJ	O	O
other	ADJ	O	O
histopathologic,	SYM	O	O
motility,	ADJ	O	O
or	CCONJ	O	O
structural	ADJ	O	O
abnormality).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
A	DET	O	O
self-administered	VERB	O	O
rehabilitation	NOUN	O	O
program	NOUN	O	O
for	ADP	O	O
painful	NOUN	O	O
shoulder	NOUN	O	O
was	VERB	O	O
non-inferior	ADJ	O	O
than	ADP	O	O
usual	ADJ	O	O
physical	ADJ	O	O
therapy.	NOUN	O	O

Trial	NOUN	O	O
Registration	NOUN	O	O
Date:	NOUN	O	O
August	NOUN	O	O
22,	NUM	O	O
2017.	NUM	O	O

The	DET	O	O
comparison	NOUN	O	O
between	ADP	O	O
two	NUM	O	O
doses	NOUN	O	O
revealed	VERB	O	O
a	DET	O	O
non-significant	ADJ	O	O
difference	NOUN	O	O
(p=.118	NUM	O	O
&	CCONJ	O	O
p=.149	NOUN	O	O
respectively).	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
clinical	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
variation	NOUN	O	O
in	ADP	O	O
thirst	ADV	O	B-outcome
intensity	NOUN	O	I-outcome
,	PUNCT	O	O
evaluated	VERB	O	O
by	ADP	O	O
the	DET	O	O
Numeral	ADJ	O	O
Verbal	ADV	O	O
Scale],	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
secondary,	NOUN	O	O
the	DET	O	O
variation	NOUN	O	O
of	ADP	O	O
the	DET	O	O
discomfort	NOUN	O	B-outcome
of	ADP	O	I-outcome
thirst	ADV	O	I-outcome
,	PUNCT	O	O
evaluated	VERB	O	O
by	ADP	O	O
the	DET	O	O
Perioperative	ADJ	O	O
Thirst	ADV	O	B-outcome
Discomfort	NOUN	O	I-outcome
Scale].	NOUN	O	O
Mann-Whitney	NOUN	O	O
test	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
measures	NOUN	O	O
between	ADP	O	O
groups.	NOUN	O	O

Exercise	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
during	ADP	O	O
out-of-lab	NOUN	O	O
exercise	NOUN	O	O
and	CCONJ	O	O
+25d	NOUN	O	O
post-exercise	NOUN	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
were	VERB	O	O
correlated	VERB	O	O
(r=-0.89,	NOUN	O	O
p=0.02)	ADJ	O	O
in	ADP	O	O
IHE.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/09	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
drugs	NOUN	O	O
in	ADP	O	O
dermatology	NOUN	O	O
:	PUNCT	O	O
JDD	NOUN	O	O

BACKGROUND:	NOUN	O	O
Acute	ADJ	O	O
bacterial	ADJ	O	O
skin	NOUN	O	O
and	CCONJ	O	O
skin-structure	NOUN	O	O
infections	NOUN	O	O
are	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
substantial	ADJ	O	O
morbidity	NOUN	O	O
and	CCONJ	O	O
health	NOUN	O	O
care	NOUN	O	O
costs.	NOUN	O	O

Primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
current	ADJ	O	O
pain	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
(100-mm	NOUN	O	O
visual	ADJ	O	O
analog	NOUN	O	O
scale);	NOUN	O	O
secondary	ADJ	O	O
outcome	NOUN	O	O
measures	NOUN	O	O
included	VERB	O	O
function	NOUN	O	B-outcome
(	NOUN	O	O
Oswestry	NOUN	O	O
Disability	NOUN	O	B-outcome
Index]),	NOUN	O	O
pain	NOUN	O	B-outcome
on	ADP	O	O
movement	NOUN	O	O
(	PUNCT	O	O
Pain	NOUN	O	B-outcome
on	ADP	O	O
Movement	NOUN	O	O
Questionnaire),	NOUN	O	O
perceived	VERB	O	B-outcome
change	NOUN	O	X
in	NOUN	O	X
health	NOUN	O	I-outcome
status	NOUN	O	I-outcome
,	PUNCT	O	O
pressure	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
threshold,	NOUN	O	O
mechanical	ADJ	O	B-outcome
detection	NOUN	O	I-outcome
threshold,	NOUN	O	O
and	CCONJ	O	O
vibration	NOUN	O	B-outcome
detection	NOUN	O	I-outcome
threshold.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoints	NOUN	O	O
were	VERB	O	O
low	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
weight	NOUN	O	I-outcome
(LBW)	NUM	O	I-outcome
,	PUNCT	O	O
peripheral,	ADJ	O	B-outcome
and	CCONJ	O	Seperator
placental	ADJ	O	B-outcome
parasitaemia	NOUN	O	E1-outcome
,	PUNCT	O	O
while	ADP	O	O
the	DET	O	O
secondary	ADJ	O	O
endpoints	NOUN	O	O
were	VERB	O	O
maternal	ADJ	O	B-outcome
anaemia	NOUN	O	I-outcome
,	PUNCT	O	O
pre-term	NOUN	O	B-outcome
birth	NOUN	O	I-outcome
,	PUNCT	O	O
clinical	ADJ	O	B-outcome
malaria	NOUN	O	I-outcome
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
of	ADP	O	O
SP.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Exercise	NOUN	O	O
once	ADP	O	O
a	DET	O	O
week	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
five	NUM	O	O
sessions	NOUN	O	O
of	ADP	O	O
back	ADP	O	O
care	NOUN	O	O
counseling	VERB	O	O
after	ADP	O	O
working	VERB	O	O
hours	NOUN	O	O
in	ADP	O	O
real-life	NOUN	O	O
settings	NOUN	O	O
effectively	ADV	O	O
reduced	VERB	O	O
the	DET	O	O
intensity	NOUN	O	B-outcome
of	ADP	O	I-outcome
low	ADJ	O	I-outcome
back	ADP	O	I-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
work	NOUN	O	B-outcome
interference	NOUN	O	I-outcome
due	ADJ	O	O
to	PART	O	O
LBP,	NOUN	O	O
and	CCONJ	O	O
fear	ADJ	O	B-outcome
of	ADP	O	I-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
but	CCONJ	O	O
was	VERB	O	O
not	ADV	O	O
cost-effective.	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Multicenter	NOUN	O	O
Study,	NOUN	O	O
Pragmatic	NOUN	O	O
Clinical	ADJ	O	O
Trial,	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O
Research	NOUN	O	O
Support,	NOUN	O	O
Non-U.S.	NOUN	O	O
Gov't,	NOUN	O	O

Though	ADP	O	O
much	DET	O	O
of	ADP	O	O
this	DET	O	O
risk	NOUN	O	O
is	VERB	O	O
mitigated	VERB	O	O
with	ADP	O	O
trigger	ADP	O	O
using	VERB	O	O
gonadotropin	NOUN	O	O
releasing-hormone	NOUN	O	O
(GnRH)	NUM	O	O
agonist	NOUN	O	O
alone,	NOUN	O	O
it	PRON	O	O
may	VERB	O	O
result	VERB	O	O
in	ADP	O	O
lower	ADJ	O	O
birth	NOUN	O	O
rates.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
included	VERB	O	O
symptoms	NOUN	O	B-outcome
severity	NOUN	O	I-outcome
and	CCONJ	O	O
appetite	NOUN	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
included	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
MD	NOUN	O	O
Anderson	NOUN	O	O
Symptom	NOUN	O	O
Inventory	ADJ	O	O
(MDASI)	NUM	O	O
score,	NOUN	O	O
and	CCONJ	O	O
functional	ADJ	O	B-outcome
impairment	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
evaluated	VERB	O	O
by	ADP	O	O
the	DET	O	O
Karnofsky	NOUN	O	O
score.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

And	CCONJ	O	O
the	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
berberine	NOUN	O	O
was	VERB	O	O
assessed.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Given	VERB	O	O
the	DET	O	O
documented	VERB	O	O
decline	NOUN	O	O
in	ADP	O	O
levels	NOUN	O	O
of	ADP	O	O
physical	ADJ	O	O
activity	NOUN	O	O
in	ADP	O	O
early	ADJ	O	O
adolescence,	NOUN	O	O
promoting	VERB	O	O
physical	ADJ	O	O
activity	NOUN	O	O
in	ADP	O	O
young	ADJ	O	O
people	NOUN	O	O
is	VERB	O	O
a	DET	O	O
priority	NOUN	O	O
for	ADP	O	O
health	NOUN	O	O
promotion.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(PFS)	NOUN	O	I-outcome
by	ADP	O	O
intention-to-treat	NOUN	O	O
analysis.	NOUN	O	O

RESULTS:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
median	ADJ	O	O
iodine	NOUN	O	O
dose	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
normal	ADJ	O	O
or	CCONJ	O	O
high	ADJ	O	O
BMI	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
it	PRON	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
under	ADP	O	O
the	DET	O	O
LBW	NOUN	O	O
protocol	NOUN	O	O
than	ADP	O	O
the	DET	O	O
TBW	NOUN	O	O
protocol	NOUN	O	O
(558.2	PUNCT	O	O
and	CCONJ	O	O
507.0	NUM	O	O
mg	NOUN	O	O
iodine/kg,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.001,	NUM	O	O
respectively).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/20	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

All	DET	O	O
eye	NOUN	O	O
drops	NOUN	O	O
were	VERB	O	O
placed	VERB	O	O
in	ADP	O	O
identical,	ADJ	O	O
unlabelled	VERB	O	O
vials.	NOUN	O	O

Date	NOUN	O	O
of	ADP	O	O
enrolment	ADJ	O	O
of	ADP	O	O
the	DET	O	O
first	ADV	O	O
participant	ADJ	O	O
to	PART	O	O
the	DET	O	O
trial:	NOUN	O	O
02/02/2016.	NUM	O	O

Twenty-eight	NUM	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
painless	NOUN	O	O
fiberbronchoscopy	NOUN	O	O
in	ADP	O	O
Hangzhou	NOUN	O	O
First	ADV	O	O
People's	NOUN	O	O
Hospital	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups(n=14):	NOUN	O	O
supraglottic	ADJ	O	O
tracheal	ADJ	O	O
tube	NOUN	O	O
ventilation(group	ADJ	O	O
A)	NOUN	O	O
and	CCONJ	O	O
modified	VERB	O	O
laryngeal	ADJ	O	O
mask	NOUN	O	O
airway(group	NOUN	O	O
B).	NOUN	O	O

Methods:	NOUN	O	O
A	DET	O	O
random	NOUN	O	O
cluster	NOUN	O	O
sampling	VERB	O	O
method	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
used,	NOUN	O	O
including	VERB	O	O
300	NUM	O	O
rural	ADJ	O	O
residents	NOUN	O	O
aged	VERB	O	O
above	ADP	O	O
18	NUM	O	O
years	NOUN	O	O
old	ADJ	O	O
from	ADP	O	O
three	NUM	O	O
villages	NOUN	O	O
(184	NUM	O	O
in	ADP	O	O
control	NOUN	O	O
group,	NOUN	O	O
116	NUM	O	O
in	ADP	O	O
intervention	NOUN	O	O
group),	NOUN	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
proceed	NOUN	O	O
the	DET	O	O
physical	ADJ	O	O
check-up	VERB	O	O
and	CCONJ	O	O
health	NOUN	O	O
education	NOUN	O	O
programs.	NOUN	O	O

Seventeen	NUM	O	O
patients	NOUN	O	O
(17%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
MRI-guided	VERB	O	O
treat-to-target	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
patients	NOUN	O	O
(6%)	ADV	O	O
in	ADP	O	O
the	DET	O	O
conventional	ADJ	O	O
treat-to-target	NOUN	O	O
group	NOUN	O	O
experienced	VERB	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
RA	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
remission,	NOUN	O	O
an	DET	O	O
MRI-guided	VERB	O	O
treat-to-target	NOUN	O	O
strategy	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
a	DET	O	O
conventional	ADJ	O	O
treat-to-target	NOUN	O	O
strategy	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
improved	VERB	O	O
disease	NOUN	O	B-outcome
activity	NOUN	O	I-outcome
remission	NOUN	O	I-outcome
rates	NOUN	O	O
or	CCONJ	O	O
reduce	VERB	O	O
radiographic	ADJ	O	B-outcome
progression	NOUN	O	I-outcome
.	PUNCT	O	O
These	DET	O	O
findings	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
an	DET	O	O
MRI-guided	VERB	O	O
strategy	NOUN	O	O
for	ADP	O	O
treating	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
RA.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8109958	NUM	O	O

Serum	NOUN	O	O
cortisol	NOUN	O	B-outcome
level	NOUN	O	O
was	VERB	O	O
measured	VERB	O	O
before	ADP	O	O
anesthesia	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
operation	NOUN	O	O
to	PART	O	O
calculate	NOUN	O	O
the	DET	O	O
changes	NOUN	O	O
in	ADP	O	O
cortisol	NOUN	O	O
level.	NOUN	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
population,	NOUN	O	O
the	DET	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
free	ADJ	O	O
from	ADP	O	O
recurrence	NOUN	O	B-outcome
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
was	VERB	O	O
62.4%	NUM	O	O
in	ADP	O	O
the	DET	O	O
tafenoquine	NOUN	O	O
group	NOUN	O	O
(95%	PUNCT	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
54.9	NUM	O	O
to	PART	O	O
69.0),	NOUN	O	O
27.7%	NUM	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
19.6	NUM	O	O
to	PART	O	O
36.6),	NUM	O	O
and	CCONJ	O	O
69.6%	ADP	O	O
in	ADP	O	O
the	DET	O	O
primaquine	NOUN	O	O
group	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
60.2	NUM	O	O
to	PART	O	O
77.1).	NUM	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
part-time	NOUN	O	O
vs	CCONJ	O	O
full-time	NOUN	O	O
wear	ADJ	O	O
protocols	NOUN	O	O
of	ADP	O	O
Twin-block	NOUN	O	O
appliance	NOUN	O	O
on	ADP	O	O
dental	ADJ	O	B-outcome
and	CCONJ	O	O
skeletal	ADJ	O	B-outcome
changes:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/31	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
PBMCs,	NOUN	O	O
LF	NOUN	O	O
decreased	VERB	O	O
ICAM1	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
0.05),	NUM	O	O
which	ADP	O	O
was	VERB	O	O
different	ADJ	O	O
(P	NUM	O	O
=	SYM	O	O
0.06,	NUM	O	O
Bonferroni	NOUN	O	O
correction)	NOUN	O	O
from	ADP	O	O
the	DET	O	O
observed	VERB	O	O
increase	NOUN	O	O
in	ADP	O	O
the	DET	O	O
FF	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
0.05).	NOUN	O	O

GLN	NOUN	O	O
supplementation	NOUN	O	O
appeared	VERB	O	O
to	PART	O	O
significantly	ADV	O	O
delay	NOUN	O	O
acute	ADJ	O	O
radiation-induced	VERB	O	O
esophagitis	NOUN	O	B-outcome
(ARIE)	NUM	O	O
onset	NOUN	O	O
for	ADP	O	O
5.8	NUM	O	O
days	NOUN	O	O
(18.2	ADV	O	O
days	NOUN	O	O
vs	CCONJ	O	O
12.4	NUM	O	O
days;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.027)	PUNCT	O	O
and	CCONJ	O	O
reduced	VERB	O	O
incidence	NOUN	O	O
of	ADP	O	O
weight	NOUN	O	B-outcome
loss	NOUN	O	O
(20%	PUNCT	O	O
vs	CCONJ	O	O
73.3%;	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.01).	PUNCT	O	O

Interobserver	ADV	O	O
reliability	NOUN	O	O
showed	VERB	O	O
excellent	ADJ	O	O
agreement	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
intraclass	NOUN	O	O
correlation	NOUN	O	O
coefficient,	NOUN	O	O
and	CCONJ	O	O
moderate	ADJ	O	O
to	PART	O	O
almost	ADV	O	O
perfect	NOUN	O	O
agreement	NOUN	O	O
by	ADP	O	O
kappa	NOUN	O	O
statistics.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/13	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Of	ADP	O	O
these,	NOUN	O	O
105	NUM	O	O
completed	VERB	O	O
follow	VERB	O	O
up	ADP	O	O
at	ADP	O	O
12	NUM	O	O
months.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

According	ADJ	O	O
to	PART	O	O
the	DET	O	O
random	NOUN	O	O
number	NOUN	O	O
table	ADJ	O	O
method,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
non-invasive	ADJ	O	O
ventilator	NOUN	O	O
group,	NOUN	O	O
rhodiola	NOUN	O	O
rosea+non-invasive	ADJ	O	O
ventilator	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
rhodiola	NOUN	O	O
rosea	NOUN	O	O
group,	NOUN	O	O
with	ADP	O	O
30	NUM	O	O
cases	NOUN	O	O
in	ADP	O	O
each	DET	O	O
group.	VERB	O	O

Serious	ADJ	O	O
postoperative	ADJ	O	O
complications	NOUN	O	B-outcome
occurred	VERB	O	O
more	ADV	O	O
frequently	ADV	O	O
in	ADP	O	O
the	DET	O	O
lymphadenectomy	NOUN	O	O
group	NOUN	O	O
(e.g.,	NOUN	O	O
incidence	NOUN	O	O
of	ADP	O	O
repeat	NOUN	O	O
laparotomy,	NOUN	O	O
12.4%	NUM	O	O
vs.	CCONJ	O	O
6.5%	NOUN	O	O
[P	PUNCT	O	O
=	SYM	O	O
0.01];	NUM	O	O
mortality	NOUN	O	B-outcome
within	ADP	O	O
60	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
surgery,	NOUN	O	O
3.1%	NOUN	O	O
vs.	CCONJ	O	O
0.9%	NOUN	O	O
[P	PUNCT	O	O
=	SYM	O	O
0.049]).	ADJ	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

At	ADP	O	O
the	DET	O	O
16-week	NOUN	O	O
follow-up,	ADP	O	O
significant	ADJ	O	O
group	NOUN	O	O
by	ADP	O	O
time	NOUN	O	O
interaction	NOUN	O	O
effects	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
percentage	NOUN	O	O
body	NOUN	O	B-outcome
fat	NOUN	O	I-outcome
(%BF)	ADV	O	O
(beta	NUM	O	O
=	SYM	O	O
-1.52,	NOUN	O	O
95%CI	NOUN	O	O
=	SYM	O	O
-2.58(-)-0.45),	NOUN	O	O
lean	ADJ	O	B-outcome
body	NOUN	O	I-outcome
mass	NOUN	O	I-outcome
(LM)	NUM	O	I-outcome
(beta	NUM	O	O
=	SYM	O	O
1.20,	NUM	O	O
95%CI	NOUN	O	O
=	SYM	O	O
0.12(-)2.29),	NUM	O	O
diastolic	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
(beta	NUM	O	O
=	SYM	O	O
-5.24,	ADJ	O	O
95%CI	NOUN	O	O
=	SYM	O	O
-9.66(-)-0.83),	NOUN	O	O
high-sensitivity	NOUN	O	B-outcome
C-reactive	ADJ	O	I-outcome
protein	NOUN	O	I-outcome
(beta	NUM	O	O
=	SYM	O	O
-1.67,	NOUN	O	O
95%CI	NOUN	O	O
=	SYM	O	O
-2.77(-)-1.01),	NOUN	O	O
and	CCONJ	O	O
wall	NOUN	O	O
sit	NOUN	O	O
test	NOUN	O	O
score	NOUN	O	O
(beta	NUM	O	O
=	SYM	O	O
50.74,	NOUN	O	O
95%CI	NOUN	O	O
=	SYM	O	O
32.30(-)69.18).	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
to	PART	O	O
Evaluate	NOUN	O	O
the	DET	O	O
Effect	NOUN	O	O
of	ADP	O	O
Toric	ADJ	O	O
Versus	CCONJ	O	O
Spherical	NOUN	O	O
Contact	NOUN	O	O
Lenses	NOUN	O	O
on	ADP	O	O
Vision	NOUN	O	B-outcome
and	CCONJ	O	O
Eyestrain	NOUN	O	B-outcome
.	PUNCT	O	O

Both	CCONJ	O	O
LOCF	NOUN	O	O
and	CCONJ	O	O
BOCF	NOUN	O	O
showed	VERB	O	O
similar	ADJ	O	O
results	NOUN	O	O
but	CCONJ	O	O
lower	ADJ	O	O
effect	NOUN	O	O
sizes.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
TFP	NOUN	O	O
(25	NOUN	O	O
mug/h)	NOUN	O	O
affixed	VERB	O	O
14	NUM	O	O
h	NOUN	O	O
before	ADP	O	O
surgery	NOUN	O	O
reached	VERB	O	O
a	DET	O	O
higher	ADJ	O	O
constant	NOUN	O	B-outcome
concentration	NOUN	O	I-outcome
than	ADP	O	O
the	DET	O	O
same	ADJ	O	O
dose	NOUN	O	O
setting	VERB	O	O
of	ADP	O	O
a	DET	O	O
constant	NOUN	O	O
IV	NUM	O	O
infusion	NOUN	O	O
of	ADP	O	O
fentanyl	NOUN	O	O
after	ADP	O	O
surgery.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101090552	NUM	O	O

BACKGROUND:	NOUN	O	O
Mothers	NOUN	O	O
in	ADP	O	O
Motion	NOUN	O	O
(MIM),	ADV	O	O
a	DET	O	O
community-based	VERB	O	O
intervention	NOUN	O	O
program,	NOUN	O	O
was	VERB	O	O
designed	VERB	O	O
to	PART	O	O
help	VERB	O	O
young,	NOUN	O	O
low-income	NOUN	O	O
women	NOUN	O	O
with	ADP	O	O
overweight	NUM	O	O
or	CCONJ	O	O
obesity	NOUN	O	O
prevent	NOUN	O	O
further	ADV	O	O
weight	NOUN	O	O
gain	VERB	O	O
by	ADP	O	O
promoting	VERB	O	O
stress	NOUN	O	O
management,	NOUN	O	O
healthy	ADJ	O	O
eating,	NOUN	O	O
and	CCONJ	O	O
physical	ADJ	O	O
activity.	NOUN	O	O

The	DET	O	O
initial	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
bupivacaine	NOUN	O	O
in	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
was	VERB	O	O
4	NUM	O	O
mg,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
subsequent	ADJ	O	O
dose	NOUN	O	O
for	ADP	O	O
the	DET	O	O
following	VERB	O	O
patient	NOUN	O	O
was	VERB	O	O
depended	VERB	O	O
on	ADP	O	O
the	DET	O	O
probability	NOUN	O	O
of	ADP	O	O
the	DET	O	O
current	ADJ	O	O
dose.	NOUN	O	O

Results:	NOUN	O	O
Smoking	VERB	O	O
a	DET	O	O
cigarette	NOUN	O	O
for	ADP	O	O
five	NUM	O	O
minutes	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
of	ADP	O	O
exhaled	VERB	O	B-outcome
CO	NOUN	O	I-outcome
,	PUNCT	O	O
whereas	ADP	O	O
using	VERB	O	O
an	DET	O	O
IQOS(TM)	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
a	DET	O	O
small	ADJ	O	O
but	CCONJ	O	O
reliable	ADJ	O	O
increase	NOUN	O	O
(0.3	NOUN	O	O
ppm).	NOUN	O	O

Cholesterol	NOUN	O	B-outcome
reduction	NOUN	O	O
is	VERB	O	O
achieved	NOUN	O	O
without	ADP	O	O
concomitant	ADJ	O	O
reduction	NOUN	O	O
of	ADP	O	O
Coenzyme	NOUN	O	B-outcome
Q10	NOUN	O	I-outcome
(CoQ10)	PUNCT	O	I-outcome
,	PUNCT	O	O
in	ADP	O	O
contrast	NOUN	O	O
to	PART	O	O
what	DET	O	O
is	VERB	O	O
observed	VERB	O	O
with	ADP	O	O
statins.	NUM	O	O

Title:	NOUN	O	O
The	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
enamel	NOUN	O	O
matrix	NOUN	O	O
derivatives	NOUN	O	O
on	ADP	O	O
root	NOUN	O	B-outcome
coverage	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
12-month	NOUN	O	O
follow-up	NOUN	O	O
of	ADP	O	O
a	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Clinical	ADJ	O	O
Outcome	NOUN	O	O
following	VERB	O	O
Intra-articular	ADJ	O	O
Triamcinolone	NOUN	O	O
Injection	NOUN	O	O
in	ADP	O	O
Osteoarthritic	ADJ	O	O
Knee	NOUN	O	O
at	ADP	O	O
the	DET	O	O
Community:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Double	ADV	O	O
Blind	NOUN	O	O
Placebo	NOUN	O	O
Controlled	VERB	O	O
Trial.	NOUN	O	O

Delirium	NOUN	O	B-outcome
during	ADP	O	O
postoperative	ADJ	O	O
days	NOUN	O	O
1	NUM	O	O
to	PART	O	O
5	NUM	O	O
occurred	VERB	O	O
in	ADP	O	O
157	NUM	O	O
of	ADP	O	O
604	NUM	O	O
patients	NOUN	O	O
(26.0%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
guided	VERB	O	O
group	NOUN	O	O
and	CCONJ	O	O
140	NUM	O	O
of	ADP	O	O
609	NUM	O	O
patients	NOUN	O	O
(23.0%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
care	NOUN	O	O
group	NOUN	O	O
(difference,	ADV	O	O
3.0%	NOUN	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-2.0%	NUM	O	O
to	PART	O	O
8.0%];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.22).	NUM	O	O

Larger	ADJ	O	O
studies	NOUN	O	O
with	ADP	O	O
longer	ADJ	O	O
follow-up	NOUN	O	O
periods	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
required	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
these	DET	O	O
findings.	NOUN	O	O

This	DET	O	O
study,	NOUN	O	O
therefore,	NOUN	O	O
attempted	VERB	O	O
to	PART	O	O
explore	ADP	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
TC	NOUN	O	O
on	ADP	O	O
depression	NOUN	O	B-outcome
and	CCONJ	O	O
on	ADP	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
(HRV)	NUM	O	I-outcome
parameters.	NOUN	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
study	NOUN	O	O
the	DET	O	O
radiation	NOUN	O	B-outcome
exposure	NOUN	O	I-outcome
reduction	NOUN	O	O
to	PART	O	O
operators	NOUN	O	O
with	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
RADPAD	NOUN	O	O
and	CCONJ	O	O
also	ADV	O	O
measureradiation	NOUN	O	O
doses	NOUN	O	O
in	ADP	O	O
different	ADJ	O	O
angiographic	ADJ	O	O
projections.	NOUN	O	O

Title:	NOUN	O	O
Standard-dose	ADJ	O	O
versus	CCONJ	O	O
low-dose	NOUN	O	O
multidetector	NOUN	O	O
computed	VERB	O	O
tomography	NOUN	O	O
examinations	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
uncontrolled	VERB	O	O
chronic	ADJ	O	O
rhinosinusitis:	NOUN	O	O
A	DET	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/13	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

The	DET	O	O
effect	NOUN	O	O
on	ADP	O	O
humans	NOUN	O	O
has	VERB	O	O
not	ADV	O	O
been	VERB	O	O
elucidated,	NOUN	O	O
therefore,	NOUN	O	O
we	PRON	O	O
investigated	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
beta-Eudesmol	NOUN	O	O
on	ADP	O	O
reducing	VERB	O	O
objective	ADP	O	O
and	CCONJ	O	O
subjective	ADJ	O	O
markers	NOUN	O	O
related	VERB	O	O
to	PART	O	O
sympathetic	ADJ	O	B-outcome
nerve	NOUN	O	I-outcome
activity	NOUN	O	I-outcome
after	ADP	O	O
the	DET	O	O
application	NOUN	O	O
of	ADP	O	O
mental	ADJ	O	O
stress	NOUN	O	O
in	ADP	O	O
healthy	ADJ	O	O
participants.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

Journal-Name:	NOUN	O	O
JAMA	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/10	PUNCT	O	O
06:00'	NUM	O	O

Likewise,	NOUN	O	O
triglyceride	NOUN	O	B-outcome
net	ADJ	O	O
AUC	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
by	ADP	O	O
80	NUM	O	O
+/-	SYM	O	O
28	NUM	O	O
mumol/Lx270	NOUN	O	O
min	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.012)	NUM	O	O
after	ADP	O	O
breakfast	NOUN	O	O
but	CCONJ	O	O
reduced	VERB	O	O
by	ADP	O	O
320	NUM	O	O
+/-	SYM	O	O
60	NUM	O	O
mumol/Lx180	NOUN	O	O
min	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.001)	NUM	O	O
after	ADP	O	O
lunch	NOUN	O	O
on	ADP	O	O
the	DET	O	O
CRHP	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
CD	NOUN	O	O
diet.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
Effect	NOUN	O	O
of	ADP	O	O
Whey	NOUN	O	O
and	CCONJ	O	O
Soy	NOUN	O	O
Protein	NOUN	O	O
Isolates	NOUN	O	O
on	ADP	O	O
Cognitive	ADJ	O	B-outcome
Function	NOUN	O	I-outcome
in	ADP	O	O
Older	ADJ	O	O
Australians	NOUN	O	O
with	ADP	O	O
Low	ADJ	O	O
Vitamin	NOUN	O	O
B12:	NOUN	O	O
A	DET	O	O
Randomised	VERB	O	O
Controlled	VERB	O	O
Crossover	NOUN	O	O
Trial.	NOUN	O	O

The	DET	O	O
EIFEL	NOUN	O	O
score	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
Dallas	NOUN	O	O
Pain	NOUN	O	B-outcome
Questionnaire	NOUN	O	O
score	NOUN	O	O
had	VERB	O	O
a	DET	O	O
similar	ADJ	O	O
evolution	NOUN	O	O
over	ADP	O	O
time	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.18	PUNCT	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.50	NUM	O	O
respectively).	NOUN	O	O

RESULTS:	NOUN	O	O
left	ADV	O	B-outcome
ventricular	ADJ	O	I-outcome
ejection	NOUN	O	I-outcome
fraction	NOUN	O	I-outcome
(LVEF)	PUNCT	O	I-outcome
decreased	VERB	O	O
from	ADP	O	O
62+/-5%	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
58+/-7%	NOUN	O	O
at	ADP	O	O
6-months	NOUN	O	O
(p=0.002)	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
assigned	VERB	O	O
to	PART	O	O
placebo	NOUN	O	O
but	CCONJ	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
changes	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
any	DET	O	O
of	ADP	O	O
the	DET	O	O
3	NUM	O	O
carvedilol	NOUN	O	O
groups.	NOUN	O	O

METHODS:	NOUN	O	O
Post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
baseline	NOUN	O	O
patient	NOUN	O	O
characteristics	NOUN	O	O
in	ADP	O	O
the	DET	O	O
randomized,	NOUN	O	O
open-label,	ADV	O	O
vision	NOUN	O	O
examiner-masked	VERB	O	O
SHORE	DET	O	O
phase	NOUN	O	O
4	NUM	O	O
study	NOUN	O	O
that	ADP	O	O
compared	VERB	O	O
monthly	ADV	O	O
versus	CCONJ	O	O
pro	ADJ	O	O
re	NOUN	O	O
nata	NOUN	O	O
dosing	VERB	O	O
of	ADP	O	O
ranibizumab	ADJ	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
branch	NOUN	O	O
and	CCONJ	O	O
central	ADJ	O	O
RVO.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

The	DET	O	O
total	ADJ	O	O
sleep	NOUN	O	B-outcome
time	NOUN	O	I-outcome
(TST)	PUNCT	O	O
and	CCONJ	O	O
daytime	NOUN	O	B-outcome
dysfunction	NOUN	O	I-outcome
(DF)	NOUN	O	I-outcome
in	ADP	O	O
PSQI	NOUN	O	O
significantly	ADV	O	O
decreased	VERB	O	O
at	ADP	O	O
week	NOUN	O	O
8	NUM	O	O
(both	NOUN	O	O
P<0.05).	NOUN	O	O
(	PUNCT	O	O

OBJECTIVE:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
aims	NOUN	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
accuracy	NOUN	O	O
of	ADP	O	O
the	DET	O	O
preoperative	ADJ	O	O
localization	NOUN	O	B-outcome
of	ADP	O	O
small	ADJ	O	O
nodules	NOUN	O	O
by	ADP	O	O
computerized	VERB	O	O
tomography	NOUN	O	O
(CT)-guided	PUNCT	O	O
placing	VERB	O	O
wire	NOUN	O	O
and	CCONJ	O	O
intrapleural	ADJ	O	O
fibrin	NOUN	O	O
glue	ADJ	O	O
near	ADV	O	O
the	DET	O	O
nodules	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
days	NOUN	O	O
before	ADP	O	O
the	DET	O	O
operation.	ADV	O	O

The	DET	O	O
intervention	NOUN	O	O
period	NOUN	O	O
was	VERB	O	O
from	ADP	O	O
April	NOUN	O	O
1	NUM	O	O
to	PART	O	O
July	NOUN	O	O
31,	NUM	O	O
2011	NUM	O	O
and	CCONJ	O	O
April	NOUN	O	O
1	NUM	O	O
to	PART	O	O
July	NOUN	O	O
31,	NUM	O	O
2012.	NUM	O	O

The	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
wearing	VERB	O	B-outcome
glasses	NOUN	O	I-outcome
was	VERB	O	O
55.2%	NUM	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
23.4%	NUM	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.01)	NUM	O	O
among	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Clinical	ADJ	O	O
Trial,	NOUN	O	O
Phase	NOUN	O	O
II	NUM	O	O

The	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
the	DET	O	O
placebo	NOUN	O	O
(distilled	PUNCT	O	O
water)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
same	ADJ	O	O
manner	NOUN	O	O
as	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group.	VERB	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
pragmatic,	NOUN	O	O
multicenter,	NOUN	O	O
open-label,	ADV	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100967802	NUM	O	O

Introduction:	NOUN	O	O
Research	NOUN	O	O
from	ADP	O	O
Philip	ADV	O	O
Morris	NOUN	O	O
International's	NOUN	O	O
science	NOUN	O	O
division	NOUN	O	O
on	ADP	O	O
its	ADJ	O	O
Heat-not-Burn	NOUN	O	O
product	NOUN	O	O
IQOS(TM)	NOUN	O	O
focused	VERB	O	O
on	ADP	O	O
its	ADJ	O	O
chemical,	ADJ	O	O
toxicological,	ADJ	O	O
clinical,	ADJ	O	O
and	CCONJ	O	O
behavioral	ADJ	O	O
aspects.	NOUN	O	O

The	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
the	DET	O	O
resin	NOUN	O	O
infiltration	NOUN	O	O
group	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
fluoride	NOUN	O	O
varnish	NOUN	O	O
group.	VERB	O	O

TRIAL	NOUN	O	O
REGISTRATION	NOUN	O	O
NUMBER:	NOUN	O	O
UMIN-CTR	NOUN	O	O
Study	NOUN	O	O
Design:	NOUN	O	O
trial	NOUN	O	O
number:	NOUN	O	O
UMIN000022032.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
collect	NOUN	O	O
data	NOUN	O	O
on	ADP	O	O
safety	NOUN	O	O
and	CCONJ	O	O
tolerability	NOUN	O	B-outcome
of	ADP	O	O
krill	NOUN	O	O
powder	NOUN	O	O
in	ADP	O	O
humans	NOUN	O	O
and	CCONJ	O	O
simultaneously	ADV	O	O
gain	VERB	O	O
efficacy	NOUN	O	O
data	NOUN	O	O
by	ADP	O	O
measuring	VERB	O	O
the	DET	O	O
risk	NOUN	O	O
factors	NOUN	O	O
for	ADP	O	O
cardiovascular	ADJ	O	O
disease.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
The	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
prospectively	ADV	O	O
with	ADP	O	O
the	DET	O	O
national	ADJ	O	O
database	NOUN	O	O
at	ADP	O	O
the	DET	O	O
Clinical	ADJ	O	O
Research	NOUN	O	O
Network	NOUN	O	O
(UKCRN	NOUN	O	O
Portfolio	NOUN	O	O
9366).	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
therefore	ADV	O	O
aimed	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
whether	ADP	O	O
a	DET	O	O
short-term	NOUN	O	O
LOWFODMAP	NOUN	O	O
diet	NOUN	O	O
improved	VERB	O	O
exercise-related	VERB	O	O
GI	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
perceived	VERB	O	O
ability	NOUN	O	B-outcome
to	PART	O	O
exercise	NOUN	O	O
in	ADP	O	O
recreational	ADJ	O	O
runners.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
18	NUM	O	O
of	ADP	O	O
102	NUM	O	O
patients	NOUN	O	O
(18%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
hybrid-procedure	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
a	DET	O	O
major	ADJ	O	O
pulmonary	ADJ	O	B-outcome
complication	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
31	NUM	O	O
of	ADP	O	O
103	NUM	O	O
(30%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
open-procedure	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
lavender	NOUN	O	O
aromatherapy	NOUN	O	O
through	ADP	O	O
inhalation	NOUN	O	O
on	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
among	ADP	O	O
postmenopausal	ADJ	O	O
women	NOUN	O	O
covered	VERB	O	O
by	ADP	O	O
a	DET	O	O
governmental	ADJ	O	O
health	NOUN	O	O
center	NOUN	O	O
in	ADP	O	O
Isfahan,	CCONJ	O	O
Iran:	NOUN	O	O
A	DET	O	O
single-blind	NOUN	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

Regression	NOUN	O	O
multivariate	ADJ	O	O
analysis	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
cortisol	NOUN	O	B-outcome
and	CCONJ	O	O
testosterone	NOUN	O	B-outcome
levels	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
25(OH)D	NUM	O	B-outcome
levels	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

RESULTS:	NOUN	O	O
Thirty-four	NUM	O	O
subjects	NOUN	O	O
high-responder	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
receive	VERB	O	O
low-dose	NOUN	O	O
hCG	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
GnRH-agonist	NOUN	O	O
trigger	ADP	O	O
(Group	PUNCT	O	O
1)	NUM	O	O
and	CCONJ	O	O
37	NUM	O	O
received	VERB	O	O
low-dose	NOUN	O	O
hCG	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
oocyte	NOUN	O	O
retrieval	ADV	O	O
(Group	PUNCT	O	O
2).	NOUN	O	O

Title:	NOUN	O	O
[Nursing	VERB	O	O
intervention	NOUN	O	O
for	ADP	O	O
respiratory	ADJ	O	O
function	NOUN	O	O
exercise	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
silicosis	NOUN	O	O
complicated	VERB	O	O
by	ADP	O	O
stable	ADJ	O	O
chronic	ADJ	O	O
obstructive	ADJ	O	O
pulmonary	ADJ	O	O
disease].	NOUN	O	O

BACKGROUND:	NOUN	O	O
Nutrition	NOUN	O	O
cares	NOUN	O	O
are	VERB	O	O
of	ADP	O	O
the	DET	O	O
main	ADJ	O	O
measures	NOUN	O	O
to	PART	O	O
save	ADP	O	O
premature	ADJ	O	O
infants.	NOUN	O	O

Outcomes	NOUN	O	O
after	ADP	O	O
16	NUM	O	O
weeks	NOUN	O	O
are	VERB	O	O
amount	NOUN	O	O
and	CCONJ	O	O
distribution	NOUN	O	B-outcome
of	ADP	O	I-outcome
abdominal	ADJ	O	B-outcome
fat	NOUN	O	E2-outcome
,	PUNCT	O	O
measured	VERB	O	O
by	ADP	O	O
magnetic	ADJ	O	O
resonance	NOUN	O	O
imaging	VERB	O	O
(MRI)	PUNCT	O	O
with	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
the	DET	O	O
three-point	NOUN	O	O
IDEAL	ADV	O	O
Dixon	NOUN	O	O
method.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
degree	NOUN	O	O
of	ADP	O	O
injured	VERB	O	O
vertebra	NOUN	O	B-outcome
compression	NOUN	O	I-outcome
,	PUNCT	O	O
visual	ADJ	O	O
analogue	NOUN	O	O
scale	NOUN	O	O
(VAS)	PUNCT	O	O
score,	NOUN	O	O
and	CCONJ	O	O
Oswestry	NOUN	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(ODI)	NOUN	O	O
score	NOUN	O	O
at	ADP	O	O
preoperation,	NOUN	O	O
immediate	ADJ	O	O
after	ADP	O	O
operation,	NOUN	O	O
and	CCONJ	O	O
last	NOUN	O	O
follow-up	NOUN	O	O
were	VERB	O	O
calculated	VERB	O	O
and	CCONJ	O	O
compared	VERB	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Subjects	NOUN	O	O
were	VERB	O	O
fed	VERB	O	O
a	DET	O	O
fully	ADV	O	O
controlled	VERB	O	O
base	NOUN	O	O
diet	NOUN	O	O
for	ADP	O	O
4	NUM	O	O
weeks	NOUN	O	O
with	ADP	O	O
either	CCONJ	O	O
no	DET	O	O
additions	NOUN	O	O
or	CCONJ	O	O
with	ADP	O	O
the	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
42	NUM	O	O
g/day	NOUN	O	O
(1.5	NOUN	O	O
servings)	NOUN	O	O
of	ADP	O	O
cashew	NOUN	O	O
nuts,	NOUN	O	O
with	ADP	O	O
the	DET	O	O
final	ADJ	O	O
treatment	NOUN	O	O
diets	NOUN	O	O
being	VERB	O	O
isocaloric.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Body	NOUN	O	O
posture	ADJ	O	O
is	VERB	O	O
directly	ADV	O	O
related	VERB	O	O
to	PART	O	O
PA	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
lack	NOUN	O	O
of	ADP	O	O
activity	NOUN	O	O
affects	NOUN	O	O
disturbances	NOUN	O	O
within	ADP	O	O
posturometric	ADJ	O	O
parameters.	NOUN	O	O

Primary	ADJ	O	O
endpoint	NOUN	O	O
is	VERB	O	O
the	DET	O	O
success	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
randomised	VERB	O	O
treatment,	NOUN	O	O
defined	VERB	O	O
as	ADP	O	O
resolution	NOUN	O	B-outcome
of	ADP	O	I-outcome
acute	ADJ	O	I-outcome
appendicitis	NOUN	O	I-outcome
resulting	VERB	O	O
in	ADP	O	O
discharge	NOUN	O	B-outcome
from	ADP	O	I-outcome
the	DET	O	Seperator
hospital	NOUN	O	I-outcome
without	ADP	O	O
the	DET	O	O
need	NOUN	O	O
for	ADP	O	O
surgical	ADJ	O	B-outcome
intervention	NOUN	O	I-outcome
and	CCONJ	O	O
no	DET	O	O
recurrent	ADP	O	B-outcome
appendicitis	NOUN	O	I-outcome
during	ADP	O	O
one-year	NOUN	O	O
follow-up.	PUNCT	O	O

Sixty	NUM	O	O
patients	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

Missing	VERB	O	O
values	NOUN	O	O
were	VERB	O	O
imputed	VERB	O	O
by	ADP	O	O
linear	ADJ	O	O
interpolation	NOUN	O	O
(intermittent),	PUNCT	O	O
backfilling	VERB	O	O
(beginning)	NOUN	O	O
or	CCONJ	O	O
carry	NOUN	O	O
forward	ADV	O	O
(end).	PUNCT	O	O

The	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
endpoints	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
by	ADP	O	O
urodynamic	ADJ	O	B-outcome
values,	NOUN	O	O
and	CCONJ	O	O
Overactive	ADJ	O	B-outcome
Bladder	NOUN	O	I-outcome
Symptom	NOUN	O	I-outcome
Score	NOUN	O	O
(OABSS)].	NOUN	O	O
The	DET	O	O
secondary	ADJ	O	O
efficacy	NOUN	O	O
endpoints	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
International	ADJ	O	O
Consultation	NOUN	O	O
on	ADP	O	O
Incontinence	NOUN	O	B-outcome
Questionnaire-Short	NOUN	O	O
Form	NOUN	O	O
(ICIQ-SF)	NUM	O	O
score,	NOUN	O	O
Barthel	PROPN	O	O
Index	NOUN	O	O
(BI)	NOUN	O	O
scale,	NOUN	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
All	DET	O	O
outcomes	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
10	NUM	O	O
weeks	NOUN	O	O
treatment.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials	NOUN	O	O
ChiCTR-INR-16008863	NOUN	O	O
(Date	PUNCT	O	O
of	ADP	O	O
registration:	NOUN	O	O
20	NUM	O	O
July	NOUN	O	O
2016).	NOUN	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
a	DET	O	O
nootropic	ADJ	O	O
spearmint	NOUN	O	O
extract	NOUN	O	O
on	ADP	O	O
reactive	ADJ	O	B-outcome
agility	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled,	NOUN	O	O
parallel	ADJ	O	O
trial.	NOUN	O	O

Aerosp	NOUN	O	O
Med	NOUN	O	O
Hum	NOUN	O	O
Perform.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101147696	NUM	O	O

Two	NUM	O	O
operative	ADJ	O	O
procedures	NOUN	O	O
were	VERB	O	O
evaluated;	NOUN	O	O
a	DET	O	O
fascia	NOUN	O	O
lata	NOUN	O	O
allograft	NOUN	O	O
and	CCONJ	O	O
an	DET	O	O
autologous	ADJ	O	O
gracilis	NOUN	O	O
graft.	VERB	O	O

Journal-Name:Medicine	NOUN	O	O

METHODS::	NOUN	O	O
Five	NUM	O	O
therapeutic	ADJ	O	O
radiographers	NOUN	O	O
contoured	VERB	O	O
the	DET	O	O
prostate	NOUN	O	O
individually	ADV	O	O
on	ADP	O	O
CT,	NOUN	O	O
T2	NOUN	O	O
weighted	VERB	O	O
(T2W)	NOUN	O	O
and	CCONJ	O	O
T2*	NOUN	O	O
weighted	VERB	O	O
(T2*W)	NUM	O	O
imaging	VERB	O	O
for	ADP	O	O
10	NUM	O	O
patients.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101578780	NUM	O	O

These	DET	O	O
have	VERB	O	O
been	VERB	O	O
shown	VERB	O	O
to	PART	O	O
be	VERB	O	O
immunogenic	ADJ	O	O
and	CCONJ	O	O
safe	ADJ	O	O
in	ADP	O	O
European	NOUN	O	O
children;	NOUN	O	O
however,	ADV	O	O
their	ADJ	O	O
immunogenicity	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
have	VERB	O	O
not	ADV	O	O
been	VERB	O	O
investigated	VERB	O	O
among	ADP	O	O
Korean	NOUN	O	O
children.	NOUN	O	O

Antimicrobial	ADJ	O	O
photodynamic	ADJ	O	O
therapy	NOUN	O	O
(aPDT)	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
widely	ADV	O	O
used	VERB	O	O
with	ADP	O	O
very	ADV	O	O
satisfactory	ADJ	O	O
results	NOUN	O	O
in	ADP	O	O
the	DET	O	O
health	NOUN	O	O
sciences.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2017/11/15	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Recovery	NOUN	O	O
of	ADP	O	O
TOFr	NOUN	O	O
from	ADP	O	O
0.25	NUM	O	O
to	PART	O	O
0.75	NUM	O	O
and	CCONJ	O	O
from	ADP	O	O
0.25	NUM	O	O
to	PART	O	O
0.9	NUM	O	O
was	VERB	O	O
longer	ADJ	O	O
in	ADP	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
rocuronium	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
those	DET	O	O
treated	VERB	O	O
with	ADP	O	O
cisatracurium	NOUN	O	O
(both	NOUN	O	O
P	NOUN	O	O
<.001).	NUM	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

The	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
morphine	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
was	VERB	O	O
not	ADV	O	O
statistically	ADV	O	O
significant	ADJ	O	O
for	ADP	O	O
the	DET	O	O
PCM	NOUN	O	O
+	SYM	O	O
IBU	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
HS-PCM	NOUN	O	O
+	SYM	O	O
IBU	NOUN	O	O
(8	NOUN	O	O
mg	NOUN	O	O
[99.6%	NOUN	O	O
CI,	NOUN	O	O
-2	NUM	O	O
to	PART	O	O
16];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.005)	PUNCT	O	O
or	CCONJ	O	O
for	ADP	O	O
the	DET	O	O
PCM-alone	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
IBU	NOUN	O	O
alone	ADJ	O	O
(10	NOUN	O	O
mg	NOUN	O	O
[99.6%	NOUN	O	O
CI,	NOUN	O	O
-2	NUM	O	O
to	PART	O	O
16];	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.004)	PUNCT	O	O
after	ADP	O	O
adjustment	NOUN	O	O
for	ADP	O	O
multiple	ADJ	O	O
comparisons	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
co-primary	ADJ	O	O
outcomes.	ADJ	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
repeated	VERB	O	O
measures	NOUN	O	O
ANOVA	NOUN	O	O
revealed	VERB	O	O
significant	ADJ	O	O
time-dependent	ADJ	O	O
increases	NOUN	O	O
in	ADP	O	O
plasma	NOUN	O	O
epinephrine	NOUN	O	B-outcome
(E)	NUM	O	I-outcome
and	CCONJ	O	O
norepinephrine	NOUN	O	B-outcome
(NE)	NOUN	O	I-outcome
at	ADP	O	O
I2	NOUN	O	O
only	ADV	O	O
in	ADP	O	O
the	DET	O	O
CA	NOUN	O	O
+	SYM	O	O
C	NOUN	O	O
trial	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05),	NUM	O	O
and	CCONJ	O	O
a	DET	O	O
significant	ADJ	O	O
decrease	NOUN	O	O
in	ADP	O	O
blood	NOUN	O	O
glucose	NOUN	O	B-outcome
at	ADP	O	O
I2	NOUN	O	O
in	ADP	O	O
the	DET	O	O
PLA	NOUN	O	O
trial	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05);	NUM	O	O
however,	ADV	O	O
no	DET	O	O
meaningful	ADJ	O	O
changes	NOUN	O	O
in	ADP	O	O
glucose	NOUN	O	B-outcome
was	VERB	O	O
observed	VERB	O	O
following	VERB	O	O
CA	NOUN	O	O
+	SYM	O	O
C	NOUN	O	O
ingestion.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/07/27	ADV	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
repellent	NOUN	O	O
delivered	VERB	O	O
through	ADP	O	O
village	NOUN	O	O
health	NOUN	O	O
volunteers	NOUN	O	O
on	ADP	O	O
malaria	NOUN	O	B-outcome
incidence	NOUN	O	O
in	ADP	O	O
villages	NOUN	O	O
in	ADP	O	O
South-East	NOUN	O	O
Myanmar:	NOUN	O	O
a	DET	O	O
stepped-wedge	NOUN	O	O
cluster-randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
protocol.	NOUN	O	O

Journal-Name:Cornea	NOUN	O	O

The	DET	O	O
likelihood	NOUN	O	O
for	ADP	O	O
cost-effectiveness,	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
a	DET	O	O
willingness	ADP	O	O
to	PART	O	O
pay	NOUN	O	O
50,000	NUM	O	O
USD	NOUN	O	O
per	ADP	O	O
QALY,	NOUN	O	O
was	VERB	O	O
0.77-1.00.	PUNCT	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
other	ADJ	O	O
6	NUM	O	O
secondary	ADJ	O	O
outcomes.	ADJ	O	O

and	CCONJ	O	O
1	NUM	O	O
y,	NOUN	O	O
with	ADP	O	O
pronounced	VERB	O	O
differences	NOUN	O	O
for	ADP	O	O
the	DET	O	O
dimensions	NOUN	O	O
general	ADJ	O	B-outcome
health	NOUN	O	I-outcome
and	CCONJ	O	O
mental	ADJ	O	B-outcome
health	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
mental	ADJ	O	B-outcome
component	NOUN	O	O
summary	NOUN	O	O
score	NOUN	O	O
(all	PUNCT	O	O
p	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
caplacizumab	NOUN	O	O
needed	VERB	O	O
less	ADV	O	O
plasma	NOUN	O	B-outcome
exchange	NOUN	O	I-outcome
and	CCONJ	O	O
had	VERB	O	O
a	DET	O	O
shorter	ADJ	O	O
hospitalization	NOUN	O	B-outcome
than	ADP	O	O
those	DET	O	O
who	ADP	O	O
received	VERB	O	O
placebo.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
LBW	NOUN	O	O
protocol	NOUN	O	O
can	VERB	O	O
avoid	NOUN	O	O
iodine	NOUN	O	O
overdosing	VERB	O	B-outcome
,	PUNCT	O	O
especially	ADV	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
high	ADJ	O	O
BMI.	NOUN	O	O

OBJECTIVES:	NOUN	O	O
We	PRON	O	O
describe	NOUN	O	O
a	DET	O	O
research	NOUN	O	O
protocol	NOUN	O	O
and	CCONJ	O	O
lessons	NOUN	O	O
learned	VERB	O	O
from	ADP	O	O
a	DET	O	O
partnership	NOUN	O	O
between	ADP	O	O
Johns	NOUN	O	O
Hopkins	NOUN	O	O
Health	NOUN	O	O
System	NOUN	O	O
and	CCONJ	O	O
11	NUM	O	O
CBOs.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101125284	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
a	DET	O	O
composite	NOUN	O	O
of	ADP	O	O
objectively	ADV	O	O
confirmed	VERB	O	O
proximal	ADJ	O	B-outcome
deep-vein	NOUN	O	I-outcome
thrombosis	NOUN	O	I-outcome
in	ADP	O	Seperator
a	DET	O	Seperator
lower	ADJ	O	I-outcome
limb	NOUN	O	I-outcome
,	PUNCT	O	O
pulmonary	ADJ	O	B-outcome
embolism	NOUN	O	I-outcome
,	PUNCT	O	O
symptomatic	ADJ	O	B-outcome
deep-vein	NOUN	O	I-outcome
thrombosis	NOUN	O	I-outcome
in	ADP	O	Seperator
an	DET	O	Seperator
upper	ADJ	O	I-outcome
limb	NOUN	O	I-outcome
or	CCONJ	O	O
distal	ADJ	O	B-outcome
deep-vein	NOUN	O	I-outcome
thrombosis	NOUN	O	I-outcome
in	ADP	O	Seperator
a	DET	O	Seperator
lower	ADJ	O	I-outcome
limb	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
venous	ADJ	O	I-outcome
thromboembolism	NOUN	O	I-outcome
and	CCONJ	O	O
was	VERB	O	O
assessed	VERB	O	O
up	ADP	O	O
to	PART	O	O
day	NOUN	O	O
180.	NOUN	O	O

The	DET	O	O
subsequent	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
bupivacaine	NOUN	O	O
was	VERB	O	O
determined	VERB	O	O
by	ADP	O	O
the	DET	O	O
improved	VERB	O	O
up-down	VERB	O	O
allocation	NOUN	O	O
method.	NOUN	O	O

Participants	NOUN	O	O
(55%	PUNCT	O	O
female)	NOUN	O	O
consumed	VERB	O	O
50	NUM	O	O
g	NOUN	O	O
whey	NOUN	O	O
(WPI;	NUM	O	O
active)	ADJ	O	O
or	CCONJ	O	O
soy	ADJ	O	O
protein	NOUN	O	O
isolate	VERB	O	O
(SPI;	NOUN	O	O
control)	NOUN	O	O
for	ADP	O	O
eight	NUM	O	O
weeks.	NOUN	O	O

Australian	ADJ	O	O
adults	NOUN	O	O
(N	PUNCT	O	O
=	SYM	O	O
1132)	NOUN	O	O
aged	VERB	O	O
18-24	NUM	O	O
years	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
via	ADP	O	O
a	DET	O	O
national	ADJ	O	O
online	ADP	O	O
panel.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101153626	NUM	O	O

Physical	ADJ	O	O
exercise	NOUN	O	O
remains	NOUN	O	O
a	DET	O	O
potentially	ADV	O	O
useful	ADJ	O	O
adjunct	ADP	O	O
therapy	NOUN	O	O
in	ADP	O	O
CD.	NOUN	O	O
[	PUNCT	O	O

PMID:	NOUN	O	O
31596415	NUM	O	O

CONCLUSIONS:	NOUN	O	O
L-Methylfolate	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
no	DET	O	O
change	NOUN	O	O
in	ADP	O	O
efficacy	NOUN	O	O
on	ADP	O	O
measures	NOUN	O	O
relevant	ADJ	O	O
to	PART	O	O
neuropsychiatric	ADJ	O	B-outcome
function	NOUN	O	I-outcome
in	ADP	O	O
adults	NOUN	O	O
with	ADP	O	O
ADHD,	ADJ	O	O
other	ADJ	O	O
than	ADP	O	O
suggestion	NOUN	O	O
of	ADP	O	O
reduced	VERB	O	O
efficacy	NOUN	O	O
of	ADP	O	O
methylphenidate.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/17	NOUN	O	O
06:00'	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
sustained	VERB	O	O
abstinence	NOUN	O	B-outcome
for	ADP	O	O
1	NUM	O	O
year,	ADV	O	O
which	ADP	O	O
was	VERB	O	O
validated	VERB	O	O
biochemically	ADV	O	O
at	ADP	O	O
the	DET	O	O
final	ADJ	O	O
visit.	NOUN	O	O

Increases	NOUN	O	O
in	ADP	O	O
serum	NOUN	O	O
creatinine	NOUN	O	B-outcome
levels	NOUN	O	O
of	ADP	O	O
0.5	NUM	O	O
mg	NOUN	O	O
or	CCONJ	O	O
more	ADV	O	O
per	ADP	O	O
deciliter	NOUN	O	O
(>/=40	NUM	O	O
mumol	NOUN	O	O
per	ADP	O	O
liter)	NOUN	O	O
above	ADP	O	O
baseline	NOUN	O	O
occurred	VERB	O	O
in	ADP	O	O
7.0%	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
plazomicin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
4.0%	NOUN	O	O
in	ADP	O	O
the	DET	O	O
meropenem	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
Adjunctive	ADJ	O	O
Use	PUNCT	O	O
of	ADP	O	O
Low-Level	NUM	O	O
Laser	NOUN	O	O
Therapy	NOUN	O	O
and	CCONJ	O	O
Photodynamic	ADJ	O	O
Therapy	NOUN	O	O
After	ADP	O	O
Scaling	VERB	O	O
and	CCONJ	O	O
Root	ADJ	O	O
Planing	VERB	O	O
in	ADP	O	O
Patients	NOUN	O	O
with	ADP	O	O
Chronic	ADJ	O	O
Periodontitis.	NOUN	O	O

It	PRON	O	O
is	VERB	O	O
currently	ADV	O	O
unknown	VERB	O	O
whether	ADP	O	O
these	DET	O	O
unilateral	ADJ	O	O
deficits	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
corrected	VERB	O	O
by	ADP	O	O
a	DET	O	O
standard	ADJ	O	O
bilateral	ADJ	O	O
strength	NOUN	O	O
training	VERB	O	O
intervention.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
AmBisome	NOUN	O	O
monotherapy	NOUN	O	O
and	CCONJ	O	O
AmBisome	NOUN	O	O
and	CCONJ	O	O
miltefosine	NOUN	O	O
combination	NOUN	O	O
to	PART	O	O
treat	NOUN	O	O
visceral	ADJ	O	O
leishmaniasis	NOUN	O	O
in	ADP	O	O
HIV	NOUN	O	O
co-infected	VERB	O	O
patients	NOUN	O	O
in	ADP	O	O
Ethiopia.	NOUN	O	O

L(-	NOUN	O	O
1);	NOUN	O	O
betaA2:	NOUN	O	O
9.2	NUM	O	O
+/-	SYM	O	O
1.1	NUM	O	O
mmol.	NOUN	O	O

Journal-Name:Clinical	ADJ	O	O
interventions	NOUN	O	O
in	ADP	O	O
aging	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
changes	NOUN	O	O
of	ADP	O	O
Self-rating	VERB	O	O
depression	NOUN	O	B-outcome
scale	NOUN	O	O
(SDS)	PUNCT	O	O
and	CCONJ	O	O
self-rating	VERB	O	O
anxiety	NOUN	O	B-outcome
scale	NOUN	O	O
SAS	NUM	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
three	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
compared,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
changes	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
SOD	NOUN	O	O
and	CCONJ	O	O
MDA	NOUN	O	O
were	VERB	O	O
detected	VERB	O	O
by	ADP	O	O
immunoenzyme-linked	VERB	O	O
adsorption	NOUN	O	O
for	ADP	O	O
comparative	ADJ	O	O
analysis.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
The	DET	O	O
assessment	NOUN	O	O
of	ADP	O	O
pelvis	NOUN	O	O
reposition	NOUN	O	O
exercise	NOUN	O	O
efficacy	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
pelvic	ADJ	O	O
floor	NOUN	O	O
muscles	NOUN	O	O
(PFM)	PUNCT	O	O
asymmetry.	VERB	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
split-mouth	NOUN	O	O
and	CCONJ	O	O
randomized	VERB	O	O
controlled	VERB	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
aesthetical	ADJ	O	O
impacts	NOUN	O	O
of	ADP	O	O
EMD	NOUN	O	O
application	NOUN	O	O
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
SCTG+CAF	NUM	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
Miller's	NOUN	O	O
Class	NOUN	O	O
I	NUM	O	O
and	CCONJ	O	O
II	NUM	O	O
gingival	ADJ	O	O
recessions	NOUN	O	O
in	ADP	O	O
contralateral	ADJ	O	O
canines	NOUN	O	O
of	ADP	O	O
the	DET	O	O
maxilla.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101090633	NUM	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
management	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
esophageal	ADJ	O	O
variceal	ADJ	O	O
bleeding	VERB	O	O
remains	NOUN	O	O
a	DET	O	O
clinical	ADJ	O	O
challenge.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

The	DET	O	O
number	NOUN	O	O
of	ADP	O	O
mature	ADJ	O	B-outcome
follicles	NOUN	O	I-outcome
and	CCONJ	O	O
cervical	ADJ	O	B-outcome
mucus	NOUN	O	I-outcome
score],	NUM	O	O
follicular	ADJ	O	B-outcome
development	NOUN	O	I-outcome
rate	NOUN	O	O
and	CCONJ	O	O
single	ADJ	O	B-outcome
follicle	NOUN	O	I-outcome
ovulation	NOUN	O	I-outcome
rate,	NOUN	O	O
cycle	NOUN	O	B-outcome
pregnancy	NOUN	O	I-outcome
rate,	NOUN	O	O
early	ADJ	O	B-outcome
miscarriage	NOUN	O	I-outcome
rate,	NOUN	O	O
ovulation	NOUN	O	B-outcome
rate,	NOUN	O	O
endometrial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
,	PUNCT	O	O
positive	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
three	NUM	O	B-outcome
lines	NOUN	O	I-outcome
sign	ADV	O	I-outcome
,	PUNCT	O	O
follicle	NOUN	O	B-outcome
stimulating	VERB	O	I-outcome
hormone	NOUN	O	I-outcome
level	NOUN	O	O
and	CCONJ	O	O
luteinizing	VERB	O	B-outcome
hormone	NOUN	O	I-outcome
level	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/22	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
3-year	NOUN	O	O
assessment	NOUN	O	O
included	VERB	O	O
45	NUM	O	O
conical	ADJ	O	O
interface	NOUN	O	O
(CI),	ADJ	O	O
34	NUM	O	O
flat-to-flat	NOUN	O	O
interface	NOUN	O	O
(FI),	PUNCT	O	O
and	CCONJ	O	O
32	NUM	O	O
platform-switched	VERB	O	O
interface	NOUN	O	O
(PS)	NOUN	O	O
implants	NOUN	O	O
in	ADP	O	O
111	NUM	O	O
participants.	NOUN	O	O

Localization	NOUN	O	B-outcome
accuracy,	NOUN	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
and	CCONJ	O	O
difficulty	NOUN	O	B-outcome
in	ADP	O	O
postoperative	ADJ	O	O
seeking	VERB	O	O
for	ADP	O	O
pathological	ADJ	O	O
specimens	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
these	DET	O	O
2	NUM	O	O
groups.	NOUN	O	O

6.9%	NOUN	O	O
reported	VERB	O	O
feeling	VERB	O	O
down,	ADJ	O	O
depressed	VERB	O	O
or	CCONJ	O	O
hopeless	ADV	O	O
in	ADP	O	O
the	DET	O	O
past	NOUN	O	O
2	NUM	O	O
weeks.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
points	NOUN	O	O
were	VERB	O	O
composite	NOUN	O	O
cure	NOUN	O	B-outcome
(	PUNCT	O	O
clinical	ADJ	O	B-outcome
cure	NOUN	O	I-outcome
and	CCONJ	O	Seperator
microbiologic	ADJ	O	I-outcome
eradication	NOUN	O	I-outcome
)	PUNCT	O	O
at	ADP	O	O
day	NOUN	O	O
5	NUM	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
test-of-cure	NOUN	O	O
visit	NOUN	O	O
(15	PUNCT	O	O
to	PART	O	O
19	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
initiation	NOUN	O	O
of	ADP	O	O
therapy)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
microbiologic	ADJ	O	O
modified	VERB	O	O
intention-to-treat	NOUN	O	O
population.	ADV	O	O

In	ADP	O	O
addition,	NOUN	O	O
subjects	NOUN	O	O
were	VERB	O	O
monitored	VERB	O	O
for	ADP	O	O
eligible	ADJ	O	O
and	CCONJ	O	O
ineligible	ADJ	O	O
criteria.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
endpoint	NOUN	O	O
was	VERB	O	O
cumulative	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
chronic	ADJ	O	B-outcome
graft-versus-host	ADV	O	I-outcome
disease	NOUN	O	I-outcome
(cGVHD)	NOUN	O	I-outcome
at	ADP	O	O
2	NUM	O	O
years.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
The	DET	O	O
application	NOUN	O	O
of	ADP	O	O
OPEP	NOUN	O	O
device	NOUN	O	O
during	ADP	O	O
the	DET	O	O
perioperative	ADJ	O	O
period	NOUN	O	O
was	VERB	O	O
valuable	ADJ	O	O
in	ADP	O	O
decreasing	VERB	O	O
pulmonary	ADJ	O	B-outcome
complications	NOUN	O	I-outcome
and	CCONJ	O	O
enhancing	VERB	O	O
recovery	NOUN	O	B-outcome
for	ADP	O	O
lung	NOUN	O	O
cancer	NOUN	O	O
patients	NOUN	O	O
receiving	VERB	O	O
VATS	NOUN	O	O
lobectomy.	NOUN	O	O

Mean	NOUN	O	O
wear	ADJ	O	B-outcome
durations	NOUN	O	I-outcome
were	VERB	O	O
8.78	NUM	O	O
hours	NOUN	O	O
a	DET	O	O
day	NOUN	O	O
in	ADP	O	O
the	DET	O	O
PT	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
12.38	NUM	O	O
hours	NOUN	O	O
in	ADP	O	O
the	DET	O	O
FT	NOUN	O	O
group.	VERB	O	O

Using	VERB	O	O
a	DET	O	O
theory-based	VERB	O	O
approach,	NOUN	O	O
we	PRON	O	O
hypothesized	VERB	O	O
that	ADP	O	O
learning	VERB	O	O
acceptance	NOUN	O	O
skills	NOUN	O	O
in	ADP	O	O
mindfulness	ADV	O	O
interventions	NOUN	O	O
helps	ADJ	O	O
people	NOUN	O	O
notice	NOUN	O	O
more	ADV	O	O
positive	ADJ	O	O
experiences	NOUN	O	O
in	ADP	O	O
daily	ADJ	O	O
life,	ADJ	O	O
and	CCONJ	O	O
tested	VERB	O	O
whether	ADP	O	O
removing	VERB	O	O
acceptance	NOUN	O	O
training	VERB	O	O
from	ADP	O	O
mindfulness	ADV	O	O
interventions	NOUN	O	O
would	VERB	O	O
eliminate	NOUN	O	O
intervention-related	VERB	O	O
boosts	NOUN	O	O
in	ADP	O	O
positive	ADJ	O	O
affect.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
management	NOUN	O	O
of	ADP	O	O
complex	NOUN	O	O
orthopedic	ADJ	O	O
infections	NOUN	O	O
usually	ADV	O	O
includes	NOUN	O	O
a	DET	O	O
prolonged	VERB	O	O
course	NOUN	O	O
of	ADP	O	O
intravenous	ADJ	O	O
antibiotic	ADJ	O	O
agents.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
cardiac	ADJ	O	O
surgery	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
general	ADJ	O	O
clinical	ADJ	O	O
data	NOUN	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
including	VERB	O	O
gender,	NOUN	O	O
gestational	ADJ	O	O
age,	NOUN	O	O
birth	NOUN	O	O
weight,	NOUN	O	O
age,	NOUN	O	O
5-minute	NOUN	O	O
neonatal	ADJ	O	O
asphyxia	NOUN	O	O
score	NOUN	O	O
(Apgar	NOUN	O	O
score),	NOUN	O	O
score	NOUN	O	O
for	ADP	O	O
neonatal	ADJ	O	O
acute	ADJ	O	O
physiology	NOUN	O	O
perinatal	ADJ	O	O
extension	NOUN	O	O
version	NOUN	O	O
II	NUM	O	O
(SNAPPE	NOUN	O	O
II)	NOUN	O	O
were	VERB	O	O
collected.	NOUN	O	O

A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101303164	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0372541	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

CONCLUSION:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
a	DET	O	O
strong	ADJ	O	O
correlation	NOUN	O	O
between	ADP	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
and	CCONJ	O	O
TOFr	NOUN	O	O
during	ADP	O	O
recovery	NOUN	O	O
from	ADP	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

Secondary	ADJ	O	O
endpoints:	NOUN	O	O
longitudinal	ADJ	O	O
HIV	NOUN	O	B-outcome
viral	ADJ	O	I-outcome
load	NOUN	O	I-outcome
,	PUNCT	O	O
T	NOUN	O	B-outcome
cell	NOUN	O	I-outcome
counts	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
mass	NOUN	O	I-outcome
index	NOUN	O	I-outcome
(BMI)	PUNCT	O	I-outcome
,	PUNCT	O	O
middle-upper-arm	NOUN	O	B-outcome
circumference	NOUN	O	I-outcome
(MUAC)	NUM	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
25(OH)D(3)	NOUN	O	B-outcome
levels	NOUN	O	O
in	ADP	O	O
plasma.	NOUN	O	O

Patients	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
improved	VERB	O	O
significantly	ADV	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
Barthel	PROPN	O	O
index	NOUN	O	O
(BI)],	NOUN	O	O
elbow	NOUN	O	B-outcome
range	NOUN	O	I-outcome
of	ADP	O	I-outcome
motion	NOUN	O	I-outcome
(ROM)	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
elbow	NOUN	O	B-outcome
muscles	NOUN	O	I-outcome
strength	NOUN	O	I-outcome
.	PUNCT	O	O
However,	ADV	O	O
muscle	NOUN	O	B-outcome
tone	NOUN	O	I-outcome
in	ADP	O	O
elbow	NOUN	O	O
joint	NOUN	O	O
of	ADP	O	O
the	DET	O	O
hemiplegic	ADJ	O	O
upper	ADJ	O	O
extremity	NOUN	O	O
improved	VERB	O	O
significantly	ADV	O	O
after	ADP	O	O
SMV	NOUN	O	O
only	ADV	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(SPT-SMV).	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
UGPRF	NOUN	O	O
may	VERB	O	O
benefit	NUM	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
FS	NOUN	O	O
after	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
treatment.	NOUN	O	O

Electronic	ADJ	O	O
randomization	NOUN	O	O
was	VERB	O	O
undertaken,	ADJ	O	O
with	ADP	O	O
group	NOUN	O	O
allocation	NOUN	O	O
concealed	VERB	O	O
using	VERB	O	O
opaque,	ADV	O	O
sealed	VERB	O	O
envelopes.	NUM	O	O

At	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
12-month	NOUN	O	O
follow-up,	ADP	O	O
ocular	ADJ	O	O
exams	NOUN	O	O
for	ADP	O	O
trachoma	NOUN	O	B-outcome
,	PUNCT	O	O
ocular	ADJ	O	O
swabs	NOUN	O	O
for	ADP	O	O
detection	NOUN	O	O
of	ADP	O	O
chlamydial	ADJ	O	B-outcome
DNA	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
finger	NOUN	O	O
prick	NOUN	O	O
blood	NOUN	O	O
for	ADP	O	O
analysis	NOUN	O	O
of	ADP	O	O
anti-chlamydial	ADJ	O	B-outcome
antibody	NOUN	O	I-outcome
were	VERB	O	O
taken.	NOUN	O	O

